<SEC-DOCUMENT>0001792044-23-000017.txt : 20230508
<SEC-HEADER>0001792044-23-000017.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508160416
ACCESSION NUMBER:		0001792044-23-000017
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		112
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viatris Inc
		CENTRAL INDEX KEY:			0001792044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				834364296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39695
		FILM NUMBER:		23897665

	BUSINESS ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317
		BUSINESS PHONE:		(724) 514-1465

	MAIL ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Upjohn Inc
		DATE OF NAME CHANGE:	20191023
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>vtrs-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:4f7b9844-2b6e-46d6-b212-7616af324858,g:ca8e76fc-c8f0-4b96-ac37-00e89e4a2911,d:4aaf90299ead4f42aa5d7a1f46495b27--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:vtrs="http://www.viatris.com/20230331" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vtrs-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl80LTEtMS0xLTE1MjIwOQ_c0fa964f-18e7-425e-ac20-4f12ed1227c3">0001792044</ix:nonNumeric><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl83LTEtMS0xLTE1MjIwOQ_5069c068-7fb8-42f5-b9bf-40d1da0c2ba1">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl84LTEtMS0xLTE1MjIwOQ_3e9e1e0a-45fa-482f-80b8-57557909dbe4">2023</ix:nonNumeric><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl85LTEtMS0xLTE1MjIwOQ_5e46700d-6a3f-438e-8493-1007cad52271">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl8xMC0xLTEtMS0xNTIyMDk_326b6bc0-8a19-49ba-a1ff-269901e6536b">12/31</ix:nonNumeric><ix:nonNumeric contextRef="if734110c24414049836d43cd6a8c0b78_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTUyOQ_2c493640-95e1-4300-976d-938a30e9093d">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vtrs-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ia5d1e0b219ef415a908da6f31c85ce7d_I20230503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c20f38e954342feab4c7bcbfd900aa8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e08bc84193b4903b33772dc3585c892_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i8bb079be9f2d4c24819ae36c2b302e6d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i418126eb87c5476d8026496585618173_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a67a90d54547af9bc6e44f907032d6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d5b3231d1f2486e8776063341b0d566_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9440af4fd7ba4f0897656b04de8153dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8081836e4984486b7ec3a50c02a9559_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic447b8cafe1b4bf6a2da44f4d2a51964_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cc0d13e968f4d37b19959f0bd920ba7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3c5ed2af71e43d5ae5bf2d744c4be2a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9327c5d38c14a729ad52d76d711896b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i642a69b7eb80475580b6dfe8e7de979e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c7059ab4614911998f86f4b745dea0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f24a7f585704f55918c29eab904acb3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-17</xbrli:startDate><xbrli:endDate>2023-03-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i561d51a7e3784b178fe2847410f076e4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06f4f79c2ca443ba927ddb45fabccf40_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11b6d5faae2a48a18b3efb5b7931433d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b279406fb1545e4a9b41bef21012362_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6bcf9a93f5b44e6adf971fc8c993b9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f829281a5504ccaaf32eb2afd8061d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee68d18c353b4a1bbbe750b60203792b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12dff40a692c45c8b91c8911ee689533_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5cca97d09754ca0bea07369d3464420_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1ed98849f874127b2a3dc2dc4a7df89_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i391ee8214e954c59b805e6ec8a55bdd2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57b79d768af5428b9e726a123ceb19b9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id99e77e7afb3472d9a21cf0bc27a911a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7921bbbcfff48129188154f61fc9281_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ecb1e1f965b4571b9238fdf9bb67f7b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica08d82424e74ae4a9d160bbc2691906_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8e5c94cf86d4321a4e0a9f4c01d3c24_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id19bcca8b59e49f9bd2243c802592021_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i704078a8122d4548985aecc73b821530_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92922c90fca14d05bf112c8f1126b7cc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7512eaf443a41ad8f1edd112dd540e0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fb2e0a0aa064c1d96030296b9432c85_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3eb96c8f3584c52bfaa3c801011fdac_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife01b67ec63f4327b09c466ff8b6394b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc5e3ed0cebd408f8ab74c7381532a00_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeb5e53a9f0d46b782ce87d07e4fbac4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa88d983842143b5bccdb89bcd185908_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibba322c953c54a6a9a2cc16a92d69055_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e611f955781478d9ef741924e6d669b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacdce5f01a244464a3cad307e21ef9b6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f4ad7a4e06444cd91270a3c5d11af96_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie98262c314234c0dada44293b3622bd2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff6f2a14b0ce43ab83b734dd64d12bf6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fe5245728a44cb18a87377e4c3de0c8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i717ccb375e6a4e1a88e76775cf3a0015_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id962b30d667e44d79767fd8e3799bc1d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38d981aefd18465fa3436254a0f36c4f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d994597d6e1416a86a2c96f63285849_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e03815fe4df401db12f5e4fed5d678b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39b03de3e86b414dbeb9fb6d61078f2e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbf905bb0a554b358d94dd2e66066fd6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ff2c602eaa44eccb62f90e702abbf78_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i971cc687ee2a4eb99860d0f9c63905b5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8a81007b4bc4e578d7d99563ce6d1da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a00915b25a548e6a59fb781b78db94f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c3c8f8610e944e9b5a18cae61033feb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5215e33461184efabc64594166dddbc7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44a92534985b4fa8a89210f1ef780e8f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib17e1e4ae1dc41f4910694c744638d06_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5874f6fd7aa4dae89158ea58919c58f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a4e2f9b5b0d48b8b618be462d213bb5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09ea4f3f734d40279fcbeea57318b608_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44dcb2e059604510889393247056ff68_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37f11f4d488d4d6b8d1b2a5657ed7bd8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8791ebb35b584298bcab2b2bcfa56d9d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63daf2f5870d4537b44c66577922f2e0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eedbf09d08e4fe2b98d92fe6d16ed90_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i035a8072fe08425aa2db4bf6f2f43f08_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54a5abed27e41d198391fc5eb34c417_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1d94644d7ec4cacb1adf2ab3a5a74b4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa045f9e59554b078d808553a9e85eb4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7813ac9a34bc41109808afe80308fb10_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34b5947dc7a24798afe8946af5790adb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e7b222b3a924b69bb5ce8f834eadfae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a9412e767ac487189d1ecb36b20b8da_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ca2f2f3badd41a5a8b132f9bfeca53a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0665158c01343f5a7c7b1f984e8ac2f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b785c729ea46afa207062149ec382a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4f3a9d5832c47df837ef0c77371bc0b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i258aad0139aa41dea358da8a65ba8ee9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4bf34b1589a4aff9e5ca7af9d52fc39_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib00afe9957bb4659a032e5d0aa0e7fde_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cf83d236a5d43429ebd63458e92e95a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6627a856378146a885c26dac6939f5c4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5973b7e40c443749f09dd0bc3830976_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief173fc589434105b1a87eaf65f45ef2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06c43c95288348ae8a9480b0bb2345f6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64d037b97410486e8dc70388130c2a7a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2637a3b77344ad6bf7fc87e0c624aa0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia605839e071b4886950912140c4508cd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34306124574e4ff48c6728b14b8379a4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23fd6ab670e74679987bf4ab0632302b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3881f88980d444c98a395628ac04a37d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4918a7af8b94d9fa608eb50e7d397be_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibafb46da05ec4f79a412ebc6f057d351_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55285f970c3f4df4babe369127a8eb7e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dd48064c677421ca76bbbd5f64574f3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89dba480a3de4cda97573dc8978499c0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="right"><xbrli:measure>vtrs:right</xbrli:measure></xbrli:unit><xbrli:context id="ie6948cc281cf4adbac2e6725c137289c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">vtrs:ProductRightsAndLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8137e6d5778e45d7ac3a688bd6c289d4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">vtrs:ProductRightsAndLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ad3994dc65d497295612fdbd82d203a_D20230103-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-03</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icce36ab95a904a348f3538311028617b_D20221107-20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:FamyLifeSciencesAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-07</xbrli:startDate><xbrli:endDate>2022-11-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7828558df2f6496fabe44db31c95df87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">vtrs:ViatrisIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i978bcc6ddcd84e688fa210aa490cfa7b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:FamyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39ea09d1bb094c10861e55e7f13a92d8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:FamyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eb64dc34ecb4aa689649d663412eff2_I20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:FamyLifeSciencesAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i996c937d9d5d48bda3c5200c4b48c99f_I20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:FamyLifeSciencesAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2de5309c551f46c095be838450a8464a_I20241231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:FamyLifeSciencesAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia674853b0e45470192385b041b369637_I20221129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-29</xbrli:startDate><xbrli:endDate>2022-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5675703bf7c4d4d9da547d52dcba0ae_D20240101-20241231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i038641544e90455d9e0b031976fcd4f7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b2491c72c1440ca895b054425f97641_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92b7b3d4e0c941a592801ccaf3b5a117_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf62a3adcc2b4c4c84b6baf6c88c9459_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InventoriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c3140d7b1784dea88bd3908f0f56a43_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29d41bac887c45c4a70ffcc400a93b6a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f1f9e0ec712462aa02e10848d2f65c0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddf72d19b27c4e84b44267057cabd078_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib44a8bb4acc54d0893dec83f4f70479a_I20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaabcbd4e36f64c80a1d3a99c36f4e4b9_D20201116-20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-16</xbrli:startDate><xbrli:endDate>2020-11-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38b4ae4464494ecba320ebadb2cf078b_I20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if734110c24414049836d43cd6a8c0b78_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1eb88e565a848ebb8dc702db55d4f88_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc3bcc18e42c4bd1a5362ab466d46293_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6be2e59be8047b5bdb3bca88fdac9b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79133970a2b34e65b4753f058974244f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c529f37c6a8452daf8c5630c4b137dc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a6b105d683e44f1b695dbd0fdd19afa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f1530fe010f4d8283807e9da9561509_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1af79b8021fc47028b95741c1cc39d78_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dea885604594444a89c859250a37b79_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfd05d1cfff54696a4f01f4ac88a2938_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05e11cf9ad644b68af5c0ac002a0b693_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i203edc74353240bcb584d5be70ab7977_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie899de488efe457d85cdd16eebe2e01a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i622683f47bb4406a81794008b13dda9d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5dd0738d5ad4d438464fda8015cbfc8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccaac04969444cd0ac6e71b631cc378d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie37168f0983848249b7f1e89a1acb5bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefd395d7495640418781dfc639bb703c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aaabd86415e4b8c9c1cbaa20a6ed1e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf65b15f46464ee7bcba67fd57306449_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vtrs:PrivateEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i494e53d7c58e4d6584c23bf2ff9bfdde_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vtrs:PrivateEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife9befdab44e4072aed4aebf4c9a7ee7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93a2d261bfaa44f3a3567fe550854179_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1b9374126f5469796e980e745fabbf4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e2ad85211354ff6a1843c453c13ec41_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icabcde1e2ac34fc091515c433c41ff7c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc8794cd5f5a45ab8724cd054ea59719_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4564ffd038a447684a267ff28783411_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14e5adad79794593a0ea10be84abb721_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7752f8ef2694f2a99cedc3a924ac6ed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic37bdf396cbd4497bee0629253c5ed9c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibce300835f6a4dfb8c87fe6f01d94e1f_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44a168ceffc44ea799955f726965f1d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2da830898fd40bb9b3668c5d10555ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc04d16f571a462c997b93a923f5bc5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2d05d24b3984c6196b0e4b79ecd82ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cd4d116cadd4b549d18354ea24d6cf5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba15018bb1de4cb0a89b3428e670872a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcf87e3010d4446e9ea5180d2ecfef7e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b51c9edce9241cf9e636f46dacbbb52_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24c5aa3032494e489c927959f359a259_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23d68b002f394987b51c9b480def8689_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7adead5a097460c92b6ed763747d384_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia03f8b88b0e846a5a2bdd752c26504f1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic982925cfce647cf82de79117dfbd341_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1f049b3f11b4f54b61c23025e02cd69_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbe3333f61454c84aa7ec708e22cf50c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="ie396961017544da680998993a54500ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica7ce119b71f4c0f84b95edb750bd215_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i885ad38fc2be452e97695525e6721fa0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c21320592b2492982ea12b7c9ddd364_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic304f109b5af446bba86e77735791f79_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a2b9e568d104103be8e6c431eeddd69_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a47696467454d118794e701966eb0aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib05ddeb5d86c4f4cbb3686204e71d481_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57bb0ac7d16846ecaeeda10a472323ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8965fb764557415db2ad30aa82c09452_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a888a26f4245358cf12889162baef1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19cf17be970444d4845ad42cb06b2677_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f1a8fa6fa4437c9bd8dd8ddc85d818_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e3d152425d4436f82b8f359ed8c09f4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="ib0852b77d93a45c1a8784b9f5e09c74a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3e1cb3c13a143b689debc78a157f9c9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32bb170f1dbc494785245d5ad91eba44_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb5d765ee12a43d8989fbf61ed0f5502_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id328c8b356cb438ba2e2f88139f233d0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4da6cef7335b4e4db5c63ae8d42c311a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95612143e25a4851b2e592fb2c3a2107_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9f6de36f5e14d028a657fc060b5a560_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c95a99b1fb14d86b6a9b89d594cce92_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d16ca0470534939982b3b58e635e4cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76576107d9424efab6ea88538bb83135_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56d3bcc8d2474192926ed306031b5219_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a79042b83904696b7dab397210c97de_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41550c188ad64365a22d3f4a47fc1c72_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb5fda2dcee4ee48e405c5c088a9cba_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa16117507db4c7d96b63dc143d74a16_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6aaffa691e74bc68e8db4464b4b93b0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i033455f156d34be29697cc8ac9e0a137_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2d01ba8a140497580deaf3d68bc57c6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c134b8f719242bcac28ad4399b788eb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib20e6f463286430596383180d843d2b3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id19bc1f2778e4b71aa630ae6b6490e7f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff39c4924c6045ef84e3abaad48f1286_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib09b7735438346cf9ab1c042bed96f76_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb50b90a095f42bfbdbed451dae7f23a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i727faafb4659486cb209f1a14a62e389_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i136bafc75ccd449baf4eeb49e8ed395c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102e0cf7ff2044a6938b0f83e352bb2d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39da740d7a5e4e9cad2bd54f10ce8b8d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb432e1314914336835cf836fe99ecf1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f3e2b23886947408f9c609cccaed1aa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i270cf7b9b34147cdaf4584be4a06eb92_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d5fffc549546b2a7f21ebeacd3566a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bf9a42591eb4cefaba32caf3d775d3d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4d0ff8e2db44ce9ae2f1ca09cfc8552_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i643ad899563b4c6287162649c1da7644_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0450507d0a453d85394a568087e78a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i008ef5af2daf4f18a58c19dbec22403d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df571154fb44e9dbe311072fe73af02_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc9395cd9b914745ac220a1b31c0d019_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cfb2649e55847359386336e4a39492b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b47320bd11d4ba6a393be87cd0c63dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26f62ce70fb445afa3148d671d5ebd33_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69dfbf841e784966a9622614817e595e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id230763240ed4c6c83ac699f54873ca3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic78bfd7523094db7ac5361c6c822eb32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9607c4d62444cf687b9b06b8559c927_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica8cc0295da54b078e56ab7384f33b40_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ea89f8fb0aa40198430e003e80835d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fb8b8df80f6437d9eb2ba03e638b416_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1131eca694994821b250886968225201_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b1cf6b0039a4e34bf81064509086ca1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc9b2995dd46460594e214fd8e8ee132_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee880d6bc130465f829292543ad30b02_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1fa0b36fa9a43ebb31730df132d5260_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if59e5e36fb7b445db0598c8c22d1736c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf2bf973f8224e918b2deff514202349_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i805aacd5cf1a4ce1ba773d8974bb6661_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if318bfa8c5bc43749fd2a6b351b2adc5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16bd0a431ac944bbadbc94516ff5579b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i527c9f5ddc6248d0bd4ecaeb320cfeab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2b328e8ff4e4db3903e428de1caf104_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fa49fa66d4a4ec1b6581ce013ff9335_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:NoteSecuritizationFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i537b244fd18e4182836b3cbcea192aa1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e90d47f433640e2bf15e3caa1252192_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf8243d3d2554b6d9cea845ed1d5d62a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d844dcfe611431e8c69a0bffa93ef38_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13546a349b7f46fa8d08aa0489cd82e4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if92b069c1f4e4856b8df4e367b12a543_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d3557139bf74fa9bdae809541e470fc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b39ad011d3c4a15991d1d4ee3f647c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3836b4fcf19c4f2da97d1cb2617e47f0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dd73adf36414a74a4252d27d4ca70ec_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13c7fadd2634767b990dc153d4bc9d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72f0ba982f0c46649f0f6561954343f1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1054d206503b46788f1af5e9ce6beaf3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86b93357479f4e96a4acc48b266c2ec1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb18dcdcc883404780abde6cf47443fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if358ae2472cf4162861457de119d795e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39cd72e6c89f4d72b882807ad54849a4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8e8bd4e2ae64bfbab3cac97c001f7ac_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i857e28cb283b4b62abcfcd309a7a0760_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9b1ab43a7b04663ade5cdd52c52abf3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i172d496acb304a198d699f43d147eb23_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fd1128fe8054c7ea24c3e527cc585e4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d043725e3814483b6471de9237a3773_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i854b8e342187430ea79336139d6db506_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c9b36997fe44efb8dfe9e0f82e471b0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a7ccd82fc9d47beaf2c85dbe5315393_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia583e565814b4727be66c81be6c677f8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b643f05917e4cadba7092929694b6d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c494b24b67e4b878e564a8146c3138e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f77f20d41cc4b8bbc1a3e3b098cc442_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41482c056aa94a55925d9dcd2e1b6b43_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4051ef5b1fdb4486882771f6cbe8ec88_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01e123519fbc4c39860f273c6d6d3ed5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a6ac2dc615d4e66b3bb6dfa9566e439_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0efddbd5dd4e48c7acdd24a96aa2380e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i645867315f0942119eafce9860005bd7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80b3a71a4e4048318317277ea1c7419c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i523192e82a694962b8a599b8e7f560b7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ef5520b9a764945b96e8cea3b80abeb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i151b130c785b49219e6112e1742e9cfa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54e64fcf3dd741b4ab858d4916d39201_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5552e043c1c444cc88e4f40941845034_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69039fe5d46240fa8529c57fdfe22935_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf2097e990594c218bca3f144aca2453_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c9f8feb05d94562b542bb89be4c3aec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45165edb089b40d0b8b4833405ea227b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d5c20c94e5f427e8b1f4cc452481487_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie091a09167a34a0fa7933475fb2de76d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6164435f803841129e7672cc12bb4100_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b9dbb9ff801489ba2f6837aa806ff2d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c7eb919fe344f70963ed690e633c735_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9bb674e162c40018526646782e70d3f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88989aa1d54540a1ba2ca6eb8ea846f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie700760d8134451a9ff6e163dcbd5a13_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5b5d8f65e7443a99c925d594d0cd6eb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bbf2add3a0c4216b0a8608247495af6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac9ac025fb9047918980605e59a944c5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcee7fb1e8624576b13773ba17f2f11f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb3b8082108848a18225ef4298c3618f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i653a14a89cb24d7c952dd0cdd3772c49_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2d9f4048943460b9f1afbb1f59b8dda_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9dbeed2d83b425eb1378354668ce7a1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87f32bd065ca46ffa60c567a5d2f9e1c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05e33061fbdd49b7968f96b8dd318a25_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8618f25668574c53b1ce780bdda393cd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i086be58c57004badb55c1e1264fe37ea_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19242480fa2943ffb4a03206eee18d1a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8647ea8c4a242b99d262a0ac976d962_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c3760f0cea642d3b75f6140cdf414f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e1a1cbd2814cdfb45518b14ca40fa2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica5b623ff3fa4a61a5c7435e3ab00ba1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b1995c57b4f49c3801e36a80fd70ceb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cbade31da7d415f8970e976b4686580_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ab095d0d7984d658aad5fc11e1e6f28_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i328661c86aa84ea7b204b4667f8a7ffb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fdf7ff53f764505aa2b21fa6a270f0f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1cc5ed71d974468b6ff290b943426c5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ae943df1fa3437894a62abc523b173a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34bb0ea6145343a2bc5c0602b02aeb12_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71aa5d94a6b94d69adfd79846798fdc1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia036fdd378d343f684dfc8d7b749bf36_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafb16f84e2694f219ad64bdc9fb4f90c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa100fdde39948c2bacf727a7f77eb4f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c4e86dc90d4fc8958401ed6a97dee9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie33127a010dd40c8adcfde67ca93dc7e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ddcf29ff66b4e319b5952469cb3a1fe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3e40190a3504890bf2e78ce510c754c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c64ee065eb44f80bd6e5ddda1a2f52d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f6070629af342578a23395267253ebb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib982817ac2e847f5a2ae10b0747f4ea8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf01e5ae97624ffbb92ea194c400357c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d522e397a694dc085575dc00034f8a1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85d12c29bdbb4f2b854964dbfa89ef0e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i269e5c8eeb184f499dfffbeebba19832_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie69330006b9941b780f7e4587eb84648_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic684496e355c490799752193e9a06c94_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1d68edf5bdd450abcf109bdfeb786ec_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d246e7b27fa4ad99062d6f448111e0c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5991ed3dd3c4634aa50d484766705da_I20231231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58d64b894a014afbab8da8528839e18b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bc609110a8445fd8d58826fa2f1726c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i453ede63a1664e9caf4cd95c380890e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebb30913444747329b7146b7a3266a55_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idab2896257be44a2b213bb8b7d4b1350_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i596abfcb4c3b421eaf653dd8ad4d37f7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaded5ca88b1f45efbecc093436d0c031_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc862c7415b2470d87c61bb71eb23e74_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c6b422602ba4e35ad86ae076e60232b_D20230301-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7e0a31051704ab8bc38fb1032e348fd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:MultiDistrictLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53082e0db5474dbba7be7c89cd35e27e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f50d795bf3f4c409462b9ddcf0db7d9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9404440f3ab340efb47100f474f62e94_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AmendedAnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>vtrs:state</xbrli:measure></xbrli:unit><xbrli:context id="icde060aa771e4f15b2dfe00c564c524c_D20210830-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:OcularASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-30</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96a44216070c4ea3999f969059533ad8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:CitalopramLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67450c71eb624b6fa6b3ab40994faf5c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:ProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b6ee837070840fcb8fedf7b1e8f59da_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3af94b01e96b43d1b3dd129d00730688_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="healthboard"><xbrli:measure>vtrs:healthBoard</xbrli:measure></xbrli:unit><xbrli:unit id="entity"><xbrli:measure>vtrs:entity</xbrli:measure></xbrli:unit><xbrli:context id="i9823c12694d24f989d655525247c08e4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:0.5pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form&#160;<ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQx_d68dd26b-e6de-4930-874b-fa859e1987bc">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6OTAwZThkNmI5OTU1NDlhMWI4ZTkyNDAyN2MwNGRkYzIvdGFibGVyYW5nZTo5MDBlOGQ2Yjk5NTU0OWExYjhlOTI0MDI3YzA0ZGRjMl8wLTAtMS0xLTE1MjIwOQ_12c6798b-39d3-463d-bb20-09d7b636909d">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xMjM_248a01e5-f2c1-4884-9253-bfe6ede73fda">March&#160;31, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6YTEyYjA1OTNiYzNmNDlmYmExN2FmZjhkNTljZDYyNzIvdGFibGVyYW5nZTphMTJiMDU5M2JjM2Y0OWZiYTE3YWZmOGQ1OWNkNjI3Ml8wLTAtMS0xLTE1MjIwOQ_3959ea72-3b54-4e71-9ae1-521f7c6bff39">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _____________to___________ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQ1_b3728687-22af-48d4-89be-8c2de11ee99c">001-39695</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8yNDE_bc9fe65a-d7f5-453a-98eb-73e3bab90638">VIATRIS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ODQwZGYyNGNkNDBhNGE2MzljYzNmYWM0MGRlYzU1Y2UvdGFibGVyYW5nZTo4NDBkZjI0Y2Q0MGE0YTYzOWNjM2ZhYzQwZGVjNTVjZV8wLTAtMS0xLTE1MjIwOQ_6de01168-f3ed-40e3-abda-99a40d880374">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ODQwZGYyNGNkNDBhNGE2MzljYzNmYWM0MGRlYzU1Y2UvdGFibGVyYW5nZTo4NDBkZjI0Y2Q0MGE0YTYzOWNjM2ZhYzQwZGVjNTVjZV8wLTItMS0xLTE1MjIwOQ_7582a5a6-54db-4721-ab01-92ac0a6060be">83-4364296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction<br/>of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQ2_970e8e83-4ccb-4165-8750-64ac4fef0637">1000 Mylan Boulevard</ix:nonNumeric>, <ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQy_0f8f7e76-79c6-46aa-a38b-50ddd9483c8f">Canonsburg</ix:nonNumeric>, <ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQz_56a1997c-6e55-4207-a7d1-20cda5a15d79">Pennsylvania</ix:nonNumeric> <ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQ0_e31ea97b-9273-4ea4-9255-b787086bc761">15317</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml80OTQ3ODAyMzI2OTQ5_86983f2f-696a-41cd-8563-7458c352c91f">724</ix:nonNumeric>) <ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml80OTQ3ODAyMzI2OTU4_637d0583-13f0-4dda-8d1a-f456bbba2e9e">514-1800</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of Each Class:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered:</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6NTY1NjMzNjEwNDI2NDQwOTliOWM4NjhkMTE1MGVmYWQvdGFibGVyYW5nZTo1NjU2MzM2MTA0MjY0NDA5OWI5Yzg2OGQxMTUwZWZhZF8yLTAtMS0xLTE1MjIwOQ_c103a2f6-36e7-40b6-8b2d-dcfe4b116bab">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6NTY1NjMzNjEwNDI2NDQwOTliOWM4NjhkMTE1MGVmYWQvdGFibGVyYW5nZTo1NjU2MzM2MTA0MjY0NDA5OWI5Yzg2OGQxMTUwZWZhZF8yLTItMS0xLTE1MjIwOQ_8239c224-4b13-422a-92fe-767733ff05cf">VTRS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6NTY1NjMzNjEwNDI2NDQwOTliOWM4NjhkMTE1MGVmYWQvdGFibGVyYW5nZTo1NjU2MzM2MTA0MjY0NDA5OWI5Yzg2OGQxMTUwZWZhZF8yLTQtMS0xLTE1MjIwOQ_c1ae15ae-4093-400e-adb8-d4c5b650198c">The NASDAQ Stock Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQ3_71f46a32-1556-404f-86f7-b9c6a34e7b00">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTM5_435857ac-df25-4ba2-b533-3b0a3b17498f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.606%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ZmZlNjQ5Y2M4YzRlNGNkOTkwNWEwMjNiMjRhNDFhYzEvdGFibGVyYW5nZTpmZmU2NDljYzhjNGU0Y2Q5OTA1YTAyM2IyNGE0MWFjMV8wLTAtMS0xLTE1MjIwOQ_3803af6f-c6cf-41d9-89e0-f8b9b64f97a9">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ZmZlNjQ5Y2M4YzRlNGNkOTkwNWEwMjNiMjRhNDFhYzEvdGFibGVyYW5nZTpmZmU2NDljYzhjNGU0Y2Q5OTA1YTAyM2IyNGE0MWFjMV8yLTYtMS0xLTE1MjIwOQ_cf317d1f-8f96-4ba9-ae93-56b587e74d13">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ZmZlNjQ5Y2M4YzRlNGNkOTkwNWEwMjNiMjRhNDFhYzEvdGFibGVyYW5nZTpmZmU2NDljYzhjNGU0Y2Q5OTA1YTAyM2IyNGE0MWFjMV80LTYtMS0xLTE1MjIwOQ_d7ba7dc3-4a07-4f3e-bf6e-491282cdae60">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr></table></div><div style="margin-top:1pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQw_5941bb73-5725-4083-942c-39bfd1ae18c2">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of common stock outstanding, par value $<ix:nonFraction unitRef="eurPerShare" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xODkw_b767692b-e314-480b-aed9-fda5e52010ea">0.01</ix:nonFraction> per share, of the registrant as of May&#160;3, 2023 was <ix:nonFraction unitRef="shares" contextRef="ia5d1e0b219ef415a908da6f31c85ce7d_I20230503" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTM1_1964ba19-e92b-421f-af08-01807c6e2dca">1,199,029,984</ix:nonFraction>.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:2pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_4"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2023 </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;I &#8212; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Financial Statements (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_19">Condensed Consolidated Statements of Operations&#160;&#8212; Three Months Ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_19">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_19"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_19">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_19">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_19">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_22">Condensed Consolidated Statements of Comprehensive Earnings</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_22"> &#8212; Three Months Ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_22">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_22"> and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_22">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_22">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_22">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_22">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_25">Condensed Consolidated Balance Sheets&#160;&#8212; March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_25">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_25"> and December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_25">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_25">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_25">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_31">Condensed Consolidated Statements of Equity&#160;&#8212; Three Months Ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_31">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_31"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_31">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_31">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_31">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_34">Condensed Consolidated Statements of Cash Flows&#160;&#8212; Three Months Ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_34">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_34"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_34">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_34">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_34">11</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_37">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_37">12</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_106">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_106">45</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_133">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_133">60</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_136">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_136">61</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;II &#8212; OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_142">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_142">62</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_145">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_145">62</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">U</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">nregistered</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136"> S</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">ales</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136"> E</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">quity</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136"> S</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">ecurities</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">and</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136"> U</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">se</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136"> Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136">62</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_151">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_151">63</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_154">SIGNATURES</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_154">64</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_10"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glossary of Defined Terms</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Unless the context requires otherwise, references to &#8220;Viatris,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; in this Form 10-Q (defined below) refer to Viatris Inc. and its subsidiaries. We also have used several other terms in this Form 10-Q, most of which are explained or defined below. Some amounts in this Form 10-Q may not add due to rounding.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2003 LTIP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Incentive Plan</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc. 2020 Stock Incentive Plan</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Form 10-K </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; annual report on Form 10-K for the fiscal year ended December 31, 2022, as amended </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP financial measure that the Company believes is appropriate to provide information to investors - EBITDA (defined below) is further adjusted for share-based compensation expense, litigation settlements, and other contingencies, net, restructuring and other special items</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AOCE</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive earnings</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">API</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active pharmaceutical ingredient</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARV</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antiretroviral medicines</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Limited</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Biologics</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Biologics Limited, a majority owned subsidiary of Biocon</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Biologics Transaction</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The transaction between Viatris and Biocon Biologics pursuant to which Viatris contributed its biosimilars portfolio, composed of the Biocon collaboration programs, biosimilars to Humira&#174;, Enbrel&#174;, and Eylea&#174;, as well as related assets and liabilities to Biocon Biologics</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The transaction agreement between Viatris and Biocon Biologics, dated February 27, 2022, relating to the Biocon Biologics Transaction, as amended by that certain Amendment No. 1 to Transaction Agreement, dated November 28, 2022</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA Inc. and Biogen International GmbH, collectively </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination Agreement, dated as of July 29, 2019, as amended from time to time, among Viatris, Mylan, Pfizer and certain of their affiliates</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCPS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compulsory convertible preferred shares</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Competition and Markets Authority</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Code</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The U.S. Internal Revenue Code of 1986, as amended</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combination</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refers to Mylan combining with Pfizer's Upjohn Business in a Reverse Morris Trust transaction to form Viatris on November 16, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Paper Program</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $1.65 billion unsecured commercial paper program entered into as of November 16, 2020 by Viatris, as issuer, Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V., as guarantors, and certain dealers from time to time</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novel coronavirus disease of 2019</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CP Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured, short-term commercial paper notes issued pursuant to the Commercial Paper Program</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets segment</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes our operations primarily in the following markets: North America and Europe</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer's distribution to Pfizer stockholders all the issued and outstanding shares of Upjohn Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DOJ</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Department of Justice</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP financial measure that the Company believes is appropriate to provide information to investors - U.S. GAAP net earnings (loss) adjusted for net contribution attributable to equity method investments, income tax provision (benefit), interest expense and depreciation and amortization</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EDPA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. District Court for the Eastern District of Pennsylvania</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes, but is not limited to, our operations primarily in the following markets: Parts of Asia, the Middle East, South and Central America, Africa, and Eastern Europe</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERP system</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise resource planning system</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Act </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Exchange Act of 1934, as amended</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Famy Life Sciences</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Famy Life Sciences Private Limited</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form 10-Q</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This quarterly report on Form 10-Q for the quarterly period ended March 31, 2023</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Systemically Important Banks</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial institutions that are considered systemically important by the Financial Stability Board.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes our operations primarily in the following markets: China, Taiwan and Hong Kong</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gx</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic drugs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter Partes review</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Internal Revenue Service</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes our operations in the following markets: Japan, Australia and New Zealand</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">London Interbank Offered Rate</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lilly</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eli Lilly and Company</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum Leverage Ratio </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The maximum consolidated leverage ratio financial covenant requiring maintenance of a maximum ratio of consolidated total indebtedness as of the end of any quarter to consolidated EBITDA for the trailing four quarters as defined in the related credit agreements from time to time</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDL</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multidistrict litigation</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MPI</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Pharmaceuticals Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan N.V. and its subsidiaries</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Inc. U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 4.200% Senior Notes due 2023, 4.550% Senior Notes due 2028, 5.400% Senior Notes due 2043 and 5.200% Senior Notes due 2048 issued by Mylan Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan II B.V., Viatris Inc. and Utah Acquisition Sub Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Securitization</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Securitization LLC</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NASDAQ</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The NASDAQ Stock Market</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New drug application</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NHS</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Health Services</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Securitization Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The note securitization facility entered into in August 2022 for borrowings up to $200 million and expiring in August 2023</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTC</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over-the-counter</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oyster Point</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oyster Point Pharma, Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmascience Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance awards</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTAB</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Patent Trial and Appeal Board</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $400 million accounts receivable entered into in August 2020 and expiring in April 2025</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registered Upjohn Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 1.650% Senior Notes due 2025, 2.300% Senior Notes due 2027, 2.700% Senior Notes due 2030, 3.850% Senior Notes due 2040 and 4.000% Senior Notes due 2050 originally issued on October 29, 2021 registered with the SEC in exchange for the corresponding Unregistered Upjohn U.S. Dollar Notes in a similar aggregate principal amount and with terms substantially identical to the corresponding Unregistered Upjohn U.S. Dollar Notes and fully and unconditionally guaranteed by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory Delivery Platform</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer&#8217;s proprietary dry powder inhaler delivery platform</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company&#8217;s nonvested restricted stock and restricted stock unit awards, including PSUs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $4.0 billion revolving facility dated as of July 1, 2021, by and among Viatris, certain lenders and issuing banks from time to time party thereto and Bank of America, N.A., as administrative agent</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RICO</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Racketeer Influenced and Corrupt Organizations Act</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company's unvested restricted stock unit awards</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi-Aventis U.S., LLC</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Appreciation Rights</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SDNY</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. District Court for the Southern District of New York</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Act</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Act of 1933, as amended</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Upjohn U.S. Dollar Notes, the Utah U.S. Dollar Notes and the Mylan Inc. U.S. Dollar Notes, collectively</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation and Distribution Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation and Distribution Agreement between Viatris and Pfizer, dated as of July 29, 2019, as amended from time to time</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOFR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured overnight financial rate</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and SARs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teva</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teva Pharmaceutical Industries Ltd.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TSA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition services agreement</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K.</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. GAAP</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting principles generally accepted in the U.S.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unregistered Upjohn U.S. Dollar Notes</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 1.650% Senior Notes due 2025, 2.300% Senior Notes due 2027, 2.700% Senior Notes due 2030, 3.850% Senior Notes due 2040 and 4.000% Senior Notes due 2050 originally issued on June 22, 2020 by Upjohn Inc. (now Viatris Inc.) in a private offering exempt from the registration requirements of the Securities Act and fully and unconditionally guaranteed by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn Inc., a wholly owned subsidiary of Pfizer prior to the Distribution, that combined with Mylan and was renamed Viatris Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn Business</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer&#8217;s off-patent branded and generic established medicines business that, in connection with the Combination, was separated from Pfizer and combined with Mylan to form Viatris</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn Distributor Markets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Select geographic markets that were part of the Combination that are smaller in nature and in which we had no established infrastructure prior to or following the Combination and that the Company intends to divest</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes denominated in U.S. dollars and originally issued by Upjohn Inc. or Viatris Inc. pursuant to an indenture dated June 22, 2020 and fully and unconditionally guaranteed by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah Acquisition Sub</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah Acquisition Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Viatris</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 3.950% Senior Notes due 2026 and 5.250% Senior Notes due 2046 issued by Utah Acquisition Sub Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Viatris Inc. and Mylan II B.V.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc., formerly known as Upjohn Inc. prior to the completion of the Combination</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">YEN Term Loan Facility</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The &#165;40 billion term loan agreement dated as of July 1, 2021, among Viatris, the guarantors from time to time party thereto, the lenders from time to time party thereto and Mizuho Bank, Ltd., as administrative agent</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I&#160;&#8212; FINANCIAL INFORMATION</span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_16"></div><div><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited; in millions, except per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNC01LTEtMS0xNTIyMDk_17000761-29a4-4f90-827b-ccceebe898d2">3,719.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNC03LTEtMS0xNTIyMDk_5658ecea-bc13-4f2d-9200-972966aa9345">4,178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c20f38e954342feab4c7bcbfd900aa8_D20230101-20230331" decimals="-5" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNS01LTEtMS0xNTIyMDk_deed90fd-6332-4d3c-a81b-e25ac9c4c703">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e08bc84193b4903b33772dc3585c892_D20220101-20220331" decimals="-5" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNS03LTEtMS0xNTIyMDk_3be51707-5f25-44f2-acc3-a66c23e24496">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNi01LTEtMS0xNTIyMDk_f1aa26f6-1875-4cf6-8976-d6a645dceb2b">3,729.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNi03LTEtMS0xNTIyMDk_6893d9c7-3354-4914-94b8-c7a2bd6403b3">4,191.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNy01LTEtMS0xNTIyMDk_c8634575-828f-4f2f-ad3e-046668d85b4f">2,186.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNy03LTEtMS0xNTIyMDk_2f369f31-c4d0-4291-bd08-7d4d4c51aaa4">2,420.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfOC01LTEtMS0xNTIyMDk_3a3b031a-92f2-4dcb-b5db-eef60ddf92e6">1,542.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfOC03LTEtMS0xNTIyMDk_ee1f1e16-023a-40a7-8e28-3dca0bc7b869">1,771.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTAtNS0xLTEtMTUyMjA5_c3f3ca92-aa57-4acc-b7c3-8269ba7f7cf9">182.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTAtNy0xLTEtMTUyMjA5_f9225dc4-df20-4396-8e39-0afedf570c11">142.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTEtNS0xLTEtMTUyMjA5_78215b6b-da87-4d0c-b5a7-b32abd0f34e7">958.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTEtNy0xLTEtMTUyMjA5_1bddaeea-c60a-4531-8be1-c193a75b040f">915.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTItNS0xLTEtMTUyMjA5_ab6d72ec-69cc-4db0-984f-125f39afcf78">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTItNy0xLTEtMTUyMjA5_c600d748-f47b-45c4-8003-c364fd0d955a">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTMtNS0xLTEtMTUyMjA5_d8c3ae61-8fc4-4137-a235-f83023c559dd">1,142.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTMtNy0xLTEtMTUyMjA5_fbe71d41-19e8-4a0f-9e60-1a20c03ed349">1,063.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTQtNS0xLTEtMTUyMjA5_4c132279-daa6-4c15-bf65-5f795671c67c">399.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTQtNy0xLTEtMTUyMjA5_713315c2-c131-4e2f-9b53-b7b94bff61b1">707.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTUtNS0xLTEtMTUyMjA5_4a98061c-a597-446f-807f-08000d5a316c">147.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTUtNy0xLTEtMTUyMjA5_fb5eb2b7-8949-4d27-af1c-d748313e0946">146.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTYtNS0xLTEtMTUyMjA5_418dea8e-734c-4be0-b337-9fc5f527721c">69.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTYtNy0xLTEtMTUyMjA5_d0226d9a-e212-4081-9f09-92ffeb7f726d">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTctNS0xLTEtMTUyMjA5_f2870882-8bf5-45e5-a5d1-cccce90db054">322.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTctNy0xLTEtMTUyMjA5_bccf82d9-ade5-475a-9a1b-8535f3aa4cfd">527.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTgtNS0xLTEtMTUyMjA5_48a306d6-d0b6-466d-95f0-8a1a9df80be4">98.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTgtNy0xLTEtMTUyMjA5_7ae0e6e3-4ddb-4299-abbb-f2f58878717e">128.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTktNS0xLTEtMTUyMjA5_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6">224.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTktNy0xLTEtMTUyMjA5_21ea8900-812e-42b1-bf29-832a88880c0e">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjEtNS0xLTEtMTUyMjA5_b57155b6-1e81-4877-a9e2-adcfc9db994c">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjEtNy0xLTEtMTUyMjA5_1e207442-ce21-48af-b38c-5170d93323b4">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjItNS0xLTEtMTUyMjA5_104acf74-a55e-4f80-ac07-90fab44094c9">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjItNy0xLTEtMTUyMjA5_39a5ebcb-0a0d-4937-9096-0d039e67dc79">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjQtNS0xLTEtMTUyMjA5_76debc38-3b8b-4b93-8a36-50dd70c3cf6e">1,202.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjQtNy0xLTEtMTUyMjA5_8b2d6b6a-6b95-4e9e-9bf5-53ff40cf0d67">1,210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjUtNS0xLTEtMTUyMjA5_dd88b844-0992-4cd0-9a61-cd5b49709139">1,205.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjUtNy0xLTEtMTUyMjA5_2aeae296-7ab9-4f06-abb6-c0e092257af6">1,213.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div><div><span><br/></span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Earnings</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited; in millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMy01LTEtMS0xNTIyMDk_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6">224.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMy03LTEtMS0xNTIyMDk_21ea8900-812e-42b1-bf29-832a88880c0e">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, before tax:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNS01LTEtMS0xNTIyMDk_6b4adaf8-69a8-4177-b683-4f837752f139">45.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNS03LTEtMS0xNTIyMDk_e66e09a7-d9e2-4f5a-a547-0707b731f3d7">469.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized gain (loss) and prior service cost related to defined benefit plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNi01LTEtMS0xNTIyMDk_e5432901-7173-49af-92fb-e181d8718758">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNi03LTEtMS0xNTIyMDk_93d28aa4-6ad2-4709-a89f-cadaa39f4b17">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain on derivatives in cash flow hedging relationships</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bb079be9f2d4c24819ae36c2b302e6d_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNy01LTEtMS0xNTIyMDk_9ad950b7-e7ee-4e17-ba1c-aaa155472292">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i418126eb87c5476d8026496585618173_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNy03LTEtMS0xNTIyMDk_5f44b323-343b-4bac-8349-914965a712fd">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized (loss) gain on derivatives in net investment hedging relationships</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5a67a90d54547af9bc6e44f907032d6_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfOC01LTEtMS0xNTIyMDk_eb04e2b8-a49a-4c0c-8f41-d82bfbf4ce62">66.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d5b3231d1f2486e8776063341b0d566_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfOC03LTEtMS0xNTIyMDk_a922f9d0-5f81-483b-9cc5-ee694a19581e">201.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain (loss) on marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfOS01LTEtMS0xNTIyMDk_6f7f4815-3f77-4e7b-9040-66bb5748a1f6">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfOS03LTEtMS0xNTIyMDk_8f0b55eb-3981-4090-8ba3-f023445dd3fd">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, before tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTAtNS0xLTEtMTUyMjA5_f15e7980-6cc3-4a58-bf19-63f8e4a8b6c7">15.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTAtNy0xLTEtMTUyMjA5_6c7618f4-591b-4bd7-9cb9-569105d4502e">272.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) provision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTEtNS0xLTEtMTUyMjA5_2e44be18-974f-4d05-b0a6-27c3905f1c5c">12.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTEtNy0xLTEtMTUyMjA5_38f2a03e-ed15-45d2-bf95-2fdfe6d96231">44.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTItNS0xLTEtMTUyMjA5_0b503fc1-2141-4ad1-bc8b-9ca4bf212fc8">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTItNy0xLTEtMTUyMjA5_ff37b494-4346-451b-84d4-ee6d09ad05b4">316.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTMtNS0xLTEtMTUyMjA5_55b0e3c1-d325-47e8-acf0-365808a02ff4">221.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTMtNy0xLTEtMTUyMjA5_0ae66880-0a04-483c-af9f-8074b8bb3603">82.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div><div><span><br/></span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited in millions, except share and per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">ASSETS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNC0xLTEtMS0xNTIyMDk_74f28a0b-8f02-40c1-9459-50fa1a806160">506.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNC0zLTEtMS0xNTIyMDk_4e8a328d-64b7-42b6-87e0-5599999a0433">1,259.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNS0xLTEtMS0xNTIyMDk_8e743497-9f70-4491-b3e8-4f23bbb17afe">3,497.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNS0zLTEtMS0xNTIyMDk_ab3addb2-ebe3-44bf-a6ec-d7b0a5f3aebb">3,814.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNi0xLTEtMS0xNTIyMDk_3d96e1d8-f0a9-4c40-8955-35f110717429">3,664.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNi0zLTEtMS0xNTIyMDk_a5a69ec4-bbf2-4c33-8bfe-3d0b243106a6">3,519.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNy0xLTEtMS0xNTIyMDk_7f54f218-bf3f-4b33-b846-6f2f1e015738">1,763.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNy0zLTEtMS0xNTIyMDk_0df26cb5-b41e-400c-a0bf-7aba3364c9c7">1,811.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfOC0xLTEtMS0xNTIyMDk_88157663-16a2-48c0-9810-5ef79b999670">198.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfOC0zLTEtMS0xNTIyMDk_12f3206a-1193-4789-8679-e7d2c256f8ec">230.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfOS0xLTEtMS0xNTIyMDk_229e6415-422f-4af9-ad88-540bbfd1bbef">9,630.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfOS0zLTEtMS0xNTIyMDk_966583e7-3ee4-470f-87f4-193826581897">10,635.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTAtMS0xLTEtMTUyMjA5_50d20b92-ddb5-4986-884b-0a67870fd2ca">3,007.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTAtMy0xLTEtMTUyMjA5_ea87fbb3-ef71-4558-a771-e6c1e00d63b6">3,024.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTEtMS0xLTEtMTUyMjA5_1b9176d6-9608-4da6-88fb-9c1773c0d74a">22,701.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTEtMy0xLTEtMTUyMjA5_1d404bce-2277-4405-9b92-86064d6e9983">22,607.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTItMS0xLTEtMTUyMjA5_70b58e1f-a670-4fd6-ade6-fd789b1eeea6">10,573.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTItMy0xLTEtMTUyMjA5_ca93f983-6642-4986-ae11-89cc560a8709">10,425.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTMtMS0xLTEtMTUyMjA5_98389ee0-b4b9-4da8-a52b-e8f69512ebe7">959.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTMtMy0xLTEtMTUyMjA5_4fb85a01-9eb7-4f25-871b-4c1d1f6f63a2">925.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTQtMS0xLTEtMTUyMjA5_a1a0dc9a-f0c7-448c-9b93-595dde5a7e97">2,418.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTQtMy0xLTEtMTUyMjA5_9810154f-5307-4282-b2ec-04a827cc4da7">2,403.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTUtMS0xLTEtMTUyMjA5_84d76a61-ef16-4d73-87ce-db7af6b8e7f4">49,290.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTUtMy0xLTEtMTUyMjA5_a946338b-3873-404c-b056-59fd74dca459">50,022.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjAtMS0xLTEtMTUyMjA5_2909fd6b-1f09-4623-8d68-ce746d6efa00">1,957.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjAtMy0xLTEtMTUyMjA5_6a546eb3-1b9a-4017-b910-c8b5895d68ad">1,766.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjEtMS0xLTEtMTUyMjA5_9ec82bdd-ead5-4135-9fce-67c318295659">204.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjEtMy0xLTEtMTUyMjA5_597f9227-eadf-4d4c-b6ed-c04368c429f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjItMS0xLTEtMTUyMjA5_05e6e7d2-a80c-4549-9272-8070e0991c69">244.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjItMy0xLTEtMTUyMjA5_652c24f7-239e-46e9-9cfe-86393d731e8e">279.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt and other long-term obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjMtMS0xLTEtMTUyMjA5_5c653bd5-5f20-4921-a591-2d04897225d6">508.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjMtMy0xLTEtMTUyMjA5_e6d6582a-7385-40fd-b74d-7a8010b0e7a6">1,259.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjUtMS0xLTEtMTUyMjA5_95c77a53-7718-4f1a-9bf8-37f31ccd1ba3">3,192.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjUtMy0xLTEtMTUyMjA5_d13949e9-fe7b-45ef-a497-da9fabba9014">3,440.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjYtMS0xLTEtMTUyMjA5_64f316ff-7404-4963-a131-2f3b1d23af7f">6,108.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjYtMy0xLTEtMTUyMjA5_edb96c39-18cb-4019-87d3-defdf981deda">6,746.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjctMS0xLTEtMTUyMjA5_014ee4f0-8d76-4f7d-b2d3-73bdbc237c78">18,069.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjctMy0xLTEtMTUyMjA5_22ba4421-2fbb-4f0a-9abb-3dc5f2cc9048">18,015.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjgtMS0xLTEtMTUyMjA5_f585c12d-79a8-43c4-be88-884f9935efc1">2,465.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjgtMy0xLTEtMTUyMjA5_0b77a448-97ac-47ef-8acc-2657d303cd76">2,432.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjktMS0xLTEtMTUyMjA5_04b5a2a1-0eb5-477c-b3b0-8456beba7252">1,719.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjktMy0xLTEtMTUyMjA5_14d901d3-3924-4d76-ae67-1dddf8ca026a">1,756.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzAtMS0xLTEtMTUyMjA5_47b9d8fd-5846-4ad1-8769-c58864aa0df0">28,362.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzAtMy0xLTEtMTUyMjA5_4c6bab85-4971-4f7b-a7a8-2408644b5e6d">28,949.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc. shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="eurPerShare" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246ZmY0MGFhYTIzZGQ2NDEyZmI2NGNmNzQzNDc4OGM0ZGJfMTg_b767692b-e314-480b-aed9-fda5e52010ea">0.01</ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246ZmY0MGFhYTIzZGQ2NDEyZmI2NGNmNzQzNDc4OGM0ZGJfMzI_3463e3c2-3db5-4b1b-a84d-685831f1c8bd">3,000,000,000</ix:nonFraction> shares authorized; shares issued: <ix:nonFraction unitRef="shares" contextRef="ic8081836e4984486b7ec3a50c02a9559_I20230331" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246ZmY0MGFhYTIzZGQ2NDEyZmI2NGNmNzQzNDc4OGM0ZGJfODU_f58ca5ae-7e6d-4ea0-b643-693c9d93216a">1,220,224,204</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic447b8cafe1b4bf6a2da44f4d2a51964_I20221231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246ZmY0MGFhYTIzZGQ2NDEyZmI2NGNmNzQzNDc4OGM0ZGJfOTI_a4ef9a21-7675-4144-ab61-28a3f88477cf">1,213,793,231</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMS0xLTEtMTUyMjA5_7a394caa-2052-43b4-ae4f-274368a24d9f">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMy0xLTEtMTUyMjA5_4e9e8cf1-13f5-4023-8f92-5e29d791269b">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzQtMS0xLTEtMTUyMjA5_4a4ab3f9-b21a-4332-9d84-b6da92681b8c">18,679.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzQtMy0xLTEtMTUyMjA5_2f176414-36c1-404f-9c17-f4821fdd7b71">18,645.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzUtMS0xLTEtMTUyMjA5_7207fd75-559c-4538-899c-227dfefadab6">5,252.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzUtMy0xLTEtMTUyMjA5_1d3a7214-bdff-4ec9-a876-5955903d66a2">5,175.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzYtMS0xLTEtMTUyMjA5_7aada9a8-b7a4-4e4e-a047-f7908ceb5c7e">2,764.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzYtMy0xLTEtMTUyMjA5_3bb63c4d-4aa6-4b1c-93e2-70ba0bf1eccd">2,761.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="vtrs:StockholdersEquityParentBeforeTreasuryStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzctMS0xLTEtMTUyMjA5_46277ec1-0158-4774-a83b-5c3743c61fb7">21,179.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="vtrs:StockholdersEquityParentBeforeTreasuryStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzctMy0xLTEtMTUyMjA5_a4f78067-8496-4631-ada8-2257d9eb8fcb">21,072.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Treasury stock &#8212; at cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock shares: <ix:nonFraction unitRef="shares" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDAtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246NTBiNDkyYmYzZmYyNDcyNWIyMjIzZmQwNDU2MGNjZmNfNTQ5NzU1ODEzOTgy_4deabfab-8301-480a-a4a3-53cf44b7e800">21,239,521</ix:nonFraction> as of March 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDAtMS0xLTEtMTUyMjA5_eda466f6-266a-4181-9ea7-0bfff33ef9b7">251.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:TreasuryStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDAtMy0xLTEtMTUyMjA5_50a70577-0443-4a64-b4e9-0086f2a792d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDEtMS0xLTEtMTUyMjA5_07ab2797-cad7-4b12-b969-f9fe93571e3b">20,927.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDEtMy0xLTEtMTUyMjA5_c2990a83-2e17-4d58-b4bb-f895a9bab478">21,072.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDMtMS0xLTEtMTUyMjA5_c7f4f49f-3c0d-44e5-9974-b8b5fda8ad6c">49,290.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDMtMy0xLTEtMTUyMjA5_eb590cea-74e4-4f8b-8fed-178e0b659ac6">50,022.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div><div><span><br/></span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Equity</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited; in millions, except share and per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.675%"><tr><td style="width:1.0%"></td><td style="width:37.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic447b8cafe1b4bf6a2da44f4d2a51964_I20221231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMS0xLTEtMTUyMjA5_a4ef9a21-7675-4144-ab61-28a3f88477cf">1,213,793,231</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic447b8cafe1b4bf6a2da44f4d2a51964_I20221231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMy0xLTEtMTUyMjA5_63e5b4b7-35d2-47a1-8499-5a68fcbf1c08">12.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc0d13e968f4d37b19959f0bd920ba7_I20221231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktNS0xLTEtMTUyMjA5_c6bb591e-b844-4435-be00-57f7bc7afb38">18,645.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c5ed2af71e43d5ae5bf2d744c4be2a_I20221231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktNy0xLTEtMTUyMjA5_db98d51c-6bbf-44b3-a707-071545856fd4">5,175.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktOS0xLTEtMTUyMjA5_f7b8b8a2-b6a1-46fa-9e29-7ae5ad87e590">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:TreasuryStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMTEtMS0xLTE1MjIwOQ_92156671-e3cb-4afa-96d4-d9c39f127577">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9327c5d38c14a729ad52d76d711896b_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMTMtMS0xLTE1MjIwOQ_d70a9283-0ff5-4e00-947c-0ec93336b993">2,761.2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMTctMS0xLTE1MjIwOQ_c2990a83-2e17-4d58-b4bb-f895a9bab478">21,072.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjAtNy0xLTEtMTUyMjA5_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6">224.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjAtMTctMS0xLTE1MjIwOQ_553fa887-7c39-4ec6-9abb-349826e9c8cd">224.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i642a69b7eb80475580b6dfe8e7de979e_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjEtMTMtMS0xLTE1MjIwOQ_471366e7-1894-4321-b055-ea7e27fe835e">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjEtMTctMS0xLTE1MjIwOQ_32226617-4a03-4955-9609-522031930e04">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock and stock options exercised, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i30c7059ab4614911998f86f4b745dea0_D20230101-20230331" decimals="INF" name="vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjItMS0xLTEtMTUyMjA5_682e8eec-bc4f-4a16-8e84-ba537076de4b">6,350,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c7059ab4614911998f86f4b745dea0_D20230101-20230331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjItMy0xLTEtMTUyMjA5_ef693c03-3281-439e-9b01-6068838fc225">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjItNS0xLTEtMTUyMjA5_64a43314-0b51-4981-8e52-e81373da311f">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjItMTctMS0xLTE1MjIwOQ_438db115-8236-4c3d-a770-1322de20dc2f">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes related to the net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjMtNS0xLTEtMTUyMjA5_5e1bb2b0-7b47-4065-b1c4-1dbf20413e9a">19.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjMtMTctMS0xLTE1MjIwOQ_99e44fe4-2d9b-4790-8e6e-751363b94e5f">19.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjQtNS0xLTEtMTUyMjA5_5179174e-e710-4e97-8972-26b2e982f3f7">42.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjQtMTctMS0xLTE1MjIwOQ_0176d2d5-9e2f-473b-8923-2d7ea42a64bf">42.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4f24a7f585704f55918c29eab904acb3_D20230101-20230331" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjYtOS0xLTEtMTUyMjA5_1accb056-fa21-439b-8ed3-6636b175f0a6">21,239,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f24a7f585704f55918c29eab904acb3_D20230101-20230331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjYtMTEtMS0xLTE1MjIwOQ_4d51e25b-5b5e-4e63-9349-7d153020b252">251.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjYtMTctMS0xLTE1MjIwOQ_8827abca-c52b-4ca2-80de-04629a2e3586">251.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i30c7059ab4614911998f86f4b745dea0_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjgtMS0xLTEtMTUyMjA5_1002c98e-4a4a-4cfe-8043-83bd425dae01">80,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjgtNS0xLTEtMTUyMjA5_e2903a20-29b8-4972-9c39-5fae05d4b50e">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjgtMTctMS0xLTE1MjIwOQ_b2572043-3cfd-4763-963a-6f34f581a78b">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjktMC0xLTEtMTUyMjA5L3RleHRyZWdpb246YTNkY2JjMTU5YWViNGNiMjljMWU5NGMwMzEwMDEwMTVfNTQ5NzU1ODEzOTQ1_11ef565d-0cdf-43aa-8520-ab4cf2058a99">0.12</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561d51a7e3784b178fe2847410f076e4_D20230101-20230331" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjktNy0xLTEtMTUyMjA5_1615374d-4caf-4409-958c-6a5e02a7dd6a">147.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjktMTctMS0xLTE1MjIwOQ_73b525d6-3282-4d98-9b90-a0e9728e92e9">147.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzAtNS0xLTEtMTUyMjA5_560c5f9f-2181-4cae-91b4-e1eaf8cda670">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzAtMTctMS0xLTE1MjIwOQ_dd7a16f8-8868-4145-b63c-c247f417fdb9">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8081836e4984486b7ec3a50c02a9559_I20230331" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMS0xLTEtMTUyMjA5_f58ca5ae-7e6d-4ea0-b643-693c9d93216a">1,220,224,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8081836e4984486b7ec3a50c02a9559_I20230331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMy0xLTEtMTUyMjA5_743a2e32-73fa-41b0-83f1-a1285c585afd">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f4f79c2ca443ba927ddb45fabccf40_I20230331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtNS0xLTEtMTUyMjA5_61bab21f-0041-4afc-8e46-25d9aa0f2977">18,679.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b6d5faae2a48a18b3efb5b7931433d_I20230331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtNy0xLTEtMTUyMjA5_534aa62b-49f5-4b01-898c-d6794cb1b288">5,252.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtOS0xLTEtMTUyMjA5_4deabfab-8301-480a-a4a3-53cf44b7e800">21,239,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMTEtMS0xLTE1MjIwOQ_fd5417c5-866b-49b4-a6ae-8eeac4904d7e">251.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b279406fb1545e4a9b41bef21012362_I20230331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMTMtMS0xLTE1MjIwOQ_78b344ee-72ae-498a-9995-6520173d7cfb">2,764.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMTctMS0xLTE1MjIwOQ_07ab2797-cad7-4b12-b969-f9fe93571e3b">20,927.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.675%"><tr><td style="width:1.0%"></td><td style="width:37.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6bcf9a93f5b44e6adf971fc8c993b9b_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMS0xLTEtMTUyMjA5_3c0748c5-8960-4b13-a2e0-b37bb1e15ee7">1,209,507,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6bcf9a93f5b44e6adf971fc8c993b9b_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMy0xLTEtMTUyMjA5_f475ea06-5c68-487c-b09c-10fb5123e324">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f829281a5504ccaaf32eb2afd8061d5_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtNS0xLTEtMTUyMjA5_a452bd0f-3335-4666-9f73-28a095e7b60b">18,536.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee68d18c353b4a1bbbe750b60203792b_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtNy0xLTEtMTUyMjA5_f166d436-3825-4055-a275-f3ac3986b1bb">3,688.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12dff40a692c45c8b91c8911ee689533_I20211231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtOS0xLTEtMTUyMjA5_2ade24f2-4684-4388-967b-0d1bdfbfc3ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12dff40a692c45c8b91c8911ee689533_I20211231" decimals="-5" name="us-gaap:TreasuryStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMTEtMS0xLTE1MjIwOQ_490d0d9a-cab1-4c44-95cb-5f6bdffe8a7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5cca97d09754ca0bea07369d3464420_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMTMtMS0xLTE1MjIwOQ_75c45c2d-227e-4ddf-b762-0c9916972aa2">1,744.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12dff40a692c45c8b91c8911ee689533_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMTctMS0xLTE1MjIwOQ_2d4da9ee-2029-4039-b16c-c10e8ce6cd8d">20,492.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTktNy0xLTEtMTUyMjA5_21ea8900-812e-42b1-bf29-832a88880c0e">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTktMTctMS0xLTE1MjIwOQ_92c8ecae-5ca2-4cad-995e-39134add15f4">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1ed98849f874127b2a3dc2dc4a7df89_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjAtMTMtMS0xLTE1MjIwOQ_e48e18d1-36fc-4821-9ef0-070af25aa3d9">316.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjAtMTctMS0xLTE1MjIwOQ_3016c6d0-b343-40b8-bd0b-f570637e73ad">316.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i391ee8214e954c59b805e6ec8a55bdd2_D20220101-20220331" decimals="INF" name="vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjEtMS0xLTEtMTUyMjA5_0b1b61d1-fdde-4aad-9937-15045310739a">2,816,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57b79d768af5428b9e726a123ceb19b9_D20220101-20220331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjEtNS0xLTEtMTUyMjA5_2bf05af9-1249-402c-8cb4-8674d6f6045c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjEtMTctMS0xLTE1MjIwOQ_9b2a9652-f4de-4df1-836d-b3c59ca0123b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes related to the net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57b79d768af5428b9e726a123ceb19b9_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjItNS0xLTEtMTUyMjA5_cdbefd22-5456-4e0d-82f9-e7681928a94a">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjItMTctMS0xLTE1MjIwOQ_b4503bab-d409-456a-a7b2-6e09c9f4b167">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57b79d768af5428b9e726a123ceb19b9_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjMtNS0xLTEtMTUyMjA5_7ad4cb00-88ef-40bc-aabf-4b1106ae5ba4">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjMtMTctMS0xLTE1MjIwOQ_7664e23f-06b8-40fc-b5df-cc5a0d1c086f">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjYtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246NDk4ZDMxOTllOWUwNDQyOGE2YWVjNjcxNmM1MzM3YWNfNTQ5NzU1ODEzOTQ2_11ef565d-0cdf-43aa-8520-ab4cf2058a99">0.12</ix:nonFraction> per common share </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id99e77e7afb3472d9a21cf0bc27a911a_D20220101-20220331" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjYtNy0xLTEtMTUyMjA5_b52ece8f-e140-46d2-983c-8b83fc86339b">146.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjYtMTctMS0xLTE1MjIwOQ_a1065641-ea2b-449a-b4ed-659a453bdf31">146.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7921bbbcfff48129188154f61fc9281_I20220331" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMS0xLTEtMTUyMjA5_d0c05aea-dd16-4d3a-b252-109111824820">1,212,323,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7921bbbcfff48129188154f61fc9281_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMy0xLTEtMTUyMjA5_e888d1f9-2e9e-4e58-b945-b1e1f093bc25">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ecb1e1f965b4571b9238fdf9bb67f7b_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtNS0xLTEtMTUyMjA5_5dc85e38-6c36-46e0-ae23-090715d20863">18,555.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica08d82424e74ae4a9d160bbc2691906_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtNy0xLTEtMTUyMjA5_5e7eaf54-b86a-43c4-84a5-7c8a70b569e9">3,941.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtOS0xLTEtMTUyMjA5_ae93b6f5-81f5-4d49-8dce-e00f2a189ca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331" decimals="-5" name="us-gaap:TreasuryStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMTEtMS0xLTE1MjIwOQ_57842de1-fa8e-4e4d-a26f-a52dc383d65f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8e5c94cf86d4321a4e0a9f4c01d3c24_I20220331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMTMtMS0xLTE1MjIwOQ_e2933ee1-d459-4810-bda0-61ad08c1ecef">2,061.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMTctMS0xLTE1MjIwOQ_24aaa10b-3da6-40b1-b58c-5809281d02d2">20,447.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div><div><span><br/></span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited; in millions)</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNC0xLTEtMS0xNTIyMDk_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6">224.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNC0zLTEtMS0xNTIyMDk_4839a2dd-fa2e-469a-b533-15c2a308962b">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNi0xLTEtMS0xNTIyMDk_d68856ac-cffc-4605-ba2c-0a15731663a4">730.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNi0zLTEtMS0xNTIyMDk_efd469a2-2b37-4e60-aff5-933045265d1b">736.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNy0xLTEtMS0xNTIyMDk_c5a1c216-2e6b-4d81-b79f-1d34e5c00645">42.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNy0zLTEtMS0xNTIyMDk_0d5aa26a-47b5-4202-9119-6a140ea50469">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfOC0xLTEtMS0xNTIyMDk_77b4e5b1-957c-45c8-b7b4-335686b61efe">26.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfOC0zLTEtMS0xNTIyMDk_668a6485-5da0-4d2f-80da-44d586fff202">52.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfOS0xLTEtMS0xNTIyMDk_191c4fc3-d687-4e2e-8040-4fe4fa568156">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfOS0zLTEtMS0xNTIyMDk_f849ff6f-19a3-4fd4-b6c3-917f3834c19c">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTAtMS0xLTEtMTUyMjA5_b586c11b-3a0a-4b70-9392-b40539c7a059">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTAtMy0xLTEtMTUyMjA5_96c132b4-dfc3-45ce-8791-f1a2f94cee11">37.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="vtrs:Changeinnoncashlitigationsettlementsnet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTEtMS0xLTEtMTUyMjA5_3298ec5f-0819-43a1-ace9-bd3b2ae9a9db">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="vtrs:Changeinnoncashlitigationsettlementsnet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTEtMy0xLTEtMTUyMjA5_30f5b5ad-8296-4e32-ae81-9ed3d9352acd">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTMtMS0xLTEtMTUyMjA5_4afa3a17-d2db-48db-b527-d6cdf767921b">215.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTMtMy0xLTEtMTUyMjA5_f6957d8c-5587-4a79-a705-471e4e3e77d2">115.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTQtMS0xLTEtMTUyMjA5_f7274e95-04c0-4f1f-b123-551d3addd5c2">151.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTQtMy0xLTEtMTUyMjA5_94fb9804-fb17-4cb1-8161-1a8cad612f25">69.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTUtMS0xLTEtMTUyMjA5_d862db05-4fb8-4afd-8c7f-f04be06a0197">183.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTUtMy0xLTEtMTUyMjA5_a730633d-327c-4e63-ac28-623553585a38">30.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTYtMS0xLTEtMTUyMjA5_d1cd2567-a0db-46f5-a060-4d4e727b729d">53.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTYtMy0xLTEtMTUyMjA5_ac04c9a2-13d5-4e97-bdfe-9f5c2d066bed">67.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating assets and liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTctMS0xLTEtMTUyMjA5_5568f731-ece1-421f-ba4f-025e5096a3bf">224.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTctMy0xLTEtMTUyMjA5_244a9dbe-9429-471b-ab15-60841b70699d">132.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTgtMS0xLTEtMTUyMjA5_dedb8ea7-c5d6-483a-85a2-b214384636f1">971.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTgtMy0xLTEtMTUyMjA5_76207a31-f4ae-4d88-87a4-50c132a2c69d">1,138.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjAtMS0xLTEtMTUyMjA5_c768d388-f896-43da-b49f-d689d0f9a270">667.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjAtMy0xLTEtMTUyMjA5_479208be-282b-4d91-a515-eb6101eedcf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjEtMS0xLTEtMTUyMjA5_a1d14085-569f-446c-8756-6de1fd3045ad">47.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjEtMy0xLTEtMTUyMjA5_7baa3adb-26fa-418c-bccd-889a7c96d99d">64.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjItMS0xLTEtMTUyMjA5_4c6225fd-68e7-4051-82b7-f29d8fd1a22a">9.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjItMy0xLTEtMTUyMjA5_9661f37d-d332-4a5e-9481-23db1eb98486">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from the sale of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjMtMS0xLTEtMTUyMjA5_0b1fd09c-b8b2-47f4-9e05-f14fd6d85209">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjMtMy0xLTEtMTUyMjA5_cbf498ec-5ab5-4276-ba62-efa469fd4b37">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for product rights and other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjQtMS0xLTEtMTUyMjA5_5272eb6b-19c6-4c29-b338-9cc20acbbed1">34.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjQtMy0xLTEtMTUyMjA5_8a50393e-b9c5-42f8-b607-7bde64a39c0a">7.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from the sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjUtMS0xLTEtMTUyMjA5_af8a4b8b-6c8c-4c9d-aa29-94c5f8bf539e">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjUtMy0xLTEtMTUyMjA5_0b8bf1af-af00-48ff-aae7-b07e533966b0">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjYtMS0xLTEtMTUyMjA5_4809efc7-b9a9-4974-a6a8-e16b43a4c04b">749.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjYtMy0xLTEtMTUyMjA5_3120b76d-7604-41d0-9b89-55d79d2c5cf7">66.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjgtMS0xLTEtMTUyMjA5_ec83cc43-f26f-4f38-b74d-b485f28f7985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjgtMy0xLTEtMTUyMjA5_c4a6c95e-3ce0-46c7-8ee3-cfeb0c4d6e94">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjktMS0xLTEtMTUyMjA5_e6509cdb-7d4f-4bb2-9208-9432781a59aa">750.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjktMy0xLTEtMTUyMjA5_2b2516a8-b80e-4569-93f7-ac3e262ef82b">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzAtMS0xLTEtMTUyMjA5_9d4579f7-2649-4e25-9a73-c0898d82b044">250.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzAtMy0xLTEtMTUyMjA5_2b833327-d093-4b41-955f-9ab92dcc661e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in short-term borrowings, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzEtMS0xLTEtMTUyMjA5_19ddb301-b513-40dc-82f2-62ef078d3a91">204.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzEtMy0xLTEtMTUyMjA5_388415b3-5346-4da5-a587-e6dccab1fbc2">837.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzItMS0xLTEtMTUyMjA5_9ea89600-34db-415e-9b22-f3ad08d3b525">30.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzItMy0xLTEtMTUyMjA5_4425fbf4-9054-4022-b317-450199f9dab1">9.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzMtMS0xLTEtMTUyMjA5_64adcf7b-276c-476c-9f92-273391648154">8.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzMtMy0xLTEtMTUyMjA5_46ba8a95-b85c-4f3c-8fda-b51e743bef77">15.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of financing fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzQtMS0xLTEtMTUyMjA5_72779a72-8151-4219-8114-8583a2a7aa29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzQtMy0xLTEtMTUyMjA5_71f34dbb-07a1-4f63-9f61-554dd8c52d39">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzUtMS0xLTEtMTUyMjA5_15020c68-c22e-4d74-a0d5-1fbd41e03b5d">143.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzUtMy0xLTEtMTUyMjA5_0dcb34e2-e9f6-4533-84c3-aa69c16821b7">145.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contingent payments for product rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:PaymentsToAcquireIntangibleAssetsFinancingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzYtMS0xLTEtMTcxMzIy_14ae3681-cad1-4f3e-b360-a3c5af5be958">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="vtrs:PaymentsToAcquireIntangibleAssetsFinancingActivity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzYtMy0xLTEtMTcxMzMz_96ddaad4-c463-4c0e-8133-e3bb2da057d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzYtMS0xLTEtMTUyMjA5_bed69c80-f44f-4ace-b8aa-3ddfd51f8a85">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzYtMy0xLTEtMTUyMjA5_191ba854-56ab-40d7-b423-b6ba579dd0c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other items, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzctMS0xLTEtMTUyMjA5_32e18c98-5172-4e21-a31c-996ee919d10f">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzctMy0xLTEtMTUyMjA5_db64f04b-d6d9-49da-9be5-7ba118ed902b">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzgtMS0xLTEtMTUyMjA5_e25cf692-6d5d-483e-b4c0-3e8a011d3ea3">974.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzgtMy0xLTEtMTUyMjA5_55023a01-267f-4c85-8fd0-3b703053009f">1,009.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on cash of changes in exchange rates</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzktMS0xLTEtMTUyMjA5_1d0f60d7-240a-4828-8026-6800a7664cd3">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzktMy0xLTEtMTUyMjA5_7526e87d-6ae9-492f-9b57-03cd59de415b">11.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDAtMS0xLTEtMTUyMjA5_f7b47355-0d4e-4c0f-9f2d-c1a7de11dc48">751.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDAtMy0xLTEtMTUyMjA5_a6a02a25-f2e0-484c-9599-6256b2766203">51.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash &#8212; beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDEtMS0xLTEtMTUyMjA5_d0264ea9-21eb-45a6-aee2-24e882bf35e0">1,262.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12dff40a692c45c8b91c8911ee689533_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDEtMy0xLTEtMTUyMjA5_9d1096e6-09b3-4942-aa9a-290650001739">706.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash &#8212; end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDItMS0xLTEtMTUyMjA5_84e966c3-6510-4cae-af8e-afb8587b91f6">510.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDItMy0xLTEtMTUyMjA5_b385c28b-57f3-4ab3-abde-74673e3ecdbb">757.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div><div><span><br/></span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_37"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">                                              </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div></div><div><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_40"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180MC9mcmFnOmRjNjkyZGI1NDRjMDRmYTQ5MTA1NmVhNDIwNmRmMTJmL3RleHRyZWdpb246ZGM2OTJkYjU0NGMwNGZhNDkxMDU2ZWE0MjA2ZGYxMmZfMTY2Nw_a44b1b5a-0a00-4732-8d87-3f3cfc1255f0" continuedAt="i751ecfd6ef1e4aa7ad33189bfd0b4fdc" escape="true">General</ix:nonNumeric></span></div><ix:continuation id="i751ecfd6ef1e4aa7ad33189bfd0b4fdc"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180MC9mcmFnOmRjNjkyZGI1NDRjMDRmYTQ5MTA1NmVhNDIwNmRmMTJmL3RleHRyZWdpb246ZGM2OTJkYjU0NGMwNGZhNDkxMDU2ZWE0MjA2ZGYxMmZfMTY4MA_9a3b741f-cb0e-4ebd-ad30-5e59f160de4d" escape="true">The accompanying unaudited condensed consolidated financial statements (&#8220;interim financial statements&#8221;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto in Viatris&#8217; 2022 Form&#160;10-K. The December&#160;31, 2022 condensed consolidated balance sheet was derived from audited financial statements. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim results of operations, comprehensive earnings and cash flows for the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full fiscal year or any other future period.</span></div></ix:continuation><div id="i4aaf90299ead4f42aa5d7a1f46495b27_43"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzQwNA_5db3f0e0-b97b-432d-b359-47a28194b8e3" continuedAt="id1e42912cdd14c2e85f8abbf12c82f95" escape="true">Revenue Recognition and Accounts Receivable</ix:nonNumeric></span></div><ix:continuation id="id1e42912cdd14c2e85f8abbf12c82f95" continuedAt="id2c043fc40754474928c19c8d4c01bfe"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenues in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the condensed consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash).</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#8217;s subsequent sales or usages occur. Such consideration is included in other revenues in the condensed consolidated statements of operations.</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzQxMA_25fae66c-bb9b-4f4f-bbe7-91715d69f22a" continuedAt="iba124205a60348a3933c97d37fe5363e" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2023 and 2022, respectively:</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:37.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19bcca8b59e49f9bd2243c802592021_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi0xLTEtMS0xNTIyMDk_6a0cdd34-e7ef-47f9-9677-2fd3355a979b">1,232.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704078a8122d4548985aecc73b821530_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi0zLTEtMS0xNTIyMDk_2f038604-1968-408e-8834-ef8a4138f841">562.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92922c90fca14d05bf112c8f1126b7cc_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi01LTEtMS0xNTIyMDk_6ccdf90f-cea9-4af1-a8b0-a2f08e24f28b">190.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7512eaf443a41ad8f1edd112dd540e0_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi03LTEtMS0xNTIyMDk_edcc06f0-fadb-4706-8a7c-6c557eb1b6f2">435.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fb2e0a0aa064c1d96030296b9432c85_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi05LTEtMS0xNTIyMDk_790cf52c-e184-48d3-bf40-e12c5775bb70">2,420.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3eb96c8f3584c52bfaa3c801011fdac_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy0xLTEtMS0xNTIyMDk_846e6f30-3ab3-4b0f-b557-55d3967f31f6">129.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife01b67ec63f4327b09c466ff8b6394b_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy0zLTEtMS0xNTIyMDk_bf939d3f-3c34-4db2-90a6-520299779bd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5e3ed0cebd408f8ab74c7381532a00_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy01LTEtMS0xNTIyMDk_62c0e876-4d05-44b0-a5ca-640dd22756f7">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb5e53a9f0d46b782ce87d07e4fbac4_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy03LTEtMS0xNTIyMDk_6403c157-13d6-4f25-97cb-ab4997a870cd">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa88d983842143b5bccdb89bcd185908_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy05LTEtMS0xNTIyMDk_35f4baca-703f-4dbf-a32c-66d9f07ef445">136.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba322c953c54a6a9a2cc16a92d69055_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC0xLTEtMS0xNTIyMDk_6eb77838-4509-461e-9310-9b526fdee44c">808.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e611f955781478d9ef741924e6d669b_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC0zLTEtMS0xNTIyMDk_c5ce6df0-a1d4-4df3-a48e-bd700de6cee6">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacdce5f01a244464a3cad307e21ef9b6_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC01LTEtMS0xNTIyMDk_e4e1c969-e648-4e67-a3f6-be377daf546f">145.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4ad7a4e06444cd91270a3c5d11af96_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC03LTEtMS0xNTIyMDk_db169c91-5fd5-4631-8841-5425c2053d6b">206.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98262c314234c0dada44293b3622bd2_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC05LTEtMS0xNTIyMDk_af76a2fa-d739-4434-af58-2de9180a12b2">1,162.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6f2a14b0ce43ab83b734dd64d12bf6_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS0xLTEtMS0xNTIyMDk_25970763-f17c-4675-a1db-4f09144c8c8a">2,170.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe5245728a44cb18a87377e4c3de0c8_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS0zLTEtMS0xNTIyMDk_90db45f0-27d6-4ac3-816d-6033337c0b84">564.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717ccb375e6a4e1a88e76775cf3a0015_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS01LTEtMS0xNTIyMDk_bae695cd-d7a6-43fb-99d9-5bfd69a4a186">342.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id962b30d667e44d79767fd8e3799bc1d_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS03LTEtMS0xNTIyMDk_d927bef0-a473-41e9-bea6-e0c4cfd326ec">641.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS05LTEtMS0xNTIyMDk_17000761-29a4-4f90-827b-ccceebe898d2">3,719.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="id2c043fc40754474928c19c8d4c01bfe" continuedAt="iaa4e0ce283e7448e8c37de98e5ae84c1"><ix:continuation id="iba124205a60348a3933c97d37fe5363e" continuedAt="i47bb2f315b0e46a994e2664d966b138a"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:37.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d981aefd18465fa3436254a0f36c4f_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi0xLTEtMS0xNTIyMDk_acdd0c25-51a8-43b0-a342-3f88ade7c109">1,298.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d994597d6e1416a86a2c96f63285849_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi0zLTEtMS0xNTIyMDk_e900fad7-7ddc-4ad9-b432-927707928c3f">569.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e03815fe4df401db12f5e4fed5d678b_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi01LTEtMS0xNTIyMDk_70facf9d-08c6-4866-8613-aa719d334bc3">249.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39b03de3e86b414dbeb9fb6d61078f2e_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi03LTEtMS0xNTIyMDk_3a31bd95-266b-4fc2-bf48-db02b192d944">436.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbf905bb0a554b358d94dd2e66066fd6_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi05LTEtMS0xNTIyMDk_8b5e317d-bde2-4d34-8c9d-42c8ded743e5">2,554.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff2c602eaa44eccb62f90e702abbf78_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy0xLTEtMS0xNTIyMDk_f3fcdee2-9cb8-418f-8c06-f1cc418df2ee">364.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i971cc687ee2a4eb99860d0f9c63905b5_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy0zLTEtMS0xNTIyMDk_c96cd096-915e-4c77-bf59-21306119382d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a81007b4bc4e578d7d99563ce6d1da_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy01LTEtMS0xNTIyMDk_77ab56e2-7a49-4f70-a932-9477b67ab592">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a00915b25a548e6a59fb781b78db94f_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy03LTEtMS0xNTIyMDk_33561e5e-1b97-4972-b657-e5fe6e7acd70">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c3c8f8610e944e9b5a18cae61033feb_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy05LTEtMS0xNTIyMDk_30ccc1b9-c5d8-42f1-8ab6-0414fc1adaca">390.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5215e33461184efabc64594166dddbc7_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC0xLTEtMS0xNTIyMDk_c1e0f988-f980-432a-8997-c016168fbcca">813.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a92534985b4fa8a89210f1ef780e8f_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC0zLTEtMS0xNTIyMDk_b78ee55e-3904-4be2-870a-1bfe95406f6b">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17e1e4ae1dc41f4910694c744638d06_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC01LTEtMS0xNTIyMDk_07be5937-fce9-4d56-a1e8-b1717e473c6f">164.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5874f6fd7aa4dae89158ea58919c58f_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC03LTEtMS0xNTIyMDk_b364e6c3-4235-4362-ad89-6ff74016acae">252.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a4e2f9b5b0d48b8b618be462d213bb5_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC05LTEtMS0xNTIyMDk_97249c3e-ebd3-4d8f-922b-c3570ff4b554">1,233.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ea4f3f734d40279fcbeea57318b608_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS0xLTEtMS0xNTIyMDk_49fdb471-2838-45eb-b491-1ef09740d941">2,476.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dcb2e059604510889393247056ff68_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS0zLTEtMS0xNTIyMDk_3b63d654-bca9-4f49-8950-c2ebc63300e8">573.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f11f4d488d4d6b8d1b2a5657ed7bd8_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS01LTEtMS0xNTIyMDk_547ac9f4-75dc-47a8-a894-872271f3bb03">423.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8791ebb35b584298bcab2b2bcfa56d9d_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS03LTEtMS0xNTIyMDk_3ef45d50-3390-42e9-8c53-a83d6f809408">705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS05LTEtMS0xNTIyMDk_5658ecea-bc13-4f2d-9200-972966aa9345">4,178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.43pt">Amounts for the three months ended March&#160;31, 2022 include $<ix:nonFraction unitRef="usd" contextRef="i63daf2f5870d4537b44c66577922f2e0_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMjE5OTAyMzI2MDQxMw_5005eabe-f6d5-49ae-a6c4-313eace8d76b">164.8</ix:nonFraction> million related to the biosimilars business which was subsequently contributed to Biocon Biologics in November 2022. The Company has not recognized the results of the biosimilars business in its consolidated financial statements subsequent to November 29, 2022.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2023 and 2022: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:71.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Global Products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipitor &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eedbf09d08e4fe2b98d92fe6d16ed90_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNC0yLTEtMS0xNTIyMDk_0f43c1a2-3148-4820-94d0-474510d9ae2c">417.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035a8072fe08425aa2db4bf6f2f43f08_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNC00LTEtMS0xNTIyMDk_d1df50d0-3651-4e8e-99e6-d36a0bd449ed">440.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norvasc &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54a5abed27e41d198391fc5eb34c417_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNS0yLTEtMS0xNTIyMDk_e409b300-a821-4227-8af7-7a3fccb96872">202.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1d94644d7ec4cacb1adf2ab3a5a74b4_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNS00LTEtMS0xNTIyMDk_df5952e4-1a74-45b8-8dbf-cbf6d90885e7">207.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyrica &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa045f9e59554b078d808553a9e85eb4_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNi0yLTEtMS0xNTIyMDk_d11457e0-e550-4130-9b52-4dbdd9b0f365">144.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7813ac9a34bc41109808afe80308fb10_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNi00LTEtMS0xNTIyMDk_720e04dd-2236-411d-875e-fe07a261f357">171.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viagra &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b5947dc7a24798afe8946af5790adb_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNy0yLTEtMS0xNTIyMDk_666f79cf-cbb9-4375-ad69-4ceebd980da6">115.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e7b222b3a924b69bb5ce8f834eadfae_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNy00LTEtMS0xNTIyMDk_9589b239-ce2a-463d-b911-019cbc0b7632">129.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EpiPen&#174; Auto-Injectors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9412e767ac487189d1ecb36b20b8da_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfOC0yLTEtMS0xNTIyMDk_d3838c4b-b056-4578-9e2c-9b12d864fbcc">95.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca2f2f3badd41a5a8b132f9bfeca53a_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfOC00LTEtMS0xNTIyMDk_d9f765c3-dfd4-4625-bf1a-58a00eed0d05">88.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celebrex &#174;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0665158c01343f5a7c7b1f984e8ac2f_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfOS0yLTEtMS0xNTIyMDk_9c4a7735-f308-4d72-b438-283768f0a9a6">88.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b785c729ea46afa207062149ec382a_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfOS00LTEtMS0xNTIyMDk_e2c671b4-afdb-4f3b-ba57-36a85bee1450">85.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creon &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f3a9d5832c47df837ef0c77371bc0b_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTAtMi0xLTEtMTcwMjI2_e0feec0e-2a21-43ec-a9bc-8f94f3908242">72.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i258aad0139aa41dea358da8a65ba8ee9_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTAtNC0xLTEtMTcwMjI2_93148415-590e-43e1-9699-cc1eec2706cf">74.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effexor &#174;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bf34b1589a4aff9e5ca7af9d52fc39_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTAtMi0xLTEtMTUyMjA5_572261da-d522-4ef0-9aa3-0792280833fe">64.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib00afe9957bb4659a032e5d0aa0e7fde_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTAtNC0xLTEtMTUyMjA5_28bba5de-467e-48ae-9355-a97baf83883c">77.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zoloft &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf83d236a5d43429ebd63458e92e95a_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTItMi0xLTEtMTUyMjA5_1fa94bea-a880-443c-8d7a-5297b5926b28">56.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6627a856378146a885c26dac6939f5c4_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTItNC0xLTEtMTUyMjA5_6ad6747d-3c07-455e-9ce3-f707a7296985">73.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xalabrands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5973b7e40c443749f09dd0bc3830976_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTMtMi0xLTEtMTUyMjA5_036166ce-0942-4115-add4-601c1d93ce17">46.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief173fc589434105b1a87eaf65f45ef2_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTMtNC0xLTEtMTUyMjA5_c0349b4b-4c2a-4718-9fef-1e3cc84b7b1d">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Segment Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dymista &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c43c95288348ae8a9480b0bb2345f6_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTctMi0xLTEtMTUyMjA5_f1d7d4ba-8fbf-4d3e-a446-13ad90c101aa">53.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d037b97410486e8dc70388130c2a7a_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTctNC0xLTEtMTUyMjA5_c2b72b82-fcd2-49fa-8abd-0e20d607ee56">44.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yupelri &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2637a3b77344ad6bf7fc87e0c624aa0_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTgtMi0xLTEtMTUyMjA5_1a91d216-49b4-4150-b370-196008c65cd6">47.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia605839e071b4886950912140c4508cd_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTgtNC0xLTEtMTUyMjA5_e4e5d251-0dda-4219-8954-56c2788700c1">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xanax &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34306124574e4ff48c6728b14b8379a4_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTktMi0xLTEtMTcwMjMz_463a9f37-37f1-47b4-98a8-a0ee323046b3">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fd6ab670e74679987bf4ab0632302b_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTktNC0xLTEtMTcwMjMz_ffcf2266-ae7e-4b9b-95f4-b2d269a16649">40.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amitiza &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3881f88980d444c98a395628ac04a37d_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTktMi0xLTEtMTUyMjA5_a81b7bbc-cfb1-4af2-98ec-193c1f6e5ec5">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4918a7af8b94d9fa608eb50e7d397be_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTktNC0xLTEtMTUyMjA5_b4ff5308-8961-4232-866e-3ad9ab86892a">41.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">The Company does not disclose net sales for any products considered competitively sensitive.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="iaa4e0ce283e7448e8c37de98e5ae84c1"><ix:continuation id="i47bb2f315b0e46a994e2664d966b138a"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration and Accounts Receivable</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2023 and 2022, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:RevenuefromContractwithCustomerGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfMy01LTEtMS0xNTIyMDk_063f27c7-041d-4386-903e-ff66f2a3d679">6,273.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="vtrs:RevenuefromContractwithCustomerGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfMy03LTEtMS0xNTIyMDk_1be58505-c896-4691-9a97-151eb6c12727">7,198.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross to net adjustments:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:Chargebacks" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNS01LTEtMS0xNTIyMDk_d2531b2c-565c-4437-8cf7-eee5911f6028">1,350.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="vtrs:Chargebacks" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNS03LTEtMS0xNTIyMDk_af5635e2-f39a-4ac0-9e08-d8155f9b51d1">1,584.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:AccruedSalesAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNi01LTEtMS0xNTIyMDk_630821dc-f5ee-4ea7-929f-4fc2e13a8535">992.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="vtrs:AccruedSalesAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNi03LTEtMS0xNTIyMDk_a5d9d9d8-64cc-4785-b436-461d5dcf61ff">1,205.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:RevenuefromContractwithCustomerReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNy01LTEtMS0xNTIyMDk_d5b9342a-51c8-40b4-95f5-bd8bc9db2b3b">50.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="vtrs:RevenuefromContractwithCustomerReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNy03LTEtMS0xNTIyMDk_204e0d72-df3c-4759-8b39-310aa3a0684c">82.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:Medicaidandothergovernmentalrebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfOC01LTEtMS0xNTIyMDk_973accd2-32af-4f0e-b8e9-39e5716039cd">160.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="vtrs:Medicaidandothergovernmentalrebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfOC03LTEtMS0xNTIyMDk_9722e740-2a81-455d-b8a4-ff330c93bba9">147.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross to net adjustments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:SalesRevenueGrosstonetadjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfOS01LTEtMS0xNTIyMDk_cec01bbf-7202-48be-aff4-df32fcd02fbf">2,553.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="vtrs:SalesRevenueGrosstonetadjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfOS03LTEtMS0xNTIyMDk_f01093b2-8bd0-4bdb-b70f-431921536ff0">3,020.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfMTAtNS0xLTEtMTUyMjA5_17000761-29a4-4f90-827b-ccceebe898d2">3,719.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfMTAtNy0xLTEtMTUyMjA5_5658ecea-bc13-4f2d-9200-972966aa9345">4,178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No significant revisions were made to the methodology used in determining these provisions or the nature of the provisions during the three months ended March&#160;31, 2023. <ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzQxNw_ba139a1d-84aa-414d-89a8-215e05ba9378" continuedAt="ib8b1b9c83ab141949d5f24785fbe4ba0" escape="true">Such allowances were comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:</ix:nonNumeric></span></div><ix:continuation id="ib8b1b9c83ab141949d5f24785fbe4ba0"><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibafb46da05ec4f79a412ebc6f057d351_I20230331" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMS0xLTEtMS0xNTIyMDk_2b3bb4ad-3bdb-4bee-80ad-47e8334b1afc">1,739.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55285f970c3f4df4babe369127a8eb7e_I20221231" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMS0zLTEtMS0xNTIyMDk_881d3e18-7143-4dd6-a602-18addcbe1332">1,798.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibafb46da05ec4f79a412ebc6f057d351_I20230331" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMi0xLTEtMS0xNTIyMDk_83d7c5fa-e9af-4ccd-a4e0-a6c8d20e4a25">851.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55285f970c3f4df4babe369127a8eb7e_I20221231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMi0zLTEtMS0xNTIyMDk_46322539-fd5a-4262-b337-3491a59285c1">888.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibafb46da05ec4f79a412ebc6f057d351_I20230331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMy0xLTEtMS0xNTIyMDk_7e419c85-bba2-4f94-bdb4-585de688ca01">2,591.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55285f970c3f4df4babe369127a8eb7e_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMy0zLTEtMS0xNTIyMDk_cad6e565-3766-4733-a308-330cd8ffb16d">2,687.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net was comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:76.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMS0xLTEtMS0xNTIyMDk_6ed15126-d9eb-49e6-964a-070b8368c585">3,021.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMS0zLTEtMS0xNTIyMDk_c6716529-d879-4ca4-a9ad-5abe67b4631b">3,243.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMi0xLTEtMS0xNTIyMDk_680fea5e-767a-488b-976b-9a194888e323">475.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMi0zLTEtMS0xNTIyMDk_bea0e2dc-ca27-4c8d-ab51-54e04550647c">570.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMy0xLTEtMS0xNTIyMDk_8e743497-9f70-4491-b3e8-4f23bbb17afe">3,497.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMy0zLTEtMS0xNTIyMDk_ab3addb2-ebe3-44bf-a6ec-d7b0a5f3aebb">3,814.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Factoring Arrangements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromSaleAndCollectionOfReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzI5NA_68ccefc5-48fb-429b-afff-cb81a506e714">76.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1dd48064c677421ca76bbbd5f64574f3_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromSaleAndCollectionOfReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzMwMQ_7b321d9a-a34b-4584-87c6-267b47673257">34.7</ix:nonFraction> million of accounts receivable as of March&#160;31, 2023 and December&#160;31, 2022, respectively, under these factoring arrangements.</span></div></ix:continuation><div id="i4aaf90299ead4f42aa5d7a1f46495b27_46"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180Ni9mcmFnOjEyOWZhNTk3MzE2NzRhY2NiZTFlZmE1YjI1YWFmNzI2L3RleHRyZWdpb246MTI5ZmE1OTczMTY3NGFjY2JlMWVmYTViMjVhYWY3MjZfNzk4_5aa1cce2-12f9-4310-8ae7-23ebb9b9aa62" continuedAt="i0903530a5ac84248a8a93a92cf3cfb20" escape="true">Recent Accounting Pronouncements</ix:nonNumeric></span></div><ix:continuation id="i0903530a5ac84248a8a93a92cf3cfb20" continuedAt="idd257057828d4fc49bf7df5078f40c10"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standards</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued Accounting Standards Update 2022-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities&#8212;Supplier Finance Programs (Subtopic 405-50), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which requires entities to provide qualitative and quantitative disclosures about their supplier finance programs, including a rollforward of related obligations. The adoption of ASU 2022-04 did not affect the Company&#8217;s financial condition, results of operations or cash flows as the guidance only requires additional disclosures. We adopted this ASU effective January 1, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="idd257057828d4fc49bf7df5078f40c10"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain voluntary supply chain finance programs with financial intermediaries which provide participating suppliers the option to be paid by the intermediary earlier than the original invoice due date. The Company&#8217;s responsibility is limited to making payments on the terms originally negotiated with the suppliers, regardless of whether the intermediary pays the supplier in advance of the original due date. The range of payment terms the Company negotiates with suppliers are consistent, regardless of whether a supplier participates in a supply chain finance program. The total amounts due to financial intermediaries to settle supplier invoices under supply chain finance programs as of March&#160;31, 2023 and December&#160;31, 2022 were $<ix:nonFraction unitRef="usd" contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331" decimals="-5" name="us-gaap:SupplierFinanceProgramObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180Ni9mcmFnOjEyOWZhNTk3MzE2NzRhY2NiZTFlZmE1YjI1YWFmNzI2L3RleHRyZWdpb246MTI5ZmE1OTczMTY3NGFjY2JlMWVmYTViMjVhYWY3MjZfMzg0ODI5MDcwODU2Mw_cbde3511-b345-4c3d-a9c7-f1c84a4024fe">55.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:SupplierFinanceProgramObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180Ni9mcmFnOjEyOWZhNTk3MzE2NzRhY2NiZTFlZmE1YjI1YWFmNzI2L3RleHRyZWdpb246MTI5ZmE1OTczMTY3NGFjY2JlMWVmYTViMjVhYWY3MjZfMzg0ODI5MDcwODU3OA_45352586-a7d3-4ea5-8470-54ceb80ef24c">33.4</ix:nonFraction>&#160;million, respectively. These amounts are included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated balance sheets.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other significant changes in new accounting standards from those disclosed in Viatris&#8217; 2022 Form 10-K. Refer to Viatris&#8217; 2022 Form 10-K for additional information.</span></div></ix:continuation><div id="i4aaf90299ead4f42aa5d7a1f46495b27_49"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTkwNQ_810e9229-8c4f-4e07-b5da-8a0a23d46fc2" continuedAt="i8b5a0714099d4148bd9a3b5c35508926" escape="true">Acquisitions and Other Transactions</ix:nonNumeric></span></div><ix:continuation id="i8b5a0714099d4148bd9a3b5c35508926" continuedAt="i03e184647e7f492f9052e5f4b8c72ba8"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oyster Point Acquisition</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, the Company completed the acquisition of Oyster Point for approximately $<ix:nonFraction unitRef="usd" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MDc2_8d19142f-a72e-45f0-b15e-fb504b5ae64a">427.4</ix:nonFraction>&#160;million in cash, which included $<ix:nonFraction unitRef="usdPerShare" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MDkw_920a2255-dbb3-439a-8a75-c39eafe5acf3">11</ix:nonFraction> per share paid to Oyster Point stockholders through a tender offer, payment for vested share-based awards, and the repayment of debt of Oyster Point. In addition to the upfront cash consideration, each Oyster Point stockholder received <ix:nonFraction unitRef="right" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="INF" name="vtrs:BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNDk0NzgwMjM5NDI3MA_b015eadd-b9a9-41a8-a6d8-6d8606965132">one</ix:nonFraction> non-tradeable contingent value right representing up to an additional $<ix:nonFraction unitRef="usdPerShare" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="INF" name="vtrs:BusinessAcquisitionContingentConsiderationPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTA4_ae624915-1a85-41be-b66a-221a627ec097">2</ix:nonFraction> per share, or approximately $<ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MDk1_bf5b040b-e7cb-4922-b398-237df014f027">60</ix:nonFraction>&#160;million in the aggregate, contingent upon Oyster Point achieving certain metrics based upon full year 2022 performance. Oyster Point did not achieve the metrics that would have triggered a contingent payment and the contingent value rights have expired. Oyster Point is focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested share-based awards to acquire Oyster Point common stock that were outstanding immediately prior to the closing of the acquisition were cancelled in exchange for the right to receive an amount in cash based upon a formula contained within the merger agreement. The unvested share-based awards were converted into Viatris share-based awards based upon a formula contained within the merger agreement. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. During the three months ended March&#160;31, 2023, the Company incurred acquisition related costs of approximately $<ix:nonFraction unitRef="usd" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNjgzNQ_f07f7cd8-df49-4387-9152-694f4187d87e">18.3</ix:nonFraction>&#160;million, which were recorded primarily in SG&amp;A in the condensed consolidated statement of operations.</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNDk0NzgwMjM5NDI3OA_8ba9bff2-c935-4883-8649-b138ce7fff98" continuedAt="i143247f9fc1e4ed4909f6bb1bab8d66c" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. GAAP purchase price was $<ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMwOTU1NA_193d1675-9236-40c1-b5ad-9790cabda871">392.7</ix:nonFraction>&#160;million, net of cash acquired. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Oyster Point is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:82.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.092%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets (excluding inventories and net of cash acquired)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMS0xLTEtMS0xODAyOTA_4e4b0487-c6bc-46bf-8a0d-376dfb382d7c">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMi0xLTEtMS0xODAyOTA_50287abe-fb24-4708-a5fd-8428394ed79b">37.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMy0xLTEtMS0xODAyOTA_d545ff68-b495-4206-9a96-78a5e9b93e75">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6948cc281cf4adbac2e6725c137289c_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfNC0xLTEtMS0xNjgxNTE_3566d447-fa07-47d0-954b-da98e8925296">334.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfNS0xLTEtMS0xNjgxNjY_ac8086fe-5a30-4257-900e-87409691b791">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfNi0xLTEtMS0xODAyOTI_6909bcd2-75d7-4a2b-818a-4b89566b425b">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfNy0xLTEtMS0xODAyOTI_126420a0-318e-453d-b0e5-8305f0f4d776">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfOC0xLTEtMS0xODAyOTM_9c39aedb-0a14-4998-a4df-a2d00e7d92e1">431.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfOS0xLTEtMS0xODAyOTM_035695a0-46de-408c-9379-7c077f3ac700">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMTEtMS0xLTEtMTgwMjkz_29cf26e0-67ba-41ca-83f1-f2a096df3382">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $34.7 of cash acquired)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMTItMS0xLTEtMTY4Mjc0_193d1675-9236-40c1-b5ad-9790cabda871">392.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i03e184647e7f492f9052e5f4b8c72ba8" continuedAt="id4d69e395d7e43ec8185f779ba10dbd1"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair value estimates for the assets acquired and liabilities assumed were based upon preliminary calculations, valuations and assumptions that are subject to change as the Company obtains additional information during the measurement period (up to one year from the acquisition date). The primary areas subject to change relate to the finalization of the valuation of intangible assets and income taxes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a step-up in the fair value of inventory of approximately $<ix:nonFraction unitRef="usd" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="-5" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNTI0Nw_2b3ad88a-3972-4144-b9a9-664dd7c14d4c">29.3</ix:nonFraction>&#160;million. During the three months ended March&#160;31, 2023, the Company recorded amortization of the inventory step-up of approximately $<ix:nonFraction unitRef="usd" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="-5" name="vtrs:BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNTU4MA_98ea01d9-4922-4feb-9796-d3f43a02fbdb">7.3</ix:nonFraction>&#160;million, which is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The identified intangible assets of $<ix:nonFraction unitRef="usd" contextRef="ie6948cc281cf4adbac2e6725c137289c_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzI5NjQ4OA_3566d447-fa07-47d0-954b-da98e8925296">334.0</ix:nonFraction> million are comprised of product rights and licenses related to a commercial asset, Tyrvaya&#174;, for the treatment of dry eye disease, that have an estimated useful life of <ix:nonNumeric contextRef="i8137e6d5778e45d7ac3a688bd6c289d4_I20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNjY4Mw_cdea5936-960f-4b45-8d8f-b3ce233f3b1a">10</ix:nonNumeric> years. Significant assumptions utilized in the valuation of identified intangible assets were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by U.S. GAAP.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill of $<ix:nonFraction unitRef="usd" contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzI5NjUxMQ_ac8086fe-5a30-4257-900e-87409691b791">5.9</ix:nonFraction> million arising from the acquisition consisted largely of the value of the employee workforce and the expected value of products to be developed in the future. All of the goodwill was assigned to the Developed Markets segment. None of the goodwill recognized in this transaction is currently expected to be deductible for income tax purposes. The operating results of Oyster Point have been included in the Company&#8217;s condensed consolidated statements of operations since the acquisition date. The total revenues of Oyster Point for the period from the acquisition date to March 31, 2023, were $<ix:nonFraction unitRef="usd" contextRef="i3ad3994dc65d497295612fdbd82d203a_D20230103-20230331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc2ODIxMw_3f8a0b62-0db7-4cde-a579-cbc1fd7e47ac">6.3</ix:nonFraction>&#160;million and net loss, net of tax, was approximately $<ix:nonFraction unitRef="usd" contextRef="i3ad3994dc65d497295612fdbd82d203a_D20230103-20230331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODg0OTQ0_c7b79402-ab19-4e31-b7f0-e50bdaf4d980">49.3</ix:nonFraction>&#160;million. The net loss for the period includes the effect of the purchase accounting adjustments and acquisition related costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNDk0NzgwMjM5NDI4Mw_c649b3e8-053c-4206-a8d7-45480b646c56" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental unaudited pro forma information for the acquisition, as if it had occurred on January 1, 2022. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased amortization expense based on the fair value of assets acquired, the impact of transaction costs and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable, or have been achieved, subsequent to the closing of the acquisition. Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:65.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.189%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited, in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfMi0xLTEtMS0xODAzMDM_3184567f-a2ce-411c-b5f4-9043b6afe99a">3,729.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfMi0zLTEtMS0xODAzMDQ_95b2d23e-6157-407c-841b-5726c3467d34">4,194.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfMy0xLTEtMS0xODAzMDM_552c11b2-f26e-48bc-8364-1016d8e82635">260.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfMy0zLTEtMS0xODAzMDQ_76b1eb7f-1a3a-4cb9-afdb-0a340ea69003">337.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="INF" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfNS0xLTEtMS0xODAzMDY_26633659-0bcf-4141-8d8c-32c174faf3ed">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331" decimals="INF" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfNS0zLTEtMS0xODAzMDg_32c801a7-3df1-4bf7-b265-edc07ca922ea">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="INF" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfNi0xLTEtMS0xODAzMDY_dbee1b3e-181f-49c2-8aee-d1e33b4c7cd0">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331" decimals="INF" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfNi0zLTEtMS0xODAzMDg_d556ec82-8215-40bb-a7c4-ef25f058e2c3">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfOC0xLTEtMS0xODAzMTA_3c6538f8-b324-443a-9f48-c2d95ea295ef">1,202.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfOC0zLTEtMS0xODAzMTI_6b81ffd0-53ba-482d-b2be-3a9f2703c6ce">1,210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331" decimals="-3" name="us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfOS0xLTEtMS0xODAzMTA_38d08582-7d2f-4f9f-9a38-40305c44d03e">1,205.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331" decimals="-3" name="us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfOS0zLTEtMS0xODAzMTI_b4f44d3e-a376-487a-9f0f-8e0cce088fbd">1,213.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Famy Life Sciences Acquisition</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2022, the Company entered into a definitive agreement to acquire the remaining equity shares of Famy Life Sciences, a privately-owned research company with a complementary portfolio of ophthalmology therapies under development, for consideration of $<ix:nonFraction unitRef="usd" contextRef="icce36ab95a904a348f3538311028617b_D20221107-20221107" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTEy_887df470-2690-4a7f-a8bc-7e23494c1d2a">281</ix:nonFraction>&#160;million. The Company had previously entered into a Master Development Agreement with Famy Life Sciences on December 20, 2019 under which the Company obtained rights with respect to acquiring certain pharmaceutical products and had also acquired shares representing approximately <ix:nonFraction unitRef="number" contextRef="i7828558df2f6496fabe44db31c95df87_I20201231" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTI2_b49fa32d-73a9-4638-beb1-2dd8e462c070">13.5</ix:nonFraction>% equity interest in Famy Life Sciences for $<ix:nonFraction unitRef="usd" contextRef="i978bcc6ddcd84e688fa210aa490cfa7b_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTMz_7ba7044d-711d-41ae-8569-a40ab0937dbd">25.0</ix:nonFraction>&#160;million at December 31, 2020. The investment was accounted for in accordance with ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="id4d69e395d7e43ec8185f779ba10dbd1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction to acquire the remaining equity shares of Famy Life Sciences closed during the first quarter of 2023. The Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i39ea09d1bb094c10861e55e7f13a92d8_D20230101-20230331" decimals="-5" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTQ4_34a9498a-cfc9-4a24-9f5c-544df76363f3">18.9</ix:nonFraction>&#160;million during the first quarter of 2023 as a result of remeasuring its pre-existing <ix:nonFraction unitRef="number" contextRef="i7828558df2f6496fabe44db31c95df87_I20201231" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTYz_835c71bd-8da5-4f10-83c8-12cb17eafbda">13.5</ix:nonFraction>% equity interest in Famy Life Sciences to fair value, which was recorded as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statement of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. The U.S. GAAP purchase price allocated to the transaction was $<ix:nonFraction unitRef="usd" contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc1Nzc5NQ_396b845e-4d64-4708-896e-762c1ae7763b">325.0</ix:nonFraction>&#160;million, which consisted of $<ix:nonFraction unitRef="usd" contextRef="icce36ab95a904a348f3538311028617b_D20221107-20221107" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc1ODIyMA_887df470-2690-4a7f-a8bc-7e23494c1d2a">281</ix:nonFraction>&#160;million of cash consideration paid for the remaining equity shares and $<ix:nonFraction unitRef="usd" contextRef="icce36ab95a904a348f3538311028617b_D20221107-20221107" decimals="-5" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc1ODI3MA_822b2e26-5e5b-4a2d-a6b9-8924dd80d686">43.9</ix:nonFraction>&#160;million for the fair value of the pre-existing <ix:nonFraction unitRef="number" contextRef="i7828558df2f6496fabe44db31c95df87_I20201231" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc1ODIwOA_835c71bd-8da5-4f10-83c8-12cb17eafbda">13.5</ix:nonFraction>% equity interest. <ix:continuation id="i143247f9fc1e4ed4909f6bb1bab8d66c" continuedAt="ibd07c4507cfc45358b7956889f6f2c84">The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Famy Life Sciences is as follows:</ix:continuation></span></div><div style="margin-bottom:12pt"><ix:continuation id="ibd07c4507cfc45358b7956889f6f2c84"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:82.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.092%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996c937d9d5d48bda3c5200c4b48c99f_I20221107" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNC0xLTEtMS0xNjgyMzI_a80d4c82-429c-400a-b0b8-6219fda0e9e5">290.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNS0xLTEtMS0xNjgyNDU_4381704e-1aaf-4734-a245-ce97a7d37d1e">89.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNS0xLTEtMS0xODA1NzE_50c42996-10bb-419d-a68a-cfab33c23a40">379.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNi0xLTEtMS0xODA1ODE_0603e4b5-eead-4c2f-9ede-c56cefafb4d7">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNy0xLTEtMS0xODA1ODM_601a0d43-e0fe-4b6a-ab6e-03986f18c89c">52.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $0.2 of cash acquired)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfOC0xLTEtMS0xNjk3MzY_396b845e-4d64-4708-896e-762c1ae7763b">325.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair value estimates for the assets acquired and liabilities assumed were based upon preliminary calculations, valuations and assumptions that are subject to change as the Company obtains additional information during the measurement period (up to one year from the acquisition date). The primary areas subject to change relate to the finalization of the valuation of IPR&amp;D and income taxes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount allocated to IPR&amp;D represents an estimate of the fair value of purchased in-process technology for research projects that, as of the closing date of the acquisition, had not reached technological feasibility and had no alternative future use. The fair value of IPR&amp;D of $<ix:nonFraction unitRef="usd" contextRef="i996c937d9d5d48bda3c5200c4b48c99f_I20221107" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxMDk3Mg_a80d4c82-429c-400a-b0b8-6219fda0e9e5">290.0</ix:nonFraction> million was based on the excess earnings method, which utilizes forecasts of expected cash inflows (including estimates for ongoing costs) and other contributory charges. A discount rate of 23.9% was utilized to discount net cash inflows to present values. IPR&amp;D is accounted for as an indefinite-lived intangible asset and will be subject to impairment testing until completion or abandonment of the projects. Upon successful completion and launch of each product, the Company will make a determination of the estimated useful life of the individual asset. The acquired IPR&amp;D projects are in various stages of completion and the estimated costs to complete these projects total approximately $<ix:nonFraction unitRef="usd" contextRef="i2de5309c551f46c095be838450a8464a_I20241231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNTY2NQ_01829b9c-36bb-4d98-910d-356785fa8560">120</ix:nonFraction>&#160;million, which are expected to be incurred through 2024. There are risks and uncertainties associated with the timely and successful completion of the projects included in IPR&amp;D, and no assurances can be given that the underlying assumptions used to estimate the fair value of IPR&amp;D will not change or the timely completion of each project to commercial success will occur.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill of $<ix:nonFraction unitRef="usd" contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzI5ODAxNA_4381704e-1aaf-4734-a245-ce97a7d37d1e">89.3</ix:nonFraction> million arising from the acquisition consisted largely of the value of the employee workforce and the expected value of products to be developed in the future. All of the goodwill was assigned to the Developed Markets segment. None of the goodwill recognized in this transaction is currently expected to be deductible for income tax purposes. The acquisition did not have a material impact on the Company&#8217;s results of operations since the acquisition date or on a pro forma basis for the three months ended March 31, 2023 and 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ophthalmology is one of the key therapeutic areas of focus that the Company announced in February 2022 when it announced plans for certain strategic actions. With the combination of Viatris' global commercial footprint, R&amp;D and regulatory capabilities and supply chain, along with Oyster Point's deep knowledge of the ophthalmology space from a clinical, medical, regulatory and commercial perspective&#8212;including Tyrvaya&#174;&#8212;and Famy Life Sciences' Phase III-ready pipeline, the Company believes it has the foundation to create a leading global ophthalmology franchise, accelerating efforts to address the unmet needs of patients with ophthalmic disease and the eye care professionals who treat them.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_549755815215"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzQ5NDc4MDIzNjQyNjg_67941785-6f36-41fa-b280-d9b16b1e6ec3" continuedAt="i4b595ec759914a168d7c6e4649907b24" escape="true">Divestitures</ix:nonNumeric></span></div><ix:continuation id="i4b595ec759914a168d7c6e4649907b24"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biocon Biologics Transaction</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2022, Viatris completed a transaction to contribute its biosimilars portfolio to Biocon Biologics. Under the terms of the Biocon Agreement, Viatris received $<ix:nonFraction unitRef="usd" contextRef="ia674853b0e45470192385b041b369637_I20221129" decimals="-9" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1NjkwNQ_0adac65d-316c-461d-9517-e8700aa9a5c0">3</ix:nonFraction>&#160;billion in consideration in the form of a $<ix:nonFraction unitRef="usd" contextRef="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129" decimals="-9" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1NjkxNw_06d5b10d-843a-418f-a034-9675075d10d4">2</ix:nonFraction>&#160;billion cash payment, adjusted as set forth in the Biocon Agreement, and approximately $<ix:nonFraction unitRef="usd" contextRef="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129" decimals="-9" name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1NjkzMA_6e8f3928-34c7-4972-9dfb-c3ec685aac47">1</ix:nonFraction>&#160;billion of CCPS representing a stake of approximately <ix:nonFraction unitRef="number" contextRef="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129" decimals="3" name="vtrs:DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1Njk0Mw_33230256-de5f-4f46-98b2-62e676b6bac4">12.9</ix:nonFraction>% (on a fully diluted basis) in Biocon Biologics. Viatris also is entitled to $<ix:nonFraction unitRef="usd" contextRef="ie5675703bf7c4d4d9da547d52dcba0ae_D20240101-20241231" decimals="-6" name="vtrs:DivestitureOfBusinessDeferredCashConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1Njk1MA_eccb7eef-8cde-4fe0-a82d-9b1eecc7d4ac">335</ix:nonFraction>&#160;million of additional cash payments in 2024. In addition, Viatris and Biocon Biologics have agreed to a closing working capital target of $<ix:nonFraction unitRef="usd" contextRef="ia674853b0e45470192385b041b369637_I20221129" decimals="-6" name="vtrs:DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1Njk2NA_69e5db13-1954-49ed-939e-196aec8b7daa">250</ix:nonFraction>&#160;million. An amount of cash equal to all or a portion of the closing working capital target may become payable to Biocon Biologics in connection with certain events in the future, depending on the valuations attributable to such events. Refer to Note 8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Components</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on assets and liabilities related to Biocon Biologics. The Company&#8217;s CCPS in Biocon Biologics are classified as equity securities, refer to Note 11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris and Biocon Biologics also entered an agreement pursuant to which Viatris is providing commercialization and certain other transition services on behalf of Biocon Biologics, including billings, collections, and the remittance of rebates, to ensure business continuity for patients, customers and colleagues. The term of the transition services agreement is generally up to <ix:nonNumeric contextRef="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129" name="vtrs:DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1NzE4OQ_93bd73ed-d5df-432e-be2a-a7a8ff2c03f8">two years</ix:nonNumeric>. Under the transition services agreement, Viatris is entitled to be reimbursed for its costs (subject to certain caps) plus a markup. During the three months ended March 31, 2023, the Company recognized TSA income of approximately $<ix:nonFraction unitRef="usd" contextRef="i038641544e90455d9e0b031976fcd4f7_D20230101-20230331" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1Njk3OA_71e44d3b-c27c-47c9-afa9-83f3e2bca72d">45.7</ix:nonFraction>&#160;million as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (Income) Expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Potential Divestitures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company provided an update on the strategic priorities announced in February 2022, including identifying the following businesses no longer considered core to its future strategy that the Company intends to divest:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">OTC;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">API (while retaining some selective development API capabilities);</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Women&#8217;s health care, primarily related to our oral and injectable contraceptives. This does not include all of our women&#8217;s health care related products; as an example, our Xulane&#174; product in the U.S. is excluded; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">Upjohn Distributor Markets. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, we determined that our Upjohn Distributor Markets should be classified as held for sale. Upon classification as held for sale, we recognized a total charge of $<ix:nonFraction unitRef="usd" contextRef="i4b2491c72c1440ca895b054425f97641_D20221001-20221231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMDgwNg_baba3bb9-1eb8-480c-823d-079fc9008f50">374.2</ix:nonFraction>&#160;million during the three months ended December 31, 2022. This was comprised of a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i92b7b3d4e0c941a592801ccaf3b5a117_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMDc3NA_1edae42d-7326-4f45-ab61-b6972ece67dd">117.0</ix:nonFraction>&#160;million, other charges, principally inventory write-offs, of $<ix:nonFraction unitRef="usd" contextRef="idf62a3adcc2b4c4c84b6baf6c88c9459_D20221001-20221231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMTEwNA_37d25eea-e33a-4f9c-96c4-f9934cc89911">84.3</ix:nonFraction>&#160;million and a charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i6c3140d7b1784dea88bd3908f0f56a43_D20221001-20221231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMDc5MA_e0076cb9-7179-4dff-912e-1f1cae4f55c3">172.9</ix:nonFraction>&#160;million to write down the disposal group to fair value, less cost to sell. During the three months ended March&#160;31, 2023, the Company recorded additional inventory reserves of $<ix:nonFraction unitRef="usd" contextRef="i29d41bac887c45c4a70ffcc400a93b6a_I20221231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzM4NDgyOTA3MzIwMTI_a76efe19-0b57-4bfb-a4a2-52219d001e68">9.2</ix:nonFraction>&#160;million and an intangible asset charge of $<ix:nonFraction unitRef="usd" contextRef="i3f1f9e0ec712462aa02e10848d2f65c0_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzM4NDgyOTA3MzE5NjI_49a088d1-e711-463f-a7c2-10bb13813cbe">32.0</ix:nonFraction>&#160;million to write down the disposal group to fair value, less cost to sell. As of March&#160;31, 2023 and December&#160;31, 2022, assets held for sale associated with the Upjohn Distributor Markets consisted of intangible assets of $<ix:nonFraction unitRef="usd" contextRef="iddf72d19b27c4e84b44267057cabd078_I20230331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1MzE4Mg_cfafc4da-660b-40a2-af56-5cf17b7cc543">198.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzIxOTkwMjMyODA2NjI_12f3206a-1193-4789-8679-e7d2c256f8ec">230.3</ix:nonFraction>&#160;million, respectively. If these transactions are not completed, the distribution arrangements will expire in accordance with our agreement with Pfizer and the Company will wind down operations in these markets, which may result in additional asset write-offs and other costs being incurred. These additional charges could be in excess of $<ix:nonFraction unitRef="usd" contextRef="iddf72d19b27c4e84b44267057cabd078_I20230331" decimals="-6" name="vtrs:LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMDgyMg_2dcc09c2-5c6b-4fb9-949d-06338e4b7d71">250</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_52"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjU1OQ_8dc14eb6-e138-47b0-b1f8-2b49389b60be" continuedAt="i3286cb9ea0d94b90898ce631136ab04d" escape="true">Share-Based Incentive Plan</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:continuation id="i3286cb9ea0d94b90898ce631136ab04d" continuedAt="ie3e7e0c49d464417ae639777c37028ae"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution, Viatris adopted and Pfizer, in the capacity as Viatris&#8217; sole stockholder at such time, approved the 2020 Incentive Plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Viatris Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Stock Incentive Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) which became effective as of the Distribution. In connection with the Combination, as of November 16, 2020, the Company assumed the 2003 LTIP (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which had previously been approved by Mylan shareholders. The 2020 Incentive Plan and 2003 LTIP include (i) <ix:nonFraction unitRef="shares" contextRef="ib44a8bb4acc54d0893dec83f4f70479a_I20201116" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfNDAx_ea791b3e-e27e-4ace-bb03-d2891b758c93">72,500,000</ix:nonFraction> shares of Common Stock authorized for grant pursuant to the 2020 Incentive Plan, which may include dividend payments payable in Common Stock on unvested shares granted under awards, (ii) <ix:nonFraction unitRef="shares" contextRef="iaabcbd4e36f64c80a1d3a99c36f4e4b9_D20201116-20201116" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfNTc2_3570a63a-6501-4333-89ae-dd92002c94be">6,757,640</ix:nonFraction> shares of Common Stock to be issued pursuant to the exercise of outstanding stock options granted to participants under the 2003 LTIP and assumed by Viatris in connection with the Combination and (iii) <ix:nonFraction unitRef="shares" contextRef="i38b4ae4464494ecba320ebadb2cf078b_I20201116" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfNzgx_d312b00b-0b57-4043-8c82-735c606bb577">13,535,627</ix:nonFraction> shares of Common Stock subject to outstanding equity-based awards, other than stock options, assumed by Viatris in connection with the Combination, or that otherwise remain available for issuance under the 2003 LTIP.</span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="ie3e7e0c49d464417ae639777c37028ae"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2020 Incentive Plan and 2003 LTIP, shares are reserved for issuance to key employees, consultants, independent contractors and non-employee directors of the Company through a variety of incentive awards, including: stock options, SARs, restricted stock and units, PSUs, other stock-based awards and short-term cash awards. Stock option awards are granted with an exercise price equal to the fair market value of the shares underlying the stock options at the date of the grant, generally become exercisable over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTUyOQ_2c493640-95e1-4300-976d-938a30e9093d">three</span> to <ix:nonNumeric contextRef="ib1eb88e565a848ebb8dc702db55d4f88_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTUzNQ_ffdd3d10-1a28-445c-b320-c4a1f22b764e">four years</ix:nonNumeric>, and generally expire in <ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTU2Mw_f28a2903-df75-4519-bf3f-096ed8144158">ten years</ix:nonNumeric>.</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjU3NQ_fef892f1-6de3-4163-90a7-2f0260267190" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock awards (stock options and SARs) activity under the 2020 Incentive Plan and 2003 LTIP:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Under Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMS0xLTEtMS0xNTIyMDk_7413c8e5-9dde-4bf0-9c11-b1c80471e4a7">4,449,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMS0zLTEtMS0xNTIyMDk_f6411bfb-221c-4570-b0e0-51f8f49ac232">38.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMi0xLTEtMS0xNTIyMDk_ff2e269e-6342-4b99-9b19-c1ac7e60b5db">283,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMi0zLTEtMS0xNTIyMDk_98a9110e-eff4-472c-8384-45b5d67b372b">7.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMy0xLTEtMS0xNTIyMDk_23f57d68-3566-4ecb-ae38-0834dbef971a">5,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMy0zLTEtMS0xNTIyMDk_8765327d-3d66-4393-9ca0-e532c6965479">5.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNC0xLTEtMS0xNTIyMDk_d433d875-b21f-4242-85bf-9327023073cb">242,165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNC0zLTEtMS0xNTIyMDk_c3573ea5-4695-41a2-9f08-06c6d72b06e8">31.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNS0xLTEtMS0xNTIyMDk_9e31d140-1999-471a-8a9d-c67e2d93618a">4,485,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNS0zLTEtMS0xNTIyMDk_82ac31f7-b66c-4245-86bb-b1182bb76eb4">37.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNi0xLTEtMS0xNTIyMDk_1d25994e-092e-4040-a834-aaad0096c555">4,452,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNi0zLTEtMS0xNTIyMDk_027ee9a8-68ca-40c3-bc3b-fe8120fa975e">37.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNy0xLTEtMS0xNTIyMDk_a8a05c23-0611-41bd-838c-87c8906539e5">4,185,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNy0zLTEtMS0xNTIyMDk_3a7d16d8-aa6b-4131-b665-4e0dbe49337f">38.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had average remaining contractual terms of <ix:nonNumeric contextRef="idc3bcc18e42c4bd1a5362ab466d46293_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTgyNg_c02d2ce0-11c7-4479-bd00-a185a806a3a2">4.4</ix:nonNumeric> years, <ix:nonNumeric contextRef="idc3bcc18e42c4bd1a5362ab466d46293_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTgzMA_bfeaad81-5e6b-4395-bb1a-bab79c43a5d4">4.4</ix:nonNumeric> years and <ix:nonNumeric contextRef="idc3bcc18e42c4bd1a5362ab466d46293_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTgzNw_d5798688-aa2a-49ac-b737-54fed72cc876">4.0</ix:nonNumeric> years, respectively. Also, at March&#160;31, 2023, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had aggregate intrinsic values of $<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTY0OTI2NzQ0NTEzNw_7a627f44-83ed-4146-8013-a7e79a67bd86">0.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTY0OTI2NzQ0NTE0Mw_554b67af-821e-43be-84cf-06fca23494b0">0.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTY0OTI2NzQ0NTE1Mw_f7f35661-9610-4627-9567-75927e10e188">0.1</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjU1Mw_ae1c2100-b3fd-41b8-b851-9a96b70050f8" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the Company&#8217;s nonvested Restricted Stock Awards (restricted stock and restricted stock unit awards, including PSUs) from December&#160;31, 2022 to March&#160;31, 2023 is presented below:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Restricted Stock&#160;Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair&#160;Value&#160;Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6be2e59be8047b5bdb3bca88fdac9b2_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMS0xLTEtMS0xNTIyMDk_50c77372-7ad4-4a82-96e6-19ebda1f400b">27,271,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib6be2e59be8047b5bdb3bca88fdac9b2_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMS0zLTEtMS0xNTIyMDk_acaa62c2-b17d-42c8-b0ce-c1f98137d241">11.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMi0xLTEtMS0xNTIyMDk_e8703ba8-81a3-4674-8d59-09d4f4b32a07">19,043,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMi0zLTEtMS0xNTIyMDk_141d1cce-f01c-47a1-a5a8-c521f5c55f3f">11.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMy0xLTEtMS0xNTIyMDk_d283d588-bebd-497f-a3c6-36c90696d918">7,743,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMy0zLTEtMS0xNTIyMDk_c4fd2237-3801-4fd4-9740-69ef6a6defe8">13.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfNC0xLTEtMS0xNTIyMDk_094c3562-1d6f-4ea8-8b7e-7fee03e3f2e7">267,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfNC0zLTEtMS0xNTIyMDk_16dc58e8-ebc9-49ad-a022-441b0c227868">11.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c529f37c6a8452daf8c5630c4b137dc_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfNS0xLTEtMS0xNTIyMDk_c44d4c0f-313e-4568-a6c6-d2b2e0f711ae">38,304,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c529f37c6a8452daf8c5630c4b137dc_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfNS0zLTEtMS0xNTIyMDk_8561a94b-ac55-4b05-a2b2-039eccdfdf0b">11.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had $<ix:nonFraction unitRef="usd" contextRef="i0a6b105d683e44f1b695dbd0fdd19afa_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjIzMg_63779230-24eb-4500-b7fb-2a769eeddf6c">213.8</ix:nonFraction> million of total unrecognized compensation expense, net of estimated forfeitures, related to all of its stock-based awards, which we expect to recognize over the remaining weighted average vesting period of <ix:nonNumeric contextRef="i3f1530fe010f4d8283807e9da9561509_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjQzNA_5754a916-e085-40e0-8649-ece26b3cda68">1.7</ix:nonNumeric> years. The total intrinsic value of Restricted Stock Awards released during the three months ended March&#160;31, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="i3f1530fe010f4d8283807e9da9561509_D20230101-20230331" decimals="-5" name="vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjUyNw_7b717f40-5e7e-4f71-9a51-ab3e2932590d">100.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1af79b8021fc47028b95741c1cc39d78_D20220101-20220331" decimals="-5" name="vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjUzNA_7037727e-ae9d-456a-a6f6-ffc9a98a2948">63.1</ix:nonFraction> million, respectively.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_58"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RleHRyZWdpb246M2MxYjY1ZTY4YTc4NGYzYTg0YjMyMzc4MTBmNDg0OGFfMTM0OA_15c3d1ec-0e73-4d2b-bf20-ab6df90a044c" continuedAt="i3c83abc3b73647a4b59e870f86a4a281" escape="true">Pensions and Other Postretirement Benefits</ix:nonNumeric></span></div><ix:continuation id="i3c83abc3b73647a4b59e870f86a4a281" continuedAt="i56a8d7d4ce7d420eba78d103c4a374ea"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various defined benefit pension plans in several countries. Benefits provided generally depend on length of service, pay grade and remuneration levels. Employees in the U.S., Puerto Rico and certain international locations are also provided retirement benefits through defined contribution plans.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sponsors other postretirement benefit plans including plans that provide for postretirement supplemental medical coverage. Benefits from these plans are provided to employees and their spouses and dependents who meet various minimum age and service requirements. In addition, the Company sponsors other plans that provide for life insurance benefits and postretirement medical coverage for certain officers and management employees.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i56a8d7d4ce7d420eba78d103c4a374ea"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RleHRyZWdpb246M2MxYjY1ZTY4YTc4NGYzYTg0YjMyMzc4MTBmNDg0OGFfMTM0Mw_d318e262-eece-4011-a72a-a21f758d7ade" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNC01LTEtMS0xNTIyMDk_2fbba23c-d45b-4ac7-8f6d-28880c920cc5">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNC03LTEtMS0xNTIyMDk_155b841e-72a8-4d7c-ad31-3247bb70eec1">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNS01LTEtMS0xNTIyMDk_1d21871a-5a40-4e8e-8164-5939c3a8a4a3">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNS03LTEtMS0xNTIyMDk_472cd6ab-e050-4118-ab73-9819fc437ee7">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNi01LTEtMS0xNTIyMDk_cb0ba90e-73e0-42dd-995a-77eb7e7bb61d">16.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNi03LTEtMS0xNTIyMDk_e903afc9-4b8e-48a8-bf52-dad53c85364a">16.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNy01LTEtMS0xNTIyMDk_59dc3a84-2c6e-493f-ab74-6ed74071c4b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNy03LTEtMS0xNTIyMDk_187cba54-e453-49ac-9332-70c82863bfb4">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfOC01LTEtMS0xNTIyMDk_25e2bf52-d8c4-4b47-9a2c-4ccfb3c9bfb7">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfOC03LTEtMS0xNTIyMDk_00c9cc7d-c64b-4dee-9243-021920116b3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfOS01LTEtMS0xNTIyMDk_95e38c16-9b39-4774-8403-c6b6e67c0cab">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfOS03LTEtMS0xNTIyMDk_a0b8ce1c-2577-4c6f-b425-ea49cc5dc246">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is making the minimum mandatory contributions to its defined benefit pension plans in the U.S. and Puerto Rico for the 2023 plan year. The Company expects to make total benefit payments of approximately $<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RleHRyZWdpb246M2MxYjY1ZTY4YTc4NGYzYTg0YjMyMzc4MTBmNDg0OGFfMTE1OA_3b6b41c4-2bee-4632-b290-776ed2a91736">108.5</ix:nonFraction> million from pension and other postretirement benefit plans in 2023. The Company anticipates making contributions to pension and other postretirement benefit plans of approximately $<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RleHRyZWdpb246M2MxYjY1ZTY4YTc4NGYzYTg0YjMyMzc4MTBmNDg0OGFfMTMzMg_9556e5fd-3045-4467-ba61-b3da97bc571d">51.3</ix:nonFraction> million in 2023.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_61"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAxMA_9888bcd5-fbb9-431e-bf44-200d8808c08d" continuedAt="ic915ff47de6e443686177b3d1cd8b78b" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="ic915ff47de6e443686177b3d1cd8b78b" continuedAt="iaccaeeeaf2b64e48a0247ae3749c40c5"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected balance sheet components consist of the following:</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMTk5Mw_43fd57c8-e221-4019-99e6-4cd18dd36080" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and restricted cash</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMS0xLTEtMS0xNTIyMDk_74f28a0b-8f02-40c1-9459-50fa1a806160">506.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMS0zLTEtMS0xNTIyMDk_4e8a328d-64b7-42b6-87e0-5599999a0433">1,259.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMS01LTEtMS0xNTIyMDk_ba8f72e0-2f6e-4f85-aa01-72d96f1637e3">752.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMi0xLTEtMS0xNTIyMDk_d1d7107e-7c55-4822-95e7-c4b9c7bd3a7d">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMi0zLTEtMS0xNTIyMDk_a5e15c3f-c3ab-42af-a82e-c94d22f3f268">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMi01LTEtMS0xNTIyMDk_5f38ea6b-1f48-4a00-8d34-afc16bcf77f7">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMy0xLTEtMS0xNTIyMDk_84e966c3-6510-4cae-af8e-afb8587b91f6">510.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMy0zLTEtMS0xNTIyMDk_d0264ea9-21eb-45a6-aee2-24e882bf35e0">1,262.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMy01LTEtMS0xNTIyMDk_eac84794-b3db-4cd5-9f96-bf38338421e2">757.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAzNg_0439f3b4-a594-453b-80a0-c381a33dc753" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMS0xLTEtMS0xNTIyMDk_2116a6b3-d59b-47b7-a6b8-11dba4668e6c">667.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMS0zLTEtMS0xNTIyMDk_826dc469-4e55-446e-8cc6-8ac99ef76409">571.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMi0xLTEtMS0xNTIyMDk_05297ef7-e41c-49a6-9a58-af38cffaa9d8">697.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMi0zLTEtMS0xNTIyMDk_ea4c17c8-5ef8-4a70-a7cd-04f337ec966b">755.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMy0xLTEtMS0xNTIyMDk_fc35aa19-58c3-4a15-9012-c83a1de7d521">2,299.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMy0zLTEtMS0xNTIyMDk_0dc8e12e-e088-4bea-9f99-fa454150eb63">2,192.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfNC0xLTEtMS0xNTIyMDk_3d96e1d8-f0a9-4c40-8955-35f110717429">3,664.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfNC0zLTEtMS0xNTIyMDk_a5a69ec4-bbf2-4c33-8bfe-3d0b243106a6">3,519.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="iaccaeeeaf2b64e48a0247ae3749c40c5" continuedAt="ia2431d5719464ac497cbff6e674ec3fb"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjA0OA_76e8a000-6d66-4c21-8d8f-e163f4570ba8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfMS0xLTEtMS0xNTIyMDk_9cf530a4-11ff-4a8c-aa6b-fe00fdba138f">239.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfMS0zLTEtMS0xNTIyMDk_706813f7-8a93-4b45-a660-dc08892f18fc">194.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfd05d1cfff54696a4f01f4ac88a2938_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfMy0xLTEtMS0xNTIyMDk_eebb0f2d-39d9-4f65-9986-359be8d2e1c0">36.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e11cf9ad644b68af5c0ac002a0b693_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfMy0zLTEtMS0xNTIyMDk_38efbfb2-cf08-444f-9b7b-00f57f39f385">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNC0xLTEtMS0xNTIyMDk_f9d9dca7-9a73-45b9-ae62-a945dcfde9e5">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNC0zLTEtMS0xNTIyMDk_560e0178-bbe0-4bec-ba55-641c9746c4ec">134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNS0xLTEtMS0xNTIyMDk_1c0838e3-5448-4e88-959c-4bc926bf8eff">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNS0zLTEtMS0xNTIyMDk_1350c63d-7f66-418a-926c-05577e3374cb">42.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNi0xLTEtMS0xNTIyMDk_8647db03-7c46-4f31-ac9a-cbc7cd97ca3d">1,350.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNi0zLTEtMS0xNTIyMDk_341b0e78-8805-4fea-b7a9-9f3e45cb1765">1,404.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNy0xLTEtMS0xNTIyMDk_7f54f218-bf3f-4b33-b846-6f2f1e015738">1,763.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNy0zLTEtMS0xNTIyMDk_0df26cb5-b41e-400c-a0bf-7aba3364c9c7">1,811.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses consist primarily of prepaid rent, insurance and other individually insignificant items. </span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAxNA_a94ddcfd-2487-4006-bb32-c68b4d682c65" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i203edc74353240bcb584d5be70ab7977_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMS0xLTEtMS0xNTIyMDk_6c9ddd3a-9f91-4610-a14c-2870d99ed9ee">3,051.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie899de488efe457d85cdd16eebe2e01a_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMS0zLTEtMS0xNTIyMDk_80b1ca17-9bfb-480d-839d-46adade75c0b">2,936.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i622683f47bb4406a81794008b13dda9d_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMi0xLTEtMS0xNTIyMDk_8c618b41-b167-4f98-9131-6be5e4e17ed8">1,548.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5dd0738d5ad4d438464fda8015cbfc8_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMi0zLTEtMS0xNTIyMDk_18f35f5e-8f71-4bf0-990c-6b3274dc05cb">1,539.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccaac04969444cd0ac6e71b631cc378d_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMy0xLTEtMS0xNTIyMDk_1d3eb005-774f-481b-b74c-938a6fb702f6">410.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie37168f0983848249b7f1e89a1acb5bd_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMy0zLTEtMS0xNTIyMDk_e74e7019-c194-42c6-871d-8d35c7d19335">474.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefd395d7495640418781dfc639bb703c_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNC0xLTEtMS0xNTIyMDk_93f11582-dbde-4b74-8bb6-b71c7459d2b9">135.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5aaabd86415e4b8c9c1cbaa20a6ed1e9_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNC0zLTEtMS0xNTIyMDk_b4f8e7d2-13ca-4d03-8152-1358d3979130">133.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNS0xLTEtMS0xNTIyMDk_99dee379-f8c5-4978-8656-637f999a6129">5,145.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNS0zLTEtMS0xNTIyMDk_10afdbc4-3c7e-460a-b6e7-bfae7f37a59a">5,083.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNi0xLTEtMS0xNTIyMDk_ecf24c10-d180-48bd-b68a-852aa1aaea07">2,137.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNi0zLTEtMS0xNTIyMDk_3058d170-01d5-47ee-a0c7-208c1bd8332a">2,059.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNy0xLTEtMS0xNTIyMDk_50d20b92-ddb5-4986-884b-0a67870fd2ca">3,007.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNy0zLTEtMS0xNTIyMDk_ea87fbb3-ef71-4558-a771-e6c1e00d63b6">3,024.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMTk5Nw_a6627e0a-986a-4c89-9226-05bb547a1fd2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other assets</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf65b15f46464ee7bcba67fd57306449_I20230331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMi0xLTEtMS0xNTU3MTU_6aa14494-de00-4522-9258-cbbf8e2eaeb0">78.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494e53d7c58e4d6584c23bf2ff9bfdde_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMi0zLTEtMS0xNTU3Mjc_70740fb1-d8d3-4faf-bfd2-ad821c826b94">94.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred consideration due from Biocon Biologics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife9befdab44e4072aed4aebf4c9a7ee7_I20230331" decimals="-5" name="vtrs:DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMy0xLTEtMS0xNTU3MTU_eec4d82e-8fea-4445-8c06-7599648c6446">305.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a2d261bfaa44f3a3567fe550854179_I20221231" decimals="-5" name="vtrs:DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMy0zLTEtMS0xNTU3Mjc_ba539502-888a-4f64-9b8a-1f30cc1d13f8">299.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCPS in Biocon Biologics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b9374126f5469796e980e745fabbf4_I20230331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfNC0xLTEtMS0xNTU3NDE_0b7b5339-e2f4-44f2-a38d-c844ea24d789">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2ad85211354ff6a1843c453c13ec41_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfNC0zLTEtMS0xNTU3NDg_04f80433-d710-4ac0-a094-160a97101e8b">997.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMi0xLTEtMS0xNTIyMDk_b312b5c4-7795-46d4-bc7d-2cc824fc971f">253.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMi0zLTEtMS0xNTIyMDk_a2f128ee-9d84-4e05-9b02-03a9b639209b">259.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="vtrs:Otherlongtermassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMy0xLTEtMS0xNTIyMDk_d0880237-b03a-4bfd-9ff1-2aaead05034d">779.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="vtrs:Otherlongtermassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMy0zLTEtMS0xNTIyMDk_a7bd17f3-3853-47d8-8730-d1d86810e8ab">753.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfNC0xLTEtMS0xNTIyMDk_a1a0dc9a-f0c7-448c-9b93-595dde5a7e97">2,418.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfNC0zLTEtMS0xNTIyMDk_9810154f-5307-4282-b2ec-04a827cc4da7">2,403.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAyMw_3f9255a2-6a1b-4e08-baa2-64af5e4656c1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts payable</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMS0xLTEtMS0xNTIyMDk_52fa197d-52c8-4759-b4d2-ef6d01e06ff9">1,415.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMS0zLTEtMS0xNTIyMDk_f682140d-4de3-400c-8a55-933724ebbb26">1,158.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMi0xLTEtMS0xNTIyMDk_a215af09-fecb-45fb-9235-8e6d582906e6">542.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMi0zLTEtMS0xNTIyMDk_32a5b430-d837-4045-a930-716a7c90f385">608.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMy0xLTEtMS0xNTIyMDk_2909fd6b-1f09-4623-8d68-ce746d6efa00">1,957.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMy0zLTEtMS0xNTIyMDk_6a546eb3-1b9a-4017-b910-c8b5895d68ad">1,766.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="ia2431d5719464ac497cbff6e674ec3fb"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAzNA_2ab9b85a-8a5d-4b01-a2cf-12332a7a5cd8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales allowances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibafb46da05ec4f79a412ebc6f057d351_I20230331" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMS0xLTEtMS0xNTIyMDk_83d7c5fa-e9af-4ccd-a4e0-a6c8d20e4a25">851.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55285f970c3f4df4babe369127a8eb7e_I20221231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMS0zLTEtMS0xNTIyMDk_46322539-fd5a-4262-b337-3491a59285c1">888.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and professional accruals, including litigation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMi0xLTEtMS0xNTIyMDk_d92c3fd8-ca93-4064-bfec-e34abdc2c90b">288.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMi0zLTEtMS0xNTIyMDk_89a71fec-8549-4efe-8e3b-a47687c85929">297.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee benefit liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMy0xLTEtMS0xNTIyMDk_f9a8f0bf-5204-4c1d-9415-c8965a9fb911">617.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMy0zLTEtMS0xNTIyMDk_ec072ec8-1e5f-4612-8f59-b5375a4e616f">746.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icabcde1e2ac34fc091515c433c41ff7c_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNC0xLTEtMS0xNTIyMDk_0c3f0492-629c-47e3-8249-e890726918b4">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc8794cd5f5a45ab8724cd054ea59719_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNC0zLTEtMS0xNTIyMDk_cad52d07-58df-456a-bc8b-96c879a8d598">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNS0xLTEtMS0xNTIyMDk_fbaaa735-c48d-45b1-87a3-8d0e32a4366e">74.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNS0zLTEtMS0xNTIyMDk_f52e87ef-ce9a-4519-b657-0ab7c65b8e25">95.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNi0xLTEtMS0xNTIyMDk_8b123791-3b9f-4004-bb37-2d6c45172208">214.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNi0zLTEtMS0xNTIyMDk_7cd47931-746f-42fc-a3b7-697ff49ac9a0">80.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfOS0xLTEtMS0xNTIyMDk_bf9f9903-f10e-4c7d-b7a5-2eab15041486">98.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfOS0zLTEtMS0xNTIyMDk_215fabc6-8e58-432a-93e7-8f52c02c9d9b">187.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to Biocon Biologics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTAtMS0xLTEtMTU1NzYz_aca02d64-f1e4-444f-b542-8a30a1765cf9">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTAtMy0xLTEtMTU1Nzcw_63ee7c76-7fbf-4dcb-85f2-ada6e53e75a1">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTAtMS0xLTEtMTUyMjA5_31a46bdc-fcd2-416d-8083-609db1e56dde">83.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTAtMy0xLTEtMTUyMjA5_b9f86921-de6a-4add-bc00-0e4997825587">80.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTEtMS0xLTEtMTUyMjA5_9d263e90-9d13-4ba7-9b84-58a4e1753e0b">866.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTEtMy0xLTEtMTUyMjA5_abffc416-3e23-4333-b528-24e2c0b66baf">978.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTItMS0xLTEtMTUyMjA5_95c77a53-7718-4f1a-9bf8-37f31ccd1ba3">3,192.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTItMy0xLTEtMTUyMjA5_d13949e9-fe7b-45ef-a497-da9fabba9014">3,440.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAyMg_fc1de333-2729-41f4-865f-b22822f5ba00" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term obligations</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfMS0xLTEtMS0xNTIyMDk_9932fa61-854d-4e86-89c5-fff17b87a36c">542.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfMS0zLTEtMS0xNTIyMDk_537efbfa-337b-41af-8f70-2eba032f0a52">544.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4564ffd038a447684a267ff28783411_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfMi0xLTEtMS0xNTIyMDk_4467f419-0ef0-4f1f-8150-e79f3b2e2a46">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14e5adad79794593a0ea10be84abb721_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfMi0zLTEtMS0xNTIyMDk_895fb99a-66f5-4136-b1a5-61cc28bb7030">310.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax related items, including contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNC0xLTEtMS0xNTIyMDk_a626c1f1-50d2-4d88-b3df-1cb17b33f4e6">418.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNC0zLTEtMS0xNTIyMDk_8212b814-8d7f-4efb-a132-5456e4c585e3">414.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNS0xLTEtMS0xNTIyMDk_b311b34e-21dd-412b-9d6d-4d932f25ce3c">173.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNS0zLTEtMS0xNTIyMDk_13a62aac-15d5-42b1-bd93-70cfe13f756a">181.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNi0xLTEtMS0xNTIyMDk_026876b7-f0a8-4b46-bd2b-53d7c7aee730">58.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNi0zLTEtMS0xNTIyMDk_dde2a22a-6771-4636-844e-7ea1d2f12189">60.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNy0xLTEtMS0xNTIyMDk_af761789-ae86-42e4-a706-5fe264131190">221.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNy0zLTEtMS0xNTIyMDk_0a49138e-93c9-4745-9f05-330e5d0fbadb">244.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfOC0xLTEtMS0xNTIyMDk_04b5a2a1-0eb5-477c-b3b0-8456beba7252">1,719.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfOC0zLTEtMS0xNTIyMDk_14d901d3-3924-4d76-ae67-1dddf8ca026a">1,756.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balances as of March&#160;31, 2023 and December&#160;31, 2022 include $<ix:nonFraction unitRef="usd" contextRef="ia7752f8ef2694f2a99cedc3a924ac6ed_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMzI5ODUzNDg4NzQ3Mg_3b48ca21-a723-4a2f-82b6-f1b794c94988">224.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic37bdf396cbd4497bee0629253c5ed9c_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMzI5ODUzNDg4NzUwMg_23da7e70-b881-47ef-a1b5-3a6816b8a772">221.2</ix:nonFraction>&#160;million, respectively, due to Biocon Biologics. Refer to Note 11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_73"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfNDk0NzgwMjMzODYwNg_20815689-e33b-4f25-86cd-9988f19fb5f3" continuedAt="i09975bb880a44f1baa174a200e936057" escape="true">Earnings&#160;per Share</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i09975bb880a44f1baa174a200e936057" continuedAt="i8e912cf2f6b345db8bc34838097ca30e"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMjYxMQ_011dd5bb-e3e4-400d-b34e-d45e0bfae99e" escape="true">Basic earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive</ix:nonNumeric>.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i8e912cf2f6b345db8bc34838097ca30e" continuedAt="i8b951f792af74fd4a86fe29b96ee0a2f"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMjYyNg_e0052822-9ddd-484a-b51e-fabde3d72247" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNC01LTEtMS0xNTIyMDk_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6">224.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNC03LTEtMS0xNTIyMDk_21ea8900-812e-42b1-bf29-832a88880c0e">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNi01LTEtMS0xNTIyMDk_76debc38-3b8b-4b93-8a36-50dd70c3cf6e">1,202.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNi03LTEtMS0xNTIyMDk_8b2d6b6a-6b95-4e9e-9bf5-53ff40cf0d67">1,210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNy01LTEtMS0xNTIyMDk_b57155b6-1e81-4877-a9e2-adcfc9db994c">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNy03LTEtMS0xNTIyMDk_1e207442-ce21-48af-b38c-5170d93323b4">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTAtNS0xLTEtMTUyMjA5_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6">224.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTAtNy0xLTEtMTUyMjA5_21ea8900-812e-42b1-bf29-832a88880c0e">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTItNS0xLTEtMTUyMjA5_76debc38-3b8b-4b93-8a36-50dd70c3cf6e">1,202.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTItNy0xLTEtMTUyMjA5_8b2d6b6a-6b95-4e9e-9bf5-53ff40cf0d67">1,210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTMtNS0xLTEtMTUyMjA5_90935131-8aaa-460a-993a-a37578822545">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTMtNy0xLTEtMTUyMjA5_869478ff-6fdd-496c-85bf-e8dc65777800">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTQtNS0xLTEtMTUyMjA5_dd88b844-0992-4cd0-9a61-cd5b49709139">1,205.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTQtNy0xLTEtMTUyMjA5_2aeae296-7ab9-4f06-abb6-c0e092257af6">1,213.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTUtNS0xLTEtMTUyMjA5_104acf74-a55e-4f80-ac07-90fab44094c9">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTUtNy0xLTEtMTUyMjA5_39a5ebcb-0a0d-4937-9096-0d039e67dc79">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional stock awards and Restricted Stock Awards were outstanding during the three months ended March&#160;31, 2023 and 2022, but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares at March&#160;31, 2023 include certain share-based compensation awards whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented <ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMTAxMQ_573af268-8ffe-4cb4-82bb-79d3842e0f56">13.9</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMTAyNQ_10cbffe2-31e4-4f21-8a1a-5c4de3d18946">15.5</ix:nonFraction> million shares for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid a quarterly dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMTExMg_11ef565d-0cdf-43aa-8520-ab4cf2058a99">0.12</ix:nonFraction> per share on the Company&#8217;s issued and outstanding common stock on March 17, 2023. On May&#160;5, 2023, the Company&#8217;s Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMjc0ODc3OTA3NjQyNQ_11ef565d-0cdf-43aa-8520-ab4cf2058a99">0.12</ix:nonFraction> per share on the Company&#8217;s issued and outstanding common stock, which will be payable on June&#160;16, 2023 to shareholders of record as of the close of business on May&#160;24, 2023. The declaration and payment of future dividends to holders of the Company&#8217;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#8217;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8b951f792af74fd4a86fe29b96ee0a2f">On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ibce300835f6a4dfb8c87fe6f01d94e1f_I20220228" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMjM0Mg_ea83f89f-b825-4f53-8795-1bd847d8564a">1.0</ix:nonFraction>&#160;billion of the Company&#8217;s shares of common stock. Such repurchases may be made from time-to-time at the Company&#8217;s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the three months ended March 31, 2023, the Company repurchased approximately <ix:nonFraction unitRef="shares" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfNTQ5NzU1ODI2Mzcw_86c482a7-97da-4c67-aee1-f13d536a1124">21.2</ix:nonFraction>&#160;million shares of common stock at a cost of approximately $<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfNTQ5NzU1ODI1MDU5_9d4579f7-2649-4e25-9a73-c0898d82b044">250</ix:nonFraction> million. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_76"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNDk0NzgwMjM2Mjc1OA_e975d4c3-b6f3-4db5-b7c6-87b05eb9655d" continuedAt="ie00116aeb68f4abf83a11303e4de06fb" escape="true">Goodwill and Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="ie00116aeb68f4abf83a11303e4de06fb" continuedAt="if816f4e74a3843f48ca5e95c37537caa"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNTc3Ng_29c3613a-1f8c-482b-936f-77fdbfbb9bc2" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a168ceffc44ea799955f726965f1d0_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC0xLTEtMS0xNTIyMDk_aba6f7c8-ba92-4390-826d-b008c60d1d81">7,461.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2da830898fd40bb9b3668c5d10555ed_I20221231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC0zLTEtMS0xNTIyMDk_3d28028d-90fe-4a5e-b7c0-fc5b25b4929f">940.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc04d16f571a462c997b93a923f5bc5a_I20221231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC01LTEtMS0xNTIyMDk_de2ee191-bed8-4092-be78-088ef668758b">689.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d05d24b3984c6196b0e4b79ecd82ef_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC03LTEtMS0xNTIyMDk_669134ac-1ef6-43fe-b19d-f90524dd3b68">1,334.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC05LTEtMS0xNTIyMDk_ca93f983-6642-4986-ae11-89cc560a8709">10,425.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cd4d116cadd4b549d18354ea24d6cf5_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS0xLTEtMS0xNTcyNjc_e7f528c1-8c0f-4801-a982-bbc8f2cbfc06">95.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba15018bb1de4cb0a89b3428e670872a_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS0zLTEtMS0xNTcyNzg_81d771d4-a7a9-4609-b64a-62983d694c31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcf87e3010d4446e9ea5180d2ecfef7e_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS01LTEtMS0xNTcyODc_658c16c7-0772-462d-ab64-43a098cabba0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b51c9edce9241cf9e636f46dacbbb52_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS03LTEtMS0xNTcyOTc_cb597eca-7b0e-4ad2-9dea-c3cdeb92a8ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS05LTEtMS0xNTcwOTE_61ba202b-7745-470e-b18d-9f1a25424d95">95.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cd4d116cadd4b549d18354ea24d6cf5_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi0xLTEtMS0xNTIyMDk_adaf76b4-194e-46e3-8dcb-47247f36ecdd">60.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba15018bb1de4cb0a89b3428e670872a_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi0zLTEtMS0xNTIyMDk_3e7b60eb-2dbc-489a-b4be-7bf69c8c9782">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcf87e3010d4446e9ea5180d2ecfef7e_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi01LTEtMS0xNTIyMDk_ebac5971-df9b-499a-a0fd-eebf4ac05506">8.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b51c9edce9241cf9e636f46dacbbb52_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi03LTEtMS0xNTIyMDk_f83e384f-a790-4e5b-8454-69970fec81a4">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi05LTEtMS0xNTIyMDk_c85a0e76-8b57-4420-a66b-547ab18e7cf9">52.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c5aa3032494e489c927959f359a259_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy0xLTEtMS0xNTIyMDk_91d71066-89c7-4e99-a358-310bf2ac4b1d">7,616.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d68b002f394987b51c9b480def8689_I20230331" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy0zLTEtMS0xNTIyMDk_c1e7f3ae-3985-4576-8150-c8ce3c258e80">940.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7adead5a097460c92b6ed763747d384_I20230331" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy01LTEtMS0xNTIyMDk_5afad424-80ca-4bb8-85a6-16437fec3646">680.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia03f8b88b0e846a5a2bdd752c26504f1_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy03LTEtMS0xNTIyMDk_0a38d719-4d21-4fe0-9247-f048801876d5">1,335.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy05LTEtMS0xNTIyMDk_70b58e1f-a670-4fd6-ade6-fd789b1eeea6">10,573.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $<ix:nonFraction unitRef="usd" contextRef="i44a168ceffc44ea799955f726965f1d0_I20221231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMTY0OTI2NzQ3MTA1MQ_1013b246-d91f-4c70-911d-f294742369d0"><ix:nonFraction unitRef="usd" contextRef="i24c5aa3032494e489c927959f359a259_I20230331" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMTY0OTI2NzQ3MTA1MQ_b71d1cd8-5146-4247-b6a3-d3ec465c8d0d">385.0</ix:nonFraction></ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $<ix:nonFraction unitRef="usd" contextRef="ia2d05d24b3984c6196b0e4b79ecd82ef_I20221231" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMTY0OTI2NzQ3MTE0OA_ad71c161-e151-42b2-aaf2-aef7903aa7d8"><ix:nonFraction unitRef="usd" contextRef="ia03f8b88b0e846a5a2bdd752c26504f1_I20230331" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMTY0OTI2NzQ3MTE0OA_f2899f44-748b-48a2-9b9c-d802a39df5e6">117.0</ix:nonFraction></ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNTgwMQ_21a27878-106c-4eb9-8cdc-26293e929b38" continuedAt="ib6eca99b8ce94323b49a5c0b1b76dbcb" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following components at March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Original Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic982925cfce647cf82de79117dfbd341_I20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMi0xLTEtMS0xNTIyMDk_bf2b3177-3302-410f-87c4-bdf6ee236314">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMi0zLTEtMS0xNTIyMDk_c212b51c-4977-4021-9787-7c74623daef4">37,975.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMi01LTEtMS0xNTIyMDk_7a9bb538-2f23-4526-a8f8-1027001ff424">15,604.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMi03LTEtMS0xNTIyMDk_6df2d826-264b-40bd-8c0b-bf1b17d14873">22,370.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMy0zLTEtMS0xNTIyMDk_2e1c091e-99bb-446c-8b30-a77b3b1a083e">331.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMy03LTEtMS0xNTIyMDk_78deeb54-2b4d-465b-9736-03f76a789b66">331.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNC0zLTEtMS0xNTIyMDk_17ecbcbc-7e1c-4496-90b4-d99b32d341c0">38,306.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNC01LTEtMS0xNTIyMDk_caeff1a4-f631-4373-bb53-e517607287a9">15,604.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNC03LTEtMS0xNTIyMDk_1b9176d6-9608-4da6-88fb-9c1773c0d74a">22,701.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1f049b3f11b4f54b61c23025e02cd69_I20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNi0xLTEtMS0xNTIyMDk_ddd622f4-a8ad-4567-854c-112ba10d4035">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNi0zLTEtMS0xNTIyMDk_cdb07c10-a74d-4e3e-bde6-51dc30657184">37,490.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNi01LTEtMS0xNTIyMDk_37bb4cad-7c7d-4fec-be1e-b7555f3fba88">14,923.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNi03LTEtMS0xNTIyMDk_8c90f84c-e274-4bb5-91f2-77870289df20">22,566.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNy0zLTEtMS0xNTIyMDk_f2f663f9-5778-496b-953e-8a70b14a6c97">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNy03LTEtMS0xNTIyMDk_a01e7b88-9f5b-44b1-b4df-8682df78ffdb">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfOC0zLTEtMS0xNTIyMDk_a3a05de8-c446-4a92-aaa1-c7ef9f6f7b4a">37,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfOC01LTEtMS0xNTIyMDk_0201eba0-a0c6-4fd3-ae74-e807210c8876">14,923.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfOC03LTEtMS0xNTIyMDk_1d404bce-2277-4405-9b92-86064d6e9983">22,607.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div></ix:nonNumeric><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"><ix:continuation id="ib6eca99b8ce94323b49a5c0b1b76dbcb" continuedAt="i3db5160143e347adbc94d64a0dd979e3">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"><ix:continuation id="i3db5160143e347adbc94d64a0dd979e3">Represents amortizable intangible assets. Other intangible assets consists principally of customer lists and contractual rights.</ix:continuation> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, the Company acquired product rights and licenses from Oyster Point of approximately $<ix:nonFraction unitRef="usd" contextRef="ie6948cc281cf4adbac2e6725c137289c_I20230331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMjE5OTAyMzI4NjgxNA_3566d447-fa07-47d0-954b-da98e8925296">334.0</ix:nonFraction> million and IPR&amp;D of approximately $<ix:nonFraction unitRef="usd" contextRef="i996c937d9d5d48bda3c5200c4b48c99f_I20221107" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMjE5OTAyMzI4NjkwNg_a80d4c82-429c-400a-b0b8-6219fda0e9e5">290.0</ix:nonFraction> million from Famy Life Sciences. Refer to Note 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Other Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense and intangible asset disposal &amp; impairment charges (which are included as a component of amortization expense) are classified primarily within cost of sales in the condensed consolidated statements of operations and were as follows for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNTgxMQ_7e4b878c-8aad-4f21-8866-839831ce3dfc" continuedAt="ie7b4df96163d49b793bad2f2bf71001a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfMy01LTEtMS0xNTIyMDk_16e9de0a-d0f6-49ac-a5f4-c90d5912cc01">603.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfMy03LTEtMS0xNTIyMDk_b92b0048-3953-4c34-be38-41f0ea2a2fe7">648.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset disposal &amp; impairment charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfNC01LTEtMS0xNTIyMDk_7e707cc5-e3e7-446d-930e-5d7a8c3c5651">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfNC03LTEtMS0xNTIyMDk_f112dde4-89d9-43e4-b6b4-80db716c38e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible asset amortization expense (including disposal &amp; impairment charges)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfNi01LTEtMS0xNTIyMDk_ae796878-6d04-46cf-bd69-7776e294a640">635.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfNi03LTEtMS0xNTIyMDk_295dd9b0-e38f-4277-a978-229d289f7b81">648.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="if816f4e74a3843f48ca5e95c37537caa"><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><ix:continuation id="ie7b4df96163d49b793bad2f2bf71001a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company recognized an intangible asset charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i3f1f9e0ec712462aa02e10848d2f65c0_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMzg0ODI5MDcyNzgzOA_49a088d1-e711-463f-a7c2-10bb13813cbe">32.0</ix:nonFraction>&#160;million, which was recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statement of operations, to write down the disposal group to fair value, less cost to sell, related to our Upjohn Distributor Markets, which are classified as held for sale. As of March&#160;31, 2023 and December&#160;31, 2022, the Company has approximately $<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMzg0ODI5MDcyNzg1NQ_88157663-16a2-48c0-9810-5ef79b999670">198.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMzg0ODI5MDcyNzkzNw_12f3206a-1193-4789-8679-e7d2c256f8ec">230.3</ix:nonFraction>&#160;million, respectively, of intangible assets related to the Upjohn Distributor Markets that are classified as held for sale in the condensed consolidated balance sheets. Refer to Note 5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></ix:continuation></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNTc4NQ_5e5c34cc-3f6e-4930-b74d-998c99be6ed2" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense over the remainder of 2023 and for the years ending December&#160;31, 2024 through 2027 is estimated to be as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:88.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfMS0xLTEtMS0xNTIyMDk_c81f4858-204f-459d-975d-f4bd5c909458">1,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfMi0xLTEtMS0xNTIyMDk_d3855657-ca23-4345-9898-f488e9c2d401">2,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfMy0xLTEtMS0xNTIyMDk_5cd4022c-f46c-4770-8fe8-a8fd82f0f703">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfNC0xLTEtMS0xNTIyMDk_b7ac0739-4e9c-4bf3-a3d2-fe949c780372">2,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfNS0xLTEtMS0xNTIyMDk_c3d2065e-e9e8-4673-a6af-62f3bdeab47f">1,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_79"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"> <ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfNDk0NzgwMjMzOTg0NA_055d44f5-69df-4941-92cf-229936e156d4" continuedAt="i78ea61959d984f6f83f9ece927c3e29a" escape="true">Financial Instruments and Risk Management </ix:nonNumeric></span></div><ix:continuation id="i78ea61959d984f6f83f9ece927c3e29a" continuedAt="i731b8469032a47d68423629795cc8a89"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain financial risks relating to its ongoing business operations. The primary financial risks that are managed by using derivative instruments are foreign currency risk and interest rate risk.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage certain foreign currency risks, the Company enters into foreign exchange forward contracts to mitigate risk associated with changes in spot exchange rates of mainly non-functional currency denominated assets or liabilities. The foreign exchange forward contracts are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. Any gains or losses on the foreign exchange forward contracts are recognized in earnings in the period incurred in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also entered into forward contracts to hedge forecasted foreign currency denominated sales from certain international subsidiaries and a portion of forecasted intercompany inventory sales denominated in Euro, Japanese Yen, Chinese Renminbi and Indian Rupee for up to twenty-four months. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are deferred in AOCE and are reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries by either borrowing directly in foreign currencies and designating all or a portion of the foreign currency debt as a hedge of the applicable net investment position or entering into foreign currency swaps that are designated as hedges of net investments. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated certain Euro and Yen borrowings as a hedge of its investment in certain Euro-functional and Yen-functional currency subsidiaries in order to manage foreign currency translation risk. Borrowings designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of AOCE until the sale or substantial liquidation of the underlying net investments. In addition, the Company manages the related foreign exchange risk of the Euro and Yen borrowings not designated as net investment hedges through certain Euro and Yen denominated financial assets and forward currency swaps. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i731b8469032a47d68423629795cc8a89" continuedAt="i54c5a9b9c2814270b946b60abf82f90c"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfNDk0NzgwMjMzOTg0NQ_389109d4-ed86-433f-93d8-572986beed94" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the principal amounts of the Company&#8217;s outstanding Euro and Yen borrowings and the notional amounts of the Euro and Yen borrowings designated as net investment hedges: </span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount Designated as a Net Investment Hedge</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250% Euro Senior Notes due 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifbe3333f61454c84aa7ec708e22cf50c_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMi0yLTEtMS0xNTIyMDk_d4610f66-402f-48f5-8b47-c28b63df1e85">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifbe3333f61454c84aa7ec708e22cf50c_I20230331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMi00LTEtMS0xNTIyMDk_e40750c0-31d6-4314-97d0-33c9501e39ef">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie396961017544da680998993a54500ae_I20221231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMi02LTEtMS0xNTIyMDk_0fcda3ba-cac9-4021-9466-b96b5f0226c8">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% Euro Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ica7ce119b71f4c0f84b95edb750bd215_I20230331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMy0yLTEtMS0xNTIyMDk_bbc95f41-dc14-4a6d-8787-64a554f1f98b">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ica7ce119b71f4c0f84b95edb750bd215_I20230331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMy00LTEtMS0xNTIyMDk_2661d4d1-00c3-4681-a172-b1eaa7e31774">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i885ad38fc2be452e97695525e6721fa0_I20221231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMy02LTEtMS0xNTIyMDk_8fbeff54-ed96-4f9f-a7c0-93039ab34ea9">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.125% Euro Senior Notes due 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c21320592b2492982ea12b7c9ddd364_I20230331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNS0yLTEtMS0xNTIyMDk_35a44080-fd21-4898-bdb6-6583584ae5b6">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c21320592b2492982ea12b7c9ddd364_I20230331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNS00LTEtMS0xNTIyMDk_1eacf5f0-225c-4f44-8075-21eb01195b70">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic304f109b5af446bba86e77735791f79_I20221231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNS02LTEtMS0xNTIyMDk_fcc41624-b12e-4da2-81b3-76a0d3f048b4">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.023% Euro Senior Notes due 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8a2b9e568d104103be8e6c431eeddd69_I20230331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNy0yLTEtMS0xNTIyMDk_139b39fa-1511-44e8-bd8d-846a8d8257f5">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8a2b9e568d104103be8e6c431eeddd69_I20230331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNy00LTEtMS0xNTIyMDk_290d5e63-59d7-4c87-be69-c37ff6cf32bf">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8a47696467454d118794e701966eb0aa_I20221231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNy02LTEtMS0xNTIyMDk_4ede21c7-9380-4880-988d-6208a0fa5945">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.362% Euro Senior Notes due 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib05ddeb5d86c4f4cbb3686204e71d481_I20230331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOC0yLTEtMS0xNTIyMDk_99ad04f9-7464-431c-bd84-7a539c2ea776">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib05ddeb5d86c4f4cbb3686204e71d481_I20230331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOC00LTEtMS0xNTIyMDk_918aa07b-6819-4b1e-8b0a-0ae1bf368086">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57bb0ac7d16846ecaeeda10a472323ef_I20221231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOC02LTEtMS0xNTIyMDk_2b06e083-0ee3-4d3d-85ab-d88a741ed57d">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.908% Euro Senior Notes due 2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8965fb764557415db2ad30aa82c09452_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOS0yLTEtMS0xNTIyMDk_e804f6ee-4a74-4d86-866c-18054195db04">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8965fb764557415db2ad30aa82c09452_I20230331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOS00LTEtMS0xNTIyMDk_c39a2ca9-c6c6-447a-834d-2e694e2ca832">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i56a888a26f4245358cf12889162baef1_I20221231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOS02LTEtMS0xNTIyMDk_37a22c52-65b4-45dc-bec3-ad1ff7eb7011">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i19cf17be970444d4845ad42cb06b2677_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTEtMi0xLTEtMTUyMjA5_a8e19829-0855-4df1-813e-a2c06db2bf67">5,100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i19cf17be970444d4845ad42cb06b2677_I20230331" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTEtNC0xLTEtMTUyMjA5_e8780746-dc50-4702-ae9a-b626e90a5473">5,100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia1f1a8fa6fa4437c9bd8dd8ddc85d818_I20221231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTEtNi0xLTEtMTUyMjA5_2e270228-c66b-4194-88a7-8fa48c94831b">5,100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yen</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i3e3d152425d4436f82b8f359ed8c09f4_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTQtMi0xLTEtMTUyMjA5_2db5a43f-5619-4364-84bc-711af11e7204">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i3e3d152425d4436f82b8f359ed8c09f4_I20230331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTQtNC0xLTEtMTUyMjA5_dc42bbd2-32e8-4b1c-b34e-766d0f812b7c">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="ib0852b77d93a45c1a8784b9f5e09c74a_I20221231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTQtNi0xLTEtMTUyMjA5_ba82cd0f-9a55-4ac7-ac37-c191e84b28b3">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i19cf17be970444d4845ad42cb06b2677_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTUtMi0xLTEtMTUyMjA5_07056291-53a6-43ea-9fc5-ca62d8600f7e">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i19cf17be970444d4845ad42cb06b2677_I20230331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTUtNC0xLTEtMTUyMjA5_80e4b8c0-293b-4cac-9b95-eee7128e4e0a">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="ia1f1a8fa6fa4437c9bd8dd8ddc85d818_I20221231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTUtNi0xLTEtMTUyMjA5_94b963a7-901c-4373-928d-7a1815883846">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the principal amount of the Company&#8217;s outstanding Yen borrowings and the notional amount of the Yen borrowings designated as net investment hedge was $<ix:nonFraction unitRef="usd" contextRef="ie3e1cb3c13a143b689debc78a157f9c9_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfMTY0OTI2NzQ1MTAxOQ_a99b1ab6-e63a-4c89-9c51-136746bb8001">301.1</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into interest rate swaps from time to time in order to manage interest rate risk associated with the Company&#8217;s fixed-rate and floating-rate debt. Interest rate swaps that meet specific accounting criteria are accounted for as fair value or cash flow hedges. All derivative instruments used to manage interest rate risk are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. For fair value hedges, the changes in the fair value of both the hedging instrument and the underlying debt obligations are included in interest expense. For cash flow hedges, the change in fair value of the hedging instrument is deferred through AOCE and is reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews the creditworthiness of its financial counterparties and does not expect to incur a significant loss from the failure of any counterparties to perform under any agreements. The Company is not subject to any obligations to post collateral under derivative instrument contracts. Certain derivative instrument contracts entered into by the Company are governed by master agreements, which contain credit-risk-related contingent features that would allow the counterparties to terminate the contracts early and request immediate payment should the Company trigger an event of default on other specified borrowings. The Company records all derivative instruments on a gross basis in the condensed consolidated balance sheets. Accordingly, there are no offsetting amounts that net assets against liabilities. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i54c5a9b9c2814270b946b60abf82f90c" continuedAt="if627cc56fbee454e9b9dda050714a3ea"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfOTI5Mw_2d0fdb48-2761-4cd8-8b1a-dd63b6550a1a" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:33.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.219%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32bb170f1dbc494785245d5ad91eba44_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNS0yLTEtMS0xNTIyMDk_d32c0e9a-fb12-4b42-92a7-e2f57288fec7">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5d765ee12a43d8989fbf61ed0f5502_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNS0zLTEtMS0xNTIyMDk_cdbc373f-4552-4b97-a9e9-6ffdd6759fa2">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id328c8b356cb438ba2e2f88139f233d0_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNS02LTEtMS0xNTIyMDk_713f9ff7-9a61-4219-91d8-4808e702866b">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da6cef7335b4e4db5c63ae8d42c311a_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNS03LTEtMS0xNTIyMDk_1ebe22f0-5397-452d-8796-19de2dc149dd">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95612143e25a4851b2e592fb2c3a2107_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNi0yLTEtMS0xNTIyMDk_c2555be3-6d0d-4229-a130-3b7a19734033">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9f6de36f5e14d028a657fc060b5a560_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNi0zLTEtMS0xNTIyMDk_f3376b37-ae0e-468a-a2ae-d2d55a479f2a">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95612143e25a4851b2e592fb2c3a2107_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNi02LTEtMS0xNTIyMDk_a7157c00-933c-44b2-86ab-8e4d6107edeb">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9f6de36f5e14d028a657fc060b5a560_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNi03LTEtMS0xNTIyMDk_0fc1fe88-0811-409f-99c1-3a164a54f44e">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c95a99b1fb14d86b6a9b89d594cce92_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOC0yLTEtMS0xNTIyMDk_a6def199-8472-44ba-8f0c-54f5cfc2a40d">70.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d16ca0470534939982b3b58e635e4cc_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOC0zLTEtMS0xNTIyMDk_63f81d60-d3cf-42a9-9695-d63246eb57b2">104.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76576107d9424efab6ea88538bb83135_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOC02LTEtMS0xNTIyMDk_f8190094-6b98-49eb-9d4a-6fbb2b34e493">82.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d3bcc8d2474192926ed306031b5219_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOC03LTEtMS0xNTIyMDk_07bc996e-e790-4808-916a-dd79b08b03d3">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a79042b83904696b7dab397210c97de_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOS0yLTEtMS0xNTIyMDk_cf31a7bd-25d0-4c85-9bff-fe38efd12251">70.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41550c188ad64365a22d3f4a47fc1c72_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOS0zLTEtMS0xNTIyMDk_7eb34acf-4ca4-41b4-9586-f36b897ddc12">104.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a79042b83904696b7dab397210c97de_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOS02LTEtMS0xNTIyMDk_ab51e16b-a9b3-4006-9311-8622d6ca1696">82.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41550c188ad64365a22d3f4a47fc1c72_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOS03LTEtMS0xNTIyMDk_f4ed6a04-3e70-457f-ab03-185e5565bd86">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfMTAtMi0xLTEtMTUyMjA5_f9d9dca7-9a73-45b9-ae62-a945dcfde9e5">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfMTAtMy0xLTEtMTUyMjA5_560e0178-bbe0-4bec-ba55-641c9746c4ec">134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfMTAtNi0xLTEtMTUyMjA5_bf9f9903-f10e-4c7d-b7a5-2eab15041486">98.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfMTAtNy0xLTEtMTUyMjA5_215fabc6-8e58-432a-93e7-8f52c02c9d9b">187.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfNDk0NzgwMjMzOTg0Ng_c52f72fd-122e-43a4-8dde-57f3943de28e" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Reclassified from AOCE into Earnings </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb5fda2dcee4ee48e405c5c088a9cba_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfNy00LTEtMS0xNTIyMDk_8e448699-8973-4dcd-95f1-3752921f468d">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa16117507db4c7d96b63dc143d74a16_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfNy01LTEtMS0xNTIyMDk_e73e50dd-b6ce-46c5-bfe7-4f2d029dc28f">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb5fda2dcee4ee48e405c5c088a9cba_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfNy02LTEtMS0xNTIyMDk_033eef94-59d4-45f1-acd3-58d021d6150e">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa16117507db4c7d96b63dc143d74a16_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfNy03LTEtMS0xNTIyMDk_32b7de5f-c691-4ac2-87d0-5e8b454560df">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6aaffa691e74bc68e8db4464b4b93b0_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfOC00LTEtMS0xNTIyMDk_d03d6d78-5be7-4351-a4ed-8b173beacea9">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i033455f156d34be29697cc8ac9e0a137_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfOC01LTEtMS0xNTIyMDk_0dbe9872-758a-4752-afa2-196c29826c2c">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6aaffa691e74bc68e8db4464b4b93b0_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfOC02LTEtMS0xNTIyMDk_afd960e1-e783-4c18-b095-7c9dd40afc8f">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i033455f156d34be29697cc8ac9e0a137_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfOC03LTEtMS0xNTIyMDk_df57b89e-08dc-4560-8ec3-7f017bcb0793">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-derivative Financial Instruments in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2d01ba8a140497580deaf3d68bc57c6_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTAtNC0xLTEtMTUyMjA5_083a509b-b172-4741-9fe8-f3812cab6fcf">51.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c134b8f719242bcac28ad4399b788eb_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTAtNS0xLTEtMTUyMjA5_1f0ed790-8946-4ca5-a70b-6c395104ae46">156.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib20e6f463286430596383180d843d2b3_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTItMi0xLTEtMTUyMjA5_b86eaae4-cda6-4c83-a4fb-e0b8197ca972">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19bc1f2778e4b71aa630ae6b6490e7f_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTItMy0xLTEtMTUyMjA5_19a23206-1a4b-441a-91cb-e4d31e8bd2d5">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff39c4924c6045ef84e3abaad48f1286_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtMi0xLTEtMTUyMjA5_4ff12583-c463-4fed-bc36-27a21ed75681">44.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09b7735438346cf9ab1c042bed96f76_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtMy0xLTEtMTUyMjA5_d590b5f0-6e7c-4e53-bcda-392a6965f2a9">21.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNC0xLTEtMTUyMjA5_cef57db0-3b3f-45e4-b7d1-988969baa518">41.7</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNS0xLTEtMTUyMjA5_a993b24c-6782-4baf-a468-99f885963552">165.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNi0xLTEtMTUyMjA5_4887caca-f07f-4b0b-b696-c5e3db7fe373"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNi0xLTEtMTUyMjA5_515ed922-f212-410d-ae2c-d7742be1c98e">7.7</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNy0xLTEtMTUyMjA5_4b7092c6-41e0-4d00-8ff8-fc32cd4c9ab6">13.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">At March&#160;31, 2023, the Company expects that approximately $<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfNDg5Nw_1baaeec4-c7f4-4bc0-9735-9d64de7c7534">14.0</ix:nonFraction> million of pre-tax net losses on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) recognized in earnings on derivatives.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) reclassified from AOCE into earnings.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurement</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfOTI3MQ_52f92e27-69ba-47bb-85ee-b95964be6ddc" continuedAt="if2dcfdac09f143969c1eeb167536ec82" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;2: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="if627cc56fbee454e9b9dda050714a3ea" continuedAt="i1c93dc88d39949b4b0b8a19f0af6f417"><ix:continuation id="if2dcfdac09f143969c1eeb167536ec82"><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;3: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.</span></div></ix:continuation><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfOTMwMg_4ae91db5-e97f-4d7a-a2c9-4112aecebc7d" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb50b90a095f42bfbdbed451dae7f23a_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfNS0xLTEtMS0xNTIyMDk_5772bd00-76f7-48cf-a327-0f1185d3cc00">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727faafb4659486cb209f1a14a62e389_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfNS03LTEtMS0xNTIyMDk_3f51c74e-5b34-4dc4-bd52-6d9d2fbc3894">688.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i136bafc75ccd449baf4eeb49e8ed395c_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfNi0xLTEtMS0xNTIyMDk_49124d03-d18b-4c86-96b1-7d3c9200bef0">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102e0cf7ff2044a6938b0f83e352bb2d_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfNi03LTEtMS0xNTIyMDk_d391b666-6fe8-4e62-ba51-8b241679b841">688.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39da740d7a5e4e9cad2bd54f10ce8b8d_I20230331" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfOC0xLTEtMS0xNTIyMDk_7505d2de-6b23-452e-89db-5237af2a7b48">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb432e1314914336835cf836fe99ecf1_I20221231" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfOC03LTEtMS0xNTIyMDk_3f5b97d4-d297-4a97-9681-755814173c26">42.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3e2b23886947408f9c609cccaed1aa_I20230331" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfOS0xLTEtMS0xNTIyMDk_dfa858b0-0c51-4796-aaf2-28c8b343ac92">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i270cf7b9b34147cdaf4584be4a06eb92_I20221231" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfOS03LTEtMS0xNTIyMDk_e7251e6d-8251-4561-872b-1faf7bd9f954">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i136bafc75ccd449baf4eeb49e8ed395c_I20230331" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTAtMS0xLTEtMTUyMjA5_ecec7923-5386-4365-9e77-c2c3727fc6b1">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102e0cf7ff2044a6938b0f83e352bb2d_I20221231" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTAtNy0xLTEtMTUyMjA5_14603bb8-fcd7-456e-afb0-a2e485bc40aa">42.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCPS in Biocon Biologics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d5fffc549546b2a7f21ebeacd3566a_I20230331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTEtNS0xLTEtMTU2NTY0_8cc79dc7-f95e-4ca4-a49a-bd0f73c1b9e4">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bf9a42591eb4cefaba32caf3d775d3d_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTEtMTEtMS0xLTE1NjUxOQ_a21079ee-bda4-4695-9c23-7092e542d4b3">997.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4d0ff8e2db44ce9ae2f1ca09cfc8552_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTItMy0xLTEtMTUyMjA5_a5b5e4a0-e6a5-4974-bfc0-a0ca02fb9b40">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i643ad899563b4c6287162649c1da7644_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTItOS0xLTEtMTUyMjA5_8f2d3846-1513-4e31-99ba-3417e437af08">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e0450507d0a453d85394a568087e78a_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTMtMy0xLTEtMTUyMjA5_4809cd4b-9ece-49ea-8925-05660aff42bf">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008ef5af2daf4f18a58c19dbec22403d_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTMtOS0xLTEtMTUyMjA5_12e49f6b-f70e-4b89-b528-6491972b4856">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df571154fb44e9dbe311072fe73af02_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTQtMy0xLTEtMTUyMjA5_9752ef66-c2e2-4ccf-9c00-8fd5ca47ea6f">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc9395cd9b914745ac220a1b31c0d019_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTQtOS0xLTEtMTUyMjA5_a790a68d-9f4d-4fb4-b934-697aab659e7e">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfb2649e55847359386336e4a39492b_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTUtMy0xLTEtMTUyMjA5_1ea4c462-e8d2-4856-8df8-0e8050037307">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b47320bd11d4ba6a393be87cd0c63dc_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTUtOS0xLTEtMTUyMjA5_811b65ea-559a-4036-8b3a-5ab11cbee512">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26f62ce70fb445afa3148d671d5ebd33_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTYtMy0xLTEtMTUyMjA5_dc4bb772-0ba8-43fc-ab6e-b85e9a6f50ff">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69dfbf841e784966a9622614817e595e_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTYtOS0xLTEtMTUyMjA5_ac4c3e09-3932-4025-a8b5-36d12ac3ba9b">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id230763240ed4c6c83ac699f54873ca3_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTctMy0xLTEtMTUyMjA5_9f110b27-e22b-44b3-82c4-fdc9b764a324">36.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic78bfd7523094db7ac5361c6c822eb32_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTctOS0xLTEtMTUyMjA5_62a5be98-66d4-4b90-ae53-4f0d0f3d1adb">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9607c4d62444cf687b9b06b8559c927_I20230331" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTgtMy0xLTEtMTUyMjA5_53f879bd-477e-4fcc-be44-97217a279d1b">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8cc0295da54b078e56ab7384f33b40_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTgtOS0xLTEtMTUyMjA5_033a876f-1aaa-4c73-9559-6a44c0ea39bd">134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i136bafc75ccd449baf4eeb49e8ed395c_I20230331" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtMS0xLTEtMTUyMjA5_a378f01b-e4b1-4bbe-8b5a-f9e4ea2b8f20">63.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea89f8fb0aa40198430e003e80835d2_I20230331" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtMy0xLTEtMTUyMjA5_09736fa9-810d-496c-ab43-d7484dace503">128.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8b8df80f6437d9eb2ba03e638b416_I20220331" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtNS0xLTEtMTUyMjA5_80364e62-8710-48e7-af65-5d59028f00c3">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102e0cf7ff2044a6938b0f83e352bb2d_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtNy0xLTEtMTUyMjA5_4fa36bf8-7618-4ee8-a0f0-e0621d79bfc5">731.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1131eca694994821b250886968225201_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtOS0xLTEtMTUyMjA5_c7f75d2d-caa5-411f-a1bf-6a107bff7fca">170.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1cf6b0039a4e34bf81064509086ca1_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtMTEtMS0xLTE1MjIwOQ_c17e3f4d-5115-44d8-99b7-162a14906873">997.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9607c4d62444cf687b9b06b8559c927_I20230331" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjMtMy0xLTEtMTUyMjA5_41e6a64b-fa00-48a6-8bf9-7fea71a4c33f">98.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8cc0295da54b078e56ab7384f33b40_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjMtOS0xLTEtMTUyMjA5_1e30e2fc-e1c7-49db-ab97-f9dfc8cb69f5">187.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc9b2995dd46460594e214fd8e8ee132_I20230331" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjQtNS0xLTEtMTUyMjA5_adbb0b23-eae8-440b-a7bf-f669bc24eafb">372.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjQtMTEtMS0xLTE1MjIwOQ_57e63236-417c-4fc4-91fe-2cccc60fe31a">375.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea89f8fb0aa40198430e003e80835d2_I20230331" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjUtMy0xLTEtMTUyMjA5_82733278-bfd6-439a-b534-efb199483ce2">98.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee880d6bc130465f829292543ad30b02_I20230331" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjUtNS0xLTEtMTUyMjA5_c60b7894-8a29-497e-a653-2d6743f309a8">372.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1131eca694994821b250886968225201_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjUtOS0xLTEtMTUyMjA5_86ada482-5263-4358-bcf0-0a9b70926fa9">187.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1cf6b0039a4e34bf81064509086ca1_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjUtMTEtMS0xLTE1MjIwOQ_f0e02c07-a1dd-4c01-8a14-dfeddd615567">375.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial assets and liabilities that utilize Level&#160;2 inputs, the Company utilizes both direct and indirect observable price quotes, including the LIBOR yield curve, foreign exchange forward prices and bank price quotes. Below is a summary of valuation techniques for the Company&#8217;s financial assets and liabilities:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at observable net asset value prices.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, exchange traded funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the active quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, marketable securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using quoted stock prices from public exchanges at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">CCPS in Biocon Biologics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; valued using a Monte Carlo simulation model using Level 3 inputs. The fair value of the CCPS is sensitive to changes in the forecasts of operating metrics and changes in volatility and discount rates. The Company elected the fair value option for the CCPS under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 825. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value is reassessed </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i1c93dc88d39949b4b0b8a19f0af6f417"><div style="margin-bottom:6pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarterly and any change in the fair value estimate is recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the condensed consolidated statements of operations for that period.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale fixed income investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value, net of income taxes, are included in accumulated other comprehensive loss as a component of shareholders&#8217; equity.</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign exchange derivative assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using quoted forward foreign exchange prices and spot rates at the reporting date. Counterparties to these contracts are highly rated financial institutions.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, the Company had a contingent consideration liability of $<ix:nonFraction unitRef="usd" contextRef="ia7752f8ef2694f2a99cedc3a924ac6ed_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfMzg0ODI5MDcwOTg1Mw_3b48ca21-a723-4a2f-82b6-f1b794c94988">224.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic37bdf396cbd4497bee0629253c5ed9c_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfMzg0ODI5MDcwOTg2MQ_23da7e70-b881-47ef-a1b5-3a6816b8a772">221.2</ix:nonFraction>&#160;million, respectively, relating to the Biocon Biologics Transaction. This contingent consideration liability represents the amount of the closing working capital target to which the parties have agreed that may become payable to Biocon Biologics in connection with certain events in the future, depending on the valuations attributable to such events. The remaining contingent consideration liability represents a component of the total purchase consideration for Pfizer&#8217;s Respiratory Delivery Platform and certain other acquisitions. The measurement of these contingent consideration liabilities is calculated using unobservable Level 3 inputs based on the Company&#8217;s own assumptions primarily related to the probability and timing of future events and payments which are discounted using a market rate of return. At March&#160;31, 2023 and December&#160;31, 2022, discount rates ranging from <ix:nonFraction unitRef="number" contextRef="ic1fa0b36fa9a43ebb31730df132d5260_I20230331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfODYwOA_3b192cb9-a186-4b4a-8a16-b2ba4716898a">6.4</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="if59e5e36fb7b445db0598c8c22d1736c_I20230331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfMzg0ODI5MDcwOTMzMg_bc9e32c8-149c-4070-afe6-29ea78b12f99">9.0</ix:nonFraction>% were utilized in the valuations. Significant changes in unobservable inputs could result in material changes to the contingent consideration liability.</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfOTMwNA_6247910b-85ad-4ce4-9593-f871b6197c08" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the activity in the Company&#8217;s fair value of contingent consideration from December&#160;31, 2022 to March&#160;31, 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Portion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc8794cd5f5a45ab8724cd054ea59719_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMS0xLTEtMS0xNTIyMDk_cad52d07-58df-456a-bc8b-96c879a8d598">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14e5adad79794593a0ea10be84abb721_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMS0zLTEtMS0xNTIyMDk_895fb99a-66f5-4136-b1a5-61cc28bb7030">310.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMS01LTEtMS0xNTIyMDk_57e63236-417c-4fc4-91fe-2cccc60fe31a">375.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMi0xLTEtMS0xNTIyMDk_846d7bb4-b11a-4e8a-a86f-f3c9cc182525">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2bf973f8224e918b2deff514202349_D20230101-20230331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMi0zLTEtMS0xNTIyMDk_cb22f485-29cb-422e-86cb-2a175e604f9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMi01LTEtMS0xNTIyMDk_27f16de1-ff26-4c5d-9a94-2e1161a7873d">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMy0xLTEtMS0xNTIyMDk_3ac4e88e-6acc-42f4-9fb9-25631f84ac24">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2bf973f8224e918b2deff514202349_D20230101-20230331" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMy0zLTEtMS0xNTIyMDk_4dd06a3b-ddbb-4b87-9eb4-951a988f0121">10.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMy01LTEtMS0xNTIyMDk_b855e187-cb10-4803-b034-a8067f81e940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331" decimals="-5" name="us-gaap:AccretionExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNC0xLTEtMS0xNTIyMDk_ad4db7a1-5380-4deb-8a14-28c0dcd07107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2bf973f8224e918b2deff514202349_D20230101-20230331" decimals="-5" name="us-gaap:AccretionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNC0zLTEtMS0xNTIyMDk_f5e96fda-8709-447c-9a1e-5a58824479bb">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:AccretionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNC01LTEtMS0xNTIyMDk_5f37891e-3afa-445c-81f6-de8b4338b6e5">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNS0xLTEtMS0xNTIyMDk_dcc9c1e1-9756-4cd7-9234-4bcbf4f3b55e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2bf973f8224e918b2deff514202349_D20230101-20230331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNS0zLTEtMS0xNTIyMDk_0ff2c3d0-5dd8-44fe-b2ba-3e8d75bf8c09">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNS01LTEtMS0xNTIyMDk_634d7a42-552c-4180-84b4-23a1ef612e2e">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icabcde1e2ac34fc091515c433c41ff7c_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNi0xLTEtMS0xNTIyMDk_0c3f0492-629c-47e3-8249-e890726918b4">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4564ffd038a447684a267ff28783411_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNi0zLTEtMS0xNTIyMDk_4467f419-0ef0-4f1f-8150-e79f3b2e2a46">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNi01LTEtMS0xNTIyMDk_5c4914de-8b0d-4e64-8b20-325431a21d2e">372.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other current liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other long-term obligations in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in litigation settlements and other contingencies, net in the condensed consolidated statements of operations.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company has not elected the fair value option for other financial assets and liabilities other than the CCPS, any future transacted financial asset or liability will be evaluated for the fair value election.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_82"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfNDk0NzgwMjMzMDY2OQ_037b0e2c-2da5-4811-b3b0-33cbdc668cfe" continuedAt="iea5f22c72977427283d2931704ed8c77" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="iea5f22c72977427283d2931704ed8c77" continuedAt="i73471d7a09bf4730b50a0bd4c9ada5d0"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For additional information, see Note 11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in Viatris&#8217; 2022 Form 10-K.</span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjE2OA_9d686911-fba7-49aa-9971-3e230e380255" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s short-term borrowings:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805aacd5cf1a4ce1ba773d8974bb6661_I20230331" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfMi0xLTEtMS0xNTIyMDk_1397f033-13e1-4b73-8f10-4b4fadb79c10">197.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if318bfa8c5bc43749fd2a6b351b2adc5_I20221231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfMi0zLTEtMS0xNTIyMDk_b0f3fbb1-30f0-4b30-8e6b-4f87e4b3a130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16bd0a431ac944bbadbc94516ff5579b_I20230331" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfNC0xLTEtMS0xNTIyMDk_2823c523-fe04-49fb-ac13-b68dbbdac99f">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i527c9f5ddc6248d0bd4ecaeb320cfeab_I20221231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfNC0zLTEtMS0xNTIyMDk_98ef253a-5ea5-40cb-869f-30e06298582b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term borrowings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfNS0xLTEtMS0xNTIyMDk_9ec82bdd-ead5-4135-9fce-67c318295659">204.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfNS0zLTEtMS0xNTIyMDk_597f9227-eadf-4d4c-b6ed-c04368c429f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables Facility and Note Securitization Facility </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a $<ix:nonFraction unitRef="usd" contextRef="ia2b328e8ff4e4db3903e428de1caf104_I20230331" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjIz_1b0208e4-718a-481e-8ea8-11bb7f9caf67">400</ix:nonFraction>&#160;million Receivables Facility, which expires in April 2025 and a $<ix:nonFraction unitRef="usd" contextRef="i0fa49fa66d4a4ec1b6581ce013ff9335_I20230331" decimals="-6" name="vtrs:AccountsReceivableFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjc0ODc3OTA3MzI1Ng_3072bc2e-72c0-4034-9d29-16ebda421421">200</ix:nonFraction>&#160;million Note Securitization Facility which expires in August 2023. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The amount that we may borrow at a given point in time is determined based on the amount of qualifying accounts receivable that are present at such point in time. Amounts outstanding under either facility are included as a component of short-term borrowings, while the accounts receivables securing these obligations remain as a component of accounts receivable, net, in our condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Long-Term Debt</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective April 28, 2023, we executed an amendment to the Revolving Facility to convert the benchmark interest rate from LIBOR to an adjusted SOFR, with no change in the applicable interest rate margins. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i73471d7a09bf4730b50a0bd4c9ada5d0" continuedAt="i3e14a617c61841eab299eed14c107b45"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjE4Ng_9fc3c07b-623e-4546-9a94-84f0b672a65f" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A summary of long-term debt is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate as of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i537b244fd18e4182836b3cbcea192aa1_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTAtMS0xLTEtMTUyMjA5_1ae70157-cf1d-4804-aa95-d9f6532abcab">3.125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537b244fd18e4182836b3cbcea192aa1_I20230331" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTAtMy0xLTEtMTUyMjA5_6b66ab79-b910-455c-84ae-0253e96fb01f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e90d47f433640e2bf15e3caa1252192_I20221231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTAtNS0xLTEtMTUyMjA5_ffb5e7ae-66e7-496f-87e7-3f5cffcb568a">750.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf8243d3d2554b6d9cea845ed1d5d62a_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtMS0xLTEtMTU1MTI3_eff2f787-79c2-47c7-a0a4-ad55ac158b97">4.200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf8243d3d2554b6d9cea845ed1d5d62a_I20230331" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtMy0xLTEtMTU1MTM3_68fe9e17-d4ce-454b-9af7-140c1dbf0fb8">499.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d844dcfe611431e8c69a0bffa93ef38_I20221231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtNS0xLTEtMTU1MTg1_cb910e4f-9f27-4365-970b-986c9f4dcd21">499.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16bd0a431ac944bbadbc94516ff5579b_I20230331" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtMy0xLTEtMTUyMjA5_8b553224-3f5b-4015-8385-645a96e07aae">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i527c9f5ddc6248d0bd4ecaeb320cfeab_I20221231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtNS0xLTEtMTUyMjA5_bc4a0b99-830c-44fb-bf41-c6ec30309355">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13546a349b7f46fa8d08aa0489cd82e4_I20230331" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTItMy0xLTEtMTUyMjA5_4cb3a69e-da01-4b8b-8694-ae8a4b4b3c05">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if92b069c1f4e4856b8df4e367b12a543_I20221231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTItNS0xLTEtMTUyMjA5_dc8dc533-a409-4987-a0d2-cd981cb4fa43">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTMtMy0xLTEtMTUyMjA5_c754334d-9583-419f-a849-7a412114d403">500.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTMtNS0xLTEtMTUyMjA5_60f1a1f1-ac02-4c33-8c3a-965bf309eb1c">1,250.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current portion of long-term debt:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d3557139bf74fa9bdae809541e470fc_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjAtMS0xLTEtMTUyMjA5_e14f79f9-b6c7-4543-81de-ade9c29cac74">2.250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d3557139bf74fa9bdae809541e470fc_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjAtMy0xLTEtMTUyMjA5_c3874399-c6da-4aa1-b56c-9dceb7a74047">1,083.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b39ad011d3c4a15991d1d4ee3f647c9_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjAtNS0xLTEtMTUyMjA5_9f36fdb1-2c77-4057-a0cc-b39401ac3eb0">1,069.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3836b4fcf19c4f2da97d1cb2617e47f0_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjEtMS0xLTEtMTUyMjA5_326d87fd-18b2-4cd0-901c-977491f1ae51">1.023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd73adf36414a74a4252d27d4ca70ec_I20230331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjEtMy0xLTEtMTUyMjA5_42310aaa-ef23-4632-9fe3-982ab87a115e">821.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if13c7fadd2634767b990dc153d4bc9d1_I20221231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjEtNS0xLTEtMTUyMjA5_e83bf1a2-477c-4e5b-91ed-3bb8b095a89b">813.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i72f0ba982f0c46649f0f6561954343f1_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjItMS0xLTEtMTUyMjA5_8b6e6440-7632-4a4e-b252-83e35fa5769c">2.125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f0ba982f0c46649f0f6561954343f1_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjItMy0xLTEtMTUyMjA5_760091a9-9492-46d2-9517-548e84677f2d">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1054d206503b46788f1af5e9ce6beaf3_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjItNS0xLTEtMTUyMjA5_36426fc7-9359-4f19-877e-ea83720e95b1">534.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86b93357479f4e96a4acc48b266c2ec1_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjMtMS0xLTEtMTUyMjA5_fc1155a5-08f2-4e89-b008-7d39066c12ed">1.650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86b93357479f4e96a4acc48b266c2ec1_I20230331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjMtMy0xLTEtMTUyMjA5_22bef3f7-8c35-4138-8aa1-afeb1a21bb57">758.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb18dcdcc883404780abde6cf47443fd_I20221231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjMtNS0xLTEtMTUyMjA5_1b2cd765-480a-4dd1-9934-bc76266afd1e">759.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if358ae2472cf4162861457de119d795e_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjQtMS0xLTEtMTUyMjA5_75156627-bd0f-406a-a7d5-53de15d98600">3.950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if358ae2472cf4162861457de119d795e_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjQtMy0xLTEtMTUyMjA5_79692af8-7462-41c5-9496-d983925c34cf">2,243.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39cd72e6c89f4d72b882807ad54849a4_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjQtNS0xLTEtMTUyMjA5_32c5d2a6-4198-4acb-b380-c7434a813add">2,243.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8e8bd4e2ae64bfbab3cac97c001f7ac_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjUtMS0xLTEtMTUyMjA5_bbe8f3ba-4ecc-4f96-85b1-15d6fdd5c121">1.362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857e28cb283b4b62abcfcd309a7a0760_I20230331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjUtMy0xLTEtMTUyMjA5_68cda89e-34cf-468f-800e-7df0831b26c4">955.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b1ab43a7b04663ade5cdd52c52abf3_I20221231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjUtNS0xLTEtMTUyMjA5_c9cf2ff6-d53e-4a67-a583-4adf2377f782">945.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i172d496acb304a198d699f43d147eb23_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjYtMS0xLTEtMTUyMjA5_6176805c-7d2b-45e1-8ada-4f02875435d7">2.300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd1128fe8054c7ea24c3e527cc585e4_I20230331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjYtMy0xLTEtMTUyMjA5_4ff2ca68-7515-4b1e-8718-4442440c02ae">774.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d043725e3814483b6471de9237a3773_I20221231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjYtNS0xLTEtMTUyMjA5_4eb31cae-9171-4351-8c31-166a669241a6">775.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i854b8e342187430ea79336139d6db506_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjctMS0xLTEtMTUyMjA5_7704a575-5d75-4ee6-941b-5bbf6c704e56">3.125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854b8e342187430ea79336139d6db506_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjctMy0xLTEtMTUyMjA5_7abb196d-de93-49ee-96a0-ed554db79e9d">808.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9b36997fe44efb8dfe9e0f82e471b0_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjctNS0xLTEtMTUyMjA5_e809a58c-9cfa-42a3-8b5b-c41ea59008c4">798.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a7ccd82fc9d47beaf2c85dbe5315393_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjgtMS0xLTEtMTUyMjA5_1c51dc93-ed26-462a-80d1-0f4867425e74">4.550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia583e565814b4727be66c81be6c677f8_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjgtMy0xLTEtMTUyMjA5_01f314d4-5b8a-4beb-87d1-62cc109dc116">749.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b643f05917e4cadba7092929694b6d1_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjgtNS0xLTEtMTUyMjA5_2607dca2-8559-444e-9caf-e35dedab3217">748.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c494b24b67e4b878e564a8146c3138e_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjktMS0xLTEtMTUyMjA5_2dd1b907-7892-45fc-be87-2b4604b75ea1">2.700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c494b24b67e4b878e564a8146c3138e_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjktMy0xLTEtMTUyMjA5_936ed716-ea05-4f54-9477-81f4d513dfe7">1,510.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f77f20d41cc4b8bbc1a3e3b098cc442_I20221231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjktNS0xLTEtMTUyMjA5_39884bd6-b773-4808-9429-afc79847bf3f">1,512.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41482c056aa94a55925d9dcd2e1b6b43_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzAtMS0xLTEtMTUyMjA5_8fe7c12e-fdff-40d7-9fb2-371fed63d892">1.908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41482c056aa94a55925d9dcd2e1b6b43_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzAtMy0xLTEtMTUyMjA5_6d6efef0-0331-4578-acc2-2975280372fe">1,459.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4051ef5b1fdb4486882771f6cbe8ec88_I20221231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzAtNS0xLTEtMTUyMjA5_e5f2fa0f-d4a3-4369-ac89-c5a160651f17">1,444.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01e123519fbc4c39860f273c6d6d3ed5_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzEtMS0xLTEtMTUyMjA5_dcd92f86-8c49-4aef-bf5f-9d9d317b7509">3.850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e123519fbc4c39860f273c6d6d3ed5_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzEtMy0xLTEtMTUyMjA5_7c30e2c9-8b1a-44ab-96ba-2ffa41375b5d">1,648.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6ac2dc615d4e66b3bb6dfa9566e439_I20221231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzEtNS0xLTEtMTUyMjA5_0966d43b-02c9-4e28-84b6-f58569d98210">1,650.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0efddbd5dd4e48c7acdd24a96aa2380e_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzItMS0xLTEtMTUyMjA5_bf9ef4f8-7eff-47d4-8001-64564639e810">5.400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0efddbd5dd4e48c7acdd24a96aa2380e_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzItMy0xLTEtMTUyMjA5_a053a602-3561-49d2-ba4d-f80c48165f52">497.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i645867315f0942119eafce9860005bd7_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzItNS0xLTEtMTUyMjA5_7be58539-8ac0-4d4f-bdc4-d1478dca71aa">497.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2046 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> **</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80b3a71a4e4048318317277ea1c7419c_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzMtMS0xLTEtMTUyMjA5_859364b4-3b7b-4ce3-a011-32b587e8968a">5.250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b3a71a4e4048318317277ea1c7419c_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzMtMy0xLTEtMTUyMjA5_72a76f7e-6012-46f9-886e-4fc951cae85b">999.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i523192e82a694962b8a599b8e7f560b7_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzMtNS0xLTEtMTUyMjA5_f43e72ab-0269-4c07-b7a8-85e430fc7d91">999.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> *</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ef5520b9a764945b96e8cea3b80abeb_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzQtMS0xLTEtMTUyMjA5_65b7d255-e173-4630-9347-c645b1c9ea6a">5.200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151b130c785b49219e6112e1742e9cfa_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzQtMy0xLTEtMTUyMjA5_0bea8ba9-19b9-4dac-8e82-e6e2d4b2a1ed">747.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54e64fcf3dd741b4ab858d4916d39201_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzQtNS0xLTEtMTUyMjA5_aad9b2a8-f582-4543-be65-1aeedab68042">747.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5552e043c1c444cc88e4f40941845034_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzUtMS0xLTEtMTUyMjA5_8b5d4f15-d254-4c69-8823-42f2eef97918">4.000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5552e043c1c444cc88e4f40941845034_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzUtMy0xLTEtMTUyMjA5_dbed274c-3351-4c90-9fab-711b59b92488">2,199.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69039fe5d46240fa8529c57fdfe22935_I20221231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzUtNS0xLTEtMTUyMjA5_02072ae3-dca3-4e91-a57e-a14d4af22cf3">2,200.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2097e990594c218bca3f144aca2453_I20230331" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzYtMy0xLTEtMTUyMjA5_75005fb6-4d08-424c-adaf-c8d5bcb03397">301.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9f8feb05d94562b542bb89be4c3aec_I20221231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzYtNS0xLTEtMTUyMjA5_12904549-6aa4-4290-a0ae-2938cb96a8bb">305.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45165edb089b40d0b8b4833405ea227b_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzctMy0xLTEtMTUyMjA5_56140850-23dd-41e7-a4ad-c3505ac71efc">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d5c20c94e5f427e8b1f4cc452481487_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzctNS0xLTEtMTUyMjA5_287e2fe1-711a-4cb8-b5bf-e9911723e8ed">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzgtMy0xLTEtMTUyMjA5_7559e8a1-84f3-414d-a497-c1a5f7610b4f">33.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzgtNS0xLTEtMTUyMjA5_1154c5b3-b40a-4ce6-881c-9e3fd6eadc4c">35.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzktMy0xLTEtMTUyMjA5_014ee4f0-8d76-4f7d-b2d3-73bdbc237c78">18,069.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzktNS0xLTEtMTUyMjA5_22ba4421-2fbb-4f0a-9abb-3dc5f2cc9048">18,015.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMTM4Ng_b2cec4fc-47f3-461f-9138-2aed017e2d82">45</ix:nonFraction> million. The fair value adjustment was amortized to interest expense over the remaining term of the notes, which were repaid at maturity in the first quarter of 2023.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Mylan Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was originally issued by Mylan N.V.; now held by Utah Acquisition Sub Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Viatris Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Upjohn Finance B.V.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022, the aggregate fair value of the Company&#8217;s outstanding notes was approximately $<ix:nonFraction unitRef="usd" contextRef="ie091a09167a34a0fa7933475fb2de76d_I20230331" decimals="-7" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMTgwNw_7945866f-3f4c-4cb9-b0cd-bad0d70634d3">15.04</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i6164435f803841129e7672cc12bb4100_I20221231" decimals="-7" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMTgxNA_6c219c45-729c-49af-adfb-50d54e2ab9f0">15.36</ix:nonFraction> billion, respectively. The fair values of the outstanding notes were valued at quoted market prices from broker or dealer quotations and were classified as Level 2 in the fair value hierarchy. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i3e14a617c61841eab299eed14c107b45"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjE2NA_29a63a1e-936f-4247-b3ab-9f40122e73dc" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at March&#160;31, 2023 were as follows for each of the periods ending December 31:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:88.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfMS0xLTEtMS0xNTIyMDk_c55e603c-da6a-45a0-b56f-22c3c0280f6a">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfMi0xLTEtMS0xNTIyMDk_b9427630-803a-4dc1-974a-a6c08ab5870c">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfMy0xLTEtMS0xNTIyMDk_63838dc7-c2f4-4c43-aadc-71c133bf02aa">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfNC0xLTEtMS0xNTIyMDk_8b2d8fcf-a37f-49ba-9808-f8df1ee43b3b">2,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfNS0xLTEtMS0xNTIyMDk_a0d7e782-4d10-4b2c-868f-b6ae715b59cb">1,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfNi0xLTEtMS0xNTIyMDk_3fbb2964-4c31-4b7d-b898-01587b2cc5c8">10,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfNy0xLTEtMS0xNTIyMDk_4bf79c94-0201-4b10-b3e7-aca9676fb779">18,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4aaf90299ead4f42aa5d7a1f46495b27_88"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RleHRyZWdpb246MWY5MDU2ZWJlY2M3NDkyMjk3NzgwMTM1YTdmNjkzZjlfMjQ0_28bd8eea-fc7d-4345-920a-ac84068c00b1" continuedAt="i90ecd463ec8c4eacb60239159e28e1d4" escape="true">Comprehensive Loss</ix:nonNumeric></span></div><ix:continuation id="i90ecd463ec8c4eacb60239159e28e1d4" continuedAt="i4e88c512400b49fd93af1ccb9c944bf9"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RleHRyZWdpb246MWY5MDU2ZWJlY2M3NDkyMjk3NzgwMTM1YTdmNjkzZjlfMjU0_771a0a72-46c1-40ba-ba65-42e9c97511f8" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, is comprised of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfMi0xLTEtMS0xNTIyMDk_e32b5470-e969-41ae-9145-d0e2e0be2d00">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfMi0zLTEtMS0xNTIyMDk_8abb2c62-01a6-4d21-bc18-b3e10152f632">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain and prior service cost related to defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfMy0xLTEtMS0xNTIyMDk_4ec99cc1-0f15-40cf-9a49-6c70e3e5e9ad">269.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfMy0zLTEtMS0xNTIyMDk_700389d1-5ddc-45ce-aa48-fed75c95190f">268.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b9dbb9ff801489ba2f6837aa806ff2d_I20230331" decimals="-5" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNC0xLTEtMS0xNTIyMDk_b86725f5-e84c-4479-9128-a4ff5eb161b1">16.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c7eb919fe344f70963ed690e633c735_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNC0zLTEtMS0xNTIyMDk_8bb13535-bc94-4f35-96c8-9b90e7386110">18.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain on derivatives in net investment hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9bb674e162c40018526646782e70d3f_I20230331" decimals="-5" name="vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNS0xLTEtMS0xNTIyMDk_2c34bd4f-9f6f-4495-b2dc-431e32cc54aa">325.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88989aa1d54540a1ba2ca6eb8ea846f6_I20221231" decimals="-5" name="vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNS0zLTEtMS0xNTIyMDk_c1f57cee-224b-40df-88a0-80d78faf83fb">377.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNi0xLTEtMS0xNTIyMDk_056632b1-5c90-4666-aa9f-865f6beefcf5">3,340.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNi0zLTEtMS0xNTIyMDk_37da2eec-75eb-4a01-9047-ee9dace929e8">3,385.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNy0xLTEtMS0xNTIyMDk_7aada9a8-b7a4-4e4e-a047-f7908ceb5c7e">2,764.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNy0zLTEtMS0xNTIyMDk_3bb63c4d-4aa6-4b1c-93e2-70ba0bf1eccd">2,761.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i4e88c512400b49fd93af1ccb9c944bf9" continuedAt="idf78a39e202041ecbe43e27546d9cb8a"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RleHRyZWdpb246MWY5MDU2ZWJlY2M3NDkyMjk3NzgwMTM1YTdmNjkzZjlfMjU2_91e50fe0-7ea1-4734-883f-00b4ffb30830" continuedAt="ifa57531d56404b4d92ccc38db77fdf0e" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.121%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c7eb919fe344f70963ed690e633c735_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy01LTEtMS0xNTIyMDk_8bb13535-bc94-4f35-96c8-9b90e7386110">18.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88989aa1d54540a1ba2ca6eb8ea846f6_I20221231" decimals="-5" name="vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy03LTEtMS0xNTIyMDk_c1f57cee-224b-40df-88a0-80d78faf83fb">377.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy05LTEtMS0xNTIyMDk_8abb2c62-01a6-4d21-bc18-b3e10152f632">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy0xMS0xLTEtMTUyMjA5_700389d1-5ddc-45ce-aa48-fed75c95190f">268.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy0xMy0xLTEtMTUyMjA5_37da2eec-75eb-4a01-9047-ee9dace929e8">3,385.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy0xNS0xLTEtMTUyMjA5_3bb63c4d-4aa6-4b1c-93e2-70ba0bf1eccd">2,761.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie700760d8134451a9ff6e163dcbd5a13_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC01LTEtMS0xNTIyMDk_5cbb7fc7-02d5-4360-abfc-8aee973c85bc">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5b5d8f65e7443a99c925d594d0cd6eb_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC03LTEtMS0xNTIyMDk_71802a2f-4413-43d4-8be2-9fe12ee318e1">66.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC05LTEtMS0xNTIyMDk_6f7f4815-3f77-4e7b-9040-66bb5748a1f6">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bbf2add3a0c4216b0a8608247495af6_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC0xMS0xLTEtMTUyMjA5_96970301-30aa-475e-9bf0-4505bd9af75e">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac9ac025fb9047918980605e59a944c5_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC0xMy0xLTEtMTUyMjA5_83c970db-519f-40cf-bacd-9e500e32a4fb">45.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i642a69b7eb80475580b6dfe8e7de979e_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC0xNS0xLTEtMTUyMjA5_eb2c5d17-cf83-4b40-a604-70900555488c">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcee7fb1e8624576b13773ba17f2f11f_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNi0xLTEtMS0xNTIyMDk_05abfeb6-5137-44cc-9944-753d0fdb5d84">8.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb3b8082108848a18225ef4298c3618f_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNi01LTEtMS0xNTIyMDk_38252b75-bcb2-4530-abc1-8a6aea033f35">8.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i653a14a89cb24d7c952dd0cdd3772c49_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNi0xNS0xLTEtMTUyMjA5_9ccd48b6-2b89-43eb-a8e1-38b38734862a">8.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2d9f4048943460b9f1afbb1f59b8dda_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNy0zLTEtMS0xNTIyMDk_d90675b3-5a16-4549-a969-df02ad349a4b">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9dbeed2d83b425eb1378354668ce7a1_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNy01LTEtMS0xNTIyMDk_db7e4b6a-bbc2-4699-8b51-a7f215583d6b">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f32bd065ca46ffa60c567a5d2f9e1c_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNy0xNS0xLTEtMTUyMjA5_d2b5b369-f88b-406c-a419-afea2192a19f">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfOS0xMS0xLTEtMTUyMjA5_25e2bf52-d8c4-4b47-9a2c-4ccfb3c9bfb7">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05e33061fbdd49b7968f96b8dd318a25_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfOS0xNS0xLTEtMTUyMjA5_16eea33d-0593-47c7-bd6c-70a29da06113">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bb079be9f2d4c24819ae36c2b302e6d_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtNS0xLTEtMTUyMjA5_591ab22b-6b02-4c6e-8e75-bd7a3a81fbe5">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5b5d8f65e7443a99c925d594d0cd6eb_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtNy0xLTEtMTUyMjA5_71802a2f-4413-43d4-8be2-9fe12ee318e1">66.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtOS0xLTEtMTUyMjA5_6f7f4815-3f77-4e7b-9040-66bb5748a1f6">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtMTEtMS0xLTE1MjIwOQ_e5432901-7173-49af-92fb-e181d8718758">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac9ac025fb9047918980605e59a944c5_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtMTMtMS0xLTE1MjIwOQ_83c970db-519f-40cf-bacd-9e500e32a4fb">45.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtMTUtMS0xLTE1MjIwOQ_f15e7980-6cc3-4a58-bf19-63f8e4a8b6c7">15.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie700760d8134451a9ff6e163dcbd5a13_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtNS0xLTEtMTUyMjA5_d78a3740-a828-4c8d-a463-d602531b9484">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8618f25668574c53b1ce780bdda393cd_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtNy0xLTEtMTUyMjA5_a0e3cf9d-ed25-457f-bca7-84b68d4cb28d">14.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i086be58c57004badb55c1e1264fe37ea_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtOS0xLTEtMTUyMjA5_6899bffd-6153-4619-9039-62bf4e141e35">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19242480fa2943ffb4a03206eee18d1a_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtMTEtMS0xLTE1MjIwOQ_447feef2-3c42-4c35-b537-2170d1dec56d">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8647ea8c4a242b99d262a0ac976d962_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtMTMtMS0xLTE1MjIwOQ_5446cc62-b30f-4982-b99c-9a0da0a4abff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05e33061fbdd49b7968f96b8dd318a25_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtMTUtMS0xLTE1MjIwOQ_9e22d000-0f30-4570-8e24-3cadb67751d8">12.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b9dbb9ff801489ba2f6837aa806ff2d_I20230331" decimals="-5" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtNS0xLTEtMTUyMjA5_b86725f5-e84c-4479-9128-a4ff5eb161b1">16.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9bb674e162c40018526646782e70d3f_I20230331" decimals="-5" name="vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtNy0xLTEtMTUyMjA5_2c34bd4f-9f6f-4495-b2dc-431e32cc54aa">325.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtOS0xLTEtMTUyMjA5_e32b5470-e969-41ae-9145-d0e2e0be2d00">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtMTEtMS0xLTE1MjIwOQ_4ec99cc1-0f15-40cf-9a49-6c70e3e5e9ad">269.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtMTMtMS0xLTE1MjIwOQ_056632b1-5c90-4666-aa9f-865f6beefcf5">3,340.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtMTUtMS0xLTE1MjIwOQ_7aada9a8-b7a4-4e4e-a047-f7908ceb5c7e">2,764.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;text-align:center"><ix:continuation id="idf78a39e202041ecbe43e27546d9cb8a"><ix:continuation id="ifa57531d56404b4d92ccc38db77fdf0e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.266%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c3760f0cea642d3b75f6140cdf414f6_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy01LTEtMS0xNTIyMDk_fa99395a-96aa-47f1-a750-c3d7f5423eb0">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e1a1cbd2814cdfb45518b14ca40fa2_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy03LTEtMS0xNTIyMDk_7b3bdfff-42b9-4513-92f4-9c4f775882fa">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5b623ff3fa4a61a5c7435e3ab00ba1_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy05LTEtMS0xNTIyMDk_a204a4d0-25a3-4ac7-840c-8aea92c6203a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1995c57b4f49c3801e36a80fd70ceb_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy0xMS0xLTEtMTUyMjA5_27086a3a-b096-46a0-ab31-24de5934a3b7">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cbade31da7d415f8970e976b4686580_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy0xMy0xLTEtMTUyMjA5_56e34028-defe-4ccf-b80e-094174104ea0">1,802.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5cca97d09754ca0bea07369d3464420_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy0xNS0xLTEtMTUyMjA5_242f2139-1190-4ba6-a380-55aa80a54bbb">1,744.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab095d0d7984d658aad5fc11e1e6f28_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC01LTEtMS0xNTIyMDk_16d3b957-097f-471c-b4d3-82e4a30a699f">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i328661c86aa84ea7b204b4667f8a7ffb_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC03LTEtMS0xNTIyMDk_c63ff969-8479-4386-b490-d212c74219c7">201.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fdf7ff53f764505aa2b21fa6a270f0f_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC05LTEtMS0xNTIyMDk_4e1a8641-80bf-4184-b296-e5f26ddcf4dc">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1cc5ed71d974468b6ff290b943426c5_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC0xMS0xLTEtMTUyMjA5_93b6080c-1ab9-432c-a784-6b90512ad00d">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ae943df1fa3437894a62abc523b173a_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC0xMy0xLTEtMTUyMjA5_e71fb811-3c19-491a-a267-00578de9a5f8">469.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1ed98849f874127b2a3dc2dc4a7df89_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC0xNS0xLTEtMTUyMjA5_149b9d13-543b-4ada-92a1-b9a44e7cad5c">259.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34bb0ea6145343a2bc5c0602b02aeb12_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNi0xLTEtMS0xNTIyMDk_23fadcb6-647a-4059-899b-874a95e20fc9">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34bb0ea6145343a2bc5c0602b02aeb12_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNi01LTEtMS0xNTIyMDk_c1f5069a-5823-42d5-a3c2-7d44cd9cbb60">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71aa5d94a6b94d69adfd79846798fdc1_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNi0xNS0xLTEtMTUyMjA5_84560870-5eac-49aa-9fb8-4d56842d7ae2">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia036fdd378d343f684dfc8d7b749bf36_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNy0zLTEtMS0xNTIyMDk_a3122cc9-67b9-4129-ab72-9d0422eab0f3">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia036fdd378d343f684dfc8d7b749bf36_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNy01LTEtMS0xNTIyMDk_1e30d734-15fe-4d52-b9d0-f2d2a5a0efda">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafb16f84e2694f219ad64bdc9fb4f90c_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNy0xNS0xLTEtMTUyMjA5_e4f05689-68c6-4628-b3ff-de509e8ade18">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa100fdde39948c2bacf727a7f77eb4f_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfOC0xMS0xLTEtMTUyMjA5_3ebc7c56-7848-4e7b-be35-44d7151ca982">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c4e86dc90d4fc8958401ed6a97dee9_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfOC0xNS0xLTEtMTUyMjA5_68b7d673-4e3b-49d3-a987-03ea8c2207fa">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie33127a010dd40c8adcfde67ca93dc7e_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtNS0xLTEtMTUyMjA5_69dc9786-d0ca-44ba-a043-fd39d14a12f8">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddcf29ff66b4e319b5952469cb3a1fe_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtNy0xLTEtMTUyMjA5_920bf228-a952-4b5a-888a-324a0785065f">201.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtOS0xLTEtMTUyMjA5_8f0b55eb-3981-4090-8ba3-f023445dd3fd">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa100fdde39948c2bacf727a7f77eb4f_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtMTEtMS0xLTE1MjIwOQ_91914d86-aea8-485a-a839-e45b907905d5">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ae943df1fa3437894a62abc523b173a_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtMTMtMS0xLTE1MjIwOQ_e71fb811-3c19-491a-a267-00578de9a5f8">469.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtMTUtMS0xLTE1MjIwOQ_6c7618f4-591b-4bd7-9cb9-569105d4502e">272.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab095d0d7984d658aad5fc11e1e6f28_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtNS0xLTEtMTUyMjA5_d7770929-3d88-45a4-8731-5d7442bb3f63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i328661c86aa84ea7b204b4667f8a7ffb_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtNy0xLTEtMTUyMjA5_c5e655cb-73e3-4dfa-a47a-9030533ad134">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fdf7ff53f764505aa2b21fa6a270f0f_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtOS0xLTEtMTUyMjA5_110e5780-ea04-4b65-9eda-d206efaebf05">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1cc5ed71d974468b6ff290b943426c5_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtMTEtMS0xLTE1MjIwOQ_10c61671-61b6-4e45-b1d5-8fdcfae1d3b6">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e40190a3504890bf2e78ce510c754c_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtMTMtMS0xLTE1MjIwOQ_a95eb6c8-190e-4dbc-85da-ad4166ab2f24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ed98849f874127b2a3dc2dc4a7df89_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtMTUtMS0xLTE1MjIwOQ_4c670969-0f04-475b-8106-4c8b03040c65">44.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c64ee065eb44f80bd6e5ddda1a2f52d_I20220331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtNS0xLTEtMTUyMjA5_5fcff7d1-6859-4615-bce7-6f8fd04a6068">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6070629af342578a23395267253ebb_I20220331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtNy0xLTEtMTUyMjA5_3364762e-a372-4474-9c30-eb1dcd04e272">173.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib982817ac2e847f5a2ae10b0747f4ea8_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtOS0xLTEtMTUyMjA5_836cecca-461c-4274-a26b-00b429a0f52e">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf01e5ae97624ffbb92ea194c400357c_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtMTEtMS0xLTE1MjIwOQ_3eec3da9-5544-4d68-bf5e-572cbdcb505f">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d522e397a694dc085575dc00034f8a1_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtMTMtMS0xLTE1MjIwOQ_0df4e84f-a6c8-400f-987b-4acbc212dfcc">2,271.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8e5c94cf86d4321a4e0a9f4c01d3c24_I20220331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtMTUtMS0xLTE1MjIwOQ_d77d5036-8772-4318-8ff3-8728ae27f483">2,061.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_91"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RleHRyZWdpb246MTZjOWUxNjljYWE4NDQzZmI4OGI1NDljOGQ1ZWQ5ZTlfMzQ3OA_52941f5d-a81a-4580-b83c-f7bc40125e72" continuedAt="i3f88d435586547e899ec91ca53f33817" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="i3f88d435586547e899ec91ca53f33817" continuedAt="i1f3eea4b222c43daa2545177242b218e"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RleHRyZWdpb246MTZjOWUxNjljYWE4NDQzZmI4OGI1NDljOGQ1ZWQ5ZTlfMzQ5Mw_2bcbe016-e56b-409f-899b-2293dc32f30d" continuedAt="i799573d16542444ca07728934254bec9" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Intangible asset amortization expense and impairments of goodwill and long-lived assets;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">R&amp;D and acquired IPR&amp;D expense;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Net charges or net gains for litigation settlements and other contingencies;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i1f3eea4b222c43daa2545177242b218e"><ix:continuation id="i799573d16542444ca07728934254bec9"><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including costs related to our planned divestitures and the Biocon Biologics Transaction, and, as applicable, any associated transition activities. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the segments are the same as those described in Note 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in the 2022 Form 10-K.</span></div></ix:continuation><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RleHRyZWdpb246MTZjOWUxNjljYWE4NDQzZmI4OGI1NDljOGQ1ZWQ5ZTlfMzQ5MQ_c68b5350-0050-4031-85c6-0ecaa6d27095" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment Profitability</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reportable Segments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6f2a14b0ce43ab83b734dd64d12bf6_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNS0yLTEtMS0xNTIyMDk_549c5245-bbe0-4dcd-a11d-87a7be01d7da">2,170.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ea4f3f734d40279fcbeea57318b608_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNS00LTEtMS0xNTIyMDk_5e963337-2205-41b6-a10d-3ccafa167c6f">2,476.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6f2a14b0ce43ab83b734dd64d12bf6_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNS02LTEtMS0xNTIyMDk_cb7c1b3a-b6db-4dcd-b3fb-5e6333cf8f38">938.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ea4f3f734d40279fcbeea57318b608_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNS04LTEtMS0xNTIyMDk_6912ede1-2182-4a74-8a73-d48f69345c2c">1,211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe5245728a44cb18a87377e4c3de0c8_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNi0yLTEtMS0xNTIyMDk_8be5b063-47fb-4d52-b5a8-52e998d6bc46">564.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dcb2e059604510889393247056ff68_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNi00LTEtMS0xNTIyMDk_380ef47b-8f37-4fa9-84fe-5ffedb7ce606">573.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe5245728a44cb18a87377e4c3de0c8_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNi02LTEtMS0xNTIyMDk_7b4a7822-c5d3-4baf-b6fb-5f0dde9c725e">394.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dcb2e059604510889393247056ff68_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNi04LTEtMS0xNTIyMDk_77595102-02e3-4423-8054-590af39bba3e">417.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717ccb375e6a4e1a88e76775cf3a0015_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNy0yLTEtMS0xNTIyMDk_3af7668d-35a3-45ad-a39d-0b1e77559786">342.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f11f4d488d4d6b8d1b2a5657ed7bd8_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNy00LTEtMS0xNTIyMDk_6ab4f3f0-ebe6-4be1-952e-16936535252b">423.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717ccb375e6a4e1a88e76775cf3a0015_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNy02LTEtMS0xNTIyMDk_80c99b70-ca69-4cdf-8824-947059c7d10c">130.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f11f4d488d4d6b8d1b2a5657ed7bd8_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNy04LTEtMS0xNTIyMDk_0caf10c9-6507-42d0-a539-eb284519e3a5">174.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id962b30d667e44d79767fd8e3799bc1d_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOC0yLTEtMS0xNTIyMDk_f9b84ccb-6839-4272-9bb9-5cb6a2449456">641.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8791ebb35b584298bcab2b2bcfa56d9d_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOC00LTEtMS0xNTIyMDk_6b9d35ce-be98-4eaa-8cfa-e504be7ddcab">705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id962b30d667e44d79767fd8e3799bc1d_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOC02LTEtMS0xNTIyMDk_5ea50b4e-9eea-4a9b-a031-7f757276c4be">313.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8791ebb35b584298bcab2b2bcfa56d9d_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOC04LTEtMS0xNTIyMDk_70e4aca2-7705-4a72-86de-ef766b35261f">345.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOS0yLTEtMS0xNTIyMDk_d6a3229c-0786-4951-a5a8-4ab79b02dc94">3,719.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOS00LTEtMS0xNTIyMDk_48830341-6acf-46f1-858e-c435eee8149f">4,178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d12c29bdbb4f2b854964dbfa89ef0e_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOS02LTEtMS0xNTIyMDk_9300acd7-35a7-4abc-8648-62d0e18f5c3b">1,776.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269e5c8eeb184f499dfffbeebba19832_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOS04LTEtMS0xNTIyMDk_9234c082-3765-47a6-b011-3f12b96f2a00">2,148.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTItNi0xLTEtMTUyMjA5_f5b85f3a-3c16-4d52-8a07-529f68455191">603.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTItOC0xLTEtMTUyMjA5_6a9854e5-e326-4b4b-9a8f-8234b1b24b66">648.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset disposal &amp; impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTMtNi0xLTEtMTUyMjA5_51c6d5c9-403f-46e4-bbd0-ce46122c952f">32.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTMtOC0xLTEtMTUyMjA5_9245ad03-624f-4b0f-b240-a743f6da435d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Globally managed research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTQtNi0xLTEtMTUyMjA5_205a7c4e-185b-4f69-848b-d7f8064dae6e">182.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTQtOC0xLTEtMTUyMjA5_672b9759-4193-4ddd-9628-c5bfd3a3658e">142.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements &amp; other contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTUtNi0xLTEtMTUyMjA5_8f6058f7-288b-4923-a10d-3ae63d7ca7eb">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTUtOC0xLTEtMTUyMjA5_56914bf1-2e73-4753-8cbd-20df2beddced">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction related and other special items</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331" decimals="-5" name="vtrs:OtherOneTimeNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTYtNi0xLTEtMTUyMjA5_f7b544f2-4cc3-4831-884a-030b3ed3263f">178.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331" decimals="-5" name="vtrs:OtherOneTimeNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTYtOC0xLTEtMTUyMjA5_1f5bed6a-4723-4d6f-a9e3-8c4dc609b76e">185.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other unallocated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie69330006b9941b780f7e4587eb84648_D20230101-20230331" decimals="-5" name="vtrs:Corporatecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTctNi0xLTEtMTUyMjA5_859941c6-28dd-465c-942c-8f4f2b381285">379.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic684496e355c490799752193e9a06c94_D20220101-20220331" decimals="-5" name="vtrs:Corporatecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTctOC0xLTEtMTUyMjA5_5fa56225-bdfb-477e-b620-f540e49d5c61">459.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTgtNi0xLTEtMTUyMjA5_1703cdf1-4e68-4b84-ad89-08608744c6d4">399.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTgtOC0xLTEtMTUyMjA5_02276968-2b0b-48a6-8731-f6c495a4d04e">707.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_94"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMjA1Mg_4af14db5-11b1-41f2-a4e9-c30ecf379b24" continuedAt="if8aeecdf137544b48d7f4eb7174db011" escape="true">Restructuring</ix:nonNumeric></span></div><ix:continuation id="if8aeecdf137544b48d7f4eb7174db011" continuedAt="i46d4bde929744bcaaff5f4f5bd9e6f5a"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Restructuring Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. The remaining actions under the 2020 restructuring program include the disposal or closure of certain manufacturing facilities, which are expected to be substantially completed in 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i46d4bde929744bcaaff5f4f5bd9e6f5a"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ic1d68edf5bdd450abcf109bdfeb786ec_D20221001-20221231" decimals="-8" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfODE1_5cc12767-4982-44df-97d6-bd4cac9ee0dc">1.4</ix:nonFraction>&#160;billion. Such charges are expected to include up to approximately $<ix:nonFraction unitRef="usd" contextRef="i9d246e7b27fa4ad99062d6f448111e0c_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfODc2_55496292-4457-448c-ac43-8fc0375aaeff">450</ix:nonFraction>&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ia5991ed3dd3c4634aa50d484766705da_I20231231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTA2Mg_47b4dced-7ee5-4dc7-9208-4ee72a74f690">950</ix:nonFraction>&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges for restructuring and ongoing cost reduction initiatives are recorded in the period the Company commits to a restructuring or cost reduction plan, or executes specific actions contemplated by the plan and all criteria for liability recognition have been met. </span></div><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMjA0OA_7a73d142-81ff-4ffc-a524-b46901f314eb" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2022 to March&#160;31, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d64b894a014afbab8da8528839e18b_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMS0xLTEtMS0xNTIyMDk_2eaddd82-8bff-49d0-8877-2785dbb5cef9">155.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bc609110a8445fd8d58826fa2f1726c_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMS0zLTEtMS0xNTIyMDk_d0ea64c7-12fe-4b04-a3d6-dd48bde76714">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMS01LTEtMS0xNTIyMDk_36689257-f8b3-489e-822e-b28d3654ff1c">157.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMi0xLTEtMS0xNTIyMDk_76d2be33-a115-48e9-a6c8-761def25feb7">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMi0zLTEtMS0xNTIyMDk_eb4dcb47-1bf6-49ec-9b76-ed4a446aa385">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMi01LTEtMS0xNTIyMDk_a66069f5-6fd8-40fa-b2d5-560b740c57b2">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNC0xLTEtMS0xNTIyMDk_5684546f-f2cb-4aeb-b3a1-965f7ec5476f">24.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNC0zLTEtMS0xNTIyMDk_d7deb976-1d3d-43c5-80d8-1de8796ec5c7">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNC01LTEtMS0xNTIyMDk_07f3f702-b642-4b7f-8bc7-247e3f307a3c">27.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNS0xLTEtMS0xNTIyMDk_287fa67a-0a08-4421-b3dc-b585511c3ff3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNS0zLTEtMS0xNTIyMDk_221a88e6-1b77-47c4-bce1-d4c63c975a29">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNS01LTEtMS0xNTIyMDk_ca4cd829-3beb-4345-91c7-406abd99534d">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNi0xLTEtMS0xNTIyMDk_bf5469ee-ba07-45eb-91cb-42732561a565">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNi0zLTEtMS0xNTIyMDk_47b4db3e-80c0-473a-a6fe-23c6c19c8fd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNi01LTEtMS0xNTIyMDk_2c042d18-a22d-48d0-9730-1e1155725d52">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453ede63a1664e9caf4cd95c380890e0_I20230331" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNy0xLTEtMS0xNTIyMDk_b923fc8b-0160-4edd-9c85-a407e30fe432">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebb30913444747329b7146b7a3266a55_I20230331" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNy0zLTEtMS0xNTIyMDk_77fa687a-9767-45c5-acac-735f7355abc3">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNy01LTEtMS0xNTIyMDk_37d539ef-04e4-42df-bb8d-9eac3e4bde49">136.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the three months ended March 31, 2023, total restructuring charges in Developed Markets, Emerging Markets, Greater China, and JANZ were approximately $<ix:nonFraction unitRef="usd" contextRef="i4cd4d116cadd4b549d18354ea24d6cf5_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTgyOQ_088f2dc9-9299-40f1-bace-7e0893db2363">7.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2b51c9edce9241cf9e636f46dacbbb52_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTgzMw_ea4ee46f-8111-4c67-be50-62e2d846f0c4">1.3</ix:nonFraction> million, $(<ix:nonFraction unitRef="usd" contextRef="iba15018bb1de4cb0a89b3428e670872a_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTgzNw_653aac47-7709-4c4c-a351-1e2d2aa94b5e">0.6</ix:nonFraction>) million, and $<ix:nonFraction unitRef="usd" contextRef="ifcf87e3010d4446e9ea5180d2ecfef7e_D20230101-20230331" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTg0MQ_6773a186-ef22-4a22-9b76-dac52d647753">1.3</ix:nonFraction> million, respectively.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022, accrued liabilities for restructuring and other cost reduction programs were primarily included in other current liabilities and other long-term obligations in the condensed consolidated balance sheets.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_97"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185Ny9mcmFnOjNlNDBjOWM3YWRhOTQ0MDZhN2Q0NjgyMjUwMTk5ZWZhL3RleHRyZWdpb246M2U0MGM5YzdhZGE5NDQwNmE3ZDQ2ODIyNTAxOTllZmFfMjIzNQ_9bab6a64-3762-4055-8c20-998176b4159e" continuedAt="iead2203003c04a61b6e84f609f0ad91e" escape="true">Licensing and Other Partner Agreements</ix:nonNumeric></span></div><ix:continuation id="iead2203003c04a61b6e84f609f0ad91e"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically enter into licensing and other partner agreements with other pharmaceutical companies for the development, manufacture, marketing and/or sale of pharmaceutical products. Our significant licensing and other partner agreements are primarily focused on the development, manufacturing, supply and commercialization of multiple complex products. Under these agreements, we have future potential milestone payments and co-development expenses payable to third parties as part of our licensing, development and co-development programs. Payments under these agreements generally become due and are payable upon the satisfaction or achievement of certain developmental, regulatory or commercial milestones or as development expenses are incurred on defined projects. Milestone payment obligations are uncertain, including the prediction of timing and the occurrence of events triggering a future obligation and are not reflected as liabilities in the condensed consolidated balance sheets, except for obligations reflected as acquisition related contingent consideration. Refer to Note 11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of contingent consideration. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential maximum development milestones not accrued for at&#160;March&#160;31, 2023&#160;totaled approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="idab2896257be44a2b213bb8b7d4b1350_D20230101-20230331" decimals="-5" name="vtrs:Developmentandsalesmilestonepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185Ny9mcmFnOjNlNDBjOWM3YWRhOTQ0MDZhN2Q0NjgyMjUwMTk5ZWZhL3RleHRyZWdpb246M2U0MGM5YzdhZGE5NDQwNmE3ZDQ2ODIyNTAxOTllZmFfMTQyNw_e3adbbcc-c644-43a1-a895-695769d4162f">387</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that the amounts that may be paid through the end of 2023 to be approximately $<ix:nonFraction unitRef="usd" contextRef="i596abfcb4c3b421eaf653dd8ad4d37f7_D20230101-20230331" decimals="-5" name="vtrs:Developmentandsalesmilestonepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185Ny9mcmFnOjNlNDBjOWM3YWRhOTQ0MDZhN2Q0NjgyMjUwMTk5ZWZhL3RleHRyZWdpb246M2U0MGM5YzdhZGE5NDQwNmE3ZDQ2ODIyNTAxOTllZmFfMTUxOQ_48b6609d-bd05-41d4-a4b1-0de3ee2606da">5</ix:nonFraction> million. These agreements may also include potential sales-based milestones and call for us to pay a percentage of amounts earned from the sale of the product as a royalty or a profit share. The amounts disclosed do not include sales-based milestones or royalty or profit share obligations on future sales of product as the timing and amount of future sales levels and costs to produce products subject to these obligations is not reasonably estimable. These sales-based milestones or royalty or profit share obligations may be significant depending upon the level of commercial sales for each product.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to our licensing and other partner agreements as disclosed in our 2022 Form 10-K.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_100"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzUxMzg_5b16e76b-c0f6-4650-984d-d63299d13cec" continuedAt="ic68d02a1dba9443f91a66a118fad12e5" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="ic68d02a1dba9443f91a66a118fad12e5" continuedAt="ie98767a171074a00b16a1920ee5e7de6"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legislative Updates</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#8220;Inflation Reduction Act&#8221;) into law, which includes a new corporate alternative minimum tax (&#8220;CAMT&#8221;) and an excise tax of 1% on the fair market value of net stock repurchases. Both provisions are effective for years after December 31, 2022. The Company reflected the applicable estimated excise tax in treasury stock as part of the cost basis of the stock repurchased and recorded a corresponding liability in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our condensed consolidated balance sheet as of March 31, 2023. The share repurchase and authorization amounts disclosed in this Form 10-Q exclude the excise tax.  The Company does not anticipate being subject to the 15% CAMT tax in 2023 based on enacted law and regulatory guidance; however, our CAMT status for 2023 could change in the future, depending on new regulations or regulatory guidance issued by the U.S. Department of the Treasury.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Examinations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes and tax audits in many jurisdictions. A certain degree of estimation is thus required in recording the assets and liabilities related to income taxes. Tax audits and examinations can involve complex issues, interpretations, and judgments and the resolution of matters that may span multiple years, particularly if subject to litigation or negotiation.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that adequate provisions have been made for these uncertain tax positions, the Company&#8217;s assessment of uncertain tax positions, including those arising from legal entity restructuring transactions in connection with the Combination, is based on estimates and assumptions that the Company believes are reasonable but the estimates for unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variations from such estimates could materially affect the Company&#8217;s financial condition, results of operations or cash flows in the period of resolution, settlement or when the statutes of limitations expire.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to ongoing IRS examinations. The years 2015 through 2019 are open years under examination. The years 2012, 2013 and 2014 have one matter open, and a Tax Court petition was filed regarding the matter and a trial was held in December 2018 and is discussed further below.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several international audits are currently in progress. In some cases, the tax auditors have proposed adjustments or issued assessments to our tax positions, including with respect to intercompany transactions, and we are in ongoing discussions with some of the auditors regarding the validity of their positions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In instances where assessments have been issued, we disagree with these assessments and believe they are without merit and incorrect as a matter of law.  As a result, we anticipate that certain of these matters may become the subject of litigation before tax courts where we intend to vigorously defend our position. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Australia, the tax authorities have issued notices of assessments to the Company for the years ended December 2009 to December 2020, subject to additional interest and penalties, concerning our tax position with respect to certain intercompany transactions. The tax authorities denied our objections to the assessments for the years ended December 2009 to December 2020 and we have commenced litigation in the Australian Federal Court challenging those decisions. The Company made a partial payment of $<ix:nonFraction unitRef="usd" contextRef="iaded5ca88b1f45efbecc093436d0c031_D20220101-20221231" decimals="-5" name="vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzI2MjI_3dd81a3b-2357-4f71-8b95-4db25558b548">56.0</ix:nonFraction>&#160;million in 2021 and $<ix:nonFraction unitRef="usd" contextRef="ibc862c7415b2470d87c61bb71eb23e74_D20230101-20230331" decimals="-5" name="vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzI2Mzc_be40d7f5-f8ac-43e9-bf4b-6de2621815fb">5.2</ix:nonFraction>&#160;million in 2022 in order to stay potential interest and penalties resulting from this litigation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In France, the tax authorities have issued notices of assessments to the Company for the years ended December 2013 to December 2015 concerning our tax position with respect to whether income earned by a Company entity not domiciled in France should be subject to French tax.  We have commenced litigation before the French tax courts where the tax authorities will seek unpaid taxes, penalties, and interest.  </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In India, the tax authorities have issued notices of assessments to the Company seeking unpaid taxes and interest for the financial years covering 2013 to 2018 concerning our tax position with respect to certain corporate tax deductions and certain intercompany transactions. Some of these issues were resolved through the Company entering into an agreement with the tax authorities in March 2023 in respect of the pricing of its international transactions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recorded tax expense of approximately $<ix:nonFraction unitRef="usd" contextRef="i2c6b422602ba4e35ad86ae076e60232b_D20230301-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzIxOTkwMjMyNjEyODE_4eceadb9-7036-44bb-aed9-4f92374aaf18">21.6</ix:nonFraction>&#160;million during the three months ended March 31, 2023 due to the terms of this agreement. The remaining issues are in the audit phase or are being challenged in the Indian tax courts.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="ie98767a171074a00b16a1920ee5e7de6"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded a net reserve for uncertain tax positions of $<ix:nonFraction unitRef="usd" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="-5" name="vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzM2Nzg_2198e0a1-56d1-4ef8-b755-ee013dbcc3d6">299.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231" decimals="-5" name="vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzM2ODU_6fa257cf-1e51-49bb-8eca-e7ca9c278394">298.1</ix:nonFraction>&#160;million, including interest and penalties, in connection with its international audits at March 31, 2023 and December 31, 2022, respectively. In connection with our international tax audits, it is possible that we will incur material losses above the amounts reserved.  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s major U.S. state taxing jurisdictions remain open from fiscal year 2013 through 2021, with several state audits currently in progress. The Company&#8217;s major international taxing jurisdictions remain open from 2012 through 2021.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Court Proceedings</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. federal income tax returns for 2012 through 2014 had been subject to proceedings in U.S. Tax Court involving a dispute with the IRS regarding whether certain costs related to ANDAs were eligible to be expensed and deducted immediately or required to be amortized over longer periods. A trial was held in U.S. Tax Court in December 2018 and on April 27, 2021, the Court affirmed Mylan&#8217;s position and held that patent litigation expenses related to ANDAs are immediately deductible. The IRS appealed, the case was heard before the Third Circuit Court of Appeals on January 12, 2023 and we are awaiting a decision.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Uncertainty in Income Taxes</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of an uncertain tax position that is more likely than not of being sustained upon audit by the relevant taxing authority must be recognized at the largest amount that is more likely than not to be sustained. No portion of an uncertain tax position will be recognized if the position has less than a&#160;50%&#160;likelihood of being sustained.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_103"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzQ5NDc4MDI0OTA2Mjc_25f783f1-5cd0-4a5f-a49e-d35730fe6972" continuedAt="iabe0406ab364498d99ef689c4b328c1e" escape="true">Litigation</ix:nonNumeric></span></div><ix:continuation id="iabe0406ab364498d99ef689c4b328c1e" continuedAt="ibf136d3c693646cbbd10f4d841752f1d"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various disputes, governmental and/or regulatory inquiries, investigations and proceedings, tax proceedings and litigation matters, both in the U.S. and abroad, that arise from time to time, some of which could result in losses, including damages, fines and/or civil penalties, and/or criminal charges against the Company. These matters are often complex and have outcomes that are difficult to predict. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in connection with the Combination, the Company has generally assumed liability for, and control of, pending and threatened legal matters relating to the Upjohn Business &#8211; including certain matters initiated against Pfizer described below &#8211; and has agreed to indemnify Pfizer for liabilities arising out of such assumed legal matters. Pfizer, however, has agreed to retain various matters &#8211; including certain specified competition law matters &#8211; to the extent they arise from conduct during the pre-Distribution period and has agreed to indemnify the Company for liabilities arising out of such matters.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes that it has meritorious defenses with respect to the claims asserted against it and the assumed legal matters referenced above, and intends to vigorously defend its position, the process of resolving these matters is inherently uncertain and may develop over a long period of time, and so it is not possible to predict the ultimate resolution of any such matter. It is possible that an unfavorable resolution of any of the ongoing matters could have a material effect on the Company&#8217;s business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of these governmental inquiries, investigations, proceedings and litigation matters with which the Company is involved are described below, and unless otherwise disclosed, the Company is unable to predict the outcome of the matter or to provide an estimate of the range of reasonably possible material losses. The Company records accruals for loss contingencies to the extent we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company is also involved in other pending proceedings for which, in the opinion of the Company based upon facts and circumstances known at the time, either the likelihood of loss is remote or any reasonably possible loss associated with the resolution of such proceedings is not expected to be material to the Company&#8217;s business, financial position, results of operations, cash flows, ability to pay dividends and/or stock price. If and when any reasonably possible losses associated with the resolution of such other pending proceedings, in the opinion of the Company, become material, the Company will disclose such matters.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal costs are recorded as incurred and are classified in SG&amp;A in the Company&#8217;s condensed consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EpiPen&#174; Auto-Injector Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in a putative direct purchaser class action filed in the U.S. District Court for the District of Kansas relating to the pricing and/or marketing of the EpiPen&#174; Auto-Injector. On September 21, 2021, after Plaintiffs&#8217; then operative complaint was dismissed with an option to file a limited amended complaint, Plaintiffs filed an amended complaint asserting federal antitrust claims which are based on allegations concerning a patent settlement between Pfizer and Teva and other alleged actions regarding the launch of Teva&#8217;s generic epinephrine auto-injector. Plaintiffs&#8217; seek monetary damages, declaratory relief, attorneys&#8217; fees and costs. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in March 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in putative direct purchaser class actions filed in the U.S. District Court for the District of Minnesota relating to contracts with certain pharmacy benefit managers concerning EpiPen&#174; Auto-Injector. The plaintiffs claim that the alleged conduct resulted in the exclusion or restriction of competing products and the elimination of pricing constraints in violation of RICO and federal antitrust law. These actions have been consolidated. Plaintiffs&#8217; seek monetary damages, attorneys&#8217; fees and costs. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 24, 2017, Sanofi Aventis U.S., LLC (&#8220;Sanofi&#8221;) filed a lawsuit against the Company in the U.S. District Court for the District of New Jersey. This lawsuit was transferred into a MDL in the U.S. District Court for the District of Kansas and alleged exclusive dealing and anti-competitive marketing practices in violation of the antitrust laws in connection with the sale and marketing of the EpiPen&#174; Auto-Injector. Sanofi sought monetary damages, declaratory relief, attorneys&#8217; fees and costs. The Court granted the Company&#8217;s motion for summary judgment and dismissed Sanofi&#8217;s claims. Sanofi&#8217;s appeal was denied. Sanofi&#8217;s petition seeking review by the U.S. Supreme Court was also denied and concludes this matter.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="ibf136d3c693646cbbd10f4d841752f1d" continuedAt="i388500f325df48d49ef6c39b4b284f8d"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a total accrual of approximately $<ix:nonFraction unitRef="usd" contextRef="icabcde1e2ac34fc091515c433c41ff7c_I20230331" decimals="-5" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzYzMzU_696a97e2-f71c-42d5-be34-f0f081c453de">5.5</ix:nonFraction> million related to these matters at March&#160;31, 2023, which is included in other current liabilities in the condensed consolidated balance sheets. Although it is reasonably possible that the Company may incur additional losses from these matters, any amount cannot be reasonably estimated at this time. In addition, the Company expects to incur additional legal and other professional service expenses associated with such matters in future periods and will recognize these expenses as services are received. The Company believes that the ultimate amount paid for these services and claims could have a material effect on the Company's business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price in future periods.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drug Pricing Matters </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Justice</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2015, the Company received a subpoena from the Antitrust Division of the DOJ seeking information relating to the marketing, pricing, and sale of certain of our generic products and any communications with competitors about such products. On September 8, 2016, the Company, as well as certain employees and a member of senior management, received subpoenas from the DOJ seeking similar information. Related search warrants also were executed.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2018, the Company received a civil investigative demand from the Civil Division of the DOJ seeking information relating to the pricing and sale of its generic drug products. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have fully cooperated with these investigations, which we believe are related to a broader industry-wide investigation of the generic pharmaceutical industry.  We have not had contact from DOJ concerning the above-described subpoenas or civil investigative demand in several years.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Civil Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2016, the Company, along with other manufacturers, has been named as a defendant in lawsuits filed in the United States and Canada generally alleging anticompetitive conduct with respect to generic drugs. The lawsuits have been filed by plaintiffs, including putative classes of direct purchasers, indirect purchasers, and indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties. The lawsuits allege harm under federal laws and the United States lawsuits also allege harm under state laws, including antitrust laws, state consumer protection laws and unjust enrichment claims. Some of the United States lawsuits also name as defendants the Company&#8217;s President, including allegations against him with respect to a single drug product, and one of the Company&#8217;s sales employees, including allegations against him with respect to certain generic drugs. The vast majority of the lawsuits have been consolidated in an MDL proceeding in the Eastern District of Pennsylvania (&#8220;EDPA&#8221;). Plaintiffs generally seek monetary damages, restitution, declaratory and injunctive relief, attorneys&#8217; fees and costs. The EDPA Court has ordered certain plaintiffs&#8217; complaints regarding two single-drug product cases to proceed as bellwethers. The Company is named in those plaintiffs&#8217; complaints that regard one of the two individual drug products. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorneys General Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2015, the Company received a subpoena and interrogatories from the Connecticut Office of the Attorney General seeking information relating to the marketing, pricing and sale of certain of the Company&#8217;s generic products and communications with competitors about such products. On December 14, 2016, attorneys general of certain states filed a complaint in the United States District Court for the District of Connecticut against several generic pharmaceutical drug manufacturers, including the Company, alleging anticompetitive conduct with respect to, among other things, a single drug product. The complaint has subsequently been amended, including on June 18, 2018, to add attorneys general alleging violations of federal and state antitrust laws, as well as violations of various states&#8217; consumer protection laws. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. The operative complaint includes attorneys general of <ix:nonFraction unitRef="number" contextRef="ib7e0a31051704ab8bc38fb1032e348fd_I20230331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzEwMjQ2_0af9d00a-694b-4b2a-8c93-231616f52e6c">forty-six</ix:nonFraction> states, the District of Columbia and the Commonwealth of Puerto Rico. The Company is alleged to have engaged in anticompetitive conduct with respect to four generic drug products. The amended complaint also includes claims asserted by attorneys general of <ix:nonFraction unitRef="number" contextRef="i53082e0db5474dbba7be7c89cd35e27e_I20230331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzEwNTA1_1bd4e783-8522-4359-937d-229f707365b6">thirty-six</ix:nonFraction> states and the Commonwealth of Puerto Rico against certain individuals, including the Company&#8217;s President, with respect to a single drug product. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. The States&#8217; claim for disgorgement and restitution under federal law in this case has been dismissed.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="i388500f325df48d49ef6c39b4b284f8d" continuedAt="iff75363d4a7a4ff7b0651cd20987b6c4"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2019, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against various drug manufacturers and individuals, including the Company and one of its sales employees, alleging anticompetitive conduct with respect to additional generic drugs. On November 1, 2019, the complaint was amended, adding additional states as plaintiffs. The operative complaint is brought by attorneys general of <ix:nonFraction unitRef="number" contextRef="i0f50d795bf3f4c409462b9ddcf0db7d9_I20230331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzExMzI4_e5e4e5fd-7cb5-4228-a0e6-472902657fea">forty-seven</ix:nonFraction> states, certain territories and the District of Columbia. The amended complaint also includes claims asserted by attorneys general of <ix:nonFraction unitRef="number" contextRef="i9404440f3ab340efb47100f474f62e94_I20230331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzExNDY1_13c82bd3-4025-4ece-9840-a6c6a7c7bb15">forty-two</ix:nonFraction> states and certain territories against several individuals, including a Company sales employee. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2020, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against drug manufacturers, including the Company, and individual defendants (none from the Company), alleging anticompetitive conduct with respect to additional generic drugs. On September 9, 2021, the complaint was amended, adding an additional state as a plaintiff. The operative complaint is brought by attorneys general of <ix:nonFraction unitRef="state" contextRef="ib7e0a31051704ab8bc38fb1032e348fd_I20230331" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzI4ODYz_c84bb5fd-7d4b-4fe4-8ac3-d333310614ff">forty-six</ix:nonFraction> states, certain territories and the District of Columbia. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA and has been ordered to proceed as a bellwether.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Related Litigation </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purported class action complaints were filed in October 2016 against Mylan N.V. and Mylan Inc. (collectively &#8220;Mylan&#8221;), certain of Mylan&#8217;s former directors and officers, and certain of the Company&#8217;s current directors and officers (collectively, for purposes of this paragraph, the &#8220;defendants&#8221;) in the United States District Court for the Southern District of New York (&#8220;SDNY&#8221;) on behalf of certain purchasers of securities of Mylan on the NASDAQ. The complaints alleged that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the classification of their EpiPen&#174; Auto-Injector as a non-innovator drug for purposes of the Medicaid Drug Rebate Program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2017, a consolidated amended complaint was filed alleging substantially similar claims, but adding allegations that defendants made false or misleading statements and omissions of purportedly material fact in connection with allegedly anticompetitive conduct with respect to EpiPen&#174; Auto-Injector and certain generic drugs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operative complaint is the third amended consolidated complaint, which was filed on June 17, 2019, and contains the allegations as described above against Mylan, certain of Mylan&#8217;s former directors and officers, and certain of the Company&#8217;s current directors, officers, and employees (collectively, for purposes of this paragraph, the &#8220;defendants&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A class has been certified covering all persons or entities that purchased Mylan common stock between February 21, 2012 and May 24, 2019 excluding defendants, certain of the Company&#8217;s current directors and officers, former directors and officers of Mylan, members of their immediate families and their legal representatives, heirs, successors or assigns, and any entity in which defendants have or had a controlling interest. Plaintiffs seek damages and costs and expenses, including attorneys&#8217; fees and expert costs. On March 30, 2023, the Court dismissed all of Plaintiffs&#8217; claims by granting Defendants&#8217; motion for summary judgment and denying Plaintiffs&#8217; cross-motion for partial summary judgment. Plaintiffs have filed an appeal to the U.S. Court of Appeals for the Second Circuit.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2017, a similar lawsuit was filed in the Tel Aviv District Court (Economic Division) in Israel, which has been stayed pending a decision in the SDNY class action litigation.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Abu Dhabi Investment Authority filed a complaint against Mylan in the SDNY asserting allegations pertaining to EpiPen&#174; Auto-Injector and certain generic drugs under the federal securities laws that overlap with those asserted in the third amended complaint identified above. The Abu Dhabi Investment Authority&#8217;s complaint seeks monetary damages as well as the plaintiff&#8217;s fees and costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 26, 2020, a putative class action complaint was filed by the Public Employees Retirement System of Mississippi, which was subsequently amended on November 13, 2020, against Mylan N.V., certain of Mylan N.V.&#8217;s former directors and officers, and an officer and director of the Company (collectively for the purposes of this paragraph, the &#8220;defendants&#8221;) in the U.S. District Court for the Western District of Pennsylvania on behalf of certain purchasers of securities of Mylan N.V. The amended complaint alleges that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the Morgantown manufacturing </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="iff75363d4a7a4ff7b0651cd20987b6c4" continuedAt="ib468f33544744fa296b7b229924e67aa"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plant and inspections at the plant by the FDA. Plaintiff seeks certification of a class of purchasers of Mylan N.V. securities between February 16, 2016 and May 7, 2019. The complaint seeks monetary damages, as well as the plaintiff&#8217;s fees and costs.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2021, a complaint was filed by Skandia Mutual Life Ins. Co., Lansforsakringar AB, KBC Asset Management N.V., and GIC Private Limited, against the Company, certain of Mylan N.V.&#8217;s former directors and officers, a current director and officer of the Company, and current employees of the Company. The Complaint asserts claims which are based on allegations that are similar to those in the SDNY and the Western District of Pennsylvania complaints identified above.  Plaintiffs seek compensatory damages, costs and expenses and attorneys&#8217; fees.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company and certain of its then officers and directors were named as defendants in a putative class action lawsuit filed in the Court of Common Pleas of Allegheny County, Pennsylvania on behalf of former Mylan shareholders who received Company common stock in connection with the Combination.  A non-Viatris affiliated company and persons were also named as defendants.  The complaint alleges violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 for purportedly failing to disclose or misrepresenting material information in the registration statement and related prospectus issued in connection with the Combination. On January 3, 2023, an amended complaint was filed naming the same defendants and alleging the same violations as the original complaint. Plaintiffs seek monetary damages, reasonable costs and expenses, and certain other equitable and injunctive relief. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioids</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with other manufacturers, distributors, pharmacies, pharmacy benefit managers, and individual healthcare providers is a defendant in more than <ix:nonFraction unitRef="number" contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331" decimals="0" name="vtrs:Numberofcases" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzE3OTk4_9989232b-7695-48bb-9b34-aa607f350210">1,000</ix:nonFraction> cases in the United States and Canada filed by various plaintiffs, including counties, cities and other local governmental entities, asserting civil claims related to sales, marketing and/or distribution practices with respect to prescription opioid products. In addition, lawsuits have been filed as putative class actions including on behalf of children with Neonatal Abstinence Syndrome due to alleged exposure to opioids.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lawsuits generally seek equitable relief and monetary damages (including punitive and/or exemplary damages) based on a variety of legal theories, including various statutory and/or common law claims, such as negligence, public nuisance and unjust enrichment. The vast majority of these lawsuits have been consolidated in an MDL in the U.S. District Court for the Northern District Court of Ohio.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 13, 2023, the Company received a civil subpoena from the Attorney General of the State of New York seeking information relating to opioids manufactured, marketed, or sold by the Company and related subject matter. The Company is fully cooperating with this subpoena request.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Meda Sweden Commercial Dispute</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2021, Ocular AS and other related entities (&#8220;Claimants&#8221;) initiated an arbitration in Sweden against Meda OTC AB and Meda AB (collectively, &#8220;Meda&#8221; or the &#8220;Company&#8221;) alleging breach of a 2013 sale and purchase agreement between Claimants and Meda concerning commercialization of a dental hygiene product.  Claimants are seeking approximately $<ix:nonNumeric contextRef="icde060aa771e4f15b2dfe00c564c524c_D20210830-20210830" name="us-gaap:LossContingencyDamagesSought" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzU0OTc1NTg4MDQ2OQ_f8013473-4c89-4efe-880a-4975bbb9af1b">155&#160;million</ix:nonNumeric> in purported damages, plus interest and costs.  The Company believes that it acted lawfully and vigorously contested all aspects of Claimants&#8217; case &#8211; including their asserted damages &#8211; at an arbitration hearing that took place in February 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Citalopram</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2013, the European Commission issued a decision finding that Lundbeck and several generic companies, including Generics [U.K.] Limited (&#8220;GUK&#8221; or the &#8220;Company&#8221;), had violated EU competition rules relating to various settlement agreements entered into in 2002 for citalopram.  After various appeals, the European Commission&#8217;s decision was upheld in March 2021.  On March 28, 2023, bodies of the national health authorities in England &amp; Wales served a claim in the U.K. Competition Appeals Tribunal against parties to the citalopram investigation, including GUK, seeking monetary damages, plus interest, purportedly arising from the settlement agreements.  The Company, beginning in approximately 2018, has received notices from other health service authorities and insurers asserting an intention to file similar claims.  Pursuant to an indemnification agreement, Merck KGaA and GUK have agreed to equally share any damages claimed against Merck KGaA and/or GUK alleged to have been caused by the conduct which is the subject of the European Commission decision.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="ib468f33544744fa296b7b229924e67aa" continuedAt="ife1242f49cb14b558875a6a2657ba168"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="i96a44216070c4ea3999f969059533ad8_I20230331" decimals="-5" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzU0OTc1NTk3MDg1MQ_f307b30d-3196-41db-8136-1bf25ec6edbe">11.9</ix:nonFraction> million as of March 31, 2023 related to this matter. It is reasonably possible that we will incur additional losses above the amount accrued but we cannot estimate a range of such reasonably possible losses at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, the Company is involved in a number of product liability lawsuits related to alleged personal injuries arising out of certain products manufactured/or distributed by the Company, including but not limited to those discussed below. Plaintiffs in these cases generally seek damages and other relief on various grounds for alleged personal injury and economic loss.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i67450c71eb624b6fa6b3ab40994faf5c_I20230331" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzE5Mjgz_77751176-5d78-40ee-a89e-7baa318450eb">65.1</ix:nonFraction> million as of March&#160;31, 2023 for its product liability matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nitrosamines</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with numerous other manufacturers, retailers, and others, are parties to litigation relating to alleged trace amounts of nitrosamine impurities in certain products, including valsartan and ranitidine. The vast majority of these lawsuits naming the Company in the United States are pending in two MDLs, namely an MDL pending in the United States District Court for the District of New Jersey concerning valsartan and an MDL pending in the United States District Court for the Southern District of Florida concerning ranitidine. The lawsuits against the Company in the MDLs include putative and certified classes seeking the refund of the purchase price and other economic and punitive damages allegedly sustained by consumers and end payors as well as individuals seeking compensatory and punitive damages for personal injuries allegedly caused by ingestion of the medications. Similar lawsuits pertaining to valsartan have been filed in other countries. Third party payor, consumer and medical monitoring classes were certified in the valsartan MDL and a Rule 23(f) petition to appeal the certification decision was denied. The Company has also received claims and inquiries related to these products, as well as requests to indemnify purchasers of the Company&#8217;s API and/ or finished dose forms of these products. The original master complaints concerning ranitidine were dismissed on December 31, 2020. The end-payor plaintiff immediately appealed to the U.S. Court of Appeals for the Eleventh Circuit, which affirmed the dismissal. The personal injury and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumer putative class plaintiffs filed amended master complaints. The Company was not named as a defendant in the amended master complaints, though it was still named in certain short form complaints filed by personal injury plaintiffs. The trial court has dismissed all remaining claims against the generic defendants. Certain of the personal injury plaintiffs appealed this dismissal, which remains pending.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lipitor</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of individual and multi-plaintiff lawsuits have been filed against Pfizer in various federal and state courts alleging that the plaintiffs developed type 2 diabetes purportedly as a result of the ingestion of Lipitor. Plaintiffs seek compensatory and punitive damages. In February 2014, the federal actions were transferred for consolidated pre-trial proceedings to an MDL in the U.S. District Court for the District of South Carolina. Since 2016, certain cases in the MDL were remanded to certain state courts. In 2017, the District Court granted Pfizer&#8217;s motion for summary judgment, dismissing all of the cases pending in the MDL. In June 2018, this dismissal was affirmed by the U.S. Court of Appeals for the Fourth Circuit. The state court proceedings remain pending in Missouri and New York. Prior state court proceedings in California have now been terminated after the California Court previously granted motions (i) to exclude the opinions of plaintiffs&#8217; only general causation expert in connection with his opinions involving the three lowest doses of Lipitor (10, 20 and 40 mg); (ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for summary judgment in connection with the 10, 20, and 40 mg plaintiffs; and (iii) seeking the dismissal of the remaining cases involving the highest dose of Lipitor (80 mg).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in a number of patent litigation lawsuits involving the validity and/or infringement of patents held by branded pharmaceutical manufacturers including but not limited to the matters described below.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its business judgment to decide to market and sell certain products, in each case based on its belief that the applicable patents are invalid and/or that its products do not infringe, notwithstanding the fact that allegations of patent infringement(s) or </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) - Continued</span></div></div><ix:continuation id="ife1242f49cb14b558875a6a2657ba168"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other potential third party rights have not been finally resolved by the courts. The risk involved in doing so can be substantial because the remedies available to the owner of a patent for infringement may include, a reasonable royalty on sales or damages measured by the profits lost by the patent owner. If there is a finding of willful infringement, damages may be increased up to three times. Moreover, because of the discount pricing typically involved with bioequivalent products, patented branded products generally realize a substantially higher profit margin than generic and biosimilar products. The Company also faces challenges to its patents, including suits in various jurisdictions pursuant to which generic drug manufacturers, payers, governments, or other parties are seeking damages for allegedly causing delay of generic entry. An adverse decision in any of these matters could have an adverse effect that is material to our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i1b6ee837070840fcb8fedf7b1e8f59da_D20230101-20230331" decimals="-5" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzI1MjA0_9293ff26-f76d-4e93-ab7b-54d927980407">108.8</ix:nonFraction> million as of March&#160;31, 2023 for its intellectual property matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lyrica - United Kingdom </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2014, Pfizer was involved in patent litigation in the English courts concerning the validity of its Lyrica pain use patent. In 2015, the High Court of Justice in London ordered that the NHS England issue guidance for prescribers and pharmacists directing the prescription and dispensing of Lyrica by brand when pregabalin was prescribed for the treatment of neuropathic pain and entered a preliminary injunction against certain Sandoz group companies preventing the sale of Sandoz&#8217;s full label pregabalin product.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pfizer undertook to compensate certain generic companies and NHS entities for losses caused by these orders, which remained in effect until patent expiration in July 2017. In November 2018, the U.K. Supreme Court ruled that all the relevant claims directed to neuropathic pain were invalid. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Reddy&#8217;s Laboratories filed a claim for monetary damages, interest, and costs in May 2020, followed by the Scottish Ministers and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="healthboard" contextRef="i3af94b01e96b43d1b3dd129d00730688_I20201231" decimals="INF" name="vtrs:NumberOfScottishHealthBoardsNHSScotland" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzU0OTc1NTg5ODg4Mw_8fc29f4c-e853-486a-9ffa-2ade36c2aab5">fourteen</ix:nonFraction> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scottish Health Boards (together, NHS Scotland) in July 2020. In September 2020, Teva, Sandoz, Ranbaxy, Actavis, and the Secretary of State for Health and Social Care, together with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="entity" contextRef="i3af94b01e96b43d1b3dd129d00730688_I20201231" decimals="INF" name="vtrs:NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzU0OTc1NTg5OTk3NQ_6160d637-b409-4c84-a502-3544827ee947">32</ix:nonFraction> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other NHS entities (together, NHS England, Wales, and Northern Ireland) filed their claims. All of the claims except for those filed by Dr. Reddy&#8217;s Laboratories and NHS Scotland have been resolved. A trial on the remaining claims has been set for November 2023.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yupelri</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in January 2023, certain generic companies notified us that they had filed ANDAs with the FDA seeking approval to market generic versions of Yupelri&#174; with associated Paragraph IV certifications.  The companies assert the invalidity and/or non-infringement of polymorph patents expiring in 2030 and 2031, and a method of use patent expiring in 2039.  The companies have not filed Paragraph IV certifications to our compound patents, which currently expire in December 2025, with one compound patent subject to a patent term extension to October 2028.  In February 2023, we brought patent infringement actions against the generic filers in federal district courts, including the U.S. District Court for the District of New Jersey, the U.S. District Court for the District of Delaware, and the U.S. District Court for the Middle District of North Carolina, asserting infringement of the patents by the generic companies. The actions filed in Delaware and North Carolina have been dismissed and the actions will proceed in New Jersey. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other legal proceedings including commercial, contractual, employment, or other similar matters that are considered normal to its business. The Company has approximately $<ix:nonFraction unitRef="usd" contextRef="i9823c12694d24f989d655525247c08e4_I20230331" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzI4Nzgy_57f1034b-595d-41a8-8751-fc4adbbf7de5">8.6</ix:nonFraction> million accrued related to these various other legal proceedings at March&#160;31, 2023.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_106"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_109"></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis addresses material changes in the financial condition and results of operations of Viatris Inc. and subsidiaries for the periods presented. Unless context requires otherwise, the &#8220;Company,&#8221; &#8220;Viatris,&#8221; &#8220;our&#8221; or &#8220;we&#8221; refer to Viatris Inc. and its subsidiaries. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion and analysis should be read in conjunction with the Consolidated Financial Statements, the related Notes to Consolidated Financial Statements and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in Viatris&#8217; 2022 Form 10-K, the unaudited interim financial statements and related Notes included in Part&#160;I&#160;&#8212; ITEM&#160;1 of this Form&#160;10-Q and our other SEC filings and public disclosures. The interim results of operations and comprehensive earnings (loss) for the three months ended March&#160;31, 2023, and cash flows for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full fiscal year or any other future period. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This Form 10-Q contains &#8220;forward-looking statements&#8221;. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include, without limitation, statements about </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">the goals or outlooks with respect to the Company&#8217;s strategic initiatives, including but not limited to the Company&#8217;s two-phased strategic vision and potential divestitures and acquisitions;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> the benefits and synergies of acquisitions, divestitures or our global restructuring program; future opportunities for the Company and its products; and any other statements regarding the Company&#8217;s future operations, financial or operating results, capital allocation, dividend policy and payments, stock repurchases, debt ratio and covenants, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, commitments, confidence in future results, efforts to create, enhance or otherwise unlock the value of our unique global platform, and other expectations and targets for future periods. Forward-looking statements may often be identified by the use of words such as &#8220;will&#8221;, &#8220;may&#8221;, &#8220;could&#8221;, &#8220;should&#8221;, &#8220;would&#8221;, &#8220;project&#8221;, &#8220;believe&#8221;, &#8220;anticipate&#8221;, &#8220;expect&#8221;, &#8220;plan&#8221;, &#8220;estimate&#8221;, &#8220;forecast&#8221;, &#8220;potential&#8221;, &#8220;pipeline&#8221;, &#8220;intend&#8221;, &#8220;continue&#8221;, &#8220;target&#8221;, &#8220;seek&#8221; and variations of these words or comparable words. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the possibility that the Company may be unable to realize the intended benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with acquisitions, divestitures, or its global restructuring program within the expected timeframe or at all;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">impairment charges or other losses related to the divestiture or sale of businesses or assets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the Company&#8217;s failure to achieve expected or targeted future financial and operating performance and results; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by the COVID-19 pandemic; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">actions and decisions of healthcare and pharmaceutical regulators;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">changes in relevant laws and regulations, including but not limited to changes in tax, healthcare and pharmaceutical laws and regulations globally (including the impact of recent and potential tax reform in the U.S.);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the ability to attract and retain key personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the Company&#8217;s liquidity, capital resources and ability to obtain financing; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">any regulatory, legal or other impediments to the Company&#8217;s ability to bring new products to market, including but not limited to &#8220;at-risk launches&#8221;; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">success of clinical trials and the Company&#8217;s or its partners&#8217; ability to execute on new product opportunities and develop, manufacture and commercialize products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">any changes in or difficulties with the Company&#8217;s manufacturing facilities, including with respect to inspections, remediation and restructuring activities, supply chain or inventory or the ability to meet anticipated demand; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the scope, timing and outcome of any ongoing legal proceedings, including government inquiries or investigations, and the impact of any such proceedings on the Company; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">any significant breach of data security or data privacy or disruptions to our information technology systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">risks associated with having significant operations globally; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the ability to protect intellectual property and preserve intellectual property rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">changes in third-party relationships; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the effect of any changes in the Company&#8217;s or its partners&#8217; customer and supplier relationships and customer purchasing patterns, including customer loss and business disruption being greater than expected following an acquisition or divestiture; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the impacts of competition, including decreases in sales or revenues as a result of the loss of market exclusivity for certain products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">changes in the economic and financial conditions of the Company or its partners; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">uncertainties regarding future demand, pricing and reimbursement for the Company&#8217;s products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">uncertainties and matters beyond the control of management, including but not limited to general political and economic conditions, inflation rates and global exchange rates; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements, and the providing of estimates of financial measures, in accordance with U.S. GAAP and related standards or on an adjusted basis.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more detailed information on the risks and uncertainties associated with Viatris, see the risks described in Part I, Item 1A in the 2022 Form 10-K, and our other filings with the SEC. You can access Viatris&#8217; filings with the SEC through the SEC website at www.sec.gov or through our website, and Viatris strongly encourages you to do so. Viatris routinely posts information that may be important to investors on our website at investor.viatris.com, and we use this website address as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC&#8217;s Regulation Fair Disclosure (Reg FD). The contents of our website are not incorporated by reference in this Form 10-Q and shall not be deemed &#8220;filed&#8221; under the Securities Exchange Act of 1934, as amended. Viatris undertakes no obligation to update any statements herein for revisions or changes after the filing date of this Form 10-Q other than as required by law.</span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_112"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Company Overview</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is a global healthcare company formed in November 2020 whose mission is to empower people worldwide to live healthier at every stage of life, regardless of geography or circumstance. Improving the ability of patients to gain access to sustainable and high-quality healthcare is our relentless pursuit. One that rests on visionary thinking, determination and best-in-class capabilities that were strategically built to remove barriers across the health spectrum and advance access globally.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris&#8217; seasoned management team is focused on ensuring that the Company is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers and other key stakeholders. With a global workforce of approximately 38,000, the Company has industry leading commercial, R&amp;D, regulatory, manufacturing, legal and medical expertise complemented by a strong commitment to quality and an unparalleled geographic footprint to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris&#8217; portfolio comprises more than 1,400 approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generics, and complex generics. The Company operates approximately 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and APIs. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China and Hyderabad, India.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Certain Market and Industry Factors</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global pharmaceutical industry is a highly competitive and highly regulated industry. As a result, we face a number of industry-specific factors and challenges, which can significantly impact our results.&#160;The following discussion highlights some of these key factors and market conditions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generic products, particularly in the U.S., generally contribute most significantly to revenues and gross margins at the time of their launch, and even more so in periods of market exclusivity, or in periods of limited generic competition. As such, the timing of new product introductions can have a significant impact on the Company&#8217;s financial results. The entrance into the market of additional competition generally has a negative impact on the volume and pricing of the affected products. Additionally, pricing is often affected by factors outside of the Company&#8217;s control. Conversely, generic products generally experience less volatility over a longer period of time in Europe as compared to the U.S., primarily due to the role of government oversight of healthcare systems in the region.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For branded products, the majority of the product&#8217;s commercial value is usually realized during the period in which the product has market exclusivity. In the U.S.&#160;and some other countries, when market exclusivity expires and generic versions of a product are approved and marketed, there can often be very substantial and rapid declines in the branded product&#8217;s sales. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain markets in which we do business outside of the U.S. have undergone government-imposed price reductions, and further government-imposed price reductions are expected in the future. Such measures, along with the tender systems discussed below, are likely to have a negative impact on sales and gross profit in these markets. However, government initiatives in certain markets that appear to favor generic products could help to mitigate this unfavorable effect by increasing rates of generic substitution and penetration. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a number of markets in which we operate outside of the U.S. have implemented, or may implement, tender systems for generic pharmaceuticals in an effort to lower prices. Generally speaking, tender systems can have an unfavorable impact on sales and profitability. Under such tender systems, manufacturers submit bids that establish prices for generic pharmaceutical products. Upon winning the tender, the winning company will receive priority placement for a period of time. The tender system often results in companies underbidding one another by proposing low pricing in order to win the tender. The loss of a tender by a third party to whom we supply API can also have a negative impact on our sales and profitability. Sales continue to be negatively affected by the impact of tender systems in certain countries.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the impact of competition, government pricing actions and other measures designed to reduce healthcare costs, our results of operations, cash flows and financial condition could also be affected by other risks of doing business internationally, including the impact of public health epidemics, such as the COVID-19 pandemic, inflation, geopolitical events, including the ongoing conflict between Russia and Ukraine and related trade controls, sanctions, supply chain and staffing challenges and other economic considerations, supply chain disruptions, foreign currency exchange fluctuations, changes in intellectual property legal protections and other regulatory changes. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ophthalmology Acquisitions</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, the Company completed the acquisition of Oyster Point for approximately $427.4&#160;million in cash, which included $11 per share paid to Oyster Point stockholders through a tender offer, payment for vested share-based awards, and the repayment of debt of Oyster Point. In addition to the upfront cash consideration, each Oyster Point stockholder received one non-tradeable contingent value right representing up to an additional $2 per share, or approximately $60&#160;million in the aggregate, contingent upon Oyster Point achieving certain metrics based upon full year 2022 performance. Oyster Point did not achieve the metrics that would have triggered a contingent payment and the contingent value rights have expired. Oyster Point is focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2022, the Company entered into a definitive agreement to acquire the remaining equity shares of Famy Life Sciences, a privately-owned research company with a complementary portfolio of ophthalmology therapies under development, for consideration of $281&#160;million. The Company had previously entered into a Master Development Agreement with Famy Life Sciences on December 20, 2019 under which the Company obtained rights with respect to acquiring certain pharmaceutical products and had also acquired shares representing approximately 13.5% equity interest in Famy Life Sciences for $25.0&#160;million at December 31, 2020. The investment was accounted for in accordance with ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transaction to acquire the remaining equity shares of Famy Life Sciences closed during the first quarter of 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Other Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0 billion of the Company&#8217;s shares of common stock. Such repurchases may be made from time-to-time at the Company&#8217;s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the three months ended March 31, 2023, the Company repurchased approximately 21.2 million shares of common stock at a cost of approximately $250 million. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Restructuring Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. The remaining actions under the 2020 restructuring program include the disposal or closure of certain manufacturing facilities, which are expected to be substantially completed in 2023.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $1.4&#160;billion. Such charges are expected to include up to approximately $450&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $950&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs. In addition, management believes the potential annual savings related to these committed restructuring activities to be up to approximately $900&#160;million once fully implemented, with most of these savings expected to improve operating cash flow.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_115"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Summary</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below is a summary of the Company&#8217;s financial results for the three months ended March&#160;31, 2023 compared to the prior year period:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,729.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,191.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A detailed discussion of the Company&#8217;s financial results can be found below in the section titled &#8220;Results of Operations.&#8221; As part of this discussion, we also report sales performance using the non-GAAP financial measures of &#8220;constant currency&#8221; net sales and total revenues. These measures provide information on the change in net sales and total revenues assuming that foreign currency exchange rates had not changed between the prior and current period. The comparisons presented at constant currency rates reflect comparative local currency sales at the prior year&#8217;s foreign exchange rates. We routinely evaluate our net sales and total revenues performance at constant currency so that sales results can be viewed without the impact of foreign currency exchange rates, thereby facilitating a period-to-period comparison of our operational activities, and believe that this presentation also provides useful information to investors for the same reason.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More information about non-GAAP measures used by the Company as part of this discussion, including adjusted cost of sales, adjusted gross margins, adjusted net earnings and adjusted EBITDA (all of which are defined below) can be found in &#8220;Item 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Results of Operations - Use of Non-GAAP Financial Measures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_118"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_121"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March&#160;31, 2023 Compared to Three Months Ended March&#160;31, 2022</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:30.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except %s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 Currency Impact </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 Constant Currency Revenues</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency % Change </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,916.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated total revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,729.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,191.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Currency impact is shown as unfavorable (favorable).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The constant currency percentage change is derived by translating net sales or revenues for the current period at prior year comparative period exchange rates, and in doing so shows the percentage change from 2023 constant currency net sales or revenues to the corresponding amount in the prior year.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">For the three months ended March 31, 2023, other revenues in Developed Markets, JANZ, and Emerging Markets were approximately $7.1&#160;million, $0.2&#160;million, and $2.7&#160;million, respectively.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Amounts exclude intersegment revenue which eliminates on a consolidated basis.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenues</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, Viatris reported total revenues of $3.73 billion, compared to $4.19 billion for the comparable prior year period, representing a decrease of $462.6 million, or 11%. Total revenues include both net sales and other revenues from third parties. Net sales for the current quarter were $3.72 billion, compared to $4.18 billion for the comparable prior year period, representing a decrease of $459.1 million, or 11%. Other revenues for the current quarter were $10.0 million, compared to $13.5 million for the comparable prior year period.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in net sales was partially driven by the unfavorable impact of foreign currency translation of approximately $197.1 million, or 5%, primarily reflecting changes in the U.S. Dollar as compared to the currencies of subsidiaries in countries within the EU, China, Japan and India. Additionally, net sales further decreased by approximately $164.8 million or 4% due to the inclusion of net sales related to the divested biosimilars business in the prior year period. On a constant currency basis, the decrease in net sales from the remaining business was approximately $103.5 million, or 3% for the three months ended March&#160;31, 2023 compared to the prior year period. The decrease was due to base business erosion of approximately $188 million. The decrease in net sales from existing products was partially offset by approximately $85.2 million of new product sales, primarily in the U.S. and Europe. New product sales include new products launched in 2023 and the carryover impact of new products, including business development, launched within the last twelve months. Net sales from acquisitions totaled $6.3 million during the current quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, a limited number of our products may represent a significant portion of our net sales, gross profit and net earnings. Generally, this is due to the timing of new product introductions, seasonality, and the amount, if any, of additional competition in the market. Our top ten products in terms of net sales, in the aggregate, represented approximately 35% for the three months ended March 31, 2023 and 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are derived from our four reporting segments: Developed Markets, Greater China, JANZ, and Emerging Markets. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Developed Markets Segment</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from Developed Markets decreased by $305.7 million or 12% during the three months ended March&#160;31, 2023 when compared to the prior year period. This decrease was partially due to the unfavorable impact of foreign currency translation of approximately $73.2 million, or 3%. Net sales also decreased by approximately $144.6 million or 6% due to the inclusion of net sales related to the divested biosimilars business in the prior year period. Constant currency net sales from the remaining business decreased by approximately $94.2 million, or 4% when compared to the prior year period. Net sales within North America totaled approximately $925.8 million and net sales within Europe totaled approximately $1.24 billion. The decrease in constant currency net sales was driven by anticipated lower net sales of existing products within the U.S., including cyclosporine ophthalmic emulsion and Wixela Inhub&#174;, as a result of lower volumes and, to a lesser extent, lower pricing due to additional competition. These decreases were partially offset by new product sales, including lenalidomide in the U.S., and higher volumes of existing products in Europe. Net sales from Tyrvaya&#174; totaled $6.3 million during the current quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greater China Segment</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from Greater China decreased by $8.5 million or 1% for the three months ended March&#160;31, 2023 when compared to the prior year period. This decrease was the result of the unfavorable impact of foreign currency translation of approximately $35.0 million, or 6%. Constant currency net sales increased by approximately $26.6 million, or 5% when compared to the prior year period, driven primarily by increased volumes of existing products. The disposition of the biosimilars business did not have a significant impact on the net sales for the current quarter.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">JANZ Segment</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from JANZ decreased by $81.6 million or 19% for the three months ended March&#160;31, 2023 when compared to the prior year period. This decrease was partially the result of the unfavorable impact of foreign currency translation of approximately $33.6 million, or 8%. Constant currency net sales decreased by approximately $43.4 million, or 10% when compared to the prior year period. The decrease was due to lower net sales of existing products mainly driven by lower pricing and, to a lesser extent, volumes, in Japan as a result of government price reductions and additional competition. The disposition of the biosimilars business did not have a significant impact on the net sales for the current quarter.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emerging Markets Segment</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from Emerging Markets decreased by $63.3 million or 9% for the three months ended March&#160;31, 2023 when compared to the prior year period. This decrease was mainly driven by the unfavorable impact of foreign currency translation of approximately $55.3 million or 8%.  In addition, net sales also decreased by approximately $15.5 million, or 2% due to the inclusion of the divested biosimilars business in the prior year period. Constant currency net sales from the remaining business increased by $7.5 million, or 1% when compared to the prior year period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales and Gross Profit</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased from $2.42 billion for the three months ended March&#160;31, 2022 to $2.19 billion for the three months ended March&#160;31, 2023. Cost of sales was primarily impacted by the decrease in net sales, including the impact of the disposition of the biosimilars business in November 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the three months ended March&#160;31, 2023 was $1.54 billion and gross margins were 41%. For the three months ended March&#160;31, 2022, gross profit was $1.77 billion and gross margins were 42%. This change is primarily related to the decrease in cost of sales. Adjusted gross margins were 60% for the three months ended March&#160;31, 2023, compared to 59% for the three months ended March&#160;31, 2022. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between cost of sales, as reported under U.S. GAAP, and adjusted cost of sales and adjusted gross margin for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:77.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except %s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. GAAP cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deduct:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting related amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(658.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted cost of sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Adjusted gross profit is calculated as total revenues less adjusted cost of sales. Adjusted gross margin is calculated as adjusted gross profit divided by total revenues.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research &amp; Development Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense for the three months ended March&#160;31, 2023 was $182.9 million, compared to $142.3 million for the comparable prior year period, an increase of $40.6 million. This increase was primarily due to continued investment in our pipeline, including approximately $10.9 million related to the ophthalmology acquisitions.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General &amp; Administrative Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expense for the current quarter was $958.9 million, compared to $915.3 million for the comparable prior year period, an increase of $43.6 million. The increase was primarily due to expenses related to the ophthalmology acquisitions of approximately $33.5 million, higher investment in selling and promotional activities, and increased payroll-related costs. Partially offsetting these increases were lower acquisition and divestiture related costs of approximately $26.6 million as a result of transitioning certain support services from Pfizer during 2022.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Settlements and Other Contingencies, Net</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the losses/(gains) recognized in litigation settlements and other contingencies, net during the three months ended March&#160;31, 2023 and 2022, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:79.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration adjustment (related to the Respiratory Delivery Platform)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total litigation settlements and other contingencies, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the three months ended March&#160;31, 2023 totaled $147.0 million, compared to $146.2 million for the three months ended March&#160;31, 2022, essentially flat as higher costs related to our variable rate borrowings were offset by the impact of debt repayments.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Income) Expense, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (income) expense, net includes gains and losses from changes in the fair value of equity securities, foreign exchange, expense (income) related to post-employment benefit plans, TSA income, and interest and dividend income. Other (income) expense, net for the three months ended March 31, 2023 totaled $69.9 million of income, compared to expense of $33.7 million for the three months ended March&#160;31, 2022. The current quarter income was primarily driven by the reimbursement for transition services provided to Biocon Biologics of approximately $45.7 million. The costs related to the transition services are included in SG&amp;A and R&amp;D. The current quarter income was also attributed to a gain of approximately $18.9&#160;million as a result of remeasuring our pre-existing 13.5% equity interest in Famy Life Sciences to fair value. The prior year period expense was primarily driven by higher foreign exchange costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Provision</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, the Company recognized an income tax provision of $98.0 million, compared to $128.3 million for the comparable prior year period, a decrease of $30.3 million. The current year and prior year provisions were impacted by the levels of income and the changing mix at which it is earned in jurisdictions with differing tax rates. Also impacting the tax provision for the three months ended March&#160;31, 2023 was a tax expense of $21.6&#160;million related to an agreement with the Indian tax authorities in March 2023 in respect of the pricing of its international transactions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_127"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Non-GAAP Financial Measures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever the Company uses non-GAAP financial measures, we provide a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP financial measure. Investors and other readers are encouraged to review the related U.S. GAAP financial measures and the reconciliation of non-GAAP measures to their most directly comparable U.S. GAAP measure and should consider non-GAAP measures only as a supplement to, not as a substitute for or as a superior measure to, measures of financial performance prepared in accordance with U.S. GAAP. Additionally, since these are not measures determined in accordance with U.S. GAAP, non-GAAP financial measures have no standardized meaning across companies, or as prescribed by U.S. GAAP and, therefore, may not be comparable to the calculation of similar measures or measures with the same title used by other companies.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses these measures internally for forecasting, budgeting, measuring its operating performance, and incentive-based awards. Primarily due to acquisitions, divestitures and other significant events which may impact comparability of our periodic operating results, we believe that an evaluation of our ongoing operations (and comparisons of our current operations with historical and future operations) would be difficult if the disclosure of our financial results was limited to financial measures prepared only in accordance with U.S. GAAP. We believe that non-GAAP financial measures are useful supplemental information for our investors and when considered together with our U.S. GAAP financial measures and the reconciliation to the most directly comparable U.S. GAAP financial measure, provide a more complete understanding of the factors and trends affecting our operations. The financial performance of the Company is measured by senior management, in part, using adjusted metrics as described below, along with other performance metrics. The Company&#8217;s use of such non-GAAP measures is governed by an adjusted reporting policy maintained by the Company and such non-GAAP measures are reviewed in detail with the Audit Committee of the Board of Directors.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted Cost of Sales and Adjusted Gross Margin</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the non-GAAP financial measure &#8220;adjusted cost of sales&#8221; and the corresponding non-GAAP financial measure &#8220;adjusted gross margin.&#8221; The principal items excluded from adjusted cost of sales include restructuring, acquisition related and other special items and purchase accounting related amortization, which are described in greater detail below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted Net Earnings </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings is a non-GAAP financial measure and provides an alternative view of performance used by management. Management believes that, primarily due to acquisitions, divestitures and other significant events, an evaluation of the Company&#8217;s ongoing operations (and comparisons of its current operations with historical and future operations) would be difficult if the disclosure of its financial results were limited to financial measures prepared only in accordance with U.S. GAAP. Management believes that adjusted net earnings is an important internal financial metric related to the ongoing operating performance of the Company, and is therefore useful to investors and that their understanding of our performance is enhanced by this measure. Actual internal and forecasted operating results and annual budgets used by management include adjusted net earnings.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EBITDA and Adjusted EBITDA </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EBITDA and adjusted EBITDA are non-GAAP financial measures that the Company believes are appropriate to provide additional information to investors to demonstrate the Company&#8217;s ability to comply with financial debt covenants and assess the Company&#8217;s ability to incur additional indebtedness. The Company also believes that adjusted EBITDA better focuses management on the Company&#8217;s underlying operational results and true business performance and, is used, in part, for management&#8217;s incentive compensation. We calculate EBITDA as U.S. GAAP net earnings (loss) adjusted for net contribution attributable to equity method investments, income tax provision (benefit), interest expense and depreciation and amortization. EBITDA is further adjusted for share-based compensation expense, litigation settlements and other contingencies, net, and restructuring, impairment of long-lived assets, acquisition and divestiture related and other special items to determine adjusted EBITDA. These adjustments are generally permitted under our credit agreement in calculating adjusted EBITDA for determining compliance with our debt covenants.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant items excluded from adjusted cost of sales, adjusted net earnings, and adjusted EBITDA include:</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Accounting Amortization and Other Related Items</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing impact of certain amounts recorded in connection with acquisitions of both businesses and assets is excluded from adjusted cost of sales, adjusted net earnings, and adjusted EBITDA. These amounts include the amortization of intangible assets, inventory step-up, property, plant and equipment step-up, intangible asset impairment charges, including for in-process research and development, and impairment of goodwill. For the acquisition of businesses accounted for under the provisions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, these purchase accounting impacts are excluded regardless of the financing method used for the acquisitions, including the use of cash, long-term debt, the issuance of common stock, contingent consideration or any combination thereof.</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Adjustments, Including Contingent Consideration</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of changes to the fair value of assets and liabilities, including contingent and deferred consideration and accounting for the CCPS in Biocon Biologics, and the related accretion income or expense are excluded from adjusted net earnings and adjusted EBITDA because they are not indicative of the Company&#8217;s ongoing operations due to the variability of the amounts and the lack of predictability as to the occurrence and/or timing and management believes their exclusion is helpful to understanding the underlying, ongoing operational performance of the business.</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is excluded from adjusted cost of sales, adjusted net earnings and adjusted EBITDA. Our share-based compensation programs have become increasingly weighted toward performance-based compensation, which leads to variability and to a lack of predictability as to the occurrence and/or timing of amounts incurred. As such, management believes the exclusion of such amounts on an ongoing basis is helpful to understanding the underlying operational performance of the business. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, Acquisition and Divestiture Related and Other Special Items</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs related to restructuring, acquisition and divestiture related activities and other actions are excluded from adjusted cost of sales, adjusted net earnings and adjusted EBITDA, as applicable. These amounts include items such as: </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs related to formal restructuring programs and actions, including costs associated with facilities to be closed or divested, employee separation costs, impairment charges, accelerated depreciation, incremental manufacturing variances, equipment relocation costs, decommissioning and other restructuring related costs; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain acquisition and divestiture costs, including costs relating to integration and planning, advisory and legal fees, certain financing related costs, certain reimbursements related to the Company&#8217;s obligation to reimburse Pfizer for certain financing and transaction related costs under the Business Combination Agreement and Separation and Distribution Agreement, certain other TSA related set-up and exit costs, and other business transformation and/or optimization initiatives, which are not part of a formal restructuring program, including employee separation and post-employment costs; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The pre-tax loss of the Company&#8217;s clean energy investments, whose activities qualify for income tax credits under the Code; only included in adjusted net earnings is the net tax effect of the entity&#8217;s activities;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other costs, incurred from time to time, related to certain special events or activities that lead to gains or losses, including, but not limited to, incremental manufacturing variances, asset write-downs, including other-than-temporary impairments of investments in equity or debt instruments, or liability adjustments;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain costs to further develop and optimize our global enterprise resource planning systems, operations and supply chain; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gains or losses from divestitures, including impairments of held for sale assets; and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes related to uncertain tax positions are excluded from adjusted cost of sales and adjusted net earnings. In addition, tax adjustments to adjusted earnings are recorded to present items on an after-tax basis consistent with the presentation of adjusted net earnings.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has undertaken restructurings and other optimization initiatives of differing types, scope and amount during the covered periods and, therefore, these charges should not be considered non-recurring; however, management excludes these amounts from adjusted cost of sales, adjusted net earnings and adjusted EBITDA because it believes it is helpful to understanding the underlying, ongoing operational performance of the business.</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Settlements, Net</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges and gains related to legal matters, such as those discussed in Note 18 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Part I, Item 1 of this Form 10-Q are generally excluded from adjusted net earnings and adjusted EBITDA. Normal, ongoing defense costs of the Company made in the normal course of our business are not excluded.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reconciliation of U.S. GAAP Net Earnings to Adjusted Net Earnings </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between net earnings as reported under U.S. GAAP, and adjusted net earnings for the periods shown follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.172%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.898%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. GAAP net earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting related amortization (primarily included in cost of sales) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (primarily amortization of premiums and discounts on long term debt)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clean energy investments pre-tax gain</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture related costs (primarily included in SG&amp;A) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other special items included in:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(e)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of the above items and other income tax related items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (f)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items include the following:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">For the three months ended March&#160;31, 2023, charges include an intangible asset charge of approximately $32.0&#160;million related to the potential divestiture of the Upjohn Distributor Markets to write down the disposal group to fair value, less cost to sell. Also includes amortization of the step-up in the fair value of inventory related to the Oyster Point acquisition of approximately $7.3 million.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Acquisition and divestiture related costs consist primarily of transaction costs including legal and consulting fees and integration activities. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">For the three months ended March&#160;31, 2023, charges include approximately $10.9 million in cost of sales and approximately $(1.2) million in SG&amp;A. Refer to Note 15 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Part I, Item 1 of this Form 10-Q for additional information.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">For the three months ended March&#160;31, 2023, charges include incremental manufacturing variances at plants in the 2020 restructuring program of approximately $22.7&#160;million and inventory reserves related to the potential divestiture of the Upjohn Distributor Markets of approximately $9.2&#160;million.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">For the three months ended March&#160;31, 2023, includes a gain of approximately $18.9 million as a result of remeasuring our pre-existing 13.5% equity interest in Famy Life Sciences to fair value.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.52pt">Adjusted for changes for uncertain tax positions. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reconciliation of U.S. GAAP Net Earnings to EBITDA and Adjusted EBITDA</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a reconciliation of U.S. GAAP net earnings to EBITDA and adjusted EBITDA for the three months ended March&#160;31, 2023 compared to the prior year period:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. GAAP net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add / (deduct) adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net contribution attributable to equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, acquisition and divestiture related and other special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes amortization of premiums and discounts on long-term debt.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes purchase accounting related amortization.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See items detailed in the Reconciliation of U.S. GAAP Net Earnings to Adjusted Net Earnings.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_130"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary source of liquidity is net cash provided by operating activities, which was $971.2 million for the three months ended March&#160;31, 2023. We believe that net cash provided by operating activities and available liquidity will continue to allow us to meet our needs for working capital, capital expenditures, interest and principal payments on debt obligations, and dividend payments. Nevertheless, our ability to satisfy our working capital requirements and debt service obligations, and fund planned capital expenditures, share repurchases or dividend payments, will substantially depend upon our future operating performance (which will be affected by prevailing economic conditions), and financial, business and other factors, some of which are beyond our control.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities decreased by $167.3 million to $971.2 million for the three months ended March&#160;31, 2023, as compared to net cash provided by operating activities of $1.14 billion for the three months ended March&#160;31, 2022. Net cash provided by operating activities is derived from net earnings adjusted for non-cash operating items, gains and losses attributed to investing and financing activities and changes in operating assets and liabilities resulting from timing differences between the receipts and payments of cash, including changes in cash primarily reflecting the timing of cash collections from customers, payments to vendors and employees and tax payments in the ordinary course of business.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in net cash provided by operating activities was principally due to lower operating earnings, including as a result of the disposition of the biosimilars business in November 2022, and the timing of cash payments and collections. </span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $749.5 million for the three months ended March&#160;31, 2023, as compared to $66.9 million for the three months ended March&#160;31, 2022, an increase of $682.6 million.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2023, significant items in investing activities included the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash paid for acquisitions, net of cash acquired, of $667.7 million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capital expenditures, primarily for equipment and facilities, totaling approximately $47.8 million. While there can be no assurance that current expectations will be realized, capital expenditures for the 2023 calendar year are expected to be approximately $400 million to $500 million.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2022, significant items in investing activities included the following:</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capital expenditures, primarily for equipment and facilities, totaling approximately $64.5 million.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $974.7 million for the three months ended March&#160;31, 2023, as compared to $1.01 billion for the three months ended March&#160;31, 2022, a decrease of $34.3 million.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2023, significant items in financing activities included the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">repayment of the 3.125% Senior Notes at maturity of approximately $750.0 million;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">share repurchases of $250.0 million; </span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net short-term borrowings of $204.6 million; </span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash dividends paid of $143.8 million; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net cash of $12.1 million collected on behalf of Biocon Biologics, which is included in Other items, net.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2022, significant items in financing activities included the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net repayments of short-term borrowings of $837.9 million; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash dividends paid of $145.1 million.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Resources</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents totaled $506.6 million at March&#160;31, 2023, and the majority of these funds are held by our non-U.S. subsidiaries. In order to support our global operations, the majority of our cash and cash equivalents are held within the banking system with the majority of this at Global Systemically Important Banks. We monitor the third-party depository institutions that hold our cash and cash equivalents on a regular basis. Our primary emphasis is on the safety of the principal. Where possible, we diversify our cash and cash equivalents among counterparties to minimize exposure to any one counterparty. The Company anticipates having sufficient liquidity, including existing borrowing capacity under the Revolving Facility, Commercial Paper Program and the Receivables Facility and the Note Securitization Facility combined with cash to be generated from operations, to fund foreseeable cash needs without requiring the repatriation of non-U.S. cash.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has access to $4.0 billion under the Revolving Facility which matures in July 2026. Effective April 28, 2023, we executed an amendment to the Revolving Facility to convert the benchmark interest rate from LIBOR to an adjusted SOFR, with no change in the applicable interest rate margins. Up to $1.65 billion of the Revolving Facility may be used to support borrowings under our Commercial Paper Program. As of March&#160;31, 2023, the Company did not have any borrowings outstanding under the Commercial Paper Program and the Revolving Facility. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a $400 million Receivables Facility which expires in April 2025, and a $200 million Note Securitization Facility which expires in August 2023. As of March&#160;31, 2023, the Company had $197.0 million outstanding under the Receivables Facility and did not have any borrowings outstanding under the Note Securitization Facility. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The amount that we may borrow at a given point in time is determined based on the amount of qualifying accounts receivable that are present at such point in time. Amounts outstanding under either facility are included as a component of short-term borrowings, while the accounts receivable securing these obligations remain as a component of accounts receivable, net, in our condensed consolidated balance sheets.  In addition, the agreements governing the Receivables Facility and Note Securitization Facility contain various customary affirmative and negative covenants, and customary default and termination provisions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $76.3 million and $34.7 million of accounts receivable as of March&#160;31, 2023 and December&#160;31, 2022 under these factoring arrangements, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain voluntary supply chain finance programs with financial intermediaries which provide participating suppliers the option to be paid by the intermediary earlier than the original invoice due date. The Company&#8217;s responsibility is limited to making payments on the terms originally negotiated with the suppliers, regardless of whether the intermediary pays the supplier in advance of the original due date. The range of payment terms the Company negotiates with suppliers are consistent, regardless of whether a supplier participates in a supply chain finance program. The total amounts due to financial intermediaries to settle supplier invoices under supply chain finance programs as of March&#160;31, 2023 and December&#160;31, 2022 were $55.5&#160;million and $33.4&#160;million, respectively. These amounts are included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding our dividends paid and declared, refer to Note 9 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Part I, Item 1 of this Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuously evaluating the potential acquisition of products, as well as companies, as a strategic part of our future growth. Consequently, we may utilize current cash reserves or incur additional indebtedness to finance any such acquisitions, which could impact future liquidity. Also, on an ongoing basis, we review our operations, including the evaluation of potential divestitures of products and businesses, as part of our future strategy. Any divestitures could impact future liquidity. In addition, we plan to continue to explore various other ways to create, enhance or otherwise unlock the value of the Company&#8217;s unique global platform in order to create shareholder value.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company provided an update on the strategic priorities announced in February 2022, including identifying the following businesses no longer considered core to its future strategy that the Company intends to divest:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">OTC;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">API (while retaining some selective development API capabilities);</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Women&#8217;s health care, primarily related to our oral and injectable contraceptives. This does not include all of our women&#8217;s health care related products; as an example, our Xulane&#174; product in the U.S. is excluded; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">Upjohn Distributor Markets.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt Maturity</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding our debt agreements and mandatory minimum repayments remaining on the outstanding notional amount of long-term debt at March&#160;31, 2023, refer to Note 12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part I, Item 1 of this Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The YEN Term Loan Facility and the Revolving Facility contain customary affirmative covenants for facilities of this type, including among others, covenants pertaining to the delivery of financial statements, notices of default and certain material events, maintenance of corporate existence and rights, property, and insurance and compliance with laws, as well as customary negative covenants for facilities of this type, including a financial covenant, which set the Maximum Leverage Ratio as of the end of any quarter at 3.75 to 1.00 for the quarter ended March 31, 2023 and each quarter ending thereafter, except in circumstances as defined in the related credit agreement, and other limitations on the incurrence of subsidiary indebtedness, liens, mergers and certain other fundamental changes, investments and loans, acquisitions, transactions with affiliates, payments of dividends and other restricted payments and changes in our lines of business.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is in compliance with its covenants at March&#160;31, 2023 and expects to remain in compliance for the next twelve months. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Guarantor Financial Information</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris Inc. is the issuer of the Registered Upjohn Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Combination, Utah Acquisition Sub Inc. is the issuer of the Utah U.S. Dollar Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Viatris Inc. and Mylan II B.V.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mylan Inc. is the issuer of the Mylan Inc. U.S. Dollar Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan II B.V., Viatris Inc. and Utah Acquisition Sub Inc.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective obligations of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc., and Mylan II B.V. as guarantors of the applicable series of Senior U.S. Dollar Notes are senior unsecured obligations of the applicable guarantor and rank </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pari passu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in right of payment with all of such guarantor&#8217;s existing and future senior unsecured obligations that are not expressly subordinated to such guarantor&#8217;s guarantee of the applicable series of Senior U.S. Dollar Notes, rank senior in right of payment to any future obligations of such guarantor that are expressly subordinated to such guarantor&#8217;s guarantee of the applicable series of Senior U.S. Dollar Notes, and are effectively subordinated to such guarantor&#8217;s existing and future secured obligations to the extent of the value of the collateral securing such obligations. Such obligations are structurally subordinated to all of the existing and future liabilities, including trade payables, of the existing and future subsidiaries of such guarantor that do not guarantee the applicable series of Senior U.S. Dollar Notes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guarantees by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc. under the applicable series of Senior U.S. Dollar Notes will terminate under certain customary circumstances, each as described in the applicable indenture, including: (1) a sale or disposition of the applicable guarantor in a transaction that complies with the applicable indenture such that such guarantor ceases to be a subsidiary of the issuer of the applicable series of Senior U.S. Dollar Notes; (2) legal defeasance or covenant defeasance or if the issuer&#8217;s obligations under the applicable indenture are discharged; (3) with respect to the Utah U.S. Dollar Notes, the earlier to occur of (i) with respect to the guarantee provided by Mylan Inc., (x) the release of Utah Acquisition Sub Inc.&#8217;s guarantee under all applicable Mylan Inc. Debt (as defined in the applicable indenture) and (y) Mylan Inc. no longer having any obligations in respect of any Mylan Inc. Debt and (ii) with respect to the guarantee provided by Mylan II B.V., (x) the release of Mylan II B.V.&#8217;s guarantee under all applicable Triggering Indebtedness (as defined in the applicable indenture) and (y) the issuer and/or borrower of the applicable Triggering Indebtedness no longer having any obligations with respect to such Triggering Indebtedness; (4) with respect to the guarantees provided by Utah Acquisition Sub Inc. and Mylan II B.V. of the Mylan Inc. U.S. Dollar Notes, subject to certain exceptions set forth in the applicable indenture, such guarantor ceasing to be a guarantor or obligor in respect of any Triggering Indebtedness; and (5) with respect to the Registered Upjohn Notes, (a) upon the applicable guarantor no longer being an issuer or guarantor in respect of (i) Mylan Notes (as defined in the indenture governing the Registered Upjohn Notes) that have an aggregate principal amount in excess of $500.0 million or (ii) any Triggering Indebtedness; in each case, other than in respect of indebtedness or guarantees, as applicable, that are being concurrently released; or (b) upon receipt of the consent of holders of a majority of the aggregate principal amount of the outstanding notes of such series in accordance with the indenture governing the Registered Upjohn Notes.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guarantee obligations of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc., and Mylan II B.V. under the Senior U.S. Dollar Notes are subject to certain limitations and terms similar to those applicable to other guarantees of similar instruments, including that (i) the guarantees are subject to fraudulent transfer and conveyance laws and (ii) each guarantee is limited in amount to an amount not to exceed the maximum amount that can be guaranteed by the applicable guarantor without rendering the guarantee, as it relates to such guarantor, voidable under applicable fraudulent transfer and conveyance laws or similar laws affecting the rights of creditors generally. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents unaudited summarized financial information of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc., and Mylan II B.V. on a combined basis as of and for the three months ended March&#160;31, 2023 and as of and for the year ended December&#160;31, 2022. All intercompany balances have been eliminated in consolidation. This unaudited combined summarized financial information is presented utilizing the equity method of accounting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Combined Summarized Balance Sheet Information of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,641.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,972.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,843.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,631.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,259.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,265.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Combined Summarized Income Statement Information of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various disputes, governmental and/or regulatory inquiries, investigations and proceedings, tax proceedings and litigation matters, both in the U.S. and abroad, that arise from time to time, some of which could result in losses, including damages, fines and/or civil penalties, and/or criminal charges against the Company. These matters are often complex and have outcomes that are difficult to predict. We have approximately&#160;$200.9 million&#160;accrued for legal contingencies at&#160;March&#160;31, 2023.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes that it has meritorious defenses with respect to the claims asserted against it and the assumed legal matters referenced above, and intends to vigorously defend its position, the process of resolving these matters is inherently uncertain and may develop over a long period of time, and so it is not possible to predict the ultimate resolution of any such matter. It is possible that an unfavorable resolution of any of the ongoing matters could have a material effect on the Company&#8217;s business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the Combination, Viatris entered into a TSA with Pfizer pursuant to which each party will provide certain limited transition services to the other party generally for an initial period of 24 months from the closing date of the Combination. In addition to the monthly service fees under the TSA, Viatris agreed to reimburse Pfizer for fifty percent of the costs, up to the first $380&#160;million incurred, to establish and wind down the TSA services. Viatris will be required to fully reimburse Pfizer for total costs in excess of $380&#160;million. The Company incurred approximately $3.7 million related to this provision of the TSA during the three months ended March&#160;31, 2023 and approximately $141.7 million during the period beginning on the closing date of the Combination and ended March&#160;31, 2023. We expect to incur future costs related to the completion of the services. As of December 31, 2022, the Company has exited substantially all transition services with Pfizer.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the Biocon Biologics Transaction, Viatris and Biocon Biologics also entered an agreement pursuant to which Viatris is providing commercialization and certain other transition services on behalf of Biocon Biologics, including billings, collections and the remittance of rebates, to ensure business continuity for patients, customers and colleagues. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_133"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the Company&#8217;s market risk, see &#8220;Item&#160;7A. Quantitative and Qualitative Disclosures about Market Risk&#8221; in Viatris&#8217; 2022 Form&#160;10-K.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_136"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was performed under the supervision and with the participation of the Company&#8217;s management, including the Principal Executive Officer and the Principal Financial Officer, of the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures as of March&#160;31, 2023. Based upon that evaluation, the Principal Executive Officer and the Principal Financial Officer concluded that the Company&#8217;s disclosure controls and procedures were effective. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has not identified any changes in the Company&#8217;s internal control over financial reporting (&#8220;ICFR&#8221;) that occurred during the first quarter of 2023 that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s ICFR. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_139"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II&#160;&#8212; OTHER INFORMATION</span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_142"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding legal proceedings, refer to Note 18 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the accompanying Notes to interim financial statements in this Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_145"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in the Company&#8217;s risk factors from those disclosed in Viatris&#8217; 2022 Form 10-K.</span></div><div><span><br/></span></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_1099511629136"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Viatris Inc.</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Issuer purchases of equity securities</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (a) (b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a) (b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 - January 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,509,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,509,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888,085,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 - February 28, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,729,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,729,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750,013,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 - March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,239,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,239,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750,013,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.8pt">Refer to Part I, Item 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Management&#8217;s Discussion and Analysis of Financial Condition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Results of Operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> Results of Operations &#8211; Recent Developments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; of this Form 10-Q for additional information regarding the Company&#8217;s authorized share repurchase program. During the three months ended March&#160;31, 2023, the Company repurchased approximately 21.2&#160;million shares of common stock at a cost of approximately $250 million under this program. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The number of shares purchased is based on the purchase date and not the settlement date. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Average price per share includes commissions.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_151"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 6.     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">EXHIBITS</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312523050797/d452663dex101.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Letter with Scott A. Smith, dated February 24, 2023, filed as Exhibit 10.1 to the Report on Form 8-K filed by Viatris Inc. with the SEC on February 27, 2023, and incorporated herein by reference.*</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312523050797/d452663dex102.htm">10.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation Agreement with Michael Goettler, dated February 24, 2023, filed as Exhibit 10.2 to the Report on Form 8-K filed by Viatris Inc. with the SEC on February 27, 2023, and incorporated herein by reference.*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_103xvtrsx20230331.htm">10.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance-Based Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 3, 2023.*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_104xvtrsx20230331.htm">10.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR Transition Amendment, dated as of April 28, 2023, to the Amended and Restated Revolving Credit Agreement, dated as of July 1, 2021, among Viatris, the guarantors from time to time party thereto, the lenders and issuing banks from time to time party thereto and Bank of America, N.A., as administrative agent.&#94;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_22xvtrsx20230331.htm">22</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">List of subsidiary guarantors and issuers of guaranteed securities.<br/></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_311xvtrsx20230331.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_312xvtrsx20230331.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_32xvtrsx20230331.htm">32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Definition Linkbase</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document (included in Exhibit 101). </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denotes management contract or compensatory plan or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#94;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Annexes, schedules and/or exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Viatris agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.</span></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i4aaf90299ead4f42aa5d7a1f46495b27_154"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4aaf90299ead4f42aa5d7a1f46495b27_4">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SCOTT A. SMITH</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott A. Smith</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;8, 2023</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SANJEEV NARULA</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanjeev Narula</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;8, 2023</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>ex_103xvtrsx20230331.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id06f6cabdf4d4e6ea26dd6eb953b20ca_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">VIATRIS INC.<br>PERFORMANCE-BASED RESTRICTED STOCK UNIT <br>AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THIS PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated as of &#91;______&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Date of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), is made by and between Viatris Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and &#91;______&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Grant of Performance-Based Restricted Stock Units.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company hereby grants to the Participant a total of &#91;______&#93; target performance-based restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), on the terms and conditions set forth in this Agreement and as otherwise provided in the Viatris Inc. 2020 Stock Incentive Plan (as may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The final number of PSUs actually awarded at the end of the Vesting Period (defined below), if any, shall be based on the attainment of specified levels of the performance measures set forth on Exhibit A.  Each PSU represents the right to receive one share of the Company&#8217;s common stock, par value $0.01 per share (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The PSUs shall be credited to a separate book-entry account maintained for the Participant on the books of the Company.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Incorporation by Reference, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The provisions of the Plan are hereby incorporated herein by reference.  Except as otherwise expressly set forth herein, this Agreement shall be construed in accordance with the provisions of the Plan and any interpretations, amendments, rules and regulations promulgated by the Committee from time to time pursuant to the Plan.  Any capitalized terms not otherwise defined in this Agreement shall have the definitions set forth in the Plan.  The Committee shall have final authority to interpret and construe the Plan and this Agreement and to make any and all determinations under them, and its decision shall be binding and conclusive upon the Participant and his or her legal representative in respect of any questions arising under the Plan or this Agreement.  The Participant acknowledges that the Participant has received a copy of the Plan and has had an opportunity to review the Plan and agrees to be bound by all the terms and provisions of the Plan.  Without limiting the foregoing, the Participant acknowledges that the PSUs and any Shares acquired upon settlement of the PSUs are subject to provisions of the Plan under which, in certain circumstances, an adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">may be made to the number of the PSUs and any Shares acquired upon settlement of the PSUs.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Vesting&#59; Settlement.  </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The number of earned PSUs shall be determined based on the attainment of specified levels of the performance measures during the period beginning on January 1, 2023 and ending on December 31, 2025 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as set forth on Exhibit A.  The number of earned PSUs may range between the levels specified on Exhibit A.  Earned PSUs will cliff-vest on the third anniversary of the Date of Grant (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), subject to the Participant remaining continuously employed in active service by the Company or one of its Affiliates from the Date of Grant through the Vesting Date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Performance Measures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The performance measures under this Agreement shall be as set forth on Exhibit A. </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Committee Determination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as administratively practicable after the end of the Performance Period, the Committee shall determine the level attained for each performance measure in accordance with Exhibit A.  The Participant shall be awarded the final number of PSUs in accordance with the level of performance achieved. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise provided herein, each vested and earned PSU shall be settled in Shares within 30 days following the Vesting Date.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Dividend Equivalents.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each PSU shall be credited with Dividend Equivalents, which shall be withheld by the Company and credited to the Participant&#8217;s account (either in cash or additional Restricted Stock Units in the discretion of the Committee).  Dividend Equivalents credited to the Participant&#8217;s account and attributable to a PSU shall be distributed (without interest) to the Participant at the same time as the underlying Share is delivered upon settlement of such PSU and, if such PSU is forfeited, the Participant shall have no right to such Dividend Equivalents.  Any adjustments for Dividend Equivalents shall be in the sole discretion of the Committee and Dividend Equivalents shall be paid either in cash or Shares in the discretion of the Committee.  It is the current intention of the Company that Dividend Equivalents will accrue in additional PSUs.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Tax Withholding. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vesting and settlement of the PSUs shall be subject to the Participant satisfying any applicable U.S. Federal, state and local tax withholding obligations and non-U.S. tax withholding obligations.  The Company shall be entitled, if the Committee deems it necessary or desirable, to withhold (or secure payment from the Participant in lieu of withholding) the maximum amount of any withholding or other tax permitted by law to be withheld.  The Company shall have the right and is hereby authorized to withhold from any amounts payable to the Participant in connection with the PSUs or otherwise the amount of any required withholding taxes in respect of the PSUs, its settlement or any payment or transfer of the PSUs or under the Plan and to take any such other action as the Committee or the Company deem necessary to satisfy all obligations for the payment of such withholding taxes.  The Participant may satisfy, in whole or in part, the tax obligations by authorizing the Company to withhold Shares that would otherwise be deliverable to the Participant upon settlement of the PSUs with a Fair Market Value equal to such withholding liability.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Termination of Employment. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Termination of Employment due to Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If, prior to the Vesting Date, the Participant&#8217;s employment with the Company and its Affiliates is terminated (1) by the Company or one of its Affiliates due to the Participant&#8217;s Disability (as defined below), or (2) due to the Participant&#8217;s death, then the PSUs, to the extent unvested, shall become fully vested as of the date of termination of employment (based on target level performance).  Such vested PSUs shall be settled in Shares within 30 days following such termination date.  For the avoidance of doubt, this Section 5(a) shall not apply to any death or Disability of the Participant occurring after the date of termination of the Participant&#8217;s employment for any reason.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Termination of Employment without Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160; If, on or prior to the Vesting Date, the Participant&#8217;s employment with the Company and its Affiliates is terminated by the Company without Cause, then a prorated number of PSUs shall continue to be eligible to vest and be settled in accordance with Section 2, as if the Participant had remained continuously employed in active service by the Company or one of its Affiliates through the Vesting Date.&#160; Such prorated number of PSUs shall be calculated by multiplying (x) the number of earned PSUs, as determined by the Committee following the end of the Performance Period (or in connection with a Change in Control under Section 6), by (y) a fraction, the numerator of which is the number of completed months in the Performance Period through the effective date of the Participant&#8217;s termination, and denominator of which is the total number of months in the Performance Period.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Other Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If, prior to the Vesting Date, the Participant&#8217;s employment with the Company and its Affiliates terminates for any reason other than as set forth in Section 5(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5(b) above (including any termination of employment by the Participant for any reason, or by the Company for Cause), then all unvested PSUs shall be cancelled </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">immediately and the Participant shall not be entitled to receive any payments with respect thereto. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Change in Control.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In the event of a Change in Control in which no provision is made for assumption or substitution of the PSUs granted hereby in the manner contemplated by Section 11(c) of the Plan, the PSUs, to the extent then unvested, shall automatically be deemed vested, with the number of PSUs deemed vested determined by the Committee in its sole discretion, as of immediately prior to such Change in Control, and the PSUs shall be settled within 30 days following such Change in Control (or, to the extent the PSUs are deferred compensation subject to Section 409A of the Code, within 30 days following a payment event permissible under Section 409A of the Code), in Shares, in cash in an amount equal to the number of vested PSUs multiplied by the Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of a Share (as of a date specified by the Committee), or in a combination of cash and Shares, as determined by the Committee.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">If a Change in Control occurs in which the acquirer assumes or substitutes the PSUs granted hereby in the manner contemplated by Section 11 of the Plan, then the performance-vesting conditions of the PSUs shall be deemed waived, and the number of PSUs as determined by the Committee, in its sole discretion, shall remain eligible to vest so long as the Participant remains continuously employed in active service by the Company or one of its Affiliates through the Vesting Date.  </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Notwithstanding anything to the contrary herein, if, within the 24-month period following such Change in Control, the Participant&#8217;s employment with the Company and its Affiliates is terminated (i) by the Company or one of its Affiliates without Cause (other than due to death or Disability), (ii) by the Participant for Good Reason (defined below) or (iii) due to the Participant&#8217;s death or Disability, then the number of PSUs determined pursuant to Section 6(b), to the extent unvested, shall become fully vested as of the date of termination of employment, and promptly settled upon vesting, in a manner consistent with Section 2(d).  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meanings ascribed to them in (i) the Participant&#8217;s employment agreement with the Company or one of its subsidiaries, if applicable, or (ii) the Mylan N.V. Severance Plan and Global Guidelines, adopted July 29, 2019, as may be amended or superseded from time to time.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Rights as a Stockholder.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Participant shall not be deemed for any purpose, nor have any of the rights or privileges of, a stockholder of the Company in respect of any Shares underlying the PSUs unless, until and to the extent that (i) the Company shall have issued and delivered to the Participant the Shares underlying the vested PSUs and (ii)&#160;the Participant&#8217;s name shall have been entered as a stockholder of record with respect to such Shares on the books of the Company.  The Company shall cause the actions described in clauses (i) and (ii) of the preceding sentence to occur promptly following settlement as contemplated by this Agreement, subject to compliance with applicable laws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Compliance with Legal Requirements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The granting and settlement of the PSUs, and any other obligations of the Company under this Agreement, shall be subject to all applicable Federal, provincial, state, local and foreign laws, rules and regulations and to such approvals by any regulatory or governmental agency as may be required. The Committee shall have the right to impose such restrictions on the PSUs as it deems reasonably necessary or advisable under applicable Federal securities laws, the rules and regulations of any stock exchange or market upon which Shares are then listed or traded, and&#47;or any blue sky or state securities laws applicable to such Shares.  It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Plan and this Agreement, all of which shall be binding upon the Participant.  The </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant agrees to take all steps the Committee or the Company determines are reasonably necessary to comply with all applicable provisions of Federal and state securities law in exercising his or her rights under this Agreement.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Clawback.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The PSUs and&#47;or the Shares acquired upon settlement of the PSUs shall be subject (including on a retroactive basis) to clawback, forfeiture or similar requirements (and such requirements shall be deemed incorporated by reference into this Agreement) to the extent required by applicable law (including, without limitation, Section 304 of the Sarbanes-Oxley Act and Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act) if such requirement is in effect at the relevant time, the rules and regulations of any applicable securities exchange or inter-dealer quotation system on which the Shares may be listed or quoted or if so required pursuant to a written policy adopted by the Company.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Miscellaneous.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The PSUs may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) by the Participant other than by will or by the laws of descent and distribution, pursuant to a qualified domestic relations order or as otherwise permitted under the Plan.  Any attempted Transfer of the PSUs contrary to the provisions hereof, and the levy of any execution, attachment or similar process upon the PSUs, shall be null and void and without effect.  </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Committee at any time, and from time to time, may amend the terms of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the rights of the Participant shall not be materially adversely affected without the Participant&#8217;s written consent. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any right of the Company contained in this Agreement may be waived in writing by the Committee.  No waiver of any right hereunder by any party shall operate as a waiver of any other right, or as a waiver of the same right with respect to any subsequent occasion for its exercise, or as a waiver of any right to damages.  No waiver by any party of any breach of this Agreement shall be held to constitute a waiver of any other breach or a waiver of the continuation of the same breach.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Confidentiality Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  By accepting this grant of PSUs, the Participant hereby agrees that he or she shall be bound by, and shall comply with, (i) the Agreement Relating To Patents, Copyrights, Inventions, Confidentiality and Proprietary Information, in the form provided by the Company (if applicable) and (ii) all other agreements relating to confidentiality that the Participant has executed during the course of employment with the Company and its Affiliates as in effect from time to time (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executed Confidentiality Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Participant also agrees that, in addition to any Executed Confidentiality Agreements, Participant shall not use and&#47;or communicate or disclose, in any manner, any confidential, proprietary or privileged Viatris company information or knowledge, which he or she may have had access to while employed with a Viatris company, relating to intellectual property, trade secrets, business plans and strategies, customer plans and strategies and relationships, pricing, research and development plans and strategies, personnel, organization, strategic plans, or the commercialization of the products of Viatris or any of its subsidiaries, consistent with applicable law, including investigations by government agencies.&#160;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The PSUs are intended to be exempt from, or compliant with, Section 409A of the Code and shall be interpreted accordingly.  Notwithstanding the foregoing or any provision of the Plan or this Agreement, if any provision of the Plan or this Agreement contravenes Section 409A of the Code or could cause the Participant to incur any tax, interest or penalties under Section 409A of the Code, the Committee may, in its sole reasonable discretion and with the Participant&#8217;s consent, modify such provision to (i) comply with, or avoid being subject to, Section 409A of the Code, or to avoid the incurrence of taxes, interest and penalties under Section 409A of the Code, and (ii) maintain, to the maximum extent practicable, the original intent and economic benefit to the Participant of the applicable provision without </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">materially increasing the cost to the Company or contravening the provisions of Section 409A of the Code.  This Section&#160;does not create an obligation on the part of the Company to modify the Plan or this Agreement and does not guarantee that the PSUs or the Shares underlying the PSUs will not be subject to interest and penalties under Section 409A of the Code.  Notwithstanding anything to the contrary in the Plan or this Agreement, to the extent that the Participant is a &#8220;specified employee&#8221; (within the meaning of the Committee&#8217;s established methodology for determining &#8220;specified employees&#8221; for purposes of Section 409A of the Code), payment or distribution of any amounts with respect to the PSUs that are subject to Section 409A of the Code will be made as soon as practicable following the first business day of the seventh month following the Participant&#8217;s &#8220;separation from service&#8221; (within the meaning of Section 409A of the Code) from the Company and its Affiliates, or, if earlier, the date of the Participant&#8217;s death.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">General Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All amounts credited in respect of the PSUs to the book-entry account under this Agreement shall continue for all purposes to be part of the general assets of the Company.  The Participant&#8217;s interest in such account shall make the Participant only a general, unsecured creditor of the Company.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All notices, requests, consents and other communications to be given hereunder to any party shall be deemed to be sufficient if contained in a written instrument and shall be deemed to have been duly given when delivered in person, by telecopy, by nationally recognized overnight courier, or by first-class registered or certified mail, postage prepaid, addressed to such party at the address set forth below or such other address as may hereafter be designated in writing by the addressee to the addresser&#58;</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">if to the Company, to&#58;</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Viatris Inc.</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1000 Mylan Boulevard</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Canonsburg, PA 15317<br>Facsimile&#58;  (724) 514-1533<br>Attention&#58;  Chief Human Resources Officer</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">if to the Participant, to the Participant&#8217;s home address on file with the Company.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All such notices, requests, consents and other communications shall be deemed to have been delivered in the case of personal delivery or delivery by telecopy, on the date of such delivery, in the case of nationally recognized overnight courier, on the next business day, and in the case of mailing, on the third business day following such mailing if sent by certified mail, return receipt requested.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">No Rights to Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Nothing contained in this Agreement shall be construed as giving the Participant any right to be retained, in any position, as an employee, consultant or director of the Company or its Affiliates or shall interfere with or restrict in any way the rights of the Company or its Affiliates, which are hereby expressly reserved, to remove, terminate or discharge the Participant at any time for any reason whatsoever. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In lieu of issuing a fraction of a Share resulting from an adjustment of the PSUs pursuant to Section&#160;4(c) of the Plan or otherwise, the Company shall be entitled to pay to the Participant an amount equal to the Fair Market Value of such fractional share. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant may file with the Committee a written designation of a beneficiary on such form as may be prescribed by the Committee and may, from time to time, amend or revoke such designation.  If no beneficiary is designated, if the designation is ineffective, or if the beneficiary dies before the balance of a Participant&#8217;s benefit is paid, the balance shall be paid to the Participant&#8217;s estate.  Notwithstanding the foregoing, however, a Participant&#8217;s beneficiary shall be determined under applicable state law if such state law does not recognize beneficiary designations under Awards of this type and is not preempted by laws which recognize the provisions of this Section 10(k).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The terms of this Agreement shall be binding upon and inure to the benefit of the Company and its successors and assigns, and of the Participant and the beneficiaries, executors, administrators, heirs and successors of the Participant. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement (including Exhibit A) and the Plan contain the entire agreement and understanding of the parties hereto with respect to the subject matter contained herein and supersede all prior communications, representations and negotiations in respect thereto. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Limitation Of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">The Participant agrees that any liability of the officers, the Committee, and the Board of Directors of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">the Company to the Participant under this Agreement shall be limited to those actions or failure to take actions which constitute self-dealing, willful misconduct or recklessness.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be construed and interpreted in accordance with the laws of the Commonwealth of Pennsylvania without regard to principles of conflicts of law thereof, or principles of conflicts of laws of any other jurisdiction which could cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Consent to Jurisdiction&#59; Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant and the Company (on behalf of itself and its Affiliates) each consents to jurisdiction in the United States District Court for the Western District of Pennsylvania, or if that court is unable to exercise jurisdiction for any reason, the Court of Common Pleas of Washington County, Pennsylvania, and each waives any other requirement (whether imposed by statute, rule of court or otherwise) with respect to personal jurisdiction or service of process and waives any objection to jurisdiction based on improper venue or improper jurisdiction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY, IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THE PLAN OR THIS AGREEMENT.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The headings of the Sections hereof are provided for convenience only and are not to serve as a basis for interpretation or construction, and shall not constitute a part, of this Agreement. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in one or more counterparts (including via facsimile, electronic image scan (pdf) and electronic signature on the Merrill Lynch intranet system), each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;______&#93;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>3
<FILENAME>ex_104xvtrsx20230331.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ieebcc50b69f64208afaed04958d3857c_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Execution Version</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIBOR TRANSITION AMENDMENT TO AMENDED AND RESTATED REVOLVING CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This LIBOR TRANSITION AMENDMENT TO AMENDED AND RESTATED REVOLVING CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), dated as of April 28, 2023, is among VIATRIS INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), certain Affiliates and Subsidiaries of the Borrower from time to time party hereto as Guarantors, each Lender and Issuing Bank from time to time party hereto and BANK OF AMERICA, N.A., as administrative agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PRELIMINARY STATEMENTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;The Borrower, the Guarantors, the certain banks party thereto and the Administrative Agent are parties to that certain Amended and Restated Revolving Credit Agreement, dated as of July 1, 2021, as amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof (such Amended and Restated Revolving Credit Agreement as in effect immediately prior to giving effect to this Amendment, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and as amended hereby, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amended Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2) &#160;&#160;&#160;&#160;Certain loans, disbursements and&#47;or extensions of credit under the Existing Agreement denominated in Dollars, Sterling, Yen and Euros incur or are permitted to incur interest, fees, commissions or other amounts based on LIBOR (as defined in the Existing Agreement) in accordance with the terms of the Existing Agreement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3) &#160;&#160;&#160;&#160;The Borrower, the Lenders party hereto, being all the Lenders, and the Administrative Agent have determined, in accordance with Section 9.02(b) of the Existing Agreement, to replace LIBOR and implement customary benchmark replacement provisions&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;The Borrower, the Lenders and the Administrative Agent have agreed to amend the Existing Agreement as hereinafter set forth herein. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments to the Existing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower, the Lenders and the Administrative Agent agree that, subject to the satisfaction of the conditions precedent set forth in Section 2, (a) the Existing Agreement is hereby amended to read as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix&#160;I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto to delete the stricken text (indicated textually in the same manner as the following example&#58;</font><font style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">stricken text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and insert the added text (indicated textually in the same manner as the following example&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">added text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) as shown therein and (b) Exhibit C to the Existing Credit Agreement is deleted in its entirety and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto is substituted therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions of Amendment Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Amendment shall become effective as of the date on which the Administrative Agent shall have received a counterpart of this Amendment executed by the Borrower, the Guarantors and each Lender (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reference to and Effect on the Existing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  On and after the effectiveness of this Amendment, each reference in the Existing Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221; or words of like import referring to the Existing Agreement and each reference in each other Loan Document to &#8220;the Credit Agreement&#8221;, &#8220;thereunder&#8221;, &#8220;thereof&#8221; or words of like import referring to the Existing Agreement shall mean and be a reference to the Amended Agreement.  The Existing Agreement, as specifically amended by this Amendment, is and shall continue to be in full force and effect and is hereby in all respects ratified and confirmed.  The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under the Existing Agreement, nor constitute a waiver of any provision of the Existing Agreement.  This Amendment shall be deemed to constitute a Loan Document.  The Borrower and each Guarantor hereby acknowledges that it has read this Amendment and consents to the terms hereof and further hereby affirms, confirms, represents, warrants and agrees that notwithstanding the effectiveness of this Amendment, the obligations of the Borrower and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such Guarantors under each of the Loan Documents to which it is a party shall not be impaired and each of the Loan Documents to which the Borrower and such Guarantors are a party is, and shall continue to be, in full force and effect and are hereby confirmed and ratified in all respects, in each case, as amended hereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Representation and Warranty of the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To induce the Administrative Agent to enter into this Amendment, the Borrower represents and warrants that, as of the effectiveness of this Amendment&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The representations and warranties contained in the Amended Agreement and the other Loan Documents are true and correct in all material respects (except for any representation and warranty that is qualified by materiality, which is true and correct in all respects)&#59; provided that any representation or warranty expressly made as of a specific earlier date is true in all material respects as of such earlier date, and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;No Default has occurred and is continuing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Costs and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower agrees to pay on demand all reasonable and documented out-of-pocket costs and expenses of the Administrative Agent in connection with the preparation, execution, delivery and administration, modification and amendment of this Amendment and the other documents to be delivered hereunder (including the reasonable and documented fees and expenses of one counsel for the Administrative Agent with respect hereto and thereto) in accordance with the terms of the Amended Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Execution in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Amendment may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Amendment constitutes the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof.  The words &#8220;execute,&#8221; &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in or related to any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Amendment shall be construed in accordance with and governed by the law of the State of New York (without regard to the conflict of law principles thereof to the extent that the application of the laws of another jurisdiction would be required thereby).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation of Terms.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The provisions of Sections 9.03, 9.09, 9.10 and 9.12 of the Existing Agreement shall be incorporated into this Amendment as if set out in full in this Amendment and as if references in those sections to &#8220;this Agreement&#8221; were references to this Amendment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment, Modification and Waiver.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  This Amendment may not be amended, modified or waived except as permitted by Section 9.02 of the Amended Agreement.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as provided in Section 2, capitalized terms not otherwise defined in this Amendment shall have the same meanings as specified in the Amended Agreement. </font></div><div style="margin-bottom:12pt;margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Remainder of page intentionally left blank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Viatris &#8211; LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the parties hereto have caused this Amendment to be executed by their respective officers thereunto duly authorized, as of the date first above written.</font></div><div style="margin-bottom:24pt;padding-left:252pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">VIATRIS INC.</font></div><div style="margin-bottom:12pt;padding-left:270pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By _</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">John Miraglia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">________________<br>Name&#58;&#160;&#160;&#160;&#160;John Miraglia<br>Title&#58;&#160;&#160;&#160;&#160;Treasurer</font></div><div style="margin-bottom:12pt;padding-left:270pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="height:79.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:12pt;padding-left:270pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">MYLAN INC.</font></div><div style="margin-bottom:12pt;padding-left:270pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By _</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">John Miraglia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">________________<br>Name&#58;&#160;&#160;&#160;&#160;John Miraglia<br>Title&#58;&#160;&#160;&#160;&#160;Treasurer</font></div><div style="margin-bottom:12pt;padding-left:270pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">UTAH ACQUISITION SUB INC.</font></div><div style="margin-bottom:12pt;padding-left:270pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By _</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">John Miraglia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">________________<br>Name&#58;&#160;&#160;&#160;&#160;John Miraglia<br>Title&#58;&#160;&#160;&#160;&#160;Assistant Treasurer</font></div><div style="margin-bottom:12pt;padding-left:270pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">MYLAN II B.V.</font></div><div style="margin-bottom:12pt;padding-left:270pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By _</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">John Miraglia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">________________<br>Name&#58;&#160;&#160;&#160;&#160;John Miraglia<br>Title&#58;&#160;&#160;&#160;&#160;Board Member</font></div><div style="height:79.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.579%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:24pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BANK OF AMERICA, N.A.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as Administrative Agent</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> &#47;s&#47; Michelle D. Diggs_________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Michelle D. Diggs<br>Title&#58;   Officer</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:24pt"><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.579%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:24pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BANK OF AMERICA, N.A.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as a Lender</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> &#47;s&#47; Joseph L. Corah_________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Joseph L. Corah<br>Title&#58;   Managing Director</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BARCLAYS BANK PLC, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Warren Veech III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Warren Veech III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Vice President</font></div></td></tr></table></div><div style="margin-bottom:24pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:24pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BNP PARIBAS, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Pearce</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Michael Pearce</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Managing Director</font></div></td></tr></table></div><div style="margin-bottom:24pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.915%"><tr><td style="width:1.0%"></td><td style="width:13.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.549%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BNP PARIBAS, as a Lender</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; John Bosco</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;John Bosco</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Managing Director</font></div></td></tr></table></div><div style="margin-bottom:24pt;text-align:justify"><font><br></font></div><div style="margin-bottom:24pt;text-align:justify"><font><br></font></div><div style="margin-bottom:24pt;text-align:justify"><font><br></font></div><div style="margin-bottom:24pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Citibank, N.A., as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Eugene Yermash</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Eugene Yermash</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Vice President</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEUTSCHE BANK AG NEW YORK BRANCH, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Ming K. Chu</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Ming K. Chu</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Director</font></div></td></tr></table></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.249%"><tr><td style="width:1.0%"></td><td style="width:14.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.295%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Douglas Darman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Douglas Darman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Director</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.249%"><tr><td style="width:1.0%"></td><td style="width:14.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DNB Capital LLC, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Dania Hinedi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Dania Hinedi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Senior Vice President</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Kristie Li</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Kristie Li</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Senior Vice President</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Goldman Sachs Bank USA, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Keshia Leday</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Keshia Leday</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Authorized Signatory</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ING Bank N.V., Dublin Branch, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Cormac Langford</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Cormac Langford</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Director</font></div></td></tr></table></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.249%"><tr><td style="width:1.0%"></td><td style="width:14.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Sean Hassett</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Sean Hassett</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Director</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">JPMORGAN CHASE BANK, N.A., as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; James Kyle O&#8217;Donnell</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;James Kyle O&#8217;Donnell</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Vice President</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MIZUHO BANK, LTD., as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Tracy Rahn</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Tracy Rahn</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Executive Director</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PNC Bank, National Association, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Kathryn M. Hutterer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Kathryn M. Hutterer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Senior Vice President</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ROYAL BANK OF CANADA, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Scott MacVicar</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Scott MacVicar</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Authorized Signatory</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.249%"><tr><td style="width:1.0%"></td><td style="width:14.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MORGAN STANLEY BANK, N.A., as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Tim Kok</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Tim Kok</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Authorized Signatory</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.249%"><tr><td style="width:1.0%"></td><td style="width:14.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MUFG BANK, LTD., as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Jack Lonker</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Jack Lonker</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Authorized Signatory</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DBS BANK LTD., as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Kate Khoo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Kate Khoo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Vice President</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.912%"><tr><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Skandinaviska Enskilda Banken AB (PUBL), as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Alison Butt</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Alison Butt</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Authorised Signatory</font></div></td></tr></table></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.249%"><tr><td style="width:1.0%"></td><td style="width:14.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Andrew Moore</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Andrew Moore</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Authorised Signatory</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.745%"><tr><td style="width:1.0%"></td><td style="width:14.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.399%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SOCIETE GENERALE, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Kimberly Metzger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Kimberly Metzger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Director</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.006%"><tr><td style="width:1.0%"></td><td style="width:14.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.173%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Standard Chartered Bank, as a Lender</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 22.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Kristopher Tracy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Kristopher Tracy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Director &#8211; Financing Solutions</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:270pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:270pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to LIBOR Transition Amendment</font></div><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_19"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:171.75pt;padding-right:171.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix I</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:171.77pt;padding-right:171.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amended Agreement</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_22"></div><hr style="page-break-after:always"><div style="min-height:33.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:87.55pt;text-indent:221.5pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:line-through">EXECUTION VERSION</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix I to LIBOR Transition Amendment to Amended and Restated Revolving Credit Agreement</font></div><div><font><br></font></div><div style="margin-top:10.55pt;padding-left:317pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deal CUSIP Number&#58; 92557HAA4 Facility CUSIP Number&#58; 92557HAB2</font></div><div><font><br></font></div><div style="margin-top:10.85pt;padding-left:24.35pt;padding-right:24.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AMENDED AND RESTATED REVOLVING CREDIT AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:220.35pt;padding-right:220.35pt;text-align:center;text-indent:0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">dated as of JULY 1, 2021</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">,</font></div><div style="padding-left:24.37pt;padding-right:24.37pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:104%;text-decoration:underline">as amended by that certain LIBOR Transition Amendment to Amended and Restated Revolving</font></div><div style="padding-left:24.3pt;padding-right:24.3pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement, dated as of April 28, 2023,</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:24.32pt;padding-right:24.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">among</font></div><div><font><br></font></div><div style="padding-left:24.35pt;padding-right:24.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">VIATRIS INC.</font></div><div style="padding-left:225.55pt;padding-right:225.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">as Borrower and</font></div><div style="margin-top:0.45pt;padding-left:145.65pt;padding-right:145.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">the Guarantors from time to time party hereto and</font></div><div style="margin-top:2.25pt;padding-left:24.27pt;padding-right:24.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BANK OF AMERICA, N.A.,</font></div><div style="padding-left:24.32pt;padding-right:24.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Administrative Agent</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:24.27pt;padding-right:24.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and the Lenders and the Issuing Banks from time to time party hereto</font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:160.6pt;padding-right:160.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BofA SECURITIES, INC., BARCLAYS BANK PLC,</font></div><div style="padding-left:145.6pt;padding-right:145.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BNP PARIBAS SECURITIES CORP., CITIBANK, N.A.,</font></div><div style="padding-left:145.6pt;padding-right:145.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DEUTSCHE BANK SECURITIES INC., DNB MARKETS, INC.,</font></div><div style="padding-left:160.62pt;padding-right:160.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">GOLDMAN SACHS BANK USA, ING BANK N.V., DUBLIN BRANCH, JPMORGAN CHASE BANK, N.A., MIZUHO BANK, LTD.,</font></div><div style="padding-left:114.72pt;padding-right:114.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MORGAN STANLEY MUFG LOAN PARTNERS, LLC, PNC CAPITAL MARKETS LLC,</font></div><div style="padding-left:14.97pt;padding-right:14.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and</font></div><div style="padding-left:24.32pt;padding-right:24.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RBC CAPITAL MARKETS, LLC,</font></div><div style="padding-left:24.32pt;padding-right:24.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Lead Arrangers and Bookrunners</font></div><div style="height:56.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_25"></div><hr style="page-break-after:always"><div style="min-height:33.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:24.3pt;padding-right:24.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TABLE OF CONTENTS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-right:5.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.45pt;padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE I Definitions&#160;&#160;&#160;&#160;1</font></div><div style="margin-top:11.95pt;padding-left:38pt;padding-right:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.01 Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.02 Classification of Loans and Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">44</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.03 Terms Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">44</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.04 Accounting Terms&#59; GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">45</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.05 Payments on Business Days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">45</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.06 Divisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">46</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.07 Rounding_______________________________________________________&#160;&#160;&#160;&#160;46</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.08 Additional Alternative Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">46</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.09 Change of Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">47</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.10 Times of Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">47</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.11 Letter of Credit Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">48</font></div><div style="padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.12 Exchange Rates&#59; Currency Equivalents&#59; Interest Rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">48</font></div><div style="margin-top:11.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE II The Credits________________________________________________________&#160;&#160;&#160;&#160;48</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION  2.01 Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">48</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.02 Loans and Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">49</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.03 Requests for Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">50 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.04 Swingline Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">52 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.05 Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">54 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.06 Funding of Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">63</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.07 Market Disruption&#59; Inability to Determine Rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">64 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.08 Termination and Reduction of Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">68 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.09 Repayment of Loans&#59; Evidence of Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">69 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.10 Prepayment of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">70 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.11 Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">71</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.12 Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">72</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.13 &#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">73 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.14 Increased Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">73 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.15 Break Funding Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">75 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.16 Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">75</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.17 Payments Generally&#59; Pro Rata Treatment&#59; Sharing of Setoffs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">80 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.18 Mitigation Obligations&#59; Replacement of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">82 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.19 Expansion Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">84 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.20 Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">85 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.21 Extended Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">86 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.22 Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">88 </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.23 Sustainability Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">90</font></div><div style="height:51.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_28"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.2pt;padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE III Representations and Warranties_______________________________________&#160;&#160;&#160;&#160;91</font></div><div style="margin-top:12pt;padding-left:38pt;padding-right:5.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.01 Organization&#59; Powers&#59; Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">91</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.02 Authorization&#59; Enforceability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">92</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.03 Governmental Approvals&#59; No Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">92</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.04 Financial Statements&#59; Financial Condition&#59; No Material Adverse Change____&#160;&#160;&#160;&#160;92</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.05 Properties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">93</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.06 Litigation and Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">93</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.07 Compliance with Laws and Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">93</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.08 Investment Company Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">93</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.09 Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">94</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.10 Solvency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">94</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.11 &#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">94</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.12 Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">94</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.13 Federal Reserve Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">94</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.14 PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">94</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.15 OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">94</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.16 Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">95</font></div><div style="padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.17 Representations as to Foreign Obligors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">95</font></div><div style="margin-top:0.05pt;padding-left:38pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE IV Conditions Precedent_______________________________________________&#160;&#160;&#160;&#160;96</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.01 Initial Credit Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">96</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.02 Subsequent Credit Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">97</font></div><div style="margin-top:0.05pt;padding-left:38pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE V Affirmative Covenants______________________________________________&#160;&#160;&#160;&#160;98</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.01 Financial Statements and Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">98</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.02 Notices of Material Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.03 Existence&#59; Conduct of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.04 Payment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.05 Maintenance of Properties&#59; Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.06 Inspection Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">101</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.07 Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">101</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.08 Use of Proceeds and Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">101</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.09 Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">101</font></div><div style="margin-top:0.05pt;padding-left:38pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE VI Negative Covenants_______________________________________________&#160;&#160;&#160;&#160;102</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.01 Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">102</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.02 Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">104</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.03 Fundamental Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">107</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.04 Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">107</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.05 Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">108</font></div><div style="height:56.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_31"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.2pt;padding-right:6.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.06 Transactions with Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">109</font></div><div style="padding-right:6.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.07 Financial Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">110</font></div><div style="padding-right:6.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.08 Lines of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">111</font></div><div style="margin-top:12pt;padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE VII Events of Default________________________________________________&#160;&#160;&#160;&#160;111</font></div><div style="margin-top:12pt;padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE VIII The Administrative Agent_________________________________________&#160;&#160;&#160;&#160;114</font></div><div style="margin-top:12pt;padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE IX Miscellaneous____________________________________________________&#160;&#160;&#160;&#160;119</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.01 Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;__</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">119</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.02 Waivers&#59; Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">122</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.03 Expenses&#59; Indemnity&#59; Damage Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">123</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.04 Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">125</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.05 Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">131</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.06 Counterparts&#59; Integration&#59; Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">131</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.07 Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">131</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.08 Right of Setoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">131</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.09 Governing Law&#59; Jurisdiction&#59; Consent to Service of Process</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">132</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.10 WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">133</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.11 Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">133</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.12 Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">133</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.13 USA PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">135</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.14 Interest Rate Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">135</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.15 No Fiduciary Duty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">135</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.16 Electronic Execution of this Agreement and Other Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">136</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.17 Joint and Several</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">137</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.18 Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">137</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.19 Netherlands Loan Party Representation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">138</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.20 Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">138</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.21 Acknowledgement Regarding Any Supported QFCs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">139</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.22 Amendment and Restatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">140</font></div><div style="padding-left:38pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE X Guarantee_______________________________________________________&#160;&#160;&#160;&#160;140</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.01 Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">140</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.02 Right of Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">141</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.03 No Subrogation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">141</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.04 Amendments, etc., with Respect to the Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">142</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.05 Guarantee Absolute and Unconditional</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">142</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.06 Reinstatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">143</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.07 Obligations Independent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">143</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.08 Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">143</font></div><div style="padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.09 Subordination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">144</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_34"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.2pt;padding-left:38pt;padding-right:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.10 Stay of Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">144</font></div><div style="padding-right:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.11 Condition of Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">144</font></div><div style="padding-right:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.12 Releases</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">144</font></div><div style="margin-top:12pt;padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE XI Certain ERISA Matters____________________________________________&#160;&#160;&#160;&#160;145</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11.01&#160;&#160;&#160;&#160;Certain ERISA Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">145</font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SCHEDULES&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:38pt;padding-right:247.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 2.01&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Commitments</font></div><div style="padding-right:247.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 2.03&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Specified Litigation</font></div><div style="padding-left:38pt;padding-right:212.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 2.05&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Existing Letters of Credit</font></div><div style="padding-right:212.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 3.01&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Material Subsidiary Stocks</font></div><div style="padding-right:212.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 3.04(b)&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Material Adverse Changes</font></div><div style="padding-right:212.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 3.06&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Disclosed Matters</font></div><div style="padding-left:38pt;padding-right:150.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 3.07&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Compliance with Laws and Agreements</font></div><div style="padding-right:150.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 6.01&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Existing Indebtedness</font></div><div style="padding-right:150.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 6.02&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Existing Liens </font></div><div style="padding-right:150.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 6.04&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Restricted Payments </font></div><div style="padding-right:150.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 6.05(e)&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Investments</font></div><div style="padding-right:150.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 6.06&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Affiliate Transactions </font></div><div style="padding-right:150.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 9.01&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Notices</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBITS&#58;</font></div><div style="padding-left:38pt;padding-right:161.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit A&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Assignment and Assumption</font></div><div style="padding-right:161.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit B&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Revolving Note</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit C&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Borrowing Request</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit D&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Swingline Loan Notice</font></div><div style="padding-left:38pt;padding-right:157.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit E&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Compliance Certificate</font></div><div style="padding-right:157.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit F&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Guarantor Joinder Agreement</font></div><div style="padding-left:168.55pt;padding-right:13pt;text-indent:-130.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit G-1&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Not Partnerships For U.S. Federal Income Tax Purposes)</font></div><div style="padding-left:168.55pt;padding-right:19.6pt;text-indent:-130.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit G-2&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of U.S. Tax Compliance Certificate (For Foreign Participants That Are Not Partnerships For U.S. Federal Income Tax Purposes)</font></div><div style="padding-left:168.55pt;padding-right:19.6pt;text-indent:-130.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit G-3&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of U.S. Tax Compliance Certificate (For Foreign Participants That Are Partnerships For U.S. Federal Income Tax Purposes)</font></div><div style="padding-left:170.7pt;padding-right:10.85pt;text-indent:-131.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit G-4&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Partnerships For U.S. Federal Income Tax Purposes)</font></div><div style="padding-left:39.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit H&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Solvency Certificate</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_37"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:70.45pt;padding-right:70.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AMENDED AND RESTATED REVOLVING CREDIT AGREEMENT</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This AMENDED AND RESTATED REVOLVING CREDIT AGREEMENT (this</font></div><div style="padding-left:38pt;padding-right:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is dated as of July 1, 2021 among VIATRIS INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), certain Affiliates and Subsidiaries of the Borrower from time to time party hereto as Guarantors, each Lender and Issuing Bank from time to time party hereto, and BANK OF AMERICA, N.A., as Administrative Agent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:70.4pt;padding-right:70.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PRELIMINARY STATEMENTS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Borrower (formerly known as UPJOHN INC.), the Guarantors, certain banks and the Administrative Agent are parties to that certain Credit Agreement, dated as of June 16, 2020 (the &#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement&#8221;), pursuant to which, at the request of the Borrower, the Lenders (as defined therein) have agreed to extend credit to the Borrower in the form of Loans and Letters of Credit (each as defined therein) at any time and from time to time on and after the Closing Date and prior to the Revolving Credit Maturity Date (each as defined therein), in an aggregate principal amount not to exceed $4,000,000,000, subject to the terms and conditions thereinafter set forth&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Borrower has requested that the Lenders amend </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">and restate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Existing Credit Agreement </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">and in connection therewith, the Existing Loan (as</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(as defined in the First Amendmen</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">t (as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">defined below) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">shall be repaid in full</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">) as set forth herein</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">WHEREAS, each Lender hereunder that was also a lender under the Existing Credit Agreement, by its execution and delivery of this Agreement, hereby waives any breakage costs incurred in connection with the repayment of the Existing Loan pursuant to Section 2.15 (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:line-through">Break Funding Payments</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">) of the Existing Credit Agreement&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Lenders have indicated their willingness to agree to such amendments and restatements of the Existing Credit Agreement on the terms and subject to the conditions set forth hereinafter </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">and in the First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the premises and the mutual </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">covenants contained in this Agreement, the parties hereto agree as</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">representations, covenants and agreements of the Borrower, the Guarantors, the Administrative Agent and the lenders, each party hereto hereby promises, covenants and agrees to amend the Existing Credit Agreement with all of the terms, conditions and provisions set forth herein below and all of the terms, conditions and provisions of the Existing Credit Agreement are, subject to the occurrence of the First Amendment Effective Date, hereby deemed superseded, substituted, and replaced by the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">follow</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">s</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:33.9pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:54.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_40"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:224.12pt;padding-right:224.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE I</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:223.97pt;padding-right:223.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Definitions</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 1.01&#160;&#160;&#160;&#160;Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As used in this Agreement, the following terms have the meanings specified below&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acquired Entity or Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each Person, property, business or assets acquired by the Borrower or a Subsidiary, to the extent not subsequently sold, transferred or otherwise disposed of by the Borrower or such Subsidiary.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acquisition Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Indebtedness of the Loan Parties that has been issued for the purpose of financing, in part, the acquisition of an Acquired Entity or Business.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned in Section 9.13.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Bank of America (or any of its designated branch offices or Affiliates), in its capacity as administrative agent for the Lenders hereunder, or any successor administrative agent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent&#8217;s Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any currency, the Administrative Agent&#8217;s address and, as appropriate, account as set forth on Schedule 9.01 with respect to such currency, or such other address or account with respect to such currency as the Administrative Agent may from time to time notify the Borrower and the Lenders.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Questionnaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:53.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning assigned in Section 9.01(c). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Agreed Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; means Dollars or any Alternative Currency, as applicable. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning assigned in the preamble hereto.</font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) Euro, (b) Sterling, (c) Yen and (d) each other currency (other than Dollars) approved in accordance with Section 1.08.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Daily Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, with respect to any Credit Event&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">denominated in Sterling, the rate per annum equal to SONIA determined pursuant to the definition thereof plus the SONIA Adjustment&#59; and</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">denominated in any other Alternative Currency (to the extent such Loans denominated in such currency will bear interest at a daily rate), the daily rate per annum as designated with respect to such Alternative Currency at the time such Alternative Currency is approved by the Administrative Agent and the relevant Lenders pursuant to Section 1.08(a) plus </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the adjustment (if any) determined by the Administrative Agent and the relevant Lenders pursuant to Section 1.08(a)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, if any Alternative Currency Daily Rate shall be less than zero percent (0%), such rate shall be deemed zero percent (0%) for purposes of this Agreement. Any change in any Alternative Currency Daily Rate shall be effective from and including the date of such change without further notice.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Daily Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest at a rate based on the definition of &#8220;Alternative Currency Daily Rate.&#8221; All Alternative Currency Daily Rate Loans must be denominated in an Alternative Currency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, with respect to any amount denominated in Dollars, the equivalent amount thereof in the applicable Alternative Currency as determined by the Administrative Agent or the applicable Issuing Bank, as the case may be, at such time on the basis of the Spot Rate (determined in respect of the most recent Revaluation Date) for the purchase of such Alternative Currency with Dollars.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Alternative Currency Daily Rate Loan or an Alternative Currency Term Rate Loan, as applicable.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Term Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Interest Period, with respect to any Credit Event&#58;</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">denominated in Euros, the rate per annum equal to the Euro Interbank Offered Rate (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) on the day that is two TARGET Days preceding the first day of such Interest Period with a term equivalent to such Interest Period&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">denominated in Japanese Yen, the rate per annum equal to the Tokyo Interbank Offer Rate (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) on the Rate Determination Date with a term equivalent to such Interest Period&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">denominated in any other Alternative Currency (to the extent such Loans denominated in such currency will bear interest at a term rate), the term rate per annum as designated with respect to such Alternative Currency at the time such Alternative Currency is approved by the Administrative Agent and the relevant Lenders pursuant to Section 1.08(a)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, if any Alternative Currency Term Rate shall be less than zero percent (0%), such rate shall be deemed zero percent (0%) for purposes of this Agreement.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_43"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:10.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Term Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest at a rate based on the definition of &#8220;Alternative Currency Term Rate.&#8221; All Alternative Currency Term Rate Loans must be denominated in an Alternative Currency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(a) with respect to SOFR, the SOFR Administrator or any Governmental Authority having jurisdiction over the Administrative Agent or the SOFR Administrator with respect to its publication of SOFR, in each case acting in such capacity and</font></div><div style="padding-left:38pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">with respect to any Alternative Currency, the applicable administrator for the Relevant Rate for such Alternative Currency or any Governmental Authority having jurisdiction over the Administrative Agent or such administrator </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">with respect to its publication of the applicable Relevant Rate, in each case acting in such capacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.3pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Applicable Foreign Obligor Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; has the meaning assigned in Section 3.17(a). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Applicable Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means, with respect to any Lender at any time, a percentage</font></div><div style="padding-left:38pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">equal to a fraction the numerator of which is such Lender&#8217;s Revolving Commitment at that time and the denominator of which is the aggregate Revolving Commitments of all Revolving Lenders at that time (if the Revolving Commitments have terminated or expired, the Applicable Percentages shall be determined based upon such Lender&#8217;s share of the aggregate Revolving Credit Exposures at that time).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:9.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, from time to time, the following percentages per annum, based upon the Debt Rating as set forth below&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.783%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38.21pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.567%"><tr><td style="width:1.0%"></td><td style="width:8.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:9.8pt;padding-right:5.2pt;text-indent:-4.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Pricing Level</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:13.95pt;padding-right:13.25pt;text-indent:4.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Debt Rating</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:16.5pt;padding-right:6.45pt;text-indent:-9.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Facility Fee</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Applicable Rate for </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Term SOFR</font></div><div style="margin-top:0.05pt;padding-left:7.85pt;padding-right:7.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SOFR</font></div><div style="margin-top:1.85pt;padding-left:11.97pt;padding-right:11.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Daily Floating Rate Loans and Alternative Currency Loans</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:40.6pt;padding-right:13.25pt;text-indent:-27.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Letter of Credit Fees</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.95pt;text-align:center;text-indent:-0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Applicable Rate for Base Rate Loans and Swingline Loans</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-left:0.12pt;padding-right:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-left:24.25pt;padding-right:6.3pt;text-indent:-17.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">&#62;A- &#47; A3 &#47;A-</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-left:6.9pt;padding-right:6.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.09%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.785%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-left:33.12pt;padding-right:33.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.785%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:30.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.00%</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:0.12pt;padding-right:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:12.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BBB+ &#47;</font></div><div style="margin-top:1.85pt;padding-left:12.9pt;padding-right:14.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Baa1 &#47; BBB+</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:6.9pt;padding-right:6.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.10%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.90%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:33.12pt;padding-right:33.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.90%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-right:30.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.00%</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:0.12pt;padding-right:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BBB &#47;</font></div><div style="margin-top:1.85pt;padding-left:16pt;padding-right:14.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Baa2 &#47; BBB</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:6.9pt;padding-right:6.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.125%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.00%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:33.12pt;padding-right:33.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.00%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.25pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-right:30.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.00%</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:0.12pt;padding-right:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:14.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BBB- &#47;Baa3 &#47; BBB-</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:6.9pt;padding-right:6.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.175%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.20%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:33.12pt;padding-right:33.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.20%</font></div></td><td colspan="3" style="border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-right:30.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.20%</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:0.12pt;padding-right:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:6.3pt;padding-right:5.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8804;BB+ &#47; Ba1 &#47; BB+</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:6.9pt;padding-right:6.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.20%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.425%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:33.12pt;padding-right:33.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.425%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.5pt solid #010101;border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-right:27.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.425%</font></div></td></tr></table></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.783%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_46"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="margin-top:11.1pt;padding-left:38pt;padding-right:7.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Initially, the Applicable Rate shall be determined based upon Pricing Level 4. Thereafter, each change in the Applicable Rate resulting from a publicly announced change in the Debt Rating shall be effective during the period commencing on the date of the public announcement thereof and ending on the date immediately preceding the effective date of the next such change and, in the case of a downgrade, during the period commencing on the date of the public announcement thereof and ending on the date immediately preceding the effective date of the next such change. If the rating system of Moody&#8217;s, S&#38;P or Fitch shall change, or if any such rating agency shall cease to be in the business of rating corporate debt obligations, the Borrower and the Lenders shall negotiate in good faith to amend this definition to reflect such changed rating system or the unavailability of ratings from such rating agency and, pending the effectiveness of any such amendment, the Applicable Rate shall be determined by reference to the rating most recently in effect prior to such change or cessation.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any borrowings and payments in any Alternative Currency, the local time in the place of settlement for such Alternative Currency as may be determined by the Administrative Agent or the applicable Issuing Bank, as the case may be, to be necessary for timely settlement on the relevant date in accordance with normal banking procedures in the place of payment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;Cash Equivalents.&#8221;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Fund that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Arrangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, BofA Securities, Inc., Barclays Bank PLC, BNP Paribas Securities Corp., Citibank, N.A., Deutsche Bank Securities Inc., DNB Markets, Inc., Goldman Sachs Bank USA, ING Bank N.V., Dublin Branch, JPMorgan Chase Bank, N.A., Mizuho Bank, Ltd., Morgan Stanley MUFG Loan Partners, LLC, acting through Morgan Stanley Senior Funding, Inc. and MUFG Bank, Ltd., PNC Capital Markets LLC and RBC Capital Markets, LLC, as lead arrangers and bookrunners, as lead arrangers and bookrunners.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an assignment and assumption agreement entered into by a Lender and an assignee (with the consent of any party whose consent is required by Section 9.04 of this Agreement), and accepted by the Administrative Agent, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or any other form (including electronic documentation generated by use of an electronic platform) approved by the Administrative Agent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Attributable Receivables Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; at any time means the principal amount of Indebtedness which (i) if a Permitted Receivables Facility is structured as a secured lending agreement, would constitute the principal amount of such Indebtedness or (ii) if a Permitted Receivables Facility is structured as a purchase agreement, would be outstanding at such time under the Permitted Receivables Facility if the same were structured as a secured lending agreement rather than a purchase agreement.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_49"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:73.95pt;padding-right:35.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Augmenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning assigned to such term in Section 2.19(a). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Auto-Extension Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 2.05(b)(iii).</font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:6.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Availability Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the period from and including the Closing Date to but excluding the earlier of (a) (i) with respect to Revolving Commitments made pursuant to Section 2.01, the initial Revolving Credit Maturity Date, (ii) with respect to any Revolving Extension Series, the applicable Revolving Credit Maturity Date and (iii) with respect to any Swingline Loans, the initial Revolving Credit Maturity Date or, to the extent the Commitment of the Swingline Lender has been extended pursuant to a Revolving Extension Series, the Latest Maturity Date and (b) with respect to any Class of Revolving Commitments or the commitment of the Swingline Lender to make Swingline Loans, the date such Class of Revolving Commitments or such commitment to make Swingline Loans, as the case may be, is terminated in accordance with the provisions of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Available Tenor</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (x) if the then-current Benchmark is a term rate, any tenor for such Benchmark that is or may be used for determining the length of an Interest Period or (y) otherwise, any payment period for interest calculated with reference for such Benchmark, as applicable, pursuant to this Agreement as of such date.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">rule, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">regulation or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bank of America</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Bank of America, N.A. and its permitted successors and assigns.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means for any day a fluctuating rate of interest per annum equal to the highest of (a) the Federal Funds Effective Rate in effect on such day plus 1&#47;2 of 1%, (b) the rate of interest in effect for such day as publicly announced from time to time by Bank of America as its &#8220;prime rate,&#8221; and (c) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurocurrency Rate in effect on such day</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR for a one-month Interest Period beginning on such day (or, if such day is not a U.S. Government Securities Business Day, the immediately preceding U.S. Government Securities Business Day) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">plus 1.00%, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that if Base Rate shall be less than zero, such rate shall be deemed zero for purposes of this Agreement. The &#8220;prime rate&#8221; is a rate set by Bank of America based upon various factors including Bank of America&#8217;s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.799%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_52"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:7.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be priced at, above, or below such announced rate. Any change in such prime rate announced by Bank of America shall take effect at the opening of business on the day specified in the public announcement of such change. &#8220;Base Rate,&#8221; when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Base Rate. If the Base Rate is being used as an alternate rate of interest pursuant to Section 2.07 hereof, then the Base Rate shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause (c) above.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest at a rate based on the definition of &#8220;Base Rate.&#8221; All Base Rate Loans shall be denominated in Dollars.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.45pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Benchmark</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, initially, LIBOR&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">that if a replacement of the Benchmark has occurred pursuant to Section 2.07(b), then &#8220;Benchmark&#8221; means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate. Any reference to &#8220;Benchmark&#8221; shall include, as applicable, the published component used in the calculation thereof.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Benchmark Replacement</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.65pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(1)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:line-through">For purposes of Section 2.07(d)(i), the first alternative set forth below that can be determined by the Administrative Agent</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.3pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(a)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:line-through">the sum of&#58; (i) Term SOFR and (ii) 0.11448% (11.448 basis points) for an Available Tenor of one-month&#8217;s duration, 0.26161% (26.161 basis points) for an Available Tenor of three-months&#8217; duration, 0.42826% (42.826 basis points) for an Available Tenor of six-months&#8217; duration, and 0.71513% (71.513 basis points) for an Available Tenor of twelve-months&#8217; duration, or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.25pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(b)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:line-through">the sum of&#58; (i) Daily Simple SOFR and (ii) 0.11448% (11.448 basis points)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.7pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">that, if initially LIBOR is replaced with the rate contained in clause (b) above (Daily Simple SOFR plus the applicable spread adjustment) and subsequent to such replacement, the Administrative Agent determines that Term SOFR has become available and is administratively feasible for the Administrative Agent in its sole discretion, and the Administrative Agent notifies the Borrower and each Lender of such availability, then from and after the beginning of the Interest Period, relevant interest payment date or payment period for interest calculated, in each case, commencing no less than thirty (30) days after the date of such notice, the Benchmark Replacement shall be as set forth in clause (a) above&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(2)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:line-through">For purposes of Section 2.07(d)(ii), the sum of (a) the alternate benchmark rate and (b) an adjustment (which may be a positive or negative value or zero), in each case, that has been selected by the Administrative Agent and the Borrower as the replacement Benchmark giving due consideration to any evolving or then-prevailing market convention, including any applicable recommendations made by a Relevant Governmental Body, for U.S. dollar-denominated syndicated credit facilities at such time&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">that, if the Benchmark Replacement as determined pursuant to clause (1) or (2) above would be less than 0.00%, the Benchmark Replacement will be deemed to be 0.00% for the purposes of this Agreement and the other Loan Documents.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Any Benchmark Replacement shall be applied in a manner consistent with market practice&#59; provided that to the extent such market practice is not administratively feasible for the Administrative Agent, such Benchmark Replacement shall be applied in a manner as otherwise reasonably determined by the Administrative Agent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Benchmark Replacement Conforming Changes</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of &#8220;Base Rate,&#8221; the definition of &#8220;Business Day,&#8221; the definition of &#8220;Interest Period,&#8221; timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent decides may be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.3pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Benchmark Transition Event</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, with respect to any then-current Benchmark other than LIBOR, the occurrence of a public statement or publication of information by or on behalf of the administrator of the then-current Benchmark or a Governmental Authority with jurisdiction over such administrator announcing or stating that all Available Tenors are or will no longer be representative, or made available, or used for determining the interest rate of loans, or shall or will otherwise cease, provided that, at the time of such statement or publication, there is no successor administrator that is satisfactory to the Administrative Agent, that will continue to provide any representative tenors of such Benchmark after such specific date.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221; means a certification regarding beneficial ownership required by the Beneficial Ownership Regulation.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means 31 C.F.R. &#167; 1010.230.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:35.6pt;padding-right:6.35pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in Section 4975 of the Code or (c) any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Board of Governors of the Federal Reserve System of the United States of America.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:103.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning assigned in the preamble hereto. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 5.01.</font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:5.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) Revolving Loans of the same Type, made, converted or continued on the same date and, in the case of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans and Alternative Currency Term Rate Loans, as to which a single Interest Period is in effect or (b) a Swingline Loan.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Minimum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans, $1,000,000 and (b) with respect to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or Alternative Currency Loans, the Dollar Equivalent of $5,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, with respect to Loans denominated in any Alternative Currency other than Euros, Sterling or Yen, such amount as may be specified by the Administrative Agent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Multiple</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans,</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:37.95pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$100,000 and (b) with respect to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or Alternative Currency Loans, the Dollar Equivalent of $1,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, with respect to Loans denominated in any Alternative Currency other than Euros, Sterling or Yen, such amount as may be specified by the Administrative Agent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower for a Borrowing in accordance with Section 2.03.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any day other than a Saturday, Sunday or other day on which commercial banks are authorized to close under the Laws of, or are in fact closed in, the state where the Administrative Agent&#8217;s Office is located and&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.3pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(a)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:line-through">if such day relates to any interest rate settings as to a Eurocurrency Loan or a LIBOR Daily Floating Rate Loan, any fundings, disbursements, settlements and payments in Dollars in respect of any such Eurocurrency Loan or such LIBOR Daily Floating Rate Loan, or any other dealings in Dollars to be carried out pursuant to this Agreement in respect of any such Eurocurrency Loan or such LIBOR Daily Floating Rate Loan, means any such day on which dealings in deposits in Dollars are conducted by and between banks in the London interbank eurodollar market&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-bottom:0.3pt;padding-left:74pt;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">&#91;reserved&#93;&#59;</font></div><div style="padding-left:145.65pt"><font><br></font></div><div style="margin-top:8.7pt;padding-left:74pt;padding-right:6.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">if such day relates to any interest rate settings as to an Alternative Currency Loan denominated in Euro, any fundings, disbursements, settlements and payments in Euro in respect of any such Alternative Currency Loan, or any other dealings in Euro to be carried out pursuant to this Agreement in respect of any such Alternative Currency Loan, means a Business Day that is also a TARGET Day&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">if such day relates to any interest rate settings as to an Alternative Currency Loan denominated in (i) Sterling, means a day other than a day banks are closed for general business in London because such day is a Saturday, Sunday or a legal holiday</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">under the laws of the United Kingdom&#59; and (ii) Yen, means a day other than when banks are closed for general business in Japan&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">if such day relates to any interest rate settings as to an Alternative Currency Loan denominated in a currency other than, Euro, Sterling or Japanese Yen, means any such day on which dealings in deposits in the relevant currency are conducted by and between banks in the applicable offshore interbank market for such currency&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.9pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:line-through">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">if such day relates to any fundings, disbursements, settlements and payments in a currency other than Euro in respect of an Alternative Currency Loan denominated in a currency other than Euro, or any other dealings in any currency other than Euro to be carried out pursuant to this Agreement in respect of any such Alternative Currency Loan (other than any interest rate settings), means any such day on which banks are open for foreign exchange business in the principal financial center of the country of such currency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Lease Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; of any Person means the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP as in effect on the Closing Date, and the amount of such obligations as of any date shall be the capitalized amount thereof determined in accordance with GAAP as in effect on the Closing Date that would appear on a balance sheet of such Person prepared as of such date.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Captive Insurance Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means American Triumvirate Insurance Company, a Vermont corporation or any successor thereto, so long as such Subsidiary is maintained as a special purpose self-insurance subsidiary.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">card obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Loan Party or any Subsidiary&#8217;s participation in commercial (or purchasing) card programs.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Collateralize</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means to pledge and deposit with or deliver to the Administrative Agent, for the benefit of the applicable Issuing Bank and the Revolving Lenders, as collateral for the L&#47;C Exposure, cash or deposit account balances pursuant to documentation in form and substance reasonably satisfactory to the Administrative Agent and such Issuing Bank (which documents are hereby consented to by the Revolving Lenders). Cash Collateral shall be maintained in blocked, non-interest bearing deposit accounts at Bank of America.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">any evidence of Indebtedness issued or directly and fully guaranteed or insured by the government or any agency or instrumentality of (i) the United States, (ii) the United Kingdom or (iii) any member nation of the European Union&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">time deposits, certificates of deposit, and bank notes of any financial institution that (i) is a Lender or (ii) is a member of the Federal Reserve System (or organized in any foreign country recognized by the United States) and whose senior unsecured debt is rated at least A-2, P-2, or F-2, short-term, or A or A2, long-term, by Moody&#8217;s, S&#38;P or Fitch (any such bank in the foregoing clause (i) or (ii) being an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Issues with only one short-term credit rating must have a minimum credit rating of A 1, P 1 or F 1&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">commercial paper, including asset-backed commercial paper, and floating or fixed rate notes issued by an Approved Bank or a corporation or special purpose vehicle (other than an Affiliate or Subsidiary of the Borrower) organized and existing under the laws of the United States of America, any state thereof or the District of Columbia (or any foreign country recognized by the United States) and rated at least A 2 by S&#38;P and at least P 2 by Moody&#8217;s&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">asset-backed securities rated AAA by Moody&#8217;s, S&#38;P, or Fitch, with weighted average lives of 3 years or less (measured to the next maturity date)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">repurchase agreements and reverse repurchase agreements relating to marketable direct obligations issued or unconditionally guaranteed or insured by the government or any agency or instrumentality of (i) the United States, (ii) the United Kingdom or (iii) any member nation of the European Union maturing within 365 days from the date of acquisition&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">money market funds which invest substantially all of their assets in assets described in the preceding clauses (1) through (5)&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">instruments equivalent to those referred to in clauses (1) through (6) above denominated in any Alternative Currency or any other foreign currency comparable in credit quality and tenor to those referred to above and customarily used by corporations for cash management purposes in any jurisdiction outside the United States to the extent reasonably required in connection with any business conducted by any Subsidiary organized in such jurisdiction&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that except in the case of clauses (4) and (5) above, the maximum maturity date of individual securities or deposits will be 3 years or less at the time of purchase or deposit.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the acquisition of beneficial ownership, directly or indirectly, by any Person or group (within the meaning of the Securities Exchange Act of 1934 and the rules of the SEC thereunder as in effect on the Closing Date) of Equity Interests representing more than 35% of the aggregate ordinary voting power represented by the issued and outstanding Equity Interests of the Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) the adoption of any law, treaty, rule or regulation after the date of this Agreement, (b) any change in any law, treaty, rule or regulation or in the interpretation or application thereof by any Governmental Authority after the date of this Agreement or (c) compliance by any Lender or any Issuing Bank (or, for purposes of Section 2.14(b), by any Lending Office of such Lender or by such Lender&#8217;s or such Issuing Bank&#8217;s holding company, if any) with any request, guideline or directive (whether or not having the force of law) of any Governmental Authority made or issued after the date of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_55"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">pursuant to Basel III, shall in each case be deemed to be a &#8220;Change in Law&#8221;, regardless of the date enacted, adopted or issued.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Charges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.14.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Class</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; (a) when used with respect to Commitments, refers to whether such Commitment is a Revolving Commitment or an Extended Revolving Commitment of a given Revolving Extension Series, (b) when used with respect to Loans or a Borrowing, refers to whether such Loans, or the Loans comprising such Borrowing, are Loans under Revolving Commitments or Loans under Extended Revolving Commitments of a given Revolving Extension Series and (c) when used with respect to Lenders, refers to whether such Lender has a Loan or Commitment with respect to a particular Class of Loans or Commitments.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the date on which all the conditions specified in Section 4.01 of this Agreement are satisfied (or waived in accordance with Section 9.02 of this Agreement).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;CME&#8221; means CME Group Benchmark Administration Limited as administrator of the forward-looking term SOFR (or a successor administrator).</font></div><div style="margin-top:0.25pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means the U.S. Internal Revenue Code of 1986, as amended from time to time. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Combination Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means the combination and separation transactions by and</font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">among Pfizer Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pfizer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Borrower and Mylan N.V., including but not limited to the separation of Pfizer&#8217;s global, primarily offpatent branded and generic established medicine business and the combination of such business with Mylan N.V., the borrowings and other financings related thereto, and the payment of fees and expenses associated therewith.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Revolving Commitment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Communication</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means this Agreement, any Loan Document and any document, amendment, approval, consent, information, notice, certificate, request, statement, disclosure or authorization related to any Loan Document.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to the use, administration of or any conventions associated with </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SONIA</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">, EURIBOR, TIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or any proposed Successor Rate for an Agreed Currency </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as applicable, any conforming changes to the definitions of &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate&#8221;, &#8220;SOFR&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SONIA&#8221;, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;EURIBOR&#8221;, &#8220;TIBOR&#8221;, &#8220;Term SOFR&#8221; and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Interest Period&#8221;, timing and frequency of determining rates and making payments of interest and other technical, administrative or operational matters (including, for the avoidance of doubt, the definition</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">s </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day&#8221; and &#8220;U.S. Government Securities</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Business Day&#8221;, timing of borrowing requests or prepayment, conversion or continuation notices and length of lookback periods) as may be appropriate, in the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">reasonable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">discretion of the Administrative Agent</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">, after consultation with the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to reflect the adoption and implementation of such applicable rate(s) and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice for such Agreed Currency (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or that no market practice for the administration of such rate for such Agreed Currency exists, in such other manner of administration as the Administrative Agent determines is</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.799%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_58"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">reasonably necessary</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">, after consultation with the Borrower, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in connection with the administration of this Agreement and any other Loan Document).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Consolidated Net Income plus, without duplication and, except in the case of clause (xii), to the extent deducted from revenues in determining Consolidated Net Income, (i) Consolidated Interest Expense and charges, deferred financing fees and milestone payments in connection with any investment or series of related investments, losses on hedging obligations or other derivative instruments entered into for the purpose of hedging interest rate risk, net of gains on such hedging obligations, and costs of surety bonds in connection with financing activities, (ii) expense and provision for taxes paid or accrued, (iii) depreciation, (iv) amortization (including amortization of intangibles, including goodwill), (v) non-cash charges recorded in respect of purchase accounting or impairment of goodwill or assets and non-cash exchange, translation or performance losses relating to any foreign currency hedging transactions or currency fluctuations, (vi) any other non-cash items, (vii) any unusual, infrequent or extraordinary loss or charge (including the amount of any restructuring, integration, transition, executive severance, facility closing, unusual litigation and similar charges accrued during such period, including any charges to establish accruals and reserves or to make payments associated with the reassessment or realignment of the business and operations of the Borrower and its Subsidiaries, including the sale or closing of facilities, severance, stay bonuses and curtailments or modifications to pension and post-retirement employee benefit plans, asset write-downs or asset disposals (including leased facilities), write-downs for purchase and lease commitments, start-up costs for new facilities, write-downs of excess, obsolete or unbalanced inventories, relocation costs which are not otherwise capitalized and any related promotional costs of exiting products or product lines), (viii) non-recurring cash charges in connection with the litigation described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (ix) income of any non-wholly owned Subsidiaries and deductions attributable to minority interests, (x) any non-cash costs or expenses incurred by the Borrower or any Subsidiary pursuant to any management equity plan or stock plan, (xi) expenses with respect to casualty events, (xii) the amount of net cost savings in connection with any acquisition of an Acquired Entity or Business or otherwise projected by the Borrower in good faith to be realized as a result of specified actions taken prior to the last day of such period (calculated on a pro forma basis as though such cost savings had been realized since the first day of such period), net of the amount of actual benefits realized during such period from such actions&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (A) in connection with (1) the Combination Transactions, such actions have been taken within 24 months after the closing date of the Combination Transactions and (2) any other acquisition of an Acquired Entity or Business, such actions have been taken within 12 months after the closing date of an acquisition of an Acquired Entity or Business and (B) no cost savings shall be added pursuant to this clause (xii) to the extent duplicative of any expenses or charges relating to such cost savings that are included in clause (vii) above with respect to such period, (xiii) expenses incurred in connection with any acquisition of an Acquired Entity or Business, investment, asset disposition, issuance or repayment of debt, issuance of equity securities, refinancing transaction or amendment or other modification of any debt instrument (in each case, including any such transaction consummated prior to the Closing Date and any such transaction undertaken but not completed, and including transaction expenses incurred in connection therewith), (xiv) any contingent or deferred payments (including earn-out payments, non-compete payments and consulting payments but excluding ongoing royalty payments) made in connection with any acquisition of an Acquired Entity or Business, (xv) non-cash charges pursuant to ASC 715, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to the extent included in Consolidated Net Income, the sum of (xvi) any unusual, infrequent or extraordinary income or gains, (xvii) any other non-cash income or gains (except to the extent representing (x) an accrual for future cash income or in respect of which cash was received in a prior period or (y) the reversal of any cash reserves established in a prior period), and (xviii) any cash payment made with respect to any non-cash items added back in computing Consolidated EBITDA in a prior period pursuant to clause (vi) above), all calculated for the Borrower and its Subsidiaries (other than the Captive Insurance Subsidiary) in accordance with GAAP on a consolidated basis&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, to the extent included in Consolidated Net Income, (A) there shall be excluded in determining Consolidated EBITDA </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:37.95pt;padding-right:5.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">currency translation gains and losses related to currency remeasurements of Indebtedness (including the net loss or gain resulting from Swap Agreements for currency exchange risk) and</font></div><div style="padding-left:38pt;padding-right:6.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B) there shall be excluded in determining Consolidated EBITDA for any period any adjustments resulting from the application of SFAS 133.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Interest Expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with reference to any period, the interest expense whether or not paid in cash (including interest expense under Capital Lease Obligations that is treated as interest in accordance with GAAP, but excluding, any (i) non-cash interest expense attributable to the movement in mark-to-market valuation under Swap Agreements or other derivative instruments, (ii) non-cash interest expense attributable to the amortization of gains or losses resulting from the termination of Swap Agreements prior to or reasonably contemporaneously with the Closing Date, (iii) amortization of deferred financing fees and (iv) expensing of bridge or other financing fees) of the Borrower and its Subsidiaries (other than the Captive Insurance Subsidiary) calculated on a consolidated basis for such period in accordance with GAAP </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, without duplication&#58; (a) imputed interest attributable to Capital Lease Obligations of the Borrower and its Subsidiaries (other than the Captive Insurance Subsidiary) for such period, (b) commissions, discounts and other fees and charges owed by the Borrower or any of its Subsidiaries (other than the Captive Insurance Subsidiary) with respect to letters of credit securing financial obligations, bankers&#8217; acceptance financing and receivables financings for such period, (c) amortization or write-off of debt discount and debt issuance costs, premium, commissions, discounts and other fees and charges associated with Indebtedness of the Borrower and its Subsidiaries (other than the Captive Insurance Subsidiary) for such period, (d) cash contributions to any employee stock ownership plan or similar trust made by the Borrower or any of its Subsidiaries to the extent such contributions are used by such plan or trust to pay interest or fees to any Person (other than the Borrower or a wholly owned Subsidiary) in connection with Indebtedness incurred by such plan or trust for such period, (e) all interest paid or payable with respect to discontinued operations of the Borrower or any of its Subsidiaries for such period, (f) the interest portion of any deferred payment obligations of the Borrower or any of its Subsidiaries (other than the Captive Insurance Subsidiary) for such period, (g) all interest on any Indebtedness of the Borrower or any of its Subsidiaries (other than the Captive Insurance Subsidiary) of the type described in clause (e) or (f) of the definition of &#8220;Indebtedness&#8221; for such period and (h) the interest component of all Attributable Receivables Indebtedness of the Borrower and its Subsidiaries (other than the Captive Insurance Subsidiary).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Test Period, the ratio of (a) Consolidated Total Indebtedness net of Unrestricted Cash of the Borrower and its Subsidiaries in an amount not exceeding $1,000,000,000 as of the last day of such Test Period to (b) Consolidated EBITDA for such Test Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:7.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with reference to any period, the net income (or loss) of the Borrower and its Subsidiaries calculated in accordance with GAAP on a consolidated basis (without duplication) for such period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, in calculating Consolidated Net Income of the Borrower and its Subsidiaries for any period, there shall be excluded (a) the income (or deficit) of any Person accrued prior to the date it becomes a Subsidiary of the Borrower or is merged into or consolidated with the Borrower or any of its Subsidiaries, (b) the income (or deficit) of any Person (other than a Subsidiary of the Borrower) in which the Borrower or any of its Subsidiaries has an ownership interest, except to the extent that any such income is actually received by the Borrower or such Subsidiary in the form of dividends or similar distributions, (c) the income or deficit of the Captive Insurance Subsidiary, (d) any fees and expenses incurred during such period, or any amortization thereof for such period, in connection with the consummation of any acquisition, investment, asset disposition, issuance or repayment of debt, issuance of equity securities, refinancing transaction or amendment or other modification of any debt instrument (in each case, including any such transaction consummated prior to the Closing Date and any such transaction undertaken but not completed) and any charges or non-recurring merger costs incurred during such period as a result of any such </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:7.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">transaction, (e) any amortization of deferred charges resulting from the application of &#8220;Accounting Principles Board Opinion No. APB 14-1 &#8212; Accounting for Convertible Debt Instruments&#8221; that may be settled in cash upon conversion (including partial cash settlement) and</font></div><div style="padding-left:38pt;padding-right:7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">any income (loss) for such period attributable to the early extinguishment of Indebtedness, together with any related provision for taxes on any such income. There shall be excluded from Consolidated Net Income for any period (i) any gains or losses resulting from any reappraisal, revaluation or write-up or write-down of assets (including any gains and losses attributable to movement in the mark-to-market valuation of (1) any Permitted Convertible Indebtedness, (2) any Permitted Bond Hedge Transaction, (3) any Permitted Warrant Transaction and (4) purchase options and related contingencies), (ii) any non-cash charges recorded in respect of intangible assets (but excluding scheduled amortization of intangible assets), and (iii) the purchase accounting effects of in process research and development expenses and adjustments to property, inventory and equipment, software and other intangible assets and deferred revenue and deferred expenses in component amounts required or permitted by GAAP and related authoritative pronouncements (including the effects of such adjustments pushed down to the Borrower and its Subsidiaries), as a result of any acquisition, or the amortization or write-off of any amounts thereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Net Tangible Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to the Borrower, the total amount of assets (less applicable reserves and other properly deductible items) after deducting all goodwill, tradenames, trademarks, patents, unamortized debt discount and expense and other like intangible assets, all as set forth on the most recent consolidated balance sheet of the Borrower and its Subsidiaries delivered pursuant to Section 5.01(a) or Section 5.01(b).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Subsidiaries that would be consolidated with the Borrower in accordance with GAAP.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Total Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of the date of any determination thereof, total assets of the Borrower and its Subsidiaries calculated in accordance with GAAP on a consolidated basis as of such date.</font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:4.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Total Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means at any time the sum, without duplication, of (i) the aggregate principal amount of Indebtedness of the Borrower and its Subsidiaries (other than the Captive Insurance Subsidiary) outstanding as of such time calculated on a consolidated basis (other than Indebtedness described in clause (h), (i) or (j) of the definition of &#8220;Indebtedness&#8221; (provided that there shall be included in Consolidated Total Indebtedness, any Indebtedness (x) in respect of drawings under the items in such clauses (h) and (i) to the extent not reimbursed within two Business Days after the date of such drawing and (y) in respect of any Swap Agreement entered into for speculative purposes)) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) the principal amount of any obligations of any Person (other than the Borrower or any Subsidiary) of the type described in the foregoing clause (i) that are Guaranteed by the Borrower or any Subsidiary (whether or not reflected on a consolidated balance sheet of the Borrower). Notwithstanding the foregoing, solely for the purposes of determining Consolidated Total Indebtedness at any time on or prior to the consummation of the acquisition of an Acquired Entity or Business, the aggregate principal amount of Acquisition Indebtedness that would otherwise be included in &#8220;Consolidated Total Indebtedness&#8221; shall exclude any such Acquisition Indebtedness that includes a customary &#8220;special mandatory redemption&#8221; provision (or other similar provision) requiring a Loan Party (within a reasonable period of time following the occurrence of an event set forth in clause (a) or</font></div><div style="padding-left:38pt;padding-right:7.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">below) to redeem such Acquisition Indebtedness if (a) such acquisition is not consummated within a number of days reasonably acceptable to the Administrative Agent or (b) the acquisition agreement related to such acquisition terminates in accordance with its terms. For avoidance of doubt, the exclusion in the immediately preceding sentence shall not apply after consummation of the applicable acquisition.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, the power, directly or indirectly, to direct or cause the direction of the management and policies of such Person, whether by contract or otherwise.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each of the following&#58; (a) a Borrowing and (b) an L&#47;C Credit Extension.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Lender at any time, such Lender&#8217;s Revolving Credit Exposure at such time.</font></div><div style="margin-top:0.25pt;padding-left:74pt;padding-right:8.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Credit Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; has the meaning set forth in paragraph (l) of Article VIII. </font></div><div style="padding-left:36pt;padding-right:8.05pt;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Daily Simple SOFR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; with respect to any applicable determination date means the</font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">secured overnight financing rate (&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">SOFR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;) published on such date by the Federal Reserve Bank of New York, as the administrator of the benchmark (or a successor administrator) on the Federal Reserve Bank of New York&#8217;s website (or any successor source).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Debt Rating</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, the rating as determined by Fitch, S&#38;P and Moody&#8217;s (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Debt Ratings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of the Borrower&#8217;s non-credit-enhanced, senior unsecured long-term debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">if all three Debt Ratings are in effect, and two or more ratings are at the same Pricing Level, that Pricing Level will apply&#59;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">if all three Debt Ratings are in effect, each at a different Pricing Level, the Pricing Level of the middle Debt Rating shall apply&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">if only two Debt Ratings are in effect, the Pricing Level of the higher of such Debt Ratings shall apply (with the Debt Rating for Pricing Level 1 being the highest and the Debt Rating for Pricing Level 4 being the lowest), unless the ratings differential is two levels or more, in which case the Pricing Level that is one level lower than the Pricing Level of the higher Debt Rating shall apply&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">if there exists only one Debt Rating, such Debt Rating shall apply&#59; and</font></div><div style="margin-top:0.25pt;padding-left:74pt;padding-right:8.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;padding-left:20.7pt">if no Debt Rating is available, Pricing Level 5 shall apply. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Debtor Relief Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means the Bankruptcy Code of the United States, and all other</font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, or similar debtor relief Laws of the United States or other applicable jurisdictions from time to time in effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any event or condition, which constitutes an Event of Default or, which upon notice, lapse of time or both would, unless cured or waived, become an Event of Default.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.12(f).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Lender that (a) has failed to (i) fund all or any portion of any Loans within two Business Days of the date such Loans were required to be funded hereunder unless such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the result of such Lender&#8217;s determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied, or (ii) pay to the Administrative Agent, any Issuing Bank, the Swingline Lender or any other Lender any other amount required </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:37.95pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">to be paid by it hereunder (including in respect of its participation in Letters of Credit or Swingline Loans) within two Business Days of the date when due, (b) has notified the Borrower, the Administrative Agent or any Issuing Bank or Swingline Lender in writing that it does not intend to comply with its funding obligations hereunder or generally under other agreements in which it has committed to extend credit, or has made a public statement to that effect (unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#8217;s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) has failed, within three Business Days after written request by the Administrative Agent or the Borrower, to confirm in writing to the Administrative Agent and the Borrower that it will comply with its prospective funding obligations hereunder (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon receipt of such written confirmation by the Administrative Agent and the Borrower), or (d) has, or has a direct or indirect parent company that has, (i) become the subject of a proceeding under any Debtor Relief Law, (ii) had publicly appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or assets, including the Federal Deposit Insurance Corporation or any other state or Federal regulatory authority acting in such a capacity, or (iii) become the subject of a Bail-In Action&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any equity interest in that Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender. Any determination by the Administrative Agent that a Lender is a Defaulting Lender under any one or more of clauses (a) through (d) above shall be conclusive and binding absent manifest error, and such Lender shall be deemed to be a Defaulting Lender (subject to Section 2.22(b)) upon delivery of written notice of such determination to the Borrower, each Issuing Bank, the Swingline Lender and each Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disclosed Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the actions, suits and proceedings and the environmental matters disclosed (a) in any reports, schedules, forms, proxy statements, prospectuses (including prospectus supplements), registration statements and other information filed by the Borrower with the SEC or furnished by the Borrower to the SEC pursuant to the Securities Exchange Act, in each case, filed or furnished before the Closing Date and which are available to the Lenders before the Closing Date and (b) on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disqualified Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Equity Interest which, by its terms (or by the terms of any security or other Equity Interests into which it is convertible or for which it is exchangeable), or upon the happening of any event or condition (a) matures or is mandatorily redeemable (other than solely for Qualified Equity Interests), pursuant to a sinking fund obligation or otherwise (except as a result of a change of control, public equity offering or asset sale so long as any rights of the holders thereof upon the occurrence of a change of control, public equity offering or asset sale event shall be subject to the prior repayment in full of the Loans and all other Obligations that are accrued and payable and the termination of the Commitments and the expiration, cancellation, termination or cash collateralization of any Letters of Credit in accordance with the terms hereof), (b) is redeemable at the option of the holder thereof (other than solely for Qualified Equity Interests and except as permitted in clause</font></div><div style="padding-left:38pt;padding-right:7.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">above), in whole or in part, (c) requires the scheduled payments of dividends in cash (for this purpose, dividends shall not be considered required if the issuer has the option to permit them to accrue, cumulate, accrete or increase in liquidation preference or if the Borrower has the option to pay such dividends solely in Qualified Equity Interests), or (d) is or becomes convertible into or exchangeable for Indebtedness or any other Equity Interests that would </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">constitute Disqualified Equity Interests, in each case, prior to the date that is 91 days after the Latest Maturity Date.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, (a) with respect to any amount denominated in Dollars, such amount, and (b) with respect to any amount denominated in any Alternative Currency, the equivalent amount thereof in Dollars as determined by the Administrative Agent or the applicable Issuing Bank, as the case may be, at such time on the basis of the Spot Rate (determined in respect of the most recent Revaluation Date) for the purchase of Dollars with such Alternative Currency.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the lawful money of the United States of America.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Domestic Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Subsidiary organized under the laws of a jurisdiction located in the United States of America.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Early Opt-in Effective Date</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, with respect to any Early Opt-in Election, the sixth (6th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, so long as the Administrative Agent has not received, by 5&#58;00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, written notice of objection to such Early Opt-in Election from Lenders comprising the Required Lenders.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Early Opt-in Election</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means the occurrence of&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.35pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(1)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:line-through">a determination by the Administrative Agent, or a notification by the Borrower to the Administrative Agent that the Borrower has made a determination, that U.S. dollar-denominated syndicated credit facilities currently being executed, or that include language similar to that contained in Section 2.07(d), are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace LIBOR&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.05pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(2)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:line-through">the joint election by the Administrative Agent and the Borrower to replace LIBOR with a Benchmark Replacement and the provision by the Administrative Agent of written notice of such election to the Lenders.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of an institution described in clause (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Member Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any member state of the European Union, Iceland, Liechtenstein and Norway.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Copy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned in Section 9.16(b).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Record</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term by 15 USC &#167;7006, as it may be amended from time to time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term by 15 USC &#167;7006, as it may be amended from time to time.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_61"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Person that meets the requirements to be an assignee under Section 9.04(b)(iii), (v) and (vi) (subject to such consents, if any, as may be required under Section 9.04(b)(iii)).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EMU</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the economic and monetary union in accordance with the Treaty of Rome 1957, as amended by the Single European Act 1986, the Maastricht Treaty of 1992 and the Amsterdam Treaty of 1998.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EMU Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the legislative measures of the European Council for the introduction of, changeover to or operation of a single or unified European currency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all Laws, rules, regulations, codes, ordinances, orders, decrees, judgments, injunctions, notices or binding agreements issued, promulgated or entered into by any Governmental Authority, imposing liability or standards of conduct concerning protection of the environment, preservation or reclamation of natural resources, the management, release or threatened release of any Hazardous Material or the effect of Hazardous Materials in the environment on health and safety matters.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any liability, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties or indemnities), of the Borrower or any Subsidiary directly or indirectly resulting from or based upon (a) violation of any Environmental Law, (b) the generation, use, handling, transportation, storage, treatment or disposal of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the release or threatened release of any Hazardous Materials into the environment or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means shares of capital stock, partnership interests, membership interests in a limited liability company, beneficial interests in a trust or other equity ownership interests in a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire any such equity interest (other than, prior to such conversion, Indebtedness that is convertible into any such equity interests).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended from time to time, and the rules and regulations promulgated thereunder.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any trade or business (whether or not incorporated) that, together with any Loan Party, is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under Section 414 of the Code.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any &#8220;reportable event,&#8221; as defined in Section 4043 of ERISA or the regulations issued thereunder with respect to a Plan (other than an event for which the 30-day notice period is waived)&#59; (b) with respect to any Plan, a failure to satisfy the minimum funding standard within the meaning of Section 412 of the Code or Section 302 of ERISA), whether or not waived&#59; (c) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan&#59; (d) the incurrence by any Loan Party or any of its ERISA Affiliates of any liability under Title IV</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.799%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_64"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of ERISA with respect to the termination of any Plan&#59; (e) the receipt by any Loan Party or any ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan&#59; (f) the incurrence by any Loan Party or any of its ERISA Affiliates of any liability with respect to the withdrawal or partial withdrawal of any Loan Party or any of its ERISA Affiliates from any Plan or Multiemployer Plan&#59; or (g) the receipt by any Loan Party or any ERISA Affiliate of any notice, or the receipt by any Multiemployer Plan from any Loan Party or any ERISA Affiliate of any notice, concerning the imposition upon any Loan Party or any of its ERISA Affiliates of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent, within the meaning of Title IV of ERISA.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:103.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">ESG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 2.23. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">ESG Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 2.23. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">ESG Pricing Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 2.23. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">EU&#47;UK Listed Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning assigned in Section 3.15(a).</font></div><div style="margin-top:0.4pt;padding-left:38pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EU Bail-In Legislation Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor Person), as in effect from time to time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;Alternative Currency Term Rate.&#8221;</font></div><div><font><br></font></div><div style="margin-top:0.25pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Euro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">&#8364;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means the single currency of the Participating Member States.</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Eurocurrency</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;, when used in reference to any Loan or Borrowing, refers to whether</font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Eurocurrency Rate.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Eurocurrency Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:line-through">for any Interest Period with respect to any Credit Event denominated in Dollars, the rate per annum equal to the London Interbank Offered Rate as administered by ICE Benchmark Administration (or any other Person that takes over the administration of such rate for such currency for a period equal in length to such Interest Period) (&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;), as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) at or about 11&#58;00 a.m. (London time) on the Rate Determination Date, for deposits in the relevant currency, with a term equivalent to such Interest Period&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.75pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:line-through">for any interest calculation with respect to a Base Rate Loan on any date, the rate per annum equal to LIBOR, at or about 11&#58;00 a.m. London time determined two Business Days prior to such date for Dollar deposits with a term of one month commencing that day&#59; and</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_67"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:7.1pt;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:line-through">if the Eurocurrency Rate shall be less than zero percent (0%), such rate shall be deemed zero percent (0%)for purposes of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.35pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Eurocurrency Loan</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means a Loan that bears interest at a rate based on clause (a) of the definition of &#8220;Eurocurrency Rate.&#8221; All Eurocurrency Loans shall be denominated in Dollars.</font></div><div style="padding-right:7.35pt;text-align:justify"><font><br></font></div><div style="margin-top:0.25pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; has the meaning assigned to such term in Article VII. </font></div><div style="margin-top:0.25pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Excluded Finco</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means Finco, so long as (i) it holds (directly, and together with its</font></div><div style="padding-left:38pt;padding-right:5.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subsidiaries), not more than de minimis assets (other than (x) any intercompany notes or receivables that relate to the repayment of principal and interest of the Finco Designated Indebtedness or (y) any proceeds from any Indebtedness of Finco (so long as such proceeds are intended to be distributed to the Borrower) or intercompany notes or receivables that relate to the distribution of such proceeds to the Borrower), (ii) it does not generate more than de minimis Consolidated EBITDA and (iii) it does not at any time guarantee any third-party Indebtedness of the Borrower.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the following Taxes imposed on or with respect to any Recipient or required to be withheld or deducted from a payment to a Recipient, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i) imposed as a result of such Recipient being organized under the laws of, or having its principal office or, in the case of any Lender, its Lending Office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) in the case of a Lender, U.S. withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan or Commitment pursuant to a law in effect on the date of which (i) such Lender acquires such interest in the Loan or Commitment (other than pursuant to an assignment request by the Borrower under Section 2.18) or (ii) such Lender changes its Lending Office, except in each case to the extent that pursuant to Section 2.16, amounts with respect to such Taxes were payable either to such Lender&#8217;s assignor immediately before such Lender became a party hereto or to such Lender immediately before it changed its Lending Office, (c) Taxes attributable to such Recipient&#8217;s failure to comply with Section 2.16(e), and (d) withholding Taxes imposed pursuant to FATCA.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Existing Credit Agreement</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; has the meaning assigned in the preliminary statements</font></div><div style="padding-left:38pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:line-through">hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.04(b), (d) or (f) as</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the context may require.</font></div><div><font><br></font></div><div style="margin-top:0.3pt;padding-left:74pt;padding-right:6.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Existing Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means the Letters of Credit listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Schedule 2.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Existing Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means the Revolving Loans (as defined in the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">Credit</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Agreement) made to the Borrower under the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement and outstanding immediately prior to the Closing Date in an aggregate principal amount of $900,000,000.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Revolver Tranche</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.21(a).</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.799%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_70"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.21(a).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-right:6.95pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.21(b).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations thereof and any agreements entered into pursuant to Section 1471(b)(1) of the Code, as of the date of this Agreement (or any amended or successor versions that are each substantively comparable and not materially more onerous to comply with) and any intergovernmental agreements in respect thereof (and any legislation, regulations or other official guidance pursuant to, or in respect of, such intergovernmental agreements).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:35.45pt;padding-right:5.45pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, the rate per annum equal to the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System on such day, as published by the Federal Reserve Bank of New York on the Business Day next succeeding such day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (a) if such day is not a Business Day, the Federal Funds Effective Rate for such day shall be such rate on such transactions on the next preceding Business Day as so published on the next succeeding Business Day, and (b) if no such rate is so published on such next succeeding Business Day, the Federal Funds Effective Rate for such day shall be the average rate (rounded upward, if necessary, to a whole multiple of 1&#47;100 of 1%) charged to the Administrative Agent on such day on such transactions as determined by the Administrative Agent&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">further that if the Federal Funds Effective Rate shall be less than zero, the Federal Funds Effective Rate shall be deemed zero for purposes of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fee Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, each of the fee letters entered into by and among the Borrower and any of the Arrangers (or any of their respective affiliates) and&#47;or the Administrative Agent in connection with this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the chief financial officer, principal accounting officer, treasurer or controller of the Borrower or the relevant Loan Party, as applicable.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Finco</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Upjohn Finance B.V., a wholly owned financing subsidiary of the Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Finco Designated Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Indebtedness of Finco issued after the Effective Date (as defined in the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement) and on or prior to the closing date of the Combination Transactions, the proceeds of which are used to fund, in full or in part, the Borrower Cash Distribution (as defined in the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement) and related transaction fees and expenses.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;First Amendment&#8221; means that certain LIBOR Transition Amendment to Amended and Restated Revolving Credit Agreement, dated as of the First Amendment Effective Date, by and among the Borrower, the Guarantors, the Lenders and Issuing Bank party thereto and the Administrative Agent.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_73"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;First Amendment Effective Date&#8221; means April 28, 2023.</font></div><div><font><br></font></div><div style="margin-top:0.25pt;padding-left:74pt;padding-right:5.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Fitch</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means Fitch Ratings, Inc., or any successor to its rating agency business. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Foreign Jurisdiction Deposit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means a deposit or Guarantee incurred in the ordinary</font></div><div style="padding-left:38pt;padding-right:5.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">course of business and required by any Governmental Authority in a foreign jurisdiction as a condition of doing business in such jurisdiction.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Lender that is resident or organized under the laws of a jurisdiction other than that in which the Borrower is resident for tax purposes.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan Party that is resident or organized under the laws of a jurisdiction other than that in which the Borrower is resident, incorporated or organized.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its activities.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means generally accepted accounting principles in the United States of America as in effect from time to time (except with respect to accounting for capital leases, as to which such principles in effect on December 31, 2018 shall apply), including those set forth in the Financial Accounting Standards Board&#8217;s &#8220;Accounting Standards Codification&#8221; or in such other statements by such other entity as approved by a significant segment of the accounting profession.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the government of the United States of America, any other nation or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including the Financial Conduct Authority, the Prudential Regulation Authority and any supra-national bodies such as the European Union or the European Central Bank).</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; of or by any Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) means any obligation, contingent or otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other monetary obligation of any other Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">primary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in any manner, whether directly or indirectly, and including any obligation of the guarantor, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other monetary obligation or to purchase (or to advance or supply funds for the purchase of) any security for the payment thereof, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other monetary obligation of the payment thereof, (c) to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other monetary obligation or (d) as an account party in respect of any letter of credit or letter of guaranty issued to support such Indebtedness or monetary obligation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the term Guarantee shall not include endorsements for collection or deposit in the ordinary course of business. The amount of any Guarantee of any guaranteeing person shall be deemed to be the lower of (a) an amount equal to the stated or determinable amount of the</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_76"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:7.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">primary obligation, or portion thereof, in respect of which such Guarantee is made and (b) the maximum amount for which such guaranteeing person may be liable pursuant to the terms of the instrument embodying such Guarantee, unless such primary obligation or the maximum amount for which such guaranteeing person may be liable are not stated or determinable, in which case the amount of such Guarantee shall be such guaranteeing person&#8217;s maximum reasonably anticipated liability in respect thereof as determined by the Borrower in good faith.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantee Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Guarantee set forth in Article X or other form of guarantee agreement reasonably acceptable to the Administrative Agent and the Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, each Affiliate or Subsidiary of the Borrower (including each Mylan Guarantor), if any, that provides a guarantee of the Obligations pursuant to Section 5.09 or otherwise.</font></div><div style="margin-top:0.25pt;padding-left:74pt;padding-right:8.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Guarantor Joinder Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; has the meaning assigned in Section 5.09. </font></div><div style="margin-top:0.25pt;padding-left:74pt;padding-right:8.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means all explosive or radioactive substances or wastes and all</font></div><div style="padding-left:38pt;padding-right:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">hazardous or toxic substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated biphenyls, radon gas and all other substances or wastes (including infectious or medical wastes) of any nature regulated pursuant to any Environmental Law.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73.95pt;padding-right:29.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Honor Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 2.05(c)(i). </font></div><div style="padding-left:73.95pt;padding-right:29.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Increased Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning assigned to such term in Section 2.19(a). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Increasing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning assigned to such term in Section 2.19(a).</font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; of any Person means, without duplication, (a) all obligations of such Person for borrowed money, (b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person under conditional sale or other title retention agreements relating to property acquired by such Person, (d) all obligations of such Person in respect of the deferred purchase price of property or services (excluding accounts payable incurred in the ordinary course of business, milestone payments incurred in connection with any investment or series of related investments, any earn-out obligation except to the extent such obligation is no longer contingent and appears as a liability on the balance sheet of such Person in accordance with GAAP and deferred or equity compensation arrangements payable to directors, officers or employees), (e) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on Property owned or acquired by such Person, whether or not the Indebtedness secured thereby has been assumed, but limited to the fair market value of such Property (except to the extent otherwise provided in this definition), (f) all Guarantees by such Person of Indebtedness of others, (g) all Capital Lease Obligations of such Person, (h) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty, (i) all obligations, contingent or otherwise, of such Person in respect of bankers&#8217; acceptances, (j) all obligations of such Person under any Swap Agreement (with the &#8220;principal&#8221; amount of any Swap Agreement on any date being equal to the early termination value thereof on such date) and (k) all Attributable Receivables Indebtedness. The Indebtedness of any Person</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_79"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:6.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall (i) include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is expressly liable therefor as a result of such Person&#8217;s ownership interest in or other relationship with such entity and pursuant to contractual arrangements, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor and (ii) exclude (A) customer deposits and advances and interest payable thereon in the ordinary course of business in accordance with customary trade terms and other obligations incurred in the ordinary course of business through credit on an open account basis customarily extended to such Person, (B) obligations under customary overdraft arrangements with banks outside the United States incurred in the ordinary course of business to cover working capital needs and (C) bona fide indemnification, purchase price adjustment, earn-outs, holdback and contingency payment obligations to which the seller may become entitled to the extent such payment is determined by a final closing balance sheet or such payment depends on the performance of such business after the closing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, at the time of closing, the amount of any such payment is not determinable or is contingent and, to the extent such payment thereafter becomes fixed and determined and no longer contingent, the amount is paid within 60 days thereafter and included as Indebtedness of such Person.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnified Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of any Loan Party under any Loan Document and (b) to the extent not otherwise described in clause (a), Other Taxes.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73.95pt;padding-right:93.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 9.03(b). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning specified in Section 9.12.</font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:7.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Election Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower to convert or continue a Revolving Borrowing in accordance with Section 2.03.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, (a) as to any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan, the last day of each Interest Period applicable to such Loan and the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Maturity Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, however, that if any Interest Period for a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan exceeds three months, the respective dates that fall every three months after the beginning of such Interest Period shall also be Interest Payment Dates&#59; (b) as to any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Loan, any Alternative Currency Daily Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or Base Rate Loan (other than a Swingline Loan and other than as specified in the immediately following sub-clause </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), the last Business Day of each March, June, September and December and the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Maturity Date&#59; (c) as to any Loan that bears interest at a rate based on </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Daily Simple SOFR or SONIA</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA or any Alternative Currency Daily Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the last Business Day of each month and the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Maturity Date&#59; (d) as to any Alternative Currency Term Rate Loan, the last day of each Interest Period applicable to such Loan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, however, that if any Interest Period for an Alternative Currency Term Rate Loan exceeds three months, the respective dates that fall every three months after the beginning of such Interest Period shall be Interest Payment Dates and</font></div><div style="padding-left:54.25pt;text-align:justify;text-indent:-16.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:2.27pt">with respect to any Swingline Loan, the day that such Loan is required to be repaid.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any Borrowing of a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or of an Alternative Currency Term Rate Loan under any Class of Commitments, the period commencing on the date of such Borrowing and ending on the numerically corresponding</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.799%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_82"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:6.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">day in the calendar month that is one, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">two, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">three or six months thereafter (in each case, subject to availability </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">for the interest rate applicable to the relevant currency or currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), or such other period that is twelve months or less requested by the Borrower and that is consented to by all the Lenders </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">and the Administrative Agent (in the case of each requested Interest Period, subject to availability)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless, in the case of a Borrowing of a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or of an Alternative Currency Term Rate Loan only, such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day, (ii) any Interest Period pertaining to a Borrowing of a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or of an Alternative Currency Term Rate Loan that commences on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period and (iii) no Interest Period shall extend beyond the Revolving Credit Maturity Date with respect to such Class. For purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and, in the case of a Revolving Borrowing, thereafter shall be the effective date of the most recent conversion or continuation of such Borrowing.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Person, any direct or indirect acquisition or investment by such Person, whether by means of (a) the purchase or other acquisition of Equity Interests or debt or other securities of another Person or (b) a loan, advance or capital contribution to, Guarantee of Indebtedness of, assumption of Indebtedness of, or purchase or other acquisition of any other debt or equity participation or interest in, another Person, including any partnership or joint venture interest in such other Person or (c) the purchase or other acquisition (in one transaction or a series of transactions) of all or substantially all of the property and assets or business of another Person or assets constituting a business unit, line of business or division of such Person. For purposes of Section 6.05, (i) the amount of any Investment shall be the amount actually invested, without adjustment for subsequent increases or decreases in the value of such Investment, less any amount paid, repaid, returned, distributed or otherwise received in cash in respect of such Investment not to exceed the original amount of such Investment and (ii) in the event the Borrower or any Subsidiary (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Investing Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) transfers an amount of cash or other Property (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Invested Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) for purposes of permitting the Borrower or one or more other Subsidiaries to ultimately make an Investment of the Invested Amount in the Borrower, any Subsidiary or any other Person (the Person in which such Investment is ultimately made, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subject Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) through a series of substantially concurrent intermediate transfers of the Invested Amount to the Borrower or one or more other Subsidiaries other than the Subject Person (each an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intermediate Investing Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), including through the incurrence or repayment of intercompany Indebtedness, capital contributions or redemptions of Equity Interests, then, for all purposes of Section 6.05, any transfers of the Invested Amount to Intermediate Investing Persons in connection therewith shall be disregarded and such transaction, taken as a whole, shall be deemed to have been solely an Investment of the Invested Amount by the Initial Investing Person in the Subject Person and not an Investment in any Intermediate Investing Person.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">IRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Internal Revenue Service.</font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ISP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Letter of Credit, the &#8220;International Standby Practices 1998&#8221; published by the Institute of International Banking Law &#38; Practice, Inc. (or such later version thereof as may be in effect at the time of issuance).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuer Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any Letter of Credit, the Letter of Credit Application, and any other document, agreement and instrument entered into by the applicable Issuing Bank and the Borrower (or any Subsidiary) or in favor of the applicable Issuing Bank and relating to such Letter of Credit.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Bank of America, Goldman Sachs Bank USA and any other Lender (subject to such Lender&#8217;s consent) designated by the Borrower and consented to by the Administrative Agent (such consent not to be unreasonably withheld or delayed) that becomes an Issuing Bank, in each case in its capacity as an issuer of Letters of Credit hereunder, and any successors in such capacity as provided in Section 9.04. An Issuing Bank may, in its discretion, arrange for one or more Letters of Credit to be issued by Affiliates of such Issuing Bank, in which case the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall include any such Affiliate with respect to Letters of Credit issued by such Affiliate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">KPIs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.23.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Latest Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any date of determination, the latest Revolving Credit Maturity Date applicable to any Class of Loans or Commitments hereunder at such time, including the latest termination date of any Extended Revolving Commitment, as extended in accordance with this Agreement from time to time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, all international, foreign, Federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.11(b)(i).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Revolving Lender, such Revolving Lender&#8217;s funding of its participation in any L&#47;C Borrowing in accordance with its Applicable Percentage. All L&#47;C Advances shall be denominated in Dollars.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an extension of credit resulting from an L&#47;C Disbursement under any Letter of Credit which has not been reimbursed on the date when made or refinanced as a Base Rate Loan Borrowing. All L&#47;C Borrowings shall be denominated in Dollars.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Credit Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Letter of Credit, the issuance thereof or extension of the expiry date thereof, or the increase of the amount thereof.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Disbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a payment made by an Issuing Bank pursuant to a Letter of</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Credit.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, the sum of (a) the aggregate Outstanding Amount of</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">all Letters of Credit at such time plus (b) the aggregate Outstanding Amount of all L&#47;C Disbursements, including Unreimbursed Amounts, that have not yet been reimbursed by or on</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_85"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">behalf of the Borrower at such time. The L&#47;C Exposure of any Revolving Lender at any time shall be its Applicable Percentage of the total L&#47;C Exposure at such time. For purposes of computing the amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit shall be determined in accordance with Section 1.11. For all purposes of this Agreement, if on any date of determination a Letter of Credit has expired by its terms but any amount may still be drawn thereunder by reason of the operation of Rule 3.14 of the ISP, such Letter of Credit shall be deemed to be &#8220;outstanding&#8221; in the amount so remaining available to be drawn.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:37.95pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Exposure Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means $300,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) the Letters of Credit for which Bank of America (together with its successors and assigns) acts as Issuing Bank shall not exceed $150,000,000 at any time (as such amount may be increased from time to time in the sole discretion of Bank of America, so long as such amount does not exceed the L&#47;C Exposure Sublimit and notice of such increase is provided to the Administrative Agent) and (ii) the Letters of Credit for which Goldman Sachs Bank USA (together with its successors and assigns) acts as Issuing Bank shall not exceed $150,000,000 at any time (as such amount may be increased from time to time in the sole discretion of Goldman Sachs Bank USA, so long as such amount does not exceed the L&#47;C Exposure Sublimit).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Persons listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and any other Person that shall have become a Lender hereunder pursuant to Section 2.19 or pursuant to an Assignment and Assumption, other than any such Person that ceases to be a party hereto pursuant to an Assignment and Assumption. Unless the context otherwise requires, the term &#8220;Lenders&#8221; includes the Swingline Lender.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lender Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Administrative Agent, the Lenders (including the Swingline Lender), the Issuing Banks and each co-agent or sub-agent appointed by the Administrative Agent from time to time pursuant to clause (e) of Article VIII.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Lender, the office or offices of such Lender described as such in such Lender&#8217;s Administrative Questionnaire, or such other office or offices as a Lender may from time to time notify the Borrower and the Administrative Agent which office may include any Affiliate of such Lender or any domestic or foreign branch of such Lender or such Affiliate. Unless the context otherwise requires each reference to a Lender shall include its applicable Lending Office.</font></div><div style="margin-top:0.3pt;padding-left:74pt;padding-right:5.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means a Letter of Credit issued pursuant to Section 2.05. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Letter of Credit Application</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means an application and agreement for the issuance or</font></div><div style="padding-left:38pt;padding-right:5.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">amendment of a Letter of Credit in the form from time to time in use by the applicable Issuing Bank.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the day that is five Business Days prior to (a) the initial Revolving Credit Maturity Date or (b) if the Commitment of each applicable Issuing Bank is extended pursuant to a Revolving Extension Series, the Latest Maturity Date (or, in each case, if such day is not a Business Day, the next preceding Business Day).</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_88"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; has the meaning specified in the definition of Eurocurrency Rate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR Daily Floating Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, as of any date of determination, the rate per annum equal to the London Interbank Offered Rate as administered by ICE Benchmark Administration (or any other Person that takes over the administration of such rate) for Dollars for delivery on the date in question for a one month Interest Period beginning on that date as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) at approximately 11&#58;00 a.m., London time, two Business Days prior to the date in question, as adjusted from time to time in the Administrative Agent&#8217;s sole discretion for reserve requirements, deposit insurance assessment rates and other regulatory costs&#59; provided that if the LIBOR Daily Floating Rate shall be less than zero percent (0%), such rate shall be deemed zero percent (0%) for purposes of this Agreement. The LIBOR Daily Floating Rate is a fluctuating rate of interest which can change on each Business Day.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR Daily Floating Rate Loan</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means a Loan that bears interest based on the LIBOR Daily Floating Rate. LIBOR Daily Floating Rate Loans shall be denominated in Dollars.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any asset, any mortgage, deed of trust, lien, pledge, hypothecation, encumbrance, charge or security interest in, on or of such asset (or any capital lease having substantially the same economic effect as any of the foregoing).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means this Agreement, any Guarantee Agreement, any Guarantor Joinder Agreement, any Issuer Documents, any promissory notes executed and delivered pursuant to Section 2.09(e) and any amendments, waivers, supplements or other modifications to any of the foregoing.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Borrower and the Guarantors from time to time party hereto, if</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">any.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the loans made by the Lenders to the Borrower pursuant to this</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a material adverse effect on (a) the business, assets, property or financial condition of the Borrower and its Subsidiaries taken as a whole or (b) the validity or enforceability of this Agreement or any and all other Loan Documents, or the rights and remedies of the Administrative Agent and the Lenders thereunder.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Indebtedness (other than the Loans and Letters of Credit), of any one or more of the Loan Parties and their Subsidiaries in an aggregate principal amount exceeding $250,000,000.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Guarantor or any Subsidiary (or group of Subsidiaries as to which a specified condition applies) that would be a &#8220;significant subsidiary&#8221; under Rule 1-02(w) of Regulation S-X.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.14.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.799%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_91"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Moody&#8217;s Investors Service, Inc. and any successor thereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Multiemployer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a multiemployer plan as defined in Section 4001(a)(3) of ERISA.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mylan Guarantors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each Affiliate or Subsidiary of the Borrower, including Mylan Inc., that is an issuer or guarantor of any Mylan Notes or is otherwise required to provide a guarantee of the Obligations pursuant to Section 5.09.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mylan Indentures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the following&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.25pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Indenture dated as of December 21, 2012, among Mylan Inc., as issuer, the subsidiaries party thereto, and The Bank of New York Mellon, as trustee&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">First supplemental indenture dated as of February 27, 2015, among Mylan Inc., as issuer, Mylan N.V., as guarantor, and The Bank of New York Mellon, as trustee, to the indenture dated as of December 21, 2012&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Second supplemental indenture dated as of March 12, 2015, among Mylan Inc., as issuer, Mylan N.V., as parent, and The Bank of New York Mellon, as trustee, to the indenture dated as of December 21, 2012&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.4pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Third supplemental indenture dated as of November 16, 2020, by and among Mylan Inc., the Borrower, Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee, to the indenture dated as of December 21, 2012&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Indenture dated as of November 29, 2013, by and between Mylan Inc., as issuer, and The Bank of New York Mellon, as trustee&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">First supplemental indenture dated as of November 29, 2013, by and between Mylan Inc., as issuer, and The Bank of New York Mellon, as trustee, to the indenture dated as of November 29, 2013&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.45pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Second supplemental indenture dated as of February 27, 2015, among Mylan Inc., as issuer, Mylan N.V., as guarantor, and The Bank of New York Mellon, as trustee, to the indenture dated as of November 29, 2013&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Third supplemental indenture dated as of March 12, 2015, among Mylan Inc., as issuer, Mylan N.V., as parent, and The Bank of New York Mellon, as trustee, to the indenture dated as of November 29, 2013&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.55pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Fourth supplemental indenture dated as of November 16, 2020, by and among Mylan, Inc., the Borrower, Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee, to the indenture dated as of November 29, 2013&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Indenture dated as of June 9, 2016, among Mylan N.V., as issuer, Mylan Inc., as guarantor, and The Bank of New York Mellon, as trustee&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">First supplemental indenture dated as of November 16, 2020, by and among Mylan, Inc., the Borrower, Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee, to the indenture dated as of June 9, 2016&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Indenture dated as of November 22, 2016, among Mylan N.V., as issuer, Mylan Inc., as guarantor, and Citibank, N.A., London Branch, as trustee&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">First supplemental indenture dated as of November 16, 2020, by and among Mylan, Inc., the Borrower, Utah Acquisition Sub Inc., Mylan II B.V. and Citibank, N.A., London Branch, as trustee, to the indenture dated as of November 22, 2016&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Indenture dated as of April 9, 2018, by and between Mylan Inc., as issuer, Mylan N.V., as guarantor, and The Bank of New York Mellon, as trustee&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">First supplemental indenture dated as of November 16, 2020, by and among Mylan, Inc., the Borrower, Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee, to the indenture dated as of April 9, 2018&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Indenture dated as of May 23, 2018, by and between Mylan Inc., as issuer,</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Mylan N.V., as guarantor, and Citibank, N.A., London Branch, as trustee&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">First supplemental indenture dated as of November 16, 2020, by and among Mylan, Inc., the Borrower, Utah Acquisition Sub Inc., Mylan II B.V. and Citibank, N.A., London Branch, as trustee, to the indenture dated as of May 23, 2018.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mylan Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any senior notes issued by Mylan N.V. and Mylan Inc., as applicable, under the Mylan Indentures that are outstanding.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.04(b), (d) or (f) as the context may require.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:56.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Non-Extension Notice Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 2.05(b)(iii).</font></div><div style="padding-left:36pt;padding-right:56.25pt;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Non-SOFR Successor Rate&#8221; has the meaning specified in Section 2.07(c).</font></div><div style="padding-right:56.25pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a promissory note made by the Borrower in favor of a Lender evidencing Loans made by such Lender to the Borrower, substantially in the form of Exhibit B.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all indebtedness (including interest accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) and other monetary obligations of any of the Loan Parties to any of the Lenders, the Issuing Banks, their respective Affiliates and the Administrative Agent, individually or collectively, existing on the Closing Date or arising thereafter (direct or indirect, joint or several, absolute or contingent, matured or unmatured, liquidated or unliquidated, secured or unsecured) arising or incurred under this Agreement or any of the other Loan Documents (including under any of the Loans made or reimbursement or other monetary obligations incurred or any of the Letters of Credit or other instruments at any time evidencing any thereof), in each case whether now existing or hereafter arising, whether all such</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_94"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:36pt;padding-right:6.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">obligations arise or accrue before or after the commencement of any bankruptcy, insolvency or receivership proceedings (and whether or not such claims, interest, costs, expenses or fees are allowed or allowable in any such proceeding).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Office of Foreign Assets Control of the United States Department of the Treasury.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:101.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">OFAC Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning assigned in Section 3.15. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">OFAC Listed Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning assigned in Section 3.15.</font></div><div style="margin-top:0.4pt;padding-left:74pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Original Credit Agreement&#8221; has the meaning assigned in the preliminary statements here to.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_97"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34; has the meaning assigned in Section 2.17(a). </font></div><div style="padding-right:5.95pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34; means, with respect to any Recipient, Taxes imposed as a result of a present or former connection between such Recipient and the jurisdiction imposing such Tax (other than connections arising from such Recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.65pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Other Rate Early Opt-in</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means the Administrative Agent and the Borrower have elected to replace LIBOR with a Benchmark Replacement other than a SOFR-based rate pursuant to (x) an Early Opt-in Election and (y) Section 2.07(d)(ii) and paragraph (2) of the definition of &#8220;Benchmark Replacement&#8221;.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to Section 2.18).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Outstanding Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to Loans on any date, the Dollar Equivalent amount of the aggregate outstanding principal amount thereof after giving effect to any borrowings and prepayments or repayments of such Loans occurring on such date&#59; (ii) with respect to Swingline Loans on any date, the aggregate outstanding principal amount thereof after giving effect to any borrowings and prepayments or repayments of such Swingline Loans occurring on such date&#59; and (iii) with respect to any L&#47;C Exposure on any date, the Dollar Equivalent amount of the aggregate outstanding amount of such L&#47;C Exposure on such date after giving effect to any L&#47;C Credit Extension occurring on such date and any other changes in the aggregate amount of the L&#47;C Exposure as of such date, including as a result of any reimbursements by the Borrower of Unreimbursed Amounts.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Overnight Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, (a) with respect to any amount denominated in Dollars, the greater of (i) the Federal Funds Effective Rate and (ii) an overnight rate reasonably</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_100"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">determined by the Administrative Agent, the applicable Issuing Bank, or the Swingline Lender, as the case may be, in accordance with banking industry rules on interbank compensation, and</font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">with respect to any amount denominated in an Alternative Currency, an overnight rate reasonably determined by the Administrative Agent or the applicable Issuing Bank, as the case may be, in accordance with banking industry rules on interbank compensation.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:103.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 9.04(d). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 9.04(d).</font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:8.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participating Member State</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any member state of the European Union that has the Euro as its lawful currency in accordance with legislation of the European Union relating to Economic and Monetary Union.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PBGC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor entity performing similar functions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Bond Hedge Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any call option or capped call option (or substantively equivalent derivative transaction) on the Borrower&#8217;s common stock purchased by the Borrower in connection with an incurrence of Permitted Convertible Indebtedness and (b) any call option or capped call option (or substantively equivalent derivative transaction) replacing or refinancing the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (x) the sum of (i) the purchase price for any Permitted Bond Hedge Transaction occurring after the Closing Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) the purchase price for any Permitted Bond Hedge Transaction it is refinancing or replacing, if any, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) the cash proceeds received upon the termination or the retirement of the Permitted Bond Hedge Transaction it is replacing or refinancing, if any, less (y) the sum of (i) the cash proceeds from the sale of the related Permitted Warrant Transaction plus (ii) the cash proceeds from the sale of any Permitted Warrant Transaction refinancing or replacing such related Permitted Warrant Transaction, if any, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) the amount paid upon termination or retirement of such related Permitted Warrant Transaction, if any, does not exceed the net cash proceeds from the incurrence of the related Permitted Convertible Indebtedness.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:37.95pt;padding-right:5.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Convertible Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Indebtedness of the Borrower or any Subsidiary (which may be Guaranteed by the Guarantors) that is (a) convertible into common stock of the Borrower (and cash in lieu of fractional shares) and&#47;or cash (in an amount determined by reference to the price of such common stock) or (b) sold as units with call options, warrants, rights or obligations to purchase (or substantially equivalent derivative transactions) that are exercisable for common stock of the Borrower and&#47;or cash (in an amount determined by reference to the price of such common stock).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Encumbrances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:74pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Liens imposed by law for taxes, assessments or other governmental charges that are not overdue for a period of more than thirty (30) days or are being contested in compliance with Section 5.04&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, materialmen&#8217;s, repairmen&#8217;s, landlords&#8217;, workmen&#8217;s, suppliers&#8217; and other Liens imposed by law, arising in the ordinary</font></div><div style="text-align:justify"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">course of business and securing obligations that are not overdue by more than sixty (60) days or are being contested in compliance with Section 5.04&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">(i) Liens, pledges and deposits made in the ordinary course of business in compliance with workers&#8217; compensation, unemployment insurance and other social security laws or regulations or employment laws or to secure other public, statutory or regulatory obligations (including to support letters of credit or bank guarantees) and (ii) Liens, pledges or deposits in the ordinary course of business securing liability for premiums or reimbursement or indemnification obligations of (including obligations in respect of letters of credit or bank guarantees for the benefit of) insurance carriers providing insurance to the Borrower or any Subsidiary&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens or deposits to secure the performance of bids, trade contracts, governmental contracts, tenders, statutory bonds, leases, statutory obligations, surety, stay, customs, appeal and replevin bonds, performance bonds and other obligations of a like nature (including those to secure health, safety and environmental obligations), in each case in the ordinary course of business&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:8.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Liens in respect of judgments, decrees, attachments or awards that do not constitute an Event of Default under clause (k) of Article VII&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">easements, restrictions (including zoning restrictions), rights-of-way, covenants, licenses, encroachments, protrusions and similar encumbrances and minor title defects affecting real property imposed by law or arising in the ordinary course of business that do not secure any monetary obligations and do not materially interfere with the ordinary conduct of business of the Borrower or any Subsidiary&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">any interest or title of a lessor, sublessor, licensor or sublicensor under any lease, sub-lease, license or sublicense entered into by the Borrower or any of its Subsidiaries as a part of its business and covering only the assets so leased&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the term &#8220;Permitted Encumbrances&#8221; shall not include any Lien securing Indebtedness.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Receivables Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any receivables facility or facilities created under the Permitted Receivables Facility Documents from time to time, providing for the sale or pledge by the Borrower and&#47;or one or more other Receivables Sellers of Permitted Receivables Facility Assets (thereby providing financing to the Borrower and the Receivables Sellers) to the Receivables Entity (either directly or through another Receivables Seller), which in turn shall sell or pledge interests in the respective Permitted Receivables Facility Assets to third-party lenders or investors pursuant to the Permitted Receivables Facility Documents (with the Receivables Entity permitted to issue notes or other evidences of Indebtedness secured by Permitted Receivables Facility Assets or investor certificates, purchased interest certificates or other similar documentation evidencing interests in Permitted Receivables Facility Assets) in return for the cash used by the Receivables Entity to purchase Permitted Receivables Facility Assets from the Borrower and&#47;or the respective Receivables Sellers, in each case as more fully set forth in the Permitted Receivables Facility Documents.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_103"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Receivables Facility Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) Receivables (whether now existing or arising in the future) of the Borrower and its Subsidiaries which are transferred or pledged to a Receivables Entity pursuant to the Permitted Receivables Facility and any related Permitted Receivables Related Assets which are also so transferred or pledged to a Receivables Entity and all proceeds thereof and (ii) loans to the Borrower and its Subsidiaries secured by Receivables (whether now existing or arising in the future) of the Borrower and its Subsidiaries which are made pursuant to a Permitted Receivables Facility.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Receivables Facility Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each of the documents and agreements entered into from time to time in connection with a Permitted Receivables Facility, including all documents and agreements relating to the issuance, funding and&#47;or purchase of certificates and purchased interests, or the issuance of notes or other evidence of Indebtedness secured by such notes, all of which documents and agreements shall be in form and substance reasonably customary for transactions of this type, in each case as such documents and agreements may be amended, modified, supplemented, refinanced or replaced from time to time so long as (in the good faith determination of the Borrower) either (i) the terms as so amended, modified, supplemented, refinanced or replaced are reasonably customary for transactions of this type or (ii)(x) any such amendments, modifications, supplements, refinancings or replacements do not impose any conditions or requirements on the Borrower or any of its Subsidiaries that, taken as a whole, are more restrictive in any material respect than those in existence immediately prior to any such amendment, modification, supplement, refinancing or replacement as determined by the Borrower in good faith and (y) any such amendments, modifications, supplements, refinancings or replacements are not adverse in any material respect to the interests of the Lenders as determined by the Borrower in good faith.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Receivables Related Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any other assets that are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving receivables similar to Receivables and any collections or proceeds of any of the foregoing.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Refinancing Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any amendment, modification, refinancing, refunding, renewal, replacement or extension of any Indebtedness of such Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (a) the principal amount (or accreted value, if applicable) thereof does not exceed the principal amount (or accreted value, if applicable) of the Indebtedness so modified, refinanced, refunded, renewed, replaced or extended except by an amount equal to unpaid accrued interest and premium thereon plus other reasonable amounts paid, and fees and expenses reasonably incurred, in connection with such modification, refinancing, refunding, renewal, replacement or extension and by an amount equal to any existing commitments unutilized thereunder (in each case, provided that Indebtedness in respect of such existing unutilized commitments is then permitted under Section 6.01) (in each case, it being understood that incurrence of Indebtedness in excess of the principal amount (plus any unpaid accrued interest and premium thereon and other reasonable amounts paid, and fees and expenses reasonably incurred in connection therewith) of the Indebtedness so modified, refinanced, refunded, renewed, replaced or extended (including the amount equal to any existing commitments unutilized thereunder) shall be permitted if such excess amount is then permitted under Section 6.01 and reduces the otherwise permitted Indebtedness under Section 6.01), (b) other than with respect to Permitted Refinancing Indebtedness in respect of Indebtedness</font></div><div style="text-align:justify"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">permitted pursuant to Section 6.01(d), such modification, refinancing, refunding, renewal, replacement or extension has a final maturity date equal to or later than the earlier of (x) the final maturity date of the Indebtedness so modified, refinanced, refunded, renewed, replaced or extended and (y) the date which is 91 days after the Latest Maturity Date, (c) other than with respect to Permitted Refinancing Indebtedness in respect of Indebtedness permitted pursuant to Section 6.01(d), such modification, refinancing, refunding, renewal, replacement or extension has a Weighted Average Life to Maturity equal to or greater than the shorter of (x) the remaining Weighted Average Life to Maturity of, the Indebtedness being modified, refinanced, refunded, renewed, replaced or extended and (y) the Weighted Average Life to Maturity of the portion of such Indebtedness being modified, refinanced, refunded, renewed, replaced or extended that matures on or prior to the Latest Maturity Date and (d) to the extent such Indebtedness being modified, refinanced, refunded, renewed, replaced or extended is subordinated in right of payment to the Obligations, such modification, refinancing, refunding, renewal, replacement or extension is subordinated in right of payment to the Obligations on terms, taken as a whole, at least as favorable to the Lenders (in the good faith determination of the Borrower) as those contained in the documentation governing the Indebtedness being modified, refinanced, refunded, renewed, replaced or extended.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:35.1pt;padding-right:5.85pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Warrant Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any call options, warrants or rights to purchase (or substantively equivalent derivative transactions) on common stock of the Borrower purchased by the Borrower substantially concurrently with a Permitted Bond Hedge Transaction.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, and in respect of which any Loan Party or any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an &#8220;employer&#8221; as defined in Section 3(5) of ERISA.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 5.01.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Post-Acquisition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to (a) the Combination Transactions, the period beginning on the closing date of the Combination Transactions, and ending on the two year anniversary thereof, and (b) any other acquisition, the period beginning on the date such acquisition is consummated and ending on the one-year anniversary of the date on which such acquisition is consummated.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Pricing Level</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221; means the applicable pricing level under the column titled &#8216;Pricing Level&#8217; in the table set forth in the definition of &#8220;Applicable Rate&#8221;.</font></div><div style="margin-top:9.95pt;padding-left:38pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Forma Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any applicable period of measurement that includes all or any part of a fiscal quarter included in the Post-Acquisition Period, with respect to the Consolidated EBITDA of the applicable Acquired Entity or Business or the Consolidated EBITDA of the Borrower, the pro forma increase or decrease in such Consolidated EBITDA, projected by the Borrower in good faith as a result of (a) actions that have been taken during</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_106"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">such Post-Acquisition Period for the purposes of realizing reasonably identifiable and factually supportable cost savings or (b) any additional costs incurred during such Post-Acquisition Period, in each case in connection with the combination of the operations of such Acquired Entity or Business with the operations of the Borrower and its Subsidiaries and, in each case, which are expected to have a continuing impact on the consolidated financial results of the Borrower, calculated assuming that such actions had been taken on, or such costs had been incurred since, the first day of such period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that any such pro forma increase or decrease to such Consolidated EBITDA shall be without duplication for cost savings or additional costs already included in such Consolidated EBITDA for such period of measurement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Forma Basis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to compliance with any test covenant hereunder, that (A) to the extent applicable, the Pro Forma Adjustment shall have been made and (B) all Specified Transactions and the following transactions in connection therewith shall be deemed to have occurred as of the first day of the applicable period of measurement in such test or covenant&#58; (a) income statement items (whether positive or negative) attributable to the Property or Person subject to such Specified Transaction, (i) in the case of a disposition of all or substantially all Equity Interests in any Subsidiary of the Borrower owned by the Borrower or any of its Subsidiaries or any division, product line, or facility used for operations of the Borrower or any of its Subsidiaries, shall be excluded, and (ii) in the case of an acquisition or Investment described in the definition of &#8220;Specified Transaction,&#8221; shall be included, (b) any retirement of Indebtedness and (c) any Indebtedness incurred or assumed by the Borrower or any of the Subsidiaries in connection therewith&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, without limiting the application of the Pro Forma Adjustment pursuant to clause (A) above (but without duplication thereof), the foregoing pro forma adjustments may be applied to any such test or covenant solely to the extent that such adjustments are (x) consistent with the definition of Consolidated EBITDA and give effect to events (including operating expense reductions) that are in the good faith determination of the Borrower reasonably identifiable and factually supportable and (y) expected to have a continuing impact on the consolidated financial results of the Borrower and its Subsidiaries.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prohibition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned in Section 10.01.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any right or interest in or to property of any kind whatsoever, whether real, personal or mixed and whether tangible or intangible, including Equity Interests.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned in Section 5.01.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the acquisition by the Borrower or a Subsidiary of an Acquired Entity or Business which acquisition has been designated to the Lenders by a Responsible Officer of the Borrower as a &#8220;Qualified Acquisition&#8221; so long as, on a Pro Forma Basis, the Consolidated Leverage Ratio as of the last day of the most recently completed Test Period (for which financial statements have been delivered pursuant to Section 5.01(a) or (b)) prior to such acquisition would be at least 3.25 to 1.0&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that no such designation may be made with respect to any acquisition prior to the end of the fourth full fiscal quarter following the completion of the most recently consummated Qualified Acquisition unless the ConsolidatedLeverage Ratio as of the last day of the most recently completed Test Period (for which financial statements have been delivered pursuant to Section 5.01(a) or (b)) prior to the consummation of such acquisition was no greater than 3.0 to 1.0.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Equity Interests of the Borrower other than Disqualified Equity Interests.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rate Determination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Interest Period, two (2) Business Days prior to the commencement of such Interest Period (or such other day as is generally treated as the </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">rate fixing day by market practice in such interbank market, as determined by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, to the extent such market practice is not administratively feasible for the Administrative Agent, then &#8220;Rate Determination Date&#8221; means such other day as otherwise reasonably determined by the Administrative Agent).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all accounts receivable (including all rights to payment created by or arising from sales of goods, leases of goods or the rendition of services rendered no matter how evidenced whether or not earned by performance).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a wholly owned Subsidiary of the Borrower which engages in no activities other than in connection with the financing of Receivables of the Receivables Sellers and which is designated (as provided below) as a &#8220;Receivables Entity&#8221;. Any such designation shall be evidenced to the Administrative Agent by filing with the Administrative Agent an officer&#8217;s certificate of the Borrower certifying that, to the best of such officer&#8217;s knowledge and belief after consultation with counsel, such designation complied with the foregoing conditions.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables Sellers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Borrower and those Subsidiaries (other than Receivables Entities) that are from time to time party to the Permitted Receivables Facility Documents.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Recipient</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Administrative Agent, any Lender, and any Issuing Bank, as applicable.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 9.04(c).</font></div><div><font><br></font></div><div style="margin-top:0.25pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Regulation S-X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means Regulation S-X under the Securities Act of 1933, as amended. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Related Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means, with respect to any Person, such Person&#8217;s Affiliates and the</font></div><div style="padding-left:38pt;padding-right:8.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">partners, directors, officers, employees, agents, trustees and administrators of such Person and of such Person&#8217;s Affiliates.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.1pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Relevant Governmental Body</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_109"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any Credit Event denominated in (a) Dollars, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate or LIBOR Daily Floating Rate, as applicable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (b) Sterling, SONIA,</font></div><div style="padding-left:74pt;padding-right:35.5pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;padding-left:22.7pt">Euros, EURIBOR and (d) Japanese Yen, TIBOR, as applicable. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Removal Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in clause (f)(ii) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Article VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">.</font></div><div style="margin-top:0.45pt;padding-left:38pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, Lenders having Credit Exposure and unused Commitments representing more than 50% of the sum of the total Credit Exposure and unused Commitments at such time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the Commitment of, and the portion of the Credit Exposure held or deemed held by, any Defaulting Lender shall be excluded for purposes of making a determination of Required Lenders.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:166%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:166%;text-decoration:underline">Rescindable Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:166%">&#8221; has the meaning as defined in Section 2.17(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:166%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:166%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:166%;text-decoration:underline">Resignation Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:166%">&#8221; has the meaning set forth in clause (f)(i) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:166%;text-decoration:underline">Article VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:166%">.</font></div><div style="margin-top:6.25pt;padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:4.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Responsible Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) the chief executive officer, executive director, president, vice president, chief financial officer, treasurer, assistant treasurer or controller of the Borrower or another Loan Party, as context shall require, and (b) solely for purposes of notices given pursuant to Article II, any other officer or employee of the Borrower so designated by any of the foregoing officers in a notice to the Administrative Agent or any other officer or employee of the Borrower designated in or pursuant to an agreement between the Borrower and the Administrative Agent. Any document delivered hereunder that is signed by a Responsible Officer of the Borrower or another Loan Party shall be conclusively presumed to have been authorized by all necessary corporate, partnership and&#47;or other action on the part of the Borrower or such Loan Party and such Responsible Officer shall be conclusively presumed to have acted on behalf of the Borrower or such Loan Party.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Person, any amount of cash of such Person that is contractually required to be set aside, segregated or otherwise reserved.</font></div><div style="margin-top:6pt;padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any dividend or other distribution (whether in cash, securities or other property (other than Qualified Equity Interests)), with respect to any Equity Interests in the Borrower, or any payment (whether in cash, securities or other property (other than Qualified Equity Interests)), including any sinking fund or similar deposit, on account of the purchase, redemption, retirement, acquisition, cancellation or termination of any such Equity Interests in the Borrower or any option, warrant or other right to acquire any such Equity Interests in the Borrower.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revaluation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any Loan, each of the following&#58; (i) each date of a Borrowing of an Alternative Currency Loan, (ii) each date of a continuation of an Alternative Currency Term Rate Loan pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, and (iii) such additional dates as the Administrative Agent shall determine or the Required Lenders shall require&#59; and (b) with respect to any Letter of Credit, each of the following&#58; (i) each date of issuance of a Letter of Credit denominated in an Alternative Currency, (ii) each date of an amendment of any such Letter of Credit having the effect of increasing the amount thereof, (iii) each date of any payment by any Issuing Bank under any Letter of Credit denominated in an Alternative Currency, (iv) the first Business Day of each month following the issuance of a Letter of Credit and (v) such additional dates as the Administrative Agent or the Issuing Banks shall determine or the Required Lenders shall require.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.799%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:37.95pt;padding-right:5.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Lender, the commitment, if any, of such Lender to make Revolving Loans and to acquire participations in Letters of Credit and Swingline Loans hereunder, expressed as an amount representing the maximum possible aggregate amount of such Lender&#8217;s Revolving Credit Exposure hereunder, as such commitment may be (a) reduced from time to time pursuant to Section 2.08, (b) increased from time to time pursuant to Section 2.19 and (c) reduced, increased or extended from time to time pursuant to (i) assignments by or to such Lender pursuant to Section 9.04 of this Agreement or (ii) a Revolving Extension Amendment. The initial amount of each Lender&#8217;s Revolving Commitment is set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or in the Assignment and Assumption pursuant to which such Lender shall have assumed its Revolving Commitment or any Revolving Extension Amendment to which it is a party, as applicable. The initial aggregate amount of the Lenders&#8217; Revolving Commitments is</font></div><div style="padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$4,000,000,000.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender at any time, the sum of the outstanding Dollar Equivalent of such Lender&#8217;s Revolving Loans, L&#47;C Exposure and Swingline Exposure at such time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to the Revolving Commitments made pursuant to Section 2.01, the date that is five years from the Closing Date, or (ii) with respect to any Extended Revolving Commitments of any Revolving Extension Series, the maturity date set forth in the Revolving Extension Amendment with respect to such Revolving Extension Series&#59; provided in each case that if such day is not a Business Day, the Revolving Credit Maturity Date shall be the Business Day immediately preceding such day.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Extension Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.21(c).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.21(a).</font></div><div style="margin-top:0.25pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Revolving Extension Series</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; has the meaning assigned to such term in Section 2.21(e). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means each Lender that has a Revolving Commitment or that holds</font></div><div style="padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Revolving Credit Exposure.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:93.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Revolving Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; means a Loan made pursuant to Section 2.01. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; means S&#38;P Global Ratings, and any successor thereto.</font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Same Day Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to disbursements and payments in Dollars, immediately available funds, and (b) with respect to disbursements and payments in an Alternative Currency, same day or other funds as may be reasonably determined by the Administrative Agent or the Issuing Banks, as the case may be, to be customary in the place of</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.799%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_112"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">disbursement or payment for the settlement of international banking transactions in the relevant Alternative Currency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.07(c)(ii).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Securities and Exchange Commission, any successor thereto and any analogous Governmental Authority succeeding to any of its principal functions.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">has the meaning assigned to such term in the definition of &#8220;Daily Simple SOFR.&#8221;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">means the Secured Overnight Financing Rate as administered by the SOFR Administrator (or a successor administrator).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">SOFR Early Opt-in</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means the Administrative Agent and the Borrower have elected to replace LIBOR pursuant to (x) an Early Opt-in Election and (y) Section 2.07(d)(i) and paragraph (1) of the definition of &#8220;Benchmark Replacement&#8221;.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73.85pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#8220;SOFR Adjustment&#8221; means 0.10%.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;SOFR Administrator&#8221; means the Federal Reserve Bank of New York, as the administrator of SOFR, or any successor administrator of SOFR designated by the Federal Reserve Bank of New York.</font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;SOFR Daily Floating Rate&#8221; means, for any interest calculation with respect to a SOFR Daily Floating Rate Loan on any date, a fluctuating rate of interest, which can change on each Business Day, equal to the Term SOFR Screen Rate, two U.S. Government Securities Business Days prior to such date, with a term equivalent to one month beginning on that date&#59; provided, that if the rate is not published prior to 11&#58;00 a.m. (New York City time) on such determination date then SOFR Daily Floating Rate means the Term SOFR Screen Rate on the first (1st) U.S. Government Securities Business Day immediately prior thereto, in each case, plus the SOFR </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adjustment&#59; provided, that, if any SOFR Daily </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Floating Rate shall be less than zero percent (0%), such rate shall be deemed zero percent (0%) for purposes of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">&#8220;SOFR Scheduled Unavailability Date&#8221; has the meaning specified in Section 2.07(d)(ii). &#8220;SOFR Successor Rate&#8221; has the meaning specified in Section 2.07(d).</font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any applicable determination date, the Sterling Overnight Index Average Reference Rate published on the fifth Business Day preceding such date on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">however that if such determination date is not a Business Day, SONIA means such rate that applied on the first Business Day immediately prior thereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to SONIA, 0.0326% (3.26 basis points) per</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">annum.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.803%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_115"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Solvent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Solvency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; mean, with respect to any Person on any date of determination, that on such date (a) the fair value of the property of such Person is greater than the total amount of liabilities, including contingent liabilities, of such Person, (b) the present fair salable value of the assets of such Person is not less than the amount that will be required to pay the probable liability of such Person on its debts as they become absolute and matured, (c) such Person does not intend to, and does not believe that it will, incur debts or liabilities beyond such Person&#8217;s ability to pay such debts and liabilities as they become absolute and matured and (d) such Person is not engaged in any business, as conducted on such date and as proposed to be conducted following such date, for which such Person&#8217;s property would constitute an unreasonably small capital. The amount of contingent liabilities at any time shall be computed as the amount that, in the light of all the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Notice Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means at any time an Alternative Currency, other than the currency of a country that is a member of the Organization for Economic Cooperation and Development at such time located in North America or Europe.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">specified currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned in Section 2.20.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Test Period, any of the following events occurring after the first day of such Test Period and prior to the applicable date of determination&#58; (i) any Investment by the Borrower or any Subsidiary in any Person (including in connection with any acquisition) other than a Person that was a wholly-owned Subsidiary on the first day of such period involving consideration paid by the Borrower or such Subsidiary in excess of $50,000,000, (ii) any disposition outside the ordinary course of business of assets by the Borrower or any Subsidiary with a fair market value in excess of $50,000,000, (iii) any incurrence or repayment of Indebtedness (in each case, other than Revolving Loans, Swingline Loans and borrowings and repayments of Indebtedness in the ordinary course of business under revolving credit facilities except to the extent there is a reduction in the related Revolving Commitments or other revolving credit commitment) and (iv) any Restricted Payment involving consideration paid by the Borrower or any Subsidiary in excess of $50,000,000.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:4.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Spot Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; for a currency means the rate determined by the Administrative Agent or the applicable Issuing Bank, as applicable, to be the rate quoted by the Person acting in such capacity as the spot rate for the purchase by such Person of such currency with another currency through its principal foreign exchange trading office at approximately 11&#58;00 a.m. on the date two Business Days prior to the date as of which the foreign exchange computation is made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the Administrative Agent or the applicable Issuing Bank may obtain such spot rate from another financial institution designated by the Administrative Agent or the applicable Issuing Bank if the Person acting in such capacity does not have as of the date of determination a spot buying rate for any such currency&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the applicable Issuing Bank may use such spot rate quoted on the date as of which the foreign exchange computation is made in the case of any Letter of Credit denominated in an Alternative Currency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sterling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#163;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; mean the lawful currency of the United Kingdom.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.791%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_118"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person (the &#8220;parent&#8221;) at any date, any corporation, limited liability company, partnership, association or other entity of which securities or other ownership interests representing more than 50% of the ordinary voting power for the election of directors or other governing body are at the time beneficially owned, directly or indirectly, by the parent or one or more subsidiaries of the parent or by the parent and one or more subsidiaries of the parent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any subsidiary of the Borrower.</font></div><div><font><br></font></div><div style="margin-top:0.25pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; has the meaning assigned in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:line-through">Section 2.07(c)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Section 2.07(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Sustainability Coordinator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means BofA Securities, Inc., in its capacity as the</font></div><div style="padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">sustainability coordinator.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sustainability Linked Loan Principles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Sustainability Linked Loan Principles as most recently published by the Loan Market Association and Loan Syndications &#38; Trading Association.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swap Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any agreement with respect to any swap, forward, future or derivative transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or value or any similar transaction or any combination of these transactions&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of the Borrower or the Subsidiaries shall be a Swap Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, the aggregate principal amount of all Swingline Loans outstanding at such time. The Swingline Exposure of any Lender at any time shall be its Applicable Percentage of the total Swingline Exposure at such time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Bank of America (through itself or through one of its designated Affiliates or branch offices), in its capacity as lender of Swingline Loans hereunder, or any successor swingline lender hereunder.</font></div><div style="padding-right:6.8pt;text-align:justify"><font><br></font></div><div style="margin-top:0.25pt;padding-left:74pt;padding-right:6.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Swingline Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means a Loan made pursuant to Section 2.04. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%;text-decoration:underline">Swingline Loan Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:247%">&#8221; means a notice of a Swingline Loan Borrowing pursuant to</font></div><div style="padding-left:38pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.04, which, shall be substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit D </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or such other form as approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Loan Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means $175,000,000.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.799%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_121"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;TARGET</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2 </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">any day on which </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Trans-European Automated Real-time Gross Settlement Express Transfer </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(TARGET) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">payment system </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">which utilizes a single shared platform and which was launched on November 19, 2007.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;TARGET Day&#8221; means any day on which TARGET2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(or, if such payment system ceases to be operative, such other payment system </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">if any</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">determined by the Administrative Agent to be a suitable replacement) is open for the settlement of payments in Euro.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any and all present or future taxes, levies, imposts, duties, deductions, charges or withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:39.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">for the applicable corresponding tenor (or if any Available Tenor of a Benchmark does not correspond to an Available Tenor for the applicable Benchmark Replacement, the closest corresponding Available Tenor and if such Available Tenor corresponds equally to two Available Tenors of the applicable Benchmark Replacement, the corresponding tenor of the shorter duration shall be applied),</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">for any Interest Period with respect to a Term SOFR Loan, the rate per annum equal to the Term SOFR Screen Rate two U.S. Government Securities Business Days prior to the commencement of such Interest Period with a term equivalent to such Interest Period&#59; provided that if the rate is not published prior to 11&#58;00 a.m. (New York City time) on such determination date then Term SOFR means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">the SOFR Adjustment for such Interest Period</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">&#59; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:4.9pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">for any interest calculation with respect to a Base Rate Loan on any date, the rate per annum equal to the Term SOFR Screen Rate two U.S. Government Securities Business Days prior to such date with a term of one month commencing that day&#59; provided, that if the rate is not published prior to 11&#58;00 am on such determination date then Term SOFR means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case, plus the SOFR Adjustment for such term&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:4.9pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided that if the Term SOFR determined in accordance with either of the foregoing provisions (a) or (b) of this definition would otherwise be less than zero, the Term SOFR shall be deemed zero for purposes of this Agreement.</font></div><div style="padding-left:38pt;padding-right:8.25pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:8.25pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR Loan&#8221; means a Loan that bears interest at a rate based on clause (a) of the definition of Term SOFR.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR Screen Rate&#8221; means</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the forward-looking </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">term rate </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">based on SOFR that has been selected or recommended by the Relevant Governmental Body.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">administered by CME (or any successor administrator satisfactory to the Administrative Agent) and published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time).</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_124"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Test Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the period of four fiscal quarters of the Borrower ending on a specified date.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;Alternative Currency Term Rate.&#8221;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the execution, delivery and performance by the Loan Parties of this Agreement and the other Loan Documents, the borrowing of Loans, the use of the proceeds thereof, the issuance of Letters of Credit hereunder and the payment of fees and expenses hereunder.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Triggering Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned in Section 5.09.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Type</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, when used in reference to any Loan or Borrowing, refers to whether the rate of interest on such Loan, or on the Loans comprising such Borrowing, is determined by reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rate, the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate, the Alternative Currency Daily Rate, the Alternative Currency Term Rate or the Base Rate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">United Kingdom</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; each mean the United Kingdom of Great Britain and Northern Ireland.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UK Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended from time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UK Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">United States Tax Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 2.16(e). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Unreimbursed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; has the meaning set forth in Section 2.05(c)(i). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Unrestricted Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">&#8221; means cash other than Restricted Cash.</font></div><div style="margin-top:0.4pt;padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;U.S. Government Securities Business Day&#8221; means any Business Day, except any Business Day on which any of the Securities Industry and Financial Markets Association, the New York Stock Exchange or the Federal Reserve Bank of New York is not open for business because such day is a legal holiday under the federal laws of the United States or the laws of the State of New York, as applicable.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Person that is a &#8220;United States person&#8221; as defined in Section 7701(a)(30) of the Code.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Weighted Average Life to Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, when applied to any Indebtedness at any date, the number of years obtained by dividing (a) the then outstanding aggregate principal</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_127"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">amount of such Indebtedness into (b) the sum of the total of the products obtained by multiplying</font></div><div style="padding-left:38pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">the amount of each then remaining scheduled installment, sinking fund, serial maturity or other required payment of principal including payment at final maturity, in respect thereof, by (ii) the number of years (calculated to the nearest one-twelfth) which will elapse between such date and the making of such payment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withdrawal Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">wholly owned</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to a Subsidiary of a Person, a Subsidiary of such Person all of the outstanding Equity Interests of which (other than (x) director&#8217;s qualifying shares and (y) shares issued to foreign nationals to the extent required by applicable Law) are owned by such Person and&#47;or by one or more wholly owned Subsidiaries of such Person.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:4.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Write-Down and Conversion Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Yen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#165;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; mean the lawful money of Japan.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Classification of Loans and Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of this Agreement, Loans and Borrowings may be classified and referred to by Type (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, a &#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan&#8221;).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Terms Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed to be followed by the phrase &#8220;without limitation.&#8221; The word &#8220;will&#8221; shall be construed to have the same meaning and effect as the word &#8220;shall.&#8221; Unless the context requires otherwise (a) any definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented, refinanced, restated, replaced or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein), (b) any reference herein to any Person shall be construed to include such Person&#8217;s successors and assigns, (c) the words &#8220;herein,&#8221; &#8220;hereof&#8221; and &#8220;hereunder,&#8221; and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (d) all references herein to Articles, Sections, Exhibits and Schedules shall be construed to refer to Articles and Sections of, and Exhibits and Schedules to, this Agreement and (e) the words &#8220;asset&#8221; and &#8220;property&#8221; shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accounting Terms&#59; GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Except as otherwise expressly provided herein, all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, (i) if the Borrower notifies the Administrative Agent that the Borrower requests an </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">amendment to any provision hereof to eliminate the effect of any change occurring after the Closing Date in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith and (ii) notwithstanding anything in GAAP to the contrary, for purposes of all financial calculations hereunder, the amount of any Indebtedness outstanding at any time shall be the stated principal amount thereof (except to the extent such Indebtedness provides by its terms for the accretion of principal, in which case the amount of such Indebtedness at any time shall be its accreted amount at such time).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Notwithstanding anything to the contrary herein, for purposes of determining compliance with any test or covenant or the compliance with or availability of any basket contained in this Agreement, the Consolidated Leverage Ratio, Consolidated Total Assets and Consolidated Net Tangible Assets shall be calculated with respect to such period on a Pro Forma Basis.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payments on Business Days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. When the payment of any Obligation or the performance of any covenant, duty or obligation is stated to be due or performance required on a day which is not a Business Day, the date of such payment or performance shall extend to the immediately succeeding Business Day and such extension of time shall be reflected in computing interest or fees, as the case may be&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, with respect to any payment of interest on or principal of </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loans or Alternative</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Euro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Currency </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, if such extension would cause any such payment to be made in the next succeeding calendar month, such payment shall be made on the immediately preceding Business Day.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Divisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction&#8217;s laws)&#58; (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person, and (b) if any new Person comes into existence, such new Person shall be deemed to have been organized on the first date of its existence by the holders of its Equity Interests at such time. Any reference herein and in the Loan Documents to a merger, transfer, consolidation, amalgamation, consolidation, assignment, sale, disposition or transfer, or similar term, shall be deemed to apply to a division or plan of division of or by a limited liability company, or an allocation of assets to a series of a limited liability company (or the unwinding of such a division or allocation), as if it were a merger, transfer, consolidation, amalgamation, consolidation, assignment, sale, disposition or transfer, or similar term, as applicable, to, of or with a separate Person. Any division of a limited liability company shall constitute a separate Person hereunder (and each division of any limited liability company that is a Subsidiary, joint venture or any other like term shall also constitute such a Person or entity).</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rounding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any financial ratios required to be maintained by the Borrower and its Subsidiaries pursuant to this Agreement shall be calculated by dividing the appropriate component by the other component, carrying the result to one place more than the number of places by which such ratio is expressed herein and rounding the result up or down to the nearest number (with a rounding-up if there is no nearest number).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Alternative Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Borrower may from time to time request that Alternative Currency Loans be made and&#47;or Letters of Credit be issued in a currency other than Dollars and those </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">specifically listed in the definition of &#8220;Alternative Currencies&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that such requested currency is a lawful currency (other than Dollars) that is readily available and freely transferable and convertible into Dollars. In the case of any such request with respect to the making of Alternative Currency Loans, such request shall be subject to the approval of the Administrative Agent and each of the Revolving Lenders&#59; and in the case of any such request with respect to the issuance of Letters of Credit, such request shall be subject to the approval of the Administrative Agent and the applicable Issuing Bank.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Any such request shall be made to the Administrative Agent not later than 11&#58;00 a.m., twenty (20) Business Days prior to the date of the desired Credit Event (or such other time or date as may be agreed by the Administrative Agent and, in the case of any such request pertaining to Letters of Credit, the Issuing Banks, in its or their sole discretion). In the case of any such request pertaining to Alternative Currency Loans, the Administrative Agent shall promptly notify each Revolving Lender thereof&#59; and in the case of any such request pertaining to Letters of Credit, the Administrative Agent shall promptly notify the applicable Issuing Bank thereof. Each Revolving Lender (in the case of any such request pertaining to Revolving Loans) or the applicable Issuing Bank (in the case of a request pertaining to Letters of Credit) shall notify the Administrative Agent, not later than 11&#58;00 a.m., ten (10) Business Days after receipt of such request whether it consents, in its sole discretion, to the making of Alternative Currency Loans, or the issuance of Letters of Credit, as the case may be, in such requested currency.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Any failure by a Revolving Lender or an Issuing Bank, as the case may be, to respond to such request within the time period specified in the preceding sentence shall be deemed to be a refusal by such Revolving Lender or such Issuing Bank, as the case may be, to permit Alternative Currency Loans to be made or Letters of Credit to be issued in such requested currency. If the Administrative Agent and all the Revolving Lenders consent to making Alternative Currency Loans in such requested currency, the Administrative Agent shall so notify the Borrower and such currency shall thereupon be deemed for all purposes to be an Alternative Currency hereunder for purposes of any Borrowings of Alternative Currency Loans, as applicable&#59; and if the Administrative Agent and the applicable Issuing Bank consent to the issuance of Letters of Credit in such requested currency, the Administrative Agent shall so notify the Borrower and such currency shall thereupon be deemed for all purposes to be an Alternative Currency hereunder for purposes of any Letter of Credit issuances. If the Administrative Agent shall fail to obtain consent to any request for an additional currency under this Section 1.08, the Administrative Agent shall promptly so notify the Borrower, and the Borrower may replace such non-consenting Lender, subject to Section 2.18(b). Any specified currency of an Existing Letter of Credit that is neither Dollars nor one of the Alternative Currencies specifically listed in the definition of &#8220;Alternative Currencies&#8221; shall be deemed an Alternative Currency with respect to such Existing Letter of Credit only.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Each obligation of the Borrower to make a payment denominated in the national currency unit of any member state of the European Union that adopts the Euro as its lawful currency after the date hereof shall be redenominated into Euro at the time of such adoption (in accordance with the EMU Legislation). If, in relation to the currency of any such member state, the basis of accrual of interest expressed in this Agreement in respect of that currency shall be inconsistent with any convention or practice in the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">London </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">interbank market for the basis of accrual of interest in respect of the Euro, such expressed basis shall be replaced by such convention or practice with effect from the date on which such member state adopts the Euro as its lawful currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that if any Borrowing in the currency of such member state is outstanding immediately prior to such date, such replacement shall take effect, with respect to such Borrowing, at the end of the then current Interest Period.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Each provision of this Agreement shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify to be appropriate to reflect the adoption of the Euro by any member state of the European Union and any relevant market conventions or practices relating to the Euro.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Each provision of this Agreement also shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify to be appropriate to reflect a change in currency of any other country and any relevant market conventions or practices relating to the change in currency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Times of Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless otherwise specified, all references herein to times of day shall be references to Eastern time (daylight or standard, as applicable).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless otherwise specified herein, the amount of a Letter of Credit at any time shall be deemed to be the Dollar Equivalent of the stated amount of such Letter of Credit in effect at such time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that with respect to any Letter of Credit that, by its terms or the terms of any document related thereto, provides for one or more automatic increases in the stated amount thereof, the amount of such Letter of Credit shall be deemed to be the Dollar Equivalent of the maximum stated amount of such Letter of Credit after giving effect to all such increases, whether or not such maximum stated amount is in effect at such time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Rates&#59; Currency Equivalents&#59; Interest Rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:6.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Administrative Agent or the applicable Issuing Bank, as applicable, shall determine the Spot Rates as of each Revaluation Date to be used for calculating Dollar Equivalent amounts of Credit Events and Outstanding Amounts denominated in Alternative Currencies. Such Spot Rates shall become effective as of such Revaluation Date and shall be the Spot Rates employed in converting any amounts between the applicable currencies until the next Revaluation Date to occur. Except for purposes of financial statements delivered by Loan Parties hereunder or calculating financial covenants hereunder or except as otherwise provided herein, the applicable amount of any currency (other than Dollars) for purposes of the Loan Documents shall be such Dollar Equivalent amount as so determined by the Administrative Agent or the applicable Issuing Bank, as applicable.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Wherever in this Agreement in connection with a Borrowing, conversion, continuation or prepayment of an Alternative Currency Loan or the issuance, amendment or extension of a Letter of Credit, an amount, such as a required minimum or multiple amount, is expressed in Dollars, but such Borrowing, Alternative Currency Loan or Letter of Credit is denominated in an Alternative Currency, such amount shall be the relevant Alternative Currency Equivalent of such Dollar amount (rounded to the nearest unit of such Alternative Currency, with</font></div><div style="padding-left:38pt;padding-right:8.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.5 of a unit being rounded upward), as determined by the Administrative Agent or the applicable Issuing Bank, as the case may be.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Administrative Agent does not warrant, nor accept responsibility, nor shall the Administrative Agent have any liability with respect to the administration, submission or any other matter related to </font><font style="color:#ff0000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">rates in the definition of &#8220;Alternative Currency Daily Rate&#8221;, &#8220;Alternative Currency Term Rate&#8221;, &#8220;Eurocurrency Rate&#8221;, &#8220;LIBOR Daily Floating Rate&#8221;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">any reference rate referred to herein, the selection of rates, any related spread or adjustment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or with respect to any rate </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(including, for the avoidance of doubt, the selection of such rate and any related spread or other adjustment) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that is an alternative or replacement for or successor to any of such rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">s </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(including, without limitation, any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Benchmark Replacement and any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Successor Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(or any component of any of the foregoing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or the effect of any of the foregoing, or of any </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:6.1pt;text-align:justify"><font style="color:#ff0000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Benchmark Replacement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Conforming Changes </font><font style="color:#ff0000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">or Conforming Changes.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">. The Administrative Agent and its affiliates or other related entities may engage in transactions or other activities that affect any reference rate referred to herein, or any alternative, successor or replacement rate (including, without limitation, any Successor Rate) (or any component of any of the foregoing) or any related spread or other adjustments thereto, in each case, in a manner adverse to the Borrower. The Administrative Agent may select information sources or services in its reasonable discretion to ascertain any reference rate referred to herein or any alternative, successor or replacement rate (including, without limitation, any Successor Rate) (or any component of any of the foregoing), in each case pursuant to the terms of this Agreements, and shall have no liability to the Borrower, any Lender or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or other action or omission related to or affecting the selection, determination, or calculation of any rate (or component thereof) provided by any such information source or service.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_130"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:17.57pt;padding-right:17.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE II</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:17.47pt;padding-right:17.47pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The Credits</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:37.95pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject to the terms and conditions set forth herein, each Revolving Lender severally agrees to make Revolving Loans to the Borrower in Dollars or Alternative Currencies from time to time during the Availability Period in an aggregate principal amount that will not result in (i) the Dollar Equivalent of such Lender&#8217;s Revolving Credit Exposure exceeding such Lender&#8217;s Revolving Commitment or (ii) subject to Section 1.12, the Dollar Equivalent of the total Revolving Credit Exposures exceeding the sum of the total Revolving Commitments. Within the foregoing limits and subject to the terms and conditions set forth herein, the Borrower may borrow, prepay and reborrow Revolving Loans.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loans and Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Each Loan (other than a Swingline Loan) shall be made as part of a Borrowing consisting of Loans of the same Type made by the Lenders ratably in accordance with their respective Revolving Commitments. The failure of any Lender to make any Loan required to be made by it shall not relieve any other Lender of its obligations hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the Commitments of the Lenders are several and no Lender shall be responsible for any other Lender&#8217;s failure to make Loans as required. Any Swingline Loan shall be made in accordance with the procedures set forth in Section 2.04.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Subject to Section 2.07, each Borrowing shall be comprised entirely of Base Rate Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans, Alternative Currency Daily Rate Loans or Alternative Currency Term Rate Loans, as the Borrower may request in accordance herewith. Each Base Rate Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">, each Term SOFR Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and each </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Daily Floating Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan shall, in each case, only be made in Dollars. Each Swingline Loan shall be a Base Rate Loan. Each Lender at its option may make any Alternative Currency Loan by causing any domestic or foreign branch or Affiliate of such Lender to make such Loan&#59; provided that any exercise of such option shall not affect the obligation of the Borrower to repay such Loan in accordance with the terms of this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Each Borrowing of, conversion to or continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans or Alternative Currency Loans shall be in an aggregate amount that is an integral multiple of the Borrowing Multiple (or, if not an integral multiple, the entire available amount) and not less than the Borrowing Minimum. Each Borrowing of, conversion to or continuation of Base Rate Loans (other than Swingline Loans which shall be subject to Section 2.04) shall be in an aggregate amount that is an integral multiple of $1,000,000 and not less than $1,000,000&#59; provided that </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, Base Rate Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans and Alternative Currency Loans may be in an aggregate amount that is equal to the entire unused balance of the total Revolving Commitments or that is required to finance the reimbursement of an L&#47;C Disbursement as contemplated by Section 2.05(c). Borrowings of more than one Type may be outstanding at the same time&#59; provided that there shall not at any time be more than a total of</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_133"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">twenty (20) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Borrowings and Alternative Currency Term Rate Loans outstanding.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Notwithstanding any other provision of this Agreement, the Borrower shall not be entitled to request, or to elect to convert or continue, any Borrowing if the Interest Period requested would end after the applicable Revolving Credit Maturity Date.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">With respect to any Alternative Currency Daily Rate, the Administrative Agent will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrower and the Lenders reasonably promptly after such amendment becomes effective.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Requests for Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To request a Borrowing, a conversion of Loans from one Type to the other or a continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or Alternative Currency Term Rate Loans, the Borrower shall irrevocably notify the Administrative Agent of such request by (A) telephone or (B) a written Borrowing Request in a form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or such other form as may be approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower&#59; provided that any telephonic notice must be confirmed immediately by hand delivery or telecopy or transmission by electronic communication in accordance with Section 9.01(b) to the Administrative Agent of a written Borrowing Request. Each such Borrowing Request must be received by the Administrative Agent not later than noon (i) three </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Government Securities </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Business Days prior to the requested date of any Borrowing of, conversion to or continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or of any conversion of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans to Base Rate Loans, (ii) three Business Days (or five Business Days in the case of a Special Notice Currency) prior to the requested date of any Borrowing of Alternative Currency Loans or, in the case of Alternative Currency Term Rate Loans, any continuation thereof, and (iii) on the requested date of any Borrowing of Base Rate Loans or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if the Borrower wishes to request </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or Alternative Currency Term Rate Loans having an Interest Period other than one</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">, two</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, three or six months in duration as provided in the definition of &#8220;Interest Period,&#8221; the applicable notice must be received by the Administrative Agent not later than 11&#58;00 a.m. (i) four </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Government Securities </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Business Days prior to the requested date of such Borrowing, conversion or continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, or (ii) five Business Days (or six Business Days in the case of a Special Notice Currency) prior to the requested date of such Borrowing, conversion or continuation of Alternative Currency Term Rate Loans, whereupon the Administrative Agent shall give prompt notice to the applicable Lenders of such request and determine whether the requested Interest Period is acceptable to all of them. Not later than 11&#58;00 a.m., (i) three </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Government Securities </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Business Days before the requested date of such Borrowing, conversion or continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, or (ii) four Business Days (or five Business Days in the case of a Special Notice Currency) prior to the requested date of such Borrowing, conversion or continuation of</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_136"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Alternative Currency Term Rate Loans, the Administrative Agent shall notify the Borrower (which notice may be by telephone) whether or not the requested Interest Period has been consented to by all the applicable Lenders. Each Borrowing Request shall specify the following information in compliance with Section 2.02&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">the aggregate amount of the requested Borrowing, conversion or continuation&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">the date of such Borrowing, conversion or continuation, which shall be a Business Day&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">whether such Borrowing, conversion or continuation is to be a Base Rate Borrowing, a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Borrowing, a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Borrowing, or an Alternative Currency Borrowing&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">the currency in which such Borrowing is to be made, which shall be Dollars or an Alternative Currency&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">in the case of a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Borrowing or an Alternative Currency Term Rate Borrowing, the Interest Period to be applicable thereto, which shall be a period contemplated by the definition of the term &#8220;Interest Period&#8221;&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">the location and number of the Borrower&#8217;s account to which funds are to be disbursed, which shall comply with the requirements of Section 2.06&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.36pt">whether the Borrower is requesting a new Borrowing, a conversion of Loans from one Type to the other, or a continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or Alternative Currency Term Rate Loans&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:10.03pt">the Type of Loans to be borrowed or to which existing Loans are to be converted.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If no election as to the Type of Borrowing is specified, then, in the case of a Borrowing denominated in Dollars to the Borrower, the requested Revolving Borrowing shall be a Base Rate Borrowing. In the case of a failure to timely request a conversion or continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or Alternative Currency Term Rate Loans, such Loans shall be continued as </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or Alternative Currency Term Rate Loans in their original currency, as applicable, with an Interest Period of one month&#8217;s duration. If no Interest Period is specified with respect to any requested </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Borrowing or Alternative Currency Term Rate Borrowing or conversion or continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or Alternative Currency Term Rate Loans, then the Borrower shall be deemed to have selected an Interest Period of one month&#8217;s duration. Promptly following receipt of a Borrowing Request in accordance with this Section, the Administrative Agent shall advise each Lender of the details thereof and of the amount (and currency) of such Lender&#8217;s Loan to be made as part of the requested Borrowing. Except as otherwise provided herein, a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or an Alternative Currency Term Rate Loan may be continued or converted only on the last day of an Interest Period for such Loan. During the existence of a Default, no Loans may be requested as, converted to or continued as </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_139"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans or Alternative Currency Loans without the consent of the Required Lenders, and the Required Lenders may demand that any or all of the then outstanding Alternative Currency Loans be prepaid, or redenominated into Dollars in the amount of the Dollar Equivalent thereof promptly, in the case of Alternative Currency Daily Rate Loans or, on the last day of the then current Interest Period with respect thereto in the case of Alternative Currency Term Rate Loans. No Loan may be converted into or continued as a Loan denominated in a different currency, but instead must be prepaid in the original currency of such Loan and reborrowed in the other currency. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notwithstanding anything to the contrary in this Agreement, any Lender </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">may exchange, continue or rollover all of the portion of its Loans in </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">connection with any refinancing, extension, loan modification or similar transaction permitted by the terms of this Agreement, pursuant to a cashless settlement mechanism approved by the Borrower, the Administrative Agent, and such Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Subject to the terms and conditions set forth herein, the Swingline Lender agrees, in reliance upon the agreements of the other Lenders set forth in this Section 2.04, to make Swingline Loans in Dollars to the Borrower from time to time during the Availability Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that no such Swingline Loan shall be permitted if, after giving effect thereto, (i) the aggregate principal amount of outstanding Swingline Loans would exceed the Swingline Loan Sublimit, (ii) the aggregate Revolving Credit Exposures would exceed the total Revolving Commitments or (iii) such Swingline Lender&#8217;s Credit Exposure would exceed its Revolving Commitment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the Swingline Lender shall not be required to make a Swingline Loan to refinance an outstanding Swingline Loan. Within the foregoing limits and subject to the terms and conditions set forth herein, the Borrower may borrow, prepay and reborrow Swingline Loans. Immediately upon the making of a Swingline Loan, each Revolving Lender shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from the Swingline Lender a risk participation in such Swingline Loan in an amount equal to the product of such Revolving Lender&#8217;s Applicable Percentage times the amount of such Swingline Loan.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:6.7pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">To request a Swingline Loan, the Borrower shall notify the Administrative Agent and Swingline Lender of such request, which may be given by (A) telephone or (B) by a Swingline Loan Notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that any telephonic notice must be confirmed promptly by delivery to the Swingline Lender and the Administrative Agent of a Swingline Loan Notice, and, in each case, such notice shall be irrevocable. Each such Swingline Loan Notice must be received by the Swingline Lender and the Administrative Agent not later than 1&#58;00 p.m. on the requested borrowing date, and shall specify (i) the amount to be borrowed, which shall be a minimum of $100,000, and (ii) the requested borrowing date, which shall be a Business Day. Promptly after receipt by the Swingline Lender of any telephonic Swingline Loan Notice, the Swingline Lender will confirm with the Administrative Agent (by telephone or in writing) that the Administrative Agent has also received such Swingline Loan Notice and, if not, the Swingline Lender will notify the Administrative Agent (by telephone or in writing) of the contents thereof. Unless the Swingline Lender has received notice (by telephone or in writing) from the Administrative Agent (including at the request of any Lender) prior to 2&#58;00 p.m. on the date of the proposed Swingline Loan Borrowing (A) directing the Swingline Lender not to make such Swingline Loan as a result of the limitations set forth in Section 2.04(a), or (B) that one or more of the applicable conditions specified in Article IV is not then satisfied, then, the Swingline Lender shall make such Swingline Loan available to the Borrower by means of a credit to the general deposit account of the Borrower with the Swingline Lender (or, in the case of a Swingline Loan made to finance the reimbursement of an L&#47;C Disbursement as provided in Section 2.05(c), by remittance to the relevant Issuing Bank) by 3&#58;00 p.m. on the requested date of such Swingline Loan.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">(i) The Swingline Lender at any time in its sole and absolute discretion may request, on behalf of the Borrower (which hereby irrevocably authorizes the Swingline Lender to so request on its behalf), that each Revolving Lender make a Base Rate Loan in an amount equal to such Lender&#8217;s Applicable Percentage of the amount of the Swingline Loans then outstanding. Such request shall be made in writing (which written request shall be deemed to be a Borrowing Request for purposes hereof) and in accordance with the requirements of Section 2.02 and Section 2.03, without regard to the minimum and multiples specified therein for the principal amount of Base Rate Loans, but subject to the unutilized portion of the Revolving Commitments and the conditions set forth in Section 4.01 or Section 4.02, as applicable. The Swingline Lender shall furnish the Borrower with a copy of the applicable Borrowing Request promptly after delivering such notice to the Administrative Agent. Each Revolving Lender shall make an amount equal to its Applicable Percentage of the amount specified in such Borrowing Request available to the Administrative Agent in Same Day Funds for the account of the Swingline Lender at the Administrative Agent&#8217;s Office for Dollar-denominated payments not later than 1&#58;00 p.m. on the day specified in such Borrowing Request, whereupon, subject to Section 2.04(c)(ii), each Lender that so makes funds available shall be deemed to have made a Base Rate Loan to the Borrower in such amount. The Administrative Agent shall remit the funds so received to the Swingline Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">If for any reason any Swingline Loan cannot be refinanced by such Base Rate Loan in accordance with clause (i), the request for Base Rate Loans submitted by the Swingline Lender as set forth herein shall be deemed to be a request by the Swingline Lender that each of the Revolving Lenders fund its risk participation in the relevant Swingline Loan and such Revolving Lender&#8217;s payment to the Administrative Agent for the account of the Swingline Lender pursuant to Section 2.04(c)(i) shall be deemed payment in respect of such participation. If any Revolving Lender fails to make available to the Administrative Agent for the account of the Swingline Lender any amount required to be paid by such Revolving Lender pursuant to the foregoing provisions of this Section 2.04(c) by the time specified in Section 2.04(c)(i), the Swingline Lender shall be entitled to recover from such Revolving Lender (acting through the Administrative Agent), on demand, such amount with interest thereon for the period from the date such payment is required to the date on which such payment is immediately available to the Swingline Lender at a rate per annum equal to the applicable Overnight Rate from time to time in effect, plus any administrative, processing or similar fees customarily charged by the Swingline Lender in connection with the foregoing. If such Revolving Lender pays such amount (with interest and fees as aforesaid), the amount so paid shall constitute such Revolving Lender&#8217;s Base Rate Loan included in the relevant Borrowing or funded participation in the relevant Swingline Loan, as the case may be. A certificate of the Swingline Lender submitted to any Revolving Lender (through the Administrative Agent)</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_142"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:35.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with respect to any amounts owing under this clause (ii) shall be conclusive absent manifest error.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">Each Revolving Lender&#8217;s obligation to make Base Rate Loans or to purchase and fund risk participations in Swingline Loans pursuant to this Section 2.04(c) shall be absolute and unconditional and shall not be affected by any circumstance, including (A) any setoff, counterclaim, recoupment, defense or other right which such Lender may have against the Swingline Lender, the Borrower or any other Person for any reason whatsoever, (B) the occurrence or continuance of a Default, or (C) any other occurrence, event or condition, whether or not similar to any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that each Revolving Lender&#8217;s obligation to make Base Rate Loans pursuant to this Section 2.04(c) is subject to the conditions set forth in Section 4.01 or Section 4.02, as applicable. No such funding of risk participations shall relieve or otherwise impair the obligation of the Borrower to repay Swingline Loans, together with interest as provided herein.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">(i) At any time after any Revolving Lender has purchased and funded a risk participation in a Swingline Loan, if the Swingline Lender receives any payment on account of such Swingline Loan, the Swingline Lender will distribute to such Revolving Lender its Applicable Percentage thereof in the same funds as those received by the Swingline Lender.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) If any payment received by the Swingline Lender in respect of principal or interest on any Swingline Loan is required to be returned by the Swingline Lender under any of the circumstances described in Section 9.08 (including pursuant to any settlement entered into by the Swingline Lender in its discretion), each Revolving Lender shall pay to the Swingline Lender its Applicable Percentage thereof on demand of the Administrative Agent, plus interest thereon from the date of such demand to the date such amount is returned, at a rate per annum equal to the applicable Overnight Rate from time to time in effect. The Administrative Agent will make such demand upon the request of the Swingline Lender. The obligations of the Revolving Lenders under this clause shall survive the payment in full of the Obligations and the termination of this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Swingline Lender shall be responsible for invoicing the Borrower for interest on the Swingline Loans. Until each Revolving Lender funds its Base Rate Loan or risk participation pursuant to this Section 2.04 to refinance such Revolving Lender&#8217;s Applicable Percentage of any Swingline Loan, interest in respect of such Applicable Percentage shall be solely for the account of the Swingline Lender.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">The Borrower shall make all payments of principal and interest in respect of its Swingline Loans directly to the Swingline Lender.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">The Letter of Credit Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Subject to the terms and conditions set forth herein, (A) each Issuing Bank agrees, in reliance upon the agreements of the Revolving Lenders set forth in this Section</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_145"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:73.95pt;padding-right:7.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.05, (1) from time to time on any Business Day during the period from the Closing Date until the Letter of Credit Expiration Date, to issue Letters of Credit denominated in Dollars or in one or more Alternative Currencies for the account of the Borrower or its Subsidiaries, and to amend or extend Letters of Credit previously issued by it, in accordance with subsection (b) below, and (2) to honor drawings under the Letters of Credit&#59; and (B) the Revolving Lenders severally agree to participate in Letters of Credit issued for the account of the Borrower or its Subsidiaries and any drawings thereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that after giving effect to any L&#47;C Credit Extension with respect to any Letter of Credit, (x) the aggregate L&#47;C Exposure shall not exceed the L&#47;C Exposure Sublimit, (y) the total Revolving Credit Exposures shall not exceed the total Revolving Commitments, and (z) such Issuing Bank&#8217;s Credit Exposure shall not exceed its Revolving Commitment&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that Goldman Sachs Bank USA (or any of its Affiliates) is an Issuing Bank for the purposes of this Agreement only in respect of standby Letters of Credit. Each request by the Borrower for the issuance or amendment of a Letter of Credit shall be deemed to be a representation by the Borrower that the L&#47;C Credit Extension so requested complies with the conditions set forth in the proviso to the preceding sentence. Within the foregoing limits, and subject to the terms and conditions hereof, the Borrower&#8217;s ability to obtain Letters of Credit shall be fully revolving, and accordingly the Borrower may, during the foregoing period, obtain Letters of Credit to replace Letters of Credit that have expired or that have been drawn upon and reimbursed. All Existing Letters of Credit shall be deemed to be Letters of Credit issued pursuant to this Agreement on the Closing Date and from and after the Closing Date shall be subject to and governed by the terms and conditions hereof.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">No Issuing Bank shall issue any Letter of Credit, if&#58; (A) subject to Section 2.05(b)(iii), the expiry date of such requested Letter of Credit would occur more than twelve months after the date of issuance or last extension, unless the Required Lenders and the applicable Issuing Bank have approved such expiry date&#59; or (B) the expiry date of such requested Letter of Credit would occur after the Letter of Credit Expiration Date, unless the Administrative Agent and the applicable Issuing Bank have approved such expiry date (it being understood that in the event the expiry date of any requested Letter of Credit would occur after the Letter of Credit Expiration Date, from and after the Letter of Credit Expiration Date, the Borrower shall immediately Cash Collateralize the then Outstanding Amount of all L&#47;C Exposure in accordance with Section 2.05(g)).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">No Issuing Bank shall be under any obligation to issue any Letter of Credit</font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">if&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">any order, judgment or decree of any Governmental Authority or arbitrator</font></div><div style="padding-left:74pt;padding-right:7.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall by its terms purport to enjoin or restrain such Issuing Bank from issuing such Letter of Credit, or any Law applicable to such Issuing Bank or any request or directive (whether or not having the force of law) from any Governmental Authority with jurisdiction over such Issuing Bank shall prohibit, or request that such Issuing Bank refrain from, the issuance of letters of credit generally or such Letter of Credit in particular or shall impose upon such Issuing Bank with respect to such Letter of Credit any restriction, reserve or capital requirement (for which such Issuing Bank is not otherwise compensated hereunder) not in effect on the Closing Date, or shall impose</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_148"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">upon such Issuing Bank any unreimbursed loss, cost or expense which was not applicable on the Closing Date and which such Issuing Bank in good faith deems material to it&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.02pt">the issuance of such Letter of Credit would violate one or more policies of such Issuing Bank applicable to letters of credit generally&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.02pt">except as otherwise agreed by the Administrative Agent and such Issuing Bank, such Letter of Credit is in an initial stated amount less than $100,000, in the case of a commercial Letter of Credit, or $500,000, in the case of a standby Letter of Credit&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">except as otherwise agreed by the Administrative Agent and such Issuing Bank, such Letter of Credit is to be denominated in a currency other than Dollars or an Alternative Currency&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">such Issuing Bank does not as of the issuance date of such requested Letter of Credit issue Letters of Credit in the requested currency&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.35pt">such Letter of Credit contains any provisions for automatic reinstatement of the stated amount after any drawing thereunder&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">a default of any Revolving Lender&#8217;s obligations to fund under Section 2.05(c) exists or any Revolving Lender is at such time a Defaulting Lender hereunder, unless such Issuing Bank has entered into satisfactory arrangements (in such Issuing Bank&#8217;s sole and absolute discretion) with the Borrower or such Revolving Lender to eliminate such Issuing Bank&#8217;s risk with respect to such Revolving Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">No Issuing Bank shall amend any Letter of Credit if such Issuing Bank would not be permitted at such time to issue such Letter of Credit in its amended form under the terms hereof.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">No Issuing Bank shall be under any obligation to amend any Letter of Credit if (A) such Issuing Bank would have no obligation at such time to issue such Letter of Credit in its amended form under the terms hereof, or (B) the beneficiary of such Letter of Credit does not accept the proposed amendment to such Letter of Credit.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">Each Issuing Bank shall act on behalf of the Revolving Lenders with respect to any Letters of Credit issued by it and the documents associated therewith, and each Issuing Bank shall have all of the benefits and immunities (A) provided to the Administrative Agent in Article VIII with respect to any acts taken or omissions suffered by such Issuing Bank in connection with Letters of Credit issued by it or proposed to be issued by it and Issuer Documents pertaining to such Letters of Credit as fully as if the term &#8220;Administrative Agent&#8221; as used in Article VIII included such Issuing Bank with respect to such acts or omissions, and (B) as additionally provided herein with respect to such Issuing Bank.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_151"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:69.05pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Procedures for Issuance and Amendment of Letters of Credit&#59; Auto-Extension Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Each Letter of Credit shall be issued or amended, as the case may be, upon the request of the Borrower delivered to the applicable Issuing Bank (with a copy to the Administrative Agent) in the form of a Letter of Credit Application, appropriately completed and signed by a Responsible Officer of the Borrower. Such Letter of Credit Application must be received by the applicable Issuing Bank and the Administrative Agent not later than noon at least two Business Days (or such later date and time as the applicable Issuing Bank may agree in a particular instance in its sole discretion) prior to the proposed issuance date or date of amendment, as the case may be. In the case of a request for an initial issuance of a Letter of Credit, such Letter of Credit Application shall specify in form and detail satisfactory to the applicable Issuing Bank&#58; (A) the proposed issuance date of the requested Letter of Credit (which shall be a Business Day)&#59; (B) the amount and currency thereof&#59; (C) the expiry date thereof&#59; (D) the name and address of the beneficiary thereof&#59; (E) the documents to be presented by such beneficiary in case of any drawing thereunder&#59; (F) the full text of any certificate to be presented by such beneficiary in case of any drawing thereunder&#59; and (G) such other matters as the applicable Issuing Bank may require. In the case of a request for an amendment of any outstanding Letter of Credit, such Letter of Credit Application shall specify in form and detail satisfactory to the applicable Issuing Bank (A) the Letter of Credit to be amended&#59; (B) the proposed date of amendment thereof (which shall be a Business Day)&#59; (C) the nature of the proposed amendment&#59; and (D) such other matters as the applicable Issuing Bank may require. Additionally, the Borrower shall furnish to the applicable Issuing Bank and the Administrative Agent such other documents and information pertaining to such requested Letter of Credit issuance or amendment, including any Issuer Documents, as the applicable Issuing Bank or the Administrative Agent may reasonably require.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">Promptly after receipt of any Letter of Credit Application, the applicable Issuing Bank will confirm with the Administrative Agent (by telephone or in writing) that the Administrative Agent has received a copy of such Letter of Credit Application from the Borrower and, if not, such Issuing Bank will provide the Administrative Agent with a copy thereof. Unless an Issuing Bank has received written notice from any Revolving Lender, the Administrative Agent or any Loan Party, at least one Business Day prior to the requested date of issuance or amendment of the applicable Letter of Credit, that one or more applicable conditions contained in Article IV shall not then be satisfied, then, subject to the terms and conditions hereof, such Issuing Bank shall, on the requested date, issue a Letter of Credit for the account of the Borrower (or the applicable Subsidiary) or enter into the applicable amendment, as the case may be, in each case in accordance with such Issuing Bank&#8217;s usual and customary business practices. Immediately upon the issuance of each Letter of Credit by an Issuing Bank, each Revolving Lender shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from such Issuing Bank a risk participation in such Letter of Credit in an amount equal to the product of such Lender&#8217;s Applicable Percentage times the amount of such Letter of Credit.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_154"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">If the Borrower so requests in any applicable Letter of Credit Application, the applicable Issuing Bank may, in its sole and absolute discretion, agree to issue a Letter of Credit that has automatic extension provisions (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Auto-Extension Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that any such Auto-Extension Letter of Credit must permit the applicable Issuing Bank to prevent any such extension at least once in each twelve-month period (commencing with the date of issuance of such Letter of Credit) by giving prior notice to the beneficiary thereof not later than a day (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Extension Notice Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in each such twelve-month period to be agreed upon at the time such Letter of Credit is issued. Unless otherwise directed by the applicable Issuing Bank, the Borrower shall not be required to make a specific request to an Issuing Bank for any such extension. Once an Auto-Extension Letter of Credit has been issued, the Lenders shall be deemed to have authorized (but may not require) the applicable Issuing Bank to permit the extension of such Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no Issuing Bank shall permit any such extension if (A) such Issuing Bank has determined that it would not be permitted at such time to issue such Letter of Credit in its revised form (as extended) under the terms hereof (by reason of the provisions of clause (ii) or (iii) of Section 2.05(a) or otherwise), or (B) it has received notice (which may be by telephone or in writing) on or before the day that is ten Business Days before the Non-Extension Notice Date (1) from the Administrative Agent that the Required Lenders have elected not to permit such extension or (2) from the Administrative Agent, or any Revolving Lender or the Borrower that one or more of the applicable conditions specified in Section 4.01 or Section 4.02, as applicable, is not then satisfied, and in each such case directing such Issuing Bank not to permit such extension.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:8.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">Promptly after its delivery of any Letter of Credit or any amendment to a Letter of Credit to an advising bank with respect thereto or to the beneficiary thereof, the applicable Issuing Bank will also deliver to the Borrower and the Administrative Agent a true and complete copy of such Letter of Credit or amendment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Drawings and Reimbursements&#59; Funding of Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Upon receipt from the beneficiary of any Letter of Credit of any notice of a drawing under such Letter of Credit, the applicable Issuing Bank shall notify the Borrower and the Administrative Agent thereof.&#160;&#160;&#160;&#160;In the case of a Letter of Credit denominated in an Alternative Currency, the Borrower shall reimburse the applicable Issuing Bank in such Alternative Currency, unless (A) such Issuing Bank (at its option) shall have specified in such notice that it will require reimbursement in Dollars, or (B) in the absence of any such requirement for reimbursement in Dollars, the Borrower shall have notified such Issuing Bank promptly following receipt of the notice of drawing that the Borrower will reimburse such Issuing Bank in Dollars.&#160;&#160;&#160;&#160;In the case of any such reimbursement in Dollars of a drawing under a Letter of Credit denominated in an Alternative Currency, the applicable Issuing Bank shall notify the Borrower of the Dollar Equivalent of the amount of the drawing promptly following the determination thereof. Not later than noon on the Business Day following any payment by an Issuing Bank under a Letter of Credit to be reimbursed in Dollars, or the Applicable Time on the Business Day following any payment by an Issuing Bank under a Letter of Credit to be reimbursed in an Alternative Currency (each such date, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Honor Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Borrower</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_157"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:5.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall reimburse such Issuing Bank through the Administrative Agent in an amount equal to the amount of such drawing and in the applicable currency. In the event that (A) a drawing denominated in an Alternative Currency is to be reimbursed in Dollars pursuant to the second sentence in this Section 2.05(c)(i) and (B) the Dollar amount paid by the Borrower on the date of payment by the Borrower (whether on or after the Honor Date) shall not be adequate on the date of such payment to purchase in accordance with normal banking procedures a sum denominated in the Alternative Currency equal to the drawing, the Borrower agrees, as a separate and independent obligation, to indemnify the applicable Issuing Bank for the loss resulting from its inability on that date to purchase the Alternative Currency in the full amount of the drawing. If the Borrower fails to so reimburse such Issuing Bank by such time, the Administrative Agent shall promptly notify each Revolving Lender of the Honor Date, the amount of the unreimbursed drawing (expressed in Dollars in the amount of the Dollar Equivalent thereof in the case of a Letter of Credit denominated in an Alternative Currency) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unreimbursed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and the amount of such Revolving Lender&#8217;s Applicable Percentage thereof. In such event, the Borrower shall be deemed to have requested a Borrowing of Base Rate Loans to be disbursed on the Business Day following the Honor Date in an amount equal to the Unreimbursed Amount, without regard to the minimum and multiples specified in Section 2.02 for the principal amount of Base Rate Loans, but subject to the amount of the unutilized portion of the Revolving Commitments and the conditions set forth in Section 4.01 or Section 4.02, as applicable (other than the delivery of a Borrowing Request). Any notice given by the applicable Issuing Bank or the Administrative Agent pursuant to this Section 2.05(c)(i) may be given by telephone if immediately confirmed in writing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the lack of such an immediate confirmation shall not affect the conclusiveness or binding effect of such notice.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">Each Revolving Lender shall upon any notice pursuant to Section 2.05(c)(i) make funds available to the Administrative Agent for the account of the applicable Issuing Bank, in Dollars, at the Administrative Agent&#8217;s office for Dollar-denominated payments in an amount equal to its Applicable Percentage of the Unreimbursed Amount not later than 2&#58;00 p.m. on the Business Day specified in such notice by the Administrative Agent, whereupon, subject to the provisions of Section 2.05(c)(iii), such Revolving Lender that so makes funds available shall be deemed to have made a Base Rate Loan to the Borrower in such amount. The Administrative Agent shall remit the funds so received to the applicable Issuing Bank in Dollars.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">If any drawing under any Letter of Credit is not reimbursed on the date of drawing, the Dollar Equivalent of the amount of such drawing shall accrue interest at the rate applicable to Base Rate Loans&#59; provided that with respect to any Unreimbursed Amount in respect of a Letter of Credit that is not fully refinanced by a Revolving Borrowing of Base Rate Loans because the conditions set forth in Section 4.01 or Section 4.02, as applicable, cannot be satisfied or for any other reason, the Borrower shall be deemed to have incurred from the applicable Issuing Bank an L&#47;C Borrowing in the amount of the Unreimbursed Amount that is not so refinanced, which L&#47;C Borrowing shall be due and payable on demand (together with interest) and shall bear interest at the Default Rate. In such event, each Revolving Lender&#8217;s payment to the Administrative Agent for the account of the applicable Issuing Bank pursuant to Section 2.05(c)(ii) shall be deemed payment in respect of its participation in such L&#47;C Borrowing and shall constitute an L&#47;C Advance from such Lender in satisfaction of its participation obligation under this Section 2.05.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">Until each Revolving Lender funds its Revolving Loan or L&#47;C Advance pursuant to this Section 2.05(c) to reimburse an Issuing Bank for any amount drawn under any Letter of Credit, interest in respect of such Lender&#8217;s Applicable Percentage of such amount shall be solely for the account of such Issuing Bank.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Each Revolving Lender&#8217;s obligation to make Revolving Loans or L&#47;C Advances to reimburse each Issuing Bank for amounts drawn under Letters of Credit issued by it, as contemplated by this Section 2.05(c), shall be absolute and unconditional and shall not be affected by any circumstance, including (A) any setoff, counterclaim, recoupment, defense or other right which such Revolving Lender may have against such Issuing Bank, the Borrower, any Subsidiary or any other Person for any reason whatsoever&#59; (B) the occurrence or continuance of a Default, or (C) any other occurrence, event or condition, whether or not similar to any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that each Lender&#8217;s obligation to make Revolving Loans pursuant to this Section 2.05(c) is subject to the conditions set forth in Section 4.01 or Section 4.02, as applicable (other than delivery by the Borrower of a Borrowing Request). No such making of an L&#47;C Advance shall relieve or otherwise impair the obligation of the Borrower to reimburse an Issuing Bank for the amount of any payment made by such Issuing Bank under any Letter of Credit, together with interest as provided herein.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">If any Revolving Lender fails to make available to the Administrative Agent for the account of an Issuing Bank any amount required to be paid by such Revolving Lender pursuant to the foregoing provisions of this Section 2.05(c) by the time specified in Section 2.05(c)(ii), then, without limiting the other provisions of this Agreement, such Issuing Bank shall be entitled to recover from such Revolving Lender (acting through the Administrative Agent), on demand, such amount with interest thereon for the period from the date such payment is required to the date on which such payment is immediately available to such Issuing Bank at a rate per annum equal to the applicable Overnight Rate from time to time in effect, plus any administrative, processing or similar fees customarily charged by such Issuing Bank in connection with the foregoing. If such Revolving Lender pays such amount (with interest and fees as aforesaid), the amount so paid shall constitute such Revolving Lender&#8217;s Revolving Loan included in the relevant Borrowing or L&#47;C Advance in respect of the relevant L&#47;C Borrowing, as the case may be. A certificate of an Issuing Bank submitted to any Lender (through the Administrative Agent) with respect to any amounts owing under this clause (vi) shall be conclusive absent manifest error.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Repayment of Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">At any time after an Issuing Bank has made a payment under any Letter of Credit and has received from any Revolving Lender such Revolving Lender&#8217;s L&#47;C Advance in respect of such payment in accordance with Section 2.05(c), if the Administrative Agent receives for the account of such Issuing Bank any payment in</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_160"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">respect of the related Unreimbursed Amount or interest thereon (whether directly from the Borrower or otherwise, including proceeds of Cash Collateral applied thereto by the Administrative Agent), the Administrative Agent will distribute to such Revolving Lender its Applicable Percentage thereof in Dollars and in the same funds as those received by the Administrative Agent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">If any payment received by the Administrative Agent for the account of an Issuing Bank pursuant to Section 2.05(d)(i) is required to be returned under any of the circumstances described in Section 9.08 (including pursuant to any settlement entered into by such Issuing Bank in its discretion), each Revolving Lender shall pay to the Administrative Agent for the account of such Issuing Bank its Applicable Percentage thereof on demand of the Administrative Agent, plus interest thereon from the date of such demand to the date such amount is returned by such Revolving Lender, at a rate per annum equal to the applicable Overnight Rate from time to time in effect. The obligations of the Revolving Lenders under this clause shall survive the payment in full of the Obligations and the termination of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Obligations Absolute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The obligation of the Borrower to reimburse each Issuing Bank for each drawing under each Letter of Credit issued by it and to repay each L&#47;C Borrowing shall be absolute, unconditional and irrevocable, and shall be paid strictly in accordance with the terms of this Agreement under all circumstances, including the following&#58;</font></div><div style="padding-left:37.95pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) any lack of validity or enforceability of such Letter of Credit, this Agreement, or any other Loan Document&#59; (ii) the existence of any claim, counterclaim, setoff, defense or other right that the Borrower or any Subsidiary may have at any time against any beneficiary or any transferee of such Letter of Credit (or any Person for whom any such beneficiary or any such transferee may be acting), the applicable Issuing Bank or any other Person, whether in connection with this Agreement, the transactions contemplated hereby or by such Letter of Credit or any agreement or instrument relating thereto, or any unrelated transaction&#59; (iii) any draft, demand, certificate or other document presented under such Letter of Credit proving to be forged, fraudulent, invalid or insufficient in any respect or any statement therein being untrue or inaccurate in any respect&#59; or any loss or delay in the transmission or otherwise of any document required in order to make a drawing under such Letter of Credit&#59; (iv) waiver by any Issuing Bank of any requirement that exists for such Issuing Bank&#8217;s protection and not the protection of any Loan Party or any Subsidiary or any waiver by any Issuing Bank which does not in fact materially prejudice the Borrower&#59; (v) honor of a demand for payment presented electronically even if such Letter of Credit requires that demand be in the form of a draft&#59; (vi) any payment made by the applicable Issuing Bank in respect of an otherwise complying item presented after the date specified as the expiration date of, or the date by which documents must be received under, such Letter of Credit if presentation after such date is authorized by the UCC, the ISP or the UCP, as applicable&#59; (vii) any payment by such Issuing Bank under such Letter of Credit against presentation of a draft or certificate that does not strictly comply with the terms of such Letter of Credit&#59; or any payment made by such Issuing Bank under such Letter of Credit to any Person purporting to be a trustee in bankruptcy, debtor-in-possession, assignee for the benefit of creditors, liquidator, receiver or other representative of or successor to any beneficiary or any transferee of such Letter of Credit, including any arising in connection with any proceeding under any Debtor Relief Law&#59; (viii) any adverse change in the relevant exchange rates or in the availability of the relevant Alternative Currency to the Borrower or any Subsidiary or in the relevant currency markets generally&#59; or (ix) any other circumstance or happening whatsoever, whether or not similar to any of the foregoing, including any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Borrower or any Subsidiary. The Borrower shall promptly examine a copy of each Letter of Credit and each amendment thereto that is delivered to it and, in the event of any claim of noncompliance with the Borrower&#8217;s instructions or other irregularity, the Borrower will promptly notify the applicable Issuing Bank. The Borrower shall be conclusively deemed to have waived any such claim against the applicable Issuing Bank and its correspondents unless such notice is given as aforesaid.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt;text-decoration:underline">Role of Issuing Banks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Revolving Lender and the Borrower agree that, in paying any drawing under any Letter of Credit, no Issuing Bank shall have any responsibility to obtain any document (other than any sight draft, certificates and documents expressly required by the Letter of Credit) or to ascertain or inquire as to the validity or accuracy of any such document or the authority of the Person executing or delivering any such document. None of the Issuing Banks, the Administrative Agent, any of their respective Related Parties nor any correspondent, participant or assignee of any Issuing Bank shall be liable to any Lender for</font></div><div style="padding-left:37.95pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) any action taken or omitted in connection herewith at the request or with the approval of the Lenders or the Required Lenders, as applicable&#59; (ii) any action taken or omitted in the absence of gross negligence or willful misconduct&#59; or (iii) the due execution, effectiveness, validity or enforceability of any document or instrument related to any Letter of Credit or Issuer Document. The Borrower hereby assumes all risks of the acts or omissions of any beneficiary or transferee with respect to its use of any Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that this assumption is not intended to, and shall not, preclude the Borrower&#8217;s pursuing such rights and remedies as it may have against the beneficiary or transferee at law or under any other agreement. None of the Issuing Banks, the Administrative Agent, any of their respective Related Parties nor any correspondent, participant or assignee of any Issuing Bank shall be liable or responsible for any of the matters described in clauses (i) through (ix) of Section 2.05(e)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that anything in such clauses to the contrary notwithstanding, the Borrower may have a claim against any Issuing Bank, and such Issuing Bank may be liable to the Borrower, to the extent, but only to the extent, of any direct, as opposed to consequential or exemplary, damages suffered by the Borrower which the Borrower proves were caused by such Issuing Bank&#8217;s willful misconduct or gross negligence or such Issuing Bank&#8217;s willful failure to pay under any Letter of Credit after the presentation to it by the beneficiary of a sight draft and certificate(s) strictly complying with the terms and conditions of a Letter of Credit. In furtherance and not in limitation of the foregoing, each Issuing Bank may accept documents that appear on their face to be in order, without responsibility for further investigation, regardless of any notice or information to the contrary, and such Issuing Bank shall not be responsible for the validity or sufficiency of any instrument transferring or assigning or purporting to transfer or assign a Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole or in part, which may prove to be invalid or ineffective for any reason. The applicable Issuing Bank may send a Letter of Credit or conduct any communication to or from the beneficiary via the Society for Worldwide Interbank Financial Telecommunication (&#8220;SWIFT&#8221;) message or overnight courier, or any other commercially reasonable means of communicating with a beneficiary.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_163"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Cash Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Upon the request of the Administrative Agent, (A) if any Issuing Bank has honored any full or partial drawing request under any Letter of Credit and such drawing has resulted in an L&#47;C Borrowing, or (B) if, as of the Letter of Credit Expiration Date, any L&#47;C Exposure for any reason remains outstanding, the Borrower shall, in each case, immediately Cash Collateralize the then Outstanding Amount of all L&#47;C Exposure attributable to the Letters of Credit issued for the benefit of the Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">&#91;reserved.&#93;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">The Administrative Agent may, at any time and from time to time after the initial deposit of Cash Collateral, request that additional Cash Collateral be provided in order to protect against the results of exchange rate fluctuations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:8.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">In the event of an Event of Default, upon the request of the Required Lenders, the Borrower shall immediately Cash Collateralize the then L&#47;C Exposure of all Revolving Lenders.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Applicability of ISP and UCP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless otherwise expressly agreed by the Issuing Banks and the Borrower when a Letter of Credit is issued (including any such agreement applicable to an Existing Letter of Credit), (i) the rules of the ISP shall apply to each standby Letter of Credit, and (ii) the rules of the Uniform Customs and Practice for Documentary Credits, as most recently published by the International Chamber of Commerce at the time of issuance shall apply to each commercial Letter of Credit. Notwithstanding the foregoing, no Issuing Bank shall be responsible to the Borrower for, and each Issuing Bank&#8217;s rights and remedies against the Borrower shall not be impaired by, any action or inaction of such Issuing Bank required or permitted under any Law, order, or practice (which practice is stated in the ISP, or in the decisions, opinions, practice statements, or official commentary of the ICC Banking Commission, the Bankers Association for Finance and Trade - International Financial Services Association (BAFT-IFSA), or the Institute of International Banking Law &#38; Practice) that is required or permitted to be applied to any Letter of Credit or this Agreement, including the Law or any order of a jurisdiction where such Issuing Bank or the beneficiary is located, the practice stated in the ISP, or in the decisions, opinions, practice statements, or official commentary of the ICC Banking Commission, the Bankers Association for Finance and Trade - International Financial Services Association (BAFT-IFSA), or the Institute of International Banking Law &#38; Practice, whether or not any Letter of Credit chooses such law or practice.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt;text-decoration:underline">Conflict with Issuer Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event of any conflict between the terms hereof and the terms of any Issuer Document, the terms hereof shall control.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt;text-decoration:underline">Letters of Credit Issued for Subsidiaries or the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding that a Letter of Credit issued or outstanding hereunder is in support of any obligations of, or is for the account of, a Subsidiary, the Borrower shall be obligated to reimburse the applicable Issuing Bank hereunder for any and all drawings under such Letter of Credit. The Borrower hereby acknowledges that the issuance of Letters of Credit for the account of Subsidiaries inures</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_166"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">to the benefit of the Borrower, and that the Borrower&#8217;s business derives substantial benefits from the businesses of such Subsidiaries.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Release of Lenders&#8217; Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary contained herein or in any other Loan Document, in the event that (i) an Issuing Bank shall have issued, in accordance with Section 2.05(a)(ii)(B), a Letter of Credit with an expiry date occurring after the Letter of Credit Expiration Date and (ii) the Borrower shall have Cash Collateralized the Outstanding Amount of all such L&#47;C Exposure in respect of such Letter of Credit pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, then, upon the provision of such Cash Collateral and without any further action, each Lender hereunder shall be automatically released from any further obligation to the applicable Issuing Bank in respect of such Letter of Credit, including, any obligation of any such Lender to reimburse the applicable Issuing Bank for amounts drawn under such Letter of Credit or to purchase any risk participation therein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that all such obligations of each Lender hereunder to the applicable Issuing Bank in respect of such Letter of Credit shall be revived if any Cash Collateral provided by the Borrower in respect of such Letter of Credit is subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by the Administrative Agent or applicable Issuing Bank) to be repaid to a trustee, receiver or any other party, in connection with any proceeding under any Debtor Relief Laws or otherwise, all as if such Cash Collateral had not been provided. The obligations of the Lenders under this paragraph shall survive termination of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Funding of Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Each Lender shall make each Loan to be made by it hereunder on the proposed date thereof by wire transfer in Same Day Funds (i) in the case of Loans denominated in Dollars by 2&#58;00 p.m., New York City time, to the account of the Administrative Agent most recently designated by it for such purpose by notice to the Lenders in an amount equal to such Lender&#8217;s Applicable Percentage or other percentage provided for herein and (ii) in the case of each Loan denominated in an Alternative Currency by the Applicable Time specified by the Administrative Agent for such currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that Swingline Loans shall be made as provided in Section 2.04. The Administrative Agent will make such Loans available to the Borrower by promptly crediting the amounts so received, in like funds, to (x) an account designated by the Borrower in the applicable Borrowing Request, in the case of Loans denominated in Dollars and (y) an account of the Borrower in the relevant jurisdiction and designated by the Borrower in the applicable Borrowing Request, in the case of Loans denominated in an Alternative Currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that Base Rate Loans made to finance the reimbursement of an L&#47;C Disbursement as provided in Section 2.05(c) shall be remitted by the Administrative Agent to the relevant Issuing Bank.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Unless the Administrative Agent shall have received notice from a Lender prior to the proposed time of any Borrowing that such Lender will not make available to the Administrative Agent such Lender&#8217;s share of such Borrowing, the Administrative Agent may assume that such Lender has made such share available on such date in accordance with paragraph (a) of this Section and may, in reliance upon such assumption, make available to the Borrower a corresponding amount. In such event, if a Lender has not in fact made its share of the applicable Borrowing available to the Administrative Agent, then the applicable Lender and</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_169"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:5.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Borrower agree to pay to the Administrative Agent forthwith on demand such corresponding amount with interest thereon, for each day from and including the date such amount is made available to the Borrower to but excluding the date of payment to the Administrative Agent, at (i) in the case of such Lender, the Overnight Rate plus any administrative, processing or similar fees customarily charged by the Administrative Agent in connection with the foregoing or (ii) in the case of the Borrower, the interest rate applicable to Base Rate Loans. If such Lender pays such amount to the Administrative Agent, then such amount shall constitute such Lender&#8217;s Loan included in such Borrowing. If the Borrower pays such amount to the Administrative Agent, the amount so paid shall constitute a repayment of such Borrowing by such amount. Nothing herein shall be deemed to relieve any Lender from its obligation to fulfill its Commitment or to prejudice any rights which the Administrative Agent or the Borrower or any other Loan Party may have against any Lender as a result of any default by such Lender hereunder.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Market Disruption&#59; Inability to Determine Rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. (a) Notwithstanding the satisfaction of all conditions referred to in Article II and Article IV with respect to any Revolving Borrowing to be effected in any Alternative Currency, if (i) there shall occur on or prior to the date of such Borrowing any change in national or international financial, political or economic conditions or currency exchange rates or exchange controls which would in the reasonable opinion of the Administrative Agent, the relevant Issuing Bank (if such Credit Event is a Letter of Credit) or the Required Lenders make it impracticable for the applicable Alternative Currency Borrowings or Letters of Credit comprising such Credit Event to be denominated in the Alternative Currency specified by the Borrower or (ii) the Dollar Equivalent of such currency is not readily calculable, then the Administrative Agent shall forthwith give notice thereof to the Borrower, the Lenders and, if such Credit Event is a Letter of Credit, the relevant Issuing Bank, and such Credit Events shall not be denominated in such Alternative Currency but shall, except as otherwise set forth in Section 2.06, be made on the date of such Credit Event in Dollars, (a) if such Credit Event is a Borrowing, in an aggregate principal amount equal to the Dollar Equivalent of the aggregate principal amount specified in the related Borrowing Request or Interest Election Request, as the case may be, unless the Borrower notifies the Administrative Agent at least one (1) Business Day before such date that (i) it elects not to borrow on such date or (ii) it elects to borrow on such date in a different Alternative Currency, as the case may be, in which the denomination of such Loans would, in the reasonable opinion of the Administrative Agent or the Required Lenders, as applicable, be practicable and in an aggregate principal amount equal to the Dollar Equivalent of the aggregate principal amount specified in the related Borrowing Request or Interest Election Request, as the case may be or (b) if such Credit Event is a Letter of Credit, in a face amount equal to the Dollar Equivalent of the face amount specified in the related request or application for such Letter of Credit, unless the Borrower notifies the Administrative Agent at least one (1) Business Day before such date that</font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">it elects not to request the issuance of such Letter of Credit on such date or (ii) it elects to have such Letter of Credit issued on such date in a different currency, as the case may be, in which the denomination of such Letter of Credit would in the reasonable opinion of the relevant Issuing Bank, the Administrative Agent or the Required Lenders, as applicable, be practicable and in face amount equal to the Dollar Equivalent of the face amount specified in the related request or application for such Letter of Credit, as the case may be.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.35pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:line-through">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If in connection with any request for a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loan, SOFR Daily Floating Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or an Alternative Currency Loan or a conversion of Base Rate</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_172"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loans, SOFR Daily Floating Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Loans, or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a continuation of any of such Loans, as applicable, (i) the Administrative Agent determines (which determination shall be conclusive absent manifest error) that (A) no </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Benchmark Replacement or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Successor Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">, as applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">for the Relevant Rate for the applicable Agreed Currency has been determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.07(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.07(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as applicable, and the circumstances under clause (i) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.07(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or the Scheduled Unavailability Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">, or the SOFR Scheduled Unavailability Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">has occurred with respect to such Relevant Rate (as applicable), or (B) adequate and reasonable means do not otherwise exist for determining the Relevant Rate for the applicable Agreed Currency for any determination date(s) or requested Interest Period, as applicable, with respect to a proposed </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or a proposed Alternative Currency Loan or in connection with an existing or proposed Base Rate Loan, or (ii) the Administrative Agent or the Required Lenders determine that for any reason that the Relevant Rate with respect to a proposed Loan denominated in an Agreed Currency for any requested Interest Period or determination date(s) does not adequately and fairly reflect the cost of such Lenders of funding such Loan, the Administrative Agent will promptly notify the Borrower and each Lender. Thereafter, (x) the obligation of the Lenders to make or maintain </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loans, SOFR Daily Floating Rate Loans or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans in the affected currencies, as applicable, or to convert Base Rate Loans to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Loans,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loans, SOFR Daily Floating Rate Loans or Loans in the affected currencies, as applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall be suspended in each case to the extent of the affected </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loans, SOFR Daily Floating Rate Loans or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Alternative Currency Loans or Interest Period or determination date(s), as applicable, and (y) in the event of a determination described in the preceding sentence with respect to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">component of the Base Rate, the utilization of the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">component in determining the Base Rate shall be suspended, in each case until the Administrative Agent (or, in the case of a determination by the Required Lenders described in clause (ii) of this Section 2.07(b), until the Administrative Agent upon instruction of the Required Lenders) revokes such notice. Upon receipt of such notice, (1) the Borrower may revoke any pending request for a Borrowing or, or conversion to, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loans or SOFR Daily Floating Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, or Borrowing of, or a continuation of, Alternative Currency Loans to the extent of the affected Alternative Currency Loans or Interest Period or determination date(s), as applicable, or, failing that, will be deemed to have converted such request into a request for a Borrowing of Base Rate Loans denominated in Dollars in the Dollar Equivalent of the amount specified therein and (2)(A) any outstanding </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loans or Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans shall be deemed to have been converted to Base Rate Loans immediately and (B) any outstanding affected Alternative Currency Loans, at the Borrower&#8217;s election, shall either (I) be converted into a Borrowing of Base Rate Loans denominated in Dollars in the Dollar Equivalent of the amount of such outstanding Alternative Currency Loan immediately, in the case of an Alternative Currency Daily Rate Loan, or at the end of the applicable Interest Period, in the case of an Alternative Currency Term Rate Loan, or (II) be prepaid in full immediately, in the case of an Alternative Currency Daily Rate Loan, or at the end of the applicable Interest Period, in the case of an Alternative Currency Term Rate Loan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that if no election is made by the Borrower,</font></div><div style="padding-left:38pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(x) in the case of an Alternative Currency Daily Rate Loan, by the date that is three Business Days after receipt by the Borrower of such notice or (y) in the case of an Alternative Currency Term Rate Loan by the last day of the current Interest Period for such Alternative Currency Term Rate Loan, the Borrower shall be deemed to have elected clause (I) above.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_175"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:6.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:line-through">(c) </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Replacement of Reference Rate (other than SOFR) or Non-SOFR Successor Rate. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary in this Agreement or any other Loan Document, (x) for purposes of this Section 2.07(c), the term &#8220;Agreed Currency&#8221; shall not include Dollars and (y) if the Administrative Agent determines (which determination shall be conclusive absent manifest error), or the Borrower or Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower) that the Borrower or Required Lenders (as applicable) have determined, that&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">adequate and reasonable means do not exist for ascertaining the Relevant Rate </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(other than SOFR)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">for an Agreed Currency </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(other than Dollars)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">because none of the tenors of such Relevant Rate (including any forward-looking term rate thereof) </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(other than SOFR) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">is available or published on a current basis, and such circumstances are unlikely to be temporary, or</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:5.05pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">the Applicable Authority has made a public statement identifying a specific date after which all tenors of the Relevant Rate </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(other than SOFR) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">for an Agreed Currency (including any forward-looking term rate thereof) shall or will no longer be representative or made available, or used for determining the interest rate of loans denominated in such Agreed Currency</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(other than Dollars), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or shall or will otherwise cease, provided that, in each case, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent that will continue to provide such representative tenor(s) of the Relevant Rate </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(other than SOFR)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">for such Agreed Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">other than SOFR)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the latest date on which all tenors of the Relevant Rate </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(other than SOFR)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">for such Agreed Currency </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(other than Dollars) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(including any forward-looking term rate thereof) are no longer representative or available permanently or indefinitely, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:108pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt;text-decoration:line-through">syndicated loans currently being executed and agented in the U.S. are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace the Relevant Rate for an Agreed Currency&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or if the events or circumstances of the type described in Section 2.07(c)(i)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">or (iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">have occurred with respect to the Successor Rate then in effect, then, the Administrative Agent and the Borrower may amend this Agreement solely for the purpose of replacing the Relevant Rate for an Agreed Currency or any then current Successor Rate for an Agreed Currency in accordance with this Section 2.07 with an alternative benchmark rate giving due consideration to any evolving or then existing convention for similar credit facilities syndicated and agented in the U.S. and denominated in such Agreed Currency for such alternative benchmarks, and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar credit facilities syndicated and agented in the U.S. and denominated in such Agreed Currency for such benchmarks</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">, which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion and may be periodically updated </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(and any such proposed rate, including for the avoidance of doubt, any adjustment thereto, a &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Non-SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Successor Rate&#8221;), and any such amendment shall become effective at 5&#58;00 p.m. on the fifth Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the</font></div><div style="text-align:justify"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Borrower unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.45pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Replacement of SOFR or SOFR Successor Rate. Notwithstanding anything to the contrary in this Agreement or any other Loan Document, if the Administrative Agent determines (which determination shall be conclusive absent manifest error), or the Borrower or Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower) that the Borrower or Required Lenders (as applicable) have determined, that&#58;</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:108pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt;text-decoration:underline">adequate and reasonable means do not exist for ascertaining SOFR because SOFR is not available or published on a current basis and such circumstances are unlikely to be temporary, or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:108pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt;text-decoration:underline">the Applicable Authority has made a public statement identifying a specific date after which SOFR shall or will no longer be representative or made available, or permitted to be used for determining the interest rate of syndicated loans denominated in Dollars, or shall or will otherwise cease, provided that, in each case, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent that will continue to provide SOFR on a representative basis (the date on which SOFR is no longer representative or available permanently or indefinitely, the &#8220;SOFR Scheduled Unavailability Date&#8221;)&#59; or if the events or circumstances of the type described in Section 2.07(d)(i) or (ii) have occurred with respect to the SOFR Successor Rate then in effect, then the Administrative Agent and the Borrower may amend this Agreement solely for the purpose of replacing SOFR for Dollars or any then current SOFR Successor Rate for Dollars in accordance with this Section 2.07 with an alternative benchmark rate giving due consideration to any evolving or then existing convention for similar credit facilities syndicated and agented in the U.S. and denominated in Dollars for such alternative benchmarks, and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar credit facilities syndicated and agented in the U.S. and denominated in Dollars for such benchmarks (and any such proposed rate, including for the avoidance of doubt, any adjustment thereto, a &#8220;SOFR Successor Rate&#8221;, and collectively with the Non-SOFR Successor Rate, each a &#8220;Successor Rate&#8221;), and any such amendment shall become effective at 5&#58;00 p.m. on the fifth Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Borrower unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Administrative Agent will promptly (in one or more notices) notify the Borrower and each Lender of the implementation of any Successor Rate. Any Successor Rate shall be applied in a manner consistent with market practice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that to the extent such market practice is not administratively feasible for the Administrative Agent, such Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(in consultation with the Borrower)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything else herein, if at any time any Successor Rate as so determined would otherwise be less than zero percent (0%), the Successor Rate will be deemed to be zero percent (0%) for the purposes of this Agreement and the other Loan Documents. In connection with the implementation of a Successor Rate, the Administrative Agent will have the right to make Conforming Changes from time to time </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(in consultation with the Borrower) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrower and the Lenders reasonably promptly after such amendment becomes effective.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:127.15pt;text-indent:-17.15pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(d)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.17pt;text-decoration:line-through">Notwithstanding anything to the contrary in this Agreement or any other Loan</font></div><div style="padding-left:38pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:line-through">Document&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;text-indent:108pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(i)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt;text-decoration:line-through">On March 5, 2021 the Financial Conduct Authority (&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">FCA</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;), the</font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">regulatory supervisor of LIBOR&#8217;s administrator (&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">IBA</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;), announced in a public statement the future cessation or loss of representativeness of overnight&#47;Spot Next, 1-week, 1-month, 2-month, 3-month, 6-month and 12-month U.S. dollar LIBOR tenor settings. On the earliest of (A) the date that all Available Tenors of U.S. dollar LIBOR have permanently or indefinitely ceased to be provided by IBA or have been announced by the FCA pursuant to public statement or publication of information to be no longer representative, (B) June 30, 2023 and (C) the Early Opt-in Effective Date in respect of a SOFR Early Opt-in, if the then-current Benchmark is LIBOR, the Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any setting of such Benchmark on such day and all subsequent settings without any amendment to, or further action or consent of any other party to this Agreement or any other Loan Document. If the Benchmark Replacement is Daily Simple SOFR, all interest payments will be payable on a monthly basis.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:108pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(ii)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt;text-decoration:line-through">(x) Upon (A) the occurrence of a Benchmark Transition Event or (B) a determination by the Administrative Agent that neither of the alternatives under clause (1) of the definition of Benchmark Replacement are available, the Benchmark Replacement will replace the then-current Benchmark for all purposes hereunder and under any Loan Document in respect of any Benchmark setting at or after 5&#58;00 p.m. on the fifth (5</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">th</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from Lenders comprising the Required Lenders (and any such objection shall be conclusive and binding absent manifest error)&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">that solely in the event that the then-current Benchmark at the time of such Benchmark Transition Event is not a SOFR-based rate, the Benchmark Replacement therefor shall be determined in accordance with clause (1) of the definition of Benchmark Replacement unless the Administrative Agent determines that neither of such alternative rates is available. (y) On the Early Opt-in Effective Date in respect of an Other Rate Early Opt-in, the Benchmark Replacement will replace LIBOR for all purposes hereunder and under any Loan Document in respect of any setting of such Benchmark on such day and all subsequent settings without any amendment to, or further action or consent of any other party to this Agreement or any other Loan Document.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:38pt;padding-right:7.65pt;text-align:justify;text-indent:108pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(iii)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt;text-decoration:line-through">At any time that the administrator of the then-current Benchmark has permanently or indefinitely ceased to provide such Benchmark or such Benchmark has been</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_178"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8.7pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">announced by the regulatory supervisor for the administrator of such Benchmark pursuant to public statement or publication of information to be no longer representative of the underlying market and economic reality that such Benchmark is intended to measure and that representativeness will not be restored, the Borrower may revoke any request for a borrowing of, conversion to or continuation of Loans to be made, converted or continued that would bear interest by reference to such Benchmark until the Borrower&#8217;s receipt of notice from the Administrative Agent that a Benchmark Replacement has replaced such Benchmark, and, failing that, the Borrower will be deemed to have converted any such request into a request for a borrowing of or conversion to Base Rate Loans. During the period referenced in the foregoing sentence, the component of Base Rate based upon the Benchmark will not be used in any determination of Base Rate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.2pt;text-align:justify;text-indent:108pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(iv)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt;text-decoration:line-through">In connection with the implementation and administration of a Benchmark Replacement, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.45pt;text-align:justify;text-indent:108pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(v)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:line-through">The Administrative Agent will promptly notify the Borrower and the Lenders of (A) the implementation of any Benchmark Replacement and (B) the effectiveness of any Benchmark Replacement Conforming Changes. Any determination, decision or election that may be made by the Administrative Agent pursuant to this Section 2.07(d), including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section 2.07(d).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.2pt;text-align:justify;text-indent:108pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(vi)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt;text-decoration:line-through">At any time (including in connection with the implementation of a Benchmark Replacement), (A) if the then-current Benchmark is a term rate (including Term SOFR or LIBOR), then the Administrative Agent may remove any tenor of such Benchmark that is unavailable or non-representative for Benchmark (including Benchmark Replacement) settings and (B) the Administrative Agent may reinstate any such previously removed tenor for Benchmark (including Benchmark Replacement) settings.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination and Reduction of Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Unless previously terminated, all Revolving Commitments of any Class shall terminate on the Revolving Credit Maturity Date with respect to such Class.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Borrower may at any time terminate, or from time to time reduce, the Revolving Commitments&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) each reduction of the Revolving Commitments shall be in an amount that is an integral multiple of $1,000,000 and not less than $1,000,000 (or, if less, the remaining amount of the Revolving Commitments), (ii) the Borrower shall not terminate or reduce the Revolving Commitments if, after giving effect to any concurrent prepayment of the</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_181"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans in accordance with Section 2.10, the total Revolving Credit Exposures would exceed the total Revolving Commitments.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Borrower shall notify the Administrative Agent by telephone (confirmed by telecopy or transmission by electronic communication in accordance with Section 9.01(b)) of any election to terminate or reduce the Revolving Commitments under paragraph (b) of this Section not later than 12&#58;00 p.m. three (3) Business Days prior to the effective date of such termination or reduction, specifying such election and the effective date thereof. Promptly following receipt of any such notice, the Administrative Agent shall advise the Lenders of the contents thereof. Each notice delivered by the Borrower pursuant to this Section shall be irrevocable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that a notice of termination of the Revolving Commitments delivered by the Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities or instruments of Indebtedness or the occurrence of any other specified event, in which case such notice may be revoked by the Borrower (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied. Any termination or reduction of the Revolving Commitments shall be permanent. Each reduction of the Commitments shall be made ratably among the Lenders in accordance with their respective Commitments.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Repayment of Loans&#59; Evidence of Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Borrower hereby unconditionally promises to pay (i) to the Administrative Agent for the account of each Lender the then unpaid principal amount of each Revolving Loan of any Class made to the Borrower on the Revolving Credit Maturity Date with respect to such Class in the currency of such Loan and (ii) to the Swingline Lender the then unpaid principal amount of each Swingline Loan on the earlier of the initial Revolving Credit Maturity Date (or such later Revolving Credit Maturity Date as agreed by the Swingline Lender in connection with any Revolving Extension Amendment) and the first date after such Swingline Loan is made that is the 15th or last day of a calendar month and is at least three (3) Business Days after such Swingline Loan is made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that on each date that a Revolving Loan is made, the Borrower shall repay all Swingline Loans then outstanding.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of the Borrower to such Lender resulting from each Loan made by such Lender, including the amounts of principal and interest payable and paid to such Lender from time to time hereunder.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall maintain accounts in which it shall record</font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">the amount of each Loan made hereunder, the currency and Type thereof and the Interest Period, if any, applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from the Borrower to each Lender hereunder and (iii) the amount of any sum received by the Administrative Agent hereunder for the account of the Lenders and each Lender&#8217;s share thereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The entries made in the accounts maintained pursuant to paragraph (b) or</font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) of this Section shall be prima facie evidence of the existence and amounts of the obligations recorded therein absent manifest error&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the failure of any Lender or the</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_184"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligation of the Borrower to repay the Loans in accordance with the terms of this Agreement.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) Any Lender may request that Loans made by it be evidenced by promissory notes. In such event, the Borrower shall prepare, execute and deliver to such Lender promissory notes payable to such Lender and its registered assigns and in a form approved by the Administrative Agent. Thereafter, the Loans evidenced by such promissory notes and interest thereon shall at all times (including after assignment pursuant to Section 9.04 of this Agreement) be represented by one or more promissory notes in such form payable to the payee named therein and its registered assigns.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prepayment of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:10.6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Optional Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. (i) The Borrower shall have the right at any time and from time to time to prepay any Borrowing in whole or in part, without premium or penalty, subject to prior notice given in accordance with paragraph (a)(ii) of this Section, or otherwise in form and substance reasonably acceptable to the Administrative Agent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">The Borrower shall notify the Administrative Agent (and, in the case of prepayment of a Swingline Loan, the Swingline Lender) by telephone (confirmed by telecopy or transmission by electronic communication in accordance with Section 9.01(b)) of any prepayment hereunder (i) (x) in the case of prepayment of a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Borrowing, not later than 2&#58;00 p.m. New York City time, three</font></div><div style="padding-left:74pt;padding-right:5.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Business Days before the date of prepayment, or (y) four Business Days (or five, in the case of prepayment of Loans denominated in Special Notice Currencies) prior to any date of prepayment of Alternative Currency Loans, (ii) in the case of prepayment of a Base Rate Borrowing and </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans, not later than noon, New York City time, on the date of prepayment or (iii) in the case of prepayment of a Swingline Loan, not later than 2&#58;00 p.m., New York City time on the date of prepayment. Each such notice shall be irrevocable and shall specify the prepayment date and the principal amount of each Borrowing or portion thereof to be prepaid&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, if a notice of prepayment is given in connection with a conditional notice of termination of the Commitments as contemplated by Section 2.08, then such notice of prepayment may be revoked if such notice of termination is revoked in accordance with Section 2.08. Promptly following receipt of any such notice relating to a Borrowing, the Administrative Agent shall advise the Lenders of the contents thereof. Each partial prepayment of any Borrowing shall be in an amount that would be permitted in the case of an advance of a Borrowing of the same Type as provided in Section 2.02.&#160;&#160;&#160;&#160;Each prepayment of a Borrowing shall be applied ratably to the Loans included in the notice of prepayment. Prepayments pursuant to this Section 2.10(a) shall be accompanied by accrued interest to the extent required by Section 2.12 and shall be subject to Section 2.15.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Mandatory Prepayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:38pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Administrative Agent notifies the Borrower at any time that the Revolving Credit Exposure at such time exceeds an amount equal to 105% of the Revolving Commitments</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_187"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:6.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">then in effect, then, within two Business Days after receipt of such notice, the Borrower shall prepay Loans and&#47;or Cash Collateralize the L&#47;C Exposure in an aggregate amount sufficient to reduce such Revolving Credit Exposure as of such date of payment to an amount not to exceed 100% of the Revolving Commitments then in effect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Borrower shall not be required to Cash Collateralize the L&#47;C Exposures pursuant to this Section 2.10(b) unless after the prepayment in full of the Loans, the Revolving Credit Exposure exceeds the Revolving Commitments then in effect. The Administrative Agent may, at any time and from time to time after the initial deposit of such Cash Collateral for the L&#47;C Exposure, reasonably request that additional Cash Collateral be provided in order to protect against the results of further material exchange rate fluctuations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:4.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Borrower agrees to pay to the Administrative Agent for the account of each Revolving Lender a facility fee, which shall accrue at the Applicable Rate on the daily amount of the Revolving Commitment of such Lender (whether used or unused) during the period from and including the Closing Date to but excluding the date on which such Commitment terminates&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, if such Lender continues to have any Revolving Credit Exposure after its Revolving Commitment terminates, then such facility fee shall continue to accrue on the daily Dollar Equivalent of such Lender&#8217;s Revolving Credit Exposure from and including the date on which its Revolving Commitment terminates to but excluding the date on which such Lender ceases to have any Revolving Credit Exposure&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that any facility fee accrued with respect to the unutilized Revolving Commitment of a Defaulting Lender during the period prior to the time such Lender became a Defaulting Lender and unpaid at such time shall not be payable by the Borrower so long as such Lender shall be a Defaulting Lender except to the extent that such facility fee shall otherwise have been due and payable by the Borrower prior to such time&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that no facility fee shall accrue on the unutilized Revolving Commitment of a Defaulting Lender so long as such Lender shall be a Defaulting Lender. Accrued facility fees shall be payable in arrears on the last day of March, June, September and December of each year and on the date on which the Revolving Commitments terminate, commencing on the first such date to occur after the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Closing </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">d</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ate </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">hereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that any facility fees accruing after the date on which the Revolving Commitments terminate shall be payable on demand. All facility fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Borrower agrees to pay (i) to the Administrative Agent for the account of each Revolving Lender a participation fee with respect to its participations in Letters of Credit, which shall accrue at the same Applicable Rate used to determine the interest rate applicable to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans on the average daily Dollar Equivalent of such Lender&#8217;s L&#47;C Exposure (excluding any portion thereof attributable to unreimbursed L&#47;C Disbursements) during the period from and including the Closing Date to but excluding the later of the date on which such Lender&#8217;s Revolving Commitment terminates and the date on which such Lender ceases to have any L&#47;C Exposure (the fees referred to in this clause (i), the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (ii) to each Issuing Bank a fronting fee, which shall accrue at the rate of 0.125% per annum on the average daily Dollar Equivalent of the L&#47;C Exposure (excluding any portion thereof attributable to unreimbursed L&#47;C Disbursements) attributable to Letters of Credit</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_190"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">issued by such Issuing Bank during the period from and including the Closing Date to but excluding the later of the date of termination of the Revolving Commitments and the date on which there ceases to be any L&#47;C Exposure, as well as such Issuing Bank&#8217;s standard fees and commissions with respect to the issuance, amendment, cancellation, negotiation, transfer, presentment, renewal or extension of any Letter of Credit or processing of drawings thereunder. Unless otherwise specified above, participation fees and fronting fees accrued through and including the last day of March, June, September and December of each year shall be payable on the third (3rd) Business Day following such last day, commencing on the first such date to occur after the Closing Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that all such fees shall be payable on the date on which the Revolving Commitments terminate and any such fees accruing after the date on which the Revolving Commitments terminate shall be payable on demand. Any other fees payable to an Issuing Bank pursuant to this paragraph shall be payable within ten (10) days after demand. All participation fees and fronting fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#91;Reserved&#93;.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Borrower agrees to pay to the Administrative Agent, for its own account, fees payable in the amounts and at the times separately agreed upon between the Borrower and the Administrative Agent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">All fees payable hereunder shall be paid on the dates due, in Dollars and in Same Day Funds, to the Administrative Agent (or to the relevant Issuing Bank, in the case of fees payable to it) for distribution, in the case of facility fees and participation fees, to the Lenders. Fees paid shall not be refundable under any circumstances.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Loans comprising each Base Rate Borrowing (including each Swingline Loan) shall bear interest at the Base Rate in effect from time to time </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Applicable Rate.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Loans comprising each </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Borrowing shall bear interest at </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurocurrency Rate for the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">a rate per annum equal to the Term SOFR for such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Interest Period in effect for such Borrowing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Applicable Rate.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Loans comprising each </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Borrowing shall bear interest at the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate in effect from time to time </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Applicable Rate.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Loans comprising each Alternative Currency Daily Rate Borrowing shall bear interest at the Alternative Currency Daily Rate in effect from time to time </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Applicable Rate.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Loans comprising each Alternative Currency Term Rate Borrowing shall bear interest at the Alternative Currency Term Rate for the Interest period in effect for such Borrowing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Applicable Rate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">Notwithstanding the foregoing, at any time (x) an Event of Default has occurred and is continuing under clauses (h), (i) or (j) of Article VII or (y) if any principal of or interest on any Loan or any fee or other amount payable by the Borrower hereunder is not paid when due, whether at stated maturity, upon acceleration or otherwise, then such overdue amount shall bear interest, after as well as before judgment, at a rate per annum equal to (i) in the case of </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">overdue principal of any Loan, 2% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the rate otherwise applicable to such Loan as provided in the preceding paragraphs of this Section or (ii) in the case of any other amount, upon the request of the Required Lenders, 2% plus the rate applicable to Base Rate Loans as provided in paragraph (a) of this Section (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Accrued interest on each Loan shall be payable in arrears on each Interest Payment Date for such Loan and, in the case of Revolving Loans, upon termination of the Revolving Commitments&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) interest accrued pursuant to paragraph (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) of this Section shall be payable on demand, (ii) in the event of any repayment or prepayment of any Loan (other than a prepayment of a Base Rate Loan prior to the end of the Availability Period or a Swingline Loan), accrued interest on the principal amount repaid or prepaid shall be payable on the date of such repayment or prepayment and (iii) in the event of any conversion of any </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loan or Alternative</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Euroc</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">urrency </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan prior to the end of the current Interest Period therefor, accrued interest on such Loan shall be payable on the effective date of such conversion.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">All interest hereunder shall be computed on the basis of a year of 360 days, except that interest (i) computed by reference to the Base Rate shall be computed on the basis of a year of 365 days (or 366 days in a leap year), (ii) for Borrowings denominated in Sterling shall be computed on the basis of a year of 365 days, and in each case, shall be payable for the actual number of days elapsed (including the first day but excluding the last day) and (iii) in the case of interest in respect of Loans denominated in Alternative Currencies as to which market practice differs from the foregoing, shall be computed in accordance with such market practice. The applicable Base Rate, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rate or other Relevant Rate shall be determined by the Administrative Agent in accordance with the provisions of this Agreement, and such determination shall be conclusive absent manifest error.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:267.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">SECTION 2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">. SECTION 2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%;text-decoration:underline">Increased Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">.</font></div><div style="margin-top:0.4pt;padding-left:38pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">If any Change in Law shall&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or credit extended by, any Lender or any Issuing Bank&#59;</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_193"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">subject any Recipient to any Taxes (other than (A) Indemnified Taxes and</font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B) Excluded Taxes) on its loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:8.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">impose on any Lender or any Issuing Bank or any applicable interbank market any other condition affecting this Agreement, any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans, any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans or any Alternative Currency Loans made by such Lender or any Letter of Credit or participation therein&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and the result of any of the foregoing shall be to increase the cost to such Lender of making, converting to, continuing or maintaining any Loan under this Agreement or of maintaining its obligation to make any such Loan (including pursuant to any conversion of any Borrowing denominated in any currency into a Borrowing denominated in any other currency) or to increase the cost to such Lender or such Issuing Bank of participating in, issuing or maintaining any Letter of Credit (including pursuant to any conversion of any Borrowing denominated in any currency into a Borrowing denominated in any other currency) or to reduce the amount of any sum received or receivable by such Lender or such Issuing Bank hereunder, whether of principal, interest or otherwise (including pursuant to any conversion of any Borrowing denominated in any currency into a Borrowing denominated in any other currency), in each case by an amount deemed by such Lender or such Issuing Bank to be material in the context of its making of, and participation in, extensions of credit under this Agreement, then, upon the request of such Lender or such Issuing Bank, the Borrower will pay to such Lender or such Issuing Bank, as the case may be, such additional amount or amounts as will compensate such Lender or such Issuing Bank, as the case may be, for such additional costs incurred or reduction suffered.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">If any Lender or any Issuing Bank determines in good faith that any Change in Law regarding capital or liquidity requirements has or would have the effect of reducing the rate of return on such Lender&#8217;s or such Issuing Bank&#8217;s capital or on the capital of such Lender&#8217;s or such Issuing Bank&#8217;s holding company, if any, as a consequence of this Agreement or the Loans made by, or participations in Letters of Credit held by, such Lender, or the Letters of Credit issued by such Issuing Bank, to a level below that which such Lender or such Issuing Bank or such Lender&#8217;s or such Issuing Bank&#8217;s holding company could have achieved but for such Change in Law (taking into consideration such Lender&#8217;s or such Issuing Bank&#8217;s policies and the policies of such Lender&#8217;s or such Issuing Bank&#8217;s holding company with respect to capital adequacy or liquidity), then from time to time, upon the request of such Lender or such Issuing Bank, the Borrower will pay to such Lender or such Issuing Bank, as the case may be, such additional amount or amounts as will compensate such Lender or such Issuing Bank or such Lender&#8217;s or such Issuing Bank&#8217;s holding company for any such reduction suffered.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">A certificate of a Lender or an Issuing Bank setting forth in reasonable detail the amount or amounts necessary to compensate such Lender or such Issuing Bank or its holding company, as the case may be, as specified in paragraph (a) or (b) of this Section shall be delivered to the Borrower and shall be conclusive absent manifest error. The Borrower shall pay such Lender or such Issuing Bank, as the case may be, the amount shown as due on any such certificate within ten (10) days (or such later date as may be agreed by the applicable Lender) after receipt thereof.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_196"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Failure or delay on the part of any Lender or any Issuing Bank to demand compensation pursuant to this Section shall not constitute a waiver of such Lender&#8217;s or such Issuing Bank&#8217;s right to demand such compensation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the Borrower shall not be required to compensate a Lender or an Issuing Bank pursuant to this Section for any increased costs or reductions incurred more than 135 days prior to the date that such Lender or such Issuing Bank, as the case may be, notifies the Borrower of the Change in Law giving rise to such increased costs or reductions and of such Lender&#8217;s or such Issuing Bank&#8217;s intention to claim compensation therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the 135-day period referred to above shall be extended to include the period of retroactive effect thereof.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">A Lender&#8217;s or Issuing Bank&#8217;s claim for additional amounts pursuant to this Section 2.14 shall be generally consistent with such Lender&#8217;s or such Issuing Bank&#8217;s treatment of customers of such Lender or Issuing Bank that such Lender or Issuing Bank considers, in its reasonable discretion, to be similarly situated as the Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Break Funding Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event of&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">the payment of any principal of any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or any Alternative Currency Term Rate Loan other than on the last day of an Interest Period applicable thereto (including as a result of an Event of Default or as a result of any prepayment pursuant to Section 2.10), (b) the conversion of any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or any Alternative Currency Term Rate Loan other than on the last day of the Interest Period applicable thereto, (c) the failure to borrow, convert, continue or prepay any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or any Alternative Currency Term Rate Loan on the date specified in any notice delivered pursuant hereto (regardless of whether such notice may be revoked under Section 2.10 and is revoked in accordance therewith) or (d) the assignment of any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan or any Alternative Currency Term Rate Loan other than on the last day of the Interest Period applicable thereto as a result of a request by the Borrower pursuant to Section 2.18, then, in any such event, the Borrower shall compensate each Lender for the loss, cost and expense (excluding loss of anticipated profit) attributable to such event. Such loss, cost or expense to any Lender may be deemed to include an amount determined by such Lender to be the excess, if any, of (i) the amount of interest which would have accrued on the principal amount of such Loan had such event not occurred, at the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rate or Alternative Currency Term Rate, as applicable, that would have been applicable to such Loan (and excluding any Applicable Rate), for the period from the date of such event to the last day of the then current Interest Period therefor (or, in the case of a failure to borrow, convert or continue, for the period that would have been the Interest Period for such Loan), over (ii) the amount of interest which would accrue on such principal amount for such period at the interest rate which such Lender would bid were it to bid, at the commencement of such period, for deposits in the relevant currency of a comparable amount and period from other banks in the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">eurocurrency market or any other </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">applicable interbank market. A certificate of any Lender setting forth in reasonable detail any amount or amounts that such Lender is entitled to receive pursuant to this Section shall be delivered to the Borrower and shall be conclusive absent manifest error. The Borrower shall pay such Lender the amount shown as due on any such certificate within ten (10) days (or such later date as may be agreed by the applicable Lender) after receipt thereof.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_199"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Payments Free of Taxes&#59; Obligation to Withhold&#59; Payments on Account of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any and all payments by or on account of any obligation of any Loan Party under any Loan Document shall be made without deduction or withholding for any Taxes, except as required by applicable Laws. If any Loan Party or the Administrative Agent shall be required by any applicable Laws (as determined in good faith by the Administrative Agent or Loan Party) to withhold or deduct any Taxes from any payment, then (A) such Loan Party or the Administrative Agent, as required by such Laws, shall withhold or make such deductions as are determined by it to be required, (B) such Loan Party or the Administrative Agent, to the extent required by such Laws, shall timely pay the full amount withheld or deducted to the relevant Governmental Authority in accordance with such Laws, and (C) to the extent that the withholding or deduction is made on account of Indemnified Taxes, the sum payable by the applicable Loan Party shall be increased as necessary so that after any required withholding or the making of all required deductions (including deductions applicable to additional sums payable under this Section 2.16) the applicable Recipient receives an amount equal to the sum it would have received had no such withholding or deduction been made.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Payment of Other Taxes by the Loan Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without limiting the provisions of subsection (a) above, the Loan Parties shall timely pay to the relevant Governmental Authority in accordance with applicable Laws, or at the option of the Administrative Agent timely reimburse it for the payment of, any Other Taxes.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Tax Indemnifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Each of the Loan Parties shall indemnify each Recipient, and shall make payment in respect thereof within 10 days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section 2.16) payable or paid by such Recipient or required to be withheld or deducted from a payment to such Recipient, and any penalties, interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to the Borrower by a Lender or an Issuing Bank (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender or an Issuing Bank, shall be conclusive absent manifest error.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">Each Lender and each Issuing Bank shall, and does hereby, severally indemnify, and shall make payment in respect thereof within 10 days after written demand therefor, (x) the Administrative Agent against any Indemnified Taxes attributable to such Lender or such Issuing Bank (but only to the extent that any Loan Party has not already indemnified the Administrative Agent for such Indemnified Taxes and without limiting the obligation of the Loan Party to do so), (y) the Administrative Agent and the Loan Party, as applicable, against any Taxes attributable to such Lender&#8217;s failure to comply with the provisions of Section 9.04(d) relating to the maintenance of a Participant Register and (z) the Administrative Agent and the Loan Party, as applicable, against any Excluded Taxes attributable to such Lender or such Issuing Bank, in each</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_202"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:73.95pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">case, that are payable or paid by the Administrative Agent or a Loan Party in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent or any Loan Party, as applicable, shall be conclusive absent manifest error. Each Lender and Issuing Bank hereby authorizes the Administrative Agent or any Loan Party, as applicable, to set off and apply any and all amounts at any time owing to such Lender or such Issuing Bank, as the case may be, under this Agreement or any other Loan Document against any amount due to the Administrative Agent or any Loan Party, as applicable, under this clause (ii).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Upon request by the Borrower or the Administrative Agent, as the case may be, after any payment of Taxes on amounts payable under this Agreement or any other Loan Document by any Loan Party or by the Administrative Agent to a Governmental Authority as provided in this Section 2.16, the Borrower shall deliver to the Administrative Agent or the Administrative Agent shall deliver to the Borrower, as the case may be, the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of any return required by applicable Laws to report such payment or other evidence of such payment reasonably satisfactory to the Borrower or the Administrative Agent, as the case may be.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Status of Lenders&#59; Tax Documentation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Any Lender that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Loan Document shall deliver to the Borrower and the Administrative Agent, at the time or times reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation prescribed by applicable Laws or the taxing authorities of a jurisdiction pursuant to such applicable Laws or reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, any Lender, if reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable Laws or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and submission of such documentation (other than such documentation required pursuant to Sections 2.16(e)(ii)(A), (ii)(B) and (ii)(D) below) shall not be required if in the Lender&#8217;s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">Without limiting the generality of the foregoing,</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:110pt;padding-right:5.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">any Lender that is a U.S. Person shall deliver to the Borrower and the Administrative Agent on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_205"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:110pt;padding-right:5.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">upon the reasonable request of the Borrower or the Administrative Agent), executed copies of IRS Form W-9 certifying that such Lender is exempt from</font></div><div style="padding-left:110pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">U.S. federal backup withholding tax&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:110pt;padding-right:5.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.02pt">any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), whichever of the following is applicable&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:254pt;padding-right:5.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">in the case of a Foreign Lender claiming the benefits of an income tax treaty to which the United States is a party (x) with respect to payments of interest under any Loan Document, executed copies of IRS Form W-8BEN or W-BEN-E (or successor form) establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the &#8220;interest&#8221; article of such tax treaty and (y) with respect to any other applicable payments under any Loan Document, IRS Form W-8BEN or W-8BEN-E (or successor form) establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the &#8220;business profits&#8221; or &#8220;other income&#8221; article of such tax treaty&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:254pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">executed copies of IRS Form W-8ECI&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:254pt;padding-right:7pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881 (c) of the Code, (x) a certificate substantially in the form of Exhibit G-1 to the effect that such Foreign Lender is not a &#8220;bank&#8221; within the meaning of Section 881(c)(3)(A) of the Code, a &#8220;10 percent shareholder&#8221; of the Borrower or any Affiliate within the meaning of Section 881(c)(3)(B) of the Code, or a &#8220;controlled foreign corporation&#8221; described in Section 881(c)(3)(C) of the Code (a &#8220;United States Tax Compliance Certificate&#8221;) and (y) executed copies of IRS Form W-8BEN or W-BEN-E (or successor form)&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:254pt;padding-right:8.2pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">to the extent a Foreign Lender is not the beneficial owner, executed copies of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN or W-8BEN-E (or successor form), a United States Tax Compliance Certificate substantially in the form of Exhibit G-2 or Exhibit G-3, IRS Form W-9, and&#47;or other certification documents from each beneficial owner, as applicable&#59; provided that if the Foreign Lender is a partnership and one or more direct or indirect partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender may provide a United States Tax Compliance </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:254pt;padding-right:8.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Certificate substantially in the form of Exhibit G-4 on behalf of each such direct and indirect partner&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:110pt;padding-right:5.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.02pt">any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), executed copies of any other form prescribed by applicable Laws as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable Laws to permit the Borrower or the Administrative Agent to determine the withholding or deduction required to be made&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:110pt;padding-right:6.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">if a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by applicable Laws and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by applicable Laws (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender's obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause (D), &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:8.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">Each Lender agrees that if any form or certification it previously delivered pursuant to this Section 2.16(e) expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless required by applicable Laws, at no time shall the Administrative Agent have any obligation to file for or otherwise pursue on behalf of a Lender or an Issuing Bank, or have any obligation to pay to any Lender or an Issuing Bank, any refund of Taxes withheld or deducted from funds paid for the account of such Lender or such</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_208"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:7.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Issuing Bank, as the case may be. If any Recipient determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified by any Loan Party or with respect to which any Loan Party has paid additional amounts pursuant to this Section 2.16, it shall pay to such Loan Party an amount equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by a Loan Party under this Section 2.16 with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) incurred by such Recipient, and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund), provided that each Loan Party, upon the request of the Recipient, agrees to repay the amount paid over to such Loan Party (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Recipient in the event the Recipient is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this subsection, in no event will the applicable Recipient be required to pay any amount to such Loan Party pursuant to this subsection the payment of which would place the Recipient in a less favorable net after-Tax position than such Recipient would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. Such Recipient shall, at the Borrower&#8217;s request, provide the Borrower with a copy of any notice of assessment or other evidence of the requirement to repay such refund received from the relevant Governmental Authority (provided that the Recipient may delete any information therein that Recipient deems confidential). This subsection shall not be construed to require any Recipient to make available its tax returns (or any other information relating to its taxes that it deems confidential) to any Loan Party or any other Person.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Treatment of Swingline Lender and Issuing Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of this Section 2.16, the term &#8220;Lender&#8221; shall include any Swingline Lender and any Issuing Bank and the term &#8220;applicable Laws&#8221; includes FATCA.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each party&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.16 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Lender or any Issuing Bank, the termination of the Commitments and the repayment, satisfaction or discharge of all other Obligations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Generally&#59; Pro Rata Treatment&#59; Sharing of Setoffs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Borrower shall make each payment required to be made by it hereunder (whether of principal, interest, fees or reimbursement of L&#47;C Disbursements, or of amounts payable under Section 2.14, 2.15 or 2.16, or otherwise) without condition or deduction for any counterclaim, defense, recoupment or setoff prior to (i) in the case of payments by the Borrower denominated in Dollars, 2&#58;00 p.m., New York City time and (ii) in the case of payments denominated in an Alternative Currency, 2&#58;00 p.m., Applicable Time, in the city of the Administrative Agent&#8217;s Office for such currency, in each case on the date when due, in Same Day Funds. Any amounts received after such time on any date may, in the discretion of the Administrative Agent, be deemed to have been received on the next succeeding Business Day for purposes of calculating interest thereon. All such payments shall be made (i) in the same currency in which the applicable Credit Event was made (or where such currency has been converted to Dollars, in Dollars) and (ii) to the Administrative Agent at its offices for Dollar denominated Credit Events or, in the case of a Credit Event denominated in an Alternative Currency, the Administrative Agent&#8217;s Office for such currency, except payments to be made directly to an Issuing Bank or Swingline Lender as expressly provided herein and except that payments pursuant to Sections 2.14, 2.15, 2.16 and 9.03 shall be made directly to the Persons entitled thereto. Without limiting the generality of the foregoing, the Administrative Agent may require that any payments due under this Agreement be made in the United States. The Administrative Agent shall distribute any such payments denominated in the same currency received by it for the account of any other Person to the appropriate recipient promptly following </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">receipt thereof. If any payment hereunder shall be due on a day that is not a Business Day, the date for payment shall be extended to the next succeeding Business Day, and, in the case of any payment accruing interest, interest thereon shall be payable for the period of such extension. Notwithstanding the foregoing provisions of this Section, if, after the making of any Credit Event in any Alternative Currency, currency control or exchange regulations are imposed in the country which issues such currency with the result that the type of currency in which the Credit Event was made (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) no longer exists or the Borrower is not able to make payment to the Administrative Agent for the account of the Lenders in such Original Currency, then all payments to be made by the Borrower hereunder in such currency shall instead be made when due in Dollars in an amount equal to the Dollar Equivalent (as of the date of repayment) of such payment due, it being the intention of the parties hereto that the Borrower take all risks of the imposition of any such currency control or exchange regulations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">If at any time insufficient funds are received by and available to the Administrative Agent to pay fully all amounts of principal, unreimbursed L&#47;C Disbursements, interest and fees then due hereunder, such funds shall be applied (i) first, towards payment of interest and fees then due hereunder, ratably based on the Dollar Equivalent amount thereof among the parties entitled thereto in accordance with the amounts of interest and fees then due to such parties, and (ii) second, towards payment of principal and unreimbursed L&#47;C Disbursements then due hereunder, ratably based on the Dollar Equivalent amount thereof among the parties entitled thereto in accordance with the amounts of principal and unreimbursed L&#47;C Disbursements then due to such parties.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">If any Lender shall, by exercising any right of setoff or counterclaim or otherwise, obtain payment in respect of any principal of or interest on any of its Loans or participations in L&#47;C Disbursements or Swingline Loans resulting in such Lender receiving payment of a greater proportion of the aggregate amount of its Loans and participations in L&#47;C Disbursements and Swingline Loans and accrued interest thereon than the proportion received by any other Lender, then the Lender receiving such greater proportion shall purchase (for cash at face value) participations in the Loans and participations in L&#47;C Disbursements and Swingline Loans of other Lenders to the extent necessary so that the benefit of all such payments shall be shared by the Lenders ratably in accordance with the aggregate amount of principal of and accrued interest on their respective Loans and participations in L&#47;C Disbursements and Swingline Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) if any such participations are purchased and all or any portion of the payment giving rise thereto is recovered, such participations shall be rescinded and the purchase price restored to the extent of such recovery, without interest, and (ii) the provisions of this paragraph shall not be construed to apply to any payment made by the Borrower pursuant to and in accordance with the express terms of this Agreement or any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_211"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:5.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">participations in L&#47;C Disbursements and Swingline Loans to any assignee or participant in accordance with Section 9.04. The Borrower consents to the foregoing and agrees, to the extent it may effectively do so under applicable law, that any Lender acquiring a participation pursuant to the foregoing arrangements may exercise against the Borrower rights of setoff and counterclaim with respect to such participation as fully as if such Lender were a direct creditor of the Borrower in the amount of such participation.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">(i) Unless the Administrative Agent shall have received notice from the Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or the relevant Issuing Bank hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders or such Issuing Bank, as the case may be, the amount due&#59; and (ii) with respect to any payment that the Administrative Agent makes for the account of the Lenders or any Issuing Bank hereunder as to which the Administrative Agent determines (which determination shall be conclusive absent manifest error) that any of the following applies (such payment referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rescindable Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#58; (1) the Borrower has not in fact made such payment&#59; (2) the Administrative Agent has made a payment in excess of the amount so paid by the Borrower (whether or not then owed)&#59; or (3) the Administrative Agent has for any reason otherwise erroneously made such payment&#59; then each of the Lenders or the relevant Issuing Bank, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount so distributed to such Lender or such Issuing Bank, in immediately available funds with interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation. A notice of the Administrative Agent to any Lender, any Issuing Bank or the Borrower with respect to any amount owing under this subsection (d) shall be conclusive, absent manifest error.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">If any Lender shall fail to make any payment required to be made by it pursuant to Section 2.04, 2.05, 2.06, 2.17 or 9.03, then the Administrative Agent may, in its discretion (notwithstanding any contrary provision hereof), apply any amounts thereafter received by the Administrative Agent for the account of such Lender to satisfy such Lender&#8217;s obligations under such Sections until all such unsatisfied obligations are fully paid. The obligations of the Lenders hereunder to make Loans, to fund participations in Letters of Credit and Swingline Loans and to make payments are several and not joint. The failure of any Lender to make any Loan, to fund any such participation or to make any payment on any date required hereunder shall not relieve any other Lender of its corresponding obligation to do so on such date, and no Lender shall be responsible for the failure of any other Lender to so make its Loan, to purchase its participation or to make its payments.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mitigation Obligations&#59; Replacement of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">If any Lender requests compensation under Section 2.14, or if the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.16, then such Lender shall use reasonable efforts to designate a different Lending Office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates, if, in the good faith judgment of such Lender, such designation or assignment (i) would eliminate or reduce amounts payable pursuant to Section 2.14 or 2.16, as the case may be, in the future and (ii) would not subject such Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender. The Borrower hereby agrees to pay all reasonable out-of-pocket costs and expenses incurred by any Lender in connection with any such designation or assignment. Any Lender claiming reimbursement of such costs and </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:6.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">expenses shall deliver to the Borrower a certificate setting forth such costs and expenses in reasonable detail which shall be conclusive absent manifest error.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">If (1) any Lender requests compensation under Section 2.14, (2) the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.16, (3) any Lender is a Defaulting Lender,</font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">any Lender fails to grant a consent in connection with any proposed change, waiver, discharge or termination of the provisions of this Agreement as contemplated by Section 9.02 for which the consent of each Lender or each affected Lender is required but the consent of the Required Lenders is obtained, (5) if any Lender is prohibited under applicable Law from making Loans or Letters of Credit denominated in one or more Alternative Currencies to the Borrower in accordance with the terms of this Agreement, and at such time the Required Lenders are permitted under applicable Law (and have agreed) to make such Loans and Letters of Credit in such Alternative Currencies, or (6) if any other circumstance exists hereunder that gives the Borrower the right to replace a Lender as a party hereto, then the Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in, but excluding the consents required by, Section 9.04), all of its interests, rights and obligations under this Agreement and the related Loan Documents to an assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">the Borrower shall have paid to the Administrative Agent the assignment fee specified in Section 9.04 (unless otherwise agreed by the Administrative Agent)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">such Lender shall have received payment of an amount equal to the outstanding principal of its Loans and L&#47;C Disbursements, accrued interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Loan Documents (including any amounts under Section 2.15) from the assignee (to the extent of such outstanding principal and accrued interest and fees) or the Borrower (in the case of all other amounts)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">in the case of any such assignment resulting from a claim for compensation under Section 2.14 or payments required to be made pursuant to Section 2.16, such assignment will result in a reduction in such compensation or payments thereafter&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">in the case of an assignment resulting from an event described in clause</font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4) above, (A) the applicable assignee shall have consented to the applicable amendment, waiver or consent and (B) after giving effect to such assignment (and any other assignments made in connection therewith), each Lender shall have consented to the applicable amendment, waiver or consent&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">in the case of an assignment resulting from a circumstance described in clause (5) above, (A) the applicable assignee shall be permitted under Law to make Loans and Letters of Credit in all Alternative Currencies to the Borrower in accordance with the terms of this Agreement and the other Loan Documents, and (B) after giving effect to such assignment (and any other assignments made in connection therewith), each Lender shall be permitted under applicable Law to make Loans to and Letters of Credit to the Borrower in all Alternative Currencies&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">in the case of an assignment resulting from a circumstance described in clause (6) above, (A) the applicable assignee shall be permitted under Law and licensed to make Loans and other applicable extensions of credit to the Borrower in accordance </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:74pt;padding-right:7.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with the terms of this Agreement and (B) after giving effect to such assignment (and to any other assignments made in connection therewith), each Lender shall be permitted under applicable Law and licensed to make such Loans and other applicable extensions of credit under this Agreement&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15.36pt">such assignment does not conflict with applicable Laws.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A Lender shall not be required to make any such assignment or delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Expansion Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Borrower may from time to time after the Closing Date elect to increase the Revolving Commitments (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Increased Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in an aggregate principal amount of not less than $25,000,000. The Borrower may arrange for any such increase to be provided by one or more Lenders (each Lender so agreeing to an increase in its Revolving Commitment, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Increasing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), or by one or more new banks, financial institutions or other entities (each such new bank, financial institution or other entity, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Augmenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), to increase their existing Revolving Commitments or to participate in such Revolving Commitments, as the case may be&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that each Augmenting Lender (and, in the case of an Increased Commitment, each Increasing Lender) shall be subject to the approval of the Borrower, the Administrative Agent, each Issuing Bank and Swingline Lender (such consents not to be unreasonably withheld or delayed). Without the consent of any Lenders other than the relevant Increasing Lenders or Augmenting Lenders, this Agreement and the other Loan Documents may be amended pursuant to an Additional Credit Extension Amendment as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower, to effect the provisions of this Section 2.19. Increases of Revolving Commitments shall become effective on the date agreed by the Borrower, the Administrative Agent and the relevant Increasing Lenders or Augmenting Lenders and the Administrative Agent shall notify each Lender thereof. Notwithstanding the foregoing, no increase in the Revolving Commitments shall be permitted under this paragraph unless on the proposed date of the effectiveness of such increase in the Revolving Commitments, (i) the conditions set forth in paragraphs (a) and (b) of</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_214"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 4.02 shall be satisfied or waived by the Required Lenders and the Administrative Agent,</font></div><div style="padding-left:37.95pt;padding-right:7.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) after giving effect to such increase in the Revolving Commitments, the Borrower shall be in compliance, on a Pro Forma Basis, with the Consolidated Leverage Ratio (determined as of the most recently ended fiscal quarter and assuming that the entire amount of such increase had been borrowed as of such quarter end), and (iii) the Administrative Agent shall have received a certificate confirming (and, as applicable, setting forth reasonably detailed calculations demonstrating) compliance with each of the requirements set forth in clauses (i) and (ii) above, dated such date and executed by a Financial Officer of the Borrower. On the effective date of any increase in the Revolving Commitments, (i) each relevant Increasing Lender and Augmenting Lender shall make available to the Administrative Agent such amounts in Same Day Funds as the Administrative Agent shall determine, for the benefit of the other Lenders, as being required in order to cause, after giving effect to such increase and the use of such amounts to make payments to such other Lenders, each Lender&#8217;s portion of the outstanding Loans of all the Lenders to equal its Applicable Percentage of such outstanding Loans, and (ii) if, on the date of such increase, there are any Revolving Loans outstanding, such Revolving Loans shall on or prior to the effectiveness of such Increased Commitments be prepaid to the extent necessary from the proceeds of additional Revolving Loans made hereunder by the Increasing Lenders and Augmenting Lenders, so that, after giving effect to such prepayments and any borrowings on such date of all or any portion of such Increased Commitments, the principal balance of all outstanding Revolving Loans owing to each Lender is equal to such Lender&#8217;s pro rata share (after giving effect to any nonratable Increased Commitment pursuant to this Section 2.19) of all then outstanding Revolving Loans. The Administrative Agent and the Lenders hereby agree that the Borrowing Request, minimum borrowing, pro rata borrowing and pro rata payment requirements contained elsewhere in this Agreement shall not apply to the transactions effected pursuant to the immediately preceding sentence. The deemed payments made pursuant to clause</font></div><div style="padding-left:37.95pt;padding-right:7.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) of the second preceding sentence shall be accompanied by payment of all accrued interest on the amount prepaid and, in respect of each </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan and each Alternative Currency Term Rate Loan, shall be subject to indemnification by the Borrower pursuant to the provisions of Section 2.15 if the deemed payment occurs other than on the last day of the related Interest Periods. For the avoidance of doubt, no Lender shall have any obligation to provide any Increased Commitment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">This Section 2.19 shall override any provisions in Section 9.02 to the</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">contrary.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.20 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If for the purposes of obtaining judgment in any court it is necessary to convert a sum due from the Borrower hereunder in the currency expressed to be payable herein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">specified currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) into another currency, the parties hereto agree, to the fullest extent that they may effectively do so, that the rate of exchange used shall be that at which in accordance with normal banking procedures the Administrative Agent could purchase the specified currency with such other currency at the Administrative Agent&#8217;s main New York City office on the Business Day preceding that on which final, non-appealable judgment is given. The obligations of the Borrower in respect of any sum due to any Lender, any Issuing Bank or the Administrative Agent hereunder shall, notwithstanding any judgment in a currency other than the specified currency, be discharged only to the extent that on the Business Day following receipt by such Lender, such Issuing Bank or the Administrative Agent (as the case may be) of any sum adjudged to be so due in such other currency such Lender, such Issuing Bank or the</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_217"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Administrative Agent (as the case may be) may in accordance with normal, reasonable banking procedures purchase the specified currency with such other currency. If the amount of the specified currency so purchased is less than the sum originally due to such Lender, such Issuing Bank or the Administrative Agent, as the case may be, in the specified currency, the Borrower agrees, to the fullest extent that it may effectively do so, as a separate obligation and notwithstanding any such judgment, to indemnify such Lender, such Issuing Bank or the Administrative Agent, as the case may be, against such loss, and if the amount of the specified currency so purchased exceeds (a) the sum originally due to any Lender or the Administrative Agent, as the case may be, in the specified currency and (b) any amounts shared with other Lenders as a result of allocations of such excess as a disproportionate payment to such Lender under Section 2.17, such Lender or the Administrative Agent, as the case may be, agrees to remit such excess to the Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.21&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.35pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Request for Extended Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower may at any time and from time to time after the Closing Date, upon written request to and the consent of the Administrative Agent (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), request that an aggregate principal amount of not less than $300,000,000 of the then existing Commitments of any Class (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Revolver Tranche</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) be amended to, among other things, extend the applicable Revolving Credit Maturity Date with respect thereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to a date that is no earlier than the then Latest Maturity Date of any other Commitment hereunder (any such Revolving Commitments so amended, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; provided that (i) after giving effect to any Extended Revolving Commitment under this Section 2.21, there shall be no more than three (3) Classes of Commitments outstanding at any time and</font></div><div style="padding-left:37.95pt;padding-right:8.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) any such Extended Revolving Commitments shall be offered on the same terms (including as to the proposed interest rates and fees) to each Revolving Lender under the applicable Existing Revolver Tranche on a ratable basis. Promptly after receipt of any Revolving Extension Request, the Administrative Agent shall provide a copy of such request to each of the Revolving Lenders under the applicable Existing Revolver Tranche to be amended, which request shall set forth the proposed terms (which shall be determined in consultation with the Administrative Agent) of the Extended Revolving Commitments to be established. Each Revolving Extension Request shall specify (A) the applicable Class of Commitments and Loans hereunder to be extended, (B) the date to which the applicable maturity date is sought to be extended, (C) the changes, if any, to the Applicable Rate to be applied in determining the interest payable on the Loans of, and fees payable hereunder to, Extending Revolving Lenders (as defined below) in respect of that portion of their Commitments and Loans extended to such new maturity date and the time as of which such changes will become effective (which may be prior to the Existing Maturity Date) and (D) any other amendments or modifications to this Agreement applicable to such Extended Revolving Commitments, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">no such changes or modifications pursuant to this clause (D) shall become effective prior to the then Latest Maturity Date. At the time of sending such notice, the Borrower (in consultation with the Administrative Agent) shall specify the time period within which each applicable Revolving Lender is requested to respond to such request (which shall in no event be less than fifteen (15) calendar days (or such shorter period as may be agreed by the Administrative Agent) from the date of delivery of such notice to such Revolving Lenders) and shall agree to such procedures, if any, as may be established by, or</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_220"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">reasonably acceptable to, the Administrative Agent to accomplish the purposes of this Section 2.21.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:5.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Election to Extend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Revolving Lender wishing to have all or a portion of its Revolving Commitments under the Existing Revolver Tranche amended into Extended Revolving Commitments (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) specified in the Revolving Extension Request shall notify the Administrative Agent on or prior to the response date specified in such Revolving Extension Request of the amount of its Revolving Commitments it has elected to be amended (subject to any minimum denomination requirements imposed by the Administrative Agent not to exceed $50,000,000). No Revolving Lender shall have any obligation to agree to provide any Extended Revolving Commitment pursuant to any Revolving Extension Request. Any Revolving Lender not responding on or prior to such response date shall be deemed to have declined such Revolving Extension Request. The Administrative Agent shall notify the Borrower and each Revolving Lender under the applicable Existing Revolver Tranche of responses to such Revolving Extension Request. In the event that the aggregate principal amount of existing Revolving Commitments that the Extending Revolving Lenders have elected to amend pursuant to the relevant Revolving Extension Request exceeds the amount of Extended Revolving Commitments requested by the Borrower, the principal amount of Extended Revolving Commitments requested by the Borrower shall be allocated to each Extending Revolving Lender in such manner and in such amounts as may be agreed by Administrative Agent and the Borrower, in their sole discretion.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Revolving Extension Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Extended Revolving Commitments shall be established pursuant to an amendment (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Extension Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to this Agreement among the Borrower, the Administrative Agent and each Extending Revolving Lender, if any, providing an Extended Revolving Commitment thereunder, which shall be consistent with the provisions set forth in Sections 2.21(a), (b) and (d) (but which shall not require the consent of any other Lender). The effectiveness of any Revolving Extension Amendment shall be subject to the satisfaction on the date thereof of each of the conditions set forth in Sections 4.02(a) and (b) (with all references in such Sections to a Borrowing being deemed to be references to such Revolving Extension Request) and receipt of a certificate to that effect and, any other condition as may be agreed among the Borrower, the Administrative Agent and the Extending Revolving Lenders. The Administrative Agent shall promptly notify each Revolving Lender as to the effectiveness of each Revolving Extension Amendment and the matters specified therein. Each of the parties hereto hereby agrees that this Agreement and the other Loan Documents may be amended pursuant to a Revolving Extension Amendment, without the consent of any other Lender, to the extent (but only to the extent) necessary to (i) reflect the existence and terms of the Extended Revolving Commitments incurred pursuant thereto, and (ii) effect such other amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower, to effect the provisions of this Section 2.21, in each case, in a manner consistent with the terms of this Section 2.21 and the Required Lenders hereby expressly authorize the Administrative Agent to enter into any such Revolving Extension Amendment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Terms of Extended Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as expressly provided herein, all Extended Revolving Commitments effected pursuant to any Revolving Extension Request and Revolving Extension Amendment shall be subject to the same terms</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_223"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:5.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(including borrowing terms, interest terms and payment terms), and shall be subject to the same conditions as the then existing Revolving Commitments (it being understood that customary arrangement or commitment fees payable to one or more Arrangers (or their Affiliates) or one or more Extending Revolving Lenders, as the case may be, may be different than those paid with respect to the existing Revolving Lenders under the then existing Revolving Commitments on or prior to the Closing Date or with respect to any other Extending Revolving Lenders in connection with any other Extended Revolving Commitments effected pursuant to this Section 2.21)&#59; provided, however, that at the election of the Borrower (in consultation with the Administrative Agent), the Borrower may offer to effect Extended Revolving Commitments with (i) interest and fees at different rates applicable solely with respect to such Extended Revolving Commitments (and related outstandings), which may take effect as of the date of the Revolving Extension Amendment, and (ii) such other covenants and terms, which in the case of this clause (ii), apply to any period after the Latest Maturity Date that is in effect on the effective date of the Revolving Extension Amendment related thereto (immediately prior to the establishment of such Extended Revolving Commitments). After giving effect to any Extended Revolving Commitment, all borrowings under the Revolving Commitments (including any such Extended Revolving Commitments) and repayments thereunder shall be made on a pro rata basis (except for (x) any payments of interest and fees at different rates on any Revolving Extension Series (and related Loans thereunder) and (y) repayments required upon the applicable Revolving Credit Maturity Date of other Revolving Commitments). If a Revolving Extension Amendment has become effective hereunder, not later than the fifth Business Day prior to the Existing Maturity Date the Borrower shall make prepayments of Revolving Loans and shall Cash Collateralize Letters of Credit, such that, after giving effect to such prepayments and such provision of cash collateral, the aggregate Revolving Credit Exposure as of such date will not exceed the aggregate Extended Revolving Commitments of the Extending Revolving Lenders extended pursuant to this Section 2.21 (and the Borrower shall not be permitted thereafter to request any Revolving Loan or any issuance, amendment, renewal or extension of a Letter of Credit if, after giving effect thereto, the aggregate Revolving Credit Exposure would exceed the aggregate amount of the Extended Revolving Commitments then in effect).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Revolving Extension Series</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Extended Revolving Commitments effected pursuant to a Revolving Extension Request shall be designated a series (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Extension Series</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of Extended Revolving Commitments for all purposes of this Agreement&#59; provided that any Extended Revolving Commitments effected from an Existing Revolver Tranche may, to the extent provided in the applicable Revolving Extension Amendment, be designated as an increase in any previously established Revolving Extension Series with respect to such Existing Revolver Tranche.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.22&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Defaulting Lender Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender, then, until such time as such Lender is no longer a Defaulting Lender, to the extent permitted by applicable law&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:36.55pt;padding-right:7.7pt;text-align:justify;text-indent:98.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.99pt;text-decoration:underline">Defaulting Lender Waterfall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any payment of principal, interest, fees or other amounts received by the Administrative Agent for the account of such Defaulting Lender (whether voluntary or mandatory, at maturity, pursuant to Article VII or otherwise) or received by the Administrative Agent from a Defaulting Lender pursuant to Section 9.08 shall be applied at such time or times as may be determined by the Administrative Agent as follows&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to the payment on a pro rata basis of any amounts owing by such Defaulting Lender to any Issuing Bank or Swingline Lender hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to Cash Collateralize the Issuing Banks&#8217; L&#47;C Exposure with respect to such Defaulting Lender in accordance with Section 2.05(g)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as the Borrower may request (so long as no Default or Event of Default exists), to the funding of any Loan in respect of which such Defaulting Lender </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:36.55pt;padding-right:7.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">has failed to fund its portion thereof as required by this Agreement, as determined by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, if so determined by the Administrative Agent and the Borrower, to be held in a deposit account and released pro rata in order to (x) satisfy such Defaulting Lender&#8217;s potential future funding obligations with respect to Loans under this Agreement and (y) Cash Collateralize the Issuing Banks&#8217; future L&#47;C Exposure with respect to such Defaulting Lender with respect to future Letters of Credit issued under this Agreement, in accordance with Section 2.05(g)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to the payment of any amounts owing to the Lenders, the Issuing Banks or Swingline Lenders as a result of any judgment of a court of competent jurisdiction obtained by any Lender, the Issuing Banks or Swingline Lenders against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">seventh</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, so long as no Default or Event of Default exists, to the payment of any amounts owing to the Borrower as a result of any judgment of a court of competent jurisdiction obtained by the Borrower against such Defaulting Lender as a result of such Defaulting Lender's breach of its obligations under this Agreement&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">eighth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that if (x) such payment is a payment of the principal amount of any Loans or L&#47;C Disbursements in respect of which such Defaulting Lender has not fully funded its appropriate share, and (y) such Loans were made or the related Letters of Credit were issued at a time when the conditions set forth in Section 4.01 or Section 4.02, as applicable, were satisfied or waived, such payment shall be applied solely to pay the Loans of, and L&#47;C Disbursements owed to, all non-Defaulting Lenders on a pro rata basis prior to being applied to the payment of any Loans of, or L&#47;C Disbursements owed to, such Defaulting Lender until such time as all Loans and funded and unfunded participations in L&#47;C Disbursements and Swingline Loans are held by the Lenders pro rata in accordance with the Commitments without giving effect to Section 2.22(a)(ii). Any payments, prepayments or other amounts paid or payable to a Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender or to post Cash Collateral pursuant to this Section 2.22(a)(i) shall be deemed paid to and redirected by such Defaulting Lender, and each Lender irrevocably consents hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:36.55pt;padding-right:6.7pt;text-indent:94.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.01pt;text-decoration:underline">Reallocation of Participations to Reduce Fronting Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All or any part of such Defaulting Lender&#8217;s participation in L&#47;C Disbursements and Swingline Loans shall be reallocated among the non-Defaulting Lenders in accordance with their respective Applicable Percentages (calculated without regard to such Defaulting Lender&#8217;s Commitment) but only to the extent that such reallocation does not cause the aggregate Revolving Credit Exposure of any non-Defaulting Lender to exceed such non-Defaulting Lender&#8217;s Revolving Commitment. Subject to Section 9.20, no reallocation hereunder shall constitute a waiver or release of any claim of any party hereunder against a Defaulting Lender arising from that Lender having become a Defaulting Lender, including any claim of a non-Defaulting Lender as a result of such non-Defaulting Lender&#8217;s increased exposure following such reallocation.</font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:36.55pt;padding-right:7.55pt;text-align:justify;text-indent:91.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.03pt;text-decoration:underline">Cash Collateral, Repayment of Swingline Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the reallocation described in Section 2.22(a)(ii) above cannot, or can only partially, be effected, the Borrower shall, without prejudice to any right or remedy available to it hereunder or under law,</font></div><div style="padding-left:36.55pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(x) first, prepay Swingline Loans in an amount equal to the Swingline Lenders&#8217; Swingline Exposure and (y) second, Cash Collateralize the Issuing Banks&#8217; L&#47;C Exposure in accordance with the procedures set forth in Section 2.05(g).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Defaulting Lender Cure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the Borrower, the Administrative Agent and each Swingline Lender and Issuing Bank agree in writing that a Lender is no longer a Defaulting Lender, the Administrative Agent will so notify the parties hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth therein (which may include arrangements with respect to any Cash Collateral), that Lender will, to the extent applicable, purchase at par that portion of outstanding Loans of the other Lenders or take such other actions as the Administrative Agent may determine to be necessary to cause the Loans and funded and unfunded participations in Letters of Credit and Swingline Loans to be held pro rata by the Lenders in accordance with the Commitments (without giving effect to Section 2.22(a)(ii)), </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">whereupon such Lender will cease to be a Defaulting Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that no adjustments will be made retroactively with respect to fees accrued or payments made by or on behalf of the Borrower while that Lender was a Defaulting Lender&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that except to the extent otherwise expressly agreed by the affected parties, no change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender&#8217;s having been a Defaulting Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">New Swingline Loans&#47;Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. So long as any Lender is a Defaulting Lender, the Swingline Lender shall not be required to fund any Swingline Loan and no Issuing Bank shall be required to issue, amend or increase any Letter of Credit, unless it is satisfied that, after giving effect to such Swingline Loan or Letter of Credit and the reallocation of all Defaulting Lenders&#8217; participation therein pursuant to Section 2.22(a)(ii), the aggregate Revolving Credit Exposure of all non-Defaulting Lenders does not exceed the aggregate Revolving Commitments of all non-Defaulting Lenders.</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.23&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sustainability Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">ESG Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. After the Closing Date, the Borrower, in consultation with the Sustainability Coordinator, shall be entitled to establish specified key performance indicators (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">KPIs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) with respect to certain environmental, social and governance (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ESG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) targets of the Borrower and its Subsidiaries. The Sustainability Coordinator and the Borrower may amend this Agreement (such amendment, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ESG Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) solely for the purpose of incorporating the KPIs and other related provisions (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ESG Pricing Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) into this Agreement, and any such amendment shall become effective at 5&#58;00 p.m., New York City time, on the tenth Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Borrower unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent (who shall promptly notify the Borrower) written notice that such Required Lenders object to such ESG Amendment. In the event that Required Lenders deliver a written notice objecting to any such ESG Amendment, an alternative ESG Amendment may be effectuated with the consent of the Required Lenders, the Borrower and the Sustainability Coordinator. Upon the effectiveness of any such ESG Amendment, based on the Borrower&#8217;s performance against the KPIs, certain adjustments (increase, decrease or no adjustment) to the otherwise applicable facility fee, Applicable Rate for Base Rate Loans, Swingline Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, Alternative Currency Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans and Letter of Credit Fees will be made&#59; provided that the amount of such adjustments shall not exceed (i) in the case of the facility fee, an increase and&#47;or decrease of 0.01% and (ii) in the case of the Applicable Rate for </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, Alternative Currency Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans and Letter of Credit Fees, an increase and&#47;or decrease of 0.04%, and the adjustments to the Applicable Rate for Base Rate Loans and Swingline Loans shall be the same amount, in basis points, as the adjustments to the Applicable Rate for </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans and Letter of Credit Fees, provided that in no event shall the Applicable Rate for Base Rate Loans and Swingline Loans be less than zero. The pricing adjustments pursuant to the KPIs will require, among other things, reporting and validation of the measurement of the KPIs in a manner that is aligned with the Sustainability Linked Loan Principles and is to be agreed between the Borrower and the Sustainability Coordinator (each acting reasonably). Following the effectiveness of the ESG Amendment&#58;</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">any modification to the ESG Pricing Provisions which has the effect of (x) reducing the facility fee, Applicable Rate for Base Rate Loans and Swingline Loans, or Applicable Rate for </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, Alternative Currency Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans and Letter of Credit Fees to a level not otherwise permitted by Section 2.23(a) or (y) increasing the facility fee, Applicable Rate for Base Rate </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:6.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans and Swingline Loans, or Applicable Rate for </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, Alternative Currency Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans and Letter of Credit Fees that is not accompanied by a corresponding reduction of the facility fee, Applicable Rate for Base Rate Loans and Swingline Loans, or Applicable Rate for </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans, Alternative Currency Loans, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Floating Rate Loans and Letter of Credit Fees by a percentage equivalent to such increase, shall (in each case) be subject to the consent of all Lenders&#59; and</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.4pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">any other modification to the ESG Pricing Provisions (other than as provided for in Section 2.23(a)(i) above) shall be subject only to the consent of the Required Lenders.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Sustainability Coordinator</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Sustainability Coordinator will (i) assist the Borrower in determining the ESG Pricing Provisions in connection with the ESG Amendment and (ii) assist the Borrower in preparing informational materials focused on ESG to be used in connection with the ESG Amendment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Conflicting Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Section shall supersede any provisions in Section 9.02 to the contrary.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 2.24 Illegality. If any Lender determines that any Law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its applicable Lending Office to make, maintain or fund or charge interest with respect to any</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_226"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:6.6pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Event, or to determine or charge interest rates based upon a Relevant Rate, or to determine or charge interest rates based upon a Relevant Rate purchase or sell, or to take deposits of, Dollars or any Alternative Currency in the applicable interbank market, then, upon notice thereof by such Lender to the Borrower (through the Administrative Agent), (i) any obligation of such Lender to make or maintain Alternative Currency Loans in the affected currency or currencies or, in the case of Loans denominated in Dollars, any obligation of such Lender to make or continue Term SOFR Loans, SOFR Daily Floating Rate Loans, Alternative Currency Loans or to convert Base Rate Loans to Term SOFR Loans or SOFR Daily Floating Rate Loans shall be suspended, and (ii) if such notice asserts the illegality of such Lender making or maintaining Base Rate Loans the interest rate on which is determined by reference to the Term SOFR component of the Base Rate, the interest rate on which Base Rate Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the Term SOFR component of the Base Rate, in each case until such Lender notifies the Administrative Agent and the Borrower that the circumstances giving rise to such determination no longer exist. Upon receipt of such notice, (A) the Borrower shall, promptly, following written demand from such Lender (with a copy to the Administrative Agent), prepay all Term SOFR Loans, SOFR Daily Floating Rate Loans or Alternative Currency Loans, as applicable in the affected currency or currencies or, if applicable, convert all Term SOFR Loans, SOFR Daily Floating Rate Loans or Alternative Currency Loans of such Lender to Base Rate Loans (the interest rate on which Base Rate Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the Term SOFR component of the Base Rate), in each case, immediately, or, in the case of Alternative Currency Term Rate Loans, on the last day of the Interest Period therefor, if such Lender may lawfully continue to maintain such Alternative Currency Term Rate Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such Alternative Currency Term Rate Loans and (B) if such notice asserts the illegality of such Lender determining or charging interest rates based upon SOFR, the Administrative Agent shall during the period of such suspension compute the Base Rate applicable to such Lender without reference to the Term SOFR component thereof until the Administrative Agent is advised in writing by such Lender that it is no longer illegal for such Lender to determine or charge interest rates based upon SOFR. Upon any such prepayment or conversion, the Borrower shall also pay accrued interest on the amount so prepaid or converted, together with any additional amounts required by Section 2.15. Each Lender agrees to use reasonable efforts to designate a different Lending Office if such designation will avoid the need for such notice and will not, in good faith judgment of such Lender, otherwise be materially disadvantageous to such Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:17.5pt;padding-right:17.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE III</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:17.5pt;padding-right:17.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Representations and Warranties</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower represents and warrants to the Administrative Agent, the Lenders and the Issuing Banks as of the Closing Date and (except as to representations and warranties made as of a date certain) as of the date such representations and warranties are deemed to be made under Section 4.02 of this Agreement, that&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Organization&#59; Powers&#59; Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower and its Material Subsidiaries are duly organized, validly existing and in good standing (to the extent such concept is applicable in the relevant jurisdiction) under the laws of the jurisdiction of its organization, have all requisite power and authority to carry on their respective business as now conducted and, except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect, are qualified to do business in, and are in good standing (to the extent such concept is applicable) in, every jurisdiction where such qualification is required.&#160;&#160;&#160;&#160;All of the outstanding shares of capital stock and other equity interests on the Closing Date, to the extent owned by the Borrower or any Subsidiary, of each Material Subsidiary are validly issued and outstanding and fully paid and nonassessable (if </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">applicable) and all such shares and other equity interests are owned, beneficially and of record, by the Borrower or such other Subsidiary on the Closing Date free and clear of all Liens, other than Liens permitted under Section 6.02&#59; provided that any untruth, misstatement or inaccuracy of the foregoing representation in this sentence shall only be deemed a breach of such representation to the extent such untruth, misstatement or inaccuracy is material to the interests of the Lenders. As of the Closing Date, there are no outstanding commitments or other obligations of the Borrower or any Subsidiary to issue, and no options, warrants or other rights of any Person other than the Borrower or any Subsidiary to acquire, any shares of any class of capital stock or other equity interests of any Material Subsidiary, except as disclosed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Authorization&#59; Enforceability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Transactions are within each Loan Party&#8217;s corporate, limited liability company or partnership powers and have been duly authorized by all necessary corporate or other organizational and, if required, stockholder action. The Loan Documents have been duly executed and delivered by each Loan Party party thereto and constitute a legal, valid and binding obligation of each Loan Party party thereto, enforceable against such Loan Party in accordance with their terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other Debtor Relief Laws and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Approvals&#59; No Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Transactions (a) do not require any consent or approval of, registration or filing with, or any other action by, any Governmental Authority, except for (A) the approvals, consents, registrations, actions and filings which have been duly obtained, taken, given or made and are in full force and effect and (B) those approvals, consents, registrations or other actions or filings, the failure of which to obtain or make would not reasonably be expected to have a Material Adverse Effect, (b) will not violate</font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">any applicable law or regulation or order of any Governmental Authority or (ii) the charter, by-laws or other organizational documents of any Loan Party, (c) will not violate or result in a default under any indenture, agreement or other instrument binding upon any Loan Party or its assets, or give rise to a right thereunder to require any payment to be made by any Loan Party, and (d) will not result in the creation or imposition of any Lien on any material asset of any Loan Party (other than pursuant to the Loan Documents and Liens permitted by Section 6.02)&#59; except with respect to any violation or default referred to in clause (b)(i) or (c) above, to the extent that such violation or default would not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements&#59; Financial Condition&#59; No Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:6.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Borrower has heretofore furnished to the Lenders the Borrower&#8217;s consolidated balance sheet and statements of earnings, stockholders equity and cash flows, (x)</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_229"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">for each of the three fiscal years ended December 31, 2020, December 31, 2019 and December 31, 2018 reported on by Deloitte &#38; Touche LLP, independent public accountants, and (y) as of, and for the fiscal quarter ended, March 31, 2020, certified by its chief financial officer which financial statements present fairly, in all material respects, the consolidated financial position and results of operations and cash flows of the Borrower as of such dates and for such periods in accordance with GAAP.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.04(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, since December 31, 2020, there has been no material adverse change in the business, assets, properties or financial condition of the Borrower and its Subsidiaries, taken as a whole.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Properties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Each Loan Party has good and marketable title to, or valid leasehold interests in, all its material real and personal property material to its business, except for minor defects in title that do not interfere with its ability to conduct its business as currently conducted or to utilize such properties for their intended purposes and except where the failure to have such title or interest would not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Borrower and its Subsidiaries own, or are licensed or possess the right to use, all trademarks, tradenames, copyrights, patents and other intellectual property material to the operation of the business of the Borrower and its Subsidiaries, taken as a whole, and, to the knowledge of the Borrower, the use thereof by the Borrower and its Subsidiaries does not infringe upon the rights of any other Person, except for any such infringements that, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation and Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">There are no actions, suits or proceedings by or before any arbitrator or Governmental Authority pending against or, to the knowledge of the Borrower, threatened against or affecting the Borrower or any of its Subsidiaries as to which there is a reasonable possibility of an adverse determination that would reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect (other than the Disclosed Matters). There are no labor controversies pending against or, to the knowledge of the Borrower, threatened against or affecting the Borrower or any of its Subsidiaries which would reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Except for the Disclosed Matters and except with respect to any other matters that, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect, neither the Borrower nor any of its Subsidiaries (i) has failed to comply with any applicable Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (ii) has become subject to any pending or known Environmental Liability, (iii) has received notice of any claim with respect to any Environmental Liability or (iv) knows of any basis for any Environmental Liability.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Laws and Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, each of the Borrower and its Subsidiaries is in compliance with all laws, regulations and orders of any Governmental Authority applicable to it or its property and all</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_232"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">agreements and other instruments (excluding agreements governing Indebtedness) binding upon it or its property, except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.08 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Company Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the Borrower nor any other Loan Party is required to register as an &#8220;investment company&#8221; as defined in the Investment Company Act of 1940.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.09 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each of the Borrower and its Subsidiaries has filed or caused to be filed all Tax returns and reports required to have been filed and has paid or caused to be paid all Taxes (including any Taxes in the capacity of a withholding agent) required to have been paid by it, except (a) Taxes that are being contested in good faith by appropriate proceedings and for which the Borrower or such Subsidiary, as applicable, has set aside on its books reserves to the extent required by GAAP or (b) to the extent that the failure to do so would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Solvency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. On the Closing Date after giving effect to the Transactions, the Borrower and its Subsidiaries, on a consolidated basis, are Solvent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. None of the reports, financial statements, certificates or other written information (excluding any financial projections or pro forma financial information and information of a general economic or general industry nature) furnished by or on behalf of the Borrower to the Administrative Agent or any Lender in connection with the negotiation of this Agreement or delivered hereunder (as modified or supplemented by other information so furnished), when taken as a whole and when taken together with the Borrower&#8217;s SEC filings at such time, contains as of the date such statement, information, document or certificate was so furnished any material misstatement of fact or omits to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. The projections and pro forma financial information contained in the materials referenced above have been prepared in good faith based upon assumptions believed by management of the Borrower to be reasonable at the time made, it being recognized by the Lenders that such financial information is not to be viewed as fact and that actual results during the period or periods covered by such financial information may differ from the projected results set forth therein by a material amount.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.13 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Reserve Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No part of the proceeds of any Loan have been used or will be used, whether directly or indirectly, for any purpose that entails a violation of any of the Regulations of the Board, including Regulations T, U and X.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.14 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each of the Loan Parties and each of their respective Subsidiaries are in compliance, in all material respects, with the Act. No part of the proceeds of the Loans will be used, directly or, to the knowledge of the Borrower, indirectly, for any payments to any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain,</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_235"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">retain or direct business or obtain any improper advantage, in violation of the United States Foreign Corrupt Practices Act of 1977, as amended.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Neither the Borrower, nor any Subsidiary is (i) a Person whose name appears on the list of Specially Designated Nationals and Blocked Persons published by OFAC (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC Listed Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or a Person sanctioned by the United States of America pursuant to any of the regulations administered or enforced by OFAC (31 C.F.R., Subtitle B, Chapter V, as amended) or a Person whose name appears on any economic sanctions list administered by the European Union or Her Majesty&#8217;s Treasury (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EU&#47;UK Listed Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or a Person that is the target of European Union or United Kingdom economic sanctions&#59; or (ii) a department, agency or instrumentality of, or is otherwise controlled by or acting on behalf of, directly or indirectly,</font></div><div style="padding-left:38pt;padding-right:5.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(x) any OFAC Listed Person or any EU&#47;UK Listed Person, or (y) the government of a country the subject of comprehensive U.S. economic sanctions administered by OFAC (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Borrower represents and covenants that no Loan, nor the proceeds from any Loan, has been or will be used, directly or, to the knowledge of the Borrower, indirectly, to lend, contribute, provide or has otherwise been made or will otherwise be made available for the purpose of funding any activity or business in any OFAC Countries or for the purpose of funding any prohibited activity or business of any Person located, organized or residing in any OFAC Country or who is an OFAC Listed Person or an EU&#47;UK Listed Person, absent valid and effective license and permits issued by the government of the United States or otherwise in accordance with applicable Laws, or in any other manner that will result in any material violation by any Lender, any Arranger or the Administrative Agent of the sanctions administered or enforced by OFAC (31 C.F.R., Subtitle B, Chapter V, as amended).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.55pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The information included in the Beneficial Ownership Certification, if applicable, is true and correct in all respects, as of the Closing Date and each other date on which such Beneficial Ownership Certification is delivered.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Representations as to Foreign Obligors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;Each Foreign Obligor represents and warrants to the Administrative Agent, the Lenders and the Issuing Banks that&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Such Foreign Obligor is subject to civil and commercial Laws with respect to its obligations under this Agreement and the other Loan Documents to which it is a party (collectively as to such Foreign Obligor, the &#8220;Applicable Foreign Obligor Documents&#8221;), and the execution, delivery and performance by such Foreign Obligor of the Applicable Foreign Obligor Documents constitute and will constitute private and commercial acts and not public or governmental acts. Neither such Foreign Obligor nor any of its property (other than, in case of a Foreign Obligor organized under the laws of the Netherlands, assets located in the Netherlands that are destined for public service and books and records) has any immunity from jurisdiction of any court or from any legal process (whether through service or notice, attachment prior to judgment, attachment in aid of execution, execution or otherwise) under the laws of the</font></div><div style="text-align:justify"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">jurisdiction in which such Foreign Obligor is organized and existing in respect of its obligations under the Applicable Foreign Obligor Documents.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Applicable Foreign Obligor Documents are in proper legal form under the Laws of the jurisdiction in which such Foreign Obligor is organized and existing for the enforcement thereof against such Foreign Obligor under the Laws of such jurisdiction, and to ensure the legality, validity, enforceability, priority or admissibility in evidence of the Applicable Foreign Obligor Documents. It is not necessary to ensure the legality, validity, enforceability, priority or admissibility in evidence of the Applicable Foreign Obligor Documents that the Applicable Foreign Obligor Documents be filed, registered or recorded with, or executed or notarized before, any court or other authority in the jurisdiction in which such Foreign Obligor is organized and existing or that any registration charge or stamp or similar tax be paid on or in respect of the Applicable Foreign Obligor Documents or any other document, except for (i) any such filing, registration, recording, execution or notarization as has been made or is not required to be made until the Applicable Foreign Obligor Document or any other document is sought to be enforced and (ii) any charge or tax as has been timely paid.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The execution, delivery and performance of the Applicable Foreign Obligor Documents executed by such Foreign Obligor are, under applicable foreign exchange control regulations of the jurisdiction in which such Foreign Obligor is organized and existing, not subject to any notification or authorization except (i) such as have been made or obtained or</font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">such as cannot be made or obtained until a later date (provided that any notification or authorization described in clause (ii) shall be made or obtained as soon as is reasonably practicable).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:70.35pt;padding-right:70.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE IV</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:70.35pt;padding-right:70.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conditions Precedent</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Credit Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The obligations of the Lenders to make Loans and of the Issuing Banks to issue Letters of Credit on the Closing Date are subject to each of the following conditions being satisfied on or prior to the Closing Date&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Administrative Agent (or its counsel) shall have received from</font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) each party hereto either (A) a counterpart of this Agreement duly executed and delivered by or on behalf of such party or (B) written evidence reasonably satisfactory to the Administrative Agent (which may include telecopy or electronic mail transmission in accordance with Section 9.01) that such party has signed a counterpart of this Agreement&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Administrative Agent shall have received the executed legal opinions of (i) Cravath, Swaine &#38; Moore LLP, special New York counsel to the Borrower and the Loan Parties, (ii) Morgan, Lewis &#38; Bockius LLP, special Pennsylvania counsel to the Borrower and the Loan Parties, and (iii) NautaDutilh N.V., special Dutch counsel to the Borrower and the Loan Parties, in each case in a form reasonably satisfactory to the Administrative Agent. The Borrower hereby requests such counsel to deliver such opinions&#59;</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_238"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Administrative Agent shall have received such customary closing documents and certificates as the Administrative Agent or its counsel may reasonably request relating to the organization, existence and good standing (to the extent such concept is applicable in the relevant jurisdiction) of the Borrower and the Loan Parties, the authorization of the Transactions and any other legal matters relating to the Borrower and the Loan Parties, the Loan Documents or the Transactions, all in form and substance reasonably satisfactory to the Administrative Agent and its counsel&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Administrative Agent shall have received evidence reasonably satisfactory to it that prior to or substantially concurrently with the making of the initial Credit Events hereunder, all Indebtedness under the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement and all other amounts payable thereunder have been paid in full and all commitments to extend credit thereunder shall have terminated&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Administrative Agent shall have received a certificate attesting to the Solvency of the Borrower and its Subsidiaries (taken as a whole) on the Closing Date after giving effect to the Transactions in or substantially in the form attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit H </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">hereto, from a Financial Officer of the Borrower&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">(i) Upon the reasonable request of the Administrative Agent or any Lender made at least ten days prior to the Closing Date, the Borrower shall have provided to the Administrative Agent or such Lender the documentation and other information so requested in connection with applicable &#8220;know your customer&#8221; and anti-money-laundering rules and regulations, including the Act, in each case at least five days prior to the Closing Date and (ii) at least five days prior to the Closing Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, the Borrower shall deliver to the Administrative Agent and the Lenders a Beneficial Ownership Certification in relation to the Borrower&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">All costs, fees, expenses (including legal fees and expenses) to the extent invoiced at least two Business Days prior to the Closing Date and the fees contemplated by the Fee Letters payable to the Arrangers, the Administrative Agent or the Lenders shall have been paid on or prior to the Closing Date, in each case, to the extent required by the Fee Letters or the Loan Documents to be paid on or prior to the Closing Date&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Administrative Agent shall have received Notes executed by the Borrower in favor of each Lender requesting Notes at least three Business Days prior to the Closing Date&#59;</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">The Administrative Agent shall have received a certificate signed by a Responsible Officer of the Borrower certifying (A) that the conditions specified in Section 4.02(a) and Section 4.02(b) have been satisfied and (B) that, except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.04(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, there has been no event or circumstance since the date of the audited financial statements that has had or could be reasonably expected to have, either individually or in the aggregate, a Material Adverse Effect&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">The Administrative Agent shall have received a Borrowing Request, duly completed and executed by the Borrower.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_241"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:110pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limiting the generality of the provisions of the sub-clause (e)(v) of clause</font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">of Article VIII, for purposes of determining compliance with the conditions specified in this Section 4.01, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Closing Date specifying its objection thereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsequent Credit Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The obligation of each Lender to make a Loan on the occasion of any Borrowing (but not a conversion or continuation of Loans), and of the Issuing Banks to issue, amend, renew or extend any Letter of Credit, in each case, following the Closing Date is subject to the satisfaction of the following conditions&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The representations and warranties of the Borrower set forth in this Agreement and the other Loan Documents shall be true and correct in all material respects (except to the extent that any representation and warranty that is qualified by materiality shall be true and correct in all respects) on and as of the date of such Borrowing or the date of issuance, amendment, renewal or extension of such Letter of Credit, as applicable, except (i) where any representation and warranty is expressly made as of a specific earlier date, such representation and warranty shall be true in all material respects as of any such earlier date and (ii) the representations and warranties set forth in Section 3.04(b) and Section 3.06 shall only be required to be made on the Closing Date and shall not be required to be made for any Credit Event following the Closing Date (but shall be required to be made on the date any Increased Commitments are established)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">At the time of and immediately after giving effect to such Borrowing or the issuance, amendment, renewal or extension of such Letter of Credit, as applicable, no Default shall have occurred and be continuing&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Administrative Agent shall have received a Borrowing Request, duly completed and executed by the Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:8.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent required above, each Borrowing and each issuance, amendment, renewal or extension of a Letter of Credit shall be deemed to constitute a representation and warranty by the Borrower on the date thereof as to the matters specified in paragraphs (a) and (b) of this Section 4.02.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:70.4pt;padding-right:70.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE V</font></div><div><font><br></font></div><div style="padding-left:70.37pt;padding-right:70.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Affirmative Covenants</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:37.95pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Until the Commitments have expired or been terminated and the principal of and interest on each Loan and all fees payable hereunder shall have been paid in full and all Letters of Credit shall have expired or terminated or been Cash Collateralized on terms satisfactory to the Issuing Banks and all L&#47;C Disbursements shall have been reimbursed, the Borrower covenants and agrees with the Administrative Agent, the Lenders and the Issuing Banks that&#58;</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_244"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:6.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements and Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;The Borrower will furnish to the Administrative Agent (who shall promptly furnish a copy to each Lender)&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">as soon as available, but in any event within ninety (90) days after the end of each fiscal year of the Borrower, the audited consolidated balance sheet of the Borrower and its Consolidated Subsidiaries and related statements of operations, stockholders&#8217; equity and cash flows as of the end of and for such year, setting forth in each case in comparative form the figures for the previous fiscal year, all reported on by an independent public accountant of recognized national standing (without a &#8220;going concern&#8221; or like qualification or exception and without any qualification or exception as to the scope of such audit) to the effect that such consolidated financial statements present fairly in all material respects the financial position and results of operations of the Borrower and its Consolidated Subsidiaries on a consolidated basis in accordance with GAAP&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">as soon as available, but in any event within forty-five (45) days after the end of each of the first three fiscal quarters of each fiscal year of the Borrower, the unaudited consolidated balance sheet of the Borrower and its Consolidated Subsidiaries and related statements of operations and cash flows as of the end of and for such fiscal quarter and the then elapsed portion of the fiscal year, setting forth in each case in comparative form the figures for the corresponding period or periods of (or, in the case of the balance sheet, as of the end of) the previous fiscal year, all certified by one of its Financial Officers as presenting fairly in all material respects the financial position and results of operations of the Borrower and its Consolidated Subsidiaries on a consolidated basis in accordance with GAAP, subject to normal year-end audit adjustments and the absence of footnotes&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">concurrently with any delivery of financial statements under clause (a) or</font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">above, a certificate substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit E </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">executed by a Financial Officer (x) certifying as to whether, to the knowledge of such Financial Officer after reasonable inquiry, a Default has occurred and is continuing and, if so, specifying the details thereof and any action taken or proposed to be taken with respect thereto&#59; and (y) setting forth reasonably detailed calculations demonstrating compliance with Section 6.07&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">&#91;reserved&#93;&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">promptly after the same become publicly available, copies of all annual, quarterly and current reports and proxy statements filed by the Borrower or any Subsidiary with the SEC, or any Governmental Authority succeeding to any or all of the functions of the SEC&#59; and</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:6.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">promptly following any request therefor, such other information regarding the operations, business affairs and financial condition of the Borrower or any Subsidiary, or compliance with the terms of this Agreement, as the Administrative Agent or any Lender (through the Administrative Agent) may reasonably request.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Financial statements and other information required to be delivered pursuant to Sections 5.01(a), 5.01(b) and 5.01(e) shall be deemed to have been delivered if such statements and information shall have been posted by the Borrower on its website or shall have been posted on IntraLinks or</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_247"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">similar site to which all of the Lenders have been granted access or are publicly available on the SEC&#8217;s website pursuant to the EDGAR system.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower acknowledges that (a) the Administrative Agent and&#47;or the Arrangers may, but shall not be obligated to, make available to the Lenders and the Issuing Banks materials and&#47;or information provided by or on behalf of the Borrower hereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) by posting such information on DebtDomain, IntraLinks, Syndtrak, ClearPar, or similar electronic transmission system (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (b) certain of the Lenders may be &#8220;public side&#8221; Lenders (i.e., Lenders that do not wish to receive material non-public information with respect to the Borrower, its Subsidiaries or their securities) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Borrower agrees to identify that portion of the information to be provided to Public Lenders hereunder as &#8220;PUBLIC&#8221; and that such information will not contain material non-public information relating to the Borrower or its Subsidiaries (or any of their securities).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices of Material Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will furnish to the Administrative Agent (for prompt notification to each Lender) prompt (but in any event within five (5) Business Days) written notice after any Financial Officer obtains knowledge of the following&#58;</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">the occurrence of any continuing Default&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">the filing or commencement of any action, suit or proceeding by or before any arbitrator or Governmental Authority against or affecting the Borrower or any Subsidiary thereof that would reasonably be expected to result in a Material Adverse Effect&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">the occurrence of any ERISA Event that, alone or together with any other ERISA Events that have occurred, would reasonably be expected to result in a Material Adverse Effect&#59; and</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:4.9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">any change in the information provided in the Beneficial Ownership Certification that would result in a change to the list of beneficial owners identified in parts (c) or</font></div><div style="padding-left:54.95pt;text-align:justify;text-indent:-16.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:2.97pt">of such certification.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each notice delivered under this Section shall be accompanied by a statement of a Financial Officer or other executive officer of the Borrower setting forth the details of the event or development requiring such notice and any action taken or proposed to be taken with respect thereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existence&#59; Conduct of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will, and will cause each of its Material Subsidiaries to, do or cause to be done all things necessary to preserve, renew and keep in full force and effect (i) its legal existence, and (ii) the rights, licenses, permits, privileges and franchises material to the conduct of its business, except, in the case of the preceding clause (ii), to the extent that the failure to do so would not reasonably be expected to have a Material Adverse Effect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the foregoing shall not prohibit any transaction that is not otherwise prohibited under Section 6.03.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will, and will cause each of its Subsidiaries to, pay its obligations (other than Indebtedness), including Tax liabilities, before the same shall become delinquent or in default, except where (a) (i) the validity or amount thereof is being contested in good faith by appropriate proceedings and (ii) the Borrower or such Subsidiary has set aside on its books reserves with respect thereto to the extent required by GAAP or (b) the failure to make payment would not reasonably be expected to, individually or in the aggregate, result in a Material Adverse Effect.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Maintenance of Properties&#59; Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will, and will cause each of its Material Subsidiaries to, (a) keep and maintain all Property material to the conduct of </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:6.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">its business in good working order and condition, ordinary wear and tear excepted and casualty or condemnation excepted, except if the failure to do so would not reasonably be expected to have a Material Adverse Effect, and (b) maintain, with financially sound and reputable insurance companies or through self-insurance, insurance in such amounts and against such risks as are customarily maintained by companies engaged in the same or similar businesses operating in the same or similar locations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Inspection Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will, and will cause each of its Subsidiaries to, permit any representatives designated by the Administrative Agent or, during the continuance of an Event of Default, any Lender, upon reasonable prior notice, to visit and inspect its properties, to examine and make extracts from its books and records, and to discuss its affairs, finances and condition with its senior officers and use commercially reasonable efforts to make its independent accountants available to discuss the affairs, finances and condition of the Borrower, all at such reasonable times and as often as reasonably requested and in all cases subject to applicable Law and the terms of applicable confidentiality agreements and to the extent the Borrower reasonably determines that such inspection, examination or discussion will not violate or result in the waiver of any attorney-client privilege&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) the Lenders will conduct such requests for visits and inspections through the Administrative Agent and (ii) unless an Event of Default has occurred and is continuing, such visits and inspections can occur no more frequently than once per year. The Administrative Agent and the Lenders shall give the Borrower the opportunity to participate in any discussions with the Borrower&#8217;s independent accountants.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will, and will cause each of its Subsidiaries to, comply with all laws, rules, regulations and orders of any Governmental Authority applicable to it or its property (including Environmental Laws), except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.08 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds and Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The proceeds of Loans and other Credit Events will be used for general lawful corporate purposes of the Borrower and its Subsidiaries. No part of the proceeds of any Loan will be used, whether directly or indirectly, for any purpose that entails a violation of any of the Regulations of the Board, including Regulations T, U and X.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.09 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. (i) In the event that any Subsidiary of the Borrower (other than an Excluded Finco or a Receivables Entity) incurs or guarantees (x) any Indebtedness of the Borrower, owed to a Person other than any Subsidiary, in excess of an aggregate principal amount of $500,000,000 for all such Indebtedness of such Subsidiary with respect to the Borrower (such Indebtedness of such Subsidiary with respect to the Borrower, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Triggering Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or (y) Mylan Notes in excess of an aggregate principal amount of $500,000,000, and (ii) if Finco ceases to be an Excluded Finco and would otherwise satisfy clause (i) above, then, in each case, the Borrower shall cause each such Subsidiary to Guarantee the Obligations in favor of the Administrative Agent for the benefit of the Administrative Agent and the Lenders and shall cause each such Subsidiary to deliver to the Administrative Agent (A) a joinder to this Agreement in or substantially in the form attached as Exhibit F (each such joinder, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantor Joinder Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) duly executed and delivered by such Subsidiary, (B) all documents and other information reasonably requested by the Lenders in order to allow the Lenders to comply with the Act and the Beneficial Ownership Regulation, (C) customary legal opinions substantially similar to those delivered pursuant to Section 4.01(b) (with such changes as may be appropriate to reflect local law concerns), (D) customary closing documents substantially similar to those delivered pursuant to Section 4.01(c) and (E) other documentation required under applicable Laws (it being understood that any such guarantee of Indebtedness by such Subsidiary shall be subject to the provisions of Section 6.01 of this Agreement). In the event that (1) the Administrative Agent receives evidence reasonably satisfactory to it that any Guarantor </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">has been or will concurrently be released from, or otherwise not be an issuer or guarantor in respect of, (i) Triggering Indebtedness of such Guarantor and (ii) Mylan Notes in excess of an aggregate principal amount of $500,000,000, or (2) Finco becomes an Excluded Finco, then, in each case, at the request of the Borrower, such Guarantor shall be released from the Guarantee Agreement (and, for the avoidance of doubt, such release shall not require the approval of the Lenders) so long as at the time of and after giving effect to such release and all such concurrent releases, all of such Guarantor&#8217;s then outstanding Indebtedness would then be permitted to be incurred at such time under Section 6.01 (treating, for this purpose, all Indebtedness of such Guarantor as being incurred at the time of such release).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:70.22pt;padding-right:70.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE VI</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:70.37pt;padding-right:70.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Negative Covenants</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Until the Commitments have expired or terminated and the principal of and interest on each Loan and all fees payable hereunder have been paid in full and all Letters of Credit have expired or terminated or been Cash Collateralized on terms satisfactory to the Issuing Banks and all L&#47;C Disbursements shall have been reimbursed, the Borrower covenants and agrees with the Administrative Agent, the Lenders and the Issuing Banks that&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will not permit any Subsidiary that is not a Loan Party to create, incur, assume or permit to exist any Indebtedness, except&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Indebtedness created under the Loan Documents&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Indebtedness existing on the Closing Date and set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or that could be incurred on the Closing Date pursuant to commitments set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule</font></div><div style="padding-left:38pt;padding-right:8.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">6.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or as contemplated in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and Permitted Refinancing Indebtedness in respect of Indebtedness permitted by this clause (b)&#59;</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_250"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:6.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">(i) Indebtedness of any Subsidiary that is not a Loan Party owing to (x) a Loan Party or (y) any other Subsidiary&#59; and (ii) Guarantees of Indebtedness of any Loan Party or any Subsidiary by any other Subsidiary, to the extent such Indebtedness is otherwise permitted under this Agreement&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">(i) Indebtedness incurred to finance the acquisition, construction, repair, replacement or improvement of any fixed or capital assets, including Capital Lease Obligations and any Indebtedness assumed in connection with the acquisition of any such assets or secured by a Lien on any such assets prior to the acquisition thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (A) such Indebtedness is incurred prior to or within two hundred seventy (270) days after such acquisition or the completion of such construction, repair, replacement or improvement and (B) the aggregate principal amount of Indebtedness permitted by this clause (d) shall not exceed the greater of</font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(x) $375,000,000 and (y) 1.05% of Consolidated Total Assets, determined as of the last day of the most recent fiscal quarter prior to the date such Indebtedness is incurred for which financial statements have been delivered pursuant to Section 5.01(a) or (b) and (ii) any Permitted Refinancing Indebtedness in respect of Indebtedness permitted by clause (i) of this clause (d)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Indebtedness in respect of letters of credit (including trade letters of credit), bank guarantees or similar instruments issued or incurred in the ordinary course of business, including in respect of card obligations or any overdraft and related liabilities arising from treasury, depository and cash management services or any automated clearing house transfers, workers compensation claims, health, disability or other employee benefits or property, casualty or liability insurance or self-insurance or other Indebtedness with respect to reimbursement-type obligations regarding workers compensation claims&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">Indebtedness incurred pursuant to Permitted Receivables Facilities&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the Attributable Receivables Indebtedness thereunder shall not exceed at any time outstanding (x) $750,000,000, in the case of all Domestic Subsidiaries and (y) $750,000,000, in the case of all other Subsidiaries&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Indebtedness under Swap Agreements entered into in the ordinary course of business and not for speculative purposes&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Indebtedness in respect of bid, performance, surety, stay, customs, appeal or replevin bonds or performance and completion guarantees and similar obligations issued or incurred in the ordinary course of business, including guarantees or obligations of any Subsidiary with respect to letters of credit, bank guarantees or similar instruments supporting such obligation, in each case, not in connection with Indebtedness for money borrowed&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Indebtedness in respect of judgments, decrees, attachments or awards that do not constitute an Event of Default under clause (k) of Article VII&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Indebtedness consisting of bona fide purchase price adjustments, earn-outs, indemnification obligations, obligations under deferred compensation or similar arrangements and similar items incurred in connection with acquisitions and asset sales not prohibited by Section 6.05 or 6.03&#59;</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_253"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Indebtedness in respect of letters of credit denominated in currencies other than Dollars in an aggregate amount outstanding not to exceed the greater of the foreign currency equivalent of (x) $325,000,000 and (y) 0.85% of Consolidated Total Assets, determined as of the last day of the most recent fiscal quarter prior to the date such Indebtedness is incurred for which financial statements have been delivered pursuant to Section 5.01(a) or (b)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Indebtedness in respect of card obligations, netting services, overdraft protections and similar arrangements in each case in connection with deposit accounts&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">Indebtedness consisting of (x) the financing of insurance premiums with the providers of such insurance or their affiliates or (y) take-or-pay obligations contained in supply arrangements, in each case, in the ordinary course of business&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Foreign Jurisdiction Deposits&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">(i) so long as the Borrower is in compliance with Section 6.07 on a Pro Forma Basis as of the last day of the most recently completed Test Period (for which financial statements have been delivered pursuant to Section 5.01(a) or (b)), other Indebtedness in an aggregate amount, when aggregated with the amount of Indebtedness of the Loan Parties secured by Liens pursuant to Section 6.02(r), not to exceed the greater of (x) $2,750,000,000 and (y) 15% of Consolidated Net Tangible Assets, determined as of the last day of the most recent fiscal quarter prior to the date such Indebtedness is incurred for which financial statements have been delivered pursuant to Section 5.01(a) or (b) and (ii) Permitted Refinancing Indebtedness in respect of Indebtedness permitted by clause (i) of this clause (o)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">(i) Indebtedness of a Person existing at the time such Person becomes a Subsidiary and not created in contemplation thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, after giving effect to the acquisition of such Person, on a Pro Forma Basis, the Borrower would be in compliance with Section 6.07 as of the last day of the most recent fiscal year or fiscal quarter for which financial statements have been delivered pursuant to Section 5.01(a) or 5.01(b) and (ii) any Permitted Refinancing Indebtedness in respect of Indebtedness permitted by this clause (p)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Indebtedness supported by a Letter of Credit, in a principal amount not to exceed the face amount of such Letter of Credit&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Indebtedness in respect of Investments permitted by Section 6.05(q)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">all premiums (if any), interest (including post-petition interest), fees, expenses, charges and additional or contingent interest on obligations described in clauses (a) through (r) above&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Indebtedness of the Excluded Finco.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will not, and will not permit any Subsidiary to, create, incur, assume or permit to exist any Lien on any Property now owned or hereafter acquired by it, except&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Permitted Encumbrances&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">any Lien on any Property of the Borrower or any Subsidiary existing on the Closing Date and set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and any modifications, replacements, renewals or extensions thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) such Lien shall not apply to any other Property of the Borrower or any other Subsidiary other than (A) improvements and after-acquired Property that is affixed or incorporated into the Property covered by such Lien or financed by Indebtedness permitted under Section 6.01, and (B) proceeds and products thereof, and (ii) such Lien shall </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">secure only those obligations which it secures on the Closing Date and any Permitted Refinancing Indebtedness in respect thereof&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">any Lien existing on any Property prior to the acquisition thereof by the Borrower or any Subsidiary or existing on any Property of any Person that becomes a Subsidiary after the Closing Date prior to the time such Person becomes a Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) such Lien is not created in contemplation of or in connection with such acquisition or such Person becoming a Subsidiary, as the case may be, (ii) such Lien shall not apply to any other Property of the Borrower or any other Subsidiary (other than the proceeds or products of the Property covered by such Lien and other than improvements and after-acquired property that is affixed or incorporated into the Property covered by such Lien) and (iii) such Lien shall secure only those obligations which it secures on the date of such acquisition or the date such Person becomes a Subsidiary, as the case may be, and Permitted Refinancing Indebtedness in respect thereof&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">(i) Liens on fixed or capital assets acquired, constructed, repaired, replaced or improved by the Borrower or any Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) such security interests secure Indebtedness incurred to fund the acquisition of such assets in an aggregate principal amount not to exceed the greater of $400,000,000 and 1.05% of Consolidated Total Assets (determined as of the last day of the most recent fiscal quarter prior to the date such Indebtedness is incurred for which financial statements have been delivered pursuant to Section 5.01(a) or (b) (or any Permitted Refinancing Indebtedness in respect of the foregoing)), (ii) such security interests and the Indebtedness secured thereby are incurred prior to or within two hundred seventy (270) days after such acquisition or the completion of such construction, repair or replacement or improvement, (iii) the Indebtedness secured thereby does not exceed the cost of acquiring, constructing or improving such fixed or capital assets and (iv) such security interests shall not apply to any other Property of the Borrower or any Subsidiary, except for accessions to such fixed or capital assets covered by such Lien, Property financed by such Indebtedness and the proceeds and products thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that individual financings of fixed or capital assets provided by one lender may be cross-collateralized to other financings of fixed or capital assets provided by such lender&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">rights of setoff and similar arrangements and Liens in favor of depository and securities intermediaries to secure obligations owed in respect of card obligations or any overdraft and related liabilities arising from treasury, depository and cash management services or any automated clearing house transfers of funds and fees and similar amounts related to bank accounts or securities accounts (including Liens securing letters of credit, bank guarantees or similar instruments supporting any of the foregoing)&#59;</font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:22.03pt">Liens on Receivables and Permitted Receivables Facility Assets securing Indebtedness arising under Permitted Receivables Facilities&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">that a Lien shall be permitted to be incurred pursuant to this clause (f) only if at the time such Lien is incurred the aggregate principal amount of the obligations secured at such time (including such Lien) by Liens outstanding </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:117%">pursuant to this clause (f) would not exceed (x) $750,000,000, in the case of all Domestic Subsidiaries and (y) $750,000,000, in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">the case of all other Subsidiaries&#59;</font></div><div style="margin-top:11.85pt;padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens (i) on &#8220;earnest money&#8221; or similar deposits or other cash advances in connection with acquisitions permitted by Section 6.05 or (ii) consisting of an agreement to dispose of any Property in a disposition permitted under this Agreement including customary rights and restrictions contained in such agreements&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens on cash, cash equivalents or other assets securing Indebtedness permitted by Section 6.01(g)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">leases, licenses, subleases or sublicenses granted to others in the ordinary course of business which do not (i) interfere in any material respect with the business of the Borrower or any Subsidiary or (ii) secure any Indebtedness&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods in the ordinary course of business&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens (i) of a collection bank arising under Section 4-210 of the Uniform Commercial Code on items in the course of collection and (ii) attaching to commodity trading accounts or other commodities brokerage accounts incurred in the ordinary course of business, including Liens encumbering reasonable customary initial deposits and margin deposits&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Liens arising out of conditional sale, title retention, consignment or similar arrangements for sale of goods entered into by a Loan Party or any Subsidiary in the ordinary course of business&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">Liens deemed to exist in connection with Investments in repurchase agreements permitted under Section 6.05&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">rights of setoff relating to purchase orders and other agreements entered into with customers of the Borrower or any Subsidiary in the ordinary course of business&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">ground leases in respect of real property on which facilities owned or leased by the Borrower or any of its Subsidiaries are located and other Liens affecting the interest of any landlord (and any underlying landlord) of any real property leased by the Borrower or any Subsidiary&#59;</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens on equipment owned by the Borrower or any Subsidiary and located on the premises of any supplier and used in the ordinary course of business and not securing Indebtedness&#59;</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_256"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">any restriction or encumbrance with respect to the pledge or transfer of the Equity Interests of a joint venture&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">Liens not otherwise permitted by this Section 6.02, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that a Lien shall be permitted to be incurred pursuant to this clause (r) only if at the time such Lien is incurred the aggregate principal amount of Indebtedness secured at such time (including such Lien) by Liens outstanding pursuant to this clause (r) (when taken together, without duplication, with the amount of obligations outstanding pursuant to Section 6.01(o)) would not exceed the greater of (x) $2,750,000,000 and (y) 15% of Consolidated Net Tangible Assets, determined as of the last day of the most recent fiscal quarter prior to the date such Indebtedness is incurred for which financial statements have been delivered pursuant to Section 5.01(a) or (b) (or any Permitted Refinancing Indebtedness in respect of the foregoing)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">Liens on any Property of the Borrower or any Subsidiary in favor of the Borrower or any other Subsidiary&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Liens on specific items of inventory or other goods and proceeds of any Person securing such Person&#8217;s obligations in respect of bankers&#8217; acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods&#59;</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens arising from Uniform Commercial Code financing statement filings regarding operating leases or consignments entered into by the Borrower and its Subsidiaries in the ordinary course of business&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens, pledges or deposits made in the ordinary course of business to secure liability to insurance carriers&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">Liens securing insurance premiums financing arrangements&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that such Liens are limited to the applicable unpaid insurance premiums under the insurance policy related to such insurance premium financing arrangement&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens on Cash Equivalents deposited as Cash Collateral on Letters of Credit as contemplated by this Agreement&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens on any Property of any Subsidiary that is not a Loan Party securing Indebtedness of such Subsidiary that is otherwise permitted under Section 6.01&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Liens on equity interests of any Person formed for the purposes of engaging in activities in the renewable energy sector (including refined coal) that qualify for federal tax benefits allocable to the Borrower and its Subsidiaries in which the Borrower or any Subsidiary has made an investment and Liens on the rights of the Borrower and its Subsidiaries under any agreement relating to any such investment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fundamental Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will not merge into or consolidate with or transfer all or substantially all of its assets to any other Person, or permit any other Person to merge into or consolidate with it, or liquidate or dissolve, except that, if at the time thereof and immediately after giving effect thereto no Event of Default shall have occurred</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_259"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and be continuing, the Borrower may be consolidated with or merged into any Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that any Investment in connection therewith is otherwise permitted by Section 6.05&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, simultaneously with such transaction, (x) the Person formed by such consolidation or into which the Borrower is merged shall expressly assume all obligations of the Borrower under the Loan Documents, (y) the Person formed by such consolidation or into which the Borrower is merged shall be a corporation organized under the laws of a State in the United States, and shall take all actions as may be required to preserve the enforceability of the Loan Documents and (z) the Borrower shall have delivered to the Administrative Agent an officer&#8217;s certificate and an opinion of counsel, each stating that such merger or consolidation and such supplement to this Agreement comply with this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will not, and will not permit any of its Subsidiaries to, declare or make, or agree to pay or make, directly or indirectly, any Restricted Payment, except (a) the Borrower or any Subsidiary may declare and pay dividends or other distributions with respect to its Equity Interests payable solely in additional shares of its Qualified Equity Interests or options to purchase Qualified Equity Interests&#59; (b) Subsidiaries may declare and make Restricted Payments ratably with respect to their Equity Interests&#59; (c) the Borrower or any Subsidiary may make Restricted Payments pursuant to and in accordance with stock option plans or other benefit plans for present or former officers, directors, consultants or employees of the Borrower and its Subsidiaries in an amount not to exceed $20,000,000 in any fiscal year (with any unused amount of such base amount available for use in the next succeeding fiscal year)&#59; (d) the Borrower or any Subsidiary may make Restricted Payments so long as no Event of Default has occurred and is continuing&#59; (e) repurchases of Equity Interests in any Loan Party or any Subsidiary deemed to occur upon exercise of stock options or warrants if such Equity Interests represent a portion of the exercise price of such options or warrants&#59; (f) the payment of cash in lieu of the issuance of fractional shares in connection with the exercise of warrants, options or other securities convertible into or exercisable for Qualified Equity Interests of the Borrower&#59; (g) payments made to exercise, settle or terminate any Permitted Warrant Transaction (A) by delivery of the Borrower&#8217;s common stock, (B) by set-off against the related Permitted Bond Hedge Transaction, or (C) with cash payments in an aggregate amount not to exceed the aggregate amount of any payments received by the Borrower or any of its Subsidiaries pursuant to the exercise, settlement or termination of any related Permitted Bond Hedge Transaction&#59; (h) payments made in connection with any Permitted Bond Hedge Transaction&#59; and (i) the Borrower or any Subsidiary may make Restricted Payments pursuant to the arrangements set forth in Schedule 6.04.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will not, and will not allow any of its Subsidiaries to make or hold any Investments, except&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Investments by the Borrower or a Subsidiary in cash and Cash</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Equivalents&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">loans or advances to officers, directors, consultants and employees of the</font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Borrower and the Subsidiaries (i) for reasonable and customary business-related travel, entertainment, relocation and analogous ordinary business purposes, (ii) in connection with such Person&#8217;s purchase of Equity Interests of the Borrower, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the amount of such loans and advances shall be contributed to the Borrower in cash as common equity, and (iii) for</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_262"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">purposes not described in the foregoing subclauses (i) and (ii), in an aggregate principal amount outstanding not to exceed $10,000,000&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Investments by the Borrower or any Subsidiary in the Borrower or any</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Subsidiary&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">(i) Investments consisting of extensions of credit in the nature of accounts</font></div><div style="padding-left:38pt;padding-right:8.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">receivable or notes receivable arising from the grant of trade credit in the ordinary course of business, and (ii) Investments (including debt obligations and Equity Interests) received in satisfaction or partial satisfaction thereof from financially troubled account debtors and other credits to suppliers in the ordinary course of business or received in connection with the bankruptcy or reorganization of suppliers and customers or in settlement of delinquent obligations of, or other disputes with, customers and suppliers arising in the ordinary course of business or upon the foreclosure with respect to any secured Investment or other transfer of title with respect to any secured Investment&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">(i) Investments existing or contemplated on the Closing Date and set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.05(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and any modification, replacement, renewal, reinvestment or extension thereof and (ii) Investments existing on the Closing Date by the Borrower or any Subsidiary in the Borrower or any other Subsidiary and any modification, renewal or extension thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the amount of the original Investment is not increased except by the terms of such Investment or as otherwise permitted by this Section 6.05&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Investments in Swap Agreements in the ordinary course of business&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Investments in the ordinary course of business in prepaid expenses, negotiable instruments held for collection and lease, utility and worker&#8217;s compensation, performance and other similar deposits provided to third parties&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Investments in the ordinary course of business consisting of endorsements for collection or deposit&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Investments in the ordinary course of business consisting of the licensing or contribution of intellectual property pursuant to development, marketing or manufacturing agreements or arrangements or similar agreements or arrangements with other Persons&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">any Investment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that no Event of Default has occurred and is continuing at the time such Investment is made&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:8.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">advances of payroll payments, fees or other compensation to officers, directors, consultants or employees, in the ordinary course of business&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Investments to the extent that payment for such Investments is made solely with Qualified Equity Interests of the Borrower&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">lease, utility and other similar deposits in the ordinary course of business&#59;</font></div><div style="padding-left:110pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#91;reserved&#93;&#59; </font></div><div style="padding-left:110pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">customary Investments in connection with Permitted Receivables Facilities&#59; </font></div><div style="padding-left:110pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">permitted Bond Hedge Transactions&#59; </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_265"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.804%"><div><font><br></font></div></div><div style="display:inline-block;max-width:0.391%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.805%"></div></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_268"></div><hr style="page-break-after:always"><div style="min-height:48.96pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:73.95pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(q)&#160;&#160;&#160;&#160;Investments in limited liability companies formed for the purposes of engaging in activities in the renewable energy sector (including refined coal) that qualify for Federal tax benefits allocable to the Borrower and its Subsidiaries, including capital contributions and purchase price payments in respect thereof, so long as the Borrower determines in good faith that the amount of such tax benefits is expected to exceed the amount of such Investments&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, in the event that all Investments made in reliance on this clause (q) exceeds $125,000,000 in any fiscal year of the Borrower, the Borrower shall promptly provide the Administrative Agent with a certificate signed by a Financial Officer setting forth a reasonably detailed calculation of the amount of such Investments made (or to be made) in such fiscal year and the expected tax benefits from such Investments&#59; and</font></div><div style="padding-right:5.4pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(r)&#160;&#160;&#160;&#160;Investments resulting from the receipt of promissory notes and other non-cash consideration in connection with any disposition not prohibited under this Agreement or Restricted Payments permitted by Section 6.04, so long as no Event of Default has occurred and is continuing at the time of such agreement relating to such disposition or Restricted Payment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transactions with Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will not, and will not permit any of its Subsidiaries to, sell, lease or otherwise transfer any Property to, or purchase, lease or otherwise acquire any Property from, or otherwise engage in any other transactions with, any of its Affiliates, except (a) at prices and on terms and conditions substantially as favorable to the Borrower or such Subsidiary (in the good faith determination of the Borrower) as would reasonably be obtained on an arm&#8217;s-length basis from unrelated third parties, (b) transactions between or among the Borrower and its Subsidiaries and any entity that becomes a Subsidiary as a result of such transaction not involving any other Affiliate, (c) the payment of customary compensation and benefits and reimbursements of out-of-pocket costs to, and the provision of indemnity on behalf of, directors, officers, consultants, employees and members of the Boards of Directors of the Borrower or such Subsidiary, (d) loans and advances to officers, directors, consultants and employees in the ordinary course of business, (e) Restricted Payments and other payments permitted under Section 6.04, (f) employment, incentive, benefit, consulting and severance arrangements entered into (i) in the ordinary course of business or (ii) set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, in each case, with officers, directors, consultants and employees of the Borrower or its Subsidiaries, (g) the transactions pursuant to the agreements set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or any amendment thereto to the extent such an amendment, taken as a whole, is not adverse to the Lenders in any material respect (as determined in good faith by the Borrower), (h) the payment of fees and expenses related to the Transactions, (i) the issuance of Qualified Equity Interests of the Borrower and the granting of registration or other customary rights in connection therewith,</font></div><div style="padding-left:38pt;padding-right:7.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">the existence of, and the performance by the Borrower or any Subsidiary of its obligations under the terms of, any limited liability company agreement, limited partnership or other organizational document or securityholders agreement (including any registration rights</font></div><div style="height:36.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_271"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">agreement or purchase agreement related thereto) to which it is a party on the Closing Date and which is set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, and similar agreements that it may enter into thereafter, provided that the existence of, or the performance by the Borrower or any Subsidiary of obligations under, any amendment to any such existing agreement or any such similar agreement entered into after the Closing Date shall only be permitted by this Section 6.06(j) to the extent not more adverse to the interest of the Lenders in any material respect when taken as a whole (in the good faith determination of the Borrower) than any of such documents and agreements as in effect on the Closing Date, (k) consulting services to joint ventures in the ordinary course of business and any other transactions between or among the Borrower, its Subsidiaries and joint ventures in the ordinary course of business, (l) transactions with landlords, customers, clients, suppliers, joint venture partners or purchasers or sellers of goods and services, in each case in the ordinary course of business and not otherwise prohibited by this Agreement, (m) transactions effected as a part of a Qualified Receivables Transaction, (n) the provision of services to directors or officers of the Borrower or any of its Subsidiaries of the nature provided by the Borrower or any of its Subsidiaries to customers in the ordinary course of business and (o) transactions approved by the Audit Committee of the Board of Directors of the Borrower in accordance with the Borrower&#8217;s policy regarding related party transactions in effect from time to time.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:37.95pt;padding-right:6.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will not permit the Consolidated Leverage Ratio as of the last day of (x) each fiscal quarter ending after the Closing Date through and including the fiscal quarter ending June 30, 2022, to exceed 4.25 to 1.00, (y) each fiscal quarter ending after June 30, 2022 through and including the fiscal quarter ending December 31, 2022, to exceed 4.00 to 1.00 and (z) any fiscal quarter thereafter, to exceed 3.75 to 1.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that in lieu of the ratio set forth in this clause (z), for any such date occurring after a Qualified Acquisition, on or prior to the last day of the third full fiscal quarter of the Borrower after the consummation of such Qualified Acquisition, the Borrower will not permit the Consolidated Leverage Ratio as of such date to exceed 4.25 to 1.00.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.08 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lines of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Borrower will not, and will not permit any of its Subsidiaries to, engage to any material extent in any business substantially different from the businesses of the type conducted by the Borrower and its Subsidiaries on the date of execution of this Agreement and businesses reasonably related, ancillary or complementary thereto and reasonable extensions thereof.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:17.57pt;padding-right:17.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE VII</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:17.5pt;padding-right:17.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Events of Default</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If any of the following events (each an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall occur and be continuing at any time on and from the Closing Date&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">the Borrower shall fail to pay any principal of any Loan or any reimbursement obligation in respect of any L&#47;C Disbursement when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or otherwise&#59;</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_274"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">the Borrower shall fail to pay any interest on any Loan or any fee or any other amount (other than an amount referred to in clause (a) of this Article) payable under this Agreement, when and as the same shall become due and payable, and such failure shall continue unremedied for a period of five (5) Business Days&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">any representation or warranty made or deemed made by or on behalf of the Borrower or any Subsidiary in or in connection with this Agreement or any other Loan Document or any amendment or modification thereof or waiver thereunder, or in any report, certificate, financial statement or other document required to be delivered in connection with this Agreement or any other Loan Document or any amendment or modification thereof or waiver thereunder, shall prove to have been incorrect in any material respect when made or deemed made&#59;</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">the Borrower shall fail to observe or perform any covenant, condition or agreement contained in Section 5.03(i) (as to the Borrower&#8217;s existence), or Article VI&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">any Loan Party, as applicable, shall fail to observe or perform any covenant, condition or agreement contained in this Agreement (other than those specified in clause (a), (b) or (d) of this Article) or any other Loan Document, and such failure shall continue unremedied for a period of thirty (30) days after written notice thereof from the Administrative Agent to the Borrower&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">(i) any Loan Party or any Material Subsidiary shall fail to make any payment (whether of principal or interest and regardless of amount) in respect of any Material Indebtedness (other than any Swap Agreement), when and as the same shall become due and payable, or if a grace period shall be applicable to such payment under the agreement or instrument under which such Indebtedness was created, beyond such applicable grace period&#59; or</font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) the occurrence under any Swap Agreement of an &#8220;early termination date&#8221; (or equivalent event) of such Swap Agreement resulting from any event of default or &#8220;termination event&#8221; under such Swap Agreement as to which any Loan Party or any Material Subsidiary is the &#8220;defaulting party&#8221; or &#8220;affected party&#8221; (or equivalent term) and, in either event, the termination value with respect to any such Swap Agreement owed by any Loan Party or any Material Subsidiary as a result thereof is greater than $250,000,000 and any Loan Party or any Material Subsidiary fails to pay such termination value when due after applicable grace periods&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">the Borrower or any Subsidiary shall default in the performance of any obligation in respect of any Material Indebtedness or any &#8220;change of control&#8221; (or equivalent term) shall occur with respect to any Material Indebtedness, in each case, that results in such Material Indebtedness becoming due prior to its scheduled maturity or that enables or permits (with or without the giving of notice, the lapse of time or both, but after giving effect to any applicable grace period) the holder or holders of such Material Indebtedness or any trustee or agent on its or their behalf to cause such Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity (other than solely in Qualified Equity Interests)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that this clause (g) shall not apply to (i) secured Indebtedness that becomes due as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness or as a result of a casualty event affecting such property or assets&#59; or (ii) any &#8220;change of control&#8221; put arising as a result of any acquisition of any Acquired Entity or Business or any of its subsidiaries so long as any such Indebtedness that is put in accordance with the terms of such Indebtedness is paid as required by the terms of such Indebtedness&#59;</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">an involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization, moratorium, bankruptcy, dissolution or other relief in respect of any Loan Party or any Material Subsidiary or its debts, or of a substantial part of its assets, under any Federal, state or foreign bankruptcy, insolvency, </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">receivership or similar law now or hereafter in effect or (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator, administrator (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">bewindvoerder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), trustee in bankruptcy (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">curator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or similar official for any Loan Party or any Material Subsidiary or for a substantial part of its assets, and, in any such case, such proceeding or petition shall continue undismissed or unstayed for sixty (60) days or an order or decree approving or ordering any of the foregoing shall be entered&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">any Loan Party or any Material Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization, moratorium, bankruptcy, dissolution or other relief under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the institution of any proceeding or petition described in clause (h) of this Article, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator, administrator (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">bewindvoerder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), trustee in bankruptcy (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">curator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or similar official for any Loan Party or any Material Subsidiary or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any corporate action for the purpose of effecting any of the foregoing&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">any Loan Party or any Material Subsidiary shall become generally unable, admit in writing its inability generally or fail generally to pay its debts as they become due&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">one or more final, non-appealable judgments for the payment of money in an aggregate amount in excess of $250,000,000 (to the extent due and payable and not covered by insurance as to which the relevant insurance company has not denied coverage) shall be rendered against any Loan Party, any Material Subsidiary or any combination thereof and the same shall remain unpaid or undischarged for a period of thirty (30) consecutive days during which execution shall not be paid, bonded or effectively stayed&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">an ERISA Event shall have occurred that, when taken together with all other ERISA Events that have occurred, would reasonably be expected to result in a Material Adverse Effect&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">a Change in Control shall occur&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:4.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">at any time any material provision of any Guarantee Agreement, at any time after its execution and delivery and for any reason other than as expressly permitted hereunder or thereunder (including as a result of a transaction permitted under Section 6.03) or as a result of acts or omissions by the Administrative Agent or any Lender or the satisfaction in full</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_277"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of all the Obligations or pursuant to the provisions of Section 5.09, ceases to be in full force and effect&#59; or any Loan Party contests in writing the validity or enforceability of any provision of any Guarantee Agreement&#59; or any Loan Party denies in writing that it has any further liability or obligations under any Guarantee Agreement (other than as a result of repayment in full of the Obligations and termination of the Commitments or pursuant to the proviso set forth in Section 5.09), or purports in writing to revoke or rescind any Guarantee Agreement, in each case with respect to a material provision of any such Guarantee Agreement,</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">then, and in every such event (other than an event with respect to the Borrower described in clause (h), (i) or (j) of this Article), and at any time thereafter during the continuance of such event, the Administrative Agent may, and at the request of the Required Lenders shall, by notice to the Borrower, take either or both of the following actions, at the same or different times&#58; (i) terminate the Commitments, and thereupon the Commitments shall terminate immediately, and</font></div><div style="padding-left:38pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) declare the Loans then outstanding to be due and payable in whole (or in part, in which case any principal not so declared to be due and payable may thereafter be declared to be due and payable), and thereupon the principal of the Loans so declared to be due and payable, together with accrued interest thereon and all fees and other obligations of the Borrower accrued hereunder and under the other Loan Documents, shall become due and payable immediately, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower&#59; and in case of any event with respect to the Borrower described in clause (h),</font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">or (j) of this Article, the Commitments shall automatically terminate and the principal of the Loans then outstanding, together with accrued interest thereon and all fees and other Obligations accrued hereunder and under the other Loan Documents, shall automatically become due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:17.5pt;padding-right:17.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE VIII</font></div><div><font><br></font></div><div style="padding-left:17.45pt;padding-right:17.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The Administrative Agent</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:20.7pt">Each of the Lenders and the Issuing Banks hereby irrevocably appoints Bank of America </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:117%">to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">and authorizes the Administrative Agent to take such actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof and the other Loan Documents, together with such actions and powers as are reasonably incidental thereto. The provisions of this Article VIII and Article XI are solely for the benefit of the Administrative Agent, the Lenders and the Issuing Banks, and the Loan Parties shall not have rights as a third party beneficiary of any of such provisions. It is understood and agreed that the use of the term &#8220;agent&#8221; herein or in any other Loan Documents (or any other similar term) with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable Law. Instead such term is used as a matter of market custom, and is intended to create or reflect only an administrative relationship between contracting parties.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Person serving as the Administrative Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not the Administrative Agent, and the term &#8220;Lender&#8221; or &#8220;Lenders&#8221; shall,</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_280"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:5.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money to, own securities of, act as the financial advisor or in any other advisory capacity for and generally engage in any banking, trust, financial, advisory, underwriting or other kind of business with the Loan Parties or any Subsidiary or other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders or to provide notice or consent of the Lenders with respect thereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Administrative Agent or the Arrangers, as applicable, shall not have any duties or obligations except those expressly set forth herein and in the other Loan Documents, and its or their duties hereunder shall be administrative in nature. Without limiting the generality of the foregoing, the Administrative Agent or the Arrangers, as applicable, and its Related Parties (a) shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing&#59; (b) shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise in writing as directed by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or by the other Loan Documents), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable Law, including for the avoidance of doubt any action that may be in violation of the automatic stay under any Debtor Relief Law or that may effect a forfeiture, modification or termination of property of a Defaulting Lender in violation of any Debtor Relief Law&#59; (c) shall not have any duty or responsibility to disclose, and shall not be liable for the failure to disclose, to </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any Lender or any Issuing Bank, any credit or other information concerning the business, prospects, operations, property, financial and other condition or creditworthiness of any of the Loan Parties or any of their Affiliates, that is communicated to, obtained or in the possession of, the Administrative Agent, any Arranger or any of their Related Parties in any capacity, except for notices, reports and other documents expressly required to be furnished to the Lenders by the Administrative Agent herein&#59; (d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall not be liable for any action taken or not taken by it under or in connection with this Agreement or any other Loan Document or the transactions contemplated hereby or thereby (i) with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as provided herein) or (ii) in the absence of its own gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and non-appealable judgment, and the Administrative Agent shall be deemed not to have knowledge of any Default unless and until written notice describing such Default thereof is given to the Administrative Agent by the Borrower, a Lender or an Issuing Bank&#59; and (e) shall not be responsible for or have any duty or obligation to any Lender, any Issuing Bank, any Participant or any other Person to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_283"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement or any other Loan Document or any other agreement, instrument or document, or (v) the satisfaction of any condition set forth in Article IV or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person. The Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan, or the issuance, extension, renewal or increase of a Letter of Credit, that by its terms must be fulfilled to the satisfaction of a Lender or an Issuing Bank, the Administrative Agent may presume that such condition is satisfactory to such Lender or such Issuing Bank unless the Administrative Agent shall have received notice to the contrary from such Lender or such Issuing Bank prior to the making of such Loan or the issuance of such Letter of Credit. The Administrative Agent may consult with legal counsel (who may be counsel for the Loan Parties), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more subagents appointed by the Administrative Agent. The Administrative Agent and any such subagent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Article VIII shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as Administrative Agent. The Administrative Agent shall not be responsible for the negligence or misconduct of any sub-agents except to the extent that a court of competent jurisdiction determines in a final and non-appealable judgment that the Administrative Agent acted with gross negligence or willful misconduct in the selection of such sub-agents.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">(i) The Administrative Agent may at any time give notice of its resignation to the Lenders, the Issuing Banks and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, in consultation with the Borrower and (unless an Event of Default under clause (a), (b), (h), (i) or (j) of Article VII shall have occurred and be continuing) with the consent of the Borrower (which consent of the Borrower shall not be unreasonably withheld or delayed), to appoint a successor, which shall be a bank with an office in the United States, or an Affiliate of any such bank with an office in the United States. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days after the retiring Administrative Agent gives notice of its resignation (or such earlier day as shall be agreed by the Required Lenders) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the retiring Administrative Agent may (but shall not be obligated to) on behalf of the Lenders and the Issuing Banks, appoint a successor Administrative Agent meeting</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_286"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the qualifications set forth above. Whether or not a successor has been appointed, such resignation shall become effective in accordance with such notice on the Resignation Effective Date.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:74pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">If the Person serving as Administrative Agent is a Defaulting Lender pursuant to clause (d) of the definition thereof, the Required Lenders may, to the extent permitted by applicable Law, by notice in writing to the Borrower and such Person remove such Person as Administrative Agent, and the Borrower in consultation with the Lenders shall, unless an Event of Default shall have occurred and be continuing, in which case the Required Lenders in consultation with the Borrower shall, appoint a successor, which shall be a bank with an office in the United States, or an Affiliate of any such bank with an office in the United States&#59; provided that, without the consent of the Borrower (not to be unreasonably withheld), the Required Lenders shall not be permitted to select a successor that is not a U.S. financial institution described in Treasury Regulation Section 1.1441-1(b)(2)(ii) or a U.S. branch of a foreign bank described in Treasury Regulation Section 1.1441-1(b)(2)(iv)(A). If no such successor shall have been so appointed and shall have accepted such appointment within 30 days (or such earlier day as shall be agreed by the Required Lenders) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Removal Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then such removal shall nonetheless become effective in accordance with such notice on the Removal Effective Date.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:74pt;padding-right:4.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">With effect from the Resignation Effective Date or the Removal Effective Date (as applicable) (1) the retiring or removed Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents and (2) except for any indemnity payments or other amounts then owed to the retiring or removed Administrative Agent, all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Lender and each Issuing Bank directly, until such time, if any, of the appointment of a successor Administrative Agent as provided for above.&#160;&#160;&#160;&#160;Upon the acceptance of a successor&#8217;s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or removed) Administrative Agent (other than as provided in Section 2.16(e) and other than any rights to indemnity payments or other amounts owed to the retiring or removed Administrative Agent as of the Resignation Effective Date or the Removal Effective Date, as applicable), and the retiring or removed Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section). The fees payable by the Loan Parties to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor. After the retiring or removed Administrative Agent&#8217;s resignation or removal hereunder and under the other Loan Documents, the provisions of this Article VIII, Article XI and Section 9.03 shall continue in effect for the benefit of such retiring or removed Administrative Agent, its sub agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them (i) while the retiring or removed Administrative Agent was acting as Administrative Agent and (ii) </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">after such resignation or removal for as long as any of them continues to act in any capacity hereunder or under the other Loan Documents, including in respect of any actions</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_289"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:4pt;padding-left:74pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:119%">taken in connection with transferring the agency to any successor Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:74pt;padding-right:6.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">Any resignation by Bank of America as Administrative Agent pursuant to this clause (f) shall also constitute its resignation as an Issuing Bank and Swingline Lender. If Bank of America resigns as an Issuing Bank, it shall retain all the rights, powers, privileges and duties of an Issuing Bank hereunder with respect to all Letters of Credit outstanding as of the effective date of its resignation as Issuing Bank and all Obligations in respect of Letters of Credit with respect thereto, including the right to require the Lenders to make Base Rate Loans or fund risk participations in Unreimbursed Amounts pursuant to Section 2.05(c). If Bank of America resigns as Swingline Lender, it shall retain all the rights of the Swingline Lender provided for hereunder with respect to Swingline Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make Base Rate Loans or fund risk participations in outstanding Swingline Loans pursuant to Section 2.04(c). Upon the appointment by the Borrower of a successor Issuing Bank or Swingline Lender hereunder (which successor shall in all cases be a Lender other than a Defaulting Lender and shall expressly agree to assume such role), (a) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuing Bank or Swingline Lender, as applicable, (b) the retiring Issuing Bank and Swingline Lender shall be discharged from all of their respective duties and obligations hereunder or under the other Loan Documents, and (c) the successor Issuing Bank shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to Bank of America to effectively assume the obligations of Bank of America with respect to such Letters of Credit.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Each Lender and each Issuing Bank expressly acknowledges that none of the Administrative Agent nor any Arranger has made any representation or warranty to it, and that no act by the Administrative Agent or any Arranger hereafter taken, including any consent to, and acceptance of any assignment or review of the affairs of any Loan Party or any Affiliate thereof, shall be deemed to constitute any representation or warranty by the Administrative Agent or any Arranger to any Lender or any Issuing Bank as to any matter, including whether the Administrative Agent or any Arranger have disclosed material information in their (or their Related Parties&#8217;) possession. Each Lender and each Issuing Bank represents to the Administrative Agent and the Arrangers that it has, independently and without reliance upon the Administrative Agent, the Arrangers, any other Lender or other Issuing Bank or any of their respective Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis of, appraisal of, and investigation into, the business, prospects, operations, property, financial and other condition and creditworthiness of the Loan Parties and their Subsidiaries, and all applicable bank or other regulatory Laws relating to the transactions contemplated hereby, and made its own decision to enter into this Agreement and to extend credit to the Borrower hereunder. Each Lender and each Issuing Bank also acknowledges that it will, independently and without reliance upon the Administrative Agent, the Arrangers, any other Lender or other Issuing Bank or any of their respective Related Parties and based on such documents and information as it shall from time to time</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_292"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:4pt;padding-left:37.95pt;padding-right:5.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">deem appropriate, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder, and to make such investigations as it deems necessary to inform itself as to the business, prospects, operations, property, financial and other condition and creditworthiness of the Loan Parties. As of the date it becomes a Lender or an Issuing Bank, as applicable, party hereto, each Lender and each Issuing Bank represents and warrants that (i) it is the intention of such Lender or such Issuing Bank, as applicable, that the Loan Documents set forth the terms of a commercial lending facility and (ii) it is engaged in making, acquiring or holding commercial loans in the ordinary course and is entering into this Agreement as a Lender or Issuing Bank for the purpose of making, acquiring or holding commercial loans and providing other facilities set forth herein as may be applicable to such Lender or Issuing Bank, and not for the purpose of purchasing, acquiring or holding any other type of financial instrument, and each Lender and each Issuing Bank agrees not to assert a claim in contravention of the foregoing. Each Lender and each Issuing Bank represents and warrants that it is sophisticated with respect to decisions to make, acquire and&#47;or hold commercial loans and to provide other facilities set forth herein, as may be applicable to such Lender or such Issuing Bank, and either it, or the Person exercising discretion in making its decision to make, acquire and&#47;or hold such commercial loans or to provide such other facilities, is experienced in making, acquiring or holding such commercial loans or providing such other facilities.</font></div><div style="margin-top:11.9pt;padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#91;Reserved&#93;.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">The Lenders and the Issuing Banks irrevocably agree that any Guarantor shall be automatically released from its obligations under the applicable Guarantee if such Person ceases to be a Subsidiary as a result of a transaction permitted hereunder (and the Administrative Agent may rely conclusively on a certificate to that effect provided to it by a Responsible Officer of the Borrower without further inquiry). Upon request by the Administrative Agent at any time, the Required Lenders (or such greater number of Lenders as may be required by Section 9.02) will confirm in writing the Administrative Agent&#8217;s authority to release any Guarantor from its obligations under the applicable Guarantee pursuant to this paragraph (i). The Administrative Agent will (and each Lender irrevocably authorizes the Administrative Agent to), at the Borrower&#8217;s expense, execute and deliver to the applicable Loan Party such documents as such Loan Party may reasonably request to evidence the release of such Guarantor from its obligations under the applicable Guarantee.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Anything herein to the contrary notwithstanding, none of the Arrangers listed on the cover page hereof shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent, a Lender or an Issuing Bank hereunder.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Administrative Agent and each Arranger hereby informs the Lenders and the Issuing Banks that each such Person is not undertaking to provide impartial investment advice, or to give advice in a fiduciary capacity, in connection with the transactions contemplated hereby, and that such Person has a financial interest in the transactions contemplated hereby in that such Person or an Affiliate thereof (x) may receive interest or other</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_295"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">payments with respect to the Loans, the Letters of Credit, the Commitments and this Agreement,</font></div><div style="padding-left:38pt;padding-right:7.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(y) may recognize a gain if it extended the Loans, the Letters of Credit or the Commitments for an amount less than the amount being paid for an interest in the Loans, the Letters of Credit or the Commitments by such Lender or (z) may receive fees or other payments in connection with the transactions contemplated hereby, the Loan Documents or otherwise, including structuring fees, commitment fees, arrangement fees, facility fees, upfront fees, underwriting fees, ticking fees, agency fees, administrative agent or collateral agent fees, utilization fees, minimum usage fees, letter of credit fees, fronting fees, deal-away or alternate transaction fees, amendment fees, processing fees, term out premiums, banker&#8217;s acceptance fees, breakage or other early termination fees or fees similar to the foregoing.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:4.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Recovery of Erroneous Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without limitation of any other provision in this Agreement, if at any time the Administrative Agent makes a payment hereunder in error to any </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Lender or any Issuing Bank (each a &#8220;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Party</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">whether or not in respect of an Obligation due and owing by the Borrower at such time, where such payment is a Rescindable Amount, then in any such event, each Credit Party receiving a Rescindable Amount severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount received by such Credit Party in immediately available funds in the currency so received, with interest thereon, for each day from and including the date such Rescindable Amount is received by it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation. Each Credit Party irrevocably waives any and all defenses, including any &#8220;discharge for value&#8221; (under which a creditor might otherwise claim a right to retain funds mistakenly paid by a third party in respect of a debt owed by another) or similar defense to its obligation to return any Rescindable Amount. The Administrative Agent shall inform each </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Party </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">promptly upon determining that any payment made to such Credit Party comprised, in whole or in part, a Rescindable Amount.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:17.5pt;padding-right:17.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE IX</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:17.5pt;padding-right:17.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Miscellaneous</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:5.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Notices Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except in the case of notices and other communications expressly permitted to be given by telephone (and except as provided in subsection (b) below), all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by telecopier as follows, and all notices and other communications expressly permitted hereunder to be given by telephone shall be made to the applicable telephone number, as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">if to any Loan Party, the Administrative Agent, any Issuing Bank or the Swingline Lender, to the address, telecopier number, electronic mail address or telephone number specified for such Person on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 9.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; and</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_298"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">if to any other Lender, to the address, telecopier number, electronic mail address or telephone number specified in its Administrative Questionnaire.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notices and other communications sent by hand or overnight courier service, or mailed by certified or registered mail, shall be deemed to have been given when received&#59; notices and other communications sent by telecopier shall be deemed to have been given when sent (except that, if not given during normal business hours for the recipient, shall be deemed to have been given at the opening of business on the next business day for the recipient). Notices and other communications delivered through electronic communications to the extent provided in subsection (b) below, shall be effective as provided in such subsection (b).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notices and other communications to the Lenders and the Issuing Banks hereunder may be delivered or furnished by electronic communication (including e-mail, FpML messaging and Internet or intranet websites) pursuant to procedures approved by the Administrative Agent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the foregoing shall not apply to notices to any Lender or any Issuing Bank pursuant to Article II if such Lender or such Issuing Bank, as applicable, has notified the Administrative Agent that it is incapable of receiving notices under such Article by electronic communication. The Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that approval of such procedures may be limited to particular notices or communications.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Unless the Administrative Agent otherwise prescribes, (i) notices and other communications sent to an e-mail address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; function, as available, return e-mail or other written acknowledgement), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next business day for the recipient, and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing clause (i) of notification that such notice or communication is available and identifying the website address therefor.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">The Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. THE PLATFORM IS PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE.&#8221; THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR ERRORS IN OR OMISSIONS FROM THE INFORMATION. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM. In no event shall the Administrative Agent or any of its Related Parties (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) have any liability to any Loan Party, any Lender, any Issuing Bank or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of such Loan Party&#8217;s or the Administrative Agent&#8217;s transmission of Borrower Materials or notices through the platform, any other electronic platform or electronic messaging service, or through the Internet, except to the extent that such losses, claims, damages, liabilities or expenses are determined by a court of competent jurisdiction by a final and non-appealable judgment to have resulted from the gross negligence or willful misconduct of such Agent Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in no event shall any Agent Party have any liability to any Loan Party, any Lender, any Issuing Bank or any other Person for indirect, special, incidental, consequential or punitive damages (as opposed to direct or actual damages).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Change of Address, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each of the Borrower (with respect to the notice address for the Loan Parties), the Administrative Agent, any Issuing Bank and the Swingline Lender may change its address, telecopier or telephone number for notices and other communications hereunder by notice to the other parties hereto. Each other Lender may change its address, telecopier or telephone number for notices and other communications hereunder by notice to the Borrower, the Administrative Agent, the Issuing Banks and the Swingline Lender. In addition, each Lender agrees to notify the Administrative Agent from time to time to ensure that the Administrative Agent has on record (i) an effective address, contact name, telephone number, telecopier number and electronic mail address to which notices and other communications may be sent and (ii) accurate wire instructions for such Lender. Furthermore, each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the &#8220;Private Side Information&#8221; or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender&#8217;s compliance procedures and applicable Law, including United States Federal and state securities Laws, to make reference to Borrower Materials that are not made available through the &#8220;Public Side Information&#8221; portion of the Platform and that may contain material non-public information with respect to any Loan Party or any of their securities for purposes of United States Federal or state securities laws.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Reliance by Administrative Agent, Issuing Banks and Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrative Agent, the Issuing Banks and the Lenders shall be entitled to rely and act upon any notices (including telephonic or electronic notices, Letter of Credit Applications, Borrowing Requests and Swingline Loan Notices) purportedly given by or on behalf of the Loan Parties even if (i) such notices were not made in a manner specified herein, were incomplete or were not preceded or followed by any other form of notice specified herein, or (ii) the terms thereof, as understood by the recipient, varied from any confirmation thereof. Each Loan Party shall indemnify the Administrative Agent, each Issuing Bank, each Lender and the Related Parties of each of them from all losses, costs, expenses and liabilities resulting from the reliance by such Person on each notice purportedly given by or on behalf of such Loan Party unless due to such Person&#8217;s gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and non-appealable judgment. All telephonic notices to and other telephonic communications with the Administrative Agent may be recorded by the Administrative Agent, and each of the parties hereto hereby consents to such recording.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waivers&#59; Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">No failure or delay by the Administrative Agent, any Issuing Bank or any Lender in exercising any right or power hereunder or under any other Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Administrative Agent, the Issuing Banks and the Lenders hereunder and under the other Loan Documents are cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of this Agreement or consent to any departure by any Loan Party therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) of this Section, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. Without limiting the generality of the foregoing, the making of a Loan or issuance of a Letter of Credit shall not be construed as a waiver of any Default, regardless of whether the Administrative Agent, any Lender or any Issuing Bank may have had notice or knowledge of such Default at the time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Except as otherwise set forth in this Agreement or any other Loan Document (with respect to such Loan Document), neither this Agreement nor any other Loan Document nor any provision hereof or thereof may be waived, amended or modified except pursuant to an agreement or agreements in writing entered into by the Borrower and the </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Required Lenders or by the Borrower and the Administrative Agent with the consent of the Required Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no such agreement shall (i) increase the Commitment of any Lender without the written consent of each Lender directly affected thereby, it being understood that a waiver of any condition precedent set forth in Article IV or the waiver of any Default or mandatory prepayment shall not constitute an increase of any Commitment of any Lender, (ii) reduce the principal amount of any Loan or L&#47;C Advance or reduce the rate of interest or premium thereon, or reduce any fees payable hereunder, without the written consent of each Lender directly affected thereby, it being understood that any change to the definition of &#8220;Consolidated Leverage Ratio&#8221; or in the component definitions thereof shall not constitute a reduction in the rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that only the consent of the Required Lenders shall be necessary to amend Section 2.12(f) or to waive any obligation of the Borrower to pay interest at the rate set forth therein, (iii) postpone the scheduled date of payment of the principal amount of any Loan or L&#47;C Advance, or any interest thereon, or any fees payable hereunder, or reduce the amount of, waive or excuse any such payment, or postpone the scheduled date of expiration of any Commitment, without the written consent of each Lender directly affected thereby, it being understood that the waiver of (or amendment to the terms of) any mandatory prepayment of the Loans shall not constitute a postponement of any date scheduled for the payment of principal or interest, (iv) change Section 2.17(b) or (c) in a manner that would alter the pro rata sharing of payments required thereby, without the written consent of each Lender directly affected thereby,</font></div><div style="padding-left:38pt;padding-right:7.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">change any of the provisions of this Section, the definition of &#8220;Required Lenders&#8221; or the definition of &#8220;Alternative Currencies&#8221; or any other provision hereof specifying the number or percentage of Lenders required to waive, amend or modify any rights hereunder or make any determination or grant any consent hereunder without the written consent of each Lender, (vi) release all or substantially all of (A) the Guarantors from their obligations under any Guarantee Agreement (other than pursuant to the proviso set forth in Section 5.09) or (B) the value of the Guarantees of the Obligations, without the consent of each Lender or (vii) subordinate the Obligations hereunder to any other Indebtedness or other obligation, without the written consent of each Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (1) no such agreement shall amend, modify or otherwise affect the rights or duties of the Administrative Agent, any Issuing Bank or the Swingline Lender hereunder without the prior written consent of the Administrative Agent, the relevant Issuing Bank or the Swingline Lender, as the case may be and (2) the Administrative Agent and the Borrower may, with the consent of the other but without the consent of any other Person, amend, modify or supplement this Agreement and any other Loan Document to cure any ambiguity, typographical or technical error, defect or inconsistency. Notwithstanding anything to the contrary herein, no Defaulting Lender shall have any right to approve or disapprove any amendment, waiver or consent hereunder which does not require the consent of each affected Lender (it being understood that any Commitments or Loans held or deemed held by any Defaulting Lender shall be excluded for a vote of the Lenders hereunder requiring any consent of less than all affected Lenders).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, this Agreement and the other Loan Documents may be amended (or amended and restated) with the written consent of the Required Lenders, the Administrative Agent and the Borrower (i) to add one or more additional credit facilities to this Agreement and to permit the extensions of credit from time to time outstanding thereunder and the accrued interest and fees in respect thereof to share ratably in the benefits of this Agreement and the other Loan Documents with the Revolving Credit Exposures and the accrued interest and fees in respect thereof and (ii) to include appropriately the Lenders holding such credit facilities in any determination of the Required Lenders.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses&#59; Indemnity&#59; Damage Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The Borrower shall pay (i) all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent, the Arrangers and their Affiliates, including the reasonable and documented fees, charges and disbursements of a single counsel for the Arrangers and the Administrative Agent, collectively (and, if necessary, one local counsel in </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">each applicable jurisdiction and regulatory counsel), in connection with the syndication of the credit facilities provided for herein, the preparation and administration of this Agreement and the other Loan Documents or any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions contemplated hereby or thereby shall be consummated),</font></div><div style="padding-left:38pt;padding-right:4.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) all reasonable and documented out-of-pocket expenses incurred by the relevant Issuing Bank in connection with the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and (iii) all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent, any Issuing Bank or any Lender, including the reasonable and documented fees, charges and disbursements of a single counsel (and, if necessary, one local counsel in each applicable jurisdiction, regulatory counsel and one additional counsel for each party in the event of a conflict of interest), in connection with the enforcement or protection of its rights in connection with this Agreement, including its rights under this Section, or in connection with the Loans made or Letters of Credit issued hereunder, including all such reasonable and documented out-of-pocket expenses incurred during any workout, restructuring or negotiations in respect of such Loans or Letters of Credit.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Borrower shall indemnify the Administrative Agent, the Arrangers, each Issuing Bank and each Lender, and each Related Party of any of the foregoing Persons (each such Person being called an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related reasonable and documented out-of-pocket expenses, including the reasonable and documented fees, charges and disbursements of a single counsel for the Indemnitees (and, if necessary, one local counsel in each applicable jurisdiction and one additional counsel for each Indemnitee in the event of a conflict of interest), incurred by or asserted against any Indemnitee arising out of, in connection with, or as a result of (i) the execution or delivery of this Agreement or any agreement or instrument contemplated hereby (including, without limitation, any Indemnitee&#8217;s reliance on any Communication executed using an Electronic Signature, or in the form of an Electronic Record), the performance by the parties hereto of their respective obligations hereunder or the consummation of the Transactions or any other transactions contemplated hereby, (ii) any Loan or Letter of Credit or the use of the proceeds therefrom (including any refusal by any Issuing Bank to honor a demand for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), (iii) to the extent relating to or arising from any of the foregoing, any actual or alleged presence or release of Hazardous Materials on or from any property owned or operated by any Loan Party or any of its Subsidiaries, or any Environmental Liability related in any way to any Loan Party or any of its Subsidiaries, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory and regardless of whether any Indemnitee is a party thereto and whether brought by the Borrower, its equityholders or any third party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final and non-appealable judgment to have resulted from (A) the bad faith, gross negligence or willful misconduct of such Indemnitee or any of its officers, directors, employees, Affiliates or controlling Persons (such persons, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Related Indemnitee Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), (B) the material breach of this Agreement or any other Loan Document by such Indemnitee or any of its Related Indemnitee Parties or (C) any dispute solely among Indemnitees (other than any dispute involving claims against the Administrative Agent, any Arranger, the Swingline Lender or any Issuing Bank, in each case in its capacity as such) and not arising out of any act or omission of the Borrower or any of its Affiliates. In addition, such indemnity shall not, as to any Indemnitee, be available with respect to any settlements effected without the Borrower&#8217;s prior written consent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">To the extent that the Borrower fails to pay any amount required to be paid by it to the Administrative Agent, an Issuing Bank or the Swingline Lender under paragraph (a) or (b) of this Section, each Lender severally agrees to pay to the Administrative Agent, the relevant Issuing Bank or the Swingline Lender, as the case may be, such Lender&#8217;s pro rata share </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent, such Issuing Bank or the Swingline Lender in its capacity as such.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">To the extent permitted by applicable Laws, no party hereto shall assert, and each party hereto hereby waives, any claim against any other party hereto and any Indemnitee on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the Transactions, any Loan or Letter of Credit or the use of the proceeds thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that this clause (d) shall in no way limit the Borrower&#8217;s indemnification obligations set forth in this Section 9.03. No Indemnitee referred to in paragraph (b) above shall be liable for any damages arising from the use by unintended recipients of any information or other materials</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby, except to the extent that such damages are determined by a court of competent jurisdiction by final and non-appealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnitee.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">All amounts due under this Section shall be payable not later than fifteen</font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(15)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.02pt">days after written demand therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that an Indemnitee shall promptly refund any amount received under this Section 9.03 to the extent that there is a final judicial or arbitral determination that such Indemnitee was not entitled to indemnification rights with respect to such payment pursuant to the express terms of this Section 9.03.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Successors and Assigns Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby, except that neither the Borrower nor any other Loan Party may assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Administrative Agent and each Lender and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i) to an assignee in accordance with the provisions of subsection (b) of this Section, (ii) by way of participation in accordance with the provisions of subsection (d) of this Section or (iii) by way of pledge or assignment of a security interest subject to the restrictions of subsection (f) of this Section (and any other attempted assignment or transfer by any party hereto shall be null and void). Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, Participants to the extent provided in subsection (d) of this Section and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the Issuing Banks and the Lenders) any legal or equitable right, remedy or claim under or by reason of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Assignments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Lender (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) may at any time assign to one or more assignees all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans (including for purposes of this subsection (b), participations in L&#47;C Disbursement and in Swingline Loans) at the time owing to it) (each such assignee being a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that any such assignment shall be subject to the following conditions&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">in the case of an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitments and the Loans at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.02pt">in any case not described in subsection (b)(i)(A) of this Section, the aggregate amount of the Commitment (which for this purpose includes Loans outstanding thereunder) or, if the Commitment is not then in effect, the principal outstanding balance</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:7.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the Loans of the assigning Lender subject to each such assignment, determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if &#8220;Trade Date&#8221; is specified in the Assignment and Assumption, as of the Trade Date, shall not be less than $5,000,000, unless each of the Administrative Agent and, so long as no Event of Default has occurred and is continuing, the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (x) until the interpretation of the term &#8220;public&#8221; (as referred to in Article 4.1(1) of the Capital Requirements Regulation (EU 575&#47;2013)) has been published by the competent authority, the value of the rights assigned or transferred is at least &#8364;100,000 (or its equivalent in another currency) or (y) as soon as the interpretation of the term &#8220;public&#8221; has been published by the competent authority, the Lender is not considered to be part of the public on the basis of such interpretation.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt;text-decoration:underline">Proportionate Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Agreement with respect to the Loans or the Commitment of the Class being assigned, except that this clause (ii) shall not (A) apply to the Swingline Lender&#8217;s rights and obligations in respect of Swingline Loans or (B) prohibit any Lender from assigning all or a portion of its rights and obligations in respect of any Class of Loans or commitments provided hereunder and any other Class of Loans or Commitment provided hereunder on a non-pro rata basis.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No consent shall be required for any assignment except to the extent required by subsection (b)(i)(B) of this Section and, in addition&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required unless an Event of Default pursuant to clause (a), (b), (h), (i) or (j) of Article VII has occurred and is continuing at the time of such assignment or the assignment is made to a Lender, to a Lender&#8217;s Affiliate or to an Approved Fund&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the Borrower shall be deemed to have consented to any such assignment unless it shall object thereto by written notice to the Administrative Agent within ten (10) Business Days after having received notice thereof&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.02pt">the consent of the Administrative Agent (such consent not to be unreasonably withheld or delayed) shall be required for assignments in respect of any Revolving Commitment unless the assignment is to a Lender or its Affiliate&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.02pt">the consent of each Issuing Bank (such consent not to be unreasonably withheld or delayed) shall be required for any assignment that increases the obligation of the assignee to participate in exposure under one or more Letters of Credit (whether or not then outstanding)&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:74pt;padding-right:7.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">the consent of the Swingline Lender (such consent not to be unreasonably withheld or delayed) shall be required for any assignment in respect of the Revolving Loans.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee in the amount of $3,500&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Administrative Agent may, in its sole discretion, elect to waive such processing and recordation fee in the case of any assignment. The assignee, if it is not a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire and any tax forms required by Section 2.16(e).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">No Assignment to Loan Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No such assignment shall be made to any Loan Party or any Loan Party&#8217;s Affiliates or Subsidiaries.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:7.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt;text-decoration:underline">No Assignment to Natural Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No such assignment shall be made to a natural person.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.36pt;text-decoration:underline">Certain Additional Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to the assignment shall make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be outright payment, purchases by the assignee of participations or subparticipations, or other compensating actions, including funding, with the consent of the Administrative Agent and the Borrower, the applicable pro rata share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor hereby irrevocably consent), to (x) pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent, any Issuing Bank or any Lender hereunder (and interest accrued thereon) and (y) acquire (and fund as appropriate) its full pro rata share of all Loans and participations in Letters of Credit and Swingline Loans in accordance with its Applicable Percentage. Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable Law without compliance with the provisions of this paragraph, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt;padding-right:6.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:10.03pt">Subject to acceptance and recording thereof by the Administrative Agent pursuant to subsection (c) of this Section, from and after the effective date specified in each Assignment and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto) but shall continue to be entitled to the benefits of Sections 2.14, 2.15, 2.16 and 9.03 with respect to facts and circumstances occurring prior to the effective date of such assignment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that except to the extent otherwise expressly agreed by the affected parties, no assignment by a Defaulting Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender&#8217;s having been a Defaulting Lender.</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_301"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:74pt;padding-right:8.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon request, the Borrower (at its expense) shall execute and deliver a Note to the assignee Lender. Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this subsection shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with subsection (d) of this Section.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrative Agent, acting solely for this purpose as a non-fiduciary agent of the Borrower (and such agency being solely for tax purposes), shall maintain at the Administrative Agent&#8217;s Office in the United States a copy of each Assignment and Assumption delivered to it (or the equivalent thereof in electronic form) and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) and interest thereon of the Loans and L&#47;C Disbursements owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement. The Register shall be available for inspection by the Borrower and any Lender, at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Lender (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) may at any time, without the consent of, or notice to, the Borrower, the Administrative Agent, Swingline Lender or Issuing Bank, sell participations to any Person (other than a natural person, a Defaulting Lender or the Borrower or any of the Borrower&#8217;s Affiliates or Subsidiaries) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; or a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in all or a portion of such Lender&#8217;s rights and&#47;or obligations under this Agreement (including all or a portion of its Commitment and&#47;or the Loans (including such Lender&#8217;s participations in L&#47;C Disbursements and&#47;or Swingline Loans) owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) such Lender&#8217;s obligations under this Agreement shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii) the Borrower, the Administrative Agent, the Lenders and the Issuing Banks shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement. For the avoidance of doubt, each Lender shall be responsible for the indemnity under Section 9.03(c) without regard to the existence of any participation.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:39.3pt;padding-right:8.8pt;text-align:justify;text-indent:109.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, waiver or other modification described in Section 9.02(b)(i) that affects such Participant. Subject to subsection (e) of this Section, the Borrower agrees that each Participant shall be entitled to the benefits of Sections 2.14, 2.15 and</font></div><div style="padding-left:39.3pt;padding-right:8.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.16 (subject to the requirements and limitations therein, including the requirements under Section 2.16(e)) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to subsection (b) of this Section. To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 9.08 as though it were a Lender, provided such Participant agrees to be subject to Sections 2.17 and 2.18 as though it were a Lender. Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrower, maintain a register on which it enters the name and address</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_304"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:39.3pt;padding-right:7.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of each Participant and the principal amounts and interest thereon of each participant&#8217;s interest in the Loans or other obligations under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant&#8217;s interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each person whose name is recorded in the Participant Register as the owner of the participation in question for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Limitations upon New Lender Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">Subject to Section 9.04(e)(ii) below, if&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:110pt;padding-right:7.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.36pt">a Lender assigns, transfers, sells, pledges or assigns a security interest in any of its rights or obligations under this Agreement or changes its Lending Office&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:110pt;padding-right:5.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.02pt">as a result of circumstances existing at the date the assignment, transfer, sale, pledge, assignment of the security interest or change occurs, a Loan Party would be obliged to make a payment to the New Lender or Lender acting through its new Lending Office under Section 2.14 or Section 2.16,</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:110pt;padding-right:5.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">then the New Lender or Lender acting through its new Lending Office is only entitled to receive payment under those Sections to the same extent as the Existing Lender or Lender acting through its previous Lending Office would have been if the assignment, transfer, sale, pledge, assignment of the security interest or change had not occurred.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.2pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">A New Lender shall not be entitled to receive any greater payment under Section 2.14 or 2.16 than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrower&#8217;s prior written consent or results from a Change in Law after the sale of such participation. A Participant that would be a Foreign Lender if it were a Lender shall not be entitled to the benefits of Section 2.16 unless the Borrower is notified of the participation sold to such Participant and such Participant agrees, for the benefit of the Borrower, to comply with Section 2.16 as though it were a Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt;text-decoration:underline">Certain Pledges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Lender (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement (including under its Note(s), if any) to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or other central bank (each such pledgee or assignee being a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; provided that no such pledge or assignment shall</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_307"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:4.95pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Resignation as Issuing Bank or Swingline Lender after Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary contained herein, if at any time an Issuing Bank assigns all of its Revolving Commitment and Revolving Loans pursuant to subsection (b) above, such Issuing Bank may, (i) upon 30 days&#8217; notice to the Borrower and the Lenders, resign as Issuing Bank and&#47;or (ii) in the case of Bank of America, upon 30 days&#8217; notice to the Borrower, resign as Swingline Lender. In the event of any such resignation as Issuing Bank or Swingline Lender, the Borrower shall be entitled to appoint from among the Lenders a successor Issuing Bank or Swingline Lender hereunder (which successor shall expressly agree to assume such role)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no failure by the Borrower to appoint any such successor shall affect the resignation of such Issuing Bank as an Issuing Bank or (in the case of Bank of America) Swingline Lender, as the case may be. If an Issuing Bank resigns as Issuing Bank, it shall retain all the rights, powers, privileges and duties of an Issuing Bank hereunder with respect to all Letters of Credit issued by it and outstanding as of the effective date of its resignation as Issuing Bank and all L&#47;C Disbursements with respect thereto (including the right to require the Lenders to make Base Rate Loans or fund risk participations in Unreimbursed Amounts pursuant to Section 2.05(c)). If Bank of America resigns as Swingline Lender, it shall retain all the rights of the Swingline Lender provided for hereunder with respect to Swingline Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make Base Rate Loans or fund risk participations in outstanding Swingline Loans pursuant to Section 2.04. Upon the appointment of a successor Issuing Bank and&#47;or Swingline Lender, (a) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuing Bank or Swingline Lender, as the case may be, and (b) the successor Issuing Bank shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to the resigning Issuing Bank to effectively assume the obligations of such Issuing Bank with respect to such Letters of Credit.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Notwithstanding anything to the contrary contained herein, any Lender (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Granting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) may grant to a special purpose funding vehicle identified as such in writing from time to time by the Granting Lender to the Administrative Agent and the Borrower (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SPC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) the option to provide all or any part of any Loan that such Granting Lender would otherwise be obligated to make pursuant to this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that (i) nothing herein shall constitute a commitment by any SPC to fund any Loan&#59; and (ii) if an SPC elects not to exercise such option or otherwise fails to make all or any part of such Loan, the Granting Lender shall be obligated to make such Loan pursuant to the terms hereof. Each party hereto hereby agrees that</font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A) neither the grant to any SPC nor the exercise by any SPC of such option shall increase the costs or expenses or otherwise increase or change the obligations of the Borrower under this Agreement (including its obligations under Section 2.14)&#59; (B) no SPC shall be liable for any indemnity or similar payment obligation under this Agreement for which a Lender would be liable (which indemnity or similar payment obligation shall be retained by the Granting Lender)&#59; and (C) the Granting Lender shall for all purposes, including the approval of any amendment, waiver or other modification of any provision of any Loan Document, remain the lender of record hereunder. The making of a Loan by an SPC hereunder shall utilize the Commitment of the Granting Lender to the same extent, and as if, such Loan were made by such Granting</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_310"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Lender. In furtherance of the foregoing, each party hereto hereby agrees (which agreement shall survive the termination of this Agreement) that, prior to the date that is one year and one day after the payment in full of all outstanding commercial paper or other senior debt of any SPC, it will not institute against, or join any other Person in instituting against, such SPC any bankruptcy, reorganization, arrangement, insolvency or liquidation proceeding under the laws of the United States or any State thereof. Notwithstanding anything to the contrary contained herein, any SPC may (x) with notice to, but without prior consent of the Borrower and the Administrative Agent and with the payment of a processing fee of $3,500, assign all or any portion of its right to receive payment with respect to any Loan to the Granting Lender and</font></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">disclose on a confidential basis any non-public information relating to its funding of Loans to any rating agency, commercial paper dealer or provider of any surety or Guarantee or credit or liquidity enhancement to such SPC.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All representations and warranties made hereunder and in any other Loan Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof. Such representations and warranties have been or will be relied upon by the Administrative Agent and each Lender, regardless of any investigation made by the Administrative Agent or any Lender or on their behalf and notwithstanding that the Administrative Agent or any Lender may have had notice or knowledge of any Default at the time of any Credit Event, and shall continue in full force and effect as long as any Loan or any other Obligation hereunder shall remain unpaid or unsatisfied or any Letter of Credit shall remain outstanding.&#160;&#160;&#160;&#160;The provisions of Sections 2.14, 2.15, 2.16 and 9.03 and Article VIII shall survive and remain in full force and effect regardless of the consummation of the transactions contemplated hereby, the repayment of the Loans, the expiration or termination of the Letters of Credit and the Commitments or the termination of this Agreement or any other Loan Document or any provision hereof or thereof.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts&#59; Integration&#59; Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement, the other Loan Documents and any separate letter agreements with respect to fees payable to the Administrative Agent or any Issuing Bank constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 4.01, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof which, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. Delivery of an executed counterpart of a signature page of this Agreement by telecopy or pdf or other electronic transmission shall be effective as delivery of a manually executed counterpart of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any provision of this Agreement held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">enforceability of the remaining provisions hereof&#59; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Right of Setoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">If an Event of Default shall have occurred and be continuing, each Lender and each of its Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">demand, provisional or final and in whatever currency denominated) at any time held and other obligations at any time owing by such Lender or Affiliate to or for the credit or the account of the Borrower or any other Loan Party against any of and all the Obligations of the Borrower or such other Loan Party now or hereafter existing under this Agreement held by such Lender, irrespective of whether or not such Lender shall have made any demand under this Agreement and although such obligations may be unmatured. The rights of each Lender under this Section are in addition to other rights and remedies (including other rights of setoff) which such Lender may have.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:38pt;padding-right:7.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">To the extent that any payment by or on behalf of the Borrower or any other Loan Party is made to the Administrative Agent, any Issuing Bank or any Lender, or the Administrative Agent, any Issuing Bank or any Lender exercises its right of setoff, and such payment or the proceeds of such setoff or any part thereof is subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by the Administrative Agent, such Issuing Bank or such Lender in its discretion) to be repaid to a trustee, receiver or any other party, in connection with any proceeding under any Debtor Relief Law or otherwise, then (a) to the extent of such recovery, the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such setoff had not occurred, and (b) each Lender and each Issuing Bank severally agrees to pay to the Administrative Agent upon demand its applicable share (without duplication) of any amount so recovered from or repaid by the Administrative Agent, plus interest thereon from the date of such demand to the date such payment is made at a rate per annum equal to the applicable Overnight Rate from time to time in effect, in the applicable currency of such recovery or payment. The obligations of the Lenders and the Issuing Banks under clause (b) of the preceding sentence shall survive the payment in full of the Obligations and the termination of this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law&#59; Jurisdiction&#59; Consent to Service of Process</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">This Agreement shall be construed in accordance with and governed by the law of the State of New York (without regard to the conflict of law principles thereof to the extent that the application of the laws of another jurisdiction would be required thereby).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Borrower and each other Loan Party irrevocably and unconditionally agrees that it will not commence any action, litigation or proceeding of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Administrative Agent, any Lender, any Issuing Bank or any Related Party of the foregoing in any way related to this Agreement in any forum other than the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof. Each of the parties hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or any other Loan Document, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. The foregoing shall not affect any right that the Administrative Agent or any Lender may otherwise have to bring any action or proceeding relating to this Agreement or any other Loan Document against any Loan Party or its properties in the courts of any jurisdiction.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Each of the parties hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or any other Loan Document in any court referred to in paragraph (b) of this Section. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Each Guarantor hereby appoints the Borrower as its agent for service of process with respect to any matters relating to this Agreement or any other Loan Document. Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in Section 9.01. Nothing in this Agreement or any other Loan Document will affect the right of any party to this Agreement to serve process in any other manner permitted by law.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Article and Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each of the Administrative Agent, the Lenders and the Issuing Banks agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its Affiliates and to its and its Affiliates&#8217; respective partners, directors, officers, employees, agents, trustees, advisors and representatives (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to the extent requested or required by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as the National Association of Insurance Commissioners), (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that (other than in the case of any disclosure to a regulator or examiner during a routine examination) to the extent practicable and permitted by law, the Borrower has been notified prior to such disclosure so that the Borrower may seek, at the Borrower&#8217;s sole expense, a protective order or other appropriate remedy), (d) to any other party hereto, (e) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (f) subject to an agreement containing provisions substantially the same as those of this Section, to (i) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or any Eligible Assignee invited to be a Lender pursuant to Section 2.19 or (ii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction or other transaction under which payments are to be made by reference to a Loan Party and its obligations, this Agreement or payments hereunder or (iii) any insurers and&#47;or risk protection </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:37.95pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">providers relating to the transactions contemplated under this Agreement, (g) with the consent of any Loan Party, (h) to the extent such Information (x) becomes publicly available other than as a result of a breach of this Section or (y) becomes available to the Administrative Agent, any Lender, any Issuing Bank or any of their respective Affiliates on a nonconfidential basis from a source other than a Loan Party, (i) to any nationally recognized rating agency that requires access to information about a Lender&#8217;s investment portfolio in connection with ratings issued with respect to such Lender (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, prior to any such disclosure, such rating agency shall undertake in writing to preserve the confidentiality of any confidential Information relating to the Loan Parties), (j) in customary disclosure about the terms of the financing contemplated hereby in the ordinary course of business to market data collectors and similar service providers to the loan industry for league table purposes or (k) on a confidential basis to (i) the provider of any Platform or other electronic delivery service used by the Administrative Agent, any Issuing Bank or the Swingline Lender to deliver Borrower Materials or notices to the Lenders, (ii) the CUSIP Service Bureau or any similar agency in connection with the application, issuance, publishing and monitoring of CUSIP numbers or other market identifiers with respect to the credit facilities provided hereunder or (iii) other service providers to the Administrative Agent, the Lenders and the Issuing Banks in connection with the administration of this Agreement, the other Loan Documents and the Borrowings hereunder. For purposes of this Section, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all information received from the Borrower or any Subsidiary relating to the Borrower or any Subsidiary or any of their respective businesses, other than any such information that is available to the Administrative Agent, any Lender or any Issuing Bank on a nonconfidential basis prior to disclosure by the Borrower or any Subsidiary. Any Person required to maintain the confidentiality of Information as provided in this Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each of the Administrative Agent, the Lenders and the Issuing Banks acknowledges that</font></div><div style="padding-left:37.95pt;padding-right:7.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) the Information may include material non-public information concerning the Borrower or a Subsidiary, as the case may be, (b) it has developed compliance procedures regarding the use of material non-public information and (c) it will handle such material non-public information in accordance with applicable Law, including United States Federal and state securities Laws.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.13 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">USA PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Lender that is subject to the Act (as hereinafter defined) and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), it is required to obtain, verify and record information that identifies the Borrower and each other Loan Party, which information includes the name and address of the Borrower and each other Loan Party and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower and each other Loan Party in accordance with the Act. The Borrower and each other Loan Party shall, promptly following a request by the Administrative Agent or any Lender, provide all documentation and other information that the Administrative Agent or such Lender requests in order to comply with its ongoing obligations under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the Act and the Beneficial Ownership Regulation.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.14 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rate Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary contained in any Loan Document, if at any time the interest rate applicable to any Loan, together with all fees, charges and other amounts which are treated as interest on such Loan under applicable Law (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Charges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), shall exceed the maximum lawful rate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) which may be contracted for, charged, taken, received or reserved by the Lender holding such Loan in accordance with applicable Law, the rate of interest payable in respect of such Loan hereunder, together with all Charges payable in respect thereof, shall be limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:37.95pt;padding-right:7.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">been payable in respect of such Loan but were not payable as a result of the operation of this Section shall be cumulated and the interest and Charges payable to such Lender in respect of other Loans or periods shall be increased (but not above the Maximum Rate therefor) until such cumulated amount, together with interest thereon at the Federal Funds Effective Rate to the date of repayment, shall have been received by such Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.15 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Fiduciary Duty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In connection with all aspects of each transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document), the Borrower and each other Loan Party acknowledges and agrees, and acknowledges its Affiliates&#8217; understanding, that&#58; (i) (A) the arranging and other services regarding this Agreement provided by the Administrative Agent, the Arrangers and the Lenders are arm&#8217;s-length commercial transactions between the Borrower, each other Loan Party and their respective Affiliates, on the one hand, and the Administrative Agent, the Arrangers and</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_313"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Lenders, on the other hand, (B) the Borrower and each other Loan Parties has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and</font></div><div style="padding-left:38pt;padding-right:6.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.02pt">the Borrower and each other Loan Party is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents&#59; (ii) (A) the Administrative Agent, each Arranger and each Lender is and has been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for the Borrower, any other Loan Party or any of their respective Affiliates, or any other Person and (B) neither the Administrative Agent nor any Arranger nor any Lender has any obligation to the Borrower, any other Loan Party or any of their respective Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Loan Documents&#59; and (iii) the Administrative Agent, the Arrangers, the Lenders and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrower, the other Loan Parties and their respective Affiliates, and neither the Administrative Agent nor any Arranger nor any Lender has any obligation to disclose any of such interests to the Borrower, any other Loan Party or any of their respective Affiliates. To the fullest extent permitted by law, the Borrower and each other Loan Parties hereby waives and releases any claims that it may have against the Administrative Agent, the Arrangers and the Lenders with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated hereby.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:15.2pt;padding-right:15.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Execution of this Agreement and Other Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">The words &#8220;execute,&#8221; &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in or related to any document to be signed in connection with this Agreement and the transactions contemplated hereby (including this Agreement, any other Loan Document, Assignment and Assumptions, amendments or other modifications, Borrowing Requests, Swingline Loan Notices, waivers and consents) shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">This Agreement, any Loan Document and any other Communication, including Communications required to be in writing, may be in the form of an Electronic Record and may be executed using Electronic Signatures. Each of the parties hereto agrees that any Electronic Signature on or associated with any Communication shall be valid and binding on the applicable party to the same extent as a manual, original signature, and that any Communication entered into by Electronic Signature, will constitute the legal, valid and binding obligation of such party enforceable against such party in accordance with the terms thereof to the same extent as if a manually executed original signature was delivered. Any Communication may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts are one and the same Communication. For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_316"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">acceptance of a manually signed paper Communication which has been converted into electronic form (such as scanned into PDF format), or an electronically signed Communication converted into another format, for transmission, delivery and&#47;or retention. The Loan Parties, the Administrative Agent and each of the Lenders and the Issuing Banks may, at its option, create one or more copies of any Communication in the form of an imaged Electronic Record (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Copy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which shall be deemed created in the ordinary course of such Person&#8217;s business, and destroy the original paper document. All Communications in the form of an Electronic Record, including an Electronic Copy, shall be considered an original for all purposes, and shall have the same legal effect, validity and enforceability as a paper record.</font></div><div style="padding-left:37.95pt;padding-right:4.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything contained herein to the contrary, neither the Administrative Agent, any Issuing Bank nor the Swingline Lender is under any obligation to accept an Electronic Signature in any form or in any format unless expressly agreed to by such Person pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, without limiting the foregoing, (i) to the extent the Administrative Agent, any Issuing Bank and&#47;or the Swingline Lender has agreed to accept such Electronic Signature, the Loan Parties, the Administrative Agent and each of the Lenders and the Issuing Banks shall be entitled to rely on any such Electronic Signature purportedly given by or on behalf of any party hereto without further verification and regardless of the appearance or form of such Electronic Signature, and (ii) upon the request of the Administrative Agent, any Lender or any Issuing Bank, any Communication executed using an Electronic Signature shall be promptly followed by a manually executed counterpart.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Neither the Administrative Agent, any Issuing Bank nor the Swingline Lender shall be responsible for or have any duty to ascertain or inquire into the sufficiency, validity, enforceability, effectiveness or genuineness of any Loan Document or any other agreement, instrument or document (including, for the avoidance of doubt, in connection with the Administrative Agent&#8217;s, any Issuing Bank&#8217;s or the Swingline Lender&#8217;s reliance on any Electronic Signature transmitted by telecopy, emailed .pdf or any other electronic means). The Administrative Agent, any Issuing Bank and the Swingline Lender shall be entitled to rely on, and shall incur no liability under or in respect of this Agreement or any other Loan Document by acting upon, any Communication or any statement made to it orally or by telephone and believed by it to be genuine and signed or sent or otherwise authenticated (whether or not such Person in fact meets the requirements set forth in the Loan Documents for being the maker thereof).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:4.95pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">Each of the Loan Parties, the Administrative Agent, each Issuing Bank and each Lender hereby waive (i) any argument, defense or right to contest the legal effect, validity or enforceability of this Agreement or any other Loan Document based solely on the lack of paper original copies of this Agreement and&#47;or such other Loan Document, and (ii) any claim against the Administrative Agent, each Issuing Bank, each Lender and each of its respective Related Party for any liabilities arising solely from the Administrative Agent&#8217;s, any Issuing Bank&#8217;s and&#47;or any Lender&#8217;s reliance on or use of Electronic Signatures, including any liabilities arising as a result of the failure of the Loan Parties to use any available security measures in connection with the execution, delivery or transmission of any Electronic Signature.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.95pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Each of the parties hereto represents and warrants to the other parties hereto that it has the corporate capacity and authority to execute this Agreement and any other Communication through electronic means and there are no restrictions on doing so in that party&#8217;s constitutive documents.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.17 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Joint and Several</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Obligations under the Loan Documents may be enforced by the Administrative Agent and the Lenders against the Borrower or any Loan Party or all Loan Parties in any manner or order selected by the Administrative Agent or the Required Lenders in their sole discretion. The Borrower and each Loan Party hereby irrevocably waives</font></div><div style="padding-left:37.95pt;padding-right:7.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) any rights of subrogation and (ii) any rights of contribution, indemnity or reimbursement, in each case, that it may acquire or that may arise against the Borrower or any other Loan Party </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:37.95pt;padding-right:7.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">due to any payment or performance made under this Agreement, in each case until all Obligations shall have been fully satisfied.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.18 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary contained herein or in any other Loan Document, the authority to enforce rights and remedies hereunder and under the other Loan Documents against the Loan Parties or any of them shall be vested exclusively in, and all actions and proceedings at law in connection with such enforcement shall be instituted and maintained exclusively by, the Administrative Agent in accordance with Article VII for the benefit of all the Lenders and the Issuing Banks&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, however, that the foregoing shall not prohibit (a) the Administrative Agent from exercising on its own behalf the rights and remedies that inure to its benefit (solely in its capacity as Administrative Agent) hereunder and under the other Loan Documents, (b) each Issuing Bank or the Swingline Lender from exercising the rights and remedies that inure to its benefit (solely in its capacity as Issuing Bank or Swingline Lender, as the case may be) hereunder and under the other Loan Documents,</font></div><div style="padding-left:38pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">any Lender from exercising setoff rights in accordance with Section 9.08 (subject to the terms of Section 2.17(c)), or (d) any Lender from filing proofs of claim or appearing and filing pleadings on its own behalf during the pendency of a proceeding relative to any Loan Party under any Debtor Relief Law&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if at any time there is no Person acting as Administrative Agent hereunder and under the other Loan Documents, then (i) the Required Lenders shall have the rights otherwise ascribed to the Administrative Agent pursuant to Article VII and (ii) in addition to the matters set forth in clauses (b), (c) and (d) of the preceding proviso and subject to Section 2.17(c), any Lender may, with the consent of the Required Lenders, enforce any rights and remedies available to it and as authorized by the Required Lenders.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.19 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Netherlands Loan Party Representation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If any Loan Party incorporated under the laws of the Netherlands, including the Borrower, is represented by an attorney in connection with the signing and&#47;or execution of this Agreement (including by way of accession to this Agreement) or any other agreement, deed or document referred to in or made pursuant to this Agreement, it is hereby expressly acknowledged and accepted by the other parties to this Agreement that the existence and extent of the attorney&#8217;s authority and the effects of the attorney&#8217;s exercise or purported exercise of his or her authority shall be governed by the laws of the Netherlands.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.20 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the write-down and</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_319"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">conversion powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an Affected Financial Institution&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the effects of any Bail-in Action on any such liability, including, if applicable&#59;</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_322"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:5.8pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-left:72pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) a reduction in full or in part or cancellation of any such liability</font></div><div style="padding-left:0.38pt;padding-right:5.8pt;text-align:justify;text-indent:0.72pt"><font><br></font></div><div style="padding-left:72pt;padding-right:5.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) a conversion of all, or a portion of, such liability into share or other instruments of ownership in such Affected Financial Institution, its parent entity, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="padding-right:5.8pt"><font><br></font></div><div style="padding-left:72pt;padding-right:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) the variation of the terms of such liability in connection with the exercise of the write-down and conversion powers of the applicable Resolution Authority.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.21 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement Regarding Any Supported QFCs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any Swap Agreement or any other agreement or instrument that is a QFC (such support, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">QFC Credit Support</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and each such QFC a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Supported QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Special Resolution Regimes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and&#47;or of the United States or any other state of the United States)&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">In the event a Covered Entity that is party to a Supported QFC (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_325"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:146pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">As used in this Section 9.21, the following terms have the following</font></div><div style="padding-left:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">meanings&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">BHC Act Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; of a party means an &#8220;affiliate&#8221; (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the following&#58; (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b)&#59; (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b)&#59; or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.15pt;text-align:justify;text-indent:40.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Default Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.2pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to the term &#8220;qualified financial contract&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.22 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment and Restatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The parties hereto agree that, on the Closing Date, the following transactions shall be deemed to occur automatically, without further action by any party hereto&#58; (a) the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement shall be deemed to be amended and restated in its entirety pursuant to this Agreement, (b) all Obligations (as defined in the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement) under the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement shall be deemed to be Obligations outstanding hereunder and (c) all references in the other Loan Documents to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement shall be deemed to refer without further amendment to this Agreement. Further to the foregoing, the amendment of the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement in the form of this Agreement shall not constitute a novation of any amount owing under the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement or any other Loan Document and all amounts owing in respect of principal, interest, fees and other amounts pursuant to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Existing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement and the other Loan Documents shall, to the extent not paid or otherwise extinguished on the Closing Date, continue to be owing under this Agreement or such other Loan Documents until paid in accordance herewith and therewith.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:17.45pt;padding-right:17.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE X</font></div><div><font><br></font></div><div style="padding-left:17.5pt;padding-right:17.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Guarantee</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each of the Guarantors hereby, jointly and severally, unconditionally and irrevocably, guarantees to the Administrative Agent for its benefit and for the benefit of the Lender Parties, and their permitted indorsees, transferees and assigns, the prompt and complete payment and performance of the Obligations. Anything herein or in any other Loan Document to the contrary notwithstanding, the maximum liability of each Guarantor hereunder and under the other Loan Documents in respect of the Obligations shall in no event exceed the amount which can be guaranteed by such Guarantor under applicable Federal and</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_328"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:37.95pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">state laws relating to the insolvency of debtors (after giving effect to the right of contribution established in Section 10.02). Each Guarantor agrees that the Obligations may at any time and from time to time exceed the amount of the liability of such Guarantor hereunder without impairing the guarantee contained in this Section 10.01 or affecting the rights and remedies of the Administrative Agent or any other Lender Party hereunder. The guarantee contained in this Section 10.01 shall remain in full force and effect until all the Obligations (other than contingent indemnification and contingent expense reimbursement obligations) shall have been satisfied by payment in full in cash, no Letter of Credit shall be outstanding or each outstanding Letter of Credit has been Cash Collateralized, so that it is fully secured to the satisfaction of the Administrative Agent and the Commitments shall be irrevocably terminated, notwithstanding that from time to time any Loan Party may be free from any of the Obligations. Except as provided in Section 10.12, no payment made by any of the Guarantors, any other Loan Party or any other Person or received or collected by the Administrative Agent or any Lender from any of the Guarantors, any other guarantor or any other Person by virtue of any action or proceeding or any set-off or appropriation or application at any time or from time to time in reduction of or in payment of the Obligations shall be deemed to modify, reduce, release or otherwise affect the liability of any Guarantor hereunder which shall, notwithstanding any such payment (other than any payment made by such Guarantor in respect of the Obligations or any payment received or collected from such Guarantor in respect of the Obligations), remain liable for the Obligations up to the maximum liability of such Guarantor hereunder until the Obligations are paid in full in cash, either no Letter of Credit shall be outstanding or each outstanding Letter of Credit has been Cash Collateralized so that it is fully secured to the satisfaction of the Administrative Agent and the Commitments are irrevocably terminated. Notwithstanding any other provision of this Article X (Guarantee) the guarantee and other obligations of any Guarantor organized under the laws of the Netherlands expressed to be assumed in this Article X (Guarantee) shall be deemed not to be assumed by such Guarantor organized under the laws of the Netherlands to the extent that the same would constitute unlawful financial assistance within the meaning of Article 2&#58;98c of the Dutch Civil Code or any other applicable financial assistance rules under any relevant jurisdiction (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prohibition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the provisions of this Agreement and the other Loan Documents shall be construed accordingly. For the avoidance of doubt it is expressly acknowledged that the relevant Guarantors organized under the laws of the Netherlands will continue to guarantee all such obligations which, if included, do not constitute a violation of the Prohibition.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:1.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Right of Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Guarantor hereby agrees that to the extent that a Guarantor shall have paid more than its proportionate share of any payment made hereunder, such Guarantor shall be entitled to seek and receive contribution from and against any other Guarantor hereunder which has not paid its proportionate share of such payment. Each Guarantor&#8217;s right of contribution shall be subject to the terms and conditions of Section 10.03. The provisions of this Section 10.02 shall in no respect limit the obligations and liabilities of any Loan Party to the Administrative Agent and the Lender Parties, and each Guarantor shall remain liable to the Administrative Agent and the Lender Parties for the full amount guaranteed by such Guarantor hereunder.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Subrogation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any payment made by any Guarantor hereunder or any set-off or application of funds of any Guarantor by the Administrative Agent or any other Lender Party, no Guarantor shall seek to enforce any right of subrogation in respect of any of the rights of the Administrative Agent or any other Lender Party against any Loan Party or any collateral security or guarantee or right of offset held by the Administrative Agent or any other Lender Party for the payment of the Obligations, nor shall any Guarantor seek any contribution or reimbursement from any other Loan Party in respect of payments made by such Guarantor under this Article X, until all amounts owing to the Administrative Agent and the other Lender Parties by the Loan Parties on account of the Obligations are paid in full, either no Letter of Credit shall be outstanding or each outstanding Letter of Credit has been Cash Collateralized so that it is fully secured to the satisfaction of the Administrative Agent and the </font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Commitments are irrevocably terminated. If any amount shall be paid to any Guarantor on account of such subrogation rights at any time when all of the Obligations shall not have been paid in full, such amount shall be held by such Guarantor in trust for the Administrative Agent and the other Lender Parties, segregated from other funds of such Guarantor, and shall, forthwith upon receipt by such Guarantor, be turned over to the Administrative Agent in the exact form received by such Guarantor (duly indorsed by such Guarantor to the Administrative Agent, if required), to be applied against the Obligations, whether matured or unmatured, in such order as the Administrative Agent may determine. For the avoidance of doubt, nothing in the foregoing agreement by the Guarantor shall operate as a waiver of any subrogation rights.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments, etc., with Respect to the Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the fullest extent permitted by applicable law, each Guarantor shall remain obligated hereunder notwithstanding that, without any reservation of rights against any Loan Party and without notice to or further assent by any Loan Party, any demand for payment of any of the Obligations made by the Administrative Agent or any other Lender Party may be rescinded by the Administrative Agent or such Lender Party and any of the Obligations continued, and the Obligations, or the liability of any other Person upon or for any part thereof, or any collateral security or guarantee therefor or right of offset with respect thereto, may, from time to time, in whole or in part, be renewed, extended, amended, modified, accelerated, compromised, waived, surrendered or released by the Administrative Agent or any other Lender Party, and this Agreement and the other Loan Documents, any other documents executed and delivered in connection therewith, may be amended, modified, supplemented or terminated, in whole or in part, as the Administrative Agent (or the Required Lenders or all Lenders, as the case may be) may deem reasonably advisable from time to time, and any collateral security, guarantee or right of offset at any time held by the Administrative Agent or any other Lender Party for the payment of the Obligations may be sold, exchanged, waived, surrendered or released.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantee Absolute and Unconditional</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the fullest extent permitted by applicable law, each Guarantor waives any and all notice of the creation, renewal, extension or accrual of any of the Obligations and notice of or proof of reliance by the Administrative Agent or any other Lender Party upon the guarantee contained in this Article X or acceptance of the guarantee contained in this Article X&#59; the Obligations, and any of them, shall conclusively be deemed to have been created, contracted or incurred, or renewed, extended, amended or waived, in reliance upon the guarantee contained in this Article X&#59; and all dealings between the Borrower and the Guarantors, on the one hand, and the Administrative Agent and the other Lender Parties, on the other hand, likewise shall be conclusively presumed to have been had or consummated in reliance upon the guarantee contained in this Article X. To the fullest extent permitted by applicable law, each Guarantor waives diligence, presentment, protest,</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_331"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">demand for payment and notice of default or nonpayment to or upon any of the Guarantors with respect to the Obligations. Each Guarantor understands and agrees that the guarantee contained in this Article X, to the fullest extent permitted by applicable Laws, shall be construed as a continuing, absolute and unconditional guarantee of payment (and not of collection) without regard to (a) the validity or enforceability of this Agreement or any other Loan Document, any of the Obligations or any other collateral security therefor or guarantee or right of offset with respect thereto at any time or from time to time held by the Administrative Agent or any other Lender Party, (b) any defense, set-off or counterclaim (other than a defense of payment or performance) which may at any time be available to or be asserted by the Borrower, any other Loan Party or any other Person against the Administrative Agent or any other Lender Party or (c) any other circumstance whatsoever (with or without notice to or knowledge of such Guarantor) which constitutes, or might be construed to constitute, an equitable or legal discharge of such Guarantor under the guarantee contained in this Article X, in bankruptcy or in any other instance. When making any demand hereunder or otherwise pursuing its rights and remedies hereunder against any Guarantor, the Administrative Agent or any other Lender Party may, but shall be under no obligation to, make a similar demand on or otherwise pursue such rights and remedies as it may have against any Guarantor or any other Person or against any collateral security or guarantee for the Obligations or any right of offset with respect thereto, and any failure by the Administrative Agent or any other Lender Party to make any such demand, to pursue such other rights or remedies or to collect any payments from any other Guarantor or any other Person or to realize upon any such collateral security or guarantee or to exercise any such right of offset, or any release of any other Guarantor or any other Person or any such collateral security, guarantee or right of offset, shall not relieve any Guarantor of any obligation or liability hereunder, and shall not impair or affect the rights and remedies, whether express, implied or available as a matter of law, of the Administrative Agent or any Lender Party against any Guarantor. For the purposes hereof &#8220;demand&#8221; shall include the commencement and continuance of any legal proceedings</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reinstatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to Section 5.09 and Section 10.12, this Guarantee Agreement is a continuing and irrevocable guaranty of all Obligations now or hereafter existing and shall remain in full force and effect until all Obligations and any other amounts payable under this Guarantee Agreement are indefeasibly paid in full in cash and the Revolving Commitments with respect to the Obligations are terminated. Notwithstanding the foregoing, this Guarantee Agreement shall continue in full force and effect or be revived, as the case may be, if any payment by or on behalf of the Borrower or any Guarantor is made, or any of the Lender Parties exercises its right of setoff, in respect of the Obligations and such payment or the proceeds of such setoff or any part thereof is subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by any of the Lender Parties in their discretion) to be repaid to a trustee, receiver or any other party, in connection with any proceeding under any Debtor Relief Laws or otherwise, all as if such payment had not been made or such setoff had not occurred and whether or not the Lender Parties are in possession of or have released this Guarantee Agreement and regardless of any prior revocation, rescission, termination or reduction. The obligations of each Guarantor under this paragraph shall survive termination of this Guarantee Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations Independent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The obligations of each Guarantor hereunder are those of primary obligor, and not merely as surety, and are independent of the</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_334"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:8.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Obligations and the obligations of any other guarantor, and a separate action may be brought against each Guarantor to enforce this Guarantee whether or not the Borrower or any other Person or entity is joined as a party.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:6.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.08 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All payments by each Guarantor under this Guarantee Agreement shall be made in the manner, at the place and in the currency for payment required by this Agreement and the other Loan Documents&#59; provided, however, that (if the currency for payment required by this Agreement is other than Dollars) such Guarantor may, at its option (or, if for any reason whatsoever such Guarantor is unable to effect payments in the foregoing manner, such Guarantor shall be obligated to) pay to the Administrative Agent at the Administrative Agent&#8217;s Office the Dollar Equivalent of the amount of such Obligations together with any other amounts due pursuant to Section 2.15. In any case in which a Guarantor makes or is obligated to make payment in Dollars, such Guarantor shall hold the Administrative Agent harmless from any loss incurred by the Administrative Agent arising from any change in the value of Dollars in relation to the currency for payment required by this Agreement between the date the Obligation becomes due and the date the Administrative Agent is actually able, following the conversion of the Dollars paid by such Guarantor into the currency for payment required by this Agreement and remittance of such currency to the place where such Obligation is payable, to apply such payment to such Obligation. The obligations of each Guarantor hereunder shall not be affected by any acts of any legislative body or Governmental Authority affecting such Guarantor or the Borrower, including but not limited to, any restrictions on the conversion of currency or repatriation or control of funds or any total or partial expropriation of such Guarantor&#8217;s or the Borrower&#8217;s property, or by economic, political, regulatory or other events in the countries where such Guarantor or the Borrower is located.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:5.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.09 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subordination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Guarantor hereby subordinates the payment of all obligations and indebtedness of the Borrower owing to each Guarantor, whether now existing or hereafter arising, including but not limited to any obligation of the Borrower to such Guarantor as subrogee of the Lender Parties or resulting from such Guarantor&#8217;s performance under this Guarantee Agreement, to the indefeasible payment in full in cash of all Obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the foregoing subordination shall not be given effect until such time as the Lender Parties shall have made a request to the Borrower pursuant to the second sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font></div><div style="padding-left:38pt;padding-right:7.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">10.9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:10pt">At any time any Event of Default shall have occurred and be continuing, if the Lender Parties so request, any such obligation or indebtedness of any Loan Party to any Guarantor shall be enforced and performance received by such Guarantor as trustee for the Lender Parties and the proceeds thereof shall be paid over to the Lender Parties on account of the Obligations, but without reducing or affecting in any manner the liability of such under this Guarantee Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37.95pt;padding-right:7.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Stay of Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If acceleration of the time for payment of any of the Obligations is stayed, in connection with any case commenced by or against any Loan Party under any Debtor Relief Laws, or otherwise, all such amounts shall nonetheless be payable by such Guarantor immediately upon demand by the Lender Parties.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Condition of Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Guarantor acknowledges and agrees that it has the sole responsibility for, and has adequate means of, obtaining from the Borrower and any other guarantor such information concerning the financial condition, business and operations of the Borrower and any such other guarantor as each such Guarantor requires, and that none of the Lender Parties has any duty, and each Guarantor is not relying on the Lender Parties at any time, to disclose to each such Guarantor any information relating to the business, operations or financial condition of the Borrower or any other guarantor (each Guarantor waiving any duty on the part of the Lender Parties to disclose such information and any defense relating to the failure to provide the same).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:38pt;padding-right:7.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Releases</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. At such time as the Loans, the amounts owed to any Issuing Bank in respect of Letter of Credit and the other Obligations (other than contingent indemnification and contingent expense reimbursement obligations) shall have been paid in full, the Commitments have been terminated and either no Letter of Credit shall be outstanding or each outstanding Letter of Credit has been Cash Collateralized so that it is fully secured to the reasonable satisfaction of the Administrative Agent, this Agreement and all obligations (other than those expressly stated to survive such termination) of the Administrative Agent and each Guarantor hereunder shall terminate, all without delivery of any instrument or performance of any act by any party. The Guarantee of any Guarantor that is a Subsidiary of the Borrower hereunder shall be released to the extent (and in the manner) expressly set forth in Section 5.09 or in the event such Guarantor ceases to be a Subsidiary in a transaction not prohibited by the terms of this Agreement.</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:70.22pt;padding-right:70.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE XI</font></div><div><font><br></font></div><div style="padding-left:70.37pt;padding-right:70.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Certain ERISA Matters</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certain ERISA Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:6.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.7pt">Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and each Arranger and not, for the avoidance of doubt, to or for the benefit of the Borrower or any other Loan Party, that at least one of the following is and will be true&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:5.35pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.69pt">such Lender is not using &#8220;plan assets&#8221; (within the meaning of Section 3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments or this Agreement&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement,</font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ieebcc50b69f64208afaed04958d3857c_337"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:3.05pt;padding-left:38pt;padding-right:5.25pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.03pt">(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84- 14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.69pt">such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:38pt;padding-right:7.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">In addition, unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and each Arranger and not, for the avoidance of doubt, to or for the benefit of the Borrower or any other Loan Party, that none of the Administrative Agent or any Arranger is a fiduciary with respect to the assets of such Lender involved in such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:132.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Signature</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Remainder of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Page</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">s Follow </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intentionally Left Blank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:4.245%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>4
<FILENAME>ex_22xvtrsx20230331.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i25ddb184dd5a4c938aaed96ad404eaf6_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 22</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">List of Subsidiary Guarantors and Issuers of Guaranteed Securities</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of March 31, 2023, Viatris Inc., a Delaware corporation (&#8220;Viatris&#8221;), Mylan Inc., a Pennsylvania corporation (&#8220;Mylan Inc.&#8221;), and Mylan II B.V., a company incorporated under the laws of the Netherlands (&#8220;Mylan II&#8221;), were the guarantors of the 3.950% Senior Notes due 2026 and 5.250% Senior Notes due 2046 issued by Utah Acquisition Sub Inc., a Delaware corporation (&#8220;Utah&#8221;).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of March 31, 2023, Viatris, Utah and Mylan II were the guarantors of the 4.200% Senior Notes due 2023, 4.550% Senior Notes due 2028, 5.400% Senior Notes due 2043 and 5.200% Senior Notes due 2048 issued by Mylan Inc.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of March 31, 2023, Utah, Mylan Inc. and Mylan II were the guarantors of the 1.650% Senior Notes due 2025,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.300% Senior Notes due 2027, 2.700% Senior Notes due 2030, 3.850% Senior Notes due 2040 and 4.000% Senior Notes due 2050 issued by Viatris.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ex_311xvtrsx20230331.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iaa0136c9d8e348aa84ab1584ff5ac846_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit&#160;31.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Certification of Principal Executive Officer Pursuant to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">I, Scott A. Smith, certify that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.&#160;I have reviewed this quarterly report on Form&#160;10-Q of Viatris Inc.&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4.&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5.&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; SCOTT A. SMITH</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scott A. Smith</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Date&#58; May&#160;8, 2023</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ex_312xvtrsx20230331.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie6a3c01de7e445e88d4e50311abfd8e4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit&#160;31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Certification of Principal Financial Officer Pursuant to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">I, Sanjeev Narula, certify that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.&#160;I have reviewed this quarterly report on Form&#160;10-Q of Viatris Inc.&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4.&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5.&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.749%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.051%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; SANJEEV NARULA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanjeev Narula</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Date&#58; May&#160;8, 2023</font></div><div style="margin-top:9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>ex_32xvtrsx20230331.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8461bf1411c348c182cd6eb59339fa8b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit&#160;32</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In connection with the Quarterly Report on Form&#160;10-Q of Viatris Inc. (the &#8220;Company&#8221;) for the period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to his knowledge&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.&#160;The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59;&#160;and</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.749%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.051%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; SCOTT A. SMITH</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scott A. Smith</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; SANJEEV NARULA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanjeev Narula</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Date&#58; May&#160;8, 2023</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The foregoing certification is being furnished in accordance with Securities and Exchange Commission Release No.&#160;34-47551 and shall not be considered filed as part of the Form&#160;10-Q.</font></div><div style="margin-top:9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>vtrs-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4f7b9844-2b6e-46d6-b212-7616af324858,g:ca8e76fc-c8f0-4b96-ac37-00e89e4a2911-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vtrs="http://www.viatris.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.viatris.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.viatris.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfOperations" roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations">
        <link:definition>0000002 - Statement - Condensed Consolidated Statements Of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveLoss" roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>0000003 - Statement - Condensed Consolidated Statements Of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000004 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquity" roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquity">
        <link:definition>0000006 - Statement - Consolidated Statements of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements Of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingAgreements" roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreements">
        <link:definition>0000008 - Statement - Collaboration and Licensing Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="General" roleURI="http://www.viatris.com/role/General">
        <link:definition>0000009 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivable" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable">
        <link:definition>0000010 - Disclosure - Revenue Recognition and Accounts Receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentAccountingPronouncements" roleURI="http://www.viatris.com/role/RecentAccountingPronouncements">
        <link:definition>0000011 - Disclosure - Recent Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactions" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactions">
        <link:definition>0000012 - Disclosure - Acquisitions and Other Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Divestitures" roleURI="http://www.viatris.com/role/Divestitures">
        <link:definition>0000013 - Disclosure - Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlan" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlan">
        <link:definition>0000014 - Disclosure - Share-Based Incentive Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherPostretirementBenefits" roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefits">
        <link:definition>0000015 - Disclosure - Pensions and Other Postretirement Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://www.viatris.com/role/BalanceSheetComponents">
        <link:definition>0000016 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperOrdinaryShare" roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShare">
        <link:definition>0000017 - Disclosure - Earnings (Loss) per Ordinary Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssets">
        <link:definition>0000018 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagement" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagement">
        <link:definition>0000019 - Disclosure - Financial Instruments and Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.viatris.com/role/Debt">
        <link:definition>0000020 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarnings" roleURI="http://www.viatris.com/role/ComprehensiveEarnings">
        <link:definition>0000021 - Disclosure - Comprehensive Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.viatris.com/role/SegmentInformation">
        <link:definition>0000022 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.viatris.com/role/Restructuring">
        <link:definition>0000023 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.viatris.com/role/IncomeTaxes">
        <link:definition>0000024 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Litigation" roleURI="http://www.viatris.com/role/Litigation">
        <link:definition>0000025 - Disclosure - Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralPolicies" roleURI="http://www.viatris.com/role/GeneralPolicies">
        <link:definition>0000026 - Disclosure - General (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationPolicies" roleURI="http://www.viatris.com/role/SegmentInformationPolicies">
        <link:definition>0000027 - Disclosure - Segment Information (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableTables" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables">
        <link:definition>0000028 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsTables" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables">
        <link:definition>0000029 - Disclosure - Acquisitions and Other Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanTables" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanTables">
        <link:definition>0000030 - Disclosure - Share-Based Incentive Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherPostretirementBenefitsTables" roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables">
        <link:definition>0000031 - Disclosure - Pensions and Other Postretirement Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.viatris.com/role/BalanceSheetComponentsTables">
        <link:definition>0000032 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperOrdinaryShareTables" roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareTables">
        <link:definition>0000033 - Disclosure - Earnings (Loss) per Ordinary Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>0000034 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementTables" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables">
        <link:definition>0000035 - Disclosure - Financial Instruments and Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.viatris.com/role/DebtTables">
        <link:definition>0000036 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarningsTables" roleURI="http://www.viatris.com/role/ComprehensiveEarningsTables">
        <link:definition>0000037 - Disclosure - Comprehensive Earnings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.viatris.com/role/SegmentInformationTables">
        <link:definition>0000038 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringTables" roleURI="http://www.viatris.com/role/RestructuringTables">
        <link:definition>0000039 - Disclosure - Restructuring (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableNarrativeDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails">
        <link:definition>0000040 - Disclosure - Revenue Recognition and Accounts Receivable (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails">
        <link:definition>0000041 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails">
        <link:definition>0000042 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails">
        <link:definition>0000043 - Disclosure - Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" roleURI="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details">
        <link:definition>0000044 - Disclosure - Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsNarrativeDetails" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails">
        <link:definition>0000045 - Disclosure - Acquisitions and Other Transactions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails">
        <link:definition>0000046 - Disclosure - Acquisitions and Other Transactions (Purchase Price Allocations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails">
        <link:definition>0000047 - Disclosure - Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresDetails" roleURI="http://www.viatris.com/role/DivestituresDetails">
        <link:definition>0000048 - Disclosure - Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanNarrativeDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails">
        <link:definition>0000049 - Disclosure - Share-Based Incentive Plan (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanStockAwardsDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails">
        <link:definition>0000050 - Disclosure - Share-Based Incentive Plan (Stock Awards) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails">
        <link:definition>0000051 - Disclosure - Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherPostretirementBenefitNarrativeDetails" roleURI="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails">
        <link:definition>0000052 - Disclosure - Pension and Other Postretirement Benefit (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails">
        <link:definition>0000053 - Disclosure - Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails">
        <link:definition>0000054 - Disclosure - Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsInventoriesDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails">
        <link:definition>0000055 - Disclosure - Balance Sheet Components (Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>0000056 - Disclosure - Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPropertyPlantandEquipmentDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails">
        <link:definition>0000057 - Disclosure - Balance Sheet Components (Property, Plant and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOtherAssetsDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails">
        <link:definition>0000058 - Disclosure - Balance Sheet Components (Other Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTradeAccountsPayableDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails">
        <link:definition>0000059 - Disclosure - Balance Sheet Components (Trade Accounts Payable) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOtherCurrentLiabilitiesDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails">
        <link:definition>0000060 - Disclosure - Balance Sheet Components (Other Current Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOtherLongtermObligationsDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails">
        <link:definition>0000061 - Disclosure - Balance Sheet Components (Other Long-term Obligations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails">
        <link:definition>0000062 - Disclosure - Balance Sheet Components - Assets and Liabilities Held For Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperOrdinaryShareNarrativeDetails" roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails">
        <link:definition>0000063 - Disclosure - Earnings (Loss) per Ordinary Share (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails">
        <link:definition>0000064 - Disclosure - Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>0000065 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails">
        <link:definition>0000066 - Disclosure - Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails">
        <link:definition>0000067 - Disclosure - Goodwill and Intangible Assets (Components of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsAmortizationExpenseDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails">
        <link:definition>0000068 - Disclosure - Goodwill and Intangible Assets (Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails" roleURI="http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails">
        <link:definition>0000069 - Disclosure - Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementNarrativeDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails">
        <link:definition>0000070 - Disclosure - Financial Instruments and Risk Management (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails">
        <link:definition>0000071 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails">
        <link:definition>0000072 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails">
        <link:definition>0000073 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails">
        <link:definition>0000074 - Disclosure - Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails">
        <link:definition>0000075 - Disclosure - Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" roleURI="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails">
        <link:definition>0000076 - Disclosure - Debt (Receivables, Securitization Facility and Commercial Paper) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofLongTermDebtDetails" roleURI="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails">
        <link:definition>0000077 - Disclosure - Debt (Summary of Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails" roleURI="http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails">
        <link:definition>0000078 - Disclosure - Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtFairValueNarrativeDetails" roleURI="http://www.viatris.com/role/DebtFairValueNarrativeDetails">
        <link:definition>0000079 - Disclosure - Debt (Fair Value) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtMinimumRepaymentsonOutstandingBorrowingsDetails" roleURI="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails">
        <link:definition>0000080 - Disclosure - Debt (Minimum Repayments on Outstanding Borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails">
        <link:definition>0000081 - Disclosure - Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" roleURI="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails">
        <link:definition>0000082 - Disclosure - Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" roleURI="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails">
        <link:definition>0000083 - Disclosure - Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRestructuringChargesDetails" roleURI="http://www.viatris.com/role/RestructuringRestructuringChargesDetails">
        <link:definition>0000084 - Disclosure - Restructuring (Restructuring Charges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingAgreementsDetails" roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails">
        <link:definition>0000085 - Disclosure - Collaboration and Licensing Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxesDisclosureDetails" roleURI="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails">
        <link:definition>0000086 - Disclosure - Income Taxes Income Taxes Disclosure (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationLorazepamandClorazepateNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails">
        <link:definition>0000087 - Disclosure - Litigation (Lorazepam and Clorazepate) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationPricingandMedicaidLitigationNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails">
        <link:definition>0000088 - Disclosure - Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails">
        <link:definition>0000089 - Disclosure - Litigation (Modafinil Antitrust Litigation and FTC Inquiry) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationPioglitazoneNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationPioglitazoneNarrativeDetails">
        <link:definition>0000090 - Disclosure - Litigation (Pioglitazone) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationShareholderClassActionDetails" roleURI="http://www.viatris.com/role/LitigationShareholderClassActionDetails">
        <link:definition>0000091 - Disclosure - Litigation (Shareholder Class Action) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" roleURI="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails">
        <link:definition>0000092 - Disclosure - Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationDrugPricingMattersDetails" roleURI="http://www.viatris.com/role/LitigationDrugPricingMattersDetails">
        <link:definition>0000093 - Disclosure - Litigation (Drug Pricing Matters) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationEuropeanCommissionProceedingsNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails">
        <link:definition>0000094 - Disclosure - Litigation (European Commission Proceedings) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails">
        <link:definition>0000095 - Disclosure - Litigation (U.K. Competition and Markets Authority) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationProductLiabilityNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails">
        <link:definition>0000096 - Disclosure - Litigation (Product Liability) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationIntellectualPropertyNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails">
        <link:definition>0000097 - Disclosure - Litigation (Intellectual Property) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationOtherLitigationNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails">
        <link:definition>0000098 - Disclosure - Litigation (Other Litigation) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="vtrs_Numberofstates" abstract="false" name="Numberofstates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" abstract="true" name="SeniorNotesTwoThousandTwentyThree3.125PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2020RestructuringPlanMember" abstract="true" name="A2020RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ZoloftMember" abstract="true" name="ZoloftMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_CitalopramLitigationMember" abstract="true" name="CitalopramLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" abstract="true" name="ScheduleofOtherNoncurrentLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_ViatrisIncMember" abstract="true" name="ViatrisIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" abstract="false" name="AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2024EuroSeniorNotes1023Member" abstract="true" name="A2024EuroSeniorNotes1023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_PrivateEquitySecuritiesMember" abstract="true" name="PrivateEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" abstract="true" name="AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_BrandsMember" abstract="true" name="BrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ProgramNameAxis" abstract="true" name="ProgramNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" abstract="false" name="Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_OtherCurrentPortionofLongtermDebtMember" abstract="true" name="OtherCurrentPortionofLongtermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_OtherOneTimeNonoperatingExpense" abstract="false" name="OtherOneTimeNonoperatingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_AmitizaMember" abstract="true" name="AmitizaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2020EuroSeniorNotesMember" abstract="true" name="A2020EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ProgramNameDomain" abstract="true" name="ProgramNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyEightMember" abstract="true" name="SeniorNotesTwoThousandTwentyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_Medicaidandothergovernmentalrebates" abstract="false" name="Medicaidandothergovernmentalrebates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" abstract="false" name="IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" abstract="true" name="AmendedAnticompetitiveConductwithGenericDrugsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" abstract="false" name="StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vtrs_A2032EuroSeniorNotesMember" abstract="true" name="A2032EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" abstract="true" name="SeniorNotesTwoThousandFortySix5.25PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear" abstract="false" name="LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_YENTermLoanMember" abstract="true" name="YENTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EmergingMarketsSegmentMember" abstract="true" name="EmergingMarketsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_DivestitureOfBusinessDeferredCashConsideration" abstract="false" name="DivestitureOfBusinessDeferredCashConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2024EuroSeniorNotesMember" abstract="true" name="A2024EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_YupelriMember" abstract="true" name="YupelriMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_MultiDistrictLitigationMember" abstract="true" name="MultiDistrictLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_NorvascMember" abstract="true" name="NorvascMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" abstract="true" name="A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" abstract="true" name="SeniorNotesTwoThousandTwentySix3.95PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_GreaterChinaSegmentMember" abstract="true" name="GreaterChinaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_EpiPenAutoInjectorsMember" abstract="true" name="EpiPenAutoInjectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_CelebrexMember" abstract="true" name="CelebrexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_Corporatecosts" abstract="false" name="Corporatecosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_XalabrandsMember" abstract="true" name="XalabrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_NumberOfScottishHealthBoardsNHSScotland" abstract="false" name="NumberOfScottishHealthBoardsNHSScotland" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_IntangibleAssetsbyMajorClassLineItems" abstract="true" name="IntangibleAssetsbyMajorClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_DevelopedMarketsSegmentMember" abstract="true" name="DevelopedMarketsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_DymistaMember" abstract="true" name="DymistaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland" abstract="false" name="NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_ProductLiabilityMember" abstract="true" name="ProductLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" abstract="false" name="AccountsReceivableFacilityMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtrs_AccruedSalesAllowances" abstract="false" name="AccruedSalesAllowances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ReceivablesFacilityMember" abstract="true" name="ReceivablesFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_Changeinnoncashlitigationsettlementsnet" abstract="false" name="Changeinnoncashlitigationsettlementsnet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ViagraMember" abstract="true" name="ViagraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandFortyEightMember" abstract="true" name="SeniorNotesTwoThousandFortyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2050SeniorNotesMember" abstract="true" name="A2050SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_GenericsMember" abstract="true" name="GenericsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_NoteSecuritizationFacilityMember" abstract="true" name="NoteSecuritizationFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_XanaxMember" abstract="true" name="XanaxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_VariableConsiderationMember" abstract="true" name="VariableConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ProductRightsAndLicensesMember" abstract="true" name="ProductRightsAndLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_OcularASMember" abstract="true" name="OcularASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2028EuroSeniorNotesMember" abstract="true" name="A2028EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2040SeniorNotesMember" abstract="true" name="A2040SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2025EuroSeniorNotesMember" abstract="true" name="A2025EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2030SeniorNotesMember" abstract="true" name="A2030SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_FamyLifeSciencesMember" abstract="true" name="FamyLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_OtherLongTermDebtMember" abstract="true" name="OtherLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_RevenuefromContractwithCustomerReturns" abstract="false" name="RevenuefromContractwithCustomerReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2027EuroSeniorNotesMember" abstract="true" name="A2027EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_StockholdersEquityParentBeforeTreasuryStock" abstract="false" name="StockholdersEquityParentBeforeTreasuryStock" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_OysterPointPharmaAcquisitionMember" abstract="true" name="OysterPointPharmaAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ComplexGXAndBiosimilarsMember" abstract="true" name="ComplexGXAndBiosimilarsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_CreonMember" abstract="true" name="CreonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" abstract="true" name="SeniorNotesTwoThousandTwentyThree4.2PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_LongTermIncentivePlan2003Member" abstract="true" name="LongTermIncentivePlan2003Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_Numberofcases" abstract="false" name="Numberofcases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_A2025SeniorNotesMember" abstract="true" name="A2025SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" abstract="true" name="ScheduleOfIntangibleAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_RevenuefromContractwithCustomerGross" abstract="false" name="RevenuefromContractwithCustomerGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_JapanAustraliaAndNewZealandSegmentMember" abstract="true" name="JapanAustraliaAndNewZealandSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_BusinessAcquisitionContingentConsiderationPerShare" abstract="false" name="BusinessAcquisitionContingentConsiderationPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights" abstract="false" name="BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" abstract="false" name="ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="vtrs_BioconBiologicsMember" abstract="true" name="BioconBiologicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" abstract="true" name="ScheduleofOtherNoncurrentLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_Otherlongtermassets" abstract="false" name="Otherlongtermassets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_BalanceSheetComponentsAbstract" abstract="true" name="BalanceSheetComponentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_Developmentandsalesmilestonepayments" abstract="false" name="Developmentandsalesmilestonepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandFortyThreeMember" abstract="true" name="SeniorNotesTwoThousandFortyThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_Chargebacks" abstract="false" name="Chargebacks" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" abstract="false" name="ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsReclassifications" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2048SeniorNotesMember" abstract="true" name="A2048SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_SalesRevenueGrosstonetadjustments" abstract="false" name="SalesRevenueGrosstonetadjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_LipitorMember" abstract="true" name="LipitorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_CurrentPortionofLongTermDebtMember" abstract="true" name="CurrentPortionofLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_A2027SeniorNotesMember" abstract="true" name="A2027SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ScheduleofothercurrentliabilitiesLineItems" abstract="true" name="ScheduleofothercurrentliabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity" abstract="false" name="PaymentsToAcquireIntangibleAssetsFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_LyricaMember" abstract="true" name="LyricaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_ScheduleofActivityinContingentConsiderationRollForward" abstract="true" name="ScheduleofActivityinContingentConsiderationRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_ScheduleofothercurrentliabilitiesTable" abstract="true" name="ScheduleofothercurrentliabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization" abstract="false" name="BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EffexorMember" abstract="true" name="EffexorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_FamyLifeSciencesAcquisitionMember" abstract="true" name="FamyLifeSciencesAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_AnticompetitiveConductwithGenericDrugsMember" abstract="true" name="AnticompetitiveConductwithGenericDrugsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vtrs_UpjohnDistributorMarketsMember" abstract="true" name="UpjohnDistributorMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>vtrs-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4f7b9844-2b6e-46d6-b212-7616af324858,g:ca8e76fc-c8f0-4b96-ac37-00e89e4a2911-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedStatementsOfOperations"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70bd6e2e-39a0-4ebb-b1ac-3990fa4597b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_48d2de90-b64d-47ab-bdeb-2b0ffc4acd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70bd6e2e-39a0-4ebb-b1ac-3990fa4597b5" xlink:to="loc_us-gaap_OperatingIncomeLoss_48d2de90-b64d-47ab-bdeb-2b0ffc4acd9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4ec21a1a-f9de-4091-9593-07e502dfa7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70bd6e2e-39a0-4ebb-b1ac-3990fa4597b5" xlink:to="loc_us-gaap_InterestExpense_4ec21a1a-f9de-4091-9593-07e502dfa7e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2e59b159-9be5-4822-a6d7-5a8c7d4f063a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70bd6e2e-39a0-4ebb-b1ac-3990fa4597b5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2e59b159-9be5-4822-a6d7-5a8c7d4f063a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d95e61ed-eea3-4eab-b922-71f2486496d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_df564eff-9dba-4d72-82f0-272a46c06407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_d95e61ed-eea3-4eab-b922-71f2486496d3" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_df564eff-9dba-4d72-82f0-272a46c06407" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0de0b7ff-a321-43b6-9fc1-a476ed1e517d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_d95e61ed-eea3-4eab-b922-71f2486496d3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0de0b7ff-a321-43b6-9fc1-a476ed1e517d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_87959126-b0fb-4140-9858-f73a42a18c28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_34bb6037-8323-40c2-8476-79a1faba5936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_87959126-b0fb-4140-9858-f73a42a18c28" xlink:to="loc_us-gaap_Revenues_34bb6037-8323-40c2-8476-79a1faba5936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ceb10a91-274b-42ee-9064-88943c2f373f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_87959126-b0fb-4140-9858-f73a42a18c28" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ceb10a91-274b-42ee-9064-88943c2f373f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2a698565-dbe7-4e17-b805-2dd489ea4e84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9ba8087e-fdeb-4775-8a06-03bfd40e4860" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2a698565-dbe7-4e17-b805-2dd489ea4e84" xlink:to="loc_us-gaap_GrossProfit_9ba8087e-fdeb-4775-8a06-03bfd40e4860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_bf18a2b5-4d3e-45b5-9871-343ba2a872e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2a698565-dbe7-4e17-b805-2dd489ea4e84" xlink:to="loc_us-gaap_OperatingExpenses_bf18a2b5-4d3e-45b5-9871-343ba2a872e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_bfb15a8b-9ec1-4235-ad99-5fe6de662c29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f17ab26d-03b6-446f-9f22-1e4a2359de57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_bfb15a8b-9ec1-4235-ad99-5fe6de662c29" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f17ab26d-03b6-446f-9f22-1e4a2359de57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2a206224-8f49-43e6-add9-5c9518b84c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_bfb15a8b-9ec1-4235-ad99-5fe6de662c29" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2a206224-8f49-43e6-add9-5c9518b84c56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f293a971-da28-41ea-add5-f671d78eee04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_31f12bf1-8fdb-48f1-9689-f473cccf764f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f293a971-da28-41ea-add5-f671d78eee04" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_31f12bf1-8fdb-48f1-9689-f473cccf764f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9af6e052-a74f-4a48-bf10-213900531bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f293a971-da28-41ea-add5-f671d78eee04" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9af6e052-a74f-4a48-bf10-213900531bb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_b0c9e751-6756-4c6e-b086-42d043cd117f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f293a971-da28-41ea-add5-f671d78eee04" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_b0c9e751-6756-4c6e-b086-42d043cd117f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedStatementsOfComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b28e64cb-3639-4cc6-979c-c9b8a859c268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_9774c472-bb4a-4f6c-b107-0c7c7e9be3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b28e64cb-3639-4cc6-979c-c9b8a859c268" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_9774c472-bb4a-4f6c-b107-0c7c7e9be3b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_4fa7d4c8-b49d-4b40-8ba2-01b3e02391da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b28e64cb-3639-4cc6-979c-c9b8a859c268" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_4fa7d4c8-b49d-4b40-8ba2-01b3e02391da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1298b66a-0d05-46fc-ba7a-d4122d862db9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_c31e4031-d5d6-4a5c-90d0-cbdcf7a90120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1298b66a-0d05-46fc-ba7a-d4122d862db9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_c31e4031-d5d6-4a5c-90d0-cbdcf7a90120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_7f1b50ad-7d5c-493c-b158-3e44d55d3983" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1298b66a-0d05-46fc-ba7a-d4122d862db9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_7f1b50ad-7d5c-493c-b158-3e44d55d3983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_6882c154-009c-4178-9805-d5d5c475a2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1298b66a-0d05-46fc-ba7a-d4122d862db9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_6882c154-009c-4178-9805-d5d5c475a2fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c9f76804-a2b4-4f39-b107-a300d43f429b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1298b66a-0d05-46fc-ba7a-d4122d862db9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c9f76804-a2b4-4f39-b107-a300d43f429b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b6944181-7d40-45df-a88b-f97560eca952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_40a02830-80ab-48a6-bf44-952900a8871b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b6944181-7d40-45df-a88b-f97560eca952" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_40a02830-80ab-48a6-bf44-952900a8871b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_695009ec-6cb8-4836-a228-7e796e50e241" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b6944181-7d40-45df-a88b-f97560eca952" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_695009ec-6cb8-4836-a228-7e796e50e241" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7fb56d5d-5abe-4b68-9340-b99b2695ab4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3cb0ef00-318e-4e70-b161-c365f993b626" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7fb56d5d-5abe-4b68-9340-b99b2695ab4e" xlink:to="loc_us-gaap_LiabilitiesCurrent_3cb0ef00-318e-4e70-b161-c365f993b626" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_12ac9e09-8ab4-4f10-998d-0f010b27d899" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7fb56d5d-5abe-4b68-9340-b99b2695ab4e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_12ac9e09-8ab4-4f10-998d-0f010b27d899" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_816c520a-41ea-4bfc-98ad-7fded8d3e32b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7fb56d5d-5abe-4b68-9340-b99b2695ab4e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_816c520a-41ea-4bfc-98ad-7fded8d3e32b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_36abf10a-2335-4062-9087-5108ec9eabf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7fb56d5d-5abe-4b68-9340-b99b2695ab4e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_36abf10a-2335-4062-9087-5108ec9eabf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ddfed24e-c9e0-44ed-bb79-e122fbd60873" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_066c840e-46ed-49bd-b1fc-b808ce75a838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ddfed24e-c9e0-44ed-bb79-e122fbd60873" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_066c840e-46ed-49bd-b1fc-b808ce75a838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_8e436d66-e53d-480d-bc79-ad8e5068abff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ddfed24e-c9e0-44ed-bb79-e122fbd60873" xlink:to="loc_us-gaap_ShortTermBorrowings_8e436d66-e53d-480d-bc79-ad8e5068abff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_fb838cab-c69a-49b2-8642-1ce5c467e901" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ddfed24e-c9e0-44ed-bb79-e122fbd60873" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_fb838cab-c69a-49b2-8642-1ce5c467e901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_95934e0b-985f-406f-89e6-9b960683d205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ddfed24e-c9e0-44ed-bb79-e122fbd60873" xlink:to="loc_us-gaap_LongTermDebtCurrent_95934e0b-985f-406f-89e6-9b960683d205" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_7760f153-ba39-46fd-93d8-d4dc747b30fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ddfed24e-c9e0-44ed-bb79-e122fbd60873" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_7760f153-ba39-46fd-93d8-d4dc747b30fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_58cc734d-1db4-4e42-bfd0-6977c99ef375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7085c636-ee33-4539-a4e1-f0a7bd87ec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_58cc734d-1db4-4e42-bfd0-6977c99ef375" xlink:to="loc_us-gaap_AssetsCurrent_7085c636-ee33-4539-a4e1-f0a7bd87ec1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8a012028-a935-4edf-8196-c48d3616636d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_58cc734d-1db4-4e42-bfd0-6977c99ef375" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8a012028-a935-4edf-8196-c48d3616636d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56d004e9-c681-434e-ba14-d47e872cec96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_58cc734d-1db4-4e42-bfd0-6977c99ef375" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56d004e9-c681-434e-ba14-d47e872cec96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bd986d76-5b29-44d9-bb5b-1cf895d36587" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_58cc734d-1db4-4e42-bfd0-6977c99ef375" xlink:to="loc_us-gaap_Goodwill_bd986d76-5b29-44d9-bb5b-1cf895d36587" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c02c02e3-aeb7-4952-8923-c225444b5b36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_58cc734d-1db4-4e42-bfd0-6977c99ef375" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c02c02e3-aeb7-4952-8923-c225444b5b36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4b65cfcf-49be-42dd-b905-6bd243d72972" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_58cc734d-1db4-4e42-bfd0-6977c99ef375" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4b65cfcf-49be-42dd-b905-6bd243d72972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b233daa4-acd7-47e2-a29d-50263e6b1309" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ab15cd76-aa7d-4251-adc7-58e7a5dff927" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b233daa4-acd7-47e2-a29d-50263e6b1309" xlink:to="loc_us-gaap_Liabilities_ab15cd76-aa7d-4251-adc7-58e7a5dff927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9428c2b3-dd93-4a29-9411-fb5b4c22d402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b233daa4-acd7-47e2-a29d-50263e6b1309" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9428c2b3-dd93-4a29-9411-fb5b4c22d402" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6b02d205-18ec-4029-ac26-7f471ade0039" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2a3946ef-9bcd-4fd1-83ad-320a5752f157" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b02d205-18ec-4029-ac26-7f471ade0039" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2a3946ef-9bcd-4fd1-83ad-320a5752f157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a59b2dd6-c9b9-4e53-9213-a3ca9a59d346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b02d205-18ec-4029-ac26-7f471ade0039" xlink:to="loc_us-gaap_InventoryNet_a59b2dd6-c9b9-4e53-9213-a3ca9a59d346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d4b10374-a55d-43a5-8650-afdf99bd087a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b02d205-18ec-4029-ac26-7f471ade0039" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d4b10374-a55d-43a5-8650-afdf99bd087a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8163c817-9805-4222-aa1c-1a84771ce2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b02d205-18ec-4029-ac26-7f471ade0039" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8163c817-9805-4222-aa1c-1a84771ce2c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e173282f-f911-4543-afde-8eecbea8eec4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b02d205-18ec-4029-ac26-7f471ade0039" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e173282f-f911-4543-afde-8eecbea8eec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_194b9938-d383-413d-81bf-23bf1175faf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock_ff6c0525-4700-4bc3-b122-480fade60ed0" xlink:href="vtrs-20230331.xsd#vtrs_StockholdersEquityParentBeforeTreasuryStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_194b9938-d383-413d-81bf-23bf1175faf8" xlink:to="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock_ff6c0525-4700-4bc3-b122-480fade60ed0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_11ceef02-dc55-402a-87b6-e085fba3ec71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_194b9938-d383-413d-81bf-23bf1175faf8" xlink:to="loc_us-gaap_TreasuryStockValue_11ceef02-dc55-402a-87b6-e085fba3ec71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock_1fa53ce5-514c-4a9e-84c2-a7a26dba971e" xlink:href="vtrs-20230331.xsd#vtrs_StockholdersEquityParentBeforeTreasuryStock"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_832efd76-081a-46b3-bb53-9e315fc9da8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock_1fa53ce5-514c-4a9e-84c2-a7a26dba971e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_832efd76-081a-46b3-bb53-9e315fc9da8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5f0db221-dfed-4fe2-9238-96c7521dacde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock_1fa53ce5-514c-4a9e-84c2-a7a26dba971e" xlink:to="loc_us-gaap_CommonStockValue_5f0db221-dfed-4fe2-9238-96c7521dacde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84b02203-0357-409c-80ad-cbe16f84bab9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock_1fa53ce5-514c-4a9e-84c2-a7a26dba971e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84b02203-0357-409c-80ad-cbe16f84bab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_7f5fa034-5ccc-4280-9979-079d71a7a82c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock_1fa53ce5-514c-4a9e-84c2-a7a26dba971e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_7f5fa034-5ccc-4280-9979-079d71a7a82c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedStatementsOfCashFlows"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2422f091-cb75-4f35-bc74-79dbe9a277dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1eacb706-9105-47eb-b660-dc32e0eb9ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2422f091-cb75-4f35-bc74-79dbe9a277dc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1eacb706-9105-47eb-b660-dc32e0eb9ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2491950a-54f9-4821-85dd-4384aa2ab4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2422f091-cb75-4f35-bc74-79dbe9a277dc" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2491950a-54f9-4821-85dd-4384aa2ab4ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_44ca2618-4a51-4a09-bd2d-a5d22622d351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2422f091-cb75-4f35-bc74-79dbe9a277dc" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_44ca2618-4a51-4a09-bd2d-a5d22622d351" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_2c3aa47b-7bce-46c0-8a6a-201f72a4420c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2422f091-cb75-4f35-bc74-79dbe9a277dc" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_2c3aa47b-7bce-46c0-8a6a-201f72a4420c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8af99557-9e1b-4b75-9e3e-892628cba506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2422f091-cb75-4f35-bc74-79dbe9a277dc" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8af99557-9e1b-4b75-9e3e-892628cba506" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_99f7807d-8ba4-4659-85c9-4ca741a2de8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2422f091-cb75-4f35-bc74-79dbe9a277dc" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_99f7807d-8ba4-4659-85c9-4ca741a2de8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3dd93d90-40a3-4fe6-bdc3-1248b1a159ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d03d3b9f-0599-4935-8633-16994a656c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3dd93d90-40a3-4fe6-bdc3-1248b1a159ea" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d03d3b9f-0599-4935-8633-16994a656c4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b98fc2a-938b-4115-9eb4-a04b94272433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3dd93d90-40a3-4fe6-bdc3-1248b1a159ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b98fc2a-938b-4115-9eb4-a04b94272433" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d7ad04c9-62bb-41ce-91e5-51f36e57c963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3dd93d90-40a3-4fe6-bdc3-1248b1a159ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d7ad04c9-62bb-41ce-91e5-51f36e57c963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3747190-2965-4a38-a9c0-09dce734dd26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3dd93d90-40a3-4fe6-bdc3-1248b1a159ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3747190-2965-4a38-a9c0-09dce734dd26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b892556e-46f9-4f39-be05-62c1b5b9394c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b892556e-46f9-4f39-be05-62c1b5b9394c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ba234175-65e9-4c69-8657-bb34e9057ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ba234175-65e9-4c69-8657-bb34e9057ddd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_24239c63-44d3-4145-91d8-86c8d8f11d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_ShareBasedCompensation_24239c63-44d3-4145-91d8-86c8d8f11d86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_03ef03dd-0396-47f7-88e6-bbc40d673ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_03ef03dd-0396-47f7-88e6-bbc40d673ab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_350a5a42-2a2e-4331-8d6b-935cec65c232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_350a5a42-2a2e-4331-8d6b-935cec65c232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_47439369-f918-4df0-9357-7df944a6fc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_47439369-f918-4df0-9357-7df944a6fc4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Changeinnoncashlitigationsettlementsnet_dad1b35e-b020-4776-859c-955992b6f2a0" xlink:href="vtrs-20230331.xsd#vtrs_Changeinnoncashlitigationsettlementsnet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_vtrs_Changeinnoncashlitigationsettlementsnet_dad1b35e-b020-4776-859c-955992b6f2a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dc24e170-f298-473b-b981-89594de89033" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dc24e170-f298-473b-b981-89594de89033" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a5afabf0-b931-4f71-8040-daf23712cf68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a5afabf0-b931-4f71-8040-daf23712cf68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_714da9ec-21de-4e19-b428-a0d0fb1dce0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_714da9ec-21de-4e19-b428-a0d0fb1dce0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5ea1e1c7-9ace-47b0-8d37-d627ed05eca0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5ea1e1c7-9ace-47b0-8d37-d627ed05eca0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e038c8e6-0607-4239-b19d-b2e07fc5a7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b75ea5e1-c19b-4288-8cbd-c2deb5f6c0c0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e038c8e6-0607-4239-b19d-b2e07fc5a7aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cdf3a2e8-38fc-4823-90d5-7a49934abc82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cdf3a2e8-38fc-4823-90d5-7a49934abc82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7ed3fd3a-6bef-4985-a640-cfcab8361673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7ed3fd3a-6bef-4985-a640-cfcab8361673" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_1de1e833-93fb-46f7-8216-05b5c2fc01af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_1de1e833-93fb-46f7-8216-05b5c2fc01af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_e2d3a0e6-1db1-483d-a242-21bd56a948ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_e2d3a0e6-1db1-483d-a242-21bd56a948ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e35c2763-ce48-4467-9e4b-f98af16fb08e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e35c2763-ce48-4467-9e4b-f98af16fb08e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_d679eb02-463e-4ea3-b8ee-13bd7a70772d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_d679eb02-463e-4ea3-b8ee-13bd7a70772d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fdf8acff-5dbd-4921-b555-bec19f885db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fdf8acff-5dbd-4921-b555-bec19f885db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0331df85-2e2c-453d-829b-bb2e4f2495b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0331df85-2e2c-453d-829b-bb2e4f2495b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_93673fc8-b642-4a77-92c5-03be7dae714b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_93673fc8-b642-4a77-92c5-03be7dae714b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4f659ebd-e175-4622-bdab-d22f040ead8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4f659ebd-e175-4622-bdab-d22f040ead8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity_43b6bf29-dbea-4e01-9b75-f859b5f7c39d" xlink:href="vtrs-20230331.xsd#vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5367662-404d-47a3-8677-8c5b662a8fe5" xlink:to="loc_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity_43b6bf29-dbea-4e01-9b75-f859b5f7c39d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments_c617fddd-9c09-4b3a-a985-818523dcfda4" xlink:href="vtrs-20230331.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks_16110aa7-7eab-4d30-81ce-36a7886ed08a" xlink:href="vtrs-20230331.xsd#vtrs_Chargebacks"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_c617fddd-9c09-4b3a-a985-818523dcfda4" xlink:to="loc_vtrs_Chargebacks_16110aa7-7eab-4d30-81ce-36a7886ed08a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances_d5260194-fe23-4975-92ac-0c8f07ef36b0" xlink:href="vtrs-20230331.xsd#vtrs_AccruedSalesAllowances"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_c617fddd-9c09-4b3a-a985-818523dcfda4" xlink:to="loc_vtrs_AccruedSalesAllowances_d5260194-fe23-4975-92ac-0c8f07ef36b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns_e328f210-775b-420b-a98a-ef607fd77bb3" xlink:href="vtrs-20230331.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_c617fddd-9c09-4b3a-a985-818523dcfda4" xlink:to="loc_vtrs_RevenuefromContractwithCustomerReturns_e328f210-775b-420b-a98a-ef607fd77bb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates_598bc0a7-4b33-4b3b-a2b2-609cb1a0cb06" xlink:href="vtrs-20230331.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_c617fddd-9c09-4b3a-a985-818523dcfda4" xlink:to="loc_vtrs_Medicaidandothergovernmentalrebates_598bc0a7-4b33-4b3b-a2b2-609cb1a0cb06" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f8b5728d-458c-4a5b-aac7-1a3b6d6779ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_69b1ee03-5c6f-452a-8aa4-4b7263cfbeea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_f8b5728d-458c-4a5b-aac7-1a3b6d6779ef" xlink:to="loc_us-gaap_ReceivablesNetCurrent_69b1ee03-5c6f-452a-8aa4-4b7263cfbeea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_9d12e868-e801-4bb8-ac7d-59be76d19cff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_f8b5728d-458c-4a5b-aac7-1a3b6d6779ef" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_9d12e868-e801-4bb8-ac7d-59be76d19cff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4b54bf01-c2a2-45ac-9547-d98a52125ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a284c417-efc2-44a9-9cbe-53b2ba44ff84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4b54bf01-c2a2-45ac-9547-d98a52125ff8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a284c417-efc2-44a9-9cbe-53b2ba44ff84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_52393253-6661-4ae1-9ad3-4f1fefa7805e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4b54bf01-c2a2-45ac-9547-d98a52125ff8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_52393253-6661-4ae1-9ad3-4f1fefa7805e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e32a14d0-5799-4112-8326-f60d63a4f775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4b54bf01-c2a2-45ac-9547-d98a52125ff8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e32a14d0-5799-4112-8326-f60d63a4f775" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5ebf605a-5fe7-452c-bd2b-31829df6fd64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4b54bf01-c2a2-45ac-9547-d98a52125ff8" xlink:to="loc_us-gaap_Goodwill_5ebf605a-5fe7-452c-bd2b-31829df6fd64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_d2c51d32-7083-451a-a587-d17599b685ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4b54bf01-c2a2-45ac-9547-d98a52125ff8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_d2c51d32-7083-451a-a587-d17599b685ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e5fcadd1-a407-48f0-b145-d31864942277" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4b54bf01-c2a2-45ac-9547-d98a52125ff8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e5fcadd1-a407-48f0-b145-d31864942277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_916d9d2b-8c39-4d54-b9c3-12faf5d8bb32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_61425cfa-af04-4312-ab67-35eaf25ec9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_916d9d2b-8c39-4d54-b9c3-12faf5d8bb32" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_61425cfa-af04-4312-ab67-35eaf25ec9f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_72086ef0-f71b-4286-bd41-9414de0e09e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_916d9d2b-8c39-4d54-b9c3-12faf5d8bb32" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_72086ef0-f71b-4286-bd41-9414de0e09e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_69a6a218-4ac0-4c03-99c6-14d7b133d4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_916d9d2b-8c39-4d54-b9c3-12faf5d8bb32" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_69a6a218-4ac0-4c03-99c6-14d7b133d4c2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2567ebe6-3df3-4c73-892f-dc444a929796" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_76d1fda7-8a32-41fd-920a-6d11e826cae2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2567ebe6-3df3-4c73-892f-dc444a929796" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_76d1fda7-8a32-41fd-920a-6d11e826cae2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_71f3436a-222d-48af-8dd4-6b491150703d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2567ebe6-3df3-4c73-892f-dc444a929796" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_71f3436a-222d-48af-8dd4-6b491150703d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_567b64e9-ad60-426f-890d-1db17dfd722d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2567ebe6-3df3-4c73-892f-dc444a929796" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_567b64e9-ad60-426f-890d-1db17dfd722d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_e38b6956-8644-47c5-b596-8d1e4c8f7171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2567ebe6-3df3-4c73-892f-dc444a929796" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_e38b6956-8644-47c5-b596-8d1e4c8f7171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_bd95aecb-fe0a-4ddf-b00d-523a79d30913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2567ebe6-3df3-4c73-892f-dc444a929796" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_bd95aecb-fe0a-4ddf-b00d-523a79d30913" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0b838739-a349-4c09-b5dc-af9eb87808f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3edeebd9-8a83-4d30-8533-220bc8c07703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0b838739-a349-4c09-b5dc-af9eb87808f8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3edeebd9-8a83-4d30-8533-220bc8c07703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_93c7e438-a400-4d6d-abf1-4e44e4dbbd92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0b838739-a349-4c09-b5dc-af9eb87808f8" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_93c7e438-a400-4d6d-abf1-4e44e4dbbd92" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_eba2b75c-6803-42ff-9d1d-63aceb102b36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_f6c37aa4-0e19-4cb7-9476-ce82d88e580f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_eba2b75c-6803-42ff-9d1d-63aceb102b36" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_f6c37aa4-0e19-4cb7-9476-ce82d88e580f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d92d707e-39e8-439c-a891-26789d3a3b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_eba2b75c-6803-42ff-9d1d-63aceb102b36" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d92d707e-39e8-439c-a891-26789d3a3b0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_72efc8fb-ba01-410f-943d-4df4b1b921c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_eba2b75c-6803-42ff-9d1d-63aceb102b36" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_72efc8fb-ba01-410f-943d-4df4b1b921c3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a26808af-fb61-49f8-a8ca-b98b8d2335e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_7d919b8f-181a-40cb-861c-f802f96c2d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a26808af-fb61-49f8-a8ca-b98b8d2335e6" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_7d919b8f-181a-40cb-861c-f802f96c2d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_be9240b0-412a-4fbb-80d0-a1e9a0a49eda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a26808af-fb61-49f8-a8ca-b98b8d2335e6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_be9240b0-412a-4fbb-80d0-a1e9a0a49eda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fa74683f-96af-4d3d-8f04-e8f06df8dd37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a26808af-fb61-49f8-a8ca-b98b8d2335e6" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fa74683f-96af-4d3d-8f04-e8f06df8dd37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_27471b39-4b6a-440e-97e0-5a96d09ecb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a26808af-fb61-49f8-a8ca-b98b8d2335e6" xlink:to="loc_us-gaap_TradingSecurities_27471b39-4b6a-440e-97e0-5a96d09ecb7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_811bdde6-5064-491e-ad3b-d03ae1c7a31f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a26808af-fb61-49f8-a8ca-b98b8d2335e6" xlink:to="loc_us-gaap_OtherAssetsCurrent_811bdde6-5064-491e-ad3b-d03ae1c7a31f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_19e70699-05b1-4882-b109-595fe6b2fd79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_005f9669-ccfd-4b72-be12-3eb2389eba9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_19e70699-05b1-4882-b109-595fe6b2fd79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_005f9669-ccfd-4b72-be12-3eb2389eba9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e41a90ef-d1ec-4b51-864c-3572631428f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_19e70699-05b1-4882-b109-595fe6b2fd79" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e41a90ef-d1ec-4b51-864c-3572631428f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b2f6bf84-e4eb-42e3-a953-fe412e92244f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_219d96d3-fc71-48fe-9aff-f4b33de2fbde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_b2f6bf84-e4eb-42e3-a953-fe412e92244f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_219d96d3-fc71-48fe-9aff-f4b33de2fbde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets_5625f020-6592-4982-9cda-6f61a7098413" xlink:href="vtrs-20230331.xsd#vtrs_Otherlongtermassets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_b2f6bf84-e4eb-42e3-a953-fe412e92244f" xlink:to="loc_vtrs_Otherlongtermassets_5625f020-6592-4982-9cda-6f61a7098413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_25930c04-3c2f-43c8-98cf-264173c6bf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_b2f6bf84-e4eb-42e3-a953-fe412e92244f" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_25930c04-3c2f-43c8-98cf-264173c6bf4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue_8ef2172c-edfc-4104-9a3e-0e2daea2dc1f" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_b2f6bf84-e4eb-42e3-a953-fe412e92244f" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue_8ef2172c-edfc-4104-9a3e-0e2daea2dc1f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsTradeAccountsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_fa5b8df2-1c25-48ec-b44e-55d264e60515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_f7e5f113-a4fe-4edc-ab95-6ff2be014ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_fa5b8df2-1c25-48ec-b44e-55d264e60515" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_f7e5f113-a4fe-4edc-ab95-6ff2be014ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_69ea5526-e209-4f75-a6d6-864caf72682a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_fa5b8df2-1c25-48ec-b44e-55d264e60515" xlink:to="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_69ea5526-e209-4f75-a6d6-864caf72682a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16708969-d40c-4584-865c-a5b04db99920" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3fd53120-b712-4016-bbca-9a5f2b4216a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16708969-d40c-4584-865c-a5b04db99920" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3fd53120-b712-4016-bbca-9a5f2b4216a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ba6adbb2-66ae-4a08-b288-2d84f15e2a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16708969-d40c-4584-865c-a5b04db99920" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ba6adbb2-66ae-4a08-b288-2d84f15e2a4c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3053a51b-a16e-449d-be86-734065d3592e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4b8096bd-4bac-414c-8060-e4e6e0e80501" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3053a51b-a16e-449d-be86-734065d3592e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4b8096bd-4bac-414c-8060-e4e6e0e80501" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_bd599d42-c9e2-4fe3-9745-af661bc4e63c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3053a51b-a16e-449d-be86-734065d3592e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_bd599d42-c9e2-4fe3-9745-af661bc4e63c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d4a07f4e-8106-4983-952b-70f77214dd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_892be2ad-0aec-4a0f-858b-30fa1a9234d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d4a07f4e-8106-4983-952b-70f77214dd2c" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_892be2ad-0aec-4a0f-858b-30fa1a9234d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5d8431ca-b558-4726-9d16-ddb019b8851e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d4a07f4e-8106-4983-952b-70f77214dd2c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5d8431ca-b558-4726-9d16-ddb019b8851e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6e6b62e9-af4c-4dc2-a767-d52fc23e2bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6ec080a0-96e5-4d1e-a974-fdb746fb3c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6e6b62e9-af4c-4dc2-a767-d52fc23e2bd8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6ec080a0-96e5-4d1e-a974-fdb746fb3c7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3a43b830-a1d7-4d1c-a976-7d110955ae0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6e6b62e9-af4c-4dc2-a767-d52fc23e2bd8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3a43b830-a1d7-4d1c-a976-7d110955ae0c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_847cd3fa-b703-46e7-b352-d7d78ed94ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a2e1a670-6633-4b07-b8dc-4ee2cea311b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentForAmortization_847cd3fa-b703-46e7-b352-d7d78ed94ef0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a2e1a670-6633-4b07-b8dc-4ee2cea311b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8b32ec97-279f-443a-be6a-5b07c570ca94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentForAmortization_847cd3fa-b703-46e7-b352-d7d78ed94ef0" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8b32ec97-279f-443a-be6a-5b07c570ca94" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DebtMinimumRepaymentsonOutstandingBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_fba76951-476e-42af-8907-8d89c9f7eb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d9487b3e-5471-4672-9c7e-25bd2d8137b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fba76951-476e-42af-8907-8d89c9f7eb1c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d9487b3e-5471-4672-9c7e-25bd2d8137b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1602f786-7d0e-4195-a53a-27bb3a5d5690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fba76951-476e-42af-8907-8d89c9f7eb1c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1602f786-7d0e-4195-a53a-27bb3a5d5690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1370b8b3-b5b4-4fec-a4e2-52e312c9acc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fba76951-476e-42af-8907-8d89c9f7eb1c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1370b8b3-b5b4-4fec-a4e2-52e312c9acc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b659eba2-44dd-4b97-90ed-b4d471a79e99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fba76951-476e-42af-8907-8d89c9f7eb1c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b659eba2-44dd-4b97-90ed-b4d471a79e99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_335d35d7-c2dc-44f6-9e46-a455b33fb622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fba76951-476e-42af-8907-8d89c9f7eb1c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_335d35d7-c2dc-44f6-9e46-a455b33fb622" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e51cdd98-bb09-4720-b287-b206ef00d344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fba76951-476e-42af-8907-8d89c9f7eb1c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e51cdd98-bb09-4720-b287-b206ef00d344" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>vtrs-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4f7b9844-2b6e-46d6-b212-7616af324858,g:ca8e76fc-c8f0-4b96-ac37-00e89e4a2911-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedStatementsOfOperations"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended" id="ib75e2467fa3e488294f097babfec502f_CondensedConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fdc573fa-1d28-4666-bd25-a4ee0544efb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fdc573fa-1d28-4666-bd25-a4ee0544efb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_88cac754-5d6a-4c8b-b64f-52904a0ca405" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_88cac754-5d6a-4c8b-b64f-52904a0ca405" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cce3d987-3366-45a7-854f-2e00949bfdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_Revenues_cce3d987-3366-45a7-854f-2e00949bfdd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f4a0e1a2-3070-4f77-b919-51222681903c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f4a0e1a2-3070-4f77-b919-51222681903c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2502fa3b-e008-4479-a1fa-4977e13ca1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_GrossProfit_2502fa3b-e008-4479-a1fa-4977e13ca1b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bddfa79b-fde6-4885-97d5-421b155c6a71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bddfa79b-fde6-4885-97d5-421b155c6a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8257a388-7be0-43ab-bb8e-1732652d2305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8257a388-7be0-43ab-bb8e-1732652d2305" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_3b6f437c-1c41-4533-a6d7-0f8ce2137633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_3b6f437c-1c41-4533-a6d7-0f8ce2137633" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_28885b4e-7dba-4af7-8cba-8c822f8d41b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:to="loc_us-gaap_OperatingExpenses_28885b4e-7dba-4af7-8cba-8c822f8d41b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ca529a2e-8e9d-4007-b893-d50fc2a51e86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_OperatingIncomeLoss_ca529a2e-8e9d-4007-b893-d50fc2a51e86" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_678f9565-2d9f-4914-86c1-0877952a6f13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_InterestExpense_678f9565-2d9f-4914-86c1-0877952a6f13" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_99d14562-d95a-4e09-83d4-1f084ba4802e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_99d14562-d95a-4e09-83d4-1f084ba4802e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8278052b-49c2-4c7d-bc19-62465e62c4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8278052b-49c2-4c7d-bc19-62465e62c4ae" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e97cab55-dbec-4ebd-a8b3-bd1fe2637313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e97cab55-dbec-4ebd-a8b3-bd1fe2637313" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0bc5cb38-d7c0-41ce-81a4-83fde46e82b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0bc5cb38-d7c0-41ce-81a4-83fde46e82b1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_11353a18-cacd-4331-978e-d6b7b11cb2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_EarningsPerShareAbstract_11353a18-cacd-4331-978e-d6b7b11cb2ce" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_68583e14-9437-4d14-8ea3-d1a56e0b4cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_11353a18-cacd-4331-978e-d6b7b11cb2ce" xlink:to="loc_us-gaap_EarningsPerShareBasic_68583e14-9437-4d14-8ea3-d1a56e0b4cc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c6380d7d-caec-489b-926a-a0b4845a28cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_11353a18-cacd-4331-978e-d6b7b11cb2ce" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c6380d7d-caec-489b-926a-a0b4845a28cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_57516fd8-5e65-4cd9-8f60-b0a5c3f8c581" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_57516fd8-5e65-4cd9-8f60-b0a5c3f8c581" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2428c2c4-e310-4a71-8aec-749d7e4e9a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_57516fd8-5e65-4cd9-8f60-b0a5c3f8c581" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2428c2c4-e310-4a71-8aec-749d7e4e9a45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_eb27b5a2-7069-4354-93a2-99942cf36b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_57516fd8-5e65-4cd9-8f60-b0a5c3f8c581" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_eb27b5a2-7069-4354-93a2-99942cf36b70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f86a9d34-380e-434a-9471-7f069bd8560d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_StatementTable_f86a9d34-380e-434a-9471-7f069bd8560d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b2a4fcc5-9928-42ca-863f-d9ad5094bfa3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f86a9d34-380e-434a-9471-7f069bd8560d" xlink:to="loc_srt_ProductOrServiceAxis_b2a4fcc5-9928-42ca-863f-d9ad5094bfa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b2a4fcc5-9928-42ca-863f-d9ad5094bfa3_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b2a4fcc5-9928-42ca-863f-d9ad5094bfa3" xlink:to="loc_srt_ProductsAndServicesDomain_b2a4fcc5-9928-42ca-863f-d9ad5094bfa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_978219f0-1762-4c0b-b9dc-010b5058255c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b2a4fcc5-9928-42ca-863f-d9ad5094bfa3" xlink:to="loc_srt_ProductsAndServicesDomain_978219f0-1762-4c0b-b9dc-010b5058255c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_edd485f9-a41e-4b3b-a98d-d507f8db8865" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_978219f0-1762-4c0b-b9dc-010b5058255c" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_edd485f9-a41e-4b3b-a98d-d507f8db8865" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedStatementsOfComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended" id="i21dbfbfbdd684416bf9eefe9a3c7a4d2_CondensedConsolidatedStatementsOfComprehensiveLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f66f8759-8365-41b9-ada9-95546108882e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f66f8759-8365-41b9-ada9-95546108882e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4564358e-173d-4642-bbd5-6e6ce7c043e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4564358e-173d-4642-bbd5-6e6ce7c043e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4c30c2bf-bdea-42a9-825e-f84ff5d3e626" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4c30c2bf-bdea-42a9-825e-f84ff5d3e626" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_c0c84dc6-d907-49c5-add4-401556ec29ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_c0c84dc6-d907-49c5-add4-401556ec29ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_bef96b98-7463-4405-a95a-0918637a0793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_bef96b98-7463-4405-a95a-0918637a0793" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_bc668cd2-e552-4fc6-9f30-087ff96f11e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_bc668cd2-e552-4fc6-9f30-087ff96f11e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_17c31078-e281-4038-ab53-6456574ca89c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_17c31078-e281-4038-ab53-6456574ca89c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_34b5bd2d-def3-4373-93c5-1f553fd47acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_34b5bd2d-def3-4373-93c5-1f553fd47acc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e6b8c168-1dc2-46a9-b456-66f394072d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e6b8c168-1dc2-46a9-b456-66f394072d7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f71859a-43d1-4413-addc-bac0c987f2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:to="loc_us-gaap_StatementTable_1f71859a-43d1-4413-addc-bac0c987f2b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78fc68f8-3a3b-411b-977a-83211245de6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1f71859a-43d1-4413-addc-bac0c987f2b4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78fc68f8-3a3b-411b-977a-83211245de6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_78fc68f8-3a3b-411b-977a-83211245de6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78fc68f8-3a3b-411b-977a-83211245de6b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_78fc68f8-3a3b-411b-977a-83211245de6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b5b9afa3-f6a0-4479-a65d-9fa33f11976f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78fc68f8-3a3b-411b-977a-83211245de6b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b5b9afa3-f6a0-4479-a65d-9fa33f11976f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_563716bc-a57c-4c86-b734-f8ab9e1f3fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b5b9afa3-f6a0-4479-a65d-9fa33f11976f" xlink:to="loc_us-gaap_CashFlowHedgingMember_563716bc-a57c-4c86-b734-f8ab9e1f3fc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_490e974b-2b32-40f0-a50f-83246453fc24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b5b9afa3-f6a0-4479-a65d-9fa33f11976f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_490e974b-2b32-40f0-a50f-83246453fc24" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i9c7888168937448ab6d3021ab43f418c_CondensedConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_76d352aa-cb79-499d-be2f-d24a6298704a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_76d352aa-cb79-499d-be2f-d24a6298704a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_af9a798c-615c-473f-aeb0-6bc26a06ba77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_af9a798c-615c-473f-aeb0-6bc26a06ba77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_08cce447-9f42-4ecf-ae97-622b8c80dc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:to="loc_us-gaap_TreasuryStockCommonShares_08cce447-9f42-4ecf-ae97-622b8c80dc0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5a7bff0e-c9a9-443f-a7ef-b007cebba3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:to="loc_us-gaap_StatementTable_5a7bff0e-c9a9-443f-a7ef-b007cebba3b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_32ef46ff-f8d4-42f1-85c1-1631ffaea095" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5a7bff0e-c9a9-443f-a7ef-b007cebba3b7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_32ef46ff-f8d4-42f1-85c1-1631ffaea095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_32ef46ff-f8d4-42f1-85c1-1631ffaea095_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_32ef46ff-f8d4-42f1-85c1-1631ffaea095" xlink:to="loc_us-gaap_EquityComponentDomain_32ef46ff-f8d4-42f1-85c1-1631ffaea095_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ec65ffe-f239-415c-8d2e-e1ad655bb69d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_32ef46ff-f8d4-42f1-85c1-1631ffaea095" xlink:to="loc_us-gaap_EquityComponentDomain_9ec65ffe-f239-415c-8d2e-e1ad655bb69d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_39d04fc2-9176-4eac-bb95-8bcfd9638340" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9ec65ffe-f239-415c-8d2e-e1ad655bb69d" xlink:to="loc_us-gaap_CommonStockMember_39d04fc2-9176-4eac-bb95-8bcfd9638340" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ConsolidatedStatementsofEquity"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="extended" id="i2449196d12d14f4185ca8f93f6c9a590_ConsolidatedStatementsofEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_14ae4422-823a-4962-941f-3e8e47856500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_14ae4422-823a-4962-941f-3e8e47856500" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_acf1dde2-7c74-4e16-a273-99ef3c12daf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_acf1dde2-7c74-4e16-a273-99ef3c12daf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_cb556336-79d8-4fda-8c76-790934db2ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_SharesIssued_cb556336-79d8-4fda-8c76-790934db2ae7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_a0a66de5-b43a-4f41-b4e9-878f02fd0bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_TreasuryStockValue_a0a66de5-b43a-4f41-b4e9-878f02fd0bf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_8307174c-9f30-469e-b276-72b140f5e6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_TreasuryStockCommonShares_8307174c-9f30-469e-b276-72b140f5e6c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9899f12b-0ceb-414e-a81d-74a640216804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9899f12b-0ceb-414e-a81d-74a640216804" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2af8ed2b-87df-4e7b-83f0-b00532c2e7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2af8ed2b-87df-4e7b-83f0-b00532c2e7b0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_2267d7dc-ccc0-4cc0-b269-0f998ccde9a6" xlink:href="vtrs-20230331.xsd#vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_2267d7dc-ccc0-4cc0-b269-0f998ccde9a6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_a037bcdb-8389-43b2-aacf-5001d2ce7ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_a037bcdb-8389-43b2-aacf-5001d2ce7ad8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_e18ff430-2f8f-4b97-8061-4b6abd5ed2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_e18ff430-2f8f-4b97-8061-4b6abd5ed2a0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b57cbfab-786f-41e5-9e3c-215b4b438081" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b57cbfab-786f-41e5-9e3c-215b4b438081" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_74e51512-e391-4d9a-9e38-e9e0abde75f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_74e51512-e391-4d9a-9e38-e9e0abde75f2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57788d77-be70-49ac-933e-7b3e13fbab57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57788d77-be70-49ac-933e-7b3e13fbab57" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b518b5d1-be77-4974-80f2-1390ab84b9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b518b5d1-be77-4974-80f2-1390ab84b9fa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c1b1872c-ddb8-4386-998d-7f662270fb01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c1b1872c-ddb8-4386-998d-7f662270fb01" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c59c4aea-8033-4b93-aa75-4b2844b0f026" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c59c4aea-8033-4b93-aa75-4b2844b0f026" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_1e66d8da-e54f-4717-904e-7a55cb5aae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_DividendsCommonStockCash_1e66d8da-e54f-4717-904e-7a55cb5aae8c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_b30282fc-731a-450e-a80d-8b9f87c8d826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_b30282fc-731a-450e-a80d-8b9f87c8d826" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44820438-2094-4884-87b0-4be4a71206a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_5a2f7778-0f6a-4e98-89fd-cc737c3a3f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5b5cafd8-190a-4967-b3bb-b89d7f98b6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_14ae4422-823a-4962-941f-3e8e47856500" xlink:to="loc_us-gaap_StatementTable_5b5cafd8-190a-4967-b3bb-b89d7f98b6cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c3137a1d-a20a-4b2e-8c6a-fdd5aee35ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5b5cafd8-190a-4967-b3bb-b89d7f98b6cd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c3137a1d-a20a-4b2e-8c6a-fdd5aee35ab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c3137a1d-a20a-4b2e-8c6a-fdd5aee35ab7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c3137a1d-a20a-4b2e-8c6a-fdd5aee35ab7" xlink:to="loc_us-gaap_EquityComponentDomain_c3137a1d-a20a-4b2e-8c6a-fdd5aee35ab7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c3137a1d-a20a-4b2e-8c6a-fdd5aee35ab7" xlink:to="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c798e72e-8396-4e97-aa2a-a55044255ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_CommonStockMember_c798e72e-8396-4e97-aa2a-a55044255ec2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_533d2fee-cae3-4715-9654-c4154bc0ea72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_533d2fee-cae3-4715-9654-c4154bc0ea72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5dad867d-3cb6-4ef5-85ab-b2c6fcd0fd15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_RetainedEarningsMember_5dad867d-3cb6-4ef5-85ab-b2c6fcd0fd15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_98f1e3f2-a348-4721-be7d-c99072d3951c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_98f1e3f2-a348-4721-be7d-c99072d3951c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_638d6f5a-a61b-4e13-98df-7bc96f1d5b44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_TreasuryStockCommonMember_638d6f5a-a61b-4e13-98df-7bc96f1d5b44" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementTables"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="extended" id="i5d045af4ed9f43cba9c6e8f0fdb2736f_FinancialInstrumentsandRiskManagementTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_aab5e200-343c-456e-b014-236bcc714e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_aab5e200-343c-456e-b014-236bcc714e6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_49b88611-9152-47cf-971f-f6015ad03fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_49b88611-9152-47cf-971f-f6015ad03fcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8c961add-65eb-43d1-b1b6-d927a86997f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8c961add-65eb-43d1-b1b6-d927a86997f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8bba1b5d-08e7-42bb-a8c9-32c1824fe50d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8bba1b5d-08e7-42bb-a8c9-32c1824fe50d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_229f95f5-7b32-4e39-843f-8fa6412986e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_229f95f5-7b32-4e39-843f-8fa6412986e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c13e2d84-dd85-434b-a636-9bf6be5a791c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_229f95f5-7b32-4e39-843f-8fa6412986e3" xlink:to="loc_us-gaap_HedgingDesignationAxis_c13e2d84-dd85-434b-a636-9bf6be5a791c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c13e2d84-dd85-434b-a636-9bf6be5a791c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_c13e2d84-dd85-434b-a636-9bf6be5a791c" xlink:to="loc_us-gaap_HedgingDesignationDomain_c13e2d84-dd85-434b-a636-9bf6be5a791c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_21cd55c3-d25d-4b35-9758-da1946a49699" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_c13e2d84-dd85-434b-a636-9bf6be5a791c" xlink:to="loc_us-gaap_HedgingDesignationDomain_21cd55c3-d25d-4b35-9758-da1946a49699" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a933e70d-4863-43aa-88e6-9c5c9da8b67a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_21cd55c3-d25d-4b35-9758-da1946a49699" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a933e70d-4863-43aa-88e6-9c5c9da8b67a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_36849357-8d07-49e1-896c-e724b5953a90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_21cd55c3-d25d-4b35-9758-da1946a49699" xlink:to="loc_us-gaap_NondesignatedMember_36849357-8d07-49e1-896c-e724b5953a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ec33e4b0-21bc-48be-80cc-dd88f9c8cd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_229f95f5-7b32-4e39-843f-8fa6412986e3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ec33e4b0-21bc-48be-80cc-dd88f9c8cd8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ec33e4b0-21bc-48be-80cc-dd88f9c8cd8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ec33e4b0-21bc-48be-80cc-dd88f9c8cd8e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ec33e4b0-21bc-48be-80cc-dd88f9c8cd8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_989423d3-46cf-414a-8298-f930009a2604" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ec33e4b0-21bc-48be-80cc-dd88f9c8cd8e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_989423d3-46cf-414a-8298-f930009a2604" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_db82e96c-3425-4488-bd15-5a0346576900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_989423d3-46cf-414a-8298-f930009a2604" xlink:to="loc_us-gaap_CashFlowHedgingMember_db82e96c-3425-4488-bd15-5a0346576900" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_06710ea0-5a69-4d91-bdbf-d99d42cb06cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_989423d3-46cf-414a-8298-f930009a2604" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_06710ea0-5a69-4d91-bdbf-d99d42cb06cb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" xlink:type="extended" id="i7a78eb4f009041299786cfa93e394a6a_RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_7da0cef5-b15c-479a-9301-883d5b155c26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_47aed464-a2a7-4be0-8c06-b92cc170e4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7da0cef5-b15c-479a-9301-883d5b155c26" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_47aed464-a2a7-4be0-8c06-b92cc170e4e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7da0cef5-b15c-479a-9301-883d5b155c26" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_afbbf797-0d48-4856-8e18-0f257cfe2928" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:to="loc_srt_ConsolidationItemsAxis_afbbf797-0d48-4856-8e18-0f257cfe2928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_afbbf797-0d48-4856-8e18-0f257cfe2928_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_afbbf797-0d48-4856-8e18-0f257cfe2928" xlink:to="loc_srt_ConsolidationItemsDomain_afbbf797-0d48-4856-8e18-0f257cfe2928_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_470991d8-579d-43c4-b19f-5991f48fdfe1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_afbbf797-0d48-4856-8e18-0f257cfe2928" xlink:to="loc_srt_ConsolidationItemsDomain_470991d8-579d-43c4-b19f-5991f48fdfe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_3adac227-8a2f-4fb0-9bad-616509ddb3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_470991d8-579d-43c4-b19f-5991f48fdfe1" xlink:to="loc_us-gaap_OperatingSegmentsMember_3adac227-8a2f-4fb0-9bad-616509ddb3d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_49f3521b-3449-4607-a723-ed48603bbc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_49f3521b-3449-4607-a723-ed48603bbc0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_49f3521b-3449-4607-a723-ed48603bbc0d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_49f3521b-3449-4607-a723-ed48603bbc0d" xlink:to="loc_us-gaap_SegmentDomain_49f3521b-3449-4607-a723-ed48603bbc0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_49f3521b-3449-4607-a723-ed48603bbc0d" xlink:to="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_42e6cedf-ff68-4a62-9a35-ab8653e36d01" xlink:href="vtrs-20230331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_42e6cedf-ff68-4a62-9a35-ab8653e36d01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_7b18d782-0355-4550-b6b7-af671724b758" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:to="loc_vtrs_GreaterChinaSegmentMember_7b18d782-0355-4550-b6b7-af671724b758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_a1ab06b5-b724-4224-8c07-67a696603a84" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_a1ab06b5-b724-4224-8c07-67a696603a84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_5ccdbbb8-617a-4e6d-8378-5bf5cacc2dc7" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_5ccdbbb8-617a-4e6d-8378-5bf5cacc2dc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_dccc3cf6-c1b3-4e78-9b48-0c514bd9a71e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:to="loc_srt_ProductOrServiceAxis_dccc3cf6-c1b3-4e78-9b48-0c514bd9a71e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dccc3cf6-c1b3-4e78-9b48-0c514bd9a71e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_dccc3cf6-c1b3-4e78-9b48-0c514bd9a71e" xlink:to="loc_srt_ProductsAndServicesDomain_dccc3cf6-c1b3-4e78-9b48-0c514bd9a71e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_dccc3cf6-c1b3-4e78-9b48-0c514bd9a71e" xlink:to="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember_7ebd7dd8-45b2-4b3e-a21e-1dc55ab29642" xlink:href="vtrs-20230331.xsd#vtrs_BrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_BrandsMember_7ebd7dd8-45b2-4b3e-a21e-1dc55ab29642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember_2a29f879-6935-408b-8733-4be348678630" xlink:href="vtrs-20230331.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_ComplexGXAndBiosimilarsMember_2a29f879-6935-408b-8733-4be348678630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember_96e04395-008c-44ec-9736-e4eeca35601b" xlink:href="vtrs-20230331.xsd#vtrs_GenericsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_GenericsMember_96e04395-008c-44ec-9736-e4eeca35601b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LipitorMember_aab4abab-cc4a-4194-948e-f818265375ab" xlink:href="vtrs-20230331.xsd#vtrs_LipitorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_LipitorMember_aab4abab-cc4a-4194-948e-f818265375ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorvascMember_1ab16e52-a641-45f4-a9ab-67d3e474c41d" xlink:href="vtrs-20230331.xsd#vtrs_NorvascMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_NorvascMember_1ab16e52-a641-45f4-a9ab-67d3e474c41d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LyricaMember_725fef20-7d2c-48be-91c1-b1a7744aaab7" xlink:href="vtrs-20230331.xsd#vtrs_LyricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_LyricaMember_725fef20-7d2c-48be-91c1-b1a7744aaab7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViagraMember_619ac517-225c-4501-bf7b-895f8cb8f0d7" xlink:href="vtrs-20230331.xsd#vtrs_ViagraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_ViagraMember_619ac517-225c-4501-bf7b-895f8cb8f0d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorsMember_fe3be11f-f8b8-4fe8-a8dd-3651c9f122ef" xlink:href="vtrs-20230331.xsd#vtrs_EpiPenAutoInjectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_EpiPenAutoInjectorsMember_fe3be11f-f8b8-4fe8-a8dd-3651c9f122ef" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CelebrexMember_39953c65-ff0c-4827-a196-ef7338eddad1" xlink:href="vtrs-20230331.xsd#vtrs_CelebrexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_CelebrexMember_39953c65-ff0c-4827-a196-ef7338eddad1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffexorMember_de327d67-e7ff-4b64-a3f8-a1368994314e" xlink:href="vtrs-20230331.xsd#vtrs_EffexorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_EffexorMember_de327d67-e7ff-4b64-a3f8-a1368994314e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ZoloftMember_da351ff0-5d09-4fb3-9616-2ed95704b77b" xlink:href="vtrs-20230331.xsd#vtrs_ZoloftMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_ZoloftMember_da351ff0-5d09-4fb3-9616-2ed95704b77b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CreonMember_cf5ff757-6d16-4c25-8c6e-e7582204ea03" xlink:href="vtrs-20230331.xsd#vtrs_CreonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_CreonMember_cf5ff757-6d16-4c25-8c6e-e7582204ea03" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XalabrandsMember_40a596b4-7da0-40e6-b20b-e6599b63ffa5" xlink:href="vtrs-20230331.xsd#vtrs_XalabrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_XalabrandsMember_40a596b4-7da0-40e6-b20b-e6599b63ffa5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmitizaMember_793f1bfe-637d-43e6-b822-805416b0a3fa" xlink:href="vtrs-20230331.xsd#vtrs_AmitizaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_AmitizaMember_793f1bfe-637d-43e6-b822-805416b0a3fa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XanaxMember_19e76426-f590-45e9-9810-58ecaf6e2c0a" xlink:href="vtrs-20230331.xsd#vtrs_XanaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_XanaxMember_19e76426-f590-45e9-9810-58ecaf6e2c0a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DymistaMember_a79bf22a-4505-4182-a0b3-449c95a5e198" xlink:href="vtrs-20230331.xsd#vtrs_DymistaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_DymistaMember_a79bf22a-4505-4182-a0b3-449c95a5e198" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YupelriMember_eb789948-2ec9-4d8b-9f51-0e66dec59eca" xlink:href="vtrs-20230331.xsd#vtrs_YupelriMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_YupelriMember_eb789948-2ec9-4d8b-9f51-0e66dec59eca" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_679ba68e-d2c6-4806-a930-b24c71a51a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_679ba68e-d2c6-4806-a930-b24c71a51a8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_679ba68e-d2c6-4806-a930-b24c71a51a8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_679ba68e-d2c6-4806-a930-b24c71a51a8c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_679ba68e-d2c6-4806-a930-b24c71a51a8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_abb406d8-be26-403b-99f5-66085341a8db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_679ba68e-d2c6-4806-a930-b24c71a51a8c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_abb406d8-be26-403b-99f5-66085341a8db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_dbdd3919-45b1-4097-ab10-72a8917b9fd4" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_abb406d8-be26-403b-99f5-66085341a8db" xlink:to="loc_vtrs_BioconBiologicsMember_dbdd3919-45b1-4097-ab10-72a8917b9fd4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="extended" id="iffc5f7c8f9214ea8b7facf0aea61d43b_RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_63f164d0-da25-4663-8151-d1405a2923ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:to="loc_us-gaap_ReceivablesNetCurrent_63f164d0-da25-4663-8151-d1405a2923ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_2e518a6f-f7f6-46b9-8aa0-9977177e11bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_2e518a6f-f7f6-46b9-8aa0-9977177e11bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_67fa1255-6a00-4008-aecc-e6fe08b63031" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_67fa1255-6a00-4008-aecc-e6fe08b63031" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_70235b6f-00d3-4b20-b0ef-3f25a729d8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_70235b6f-00d3-4b20-b0ef-3f25a729d8b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7faf2154-7923-4c82-bf9b-7842390c4ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_70235b6f-00d3-4b20-b0ef-3f25a729d8b9" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7faf2154-7923-4c82-bf9b-7842390c4ee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_7faf2154-7923-4c82-bf9b-7842390c4ee7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7faf2154-7923-4c82-bf9b-7842390c4ee7" xlink:to="loc_us-gaap_ReceivableTypeDomain_7faf2154-7923-4c82-bf9b-7842390c4ee7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_77028859-5ac0-472c-b803-d423fae8c757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7faf2154-7923-4c82-bf9b-7842390c4ee7" xlink:to="loc_us-gaap_ReceivableTypeDomain_77028859-5ac0-472c-b803-d423fae8c757" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_ac9cb360-03c5-43ca-a38e-300b5fa9b690" xlink:href="vtrs-20230331.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_77028859-5ac0-472c-b803-d423fae8c757" xlink:to="loc_vtrs_VariableConsiderationMember_ac9cb360-03c5-43ca-a38e-300b5fa9b690" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" xlink:type="extended" id="i9aea323f51ab4b4e8cb52af96a1f631a_RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_26071588-09ab-4ba5-a352-b9039d613b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_26071588-09ab-4ba5-a352-b9039d613b81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d73ed741-b91d-4cff-acd8-6233273996b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d73ed741-b91d-4cff-acd8-6233273996b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7ea23d4a-548a-4a2d-a7e1-0581aa602fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7ea23d4a-548a-4a2d-a7e1-0581aa602fcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_82b3f32d-0a4b-45e6-b9c9-f69eee6fd84a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_Revenues_82b3f32d-0a4b-45e6-b9c9-f69eee6fd84a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9bf2eab8-4f58-46e1-9e11-4ae03d5153d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9bf2eab8-4f58-46e1-9e11-4ae03d5153d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_582385be-5e74-4031-893e-d48954af5b17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_582385be-5e74-4031-893e-d48954af5b17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9b76f0b7-36cc-4fd0-85ed-71f1b2d717f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9b76f0b7-36cc-4fd0-85ed-71f1b2d717f8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_364fe91d-c4a6-4402-875f-799d48e3a0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_364fe91d-c4a6-4402-875f-799d48e3a0b0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligation_986c31b3-dfa6-43c3-8b32-725f9560a121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierFinanceProgramObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_SupplierFinanceProgramObligation_986c31b3-dfa6-43c3-8b32-725f9560a121" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac68e6a5-c3a6-41ee-a006-d0f380dbfe6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac68e6a5-c3a6-41ee-a006-d0f380dbfe6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8b83281c-d915-4663-a852-15345e879dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac68e6a5-c3a6-41ee-a006-d0f380dbfe6f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8b83281c-d915-4663-a852-15345e879dbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b83281c-d915-4663-a852-15345e879dbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8b83281c-d915-4663-a852-15345e879dbf" xlink:to="loc_us-gaap_EquityComponentDomain_8b83281c-d915-4663-a852-15345e879dbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a9b3fe4f-047c-43ec-86f8-110b2fc8436d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8b83281c-d915-4663-a852-15345e879dbf" xlink:to="loc_us-gaap_EquityComponentDomain_a9b3fe4f-047c-43ec-86f8-110b2fc8436d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_08edff99-e2e5-4dc0-94a6-ae5b16afeb33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a9b3fe4f-047c-43ec-86f8-110b2fc8436d" xlink:to="loc_us-gaap_RetainedEarningsMember_08edff99-e2e5-4dc0-94a6-ae5b16afeb33" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#AcquisitionsandOtherTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails" xlink:type="extended" id="i0f8464186543421eb59ae2febc62e267_AcquisitionsandOtherTransactionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0857d5cd-c7ff-4d92-b3fd-2aa39302905f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0857d5cd-c7ff-4d92-b3fd-2aa39302905f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_53ab4259-a6ae-4da0-8577-d1f3f46e7e14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_53ab4259-a6ae-4da0-8577-d1f3f46e7e14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7932f5d4-eb95-422a-b1cc-44ab2b1aafbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7932f5d4-eb95-422a-b1cc-44ab2b1aafbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c3bb2573-b8dd-4f3c-9933-bd387c2008d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_Goodwill_c3bb2573-b8dd-4f3c-9933-bd387c2008d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_65f31aea-e00b-4ac2-ba80-fa45b0d627da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_65f31aea-e00b-4ac2-ba80-fa45b0d627da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_40aefbf9-c697-4bfa-aacd-174382325e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_40aefbf9-c697-4bfa-aacd-174382325e8f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_58baf9f3-04d8-48ee-9aac-d0dd020bf234" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_58baf9f3-04d8-48ee-9aac-d0dd020bf234" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights_8ab00f0c-7cd4-4d69-ab82-5dcec0a0d24b" xlink:href="vtrs-20230331.xsd#vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights_8ab00f0c-7cd4-4d69-ab82-5dcec0a0d24b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionContingentConsiderationPerShare_0bb7891c-a3e2-4995-adca-ee7804e781fd" xlink:href="vtrs-20230331.xsd#vtrs_BusinessAcquisitionContingentConsiderationPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_vtrs_BusinessAcquisitionContingentConsiderationPerShare_0bb7891c-a3e2-4995-adca-ee7804e781fd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_35ebc82e-dd4c-4328-8cf0-062b56d9e963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_35ebc82e-dd4c-4328-8cf0-062b56d9e963" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_82c33030-2488-4c99-881b-cdbbab453930" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_82c33030-2488-4c99-881b-cdbbab453930" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization_ebf07832-96da-4e05-8f7f-85f9351c6335" xlink:href="vtrs-20230331.xsd#vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization_ebf07832-96da-4e05-8f7f-85f9351c6335" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_23aded03-07ac-4a47-866c-4b4d5c5d57e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_23aded03-07ac-4a47-866c-4b4d5c5d57e0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_5005908a-5abd-4f42-9c1d-000ca61cbc67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_5005908a-5abd-4f42-9c1d-000ca61cbc67" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a8a090b9-fe10-48b7-adfc-72024cd56695" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a8a090b9-fe10-48b7-adfc-72024cd56695" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2a58f779-e872-45e8-940d-a3dec0934c40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2a58f779-e872-45e8-940d-a3dec0934c40" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_880095fb-e385-4a91-a045-3753586b2a28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_880095fb-e385-4a91-a045-3753586b2a28" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_502174bb-9821-47b8-bda2-b1ffe91032a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_502174bb-9821-47b8-bda2-b1ffe91032a0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7a786c41-7aeb-4932-abd2-bb62d6bcc7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7a786c41-7aeb-4932-abd2-bb62d6bcc7eb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_989593c4-d69f-4bbb-b8e5-e4e7aa659427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_Revenues_989593c4-d69f-4bbb-b8e5-e4e7aa659427" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7e909a68-da6c-410d-aef8-7d5f922c1811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7e909a68-da6c-410d-aef8-7d5f922c1811" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_4409a843-8148-462a-87be-89c126143b21" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_srt_OwnershipAxis_4409a843-8148-462a-87be-89c126143b21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_4409a843-8148-462a-87be-89c126143b21_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_4409a843-8148-462a-87be-89c126143b21" xlink:to="loc_srt_OwnershipDomain_4409a843-8148-462a-87be-89c126143b21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9a3dce5f-14a0-44de-be5b-b727248a4a35" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_4409a843-8148-462a-87be-89c126143b21" xlink:to="loc_srt_OwnershipDomain_9a3dce5f-14a0-44de-be5b-b727248a4a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViatrisIncMember_f126c44b-c6ea-49d0-ab04-7400305daf92" xlink:href="vtrs-20230331.xsd#vtrs_ViatrisIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_9a3dce5f-14a0-44de-be5b-b727248a4a35" xlink:to="loc_vtrs_ViatrisIncMember_f126c44b-c6ea-49d0-ab04-7400305daf92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e0be88fa-187c-4b55-8650-2dd7b58d7a73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e0be88fa-187c-4b55-8650-2dd7b58d7a73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e0be88fa-187c-4b55-8650-2dd7b58d7a73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e0be88fa-187c-4b55-8650-2dd7b58d7a73" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e0be88fa-187c-4b55-8650-2dd7b58d7a73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_030effd5-c2c1-4499-b0c2-86320465f966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e0be88fa-187c-4b55-8650-2dd7b58d7a73" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_030effd5-c2c1-4499-b0c2-86320465f966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OysterPointPharmaAcquisitionMember_0053f4e0-3e83-48e5-b6f1-273e5dff846b" xlink:href="vtrs-20230331.xsd#vtrs_OysterPointPharmaAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_030effd5-c2c1-4499-b0c2-86320465f966" xlink:to="loc_vtrs_OysterPointPharmaAcquisitionMember_0053f4e0-3e83-48e5-b6f1-273e5dff846b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesAcquisitionMember_f249dd77-4efb-4120-93ea-ec00f23a8948" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_030effd5-c2c1-4499-b0c2-86320465f966" xlink:to="loc_vtrs_FamyLifeSciencesAcquisitionMember_f249dd77-4efb-4120-93ea-ec00f23a8948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c7776713-3827-45ee-85c3-1a63b86a115b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c7776713-3827-45ee-85c3-1a63b86a115b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7776713-3827-45ee-85c3-1a63b86a115b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c7776713-3827-45ee-85c3-1a63b86a115b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7776713-3827-45ee-85c3-1a63b86a115b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b72b14a9-bf83-4696-ae80-2cfb2a63675d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c7776713-3827-45ee-85c3-1a63b86a115b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b72b14a9-bf83-4696-ae80-2cfb2a63675d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_cc8becce-dd47-4ec9-8a50-1d43482eb137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b72b14a9-bf83-4696-ae80-2cfb2a63675d" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_cc8becce-dd47-4ec9-8a50-1d43482eb137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7d7a2216-3043-4e37-aad1-42e20a203837" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_srt_RangeAxis_7d7a2216-3043-4e37-aad1-42e20a203837" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7d7a2216-3043-4e37-aad1-42e20a203837_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7d7a2216-3043-4e37-aad1-42e20a203837" xlink:to="loc_srt_RangeMember_7d7a2216-3043-4e37-aad1-42e20a203837_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae90dda5-1268-4a70-954c-c62d67da99fa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7d7a2216-3043-4e37-aad1-42e20a203837" xlink:to="loc_srt_RangeMember_ae90dda5-1268-4a70-954c-c62d67da99fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b18b0827-d992-4311-9975-554494824580" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae90dda5-1268-4a70-954c-c62d67da99fa" xlink:to="loc_srt_MinimumMember_b18b0827-d992-4311-9975-554494824580" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_52e1a34f-a956-4339-bbf4-e9b1f1f5e832" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae90dda5-1268-4a70-954c-c62d67da99fa" xlink:to="loc_srt_MaximumMember_52e1a34f-a956-4339-bbf4-e9b1f1f5e832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd4f0fc1-e677-4600-b10f-3948fbc28e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd4f0fc1-e677-4600-b10f-3948fbc28e0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd4f0fc1-e677-4600-b10f-3948fbc28e0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd4f0fc1-e677-4600-b10f-3948fbc28e0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd4f0fc1-e677-4600-b10f-3948fbc28e0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03593a64-f020-47ca-a5f5-b6987216deab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd4f0fc1-e677-4600-b10f-3948fbc28e0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03593a64-f020-47ca-a5f5-b6987216deab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductRightsAndLicensesMember_36235d86-e8cd-4dc4-ab77-7e43ee3dbbdd" xlink:href="vtrs-20230331.xsd#vtrs_ProductRightsAndLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03593a64-f020-47ca-a5f5-b6987216deab" xlink:to="loc_vtrs_ProductRightsAndLicensesMember_36235d86-e8cd-4dc4-ab77-7e43ee3dbbdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d290db91-186d-4b94-b34a-6d90e81542f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03593a64-f020-47ca-a5f5-b6987216deab" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d290db91-186d-4b94-b34a-6d90e81542f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3006d45b-4e9a-4925-8905-f21cee9fbedd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3006d45b-4e9a-4925-8905-f21cee9fbedd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3006d45b-4e9a-4925-8905-f21cee9fbedd_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3006d45b-4e9a-4925-8905-f21cee9fbedd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3006d45b-4e9a-4925-8905-f21cee9fbedd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ae6c5372-7ac7-4553-818e-2243523be6c2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3006d45b-4e9a-4925-8905-f21cee9fbedd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ae6c5372-7ac7-4553-818e-2243523be6c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesMember_9956e2fc-7029-4ba4-9961-094129f0c054" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ae6c5372-7ac7-4553-818e-2243523be6c2" xlink:to="loc_vtrs_FamyLifeSciencesMember_9956e2fc-7029-4ba4-9961-094129f0c054" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8f353b45-7c30-441c-9f7b-ec2b5ea44998" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_srt_StatementScenarioAxis_8f353b45-7c30-441c-9f7b-ec2b5ea44998" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8f353b45-7c30-441c-9f7b-ec2b5ea44998_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_8f353b45-7c30-441c-9f7b-ec2b5ea44998" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8f353b45-7c30-441c-9f7b-ec2b5ea44998_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_62b7b35e-eb70-4e0f-9562-d73b2b47e7c6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_8f353b45-7c30-441c-9f7b-ec2b5ea44998" xlink:to="loc_srt_ScenarioUnspecifiedDomain_62b7b35e-eb70-4e0f-9562-d73b2b47e7c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_023062ae-fbf1-4793-9d3b-758d0a177e73" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_62b7b35e-eb70-4e0f-9562-d73b2b47e7c6" xlink:to="loc_srt_ScenarioForecastMember_023062ae-fbf1-4793-9d3b-758d0a177e73" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="extended" id="ic3fe2976aafc49ac9a7875cc3498eb5a_AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c78582a8-07a9-48f3-8752-3a675c71e0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c78582a8-07a9-48f3-8752-3a675c71e0dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_899866bd-e97c-4ef2-ab1f-4c474f9327cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_899866bd-e97c-4ef2-ab1f-4c474f9327cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9fb4518a-4d99-42f4-8c7f-6a7c005da7da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9fb4518a-4d99-42f4-8c7f-6a7c005da7da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ef4b3099-b841-4635-87c8-3cbfaa08b9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_Goodwill_ef4b3099-b841-4635-87c8-3cbfaa08b9e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b3f38a44-1ddc-4f4b-ba0c-4c09af8bef92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b3f38a44-1ddc-4f4b-ba0c-4c09af8bef92" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0f39b06e-9d2b-42fb-a63f-4f0a16a21186" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0f39b06e-9d2b-42fb-a63f-4f0a16a21186" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_14f38ca8-001e-4818-b9e9-67d4969d44d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_14f38ca8-001e-4818-b9e9-67d4969d44d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9ac3a289-81ee-4d91-aaec-39dcbd32555e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9ac3a289-81ee-4d91-aaec-39dcbd32555e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_11480127-ef3b-4a18-b7ca-a54d739e9170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_11480127-ef3b-4a18-b7ca-a54d739e9170" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3616a3ad-85ae-43e6-baa5-4af5a252bd91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3616a3ad-85ae-43e6-baa5-4af5a252bd91" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_82ae4219-3255-403a-aea6-925f5b12f7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_82ae4219-3255-403a-aea6-925f5b12f7a6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d5fd2efc-d615-4d58-9dbb-951e4bdc882c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d5fd2efc-d615-4d58-9dbb-951e4bdc882c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c76de91-8fde-4581-be41-d848f0e3ced5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c76de91-8fde-4581-be41-d848f0e3ced5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a0deb4b2-1dee-4d14-a0c4-52a8d52c9732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c76de91-8fde-4581-be41-d848f0e3ced5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a0deb4b2-1dee-4d14-a0c4-52a8d52c9732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0deb4b2-1dee-4d14-a0c4-52a8d52c9732_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0deb4b2-1dee-4d14-a0c4-52a8d52c9732" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0deb4b2-1dee-4d14-a0c4-52a8d52c9732_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5c76b895-b660-4b41-8479-fbad26a5cf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0deb4b2-1dee-4d14-a0c4-52a8d52c9732" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5c76b895-b660-4b41-8479-fbad26a5cf1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OysterPointPharmaAcquisitionMember_af7ddf75-90b7-47f1-a7aa-995a1141384f" xlink:href="vtrs-20230331.xsd#vtrs_OysterPointPharmaAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5c76b895-b660-4b41-8479-fbad26a5cf1a" xlink:to="loc_vtrs_OysterPointPharmaAcquisitionMember_af7ddf75-90b7-47f1-a7aa-995a1141384f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesAcquisitionMember_2d504f41-6ee6-4cbb-88c6-011d4a066d8f" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5c76b895-b660-4b41-8479-fbad26a5cf1a" xlink:to="loc_vtrs_FamyLifeSciencesAcquisitionMember_2d504f41-6ee6-4cbb-88c6-011d4a066d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7330e231-b0a0-4da7-8857-b9c5809a8c01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c76de91-8fde-4581-be41-d848f0e3ced5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7330e231-b0a0-4da7-8857-b9c5809a8c01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7330e231-b0a0-4da7-8857-b9c5809a8c01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7330e231-b0a0-4da7-8857-b9c5809a8c01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7330e231-b0a0-4da7-8857-b9c5809a8c01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28e50fed-1dde-444a-9a0f-d7ab15595bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7330e231-b0a0-4da7-8857-b9c5809a8c01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28e50fed-1dde-444a-9a0f-d7ab15595bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductRightsAndLicensesMember_790ea783-e4fe-401b-b25a-d99c454ba642" xlink:href="vtrs-20230331.xsd#vtrs_ProductRightsAndLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28e50fed-1dde-444a-9a0f-d7ab15595bcc" xlink:to="loc_vtrs_ProductRightsAndLicensesMember_790ea783-e4fe-401b-b25a-d99c454ba642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_47cdba7c-e65b-404f-9faa-5eda96ae1690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28e50fed-1dde-444a-9a0f-d7ab15595bcc" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_47cdba7c-e65b-404f-9faa-5eda96ae1690" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="extended" id="ibf478685c39148f29f45bbe3ef8081a6_AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ac180c6c-e3fd-411a-9dc9-bd28e33c7b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ac180c6c-e3fd-411a-9dc9-bd28e33c7b8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e7f1f58e-1756-4f69-8aa9-23062bb4c278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e7f1f58e-1756-4f69-8aa9-23062bb4c278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_b9544bc7-97c0-4628-a564-a70de60041fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_b9544bc7-97c0-4628-a564-a70de60041fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_55b38645-14ad-4c2a-9221-c7a5b4f6e873" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_55b38645-14ad-4c2a-9221-c7a5b4f6e873" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_2c49952f-ad8e-4dd4-9f2d-d7f918e0462b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_2c49952f-ad8e-4dd4-9f2d-d7f918e0462b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_ad6d5c89-a7ba-46b7-9bb9-844d1d3094ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_ad6d5c89-a7ba-46b7-9bb9-844d1d3094ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5464b0c6-de09-4c2a-bad1-9af10cdd2aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5464b0c6-de09-4c2a-bad1-9af10cdd2aa8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a5470aed-048d-4c69-86d1-33965d513366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5464b0c6-de09-4c2a-bad1-9af10cdd2aa8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a5470aed-048d-4c69-86d1-33965d513366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a5470aed-048d-4c69-86d1-33965d513366_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a5470aed-048d-4c69-86d1-33965d513366" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a5470aed-048d-4c69-86d1-33965d513366_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d986b7c9-a9e5-41f6-8223-03379fbe51cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a5470aed-048d-4c69-86d1-33965d513366" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d986b7c9-a9e5-41f6-8223-03379fbe51cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OysterPointPharmaAcquisitionMember_b19c224e-7f81-4eea-996c-07a45e84a498" xlink:href="vtrs-20230331.xsd#vtrs_OysterPointPharmaAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d986b7c9-a9e5-41f6-8223-03379fbe51cd" xlink:to="loc_vtrs_OysterPointPharmaAcquisitionMember_b19c224e-7f81-4eea-996c-07a45e84a498" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DivestituresDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DivestituresDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DivestituresDetails" xlink:type="extended" id="ic6b8ca94d31d4ed191c7780d2ec61d73_DivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_dae6e92f-53a0-49c6-9faf-ff71c37c02b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_AssetImpairmentCharges_dae6e92f-53a0-49c6-9faf-ff71c37c02b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f7a4a6a0-7e88-41db-b0df-4e08bd531438" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f7a4a6a0-7e88-41db-b0df-4e08bd531438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2beda488-c5ba-43d0-8065-e6bc4d2d4092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2beda488-c5ba-43d0-8065-e6bc4d2d4092" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_120cff7e-aab2-43a3-b46e-81a718b63e94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_InventoryValuationReserves_120cff7e-aab2-43a3-b46e-81a718b63e94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear_5039dd39-6652-4296-95bf-f08aad0d49a2" xlink:href="vtrs-20230331.xsd#vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear_5039dd39-6652-4296-95bf-f08aad0d49a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_978d4f4d-6ba6-43b2-9002-aa9143c38d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_978d4f4d-6ba6-43b2-9002-aa9143c38d6c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_46f0b7d3-4da9-42c2-970f-506f9fffab78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_46f0b7d3-4da9-42c2-970f-506f9fffab78" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_163e0918-9f5d-43eb-b7b8-5894d2645ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_163e0918-9f5d-43eb-b7b8-5894d2645ad9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_78cc248d-4ab5-48d0-9573-5340dfa5dbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_78cc248d-4ab5-48d0-9573-5340dfa5dbfe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset_b8b82c81-33b6-489e-83a1-cfe4b7b5f108" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset_b8b82c81-33b6-489e-83a1-cfe4b7b5f108" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm_80db9b8f-73c9-480b-90fc-f661ff20a4ab" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm_80db9b8f-73c9-480b-90fc-f661ff20a4ab" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration_d77c6729-cd68-40e7-ab86-39fe22350677" xlink:href="vtrs-20230331.xsd#vtrs_DivestitureOfBusinessDeferredCashConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration_d77c6729-cd68-40e7-ab86-39fe22350677" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment_00c7a859-0567-41bc-a59a-ee0fa64c3671" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment_00c7a859-0567-41bc-a59a-ee0fa64c3671" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ba052728-ad41-41fd-995b-8418ca749306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ba052728-ad41-41fd-995b-8418ca749306" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a4704332-35a1-4c8c-8344-34194080900d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a4704332-35a1-4c8c-8344-34194080900d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a4704332-35a1-4c8c-8344-34194080900d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a4704332-35a1-4c8c-8344-34194080900d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a4704332-35a1-4c8c-8344-34194080900d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ba4d9c8b-8d56-4c14-9caa-8d023d03b5be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a4704332-35a1-4c8c-8344-34194080900d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ba4d9c8b-8d56-4c14-9caa-8d023d03b5be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnDistributorMarketsMember_04708f24-28d4-43e7-891b-08a3719998d3" xlink:href="vtrs-20230331.xsd#vtrs_UpjohnDistributorMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ba4d9c8b-8d56-4c14-9caa-8d023d03b5be" xlink:to="loc_vtrs_UpjohnDistributorMarketsMember_04708f24-28d4-43e7-891b-08a3719998d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_4ef3807d-8f4d-47cd-918c-245e9af6b4e3" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ba4d9c8b-8d56-4c14-9caa-8d023d03b5be" xlink:to="loc_vtrs_BioconBiologicsMember_4ef3807d-8f4d-47cd-918c-245e9af6b4e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_629c08eb-1487-45b4-b144-d7ec35c364c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_629c08eb-1487-45b4-b144-d7ec35c364c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_629c08eb-1487-45b4-b144-d7ec35c364c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_629c08eb-1487-45b4-b144-d7ec35c364c2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_629c08eb-1487-45b4-b144-d7ec35c364c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fb28eaae-599f-4606-9c76-226c1adf1f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_629c08eb-1487-45b4-b144-d7ec35c364c2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fb28eaae-599f-4606-9c76-226c1adf1f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_abbc2346-2ebe-47b9-8ca1-a2cde3b1a564" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fb28eaae-599f-4606-9c76-226c1adf1f7c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_abbc2346-2ebe-47b9-8ca1-a2cde3b1a564" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_625656b0-7907-4822-8b45-d5e51cfdfa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fb28eaae-599f-4606-9c76-226c1adf1f7c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_625656b0-7907-4822-8b45-d5e51cfdfa6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4b8c3555-4772-4541-bc75-5dc8409dced2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4b8c3555-4772-4541-bc75-5dc8409dced2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4b8c3555-4772-4541-bc75-5dc8409dced2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4b8c3555-4772-4541-bc75-5dc8409dced2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4b8c3555-4772-4541-bc75-5dc8409dced2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_50e93eb2-f3b9-482c-a6d3-342999007f23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4b8c3555-4772-4541-bc75-5dc8409dced2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_50e93eb2-f3b9-482c-a6d3-342999007f23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d798bd24-28b3-4035-a489-85a5b3b14cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d798bd24-28b3-4035-a489-85a5b3b14cf6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d798bd24-28b3-4035-a489-85a5b3b14cf6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d798bd24-28b3-4035-a489-85a5b3b14cf6" xlink:to="loc_us-gaap_SegmentDomain_d798bd24-28b3-4035-a489-85a5b3b14cf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aac7c9ae-1ef2-4035-8cb0-6f70dee27d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d798bd24-28b3-4035-a489-85a5b3b14cf6" xlink:to="loc_us-gaap_SegmentDomain_aac7c9ae-1ef2-4035-8cb0-6f70dee27d1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_b63989c2-40dd-4f55-8a5e-17fe08c84650" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aac7c9ae-1ef2-4035-8cb0-6f70dee27d1b" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_b63989c2-40dd-4f55-8a5e-17fe08c84650" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_29044e36-d594-47ad-a00b-595ffa36fd86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_29044e36-d594-47ad-a00b-595ffa36fd86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_29044e36-d594-47ad-a00b-595ffa36fd86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_29044e36-d594-47ad-a00b-595ffa36fd86" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_29044e36-d594-47ad-a00b-595ffa36fd86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e2755f4-1fa8-4d6c-b2ef-342a8d994aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_29044e36-d594-47ad-a00b-595ffa36fd86" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e2755f4-1fa8-4d6c-b2ef-342a8d994aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoriesMember_5dab7eee-463f-4b99-8d9c-1f60a196c263" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e2755f4-1fa8-4d6c-b2ef-342a8d994aa2" xlink:to="loc_us-gaap_InventoriesMember_5dab7eee-463f-4b99-8d9c-1f60a196c263" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74960ae7-9ed5-4cfa-87df-b94f84ee76e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74960ae7-9ed5-4cfa-87df-b94f84ee76e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_74960ae7-9ed5-4cfa-87df-b94f84ee76e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74960ae7-9ed5-4cfa-87df-b94f84ee76e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_74960ae7-9ed5-4cfa-87df-b94f84ee76e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb505a5-6d69-486e-9bff-86beac16fa06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74960ae7-9ed5-4cfa-87df-b94f84ee76e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb505a5-6d69-486e-9bff-86beac16fa06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_644936ba-4fcf-45b0-9361-dd00cae7da89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb505a5-6d69-486e-9bff-86beac16fa06" xlink:to="loc_us-gaap_LicensingAgreementsMember_644936ba-4fcf-45b0-9361-dd00cae7da89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a1df876d-b2c4-43c9-b6a8-987b340b7f87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_srt_StatementScenarioAxis_a1df876d-b2c4-43c9-b6a8-987b340b7f87" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a1df876d-b2c4-43c9-b6a8-987b340b7f87_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a1df876d-b2c4-43c9-b6a8-987b340b7f87" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a1df876d-b2c4-43c9-b6a8-987b340b7f87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_612746f9-b8a9-450b-add4-3aa1cfde43fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a1df876d-b2c4-43c9-b6a8-987b340b7f87" xlink:to="loc_srt_ScenarioUnspecifiedDomain_612746f9-b8a9-450b-add4-3aa1cfde43fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e7a3e009-558d-478f-be03-23af80b4eaf4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_612746f9-b8a9-450b-add4-3aa1cfde43fd" xlink:to="loc_srt_ScenarioForecastMember_e7a3e009-558d-478f-be03-23af80b4eaf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_70b3a9a0-60b8-4440-9867-9d929fb1c0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_70b3a9a0-60b8-4440-9867-9d929fb1c0c6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_70b3a9a0-60b8-4440-9867-9d929fb1c0c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_70b3a9a0-60b8-4440-9867-9d929fb1c0c6" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_70b3a9a0-60b8-4440-9867-9d929fb1c0c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cdc73b1d-df61-41b8-814c-64d7fb72857b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_70b3a9a0-60b8-4440-9867-9d929fb1c0c6" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cdc73b1d-df61-41b8-814c-64d7fb72857b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_8454cebc-c038-4fb9-858c-b5735c940692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cdc73b1d-df61-41b8-814c-64d7fb72857b" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_8454cebc-c038-4fb9-858c-b5735c940692" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ShareBasedIncentivePlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="extended" id="i5da976978416468490c9f7b58b355097_ShareBasedIncentivePlanNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_957a1762-0ec5-477f-830a-b66dd609b3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_957a1762-0ec5-477f-830a-b66dd609b3a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_385e24aa-09a3-46fa-8f0b-5012d128ddb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_385e24aa-09a3-46fa-8f0b-5012d128ddb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8988cb5f-e1cd-4b96-9dd1-f05cb4dd2588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8988cb5f-e1cd-4b96-9dd1-f05cb4dd2588" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_14e3599a-18ae-429b-9e1c-03cc27a3446b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_14e3599a-18ae-429b-9e1c-03cc27a3446b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5b2d0813-8055-4618-bb2a-8b05da9ce4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5b2d0813-8055-4618-bb2a-8b05da9ce4e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_995e3599-94b6-445b-acbc-b69944a377e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_995e3599-94b6-445b-acbc-b69944a377e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_97407ab1-aea5-4049-8727-54fca6620e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_97407ab1-aea5-4049-8727-54fca6620e5d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8ce081a2-3b35-4147-992f-cc67a9b677bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8ce081a2-3b35-4147-992f-cc67a9b677bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_01b18683-ccb7-446a-8383-a90493a163f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_01b18683-ccb7-446a-8383-a90493a163f0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_101c15d8-b254-4353-89db-8803af3345c8" xlink:href="vtrs-20230331.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_101c15d8-b254-4353-89db-8803af3345c8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5f5648ed-2419-410c-a5dd-6202990919a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5f5648ed-2419-410c-a5dd-6202990919a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1c305088-45df-442b-ac25-016e331b48a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1c305088-45df-442b-ac25-016e331b48a0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_19a03e74-531c-4679-8e04-eb6c5be8cbec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_19a03e74-531c-4679-8e04-eb6c5be8cbec" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1773e42a-85a7-4078-a85c-b4d064c26609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1773e42a-85a7-4078-a85c-b4d064c26609" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_9822099b-39fe-4766-a887-6245154b8f49" xlink:href="vtrs-20230331.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_9822099b-39fe-4766-a887-6245154b8f49" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_82657c22-7e54-454c-a6af-2855052da863" xlink:href="vtrs-20230331.xsd#vtrs_ProgramNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_vtrs_ProgramNameAxis_82657c22-7e54-454c-a6af-2855052da863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_82657c22-7e54-454c-a6af-2855052da863_default" xlink:href="vtrs-20230331.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_ProgramNameAxis_82657c22-7e54-454c-a6af-2855052da863" xlink:to="loc_vtrs_ProgramNameDomain_82657c22-7e54-454c-a6af-2855052da863_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_47e28c1c-1b4d-4ee9-a507-4993ddee8c16" xlink:href="vtrs-20230331.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_ProgramNameAxis_82657c22-7e54-454c-a6af-2855052da863" xlink:to="loc_vtrs_ProgramNameDomain_47e28c1c-1b4d-4ee9-a507-4993ddee8c16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8b42ae3a-26cd-4125-8bba-22bc1c66cbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_us-gaap_PlanNameAxis_8b42ae3a-26cd-4125-8bba-22bc1c66cbc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8b42ae3a-26cd-4125-8bba-22bc1c66cbc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_8b42ae3a-26cd-4125-8bba-22bc1c66cbc7" xlink:to="loc_us-gaap_PlanNameDomain_8b42ae3a-26cd-4125-8bba-22bc1c66cbc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_72ada1cd-2b96-49db-8fdc-399ebe5c22be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_8b42ae3a-26cd-4125-8bba-22bc1c66cbc7" xlink:to="loc_us-gaap_PlanNameDomain_72ada1cd-2b96-49db-8fdc-399ebe5c22be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_51f74af8-2889-4ae2-b7cd-d808742f924b" xlink:href="vtrs-20230331.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_72ada1cd-2b96-49db-8fdc-399ebe5c22be" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_51f74af8-2889-4ae2-b7cd-d808742f924b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_7abe44cf-edb8-4fdf-8bef-365177999bbc" xlink:href="vtrs-20230331.xsd#vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_72ada1cd-2b96-49db-8fdc-399ebe5c22be" xlink:to="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_7abe44cf-edb8-4fdf-8bef-365177999bbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6851ce41-f446-435c-868f-d52f1a5287d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_us-gaap_AwardTypeAxis_6851ce41-f446-435c-868f-d52f1a5287d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6851ce41-f446-435c-868f-d52f1a5287d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6851ce41-f446-435c-868f-d52f1a5287d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6851ce41-f446-435c-868f-d52f1a5287d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7998055b-ae70-48fe-941b-84d4f2126386" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6851ce41-f446-435c-868f-d52f1a5287d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7998055b-ae70-48fe-941b-84d4f2126386" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e66b3489-0af1-43d0-9aca-ee27941ab2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7998055b-ae70-48fe-941b-84d4f2126386" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e66b3489-0af1-43d0-9aca-ee27941ab2b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_81b20e6a-9628-443e-90de-457e8e14001f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_srt_RangeAxis_81b20e6a-9628-443e-90de-457e8e14001f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_81b20e6a-9628-443e-90de-457e8e14001f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_81b20e6a-9628-443e-90de-457e8e14001f" xlink:to="loc_srt_RangeMember_81b20e6a-9628-443e-90de-457e8e14001f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e139056-4063-420e-9f41-3b5da127d95c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_81b20e6a-9628-443e-90de-457e8e14001f" xlink:to="loc_srt_RangeMember_6e139056-4063-420e-9f41-3b5da127d95c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e5f96941-9368-467e-b7ce-40cbc99c3012" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e139056-4063-420e-9f41-3b5da127d95c" xlink:to="loc_srt_MinimumMember_e5f96941-9368-467e-b7ce-40cbc99c3012" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1a67b0ab-7811-4e19-a0c9-29fb4c04b34e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e139056-4063-420e-9f41-3b5da127d95c" xlink:to="loc_srt_MaximumMember_1a67b0ab-7811-4e19-a0c9-29fb4c04b34e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d885892b-2d1e-4107-8d6f-e1b2f144e21d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d885892b-2d1e-4107-8d6f-e1b2f144e21d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d885892b-2d1e-4107-8d6f-e1b2f144e21d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d885892b-2d1e-4107-8d6f-e1b2f144e21d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d885892b-2d1e-4107-8d6f-e1b2f144e21d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_27d1296c-a61f-40f3-a8fb-d66c47e2a05e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d885892b-2d1e-4107-8d6f-e1b2f144e21d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_27d1296c-a61f-40f3-a8fb-d66c47e2a05e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="extended" id="i9d036406611042aa994d8ad37afbd8bb_ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ee54b57d-91fd-49ac-8a27-2b72272a7b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ee54b57d-91fd-49ac-8a27-2b72272a7b0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1b24e29a-ca93-4ea0-8949-25d1b58d32b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1b24e29a-ca93-4ea0-8949-25d1b58d32b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_138f4393-131a-443e-bf2e-4a2fcd381041" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_138f4393-131a-443e-bf2e-4a2fcd381041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99fdb2dd-07ce-4714-bd3f-219e15872fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99fdb2dd-07ce-4714-bd3f-219e15872fa2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23af23cf-345c-4004-9fc0-51c4a9bafd77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23af23cf-345c-4004-9fc0-51c4a9bafd77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a849202a-9673-48bd-a97f-c08727b1f446" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a849202a-9673-48bd-a97f-c08727b1f446" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8f6d7657-8dcc-4af1-a3aa-f4f36d781a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8f6d7657-8dcc-4af1-a3aa-f4f36d781a1d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_453ffa32-5b0d-4088-83fd-fe3e47f1750a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_453ffa32-5b0d-4088-83fd-fe3e47f1750a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9a7e782d-864e-47a2-ace6-a6204a2c29a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9a7e782d-864e-47a2-ace6-a6204a2c29a1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9110b1e8-925c-491e-8cf3-a07896b55659" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_51e27424-5467-4f65-a1e9-bbfd938ac646" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94cdf3de-850c-49c0-b2c4-78a25e4e2385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ee54b57d-91fd-49ac-8a27-2b72272a7b0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94cdf3de-850c-49c0-b2c4-78a25e4e2385" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_60ff8966-79dc-4e06-91fe-14f88ed2107b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94cdf3de-850c-49c0-b2c4-78a25e4e2385" xlink:to="loc_us-gaap_AwardTypeAxis_60ff8966-79dc-4e06-91fe-14f88ed2107b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_60ff8966-79dc-4e06-91fe-14f88ed2107b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_60ff8966-79dc-4e06-91fe-14f88ed2107b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_60ff8966-79dc-4e06-91fe-14f88ed2107b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_056c00d4-9ddb-4eff-ae55-214928453263" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_60ff8966-79dc-4e06-91fe-14f88ed2107b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_056c00d4-9ddb-4eff-ae55-214928453263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d41e4a00-53e4-4d57-ae71-ac22b75c2f29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_056c00d4-9ddb-4eff-ae55-214928453263" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d41e4a00-53e4-4d57-ae71-ac22b75c2f29" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#PensionandOtherPostretirementBenefitNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails" xlink:type="extended" id="i41109f81c60b4f298a07e906b2365a24_PensionandOtherPostretirementBenefitNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0700e590-3ebc-4c86-a2d1-5d02bb7964f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_5c3520e3-05e4-4062-99a9-90fcff53cc5d" xlink:href="vtrs-20230331.xsd#vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0700e590-3ebc-4c86-a2d1-5d02bb7964f4" xlink:to="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_5c3520e3-05e4-4062-99a9-90fcff53cc5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_7f3c6ee1-cc2c-41b2-ad43-fa0c24750b34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0700e590-3ebc-4c86-a2d1-5d02bb7964f4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_7f3c6ee1-cc2c-41b2-ad43-fa0c24750b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cd667ea8-2c7b-48f3-bf2e-3bbfa958363b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0700e590-3ebc-4c86-a2d1-5d02bb7964f4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cd667ea8-2c7b-48f3-bf2e-3bbfa958363b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92ecba37-1ff2-4dc8-a842-aaea038398c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cd667ea8-2c7b-48f3-bf2e-3bbfa958363b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92ecba37-1ff2-4dc8-a842-aaea038398c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92ecba37-1ff2-4dc8-a842-aaea038398c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92ecba37-1ff2-4dc8-a842-aaea038398c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92ecba37-1ff2-4dc8-a842-aaea038398c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5521433e-5d03-4801-a436-e12e0c2ba22d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92ecba37-1ff2-4dc8-a842-aaea038398c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5521433e-5d03-4801-a436-e12e0c2ba22d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended" id="i27e33d3bf3da4d0d86b4974599b1fb71_PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_0e946326-ffe4-4840-a8d8-0f0caaa48e78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_0e946326-ffe4-4840-a8d8-0f0caaa48e78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6267b0da-8bfb-47d0-a89e-a2a66dde19e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6267b0da-8bfb-47d0-a89e-a2a66dde19e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_04cc7810-db1f-4dab-81e0-d61ba1abcc68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_04cc7810-db1f-4dab-81e0-d61ba1abcc68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_29c0ffd3-c4d2-4d94-8090-00cdc9944eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_29c0ffd3-c4d2-4d94-8090-00cdc9944eb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_561cffa0-fa66-43c3-b33e-3708a55f680a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_561cffa0-fa66-43c3-b33e-3708a55f680a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0114ee9d-3973-4960-8887-88be361379a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0114ee9d-3973-4960-8887-88be361379a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_41bd4e8f-3f5e-4c2b-b8ed-f8c9c6b4bf64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_41bd4e8f-3f5e-4c2b-b8ed-f8c9c6b4bf64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_41bd4e8f-3f5e-4c2b-b8ed-f8c9c6b4bf64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_41bd4e8f-3f5e-4c2b-b8ed-f8c9c6b4bf64" xlink:to="loc_us-gaap_EquityComponentDomain_41bd4e8f-3f5e-4c2b-b8ed-f8c9c6b4bf64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_643fe5ba-9661-4474-942a-0528d3722413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_41bd4e8f-3f5e-4c2b-b8ed-f8c9c6b4bf64" xlink:to="loc_us-gaap_EquityComponentDomain_643fe5ba-9661-4474-942a-0528d3722413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_6da67ea3-a9bb-49ec-b55a-3009207b652a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_643fe5ba-9661-4474-942a-0528d3722413" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_6da67ea3-a9bb-49ec-b55a-3009207b652a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_df186d78-80c7-4bf0-b80e-8537291a02c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_df186d78-80c7-4bf0-b80e-8537291a02c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_df186d78-80c7-4bf0-b80e-8537291a02c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_df186d78-80c7-4bf0-b80e-8537291a02c9" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_df186d78-80c7-4bf0-b80e-8537291a02c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_462db345-2836-4b2b-8065-303553d47f39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_df186d78-80c7-4bf0-b80e-8537291a02c9" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_462db345-2836-4b2b-8065-303553d47f39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_7dd2ad58-cc40-4987-a4c4-48a04c0016f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_462db345-2836-4b2b-8065-303553d47f39" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_7dd2ad58-cc40-4987-a4c4-48a04c0016f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_003b4ab4-b645-4208-b00f-3606b2cb2b15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_003b4ab4-b645-4208-b00f-3606b2cb2b15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_003b4ab4-b645-4208-b00f-3606b2cb2b15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_003b4ab4-b645-4208-b00f-3606b2cb2b15" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_003b4ab4-b645-4208-b00f-3606b2cb2b15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_14fd380c-4610-4d27-a5a0-88cf9887e415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_003b4ab4-b645-4208-b00f-3606b2cb2b15" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_14fd380c-4610-4d27-a5a0-88cf9887e415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_7fcebfa6-8f2e-4821-b13b-7f98e0185f93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_14fd380c-4610-4d27-a5a0-88cf9887e415" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_7fcebfa6-8f2e-4821-b13b-7f98e0185f93" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended" id="i5283b6f2b32641f3a3e73c3de1874367_BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_dd739ec2-9783-4a30-bd6c-bf6abd5a0e06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_dd739ec2-9783-4a30-bd6c-bf6abd5a0e06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3aa2bffa-d682-4bb6-87c1-0d8f11f8e12d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3aa2bffa-d682-4bb6-87c1-0d8f11f8e12d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_48bf2e6c-d1c0-47c6-91ce-d37c734d4720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_48bf2e6c-d1c0-47c6-91ce-d37c734d4720" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_a8cad799-dfcf-4d5b-9e0c-cea7f3201c94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_TradingSecurities_a8cad799-dfcf-4d5b-9e0c-cea7f3201c94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_46cb2e5b-f002-42e5-9ae4-36c8247130ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_OtherAssetsCurrent_46cb2e5b-f002-42e5-9ae4-36c8247130ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1f96459f-e4a3-43b9-bbbe-b11066618161" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1f96459f-e4a3-43b9-bbbe-b11066618161" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_675154f9-3509-41a5-be4e-350e566e68e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_675154f9-3509-41a5-be4e-350e566e68e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_675154f9-3509-41a5-be4e-350e566e68e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_675154f9-3509-41a5-be4e-350e566e68e8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_675154f9-3509-41a5-be4e-350e566e68e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7100fc04-b128-49fc-af18-8c56576ea15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_675154f9-3509-41a5-be4e-350e566e68e8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7100fc04-b128-49fc-af18-8c56576ea15e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_a4aac792-f653-4126-b6ff-956f61683085" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7100fc04-b128-49fc-af18-8c56576ea15e" xlink:to="loc_us-gaap_DebtSecuritiesMember_a4aac792-f653-4126-b6ff-956f61683085" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_deebee6d-9c4a-42e8-9013-10132c99acf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_deebee6d-9c4a-42e8-9013-10132c99acf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_deebee6d-9c4a-42e8-9013-10132c99acf6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_deebee6d-9c4a-42e8-9013-10132c99acf6" xlink:to="loc_us-gaap_ReceivableTypeDomain_deebee6d-9c4a-42e8-9013-10132c99acf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_43395db5-d921-40d7-86b4-4d4617797390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_deebee6d-9c4a-42e8-9013-10132c99acf6" xlink:to="loc_us-gaap_ReceivableTypeDomain_43395db5-d921-40d7-86b4-4d4617797390" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_ca8d144a-fa04-43e8-9c2f-4287c8d87dae" xlink:href="vtrs-20230331.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_43395db5-d921-40d7-86b4-4d4617797390" xlink:to="loc_vtrs_VariableConsiderationMember_ca8d144a-fa04-43e8-9c2f-4287c8d87dae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_dad5af67-e923-47e7-92be-5b0547764f96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_dad5af67-e923-47e7-92be-5b0547764f96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dad5af67-e923-47e7-92be-5b0547764f96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_dad5af67-e923-47e7-92be-5b0547764f96" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dad5af67-e923-47e7-92be-5b0547764f96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_073950a4-ae50-43d7-87c8-d4964389b4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_dad5af67-e923-47e7-92be-5b0547764f96" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_073950a4-ae50-43d7-87c8-d4964389b4f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_7a3851c8-6761-4eb0-badb-2e7163bae866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_073950a4-ae50-43d7-87c8-d4964389b4f7" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_7a3851c8-6761-4eb0-badb-2e7163bae866" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended" id="i944fa581ad79465ba92dc39a0e418511_BalanceSheetComponentsPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_72912026-c39d-421b-9225-a5a8950c9c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_72912026-c39d-421b-9225-a5a8950c9c22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1477f249-6672-4ed4-bba7-22f443ba1acd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1477f249-6672-4ed4-bba7-22f443ba1acd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a7830a38-0f8b-47d1-8a96-57f1c81a3f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a7830a38-0f8b-47d1-8a96-57f1c81a3f7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ad78e031-09a1-4d01-9a16-d5adbb0a3878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ad78e031-09a1-4d01-9a16-d5adbb0a3878" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ee029ee2-ffe5-4051-beb7-536c1429fb03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ad78e031-09a1-4d01-9a16-d5adbb0a3878" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ee029ee2-ffe5-4051-beb7-536c1429fb03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ee029ee2-ffe5-4051-beb7-536c1429fb03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ee029ee2-ffe5-4051-beb7-536c1429fb03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ee029ee2-ffe5-4051-beb7-536c1429fb03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ee029ee2-ffe5-4051-beb7-536c1429fb03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1cf9cf3b-b252-450b-9c68-7c48032048b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1cf9cf3b-b252-450b-9c68-7c48032048b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_57230a72-af36-4c02-92e0-5146db5b1a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_57230a72-af36-4c02-92e0-5146db5b1a0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_78b8ac3f-880c-4907-86c7-109a21fbf568" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:to="loc_us-gaap_ConstructionInProgressMember_78b8ac3f-880c-4907-86c7-109a21fbf568" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_1c5c6630-9a7f-489a-bb25-6c3245dcd8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_1c5c6630-9a7f-489a-bb25-6c3245dcd8c3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsOtherAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="extended" id="iab433cc9d5334301873a1f62e33ed867_BalanceSheetComponentsOtherAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3d1a15b7-0cc7-4e2d-8823-5e5415941fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_096fa825-3677-40d8-8820-9afdf9c77feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3d1a15b7-0cc7-4e2d-8823-5e5415941fe7" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_096fa825-3677-40d8-8820-9afdf9c77feb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue_a8ead4d8-7f72-4d3b-8110-801f6ffee164" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3d1a15b7-0cc7-4e2d-8823-5e5415941fe7" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue_a8ead4d8-7f72-4d3b-8110-801f6ffee164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0bad24c7-32de-46a9-990a-f65654203d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3d1a15b7-0cc7-4e2d-8823-5e5415941fe7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0bad24c7-32de-46a9-990a-f65654203d4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ab86d838-375b-4647-92d5-56fb30eca569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0bad24c7-32de-46a9-990a-f65654203d4c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ab86d838-375b-4647-92d5-56fb30eca569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab86d838-375b-4647-92d5-56fb30eca569_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ab86d838-375b-4647-92d5-56fb30eca569" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ab86d838-375b-4647-92d5-56fb30eca569_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86299ba0-0743-4a81-82bd-38154f7aee20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ab86d838-375b-4647-92d5-56fb30eca569" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86299ba0-0743-4a81-82bd-38154f7aee20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_a42f77f7-fbd3-4ea0-9192-33f9b23a75e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86299ba0-0743-4a81-82bd-38154f7aee20" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_a42f77f7-fbd3-4ea0-9192-33f9b23a75e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PrivateEquitySecuritiesMember_296e5b23-5234-410a-be54-18a35208c069" xlink:href="vtrs-20230331.xsd#vtrs_PrivateEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86299ba0-0743-4a81-82bd-38154f7aee20" xlink:to="loc_vtrs_PrivateEquitySecuritiesMember_296e5b23-5234-410a-be54-18a35208c069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7d89a723-cef0-4dff-872e-59162760e9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0bad24c7-32de-46a9-990a-f65654203d4c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7d89a723-cef0-4dff-872e-59162760e9ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7d89a723-cef0-4dff-872e-59162760e9ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7d89a723-cef0-4dff-872e-59162760e9ea" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7d89a723-cef0-4dff-872e-59162760e9ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a899479d-5e70-4588-b1d7-1bd83e3660fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7d89a723-cef0-4dff-872e-59162760e9ea" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a899479d-5e70-4588-b1d7-1bd83e3660fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_8374c97b-a906-4e93-90e0-210b2ed5a811" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a899479d-5e70-4588-b1d7-1bd83e3660fc" xlink:to="loc_vtrs_BioconBiologicsMember_8374c97b-a906-4e93-90e0-210b2ed5a811" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="extended" id="i7a8403a11e04475db73e06f60061cc55_BalanceSheetComponentsOtherCurrentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofothercurrentliabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_059543e0-2fde-4134-9f23-70ae4bfd743a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_059543e0-2fde-4134-9f23-70ae4bfd743a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_6f9bffcb-f38a-4a20-a528-a5317f445204" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_LitigationReserveCurrent_6f9bffcb-f38a-4a20-a528-a5317f445204" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_390218e7-f56e-46dd-9622-2c3fb7f4da58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_390218e7-f56e-46dd-9622-2c3fb7f4da58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a3b82818-7649-4eb5-b4e5-b2b48f2b400a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a3b82818-7649-4eb5-b4e5-b2b48f2b400a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_fdd43865-829b-4716-b7b7-205803ce371f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_RestructuringReserveCurrent_fdd43865-829b-4716-b7b7-205803ce371f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_56a59e41-2a1d-4d14-adf9-4ca8c873b69b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_InterestPayableCurrent_56a59e41-2a1d-4d14-adf9-4ca8c873b69b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_db6fd243-20fe-4914-affc-e6c2d1f7361e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_db6fd243-20fe-4914-affc-e6c2d1f7361e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7122fb9d-eda1-433e-9a25-444d6d72cc05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7122fb9d-eda1-433e-9a25-444d6d72cc05" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_176d55a8-9be4-484a-9311-516ba08aee3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_176d55a8-9be4-484a-9311-516ba08aee3b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_10b1467f-8129-4ef7-8cbe-be0e61118812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_10b1467f-8129-4ef7-8cbe-be0e61118812" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e4c89433-ce9f-4895-877b-30b38a9e3b20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e4c89433-ce9f-4895-877b-30b38a9e3b20" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesTable_3cfac0ce-1ccc-4724-9afd-2b847074eb75" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofothercurrentliabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_vtrs_ScheduleofothercurrentliabilitiesTable_3cfac0ce-1ccc-4724-9afd-2b847074eb75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_57748248-07bf-4d99-b281-4e9ea130864e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_3cfac0ce-1ccc-4724-9afd-2b847074eb75" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_57748248-07bf-4d99-b281-4e9ea130864e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_57748248-07bf-4d99-b281-4e9ea130864e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_57748248-07bf-4d99-b281-4e9ea130864e" xlink:to="loc_us-gaap_ReceivableTypeDomain_57748248-07bf-4d99-b281-4e9ea130864e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_c922c9c7-fe6d-465e-b4ab-a4c6c89c78f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_57748248-07bf-4d99-b281-4e9ea130864e" xlink:to="loc_us-gaap_ReceivableTypeDomain_c922c9c7-fe6d-465e-b4ab-a4c6c89c78f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_062bbd6f-45b5-4a8a-8f86-f7bd3996d02a" xlink:href="vtrs-20230331.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_c922c9c7-fe6d-465e-b4ab-a4c6c89c78f1" xlink:to="loc_vtrs_VariableConsiderationMember_062bbd6f-45b5-4a8a-8f86-f7bd3996d02a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_187f8099-95c6-4c45-b8a1-dbbef088456d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_3cfac0ce-1ccc-4724-9afd-2b847074eb75" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_187f8099-95c6-4c45-b8a1-dbbef088456d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_187f8099-95c6-4c45-b8a1-dbbef088456d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_187f8099-95c6-4c45-b8a1-dbbef088456d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_187f8099-95c6-4c45-b8a1-dbbef088456d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4e80fcab-ede9-4c74-91da-f1330e605947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_187f8099-95c6-4c45-b8a1-dbbef088456d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4e80fcab-ede9-4c74-91da-f1330e605947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b679aa53-e6c5-4153-b0cb-58e4313a4f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4e80fcab-ede9-4c74-91da-f1330e605947" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b679aa53-e6c5-4153-b0cb-58e4313a4f8f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsOtherLongtermObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails" xlink:type="extended" id="i18f7b7c40b734adbaae8b34eb0e6d3ba_BalanceSheetComponentsOtherLongtermObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_db3ffab9-3518-486b-ac75-6186af795e82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_db3ffab9-3518-486b-ac75-6186af795e82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_84e09cfd-92cf-43bc-8a66-6984ca07fa1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_84e09cfd-92cf-43bc-8a66-6984ca07fa1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_00285d77-d838-464f-a78f-0e6572d77f25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_00285d77-d838-464f-a78f-0e6572d77f25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_19cc7c81-1850-403c-beda-46089f9ad1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_19cc7c81-1850-403c-beda-46089f9ad1bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_1380aea3-2ceb-4a5c-9e74-9a0099e8349e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_1380aea3-2ceb-4a5c-9e74-9a0099e8349e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_594295d5-d660-4f8f-8b30-b95eefcf7d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_594295d5-d660-4f8f-8b30-b95eefcf7d86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ede59934-4fdb-4c27-bfd7-a341fda88bef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ede59934-4fdb-4c27-bfd7-a341fda88bef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_cacb287f-a353-4fdb-9e03-b211577ad4fc" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_cacb287f-a353-4fdb-9e03-b211577ad4fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_58126a8d-9a65-4346-a0a6-0cf2bfde0a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_cacb287f-a353-4fdb-9e03-b211577ad4fc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_58126a8d-9a65-4346-a0a6-0cf2bfde0a4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_58126a8d-9a65-4346-a0a6-0cf2bfde0a4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_58126a8d-9a65-4346-a0a6-0cf2bfde0a4d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_58126a8d-9a65-4346-a0a6-0cf2bfde0a4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ae3b1c96-5a5f-45eb-8109-0d15c05780c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_58126a8d-9a65-4346-a0a6-0cf2bfde0a4d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ae3b1c96-5a5f-45eb-8109-0d15c05780c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_63caf348-012b-4201-b21f-10e5c8d2d8db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ae3b1c96-5a5f-45eb-8109-0d15c05780c3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_63caf348-012b-4201-b21f-10e5c8d2d8db" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended" id="ie0758f632087423ea018e25294e3564c_BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8959f880-0fac-4cff-9404-3ecda6675503" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_14a73417-6100-4176-87db-00a02bb2a3da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8959f880-0fac-4cff-9404-3ecda6675503" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_14a73417-6100-4176-87db-00a02bb2a3da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e58896b0-77b0-4821-9a8a-f9b90780401d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8959f880-0fac-4cff-9404-3ecda6675503" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e58896b0-77b0-4821-9a8a-f9b90780401d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8959f880-0fac-4cff-9404-3ecda6675503" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_23923952-553d-433b-a539-be1e5e501d28" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:to="loc_srt_StatementScenarioAxis_23923952-553d-433b-a539-be1e5e501d28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_23923952-553d-433b-a539-be1e5e501d28_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_23923952-553d-433b-a539-be1e5e501d28" xlink:to="loc_srt_ScenarioUnspecifiedDomain_23923952-553d-433b-a539-be1e5e501d28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e2c82fa6-7110-4f61-a46d-cbb6f8b95e46" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_23923952-553d-433b-a539-be1e5e501d28" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e2c82fa6-7110-4f61-a46d-cbb6f8b95e46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_ad0af8fe-a394-462c-b034-0ca3841b7a9d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_e2c82fa6-7110-4f61-a46d-cbb6f8b95e46" xlink:to="loc_srt_ScenarioForecastMember_ad0af8fe-a394-462c-b034-0ca3841b7a9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e60992fa-7f5b-4ef0-b0ea-56cdf52cc324" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:to="loc_srt_CounterpartyNameAxis_e60992fa-7f5b-4ef0-b0ea-56cdf52cc324" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e60992fa-7f5b-4ef0-b0ea-56cdf52cc324_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e60992fa-7f5b-4ef0-b0ea-56cdf52cc324" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e60992fa-7f5b-4ef0-b0ea-56cdf52cc324_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1ef52c3-3a55-40cd-95ee-70215ade05c6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e60992fa-7f5b-4ef0-b0ea-56cdf52cc324" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1ef52c3-3a55-40cd-95ee-70215ade05c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_ff924ebc-ecc3-4bed-9272-419e86a2ccb0" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1ef52c3-3a55-40cd-95ee-70215ade05c6" xlink:to="loc_vtrs_BioconBiologicsMember_ff924ebc-ecc3-4bed-9272-419e86a2ccb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_b6702d4d-bcf4-4cc0-986f-8d3d941147cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_b6702d4d-bcf4-4cc0-986f-8d3d941147cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_b6702d4d-bcf4-4cc0-986f-8d3d941147cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_b6702d4d-bcf4-4cc0-986f-8d3d941147cc" xlink:to="loc_us-gaap_ReceivableTypeDomain_b6702d4d-bcf4-4cc0-986f-8d3d941147cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_2c09eaf7-bbaa-4562-9c51-c9802b60c8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_b6702d4d-bcf4-4cc0-986f-8d3d941147cc" xlink:to="loc_us-gaap_ReceivableTypeDomain_2c09eaf7-bbaa-4562-9c51-c9802b60c8dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_15e7829b-f5d9-49d4-99d0-c0f181583ab6" xlink:href="vtrs-20230331.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_2c09eaf7-bbaa-4562-9c51-c9802b60c8dc" xlink:to="loc_vtrs_VariableConsiderationMember_15e7829b-f5d9-49d4-99d0-c0f181583ab6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_48e1b397-0705-4c65-8106-737a3ebb0d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_48e1b397-0705-4c65-8106-737a3ebb0d41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_48e1b397-0705-4c65-8106-737a3ebb0d41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_48e1b397-0705-4c65-8106-737a3ebb0d41" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_48e1b397-0705-4c65-8106-737a3ebb0d41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e44635ab-68ef-4635-a310-2b1f96b7828c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_48e1b397-0705-4c65-8106-737a3ebb0d41" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e44635ab-68ef-4635-a310-2b1f96b7828c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_655286bd-df0f-4160-be88-75276573b6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e44635ab-68ef-4635-a310-2b1f96b7828c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_655286bd-df0f-4160-be88-75276573b6e9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended" id="if183f29c7f6f4db490918c124c186dc7_GoodwillandIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8299e626-88b3-49d2-9c44-43f713eae531" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8299e626-88b3-49d2-9c44-43f713eae531" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f0febaf0-7cc1-443a-8612-84f00f5f952c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f0febaf0-7cc1-443a-8612-84f00f5f952c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_28f3a136-a2b0-4ce5-90bf-89ebec8f9487" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_28f3a136-a2b0-4ce5-90bf-89ebec8f9487" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d7f771fd-fc5c-4366-a989-e16cd4274a62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d7f771fd-fc5c-4366-a989-e16cd4274a62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_04bfb817-e340-404c-be95-8825153a3ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_Goodwill_04bfb817-e340-404c-be95-8825153a3ff1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_bae80b73-b521-4623-b47c-d88f7d90994d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_bae80b73-b521-4623-b47c-d88f7d90994d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c1e49af7-d920-4832-847d-4d2a8a02d7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c1e49af7-d920-4832-847d-4d2a8a02d7e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f40f8091-45cf-4766-b179-d96971568635" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_srt_ConsolidationItemsAxis_f40f8091-45cf-4766-b179-d96971568635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f40f8091-45cf-4766-b179-d96971568635_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f40f8091-45cf-4766-b179-d96971568635" xlink:to="loc_srt_ConsolidationItemsDomain_f40f8091-45cf-4766-b179-d96971568635_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6e365876-660e-4a56-bc30-c2b6991fb000" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f40f8091-45cf-4766-b179-d96971568635" xlink:to="loc_srt_ConsolidationItemsDomain_6e365876-660e-4a56-bc30-c2b6991fb000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_95935ffb-28d5-43c3-9d2e-29976de32154" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6e365876-660e-4a56-bc30-c2b6991fb000" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_95935ffb-28d5-43c3-9d2e-29976de32154" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8786a33c-2f92-41ef-b8b1-85ed1d24caf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8786a33c-2f92-41ef-b8b1-85ed1d24caf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8786a33c-2f92-41ef-b8b1-85ed1d24caf9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8786a33c-2f92-41ef-b8b1-85ed1d24caf9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8786a33c-2f92-41ef-b8b1-85ed1d24caf9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_04bfceae-5c38-485a-8626-b0f4b2a2744a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8786a33c-2f92-41ef-b8b1-85ed1d24caf9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_04bfceae-5c38-485a-8626-b0f4b2a2744a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_60296c89-7a91-4960-953a-1b4b00173982" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_04bfceae-5c38-485a-8626-b0f4b2a2744a" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_60296c89-7a91-4960-953a-1b4b00173982" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_43dec65d-0bad-4adb-88d4-704b86516930" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_srt_RangeAxis_43dec65d-0bad-4adb-88d4-704b86516930" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_43dec65d-0bad-4adb-88d4-704b86516930_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_43dec65d-0bad-4adb-88d4-704b86516930" xlink:to="loc_srt_RangeMember_43dec65d-0bad-4adb-88d4-704b86516930_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ac964f22-1b11-4316-8d2d-048b5f07c577" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_43dec65d-0bad-4adb-88d4-704b86516930" xlink:to="loc_srt_RangeMember_ac964f22-1b11-4316-8d2d-048b5f07c577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_27402bd2-fd0d-4f9d-8370-ef9bfd293aeb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ac964f22-1b11-4316-8d2d-048b5f07c577" xlink:to="loc_srt_MinimumMember_27402bd2-fd0d-4f9d-8370-ef9bfd293aeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a24586f5-700b-4d81-98e4-8f554da140c7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ac964f22-1b11-4316-8d2d-048b5f07c577" xlink:to="loc_srt_MaximumMember_a24586f5-700b-4d81-98e4-8f554da140c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fc0a97da-67f1-4f23-81e5-5181f922b6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fc0a97da-67f1-4f23-81e5-5181f922b6b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fc0a97da-67f1-4f23-81e5-5181f922b6b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc0a97da-67f1-4f23-81e5-5181f922b6b7" xlink:to="loc_us-gaap_SegmentDomain_fc0a97da-67f1-4f23-81e5-5181f922b6b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc0a97da-67f1-4f23-81e5-5181f922b6b7" xlink:to="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_fadeb320-f36d-4f77-810d-899859de9cd4" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_fadeb320-f36d-4f77-810d-899859de9cd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_f885cb60-d1f3-45b3-962a-b9e16b4e72b5" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_f885cb60-d1f3-45b3-962a-b9e16b4e72b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_53c47444-8204-46ca-b9e4-1951a7d6ed5b" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:to="loc_vtrs_GreaterChinaSegmentMember_53c47444-8204-46ca-b9e4-1951a7d6ed5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_463199b2-7d68-4fce-9c71-15875739352a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_463199b2-7d68-4fce-9c71-15875739352a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_463199b2-7d68-4fce-9c71-15875739352a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_463199b2-7d68-4fce-9c71-15875739352a" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_463199b2-7d68-4fce-9c71-15875739352a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_587efb2b-1846-4163-b36d-558dade1b0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_463199b2-7d68-4fce-9c71-15875739352a" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_587efb2b-1846-4163-b36d-558dade1b0f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b9219627-23b1-4957-8200-eeb6c27fe5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_587efb2b-1846-4163-b36d-558dade1b0f1" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b9219627-23b1-4957-8200-eeb6c27fe5b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0a9d6fb3-232c-40d8-9b8b-19004cb3e32c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0a9d6fb3-232c-40d8-9b8b-19004cb3e32c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0a9d6fb3-232c-40d8-9b8b-19004cb3e32c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0a9d6fb3-232c-40d8-9b8b-19004cb3e32c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0a9d6fb3-232c-40d8-9b8b-19004cb3e32c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0a9d6fb3-232c-40d8-9b8b-19004cb3e32c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnDistributorMarketsMember_0d2885ff-b49f-4062-adc9-697f8f1e2f64" xlink:href="vtrs-20230331.xsd#vtrs_UpjohnDistributorMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:to="loc_vtrs_UpjohnDistributorMarketsMember_0d2885ff-b49f-4062-adc9-697f8f1e2f64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductRightsAndLicensesMember_90668fa6-06db-42e6-a578-a3ec55ee6c22" xlink:href="vtrs-20230331.xsd#vtrs_ProductRightsAndLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:to="loc_vtrs_ProductRightsAndLicensesMember_90668fa6-06db-42e6-a578-a3ec55ee6c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c15a9985-c858-41b4-b421-6280be773621" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c15a9985-c858-41b4-b421-6280be773621" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_048a15c9-1401-48da-b168-f454366a4d30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_048a15c9-1401-48da-b168-f454366a4d30" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_048a15c9-1401-48da-b168-f454366a4d30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_048a15c9-1401-48da-b168-f454366a4d30" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_048a15c9-1401-48da-b168-f454366a4d30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad82dae-85f4-4806-8db5-c88847a9f402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_048a15c9-1401-48da-b168-f454366a4d30" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad82dae-85f4-4806-8db5-c88847a9f402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OysterPointPharmaAcquisitionMember_7453b0ca-8a8f-4924-a84f-fda40e269184" xlink:href="vtrs-20230331.xsd#vtrs_OysterPointPharmaAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad82dae-85f4-4806-8db5-c88847a9f402" xlink:to="loc_vtrs_OysterPointPharmaAcquisitionMember_7453b0ca-8a8f-4924-a84f-fda40e269184" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesAcquisitionMember_18c28fc9-63e1-4472-8a63-2f08af9380b6" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad82dae-85f4-4806-8db5-c88847a9f402" xlink:to="loc_vtrs_FamyLifeSciencesAcquisitionMember_18c28fc9-63e1-4472-8a63-2f08af9380b6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="extended" id="i454fd2e822064463a8a768dc8d0c1e8b_GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c9b93fb7-c3cc-4f0a-96a3-8c3e99d8097d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_c9b93fb7-c3cc-4f0a-96a3-8c3e99d8097d" xlink:to="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_56e3fe69-0498-48a1-8c71-e876f9e72242" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:to="loc_us-gaap_Goodwill_56e3fe69-0498-48a1-8c71-e876f9e72242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0381fbd-1da7-47b0-9097-a7524c34e4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0381fbd-1da7-47b0-9097-a7524c34e4b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_379e5fff-2360-4d65-a2c7-06451b7bd716" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_379e5fff-2360-4d65-a2c7-06451b7bd716" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_645a2949-65ef-42f4-a9dc-a34affc70e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e2324e48-3655-4e87-9e16-289a3151e080" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e2324e48-3655-4e87-9e16-289a3151e080" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_506f5eda-0973-4100-8e64-22a6fbc31351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_c9b93fb7-c3cc-4f0a-96a3-8c3e99d8097d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_506f5eda-0973-4100-8e64-22a6fbc31351" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bd96ef01-ffac-457c-9d91-e8a034507ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_506f5eda-0973-4100-8e64-22a6fbc31351" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bd96ef01-ffac-457c-9d91-e8a034507ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bd96ef01-ffac-457c-9d91-e8a034507ce6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bd96ef01-ffac-457c-9d91-e8a034507ce6" xlink:to="loc_us-gaap_SegmentDomain_bd96ef01-ffac-457c-9d91-e8a034507ce6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bd96ef01-ffac-457c-9d91-e8a034507ce6" xlink:to="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_dfba55ff-724b-44a1-aaa7-d91cbcc03034" xlink:href="vtrs-20230331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_dfba55ff-724b-44a1-aaa7-d91cbcc03034" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_87d74f6d-922e-4c91-a42b-f9e8a379808a" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:to="loc_vtrs_GreaterChinaSegmentMember_87d74f6d-922e-4c91-a42b-f9e8a379808a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_ea0a87f7-f23a-44d3-8e2b-89f85b089ea3" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_ea0a87f7-f23a-44d3-8e2b-89f85b089ea3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_9b8ea716-6acd-4294-b4d8-53359e56b2bb" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_9b8ea716-6acd-4294-b4d8-53359e56b2bb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="extended" id="i2116f9c7d3bf46ef8fc14d33846727c6_GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:href="vtrs-20230331.xsd#vtrs_IntangibleAssetsbyMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2f371b26-ee04-4553-b1f0-450c30a98546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2f371b26-ee04-4553-b1f0-450c30a98546" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_25448f7c-1611-4036-b595-2e3e8093c11b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_25448f7c-1611-4036-b595-2e3e8093c11b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95288989-caeb-4549-88f0-37ebf7208eba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95288989-caeb-4549-88f0-37ebf7208eba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbb560b0-a626-472f-8b1f-3c3b1d114256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbb560b0-a626-472f-8b1f-3c3b1d114256" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_831d49c1-5942-4c3c-89eb-c1138df6702d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_831d49c1-5942-4c3c-89eb-c1138df6702d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_63bdc374-69dd-4ecd-a973-20174a2f3155" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_63bdc374-69dd-4ecd-a973-20174a2f3155" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_039a3dd6-3f28-446e-a8ca-a0f0112a8c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_039a3dd6-3f28-446e-a8ca-a0f0112a8c53" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_241f1b56-2724-4010-ba18-5e4d3f77293c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_241f1b56-2724-4010-ba18-5e4d3f77293c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_96e70d59-f120-4451-8e4d-2b795758dace" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_96e70d59-f120-4451-8e4d-2b795758dace" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c516dee2-8d22-41cb-9b04-0c885db1fa9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_96e70d59-f120-4451-8e4d-2b795758dace" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c516dee2-8d22-41cb-9b04-0c885db1fa9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c516dee2-8d22-41cb-9b04-0c885db1fa9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c516dee2-8d22-41cb-9b04-0c885db1fa9d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c516dee2-8d22-41cb-9b04-0c885db1fa9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0777ddb7-af63-4a58-b071-edc7ccdb4567" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c516dee2-8d22-41cb-9b04-0c885db1fa9d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0777ddb7-af63-4a58-b071-edc7ccdb4567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_700972fb-ebd7-401a-9892-12259888c6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0777ddb7-af63-4a58-b071-edc7ccdb4567" xlink:to="loc_us-gaap_PatentsMember_700972fb-ebd7-401a-9892-12259888c6c8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="extended" id="i706fc09a4af64f468d4b52853d6f3d8c_FinancialInstrumentsandRiskManagementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_ab239e3a-835f-44f3-abf6-b6501e6b0c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_ab239e3a-835f-44f3-abf6-b6501e6b0c6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_fa29d24b-7252-434b-a898-69d3000c9139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_fa29d24b-7252-434b-a898-69d3000c9139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ac41c31e-4748-4b4f-8a96-d34069703cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ac41c31e-4748-4b4f-8a96-d34069703cd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_dbcdf4c8-1d45-4173-bd41-d1882d0cfeae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_LongTermDebt_dbcdf4c8-1d45-4173-bd41-d1882d0cfeae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d317100a-0dc2-48aa-99e1-2aa4f92aaff5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d317100a-0dc2-48aa-99e1-2aa4f92aaff5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1c5e7158-4b36-42ea-b8e3-e9c273a3087b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1c5e7158-4b36-42ea-b8e3-e9c273a3087b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1c5e7158-4b36-42ea-b8e3-e9c273a3087b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1c5e7158-4b36-42ea-b8e3-e9c273a3087b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1c5e7158-4b36-42ea-b8e3-e9c273a3087b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_10eda881-702c-491a-a28e-b7df29d75d59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1c5e7158-4b36-42ea-b8e3-e9c273a3087b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_10eda881-702c-491a-a28e-b7df29d75d59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_260b39b0-94d6-477a-88b7-2ae6ef4004cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_10eda881-702c-491a-a28e-b7df29d75d59" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_260b39b0-94d6-477a-88b7-2ae6ef4004cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_74e9978b-b1fd-4134-bde8-685cb3217959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_74e9978b-b1fd-4134-bde8-685cb3217959" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_74e9978b-b1fd-4134-bde8-685cb3217959_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_74e9978b-b1fd-4134-bde8-685cb3217959" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_74e9978b-b1fd-4134-bde8-685cb3217959_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1f3003f7-4f7d-497d-880a-ab60bd02dd37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_74e9978b-b1fd-4134-bde8-685cb3217959" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1f3003f7-4f7d-497d-880a-ab60bd02dd37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d671fa0d-f0c6-47e2-87bd-2cb69456b74c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1f3003f7-4f7d-497d-880a-ab60bd02dd37" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d671fa0d-f0c6-47e2-87bd-2cb69456b74c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_876aa3c0-446d-4270-8c44-12ef0793447f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1f3003f7-4f7d-497d-880a-ab60bd02dd37" xlink:to="loc_us-gaap_InterestRateSwapMember_876aa3c0-446d-4270-8c44-12ef0793447f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1cc973dd-fdbb-4a33-baec-14c1483fe16b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1cc973dd-fdbb-4a33-baec-14c1483fe16b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1cc973dd-fdbb-4a33-baec-14c1483fe16b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1cc973dd-fdbb-4a33-baec-14c1483fe16b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1cc973dd-fdbb-4a33-baec-14c1483fe16b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7f9138cc-fdb5-4a62-af60-334b84597d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1cc973dd-fdbb-4a33-baec-14c1483fe16b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7f9138cc-fdb5-4a62-af60-334b84597d4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_39c1c551-8bb1-4c54-bd1f-e1ddb2edb70a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f9138cc-fdb5-4a62-af60-334b84597d4a" xlink:to="loc_us-gaap_OtherExpenseMember_39c1c551-8bb1-4c54-bd1f-e1ddb2edb70a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_757afa70-18f2-4129-aa57-4c8621d006c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_DebtInstrumentAxis_757afa70-18f2-4129-aa57-4c8621d006c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_757afa70-18f2-4129-aa57-4c8621d006c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_757afa70-18f2-4129-aa57-4c8621d006c7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_757afa70-18f2-4129-aa57-4c8621d006c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_757afa70-18f2-4129-aa57-4c8621d006c7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_64be753a-d233-4e65-8a27-afec89c63774" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_64be753a-d233-4e65-8a27-afec89c63774" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_ea17c778-563f-4072-b429-b59dd33777b0" xlink:href="vtrs-20230331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_ea17c778-563f-4072-b429-b59dd33777b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_20b27308-362e-45b9-8769-12eafc17d72c" xlink:href="vtrs-20230331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_20b27308-362e-45b9-8769-12eafc17d72c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_55f9dd4f-43da-41a0-9b83-c82b0ee77cb1" xlink:href="vtrs-20230331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_55f9dd4f-43da-41a0-9b83-c82b0ee77cb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_1bd61a58-3b80-4064-abe1-915b1ab560a7" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_1bd61a58-3b80-4064-abe1-915b1ab560a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_247ebc25-c40f-4de9-9058-4801407cff04" xlink:href="vtrs-20230331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_247ebc25-c40f-4de9-9058-4801407cff04" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_ba704d05-6cad-4556-a6f2-d000851ed524" xlink:href="vtrs-20230331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_ba704d05-6cad-4556-a6f2-d000851ed524" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember_01ee9e2c-16dd-4f3d-91d2-0659d6122022" xlink:href="vtrs-20230331.xsd#vtrs_YENTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_YENTermLoanMember_01ee9e2c-16dd-4f3d-91d2-0659d6122022" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d5ddfe62-155c-48b5-a5b5-9ec728f9b413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d5ddfe62-155c-48b5-a5b5-9ec728f9b413" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d5ddfe62-155c-48b5-a5b5-9ec728f9b413_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d5ddfe62-155c-48b5-a5b5-9ec728f9b413" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d5ddfe62-155c-48b5-a5b5-9ec728f9b413_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6e917a96-0681-4ede-a3f1-a5837a205ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d5ddfe62-155c-48b5-a5b5-9ec728f9b413" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6e917a96-0681-4ede-a3f1-a5837a205ac4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_67603912-bdf5-4fc4-bb25-9070140d2f08" xlink:href="vtrs-20230331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e917a96-0681-4ede-a3f1-a5837a205ac4" xlink:to="loc_vtrs_ContingentConsiderationMember_67603912-bdf5-4fc4-bb25-9070140d2f08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_1773d51c-2675-468b-8209-f789a617800e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e917a96-0681-4ede-a3f1-a5837a205ac4" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_1773d51c-2675-468b-8209-f789a617800e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fdb14412-4847-4820-8f9c-d25e0c8d6d10" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_srt_RangeAxis_fdb14412-4847-4820-8f9c-d25e0c8d6d10" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fdb14412-4847-4820-8f9c-d25e0c8d6d10_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fdb14412-4847-4820-8f9c-d25e0c8d6d10" xlink:to="loc_srt_RangeMember_fdb14412-4847-4820-8f9c-d25e0c8d6d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b019056-9393-49d9-b04a-d8bc1080f6c0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fdb14412-4847-4820-8f9c-d25e0c8d6d10" xlink:to="loc_srt_RangeMember_4b019056-9393-49d9-b04a-d8bc1080f6c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ae1872f5-7065-4a95-bafa-f42a55392d82" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4b019056-9393-49d9-b04a-d8bc1080f6c0" xlink:to="loc_srt_MinimumMember_ae1872f5-7065-4a95-bafa-f42a55392d82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f1ad977d-e35e-45fd-972e-9cd303e9b7ff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4b019056-9393-49d9-b04a-d8bc1080f6c0" xlink:to="loc_srt_MaximumMember_f1ad977d-e35e-45fd-972e-9cd303e9b7ff" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="extended" id="ifad13ebd39d247bd962c1f30f4882661_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a288f1a0-9b2a-4ad5-a184-94a34699a69c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a288f1a0-9b2a-4ad5-a184-94a34699a69c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d1af4179-2be5-4b78-9211-1fd81bb297a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d1af4179-2be5-4b78-9211-1fd81bb297a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0d8a2e02-9f28-4e98-9acd-cceb27d7fff1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0d8a2e02-9f28-4e98-9acd-cceb27d7fff1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e4aa47b0-d59e-4388-a299-a9c9b723db78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:to="loc_us-gaap_HedgingDesignationAxis_e4aa47b0-d59e-4388-a299-a9c9b723db78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e4aa47b0-d59e-4388-a299-a9c9b723db78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_e4aa47b0-d59e-4388-a299-a9c9b723db78" xlink:to="loc_us-gaap_HedgingDesignationDomain_e4aa47b0-d59e-4388-a299-a9c9b723db78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_911a28ab-7324-427a-a142-3143958d115f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_e4aa47b0-d59e-4388-a299-a9c9b723db78" xlink:to="loc_us-gaap_HedgingDesignationDomain_911a28ab-7324-427a-a142-3143958d115f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_184a498e-c407-420d-ac59-fb609548babe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_911a28ab-7324-427a-a142-3143958d115f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_184a498e-c407-420d-ac59-fb609548babe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_8be1906b-5b99-466b-8100-4d384465f25d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_911a28ab-7324-427a-a142-3143958d115f" xlink:to="loc_us-gaap_NondesignatedMember_8be1906b-5b99-466b-8100-4d384465f25d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4b693220-5515-4be0-aa0b-5b68c84b6554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4b693220-5515-4be0-aa0b-5b68c84b6554" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4b693220-5515-4be0-aa0b-5b68c84b6554_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4b693220-5515-4be0-aa0b-5b68c84b6554" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4b693220-5515-4be0-aa0b-5b68c84b6554_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ad17fece-2ac9-459d-a42c-48116f5a849c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4b693220-5515-4be0-aa0b-5b68c84b6554" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ad17fece-2ac9-459d-a42c-48116f5a849c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9a4a8f2a-8a0a-418e-a719-a1f73a7b0f12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ad17fece-2ac9-459d-a42c-48116f5a849c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9a4a8f2a-8a0a-418e-a719-a1f73a7b0f12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_266181a1-02d9-4ba6-8541-8bae79dec4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ad17fece-2ac9-459d-a42c-48116f5a849c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_266181a1-02d9-4ba6-8541-8bae79dec4c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0b9c0407-495b-4ed3-a711-982581d9dbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0b9c0407-495b-4ed3-a711-982581d9dbd6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0b9c0407-495b-4ed3-a711-982581d9dbd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0b9c0407-495b-4ed3-a711-982581d9dbd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0b9c0407-495b-4ed3-a711-982581d9dbd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0b9c0407-495b-4ed3-a711-982581d9dbd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4d2d0c66-b66b-42d6-ad36-ca42be96cc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:to="loc_us-gaap_InterestRateSwapMember_4d2d0c66-b66b-42d6-ad36-ca42be96cc4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_64988e49-8984-4f0b-893d-367164827c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_64988e49-8984-4f0b-893d-367164827c2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_19fd7f93-5f7f-4759-ad33-9c72484e7ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_19fd7f93-5f7f-4759-ad33-9c72484e7ee6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="extended" id="ib3e8623b8cd64829864d3f52c5a6d3be_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_4a544bc3-2ab5-4057-a0bd-cbce355ad9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_754abef7-0d6b-4e99-8c20-e1ca432cba96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4a544bc3-2ab5-4057-a0bd-cbce355ad9cc" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_754abef7-0d6b-4e99-8c20-e1ca432cba96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8fc21a7f-d04e-4540-9af5-c83fe59b5c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4a544bc3-2ab5-4057-a0bd-cbce355ad9cc" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8fc21a7f-d04e-4540-9af5-c83fe59b5c9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4a544bc3-2ab5-4057-a0bd-cbce355ad9cc" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b16fc9ae-8904-41a7-b4b4-f59778de873a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:to="loc_us-gaap_HedgingDesignationAxis_b16fc9ae-8904-41a7-b4b4-f59778de873a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b16fc9ae-8904-41a7-b4b4-f59778de873a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b16fc9ae-8904-41a7-b4b4-f59778de873a" xlink:to="loc_us-gaap_HedgingDesignationDomain_b16fc9ae-8904-41a7-b4b4-f59778de873a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8397fb26-1d33-4b22-bad8-4d2ab28ecb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b16fc9ae-8904-41a7-b4b4-f59778de873a" xlink:to="loc_us-gaap_HedgingDesignationDomain_8397fb26-1d33-4b22-bad8-4d2ab28ecb2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e12e99a7-5753-47d0-ad71-c5fffd63f210" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8397fb26-1d33-4b22-bad8-4d2ab28ecb2f" xlink:to="loc_us-gaap_NondesignatedMember_e12e99a7-5753-47d0-ad71-c5fffd63f210" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_531b34b9-c6b4-4709-bc74-be603d7e66fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_531b34b9-c6b4-4709-bc74-be603d7e66fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_531b34b9-c6b4-4709-bc74-be603d7e66fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_531b34b9-c6b4-4709-bc74-be603d7e66fe" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_531b34b9-c6b4-4709-bc74-be603d7e66fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_661dd022-fb67-4b18-a743-615bea8260fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_531b34b9-c6b4-4709-bc74-be603d7e66fe" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_661dd022-fb67-4b18-a743-615bea8260fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6a851364-dca5-42de-839e-ac3294a5e4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_661dd022-fb67-4b18-a743-615bea8260fa" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6a851364-dca5-42de-839e-ac3294a5e4ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8d73703a-250e-4cdc-9760-6a8c5b5aa171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_661dd022-fb67-4b18-a743-615bea8260fa" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8d73703a-250e-4cdc-9760-6a8c5b5aa171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_882acca4-3681-4c4d-bbf5-e24321526b02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_882acca4-3681-4c4d-bbf5-e24321526b02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_882acca4-3681-4c4d-bbf5-e24321526b02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_882acca4-3681-4c4d-bbf5-e24321526b02" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_882acca4-3681-4c4d-bbf5-e24321526b02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7ec4a6f6-036a-4383-9df5-4d49b9891ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_882acca4-3681-4c4d-bbf5-e24321526b02" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7ec4a6f6-036a-4383-9df5-4d49b9891ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ab2b2537-a8b6-431b-98a7-e822510d8d93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ec4a6f6-036a-4383-9df5-4d49b9891ef9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ab2b2537-a8b6-431b-98a7-e822510d8d93" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="extended" id="ieaf528787412486f858db2495bd05f28_FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b38e7572-dab6-40d5-908c-970a0d95628a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b38e7572-dab6-40d5-908c-970a0d95628a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_213877d9-56a7-44d7-9e19-882c32c2100c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_213877d9-56a7-44d7-9e19-882c32c2100c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fd92227a-7e29-4933-bd81-525a0ad83769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fd92227a-7e29-4933-bd81-525a0ad83769" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9dde53d4-2b87-4909-8cd7-d3dab81682f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9dde53d4-2b87-4909-8cd7-d3dab81682f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1dc4d094-fee8-4b84-ac2d-c29721e5e10b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1dc4d094-fee8-4b84-ac2d-c29721e5e10b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_eeee2e50-b40a-4f9e-948a-59cc1861a17b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_eeee2e50-b40a-4f9e-948a-59cc1861a17b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_eeee2e50-b40a-4f9e-948a-59cc1861a17b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_eeee2e50-b40a-4f9e-948a-59cc1861a17b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_eeee2e50-b40a-4f9e-948a-59cc1861a17b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f2223fd0-62c7-48e4-bd7d-e5e8005d3665" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_eeee2e50-b40a-4f9e-948a-59cc1861a17b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f2223fd0-62c7-48e4-bd7d-e5e8005d3665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_78aecd2a-1ceb-4d93-95e5-dc77fd80de97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f2223fd0-62c7-48e4-bd7d-e5e8005d3665" xlink:to="loc_us-gaap_CashFlowHedgingMember_78aecd2a-1ceb-4d93-95e5-dc77fd80de97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7865a810-1232-4fd9-9741-326207512bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f2223fd0-62c7-48e4-bd7d-e5e8005d3665" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7865a810-1232-4fd9-9741-326207512bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2e966bf3-4437-48a5-afbe-65634d4c41b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2e966bf3-4437-48a5-afbe-65634d4c41b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2e966bf3-4437-48a5-afbe-65634d4c41b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2e966bf3-4437-48a5-afbe-65634d4c41b5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2e966bf3-4437-48a5-afbe-65634d4c41b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a6e1267d-67dc-451c-a063-5927060a9db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2e966bf3-4437-48a5-afbe-65634d4c41b5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a6e1267d-67dc-451c-a063-5927060a9db8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_614c494e-24aa-4696-beb3-0ed04de45344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6e1267d-67dc-451c-a063-5927060a9db8" xlink:to="loc_us-gaap_ForeignExchangeContractMember_614c494e-24aa-4696-beb3-0ed04de45344" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5a5eb337-b61a-4272-a44b-309fe023b8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6e1267d-67dc-451c-a063-5927060a9db8" xlink:to="loc_us-gaap_InterestRateSwapMember_5a5eb337-b61a-4272-a44b-309fe023b8f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c59b15a3-9d6e-4e5d-8c1f-8123016d1862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c59b15a3-9d6e-4e5d-8c1f-8123016d1862" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c59b15a3-9d6e-4e5d-8c1f-8123016d1862_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c59b15a3-9d6e-4e5d-8c1f-8123016d1862" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c59b15a3-9d6e-4e5d-8c1f-8123016d1862_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c59b15a3-9d6e-4e5d-8c1f-8123016d1862" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_b3d42aad-51ec-4cc7-a7f4-8193864e255c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:to="loc_us-gaap_SalesMember_b3d42aad-51ec-4cc7-a7f4-8193864e255c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_37e6fa7d-c7ff-447a-bca2-3e8f46be225e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:to="loc_us-gaap_InterestExpenseMember_37e6fa7d-c7ff-447a-bca2-3e8f46be225e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_694535f3-b44e-4caa-8af0-b804a1cde061" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:to="loc_us-gaap_OtherExpenseMember_694535f3-b44e-4caa-8af0-b804a1cde061" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_59859158-1d04-49c8-8ae0-644ed7576274" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_ValuationTechniqueAxis_59859158-1d04-49c8-8ae0-644ed7576274" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_59859158-1d04-49c8-8ae0-644ed7576274_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_59859158-1d04-49c8-8ae0-644ed7576274" xlink:to="loc_us-gaap_ValuationTechniqueDomain_59859158-1d04-49c8-8ae0-644ed7576274_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_4b501068-0c74-46aa-b02d-55c60b19f1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_59859158-1d04-49c8-8ae0-644ed7576274" xlink:to="loc_us-gaap_ValuationTechniqueDomain_4b501068-0c74-46aa-b02d-55c60b19f1d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8e36c2f4-4636-48ef-a7c9-199efadc0a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8e36c2f4-4636-48ef-a7c9-199efadc0a3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8e36c2f4-4636-48ef-a7c9-199efadc0a3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8e36c2f4-4636-48ef-a7c9-199efadc0a3c" xlink:to="loc_us-gaap_EquityComponentDomain_8e36c2f4-4636-48ef-a7c9-199efadc0a3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cb5b21c7-c65f-42b9-9a31-482ab5578ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8e36c2f4-4636-48ef-a7c9-199efadc0a3c" xlink:to="loc_us-gaap_EquityComponentDomain_cb5b21c7-c65f-42b9-9a31-482ab5578ae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_9f4b6bc1-e17c-46e8-a224-f5821fb354cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cb5b21c7-c65f-42b9-9a31-482ab5578ae5" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_9f4b6bc1-e17c-46e8-a224-f5821fb354cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ebe2bdcf-cd73-4463-904b-8a678669768b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_HedgingDesignationAxis_ebe2bdcf-cd73-4463-904b-8a678669768b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ebe2bdcf-cd73-4463-904b-8a678669768b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_ebe2bdcf-cd73-4463-904b-8a678669768b" xlink:to="loc_us-gaap_HedgingDesignationDomain_ebe2bdcf-cd73-4463-904b-8a678669768b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_02f49ac7-eb18-4e50-80b5-947fdebb5947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_ebe2bdcf-cd73-4463-904b-8a678669768b" xlink:to="loc_us-gaap_HedgingDesignationDomain_02f49ac7-eb18-4e50-80b5-947fdebb5947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5b83c289-00be-409f-be44-15b9a4c76de9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_02f49ac7-eb18-4e50-80b5-947fdebb5947" xlink:to="loc_us-gaap_NondesignatedMember_5b83c289-00be-409f-be44-15b9a4c76de9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="extended" id="ieec562ddf6014465961e5450f7af0194_FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5ad45016-8596-49a8-95f4-ad9f3424696e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5ad45016-8596-49a8-95f4-ad9f3424696e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_c66a2daa-b96b-460c-b4b9-8bf9230c7a90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_TradingSecurities_c66a2daa-b96b-460c-b4b9-8bf9230c7a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0f004e5c-db16-4237-b58e-9a9d1a39c3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0f004e5c-db16-4237-b58e-9a9d1a39c3bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_06deccfe-fb31-4204-a099-4d2fce9872c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_06deccfe-fb31-4204-a099-4d2fce9872c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ff59cba6-63dc-418b-b6e7-b9bab26633e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ff59cba6-63dc-418b-b6e7-b9bab26633e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c48a810f-8016-4517-ae6e-3f8ffa550f94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c48a810f-8016-4517-ae6e-3f8ffa550f94" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_c561dd7b-a017-40a8-b207-556c80931447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_c561dd7b-a017-40a8-b207-556c80931447" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_026c5497-ee30-4093-9bcd-9f885f135940" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_026c5497-ee30-4093-9bcd-9f885f135940" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_dc83f963-dc91-4ddc-940d-fab5aa1870fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_dc83f963-dc91-4ddc-940d-fab5aa1870fc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_89600cd8-f611-45a9-bcbe-3113d08b4628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_89600cd8-f611-45a9-bcbe-3113d08b4628" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a8acd0c8-2030-4375-997e-da05675a6104" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a8acd0c8-2030-4375-997e-da05675a6104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a8acd0c8-2030-4375-997e-da05675a6104_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a8acd0c8-2030-4375-997e-da05675a6104" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a8acd0c8-2030-4375-997e-da05675a6104_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0e31a4ff-dc81-4bd6-a30b-f6ca553d9073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a8acd0c8-2030-4375-997e-da05675a6104" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0e31a4ff-dc81-4bd6-a30b-f6ca553d9073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f3b13c30-39d6-4663-a4b5-bf412465b920" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0e31a4ff-dc81-4bd6-a30b-f6ca553d9073" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f3b13c30-39d6-4663-a4b5-bf412465b920" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_18ed4086-03e9-43fc-a040-7881ba107b27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_HedgingDesignationAxis_18ed4086-03e9-43fc-a040-7881ba107b27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_18ed4086-03e9-43fc-a040-7881ba107b27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_18ed4086-03e9-43fc-a040-7881ba107b27" xlink:to="loc_us-gaap_HedgingDesignationDomain_18ed4086-03e9-43fc-a040-7881ba107b27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9af0a9b0-24ad-41f9-a221-68382a731138" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_18ed4086-03e9-43fc-a040-7881ba107b27" xlink:to="loc_us-gaap_HedgingDesignationDomain_9af0a9b0-24ad-41f9-a221-68382a731138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bcfb0444-ca33-45cf-b22c-78363d90694c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9af0a9b0-24ad-41f9-a221-68382a731138" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bcfb0444-ca33-45cf-b22c-78363d90694c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f073fc30-d95d-410a-a8cf-4fe0309adc25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f073fc30-d95d-410a-a8cf-4fe0309adc25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f073fc30-d95d-410a-a8cf-4fe0309adc25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f073fc30-d95d-410a-a8cf-4fe0309adc25" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f073fc30-d95d-410a-a8cf-4fe0309adc25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f073fc30-d95d-410a-a8cf-4fe0309adc25" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_20f559fb-9596-4b57-b53f-83cbf28e9b05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_20f559fb-9596-4b57-b53f-83cbf28e9b05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5c0aa89d-0ef0-4e25-bd22-1e3cb60734e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5c0aa89d-0ef0-4e25-bd22-1e3cb60734e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_776108eb-af0a-4f8a-9350-03835e968a69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_776108eb-af0a-4f8a-9350-03835e968a69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_47ca1443-8816-4e4e-a858-b7482f4e0b05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_47ca1443-8816-4e4e-a858-b7482f4e0b05" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_47ca1443-8816-4e4e-a858-b7482f4e0b05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_47ca1443-8816-4e4e-a858-b7482f4e0b05" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_47ca1443-8816-4e4e-a858-b7482f4e0b05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_47ca1443-8816-4e4e-a858-b7482f4e0b05" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_edd03530-2c10-4dd3-bc0b-20a5685163f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_MoneyMarketFundsMember_edd03530-2c10-4dd3-bc0b-20a5685163f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_00ab59ed-6499-4403-a10f-713b360fb13b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_00ab59ed-6499-4403-a10f-713b360fb13b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_7939f863-f114-4440-a6c2-3d0d832a6d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_7939f863-f114-4440-a6c2-3d0d832a6d02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_00fa5014-6585-4310-ad9a-6905ce428741" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_00fa5014-6585-4310-ad9a-6905ce428741" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_023b82fc-75ae-4f74-a29a-ac82f8bdde2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_023b82fc-75ae-4f74-a29a-ac82f8bdde2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f3e013ac-0550-441a-908e-b22d51afc175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f3e013ac-0550-441a-908e-b22d51afc175" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_7d73a0c3-ebb7-479f-a0ce-7bbb93826d05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_7d73a0c3-ebb7-479f-a0ce-7bbb93826d05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_45174b21-8c9a-4dfc-a1ff-eef8c0e478a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_CommonStockMember_45174b21-8c9a-4dfc-a1ff-eef8c0e478a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_743f52ac-84cb-48d4-ae02-779a1dd1b850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_InterestRateSwapMember_743f52ac-84cb-48d4-ae02-779a1dd1b850" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_952bb258-79c3-4e03-8e09-11b26afee9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_952bb258-79c3-4e03-8e09-11b26afee9b8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_92658496-dc24-4742-bb65-ce971da185d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_92658496-dc24-4742-bb65-ce971da185d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_92658496-dc24-4742-bb65-ce971da185d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_92658496-dc24-4742-bb65-ce971da185d7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_92658496-dc24-4742-bb65-ce971da185d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_92658496-dc24-4742-bb65-ce971da185d7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f969dc4f-8321-4492-8b02-2587486fe4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f969dc4f-8321-4492-8b02-2587486fe4a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5e27d7a9-91cc-49b5-bd71-e4111e4ff16f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:to="loc_us-gaap_InterestRateSwapMember_5e27d7a9-91cc-49b5-bd71-e4111e4ff16f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_1c904e89-ed57-4d1e-8d1d-6de710f96d6c" xlink:href="vtrs-20230331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:to="loc_vtrs_ContingentConsiderationMember_1c904e89-ed57-4d1e-8d1d-6de710f96d6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a93110a8-3a09-40dc-9df1-e05902434177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a93110a8-3a09-40dc-9df1-e05902434177" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a93110a8-3a09-40dc-9df1-e05902434177_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a93110a8-3a09-40dc-9df1-e05902434177" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a93110a8-3a09-40dc-9df1-e05902434177_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8d1e1c11-b6d7-479d-9c10-81f5cd3bc7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a93110a8-3a09-40dc-9df1-e05902434177" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8d1e1c11-b6d7-479d-9c10-81f5cd3bc7d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fff411e1-6703-4c67-8d8c-ae4dea9f2449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d1e1c11-b6d7-479d-9c10-81f5cd3bc7d7" xlink:to="loc_us-gaap_InterestRateSwapMember_fff411e1-6703-4c67-8d8c-ae4dea9f2449" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5829eeda-9023-4d6f-8e9a-9c238eab0633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d1e1c11-b6d7-479d-9c10-81f5cd3bc7d7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5829eeda-9023-4d6f-8e9a-9c238eab0633" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="extended" id="i69382a91a60b4823a6b41bbb99b05019_FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e38fb025-1dd3-419f-a2ff-f0fbcbf6a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofActivityinContingentConsiderationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e38fb025-1dd3-419f-a2ff-f0fbcbf6a4b1" xlink:to="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f64c907a-e9f4-4dce-a726-a0eeb62e51f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f64c907a-e9f4-4dce-a726-a0eeb62e51f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_29ff479e-9244-4b2c-b9e2-7eb4f3bce3d7" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_29ff479e-9244-4b2c-b9e2-7eb4f3bce3d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_3d3dddaf-ebef-4928-895c-d4969fc91217" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_3d3dddaf-ebef-4928-895c-d4969fc91217" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_07b33aa6-eaff-46dc-94fa-1d77a1782e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_us-gaap_AccretionExpense_07b33aa6-eaff-46dc-94fa-1d77a1782e3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_5bee9c3d-69a8-4acd-ae81-02c2a54a69cb" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_5bee9c3d-69a8-4acd-ae81-02c2a54a69cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_73273321-07e5-421b-aa9e-dc0507b48aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2391f327-5814-4e40-bcbd-7e6ae1083348" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e38fb025-1dd3-419f-a2ff-f0fbcbf6a4b1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2391f327-5814-4e40-bcbd-7e6ae1083348" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4bad86c8-22bb-439d-bfc2-e1ff2f3e9e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2391f327-5814-4e40-bcbd-7e6ae1083348" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4bad86c8-22bb-439d-bfc2-e1ff2f3e9e7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4bad86c8-22bb-439d-bfc2-e1ff2f3e9e7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4bad86c8-22bb-439d-bfc2-e1ff2f3e9e7a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4bad86c8-22bb-439d-bfc2-e1ff2f3e9e7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dc77bd98-36d8-41d1-8432-abe0e60073da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4bad86c8-22bb-439d-bfc2-e1ff2f3e9e7a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dc77bd98-36d8-41d1-8432-abe0e60073da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_3c21c791-18c8-49af-b485-6c004bdb4aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc77bd98-36d8-41d1-8432-abe0e60073da" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_3c21c791-18c8-49af-b485-6c004bdb4aae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_12bf51e7-7dbd-426a-9e10-6a9a5e1e5df5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc77bd98-36d8-41d1-8432-abe0e60073da" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_12bf51e7-7dbd-426a-9e10-6a9a5e1e5df5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_438541c3-7656-4390-a6be-233287140db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2391f327-5814-4e40-bcbd-7e6ae1083348" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_438541c3-7656-4390-a6be-233287140db8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_438541c3-7656-4390-a6be-233287140db8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_438541c3-7656-4390-a6be-233287140db8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_438541c3-7656-4390-a6be-233287140db8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5414888-286b-4699-8046-961847184797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_438541c3-7656-4390-a6be-233287140db8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5414888-286b-4699-8046-961847184797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_304f0057-c3c4-44cc-a664-f9e3708cb87e" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5414888-286b-4699-8046-961847184797" xlink:to="loc_vtrs_BioconBiologicsMember_304f0057-c3c4-44cc-a664-f9e3708cb87e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" xlink:type="extended" id="i851ea6a09e3940f783565188f3c23086_DebtReceivablesSecuritizationFacilityandCommercialPaperDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_66ec2e95-5e09-45a1-b020-1628fb632658" xlink:href="vtrs-20230331.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:to="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_66ec2e95-5e09-45a1-b020-1628fb632658" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6a1e92ea-dc20-44ad-9433-601c7cc4f710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6a1e92ea-dc20-44ad-9433-601c7cc4f710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f6a181e7-e5d4-40e0-9af8-8a9e43f891fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:to="loc_us-gaap_ShortTermBorrowings_f6a181e7-e5d4-40e0-9af8-8a9e43f891fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3de87312-ec34-404c-8d80-2bf315ce2b32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:to="loc_us-gaap_DebtInstrumentAxis_3de87312-ec34-404c-8d80-2bf315ce2b32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3de87312-ec34-404c-8d80-2bf315ce2b32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3de87312-ec34-404c-8d80-2bf315ce2b32" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3de87312-ec34-404c-8d80-2bf315ce2b32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_591e94cf-dd67-4889-b9de-6d458c4cc61f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3de87312-ec34-404c-8d80-2bf315ce2b32" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_591e94cf-dd67-4889-b9de-6d458c4cc61f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_1430f520-6800-416b-adb8-371fc3e56b88" xlink:href="vtrs-20230331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_591e94cf-dd67-4889-b9de-6d458c4cc61f" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_1430f520-6800-416b-adb8-371fc3e56b88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_8de53442-df36-4756-92a0-34cd3f0df183" xlink:href="vtrs-20230331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_591e94cf-dd67-4889-b9de-6d458c4cc61f" xlink:to="loc_vtrs_ReceivablesFacilityMember_8de53442-df36-4756-92a0-34cd3f0df183" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fd72211b-87ad-46d1-9e00-ececbb5be7c5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:to="loc_srt_RangeAxis_fd72211b-87ad-46d1-9e00-ececbb5be7c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd72211b-87ad-46d1-9e00-ececbb5be7c5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fd72211b-87ad-46d1-9e00-ececbb5be7c5" xlink:to="loc_srt_RangeMember_fd72211b-87ad-46d1-9e00-ececbb5be7c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7087c804-be43-42b4-b7ad-83b90ad52b10" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fd72211b-87ad-46d1-9e00-ececbb5be7c5" xlink:to="loc_srt_RangeMember_7087c804-be43-42b4-b7ad-83b90ad52b10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d800cc41-a29c-45de-aa04-1c292286b5af" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7087c804-be43-42b4-b7ad-83b90ad52b10" xlink:to="loc_srt_MinimumMember_d800cc41-a29c-45de-aa04-1c292286b5af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_63f3e6b5-d814-4761-8ff5-3f012040d2d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7087c804-be43-42b4-b7ad-83b90ad52b10" xlink:to="loc_srt_MaximumMember_63f3e6b5-d814-4761-8ff5-3f012040d2d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_09617c93-fe93-4edc-b68a-1df64c42fdb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_09617c93-fe93-4edc-b68a-1df64c42fdb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_09617c93-fe93-4edc-b68a-1df64c42fdb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_09617c93-fe93-4edc-b68a-1df64c42fdb7" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_09617c93-fe93-4edc-b68a-1df64c42fdb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e3211e98-a6d0-4b4e-8e45-ebed2177187d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_09617c93-fe93-4edc-b68a-1df64c42fdb7" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e3211e98-a6d0-4b4e-8e45-ebed2177187d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_722bc8fa-d122-4903-995d-d8ce00c55e4d" xlink:href="vtrs-20230331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_e3211e98-a6d0-4b4e-8e45-ebed2177187d" xlink:to="loc_vtrs_ReceivablesFacilityMember_722bc8fa-d122-4903-995d-d8ce00c55e4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember_55b875a1-a81e-42ea-b4cc-d2e6442a41ed" xlink:href="vtrs-20230331.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_e3211e98-a6d0-4b4e-8e45-ebed2177187d" xlink:to="loc_vtrs_NoteSecuritizationFacilityMember_55b875a1-a81e-42ea-b4cc-d2e6442a41ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_51e3e333-686b-4120-b7be-789ed59378aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_51e3e333-686b-4120-b7be-789ed59378aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_51e3e333-686b-4120-b7be-789ed59378aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_51e3e333-686b-4120-b7be-789ed59378aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_51e3e333-686b-4120-b7be-789ed59378aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1ae82d20-9de1-4266-95c3-e10d0b2d3e03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_51e3e333-686b-4120-b7be-789ed59378aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1ae82d20-9de1-4266-95c3-e10d0b2d3e03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_719f5ea6-124d-49b4-90ed-8232773e2b61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1ae82d20-9de1-4266-95c3-e10d0b2d3e03" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_719f5ea6-124d-49b4-90ed-8232773e2b61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DebtSummaryofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails" xlink:type="extended" id="i8922d9aa685847eda57e3f5d21b63713_DebtSummaryofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4a533ed3-78a5-4f19-ab84-d08076d1d6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4a533ed3-78a5-4f19-ab84-d08076d1d6aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_700fa27f-4d86-40eb-a0d8-025e8fbcf07b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_DebtCurrent_700fa27f-4d86-40eb-a0d8-025e8fbcf07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f9c50509-9b2f-4b1d-bf82-a49225e91fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_LongTermDebt_f9c50509-9b2f-4b1d-bf82-a49225e91fd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_a42582f9-a6f1-4c0c-9f71-b7cc81647c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_a42582f9-a6f1-4c0c-9f71-b7cc81647c6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_19a20b62-0bae-4a4f-a33d-1c1dfbdbb826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_19a20b62-0bae-4a4f-a33d-1c1dfbdbb826" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_2ab294fa-8fcd-4dd2-abd5-7a586f5522b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_2ab294fa-8fcd-4dd2-abd5-7a586f5522b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_4832ad68-b488-4bb2-91ca-c9b0932b05ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_4832ad68-b488-4bb2-91ca-c9b0932b05ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4832ad68-b488-4bb2-91ca-c9b0932b05ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4832ad68-b488-4bb2-91ca-c9b0932b05ba" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4832ad68-b488-4bb2-91ca-c9b0932b05ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a81c5a59-3b0f-40b2-9342-f103cda93bca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4832ad68-b488-4bb2-91ca-c9b0932b05ba" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a81c5a59-3b0f-40b2-9342-f103cda93bca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_37fbf27a-037b-4c8f-b648-bc5de84d3a46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a81c5a59-3b0f-40b2-9342-f103cda93bca" xlink:to="loc_us-gaap_SeniorNotesMember_37fbf27a-037b-4c8f-b648-bc5de84d3a46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_85b205a6-18f8-4823-926e-d9378cd62c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_85b205a6-18f8-4823-926e-d9378cd62c5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_85b205a6-18f8-4823-926e-d9378cd62c5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_85b205a6-18f8-4823-926e-d9378cd62c5d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_85b205a6-18f8-4823-926e-d9378cd62c5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_85b205a6-18f8-4823-926e-d9378cd62c5d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8cadb6a2-c33b-4f20-9127-635f14fd4b24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:to="loc_us-gaap_SeniorNotesMember_8cadb6a2-c33b-4f20-9127-635f14fd4b24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_e478e887-4051-4f3a-8e32-583218924904" xlink:href="vtrs-20230331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:to="loc_vtrs_OtherLongTermDebtMember_e478e887-4051-4f3a-8e32-583218924904" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CurrentPortionofLongTermDebtMember_48d6b009-209d-4166-8676-1a9b1c8a6cfe" xlink:href="vtrs-20230331.xsd#vtrs_CurrentPortionofLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:to="loc_vtrs_CurrentPortionofLongTermDebtMember_48d6b009-209d-4166-8676-1a9b1c8a6cfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8d62a566-0b97-4b13-8def-1708f67bb31a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:to="loc_us-gaap_DebtInstrumentAxis_8d62a566-0b97-4b13-8def-1708f67bb31a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8d62a566-0b97-4b13-8def-1708f67bb31a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8d62a566-0b97-4b13-8def-1708f67bb31a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8d62a566-0b97-4b13-8def-1708f67bb31a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8d62a566-0b97-4b13-8def-1708f67bb31a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_b58efcff-10d9-4eb1-a0a3-b26fa8b22272" xlink:href="vtrs-20230331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_b58efcff-10d9-4eb1-a0a3-b26fa8b22272" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_4782c42b-3699-4a48-96ea-478ec9e068d0" xlink:href="vtrs-20230331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_4782c42b-3699-4a48-96ea-478ec9e068d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_46937ce5-2b4e-4fbe-940e-94331bbca5e2" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_46937ce5-2b4e-4fbe-940e-94331bbca5e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_7aacafbf-cab8-4343-9aca-0698ddfcc2e2" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_7aacafbf-cab8-4343-9aca-0698ddfcc2e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_bcdd27cd-c9dc-4eb1-bd18-32b02c213935" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_bcdd27cd-c9dc-4eb1-bd18-32b02c213935" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_00d166c1-6d44-4691-acf0-5b9f11b9983d" xlink:href="vtrs-20230331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_00d166c1-6d44-4691-acf0-5b9f11b9983d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_dcb0b91e-9139-496c-8203-d327ebceabb9" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_dcb0b91e-9139-496c-8203-d327ebceabb9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_fc29d434-2d4e-4262-858c-3f2b6ad1ccdc" xlink:href="vtrs-20230331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_fc29d434-2d4e-4262-858c-3f2b6ad1ccdc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember_be366f18-f268-4337-ae6b-95de8b6b7c01" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember_be366f18-f268-4337-ae6b-95de8b6b7c01" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_acfd8f51-3b10-4cc7-bff1-127b029baa8a" xlink:href="vtrs-20230331.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2028SeniorNotesMember_acfd8f51-3b10-4cc7-bff1-127b029baa8a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_2a544d64-0315-496a-9641-518ac7406b24" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandFortyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_2a544d64-0315-496a-9641-518ac7406b24" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_9562aa18-bb32-4e9c-81c4-a1ce70ac581d" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_9562aa18-bb32-4e9c-81c4-a1ce70ac581d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyEightMember_6d974d2f-98d4-464d-a24a-944d636bb962" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandFortyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyEightMember_6d974d2f-98d4-464d-a24a-944d636bb962" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_1dd1fc38-f3b7-41e3-b606-624b2a753694" xlink:href="vtrs-20230331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_OtherLongTermDebtMember_1dd1fc38-f3b7-41e3-b606-624b2a753694" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_1d28ad0e-9e3c-4ff4-9757-092ce1b7eaa5" xlink:href="vtrs-20230331.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2048SeniorNotesMember_1d28ad0e-9e3c-4ff4-9757-092ce1b7eaa5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_f1e16cd3-e71e-4b68-9905-25dd39e14c1c" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_f1e16cd3-e71e-4b68-9905-25dd39e14c1c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember_9a77cdfe-0159-4d7e-9780-aa98c3116407" xlink:href="vtrs-20230331.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2025SeniorNotesMember_9a77cdfe-0159-4d7e-9780-aa98c3116407" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_9c269223-ea21-4ef3-8e20-048916c9914c" xlink:href="vtrs-20230331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_9c269223-ea21-4ef3-8e20-048916c9914c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember_f90c027b-d8ef-422a-ae7a-6991b00f377b" xlink:href="vtrs-20230331.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2027SeniorNotesMember_f90c027b-d8ef-422a-ae7a-6991b00f377b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember_718c0f66-00af-4471-b02b-a85682999b0d" xlink:href="vtrs-20230331.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2030SeniorNotesMember_718c0f66-00af-4471-b02b-a85682999b0d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_117393b9-fcc0-4d10-ad1d-c624af16ef9a" xlink:href="vtrs-20230331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_117393b9-fcc0-4d10-ad1d-c624af16ef9a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember_61306c49-b5f9-49bd-832d-54ae984e14d9" xlink:href="vtrs-20230331.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2040SeniorNotesMember_61306c49-b5f9-49bd-832d-54ae984e14d9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember_390c5e51-6a21-46de-916f-179be69a5b2e" xlink:href="vtrs-20230331.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2050SeniorNotesMember_390c5e51-6a21-46de-916f-179be69a5b2e" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DebtFairValueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="extended" id="iddfabc08a23c494a9e614b994d69779f_DebtFairValueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b1518297-2605-435a-b516-53ab56c8cc64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_bd6394c9-1b33-4847-9a20-f02bb019bb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1518297-2605-435a-b516-53ab56c8cc64" xlink:to="loc_us-gaap_DebtInstrumentFairValue_bd6394c9-1b33-4847-9a20-f02bb019bb1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dcfc4027-1a30-4fad-9861-ee8690f22168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1518297-2605-435a-b516-53ab56c8cc64" xlink:to="loc_us-gaap_DebtInstrumentTable_dcfc4027-1a30-4fad-9861-ee8690f22168" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1de7c13c-1cb5-494b-ae94-93355e454570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dcfc4027-1a30-4fad-9861-ee8690f22168" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1de7c13c-1cb5-494b-ae94-93355e454570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1de7c13c-1cb5-494b-ae94-93355e454570_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1de7c13c-1cb5-494b-ae94-93355e454570" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1de7c13c-1cb5-494b-ae94-93355e454570_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4c94a723-d58d-4b95-8f77-373431129f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1de7c13c-1cb5-494b-ae94-93355e454570" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4c94a723-d58d-4b95-8f77-373431129f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_af414305-e85b-418d-945c-551933b81b77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c94a723-d58d-4b95-8f77-373431129f7b" xlink:to="loc_us-gaap_SeniorNotesMember_af414305-e85b-418d-945c-551933b81b77" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i955394a56ef442c99c34c12c88da8fd8_ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6731c98a-eb1c-4634-b34b-74db8ac5ad0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6731c98a-eb1c-4634-b34b-74db8ac5ad0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_772f4c56-cfdd-4891-aa9a-d8898181e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_772f4c56-cfdd-4891-aa9a-d8898181e2cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_47b13afc-2b87-4aec-aa2a-c659f1e3f960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_47b13afc-2b87-4aec-aa2a-c659f1e3f960" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_26c1c73c-cfdc-4a35-a3be-83e381e21b21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_26c1c73c-cfdc-4a35-a3be-83e381e21b21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_80159e70-b026-44b1-8a43-8e6da85f4af7" xlink:href="vtrs-20230331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_80159e70-b026-44b1-8a43-8e6da85f4af7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_475693dc-6428-4095-915a-29aecbe9f4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_475693dc-6428-4095-915a-29aecbe9f4ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06af2dc5-1b7d-4e19-be62-db71fc19fd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06af2dc5-1b7d-4e19-be62-db71fc19fd1b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_777a8044-66b5-4188-a5bd-7a1877fd7e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_777a8044-66b5-4188-a5bd-7a1877fd7e8c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_20d67b3e-194e-4e13-b694-afe28e2585d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_20d67b3e-194e-4e13-b694-afe28e2585d6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_35b77649-fc8f-43f9-a285-b13ad003a488" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_35b77649-fc8f-43f9-a285-b13ad003a488" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9bbf0c1a-05cb-4bd1-8eaf-2ec92fec1aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9bbf0c1a-05cb-4bd1-8eaf-2ec92fec1aae" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bd62a1b-638b-4e4d-b741-a899d9fc2ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bd62a1b-638b-4e4d-b741-a899d9fc2ab0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_61938830-0258-4d6a-9476-412751de6aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_InterestExpense_61938830-0258-4d6a-9476-412751de6aa1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b68c99e6-5e70-41ad-b385-f921e1d5c39f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b68c99e6-5e70-41ad-b385-f921e1d5c39f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_602e64f0-25f1-4e8f-8285-3465b725e8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_602e64f0-25f1-4e8f-8285-3465b725e8ee" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_c0ee0a28-064f-4237-a2de-7e14c0fdc394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_c0ee0a28-064f-4237-a2de-7e14c0fdc394" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d2bc47c7-7003-454b-8009-b7ccd7341c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d2bc47c7-7003-454b-8009-b7ccd7341c70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d2bc47c7-7003-454b-8009-b7ccd7341c70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d2bc47c7-7003-454b-8009-b7ccd7341c70" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d2bc47c7-7003-454b-8009-b7ccd7341c70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1a7718af-67c9-4cc4-bf89-600558db635b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d2bc47c7-7003-454b-8009-b7ccd7341c70" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1a7718af-67c9-4cc4-bf89-600558db635b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_92ba2e90-17c6-42a9-8388-55b9bb0dafe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1a7718af-67c9-4cc4-bf89-600558db635b" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_92ba2e90-17c6-42a9-8388-55b9bb0dafe9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b238c298-e162-44de-b385-59ebd03ac9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b238c298-e162-44de-b385-59ebd03ac9c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b238c298-e162-44de-b385-59ebd03ac9c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b238c298-e162-44de-b385-59ebd03ac9c5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b238c298-e162-44de-b385-59ebd03ac9c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f9442705-03ca-4904-a1cb-5e9a304beeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b238c298-e162-44de-b385-59ebd03ac9c5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f9442705-03ca-4904-a1cb-5e9a304beeb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d4464fe4-1d8b-492f-8f86-9992f52f78ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9442705-03ca-4904-a1cb-5e9a304beeb5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d4464fe4-1d8b-492f-8f86-9992f52f78ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_316f431b-ab54-47fb-99e4-748bb59381f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9442705-03ca-4904-a1cb-5e9a304beeb5" xlink:to="loc_us-gaap_InterestRateSwapMember_316f431b-ab54-47fb-99e4-748bb59381f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_fa131631-dc41-4a29-a6d1-9a4b4d3c065a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_srt_ConsolidatedEntitiesAxis_fa131631-dc41-4a29-a6d1-9a4b4d3c065a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_fa131631-dc41-4a29-a6d1-9a4b4d3c065a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_fa131631-dc41-4a29-a6d1-9a4b4d3c065a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_fa131631-dc41-4a29-a6d1-9a4b4d3c065a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3d34b726-f020-4eef-aaca-da548a22a994" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_fa131631-dc41-4a29-a6d1-9a4b4d3c065a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3d34b726-f020-4eef-aaca-da548a22a994" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d94db2cb-e289-4637-92d7-6e665233cbc5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3d34b726-f020-4eef-aaca-da548a22a994" xlink:to="loc_srt_ParentCompanyMember_d94db2cb-e289-4637-92d7-6e665233cbc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d25d4e1c-30d1-4347-a802-a05fe1dae81c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d25d4e1c-30d1-4347-a802-a05fe1dae81c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d25d4e1c-30d1-4347-a802-a05fe1dae81c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d25d4e1c-30d1-4347-a802-a05fe1dae81c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d25d4e1c-30d1-4347-a802-a05fe1dae81c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_342a6f61-1f0a-4504-8e87-5ceb789b4fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d25d4e1c-30d1-4347-a802-a05fe1dae81c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_342a6f61-1f0a-4504-8e87-5ceb789b4fa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_f8d4b060-91c5-4e0b-aab5-8aa48254d71e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_342a6f61-1f0a-4504-8e87-5ceb789b4fa2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_f8d4b060-91c5-4e0b-aab5-8aa48254d71e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2a97ecb9-2c81-49a0-b3b5-900dbe397202" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2a97ecb9-2c81-49a0-b3b5-900dbe397202" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2a97ecb9-2c81-49a0-b3b5-900dbe397202_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2a97ecb9-2c81-49a0-b3b5-900dbe397202" xlink:to="loc_us-gaap_EquityComponentDomain_2a97ecb9-2c81-49a0-b3b5-900dbe397202_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2a97ecb9-2c81-49a0-b3b5-900dbe397202" xlink:to="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d69cbf5-507e-42d1-9cae-59e96f9f5d32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d69cbf5-507e-42d1-9cae-59e96f9f5d32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_ed89612b-2776-499a-bb75-d65c39f7403b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_ed89612b-2776-499a-bb75-d65c39f7403b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3a9219b5-484c-474b-b2b2-22d44259051c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3a9219b5-484c-474b-b2b2-22d44259051c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_13c6df2d-ba87-43f9-87c9-bbaa1a5d2b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_13c6df2d-ba87-43f9-87c9-bbaa1a5d2b52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_924746ef-cc9b-4467-9eca-bfa55ef1ee80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_924746ef-cc9b-4467-9eca-bfa55ef1ee80" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69984b5a-05fc-4682-b39a-97a46c5a7fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69984b5a-05fc-4682-b39a-97a46c5a7fac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_69984b5a-05fc-4682-b39a-97a46c5a7fac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69984b5a-05fc-4682-b39a-97a46c5a7fac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_69984b5a-05fc-4682-b39a-97a46c5a7fac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dd1a1338-7fa2-4d03-9385-15b208c110e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69984b5a-05fc-4682-b39a-97a46c5a7fac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dd1a1338-7fa2-4d03-9385-15b208c110e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_85262703-18f0-4727-8502-2166ba6c9995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dd1a1338-7fa2-4d03-9385-15b208c110e1" xlink:to="loc_us-gaap_CashFlowHedgingMember_85262703-18f0-4727-8502-2166ba6c9995" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a15d7f85-6b56-4505-8de4-58af85f4af83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dd1a1338-7fa2-4d03-9385-15b208c110e1" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a15d7f85-6b56-4505-8de4-58af85f4af83" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" xlink:type="extended" id="if37c5ab24aad4a28ac61560712d08eb2_ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_42c331ee-9ba9-41b6-a4ef-04bd28279d1b" xlink:href="vtrs-20230331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_42c331ee-9ba9-41b6-a4ef-04bd28279d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_9ff5d5b2-2697-4afb-af35-769858365391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_9ff5d5b2-2697-4afb-af35-769858365391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_30c1f144-7011-439b-b935-a7471e9fd924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_30c1f144-7011-439b-b935-a7471e9fd924" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c45a084b-9703-4e9f-82d5-0e2e411ec7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c45a084b-9703-4e9f-82d5-0e2e411ec7fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5443367f-2e1e-4210-92f4-efb9b90adf43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5443367f-2e1e-4210-92f4-efb9b90adf43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eed229c2-dd82-475e-91dc-bf8ac746d013" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eed229c2-dd82-475e-91dc-bf8ac746d013" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_e41a2bb2-46a9-4681-b42f-693f5193aa80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_e41a2bb2-46a9-4681-b42f-693f5193aa80" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_88620ffe-8511-4f0a-b5d0-43de701b989d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_88620ffe-8511-4f0a-b5d0-43de701b989d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_72fb4cc9-385d-4d20-88c8-3344197fc1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_InterestExpense_72fb4cc9-385d-4d20-88c8-3344197fc1ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1b718bc2-8f32-4ab9-9f3d-230606a48f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1b718bc2-8f32-4ab9-9f3d-230606a48f8d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3ef635a9-5862-49f2-a58f-b6a71c587573" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3ef635a9-5862-49f2-a58f-b6a71c587573" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d504b331-7ab8-4d35-a985-332924c1fd0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d504b331-7ab8-4d35-a985-332924c1fd0f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_c81f4c2f-baa4-4388-8939-23b205e812bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_c81f4c2f-baa4-4388-8939-23b205e812bb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6e39b590-cc9a-45c9-99b4-89e596d98d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6e39b590-cc9a-45c9-99b4-89e596d98d82" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e5980490-7843-4396-b93b-265e7cac953f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e5980490-7843-4396-b93b-265e7cac953f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f28d2d37-a448-498b-ae3f-5e7a8a0f151d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f28d2d37-a448-498b-ae3f-5e7a8a0f151d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_1a719484-8739-4f90-9248-b2f89f5ad278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_dd6cf220-6581-4bc6-9677-9b08cbfe3d17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_2574e046-7ff7-4664-a978-b9f1bbffa6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a9b19b8e-20bf-442b-9381-cf61e22328e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4d103579-c396-4c26-b13c-e53bc6183edd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_f7f746ba-0f41-4693-b3bd-957b21f04ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_f7f746ba-0f41-4693-b3bd-957b21f04ce9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2873ce4b-d61a-4b55-94c5-f09a3235a6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2873ce4b-d61a-4b55-94c5-f09a3235a6b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2873ce4b-d61a-4b55-94c5-f09a3235a6b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2873ce4b-d61a-4b55-94c5-f09a3235a6b6" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2873ce4b-d61a-4b55-94c5-f09a3235a6b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_32d72f01-1fa4-4178-acc2-0ce33a19d451" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2873ce4b-d61a-4b55-94c5-f09a3235a6b6" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_32d72f01-1fa4-4178-acc2-0ce33a19d451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_9a8f8bf6-59ae-4273-a5d2-29f4ac7a2344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_32d72f01-1fa4-4178-acc2-0ce33a19d451" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_9a8f8bf6-59ae-4273-a5d2-29f4ac7a2344" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_65a28701-5385-4ec1-a70c-e61cf6fbe47d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_65a28701-5385-4ec1-a70c-e61cf6fbe47d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_65a28701-5385-4ec1-a70c-e61cf6fbe47d_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_65a28701-5385-4ec1-a70c-e61cf6fbe47d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_65a28701-5385-4ec1-a70c-e61cf6fbe47d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_62536eee-665f-4683-aef7-2bb30117f092" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_65a28701-5385-4ec1-a70c-e61cf6fbe47d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_62536eee-665f-4683-aef7-2bb30117f092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_6f6111e8-0a94-4bd0-a361-7588a783d30b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_62536eee-665f-4683-aef7-2bb30117f092" xlink:to="loc_srt_ParentCompanyMember_6f6111e8-0a94-4bd0-a361-7588a783d30b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2d39fc3a-77a8-463f-a213-7a60a90ed06e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2d39fc3a-77a8-463f-a213-7a60a90ed06e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2d39fc3a-77a8-463f-a213-7a60a90ed06e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2d39fc3a-77a8-463f-a213-7a60a90ed06e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2d39fc3a-77a8-463f-a213-7a60a90ed06e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3769562e-1b68-460b-ba75-9688c944d13d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2d39fc3a-77a8-463f-a213-7a60a90ed06e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3769562e-1b68-460b-ba75-9688c944d13d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_89dd4e3b-a9aa-4675-bc61-f2faed4a0bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3769562e-1b68-460b-ba75-9688c944d13d" xlink:to="loc_us-gaap_CashFlowHedgingMember_89dd4e3b-a9aa-4675-bc61-f2faed4a0bb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_420604b7-905d-4cd4-8422-a80dc75e281e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3769562e-1b68-460b-ba75-9688c944d13d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_420604b7-905d-4cd4-8422-a80dc75e281e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c6693529-e121-4fef-aea8-6a903bc0fc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c6693529-e121-4fef-aea8-6a903bc0fc8b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c6693529-e121-4fef-aea8-6a903bc0fc8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c6693529-e121-4fef-aea8-6a903bc0fc8b" xlink:to="loc_us-gaap_EquityComponentDomain_c6693529-e121-4fef-aea8-6a903bc0fc8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c6693529-e121-4fef-aea8-6a903bc0fc8b" xlink:to="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_f95d3b8f-8c30-4f6c-bdc5-3d64eb564ada" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_f95d3b8f-8c30-4f6c-bdc5-3d64eb564ada" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_110adbdf-f53a-4304-879b-0e3631e26c80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_110adbdf-f53a-4304-879b-0e3631e26c80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2ad23b2c-a389-479c-9a77-815c6473c43c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2ad23b2c-a389-479c-9a77-815c6473c43c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_9a027980-4d87-46ef-899f-e4a638dd61cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_9a027980-4d87-46ef-899f-e4a638dd61cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7549e91e-3a69-444e-8b42-85c8b4455876" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7549e91e-3a69-444e-8b42-85c8b4455876" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8dc551ae-bccf-4790-83d8-9f1924cbd7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8dc551ae-bccf-4790-83d8-9f1924cbd7ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_8dc551ae-bccf-4790-83d8-9f1924cbd7ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8dc551ae-bccf-4790-83d8-9f1924cbd7ed" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_8dc551ae-bccf-4790-83d8-9f1924cbd7ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b6fe57fe-9161-43b7-947d-8058c2b2b1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8dc551ae-bccf-4790-83d8-9f1924cbd7ed" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b6fe57fe-9161-43b7-947d-8058c2b2b1f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_872c8b05-fb48-4eb0-a1c1-fe50ee84bde6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b6fe57fe-9161-43b7-947d-8058c2b2b1f2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_872c8b05-fb48-4eb0-a1c1-fe50ee84bde6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ced27952-4db5-49cf-bd49-52f0330a2426" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ced27952-4db5-49cf-bd49-52f0330a2426" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ced27952-4db5-49cf-bd49-52f0330a2426_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ced27952-4db5-49cf-bd49-52f0330a2426" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ced27952-4db5-49cf-bd49-52f0330a2426_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1882af0c-05ba-4a85-94b3-5cc43e6f7375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ced27952-4db5-49cf-bd49-52f0330a2426" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1882af0c-05ba-4a85-94b3-5cc43e6f7375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5c21cb45-2fdf-4fbf-b7ea-025884a0c955" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1882af0c-05ba-4a85-94b3-5cc43e6f7375" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5c21cb45-2fdf-4fbf-b7ea-025884a0c955" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7c5f639f-914c-4797-8b81-b7debc6a8083" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1882af0c-05ba-4a85-94b3-5cc43e6f7375" xlink:to="loc_us-gaap_InterestRateSwapMember_7c5f639f-914c-4797-8b81-b7debc6a8083" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" xlink:type="extended" id="i5f757fbfa7874bf3b96047c66ffbb4e4_SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ad85f773-57c2-415a-9d28-bc2f92fc8a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ad85f773-57c2-415a-9d28-bc2f92fc8a6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_42e77f56-e530-4219-ba70-0d1ea7144d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_Revenues_42e77f56-e530-4219-ba70-0d1ea7144d1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_32ed5329-c69b-48b4-a6ee-a3a61f437064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_32ed5329-c69b-48b4-a6ee-a3a61f437064" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_27c0c9e5-a47c-4b4b-ab36-544356fa21c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_27c0c9e5-a47c-4b4b-ab36-544356fa21c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6fc294c6-deb4-4529-ae6f-834191e5f298" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6fc294c6-deb4-4529-ae6f-834191e5f298" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Corporatecosts_befa85ab-85c9-4d92-9997-89930f692220" xlink:href="vtrs-20230331.xsd#vtrs_Corporatecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_vtrs_Corporatecosts_befa85ab-85c9-4d92-9997-89930f692220" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_c726dd9a-8ba1-447a-a28a-ed8d1f7a737a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_c726dd9a-8ba1-447a-a28a-ed8d1f7a737a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_34293846-689c-40c6-a244-fb5e9bd9f5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_OperatingIncomeLoss_34293846-689c-40c6-a244-fb5e9bd9f5b8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherOneTimeNonoperatingExpense_4692cff4-2bea-4ff6-a60a-cba30cf9be68" xlink:href="vtrs-20230331.xsd#vtrs_OtherOneTimeNonoperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_vtrs_OtherOneTimeNonoperatingExpense_4692cff4-2bea-4ff6-a60a-cba30cf9be68" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b11978d4-ed2b-4ffd-b9f9-557e6c1333a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:to="loc_srt_ProductOrServiceAxis_b11978d4-ed2b-4ffd-b9f9-557e6c1333a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b11978d4-ed2b-4ffd-b9f9-557e6c1333a3_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b11978d4-ed2b-4ffd-b9f9-557e6c1333a3" xlink:to="loc_srt_ProductsAndServicesDomain_b11978d4-ed2b-4ffd-b9f9-557e6c1333a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_321a9efe-563a-407a-a2bd-c71765a3a191" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b11978d4-ed2b-4ffd-b9f9-557e6c1333a3" xlink:to="loc_srt_ProductsAndServicesDomain_321a9efe-563a-407a-a2bd-c71765a3a191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_e3c19c0c-471a-4ab0-bc43-fa0f5006d0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_321a9efe-563a-407a-a2bd-c71765a3a191" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_e3c19c0c-471a-4ab0-bc43-fa0f5006d0b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_286fbf55-6a97-41e8-9c9f-ac22484ed6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_286fbf55-6a97-41e8-9c9f-ac22484ed6b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_286fbf55-6a97-41e8-9c9f-ac22484ed6b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_286fbf55-6a97-41e8-9c9f-ac22484ed6b8" xlink:to="loc_us-gaap_SegmentDomain_286fbf55-6a97-41e8-9c9f-ac22484ed6b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_286fbf55-6a97-41e8-9c9f-ac22484ed6b8" xlink:to="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_c23738be-4c2e-4552-b265-cdc756a34148" xlink:href="vtrs-20230331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_c23738be-4c2e-4552-b265-cdc756a34148" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_ef11fc27-eb4e-4b64-930c-ebc0be95c77b" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:to="loc_vtrs_GreaterChinaSegmentMember_ef11fc27-eb4e-4b64-930c-ebc0be95c77b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_a17906c3-6d3e-4e5f-bf47-3b50a40470ee" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_a17906c3-6d3e-4e5f-bf47-3b50a40470ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_7ae35c56-1142-467f-bbe0-79222d6fbb93" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_7ae35c56-1142-467f-bbe0-79222d6fbb93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b6b2acb1-b902-40f4-b55f-9a3a3172ecf8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:to="loc_srt_ConsolidationItemsAxis_b6b2acb1-b902-40f4-b55f-9a3a3172ecf8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b6b2acb1-b902-40f4-b55f-9a3a3172ecf8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b6b2acb1-b902-40f4-b55f-9a3a3172ecf8" xlink:to="loc_srt_ConsolidationItemsDomain_b6b2acb1-b902-40f4-b55f-9a3a3172ecf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b6b2acb1-b902-40f4-b55f-9a3a3172ecf8" xlink:to="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1d61728f-345c-43f6-97e2-3f4480e642ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:to="loc_us-gaap_OperatingSegmentsMember_1d61728f-345c-43f6-97e2-3f4480e642ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_9f7077a4-ab52-4bf4-b640-9e67cb1228cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_9f7077a4-ab52-4bf4-b640-9e67cb1228cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5fb3ecce-a800-46a4-9a02-df4022c97335" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5fb3ecce-a800-46a4-9a02-df4022c97335" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RestructuringRestructuringChargesDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RestructuringRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RestructuringRestructuringChargesDetails" xlink:type="extended" id="i5662f5983b3a466b89554d81eabe6292_RestructuringRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_8894848f-b91e-4d00-a743-d72899165417" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_8894848f-b91e-4d00-a743-d72899165417" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_a47fa16f-8970-45eb-b1c5-96f07884760a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_a47fa16f-8970-45eb-b1c5-96f07884760a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:to="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_636dce02-9b1a-4ae7-851c-fa6e0164c6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_RestructuringReserve_636dce02-9b1a-4ae7-851c-fa6e0164c6d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6d3fded5-7a0e-4f8d-be28-c8b9ab39add4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_RestructuringCharges_6d3fded5-7a0e-4f8d-be28-c8b9ab39add4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_880c4ee1-173b-47a8-96e1-9e8b37628fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_PaymentsForRestructuring_880c4ee1-173b-47a8-96e1-9e8b37628fba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_8f66b2c8-fe34-4295-b79e-964be9be20ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_8f66b2c8-fe34-4295-b79e-964be9be20ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_ea8b4d06-b0b8-4871-ad08-dfff0996e253" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_ea8b4d06-b0b8-4871-ad08-dfff0996e253" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b6411b31-669e-4088-9a9e-f6eda4abbf89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_7781df79-6483-41fc-82ec-176d06b15eda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_7781df79-6483-41fc-82ec-176d06b15eda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7781df79-6483-41fc-82ec-176d06b15eda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7781df79-6483-41fc-82ec-176d06b15eda" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7781df79-6483-41fc-82ec-176d06b15eda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_143b0142-7ad6-4e71-bbca-dc3214bbb53e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7781df79-6483-41fc-82ec-176d06b15eda" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_143b0142-7ad6-4e71-bbca-dc3214bbb53e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_7f6fa4cf-9f19-4f48-96d9-bf732c7bff8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_143b0142-7ad6-4e71-bbca-dc3214bbb53e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_7f6fa4cf-9f19-4f48-96d9-bf732c7bff8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_d64fc0be-5b48-4bdb-a7c6-7120c998e510" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_143b0142-7ad6-4e71-bbca-dc3214bbb53e" xlink:to="loc_us-gaap_OtherRestructuringMember_d64fc0be-5b48-4bdb-a7c6-7120c998e510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bd7237d6-ccf7-49ca-8fd5-305d7c654eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bd7237d6-ccf7-49ca-8fd5-305d7c654eb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bd7237d6-ccf7-49ca-8fd5-305d7c654eb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bd7237d6-ccf7-49ca-8fd5-305d7c654eb8" xlink:to="loc_us-gaap_SegmentDomain_bd7237d6-ccf7-49ca-8fd5-305d7c654eb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bd7237d6-ccf7-49ca-8fd5-305d7c654eb8" xlink:to="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_786e5f24-99e5-47df-a0dc-2f488dddf84b" xlink:href="vtrs-20230331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_786e5f24-99e5-47df-a0dc-2f488dddf84b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_43eb696f-9c47-4566-ae91-13fe20933f1b" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:to="loc_vtrs_GreaterChinaSegmentMember_43eb696f-9c47-4566-ae91-13fe20933f1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_dd613a7b-2cd0-459f-95ef-aede10a86f8e" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_dd613a7b-2cd0-459f-95ef-aede10a86f8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_da354b78-88f6-4e4e-9d00-cd74d20fe41e" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_da354b78-88f6-4e4e-9d00-cd74d20fe41e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f1ef34b7-d377-4685-819f-5ce0d6625eb1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_srt_RangeAxis_f1ef34b7-d377-4685-819f-5ce0d6625eb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f1ef34b7-d377-4685-819f-5ce0d6625eb1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f1ef34b7-d377-4685-819f-5ce0d6625eb1" xlink:to="loc_srt_RangeMember_f1ef34b7-d377-4685-819f-5ce0d6625eb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d8be84e2-cd1c-4ef6-8063-bde1f9b970c4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f1ef34b7-d377-4685-819f-5ce0d6625eb1" xlink:to="loc_srt_RangeMember_d8be84e2-cd1c-4ef6-8063-bde1f9b970c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c720b051-3a81-462b-9eb0-115add8e9c37" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d8be84e2-cd1c-4ef6-8063-bde1f9b970c4" xlink:to="loc_srt_MinimumMember_c720b051-3a81-462b-9eb0-115add8e9c37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ecaea1a2-66dd-4315-a6e2-1b5d270e7742" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d8be84e2-cd1c-4ef6-8063-bde1f9b970c4" xlink:to="loc_srt_MaximumMember_ecaea1a2-66dd-4315-a6e2-1b5d270e7742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_48093004-dfcc-4755-95ec-7aea01d3ece9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_us-gaap_RestructuringPlanAxis_48093004-dfcc-4755-95ec-7aea01d3ece9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_48093004-dfcc-4755-95ec-7aea01d3ece9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_48093004-dfcc-4755-95ec-7aea01d3ece9" xlink:to="loc_us-gaap_RestructuringPlanDomain_48093004-dfcc-4755-95ec-7aea01d3ece9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_99de307a-3807-4230-9216-186a23ef1fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_48093004-dfcc-4755-95ec-7aea01d3ece9" xlink:to="loc_us-gaap_RestructuringPlanDomain_99de307a-3807-4230-9216-186a23ef1fe8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RestructuringPlanMember_df1df667-1e63-44f4-b986-06fe1378f964" xlink:href="vtrs-20230331.xsd#vtrs_A2020RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_99de307a-3807-4230-9216-186a23ef1fe8" xlink:to="loc_vtrs_A2020RestructuringPlanMember_df1df667-1e63-44f4-b986-06fe1378f964" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4d3b968d-d5cd-4660-9582-ad71149138ef" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_srt_StatementScenarioAxis_4d3b968d-d5cd-4660-9582-ad71149138ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4d3b968d-d5cd-4660-9582-ad71149138ef_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_4d3b968d-d5cd-4660-9582-ad71149138ef" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4d3b968d-d5cd-4660-9582-ad71149138ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3723d799-74c2-4403-abe1-f7c2475e6894" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_4d3b968d-d5cd-4660-9582-ad71149138ef" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3723d799-74c2-4403-abe1-f7c2475e6894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_f6ac9b5e-f6c9-45db-82ee-fc5aa1f51dbb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_3723d799-74c2-4403-abe1-f7c2475e6894" xlink:to="loc_srt_ScenarioForecastMember_f6ac9b5e-f6c9-45db-82ee-fc5aa1f51dbb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CollaborationandLicensingAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails" xlink:type="extended" id="i2500ba430b244280bafcad33934cbdc0_CollaborationandLicensingAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8fe6794d-3e0f-4d6e-9973-0a86be6f88d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Developmentandsalesmilestonepayments_953fd5fd-2495-425c-8658-2e18946423fc" xlink:href="vtrs-20230331.xsd#vtrs_Developmentandsalesmilestonepayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8fe6794d-3e0f-4d6e-9973-0a86be6f88d5" xlink:to="loc_vtrs_Developmentandsalesmilestonepayments_953fd5fd-2495-425c-8658-2e18946423fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_15d52e88-94dc-41e6-a839-24e4fb549175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8fe6794d-3e0f-4d6e-9973-0a86be6f88d5" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_15d52e88-94dc-41e6-a839-24e4fb549175" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8ba2f981-2ca8-4ef4-9564-22106d58aa30" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_15d52e88-94dc-41e6-a839-24e4fb549175" xlink:to="loc_srt_RangeAxis_8ba2f981-2ca8-4ef4-9564-22106d58aa30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ba2f981-2ca8-4ef4-9564-22106d58aa30_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8ba2f981-2ca8-4ef4-9564-22106d58aa30" xlink:to="loc_srt_RangeMember_8ba2f981-2ca8-4ef4-9564-22106d58aa30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c1a00683-d881-41ab-adbe-12b6fab34b4d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8ba2f981-2ca8-4ef4-9564-22106d58aa30" xlink:to="loc_srt_RangeMember_c1a00683-d881-41ab-adbe-12b6fab34b4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e8f3204e-c197-417e-a81a-c92847db9607" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c1a00683-d881-41ab-adbe-12b6fab34b4d" xlink:to="loc_srt_MaximumMember_e8f3204e-c197-417e-a81a-c92847db9607" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_6448c818-ccb3-45b8-b3d7-cd9e4675dd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_15d52e88-94dc-41e6-a839-24e4fb549175" xlink:to="loc_us-gaap_TypeOfArrangementAxis_6448c818-ccb3-45b8-b3d7-cd9e4675dd4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6448c818-ccb3-45b8-b3d7-cd9e4675dd4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_6448c818-ccb3-45b8-b3d7-cd9e4675dd4c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6448c818-ccb3-45b8-b3d7-cd9e4675dd4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d9cd4bca-65c7-40c6-897b-9a847d4e5c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_6448c818-ccb3-45b8-b3d7-cd9e4675dd4c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d9cd4bca-65c7-40c6-897b-9a847d4e5c7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_6d1d1227-35ef-436b-b0cd-bf6cb4a79dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d9cd4bca-65c7-40c6-897b-9a847d4e5c7c" xlink:to="loc_us-gaap_CollaborativeArrangementMember_6d1d1227-35ef-436b-b0cd-bf6cb4a79dd7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#IncomeTaxesIncomeTaxesDisclosureDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails" xlink:type="extended" id="i061111b0693e4c62a75ae1037d37e1a1_IncomeTaxesIncomeTaxesDisclosureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e9221489-c00e-4ab6-aaaa-605f46ff0660" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e9221489-c00e-4ab6-aaaa-605f46ff0660" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_cc19b216-15ee-4d1c-9247-fc250176dc8f" xlink:href="vtrs-20230331.xsd#vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:to="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_cc19b216-15ee-4d1c-9247-fc250176dc8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_47bb66d0-a21d-4083-ad78-b9bf18a6e45b" xlink:href="vtrs-20230331.xsd#vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:to="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_47bb66d0-a21d-4083-ad78-b9bf18a6e45b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_52ae9c67-c7b7-4f81-a377-2f51ca33541f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:to="loc_srt_StatementScenarioAxis_52ae9c67-c7b7-4f81-a377-2f51ca33541f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_52ae9c67-c7b7-4f81-a377-2f51ca33541f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_52ae9c67-c7b7-4f81-a377-2f51ca33541f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_52ae9c67-c7b7-4f81-a377-2f51ca33541f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0e960cb2-17fe-4296-9a7a-94f96065c4ef" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_52ae9c67-c7b7-4f81-a377-2f51ca33541f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0e960cb2-17fe-4296-9a7a-94f96065c4ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_d74c9bda-fdd0-40ee-9b27-0637c660aede" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0e960cb2-17fe-4296-9a7a-94f96065c4ef" xlink:to="loc_srt_ScenarioForecastMember_d74c9bda-fdd0-40ee-9b27-0637c660aede" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4c3e7513-c078-4161-a338-b513655575a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4c3e7513-c078-4161-a338-b513655575a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4c3e7513-c078-4161-a338-b513655575a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4c3e7513-c078-4161-a338-b513655575a2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4c3e7513-c078-4161-a338-b513655575a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_12e21040-ded5-47a3-8344-58b1988d4d85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4c3e7513-c078-4161-a338-b513655575a2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_12e21040-ded5-47a3-8344-58b1988d4d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_60294ccd-f80f-46c0-b394-dff93c30713c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_12e21040-ded5-47a3-8344-58b1988d4d85" xlink:to="loc_us-gaap_ForeignCountryMember_60294ccd-f80f-46c0-b394-dff93c30713c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_87a97457-d3f4-4b7c-a3d8-aa468e690758" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_87a97457-d3f4-4b7c-a3d8-aa468e690758" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_87a97457-d3f4-4b7c-a3d8-aa468e690758_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_87a97457-d3f4-4b7c-a3d8-aa468e690758" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_87a97457-d3f4-4b7c-a3d8-aa468e690758_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1402e7ce-d194-42a0-94fb-f0aa2a6f75e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_87a97457-d3f4-4b7c-a3d8-aa468e690758" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1402e7ce-d194-42a0-94fb-f0aa2a6f75e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember_4e7d9b0a-a240-48cd-ac68-8838e905675e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1402e7ce-d194-42a0-94fb-f0aa2a6f75e9" xlink:to="loc_us-gaap_AustralianTaxationOfficeMember_4e7d9b0a-a240-48cd-ac68-8838e905675e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinistryOfFinanceIndiaMember_2dea5258-ba72-47d0-939b-22501c0de963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinistryOfFinanceIndiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1402e7ce-d194-42a0-94fb-f0aa2a6f75e9" xlink:to="loc_us-gaap_MinistryOfFinanceIndiaMember_2dea5258-ba72-47d0-939b-22501c0de963" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationLorazepamandClorazepateNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails" xlink:type="extended" id="icab7957b3e40478b90459b1972f2d097_LitigationLorazepamandClorazepateNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1b9ed234-8e5b-47d9-81aa-e1ddab5cfe96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6ee7d27a-e200-4cf0-8368-d005f48b2a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1b9ed234-8e5b-47d9-81aa-e1ddab5cfe96" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6ee7d27a-e200-4cf0-8368-d005f48b2a5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8172ca4c-5aef-4c1c-9f7f-9db401e9c9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_1b9ed234-8e5b-47d9-81aa-e1ddab5cfe96" xlink:to="loc_us-gaap_LossContingenciesTable_8172ca4c-5aef-4c1c-9f7f-9db401e9c9ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_595d6849-dd7a-4d4d-b45e-9dae5916609e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8172ca4c-5aef-4c1c-9f7f-9db401e9c9ce" xlink:to="loc_srt_LitigationCaseAxis_595d6849-dd7a-4d4d-b45e-9dae5916609e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_595d6849-dd7a-4d4d-b45e-9dae5916609e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_595d6849-dd7a-4d4d-b45e-9dae5916609e" xlink:to="loc_srt_LitigationCaseTypeDomain_595d6849-dd7a-4d4d-b45e-9dae5916609e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_065357c9-0f31-4f07-9956-144f811fbbff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_595d6849-dd7a-4d4d-b45e-9dae5916609e" xlink:to="loc_srt_LitigationCaseTypeDomain_065357c9-0f31-4f07-9956-144f811fbbff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9eb6f8bb-c612-4ea2-9095-555f35279605" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8172ca4c-5aef-4c1c-9f7f-9db401e9c9ce" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9eb6f8bb-c612-4ea2-9095-555f35279605" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9eb6f8bb-c612-4ea2-9095-555f35279605_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9eb6f8bb-c612-4ea2-9095-555f35279605" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9eb6f8bb-c612-4ea2-9095-555f35279605_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_dcc2fb20-95af-44e6-86a1-5bb3441844be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9eb6f8bb-c612-4ea2-9095-555f35279605" xlink:to="loc_us-gaap_LossContingencyNatureDomain_dcc2fb20-95af-44e6-86a1-5bb3441844be" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationPricingandMedicaidLitigationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails" xlink:type="extended" id="i5c124bd7dff843c780b6846df76ec13f_LitigationPricingandMedicaidLitigationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e0d4f877-176f-41ad-9be2-4dc50511ce3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_8e27cdc5-38e0-4ad7-8cfb-0e6cfd684079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e0d4f877-176f-41ad-9be2-4dc50511ce3f" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_8e27cdc5-38e0-4ad7-8cfb-0e6cfd684079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_e0d4f877-176f-41ad-9be2-4dc50511ce3f" xlink:to="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9e97c52d-11c0-40a0-afe9-83e6fc480ade" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:to="loc_srt_LitigationCaseAxis_9e97c52d-11c0-40a0-afe9-83e6fc480ade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9e97c52d-11c0-40a0-afe9-83e6fc480ade_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_9e97c52d-11c0-40a0-afe9-83e6fc480ade" xlink:to="loc_srt_LitigationCaseTypeDomain_9e97c52d-11c0-40a0-afe9-83e6fc480ade_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_71f5d288-59e9-4cef-a6d0-20fd3847136c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_9e97c52d-11c0-40a0-afe9-83e6fc480ade" xlink:to="loc_srt_LitigationCaseTypeDomain_71f5d288-59e9-4cef-a6d0-20fd3847136c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8c240899-77b4-49cf-8f3e-26d6eb63d460" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:to="loc_dei_LegalEntityAxis_8c240899-77b4-49cf-8f3e-26d6eb63d460" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8c240899-77b4-49cf-8f3e-26d6eb63d460_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8c240899-77b4-49cf-8f3e-26d6eb63d460" xlink:to="loc_dei_EntityDomain_8c240899-77b4-49cf-8f3e-26d6eb63d460_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bb1f8f5e-2840-4a18-9882-c2a7a639cb0e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8c240899-77b4-49cf-8f3e-26d6eb63d460" xlink:to="loc_dei_EntityDomain_bb1f8f5e-2840-4a18-9882-c2a7a639cb0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_07daddee-501d-4fe1-b8e4-9136eb2d33a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_07daddee-501d-4fe1-b8e4-9136eb2d33a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_07daddee-501d-4fe1-b8e4-9136eb2d33a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_07daddee-501d-4fe1-b8e4-9136eb2d33a0" xlink:to="loc_us-gaap_LossContingencyNatureDomain_07daddee-501d-4fe1-b8e4-9136eb2d33a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e695def3-106f-4e36-b165-3e0ddd723c03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_07daddee-501d-4fe1-b8e4-9136eb2d33a0" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e695def3-106f-4e36-b165-3e0ddd723c03" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" xlink:type="extended" id="i6d2339cceff0473ab2a15a47baa9ed49_LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7f8e50b8-f6a3-4dba-a31f-549054f8c7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_fbcc116a-7a77-4a35-94c9-9585fc8f806d" xlink:href="vtrs-20230331.xsd#vtrs_Numberofstates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7f8e50b8-f6a3-4dba-a31f-549054f8c7ba" xlink:to="loc_vtrs_Numberofstates_fbcc116a-7a77-4a35-94c9-9585fc8f806d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e59809d4-06db-40a7-a127-09acf53c215b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7f8e50b8-f6a3-4dba-a31f-549054f8c7ba" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e59809d4-06db-40a7-a127-09acf53c215b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5a25213f-0fa7-4596-9ab7-dfa7454b144c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_7f8e50b8-f6a3-4dba-a31f-549054f8c7ba" xlink:to="loc_us-gaap_LossContingenciesTable_5a25213f-0fa7-4596-9ab7-dfa7454b144c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9b428668-5cfe-4d39-a402-0d0602efd304" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5a25213f-0fa7-4596-9ab7-dfa7454b144c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9b428668-5cfe-4d39-a402-0d0602efd304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9b428668-5cfe-4d39-a402-0d0602efd304_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9b428668-5cfe-4d39-a402-0d0602efd304" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9b428668-5cfe-4d39-a402-0d0602efd304_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3a65523b-184b-4a79-9b7c-8ca686161e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9b428668-5cfe-4d39-a402-0d0602efd304" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3a65523b-184b-4a79-9b7c-8ca686161e2c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" xlink:type="extended" id="i0fc11e644d194e23a888436289b22da0_LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_07bff5a8-8622-4fb5-a624-dec60492a040" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_07bff5a8-8622-4fb5-a624-dec60492a040" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_83008cb5-600f-4542-a502-35d6172d601f" xlink:href="vtrs-20230331.xsd#vtrs_Numberofstates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:to="loc_vtrs_Numberofstates_83008cb5-600f-4542-a502-35d6172d601f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_a9f1554a-8263-438d-be94-3816aef11e41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:to="loc_us-gaap_LitigationReserve_a9f1554a-8263-438d-be94-3816aef11e41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8b551ed4-6d64-4fe4-8798-1dd22dce5951" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:to="loc_us-gaap_LossContingenciesTable_8b551ed4-6d64-4fe4-8798-1dd22dce5951" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_48f72d5a-006b-47a7-97ab-f432a5941335" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8b551ed4-6d64-4fe4-8798-1dd22dce5951" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_48f72d5a-006b-47a7-97ab-f432a5941335" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_48f72d5a-006b-47a7-97ab-f432a5941335_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_48f72d5a-006b-47a7-97ab-f432a5941335" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_48f72d5a-006b-47a7-97ab-f432a5941335_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2bd6494b-320f-42eb-9262-a8340ae78394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_48f72d5a-006b-47a7-97ab-f432a5941335" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2bd6494b-320f-42eb-9262-a8340ae78394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_25b00f77-97a1-4a50-abe3-2eb4fc15fd76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2bd6494b-320f-42eb-9262-a8340ae78394" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_25b00f77-97a1-4a50-abe3-2eb4fc15fd76" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationDrugPricingMattersDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationDrugPricingMattersDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationDrugPricingMattersDetails" xlink:type="extended" id="i3a004ad608564ebf9b0297aa430e963c_LitigationDrugPricingMattersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_bfec5a86-224e-4733-a66e-ca5fcdce6bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_dd69df04-e014-4570-aa6b-c752204fca28" xlink:href="vtrs-20230331.xsd#vtrs_Numberofstates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bfec5a86-224e-4733-a66e-ca5fcdce6bdd" xlink:to="loc_vtrs_Numberofstates_dd69df04-e014-4570-aa6b-c752204fca28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSought_3e599375-b6fb-401c-af46-b8237a5413dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSought"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bfec5a86-224e-4733-a66e-ca5fcdce6bdd" xlink:to="loc_us-gaap_LossContingencyDamagesSought_3e599375-b6fb-401c-af46-b8237a5413dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f8e4cd8d-ce8e-4a79-962e-38793c188acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_bfec5a86-224e-4733-a66e-ca5fcdce6bdd" xlink:to="loc_us-gaap_LossContingenciesTable_f8e4cd8d-ce8e-4a79-962e-38793c188acb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_656ae9ce-0439-4faa-88f0-d4c59cf90c3f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f8e4cd8d-ce8e-4a79-962e-38793c188acb" xlink:to="loc_srt_LitigationCaseAxis_656ae9ce-0439-4faa-88f0-d4c59cf90c3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_656ae9ce-0439-4faa-88f0-d4c59cf90c3f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_656ae9ce-0439-4faa-88f0-d4c59cf90c3f" xlink:to="loc_srt_LitigationCaseTypeDomain_656ae9ce-0439-4faa-88f0-d4c59cf90c3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_656ae9ce-0439-4faa-88f0-d4c59cf90c3f" xlink:to="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MultiDistrictLitigationMember_33feeccd-7bdf-4adc-bfeb-93ded63f8bf1" xlink:href="vtrs-20230331.xsd#vtrs_MultiDistrictLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:to="loc_vtrs_MultiDistrictLitigationMember_33feeccd-7bdf-4adc-bfeb-93ded63f8bf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_61e9f893-ad7e-4788-94b3-29036455fe4c" xlink:href="vtrs-20230331.xsd#vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:to="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_61e9f893-ad7e-4788-94b3-29036455fe4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_27c35824-52b0-46aa-8d8b-132bd4a57c20" xlink:href="vtrs-20230331.xsd#vtrs_AnticompetitiveConductwithGenericDrugsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:to="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_27c35824-52b0-46aa-8d8b-132bd4a57c20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_51583792-db95-4860-9fc9-ab2965db3700" xlink:href="vtrs-20230331.xsd#vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:to="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_51583792-db95-4860-9fc9-ab2965db3700" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ff81a5bd-c82d-4809-84b1-749d9c078e67" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f8e4cd8d-ce8e-4a79-962e-38793c188acb" xlink:to="loc_srt_CounterpartyNameAxis_ff81a5bd-c82d-4809-84b1-749d9c078e67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff81a5bd-c82d-4809-84b1-749d9c078e67_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ff81a5bd-c82d-4809-84b1-749d9c078e67" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff81a5bd-c82d-4809-84b1-749d9c078e67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c3aa332-dbf2-41fc-81f7-be4f2c796ea8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ff81a5bd-c82d-4809-84b1-749d9c078e67" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c3aa332-dbf2-41fc-81f7-be4f2c796ea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OcularASMember_7e2af4ef-69ab-4337-b129-84a5c91738b7" xlink:href="vtrs-20230331.xsd#vtrs_OcularASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c3aa332-dbf2-41fc-81f7-be4f2c796ea8" xlink:to="loc_vtrs_OcularASMember_7e2af4ef-69ab-4337-b129-84a5c91738b7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationEuropeanCommissionProceedingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails" xlink:type="extended" id="icd8ebe4b698640cd84baf43513fa43b7_LitigationEuropeanCommissionProceedingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b4567c5e-358b-4e5e-9e71-6c6cdbc4f966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_b0bdadb1-d281-4834-bbfe-5608eaccf212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4567c5e-358b-4e5e-9e71-6c6cdbc4f966" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_b0bdadb1-d281-4834-bbfe-5608eaccf212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d4341626-a27e-40af-94b2-97b580115f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4567c5e-358b-4e5e-9e71-6c6cdbc4f966" xlink:to="loc_us-gaap_LossContingenciesTable_d4341626-a27e-40af-94b2-97b580115f6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_347cf32f-afc3-4a2b-a2cd-faef53c1ce7c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d4341626-a27e-40af-94b2-97b580115f6a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_347cf32f-afc3-4a2b-a2cd-faef53c1ce7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_347cf32f-afc3-4a2b-a2cd-faef53c1ce7c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_347cf32f-afc3-4a2b-a2cd-faef53c1ce7c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_347cf32f-afc3-4a2b-a2cd-faef53c1ce7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_aa6fc744-ae34-4ac6-9844-3d5f33185c55" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_347cf32f-afc3-4a2b-a2cd-faef53c1ce7c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_aa6fc744-ae34-4ac6-9844-3d5f33185c55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8480bf8f-6df7-4858-b87e-0f833a2fdb0e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aa6fc744-ae34-4ac6-9844-3d5f33185c55" xlink:to="loc_srt_ParentCompanyMember_8480bf8f-6df7-4858-b87e-0f833a2fdb0e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" xlink:type="extended" id="if518a70d5d8d42fa8fb20dfbaf4c7268_LitigationUKCompetitionandMarketsAuthorityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_79376e0a-a9c2-4a91-ad00-fb79c8f744f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_cf2c96bb-3035-4754-8152-4987293fd28b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_79376e0a-a9c2-4a91-ad00-fb79c8f744f7" xlink:to="loc_us-gaap_LitigationReserve_cf2c96bb-3035-4754-8152-4987293fd28b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_79376e0a-a9c2-4a91-ad00-fb79c8f744f7" xlink:to="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_1e9b8ee1-a154-46dc-870c-78e8174dbb33" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:to="loc_srt_LitigationCaseAxis_1e9b8ee1-a154-46dc-870c-78e8174dbb33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1e9b8ee1-a154-46dc-870c-78e8174dbb33_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_1e9b8ee1-a154-46dc-870c-78e8174dbb33" xlink:to="loc_srt_LitigationCaseTypeDomain_1e9b8ee1-a154-46dc-870c-78e8174dbb33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a0744d01-1593-473d-8b53-c559be8b18ac" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_1e9b8ee1-a154-46dc-870c-78e8174dbb33" xlink:to="loc_srt_LitigationCaseTypeDomain_a0744d01-1593-473d-8b53-c559be8b18ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CitalopramLitigationMember_b975c4cd-4ef6-464e-8e60-b3952f02808a" xlink:href="vtrs-20230331.xsd#vtrs_CitalopramLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a0744d01-1593-473d-8b53-c559be8b18ac" xlink:to="loc_vtrs_CitalopramLitigationMember_b975c4cd-4ef6-464e-8e60-b3952f02808a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9b06d38b-9f67-43c2-904a-f8b2406bc84d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9b06d38b-9f67-43c2-904a-f8b2406bc84d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9b06d38b-9f67-43c2-904a-f8b2406bc84d_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9b06d38b-9f67-43c2-904a-f8b2406bc84d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9b06d38b-9f67-43c2-904a-f8b2406bc84d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ce08da91-e934-4b54-9e30-df46dff6c9cf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9b06d38b-9f67-43c2-904a-f8b2406bc84d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ce08da91-e934-4b54-9e30-df46dff6c9cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_3d77492a-6336-403a-92cd-9048980e8bc8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ce08da91-e934-4b54-9e30-df46dff6c9cf" xlink:to="loc_srt_ParentCompanyMember_3d77492a-6336-403a-92cd-9048980e8bc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3523fba1-c0e1-4931-a1e9-2a3ee3383c36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3523fba1-c0e1-4931-a1e9-2a3ee3383c36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_3523fba1-c0e1-4931-a1e9-2a3ee3383c36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3523fba1-c0e1-4931-a1e9-2a3ee3383c36" xlink:to="loc_us-gaap_LossContingencyNatureDomain_3523fba1-c0e1-4931-a1e9-2a3ee3383c36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_713804dd-1f2c-4d31-8e8e-06e239ba808f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3523fba1-c0e1-4931-a1e9-2a3ee3383c36" xlink:to="loc_us-gaap_LossContingencyNatureDomain_713804dd-1f2c-4d31-8e8e-06e239ba808f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember_bbc0d224-8fc2-45ca-92f0-d9cebc7fb147" xlink:href="vtrs-20230331.xsd#vtrs_ProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_713804dd-1f2c-4d31-8e8e-06e239ba808f" xlink:to="loc_vtrs_ProductLiabilityMember_bbc0d224-8fc2-45ca-92f0-d9cebc7fb147" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationProductLiabilityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails" xlink:type="extended" id="i9e766177f08e47398d5c3a474c01c662_LitigationProductLiabilityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d4cf603b-f6da-44ac-8ca9-d2e364a2f473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5e8a1293-d3f4-490f-9c1f-3d1b51dec7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d4cf603b-f6da-44ac-8ca9-d2e364a2f473" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5e8a1293-d3f4-490f-9c1f-3d1b51dec7ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f133f5a9-64e1-4362-b130-c5a326673c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_d4cf603b-f6da-44ac-8ca9-d2e364a2f473" xlink:to="loc_us-gaap_LossContingenciesTable_f133f5a9-64e1-4362-b130-c5a326673c6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d45cb1ab-dc9e-463d-a768-56a6c6eec05f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f133f5a9-64e1-4362-b130-c5a326673c6c" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d45cb1ab-dc9e-463d-a768-56a6c6eec05f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d45cb1ab-dc9e-463d-a768-56a6c6eec05f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d45cb1ab-dc9e-463d-a768-56a6c6eec05f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d45cb1ab-dc9e-463d-a768-56a6c6eec05f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_dcc88f68-8bef-4f09-bbd1-b8a1a915a030" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d45cb1ab-dc9e-463d-a768-56a6c6eec05f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_dcc88f68-8bef-4f09-bbd1-b8a1a915a030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember_8c3d7a85-d50b-4c3a-b4ca-74841fccb49a" xlink:href="vtrs-20230331.xsd#vtrs_ProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_dcc88f68-8bef-4f09-bbd1-b8a1a915a030" xlink:to="loc_vtrs_ProductLiabilityMember_8c3d7a85-d50b-4c3a-b4ca-74841fccb49a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationIntellectualPropertyNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails" xlink:type="extended" id="i80402e2c80404388b1d22648923b28dd_LitigationIntellectualPropertyNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_529a3048-f338-4294-ac13-0d5f55257dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_529a3048-f338-4294-ac13-0d5f55257dd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfScottishHealthBoardsNHSScotland_b1fd1075-83b6-4281-911e-823b0fd8bb38" xlink:href="vtrs-20230331.xsd#vtrs_NumberOfScottishHealthBoardsNHSScotland"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:to="loc_vtrs_NumberOfScottishHealthBoardsNHSScotland_b1fd1075-83b6-4281-911e-823b0fd8bb38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland_ca77392f-809b-4d8b-ab7d-aa5756681019" xlink:href="vtrs-20230331.xsd#vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:to="loc_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland_ca77392f-809b-4d8b-ab7d-aa5756681019" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c32826b9-5c7c-4978-bc6c-1a156eb06960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:to="loc_us-gaap_LossContingenciesTable_c32826b9-5c7c-4978-bc6c-1a156eb06960" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cbc1ad85-72c3-4f28-827f-fa0eb05e694d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c32826b9-5c7c-4978-bc6c-1a156eb06960" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cbc1ad85-72c3-4f28-827f-fa0eb05e694d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_cbc1ad85-72c3-4f28-827f-fa0eb05e694d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cbc1ad85-72c3-4f28-827f-fa0eb05e694d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_cbc1ad85-72c3-4f28-827f-fa0eb05e694d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_adb040dc-1408-4523-92e0-51429c579d93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cbc1ad85-72c3-4f28-827f-fa0eb05e694d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_adb040dc-1408-4523-92e0-51429c579d93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a963ff45-a1d1-4fd3-9249-5ab745ae37a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_adb040dc-1408-4523-92e0-51429c579d93" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a963ff45-a1d1-4fd3-9249-5ab745ae37a8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationOtherLitigationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails" xlink:type="extended" id="ibfbb40e0a90a4327b1eb6cab3bd5a72b_LitigationOtherLitigationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofcases_3bd66ad5-d73e-46e2-9164-11d0f0b4b132" xlink:href="vtrs-20230331.xsd#vtrs_Numberofcases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:to="loc_vtrs_Numberofcases_3bd66ad5-d73e-46e2-9164-11d0f0b4b132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_60d83c85-b0fc-4f7c-afa5-903e355c884f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_60d83c85-b0fc-4f7c-afa5-903e355c884f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_ee19f9ae-08c6-4a30-8865-a0b5df566d15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:to="loc_us-gaap_LitigationReserve_ee19f9ae-08c6-4a30-8865-a0b5df566d15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_67b052c1-4d60-46f5-97b7-0f45d253cc44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:to="loc_us-gaap_LossContingenciesTable_67b052c1-4d60-46f5-97b7-0f45d253cc44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_fd6d5870-b607-4220-a03e-abbf9083521f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_67b052c1-4d60-46f5-97b7-0f45d253cc44" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_fd6d5870-b607-4220-a03e-abbf9083521f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_fd6d5870-b607-4220-a03e-abbf9083521f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_fd6d5870-b607-4220-a03e-abbf9083521f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_fd6d5870-b607-4220-a03e-abbf9083521f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_817a919c-a5b3-4f55-ab1f-e8ae66b078d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_fd6d5870-b607-4220-a03e-abbf9083521f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_817a919c-a5b3-4f55-ab1f-e8ae66b078d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember_f0b26970-4b2e-4169-9215-5f263a5ed976" xlink:href="vtrs-20230331.xsd#vtrs_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_817a919c-a5b3-4f55-ab1f-e8ae66b078d6" xlink:to="loc_vtrs_OtherMember_f0b26970-4b2e-4169-9215-5f263a5ed976" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>vtrs-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4f7b9844-2b6e-46d6-b212-7616af324858,g:ca8e76fc-c8f0-4b96-ac37-00e89e4a2911-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_vtrs_XalabrandsMember_5a528c33-d31d-4363-b024-3e1dbe662cf4_terseLabel_en-US" xlink:label="lab_vtrs_XalabrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xalabrands</link:label>
    <link:label id="lab_vtrs_XalabrandsMember_label_en-US" xlink:label="lab_vtrs_XalabrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xalabrands [Member]</link:label>
    <link:label id="lab_vtrs_XalabrandsMember_documentation_en-US" xlink:label="lab_vtrs_XalabrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xalabrands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XalabrandsMember" xlink:href="vtrs-20230331.xsd#vtrs_XalabrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_XalabrandsMember" xlink:to="lab_vtrs_XalabrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_c37d4cc8-837d-4f15-96f7-df70f88beed3_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_dc0bc2bb-3740-4f71-a06c-6a2f9ce19c8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_ea36f3d0-873e-440f-9a56-bb4dd745a692_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term obligations</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_fb04cd96-07cf-42ee-84cb-273c3bdf2ac2_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_ad17c2a4-8950-4d20-95c1-4d11e38f0858_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_68a085db-8f29-4cac-863e-59e472506794_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_7964e433-52ff-4010-8239-ecb0f6ab8012_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_d46580f5-ed66-4741-92ba-956a368308c8_negatedLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_66189ed6-e7c1-4fac-84bd-a25197af8616_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_743f0dcf-596c-4cdb-9a85-c8f8e82840c1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option award expiration period, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ab5966e-fa42-4b67-8bbc-9601f8a89aeb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_30dcb7d3-e511-424f-b2a4-6efdc629f910_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a71661ad-1051-44fd-8c47-7d17d4320dfe_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, nonvested beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_78f507cf-04fa-4a84-a969-b1a513564b61_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, nonvested end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_f5da25c5-28e9-4076-91d6-f8fa74f65422_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_e8bb9c6f-1050-40ed-8620-7e9e92385bc0_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_7537abbc-7ed0-4597-a9fe-af7134b6ecab_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_37d27b6a-5652-45ba-a13b-55e03976e840_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_aa937ce2-50e3-4181-af4b-b82c232fd83f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_2137eca2-edb3-49c2-b2f6-c3517e77d2ab_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6d40fe0b-cbb6-4860-90a0-3b83fbf946de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_30fb68b3-f285-4dc7-a7e2-661b35cb8a9e_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_90823607-1943-4b17-8b68-2d3558a645fb_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on cash of changes in exchange rates</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_64187144-5d4f-4773-a4a8-655462955ac4_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Senior Notes (3.125% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyThree3.125Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand twenty three - 3.125 percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_efe0f03d-d8c4-4ded-925a-c7dc11a6a136_terseLabel_en-US" xlink:label="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan</link:label>
    <link:label id="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_label_en-US" xlink:label="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member]</link:label>
    <link:label id="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:href="vtrs-20230331.xsd#vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:to="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f093a043-4247-407d-8bec-05386855f67b_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_902120d5-6f56-4be1-bae6-acbc5c06537a_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_50c75a12-55ef-4124-8baa-392f1b7d3193_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write down of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_7982ba5d-e929-4360-8d53-9829b2fcddc9_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_YupelriMember_afd781c6-d349-463f-a873-b71830b04157_terseLabel_en-US" xlink:label="lab_vtrs_YupelriMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yupelri &#174;</link:label>
    <link:label id="lab_vtrs_YupelriMember_label_en-US" xlink:label="lab_vtrs_YupelriMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yupelri &#174; [Member]</link:label>
    <link:label id="lab_vtrs_YupelriMember_documentation_en-US" xlink:label="lab_vtrs_YupelriMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yupelri &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YupelriMember" xlink:href="vtrs-20230331.xsd#vtrs_YupelriMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_YupelriMember" xlink:to="lab_vtrs_YupelriMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_7d92f9c9-640b-455d-a359-aaadea8be86d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_91bc3a03-1dbb-4e96-a66e-0b38f73d19a2_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term for stock awards exercisable, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3ca99ed2-8f69-44c2-92b9-fa00a7285c23_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_9c4a522b-00cb-43ae-936a-4e424cdec62b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pension, Postretirement and Supplemental Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dd8969fc-aa38-46d1-b950-3838e7a95b01_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_3d5492a6-ecc2-4cd2-a682-897bf97a8114_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of terminated interest rate swaps</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_05dfc5ee-0b9b-4ce3-9eb5-e2158e14b2c9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset disposal &amp; impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_94b9c447-11c3-4e00-a9ea-cbc3a688908d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5e8849b3-6c70-4f2d-9bcd-4e61d311ce96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_f4196908-ffe9-484b-a71d-972b3cbebd3c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_53eec4a8-36a6-4d39-a1ef-0738589d95e2_terseLabel_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Partial Payment Of Income Tax Expense</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_label_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Partial Payment Of Income Tax Expense</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_documentation_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Partial Payment Of Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:href="vtrs-20230331.xsd#vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:to="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_babb57d4-3e73-4d39-abe8-ebef27febbdf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_93249965-9d83-4d13-9f56-0f569bbfd9ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_fec45c86-6198-4139-8d95-04d270dcac12_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ea723d7e-e801-4a0f-921e-85943be5ede7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2032EuroSeniorNotesMember_40e379d3-623a-489d-aa32-d24a834efde9_terseLabel_en-US" xlink:label="lab_vtrs_A2032EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2032 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2032EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2032EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2032 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2032EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2032EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2032 Euro Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2032EuroSeniorNotesMember" xlink:to="lab_vtrs_A2032EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember_31b505fa-56e2-4bc4-8c11-c17ad751ebac_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2043 Senior Notes (5.400% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortyThree [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand forty three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandFortyThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_3b68afaa-a9cb-4486-a269-6869bbfa0427_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ViagraMember_a1bcc0a6-01f2-4d70-882b-7bc9780ff41a_terseLabel_en-US" xlink:label="lab_vtrs_ViagraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viagra &#174;</link:label>
    <link:label id="lab_vtrs_ViagraMember_label_en-US" xlink:label="lab_vtrs_ViagraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viagra &#174; [Member]</link:label>
    <link:label id="lab_vtrs_ViagraMember_documentation_en-US" xlink:label="lab_vtrs_ViagraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viagra &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViagraMember" xlink:href="vtrs-20230331.xsd#vtrs_ViagraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ViagraMember" xlink:to="lab_vtrs_ViagraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_490520a8-441a-4daa-86fc-5ed30a230a72_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f7f36f5e-7655-4f79-b5a8-cc3103817992_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f3e39250-093e-4ce8-99c3-37c3d13d1b8f_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAbstract_3e2b6a74-4a9f-4032-af1a-8b38a408c967_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_dddfa6de-4354-4240-9a35-df7b90990e97_terseLabel_en-US" xlink:label="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</link:label>
    <link:label id="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_label_en-US" xlink:label="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</link:label>
    <link:label id="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_documentation_en-US" xlink:label="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:href="vtrs-20230331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:to="lab_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_b67188ca-671c-43d7-9188-7f4935d9a09a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_69ddbf6f-00a8-4dad-a31a-cdad5bca539d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProgramNameAxis_1091738b-6fbf-4d66-acef-48a714d85cbf_terseLabel_en-US" xlink:label="lab_vtrs_ProgramNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Axis]</link:label>
    <link:label id="lab_vtrs_ProgramNameAxis_label_en-US" xlink:label="lab_vtrs_ProgramNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Axis]</link:label>
    <link:label id="lab_vtrs_ProgramNameAxis_documentation_en-US" xlink:label="lab_vtrs_ProgramNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis" xlink:href="vtrs-20230331.xsd#vtrs_ProgramNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProgramNameAxis" xlink:to="lab_vtrs_ProgramNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_50d0f768-62af-431e-95c5-32367dc9f9a5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_52af70b0-afdc-4e7b-abf0-0d5c482016b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_b520b997-b582-40d5-a6a2-9d53e126edbe_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bf82df2d-753f-4081-8cad-857db29ebdd1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b056d4fd-bec6-4b98-973a-8c6839c28642_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per ordinary share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_295485e2-7201-4fbe-be73-40a7b825ed26_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9dec3915-3503-4177-b096-02c4e3c4fa24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_ec7ad80a-a5f7-4259-abef-d0100f5f2bc5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Treasury stock &#8212; at cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_692959c0-a376-47e6-b19f-bf1d357d5227_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_67d8e835-bbe3-41b2-9db0-16a53a1c51b5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_1ca7ce1e-07ac-4f16-80b6-23b9b68ddabc_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_466f7c66-7654-46ec-a5c9-b5729bab4a85_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_db3fae59-4704-447e-9e55-887040ba0264_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange derivative liabilities</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EpiPenAutoInjectorsMember_6663799e-6324-46ca-aae7-7dbd57bff4b6_terseLabel_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen&#174; Auto-Injectors</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorsMember_label_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen&#174; Auto-Injectors [Member]</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorsMember_documentation_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen&#174; Auto-Injectors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorsMember" xlink:href="vtrs-20230331.xsd#vtrs_EpiPenAutoInjectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EpiPenAutoInjectorsMember" xlink:to="lab_vtrs_EpiPenAutoInjectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_8f2adde3-5c89-411a-b71c-dfc16bf7df85_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_6d7fcafc-b5cf-4f94-b891-609622fee1a4_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_03d2e882-28df-4800-b219-9a4c043bbfaf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_8bc9329d-7f35-412b-b4bd-0650cecdea83_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_01cb309d-bcbe-43dc-a8db-203436b890fe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_01d3f5ba-2d33-4575-a6e8-570e774b627b_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_79611126-f98b-4105-a869-91578c737fb5_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_ed443771-5ff7-4200-b3a3-73d11e516310_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1dcbca37-cfe1-47e3-a022-af20457811df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_08814740-57f5-48dd-9fbb-f8453573914c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_f9468365-cc0b-408c-a2c0-51b7fdd34d65_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1d7ace04-fb71-4a1b-bfdc-dcb7103e8937_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss) before reclassifications, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_6cbc3d39-b603-4f50-a6b9-180254823d89_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_368588db-34c3-4756-9b3a-0851f04f8e33_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5012985d-0786-4d95-8748-3770b89a3344_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_defa3d28-af62-435e-8651-da069ad3bebe_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e4176347-6caa-4d80-8d16-1b70759daaef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_91007fab-a9c9-4c9a-8c27-eab7a5c385bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_40ebfc62-bd39-455e-96d3-1eaf1c06d8ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_11f70faf-c88f-45d6-9c48-73ea2a70b198_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale fixed income investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_023e9e11-f396-4ee0-909b-3743522803fc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_9c0a9477-fe5f-430a-a8aa-36c0bb4b930a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_8b8fd658-6f24-4fb9-bf9e-dcda73205871_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_eadc624c-c085-42ad-8bd8-9747a6fc0cd9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_50e5801e-6110-4ea1-a38e-619cf8d9382b_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0a2ffe13-2b25-41f0-81ce-6b360a7bec0a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_22f4af1b-4ca2-4632-968f-99caed1000c3_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d0aedf07-c780-4aba-84ba-fc57f1dedc89_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross, excluding goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_821aef40-7cdc-43f8-9b9f-14573e32a803_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_9dd56bc3-3b6c-4a41-ac6d-f53808cec96e_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_3ec39f46-3347-4ae4-bd7c-750266695daf_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3c81759c-a2eb-497f-842b-e7834d2cef90_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_a227d238-7930-487e-8da5-4c65ddf92b46_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01c95196-1506-42d5-904c-088f1b173d60_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b00af0fa-75a7-48ce-b005-1c73709e4e1e_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viatris Inc. shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d1161944-bb39-4238-89ec-a8da938e2ffe_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cf4fc51f-7318-4788-99cb-b5b583763846_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_12a3486e-bea0-417a-86c3-d47888e33b7f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gain on derivatives in cash flow hedging relationships</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020EuroSeniorNotesMember_30593218-ff1b-448e-9035-1f95d9707de0_terseLabel_en-US" xlink:label="lab_vtrs_A2020EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2020EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2020EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2020EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2020EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020EuroSeniorNotesMember" xlink:to="lab_vtrs_A2020EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_74a5fcda-ae75-4e94-b6e0-5a79a83e9170_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V.</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_2dc3adc4-846c-4854-ae57-262f6d64e6c7_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_ef53d182-58fc-4a1c-9790-73adf3037ebf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_6f87115d-1eff-4d33-9b25-16e2d9fbe3a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f76740cd-e88f-4aa2-b4dd-2f18f9ad2b02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option award vesting period, in years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_fb4cde56-b2ec-48ac-bf4d-7ebb8939d40b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d7b2bfe4-edaa-49f5-a793-896a3b354c42_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_666812b6-6d43-4581-bd9b-b42bc1eb8770_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_13b7f2c5-bb77-4291-a198-3d59a67b9b7a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5edb5133-042e-4939-b4aa-8a552550fa15_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_54920619-26e8-4779-8a1e-80a90d7e16eb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_25d0437b-8e88-4f84-825d-6610daf450b3_terseLabel_en-US" xlink:label="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable securitization facility maximum borrowing capacity</link:label>
    <link:label id="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Facility Maximum Borrowing Capacity</link:label>
    <link:label id="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable facility maximum borrowing capacity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:href="vtrs-20230331.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:to="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9c636fd6-43d9-4e26-85be-3be2ecd7b945_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_32aebac3-ce55-41f3-9c23-5497f41035a8_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and technologies</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_a05e4902-a5cb-460a-8267-1c184382aaa2_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_e913dcb0-e6b2-4597-8191-389b377e5202_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_20db8bb2-ef8c-4a8b-a10f-b884cc1a5cf1_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_f01902e6-24b2-4346-a3f6-729ab0f96709_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_cc68b7b6-3573-4230-9e87-18e45951f55f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_80a6a780-2468-4c31-a151-62c591e2c37e_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_298f7b0e-9a59-4b62-8d1e-dd499023446f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b01022e2-5029-4488-b52d-7ad78ac0658c_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_ae56d69e-a1d9-4150-bba2-675455b3079f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d2f4ec03-05d7-483e-9edd-3e99c56c08f0_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_8a08b47e-0cdc-448b-978d-fbe241e5acaa_negatedLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_UpjohnDistributorMarketsMember_3e9c3511-0e35-4b5f-bb53-d1849075b9a5_terseLabel_en-US" xlink:label="lab_vtrs_UpjohnDistributorMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Distributor Markets</link:label>
    <link:label id="lab_vtrs_UpjohnDistributorMarketsMember_label_en-US" xlink:label="lab_vtrs_UpjohnDistributorMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Distributor Markets [Member]</link:label>
    <link:label id="lab_vtrs_UpjohnDistributorMarketsMember_documentation_en-US" xlink:label="lab_vtrs_UpjohnDistributorMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Distributor Markets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnDistributorMarketsMember" xlink:href="vtrs-20230331.xsd#vtrs_UpjohnDistributorMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_UpjohnDistributorMarketsMember" xlink:to="lab_vtrs_UpjohnDistributorMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_dc99d34b-78bd-4e62-91e4-7936108ae7ad_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3393d283-1a4d-43e9-b66a-7648e47a31df_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_04165cb0-fcf7-47c1-996d-a37e327c1873_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020RestructuringPlanMember_cf7c713a-89d8-40f4-8b65-bac6fd28f841_terseLabel_en-US" xlink:label="lab_vtrs_A2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:label id="lab_vtrs_A2020RestructuringPlanMember_label_en-US" xlink:label="lab_vtrs_A2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan [Member]</link:label>
    <link:label id="lab_vtrs_A2020RestructuringPlanMember_documentation_en-US" xlink:label="lab_vtrs_A2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RestructuringPlanMember" xlink:href="vtrs-20230331.xsd#vtrs_A2020RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020RestructuringPlanMember" xlink:to="lab_vtrs_A2020RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_2e048e64-a578-45df-8c70-6a43428f734b_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligation_be51e72b-d642-4091-bd7a-ac5320e5d2cb_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due for supplier finance program</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligation_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program, Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierFinanceProgramObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligation" xlink:to="lab_us-gaap_SupplierFinanceProgramObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_cc97bae3-07a7-4514-90c4-3f2ed29c220e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c20fb5c6-4779-43b2-90d3-056a6e1f9ede_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_e592c333-e19d-4b57-b280-786df1b9f44f_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0b7d6ff4-34ab-477c-aecb-2fba5a1b24c2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_bd629cbc-876c-4ae8-812b-1c62933c85ca_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_ddebab80-9e6c-4760-8beb-014d28e72b55_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock and Restricted Stock Unit Awards Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_fef5521c-3a51-4fc1-80cd-8fb50f3ed099_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherCurrentPortionofLongtermDebtMember_b7de4c9c-2be9-45f6-b952-a1034189b7a4_terseLabel_en-US" xlink:label="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Portion of Long-term Debt</link:label>
    <link:label id="lab_vtrs_OtherCurrentPortionofLongtermDebtMember_label_en-US" xlink:label="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Portion of Long-term Debt [Member]</link:label>
    <link:label id="lab_vtrs_OtherCurrentPortionofLongtermDebtMember_documentation_en-US" xlink:label="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Portion of Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:href="vtrs-20230331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:to="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_e6b9bda1-c519-4621-89a6-440658e1ba79_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_9c9b63f1-cbeb-49f3-bfaa-db7e5dae8285_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_3138e80e-1c40-447c-8476-9dd1a207b965_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2f1ac4eb-a390-4f35-940a-bdb3ee2f0cbf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ac48ef8a-8b83-4e75-966b-772184d6e26d_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07123998-c3c8-4d31-bee6-3b057eb554aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_c9cc52c5-1fb7-417b-ad98-6faa6c4f7300_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes related to the net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_2f3f85a0-0332-4949-86db-1db80acf2fcc_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Numberofcases_2f7b862f-6cc8-498a-991d-4657e7f9e98b_terseLabel_en-US" xlink:label="lab_vtrs_Numberofcases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_vtrs_Numberofcases_label_en-US" xlink:label="lab_vtrs_Numberofcases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_vtrs_Numberofcases_documentation_en-US" xlink:label="lab_vtrs_Numberofcases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofcases" xlink:href="vtrs-20230331.xsd#vtrs_Numberofcases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Numberofcases" xlink:to="lab_vtrs_Numberofcases" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember_529c0d4f-a224-4fd2-adff-44207156c389_terseLabel_en-US" xlink:label="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JANZ</link:label>
    <link:label id="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember_label_en-US" xlink:label="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia and New Zealand Segment [Member]</link:label>
    <link:label id="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember_documentation_en-US" xlink:label="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia and New Zealand Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:to="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_6112a34e-8e3a-4a32-b375-432d539bf472_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_94335143-70ca-422d-adaf-064d4d6149cb_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_0ab5b020-40f6-476b-834c-859ee9ad8f7f_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_9653deab-2dce-409a-8bf5-7a7043151299_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_2651b1cd-900d-4e31-b5b0-d0a03b2c6ca4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df6ffb6e-7220-4107-8ec0-49494acc28bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesTable_754bcd7e-9250-46af-973a-0f123cc89000_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesTable_label_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofothercurrentliabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:to="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_c3941c0a-a9bc-47d3-8d40-2fae1191d57c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_32e99044-469f-4cac-a162-48b682e99d5e_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_96c09007-b986-4560-845c-10498ae2f8a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_94f8dd51-e263-4fcc-a854-029381bf69f0_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fae00ef9-eb4b-4510-8e89-1cdd7bcbe39c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_ceaef824-cf07-46e6-ab3b-b19882c3ed2f_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_c0b69bea-97f5-4ada-8b0e-5af2a0d33eed_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_StockholdersEquityParentBeforeTreasuryStock_a9858e7d-a679-4875-9794-44f873d46ff1_totalLabel_en-US" xlink:label="lab_vtrs_StockholdersEquityParentBeforeTreasuryStock" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Viatris Inc. equity, before treasury stock</link:label>
    <link:label id="lab_vtrs_StockholdersEquityParentBeforeTreasuryStock_label_en-US" xlink:label="lab_vtrs_StockholdersEquityParentBeforeTreasuryStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity Parent Before Treasury Stock</link:label>
    <link:label id="lab_vtrs_StockholdersEquityParentBeforeTreasuryStock_documentation_en-US" xlink:label="lab_vtrs_StockholdersEquityParentBeforeTreasuryStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings that are attributable to the parent company, excluding equity attributable to noncontrolling interests, and before deducting the carrying value of treasury stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock" xlink:href="vtrs-20230331.xsd#vtrs_StockholdersEquityParentBeforeTreasuryStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock" xlink:to="lab_vtrs_StockholdersEquityParentBeforeTreasuryStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_f40d8dc9-03e2-48a4-9d3a-bb98ca1f071b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_32d28d02-75d3-4279-9662-8ab0ed77707b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_24f8aaf2-478f-496c-b8f0-4da11794751f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bbb3c7ac-d152-47d6-9e68-e95bc11fa06e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f618635e-a623-4422-9b06-058e32c45160_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_a382b11e-3086-429c-8bcf-c6d6284aa5fe_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_7e82253a-84db-495c-ad06-fd4e0e64abed_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_label_en-US" xlink:label="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block]</link:label>
    <link:label id="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_documentation_en-US" xlink:label="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:to="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_cc8b3960-9859-430a-95aa-b54524f5b109_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_222e0610-17d0-4446-bb1e-bb9a8e3a33fc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_183da4b7-6079-41af-8742-94c2bf60fe77_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f19332a-07c8-470d-8138-645f2000bf42_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7bac66f5-10eb-4fb9-b619-0a31423b222a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares reserved for issuance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_e0fe36cc-5d04-4ba6-bf25-5c123f75d250_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_275dc41a-eec1-446b-95cf-1884cca7ef70_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_9bb3adac-c1de-449d-95e3-339f60e5e6cb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_104bf3fe-19ca-4fe2-98d0-9b1826290268_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term for stock awards outstanding, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_089052c1-d2de-454c-a4fc-f6dfa1e87d64_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Additional Capital</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d6491a49-1861-4047-8276-68f259cc191f_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_c07fc13e-af33-4a4b-b916-f9cb02036fcc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue_0f3d11dc-b50c-4d75-baf6-9b9809f1c8bb_terseLabel_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Consideration Due</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue_label_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Consideration Due</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue_documentation_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Consideration Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" xlink:to="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7d25c6ef-ef13-41fd-8200-1285339042af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_86d4eba7-8dcd-4d57-8615-41a9a0d85066_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_75d7fe2f-d8a5-481b-9521-1a19becb8e4d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a20de144-1459-4209-99c1-79ba48c24ae3_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1321c4fb-7978-4ee9-b9b8-dbf4d734c9bf_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_beff03ca-b005-4bf3-81ae-4f1007b62a9b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyEightMember_de127b4e-f302-463c-b34d-dce1baeba70b_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes (5.200%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyEightMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortyEight [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyEightMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortyEight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandFortyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandFortyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_08883308-00cf-4d0b-b6c5-e8d15916de31_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2b0bf57a-dfc1-492c-865e-162699cb2b29_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_1afb7a82-1f7b-4280-90ee-66a42f085242_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1f4724ed-3aac-4944-85bf-0675cc1bd4cc_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_6e0f5a89-72a4-4ac3-a8c9-0f76c60378db_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Marketable Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenseMember_7e553464-c168-413b-9532-e304ea3eef9d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenseMember" xlink:to="lab_us-gaap_OtherExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm_3e78bf0e-be31-4263-9f53-1589ce2baf18_terseLabel_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm_label_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm_documentation_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm" xlink:to="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2025EuroSeniorNotesMember_e21f6522-47f6-4f05-af89-9ed6c9aad21e_terseLabel_en-US" xlink:label="lab_vtrs_A2025EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Euro Senior Notes due 2025</link:label>
    <link:label id="lab_vtrs_A2025EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2025EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2025EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2025EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2025EuroSeniorNotesMember" xlink:to="lab_vtrs_A2025EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_891f4910-15f8-4a66-abb1-752fa403d09a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d0d38b02-e3c9-40b3-8a96-42a3cf6a0336_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization_8517d356-cf72-4e83-a27b-82f92571854c_terseLabel_en-US" xlink:label="lab_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization_label_en-US" xlink:label="lab_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization_documentation_en-US" xlink:label="lab_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization" xlink:href="vtrs-20230331.xsd#vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization" xlink:to="lab_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7ef88a83-7246-40ea-91d9-ed395db3f121_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_66447b35-a8b0-439d-93b8-4e4304c97ceb_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Senior Notes (3.950% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentySix3.95Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Senior Notes 3.950%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessAcquisitionContingentConsiderationPerShare_d33491fe-c53f-4b4c-bd0b-9be6a26d8a4a_terseLabel_en-US" xlink:label="lab_vtrs_BusinessAcquisitionContingentConsiderationPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Per Share</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionContingentConsiderationPerShare_label_en-US" xlink:label="lab_vtrs_BusinessAcquisitionContingentConsiderationPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Per Share</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionContingentConsiderationPerShare_documentation_en-US" xlink:label="lab_vtrs_BusinessAcquisitionContingentConsiderationPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionContingentConsiderationPerShare" xlink:href="vtrs-20230331.xsd#vtrs_BusinessAcquisitionContingentConsiderationPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessAcquisitionContingentConsiderationPerShare" xlink:to="lab_vtrs_BusinessAcquisitionContingentConsiderationPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_106ee71a-c06e-428b-bd9c-6c591c405778_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_9f04d135-3b83-49af-9e80-0ecb24e45c99_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net book value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_25cdbeaf-4d8c-478b-afc7-9a473f04299d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_c7d6326e-5826-4955-b59f-e698e2d5687f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_7d8b27ff-f7a7-45d9-b4bc-4fb8f629ffbb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_170dcb1a-c896-411e-80f5-34e33d25c68e_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d208089d-5fbc-4e85-8447-290cb51254a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_85b02e18-54cb-467e-938e-f10a05a0afaa_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_6471a088-c76d-478e-bbb5-6e6601beb3e0_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized losses on derivatives in net investment hedging relationships, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_49a6ed90-d1c9-44f3-9c44-78210c71476b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_92a59e2b-d009-4e20-bfdd-6dd060200541_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash &#8212; beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc071b24-0746-44e0-b7ca-fba3a55f324f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash &#8212; end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5fd6d554-ea46-4c0e-b7c7-2f06cf73480f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dfa870ce-26e6-4f65-be36-190937b36c14_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_9ff70276-b8cf-46ad-8d04-794601d599f2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2500eb30-1d3e-41a1-8e18-c6be0cec2cb3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock and stock options exercised, net</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_c1fff15d-085c-4818-a303-d1f6a0941556_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NoteSecuritizationFacilityMember_6e074c3f-26a8-4ad6-ad22-de3def9e69f3_terseLabel_en-US" xlink:label="lab_vtrs_NoteSecuritizationFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Securitization Facility</link:label>
    <link:label id="lab_vtrs_NoteSecuritizationFacilityMember_label_en-US" xlink:label="lab_vtrs_NoteSecuritizationFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Securitization Facility [Member]</link:label>
    <link:label id="lab_vtrs_NoteSecuritizationFacilityMember_documentation_en-US" xlink:label="lab_vtrs_NoteSecuritizationFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Securitization Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember" xlink:href="vtrs-20230331.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NoteSecuritizationFacilityMember" xlink:to="lab_vtrs_NoteSecuritizationFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CitalopramLitigationMember_ceac439f-0178-464d-82b9-c5a933c50bb3_terseLabel_en-US" xlink:label="lab_vtrs_CitalopramLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citalopram Litigation</link:label>
    <link:label id="lab_vtrs_CitalopramLitigationMember_label_en-US" xlink:label="lab_vtrs_CitalopramLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citalopram Litigation [Member]</link:label>
    <link:label id="lab_vtrs_CitalopramLitigationMember_documentation_en-US" xlink:label="lab_vtrs_CitalopramLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citalopram Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CitalopramLitigationMember" xlink:href="vtrs-20230331.xsd#vtrs_CitalopramLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CitalopramLitigationMember" xlink:to="lab_vtrs_CitalopramLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember_cad5c840-6aab-4ecc-8547-3e9ea4d6ae1f_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyEight [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyEight [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyEight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_3c73577d-44c2-4950-a5b3-44c6fe665f06_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExchangeTradedFundsMember_3f6f263a-f4fe-4bf1-bdca-afa5795befab_terseLabel_en-US" xlink:label="lab_us-gaap_ExchangeTradedFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange traded funds</link:label>
    <link:label id="lab_us-gaap_ExchangeTradedFundsMember_label_en-US" xlink:label="lab_us-gaap_ExchangeTradedFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Traded Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExchangeTradedFundsMember" xlink:to="lab_us-gaap_ExchangeTradedFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_46f5493f-efb8-4c91-892a-096c0d6eb58d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, released</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_2a2402ff-518f-4ab4-9c22-fe92f71ff81f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_7b3a7645-b2dc-4735-a174-952956d983cb_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_0af15186-8520-4d8c-a5c9-93aaf2d2b0c5_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_4153ab64-e4e7-4d38-abbe-e5fa969cff8c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets at recurring fair value measurement</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_92821930-ecb6-4b38-9a61-f6a94c0080ee_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BioconBiologicsMember_24832c82-f65e-4d5c-822d-a281fb802cf1_terseLabel_en-US" xlink:label="lab_vtrs_BioconBiologicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biocon Biologics</link:label>
    <link:label id="lab_vtrs_BioconBiologicsMember_label_en-US" xlink:label="lab_vtrs_BioconBiologicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biocon Biologics [Member]</link:label>
    <link:label id="lab_vtrs_BioconBiologicsMember_documentation_en-US" xlink:label="lab_vtrs_BioconBiologicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biocon Biologics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BioconBiologicsMember" xlink:to="lab_vtrs_BioconBiologicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_73123fee-e7b3-4de1-b32d-06a2dffed960_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_36fade83-2c21-4b23-9154-3a2070df6def_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_67e247c1-1c35-47aa-a17f-87d84e2cae6f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_12bcfce7-52ba-459f-b79b-0cc25432f04b_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0d8bacd-96ae-46d1-a9b2-f9bb68097dcb_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_32a26ac4-8e4f-4262-893c-8d4b8748be0c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_f532d8fa-cec3-43c1-841d-723539621a1e_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_cb17e640-3458-4720-a638-2c5eba82c16e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_499f2f2c-f39d-4c37-9944-ce3a6e6319bf_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_aed7d3a9-7e4f-4348-94ab-a97285613bed_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_209049a3-d7d8-4600-b9dd-0cb1b67bbab4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_baff54db-82e3-40c1-a973-da3ec052582c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange derivative assets</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8eb59c37-f6cc-4714-a197-cae1d861ec8d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_eadebc9d-3c19-4dc5-8ca2-422e75a35ffd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized net actuarial gains</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_399a6b34-6da9-4b2c-b892-60e6b84e74f3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c86f5484-42e9-4036-bc4a-50ceb8e95e9b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_c06fc203-915c-4ed6-944f-e40e331135c9_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_ab06cab9-1098-43c6-befb-9666b9d8b602_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_08d187d7-4f9f-4c5f-b3c1-eae929bbab22_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring - employee related</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_592a6fae-53f0-4fbf-9b0d-791de7fe1cc6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation expense, net of estimated forfeitures</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_75ecc679-107a-4918-904e-b61b11028284_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_882a02f5-9592-49fe-a27a-d2ea8bf08d01_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_774c3e7f-8570-46f5-9c4f-25c9a7403218_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_f2968623-cf4a-48a8-a6f7-3cb16d020dc0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_96c37fac-7efc-40fd-b7f3-b58f184ad296_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5705a21f-1a17-43b8-8583-067bdce3478a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchase</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6f21a8e7-119b-4335-b510-6b5c70aa0437_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8e52ab9d-2502-417f-bf7f-3307fe2ec31a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration_6ac49257-e038-49f2-b7da-94f4cd14c98a_terseLabel_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of Business, Deferred Cash Consideration.</link:label>
    <link:label id="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration_label_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of Business, Deferred Cash Consideration.</link:label>
    <link:label id="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration_documentation_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of Business, Deferred Cash Consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:href="vtrs-20230331.xsd#vtrs_DivestitureOfBusinessDeferredCashConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:to="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_00f2dcbc-3012-45d5-b1f0-8518f3d20e1f_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Incentive Plan</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_589abd9e-52db-4d77-b34f-729db6e2b03f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting Policy</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_1af3d149-e0c2-44d7-9dba-562ddc74034a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BalanceSheetComponentsAbstract_5034b365-9d73-442a-82a2-5151b7ebd952_terseLabel_en-US" xlink:label="lab_vtrs_BalanceSheetComponentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components [Abstract]</link:label>
    <link:label id="lab_vtrs_BalanceSheetComponentsAbstract_label_en-US" xlink:label="lab_vtrs_BalanceSheetComponentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components [Abstract]</link:label>
    <link:label id="lab_vtrs_BalanceSheetComponentsAbstract_documentation_en-US" xlink:label="lab_vtrs_BalanceSheetComponentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract" xlink:href="vtrs-20230331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract" xlink:to="lab_vtrs_BalanceSheetComponentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems_1d576ae6-c264-4203-ae44-ad116573bcbc_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems_label_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems_documentation_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of other current liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofothercurrentliabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:to="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_74098314-4dc0-4e4e-999c-2f8524654cc7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_8a918b48-caa2-4244-9885-1a0d78e08102_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other payables</link:label>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_9ddbd858-941a-4f97-8b3d-ed0fdf37dd79_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages to be paid</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_FamyLifeSciencesAcquisitionMember_28afc885-bdf3-454b-8a7d-0ee2ec201fce_terseLabel_en-US" xlink:label="lab_vtrs_FamyLifeSciencesAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Famy Life Sciences Acquisition</link:label>
    <link:label id="lab_vtrs_FamyLifeSciencesAcquisitionMember_label_en-US" xlink:label="lab_vtrs_FamyLifeSciencesAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Famy Life Sciences Acquisition [Member]</link:label>
    <link:label id="lab_vtrs_FamyLifeSciencesAcquisitionMember_documentation_en-US" xlink:label="lab_vtrs_FamyLifeSciencesAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Famy Life Sciences Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesAcquisitionMember" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_FamyLifeSciencesAcquisitionMember" xlink:to="lab_vtrs_FamyLifeSciencesAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_5905bafd-a802-4774-addd-097d40cf379c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoriesMember_2f48534c-2372-4f6a-b0b8-c1308d50cea7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoriesMember_label_en-US" xlink:label="lab_us-gaap_InventoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoriesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoriesMember" xlink:to="lab_us-gaap_InventoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_97f85e39-06bf-40ad-965f-801d5a050024_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_75b3aff4-6537-4225-b475-753f0772e6c1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_60c9d5a5-44c3-4a49-ac09-3daf9954d4dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_19fa5fdb-ac1e-4bc8-9793-4398165dd7bd_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccruedSalesAllowances_018aa88b-c825-41cd-85c9-a81078a8b3fc_negatedNetLabel_en-US" xlink:label="lab_vtrs_AccruedSalesAllowances" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates, promotional programs and other sales allowances</link:label>
    <link:label id="lab_vtrs_AccruedSalesAllowances_label_en-US" xlink:label="lab_vtrs_AccruedSalesAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Allowances</link:label>
    <link:label id="lab_vtrs_AccruedSalesAllowances_documentation_en-US" xlink:label="lab_vtrs_AccruedSalesAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances" xlink:href="vtrs-20230331.xsd#vtrs_AccruedSalesAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccruedSalesAllowances" xlink:to="lab_vtrs_AccruedSalesAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_ec95bf05-ae48-47c5-a20a-39d8041c0e53_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_bbe9fa7e-ecc5-43ff-a2e5-d9730b761ad6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_db96f135-953a-4ab5-b555-bae71dc79034_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_61534866-59c1-4d0b-8fc0-2a06624c7421_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_69a27ff7-2574-4e4f-acdb-c8b890163ba6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_0ce16526-4c47-460b-a453-0012aaa957e4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_51128be1-f96e-46b2-bee4-92bfdf20d36b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3f08ae9e-042d-41d4-ad17-eecc42f8d2da_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerReturns_d5d1f6ce-0798-4a8b-b841-13aa3612afcf_negatedLabel_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerReturns_label_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Returns</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerReturns_documentation_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns" xlink:href="vtrs-20230331.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RevenuefromContractwithCustomerReturns" xlink:to="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_39d6c7c9-69ae-43f0-b467-a38187f3321f_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_cedf6b96-a9ca-4e9c-8a77-b6cf7bcae07f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2027SeniorNotesMember_528a26a5-61c7-4f0c-aa40-4c2e6a68bbf6_terseLabel_en-US" xlink:label="lab_vtrs_A2027SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2027SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2027SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2027SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2027SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2027SeniorNotesMember" xlink:to="lab_vtrs_A2027SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2024EuroSeniorNotesMember_4e52fbed-2a43-41d1-bf54-d31f3dd3752f_terseLabel_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2024EuroSeniorNotesMember" xlink:to="lab_vtrs_A2024EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_caf8fd5c-f3c1-473c-bc9e-51b976183030_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Other Transactions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_01f14e83-6ff1-48bb-90b8-c82096915fd1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b2dee844-8cb9-4f18-94ee-bfb6fc6dcd17_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Ownership Percentage, Noncontrolling Owner</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Ownership Percentage, Noncontrolling Owner</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_8f03cb72-4221-4fc0-ba7b-bb8a36582e81_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_0353e218-6406-4d9d-a006-bcb3768736e1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segment</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3f0d741b-cc9c-41c4-b39a-f2513b65c32a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, nonvested beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b0f56ac7-02f1-4e05-b446-24e7e6dff1f6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, nonvested end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_0691ae49-f84b-477c-9569-8417382f9328_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_2847bbb3-621d-4fad-9c26-b3f7ec9d914a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_feca4524-cc68-49ef-8550-e2ec0553a8db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OysterPointPharmaAcquisitionMember_d7f0a572-fa3a-41db-aecd-e22edba65427_terseLabel_en-US" xlink:label="lab_vtrs_OysterPointPharmaAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oyster Point Pharma Acquisition</link:label>
    <link:label id="lab_vtrs_OysterPointPharmaAcquisitionMember_label_en-US" xlink:label="lab_vtrs_OysterPointPharmaAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oyster Point Pharma Acquisition [Member]</link:label>
    <link:label id="lab_vtrs_OysterPointPharmaAcquisitionMember_documentation_en-US" xlink:label="lab_vtrs_OysterPointPharmaAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oyster Point Pharma Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OysterPointPharmaAcquisitionMember" xlink:href="vtrs-20230331.xsd#vtrs_OysterPointPharmaAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OysterPointPharmaAcquisitionMember" xlink:to="lab_vtrs_OysterPointPharmaAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_783ce892-156f-40c8-bd3d-d6a0d25f66ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Receivable, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_9757dd2f-edcf-493c-bcce-4afb21d09aeb_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Risk Management</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_65b9cda0-48a2-4164-ad64-95dcaa9c6cdb_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_7f6f737d-9c0a-48db-a148-d984a899eea7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_85b75abb-15cc-411e-aaf3-48bfaa951f43_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_02660496-6369-44dd-8312-42ad0e8d9d5e_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MultiDistrictLitigationMember_c699edf3-db9f-41a0-9002-fd670dfb5f99_terseLabel_en-US" xlink:label="lab_vtrs_MultiDistrictLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi District Litigation [Member]</link:label>
    <link:label id="lab_vtrs_MultiDistrictLitigationMember_label_en-US" xlink:label="lab_vtrs_MultiDistrictLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi District Litigation [Member]</link:label>
    <link:label id="lab_vtrs_MultiDistrictLitigationMember_documentation_en-US" xlink:label="lab_vtrs_MultiDistrictLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi District Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MultiDistrictLitigationMember" xlink:href="vtrs-20230331.xsd#vtrs_MultiDistrictLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MultiDistrictLitigationMember" xlink:to="lab_vtrs_MultiDistrictLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_ce9f7b5c-07c5-4433-be99-c75f55678611_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_eac09fb4-41f9-4f05-8e41-dba78275434d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_69fa31cb-8013-4f4b-9fd4-7d025f9f5525_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_6270b025-bef2-4b84-889b-7bdf7c394ab5_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_ae25c62e-baec-4f77-b804-a2e246988d40_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3913d2f1-b88c-472c-82ac-2f622fb9dfdd_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_6910de38-dd08-4311-8c4c-50d95d3f9d81_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_de041821-e201-4e4d-a0dc-50cb408a1193_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_912ff176-c1d0-43e0-842c-6e5ec50e4d20_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_label_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:to="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b1cb2a48-7824-42da-88ac-9ba080e5b435_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_e0057113-0373-4f74-b79f-f5a2c8cfcf1b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_caab65e3-3ec4-43cf-9bc9-9104176865c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_cfc37ebf-c65b-486a-86c2-2ff9ae64b4b6_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Corporatecosts_a7554cd8-26aa-44be-9ea6-e7847041445a_terseLabel_en-US" xlink:label="lab_vtrs_Corporatecosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:label id="lab_vtrs_Corporatecosts_label_en-US" xlink:label="lab_vtrs_Corporatecosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:label id="lab_vtrs_Corporatecosts_documentation_en-US" xlink:label="lab_vtrs_Corporatecosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Corporatecosts" xlink:href="vtrs-20230331.xsd#vtrs_Corporatecosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Corporatecosts" xlink:to="lab_vtrs_Corporatecosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_3fbf23dc-2444-499a-8be0-67edb8670062_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_624474b1-cab3-4d0c-b095-a0ea469d0458_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79189689-08f4-4507-8bf1-f336077e3d18_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_961206de-c6dd-4a24-bb69-03eea5a21a40_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_0dafbf22-6653-4b3b-9249-8ebb5800d874_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f81224db-682e-494e-94b7-631023a38347_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3766b66a-469c-46d6-8e29-b20d348828d3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_078ee923-d366-485e-aa0c-4f47a71e92bf_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlements and other contingencies, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_8c06465f-02c8-4835-865d-9a45d75e76f2_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlements and other contingencies, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_21094991-646b-49a2-acbd-65f68956e999_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_215e205b-f4a7-466d-bede-eaec3d4c80ae_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_129595ca-811d-4f90-b763-2202acd2442e_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gains (losses) on derivatives, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_06d8e601-6cce-4eae-8622-65783a571025_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_29524715-9473-4d8b-83e7-bf4e80960871_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_3a03fa32-824a-47ad-a6f7-d0315d488846_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Divestiture, Amount of Consideration Received</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Divestiture, Amount of Consideration Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_8499fb8c-527d-4911-8217-d270a3382827_terseLabel_en-US" xlink:label="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_label_en-US" xlink:label="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Weighted Average Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:to="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9d47268c-83db-4cd1-bc0e-565fadcc04cf_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2024EuroSeniorNotes1023Member_7c987663-0e0a-49f5-b94f-5740a9e2a7fa_terseLabel_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes, 1.023%</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotes1023Member_label_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes, 1.023% [Member]</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotes1023Member_documentation_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes, 1.023%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2024EuroSeniorNotes1023Member" xlink:to="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_1c670c2f-1c2f-4152-98ec-b44c516d1925_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b2480e5b-a6e6-48f8-b46b-ebdac9826419_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_817c4a4f-aa0b-49ed-9b3f-bdf596d4c9cb_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_48ef1f8a-21a8-481f-83d3-9a7b001a4fb9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ac146558-51aa-4157-ae38-19d7c44ec92b_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38f8d207-6ae6-4294-93f7-a3e7c40e2381_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_76098b37-4bf6-46bf-a268-d9ba6c133b0a_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2046 Senior Notes (5.250% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortySix5.25Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2046 Senior Note (5.250%)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_a9412e2f-02ec-4e19-b032-0cc65eb01c5e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_4392b9a6-062e-4722-89cb-3c4e2625c32e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_0d84c46b-18b0-437a-aa42-4ff88c45383b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GenericsMember_fae93951-1471-4e29-bff1-aabf314fbba3_terseLabel_en-US" xlink:label="lab_vtrs_GenericsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics</link:label>
    <link:label id="lab_vtrs_GenericsMember_label_en-US" xlink:label="lab_vtrs_GenericsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics [Member]</link:label>
    <link:label id="lab_vtrs_GenericsMember_documentation_en-US" xlink:label="lab_vtrs_GenericsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember" xlink:href="vtrs-20230331.xsd#vtrs_GenericsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GenericsMember" xlink:to="lab_vtrs_GenericsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_340f37d3-80f0-4e0a-b1e0-5d04c415fa2f_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_037af737-eedd-4048-9517-dc8d1e8e4524_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_29560f31-dec1-4e94-89bf-6a3d9a310eaf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma_a18650be-bc3a-4465-a325-88b92f16506d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma_label_en-US" xlink:label="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Basic Shares Outstanding, Pro Forma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_ed2f5f9f-1e97-4b2d-97dd-36abae326b37_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_a6ac5d3e-c8e8-42b4-9e3b-09b485ba48d1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_ac125605-9b8b-481d-982f-c91b9b957c81_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_c50695ed-1fc1-48f2-ba97-40e31a7a0b6f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal and professional accruals, including litigation accruals</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c23001d-e49a-4833-94f3-1bca3d328894_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5f814d4d-d7bc-4dea-a795-f3d53892a86e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_375dc60c-d537-4fbd-b4a2-f380f44a2ba7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c4202c9a-bbbe-4b00-92e3-b04e36db92a1_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_35c34be4-4638-48f0-a89d-630bf41e57f6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Viatris Inc. common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1c9255c7-fe2d-4cae-ae95-3210f914fcff_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_959eafa0-b0aa-4df5-b365-367320226c64_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_355965e6-2b67-4f33-9a22-4ee521f9e487_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_e26e5f64-81aa-4ab5-9e01-5ed0bfccd6ec_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_e3893f33-c35a-43eb-bacc-4a763e2c3c0c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_17f8528e-c669-4849-94a9-929572908728_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated employer contributions in current year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2028EuroSeniorNotesMember_84b3a941-14d4-4e74-acd5-6b027fcea8df_terseLabel_en-US" xlink:label="lab_vtrs_A2028EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2028EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2028EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2028EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2028EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2028EuroSeniorNotesMember" xlink:to="lab_vtrs_A2028EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_25758fcb-e1d2-4e8f-abe9-e2751098bd2f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset_69f27fc9-29d1-4d34-a596-94e9aab701f8_terseLabel_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset_label_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset_documentation_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset" xlink:to="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_7b1d1a4b-9da2-4676-a8b2-d301a8bd9520_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets (excluding inventories and net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_270d33e3-415d-447b-9205-2a18c303b5d7_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_bd535f26-cba4-464c-9a80-9b94b94aaf4a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized gain (loss) and prior service cost related to defined benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8470d8ac-ed0a-47fa-922e-c5ad00dc019d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_fdef9d1d-7117-488e-b332-434df5c35e19_negatedNetLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized gain and prior service cost related to defined benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_dbc3bb72-bda7-44c8-a244-e2a016667469_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related items, including contingencies</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_049c33f0-ded4-4853-9e94-c7c5615aafd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Repayments on Outstanding Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_e6e709af-298f-4632-b455-0b572061328a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b8f0f754-a3dd-4f48-a83c-74537b7f86f7_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_61ebdb10-ce30-4311-b785-7ffa8f8a5ffa_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward_52d01740-d29e-4dac-b7fe-65404b04e9d5_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Contingent Consideration [Roll Forward]</link:label>
    <link:label id="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward_label_en-US" xlink:label="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Contingent Consideration [Roll Forward]</link:label>
    <link:label id="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward_documentation_en-US" xlink:label="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Contingent Consideration [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofActivityinContingentConsiderationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:to="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_5e639d7d-70c6-4967-ad5f-2e2e8f7ef269_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67b936a7-00c9-4c46-8c14-07affd6b8201_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af2ad74d-3512-4e55-95c8-6b850421d878_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CreonMember_2bb41b97-fd02-49ac-a582-5e243c8463a3_terseLabel_en-US" xlink:label="lab_vtrs_CreonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Creon &#174;</link:label>
    <link:label id="lab_vtrs_CreonMember_label_en-US" xlink:label="lab_vtrs_CreonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Creon &#174; [Member]</link:label>
    <link:label id="lab_vtrs_CreonMember_documentation_en-US" xlink:label="lab_vtrs_CreonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Creon &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CreonMember" xlink:href="vtrs-20230331.xsd#vtrs_CreonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CreonMember" xlink:to="lab_vtrs_CreonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fcb05312-9dba-4bbe-bb3d-7ac667789f6b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f037db6a-7cd9-4a77-8ab9-67f034cc0853_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_FamyLifeSciencesMember_ac4f244c-1ba3-4ddd-91be-17251d5961c9_terseLabel_en-US" xlink:label="lab_vtrs_FamyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Famy Life Sciences</link:label>
    <link:label id="lab_vtrs_FamyLifeSciencesMember_label_en-US" xlink:label="lab_vtrs_FamyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Famy Life Sciences [Member]</link:label>
    <link:label id="lab_vtrs_FamyLifeSciencesMember_documentation_en-US" xlink:label="lab_vtrs_FamyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Famy Life Sciences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesMember" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_FamyLifeSciencesMember" xlink:to="lab_vtrs_FamyLifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_de0293a8-6c0f-47b2-8356-258b3a48a2ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e092a544-d605-4a7d-9c71-01d0c8666a45_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e1858d02-285f-4621-9c79-33b4c0e6aa6b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_b1e6679f-c285-432c-b17e-decada3bad62_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6dccfab-4d4d-446c-bae4-f6ba6fda80bf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4346fa6b-7976-415e-9866-a9d7e9bdb926_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2cd8cf1c-a685-4f17-a14c-7d3fd8924dab_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Viatris Inc. shareholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_dcad3786-3ff7-4f59-846a-e9c3813cffeb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5a47cd69-90de-45ac-aef4-27c5579b2373_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CurrentPortionofLongTermDebtMember_2ccb56d5-c2cf-4d22-990e-a85b4ac3d675_terseLabel_en-US" xlink:label="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Portion of Long-Term Debt</link:label>
    <link:label id="lab_vtrs_CurrentPortionofLongTermDebtMember_label_en-US" xlink:label="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Portion of Long-Term Debt [Member]</link:label>
    <link:label id="lab_vtrs_CurrentPortionofLongTermDebtMember_documentation_en-US" xlink:label="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CurrentPortionofLongTermDebtMember" xlink:href="vtrs-20230331.xsd#vtrs_CurrentPortionofLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CurrentPortionofLongTermDebtMember" xlink:to="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_745abfa7-869c-4f7f-a48f-501e2d06f425_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued: 1,220,224,204 and 1,213,793,231, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_871a3f03-9288-4b01-8df2-4cf0265bb0f3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Numberofstates_afdd353b-db0f-4b49-b534-30c25c5981f6_terseLabel_en-US" xlink:label="lab_vtrs_Numberofstates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:label id="lab_vtrs_Numberofstates_label_en-US" xlink:label="lab_vtrs_Numberofstates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:label id="lab_vtrs_Numberofstates_documentation_en-US" xlink:label="lab_vtrs_Numberofstates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates" xlink:href="vtrs-20230331.xsd#vtrs_Numberofstates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Numberofstates" xlink:to="lab_vtrs_Numberofstates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d395ea84-acbd-4948-b295-e219090aaf4d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c41f7ef-ac0f-4340-878f-68a8d29aaa85_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2050SeniorNotesMember_025cb2c0-6740-4ab1-9dba-19489ae27104_terseLabel_en-US" xlink:label="lab_vtrs_A2050SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2050 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2050SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2050SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2050 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2050SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2050SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2050 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2050SeniorNotesMember" xlink:to="lab_vtrs_A2050SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment_69b04dc4-6c42-42cb-ac89-cc73371793e3_terseLabel_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment_label_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment</link:label>
    <link:label id="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment_documentation_en-US" xlink:label="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment" xlink:to="lab_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_cd689bb4-b66c-42c0-ad38-8152cb2b1d6a_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_c25d6d46-7c25-4a04-af52-e7662b17189b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Policy</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_39bd8c0f-fe8c-427f-9df1-9bf5fdd06492_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_8b403e80-a625-4eb3-adda-34136617eafa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_6202207f-5081-4414-83cf-73cde982c0bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, before tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSought_8b61f8d6-a169-44a6-9403-4024e0a2e93b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSought" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSought_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSought" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSought" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSought"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSought" xlink:to="lab_us-gaap_LossContingencyDamagesSought" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42d4535b-900e-4b47-a078-8ed4cba6d7b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0511e0fe-f904-423d-8fa3-c1ba84a46164_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_f70f5ea6-411a-46d2-9a7b-94657111508f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ddab5743-a915-4b81-a9d7-e9783bb879b2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_04ec7430-befb-48a7-bbf9-b194196c6add_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_e6619420-6c91-478d-ae75-79b279e04dba_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_a9ad9ceb-f629-418d-b83a-00170dc203a9_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_98766300-288d-4eff-bcfa-8b0e63a8bb14_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_009b276f-83cc-46e4-bf13-5e59ffe1a3c8_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case Type [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_86cb879b-f4a4-40c0-a709-3197eca8030a_totalLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible asset amortization expense (including disposal &amp; impairment charges)</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_815974cb-9573-44dc-98fc-66b8967cc6af_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c894b3c3-17d2-4676-931a-96ffb8085875_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d5fd04fa-02a7-4c76-8519-89858f210f60_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filler Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_fbef37e1-dbca-457a-88ed-6fe6126b661f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_c6a7ca96-84ff-421b-a177-c938d346bb2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f329a0db-365b-4cd8-a376-5ee940e36bd4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember_cbc484c0-cc25-45a9-aa2b-aac947cbe813_terseLabel_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember_label_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember_documentation_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:href="vtrs-20230331.xsd#vtrs_AnticompetitiveConductwithGenericDrugsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:to="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e8c57bac-745b-491d-ad1c-1bfb0b27d01e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e012e6f4-f0f9-4960-ae9e-07e2af33fc12_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_04c1816e-0aa6-4c64-b7cf-722d46869384_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share Policy</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e5a82dae-5cde-4e02-aeae-4293e2351b34_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1010e23d-f626-42be-a330-467be04f5725_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DevelopedMarketsSegmentMember_f9f53102-ef7d-4249-93c5-86b65512b887_terseLabel_en-US" xlink:label="lab_vtrs_DevelopedMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Markets (1)</link:label>
    <link:label id="lab_vtrs_DevelopedMarketsSegmentMember_label_en-US" xlink:label="lab_vtrs_DevelopedMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Markets Segment [Member]</link:label>
    <link:label id="lab_vtrs_DevelopedMarketsSegmentMember_documentation_en-US" xlink:label="lab_vtrs_DevelopedMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Markets Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember" xlink:href="vtrs-20230331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DevelopedMarketsSegmentMember" xlink:to="lab_vtrs_DevelopedMarketsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3f6c67f1-7a0c-40d9-aa2f-6c2a18e70f6a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_4e1716a3-1c47-4e77-80c2-bb129f962f42_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_16819bbd-1a4e-42e6-87f6-401f9da23e60_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherLongTermDebtMember_89cf693a-63d4-4eda-b6ea-18b4c44929b2_verboseLabel_en-US" xlink:label="lab_vtrs_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_vtrs_OtherLongTermDebtMember_label_en-US" xlink:label="lab_vtrs_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Debt [Member]</link:label>
    <link:label id="lab_vtrs_OtherLongTermDebtMember_documentation_en-US" xlink:label="lab_vtrs_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember" xlink:href="vtrs-20230331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherLongTermDebtMember" xlink:to="lab_vtrs_OtherLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_f12255cd-5c2e-4aa6-9074-d8efe7162715_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CelebrexMember_231d2851-07a5-4180-8b39-96c1b9c9692e_terseLabel_en-US" xlink:label="lab_vtrs_CelebrexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celebrex &#174;</link:label>
    <link:label id="lab_vtrs_CelebrexMember_label_en-US" xlink:label="lab_vtrs_CelebrexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celebrex &#174; [Member]</link:label>
    <link:label id="lab_vtrs_CelebrexMember_documentation_en-US" xlink:label="lab_vtrs_CelebrexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celebrex &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CelebrexMember" xlink:href="vtrs-20230331.xsd#vtrs_CelebrexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CelebrexMember" xlink:to="lab_vtrs_CelebrexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2028SeniorNotesMember_3cd1f1a0-26d4-4ae0-af79-ac3a12a37cf3_terseLabel_en-US" xlink:label="lab_vtrs_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2028SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2028SeniorNotesMember" xlink:to="lab_vtrs_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c6c034c4-8758-4a4e-8c89-a0981c365242_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_646c7945-ed58-44ef-a5de-32caae8165d7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_a945fd05-420f-4346-85f3-f7fb09e37a66_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_a3d1fbf7-e9b0-434b-8a62-5cad914dd8f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:to="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_dcc30cec-842a-4412-8b9d-e95186e85fc1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_bf93fc08-cc0a-40ca-82f0-fad00671aafe_terseLabel_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_label_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_documentation_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:href="vtrs-20230331.xsd#vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:to="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a8ac2551-1e4b-4878-a556-67374a390d0f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8dadaf7-50f9-4280-ae50-ccc4c5c4c615_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_188ad003-7884-455b-a56d-2de8de5e2451_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_816baf1d-39e2-40d8-818f-bdaf7e3696e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_fd760bcb-7de8-44a5-b641-aaaee17a6ede_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PrivateEquitySecuritiesMember_0648b636-2d10-4087-babd-77ad0970e4a9_terseLabel_en-US" xlink:label="lab_vtrs_PrivateEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Securities</link:label>
    <link:label id="lab_vtrs_PrivateEquitySecuritiesMember_label_en-US" xlink:label="lab_vtrs_PrivateEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Securities [Member]</link:label>
    <link:label id="lab_vtrs_PrivateEquitySecuritiesMember_documentation_en-US" xlink:label="lab_vtrs_PrivateEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PrivateEquitySecuritiesMember" xlink:href="vtrs-20230331.xsd#vtrs_PrivateEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PrivateEquitySecuritiesMember" xlink:to="lab_vtrs_PrivateEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_507f44f5-e97e-4079-85a1-92f87ba16937_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_2896384c-ed8b-410a-8971-0e0a8e6920da_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_93b2a2ed-5673-4528-80c9-ac7382237203_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_eb09e4b2-5270-48d2-80c8-708ab31ed0bc_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_d87c1cea-6932-4598-8813-795f5e195a4f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale and collection of receivables</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Collection of Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:to="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_6002e69c-1b00-4fb2-9e6c-b97552815003_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition And Accounts Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_9352f631-78be-428c-bfd3-3b98fcb268e8_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated percentage rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_031b6639-11e6-42f7-9873-1c1718044b86_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ce6bc87e-a90b-4cdd-b619-be4e12e3f6e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7b25d8da-757d-4728-b218-8d8966f0e77d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_a4468e14-0db5-45bf-bdda-723ca396da06_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Reclassifications</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Reclassifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:to="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_5f526634-e224-4429-a45a-93265cd64c46_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b2360a9d-c502-4081-9215-bf7c3ec3bd1f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_56c8aab9-29fb-41ae-9e18-1be78c9167ff_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_44a7af44-a22f-4652-807d-a5209fa7055f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LyricaMember_167245f9-97c1-4d92-bd42-45991d7faf05_terseLabel_en-US" xlink:label="lab_vtrs_LyricaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyrica &#174;</link:label>
    <link:label id="lab_vtrs_LyricaMember_label_en-US" xlink:label="lab_vtrs_LyricaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyrica &#174; [Member]</link:label>
    <link:label id="lab_vtrs_LyricaMember_documentation_en-US" xlink:label="lab_vtrs_LyricaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyrica &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LyricaMember" xlink:href="vtrs-20230331.xsd#vtrs_LyricaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LyricaMember" xlink:to="lab_vtrs_LyricaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7a74ecc4-0b67-4bc8-ac11-3549a5650a52_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7f36605e-9d58-4317-9de4-b30bd1726458_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed9326d8-4490-41c0-99de-9100f2ebd148_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f2d6e766-0579-42a5-b3b1-854dddd1c0b0_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8a11a212-a072-4220-a1ff-0dd8c5a8cade_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland_e01a94d0-d9e8-4385-b24f-959c917e8b71_terseLabel_en-US" xlink:label="lab_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Entities, National Health Service England, Wales, And Northern Ireland</link:label>
    <link:label id="lab_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland_label_en-US" xlink:label="lab_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Entities, National Health Service England, Wales, And Northern Ireland</link:label>
    <link:label id="lab_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland_documentation_en-US" xlink:label="lab_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Entities, National Health Service England, Wales, And Northern Ireland</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland" xlink:href="vtrs-20230331.xsd#vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland" xlink:to="lab_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_524b9647-3d52-4705-874f-d0f8c7f3052c_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_202057ed-ce67-459b-8aca-e96c840e174f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cf16068b-44e1-4cee-aa95-a595c9fb2241_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_3fe45083-cf69-447e-8499-82f8c0379dbf_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b93a1a6f-08fe-4f4e-bdc5-627c317e4da0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_1b04771e-3192-4d28-9793-16edccef973e_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5ede07c3-ec3b-4791-8844-e2eb5f062dc8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_9c7971ba-0edb-423b-9853-4be3d3dd0d5d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service costs</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_0668bf07-edb0-43f0-ad70-87410b458c57_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear_4d2b62a9-a314-4ad8-83eb-0d4e192109bd_terseLabel_en-US" xlink:label="lab_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year</link:label>
    <link:label id="lab_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear_label_en-US" xlink:label="lab_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year</link:label>
    <link:label id="lab_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear_documentation_en-US" xlink:label="lab_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear" xlink:href="vtrs-20230331.xsd#vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear" xlink:to="lab_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ZoloftMember_84630b29-38c0-46da-95d9-3234341a536b_terseLabel_en-US" xlink:label="lab_vtrs_ZoloftMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zoloft &#174;</link:label>
    <link:label id="lab_vtrs_ZoloftMember_label_en-US" xlink:label="lab_vtrs_ZoloftMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zoloft &#174; [Member]</link:label>
    <link:label id="lab_vtrs_ZoloftMember_documentation_en-US" xlink:label="lab_vtrs_ZoloftMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zoloft &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ZoloftMember" xlink:href="vtrs-20230331.xsd#vtrs_ZoloftMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ZoloftMember" xlink:to="lab_vtrs_ZoloftMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2040SeniorNotesMember_15215890-e114-43cf-ad99-6316c4a4c049_terseLabel_en-US" xlink:label="lab_vtrs_A2040SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2040SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2040SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2040SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2040SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2040SeniorNotesMember" xlink:to="lab_vtrs_A2040SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_3c31a4ea-e8bb-40d5-b6ec-07eaa1ee722d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b401562a-a79e-432c-bfca-3c2bf37e7a9d_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net book value, excluding goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_653f5185-27d4-4306-b053-1770dbe1b594_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_YENTermLoanMember_889d12aa-af4d-4310-8c41-8ff72ed71f9d_terseLabel_en-US" xlink:label="lab_vtrs_YENTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YEN Term Loan</link:label>
    <link:label id="lab_vtrs_YENTermLoanMember_label_en-US" xlink:label="lab_vtrs_YENTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YEN Term Loan [Member]</link:label>
    <link:label id="lab_vtrs_YENTermLoanMember_documentation_en-US" xlink:label="lab_vtrs_YENTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YEN Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember" xlink:href="vtrs-20230331.xsd#vtrs_YENTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_YENTermLoanMember" xlink:to="lab_vtrs_YENTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5c0c3fdf-a673-4c60-aed9-a2c5a2e31a3d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_158e4725-c985-4edf-ace0-7ebcb3c358d6_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a6b63cbc-73b6-4e0d-8f87-36915fe5add4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_449645f8-bfd8-41eb-a13f-05425c2ae69f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_76508a4c-58c1-4283-9e44-6c2946bd46f6_verboseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mylan N.V.</link:label>
    <link:label id="lab_srt_ParentCompanyMember_8b5ae9db-0111-4964-a96d-bf6111b54cbf_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mylan</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_98cb202e-8a66-4b3b-bbf0-7d4114b42902_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6856a5d2-4f79-4573-b250-9d833f5adcf3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2025SeniorNotesMember_dc57f9cc-c92f-46da-98a5-0d607efafb79_terseLabel_en-US" xlink:label="lab_vtrs_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2025SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2025SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2025SeniorNotesMember" xlink:to="lab_vtrs_A2025SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7a10aadc-be35-44ee-9fd9-27bda82d791f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, estimated useful life, in years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Chargebacks_621267f0-91b9-48dd-a219-8d1bb752f12c_negatedTerseLabel_en-US" xlink:label="lab_vtrs_Chargebacks" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks</link:label>
    <link:label id="lab_vtrs_Chargebacks_label_en-US" xlink:label="lab_vtrs_Chargebacks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks</link:label>
    <link:label id="lab_vtrs_Chargebacks_documentation_en-US" xlink:label="lab_vtrs_Chargebacks" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks" xlink:href="vtrs-20230331.xsd#vtrs_Chargebacks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Chargebacks" xlink:to="lab_vtrs_Chargebacks" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6befe09a-5cb0-4aba-8543-48633fb024b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_d4ed9ae8-428d-4d61-a45e-6042f905981d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_56e0a349-f477-4f77-b437-6676e7f00247_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_e0085d62-09ed-4e0e-8c77-f867c39549d4_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_38707a24-f65e-403f-b944-6e4a08e962c1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_86ac4052-a854-400c-98e2-60c84ea26cd5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d0de167e-5e73-48f3-9323-0627cf29e95b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f5b9f758-f107-43de-97a3-c966835e7a6f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_603f9e41-b166-4e78-866e-ae1d79b2ca42_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_e90f2a54-34a9-43a2-af83-dfef4440223f_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_12eb0ad5-7553-4fb1-b560-c721d848e12d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ff511269-f1ca-4bcb-b63f-973c68beaf87_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1066e546-4c4b-4e25-a8f3-44b07b6edfa0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c66a2960-ff56-4204-9fd9-fe622b58cb9f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_81d55382-ab7d-4c96-a3e3-474099c11646_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProgramNameDomain_1d90c87e-1a45-448a-bf0d-53ee96d524bb_terseLabel_en-US" xlink:label="lab_vtrs_ProgramNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Domain]</link:label>
    <link:label id="lab_vtrs_ProgramNameDomain_label_en-US" xlink:label="lab_vtrs_ProgramNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Domain]</link:label>
    <link:label id="lab_vtrs_ProgramNameDomain_documentation_en-US" xlink:label="lab_vtrs_ProgramNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Program Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain" xlink:href="vtrs-20230331.xsd#vtrs_ProgramNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProgramNameDomain" xlink:to="lab_vtrs_ProgramNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_2e411134-0e21-4e99-9323-b2ee647b44b7_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_6e867d49-3e81-44c5-8d86-c61bcfb004fa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_64c6bf1f-1547-4c8d-84b6-072680535a6a_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d350ade0-07cf-4b1d-b82c-da464d684afd_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_dc384f28-26e8-4a58-8708-6e37320ab494_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9b48b52c-eb4f-4a07-b682-cd0edc8678bb_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_67660857-99e5-4ff5-ab7e-5bddc2ed7a77_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867ae50e-4aaa-4d31-932c-b02aaba75844_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e69eb62c-86f5-4be4-a7c7-18b62f1dd0f0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_db146ceb-6d21-4a2c-8b2f-9b3d6156903c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a133db94-3282-423a-9aad-06a676a0f43a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_960bd638-201e-4095-850e-9b704f0b72c6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d1b03af3-79cd-40dc-96dc-a68ab3e3755b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_b214ea0d-456d-4bda-97f8-974cb8e099ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared, $0.12 per common share</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_db0781e7-1ceb-4e35-8ea7-72a5fb7975ac_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_b74365ce-5f7c-45c2-ab67-117023e75205_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value loss</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:to="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9bcd17da-5ae9-45cd-954b-48478bb6793e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b3a24d29-bd96-4d70-890e-d9d9f164d6c7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_98d6246b-c33f-4ba5-b0cd-d104f39cc0fa_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1283f685-3e89-4b95-9aba-8c02f2744f33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a6519854-449a-48bb-97b7-6835bcfa6c32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_bd0c2466-6259-4da5-b106-88b0ed9e3b22_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_ab08e49f-da8e-4334-85aa-4f88ca768a5e_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Revenues</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Otherlongtermassets_93861f66-0092-401e-b7ca-69289735f9b1_terseLabel_en-US" xlink:label="lab_vtrs_Otherlongtermassets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_vtrs_Otherlongtermassets_label_en-US" xlink:label="lab_vtrs_Otherlongtermassets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_vtrs_Otherlongtermassets_documentation_en-US" xlink:label="lab_vtrs_Otherlongtermassets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets" xlink:href="vtrs-20230331.xsd#vtrs_Otherlongtermassets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Otherlongtermassets" xlink:to="lab_vtrs_Otherlongtermassets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_e3adf8b6-bef5-4b39-9d80-99a27bc49908_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasuries</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProductRightsAndLicensesMember_2990ece3-6b64-4a44-957d-ba84ea416d86_terseLabel_en-US" xlink:label="lab_vtrs_ProductRightsAndLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights And Licenses</link:label>
    <link:label id="lab_vtrs_ProductRightsAndLicensesMember_label_en-US" xlink:label="lab_vtrs_ProductRightsAndLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights And Licenses [Member]</link:label>
    <link:label id="lab_vtrs_ProductRightsAndLicensesMember_documentation_en-US" xlink:label="lab_vtrs_ProductRightsAndLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights And Licenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductRightsAndLicensesMember" xlink:href="vtrs-20230331.xsd#vtrs_ProductRightsAndLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProductRightsAndLicensesMember" xlink:to="lab_vtrs_ProductRightsAndLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_23d7a60a-af75-4a82-8a7c-7979590dd43d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_629051b6-7a89-4024-b453-3082e6086a68_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_ecc72fdb-0f36-424c-b577-0910adf49ca7_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Changeinnoncashlitigationsettlementsnet_3fdd8824-7d81-4fd5-b843-6e68a3718a5d_negatedTerseLabel_en-US" xlink:label="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlements and other contingencies, net</link:label>
    <link:label id="lab_vtrs_Changeinnoncashlitigationsettlementsnet_label_en-US" xlink:label="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncash litigation settlements, net</link:label>
    <link:label id="lab_vtrs_Changeinnoncashlitigationsettlementsnet_documentation_en-US" xlink:label="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncash litigation settlements, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:href="vtrs-20230331.xsd#vtrs_Changeinnoncashlitigationsettlementsnet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:to="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_de1852a3-11c2-4de0-9dd0-75ebd1e650b0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d7b1bd85-ad17-4358-9153-0cd218052f3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for product rights and other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_8f7b50e6-04f0-48b8-aa35-88493450d1a1_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d5f154cf-1947-4589-a548-714e1b989b4e_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b16d0d5a-ac0e-425a-ac47-7e49b6ab27ac_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_c4508f27-cf69-48a4-988a-b62d3d8fe43c_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Senior Notes (4.200% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyThree4.2Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand twenty three - 4.2 percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_7f4c3e22-4f60-49be-90c3-cb71ab97cdec_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt and other long-term obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a62f74a0-c4b1-48f1-83d3-2898fee6d613_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AustralianTaxationOfficeMember_714edfa6-7db1-44c0-a5c6-74deeed63d78_terseLabel_en-US" xlink:label="lab_us-gaap_AustralianTaxationOfficeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Taxation Office</link:label>
    <link:label id="lab_us-gaap_AustralianTaxationOfficeMember_label_en-US" xlink:label="lab_us-gaap_AustralianTaxationOfficeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Taxation Office [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AustralianTaxationOfficeMember" xlink:to="lab_us-gaap_AustralianTaxationOfficeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_8638da44-79a7-47da-979b-9e7293fa0d0f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_3057d6ba-e7b5-413e-92d8-038a5e2374f1_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_3e3c6119-02df-43f5-b572-224ab6a278ff_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_d5226fde-6528-485a-93c5-d6c3afe0bfb0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_07a75d76-40fd-4a9c-bc54-12571bdf3b4b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2191c83d-24bd-4d02-94c2-a6b4a6f7dbf6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ed71e40b-017a-4a4e-ab63-6f08be1b8a04_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share attributable to Viatris Inc. shareholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f984e2b6-9549-466a-8164-698bf852f1c8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b0231d89-e37b-4c6a-9593-fe1c6dfa0f49_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss on marketable securities, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_90413e97-9d88-4c9b-a41c-1a6fca3b30c0_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain (loss) on marketable securities, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_353e2634-80d4-403b-a6cc-1a2a2a17d374_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain (loss) on marketable securities, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SalesRevenueGrosstonetadjustments_3ada2f33-219f-4381-8de2-8bffe0da8749_negatedTotalLabel_en-US" xlink:label="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross to net adjustments</link:label>
    <link:label id="lab_vtrs_SalesRevenueGrosstonetadjustments_label_en-US" xlink:label="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross to net adjustments</link:label>
    <link:label id="lab_vtrs_SalesRevenueGrosstonetadjustments_documentation_en-US" xlink:label="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross to net adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments" xlink:href="vtrs-20230331.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments" xlink:to="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_XanaxMember_264fc7a3-0c04-4e51-93c4-b5b5e46ffc48_terseLabel_en-US" xlink:label="lab_vtrs_XanaxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanax &#174;</link:label>
    <link:label id="lab_vtrs_XanaxMember_label_en-US" xlink:label="lab_vtrs_XanaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanax &#174; [Member]</link:label>
    <link:label id="lab_vtrs_XanaxMember_documentation_en-US" xlink:label="lab_vtrs_XanaxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanax &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XanaxMember" xlink:href="vtrs-20230331.xsd#vtrs_XanaxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_XanaxMember" xlink:to="lab_vtrs_XanaxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_be05f0a6-7760-49cf-b33c-d1a8e1c6460e_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_61608348-21e0-4d4a-bb76-4b448eb55f4f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_e4f6b7b2-3feb-4664-90bd-bf8d9f735577_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6c6ecc5c-5dd0-49d1-ac17-084984f4c5b8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5be2f877-4d7a-4fd2-8fae-629c5411a0e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Segment Information to Total Consolidated Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity_c6d3eb59-694d-4f6a-bde6-0a92dfb7dd6c_negatedTerseLabel_en-US" xlink:label="lab_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:label id="lab_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity_label_en-US" xlink:label="lab_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Intangible Assets, Financing Activity</link:label>
    <link:label id="lab_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity_documentation_en-US" xlink:label="lab_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Intangible Assets, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity" xlink:href="vtrs-20230331.xsd#vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity" xlink:to="lab_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_32d28630-9c83-4ca7-b66f-ab6739ab067e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b48823ff-65cb-4551-ad19-08ee0288a4b6_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term for stock awards vested and expected to vest, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ContingentConsiderationMember_a6ed0e9c-d6bb-4b04-85f2-84253dd27226_terseLabel_en-US" xlink:label="lab_vtrs_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_vtrs_ContingentConsiderationMember_label_en-US" xlink:label="lab_vtrs_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_vtrs_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_vtrs_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember" xlink:href="vtrs-20230331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ContingentConsiderationMember" xlink:to="lab_vtrs_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_8cfd7eee-88e3-46b5-8c1e-330a05e9d7f8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefit liabilities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_7d590874-e889-4066-895b-f12cd939f409_terseLabel_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of stock-based awards exercised and restricted stock units converted</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_label_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_documentation_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:href="vtrs-20230331.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:to="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_62115501-551a-4128-ae2f-7faea31ca362_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_549caffd-0189-4707-9a42-d4b4c3d39da1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VariableConsiderationMember_8ac310f5-5815-4c3f-9778-71a367bfdb15_terseLabel_en-US" xlink:label="lab_vtrs_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration</link:label>
    <link:label id="lab_vtrs_VariableConsiderationMember_label_en-US" xlink:label="lab_vtrs_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration [Member]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationMember_documentation_en-US" xlink:label="lab_vtrs_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember" xlink:href="vtrs-20230331.xsd#vtrs_VariableConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VariableConsiderationMember" xlink:to="lab_vtrs_VariableConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8c3bea33-d5d4-451c-b60f-179c12f3e966_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2030SeniorNotesMember_af86662d-7d50-456e-b49f-93bd7d95debb_terseLabel_en-US" xlink:label="lab_vtrs_A2030SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2030 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2030SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2030SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2030 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2030SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2030SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2030 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2030SeniorNotesMember" xlink:to="lab_vtrs_A2030SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b35b96d6-e283-4a20-a31d-53e3cdb46179_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_529969ae-3799-4ac9-b8c6-7ab02336c14f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_73b74b06-382e-4d98-a405-eaf1113b5755_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_3e9f8279-b8de-4efb-a527-b3ce8d2f13db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments Policy</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_7809bc48-b2b9-4134-8502-8962e1b2cc3f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d8cc1ccf-ac6d-4691-9c4a-13de9373c7cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_ff1879d7-95e6-4316-93dc-26fb57635e53_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6bac7502-11ef-4976-863b-a966b51ec1c5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_3dc2727d-d89c-4c4f-9183-489dcaf20cef_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2027EuroSeniorNotesMember_ef08c16c-1c00-4d89-9d9a-3b04266b942f_terseLabel_en-US" xlink:label="lab_vtrs_A2027EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2027EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2027EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2027EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2027EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Euro Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2027EuroSeniorNotesMember" xlink:to="lab_vtrs_A2027EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a39ff15c-b8af-4214-a3c4-e4a3010f5468_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NumberOfScottishHealthBoardsNHSScotland_b1539d90-749f-4b4b-b72f-b0bf315dd870_terseLabel_en-US" xlink:label="lab_vtrs_NumberOfScottishHealthBoardsNHSScotland" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Scottish Health Boards, NHS Scotland</link:label>
    <link:label id="lab_vtrs_NumberOfScottishHealthBoardsNHSScotland_label_en-US" xlink:label="lab_vtrs_NumberOfScottishHealthBoardsNHSScotland" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Scottish Health Boards, NHS Scotland</link:label>
    <link:label id="lab_vtrs_NumberOfScottishHealthBoardsNHSScotland_documentation_en-US" xlink:label="lab_vtrs_NumberOfScottishHealthBoardsNHSScotland" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Scottish Health Boards, NHS Scotland</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfScottishHealthBoardsNHSScotland" xlink:href="vtrs-20230331.xsd#vtrs_NumberOfScottishHealthBoardsNHSScotland"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NumberOfScottishHealthBoardsNHSScotland" xlink:to="lab_vtrs_NumberOfScottishHealthBoardsNHSScotland" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_62691b54-2472-4b71-8c97-da47f2f62ae0_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a4fcb5bb-deff-4433-aa4e-45a2157fdb02_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dfa89344-d250-4702-9c18-25691fe847e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_7045a661-8fff-4977-9e03-892111e3f884_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_e4351f23-a5fa-4d92-b3bd-af7579f0f7de_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_label_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_documentation_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:to="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_40ade449-3f66-48a6-8741-9ce2f701f4be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_78491e87-ecbc-4f0f-8492-d75fe074cb29_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_c361a261-dea8-4bb6-81ec-4f7d3bc543b9_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_d7102a90-ff04-4755-8d6a-1a29ebce4b7b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_123889f0-916d-49a8-ac69-59a84c5aacc4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_2e02cc9c-36ff-47f0-b273-a4c86f7aecda_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_861539d5-7836-4545-87ac-faa34ea547cc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_4d780bc4-ed13-4549-9451-7798e9c3079a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_6c222194-cd74-4a29-bb44-b8c2b8359dc4_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_02924ec4-ea9b-4d02-a7d1-078eeb3dc347_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ComplexGXAndBiosimilarsMember_0c2ddef7-4db6-4c3f-bd78-148dffde0eb0_terseLabel_en-US" xlink:label="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complex GX and Biosimilars</link:label>
    <link:label id="lab_vtrs_ComplexGXAndBiosimilarsMember_label_en-US" xlink:label="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complex GX and Biosimilars [Member]</link:label>
    <link:label id="lab_vtrs_ComplexGXAndBiosimilarsMember_documentation_en-US" xlink:label="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complex GX and Biosimilars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember" xlink:href="vtrs-20230331.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ComplexGXAndBiosimilarsMember" xlink:to="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_e109cd29-dc1a-418c-8fd7-51952b55e5e3_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AmitizaMember_0a4d8055-093f-43ea-9ea9-c73638090f43_terseLabel_en-US" xlink:label="lab_vtrs_AmitizaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amitiza &#174;</link:label>
    <link:label id="lab_vtrs_AmitizaMember_label_en-US" xlink:label="lab_vtrs_AmitizaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amitiza &#174; [Member]</link:label>
    <link:label id="lab_vtrs_AmitizaMember_documentation_en-US" xlink:label="lab_vtrs_AmitizaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amitiza &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmitizaMember" xlink:href="vtrs-20230331.xsd#vtrs_AmitizaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AmitizaMember" xlink:to="lab_vtrs_AmitizaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EmergingMarketsSegmentMember_766f0faf-2f39-470b-ae91-b5e6db8b4112_terseLabel_en-US" xlink:label="lab_vtrs_EmergingMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets (2)</link:label>
    <link:label id="lab_vtrs_EmergingMarketsSegmentMember_label_en-US" xlink:label="lab_vtrs_EmergingMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets Segment [Member]</link:label>
    <link:label id="lab_vtrs_EmergingMarketsSegmentMember_documentation_en-US" xlink:label="lab_vtrs_EmergingMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EmergingMarketsSegmentMember" xlink:to="lab_vtrs_EmergingMarketsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GreaterChinaSegmentMember_f498c85d-90c1-42fe-a635-5c1a375e4cf9_terseLabel_en-US" xlink:label="lab_vtrs_GreaterChinaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China</link:label>
    <link:label id="lab_vtrs_GreaterChinaSegmentMember_label_en-US" xlink:label="lab_vtrs_GreaterChinaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China Segment [Member]</link:label>
    <link:label id="lab_vtrs_GreaterChinaSegmentMember_documentation_en-US" xlink:label="lab_vtrs_GreaterChinaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GreaterChinaSegmentMember" xlink:to="lab_vtrs_GreaterChinaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ReceivablesFacilityMember_db5904a2-4ca2-444c-9f36-ec795fb2b5ea_terseLabel_en-US" xlink:label="lab_vtrs_ReceivablesFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Facility</link:label>
    <link:label id="lab_vtrs_ReceivablesFacilityMember_label_en-US" xlink:label="lab_vtrs_ReceivablesFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Facility [Member]</link:label>
    <link:label id="lab_vtrs_ReceivablesFacilityMember_documentation_en-US" xlink:label="lab_vtrs_ReceivablesFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember" xlink:href="vtrs-20230331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ReceivablesFacilityMember" xlink:to="lab_vtrs_ReceivablesFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a957292e-25b6-41bf-b131-4b0ea5d6f49e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_d35c1355-166c-4378-8cb9-d7ce62cef2bb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_7a2793c3-f80e-415c-96f9-c793b037f3d6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_0be90ef4-37e9-4844-b984-3aedbcec08c9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7a843409-c9c3-4023-a2fa-c75d66e624d4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Medicaidandothergovernmentalrebates_ef68d9aa-cb90-4408-9d09-eda473b99efa_negatedTerseLabel_en-US" xlink:label="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other governmental rebates</link:label>
    <link:label id="lab_vtrs_Medicaidandothergovernmentalrebates_label_en-US" xlink:label="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other governmental rebates</link:label>
    <link:label id="lab_vtrs_Medicaidandothergovernmentalrebates_documentation_en-US" xlink:label="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other governmental rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates" xlink:href="vtrs-20230331.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Medicaidandothergovernmentalrebates" xlink:to="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_269c2d27-9f53-4789-8504-ffd21c29495e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_2f94a935-db7b-4e81-8536-eae220831e82_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f1d183df-6f67-4ee7-9808-5ac3423ffbfb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2800ebb1-0eba-4a0f-a812-3a0b4af97d4e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bab10c1c-7286-4c53-bce5-52d16f70594b_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d583625f-284d-4acf-9fe7-913c31f46028_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_86960049-7ec3-4f17-9086-227516f3559c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Developmentandsalesmilestonepayments_1b3fc5bc-1190-429e-970c-31476524214a_terseLabel_en-US" xlink:label="lab_vtrs_Developmentandsalesmilestonepayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales milestone payments</link:label>
    <link:label id="lab_vtrs_Developmentandsalesmilestonepayments_label_en-US" xlink:label="lab_vtrs_Developmentandsalesmilestonepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales milestone payments</link:label>
    <link:label id="lab_vtrs_Developmentandsalesmilestonepayments_documentation_en-US" xlink:label="lab_vtrs_Developmentandsalesmilestonepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales milestone payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Developmentandsalesmilestonepayments" xlink:href="vtrs-20230331.xsd#vtrs_Developmentandsalesmilestonepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Developmentandsalesmilestonepayments" xlink:to="lab_vtrs_Developmentandsalesmilestonepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2e4c1f90-8110-4205-b3c4-0aa17324f3e9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_69204799-adda-4fcc-a72a-333890cd00d7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93d3669f-7d25-409e-b6e3-278ed0467cda_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_6e365f2a-4306-4d6f-bf4b-91a9d52887ec_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_02d5928f-b37c-4c36-aba3-1016f2cf67be_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ba24cd8f-3ca3-477b-97d4-203ebe70e656_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c8d60d04-a1cc-4316-9799-66aa03309fd9_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_53051534-9e5d-48c3-a8c7-8fce98af9940_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_7b2cf4c0-0d35-4118-a930-c9f2222a1ab2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_639b907a-1d6e-4296-b7fb-68f7aa577942_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_78983c84-0001-46d6-9096-fdac7998d4aa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in short-term borrowings, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_IntangibleAssetsbyMajorClassLineItems_b4b67ac1-a7b4-4daf-8ee3-f8323d3f3753_terseLabel_en-US" xlink:label="lab_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets by Major Class [Line Items]</link:label>
    <link:label id="lab_vtrs_IntangibleAssetsbyMajorClassLineItems_label_en-US" xlink:label="lab_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets by Major Class [Line Items]</link:label>
    <link:label id="lab_vtrs_IntangibleAssetsbyMajorClassLineItems_documentation_en-US" xlink:label="lab_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets by Major Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:href="vtrs-20230331.xsd#vtrs_IntangibleAssetsbyMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:to="lab_vtrs_IntangibleAssetsbyMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5171fe2b-c27d-4d30-8137-2ae8577dce43_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1444fa7d-b2ff-4312-9d37-b85a813455c1_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_99b0bcbd-695d-44ff-95b4-4c1aa8a936f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_aa08708e-019d-4aca-8c6d-9a14e2bcf7cd_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets and Liabilities Carried at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_d6795bc4-5235-40a5-a609-44be6dc7c0b6_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e51947b3-d529-426a-b27e-022415f345ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_5e683c17-ad35-414c-9fe3-bddcf1b92ce8_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LipitorMember_a10ac501-fe14-4830-b2ff-b46f46ac90ee_terseLabel_en-US" xlink:label="lab_vtrs_LipitorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lipitor</link:label>
    <link:label id="lab_vtrs_LipitorMember_label_en-US" xlink:label="lab_vtrs_LipitorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lipitor &#174; [Member]</link:label>
    <link:label id="lab_vtrs_LipitorMember_documentation_en-US" xlink:label="lab_vtrs_LipitorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lipitor &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LipitorMember" xlink:href="vtrs-20230331.xsd#vtrs_LipitorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LipitorMember" xlink:to="lab_vtrs_LipitorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_99ef8541-7d75-425c-833e-748ebb201e06_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_04a75da2-cdc5-4a4c-9445-eb031e7ed326_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_6846790d-8677-4cc1-857e-1e8f438f2d60_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_67f73e13-4601-4b21-a4ad-9394192ad2c4_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_015c655d-bd4d-4d1e-9685-742bf664afac_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_976dbd1a-e20b-43b5-b815-605a9c49b93e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_5cb673ef-d04b-4a88-9c88-da9884359b5c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_38bbad85-3fae-4985-b108-7cd013d4770c_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, original cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_dadded28-bd57-445f-ba5f-ec8cad0be1f7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_42cf47fe-8064-481c-b50d-22291d729617_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_363b7645-c012-467d-bfe4-0c91191bf42f_terseLabel_en-US" xlink:label="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Uncertain Tax Positions, Including Interest And Penalties</link:label>
    <link:label id="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_label_en-US" xlink:label="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Uncertain Tax Positions, Including Interest And Penalties</link:label>
    <link:label id="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_documentation_en-US" xlink:label="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Uncertain Tax Positions, Including Interest And Penalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:href="vtrs-20230331.xsd#vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:to="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_f541bc89-d61d-4477-ba56-0f8c775b6ed4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_5944c1bc-03a1-4171-a38b-1cbdc72f2c89_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_43586c1b-4f3d-4bf5-9695-4acd060a7229_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_628190a2-aadf-4d89-81a9-1336069a3632_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_311fa72b-2084-4bea-b7b0-3272459f02c9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and employee benefit liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_e56c9c8f-13f6-464e-8450-0c7ac28f4490_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_3d6db245-3e74-460c-9dc1-1a365fd6986c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of financing fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherMember_3e8a2c9a-8675-4ea1-9c37-3a6b488dae7d_verboseLabel_en-US" xlink:label="lab_vtrs_OtherMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Litigation</link:label>
    <link:label id="lab_vtrs_OtherMember_label_en-US" xlink:label="lab_vtrs_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_vtrs_OtherMember_documentation_en-US" xlink:label="lab_vtrs_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember" xlink:href="vtrs-20230331.xsd#vtrs_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherMember" xlink:to="lab_vtrs_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_5cb88be0-9282-4c8c-91b3-dbc87c5caa28_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Exit Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_6d09e22f-3d81-428b-882f-52b80514a905_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_d8135d10-964b-4b2d-b12f-e0045ecfc320_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BrandsMember_3f6b58d1-76ee-4149-b84b-874966bc1d30_terseLabel_en-US" xlink:label="lab_vtrs_BrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brands</link:label>
    <link:label id="lab_vtrs_BrandsMember_label_en-US" xlink:label="lab_vtrs_BrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brands [Member]</link:label>
    <link:label id="lab_vtrs_BrandsMember_documentation_en-US" xlink:label="lab_vtrs_BrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember" xlink:href="vtrs-20230331.xsd#vtrs_BrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BrandsMember" xlink:to="lab_vtrs_BrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_e1e79843-1935-4982-a4b9-bf6ba78f514f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_768221ba-c1a9-4572-a231-bfc91489412a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DymistaMember_f2233e6f-11dc-4cb0-829c-348f2c06d009_terseLabel_en-US" xlink:label="lab_vtrs_DymistaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dymista &#174;</link:label>
    <link:label id="lab_vtrs_DymistaMember_label_en-US" xlink:label="lab_vtrs_DymistaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dymista &#174; [Member]</link:label>
    <link:label id="lab_vtrs_DymistaMember_documentation_en-US" xlink:label="lab_vtrs_DymistaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dymista &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DymistaMember" xlink:href="vtrs-20230331.xsd#vtrs_DymistaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DymistaMember" xlink:to="lab_vtrs_DymistaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_debec503-d4f7-424a-8a30-f161b88c2dfb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_7587304c-bea2-4364-9309-918bab19a260_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss), reclassification adjustment from AOCE, pension and other postretirement benefit plans, for net gain (loss), before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_ac835308-fd74-4ddd-9c0b-2ae349727306_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8c1fb1f8-14cc-4f3f-a5d3-87affb2fec5b_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_50e4087a-7e41-412b-a191-20b3d15aa9d4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Goods, Net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_de2be854-923a-4847-a7ee-1313d3405ece_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_920a6540-f99a-48df-b034-1cd4d14bfe32_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0b949a91-c2fb-42a9-af5d-cab865f29e2b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_39718afa-9fd6-4820-8d39-0c7b84169b9a_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_a53716fe-7cef-4804-9c95-9fe85c413225_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_480edad6-d15c-4c3c-b6bb-eb6628403867_terseLabel_en-US" xlink:label="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans, estimated benefit payments, in current fiscal year</link:label>
    <link:label id="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_label_en-US" xlink:label="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans, estimated benefit payments, in current fiscal year</link:label>
    <link:label id="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_documentation_en-US" xlink:label="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans, estimated benefit payments, in current fiscal year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:href="vtrs-20230331.xsd#vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:to="lab_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_39800f9c-e09b-4216-974d-086f6005e62a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cd47d4d6-8d12-4316-a35b-5c33e4baba9a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions, net</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_318e3c1b-1ec7-4dc8-95e4-fce62abe543b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_6de2880b-bf55-4e4f-8985-d46c2528b60d_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_5613af05-e97f-495c-b62b-5fece3b72676_terseLabel_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="vtrs-20230331.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_373e6a5c-c8a3-4d07-a151-59cf35fce806_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Payments</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_bd26a306-4a30-4352-8fa7-6e875d99b558_negatedTerseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Payments</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:to="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_09f80484-ec7c-494b-bd17-b65571565caa_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_321a1c92-13b4-484e-b883-6949f4616ea4_terseLabel_en-US" xlink:label="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_label_en-US" xlink:label="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_documentation_en-US" xlink:label="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:href="vtrs-20230331.xsd#vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:to="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_32921b11-f84a-4dd3-b4f6-b38b4ffb9dd0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_e93b79bd-1342-4eb3-903c-015874e6e0ff_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ad4c6533-c7c3-4772-8514-67ed7f6e790d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b51fb6c7-6b95-466e-aab5-143097f7c966_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total dilutive shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_52d28080-4184-49cf-898b-9774919eb769_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_18c1e9c1-dbf9-4f20-a960-ebc843309cac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_bca7217b-a2c5-446c-b90f-55790d5f62c9_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_98258867-e605-4428-9ad6-fd492200ebc0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProductLiabilityMember_54ccdb7d-6ef5-49ba-bfae-c953a2e4a63c_terseLabel_en-US" xlink:label="lab_vtrs_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability</link:label>
    <link:label id="lab_vtrs_ProductLiabilityMember_label_en-US" xlink:label="lab_vtrs_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability [Member]</link:label>
    <link:label id="lab_vtrs_ProductLiabilityMember_documentation_en-US" xlink:label="lab_vtrs_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember" xlink:href="vtrs-20230331.xsd#vtrs_ProductLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProductLiabilityMember" xlink:to="lab_vtrs_ProductLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_be02ad9e-62f3-4f1a-94b3-1d45095e5a65_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_a83eb42a-167f-43a4-b575-9a1ab9b5f3e2_terseLabel_en-US" xlink:label="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of shares withheld (in shares)</link:label>
    <link:label id="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_label_en-US" xlink:label="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment</link:label>
    <link:label id="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_documentation_en-US" xlink:label="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:href="vtrs-20230331.xsd#vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:to="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_70733197-2694-4cc2-aff2-4df29ef3c6ff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_ce3d1cee-2bc0-407c-8adc-c45c157b1f8b_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_label_en-US" xlink:label="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:to="lab_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bbb69730-9e8b-4839-afbd-c6b0e28d80fc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OcularASMember_b4b52be3-19e2-40ff-99a7-91a7c283f4c2_terseLabel_en-US" xlink:label="lab_vtrs_OcularASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ocular AS</link:label>
    <link:label id="lab_vtrs_OcularASMember_label_en-US" xlink:label="lab_vtrs_OcularASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ocular AS [Member]</link:label>
    <link:label id="lab_vtrs_OcularASMember_documentation_en-US" xlink:label="lab_vtrs_OcularASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ocular AS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OcularASMember" xlink:href="vtrs-20230331.xsd#vtrs_OcularASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OcularASMember" xlink:to="lab_vtrs_OcularASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_707d31ae-7726-45c9-93f9-e69b67e568bb_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d1c39bcf-5402-405e-b4ee-4c2db8b34a5e_verboseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_62a0a58e-0677-4626-a642-5503186d20a0_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_d0b31dd6-653c-495e-8961-99ced1c0ecf1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_ea1dfcf4-5841-40b5-935e-c6b277ba816e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ce025715-31bd-4795-933f-09f590e4ac76_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EffexorMember_930d03b9-fc0b-4279-98aa-72c43c8aae9d_terseLabel_en-US" xlink:label="lab_vtrs_EffexorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effexor &#174;</link:label>
    <link:label id="lab_vtrs_EffexorMember_label_en-US" xlink:label="lab_vtrs_EffexorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effexor &#174; [Member]</link:label>
    <link:label id="lab_vtrs_EffexorMember_documentation_en-US" xlink:label="lab_vtrs_EffexorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effexor &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffexorMember" xlink:href="vtrs-20230331.xsd#vtrs_EffexorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EffexorMember" xlink:to="lab_vtrs_EffexorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_6feba859-8178-4a20-868b-05e6b471a69a_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f212f8b8-e98a-41e0-a1df-35aba4d6fb68_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_33203fca-8ffc-4396-a748-a12a17ea37d4_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_9fbba63c-d587-46ec-9794-73140ccd5087_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciling items:</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NorvascMember_ffab3f63-d03e-43d6-86f3-f9087ad7b3f4_terseLabel_en-US" xlink:label="lab_vtrs_NorvascMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norvasc</link:label>
    <link:label id="lab_vtrs_NorvascMember_label_en-US" xlink:label="lab_vtrs_NorvascMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norvasc &#174; [Member]</link:label>
    <link:label id="lab_vtrs_NorvascMember_documentation_en-US" xlink:label="lab_vtrs_NorvascMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norvasc &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorvascMember" xlink:href="vtrs-20230331.xsd#vtrs_NorvascMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NorvascMember" xlink:to="lab_vtrs_NorvascMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_9bda25ae-6d3c-4df9-a38c-bf792f38033b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_76f5e815-da91-4362-826f-6250748da4b8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term obligations</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_853d6597-0496-40ea-aaca-9b60d2c4f951_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, released</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_4d2f575a-985c-464d-b163-3f37c9fb7862_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_9dc4c975-2597-46f2-92b1-6bfba749d824_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_c9256591-ac27-4cf0-9fd0-66c314503000_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e0310f23-11ca-4aa0-b78e-1b028dfd782d_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LongTermIncentivePlan2003Member_65688734-5cdf-4ad5-9d82-85993b0d0d36_terseLabel_en-US" xlink:label="lab_vtrs_LongTermIncentivePlan2003Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Incentive Plan 2003</link:label>
    <link:label id="lab_vtrs_LongTermIncentivePlan2003Member_label_en-US" xlink:label="lab_vtrs_LongTermIncentivePlan2003Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan 2003 [Member]</link:label>
    <link:label id="lab_vtrs_LongTermIncentivePlan2003Member_documentation_en-US" xlink:label="lab_vtrs_LongTermIncentivePlan2003Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Incentive 2003 Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member" xlink:href="vtrs-20230331.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LongTermIncentivePlan2003Member" xlink:to="lab_vtrs_LongTermIncentivePlan2003Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_be5b1cc5-f0d1-4351-b827-84af53c445c4_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_6449c0e5-8f0a-4b63-b6e1-b08552b0fa2f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_cfe93358-4500-4429-8de1-dd121651ce95_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerGross_5b140280-0459-410f-9df3-1fc36d14de87_terseLabel_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross sales</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerGross_label_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Gross</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerGross_documentation_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerGross" xlink:href="vtrs-20230331.xsd#vtrs_RevenuefromContractwithCustomerGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RevenuefromContractwithCustomerGross" xlink:to="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights_ea3a6735-b546-46ba-bd79-ac5ba0eaaa8e_terseLabel_en-US" xlink:label="lab_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights_label_en-US" xlink:label="lab_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights_documentation_en-US" xlink:label="lab_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights" xlink:href="vtrs-20230331.xsd#vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights" xlink:to="lab_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_71e0ec84-d1df-4049-9ca0-8a3a4ffcf927_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_fee65285-9238-44d1-b563-4ee24b0e9aa8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_afdd428f-d012-405b-9f53-45fb1f993629_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ViatrisIncMember_ef036d76-e751-4ad6-b5c6-c3390d82cec3_terseLabel_en-US" xlink:label="lab_vtrs_ViatrisIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viatris Inc.</link:label>
    <link:label id="lab_vtrs_ViatrisIncMember_label_en-US" xlink:label="lab_vtrs_ViatrisIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viatris Inc. [Member]</link:label>
    <link:label id="lab_vtrs_ViatrisIncMember_documentation_en-US" xlink:label="lab_vtrs_ViatrisIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viatris Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViatrisIncMember" xlink:href="vtrs-20230331.xsd#vtrs_ViatrisIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ViatrisIncMember" xlink:to="lab_vtrs_ViatrisIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_503956af-c8c1-4e26-b3e3-0e33b27bb1c1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_b0ed9300-8399-4291-bf4d-4280ec9c094c_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Cost</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_2052c85e-22fb-43b1-80f3-4945a1bf576d_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_28ec321a-7f6b-46bd-9cf7-45b8c4d27157_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_de6e52e9-e199-4582-8fd5-d65834aeb109_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c65c90cb-9637-4aa2-924b-66ba239236f0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e8b9b2e3-2ac8-4fb3-8a91-ea63f4595f8d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_2b20be29-a885-4138-9d7f-90f0d2b37b0b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_00ded14d-0684-4c6d-b714-ef8133993b24_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance expense</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8b10f67b-f216-455b-af8d-c76569351609_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_f97af59d-7e9d-4b2c-8547-64dcc2fd9399_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_792843e2-16d6-442d-becc-af008f05ccf4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Merger Related Costs, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:to="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_9347cf25-a9cd-4507-9022-dd15f4769e6c_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a8c3a88c-bdc1-46d8-8393-b814789ae8bc_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_708e1d84-520a-47b0-b5a7-07da2a5fbea2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_8fe9f0df-6347-4897-97cf-aef69017986f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinistryOfFinanceIndiaMember_40c885eb-7227-4c67-8adc-9f7493c73aa6_terseLabel_en-US" xlink:label="lab_us-gaap_MinistryOfFinanceIndiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ministry of Finance, India</link:label>
    <link:label id="lab_us-gaap_MinistryOfFinanceIndiaMember_label_en-US" xlink:label="lab_us-gaap_MinistryOfFinanceIndiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ministry of Finance, India [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinistryOfFinanceIndiaMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinistryOfFinanceIndiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinistryOfFinanceIndiaMember" xlink:to="lab_us-gaap_MinistryOfFinanceIndiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionExpense_e0d8d047-3c95-4931-b6b2-efb399c90a28_terseLabel_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion expense</link:label>
    <link:label id="lab_us-gaap_AccretionExpense_label_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionExpense" xlink:to="lab_us-gaap_AccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e82da532-e8d4-48f0-8546-8960bfefd73b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_a4c9b152-7084-448f-92a3-104da7a1b50b_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_c1d45922-0787-4785-86bf-cb86b16ccaa9_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralized Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_5f9a7bc9-6a25-4614-be7f-6211a6c00fc8_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_e7eac0bf-fb6f-4a13-8aed-2f35afbc2ffe_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_cc2509a7-32bd-475c-920c-c4b4f6ca1f89_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherOneTimeNonoperatingExpense_e818974a-92f3-43b8-aa55-f5320133211e_negatedTerseLabel_en-US" xlink:label="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other One-Time Nonoperating Expense</link:label>
    <link:label id="lab_vtrs_OtherOneTimeNonoperatingExpense_label_en-US" xlink:label="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other One-Time Nonoperating Expense</link:label>
    <link:label id="lab_vtrs_OtherOneTimeNonoperatingExpense_documentation_en-US" xlink:label="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other One-Time Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherOneTimeNonoperatingExpense" xlink:href="vtrs-20230331.xsd#vtrs_OtherOneTimeNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherOneTimeNonoperatingExpense" xlink:to="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_de74b3bc-1be3-49e6-8b00-d56decd6f7de_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2048SeniorNotesMember_8106204c-f208-465a-8d3a-d14b8a06e1f5_terseLabel_en-US" xlink:label="lab_vtrs_A2048SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2048SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2048SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2048SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2048SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember" xlink:href="vtrs-20230331.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2048SeniorNotesMember" xlink:to="lab_vtrs_A2048SeniorNotesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>vtrs-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4f7b9844-2b6e-46d6-b212-7616af324858,g:ca8e76fc-c8f0-4b96-ac37-00e89e4a2911-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.viatris.com/role/CoverPage" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9b6c8d2c-5166-4a72-acff-87c244f35203" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_DocumentType_9b6c8d2c-5166-4a72-acff-87c244f35203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_677e3b91-f625-4b12-8cd7-76abf574f33c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_DocumentQuarterlyReport_677e3b91-f625-4b12-8cd7-76abf574f33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_959f8598-02db-4bb3-959d-ac4627d01c2b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_DocumentPeriodEndDate_959f8598-02db-4bb3-959d-ac4627d01c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_4ea0f4c8-f8c7-4a2b-a6f9-9ac998fc1119" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_DocumentTransitionReport_4ea0f4c8-f8c7-4a2b-a6f9-9ac998fc1119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_032c487d-fe3d-47e9-bb74-0c7eb7cfc9a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityFileNumber_032c487d-fe3d-47e9-bb74-0c7eb7cfc9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_416aa143-2f00-4d0c-83e7-62856b3dced8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityRegistrantName_416aa143-2f00-4d0c-83e7-62856b3dced8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_135fec48-6363-4036-b1ef-e901c2702431" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityIncorporationStateCountryCode_135fec48-6363-4036-b1ef-e901c2702431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0369da13-e6db-4173-91ea-bd671101fae1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityTaxIdentificationNumber_0369da13-e6db-4173-91ea-bd671101fae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b1e015ac-7e1a-48a8-b8a7-637f47658fa5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityAddressAddressLine1_b1e015ac-7e1a-48a8-b8a7-637f47658fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_00428de6-6f68-4cd8-aa9a-0eb94380eac1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityAddressCityOrTown_00428de6-6f68-4cd8-aa9a-0eb94380eac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_cf44a34b-6bed-4fc7-9ec7-f0ccc5499489" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityAddressStateOrProvince_cf44a34b-6bed-4fc7-9ec7-f0ccc5499489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1bd92320-86b5-4dff-bc18-2049880b5cd4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityAddressPostalZipCode_1bd92320-86b5-4dff-bc18-2049880b5cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4e466053-e64b-4a7e-9e35-ce5162b5cbed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_CityAreaCode_4e466053-e64b-4a7e-9e35-ce5162b5cbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d3271695-e585-4af6-91b2-7c4f5eecc1c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_LocalPhoneNumber_d3271695-e585-4af6-91b2-7c4f5eecc1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3c3affca-28ce-4969-9b21-cca1441ad934" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_Security12bTitle_3c3affca-28ce-4969-9b21-cca1441ad934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1ebfb203-ae88-485e-96f6-c6a94d0e6bdd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_TradingSymbol_1ebfb203-ae88-485e-96f6-c6a94d0e6bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c17fe0ea-884e-4f8b-b883-34c04af00466" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_SecurityExchangeName_c17fe0ea-884e-4f8b-b883-34c04af00466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_645f6465-b3da-4f4d-b717-d0f1fc9ff8ba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityCurrentReportingStatus_645f6465-b3da-4f4d-b717-d0f1fc9ff8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_97ffbcae-d87a-4b79-8fbd-345ec17c11a4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityInteractiveDataCurrent_97ffbcae-d87a-4b79-8fbd-345ec17c11a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_0b10e51f-2194-4266-8ed6-9a43c746da5e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityFilerCategory_0b10e51f-2194-4266-8ed6-9a43c746da5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0b05c058-d276-4200-ba9b-18e162d490c6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntitySmallBusiness_0b05c058-d276-4200-ba9b-18e162d490c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1b9acefb-b09c-471e-a57f-26bfbd786761" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityEmergingGrowthCompany_1b9acefb-b09c-471e-a57f-26bfbd786761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_5be6c22b-54f6-4676-af13-f7f60dace7ae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityShellCompany_5be6c22b-54f6-4676-af13-f7f60dace7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8e6c0c74-6f56-4aac-adb2-1aa64422812b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8e6c0c74-6f56-4aac-adb2-1aa64422812b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_14072554-7597-4ad2-b7d8-dc2899b59ab2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_14072554-7597-4ad2-b7d8-dc2899b59ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_eb959c45-6541-4ac5-8f1e-6db5c449a1bc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_EntityCentralIndexKey_eb959c45-6541-4ac5-8f1e-6db5c449a1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d86d963a-b9ab-4483-8833-4797dbebf80b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_AmendmentFlag_d86d963a-b9ab-4483-8833-4797dbebf80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d2eeb49a-11fd-4584-858d-9d29aa493d77" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_DocumentFiscalYearFocus_d2eeb49a-11fd-4584-858d-9d29aa493d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10bde3e2-bbd9-438a-afc5-377bc1e767a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10bde3e2-bbd9-438a-afc5-377bc1e767a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4b512fbf-d39c-43f4-95c6-e27ae1e7d4e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1f073be9-3a7c-4ffb-a8a4-5950e2f44f97" xlink:to="loc_dei_CurrentFiscalYearEndDate_4b512fbf-d39c-43f4-95c6-e27ae1e7d4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedStatementsOfOperations"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_70285e41-7789-4b1e-9a36-6e08db940419" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f86a9d34-380e-434a-9471-7f069bd8560d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_70285e41-7789-4b1e-9a36-6e08db940419" xlink:to="loc_us-gaap_StatementTable_f86a9d34-380e-434a-9471-7f069bd8560d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b2a4fcc5-9928-42ca-863f-d9ad5094bfa3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f86a9d34-380e-434a-9471-7f069bd8560d" xlink:to="loc_srt_ProductOrServiceAxis_b2a4fcc5-9928-42ca-863f-d9ad5094bfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_978219f0-1762-4c0b-b9dc-010b5058255c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b2a4fcc5-9928-42ca-863f-d9ad5094bfa3" xlink:to="loc_srt_ProductsAndServicesDomain_978219f0-1762-4c0b-b9dc-010b5058255c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_edd485f9-a41e-4b3b-a98d-d507f8db8865" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_978219f0-1762-4c0b-b9dc-010b5058255c" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_edd485f9-a41e-4b3b-a98d-d507f8db8865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f86a9d34-380e-434a-9471-7f069bd8560d" xlink:to="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fdc573fa-1d28-4666-bd25-a4ee0544efb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fdc573fa-1d28-4666-bd25-a4ee0544efb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_88cac754-5d6a-4c8b-b64f-52904a0ca405" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_88cac754-5d6a-4c8b-b64f-52904a0ca405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cce3d987-3366-45a7-854f-2e00949bfdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_Revenues_cce3d987-3366-45a7-854f-2e00949bfdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f4a0e1a2-3070-4f77-b919-51222681903c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f4a0e1a2-3070-4f77-b919-51222681903c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2502fa3b-e008-4479-a1fa-4977e13ca1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_GrossProfit_2502fa3b-e008-4479-a1fa-4977e13ca1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bddfa79b-fde6-4885-97d5-421b155c6a71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bddfa79b-fde6-4885-97d5-421b155c6a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8257a388-7be0-43ab-bb8e-1732652d2305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8257a388-7be0-43ab-bb8e-1732652d2305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_3b6f437c-1c41-4533-a6d7-0f8ce2137633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_3b6f437c-1c41-4533-a6d7-0f8ce2137633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_28885b4e-7dba-4af7-8cba-8c822f8d41b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0601823c-99e7-4486-98f0-c0f83147bb45" xlink:to="loc_us-gaap_OperatingExpenses_28885b4e-7dba-4af7-8cba-8c822f8d41b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ca529a2e-8e9d-4007-b893-d50fc2a51e86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_OperatingIncomeLoss_ca529a2e-8e9d-4007-b893-d50fc2a51e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_678f9565-2d9f-4914-86c1-0877952a6f13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_InterestExpense_678f9565-2d9f-4914-86c1-0877952a6f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_99d14562-d95a-4e09-83d4-1f084ba4802e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_99d14562-d95a-4e09-83d4-1f084ba4802e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8278052b-49c2-4c7d-bc19-62465e62c4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8278052b-49c2-4c7d-bc19-62465e62c4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e97cab55-dbec-4ebd-a8b3-bd1fe2637313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e97cab55-dbec-4ebd-a8b3-bd1fe2637313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0bc5cb38-d7c0-41ce-81a4-83fde46e82b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0bc5cb38-d7c0-41ce-81a4-83fde46e82b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_11353a18-cacd-4331-978e-d6b7b11cb2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_EarningsPerShareAbstract_11353a18-cacd-4331-978e-d6b7b11cb2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_68583e14-9437-4d14-8ea3-d1a56e0b4cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_11353a18-cacd-4331-978e-d6b7b11cb2ce" xlink:to="loc_us-gaap_EarningsPerShareBasic_68583e14-9437-4d14-8ea3-d1a56e0b4cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c6380d7d-caec-489b-926a-a0b4845a28cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_11353a18-cacd-4331-978e-d6b7b11cb2ce" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c6380d7d-caec-489b-926a-a0b4845a28cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_57516fd8-5e65-4cd9-8f60-b0a5c3f8c581" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d63ec1f2-da5c-4cd9-8ac9-d50f6d15c5c5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_57516fd8-5e65-4cd9-8f60-b0a5c3f8c581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2428c2c4-e310-4a71-8aec-749d7e4e9a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_57516fd8-5e65-4cd9-8f60-b0a5c3f8c581" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2428c2c4-e310-4a71-8aec-749d7e4e9a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_eb27b5a2-7069-4354-93a2-99942cf36b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_57516fd8-5e65-4cd9-8f60-b0a5c3f8c581" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_eb27b5a2-7069-4354-93a2-99942cf36b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedStatementsOfComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_102211e0-18a4-49bd-bac9-d719c87d2f36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f71859a-43d1-4413-addc-bac0c987f2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_102211e0-18a4-49bd-bac9-d719c87d2f36" xlink:to="loc_us-gaap_StatementTable_1f71859a-43d1-4413-addc-bac0c987f2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78fc68f8-3a3b-411b-977a-83211245de6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f71859a-43d1-4413-addc-bac0c987f2b4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78fc68f8-3a3b-411b-977a-83211245de6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b5b9afa3-f6a0-4479-a65d-9fa33f11976f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78fc68f8-3a3b-411b-977a-83211245de6b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b5b9afa3-f6a0-4479-a65d-9fa33f11976f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_563716bc-a57c-4c86-b734-f8ab9e1f3fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b5b9afa3-f6a0-4479-a65d-9fa33f11976f" xlink:to="loc_us-gaap_CashFlowHedgingMember_563716bc-a57c-4c86-b734-f8ab9e1f3fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_490e974b-2b32-40f0-a50f-83246453fc24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b5b9afa3-f6a0-4479-a65d-9fa33f11976f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_490e974b-2b32-40f0-a50f-83246453fc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f71859a-43d1-4413-addc-bac0c987f2b4" xlink:to="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f66f8759-8365-41b9-ada9-95546108882e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f66f8759-8365-41b9-ada9-95546108882e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4564358e-173d-4642-bbd5-6e6ce7c043e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4564358e-173d-4642-bbd5-6e6ce7c043e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4c30c2bf-bdea-42a9-825e-f84ff5d3e626" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4c30c2bf-bdea-42a9-825e-f84ff5d3e626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_c0c84dc6-d907-49c5-add4-401556ec29ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_c0c84dc6-d907-49c5-add4-401556ec29ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_bef96b98-7463-4405-a95a-0918637a0793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_bef96b98-7463-4405-a95a-0918637a0793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_bc668cd2-e552-4fc6-9f30-087ff96f11e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_bc668cd2-e552-4fc6-9f30-087ff96f11e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_17c31078-e281-4038-ab53-6456574ca89c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_17c31078-e281-4038-ab53-6456574ca89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_34b5bd2d-def3-4373-93c5-1f553fd47acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_048aba95-1678-4c61-bf7b-908aa296bc4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_34b5bd2d-def3-4373-93c5-1f553fd47acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e6b8c168-1dc2-46a9-b456-66f394072d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5117492-d6cd-4736-aae2-28f419d741b1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e6b8c168-1dc2-46a9-b456-66f394072d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c04dc291-8fe5-499a-9b31-4072c2302e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ffafe5d9-81df-4b8f-bec2-6b104cd5fa47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c04dc291-8fe5-499a-9b31-4072c2302e9c" xlink:to="loc_us-gaap_AssetsAbstract_ffafe5d9-81df-4b8f-bec2-6b104cd5fa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_66409761-64c6-4617-b7c0-92a9a4eebe70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffafe5d9-81df-4b8f-bec2-6b104cd5fa47" xlink:to="loc_us-gaap_AssetsCurrentAbstract_66409761-64c6-4617-b7c0-92a9a4eebe70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a1cb026-4a72-4e97-b962-8ac3713050bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66409761-64c6-4617-b7c0-92a9a4eebe70" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a1cb026-4a72-4e97-b962-8ac3713050bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0d02bfd9-9c66-4f8c-b28a-ab48580c93db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66409761-64c6-4617-b7c0-92a9a4eebe70" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0d02bfd9-9c66-4f8c-b28a-ab48580c93db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cea96f71-acc4-4c24-a22f-c85b9add6463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66409761-64c6-4617-b7c0-92a9a4eebe70" xlink:to="loc_us-gaap_InventoryNet_cea96f71-acc4-4c24-a22f-c85b9add6463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_681fee4b-758b-42ad-818e-70fb026e1efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66409761-64c6-4617-b7c0-92a9a4eebe70" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_681fee4b-758b-42ad-818e-70fb026e1efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_5ba157b5-800e-46e2-848c-b556be631bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66409761-64c6-4617-b7c0-92a9a4eebe70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_5ba157b5-800e-46e2-848c-b556be631bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e0c0d48f-17da-4840-9089-56e495f08c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66409761-64c6-4617-b7c0-92a9a4eebe70" xlink:to="loc_us-gaap_AssetsCurrent_e0c0d48f-17da-4840-9089-56e495f08c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f183b6f2-8e25-4171-82c0-73a4ca661d68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffafe5d9-81df-4b8f-bec2-6b104cd5fa47" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f183b6f2-8e25-4171-82c0-73a4ca661d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9ac37d0e-d195-4da0-a95d-712aeef65f59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffafe5d9-81df-4b8f-bec2-6b104cd5fa47" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9ac37d0e-d195-4da0-a95d-712aeef65f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_82a915d5-14b2-4631-a251-4666a1082c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffafe5d9-81df-4b8f-bec2-6b104cd5fa47" xlink:to="loc_us-gaap_Goodwill_82a915d5-14b2-4631-a251-4666a1082c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_6accbd7a-b0a9-4ef0-8745-db8a0854b6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffafe5d9-81df-4b8f-bec2-6b104cd5fa47" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_6accbd7a-b0a9-4ef0-8745-db8a0854b6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f47bb043-4783-4a0a-a243-24a713e73add" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffafe5d9-81df-4b8f-bec2-6b104cd5fa47" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f47bb043-4783-4a0a-a243-24a713e73add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_05c18b41-7def-40ec-952a-6fb157d5dd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffafe5d9-81df-4b8f-bec2-6b104cd5fa47" xlink:to="loc_us-gaap_Assets_05c18b41-7def-40ec-952a-6fb157d5dd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d475da6-22e2-4a6d-8666-b970aaf8c686" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c04dc291-8fe5-499a-9b31-4072c2302e9c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d475da6-22e2-4a6d-8666-b970aaf8c686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_36a85d63-20e0-461c-a6f4-3dd442ca8dac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d475da6-22e2-4a6d-8666-b970aaf8c686" xlink:to="loc_us-gaap_LiabilitiesAbstract_36a85d63-20e0-461c-a6f4-3dd442ca8dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_419ba6f9-dc10-4a87-8150-31a63eb46ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_36a85d63-20e0-461c-a6f4-3dd442ca8dac" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_419ba6f9-dc10-4a87-8150-31a63eb46ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_9998b0a8-9521-4dc2-a27c-affa9fba80d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_419ba6f9-dc10-4a87-8150-31a63eb46ec0" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_9998b0a8-9521-4dc2-a27c-affa9fba80d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f26f3c15-747f-49fb-9d54-d81cf5781a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_419ba6f9-dc10-4a87-8150-31a63eb46ec0" xlink:to="loc_us-gaap_ShortTermBorrowings_f26f3c15-747f-49fb-9d54-d81cf5781a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_94414f36-062b-4069-ba1f-da67c2b554db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_419ba6f9-dc10-4a87-8150-31a63eb46ec0" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_94414f36-062b-4069-ba1f-da67c2b554db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6889b1cc-876b-4497-afa3-26aba733e433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_419ba6f9-dc10-4a87-8150-31a63eb46ec0" xlink:to="loc_us-gaap_LongTermDebtCurrent_6889b1cc-876b-4497-afa3-26aba733e433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_93391d39-dd2f-4840-a0a7-d06ee5d7d8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_419ba6f9-dc10-4a87-8150-31a63eb46ec0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_93391d39-dd2f-4840-a0a7-d06ee5d7d8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bd894c49-eaf6-45e7-9972-e8ae557819c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_419ba6f9-dc10-4a87-8150-31a63eb46ec0" xlink:to="loc_us-gaap_LiabilitiesCurrent_bd894c49-eaf6-45e7-9972-e8ae557819c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7ce35666-2c0f-4e56-977a-448b1e1abe97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_36a85d63-20e0-461c-a6f4-3dd442ca8dac" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7ce35666-2c0f-4e56-977a-448b1e1abe97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b8d38079-95c3-470a-97ad-212406784e99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_36a85d63-20e0-461c-a6f4-3dd442ca8dac" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b8d38079-95c3-470a-97ad-212406784e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_163825c3-f838-46fa-80a1-765ff5f381ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_36a85d63-20e0-461c-a6f4-3dd442ca8dac" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_163825c3-f838-46fa-80a1-765ff5f381ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7d606a59-4359-4ec3-b3cf-3b414173152d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_36a85d63-20e0-461c-a6f4-3dd442ca8dac" xlink:to="loc_us-gaap_Liabilities_7d606a59-4359-4ec3-b3cf-3b414173152d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9028edb4-b904-4601-8846-0927d0dd48f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d475da6-22e2-4a6d-8666-b970aaf8c686" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9028edb4-b904-4601-8846-0927d0dd48f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_ba627817-2293-43db-ad1a-8094a5d033f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9028edb4-b904-4601-8846-0927d0dd48f4" xlink:to="loc_us-gaap_StockholdersEquityAbstract_ba627817-2293-43db-ad1a-8094a5d033f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8fb69cdb-8607-4c45-a5f4-6cb945528d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba627817-2293-43db-ad1a-8094a5d033f5" xlink:to="loc_us-gaap_CommonStockValue_8fb69cdb-8607-4c45-a5f4-6cb945528d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a8e302d3-9257-4800-9924-6bc7e9cd6ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba627817-2293-43db-ad1a-8094a5d033f5" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a8e302d3-9257-4800-9924-6bc7e9cd6ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_180dc5cd-261d-4aa4-bf12-acb33532a55b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba627817-2293-43db-ad1a-8094a5d033f5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_180dc5cd-261d-4aa4-bf12-acb33532a55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66e145bf-60eb-4cd7-ac30-624a6b8963d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba627817-2293-43db-ad1a-8094a5d033f5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66e145bf-60eb-4cd7-ac30-624a6b8963d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock_749befb0-b5eb-48ea-9a3d-515224267c40" xlink:href="vtrs-20230331.xsd#vtrs_StockholdersEquityParentBeforeTreasuryStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba627817-2293-43db-ad1a-8094a5d033f5" xlink:to="loc_vtrs_StockholdersEquityParentBeforeTreasuryStock_749befb0-b5eb-48ea-9a3d-515224267c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_79621c5f-5b57-4463-9c9f-1ef1be5702a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba627817-2293-43db-ad1a-8094a5d033f5" xlink:to="loc_us-gaap_TreasuryStockValue_79621c5f-5b57-4463-9c9f-1ef1be5702a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3a7db29a-451f-4d52-a3cc-30030cb62965" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9028edb4-b904-4601-8846-0927d0dd48f4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3a7db29a-451f-4d52-a3cc-30030cb62965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c589884-41f6-4cc3-a86b-98473ef632c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d475da6-22e2-4a6d-8666-b970aaf8c686" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2c589884-41f6-4cc3-a86b-98473ef632c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6c2a947f-12c4-4728-b675-5264f8986d99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5a7bff0e-c9a9-443f-a7ef-b007cebba3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6c2a947f-12c4-4728-b675-5264f8986d99" xlink:to="loc_us-gaap_StatementTable_5a7bff0e-c9a9-443f-a7ef-b007cebba3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_32ef46ff-f8d4-42f1-85c1-1631ffaea095" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5a7bff0e-c9a9-443f-a7ef-b007cebba3b7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_32ef46ff-f8d4-42f1-85c1-1631ffaea095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ec65ffe-f239-415c-8d2e-e1ad655bb69d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_32ef46ff-f8d4-42f1-85c1-1631ffaea095" xlink:to="loc_us-gaap_EquityComponentDomain_9ec65ffe-f239-415c-8d2e-e1ad655bb69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_39d04fc2-9176-4eac-bb95-8bcfd9638340" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9ec65ffe-f239-415c-8d2e-e1ad655bb69d" xlink:to="loc_us-gaap_CommonStockMember_39d04fc2-9176-4eac-bb95-8bcfd9638340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5a7bff0e-c9a9-443f-a7ef-b007cebba3b7" xlink:to="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_76d352aa-cb79-499d-be2f-d24a6298704a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_76d352aa-cb79-499d-be2f-d24a6298704a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_af9a798c-615c-473f-aeb0-6bc26a06ba77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_af9a798c-615c-473f-aeb0-6bc26a06ba77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_08cce447-9f42-4ecf-ae97-622b8c80dc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e1e1a262-dedb-491d-861f-de7ff82c9594" xlink:to="loc_us-gaap_TreasuryStockCommonShares_08cce447-9f42-4ecf-ae97-622b8c80dc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ConsolidatedStatementsofEquity"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6b38c194-1344-46d5-859b-d983b7839353" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5b5cafd8-190a-4967-b3bb-b89d7f98b6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6b38c194-1344-46d5-859b-d983b7839353" xlink:to="loc_us-gaap_StatementTable_5b5cafd8-190a-4967-b3bb-b89d7f98b6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c3137a1d-a20a-4b2e-8c6a-fdd5aee35ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5b5cafd8-190a-4967-b3bb-b89d7f98b6cd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c3137a1d-a20a-4b2e-8c6a-fdd5aee35ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c3137a1d-a20a-4b2e-8c6a-fdd5aee35ab7" xlink:to="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c798e72e-8396-4e97-aa2a-a55044255ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_CommonStockMember_c798e72e-8396-4e97-aa2a-a55044255ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_533d2fee-cae3-4715-9654-c4154bc0ea72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_533d2fee-cae3-4715-9654-c4154bc0ea72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5dad867d-3cb6-4ef5-85ab-b2c6fcd0fd15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_RetainedEarningsMember_5dad867d-3cb6-4ef5-85ab-b2c6fcd0fd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_98f1e3f2-a348-4721-be7d-c99072d3951c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_98f1e3f2-a348-4721-be7d-c99072d3951c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_638d6f5a-a61b-4e13-98df-7bc96f1d5b44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_819ddcaf-d83e-41a8-b3ee-684c148e9ebe" xlink:to="loc_us-gaap_TreasuryStockCommonMember_638d6f5a-a61b-4e13-98df-7bc96f1d5b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_14ae4422-823a-4962-941f-3e8e47856500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5b5cafd8-190a-4967-b3bb-b89d7f98b6cd" xlink:to="loc_us-gaap_StatementLineItems_14ae4422-823a-4962-941f-3e8e47856500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_14ae4422-823a-4962-941f-3e8e47856500" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_acf1dde2-7c74-4e16-a273-99ef3c12daf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_acf1dde2-7c74-4e16-a273-99ef3c12daf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_cb556336-79d8-4fda-8c76-790934db2ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_SharesIssued_cb556336-79d8-4fda-8c76-790934db2ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_a0a66de5-b43a-4f41-b4e9-878f02fd0bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_TreasuryStockValue_a0a66de5-b43a-4f41-b4e9-878f02fd0bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_8307174c-9f30-469e-b276-72b140f5e6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_TreasuryStockCommonShares_8307174c-9f30-469e-b276-72b140f5e6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9899f12b-0ceb-414e-a81d-74a640216804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9899f12b-0ceb-414e-a81d-74a640216804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2af8ed2b-87df-4e7b-83f0-b00532c2e7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2af8ed2b-87df-4e7b-83f0-b00532c2e7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_2267d7dc-ccc0-4cc0-b269-0f998ccde9a6" xlink:href="vtrs-20230331.xsd#vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_2267d7dc-ccc0-4cc0-b269-0f998ccde9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_a037bcdb-8389-43b2-aacf-5001d2ce7ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_a037bcdb-8389-43b2-aacf-5001d2ce7ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_e18ff430-2f8f-4b97-8061-4b6abd5ed2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_e18ff430-2f8f-4b97-8061-4b6abd5ed2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b57cbfab-786f-41e5-9e3c-215b4b438081" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b57cbfab-786f-41e5-9e3c-215b4b438081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_74e51512-e391-4d9a-9e38-e9e0abde75f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_74e51512-e391-4d9a-9e38-e9e0abde75f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57788d77-be70-49ac-933e-7b3e13fbab57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57788d77-be70-49ac-933e-7b3e13fbab57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b518b5d1-be77-4974-80f2-1390ab84b9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b518b5d1-be77-4974-80f2-1390ab84b9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c1b1872c-ddb8-4386-998d-7f662270fb01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c1b1872c-ddb8-4386-998d-7f662270fb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c59c4aea-8033-4b93-aa75-4b2844b0f026" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c59c4aea-8033-4b93-aa75-4b2844b0f026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_1e66d8da-e54f-4717-904e-7a55cb5aae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_DividendsCommonStockCash_1e66d8da-e54f-4717-904e-7a55cb5aae8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_b30282fc-731a-450e-a80d-8b9f87c8d826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_b30282fc-731a-450e-a80d-8b9f87c8d826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44820438-2094-4884-87b0-4be4a71206a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44820438-2094-4884-87b0-4be4a71206a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_5a2f7778-0f6a-4e98-89fd-cc737c3a3f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4c852e2-0ed4-4d95-9ad6-cba239e9e44f" xlink:to="loc_us-gaap_SharesIssued_5a2f7778-0f6a-4e98-89fd-cc737c3a3f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CondensedConsolidatedStatementsOfCashFlows"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6bb39f8-d239-4661-81ff-e460ae3aaf26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6bb39f8-d239-4661-81ff-e460ae3aaf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2ffda0fe-7e23-4bd9-be27-e92386bf903a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6bb39f8-d239-4661-81ff-e460ae3aaf26" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2ffda0fe-7e23-4bd9-be27-e92386bf903a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4b4d8e99-3b71-4582-969a-635fde8ee286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6bb39f8-d239-4661-81ff-e460ae3aaf26" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4b4d8e99-3b71-4582-969a-635fde8ee286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_364a019d-1cd1-4a2b-8c12-7d9c4ec0ed86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4b4d8e99-3b71-4582-969a-635fde8ee286" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_364a019d-1cd1-4a2b-8c12-7d9c4ec0ed86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a3fb9e20-1ada-48ec-9dca-6adceb8183de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4b4d8e99-3b71-4582-969a-635fde8ee286" xlink:to="loc_us-gaap_ShareBasedCompensation_a3fb9e20-1ada-48ec-9dca-6adceb8183de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9bb86565-0aae-4d8e-b70f-8803effad52c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4b4d8e99-3b71-4582-969a-635fde8ee286" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9bb86565-0aae-4d8e-b70f-8803effad52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4dcf28a1-3719-4c76-ac04-907b54b75505" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4b4d8e99-3b71-4582-969a-635fde8ee286" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4dcf28a1-3719-4c76-ac04-907b54b75505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_2d8d59ae-5857-44ab-99bf-6cd0036a31e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4b4d8e99-3b71-4582-969a-635fde8ee286" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_2d8d59ae-5857-44ab-99bf-6cd0036a31e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Changeinnoncashlitigationsettlementsnet_fc063f45-e8f8-462c-99cc-7a892e984db4" xlink:href="vtrs-20230331.xsd#vtrs_Changeinnoncashlitigationsettlementsnet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4b4d8e99-3b71-4582-969a-635fde8ee286" xlink:to="loc_vtrs_Changeinnoncashlitigationsettlementsnet_fc063f45-e8f8-462c-99cc-7a892e984db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bc90d065-90d9-4fb9-94cf-a5327bd2932d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6bb39f8-d239-4661-81ff-e460ae3aaf26" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bc90d065-90d9-4fb9-94cf-a5327bd2932d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_37482540-28dc-40c0-978b-45723ef338e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bc90d065-90d9-4fb9-94cf-a5327bd2932d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_37482540-28dc-40c0-978b-45723ef338e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8ad5738a-9295-470c-9253-f80473e9e29d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bc90d065-90d9-4fb9-94cf-a5327bd2932d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8ad5738a-9295-470c-9253-f80473e9e29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_e274c242-fb26-46f8-9bad-0e79ebfe7d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bc90d065-90d9-4fb9-94cf-a5327bd2932d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_e274c242-fb26-46f8-9bad-0e79ebfe7d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ddf104b2-9ad8-44b9-95e1-c9f5d54ad13c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bc90d065-90d9-4fb9-94cf-a5327bd2932d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ddf104b2-9ad8-44b9-95e1-c9f5d54ad13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ca9f9115-a3b7-4ae5-9eae-acae34db25ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bc90d065-90d9-4fb9-94cf-a5327bd2932d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ca9f9115-a3b7-4ae5-9eae-acae34db25ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd2fdc45-80a9-4530-ab25-36b29f77098a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6bb39f8-d239-4661-81ff-e460ae3aaf26" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd2fdc45-80a9-4530-ab25-36b29f77098a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9540f42-e01e-4210-93ef-5cdd294d279b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9540f42-e01e-4210-93ef-5cdd294d279b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_84d4cfd7-c5cf-4cc2-a3ec-f438ab3e50a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9540f42-e01e-4210-93ef-5cdd294d279b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_84d4cfd7-c5cf-4cc2-a3ec-f438ab3e50a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2146985b-a496-4b0e-9f01-b7dcca6794f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9540f42-e01e-4210-93ef-5cdd294d279b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2146985b-a496-4b0e-9f01-b7dcca6794f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5dbc8917-2534-4856-8b12-28167ab621db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9540f42-e01e-4210-93ef-5cdd294d279b" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5dbc8917-2534-4856-8b12-28167ab621db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_97b8aede-aa5f-4784-b8b3-f8f825429d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9540f42-e01e-4210-93ef-5cdd294d279b" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_97b8aede-aa5f-4784-b8b3-f8f825429d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6562f010-f227-49b7-a96a-1b5e96a673a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9540f42-e01e-4210-93ef-5cdd294d279b" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6562f010-f227-49b7-a96a-1b5e96a673a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_d4221830-6d61-49cf-b740-6ec0a6cce72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9540f42-e01e-4210-93ef-5cdd294d279b" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_d4221830-6d61-49cf-b740-6ec0a6cce72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_56aafc0b-0aac-400a-99f5-e0104e4ec6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9540f42-e01e-4210-93ef-5cdd294d279b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_56aafc0b-0aac-400a-99f5-e0104e4ec6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1efdc0bd-16cd-4930-954d-3d9247181a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1efdc0bd-16cd-4930-954d-3d9247181a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d850bdea-0e9c-4fb4-8969-147c9b80d21d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d850bdea-0e9c-4fb4-8969-147c9b80d21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f1d3631a-c1d8-4d18-94e5-06ddaa475e69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f1d3631a-c1d8-4d18-94e5-06ddaa475e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6ea731b9-fc13-4192-99f8-410ace25eae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6ea731b9-fc13-4192-99f8-410ace25eae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_cfe8580f-d6bc-472e-af50-7ccaec1c721a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_cfe8580f-d6bc-472e-af50-7ccaec1c721a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_86ffb317-eda0-4cbb-9a3a-0306bf62365a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_86ffb317-eda0-4cbb-9a3a-0306bf62365a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_511b8524-e26f-4605-b0e9-e54f1e230d50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_511b8524-e26f-4605-b0e9-e54f1e230d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d3e255a-9ff9-4513-afa6-11ba4a1fc87f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1d6ea81d-f9f4-4fe3-a12d-b9f9c9e5269d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d3e255a-9ff9-4513-afa6-11ba4a1fc87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f51e333f-927b-459e-b25f-5117f251ef4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f51e333f-927b-459e-b25f-5117f251ef4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_afe14ba5-298f-4528-8671-be369386bffa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_afe14ba5-298f-4528-8671-be369386bffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19fc5195-f057-4cf0-bfa7-cc025b19e173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19fc5195-f057-4cf0-bfa7-cc025b19e173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f784a78-994c-4838-ab1b-e4084eed7e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f784a78-994c-4838-ab1b-e4084eed7e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_b7935c51-f333-44e0-9ae2-8cba735b08ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_b7935c51-f333-44e0-9ae2-8cba735b08ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity_284a7bbc-65d3-47b7-adbd-b64ea18263b6" xlink:href="vtrs-20230331.xsd#vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity_284a7bbc-65d3-47b7-adbd-b64ea18263b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_20b90ab0-0b9b-44c3-8d40-693e6378b2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_20b90ab0-0b9b-44c3-8d40-693e6378b2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_69e13000-22c8-42bd-87fe-432978c6b584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d1f79594-f375-446a-8367-44a39937c1f3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_69e13000-22c8-42bd-87fe-432978c6b584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreements" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CollaborationandLicensingAgreements"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CollaborationandLicensingAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c2bbbf59-9fe0-402c-b095-fe99aac32d77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_ffd2254e-79ef-4780-865d-a9395c735c58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c2bbbf59-9fe0-402c-b095-fe99aac32d77" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_ffd2254e-79ef-4780-865d-a9395c735c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/General" xlink:type="simple" xlink:href="vtrs-20230331.xsd#General"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/General" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e2b0ac2-2ff2-41c8-85ce-9e612b47128f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6f1832e0-5ad3-4d5a-80ae-08e1b7476377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e2b0ac2-2ff2-41c8-85ce-9e612b47128f" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6f1832e0-5ad3-4d5a-80ae-08e1b7476377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivable"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1733ba50-26c0-469e-a868-d60cbb6a093f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0770c0e7-1c13-4c9e-8c9b-7fea36311e16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1733ba50-26c0-469e-a868-d60cbb6a093f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0770c0e7-1c13-4c9e-8c9b-7fea36311e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RecentAccountingPronouncements" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RecentAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RecentAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_5bed34c0-e72a-4219-8762-287f1d904ece" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_44757e11-fe68-48d3-97c3-ee7010540f36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_5bed34c0-e72a-4219-8762-287f1d904ece" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_44757e11-fe68-48d3-97c3-ee7010540f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactions" xlink:type="simple" xlink:href="vtrs-20230331.xsd#AcquisitionsandOtherTransactions"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3be8c568-7bc2-470d-84cb-1e43fe4724a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_76374271-5376-4385-9cce-03cbbb384340" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3be8c568-7bc2-470d-84cb-1e43fe4724a0" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_76374271-5376-4385-9cce-03cbbb384340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Divestitures" xlink:type="simple" xlink:href="vtrs-20230331.xsd#Divestitures"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Divestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6cc398d8-a626-41dd-9544-01d290bb5398" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d0b67178-28c8-4faf-a81e-b9fcfa55a32f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6cc398d8-a626-41dd-9544-01d290bb5398" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d0b67178-28c8-4faf-a81e-b9fcfa55a32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlan" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ShareBasedIncentivePlan"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ece908f3-9762-41a3-a9d4-1628c58a416b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_79f26e02-46cf-4587-9879-d33da463b5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ece908f3-9762-41a3-a9d4-1628c58a416b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_79f26e02-46cf-4587-9879-d33da463b5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefits" xlink:type="simple" xlink:href="vtrs-20230331.xsd#PensionsandOtherPostretirementBenefits"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62b7037b-6d67-4305-b3e5-6a8bea27ab9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ee3b7f36-6964-4c7d-b219-959246a0f5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62b7037b-6d67-4305-b3e5-6a8bea27ab9a" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ee3b7f36-6964-4c7d-b219-959246a0f5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_7f46f1f6-c3b9-42dc-ab88-be818a55b565" xlink:href="vtrs-20230331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a91668ff-656d-4af6-9bea-9b4124add04c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_7f46f1f6-c3b9-42dc-ab88-be818a55b565" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a91668ff-656d-4af6-9bea-9b4124add04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShare" xlink:type="simple" xlink:href="vtrs-20230331.xsd#EarningsLossperOrdinaryShare"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_399364ce-ad98-40aa-9f1f-08b05dbb07b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_20a733ab-1c9e-47da-9a57-0c83329109e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_399364ce-ad98-40aa-9f1f-08b05dbb07b4" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_20a733ab-1c9e-47da-9a57-0c83329109e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d931a71-0410-445d-b532-fb0884f52b31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6e658008-ca84-410a-9631-829d081e86f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d931a71-0410-445d-b532-fb0884f52b31" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6e658008-ca84-410a-9631-829d081e86f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagement" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagement"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_84d0ce51-0d68-4482-999e-2b978ee0935c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_6cae2bc5-9463-472d-a397-99e0c679a3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_84d0ce51-0d68-4482-999e-2b978ee0935c" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_6cae2bc5-9463-472d-a397-99e0c679a3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Debt" xlink:type="simple" xlink:href="vtrs-20230331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c95f8682-0457-439a-a3c1-029efefa049a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7d368f0b-8d9d-4b26-8d35-f49b71874535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c95f8682-0457-439a-a3c1-029efefa049a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7d368f0b-8d9d-4b26-8d35-f49b71874535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarnings" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ComprehensiveEarnings"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_842e821d-213f-4245-9d88-df4a7072c90f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a3c9b79b-a496-4c82-8224-2a3aa4d4578b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_842e821d-213f-4245-9d88-df4a7072c90f" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a3c9b79b-a496-4c82-8224-2a3aa4d4578b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformation" xlink:type="simple" xlink:href="vtrs-20230331.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0155bafb-d292-4154-8e35-4a71915ad529" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_543cc660-19d7-4627-98a1-1f16aaf147bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0155bafb-d292-4154-8e35-4a71915ad529" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_543cc660-19d7-4627-98a1-1f16aaf147bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Restructuring" xlink:type="simple" xlink:href="vtrs-20230331.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5d1b43e3-3cd5-496c-a3c4-10174cf5807d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1148a346-53a4-4993-bede-4600e34da227" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5d1b43e3-3cd5-496c-a3c4-10174cf5807d" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1148a346-53a4-4993-bede-4600e34da227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxes" xlink:type="simple" xlink:href="vtrs-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_55ca7925-6ee7-46ff-b7d6-bf6b7ef66c11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_e55a3e9f-1119-4257-8b3f-1c596950257d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_55ca7925-6ee7-46ff-b7d6-bf6b7ef66c11" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_e55a3e9f-1119-4257-8b3f-1c596950257d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Litigation" xlink:type="simple" xlink:href="vtrs-20230331.xsd#Litigation"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Litigation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b0ef6326-8436-4c3e-8d41-d64c34b336c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4781b646-bf23-47ce-a442-92afcbc7ae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b0ef6326-8436-4c3e-8d41-d64c34b336c5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4781b646-bf23-47ce-a442-92afcbc7ae9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GeneralPolicies" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GeneralPolicies"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GeneralPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0344169f-dcc6-4ee8-b4e6-9b11445a97b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1fc1c3f9-80fd-4be3-9347-dc61a2b36395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0344169f-dcc6-4ee8-b4e6-9b11445a97b4" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1fc1c3f9-80fd-4be3-9347-dc61a2b36395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_3fd04d1b-e1cc-483d-98a3-a9c9b7dc81a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0344169f-dcc6-4ee8-b4e6-9b11445a97b4" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_3fd04d1b-e1cc-483d-98a3-a9c9b7dc81a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_02120d54-3269-4e82-97b5-84baefc4acb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0344169f-dcc6-4ee8-b4e6-9b11445a97b4" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_02120d54-3269-4e82-97b5-84baefc4acb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationPolicies" xlink:type="simple" xlink:href="vtrs-20230331.xsd#SegmentInformationPolicies"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f4c32d45-acc8-43bc-a134-7ae6a7dc65af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_32122ad9-642c-4fd9-b71f-7de35d862289" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f4c32d45-acc8-43bc-a134-7ae6a7dc65af" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_32122ad9-642c-4fd9-b71f-7de35d862289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivableTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_14f5c732-02bf-4a2d-88ee-156932dfe5da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_593b1d7e-e163-4e77-8295-a7b15c7e50d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_14f5c732-02bf-4a2d-88ee-156932dfe5da" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_593b1d7e-e163-4e77-8295-a7b15c7e50d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d8d12a78-ed4f-4467-bf3c-c1a2333791fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_14f5c732-02bf-4a2d-88ee-156932dfe5da" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d8d12a78-ed4f-4467-bf3c-c1a2333791fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#AcquisitionsandOtherTransactionsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c4363c34-b688-40cc-8cb5-3d1ac0f1f23c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_994204be-9e86-4995-b46d-f2d9bc18c37b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c4363c34-b688-40cc-8cb5-3d1ac0f1f23c" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_994204be-9e86-4995-b46d-f2d9bc18c37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_4c9f93a7-5e1c-4246-8f00-69ae5bfc2565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c4363c34-b688-40cc-8cb5-3d1ac0f1f23c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_4c9f93a7-5e1c-4246-8f00-69ae5bfc2565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ShareBasedIncentivePlanTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33f14f2b-d8f7-46aa-a2ba-d18e6588b6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1fcc5964-607a-4717-9d06-3cb8f3c14c46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33f14f2b-d8f7-46aa-a2ba-d18e6588b6d2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1fcc5964-607a-4717-9d06-3cb8f3c14c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_78a3575e-d4b2-456d-b3f7-2c74531306db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33f14f2b-d8f7-46aa-a2ba-d18e6588b6d2" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_78a3575e-d4b2-456d-b3f7-2c74531306db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#PensionsandOtherPostretirementBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9c09862e-7a5f-4a78-815b-6fcc2e91aac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_37023f00-fdf7-4e9e-baf0-2420b29c7fda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9c09862e-7a5f-4a78-815b-6fcc2e91aac6" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_37023f00-fdf7-4e9e-baf0-2420b29c7fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_cfba13de-7c20-4e63-b02a-5acdf0605919" xlink:href="vtrs-20230331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_6959f991-ef7a-4b66-b970-318f621af24d" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_cfba13de-7c20-4e63-b02a-5acdf0605919" xlink:to="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_6959f991-ef7a-4b66-b970-318f621af24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f814fdcc-7832-489f-98bf-149471e45285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_cfba13de-7c20-4e63-b02a-5acdf0605919" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f814fdcc-7832-489f-98bf-149471e45285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_f42ca010-bc25-4a3b-a686-834c5097bf39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_cfba13de-7c20-4e63-b02a-5acdf0605919" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_f42ca010-bc25-4a3b-a686-834c5097bf39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a12ffbc0-c91b-4cb4-9370-241e398a4c01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_cfba13de-7c20-4e63-b02a-5acdf0605919" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a12ffbc0-c91b-4cb4-9370-241e398a4c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_cccac347-5d9f-4c08-b0a8-ca44fc321df5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_cfba13de-7c20-4e63-b02a-5acdf0605919" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_cccac347-5d9f-4c08-b0a8-ca44fc321df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_903a397c-2add-4daa-aac7-3ffce4799df4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_cfba13de-7c20-4e63-b02a-5acdf0605919" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_903a397c-2add-4daa-aac7-3ffce4799df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9904378f-508c-4a52-b938-53d021c6e71e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_cfba13de-7c20-4e63-b02a-5acdf0605919" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9904378f-508c-4a52-b938-53d021c6e71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_c7a9a265-ae7a-4a58-bd88-e1e78000289b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_cfba13de-7c20-4e63-b02a-5acdf0605919" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_c7a9a265-ae7a-4a58-bd88-e1e78000289b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#EarningsLossperOrdinaryShareTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2cecb708-d1fe-465f-b87e-c62ab9a5543b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f468aaa5-79e9-4f16-9148-697f09c6bea3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2cecb708-d1fe-465f-b87e-c62ab9a5543b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f468aaa5-79e9-4f16-9148-697f09c6bea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66978710-d3bc-4e27-96ce-2362c9a21438" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_0f5f0400-af0e-4ec3-a5b9-1cce8d5a79a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66978710-d3bc-4e27-96ce-2362c9a21438" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_0f5f0400-af0e-4ec3-a5b9-1cce8d5a79a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4feed1db-43c1-4638-ae51-e52c1aadadd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66978710-d3bc-4e27-96ce-2362c9a21438" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4feed1db-43c1-4638-ae51-e52c1aadadd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_5dd661ad-63c1-46df-bc69-d2c351ad700f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66978710-d3bc-4e27-96ce-2362c9a21438" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_5dd661ad-63c1-46df-bc69-d2c351ad700f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2c3b7f63-0e90-4db4-bccd-569baab82a95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66978710-d3bc-4e27-96ce-2362c9a21438" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2c3b7f63-0e90-4db4-bccd-569baab82a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bf4d90c1-4649-4b62-b360-8da22f3027df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_229f95f5-7b32-4e39-843f-8fa6412986e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bf4d90c1-4649-4b62-b360-8da22f3027df" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_229f95f5-7b32-4e39-843f-8fa6412986e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c13e2d84-dd85-434b-a636-9bf6be5a791c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_229f95f5-7b32-4e39-843f-8fa6412986e3" xlink:to="loc_us-gaap_HedgingDesignationAxis_c13e2d84-dd85-434b-a636-9bf6be5a791c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_21cd55c3-d25d-4b35-9758-da1946a49699" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_c13e2d84-dd85-434b-a636-9bf6be5a791c" xlink:to="loc_us-gaap_HedgingDesignationDomain_21cd55c3-d25d-4b35-9758-da1946a49699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a933e70d-4863-43aa-88e6-9c5c9da8b67a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_21cd55c3-d25d-4b35-9758-da1946a49699" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a933e70d-4863-43aa-88e6-9c5c9da8b67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_36849357-8d07-49e1-896c-e724b5953a90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_21cd55c3-d25d-4b35-9758-da1946a49699" xlink:to="loc_us-gaap_NondesignatedMember_36849357-8d07-49e1-896c-e724b5953a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ec33e4b0-21bc-48be-80cc-dd88f9c8cd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_229f95f5-7b32-4e39-843f-8fa6412986e3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ec33e4b0-21bc-48be-80cc-dd88f9c8cd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_989423d3-46cf-414a-8298-f930009a2604" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ec33e4b0-21bc-48be-80cc-dd88f9c8cd8e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_989423d3-46cf-414a-8298-f930009a2604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_db82e96c-3425-4488-bd15-5a0346576900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_989423d3-46cf-414a-8298-f930009a2604" xlink:to="loc_us-gaap_CashFlowHedgingMember_db82e96c-3425-4488-bd15-5a0346576900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_06710ea0-5a69-4d91-bdbf-d99d42cb06cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_989423d3-46cf-414a-8298-f930009a2604" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_06710ea0-5a69-4d91-bdbf-d99d42cb06cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_229f95f5-7b32-4e39-843f-8fa6412986e3" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_aab5e200-343c-456e-b014-236bcc714e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_aab5e200-343c-456e-b014-236bcc714e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_49b88611-9152-47cf-971f-f6015ad03fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_49b88611-9152-47cf-971f-f6015ad03fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8c961add-65eb-43d1-b1b6-d927a86997f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8c961add-65eb-43d1-b1b6-d927a86997f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8bba1b5d-08e7-42bb-a8c9-32c1824fe50d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b44dd0f9-607e-4a9b-a1fd-af04d4372d82" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8bba1b5d-08e7-42bb-a8c9-32c1824fe50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_f5aa69e0-ab76-4846-9cea-b2b1708903cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bf4d90c1-4649-4b62-b360-8da22f3027df" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_f5aa69e0-ab76-4846-9cea-b2b1708903cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4e4408e5-9f10-44d2-97f4-b9c6b6497306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_c00aa351-92b7-44d7-9df4-2c2a9985147f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4e4408e5-9f10-44d2-97f4-b9c6b6497306" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_c00aa351-92b7-44d7-9df4-2c2a9985147f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d1df4901-26c0-4a90-9587-8fee3cf2af1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4e4408e5-9f10-44d2-97f4-b9c6b6497306" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d1df4901-26c0-4a90-9587-8fee3cf2af1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_c7c30f8f-1d8a-476e-99e7-696cd432b738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4e4408e5-9f10-44d2-97f4-b9c6b6497306" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_c7c30f8f-1d8a-476e-99e7-696cd432b738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ComprehensiveEarningsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_35622d2f-4341-45e4-9362-ac54514ad5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_51616f19-a9c4-4dad-8268-90d0e4d9c082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_35622d2f-4341-45e4-9362-ac54514ad5ee" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_51616f19-a9c4-4dad-8268-90d0e4d9c082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_7359976b-2336-43e3-8949-697c03db4a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_35622d2f-4341-45e4-9362-ac54514ad5ee" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_7359976b-2336-43e3-8949-697c03db4a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3fab37a7-51ef-4f51-b0e3-9e1e204841e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_417c3200-cb0b-4a67-9211-e53b9f48fe93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3fab37a7-51ef-4f51-b0e3-9e1e204841e9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_417c3200-cb0b-4a67-9211-e53b9f48fe93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RestructuringTables" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RestructuringTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RestructuringTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f86dce09-4be5-479a-8e4a-cdbfb6e564d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_40b4f009-2229-4b4c-8bab-5eed7e3b04a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f86dce09-4be5-479a-8e4a-cdbfb6e564d6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_40b4f009-2229-4b4c-8bab-5eed7e3b04a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fa6b06c0-91fd-4ec1-88db-afcaefc76ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_4171e379-11a6-450d-b80e-39dcec7ed7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fa6b06c0-91fd-4ec1-88db-afcaefc76ca7" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_4171e379-11a6-450d-b80e-39dcec7ed7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d0b8bdcb-9e2e-4aa3-9f8d-753b1aa8fabf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d0b8bdcb-9e2e-4aa3-9f8d-753b1aa8fabf" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_afbbf797-0d48-4856-8e18-0f257cfe2928" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:to="loc_srt_ConsolidationItemsAxis_afbbf797-0d48-4856-8e18-0f257cfe2928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_470991d8-579d-43c4-b19f-5991f48fdfe1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_afbbf797-0d48-4856-8e18-0f257cfe2928" xlink:to="loc_srt_ConsolidationItemsDomain_470991d8-579d-43c4-b19f-5991f48fdfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_3adac227-8a2f-4fb0-9bad-616509ddb3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_470991d8-579d-43c4-b19f-5991f48fdfe1" xlink:to="loc_us-gaap_OperatingSegmentsMember_3adac227-8a2f-4fb0-9bad-616509ddb3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_49f3521b-3449-4607-a723-ed48603bbc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_49f3521b-3449-4607-a723-ed48603bbc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_49f3521b-3449-4607-a723-ed48603bbc0d" xlink:to="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_42e6cedf-ff68-4a62-9a35-ab8653e36d01" xlink:href="vtrs-20230331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_42e6cedf-ff68-4a62-9a35-ab8653e36d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_7b18d782-0355-4550-b6b7-af671724b758" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:to="loc_vtrs_GreaterChinaSegmentMember_7b18d782-0355-4550-b6b7-af671724b758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_a1ab06b5-b724-4224-8c07-67a696603a84" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_a1ab06b5-b724-4224-8c07-67a696603a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_5ccdbbb8-617a-4e6d-8378-5bf5cacc2dc7" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_19616bbf-d1fc-4898-8be0-c0aeaed7602f" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_5ccdbbb8-617a-4e6d-8378-5bf5cacc2dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_dccc3cf6-c1b3-4e78-9b48-0c514bd9a71e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:to="loc_srt_ProductOrServiceAxis_dccc3cf6-c1b3-4e78-9b48-0c514bd9a71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_dccc3cf6-c1b3-4e78-9b48-0c514bd9a71e" xlink:to="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember_7ebd7dd8-45b2-4b3e-a21e-1dc55ab29642" xlink:href="vtrs-20230331.xsd#vtrs_BrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_BrandsMember_7ebd7dd8-45b2-4b3e-a21e-1dc55ab29642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember_2a29f879-6935-408b-8733-4be348678630" xlink:href="vtrs-20230331.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_ComplexGXAndBiosimilarsMember_2a29f879-6935-408b-8733-4be348678630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember_96e04395-008c-44ec-9736-e4eeca35601b" xlink:href="vtrs-20230331.xsd#vtrs_GenericsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_GenericsMember_96e04395-008c-44ec-9736-e4eeca35601b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LipitorMember_aab4abab-cc4a-4194-948e-f818265375ab" xlink:href="vtrs-20230331.xsd#vtrs_LipitorMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_LipitorMember_aab4abab-cc4a-4194-948e-f818265375ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorvascMember_1ab16e52-a641-45f4-a9ab-67d3e474c41d" xlink:href="vtrs-20230331.xsd#vtrs_NorvascMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_NorvascMember_1ab16e52-a641-45f4-a9ab-67d3e474c41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LyricaMember_725fef20-7d2c-48be-91c1-b1a7744aaab7" xlink:href="vtrs-20230331.xsd#vtrs_LyricaMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_LyricaMember_725fef20-7d2c-48be-91c1-b1a7744aaab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViagraMember_619ac517-225c-4501-bf7b-895f8cb8f0d7" xlink:href="vtrs-20230331.xsd#vtrs_ViagraMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_ViagraMember_619ac517-225c-4501-bf7b-895f8cb8f0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorsMember_fe3be11f-f8b8-4fe8-a8dd-3651c9f122ef" xlink:href="vtrs-20230331.xsd#vtrs_EpiPenAutoInjectorsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_EpiPenAutoInjectorsMember_fe3be11f-f8b8-4fe8-a8dd-3651c9f122ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CelebrexMember_39953c65-ff0c-4827-a196-ef7338eddad1" xlink:href="vtrs-20230331.xsd#vtrs_CelebrexMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_CelebrexMember_39953c65-ff0c-4827-a196-ef7338eddad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffexorMember_de327d67-e7ff-4b64-a3f8-a1368994314e" xlink:href="vtrs-20230331.xsd#vtrs_EffexorMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_EffexorMember_de327d67-e7ff-4b64-a3f8-a1368994314e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ZoloftMember_da351ff0-5d09-4fb3-9616-2ed95704b77b" xlink:href="vtrs-20230331.xsd#vtrs_ZoloftMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_ZoloftMember_da351ff0-5d09-4fb3-9616-2ed95704b77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CreonMember_cf5ff757-6d16-4c25-8c6e-e7582204ea03" xlink:href="vtrs-20230331.xsd#vtrs_CreonMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_CreonMember_cf5ff757-6d16-4c25-8c6e-e7582204ea03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XalabrandsMember_40a596b4-7da0-40e6-b20b-e6599b63ffa5" xlink:href="vtrs-20230331.xsd#vtrs_XalabrandsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_XalabrandsMember_40a596b4-7da0-40e6-b20b-e6599b63ffa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmitizaMember_793f1bfe-637d-43e6-b822-805416b0a3fa" xlink:href="vtrs-20230331.xsd#vtrs_AmitizaMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_AmitizaMember_793f1bfe-637d-43e6-b822-805416b0a3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XanaxMember_19e76426-f590-45e9-9810-58ecaf6e2c0a" xlink:href="vtrs-20230331.xsd#vtrs_XanaxMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_XanaxMember_19e76426-f590-45e9-9810-58ecaf6e2c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DymistaMember_a79bf22a-4505-4182-a0b3-449c95a5e198" xlink:href="vtrs-20230331.xsd#vtrs_DymistaMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_DymistaMember_a79bf22a-4505-4182-a0b3-449c95a5e198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YupelriMember_eb789948-2ec9-4d8b-9f51-0e66dec59eca" xlink:href="vtrs-20230331.xsd#vtrs_YupelriMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b376c1c6-8e6e-45f5-bfc3-5d3ece2948ec" xlink:to="loc_vtrs_YupelriMember_eb789948-2ec9-4d8b-9f51-0e66dec59eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_679ba68e-d2c6-4806-a930-b24c71a51a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_679ba68e-d2c6-4806-a930-b24c71a51a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_abb406d8-be26-403b-99f5-66085341a8db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_679ba68e-d2c6-4806-a930-b24c71a51a8c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_abb406d8-be26-403b-99f5-66085341a8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_dbdd3919-45b1-4097-ab10-72a8917b9fd4" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_abb406d8-be26-403b-99f5-66085341a8db" xlink:to="loc_vtrs_BioconBiologicsMember_dbdd3919-45b1-4097-ab10-72a8917b9fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_7da0cef5-b15c-479a-9301-883d5b155c26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bffd0bb3-8282-4cda-a3c6-68251724cf6e" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_7da0cef5-b15c-479a-9301-883d5b155c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_47aed464-a2a7-4be0-8c06-b92cc170e4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7da0cef5-b15c-479a-9301-883d5b155c26" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_47aed464-a2a7-4be0-8c06-b92cc170e4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4b33c61-66fe-4008-9a01-b5b62288a280" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerGross_90356c14-ce79-40b0-859b-c2d2542e34ae" xlink:href="vtrs-20230331.xsd#vtrs_RevenuefromContractwithCustomerGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4b33c61-66fe-4008-9a01-b5b62288a280" xlink:to="loc_vtrs_RevenuefromContractwithCustomerGross_90356c14-ce79-40b0-859b-c2d2542e34ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks_4e05297b-077f-4a21-851f-a928efa3655a" xlink:href="vtrs-20230331.xsd#vtrs_Chargebacks"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4b33c61-66fe-4008-9a01-b5b62288a280" xlink:to="loc_vtrs_Chargebacks_4e05297b-077f-4a21-851f-a928efa3655a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances_712a4e77-4907-42c6-a8bb-5fb07992f2c4" xlink:href="vtrs-20230331.xsd#vtrs_AccruedSalesAllowances"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4b33c61-66fe-4008-9a01-b5b62288a280" xlink:to="loc_vtrs_AccruedSalesAllowances_712a4e77-4907-42c6-a8bb-5fb07992f2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns_193ec0eb-a462-4d32-85e1-4f49a62c911f" xlink:href="vtrs-20230331.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4b33c61-66fe-4008-9a01-b5b62288a280" xlink:to="loc_vtrs_RevenuefromContractwithCustomerReturns_193ec0eb-a462-4d32-85e1-4f49a62c911f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates_a949e699-e107-4fcf-8eed-3e111d146114" xlink:href="vtrs-20230331.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4b33c61-66fe-4008-9a01-b5b62288a280" xlink:to="loc_vtrs_Medicaidandothergovernmentalrebates_a949e699-e107-4fcf-8eed-3e111d146114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments_e8eb303f-ded8-49b4-aa12-84102883ba5d" xlink:href="vtrs-20230331.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4b33c61-66fe-4008-9a01-b5b62288a280" xlink:to="loc_vtrs_SalesRevenueGrosstonetadjustments_e8eb303f-ded8-49b4-aa12-84102883ba5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6875ceb4-2639-4884-b719-ce169f4ecfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4b33c61-66fe-4008-9a01-b5b62288a280" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6875ceb4-2639-4884-b719-ce169f4ecfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a43676cf-4a1d-4641-b62a-4ade8a731f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_70235b6f-00d3-4b20-b0ef-3f25a729d8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a43676cf-4a1d-4641-b62a-4ade8a731f33" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_70235b6f-00d3-4b20-b0ef-3f25a729d8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7faf2154-7923-4c82-bf9b-7842390c4ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_70235b6f-00d3-4b20-b0ef-3f25a729d8b9" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7faf2154-7923-4c82-bf9b-7842390c4ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_77028859-5ac0-472c-b803-d423fae8c757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7faf2154-7923-4c82-bf9b-7842390c4ee7" xlink:to="loc_us-gaap_ReceivableTypeDomain_77028859-5ac0-472c-b803-d423fae8c757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_ac9cb360-03c5-43ca-a38e-300b5fa9b690" xlink:href="vtrs-20230331.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_77028859-5ac0-472c-b803-d423fae8c757" xlink:to="loc_vtrs_VariableConsiderationMember_ac9cb360-03c5-43ca-a38e-300b5fa9b690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_70235b6f-00d3-4b20-b0ef-3f25a729d8b9" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_63f164d0-da25-4663-8151-d1405a2923ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:to="loc_us-gaap_ReceivablesNetCurrent_63f164d0-da25-4663-8151-d1405a2923ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_2e518a6f-f7f6-46b9-8aa0-9977177e11bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_2e518a6f-f7f6-46b9-8aa0-9977177e11bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_67fa1255-6a00-4008-aecc-e6fe08b63031" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7ed632c4-4cf0-4285-93b8-a71cf9759074" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_67fa1255-6a00-4008-aecc-e6fe08b63031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_f2187c04-2cbd-4e58-9096-94ef66c54cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac68e6a5-c3a6-41ee-a006-d0f380dbfe6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_f2187c04-2cbd-4e58-9096-94ef66c54cbc" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac68e6a5-c3a6-41ee-a006-d0f380dbfe6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8b83281c-d915-4663-a852-15345e879dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac68e6a5-c3a6-41ee-a006-d0f380dbfe6f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8b83281c-d915-4663-a852-15345e879dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a9b3fe4f-047c-43ec-86f8-110b2fc8436d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8b83281c-d915-4663-a852-15345e879dbf" xlink:to="loc_us-gaap_EquityComponentDomain_a9b3fe4f-047c-43ec-86f8-110b2fc8436d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_08edff99-e2e5-4dc0-94a6-ae5b16afeb33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a9b3fe4f-047c-43ec-86f8-110b2fc8436d" xlink:to="loc_us-gaap_RetainedEarningsMember_08edff99-e2e5-4dc0-94a6-ae5b16afeb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac68e6a5-c3a6-41ee-a006-d0f380dbfe6f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_26071588-09ab-4ba5-a352-b9039d613b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_26071588-09ab-4ba5-a352-b9039d613b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d73ed741-b91d-4cff-acd8-6233273996b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d73ed741-b91d-4cff-acd8-6233273996b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7ea23d4a-548a-4a2d-a7e1-0581aa602fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7ea23d4a-548a-4a2d-a7e1-0581aa602fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_82b3f32d-0a4b-45e6-b9c9-f69eee6fd84a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_Revenues_82b3f32d-0a4b-45e6-b9c9-f69eee6fd84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9bf2eab8-4f58-46e1-9e11-4ae03d5153d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9bf2eab8-4f58-46e1-9e11-4ae03d5153d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_582385be-5e74-4031-893e-d48954af5b17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_582385be-5e74-4031-893e-d48954af5b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9b76f0b7-36cc-4fd0-85ed-71f1b2d717f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9b76f0b7-36cc-4fd0-85ed-71f1b2d717f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_364fe91d-c4a6-4402-875f-799d48e3a0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_364fe91d-c4a6-4402-875f-799d48e3a0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligation_986c31b3-dfa6-43c3-8b32-725f9560a121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierFinanceProgramObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d47f518f-b4f4-44cd-8ae4-b94bd8638042" xlink:to="loc_us-gaap_SupplierFinanceProgramObligation_986c31b3-dfa6-43c3-8b32-725f9560a121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#AcquisitionsandOtherTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3de3e7b6-b204-4ef9-b40a-171c2107be41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3de3e7b6-b204-4ef9-b40a-171c2107be41" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_4409a843-8148-462a-87be-89c126143b21" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_srt_OwnershipAxis_4409a843-8148-462a-87be-89c126143b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9a3dce5f-14a0-44de-be5b-b727248a4a35" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_4409a843-8148-462a-87be-89c126143b21" xlink:to="loc_srt_OwnershipDomain_9a3dce5f-14a0-44de-be5b-b727248a4a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViatrisIncMember_f126c44b-c6ea-49d0-ab04-7400305daf92" xlink:href="vtrs-20230331.xsd#vtrs_ViatrisIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_9a3dce5f-14a0-44de-be5b-b727248a4a35" xlink:to="loc_vtrs_ViatrisIncMember_f126c44b-c6ea-49d0-ab04-7400305daf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e0be88fa-187c-4b55-8650-2dd7b58d7a73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e0be88fa-187c-4b55-8650-2dd7b58d7a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_030effd5-c2c1-4499-b0c2-86320465f966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e0be88fa-187c-4b55-8650-2dd7b58d7a73" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_030effd5-c2c1-4499-b0c2-86320465f966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OysterPointPharmaAcquisitionMember_0053f4e0-3e83-48e5-b6f1-273e5dff846b" xlink:href="vtrs-20230331.xsd#vtrs_OysterPointPharmaAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_030effd5-c2c1-4499-b0c2-86320465f966" xlink:to="loc_vtrs_OysterPointPharmaAcquisitionMember_0053f4e0-3e83-48e5-b6f1-273e5dff846b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesAcquisitionMember_f249dd77-4efb-4120-93ea-ec00f23a8948" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_030effd5-c2c1-4499-b0c2-86320465f966" xlink:to="loc_vtrs_FamyLifeSciencesAcquisitionMember_f249dd77-4efb-4120-93ea-ec00f23a8948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c7776713-3827-45ee-85c3-1a63b86a115b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c7776713-3827-45ee-85c3-1a63b86a115b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b72b14a9-bf83-4696-ae80-2cfb2a63675d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c7776713-3827-45ee-85c3-1a63b86a115b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b72b14a9-bf83-4696-ae80-2cfb2a63675d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_cc8becce-dd47-4ec9-8a50-1d43482eb137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b72b14a9-bf83-4696-ae80-2cfb2a63675d" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_cc8becce-dd47-4ec9-8a50-1d43482eb137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7d7a2216-3043-4e37-aad1-42e20a203837" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_srt_RangeAxis_7d7a2216-3043-4e37-aad1-42e20a203837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae90dda5-1268-4a70-954c-c62d67da99fa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7d7a2216-3043-4e37-aad1-42e20a203837" xlink:to="loc_srt_RangeMember_ae90dda5-1268-4a70-954c-c62d67da99fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b18b0827-d992-4311-9975-554494824580" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae90dda5-1268-4a70-954c-c62d67da99fa" xlink:to="loc_srt_MinimumMember_b18b0827-d992-4311-9975-554494824580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_52e1a34f-a956-4339-bbf4-e9b1f1f5e832" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae90dda5-1268-4a70-954c-c62d67da99fa" xlink:to="loc_srt_MaximumMember_52e1a34f-a956-4339-bbf4-e9b1f1f5e832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd4f0fc1-e677-4600-b10f-3948fbc28e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd4f0fc1-e677-4600-b10f-3948fbc28e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03593a64-f020-47ca-a5f5-b6987216deab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd4f0fc1-e677-4600-b10f-3948fbc28e0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03593a64-f020-47ca-a5f5-b6987216deab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductRightsAndLicensesMember_36235d86-e8cd-4dc4-ab77-7e43ee3dbbdd" xlink:href="vtrs-20230331.xsd#vtrs_ProductRightsAndLicensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03593a64-f020-47ca-a5f5-b6987216deab" xlink:to="loc_vtrs_ProductRightsAndLicensesMember_36235d86-e8cd-4dc4-ab77-7e43ee3dbbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d290db91-186d-4b94-b34a-6d90e81542f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03593a64-f020-47ca-a5f5-b6987216deab" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d290db91-186d-4b94-b34a-6d90e81542f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3006d45b-4e9a-4925-8905-f21cee9fbedd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3006d45b-4e9a-4925-8905-f21cee9fbedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ae6c5372-7ac7-4553-818e-2243523be6c2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3006d45b-4e9a-4925-8905-f21cee9fbedd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ae6c5372-7ac7-4553-818e-2243523be6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesMember_9956e2fc-7029-4ba4-9961-094129f0c054" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ae6c5372-7ac7-4553-818e-2243523be6c2" xlink:to="loc_vtrs_FamyLifeSciencesMember_9956e2fc-7029-4ba4-9961-094129f0c054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8f353b45-7c30-441c-9f7b-ec2b5ea44998" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_srt_StatementScenarioAxis_8f353b45-7c30-441c-9f7b-ec2b5ea44998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_62b7b35e-eb70-4e0f-9562-d73b2b47e7c6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_8f353b45-7c30-441c-9f7b-ec2b5ea44998" xlink:to="loc_srt_ScenarioUnspecifiedDomain_62b7b35e-eb70-4e0f-9562-d73b2b47e7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_023062ae-fbf1-4793-9d3b-758d0a177e73" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_62b7b35e-eb70-4e0f-9562-d73b2b47e7c6" xlink:to="loc_srt_ScenarioForecastMember_023062ae-fbf1-4793-9d3b-758d0a177e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ec49d35d-a20c-4a89-83f0-5b0ae3f96f61" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0857d5cd-c7ff-4d92-b3fd-2aa39302905f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0857d5cd-c7ff-4d92-b3fd-2aa39302905f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_53ab4259-a6ae-4da0-8577-d1f3f46e7e14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_53ab4259-a6ae-4da0-8577-d1f3f46e7e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7932f5d4-eb95-422a-b1cc-44ab2b1aafbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7932f5d4-eb95-422a-b1cc-44ab2b1aafbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c3bb2573-b8dd-4f3c-9933-bd387c2008d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_Goodwill_c3bb2573-b8dd-4f3c-9933-bd387c2008d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_65f31aea-e00b-4ac2-ba80-fa45b0d627da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_65f31aea-e00b-4ac2-ba80-fa45b0d627da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_40aefbf9-c697-4bfa-aacd-174382325e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_40aefbf9-c697-4bfa-aacd-174382325e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_58baf9f3-04d8-48ee-9aac-d0dd020bf234" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_58baf9f3-04d8-48ee-9aac-d0dd020bf234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights_8ab00f0c-7cd4-4d69-ab82-5dcec0a0d24b" xlink:href="vtrs-20230331.xsd#vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights_8ab00f0c-7cd4-4d69-ab82-5dcec0a0d24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionContingentConsiderationPerShare_0bb7891c-a3e2-4995-adca-ee7804e781fd" xlink:href="vtrs-20230331.xsd#vtrs_BusinessAcquisitionContingentConsiderationPerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_vtrs_BusinessAcquisitionContingentConsiderationPerShare_0bb7891c-a3e2-4995-adca-ee7804e781fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_35ebc82e-dd4c-4328-8cf0-062b56d9e963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_35ebc82e-dd4c-4328-8cf0-062b56d9e963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_82c33030-2488-4c99-881b-cdbbab453930" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_82c33030-2488-4c99-881b-cdbbab453930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization_ebf07832-96da-4e05-8f7f-85f9351c6335" xlink:href="vtrs-20230331.xsd#vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization_ebf07832-96da-4e05-8f7f-85f9351c6335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_23aded03-07ac-4a47-866c-4b4d5c5d57e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_23aded03-07ac-4a47-866c-4b4d5c5d57e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_5005908a-5abd-4f42-9c1d-000ca61cbc67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_5005908a-5abd-4f42-9c1d-000ca61cbc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a8a090b9-fe10-48b7-adfc-72024cd56695" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a8a090b9-fe10-48b7-adfc-72024cd56695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2a58f779-e872-45e8-940d-a3dec0934c40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2a58f779-e872-45e8-940d-a3dec0934c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_880095fb-e385-4a91-a045-3753586b2a28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_880095fb-e385-4a91-a045-3753586b2a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_502174bb-9821-47b8-bda2-b1ffe91032a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_502174bb-9821-47b8-bda2-b1ffe91032a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7a786c41-7aeb-4932-abd2-bb62d6bcc7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7a786c41-7aeb-4932-abd2-bb62d6bcc7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_989593c4-d69f-4bbb-b8e5-e4e7aa659427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_Revenues_989593c4-d69f-4bbb-b8e5-e4e7aa659427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7e909a68-da6c-410d-aef8-7d5f922c1811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_519a96fe-54cc-43c4-bfa4-70aba758f6f0" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7e909a68-da6c-410d-aef8-7d5f922c1811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_242fce00-5b9f-4731-ba57-af890d3a28d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3de3e7b6-b204-4ef9-b40a-171c2107be41" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_242fce00-5b9f-4731-ba57-af890d3a28d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6b3663b2-ae45-41f3-98bb-7df515041f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c76de91-8fde-4581-be41-d848f0e3ced5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6b3663b2-ae45-41f3-98bb-7df515041f8f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c76de91-8fde-4581-be41-d848f0e3ced5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a0deb4b2-1dee-4d14-a0c4-52a8d52c9732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c76de91-8fde-4581-be41-d848f0e3ced5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a0deb4b2-1dee-4d14-a0c4-52a8d52c9732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5c76b895-b660-4b41-8479-fbad26a5cf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0deb4b2-1dee-4d14-a0c4-52a8d52c9732" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5c76b895-b660-4b41-8479-fbad26a5cf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OysterPointPharmaAcquisitionMember_af7ddf75-90b7-47f1-a7aa-995a1141384f" xlink:href="vtrs-20230331.xsd#vtrs_OysterPointPharmaAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5c76b895-b660-4b41-8479-fbad26a5cf1a" xlink:to="loc_vtrs_OysterPointPharmaAcquisitionMember_af7ddf75-90b7-47f1-a7aa-995a1141384f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesAcquisitionMember_2d504f41-6ee6-4cbb-88c6-011d4a066d8f" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5c76b895-b660-4b41-8479-fbad26a5cf1a" xlink:to="loc_vtrs_FamyLifeSciencesAcquisitionMember_2d504f41-6ee6-4cbb-88c6-011d4a066d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7330e231-b0a0-4da7-8857-b9c5809a8c01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c76de91-8fde-4581-be41-d848f0e3ced5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7330e231-b0a0-4da7-8857-b9c5809a8c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28e50fed-1dde-444a-9a0f-d7ab15595bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7330e231-b0a0-4da7-8857-b9c5809a8c01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28e50fed-1dde-444a-9a0f-d7ab15595bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductRightsAndLicensesMember_790ea783-e4fe-401b-b25a-d99c454ba642" xlink:href="vtrs-20230331.xsd#vtrs_ProductRightsAndLicensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28e50fed-1dde-444a-9a0f-d7ab15595bcc" xlink:to="loc_vtrs_ProductRightsAndLicensesMember_790ea783-e4fe-401b-b25a-d99c454ba642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_47cdba7c-e65b-404f-9faa-5eda96ae1690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28e50fed-1dde-444a-9a0f-d7ab15595bcc" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_47cdba7c-e65b-404f-9faa-5eda96ae1690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5c76de91-8fde-4581-be41-d848f0e3ced5" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c78582a8-07a9-48f3-8752-3a675c71e0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c78582a8-07a9-48f3-8752-3a675c71e0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_899866bd-e97c-4ef2-ab1f-4c474f9327cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_899866bd-e97c-4ef2-ab1f-4c474f9327cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9fb4518a-4d99-42f4-8c7f-6a7c005da7da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9fb4518a-4d99-42f4-8c7f-6a7c005da7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ef4b3099-b841-4635-87c8-3cbfaa08b9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_Goodwill_ef4b3099-b841-4635-87c8-3cbfaa08b9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b3f38a44-1ddc-4f4b-ba0c-4c09af8bef92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b3f38a44-1ddc-4f4b-ba0c-4c09af8bef92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0f39b06e-9d2b-42fb-a63f-4f0a16a21186" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0f39b06e-9d2b-42fb-a63f-4f0a16a21186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_14f38ca8-001e-4818-b9e9-67d4969d44d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_14f38ca8-001e-4818-b9e9-67d4969d44d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9ac3a289-81ee-4d91-aaec-39dcbd32555e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9ac3a289-81ee-4d91-aaec-39dcbd32555e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_11480127-ef3b-4a18-b7ca-a54d739e9170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_11480127-ef3b-4a18-b7ca-a54d739e9170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3616a3ad-85ae-43e6-baa5-4af5a252bd91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3616a3ad-85ae-43e6-baa5-4af5a252bd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_82ae4219-3255-403a-aea6-925f5b12f7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_82ae4219-3255-403a-aea6-925f5b12f7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d5fd2efc-d615-4d58-9dbb-951e4bdc882c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_898992c6-a4e4-4d5a-9fb6-303b5a4c2ba9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d5fd2efc-d615-4d58-9dbb-951e4bdc882c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e15177bc-4035-4f03-be47-082e4309a280" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5464b0c6-de09-4c2a-bad1-9af10cdd2aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e15177bc-4035-4f03-be47-082e4309a280" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5464b0c6-de09-4c2a-bad1-9af10cdd2aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a5470aed-048d-4c69-86d1-33965d513366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5464b0c6-de09-4c2a-bad1-9af10cdd2aa8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a5470aed-048d-4c69-86d1-33965d513366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d986b7c9-a9e5-41f6-8223-03379fbe51cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a5470aed-048d-4c69-86d1-33965d513366" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d986b7c9-a9e5-41f6-8223-03379fbe51cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OysterPointPharmaAcquisitionMember_b19c224e-7f81-4eea-996c-07a45e84a498" xlink:href="vtrs-20230331.xsd#vtrs_OysterPointPharmaAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d986b7c9-a9e5-41f6-8223-03379fbe51cd" xlink:to="loc_vtrs_OysterPointPharmaAcquisitionMember_b19c224e-7f81-4eea-996c-07a45e84a498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5464b0c6-de09-4c2a-bad1-9af10cdd2aa8" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ac180c6c-e3fd-411a-9dc9-bd28e33c7b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ac180c6c-e3fd-411a-9dc9-bd28e33c7b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e7f1f58e-1756-4f69-8aa9-23062bb4c278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e7f1f58e-1756-4f69-8aa9-23062bb4c278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_b9544bc7-97c0-4628-a564-a70de60041fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_b9544bc7-97c0-4628-a564-a70de60041fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_55b38645-14ad-4c2a-9221-c7a5b4f6e873" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_55b38645-14ad-4c2a-9221-c7a5b4f6e873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_2c49952f-ad8e-4dd4-9f2d-d7f918e0462b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_2c49952f-ad8e-4dd4-9f2d-d7f918e0462b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_ad6d5c89-a7ba-46b7-9bb9-844d1d3094ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b993194-6942-40f8-bdd9-58bf71a1e0ba" xlink:to="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_ad6d5c89-a7ba-46b7-9bb9-844d1d3094ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DivestituresDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DivestituresDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b9844387-2198-4614-9790-7999fbbc9a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b9844387-2198-4614-9790-7999fbbc9a1f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a4704332-35a1-4c8c-8344-34194080900d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a4704332-35a1-4c8c-8344-34194080900d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ba4d9c8b-8d56-4c14-9caa-8d023d03b5be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a4704332-35a1-4c8c-8344-34194080900d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ba4d9c8b-8d56-4c14-9caa-8d023d03b5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnDistributorMarketsMember_04708f24-28d4-43e7-891b-08a3719998d3" xlink:href="vtrs-20230331.xsd#vtrs_UpjohnDistributorMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ba4d9c8b-8d56-4c14-9caa-8d023d03b5be" xlink:to="loc_vtrs_UpjohnDistributorMarketsMember_04708f24-28d4-43e7-891b-08a3719998d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_4ef3807d-8f4d-47cd-918c-245e9af6b4e3" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ba4d9c8b-8d56-4c14-9caa-8d023d03b5be" xlink:to="loc_vtrs_BioconBiologicsMember_4ef3807d-8f4d-47cd-918c-245e9af6b4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_629c08eb-1487-45b4-b144-d7ec35c364c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_629c08eb-1487-45b4-b144-d7ec35c364c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fb28eaae-599f-4606-9c76-226c1adf1f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_629c08eb-1487-45b4-b144-d7ec35c364c2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fb28eaae-599f-4606-9c76-226c1adf1f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_abbc2346-2ebe-47b9-8ca1-a2cde3b1a564" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fb28eaae-599f-4606-9c76-226c1adf1f7c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_abbc2346-2ebe-47b9-8ca1-a2cde3b1a564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_625656b0-7907-4822-8b45-d5e51cfdfa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fb28eaae-599f-4606-9c76-226c1adf1f7c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_625656b0-7907-4822-8b45-d5e51cfdfa6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4b8c3555-4772-4541-bc75-5dc8409dced2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4b8c3555-4772-4541-bc75-5dc8409dced2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_50e93eb2-f3b9-482c-a6d3-342999007f23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4b8c3555-4772-4541-bc75-5dc8409dced2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_50e93eb2-f3b9-482c-a6d3-342999007f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d798bd24-28b3-4035-a489-85a5b3b14cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d798bd24-28b3-4035-a489-85a5b3b14cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aac7c9ae-1ef2-4035-8cb0-6f70dee27d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d798bd24-28b3-4035-a489-85a5b3b14cf6" xlink:to="loc_us-gaap_SegmentDomain_aac7c9ae-1ef2-4035-8cb0-6f70dee27d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_b63989c2-40dd-4f55-8a5e-17fe08c84650" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aac7c9ae-1ef2-4035-8cb0-6f70dee27d1b" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_b63989c2-40dd-4f55-8a5e-17fe08c84650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_29044e36-d594-47ad-a00b-595ffa36fd86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_29044e36-d594-47ad-a00b-595ffa36fd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e2755f4-1fa8-4d6c-b2ef-342a8d994aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_29044e36-d594-47ad-a00b-595ffa36fd86" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e2755f4-1fa8-4d6c-b2ef-342a8d994aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoriesMember_5dab7eee-463f-4b99-8d9c-1f60a196c263" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1e2755f4-1fa8-4d6c-b2ef-342a8d994aa2" xlink:to="loc_us-gaap_InventoriesMember_5dab7eee-463f-4b99-8d9c-1f60a196c263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74960ae7-9ed5-4cfa-87df-b94f84ee76e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74960ae7-9ed5-4cfa-87df-b94f84ee76e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb505a5-6d69-486e-9bff-86beac16fa06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74960ae7-9ed5-4cfa-87df-b94f84ee76e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb505a5-6d69-486e-9bff-86beac16fa06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_644936ba-4fcf-45b0-9361-dd00cae7da89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_feb505a5-6d69-486e-9bff-86beac16fa06" xlink:to="loc_us-gaap_LicensingAgreementsMember_644936ba-4fcf-45b0-9361-dd00cae7da89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a1df876d-b2c4-43c9-b6a8-987b340b7f87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_srt_StatementScenarioAxis_a1df876d-b2c4-43c9-b6a8-987b340b7f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_612746f9-b8a9-450b-add4-3aa1cfde43fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a1df876d-b2c4-43c9-b6a8-987b340b7f87" xlink:to="loc_srt_ScenarioUnspecifiedDomain_612746f9-b8a9-450b-add4-3aa1cfde43fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e7a3e009-558d-478f-be03-23af80b4eaf4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_612746f9-b8a9-450b-add4-3aa1cfde43fd" xlink:to="loc_srt_ScenarioForecastMember_e7a3e009-558d-478f-be03-23af80b4eaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_70b3a9a0-60b8-4440-9867-9d929fb1c0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_70b3a9a0-60b8-4440-9867-9d929fb1c0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cdc73b1d-df61-41b8-814c-64d7fb72857b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_70b3a9a0-60b8-4440-9867-9d929fb1c0c6" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cdc73b1d-df61-41b8-814c-64d7fb72857b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_8454cebc-c038-4fb9-858c-b5735c940692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cdc73b1d-df61-41b8-814c-64d7fb72857b" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_8454cebc-c038-4fb9-858c-b5735c940692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d3285fe9-918c-4ba0-9065-966ff1a1c2d2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_dae6e92f-53a0-49c6-9faf-ff71c37c02b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_AssetImpairmentCharges_dae6e92f-53a0-49c6-9faf-ff71c37c02b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f7a4a6a0-7e88-41db-b0df-4e08bd531438" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f7a4a6a0-7e88-41db-b0df-4e08bd531438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2beda488-c5ba-43d0-8065-e6bc4d2d4092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2beda488-c5ba-43d0-8065-e6bc4d2d4092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_120cff7e-aab2-43a3-b46e-81a718b63e94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_InventoryValuationReserves_120cff7e-aab2-43a3-b46e-81a718b63e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear_5039dd39-6652-4296-95bf-f08aad0d49a2" xlink:href="vtrs-20230331.xsd#vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear_5039dd39-6652-4296-95bf-f08aad0d49a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_978d4f4d-6ba6-43b2-9002-aa9143c38d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_978d4f4d-6ba6-43b2-9002-aa9143c38d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_46f0b7d3-4da9-42c2-970f-506f9fffab78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_46f0b7d3-4da9-42c2-970f-506f9fffab78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_163e0918-9f5d-43eb-b7b8-5894d2645ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_163e0918-9f5d-43eb-b7b8-5894d2645ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_78cc248d-4ab5-48d0-9573-5340dfa5dbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_78cc248d-4ab5-48d0-9573-5340dfa5dbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset_b8b82c81-33b6-489e-83a1-cfe4b7b5f108" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset_b8b82c81-33b6-489e-83a1-cfe4b7b5f108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm_80db9b8f-73c9-480b-90fc-f661ff20a4ab" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm_80db9b8f-73c9-480b-90fc-f661ff20a4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration_d77c6729-cd68-40e7-ab86-39fe22350677" xlink:href="vtrs-20230331.xsd#vtrs_DivestitureOfBusinessDeferredCashConsideration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration_d77c6729-cd68-40e7-ab86-39fe22350677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment_00c7a859-0567-41bc-a59a-ee0fa64c3671" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment_00c7a859-0567-41bc-a59a-ee0fa64c3671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ba052728-ad41-41fd-995b-8418ca749306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7899830e-008e-4bb2-9c90-a2fa54dda30f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ba052728-ad41-41fd-995b-8418ca749306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ShareBasedIncentivePlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c87941f4-2e8e-404e-b80a-688f4007a3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c87941f4-2e8e-404e-b80a-688f4007a3ce" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_82657c22-7e54-454c-a6af-2855052da863" xlink:href="vtrs-20230331.xsd#vtrs_ProgramNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_vtrs_ProgramNameAxis_82657c22-7e54-454c-a6af-2855052da863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_47e28c1c-1b4d-4ee9-a507-4993ddee8c16" xlink:href="vtrs-20230331.xsd#vtrs_ProgramNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ProgramNameAxis_82657c22-7e54-454c-a6af-2855052da863" xlink:to="loc_vtrs_ProgramNameDomain_47e28c1c-1b4d-4ee9-a507-4993ddee8c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8b42ae3a-26cd-4125-8bba-22bc1c66cbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_us-gaap_PlanNameAxis_8b42ae3a-26cd-4125-8bba-22bc1c66cbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_72ada1cd-2b96-49db-8fdc-399ebe5c22be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_8b42ae3a-26cd-4125-8bba-22bc1c66cbc7" xlink:to="loc_us-gaap_PlanNameDomain_72ada1cd-2b96-49db-8fdc-399ebe5c22be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_51f74af8-2889-4ae2-b7cd-d808742f924b" xlink:href="vtrs-20230331.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_72ada1cd-2b96-49db-8fdc-399ebe5c22be" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_51f74af8-2889-4ae2-b7cd-d808742f924b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_7abe44cf-edb8-4fdf-8bef-365177999bbc" xlink:href="vtrs-20230331.xsd#vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_72ada1cd-2b96-49db-8fdc-399ebe5c22be" xlink:to="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_7abe44cf-edb8-4fdf-8bef-365177999bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6851ce41-f446-435c-868f-d52f1a5287d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_us-gaap_AwardTypeAxis_6851ce41-f446-435c-868f-d52f1a5287d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7998055b-ae70-48fe-941b-84d4f2126386" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6851ce41-f446-435c-868f-d52f1a5287d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7998055b-ae70-48fe-941b-84d4f2126386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e66b3489-0af1-43d0-9aca-ee27941ab2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7998055b-ae70-48fe-941b-84d4f2126386" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e66b3489-0af1-43d0-9aca-ee27941ab2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_81b20e6a-9628-443e-90de-457e8e14001f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_srt_RangeAxis_81b20e6a-9628-443e-90de-457e8e14001f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e139056-4063-420e-9f41-3b5da127d95c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_81b20e6a-9628-443e-90de-457e8e14001f" xlink:to="loc_srt_RangeMember_6e139056-4063-420e-9f41-3b5da127d95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e5f96941-9368-467e-b7ce-40cbc99c3012" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e139056-4063-420e-9f41-3b5da127d95c" xlink:to="loc_srt_MinimumMember_e5f96941-9368-467e-b7ce-40cbc99c3012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1a67b0ab-7811-4e19-a0c9-29fb4c04b34e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e139056-4063-420e-9f41-3b5da127d95c" xlink:to="loc_srt_MaximumMember_1a67b0ab-7811-4e19-a0c9-29fb4c04b34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d885892b-2d1e-4107-8d6f-e1b2f144e21d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d885892b-2d1e-4107-8d6f-e1b2f144e21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_27d1296c-a61f-40f3-a8fb-d66c47e2a05e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d885892b-2d1e-4107-8d6f-e1b2f144e21d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_27d1296c-a61f-40f3-a8fb-d66c47e2a05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_612d0e97-b701-4296-a70a-e97e86708ad8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_957a1762-0ec5-477f-830a-b66dd609b3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_957a1762-0ec5-477f-830a-b66dd609b3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_385e24aa-09a3-46fa-8f0b-5012d128ddb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_385e24aa-09a3-46fa-8f0b-5012d128ddb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8988cb5f-e1cd-4b96-9dd1-f05cb4dd2588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8988cb5f-e1cd-4b96-9dd1-f05cb4dd2588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_14e3599a-18ae-429b-9e1c-03cc27a3446b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_14e3599a-18ae-429b-9e1c-03cc27a3446b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5b2d0813-8055-4618-bb2a-8b05da9ce4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5b2d0813-8055-4618-bb2a-8b05da9ce4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_995e3599-94b6-445b-acbc-b69944a377e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_995e3599-94b6-445b-acbc-b69944a377e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_97407ab1-aea5-4049-8727-54fca6620e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_97407ab1-aea5-4049-8727-54fca6620e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8ce081a2-3b35-4147-992f-cc67a9b677bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8ce081a2-3b35-4147-992f-cc67a9b677bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_01b18683-ccb7-446a-8383-a90493a163f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_01b18683-ccb7-446a-8383-a90493a163f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_101c15d8-b254-4353-89db-8803af3345c8" xlink:href="vtrs-20230331.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_101c15d8-b254-4353-89db-8803af3345c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5f5648ed-2419-410c-a5dd-6202990919a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5f5648ed-2419-410c-a5dd-6202990919a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1c305088-45df-442b-ac25-016e331b48a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1c305088-45df-442b-ac25-016e331b48a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_19a03e74-531c-4679-8e04-eb6c5be8cbec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_19a03e74-531c-4679-8e04-eb6c5be8cbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1773e42a-85a7-4078-a85c-b4d064c26609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1773e42a-85a7-4078-a85c-b4d064c26609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_9822099b-39fe-4766-a887-6245154b8f49" xlink:href="vtrs-20230331.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9da32ae9-64c7-407c-b820-1f66dc236644" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_9822099b-39fe-4766-a887-6245154b8f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ShareBasedIncentivePlanStockAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_71306ee6-50ff-4e64-b80e-93b00eb5f461" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_71306ee6-50ff-4e64-b80e-93b00eb5f461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_614cbcb8-e4a3-4bd9-955d-8592e796b392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_614cbcb8-e4a3-4bd9-955d-8592e796b392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ec0dcec1-df71-4b4f-bec5-7db181769e89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ec0dcec1-df71-4b4f-bec5-7db181769e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6d929c8b-030f-46f7-89f4-5a1de43dd2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6d929c8b-030f-46f7-89f4-5a1de43dd2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e3d7718e-b0f9-4c5d-8881-bbad4c081426" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e3d7718e-b0f9-4c5d-8881-bbad4c081426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_220a3b92-bea7-4e3e-aadd-0c0762461a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_220a3b92-bea7-4e3e-aadd-0c0762461a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4dfa9ac4-9b13-4c98-8d5d-c94c3febbf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4dfa9ac4-9b13-4c98-8d5d-c94c3febbf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fdb36bd1-db87-4370-8338-85129532821b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fdb36bd1-db87-4370-8338-85129532821b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b540d937-9b17-4e4d-8248-9e425337c927" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b540d937-9b17-4e4d-8248-9e425337c927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6f9c5da4-bf26-4514-8a2c-65ffa2a56b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6f9c5da4-bf26-4514-8a2c-65ffa2a56b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_7dfc41de-a376-41f7-ae89-d936c46612ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_7dfc41de-a376-41f7-ae89-d936c46612ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0622b820-7322-45ad-9da3-6be0a9617050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0622b820-7322-45ad-9da3-6be0a9617050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e2b1f33b-20b3-414f-8810-6a67ea68dd09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_824b0b90-2aba-47e6-87c9-5c6a48cd87dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e2b1f33b-20b3-414f-8810-6a67ea68dd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_51d99ed1-ed59-4ffd-8b6a-9ddec2420777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94cdf3de-850c-49c0-b2c4-78a25e4e2385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_51d99ed1-ed59-4ffd-8b6a-9ddec2420777" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94cdf3de-850c-49c0-b2c4-78a25e4e2385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_60ff8966-79dc-4e06-91fe-14f88ed2107b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94cdf3de-850c-49c0-b2c4-78a25e4e2385" xlink:to="loc_us-gaap_AwardTypeAxis_60ff8966-79dc-4e06-91fe-14f88ed2107b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_056c00d4-9ddb-4eff-ae55-214928453263" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_60ff8966-79dc-4e06-91fe-14f88ed2107b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_056c00d4-9ddb-4eff-ae55-214928453263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d41e4a00-53e4-4d57-ae71-ac22b75c2f29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_056c00d4-9ddb-4eff-ae55-214928453263" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d41e4a00-53e4-4d57-ae71-ac22b75c2f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ee54b57d-91fd-49ac-8a27-2b72272a7b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94cdf3de-850c-49c0-b2c4-78a25e4e2385" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ee54b57d-91fd-49ac-8a27-2b72272a7b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ee54b57d-91fd-49ac-8a27-2b72272a7b0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1b24e29a-ca93-4ea0-8949-25d1b58d32b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1b24e29a-ca93-4ea0-8949-25d1b58d32b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_138f4393-131a-443e-bf2e-4a2fcd381041" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_138f4393-131a-443e-bf2e-4a2fcd381041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99fdb2dd-07ce-4714-bd3f-219e15872fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99fdb2dd-07ce-4714-bd3f-219e15872fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23af23cf-345c-4004-9fc0-51c4a9bafd77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23af23cf-345c-4004-9fc0-51c4a9bafd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a849202a-9673-48bd-a97f-c08727b1f446" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a849202a-9673-48bd-a97f-c08727b1f446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8f6d7657-8dcc-4af1-a3aa-f4f36d781a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8f6d7657-8dcc-4af1-a3aa-f4f36d781a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_453ffa32-5b0d-4088-83fd-fe3e47f1750a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_453ffa32-5b0d-4088-83fd-fe3e47f1750a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9a7e782d-864e-47a2-ace6-a6204a2c29a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9a7e782d-864e-47a2-ace6-a6204a2c29a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9110b1e8-925c-491e-8cf3-a07896b55659" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9110b1e8-925c-491e-8cf3-a07896b55659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_51e27424-5467-4f65-a1e9-bbfd938ac646" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cfc88f7d-f9de-4c58-a37e-5ed4a3cea4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_51e27424-5467-4f65-a1e9-bbfd938ac646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#PensionandOtherPostretirementBenefitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf588f03-5fec-4ffc-9c00-070e954b363f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cd667ea8-2c7b-48f3-bf2e-3bbfa958363b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf588f03-5fec-4ffc-9c00-070e954b363f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cd667ea8-2c7b-48f3-bf2e-3bbfa958363b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92ecba37-1ff2-4dc8-a842-aaea038398c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cd667ea8-2c7b-48f3-bf2e-3bbfa958363b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92ecba37-1ff2-4dc8-a842-aaea038398c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5521433e-5d03-4801-a436-e12e0c2ba22d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92ecba37-1ff2-4dc8-a842-aaea038398c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5521433e-5d03-4801-a436-e12e0c2ba22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0700e590-3ebc-4c86-a2d1-5d02bb7964f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cd667ea8-2c7b-48f3-bf2e-3bbfa958363b" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0700e590-3ebc-4c86-a2d1-5d02bb7964f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_5c3520e3-05e4-4062-99a9-90fcff53cc5d" xlink:href="vtrs-20230331.xsd#vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0700e590-3ebc-4c86-a2d1-5d02bb7964f4" xlink:to="loc_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear_5c3520e3-05e4-4062-99a9-90fcff53cc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_7f3c6ee1-cc2c-41b2-ad43-fa0c24750b34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0700e590-3ebc-4c86-a2d1-5d02bb7964f4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_7f3c6ee1-cc2c-41b2-ad43-fa0c24750b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f6bb446-124c-460a-be4b-d1d5aa97b094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f6bb446-124c-460a-be4b-d1d5aa97b094" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_41bd4e8f-3f5e-4c2b-b8ed-f8c9c6b4bf64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_41bd4e8f-3f5e-4c2b-b8ed-f8c9c6b4bf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_643fe5ba-9661-4474-942a-0528d3722413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_41bd4e8f-3f5e-4c2b-b8ed-f8c9c6b4bf64" xlink:to="loc_us-gaap_EquityComponentDomain_643fe5ba-9661-4474-942a-0528d3722413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_6da67ea3-a9bb-49ec-b55a-3009207b652a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_643fe5ba-9661-4474-942a-0528d3722413" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_6da67ea3-a9bb-49ec-b55a-3009207b652a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_df186d78-80c7-4bf0-b80e-8537291a02c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_df186d78-80c7-4bf0-b80e-8537291a02c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_462db345-2836-4b2b-8065-303553d47f39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_df186d78-80c7-4bf0-b80e-8537291a02c9" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_462db345-2836-4b2b-8065-303553d47f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_7dd2ad58-cc40-4987-a4c4-48a04c0016f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_462db345-2836-4b2b-8065-303553d47f39" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_7dd2ad58-cc40-4987-a4c4-48a04c0016f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_003b4ab4-b645-4208-b00f-3606b2cb2b15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_003b4ab4-b645-4208-b00f-3606b2cb2b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_14fd380c-4610-4d27-a5a0-88cf9887e415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_003b4ab4-b645-4208-b00f-3606b2cb2b15" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_14fd380c-4610-4d27-a5a0-88cf9887e415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_7fcebfa6-8f2e-4821-b13b-7f98e0185f93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_14fd380c-4610-4d27-a5a0-88cf9887e415" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_7fcebfa6-8f2e-4821-b13b-7f98e0185f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c935a5e9-a0c9-432f-887d-59e1f31a6843" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_0e946326-ffe4-4840-a8d8-0f0caaa48e78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_0e946326-ffe4-4840-a8d8-0f0caaa48e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6267b0da-8bfb-47d0-a89e-a2a66dde19e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6267b0da-8bfb-47d0-a89e-a2a66dde19e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_04cc7810-db1f-4dab-81e0-d61ba1abcc68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_04cc7810-db1f-4dab-81e0-d61ba1abcc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_29c0ffd3-c4d2-4d94-8090-00cdc9944eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_29c0ffd3-c4d2-4d94-8090-00cdc9944eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_561cffa0-fa66-43c3-b33e-3708a55f680a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_561cffa0-fa66-43c3-b33e-3708a55f680a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0114ee9d-3973-4960-8887-88be361379a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0944fcc8-76a5-4b21-97ba-9eeb5a19b9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0114ee9d-3973-4960-8887-88be361379a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_4835bcbb-6478-4501-841f-7d1f768cc13b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d56da684-6a97-4684-a7d1-1777a11401e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_4835bcbb-6478-4501-841f-7d1f768cc13b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d56da684-6a97-4684-a7d1-1777a11401e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f007143b-7b4d-4e6d-82b8-ae75cd1adeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_4835bcbb-6478-4501-841f-7d1f768cc13b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f007143b-7b4d-4e6d-82b8-ae75cd1adeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2547db76-c235-4cb4-a0ea-46e792f03518" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_4835bcbb-6478-4501-841f-7d1f768cc13b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2547db76-c235-4cb4-a0ea-46e792f03518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_f914a83f-8e34-4ada-923d-55f6ea791361" xlink:href="vtrs-20230331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d2ac2395-7a41-4dcc-ba49-865b23bd01dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_f914a83f-8e34-4ada-923d-55f6ea791361" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d2ac2395-7a41-4dcc-ba49-865b23bd01dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2627509d-0d1e-416b-89ca-0daf67e74107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_f914a83f-8e34-4ada-923d-55f6ea791361" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2627509d-0d1e-416b-89ca-0daf67e74107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a64994a6-47f1-4d73-abd4-b7967511f889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_f914a83f-8e34-4ada-923d-55f6ea791361" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a64994a6-47f1-4d73-abd4-b7967511f889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_200e9f8b-502f-4c6b-80eb-26810b1fb938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_f914a83f-8e34-4ada-923d-55f6ea791361" xlink:to="loc_us-gaap_InventoryNet_200e9f8b-502f-4c6b-80eb-26810b1fb938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_32564700-0ac1-42ef-aeb5-2b89110e88fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_32564700-0ac1-42ef-aeb5-2b89110e88fd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_675154f9-3509-41a5-be4e-350e566e68e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_675154f9-3509-41a5-be4e-350e566e68e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7100fc04-b128-49fc-af18-8c56576ea15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_675154f9-3509-41a5-be4e-350e566e68e8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7100fc04-b128-49fc-af18-8c56576ea15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_a4aac792-f653-4126-b6ff-956f61683085" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7100fc04-b128-49fc-af18-8c56576ea15e" xlink:to="loc_us-gaap_DebtSecuritiesMember_a4aac792-f653-4126-b6ff-956f61683085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_deebee6d-9c4a-42e8-9013-10132c99acf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_deebee6d-9c4a-42e8-9013-10132c99acf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_43395db5-d921-40d7-86b4-4d4617797390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_deebee6d-9c4a-42e8-9013-10132c99acf6" xlink:to="loc_us-gaap_ReceivableTypeDomain_43395db5-d921-40d7-86b4-4d4617797390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_ca8d144a-fa04-43e8-9c2f-4287c8d87dae" xlink:href="vtrs-20230331.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_43395db5-d921-40d7-86b4-4d4617797390" xlink:to="loc_vtrs_VariableConsiderationMember_ca8d144a-fa04-43e8-9c2f-4287c8d87dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_dad5af67-e923-47e7-92be-5b0547764f96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_dad5af67-e923-47e7-92be-5b0547764f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_073950a4-ae50-43d7-87c8-d4964389b4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_dad5af67-e923-47e7-92be-5b0547764f96" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_073950a4-ae50-43d7-87c8-d4964389b4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_7a3851c8-6761-4eb0-badb-2e7163bae866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_073950a4-ae50-43d7-87c8-d4964389b4f7" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_7a3851c8-6761-4eb0-badb-2e7163bae866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5cee3fac-42df-4799-885f-cb5834fb38b9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_dd739ec2-9783-4a30-bd6c-bf6abd5a0e06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_dd739ec2-9783-4a30-bd6c-bf6abd5a0e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3aa2bffa-d682-4bb6-87c1-0d8f11f8e12d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3aa2bffa-d682-4bb6-87c1-0d8f11f8e12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_48bf2e6c-d1c0-47c6-91ce-d37c734d4720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_48bf2e6c-d1c0-47c6-91ce-d37c734d4720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_a8cad799-dfcf-4d5b-9e0c-cea7f3201c94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_TradingSecurities_a8cad799-dfcf-4d5b-9e0c-cea7f3201c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_46cb2e5b-f002-42e5-9ae4-36c8247130ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_OtherAssetsCurrent_46cb2e5b-f002-42e5-9ae4-36c8247130ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1f96459f-e4a3-43b9-bbbe-b11066618161" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_26a986c0-ce49-42d2-b78b-07ef18c17e3f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1f96459f-e4a3-43b9-bbbe-b11066618161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_7b3c48be-34f8-4d7f-b2aa-e0268d119447" xlink:href="vtrs-20230331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ad78e031-09a1-4d01-9a16-d5adbb0a3878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_7b3c48be-34f8-4d7f-b2aa-e0268d119447" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ad78e031-09a1-4d01-9a16-d5adbb0a3878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ee029ee2-ffe5-4051-beb7-536c1429fb03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ad78e031-09a1-4d01-9a16-d5adbb0a3878" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ee029ee2-ffe5-4051-beb7-536c1429fb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ee029ee2-ffe5-4051-beb7-536c1429fb03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1cf9cf3b-b252-450b-9c68-7c48032048b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1cf9cf3b-b252-450b-9c68-7c48032048b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_57230a72-af36-4c02-92e0-5146db5b1a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_57230a72-af36-4c02-92e0-5146db5b1a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_78b8ac3f-880c-4907-86c7-109a21fbf568" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:to="loc_us-gaap_ConstructionInProgressMember_78b8ac3f-880c-4907-86c7-109a21fbf568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_1c5c6630-9a7f-489a-bb25-6c3245dcd8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_48250aa8-2d13-4ca6-b7f5-6a251ec303fb" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_1c5c6630-9a7f-489a-bb25-6c3245dcd8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ad78e031-09a1-4d01-9a16-d5adbb0a3878" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_72912026-c39d-421b-9225-a5a8950c9c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_72912026-c39d-421b-9225-a5a8950c9c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1477f249-6672-4ed4-bba7-22f443ba1acd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1477f249-6672-4ed4-bba7-22f443ba1acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a7830a38-0f8b-47d1-8a96-57f1c81a3f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf4a4ca1-1c70-4678-abd4-796493f54efe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a7830a38-0f8b-47d1-8a96-57f1c81a3f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_9e8d8ad5-ed38-4c84-ae15-cede8382b9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_11334a61-7040-4b5d-a417-4c108b4ecaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_9e8d8ad5-ed38-4c84-ae15-cede8382b9dd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_11334a61-7040-4b5d-a417-4c108b4ecaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets_74abc50f-0500-4d95-9eac-fc8a934a93dd" xlink:href="vtrs-20230331.xsd#vtrs_Otherlongtermassets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_9e8d8ad5-ed38-4c84-ae15-cede8382b9dd" xlink:to="loc_vtrs_Otherlongtermassets_74abc50f-0500-4d95-9eac-fc8a934a93dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_940161a5-1cce-413f-8bfd-a1c7f0132036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_9e8d8ad5-ed38-4c84-ae15-cede8382b9dd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_940161a5-1cce-413f-8bfd-a1c7f0132036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0bad24c7-32de-46a9-990a-f65654203d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_9e8d8ad5-ed38-4c84-ae15-cede8382b9dd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0bad24c7-32de-46a9-990a-f65654203d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ab86d838-375b-4647-92d5-56fb30eca569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0bad24c7-32de-46a9-990a-f65654203d4c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ab86d838-375b-4647-92d5-56fb30eca569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86299ba0-0743-4a81-82bd-38154f7aee20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ab86d838-375b-4647-92d5-56fb30eca569" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86299ba0-0743-4a81-82bd-38154f7aee20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_a42f77f7-fbd3-4ea0-9192-33f9b23a75e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86299ba0-0743-4a81-82bd-38154f7aee20" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_a42f77f7-fbd3-4ea0-9192-33f9b23a75e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PrivateEquitySecuritiesMember_296e5b23-5234-410a-be54-18a35208c069" xlink:href="vtrs-20230331.xsd#vtrs_PrivateEquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86299ba0-0743-4a81-82bd-38154f7aee20" xlink:to="loc_vtrs_PrivateEquitySecuritiesMember_296e5b23-5234-410a-be54-18a35208c069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7d89a723-cef0-4dff-872e-59162760e9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0bad24c7-32de-46a9-990a-f65654203d4c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7d89a723-cef0-4dff-872e-59162760e9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a899479d-5e70-4588-b1d7-1bd83e3660fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7d89a723-cef0-4dff-872e-59162760e9ea" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a899479d-5e70-4588-b1d7-1bd83e3660fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_8374c97b-a906-4e93-90e0-210b2ed5a811" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a899479d-5e70-4588-b1d7-1bd83e3660fc" xlink:to="loc_vtrs_BioconBiologicsMember_8374c97b-a906-4e93-90e0-210b2ed5a811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3d1a15b7-0cc7-4e2d-8823-5e5415941fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0bad24c7-32de-46a9-990a-f65654203d4c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3d1a15b7-0cc7-4e2d-8823-5e5415941fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_096fa825-3677-40d8-8820-9afdf9c77feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3d1a15b7-0cc7-4e2d-8823-5e5415941fe7" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_096fa825-3677-40d8-8820-9afdf9c77feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue_a8ead4d8-7f72-4d3b-8110-801f6ffee164" xlink:href="vtrs-20230331.xsd#vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3d1a15b7-0cc7-4e2d-8823-5e5415941fe7" xlink:to="loc_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue_a8ead4d8-7f72-4d3b-8110-801f6ffee164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsTradeAccountsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAbstract_f1ea8996-2f88-4efb-9a05-4b61c66c2115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_4d364b17-09fa-4fca-8e36-dd0a06150960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract_f1ea8996-2f88-4efb-9a05-4b61c66c2115" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_4d364b17-09fa-4fca-8e36-dd0a06150960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_4b53daa0-9379-42a5-987a-1b3c369a430b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract_f1ea8996-2f88-4efb-9a05-4b61c66c2115" xlink:to="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_4b53daa0-9379-42a5-987a-1b3c369a430b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_c152734a-649f-4dad-af0f-6370d0cc734e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract_f1ea8996-2f88-4efb-9a05-4b61c66c2115" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_c152734a-649f-4dad-af0f-6370d0cc734e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_d4aaf432-f6c0-448c-b6aa-9e142cedcca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesTable_3cfac0ce-1ccc-4724-9afd-2b847074eb75" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofothercurrentliabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_d4aaf432-f6c0-448c-b6aa-9e142cedcca1" xlink:to="loc_vtrs_ScheduleofothercurrentliabilitiesTable_3cfac0ce-1ccc-4724-9afd-2b847074eb75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_57748248-07bf-4d99-b281-4e9ea130864e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_3cfac0ce-1ccc-4724-9afd-2b847074eb75" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_57748248-07bf-4d99-b281-4e9ea130864e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_c922c9c7-fe6d-465e-b4ab-a4c6c89c78f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_57748248-07bf-4d99-b281-4e9ea130864e" xlink:to="loc_us-gaap_ReceivableTypeDomain_c922c9c7-fe6d-465e-b4ab-a4c6c89c78f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_062bbd6f-45b5-4a8a-8f86-f7bd3996d02a" xlink:href="vtrs-20230331.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_c922c9c7-fe6d-465e-b4ab-a4c6c89c78f1" xlink:to="loc_vtrs_VariableConsiderationMember_062bbd6f-45b5-4a8a-8f86-f7bd3996d02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_187f8099-95c6-4c45-b8a1-dbbef088456d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_3cfac0ce-1ccc-4724-9afd-2b847074eb75" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_187f8099-95c6-4c45-b8a1-dbbef088456d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4e80fcab-ede9-4c74-91da-f1330e605947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_187f8099-95c6-4c45-b8a1-dbbef088456d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4e80fcab-ede9-4c74-91da-f1330e605947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b679aa53-e6c5-4153-b0cb-58e4313a4f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4e80fcab-ede9-4c74-91da-f1330e605947" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b679aa53-e6c5-4153-b0cb-58e4313a4f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofothercurrentliabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_3cfac0ce-1ccc-4724-9afd-2b847074eb75" xlink:to="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_059543e0-2fde-4134-9f23-70ae4bfd743a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_059543e0-2fde-4134-9f23-70ae4bfd743a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_6f9bffcb-f38a-4a20-a528-a5317f445204" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_LitigationReserveCurrent_6f9bffcb-f38a-4a20-a528-a5317f445204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_390218e7-f56e-46dd-9622-2c3fb7f4da58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_390218e7-f56e-46dd-9622-2c3fb7f4da58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a3b82818-7649-4eb5-b4e5-b2b48f2b400a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a3b82818-7649-4eb5-b4e5-b2b48f2b400a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_fdd43865-829b-4716-b7b7-205803ce371f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_RestructuringReserveCurrent_fdd43865-829b-4716-b7b7-205803ce371f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_56a59e41-2a1d-4d14-adf9-4ca8c873b69b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_InterestPayableCurrent_56a59e41-2a1d-4d14-adf9-4ca8c873b69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_db6fd243-20fe-4914-affc-e6c2d1f7361e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_db6fd243-20fe-4914-affc-e6c2d1f7361e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7122fb9d-eda1-433e-9a25-444d6d72cc05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7122fb9d-eda1-433e-9a25-444d6d72cc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_176d55a8-9be4-484a-9311-516ba08aee3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_176d55a8-9be4-484a-9311-516ba08aee3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_10b1467f-8129-4ef7-8cbe-be0e61118812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_10b1467f-8129-4ef7-8cbe-be0e61118812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e4c89433-ce9f-4895-877b-30b38a9e3b20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_4e0b71e7-b5a0-435e-9ece-33f5b8557737" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e4c89433-ce9f-4895-877b-30b38a9e3b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsOtherLongtermObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_909c6ab5-51ba-45af-b5d0-e09e09dfe378" xlink:href="vtrs-20230331.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_cacb287f-a353-4fdb-9e03-b211577ad4fc" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_909c6ab5-51ba-45af-b5d0-e09e09dfe378" xlink:to="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_cacb287f-a353-4fdb-9e03-b211577ad4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_58126a8d-9a65-4346-a0a6-0cf2bfde0a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_cacb287f-a353-4fdb-9e03-b211577ad4fc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_58126a8d-9a65-4346-a0a6-0cf2bfde0a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ae3b1c96-5a5f-45eb-8109-0d15c05780c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_58126a8d-9a65-4346-a0a6-0cf2bfde0a4d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ae3b1c96-5a5f-45eb-8109-0d15c05780c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_63caf348-012b-4201-b21f-10e5c8d2d8db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ae3b1c96-5a5f-45eb-8109-0d15c05780c3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_63caf348-012b-4201-b21f-10e5c8d2d8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_cacb287f-a353-4fdb-9e03-b211577ad4fc" xlink:to="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_db3ffab9-3518-486b-ac75-6186af795e82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_db3ffab9-3518-486b-ac75-6186af795e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_84e09cfd-92cf-43bc-8a66-6984ca07fa1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_84e09cfd-92cf-43bc-8a66-6984ca07fa1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_00285d77-d838-464f-a78f-0e6572d77f25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_00285d77-d838-464f-a78f-0e6572d77f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_19cc7c81-1850-403c-beda-46089f9ad1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_19cc7c81-1850-403c-beda-46089f9ad1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_1380aea3-2ceb-4a5c-9e74-9a0099e8349e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_1380aea3-2ceb-4a5c-9e74-9a0099e8349e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_594295d5-d660-4f8f-8b30-b95eefcf7d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_594295d5-d660-4f8f-8b30-b95eefcf7d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ede59934-4fdb-4c27-bfd7-a341fda88bef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_5c0d771e-9c4b-472f-ba36-f710d5d68d0d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ede59934-4fdb-4c27-bfd7-a341fda88bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36f04606-d6c3-47b2-873b-fe219571aaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36f04606-d6c3-47b2-873b-fe219571aaf3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_23923952-553d-433b-a539-be1e5e501d28" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:to="loc_srt_StatementScenarioAxis_23923952-553d-433b-a539-be1e5e501d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e2c82fa6-7110-4f61-a46d-cbb6f8b95e46" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_23923952-553d-433b-a539-be1e5e501d28" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e2c82fa6-7110-4f61-a46d-cbb6f8b95e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_ad0af8fe-a394-462c-b034-0ca3841b7a9d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_e2c82fa6-7110-4f61-a46d-cbb6f8b95e46" xlink:to="loc_srt_ScenarioForecastMember_ad0af8fe-a394-462c-b034-0ca3841b7a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e60992fa-7f5b-4ef0-b0ea-56cdf52cc324" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:to="loc_srt_CounterpartyNameAxis_e60992fa-7f5b-4ef0-b0ea-56cdf52cc324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1ef52c3-3a55-40cd-95ee-70215ade05c6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e60992fa-7f5b-4ef0-b0ea-56cdf52cc324" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1ef52c3-3a55-40cd-95ee-70215ade05c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_ff924ebc-ecc3-4bed-9272-419e86a2ccb0" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1ef52c3-3a55-40cd-95ee-70215ade05c6" xlink:to="loc_vtrs_BioconBiologicsMember_ff924ebc-ecc3-4bed-9272-419e86a2ccb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_b6702d4d-bcf4-4cc0-986f-8d3d941147cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_b6702d4d-bcf4-4cc0-986f-8d3d941147cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_2c09eaf7-bbaa-4562-9c51-c9802b60c8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_b6702d4d-bcf4-4cc0-986f-8d3d941147cc" xlink:to="loc_us-gaap_ReceivableTypeDomain_2c09eaf7-bbaa-4562-9c51-c9802b60c8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_15e7829b-f5d9-49d4-99d0-c0f181583ab6" xlink:href="vtrs-20230331.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_2c09eaf7-bbaa-4562-9c51-c9802b60c8dc" xlink:to="loc_vtrs_VariableConsiderationMember_15e7829b-f5d9-49d4-99d0-c0f181583ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_48e1b397-0705-4c65-8106-737a3ebb0d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_48e1b397-0705-4c65-8106-737a3ebb0d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e44635ab-68ef-4635-a310-2b1f96b7828c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_48e1b397-0705-4c65-8106-737a3ebb0d41" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e44635ab-68ef-4635-a310-2b1f96b7828c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_655286bd-df0f-4160-be88-75276573b6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e44635ab-68ef-4635-a310-2b1f96b7828c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_655286bd-df0f-4160-be88-75276573b6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8959f880-0fac-4cff-9404-3ecda6675503" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_552fbece-4190-4e45-9bbc-a8af591c31e6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8959f880-0fac-4cff-9404-3ecda6675503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_14a73417-6100-4176-87db-00a02bb2a3da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8959f880-0fac-4cff-9404-3ecda6675503" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_14a73417-6100-4176-87db-00a02bb2a3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e58896b0-77b0-4821-9a8a-f9b90780401d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8959f880-0fac-4cff-9404-3ecda6675503" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e58896b0-77b0-4821-9a8a-f9b90780401d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#EarningsLossperOrdinaryShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_12c7f2e9-a849-4fa2-9442-94d8804ac54b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0820e076-40bc-4a54-b73f-d59f84a80456" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12c7f2e9-a849-4fa2-9442-94d8804ac54b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0820e076-40bc-4a54-b73f-d59f84a80456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78fde674-f875-4eaf-9aff-266ed800b1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12c7f2e9-a849-4fa2-9442-94d8804ac54b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78fde674-f875-4eaf-9aff-266ed800b1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_214720a3-f05f-48ea-82b4-e6033b9dd1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12c7f2e9-a849-4fa2-9442-94d8804ac54b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_214720a3-f05f-48ea-82b4-e6033b9dd1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_cad5843b-158a-4f50-b8d8-bde0db0e0b94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12c7f2e9-a849-4fa2-9442-94d8804ac54b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_cad5843b-158a-4f50-b8d8-bde0db0e0b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3cd400fa-ab82-4993-8aca-c4d4c01eea38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12c7f2e9-a849-4fa2-9442-94d8804ac54b" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3cd400fa-ab82-4993-8aca-c4d4c01eea38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_29a9c788-adf9-4588-bedb-c62b7303624a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f575613a-3c06-4018-a79a-eb8525998db3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29a9c788-adf9-4588-bedb-c62b7303624a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f575613a-3c06-4018-a79a-eb8525998db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_deb86d5b-8e47-4a5e-a1b4-af572118c63a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29a9c788-adf9-4588-bedb-c62b7303624a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_deb86d5b-8e47-4a5e-a1b4-af572118c63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_03725eaf-9201-4e40-ac86-58a45b9697ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29a9c788-adf9-4588-bedb-c62b7303624a" xlink:to="loc_us-gaap_EarningsPerShareBasic_03725eaf-9201-4e40-ac86-58a45b9697ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d79b612e-14ab-4eec-a588-47efafd65c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29a9c788-adf9-4588-bedb-c62b7303624a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d79b612e-14ab-4eec-a588-47efafd65c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1094d9c-376a-4c66-bff7-b4ad9e71985e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29a9c788-adf9-4588-bedb-c62b7303624a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1094d9c-376a-4c66-bff7-b4ad9e71985e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_84b3a016-46aa-47e4-b659-950a782f0226" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29a9c788-adf9-4588-bedb-c62b7303624a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_84b3a016-46aa-47e4-b659-950a782f0226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a6439527-1005-4484-b448-2fe8d4aebc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a6439527-1005-4484-b448-2fe8d4aebc8f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f40f8091-45cf-4766-b179-d96971568635" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_srt_ConsolidationItemsAxis_f40f8091-45cf-4766-b179-d96971568635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6e365876-660e-4a56-bc30-c2b6991fb000" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f40f8091-45cf-4766-b179-d96971568635" xlink:to="loc_srt_ConsolidationItemsDomain_6e365876-660e-4a56-bc30-c2b6991fb000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_95935ffb-28d5-43c3-9d2e-29976de32154" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6e365876-660e-4a56-bc30-c2b6991fb000" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_95935ffb-28d5-43c3-9d2e-29976de32154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8786a33c-2f92-41ef-b8b1-85ed1d24caf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8786a33c-2f92-41ef-b8b1-85ed1d24caf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_04bfceae-5c38-485a-8626-b0f4b2a2744a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8786a33c-2f92-41ef-b8b1-85ed1d24caf9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_04bfceae-5c38-485a-8626-b0f4b2a2744a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_60296c89-7a91-4960-953a-1b4b00173982" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_04bfceae-5c38-485a-8626-b0f4b2a2744a" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_60296c89-7a91-4960-953a-1b4b00173982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_43dec65d-0bad-4adb-88d4-704b86516930" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_srt_RangeAxis_43dec65d-0bad-4adb-88d4-704b86516930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ac964f22-1b11-4316-8d2d-048b5f07c577" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_43dec65d-0bad-4adb-88d4-704b86516930" xlink:to="loc_srt_RangeMember_ac964f22-1b11-4316-8d2d-048b5f07c577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_27402bd2-fd0d-4f9d-8370-ef9bfd293aeb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ac964f22-1b11-4316-8d2d-048b5f07c577" xlink:to="loc_srt_MinimumMember_27402bd2-fd0d-4f9d-8370-ef9bfd293aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a24586f5-700b-4d81-98e4-8f554da140c7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ac964f22-1b11-4316-8d2d-048b5f07c577" xlink:to="loc_srt_MaximumMember_a24586f5-700b-4d81-98e4-8f554da140c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fc0a97da-67f1-4f23-81e5-5181f922b6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fc0a97da-67f1-4f23-81e5-5181f922b6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc0a97da-67f1-4f23-81e5-5181f922b6b7" xlink:to="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_fadeb320-f36d-4f77-810d-899859de9cd4" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_fadeb320-f36d-4f77-810d-899859de9cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_f885cb60-d1f3-45b3-962a-b9e16b4e72b5" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_f885cb60-d1f3-45b3-962a-b9e16b4e72b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_53c47444-8204-46ca-b9e4-1951a7d6ed5b" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a5851ca1-66bd-40b9-bcc1-cd7cef41cc57" xlink:to="loc_vtrs_GreaterChinaSegmentMember_53c47444-8204-46ca-b9e4-1951a7d6ed5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_463199b2-7d68-4fce-9c71-15875739352a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_463199b2-7d68-4fce-9c71-15875739352a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_587efb2b-1846-4163-b36d-558dade1b0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_463199b2-7d68-4fce-9c71-15875739352a" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_587efb2b-1846-4163-b36d-558dade1b0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b9219627-23b1-4957-8200-eeb6c27fe5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_587efb2b-1846-4163-b36d-558dade1b0f1" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b9219627-23b1-4957-8200-eeb6c27fe5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0a9d6fb3-232c-40d8-9b8b-19004cb3e32c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0a9d6fb3-232c-40d8-9b8b-19004cb3e32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0a9d6fb3-232c-40d8-9b8b-19004cb3e32c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnDistributorMarketsMember_0d2885ff-b49f-4062-adc9-697f8f1e2f64" xlink:href="vtrs-20230331.xsd#vtrs_UpjohnDistributorMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:to="loc_vtrs_UpjohnDistributorMarketsMember_0d2885ff-b49f-4062-adc9-697f8f1e2f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductRightsAndLicensesMember_90668fa6-06db-42e6-a578-a3ec55ee6c22" xlink:href="vtrs-20230331.xsd#vtrs_ProductRightsAndLicensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:to="loc_vtrs_ProductRightsAndLicensesMember_90668fa6-06db-42e6-a578-a3ec55ee6c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c15a9985-c858-41b4-b421-6280be773621" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_badcfe4e-c3c8-48fd-bfd2-df7aa42413d3" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c15a9985-c858-41b4-b421-6280be773621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_048a15c9-1401-48da-b168-f454366a4d30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_048a15c9-1401-48da-b168-f454366a4d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad82dae-85f4-4806-8db5-c88847a9f402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_048a15c9-1401-48da-b168-f454366a4d30" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad82dae-85f4-4806-8db5-c88847a9f402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OysterPointPharmaAcquisitionMember_7453b0ca-8a8f-4924-a84f-fda40e269184" xlink:href="vtrs-20230331.xsd#vtrs_OysterPointPharmaAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad82dae-85f4-4806-8db5-c88847a9f402" xlink:to="loc_vtrs_OysterPointPharmaAcquisitionMember_7453b0ca-8a8f-4924-a84f-fda40e269184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FamyLifeSciencesAcquisitionMember_18c28fc9-63e1-4472-8a63-2f08af9380b6" xlink:href="vtrs-20230331.xsd#vtrs_FamyLifeSciencesAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fad82dae-85f4-4806-8db5-c88847a9f402" xlink:to="loc_vtrs_FamyLifeSciencesAcquisitionMember_18c28fc9-63e1-4472-8a63-2f08af9380b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c663ea53-cfce-4bce-83f2-be5891d3acbe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8299e626-88b3-49d2-9c44-43f713eae531" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8299e626-88b3-49d2-9c44-43f713eae531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f0febaf0-7cc1-443a-8612-84f00f5f952c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f0febaf0-7cc1-443a-8612-84f00f5f952c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_28f3a136-a2b0-4ce5-90bf-89ebec8f9487" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_28f3a136-a2b0-4ce5-90bf-89ebec8f9487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d7f771fd-fc5c-4366-a989-e16cd4274a62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d7f771fd-fc5c-4366-a989-e16cd4274a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_04bfb817-e340-404c-be95-8825153a3ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_Goodwill_04bfb817-e340-404c-be95-8825153a3ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_bae80b73-b521-4623-b47c-d88f7d90994d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_bae80b73-b521-4623-b47c-d88f7d90994d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c1e49af7-d920-4832-847d-4d2a8a02d7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04f1c36d-9bbb-41bf-ae41-1f0368e5cd33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c1e49af7-d920-4832-847d-4d2a8a02d7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c1a3b8f3-cc3c-415f-8ccf-51f876cc16ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_506f5eda-0973-4100-8e64-22a6fbc31351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c1a3b8f3-cc3c-415f-8ccf-51f876cc16ff" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_506f5eda-0973-4100-8e64-22a6fbc31351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bd96ef01-ffac-457c-9d91-e8a034507ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_506f5eda-0973-4100-8e64-22a6fbc31351" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bd96ef01-ffac-457c-9d91-e8a034507ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bd96ef01-ffac-457c-9d91-e8a034507ce6" xlink:to="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_dfba55ff-724b-44a1-aaa7-d91cbcc03034" xlink:href="vtrs-20230331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_dfba55ff-724b-44a1-aaa7-d91cbcc03034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_87d74f6d-922e-4c91-a42b-f9e8a379808a" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:to="loc_vtrs_GreaterChinaSegmentMember_87d74f6d-922e-4c91-a42b-f9e8a379808a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_ea0a87f7-f23a-44d3-8e2b-89f85b089ea3" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_ea0a87f7-f23a-44d3-8e2b-89f85b089ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_9b8ea716-6acd-4294-b4d8-53359e56b2bb" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7b62b174-bb27-41c6-b87a-5fce28c8fd10" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_9b8ea716-6acd-4294-b4d8-53359e56b2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c9b93fb7-c3cc-4f0a-96a3-8c3e99d8097d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_506f5eda-0973-4100-8e64-22a6fbc31351" xlink:to="loc_us-gaap_GoodwillLineItems_c9b93fb7-c3cc-4f0a-96a3-8c3e99d8097d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_c9b93fb7-c3cc-4f0a-96a3-8c3e99d8097d" xlink:to="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_56e3fe69-0498-48a1-8c71-e876f9e72242" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:to="loc_us-gaap_Goodwill_56e3fe69-0498-48a1-8c71-e876f9e72242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0381fbd-1da7-47b0-9097-a7524c34e4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0381fbd-1da7-47b0-9097-a7524c34e4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_379e5fff-2360-4d65-a2c7-06451b7bd716" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_379e5fff-2360-4d65-a2c7-06451b7bd716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_645a2949-65ef-42f4-a9dc-a34affc70e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:to="loc_us-gaap_Goodwill_645a2949-65ef-42f4-a9dc-a34affc70e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e2324e48-3655-4e87-9e16-289a3151e080" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_214a3a8c-4934-49c3-8cda-67e2a6076c14" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e2324e48-3655-4e87-9e16-289a3151e080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9bfe7a92-fe3a-4cfa-99a1-e0ccc5e89420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_96e70d59-f120-4451-8e4d-2b795758dace" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9bfe7a92-fe3a-4cfa-99a1-e0ccc5e89420" xlink:to="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_96e70d59-f120-4451-8e4d-2b795758dace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c516dee2-8d22-41cb-9b04-0c885db1fa9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_96e70d59-f120-4451-8e4d-2b795758dace" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c516dee2-8d22-41cb-9b04-0c885db1fa9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0777ddb7-af63-4a58-b071-edc7ccdb4567" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c516dee2-8d22-41cb-9b04-0c885db1fa9d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0777ddb7-af63-4a58-b071-edc7ccdb4567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_700972fb-ebd7-401a-9892-12259888c6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0777ddb7-af63-4a58-b071-edc7ccdb4567" xlink:to="loc_us-gaap_PatentsMember_700972fb-ebd7-401a-9892-12259888c6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:href="vtrs-20230331.xsd#vtrs_IntangibleAssetsbyMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleOfIntangibleAssetsByMajorClassTable_96e70d59-f120-4451-8e4d-2b795758dace" xlink:to="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2f371b26-ee04-4553-b1f0-450c30a98546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2f371b26-ee04-4553-b1f0-450c30a98546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_25448f7c-1611-4036-b595-2e3e8093c11b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_25448f7c-1611-4036-b595-2e3e8093c11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95288989-caeb-4549-88f0-37ebf7208eba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95288989-caeb-4549-88f0-37ebf7208eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbb560b0-a626-472f-8b1f-3c3b1d114256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbb560b0-a626-472f-8b1f-3c3b1d114256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_831d49c1-5942-4c3c-89eb-c1138df6702d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_831d49c1-5942-4c3c-89eb-c1138df6702d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_63bdc374-69dd-4ecd-a973-20174a2f3155" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_63bdc374-69dd-4ecd-a973-20174a2f3155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_039a3dd6-3f28-446e-a8ca-a0f0112a8c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_039a3dd6-3f28-446e-a8ca-a0f0112a8c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_241f1b56-2724-4010-ba18-5e4d3f77293c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_IntangibleAssetsbyMajorClassLineItems_c90c4cd7-6774-428c-9cec-ea73d234e843" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_241f1b56-2724-4010-ba18-5e4d3f77293c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangibleAssetsAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c8056019-b799-452a-a0b7-7a954da65991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_39fd76ff-a00b-41ef-8418-5a807e2de0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c8056019-b799-452a-a0b7-7a954da65991" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_39fd76ff-a00b-41ef-8418-5a807e2de0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_0bff3b62-b7ac-456e-9c79-6671f87d1fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c8056019-b799-452a-a0b7-7a954da65991" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_0bff3b62-b7ac-456e-9c79-6671f87d1fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_f567de6d-b2d8-4b75-b50b-d0a557f1275a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c8056019-b799-452a-a0b7-7a954da65991" xlink:to="loc_us-gaap_AdjustmentForAmortization_f567de6d-b2d8-4b75-b50b-d0a557f1275a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9835bc7a-a62b-4b6e-9ff8-312c733672d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3c9f5aa6-40a0-4627-a998-e99c5fdb16d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9835bc7a-a62b-4b6e-9ff8-312c733672d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3c9f5aa6-40a0-4627-a998-e99c5fdb16d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_35ebd503-569a-4f5e-9ffa-424756590ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9835bc7a-a62b-4b6e-9ff8-312c733672d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_35ebd503-569a-4f5e-9ffa-424756590ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3f0d4355-eebb-4aab-97f2-7a245842c62c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9835bc7a-a62b-4b6e-9ff8-312c733672d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3f0d4355-eebb-4aab-97f2-7a245842c62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_09f67f3a-7dae-413c-a305-07de0e135cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9835bc7a-a62b-4b6e-9ff8-312c733672d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_09f67f3a-7dae-413c-a305-07de0e135cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_45c387e8-55b2-423f-8897-58a6fbeae9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9835bc7a-a62b-4b6e-9ff8-312c733672d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_45c387e8-55b2-423f-8897-58a6fbeae9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2d02d791-7931-4684-b3be-0eb92048d0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2d02d791-7931-4684-b3be-0eb92048d0bc" xlink:to="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1c5e7158-4b36-42ea-b8e3-e9c273a3087b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1c5e7158-4b36-42ea-b8e3-e9c273a3087b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_10eda881-702c-491a-a28e-b7df29d75d59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1c5e7158-4b36-42ea-b8e3-e9c273a3087b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_10eda881-702c-491a-a28e-b7df29d75d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_260b39b0-94d6-477a-88b7-2ae6ef4004cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_10eda881-702c-491a-a28e-b7df29d75d59" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_260b39b0-94d6-477a-88b7-2ae6ef4004cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_74e9978b-b1fd-4134-bde8-685cb3217959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_74e9978b-b1fd-4134-bde8-685cb3217959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1f3003f7-4f7d-497d-880a-ab60bd02dd37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_74e9978b-b1fd-4134-bde8-685cb3217959" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1f3003f7-4f7d-497d-880a-ab60bd02dd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d671fa0d-f0c6-47e2-87bd-2cb69456b74c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1f3003f7-4f7d-497d-880a-ab60bd02dd37" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d671fa0d-f0c6-47e2-87bd-2cb69456b74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_876aa3c0-446d-4270-8c44-12ef0793447f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1f3003f7-4f7d-497d-880a-ab60bd02dd37" xlink:to="loc_us-gaap_InterestRateSwapMember_876aa3c0-446d-4270-8c44-12ef0793447f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1cc973dd-fdbb-4a33-baec-14c1483fe16b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1cc973dd-fdbb-4a33-baec-14c1483fe16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7f9138cc-fdb5-4a62-af60-334b84597d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1cc973dd-fdbb-4a33-baec-14c1483fe16b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7f9138cc-fdb5-4a62-af60-334b84597d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_39c1c551-8bb1-4c54-bd1f-e1ddb2edb70a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f9138cc-fdb5-4a62-af60-334b84597d4a" xlink:to="loc_us-gaap_OtherExpenseMember_39c1c551-8bb1-4c54-bd1f-e1ddb2edb70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_757afa70-18f2-4129-aa57-4c8621d006c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_DebtInstrumentAxis_757afa70-18f2-4129-aa57-4c8621d006c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_757afa70-18f2-4129-aa57-4c8621d006c7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_64be753a-d233-4e65-8a27-afec89c63774" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_64be753a-d233-4e65-8a27-afec89c63774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_ea17c778-563f-4072-b429-b59dd33777b0" xlink:href="vtrs-20230331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_ea17c778-563f-4072-b429-b59dd33777b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_20b27308-362e-45b9-8769-12eafc17d72c" xlink:href="vtrs-20230331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_20b27308-362e-45b9-8769-12eafc17d72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_55f9dd4f-43da-41a0-9b83-c82b0ee77cb1" xlink:href="vtrs-20230331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_55f9dd4f-43da-41a0-9b83-c82b0ee77cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_1bd61a58-3b80-4064-abe1-915b1ab560a7" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_1bd61a58-3b80-4064-abe1-915b1ab560a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_247ebc25-c40f-4de9-9058-4801407cff04" xlink:href="vtrs-20230331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_247ebc25-c40f-4de9-9058-4801407cff04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_ba704d05-6cad-4556-a6f2-d000851ed524" xlink:href="vtrs-20230331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_ba704d05-6cad-4556-a6f2-d000851ed524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember_01ee9e2c-16dd-4f3d-91d2-0659d6122022" xlink:href="vtrs-20230331.xsd#vtrs_YENTermLoanMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9b1678b-8e84-4a7e-bee3-a2548bf0d4b1" xlink:to="loc_vtrs_YENTermLoanMember_01ee9e2c-16dd-4f3d-91d2-0659d6122022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d5ddfe62-155c-48b5-a5b5-9ec728f9b413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d5ddfe62-155c-48b5-a5b5-9ec728f9b413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6e917a96-0681-4ede-a3f1-a5837a205ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d5ddfe62-155c-48b5-a5b5-9ec728f9b413" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6e917a96-0681-4ede-a3f1-a5837a205ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_67603912-bdf5-4fc4-bb25-9070140d2f08" xlink:href="vtrs-20230331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e917a96-0681-4ede-a3f1-a5837a205ac4" xlink:to="loc_vtrs_ContingentConsiderationMember_67603912-bdf5-4fc4-bb25-9070140d2f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_1773d51c-2675-468b-8209-f789a617800e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e917a96-0681-4ede-a3f1-a5837a205ac4" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_1773d51c-2675-468b-8209-f789a617800e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fdb14412-4847-4820-8f9c-d25e0c8d6d10" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_srt_RangeAxis_fdb14412-4847-4820-8f9c-d25e0c8d6d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b019056-9393-49d9-b04a-d8bc1080f6c0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fdb14412-4847-4820-8f9c-d25e0c8d6d10" xlink:to="loc_srt_RangeMember_4b019056-9393-49d9-b04a-d8bc1080f6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ae1872f5-7065-4a95-bafa-f42a55392d82" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4b019056-9393-49d9-b04a-d8bc1080f6c0" xlink:to="loc_srt_MinimumMember_ae1872f5-7065-4a95-bafa-f42a55392d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f1ad977d-e35e-45fd-972e-9cd303e9b7ff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4b019056-9393-49d9-b04a-d8bc1080f6c0" xlink:to="loc_srt_MaximumMember_f1ad977d-e35e-45fd-972e-9cd303e9b7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2464fcf1-e22f-4311-99e7-0e00b5af4308" xlink:to="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_ab239e3a-835f-44f3-abf6-b6501e6b0c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_ab239e3a-835f-44f3-abf6-b6501e6b0c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_fa29d24b-7252-434b-a898-69d3000c9139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_fa29d24b-7252-434b-a898-69d3000c9139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ac41c31e-4748-4b4f-8a96-d34069703cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ac41c31e-4748-4b4f-8a96-d34069703cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_dbcdf4c8-1d45-4173-bd41-d1882d0cfeae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_LongTermDebt_dbcdf4c8-1d45-4173-bd41-d1882d0cfeae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d317100a-0dc2-48aa-99e1-2aa4f92aaff5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cdb10cf8-1af4-44e8-b14a-b5c3e62a6e39" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d317100a-0dc2-48aa-99e1-2aa4f92aaff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9d0b053b-4f9a-4c10-9ad4-bce9dfdd4f56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9d0b053b-4f9a-4c10-9ad4-bce9dfdd4f56" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e4aa47b0-d59e-4388-a299-a9c9b723db78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:to="loc_us-gaap_HedgingDesignationAxis_e4aa47b0-d59e-4388-a299-a9c9b723db78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_911a28ab-7324-427a-a142-3143958d115f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e4aa47b0-d59e-4388-a299-a9c9b723db78" xlink:to="loc_us-gaap_HedgingDesignationDomain_911a28ab-7324-427a-a142-3143958d115f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_184a498e-c407-420d-ac59-fb609548babe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_911a28ab-7324-427a-a142-3143958d115f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_184a498e-c407-420d-ac59-fb609548babe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_8be1906b-5b99-466b-8100-4d384465f25d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_911a28ab-7324-427a-a142-3143958d115f" xlink:to="loc_us-gaap_NondesignatedMember_8be1906b-5b99-466b-8100-4d384465f25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4b693220-5515-4be0-aa0b-5b68c84b6554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4b693220-5515-4be0-aa0b-5b68c84b6554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ad17fece-2ac9-459d-a42c-48116f5a849c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4b693220-5515-4be0-aa0b-5b68c84b6554" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ad17fece-2ac9-459d-a42c-48116f5a849c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9a4a8f2a-8a0a-418e-a719-a1f73a7b0f12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ad17fece-2ac9-459d-a42c-48116f5a849c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9a4a8f2a-8a0a-418e-a719-a1f73a7b0f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_266181a1-02d9-4ba6-8541-8bae79dec4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ad17fece-2ac9-459d-a42c-48116f5a849c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_266181a1-02d9-4ba6-8541-8bae79dec4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0b9c0407-495b-4ed3-a711-982581d9dbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0b9c0407-495b-4ed3-a711-982581d9dbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0b9c0407-495b-4ed3-a711-982581d9dbd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4d2d0c66-b66b-42d6-ad36-ca42be96cc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:to="loc_us-gaap_InterestRateSwapMember_4d2d0c66-b66b-42d6-ad36-ca42be96cc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_64988e49-8984-4f0b-893d-367164827c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_64988e49-8984-4f0b-893d-367164827c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_19fd7f93-5f7f-4759-ad33-9c72484e7ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4a805ad9-8d59-4455-9ad1-031ca2e317d5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_19fd7f93-5f7f-4759-ad33-9c72484e7ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_03d59698-f8a4-4437-b453-7bb9837b0462" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a288f1a0-9b2a-4ad5-a184-94a34699a69c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a288f1a0-9b2a-4ad5-a184-94a34699a69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d1af4179-2be5-4b78-9211-1fd81bb297a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d1af4179-2be5-4b78-9211-1fd81bb297a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0d8a2e02-9f28-4e98-9acd-cceb27d7fff1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_cfa21d93-0b46-4d20-8313-af7ff6e6817c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0d8a2e02-9f28-4e98-9acd-cceb27d7fff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c8e4b70-8a08-4cb3-9f7b-dd4062602a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c8e4b70-8a08-4cb3-9f7b-dd4062602a6e" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b16fc9ae-8904-41a7-b4b4-f59778de873a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:to="loc_us-gaap_HedgingDesignationAxis_b16fc9ae-8904-41a7-b4b4-f59778de873a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8397fb26-1d33-4b22-bad8-4d2ab28ecb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b16fc9ae-8904-41a7-b4b4-f59778de873a" xlink:to="loc_us-gaap_HedgingDesignationDomain_8397fb26-1d33-4b22-bad8-4d2ab28ecb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e12e99a7-5753-47d0-ad71-c5fffd63f210" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8397fb26-1d33-4b22-bad8-4d2ab28ecb2f" xlink:to="loc_us-gaap_NondesignatedMember_e12e99a7-5753-47d0-ad71-c5fffd63f210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_531b34b9-c6b4-4709-bc74-be603d7e66fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_531b34b9-c6b4-4709-bc74-be603d7e66fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_661dd022-fb67-4b18-a743-615bea8260fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_531b34b9-c6b4-4709-bc74-be603d7e66fe" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_661dd022-fb67-4b18-a743-615bea8260fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6a851364-dca5-42de-839e-ac3294a5e4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_661dd022-fb67-4b18-a743-615bea8260fa" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6a851364-dca5-42de-839e-ac3294a5e4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8d73703a-250e-4cdc-9760-6a8c5b5aa171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_661dd022-fb67-4b18-a743-615bea8260fa" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8d73703a-250e-4cdc-9760-6a8c5b5aa171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_882acca4-3681-4c4d-bbf5-e24321526b02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_882acca4-3681-4c4d-bbf5-e24321526b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7ec4a6f6-036a-4383-9df5-4d49b9891ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_882acca4-3681-4c4d-bbf5-e24321526b02" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7ec4a6f6-036a-4383-9df5-4d49b9891ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ab2b2537-a8b6-431b-98a7-e822510d8d93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ec4a6f6-036a-4383-9df5-4d49b9891ef9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ab2b2537-a8b6-431b-98a7-e822510d8d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_4a544bc3-2ab5-4057-a0bd-cbce355ad9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6f379f89-425e-4a83-ace3-185182fe83da" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_4a544bc3-2ab5-4057-a0bd-cbce355ad9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_754abef7-0d6b-4e99-8c20-e1ca432cba96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4a544bc3-2ab5-4057-a0bd-cbce355ad9cc" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_754abef7-0d6b-4e99-8c20-e1ca432cba96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8fc21a7f-d04e-4540-9af5-c83fe59b5c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4a544bc3-2ab5-4057-a0bd-cbce355ad9cc" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8fc21a7f-d04e-4540-9af5-c83fe59b5c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e99cf241-6f54-4d4e-8950-ebb79ca52355" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e99cf241-6f54-4d4e-8950-ebb79ca52355" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_eeee2e50-b40a-4f9e-948a-59cc1861a17b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_eeee2e50-b40a-4f9e-948a-59cc1861a17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f2223fd0-62c7-48e4-bd7d-e5e8005d3665" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_eeee2e50-b40a-4f9e-948a-59cc1861a17b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f2223fd0-62c7-48e4-bd7d-e5e8005d3665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_78aecd2a-1ceb-4d93-95e5-dc77fd80de97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f2223fd0-62c7-48e4-bd7d-e5e8005d3665" xlink:to="loc_us-gaap_CashFlowHedgingMember_78aecd2a-1ceb-4d93-95e5-dc77fd80de97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7865a810-1232-4fd9-9741-326207512bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f2223fd0-62c7-48e4-bd7d-e5e8005d3665" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7865a810-1232-4fd9-9741-326207512bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2e966bf3-4437-48a5-afbe-65634d4c41b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2e966bf3-4437-48a5-afbe-65634d4c41b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a6e1267d-67dc-451c-a063-5927060a9db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2e966bf3-4437-48a5-afbe-65634d4c41b5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a6e1267d-67dc-451c-a063-5927060a9db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_614c494e-24aa-4696-beb3-0ed04de45344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6e1267d-67dc-451c-a063-5927060a9db8" xlink:to="loc_us-gaap_ForeignExchangeContractMember_614c494e-24aa-4696-beb3-0ed04de45344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5a5eb337-b61a-4272-a44b-309fe023b8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6e1267d-67dc-451c-a063-5927060a9db8" xlink:to="loc_us-gaap_InterestRateSwapMember_5a5eb337-b61a-4272-a44b-309fe023b8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c59b15a3-9d6e-4e5d-8c1f-8123016d1862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c59b15a3-9d6e-4e5d-8c1f-8123016d1862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c59b15a3-9d6e-4e5d-8c1f-8123016d1862" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_b3d42aad-51ec-4cc7-a7f4-8193864e255c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:to="loc_us-gaap_SalesMember_b3d42aad-51ec-4cc7-a7f4-8193864e255c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_37e6fa7d-c7ff-447a-bca2-3e8f46be225e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:to="loc_us-gaap_InterestExpenseMember_37e6fa7d-c7ff-447a-bca2-3e8f46be225e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_694535f3-b44e-4caa-8af0-b804a1cde061" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b56ea1d6-da63-4dba-97a2-c4d09678fd4e" xlink:to="loc_us-gaap_OtherExpenseMember_694535f3-b44e-4caa-8af0-b804a1cde061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_59859158-1d04-49c8-8ae0-644ed7576274" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_ValuationTechniqueAxis_59859158-1d04-49c8-8ae0-644ed7576274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_4b501068-0c74-46aa-b02d-55c60b19f1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_59859158-1d04-49c8-8ae0-644ed7576274" xlink:to="loc_us-gaap_ValuationTechniqueDomain_4b501068-0c74-46aa-b02d-55c60b19f1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8e36c2f4-4636-48ef-a7c9-199efadc0a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8e36c2f4-4636-48ef-a7c9-199efadc0a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cb5b21c7-c65f-42b9-9a31-482ab5578ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8e36c2f4-4636-48ef-a7c9-199efadc0a3c" xlink:to="loc_us-gaap_EquityComponentDomain_cb5b21c7-c65f-42b9-9a31-482ab5578ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_9f4b6bc1-e17c-46e8-a224-f5821fb354cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cb5b21c7-c65f-42b9-9a31-482ab5578ae5" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_9f4b6bc1-e17c-46e8-a224-f5821fb354cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ebe2bdcf-cd73-4463-904b-8a678669768b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_HedgingDesignationAxis_ebe2bdcf-cd73-4463-904b-8a678669768b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_02f49ac7-eb18-4e50-80b5-947fdebb5947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_ebe2bdcf-cd73-4463-904b-8a678669768b" xlink:to="loc_us-gaap_HedgingDesignationDomain_02f49ac7-eb18-4e50-80b5-947fdebb5947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5b83c289-00be-409f-be44-15b9a4c76de9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_02f49ac7-eb18-4e50-80b5-947fdebb5947" xlink:to="loc_us-gaap_NondesignatedMember_5b83c289-00be-409f-be44-15b9a4c76de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_769b74f7-ce50-4b4d-8331-e71a97f16b7d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b38e7572-dab6-40d5-908c-970a0d95628a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b38e7572-dab6-40d5-908c-970a0d95628a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_213877d9-56a7-44d7-9e19-882c32c2100c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_213877d9-56a7-44d7-9e19-882c32c2100c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fd92227a-7e29-4933-bd81-525a0ad83769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fd92227a-7e29-4933-bd81-525a0ad83769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9dde53d4-2b87-4909-8cd7-d3dab81682f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9dde53d4-2b87-4909-8cd7-d3dab81682f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1dc4d094-fee8-4b84-ac2d-c29721e5e10b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fdd78073-d201-4512-82d5-9eb20e41571b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1dc4d094-fee8-4b84-ac2d-c29721e5e10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8a689b7b-6f58-4d14-a36a-404abdb1ce6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8a689b7b-6f58-4d14-a36a-404abdb1ce6a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a8acd0c8-2030-4375-997e-da05675a6104" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a8acd0c8-2030-4375-997e-da05675a6104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0e31a4ff-dc81-4bd6-a30b-f6ca553d9073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a8acd0c8-2030-4375-997e-da05675a6104" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0e31a4ff-dc81-4bd6-a30b-f6ca553d9073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f3b13c30-39d6-4663-a4b5-bf412465b920" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0e31a4ff-dc81-4bd6-a30b-f6ca553d9073" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f3b13c30-39d6-4663-a4b5-bf412465b920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_18ed4086-03e9-43fc-a040-7881ba107b27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_HedgingDesignationAxis_18ed4086-03e9-43fc-a040-7881ba107b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9af0a9b0-24ad-41f9-a221-68382a731138" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_18ed4086-03e9-43fc-a040-7881ba107b27" xlink:to="loc_us-gaap_HedgingDesignationDomain_9af0a9b0-24ad-41f9-a221-68382a731138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bcfb0444-ca33-45cf-b22c-78363d90694c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9af0a9b0-24ad-41f9-a221-68382a731138" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bcfb0444-ca33-45cf-b22c-78363d90694c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f073fc30-d95d-410a-a8cf-4fe0309adc25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f073fc30-d95d-410a-a8cf-4fe0309adc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f073fc30-d95d-410a-a8cf-4fe0309adc25" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_20f559fb-9596-4b57-b53f-83cbf28e9b05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_20f559fb-9596-4b57-b53f-83cbf28e9b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5c0aa89d-0ef0-4e25-bd22-1e3cb60734e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5c0aa89d-0ef0-4e25-bd22-1e3cb60734e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_776108eb-af0a-4f8a-9350-03835e968a69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7d74ff7-0338-4611-be4b-2e6b63a187c8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_776108eb-af0a-4f8a-9350-03835e968a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_47ca1443-8816-4e4e-a858-b7482f4e0b05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_47ca1443-8816-4e4e-a858-b7482f4e0b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_47ca1443-8816-4e4e-a858-b7482f4e0b05" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_edd03530-2c10-4dd3-bc0b-20a5685163f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_MoneyMarketFundsMember_edd03530-2c10-4dd3-bc0b-20a5685163f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_00ab59ed-6499-4403-a10f-713b360fb13b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_00ab59ed-6499-4403-a10f-713b360fb13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_7939f863-f114-4440-a6c2-3d0d832a6d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_7939f863-f114-4440-a6c2-3d0d832a6d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_00fa5014-6585-4310-ad9a-6905ce428741" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_00fa5014-6585-4310-ad9a-6905ce428741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_023b82fc-75ae-4f74-a29a-ac82f8bdde2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_023b82fc-75ae-4f74-a29a-ac82f8bdde2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f3e013ac-0550-441a-908e-b22d51afc175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f3e013ac-0550-441a-908e-b22d51afc175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_7d73a0c3-ebb7-479f-a0ce-7bbb93826d05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_5c297112-d0ee-475b-95fb-308baeed699a" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_7d73a0c3-ebb7-479f-a0ce-7bbb93826d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_45174b21-8c9a-4dfc-a1ff-eef8c0e478a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_CommonStockMember_45174b21-8c9a-4dfc-a1ff-eef8c0e478a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_743f52ac-84cb-48d4-ae02-779a1dd1b850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_InterestRateSwapMember_743f52ac-84cb-48d4-ae02-779a1dd1b850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_952bb258-79c3-4e03-8e09-11b26afee9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cf7a312b-a850-4b08-a5cd-028af2de9b91" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_952bb258-79c3-4e03-8e09-11b26afee9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_92658496-dc24-4742-bb65-ce971da185d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_92658496-dc24-4742-bb65-ce971da185d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_92658496-dc24-4742-bb65-ce971da185d7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f969dc4f-8321-4492-8b02-2587486fe4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f969dc4f-8321-4492-8b02-2587486fe4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5e27d7a9-91cc-49b5-bd71-e4111e4ff16f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:to="loc_us-gaap_InterestRateSwapMember_5e27d7a9-91cc-49b5-bd71-e4111e4ff16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_1c904e89-ed57-4d1e-8d1d-6de710f96d6c" xlink:href="vtrs-20230331.xsd#vtrs_ContingentConsiderationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e2d0de0e-b9a8-4c09-accd-f5c99e6089df" xlink:to="loc_vtrs_ContingentConsiderationMember_1c904e89-ed57-4d1e-8d1d-6de710f96d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a93110a8-3a09-40dc-9df1-e05902434177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a93110a8-3a09-40dc-9df1-e05902434177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8d1e1c11-b6d7-479d-9c10-81f5cd3bc7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a93110a8-3a09-40dc-9df1-e05902434177" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8d1e1c11-b6d7-479d-9c10-81f5cd3bc7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fff411e1-6703-4c67-8d8c-ae4dea9f2449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d1e1c11-b6d7-479d-9c10-81f5cd3bc7d7" xlink:to="loc_us-gaap_InterestRateSwapMember_fff411e1-6703-4c67-8d8c-ae4dea9f2449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5829eeda-9023-4d6f-8e9a-9c238eab0633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d1e1c11-b6d7-479d-9c10-81f5cd3bc7d7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5829eeda-9023-4d6f-8e9a-9c238eab0633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dbf3f32-1f78-4a48-a9d7-2e7e53905a30" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5ad45016-8596-49a8-95f4-ad9f3424696e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5ad45016-8596-49a8-95f4-ad9f3424696e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_c66a2daa-b96b-460c-b4b9-8bf9230c7a90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_TradingSecurities_c66a2daa-b96b-460c-b4b9-8bf9230c7a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0f004e5c-db16-4237-b58e-9a9d1a39c3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0f004e5c-db16-4237-b58e-9a9d1a39c3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_06deccfe-fb31-4204-a099-4d2fce9872c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_06deccfe-fb31-4204-a099-4d2fce9872c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ff59cba6-63dc-418b-b6e7-b9bab26633e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ff59cba6-63dc-418b-b6e7-b9bab26633e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c48a810f-8016-4517-ae6e-3f8ffa550f94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c48a810f-8016-4517-ae6e-3f8ffa550f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_c561dd7b-a017-40a8-b207-556c80931447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_c561dd7b-a017-40a8-b207-556c80931447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_026c5497-ee30-4093-9bcd-9f885f135940" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_026c5497-ee30-4093-9bcd-9f885f135940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_dc83f963-dc91-4ddc-940d-fab5aa1870fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_dc83f963-dc91-4ddc-940d-fab5aa1870fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_89600cd8-f611-45a9-bcbe-3113d08b4628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2cc60f77-c221-4396-bb39-0238febecdbf" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_89600cd8-f611-45a9-bcbe-3113d08b4628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_65bf2255-46b6-4061-bd6f-083ba711d4de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2391f327-5814-4e40-bcbd-7e6ae1083348" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_65bf2255-46b6-4061-bd6f-083ba711d4de" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2391f327-5814-4e40-bcbd-7e6ae1083348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4bad86c8-22bb-439d-bfc2-e1ff2f3e9e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2391f327-5814-4e40-bcbd-7e6ae1083348" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4bad86c8-22bb-439d-bfc2-e1ff2f3e9e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dc77bd98-36d8-41d1-8432-abe0e60073da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4bad86c8-22bb-439d-bfc2-e1ff2f3e9e7a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dc77bd98-36d8-41d1-8432-abe0e60073da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_3c21c791-18c8-49af-b485-6c004bdb4aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc77bd98-36d8-41d1-8432-abe0e60073da" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_3c21c791-18c8-49af-b485-6c004bdb4aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_12bf51e7-7dbd-426a-9e10-6a9a5e1e5df5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc77bd98-36d8-41d1-8432-abe0e60073da" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_12bf51e7-7dbd-426a-9e10-6a9a5e1e5df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_438541c3-7656-4390-a6be-233287140db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2391f327-5814-4e40-bcbd-7e6ae1083348" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_438541c3-7656-4390-a6be-233287140db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5414888-286b-4699-8046-961847184797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_438541c3-7656-4390-a6be-233287140db8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5414888-286b-4699-8046-961847184797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BioconBiologicsMember_304f0057-c3c4-44cc-a664-f9e3708cb87e" xlink:href="vtrs-20230331.xsd#vtrs_BioconBiologicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5414888-286b-4699-8046-961847184797" xlink:to="loc_vtrs_BioconBiologicsMember_304f0057-c3c4-44cc-a664-f9e3708cb87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e38fb025-1dd3-419f-a2ff-f0fbcbf6a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2391f327-5814-4e40-bcbd-7e6ae1083348" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e38fb025-1dd3-419f-a2ff-f0fbcbf6a4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:href="vtrs-20230331.xsd#vtrs_ScheduleofActivityinContingentConsiderationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e38fb025-1dd3-419f-a2ff-f0fbcbf6a4b1" xlink:to="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f64c907a-e9f4-4dce-a726-a0eeb62e51f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f64c907a-e9f4-4dce-a726-a0eeb62e51f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_29ff479e-9244-4b2c-b9e2-7eb4f3bce3d7" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_29ff479e-9244-4b2c-b9e2-7eb4f3bce3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_3d3dddaf-ebef-4928-895c-d4969fc91217" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_3d3dddaf-ebef-4928-895c-d4969fc91217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_07b33aa6-eaff-46dc-94fa-1d77a1782e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_us-gaap_AccretionExpense_07b33aa6-eaff-46dc-94fa-1d77a1782e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_5bee9c3d-69a8-4acd-ae81-02c2a54a69cb" xlink:href="vtrs-20230331.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_5bee9c3d-69a8-4acd-ae81-02c2a54a69cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_73273321-07e5-421b-aa9e-dc0507b48aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_88d4c8d0-d8d4-4d12-bf6e-68f4fb08a5f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_73273321-07e5-421b-aa9e-dc0507b48aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_78b651c3-d76d-4af5-b7d6-99e9af9c3817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_78b651c3-d76d-4af5-b7d6-99e9af9c3817" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3de87312-ec34-404c-8d80-2bf315ce2b32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:to="loc_us-gaap_DebtInstrumentAxis_3de87312-ec34-404c-8d80-2bf315ce2b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_591e94cf-dd67-4889-b9de-6d458c4cc61f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3de87312-ec34-404c-8d80-2bf315ce2b32" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_591e94cf-dd67-4889-b9de-6d458c4cc61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_1430f520-6800-416b-adb8-371fc3e56b88" xlink:href="vtrs-20230331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_591e94cf-dd67-4889-b9de-6d458c4cc61f" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_1430f520-6800-416b-adb8-371fc3e56b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_8de53442-df36-4756-92a0-34cd3f0df183" xlink:href="vtrs-20230331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_591e94cf-dd67-4889-b9de-6d458c4cc61f" xlink:to="loc_vtrs_ReceivablesFacilityMember_8de53442-df36-4756-92a0-34cd3f0df183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fd72211b-87ad-46d1-9e00-ececbb5be7c5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:to="loc_srt_RangeAxis_fd72211b-87ad-46d1-9e00-ececbb5be7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7087c804-be43-42b4-b7ad-83b90ad52b10" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fd72211b-87ad-46d1-9e00-ececbb5be7c5" xlink:to="loc_srt_RangeMember_7087c804-be43-42b4-b7ad-83b90ad52b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d800cc41-a29c-45de-aa04-1c292286b5af" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7087c804-be43-42b4-b7ad-83b90ad52b10" xlink:to="loc_srt_MinimumMember_d800cc41-a29c-45de-aa04-1c292286b5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_63f3e6b5-d814-4761-8ff5-3f012040d2d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7087c804-be43-42b4-b7ad-83b90ad52b10" xlink:to="loc_srt_MaximumMember_63f3e6b5-d814-4761-8ff5-3f012040d2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_09617c93-fe93-4edc-b68a-1df64c42fdb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_09617c93-fe93-4edc-b68a-1df64c42fdb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e3211e98-a6d0-4b4e-8e45-ebed2177187d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_09617c93-fe93-4edc-b68a-1df64c42fdb7" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e3211e98-a6d0-4b4e-8e45-ebed2177187d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_722bc8fa-d122-4903-995d-d8ce00c55e4d" xlink:href="vtrs-20230331.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_e3211e98-a6d0-4b4e-8e45-ebed2177187d" xlink:to="loc_vtrs_ReceivablesFacilityMember_722bc8fa-d122-4903-995d-d8ce00c55e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember_55b875a1-a81e-42ea-b4cc-d2e6442a41ed" xlink:href="vtrs-20230331.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_e3211e98-a6d0-4b4e-8e45-ebed2177187d" xlink:to="loc_vtrs_NoteSecuritizationFacilityMember_55b875a1-a81e-42ea-b4cc-d2e6442a41ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_51e3e333-686b-4120-b7be-789ed59378aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_51e3e333-686b-4120-b7be-789ed59378aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1ae82d20-9de1-4266-95c3-e10d0b2d3e03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_51e3e333-686b-4120-b7be-789ed59378aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1ae82d20-9de1-4266-95c3-e10d0b2d3e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_719f5ea6-124d-49b4-90ed-8232773e2b61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1ae82d20-9de1-4266-95c3-e10d0b2d3e03" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_719f5ea6-124d-49b4-90ed-8232773e2b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_49c28dea-c8f2-47a7-ae6d-d76700fca41a" xlink:to="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_66ec2e95-5e09-45a1-b020-1628fb632658" xlink:href="vtrs-20230331.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:to="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_66ec2e95-5e09-45a1-b020-1628fb632658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6a1e92ea-dc20-44ad-9433-601c7cc4f710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6a1e92ea-dc20-44ad-9433-601c7cc4f710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f6a181e7-e5d4-40e0-9af8-8a9e43f891fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_98f21298-2a81-4aae-a446-e529be223d4f" xlink:to="loc_us-gaap_ShortTermBorrowings_f6a181e7-e5d4-40e0-9af8-8a9e43f891fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DebtSummaryofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f3127bf3-fb4c-4527-9c07-1875d077953f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3127bf3-fb4c-4527-9c07-1875d077953f" xlink:to="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_4832ad68-b488-4bb2-91ca-c9b0932b05ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_4832ad68-b488-4bb2-91ca-c9b0932b05ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a81c5a59-3b0f-40b2-9342-f103cda93bca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4832ad68-b488-4bb2-91ca-c9b0932b05ba" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a81c5a59-3b0f-40b2-9342-f103cda93bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_37fbf27a-037b-4c8f-b648-bc5de84d3a46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a81c5a59-3b0f-40b2-9342-f103cda93bca" xlink:to="loc_us-gaap_SeniorNotesMember_37fbf27a-037b-4c8f-b648-bc5de84d3a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_85b205a6-18f8-4823-926e-d9378cd62c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_85b205a6-18f8-4823-926e-d9378cd62c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_85b205a6-18f8-4823-926e-d9378cd62c5d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8cadb6a2-c33b-4f20-9127-635f14fd4b24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:to="loc_us-gaap_SeniorNotesMember_8cadb6a2-c33b-4f20-9127-635f14fd4b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_e478e887-4051-4f3a-8e32-583218924904" xlink:href="vtrs-20230331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:to="loc_vtrs_OtherLongTermDebtMember_e478e887-4051-4f3a-8e32-583218924904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CurrentPortionofLongTermDebtMember_48d6b009-209d-4166-8676-1a9b1c8a6cfe" xlink:href="vtrs-20230331.xsd#vtrs_CurrentPortionofLongTermDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6814c86f-f172-4d72-b798-68f6628bf5ac" xlink:to="loc_vtrs_CurrentPortionofLongTermDebtMember_48d6b009-209d-4166-8676-1a9b1c8a6cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8d62a566-0b97-4b13-8def-1708f67bb31a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:to="loc_us-gaap_DebtInstrumentAxis_8d62a566-0b97-4b13-8def-1708f67bb31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8d62a566-0b97-4b13-8def-1708f67bb31a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_b58efcff-10d9-4eb1-a0a3-b26fa8b22272" xlink:href="vtrs-20230331.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_b58efcff-10d9-4eb1-a0a3-b26fa8b22272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_4782c42b-3699-4a48-96ea-478ec9e068d0" xlink:href="vtrs-20230331.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_4782c42b-3699-4a48-96ea-478ec9e068d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_46937ce5-2b4e-4fbe-940e-94331bbca5e2" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_46937ce5-2b4e-4fbe-940e-94331bbca5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_7aacafbf-cab8-4343-9aca-0698ddfcc2e2" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_7aacafbf-cab8-4343-9aca-0698ddfcc2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_bcdd27cd-c9dc-4eb1-bd18-32b02c213935" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_bcdd27cd-c9dc-4eb1-bd18-32b02c213935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_00d166c1-6d44-4691-acf0-5b9f11b9983d" xlink:href="vtrs-20230331.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_00d166c1-6d44-4691-acf0-5b9f11b9983d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_dcb0b91e-9139-496c-8203-d327ebceabb9" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_dcb0b91e-9139-496c-8203-d327ebceabb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_fc29d434-2d4e-4262-858c-3f2b6ad1ccdc" xlink:href="vtrs-20230331.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_fc29d434-2d4e-4262-858c-3f2b6ad1ccdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember_be366f18-f268-4337-ae6b-95de8b6b7c01" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandTwentyEightMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyEightMember_be366f18-f268-4337-ae6b-95de8b6b7c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_acfd8f51-3b10-4cc7-bff1-127b029baa8a" xlink:href="vtrs-20230331.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2028SeniorNotesMember_acfd8f51-3b10-4cc7-bff1-127b029baa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_2a544d64-0315-496a-9641-518ac7406b24" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandFortyThreeMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_2a544d64-0315-496a-9641-518ac7406b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_9562aa18-bb32-4e9c-81c4-a1ce70ac581d" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_9562aa18-bb32-4e9c-81c4-a1ce70ac581d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyEightMember_6d974d2f-98d4-464d-a24a-944d636bb962" xlink:href="vtrs-20230331.xsd#vtrs_SeniorNotesTwoThousandFortyEightMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyEightMember_6d974d2f-98d4-464d-a24a-944d636bb962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_1dd1fc38-f3b7-41e3-b606-624b2a753694" xlink:href="vtrs-20230331.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_OtherLongTermDebtMember_1dd1fc38-f3b7-41e3-b606-624b2a753694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_1d28ad0e-9e3c-4ff4-9757-092ce1b7eaa5" xlink:href="vtrs-20230331.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2048SeniorNotesMember_1d28ad0e-9e3c-4ff4-9757-092ce1b7eaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_f1e16cd3-e71e-4b68-9905-25dd39e14c1c" xlink:href="vtrs-20230331.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_f1e16cd3-e71e-4b68-9905-25dd39e14c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember_9a77cdfe-0159-4d7e-9780-aa98c3116407" xlink:href="vtrs-20230331.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2025SeniorNotesMember_9a77cdfe-0159-4d7e-9780-aa98c3116407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_9c269223-ea21-4ef3-8e20-048916c9914c" xlink:href="vtrs-20230331.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_9c269223-ea21-4ef3-8e20-048916c9914c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember_f90c027b-d8ef-422a-ae7a-6991b00f377b" xlink:href="vtrs-20230331.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2027SeniorNotesMember_f90c027b-d8ef-422a-ae7a-6991b00f377b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember_718c0f66-00af-4471-b02b-a85682999b0d" xlink:href="vtrs-20230331.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2030SeniorNotesMember_718c0f66-00af-4471-b02b-a85682999b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_117393b9-fcc0-4d10-ad1d-c624af16ef9a" xlink:href="vtrs-20230331.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_117393b9-fcc0-4d10-ad1d-c624af16ef9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember_61306c49-b5f9-49bd-832d-54ae984e14d9" xlink:href="vtrs-20230331.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2040SeniorNotesMember_61306c49-b5f9-49bd-832d-54ae984e14d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember_390c5e51-6a21-46de-916f-179be69a5b2e" xlink:href="vtrs-20230331.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_250277c0-46ee-4c31-a9c6-7aa00cfa2a4d" xlink:to="loc_vtrs_A2050SeniorNotesMember_390c5e51-6a21-46de-916f-179be69a5b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7d34b0b3-473c-4e98-9f2d-b9f97e99f150" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4a533ed3-78a5-4f19-ab84-d08076d1d6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4a533ed3-78a5-4f19-ab84-d08076d1d6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_700fa27f-4d86-40eb-a0d8-025e8fbcf07b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_DebtCurrent_700fa27f-4d86-40eb-a0d8-025e8fbcf07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f9c50509-9b2f-4b1d-bf82-a49225e91fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_LongTermDebt_f9c50509-9b2f-4b1d-bf82-a49225e91fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_a42582f9-a6f1-4c0c-9f71-b7cc81647c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_a42582f9-a6f1-4c0c-9f71-b7cc81647c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_19a20b62-0bae-4a4f-a33d-1c1dfbdbb826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_19a20b62-0bae-4a4f-a33d-1c1dfbdbb826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_2ab294fa-8fcd-4dd2-abd5-7a586f5522b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f49456bd-e3b0-4e26-864f-d65ac3394bb8" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_2ab294fa-8fcd-4dd2-abd5-7a586f5522b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_55d52e32-ed92-4cd8-988b-8fefcafc29cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_deaa28f2-fbef-45c5-ace4-e8dea19965dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_55d52e32-ed92-4cd8-988b-8fefcafc29cd" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_deaa28f2-fbef-45c5-ace4-e8dea19965dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_081e43ac-a264-4e38-912e-621c58cb8d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_55d52e32-ed92-4cd8-988b-8fefcafc29cd" xlink:to="loc_us-gaap_DebtCurrent_081e43ac-a264-4e38-912e-621c58cb8d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ef99cd87-ab57-4fdf-a29a-202d641b9868" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_55d52e32-ed92-4cd8-988b-8fefcafc29cd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ef99cd87-ab57-4fdf-a29a-202d641b9868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DebtFairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b3b41633-a1e4-4bf2-9214-c571bafb22da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dcfc4027-1a30-4fad-9861-ee8690f22168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b3b41633-a1e4-4bf2-9214-c571bafb22da" xlink:to="loc_us-gaap_DebtInstrumentTable_dcfc4027-1a30-4fad-9861-ee8690f22168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1de7c13c-1cb5-494b-ae94-93355e454570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcfc4027-1a30-4fad-9861-ee8690f22168" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1de7c13c-1cb5-494b-ae94-93355e454570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4c94a723-d58d-4b95-8f77-373431129f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1de7c13c-1cb5-494b-ae94-93355e454570" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4c94a723-d58d-4b95-8f77-373431129f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_af414305-e85b-418d-945c-551933b81b77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c94a723-d58d-4b95-8f77-373431129f7b" xlink:to="loc_us-gaap_SeniorNotesMember_af414305-e85b-418d-945c-551933b81b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b1518297-2605-435a-b516-53ab56c8cc64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcfc4027-1a30-4fad-9861-ee8690f22168" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b1518297-2605-435a-b516-53ab56c8cc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_bd6394c9-1b33-4847-9a20-f02bb019bb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1518297-2605-435a-b516-53ab56c8cc64" xlink:to="loc_us-gaap_DebtInstrumentFairValue_bd6394c9-1b33-4847-9a20-f02bb019bb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#DebtMinimumRepaymentsonOutstandingBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_45996f2b-20c0-46b0-9b87-633e8a77bfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_95ba7b11-417a-4c42-85d3-e374c517bfd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_45996f2b-20c0-46b0-9b87-633e8a77bfe0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_95ba7b11-417a-4c42-85d3-e374c517bfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b7a9f10a-fc6b-43d7-a9e1-988f98547b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_45996f2b-20c0-46b0-9b87-633e8a77bfe0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b7a9f10a-fc6b-43d7-a9e1-988f98547b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0d6678c5-6150-4580-8037-6f8fbdf942be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_45996f2b-20c0-46b0-9b87-633e8a77bfe0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0d6678c5-6150-4580-8037-6f8fbdf942be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6e5ffddf-b661-4498-aeb3-9a08f10095fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_45996f2b-20c0-46b0-9b87-633e8a77bfe0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6e5ffddf-b661-4498-aeb3-9a08f10095fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a23f8730-8064-4457-a487-84eb94662be0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_45996f2b-20c0-46b0-9b87-633e8a77bfe0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a23f8730-8064-4457-a487-84eb94662be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_63a40712-eeac-484f-bfeb-085c931d7dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_45996f2b-20c0-46b0-9b87-633e8a77bfe0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_63a40712-eeac-484f-bfeb-085c931d7dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ae11079a-4370-4dcb-99ab-7e221c173408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_45996f2b-20c0-46b0-9b87-633e8a77bfe0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ae11079a-4370-4dcb-99ab-7e221c173408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f28c0b9c-e679-410e-b405-25acfae1ee06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f28c0b9c-e679-410e-b405-25acfae1ee06" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d2bc47c7-7003-454b-8009-b7ccd7341c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d2bc47c7-7003-454b-8009-b7ccd7341c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1a7718af-67c9-4cc4-bf89-600558db635b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d2bc47c7-7003-454b-8009-b7ccd7341c70" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1a7718af-67c9-4cc4-bf89-600558db635b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_92ba2e90-17c6-42a9-8388-55b9bb0dafe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1a7718af-67c9-4cc4-bf89-600558db635b" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_92ba2e90-17c6-42a9-8388-55b9bb0dafe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b238c298-e162-44de-b385-59ebd03ac9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b238c298-e162-44de-b385-59ebd03ac9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f9442705-03ca-4904-a1cb-5e9a304beeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b238c298-e162-44de-b385-59ebd03ac9c5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f9442705-03ca-4904-a1cb-5e9a304beeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d4464fe4-1d8b-492f-8f86-9992f52f78ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9442705-03ca-4904-a1cb-5e9a304beeb5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d4464fe4-1d8b-492f-8f86-9992f52f78ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_316f431b-ab54-47fb-99e4-748bb59381f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9442705-03ca-4904-a1cb-5e9a304beeb5" xlink:to="loc_us-gaap_InterestRateSwapMember_316f431b-ab54-47fb-99e4-748bb59381f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_fa131631-dc41-4a29-a6d1-9a4b4d3c065a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_srt_ConsolidatedEntitiesAxis_fa131631-dc41-4a29-a6d1-9a4b4d3c065a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3d34b726-f020-4eef-aaca-da548a22a994" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_fa131631-dc41-4a29-a6d1-9a4b4d3c065a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3d34b726-f020-4eef-aaca-da548a22a994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d94db2cb-e289-4637-92d7-6e665233cbc5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3d34b726-f020-4eef-aaca-da548a22a994" xlink:to="loc_srt_ParentCompanyMember_d94db2cb-e289-4637-92d7-6e665233cbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d25d4e1c-30d1-4347-a802-a05fe1dae81c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d25d4e1c-30d1-4347-a802-a05fe1dae81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_342a6f61-1f0a-4504-8e87-5ceb789b4fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d25d4e1c-30d1-4347-a802-a05fe1dae81c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_342a6f61-1f0a-4504-8e87-5ceb789b4fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_f8d4b060-91c5-4e0b-aab5-8aa48254d71e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_342a6f61-1f0a-4504-8e87-5ceb789b4fa2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_f8d4b060-91c5-4e0b-aab5-8aa48254d71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2a97ecb9-2c81-49a0-b3b5-900dbe397202" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2a97ecb9-2c81-49a0-b3b5-900dbe397202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2a97ecb9-2c81-49a0-b3b5-900dbe397202" xlink:to="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d69cbf5-507e-42d1-9cae-59e96f9f5d32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d69cbf5-507e-42d1-9cae-59e96f9f5d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_ed89612b-2776-499a-bb75-d65c39f7403b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_ed89612b-2776-499a-bb75-d65c39f7403b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3a9219b5-484c-474b-b2b2-22d44259051c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3a9219b5-484c-474b-b2b2-22d44259051c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_13c6df2d-ba87-43f9-87c9-bbaa1a5d2b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_13c6df2d-ba87-43f9-87c9-bbaa1a5d2b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_924746ef-cc9b-4467-9eca-bfa55ef1ee80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a4b0ff17-66d6-4217-8c3a-92b3e903ecaa" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_924746ef-cc9b-4467-9eca-bfa55ef1ee80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69984b5a-05fc-4682-b39a-97a46c5a7fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69984b5a-05fc-4682-b39a-97a46c5a7fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dd1a1338-7fa2-4d03-9385-15b208c110e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69984b5a-05fc-4682-b39a-97a46c5a7fac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dd1a1338-7fa2-4d03-9385-15b208c110e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_85262703-18f0-4727-8502-2166ba6c9995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dd1a1338-7fa2-4d03-9385-15b208c110e1" xlink:to="loc_us-gaap_CashFlowHedgingMember_85262703-18f0-4727-8502-2166ba6c9995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a15d7f85-6b56-4505-8de4-58af85f4af83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dd1a1338-7fa2-4d03-9385-15b208c110e1" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a15d7f85-6b56-4505-8de4-58af85f4af83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_12475168-c38e-472b-ac74-273d7e1e2130" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6731c98a-eb1c-4634-b34b-74db8ac5ad0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6731c98a-eb1c-4634-b34b-74db8ac5ad0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_772f4c56-cfdd-4891-aa9a-d8898181e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_772f4c56-cfdd-4891-aa9a-d8898181e2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_47b13afc-2b87-4aec-aa2a-c659f1e3f960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_47b13afc-2b87-4aec-aa2a-c659f1e3f960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_26c1c73c-cfdc-4a35-a3be-83e381e21b21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_26c1c73c-cfdc-4a35-a3be-83e381e21b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_80159e70-b026-44b1-8a43-8e6da85f4af7" xlink:href="vtrs-20230331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_80159e70-b026-44b1-8a43-8e6da85f4af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_475693dc-6428-4095-915a-29aecbe9f4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_475693dc-6428-4095-915a-29aecbe9f4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06af2dc5-1b7d-4e19-be62-db71fc19fd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06af2dc5-1b7d-4e19-be62-db71fc19fd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_777a8044-66b5-4188-a5bd-7a1877fd7e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_777a8044-66b5-4188-a5bd-7a1877fd7e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_20d67b3e-194e-4e13-b694-afe28e2585d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_20d67b3e-194e-4e13-b694-afe28e2585d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_35b77649-fc8f-43f9-a285-b13ad003a488" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_35b77649-fc8f-43f9-a285-b13ad003a488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9bbf0c1a-05cb-4bd1-8eaf-2ec92fec1aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9bbf0c1a-05cb-4bd1-8eaf-2ec92fec1aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bd62a1b-638b-4e4d-b741-a899d9fc2ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bd62a1b-638b-4e4d-b741-a899d9fc2ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_61938830-0258-4d6a-9476-412751de6aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_InterestExpense_61938830-0258-4d6a-9476-412751de6aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b68c99e6-5e70-41ad-b385-f921e1d5c39f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b68c99e6-5e70-41ad-b385-f921e1d5c39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_602e64f0-25f1-4e8f-8285-3465b725e8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_602e64f0-25f1-4e8f-8285-3465b725e8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_c0ee0a28-064f-4237-a2de-7e14c0fdc394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdb4b447-1b9d-4d7c-8e8c-fb672068d73a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_c0ee0a28-064f-4237-a2de-7e14c0fdc394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_57528793-e876-4177-b18e-5d1637c27757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_57528793-e876-4177-b18e-5d1637c27757" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2873ce4b-d61a-4b55-94c5-f09a3235a6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2873ce4b-d61a-4b55-94c5-f09a3235a6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_32d72f01-1fa4-4178-acc2-0ce33a19d451" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2873ce4b-d61a-4b55-94c5-f09a3235a6b6" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_32d72f01-1fa4-4178-acc2-0ce33a19d451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_9a8f8bf6-59ae-4273-a5d2-29f4ac7a2344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_32d72f01-1fa4-4178-acc2-0ce33a19d451" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_9a8f8bf6-59ae-4273-a5d2-29f4ac7a2344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_65a28701-5385-4ec1-a70c-e61cf6fbe47d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_65a28701-5385-4ec1-a70c-e61cf6fbe47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_62536eee-665f-4683-aef7-2bb30117f092" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_65a28701-5385-4ec1-a70c-e61cf6fbe47d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_62536eee-665f-4683-aef7-2bb30117f092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_6f6111e8-0a94-4bd0-a361-7588a783d30b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_62536eee-665f-4683-aef7-2bb30117f092" xlink:to="loc_srt_ParentCompanyMember_6f6111e8-0a94-4bd0-a361-7588a783d30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2d39fc3a-77a8-463f-a213-7a60a90ed06e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2d39fc3a-77a8-463f-a213-7a60a90ed06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3769562e-1b68-460b-ba75-9688c944d13d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2d39fc3a-77a8-463f-a213-7a60a90ed06e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3769562e-1b68-460b-ba75-9688c944d13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_89dd4e3b-a9aa-4675-bc61-f2faed4a0bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3769562e-1b68-460b-ba75-9688c944d13d" xlink:to="loc_us-gaap_CashFlowHedgingMember_89dd4e3b-a9aa-4675-bc61-f2faed4a0bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_420604b7-905d-4cd4-8422-a80dc75e281e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3769562e-1b68-460b-ba75-9688c944d13d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_420604b7-905d-4cd4-8422-a80dc75e281e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c6693529-e121-4fef-aea8-6a903bc0fc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c6693529-e121-4fef-aea8-6a903bc0fc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c6693529-e121-4fef-aea8-6a903bc0fc8b" xlink:to="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_f95d3b8f-8c30-4f6c-bdc5-3d64eb564ada" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_f95d3b8f-8c30-4f6c-bdc5-3d64eb564ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_110adbdf-f53a-4304-879b-0e3631e26c80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_110adbdf-f53a-4304-879b-0e3631e26c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2ad23b2c-a389-479c-9a77-815c6473c43c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2ad23b2c-a389-479c-9a77-815c6473c43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_9a027980-4d87-46ef-899f-e4a638dd61cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_9a027980-4d87-46ef-899f-e4a638dd61cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7549e91e-3a69-444e-8b42-85c8b4455876" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c24086e5-3ede-4acb-b513-f817a1a8495f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7549e91e-3a69-444e-8b42-85c8b4455876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8dc551ae-bccf-4790-83d8-9f1924cbd7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8dc551ae-bccf-4790-83d8-9f1924cbd7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b6fe57fe-9161-43b7-947d-8058c2b2b1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8dc551ae-bccf-4790-83d8-9f1924cbd7ed" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b6fe57fe-9161-43b7-947d-8058c2b2b1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_872c8b05-fb48-4eb0-a1c1-fe50ee84bde6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b6fe57fe-9161-43b7-947d-8058c2b2b1f2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_872c8b05-fb48-4eb0-a1c1-fe50ee84bde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ced27952-4db5-49cf-bd49-52f0330a2426" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ced27952-4db5-49cf-bd49-52f0330a2426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1882af0c-05ba-4a85-94b3-5cc43e6f7375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ced27952-4db5-49cf-bd49-52f0330a2426" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1882af0c-05ba-4a85-94b3-5cc43e6f7375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5c21cb45-2fdf-4fbf-b7ea-025884a0c955" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1882af0c-05ba-4a85-94b3-5cc43e6f7375" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5c21cb45-2fdf-4fbf-b7ea-025884a0c955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7c5f639f-914c-4797-8b81-b7debc6a8083" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1882af0c-05ba-4a85-94b3-5cc43e6f7375" xlink:to="loc_us-gaap_InterestRateSwapMember_7c5f639f-914c-4797-8b81-b7debc6a8083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_411be680-da42-45fb-a6ce-525022cd51e0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_42c331ee-9ba9-41b6-a4ef-04bd28279d1b" xlink:href="vtrs-20230331.xsd#vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx_42c331ee-9ba9-41b6-a4ef-04bd28279d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_9ff5d5b2-2697-4afb-af35-769858365391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_9ff5d5b2-2697-4afb-af35-769858365391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_30c1f144-7011-439b-b935-a7471e9fd924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_30c1f144-7011-439b-b935-a7471e9fd924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c45a084b-9703-4e9f-82d5-0e2e411ec7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c45a084b-9703-4e9f-82d5-0e2e411ec7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5443367f-2e1e-4210-92f4-efb9b90adf43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5443367f-2e1e-4210-92f4-efb9b90adf43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eed229c2-dd82-475e-91dc-bf8ac746d013" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eed229c2-dd82-475e-91dc-bf8ac746d013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_e41a2bb2-46a9-4681-b42f-693f5193aa80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_e41a2bb2-46a9-4681-b42f-693f5193aa80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_88620ffe-8511-4f0a-b5d0-43de701b989d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_88620ffe-8511-4f0a-b5d0-43de701b989d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_72fb4cc9-385d-4d20-88c8-3344197fc1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_InterestExpense_72fb4cc9-385d-4d20-88c8-3344197fc1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1b718bc2-8f32-4ab9-9f3d-230606a48f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1b718bc2-8f32-4ab9-9f3d-230606a48f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3ef635a9-5862-49f2-a58f-b6a71c587573" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3ef635a9-5862-49f2-a58f-b6a71c587573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d504b331-7ab8-4d35-a985-332924c1fd0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d504b331-7ab8-4d35-a985-332924c1fd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_c81f4c2f-baa4-4388-8939-23b205e812bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent_c81f4c2f-baa4-4388-8939-23b205e812bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6e39b590-cc9a-45c9-99b4-89e596d98d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6e39b590-cc9a-45c9-99b4-89e596d98d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e5980490-7843-4396-b93b-265e7cac953f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e5980490-7843-4396-b93b-265e7cac953f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f28d2d37-a448-498b-ae3f-5e7a8a0f151d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f28d2d37-a448-498b-ae3f-5e7a8a0f151d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_1a719484-8739-4f90-9248-b2f89f5ad278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_1a719484-8739-4f90-9248-b2f89f5ad278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_dd6cf220-6581-4bc6-9677-9b08cbfe3d17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_dd6cf220-6581-4bc6-9677-9b08cbfe3d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_2574e046-7ff7-4664-a978-b9f1bbffa6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_2574e046-7ff7-4664-a978-b9f1bbffa6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a9b19b8e-20bf-442b-9381-cf61e22328e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a9b19b8e-20bf-442b-9381-cf61e22328e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4d103579-c396-4c26-b13c-e53bc6183edd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4d103579-c396-4c26-b13c-e53bc6183edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_f7f746ba-0f41-4693-b3bd-957b21f04ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5b88b45d-d802-492a-9f02-937ad9903dcc" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_f7f746ba-0f41-4693-b3bd-957b21f04ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_74bd95cf-93a9-465f-9d29-e65a1131cd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_74bd95cf-93a9-465f-9d29-e65a1131cd4b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b11978d4-ed2b-4ffd-b9f9-557e6c1333a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:to="loc_srt_ProductOrServiceAxis_b11978d4-ed2b-4ffd-b9f9-557e6c1333a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_321a9efe-563a-407a-a2bd-c71765a3a191" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b11978d4-ed2b-4ffd-b9f9-557e6c1333a3" xlink:to="loc_srt_ProductsAndServicesDomain_321a9efe-563a-407a-a2bd-c71765a3a191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_e3c19c0c-471a-4ab0-bc43-fa0f5006d0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_321a9efe-563a-407a-a2bd-c71765a3a191" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_e3c19c0c-471a-4ab0-bc43-fa0f5006d0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_286fbf55-6a97-41e8-9c9f-ac22484ed6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_286fbf55-6a97-41e8-9c9f-ac22484ed6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_286fbf55-6a97-41e8-9c9f-ac22484ed6b8" xlink:to="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_c23738be-4c2e-4552-b265-cdc756a34148" xlink:href="vtrs-20230331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_c23738be-4c2e-4552-b265-cdc756a34148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_ef11fc27-eb4e-4b64-930c-ebc0be95c77b" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:to="loc_vtrs_GreaterChinaSegmentMember_ef11fc27-eb4e-4b64-930c-ebc0be95c77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_a17906c3-6d3e-4e5f-bf47-3b50a40470ee" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_a17906c3-6d3e-4e5f-bf47-3b50a40470ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_7ae35c56-1142-467f-bbe0-79222d6fbb93" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_039ccc9f-f98d-40bc-a5d8-837c36ae5692" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_7ae35c56-1142-467f-bbe0-79222d6fbb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b6b2acb1-b902-40f4-b55f-9a3a3172ecf8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:to="loc_srt_ConsolidationItemsAxis_b6b2acb1-b902-40f4-b55f-9a3a3172ecf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b6b2acb1-b902-40f4-b55f-9a3a3172ecf8" xlink:to="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1d61728f-345c-43f6-97e2-3f4480e642ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:to="loc_us-gaap_OperatingSegmentsMember_1d61728f-345c-43f6-97e2-3f4480e642ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_9f7077a4-ab52-4bf4-b640-9e67cb1228cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_9f7077a4-ab52-4bf4-b640-9e67cb1228cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5fb3ecce-a800-46a4-9a02-df4022c97335" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_93de7f63-7876-4029-878a-024419051f6b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5fb3ecce-a800-46a4-9a02-df4022c97335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6097e5e1-e6de-4926-b0bf-fc0d78d9e3fd" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ad85f773-57c2-415a-9d28-bc2f92fc8a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ad85f773-57c2-415a-9d28-bc2f92fc8a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_42e77f56-e530-4219-ba70-0d1ea7144d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_Revenues_42e77f56-e530-4219-ba70-0d1ea7144d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_32ed5329-c69b-48b4-a6ee-a3a61f437064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_32ed5329-c69b-48b4-a6ee-a3a61f437064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_27c0c9e5-a47c-4b4b-ab36-544356fa21c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_27c0c9e5-a47c-4b4b-ab36-544356fa21c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6fc294c6-deb4-4529-ae6f-834191e5f298" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6fc294c6-deb4-4529-ae6f-834191e5f298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Corporatecosts_befa85ab-85c9-4d92-9997-89930f692220" xlink:href="vtrs-20230331.xsd#vtrs_Corporatecosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_vtrs_Corporatecosts_befa85ab-85c9-4d92-9997-89930f692220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_c726dd9a-8ba1-447a-a28a-ed8d1f7a737a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_c726dd9a-8ba1-447a-a28a-ed8d1f7a737a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_34293846-689c-40c6-a244-fb5e9bd9f5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_us-gaap_OperatingIncomeLoss_34293846-689c-40c6-a244-fb5e9bd9f5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherOneTimeNonoperatingExpense_4692cff4-2bea-4ff6-a60a-cba30cf9be68" xlink:href="vtrs-20230331.xsd#vtrs_OtherOneTimeNonoperatingExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf768533-4369-4fa0-b940-c6afd5b2279e" xlink:to="loc_vtrs_OtherOneTimeNonoperatingExpense_4692cff4-2bea-4ff6-a60a-cba30cf9be68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RestructuringRestructuringChargesDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#RestructuringRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RestructuringRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4b712e50-d031-4e54-af01-df7e41947556" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4b712e50-d031-4e54-af01-df7e41947556" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_7781df79-6483-41fc-82ec-176d06b15eda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_7781df79-6483-41fc-82ec-176d06b15eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_143b0142-7ad6-4e71-bbca-dc3214bbb53e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7781df79-6483-41fc-82ec-176d06b15eda" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_143b0142-7ad6-4e71-bbca-dc3214bbb53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_7f6fa4cf-9f19-4f48-96d9-bf732c7bff8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_143b0142-7ad6-4e71-bbca-dc3214bbb53e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_7f6fa4cf-9f19-4f48-96d9-bf732c7bff8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_d64fc0be-5b48-4bdb-a7c6-7120c998e510" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_143b0142-7ad6-4e71-bbca-dc3214bbb53e" xlink:to="loc_us-gaap_OtherRestructuringMember_d64fc0be-5b48-4bdb-a7c6-7120c998e510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bd7237d6-ccf7-49ca-8fd5-305d7c654eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bd7237d6-ccf7-49ca-8fd5-305d7c654eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bd7237d6-ccf7-49ca-8fd5-305d7c654eb8" xlink:to="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_786e5f24-99e5-47df-a0dc-2f488dddf84b" xlink:href="vtrs-20230331.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_786e5f24-99e5-47df-a0dc-2f488dddf84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_43eb696f-9c47-4566-ae91-13fe20933f1b" xlink:href="vtrs-20230331.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:to="loc_vtrs_GreaterChinaSegmentMember_43eb696f-9c47-4566-ae91-13fe20933f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_dd613a7b-2cd0-459f-95ef-aede10a86f8e" xlink:href="vtrs-20230331.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_dd613a7b-2cd0-459f-95ef-aede10a86f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_da354b78-88f6-4e4e-9d00-cd74d20fe41e" xlink:href="vtrs-20230331.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d692f3ee-771c-47cb-a66f-d3d682358368" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_da354b78-88f6-4e4e-9d00-cd74d20fe41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f1ef34b7-d377-4685-819f-5ce0d6625eb1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_srt_RangeAxis_f1ef34b7-d377-4685-819f-5ce0d6625eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d8be84e2-cd1c-4ef6-8063-bde1f9b970c4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f1ef34b7-d377-4685-819f-5ce0d6625eb1" xlink:to="loc_srt_RangeMember_d8be84e2-cd1c-4ef6-8063-bde1f9b970c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c720b051-3a81-462b-9eb0-115add8e9c37" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d8be84e2-cd1c-4ef6-8063-bde1f9b970c4" xlink:to="loc_srt_MinimumMember_c720b051-3a81-462b-9eb0-115add8e9c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ecaea1a2-66dd-4315-a6e2-1b5d270e7742" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d8be84e2-cd1c-4ef6-8063-bde1f9b970c4" xlink:to="loc_srt_MaximumMember_ecaea1a2-66dd-4315-a6e2-1b5d270e7742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_48093004-dfcc-4755-95ec-7aea01d3ece9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_us-gaap_RestructuringPlanAxis_48093004-dfcc-4755-95ec-7aea01d3ece9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_99de307a-3807-4230-9216-186a23ef1fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_48093004-dfcc-4755-95ec-7aea01d3ece9" xlink:to="loc_us-gaap_RestructuringPlanDomain_99de307a-3807-4230-9216-186a23ef1fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RestructuringPlanMember_df1df667-1e63-44f4-b986-06fe1378f964" xlink:href="vtrs-20230331.xsd#vtrs_A2020RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_99de307a-3807-4230-9216-186a23ef1fe8" xlink:to="loc_vtrs_A2020RestructuringPlanMember_df1df667-1e63-44f4-b986-06fe1378f964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4d3b968d-d5cd-4660-9582-ad71149138ef" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_srt_StatementScenarioAxis_4d3b968d-d5cd-4660-9582-ad71149138ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3723d799-74c2-4403-abe1-f7c2475e6894" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_4d3b968d-d5cd-4660-9582-ad71149138ef" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3723d799-74c2-4403-abe1-f7c2475e6894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_f6ac9b5e-f6c9-45db-82ee-fc5aa1f51dbb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_3723d799-74c2-4403-abe1-f7c2475e6894" xlink:to="loc_srt_ScenarioForecastMember_f6ac9b5e-f6c9-45db-82ee-fc5aa1f51dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e321e66d-df8b-4f1d-b8da-1bcb71f33b25" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_8894848f-b91e-4d00-a743-d72899165417" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_8894848f-b91e-4d00-a743-d72899165417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_a47fa16f-8970-45eb-b1c5-96f07884760a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_a47fa16f-8970-45eb-b1c5-96f07884760a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f890a460-57d9-4f7d-b743-1fe0c6387bc8" xlink:to="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_636dce02-9b1a-4ae7-851c-fa6e0164c6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_RestructuringReserve_636dce02-9b1a-4ae7-851c-fa6e0164c6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6d3fded5-7a0e-4f8d-be28-c8b9ab39add4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_RestructuringCharges_6d3fded5-7a0e-4f8d-be28-c8b9ab39add4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_880c4ee1-173b-47a8-96e1-9e8b37628fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_PaymentsForRestructuring_880c4ee1-173b-47a8-96e1-9e8b37628fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_8f66b2c8-fe34-4295-b79e-964be9be20ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_8f66b2c8-fe34-4295-b79e-964be9be20ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_ea8b4d06-b0b8-4871-ad08-dfff0996e253" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_ea8b4d06-b0b8-4871-ad08-dfff0996e253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b6411b31-669e-4088-9a9e-f6eda4abbf89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6296fc65-63da-4b0e-965a-832943fe74f0" xlink:to="loc_us-gaap_RestructuringReserve_b6411b31-669e-4088-9a9e-f6eda4abbf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#CollaborationandLicensingAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a9fac0df-633d-43f5-bea1-49c03bf930d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_15d52e88-94dc-41e6-a839-24e4fb549175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a9fac0df-633d-43f5-bea1-49c03bf930d9" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_15d52e88-94dc-41e6-a839-24e4fb549175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8ba2f981-2ca8-4ef4-9564-22106d58aa30" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_15d52e88-94dc-41e6-a839-24e4fb549175" xlink:to="loc_srt_RangeAxis_8ba2f981-2ca8-4ef4-9564-22106d58aa30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c1a00683-d881-41ab-adbe-12b6fab34b4d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8ba2f981-2ca8-4ef4-9564-22106d58aa30" xlink:to="loc_srt_RangeMember_c1a00683-d881-41ab-adbe-12b6fab34b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e8f3204e-c197-417e-a81a-c92847db9607" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c1a00683-d881-41ab-adbe-12b6fab34b4d" xlink:to="loc_srt_MaximumMember_e8f3204e-c197-417e-a81a-c92847db9607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_6448c818-ccb3-45b8-b3d7-cd9e4675dd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_15d52e88-94dc-41e6-a839-24e4fb549175" xlink:to="loc_us-gaap_TypeOfArrangementAxis_6448c818-ccb3-45b8-b3d7-cd9e4675dd4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d9cd4bca-65c7-40c6-897b-9a847d4e5c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_6448c818-ccb3-45b8-b3d7-cd9e4675dd4c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d9cd4bca-65c7-40c6-897b-9a847d4e5c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_6d1d1227-35ef-436b-b0cd-bf6cb4a79dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d9cd4bca-65c7-40c6-897b-9a847d4e5c7c" xlink:to="loc_us-gaap_CollaborativeArrangementMember_6d1d1227-35ef-436b-b0cd-bf6cb4a79dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8fe6794d-3e0f-4d6e-9973-0a86be6f88d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_15d52e88-94dc-41e6-a839-24e4fb549175" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8fe6794d-3e0f-4d6e-9973-0a86be6f88d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Developmentandsalesmilestonepayments_953fd5fd-2495-425c-8658-2e18946423fc" xlink:href="vtrs-20230331.xsd#vtrs_Developmentandsalesmilestonepayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8fe6794d-3e0f-4d6e-9973-0a86be6f88d5" xlink:to="loc_vtrs_Developmentandsalesmilestonepayments_953fd5fd-2495-425c-8658-2e18946423fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#IncomeTaxesIncomeTaxesDisclosureDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d8a013c8-340b-45e6-a968-8362c5ba653c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d8a013c8-340b-45e6-a968-8362c5ba653c" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_52ae9c67-c7b7-4f81-a377-2f51ca33541f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:to="loc_srt_StatementScenarioAxis_52ae9c67-c7b7-4f81-a377-2f51ca33541f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0e960cb2-17fe-4296-9a7a-94f96065c4ef" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_52ae9c67-c7b7-4f81-a377-2f51ca33541f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0e960cb2-17fe-4296-9a7a-94f96065c4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_d74c9bda-fdd0-40ee-9b27-0637c660aede" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0e960cb2-17fe-4296-9a7a-94f96065c4ef" xlink:to="loc_srt_ScenarioForecastMember_d74c9bda-fdd0-40ee-9b27-0637c660aede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4c3e7513-c078-4161-a338-b513655575a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4c3e7513-c078-4161-a338-b513655575a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_12e21040-ded5-47a3-8344-58b1988d4d85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4c3e7513-c078-4161-a338-b513655575a2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_12e21040-ded5-47a3-8344-58b1988d4d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_60294ccd-f80f-46c0-b394-dff93c30713c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_12e21040-ded5-47a3-8344-58b1988d4d85" xlink:to="loc_us-gaap_ForeignCountryMember_60294ccd-f80f-46c0-b394-dff93c30713c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_87a97457-d3f4-4b7c-a3d8-aa468e690758" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_87a97457-d3f4-4b7c-a3d8-aa468e690758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1402e7ce-d194-42a0-94fb-f0aa2a6f75e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_87a97457-d3f4-4b7c-a3d8-aa468e690758" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1402e7ce-d194-42a0-94fb-f0aa2a6f75e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember_4e7d9b0a-a240-48cd-ac68-8838e905675e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1402e7ce-d194-42a0-94fb-f0aa2a6f75e9" xlink:to="loc_us-gaap_AustralianTaxationOfficeMember_4e7d9b0a-a240-48cd-ac68-8838e905675e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinistryOfFinanceIndiaMember_2dea5258-ba72-47d0-939b-22501c0de963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinistryOfFinanceIndiaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1402e7ce-d194-42a0-94fb-f0aa2a6f75e9" xlink:to="loc_us-gaap_MinistryOfFinanceIndiaMember_2dea5258-ba72-47d0-939b-22501c0de963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5b34bb52-29a7-48c9-8c9a-cf41d4a3c121" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e9221489-c00e-4ab6-aaaa-605f46ff0660" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e9221489-c00e-4ab6-aaaa-605f46ff0660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_cc19b216-15ee-4d1c-9247-fc250176dc8f" xlink:href="vtrs-20230331.xsd#vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:to="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_cc19b216-15ee-4d1c-9247-fc250176dc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_47bb66d0-a21d-4083-ad78-b9bf18a6e45b" xlink:href="vtrs-20230331.xsd#vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8520c296-325a-4e0c-8e67-1f1c9b9437ea" xlink:to="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_47bb66d0-a21d-4083-ad78-b9bf18a6e45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationLorazepamandClorazepateNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_546582b4-14ad-4968-bab9-166442154c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8172ca4c-5aef-4c1c-9f7f-9db401e9c9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_546582b4-14ad-4968-bab9-166442154c3b" xlink:to="loc_us-gaap_LossContingenciesTable_8172ca4c-5aef-4c1c-9f7f-9db401e9c9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_595d6849-dd7a-4d4d-b45e-9dae5916609e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8172ca4c-5aef-4c1c-9f7f-9db401e9c9ce" xlink:to="loc_srt_LitigationCaseAxis_595d6849-dd7a-4d4d-b45e-9dae5916609e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_065357c9-0f31-4f07-9956-144f811fbbff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_595d6849-dd7a-4d4d-b45e-9dae5916609e" xlink:to="loc_srt_LitigationCaseTypeDomain_065357c9-0f31-4f07-9956-144f811fbbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9eb6f8bb-c612-4ea2-9095-555f35279605" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8172ca4c-5aef-4c1c-9f7f-9db401e9c9ce" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9eb6f8bb-c612-4ea2-9095-555f35279605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_dcc2fb20-95af-44e6-86a1-5bb3441844be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9eb6f8bb-c612-4ea2-9095-555f35279605" xlink:to="loc_us-gaap_LossContingencyNatureDomain_dcc2fb20-95af-44e6-86a1-5bb3441844be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1b9ed234-8e5b-47d9-81aa-e1ddab5cfe96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8172ca4c-5aef-4c1c-9f7f-9db401e9c9ce" xlink:to="loc_us-gaap_LossContingenciesLineItems_1b9ed234-8e5b-47d9-81aa-e1ddab5cfe96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6ee7d27a-e200-4cf0-8368-d005f48b2a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1b9ed234-8e5b-47d9-81aa-e1ddab5cfe96" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6ee7d27a-e200-4cf0-8368-d005f48b2a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationPricingandMedicaidLitigationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d3597210-59f3-4e14-b040-e445bddd7dff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d3597210-59f3-4e14-b040-e445bddd7dff" xlink:to="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9e97c52d-11c0-40a0-afe9-83e6fc480ade" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:to="loc_srt_LitigationCaseAxis_9e97c52d-11c0-40a0-afe9-83e6fc480ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_71f5d288-59e9-4cef-a6d0-20fd3847136c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_9e97c52d-11c0-40a0-afe9-83e6fc480ade" xlink:to="loc_srt_LitigationCaseTypeDomain_71f5d288-59e9-4cef-a6d0-20fd3847136c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8c240899-77b4-49cf-8f3e-26d6eb63d460" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:to="loc_dei_LegalEntityAxis_8c240899-77b4-49cf-8f3e-26d6eb63d460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bb1f8f5e-2840-4a18-9882-c2a7a639cb0e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8c240899-77b4-49cf-8f3e-26d6eb63d460" xlink:to="loc_dei_EntityDomain_bb1f8f5e-2840-4a18-9882-c2a7a639cb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_07daddee-501d-4fe1-b8e4-9136eb2d33a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_07daddee-501d-4fe1-b8e4-9136eb2d33a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e695def3-106f-4e36-b165-3e0ddd723c03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_07daddee-501d-4fe1-b8e4-9136eb2d33a0" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e695def3-106f-4e36-b165-3e0ddd723c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e0d4f877-176f-41ad-9be2-4dc50511ce3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_761be171-b1ef-4e8b-a993-5c49e38c3265" xlink:to="loc_us-gaap_LossContingenciesLineItems_e0d4f877-176f-41ad-9be2-4dc50511ce3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_8e27cdc5-38e0-4ad7-8cfb-0e6cfd684079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e0d4f877-176f-41ad-9be2-4dc50511ce3f" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_8e27cdc5-38e0-4ad7-8cfb-0e6cfd684079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_94910893-2490-4c1f-8f47-5f361a254ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5a25213f-0fa7-4596-9ab7-dfa7454b144c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_94910893-2490-4c1f-8f47-5f361a254ae5" xlink:to="loc_us-gaap_LossContingenciesTable_5a25213f-0fa7-4596-9ab7-dfa7454b144c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9b428668-5cfe-4d39-a402-0d0602efd304" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5a25213f-0fa7-4596-9ab7-dfa7454b144c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9b428668-5cfe-4d39-a402-0d0602efd304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3a65523b-184b-4a79-9b7c-8ca686161e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9b428668-5cfe-4d39-a402-0d0602efd304" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3a65523b-184b-4a79-9b7c-8ca686161e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7f8e50b8-f6a3-4dba-a31f-549054f8c7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5a25213f-0fa7-4596-9ab7-dfa7454b144c" xlink:to="loc_us-gaap_LossContingenciesLineItems_7f8e50b8-f6a3-4dba-a31f-549054f8c7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_fbcc116a-7a77-4a35-94c9-9585fc8f806d" xlink:href="vtrs-20230331.xsd#vtrs_Numberofstates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7f8e50b8-f6a3-4dba-a31f-549054f8c7ba" xlink:to="loc_vtrs_Numberofstates_fbcc116a-7a77-4a35-94c9-9585fc8f806d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e59809d4-06db-40a7-a127-09acf53c215b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7f8e50b8-f6a3-4dba-a31f-549054f8c7ba" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e59809d4-06db-40a7-a127-09acf53c215b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationPioglitazoneNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationPioglitazoneNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationPioglitazoneNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_04a214fc-f16f-44d0-b06b-0ed7aa8ce701" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b51ef1a5-2790-48b0-a57e-a0a0f0343926" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_04a214fc-f16f-44d0-b06b-0ed7aa8ce701" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b51ef1a5-2790-48b0-a57e-a0a0f0343926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationShareholderClassActionDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationShareholderClassActionDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationShareholderClassActionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7566c430-8b34-4806-a079-09a3813cdc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8b551ed4-6d64-4fe4-8798-1dd22dce5951" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7566c430-8b34-4806-a079-09a3813cdc1c" xlink:to="loc_us-gaap_LossContingenciesTable_8b551ed4-6d64-4fe4-8798-1dd22dce5951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_48f72d5a-006b-47a7-97ab-f432a5941335" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8b551ed4-6d64-4fe4-8798-1dd22dce5951" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_48f72d5a-006b-47a7-97ab-f432a5941335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2bd6494b-320f-42eb-9262-a8340ae78394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_48f72d5a-006b-47a7-97ab-f432a5941335" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2bd6494b-320f-42eb-9262-a8340ae78394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_25b00f77-97a1-4a50-abe3-2eb4fc15fd76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2bd6494b-320f-42eb-9262-a8340ae78394" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_25b00f77-97a1-4a50-abe3-2eb4fc15fd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8b551ed4-6d64-4fe4-8798-1dd22dce5951" xlink:to="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_07bff5a8-8622-4fb5-a624-dec60492a040" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_07bff5a8-8622-4fb5-a624-dec60492a040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_83008cb5-600f-4542-a502-35d6172d601f" xlink:href="vtrs-20230331.xsd#vtrs_Numberofstates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:to="loc_vtrs_Numberofstates_83008cb5-600f-4542-a502-35d6172d601f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_a9f1554a-8263-438d-be94-3816aef11e41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f64caae7-0b6b-43f6-bc85-ce90a812cce4" xlink:to="loc_us-gaap_LitigationReserve_a9f1554a-8263-438d-be94-3816aef11e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationDrugPricingMattersDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationDrugPricingMattersDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationDrugPricingMattersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_35b59ada-c0c6-45e6-9791-e7f506cc8147" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f8e4cd8d-ce8e-4a79-962e-38793c188acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_35b59ada-c0c6-45e6-9791-e7f506cc8147" xlink:to="loc_us-gaap_LossContingenciesTable_f8e4cd8d-ce8e-4a79-962e-38793c188acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_656ae9ce-0439-4faa-88f0-d4c59cf90c3f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f8e4cd8d-ce8e-4a79-962e-38793c188acb" xlink:to="loc_srt_LitigationCaseAxis_656ae9ce-0439-4faa-88f0-d4c59cf90c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_656ae9ce-0439-4faa-88f0-d4c59cf90c3f" xlink:to="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MultiDistrictLitigationMember_33feeccd-7bdf-4adc-bfeb-93ded63f8bf1" xlink:href="vtrs-20230331.xsd#vtrs_MultiDistrictLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:to="loc_vtrs_MultiDistrictLitigationMember_33feeccd-7bdf-4adc-bfeb-93ded63f8bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_61e9f893-ad7e-4788-94b3-29036455fe4c" xlink:href="vtrs-20230331.xsd#vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:to="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_61e9f893-ad7e-4788-94b3-29036455fe4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_27c35824-52b0-46aa-8d8b-132bd4a57c20" xlink:href="vtrs-20230331.xsd#vtrs_AnticompetitiveConductwithGenericDrugsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:to="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_27c35824-52b0-46aa-8d8b-132bd4a57c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_51583792-db95-4860-9fc9-ab2965db3700" xlink:href="vtrs-20230331.xsd#vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3023072e-542b-461f-a2d7-b8a12e472af0" xlink:to="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_51583792-db95-4860-9fc9-ab2965db3700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ff81a5bd-c82d-4809-84b1-749d9c078e67" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f8e4cd8d-ce8e-4a79-962e-38793c188acb" xlink:to="loc_srt_CounterpartyNameAxis_ff81a5bd-c82d-4809-84b1-749d9c078e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c3aa332-dbf2-41fc-81f7-be4f2c796ea8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ff81a5bd-c82d-4809-84b1-749d9c078e67" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c3aa332-dbf2-41fc-81f7-be4f2c796ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OcularASMember_7e2af4ef-69ab-4337-b129-84a5c91738b7" xlink:href="vtrs-20230331.xsd#vtrs_OcularASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c3aa332-dbf2-41fc-81f7-be4f2c796ea8" xlink:to="loc_vtrs_OcularASMember_7e2af4ef-69ab-4337-b129-84a5c91738b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_bfec5a86-224e-4733-a66e-ca5fcdce6bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f8e4cd8d-ce8e-4a79-962e-38793c188acb" xlink:to="loc_us-gaap_LossContingenciesLineItems_bfec5a86-224e-4733-a66e-ca5fcdce6bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_dd69df04-e014-4570-aa6b-c752204fca28" xlink:href="vtrs-20230331.xsd#vtrs_Numberofstates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bfec5a86-224e-4733-a66e-ca5fcdce6bdd" xlink:to="loc_vtrs_Numberofstates_dd69df04-e014-4570-aa6b-c752204fca28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSought_3e599375-b6fb-401c-af46-b8237a5413dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSought"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bfec5a86-224e-4733-a66e-ca5fcdce6bdd" xlink:to="loc_us-gaap_LossContingencyDamagesSought_3e599375-b6fb-401c-af46-b8237a5413dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationEuropeanCommissionProceedingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8e77b770-34a2-4da6-992f-4fdaa3389248" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d4341626-a27e-40af-94b2-97b580115f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8e77b770-34a2-4da6-992f-4fdaa3389248" xlink:to="loc_us-gaap_LossContingenciesTable_d4341626-a27e-40af-94b2-97b580115f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_347cf32f-afc3-4a2b-a2cd-faef53c1ce7c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d4341626-a27e-40af-94b2-97b580115f6a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_347cf32f-afc3-4a2b-a2cd-faef53c1ce7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_aa6fc744-ae34-4ac6-9844-3d5f33185c55" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_347cf32f-afc3-4a2b-a2cd-faef53c1ce7c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_aa6fc744-ae34-4ac6-9844-3d5f33185c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8480bf8f-6df7-4858-b87e-0f833a2fdb0e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aa6fc744-ae34-4ac6-9844-3d5f33185c55" xlink:to="loc_srt_ParentCompanyMember_8480bf8f-6df7-4858-b87e-0f833a2fdb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b4567c5e-358b-4e5e-9e71-6c6cdbc4f966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d4341626-a27e-40af-94b2-97b580115f6a" xlink:to="loc_us-gaap_LossContingenciesLineItems_b4567c5e-358b-4e5e-9e71-6c6cdbc4f966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_b0bdadb1-d281-4834-bbfe-5608eaccf212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4567c5e-358b-4e5e-9e71-6c6cdbc4f966" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_b0bdadb1-d281-4834-bbfe-5608eaccf212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9f0abfa5-4ecb-418d-b4f0-346bb3843092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9f0abfa5-4ecb-418d-b4f0-346bb3843092" xlink:to="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_1e9b8ee1-a154-46dc-870c-78e8174dbb33" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:to="loc_srt_LitigationCaseAxis_1e9b8ee1-a154-46dc-870c-78e8174dbb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a0744d01-1593-473d-8b53-c559be8b18ac" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_1e9b8ee1-a154-46dc-870c-78e8174dbb33" xlink:to="loc_srt_LitigationCaseTypeDomain_a0744d01-1593-473d-8b53-c559be8b18ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CitalopramLitigationMember_b975c4cd-4ef6-464e-8e60-b3952f02808a" xlink:href="vtrs-20230331.xsd#vtrs_CitalopramLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a0744d01-1593-473d-8b53-c559be8b18ac" xlink:to="loc_vtrs_CitalopramLitigationMember_b975c4cd-4ef6-464e-8e60-b3952f02808a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9b06d38b-9f67-43c2-904a-f8b2406bc84d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9b06d38b-9f67-43c2-904a-f8b2406bc84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ce08da91-e934-4b54-9e30-df46dff6c9cf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9b06d38b-9f67-43c2-904a-f8b2406bc84d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ce08da91-e934-4b54-9e30-df46dff6c9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_3d77492a-6336-403a-92cd-9048980e8bc8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ce08da91-e934-4b54-9e30-df46dff6c9cf" xlink:to="loc_srt_ParentCompanyMember_3d77492a-6336-403a-92cd-9048980e8bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3523fba1-c0e1-4931-a1e9-2a3ee3383c36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3523fba1-c0e1-4931-a1e9-2a3ee3383c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_713804dd-1f2c-4d31-8e8e-06e239ba808f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3523fba1-c0e1-4931-a1e9-2a3ee3383c36" xlink:to="loc_us-gaap_LossContingencyNatureDomain_713804dd-1f2c-4d31-8e8e-06e239ba808f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember_bbc0d224-8fc2-45ca-92f0-d9cebc7fb147" xlink:href="vtrs-20230331.xsd#vtrs_ProductLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_713804dd-1f2c-4d31-8e8e-06e239ba808f" xlink:to="loc_vtrs_ProductLiabilityMember_bbc0d224-8fc2-45ca-92f0-d9cebc7fb147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_79376e0a-a9c2-4a91-ad00-fb79c8f744f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cfc84344-0182-4d0b-88b3-039484550f32" xlink:to="loc_us-gaap_LossContingenciesLineItems_79376e0a-a9c2-4a91-ad00-fb79c8f744f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_cf2c96bb-3035-4754-8152-4987293fd28b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_79376e0a-a9c2-4a91-ad00-fb79c8f744f7" xlink:to="loc_us-gaap_LitigationReserve_cf2c96bb-3035-4754-8152-4987293fd28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationProductLiabilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f8210ec-d4fb-4658-a97d-9a8a22606e15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f133f5a9-64e1-4362-b130-c5a326673c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f8210ec-d4fb-4658-a97d-9a8a22606e15" xlink:to="loc_us-gaap_LossContingenciesTable_f133f5a9-64e1-4362-b130-c5a326673c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d45cb1ab-dc9e-463d-a768-56a6c6eec05f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f133f5a9-64e1-4362-b130-c5a326673c6c" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d45cb1ab-dc9e-463d-a768-56a6c6eec05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_dcc88f68-8bef-4f09-bbd1-b8a1a915a030" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d45cb1ab-dc9e-463d-a768-56a6c6eec05f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_dcc88f68-8bef-4f09-bbd1-b8a1a915a030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember_8c3d7a85-d50b-4c3a-b4ca-74841fccb49a" xlink:href="vtrs-20230331.xsd#vtrs_ProductLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_dcc88f68-8bef-4f09-bbd1-b8a1a915a030" xlink:to="loc_vtrs_ProductLiabilityMember_8c3d7a85-d50b-4c3a-b4ca-74841fccb49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d4cf603b-f6da-44ac-8ca9-d2e364a2f473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f133f5a9-64e1-4362-b130-c5a326673c6c" xlink:to="loc_us-gaap_LossContingenciesLineItems_d4cf603b-f6da-44ac-8ca9-d2e364a2f473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5e8a1293-d3f4-490f-9c1f-3d1b51dec7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d4cf603b-f6da-44ac-8ca9-d2e364a2f473" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5e8a1293-d3f4-490f-9c1f-3d1b51dec7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationIntellectualPropertyNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cdbcd00b-b013-4124-8ca8-002643d8c099" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c32826b9-5c7c-4978-bc6c-1a156eb06960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cdbcd00b-b013-4124-8ca8-002643d8c099" xlink:to="loc_us-gaap_LossContingenciesTable_c32826b9-5c7c-4978-bc6c-1a156eb06960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cbc1ad85-72c3-4f28-827f-fa0eb05e694d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c32826b9-5c7c-4978-bc6c-1a156eb06960" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cbc1ad85-72c3-4f28-827f-fa0eb05e694d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_adb040dc-1408-4523-92e0-51429c579d93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cbc1ad85-72c3-4f28-827f-fa0eb05e694d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_adb040dc-1408-4523-92e0-51429c579d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a963ff45-a1d1-4fd3-9249-5ab745ae37a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_adb040dc-1408-4523-92e0-51429c579d93" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a963ff45-a1d1-4fd3-9249-5ab745ae37a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c32826b9-5c7c-4978-bc6c-1a156eb06960" xlink:to="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_529a3048-f338-4294-ac13-0d5f55257dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_529a3048-f338-4294-ac13-0d5f55257dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfScottishHealthBoardsNHSScotland_b1fd1075-83b6-4281-911e-823b0fd8bb38" xlink:href="vtrs-20230331.xsd#vtrs_NumberOfScottishHealthBoardsNHSScotland"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:to="loc_vtrs_NumberOfScottishHealthBoardsNHSScotland_b1fd1075-83b6-4281-911e-823b0fd8bb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland_ca77392f-809b-4d8b-ab7d-aa5756681019" xlink:href="vtrs-20230331.xsd#vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b2e84b50-9d3a-46cf-bc62-d7f88186cd7c" xlink:to="loc_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland_ca77392f-809b-4d8b-ab7d-aa5756681019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20230331.xsd#LitigationOtherLitigationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_886687bd-9d26-459d-9950-b3a6edea6bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_67b052c1-4d60-46f5-97b7-0f45d253cc44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_886687bd-9d26-459d-9950-b3a6edea6bd8" xlink:to="loc_us-gaap_LossContingenciesTable_67b052c1-4d60-46f5-97b7-0f45d253cc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_fd6d5870-b607-4220-a03e-abbf9083521f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_67b052c1-4d60-46f5-97b7-0f45d253cc44" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_fd6d5870-b607-4220-a03e-abbf9083521f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_817a919c-a5b3-4f55-ab1f-e8ae66b078d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_fd6d5870-b607-4220-a03e-abbf9083521f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_817a919c-a5b3-4f55-ab1f-e8ae66b078d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember_f0b26970-4b2e-4169-9215-5f263a5ed976" xlink:href="vtrs-20230331.xsd#vtrs_OtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_817a919c-a5b3-4f55-ab1f-e8ae66b078d6" xlink:to="loc_vtrs_OtherMember_f0b26970-4b2e-4169-9215-5f263a5ed976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_67b052c1-4d60-46f5-97b7-0f45d253cc44" xlink:to="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofcases_3bd66ad5-d73e-46e2-9164-11d0f0b4b132" xlink:href="vtrs-20230331.xsd#vtrs_Numberofcases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:to="loc_vtrs_Numberofcases_3bd66ad5-d73e-46e2-9164-11d0f0b4b132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_60d83c85-b0fc-4f7c-afa5-903e355c884f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_60d83c85-b0fc-4f7c-afa5-903e355c884f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_ee19f9ae-08c6-4a30-8865-a0b5df566d15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0a22986c-99a7-41bb-8b07-0274da6e4e1a" xlink:to="loc_us-gaap_LitigationReserve_ee19f9ae-08c6-4a30-8865-a0b5df566d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650919293744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - &#8364; / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 03, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIATRIS INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-4364296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1000 Mylan Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Canonsburg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">15317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">514-1800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VTRS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filler Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,199,029,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001792044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916363120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,719.1<span></span>
</td>
<td class="nump">$ 4,178.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">3,729.1<span></span>
</td>
<td class="nump">4,191.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,186.9<span></span>
</td>
<td class="nump">2,420.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,542.2<span></span>
</td>
<td class="nump">1,771.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">182.9<span></span>
</td>
<td class="nump">142.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">958.9<span></span>
</td>
<td class="nump">915.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlements and other contingencies, net</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,142.4<span></span>
</td>
<td class="nump">1,063.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">399.8<span></span>
</td>
<td class="nump">707.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">147.0<span></span>
</td>
<td class="nump">146.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(69.9)<span></span>
</td>
<td class="nump">33.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">322.7<span></span>
</td>
<td class="nump">527.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">98.0<span></span>
</td>
<td class="nump">128.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings</a></td>
<td class="nump">$ 224.7<span></span>
</td>
<td class="nump">$ 399.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to Viatris Inc. shareholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">1,202.5<span></span>
</td>
<td class="nump">1,210.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">1,205.6<span></span>
</td>
<td class="nump">1,213.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Other revenues</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 13.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916702352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Comprehensive Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings attributable to Viatris Inc. common shareholders</a></td>
<td class="nump">$ 224.7<span></span>
</td>
<td class="nump">$ 399.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">45.3<span></span>
</td>
<td class="num">(469.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Change in unrecognized gain (loss) and prior service cost related to defined benefit plans</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Other comprehensive loss, before tax</a></td>
<td class="num">(15.9)<span></span>
</td>
<td class="num">(272.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax (benefit) provision</a></td>
<td class="num">(12.5)<span></span>
</td>
<td class="nump">44.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(316.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive earnings</a></td>
<td class="nump">221.3<span></span>
</td>
<td class="nump">82.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Net unrecognized gain (loss) on derivatives</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Net unrecognized gain (loss) on derivatives</a></td>
<td class="num">$ (66.2)<span></span>
</td>
<td class="nump">$ 201.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650922799632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 506.6<span></span>
</td>
<td class="nump">$ 1,259.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">3,497.5<span></span>
</td>
<td class="nump">3,814.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,664.3<span></span>
</td>
<td class="nump">3,519.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,763.6<span></span>
</td>
<td class="nump">1,811.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Assets held for sale</a></td>
<td class="nump">198.3<span></span>
</td>
<td class="nump">230.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">9,630.3<span></span>
</td>
<td class="nump">10,635.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">3,007.8<span></span>
</td>
<td class="nump">3,024.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">22,701.6<span></span>
</td>
<td class="nump">22,607.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,573.2<span></span>
</td>
<td class="nump">10,425.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax benefit</a></td>
<td class="nump">959.1<span></span>
</td>
<td class="nump">925.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">2,418.2<span></span>
</td>
<td class="nump">2,403.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">49,290.2<span></span>
</td>
<td class="nump">50,022.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">1,957.5<span></span>
</td>
<td class="nump">1,766.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">204.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">244.5<span></span>
</td>
<td class="nump">279.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt and other long-term obligations</a></td>
<td class="nump">508.7<span></span>
</td>
<td class="nump">1,259.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">3,192.8<span></span>
</td>
<td class="nump">3,440.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">6,108.1<span></span>
</td>
<td class="nump">6,746.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">18,069.4<span></span>
</td>
<td class="nump">18,015.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liability</a></td>
<td class="nump">2,465.0<span></span>
</td>
<td class="nump">2,432.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term obligations</a></td>
<td class="nump">1,719.8<span></span>
</td>
<td class="nump">1,756.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">28,362.3<span></span>
</td>
<td class="nump">28,949.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Viatris Inc. shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued: 1,220,224,204 and 1,213,793,231, respectively</a></td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">12.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">18,679.6<span></span>
</td>
<td class="nump">18,645.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">5,252.5<span></span>
</td>
<td class="nump">5,175.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(2,764.6)<span></span>
</td>
<td class="num">(2,761.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_StockholdersEquityParentBeforeTreasuryStock', window );">Total Viatris Inc. equity, before treasury stock</a></td>
<td class="nump">21,179.7<span></span>
</td>
<td class="nump">21,072.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less: Treasury stock &#8212; at cost</a></td>
<td class="nump">251.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">20,927.9<span></span>
</td>
<td class="nump">21,072.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 49,290.2<span></span>
</td>
<td class="nump">$ 50,022.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_StockholdersEquityParentBeforeTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings that are attributable to the parent company, excluding equity attributable to noncontrolling interests, and before deducting the carrying value of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_StockholdersEquityParentBeforeTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920548048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">3,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650921324816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 20,492,700<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
<td class="nump">$ 18,536,100<span></span>
</td>
<td class="nump">$ 3,688,800<span></span>
</td>
<td class="num">$ (1,744,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,209,507,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings (loss)</a></td>
<td class="nump">399,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(316,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(316,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment', window );">Issuance of restricted stock, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,816,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Issuance of restricted stock and stock options exercised, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes related to the net share settlement of equity awards</a></td>
<td class="num">(9,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">28,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared, $0.12 per common share</a></td>
<td class="num">(146,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(146,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">20,447,700<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
<td class="nump">18,555,100<span></span>
</td>
<td class="nump">3,941,500<span></span>
</td>
<td class="num">(2,061,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,212,323,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 21,072,300<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
<td class="nump">18,645,800<span></span>
</td>
<td class="nump">5,175,600<span></span>
</td>
<td class="num">(2,761,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,213,793,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings (loss)</a></td>
<td class="nump">224,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(3,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment', window );">Issuance of restricted stock, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,350,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Issuance of restricted stock and stock options exercised, net</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes related to the net share settlement of equity awards</a></td>
<td class="num">(19,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">42,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchase</a></td>
<td class="num">(251,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (251,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="nump">21,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,239,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared, $0.12 per common share</a></td>
<td class="num">(147,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Other Additional Capital</a></td>
<td class="nump">6,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">20,927,900<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="nump">$ 18,679,600<span></span>
</td>
<td class="nump">$ 5,252,500<span></span>
</td>
<td class="num">$ (2,764,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,220,224,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, Value</a></td>
<td class="num">$ (251,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">21,239,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650919798800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings attributable to Viatris Inc. common shareholders</a></td>
<td class="nump">$ 224.7<span></span>
</td>
<td class="nump">$ 399.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">730.0<span></span>
</td>
<td class="nump">736.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">42.6<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="num">(26.7)<span></span>
</td>
<td class="num">(52.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Gain from equity method investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">29.6<span></span>
</td>
<td class="nump">37.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Changeinnoncashlitigationsettlementsnet', window );">Litigation settlements and other contingencies, net</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">215.0<span></span>
</td>
<td class="num">(115.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(151.1)<span></span>
</td>
<td class="num">(69.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">183.4<span></span>
</td>
<td class="num">(30.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(53.9)<span></span>
</td>
<td class="nump">67.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other operating assets and liabilities, net</a></td>
<td class="num">(224.8)<span></span>
</td>
<td class="nump">132.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">971.2<span></span>
</td>
<td class="nump">1,138.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net</a></td>
<td class="num">(667.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(47.8)<span></span>
</td>
<td class="num">(64.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(9.0)<span></span>
</td>
<td class="num">(8.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from the sale of marketable securities</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Payments for product rights and other, net</a></td>
<td class="num">(34.7)<span></span>
</td>
<td class="num">(7.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from the sale of assets</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(749.5)<span></span>
</td>
<td class="num">(66.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments of long-term debt</a></td>
<td class="num">(750.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Change in short-term borrowings, net</a></td>
<td class="nump">204.6<span></span>
</td>
<td class="num">(837.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(30.0)<span></span>
</td>
<td class="num">(9.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities', window );">Contingent consideration payments</a></td>
<td class="num">(8.4)<span></span>
</td>
<td class="num">(15.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments of financing fees</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other items, net</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(974.7)<span></span>
</td>
<td class="num">(1,009.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect on cash of changes in exchange rates</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(11.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(751.8)<span></span>
</td>
<td class="nump">51.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash &#8212; beginning of period</a></td>
<td class="nump">1,262.5<span></span>
</td>
<td class="nump">706.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash &#8212; end of period</a></td>
<td class="nump">510.7<span></span>
</td>
<td class="nump">757.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(143.8)<span></span>
</td>
<td class="num">(145.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity', window );">Payments to Acquire Productive Assets</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="num">(250.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for financing costs associated with business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Changeinnoncashlitigationsettlementsnet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in noncash litigation settlements, net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Changeinnoncashlitigationsettlementsnet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Intangible Assets, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140651005927728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Licensing Agreements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration and Licensing Agreements</a></td>
<td class="text">Licensing and Other Partner Agreements<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically enter into licensing and other partner agreements with other pharmaceutical companies for the development, manufacture, marketing and/or sale of pharmaceutical products. Our significant licensing and other partner agreements are primarily focused on the development, manufacturing, supply and commercialization of multiple complex products. Under these agreements, we have future potential milestone payments and co-development expenses payable to third parties as part of our licensing, development and co-development programs. Payments under these agreements generally become due and are payable upon the satisfaction or achievement of certain developmental, regulatory or commercial milestones or as development expenses are incurred on defined projects. Milestone payment obligations are uncertain, including the prediction of timing and the occurrence of events triggering a future obligation and are not reflected as liabilities in the condensed consolidated balance sheets, except for obligations reflected as acquisition related contingent consideration. Refer to Note 11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of contingent consideration. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential maximum development milestones not accrued for at&#160;March&#160;31, 2023&#160;totaled approximately&#160;$387 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that the amounts that may be paid through the end of 2023 to be approximately $5 million. These agreements may also include potential sales-based milestones and call for us to pay a percentage of amounts earned from the sale of the product as a royalty or a profit share. The amounts disclosed do not include sales-based milestones or royalty or profit share obligations on future sales of product as the timing and amount of future sales levels and costs to produce products subject to these obligations is not reasonably estimable. These sales-based milestones or royalty or profit share obligations may be significant depending upon the level of commercial sales for each product.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to our licensing and other partner agreements as disclosed in our 2022 Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920046432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">General</a></td>
<td class="text">General<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements (&#8220;interim financial statements&#8221;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto in Viatris&#8217; 2022 Form&#160;10-K. The December&#160;31, 2022 condensed consolidated balance sheet was derived from audited financial statements. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim results of operations, comprehensive earnings and cash flows for the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full fiscal year or any other future period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920573104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition and Accounts Receivable</a></td>
<td class="text">Revenue Recognition and Accounts Receivable<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenues in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the condensed consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash).</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#8217;s subsequent sales or usages occur. Such consideration is included in other revenues in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2023 and 2022, respectively:</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.43pt">Amounts for the three months ended March&#160;31, 2022 include $164.8 million related to the biosimilars business which was subsequently contributed to Biocon Biologics in November 2022. The Company has not recognized the results of the biosimilars business in its consolidated financial statements subsequent to November 29, 2022.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2023 and 2022: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:71.681%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.920%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Global Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipitor &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norvasc &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyrica &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viagra &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EpiPen&#174; Auto-Injectors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celebrex &#174;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creon &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effexor &#174;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zoloft &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xalabrands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Segment Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dymista &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yupelri &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xanax &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amitiza &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">The Company does not disclose net sales for any products considered competitively sensitive.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration and Accounts Receivable</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2023 and 2022, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,273.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,198.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross to net adjustments:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,350.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,584.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(992.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,205.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross to net adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,553.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,020.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No significant revisions were made to the methodology used in determining these provisions or the nature of the provisions during the three months ended March&#160;31, 2023. Such allowances were comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net was comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:76.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,021.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,243.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,497.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,814.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Factoring Arrangements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $76.3 million and $34.7 million of accounts receivable as of March&#160;31, 2023 and December&#160;31, 2022, respectively, under these factoring arrangements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920523008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">Recent Accounting Pronouncements<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standards</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued Accounting Standards Update 2022-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities&#8212;Supplier Finance Programs (Subtopic 405-50), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which requires entities to provide qualitative and quantitative disclosures about their supplier finance programs, including a rollforward of related obligations. The adoption of ASU 2022-04 did not affect the Company&#8217;s financial condition, results of operations or cash flows as the guidance only requires additional disclosures. We adopted this ASU effective January 1, 2023.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain voluntary supply chain finance programs with financial intermediaries which provide participating suppliers the option to be paid by the intermediary earlier than the original invoice due date. The Company&#8217;s responsibility is limited to making payments on the terms originally negotiated with the suppliers, regardless of whether the intermediary pays the supplier in advance of the original due date. The range of payment terms the Company negotiates with suppliers are consistent, regardless of whether a supplier participates in a supply chain finance program. The total amounts due to financial intermediaries to settle supplier invoices under supply chain finance programs as of March&#160;31, 2023 and December&#160;31, 2022 were $55.5&#160;million and $33.4&#160;million, respectively. These amounts are included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated balance sheets.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other significant changes in new accounting standards from those disclosed in Viatris&#8217; 2022 Form 10-K. Refer to Viatris&#8217; 2022 Form 10-K for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -Publisher FASB<br> -URI https://asc.fasb.org//250/tableOfContent<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -SubTopic 20<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -SubTopic 20<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920557168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Other Transactions</a></td>
<td class="text">Acquisitions and Other Transactions<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oyster Point Acquisition</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, the Company completed the acquisition of Oyster Point for approximately $427.4&#160;million in cash, which included $11 per share paid to Oyster Point stockholders through a tender offer, payment for vested share-based awards, and the repayment of debt of Oyster Point. In addition to the upfront cash consideration, each Oyster Point stockholder received one non-tradeable contingent value right representing up to an additional $2 per share, or approximately $60&#160;million in the aggregate, contingent upon Oyster Point achieving certain metrics based upon full year 2022 performance. Oyster Point did not achieve the metrics that would have triggered a contingent payment and the contingent value rights have expired. Oyster Point is focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested share-based awards to acquire Oyster Point common stock that were outstanding immediately prior to the closing of the acquisition were cancelled in exchange for the right to receive an amount in cash based upon a formula contained within the merger agreement. The unvested share-based awards were converted into Viatris share-based awards based upon a formula contained within the merger agreement. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. During the three months ended March&#160;31, 2023, the Company incurred acquisition related costs of approximately $18.3&#160;million, which were recorded primarily in SG&amp;A in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. GAAP purchase price was $392.7&#160;million, net of cash acquired. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Oyster Point is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:82.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.092%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets (excluding inventories and net of cash acquired)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $34.7 of cash acquired)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair value estimates for the assets acquired and liabilities assumed were based upon preliminary calculations, valuations and assumptions that are subject to change as the Company obtains additional information during the measurement period (up to one year from the acquisition date). The primary areas subject to change relate to the finalization of the valuation of intangible assets and income taxes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a step-up in the fair value of inventory of approximately $29.3&#160;million. During the three months ended March&#160;31, 2023, the Company recorded amortization of the inventory step-up of approximately $7.3&#160;million, which is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The identified intangible assets of $334.0 million are comprised of product rights and licenses related to a commercial asset, Tyrvaya&#174;, for the treatment of dry eye disease, that have an estimated useful life of 10 years. Significant assumptions utilized in the valuation of identified intangible assets were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by U.S. GAAP.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill of $5.9 million arising from the acquisition consisted largely of the value of the employee workforce and the expected value of products to be developed in the future. All of the goodwill was assigned to the Developed Markets segment. None of the goodwill recognized in this transaction is currently expected to be deductible for income tax purposes. The operating results of Oyster Point have been included in the Company&#8217;s condensed consolidated statements of operations since the acquisition date. The total revenues of Oyster Point for the period from the acquisition date to March 31, 2023, were $6.3&#160;million and net loss, net of tax, was approximately $49.3&#160;million. The net loss for the period includes the effect of the purchase accounting adjustments and acquisition related costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental unaudited pro forma information for the acquisition, as if it had occurred on January 1, 2022. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased amortization expense based on the fair value of assets acquired, the impact of transaction costs and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable, or have been achieved, subsequent to the closing of the acquisition. Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:65.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited, in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,729.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,194.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Famy Life Sciences Acquisition</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2022, the Company entered into a definitive agreement to acquire the remaining equity shares of Famy Life Sciences, a privately-owned research company with a complementary portfolio of ophthalmology therapies under development, for consideration of $281&#160;million. The Company had previously entered into a Master Development Agreement with Famy Life Sciences on December 20, 2019 under which the Company obtained rights with respect to acquiring certain pharmaceutical products and had also acquired shares representing approximately 13.5% equity interest in Famy Life Sciences for $25.0&#160;million at December 31, 2020. The investment was accounted for in accordance with ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction to acquire the remaining equity shares of Famy Life Sciences closed during the first quarter of 2023. The Company recognized a gain of $18.9&#160;million during the first quarter of 2023 as a result of remeasuring its pre-existing 13.5% equity interest in Famy Life Sciences to fair value, which was recorded as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statement of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. The U.S. GAAP purchase price allocated to the transaction was $325.0&#160;million, which consisted of $281&#160;million of cash consideration paid for the remaining equity shares and $43.9&#160;million for the fair value of the pre-existing 13.5% equity interest. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Famy Life Sciences is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:82.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.092%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $0.2 of cash acquired)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair value estimates for the assets acquired and liabilities assumed were based upon preliminary calculations, valuations and assumptions that are subject to change as the Company obtains additional information during the measurement period (up to one year from the acquisition date). The primary areas subject to change relate to the finalization of the valuation of IPR&amp;D and income taxes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount allocated to IPR&amp;D represents an estimate of the fair value of purchased in-process technology for research projects that, as of the closing date of the acquisition, had not reached technological feasibility and had no alternative future use. The fair value of IPR&amp;D of $290.0 million was based on the excess earnings method, which utilizes forecasts of expected cash inflows (including estimates for ongoing costs) and other contributory charges. A discount rate of 23.9% was utilized to discount net cash inflows to present values. IPR&amp;D is accounted for as an indefinite-lived intangible asset and will be subject to impairment testing until completion or abandonment of the projects. Upon successful completion and launch of each product, the Company will make a determination of the estimated useful life of the individual asset. The acquired IPR&amp;D projects are in various stages of completion and the estimated costs to complete these projects total approximately $120&#160;million, which are expected to be incurred through 2024. There are risks and uncertainties associated with the timely and successful completion of the projects included in IPR&amp;D, and no assurances can be given that the underlying assumptions used to estimate the fair value of IPR&amp;D will not change or the timely completion of each project to commercial success will occur.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill of $89.3 million arising from the acquisition consisted largely of the value of the employee workforce and the expected value of products to be developed in the future. All of the goodwill was assigned to the Developed Markets segment. None of the goodwill recognized in this transaction is currently expected to be deductible for income tax purposes. The acquisition did not have a material impact on the Company&#8217;s results of operations since the acquisition date or on a pro forma basis for the three months ended March 31, 2023 and 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ophthalmology is one of the key therapeutic areas of focus that the Company announced in February 2022 when it announced plans for certain strategic actions. With the combination of Viatris' global commercial footprint, R&amp;D and regulatory capabilities and supply chain, along with Oyster Point's deep knowledge of the ophthalmology space from a clinical, medical, regulatory and commercial perspective&#8212;including Tyrvaya&#174;&#8212;and Famy Life Sciences' Phase III-ready pipeline, the Company believes it has the foundation to create a leading global ophthalmology franchise, accelerating efforts to address the unmet needs of patients with ophthalmic disease and the eye care professionals who treat them.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140651005658752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Disposal Groups, Including Discontinued Operations, Disclosure</a></td>
<td class="text">Divestitures<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biocon Biologics Transaction</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2022, Viatris completed a transaction to contribute its biosimilars portfolio to Biocon Biologics. Under the terms of the Biocon Agreement, Viatris received $3&#160;billion in consideration in the form of a $2&#160;billion cash payment, adjusted as set forth in the Biocon Agreement, and approximately $1&#160;billion of CCPS representing a stake of approximately 12.9% (on a fully diluted basis) in Biocon Biologics. Viatris also is entitled to $335&#160;million of additional cash payments in 2024. In addition, Viatris and Biocon Biologics have agreed to a closing working capital target of $250&#160;million. An amount of cash equal to all or a portion of the closing working capital target may become payable to Biocon Biologics in connection with certain events in the future, depending on the valuations attributable to such events. Refer to Note 8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Components</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on assets and liabilities related to Biocon Biologics. The Company&#8217;s CCPS in Biocon Biologics are classified as equity securities, refer to Note 11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris and Biocon Biologics also entered an agreement pursuant to which Viatris is providing commercialization and certain other transition services on behalf of Biocon Biologics, including billings, collections, and the remittance of rebates, to ensure business continuity for patients, customers and colleagues. The term of the transition services agreement is generally up to two years. Under the transition services agreement, Viatris is entitled to be reimbursed for its costs (subject to certain caps) plus a markup. During the three months ended March 31, 2023, the Company recognized TSA income of approximately $45.7&#160;million as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (Income) Expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Potential Divestitures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company provided an update on the strategic priorities announced in February 2022, including identifying the following businesses no longer considered core to its future strategy that the Company intends to divest:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">OTC;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">API (while retaining some selective development API capabilities);</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Women&#8217;s health care, primarily related to our oral and injectable contraceptives. This does not include all of our women&#8217;s health care related products; as an example, our Xulane&#174; product in the U.S. is excluded; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">Upjohn Distributor Markets. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, we determined that our Upjohn Distributor Markets should be classified as held for sale. Upon classification as held for sale, we recognized a total charge of $374.2&#160;million during the three months ended December 31, 2022. This was comprised of a goodwill impairment charge of $117.0&#160;million, other charges, principally inventory write-offs, of $84.3&#160;million and a charge of approximately $172.9&#160;million to write down the disposal group to fair value, less cost to sell. During the three months ended March&#160;31, 2023, the Company recorded additional inventory reserves of $9.2&#160;million and an intangible asset charge of $32.0&#160;million to write down the disposal group to fair value, less cost to sell. As of March&#160;31, 2023 and December&#160;31, 2022, assets held for sale associated with the Upjohn Distributor Markets consisted of intangible assets of $198.3&#160;million and $230.3&#160;million, respectively. If these transactions are not completed, the distribution arrangements will expire in accordance with our agreement with Pfizer and the Company will wind down operations in these markets, which may result in additional asset write-offs and other costs being incurred. These additional charges could be in excess of $250&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650923503664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Incentive Plan</a></td>
<td class="text">Share-Based Incentive Plan<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution, Viatris adopted and Pfizer, in the capacity as Viatris&#8217; sole stockholder at such time, approved the 2020 Incentive Plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Viatris Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Stock Incentive Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) which became effective as of the Distribution. In connection with the Combination, as of November 16, 2020, the Company assumed the 2003 LTIP (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which had previously been approved by Mylan shareholders. The 2020 Incentive Plan and 2003 LTIP include (i) 72,500,000 shares of Common Stock authorized for grant pursuant to the 2020 Incentive Plan, which may include dividend payments payable in Common Stock on unvested shares granted under awards, (ii) 6,757,640 shares of Common Stock to be issued pursuant to the exercise of outstanding stock options granted to participants under the 2003 LTIP and assumed by Viatris in connection with the Combination and (iii) 13,535,627 shares of Common Stock subject to outstanding equity-based awards, other than stock options, assumed by Viatris in connection with the Combination, or that otherwise remain available for issuance under the 2003 LTIP.</span><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2020 Incentive Plan and 2003 LTIP, shares are reserved for issuance to key employees, consultants, independent contractors and non-employee directors of the Company through a variety of incentive awards, including: stock options, SARs, restricted stock and units, PSUs, other stock-based awards and short-term cash awards. Stock option awards are granted with an exercise price equal to the fair market value of the shares underlying the stock options at the date of the grant, generally become exercisable over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTUyOQ_2c493640-95e1-4300-976d-938a30e9093d">three</span> to four years, and generally expire in ten years.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock awards (stock options and SARs) activity under the 2020 Incentive Plan and 2003 LTIP:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Under Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,449,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,485,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452,279&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,185,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had average remaining contractual terms of 4.4 years, 4.4 years and 4.0 years, respectively. Also, at March&#160;31, 2023, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had aggregate intrinsic values of $0.6 million, $0.5 million, and $0.1 million, respectively.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the Company&#8217;s nonvested Restricted Stock Awards (restricted stock and restricted stock unit awards, including PSUs) from December&#160;31, 2022 to March&#160;31, 2023 is presented below:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Restricted Stock&#160;Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair&#160;Value&#160;Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,271,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,043,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,743,490)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267,038)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,304,863&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had $213.8 million of total unrecognized compensation expense, net of estimated forfeitures, related to all of its stock-based awards, which we expect to recognize over the remaining weighted average vesting period of 1.7 years. The total intrinsic value of Restricted Stock Awards released during the three months ended March&#160;31, 2023 and 2022 was $100.8 million and $63.1 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920545152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Postretirement Benefits<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension and Other Postretirement Benefits Disclosure</a></td>
<td class="text">Pensions and Other Postretirement Benefits<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various defined benefit pension plans in several countries. Benefits provided generally depend on length of service, pay grade and remuneration levels. Employees in the U.S., Puerto Rico and certain international locations are also provided retirement benefits through defined contribution plans.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sponsors other postretirement benefit plans including plans that provide for postretirement supplemental medical coverage. Benefits from these plans are provided to employees and their spouses and dependents who meet various minimum age and service requirements. In addition, the Company sponsors other plans that provide for life insurance benefits and postretirement medical coverage for certain officers and management employees.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is making the minimum mandatory contributions to its defined benefit pension plans in the U.S. and Puerto Rico for the 2023 plan year. The Company expects to make total benefit payments of approximately $108.5 million from pension and other postretirement benefit plans in 2023. The Company anticipates making contributions to pension and other postretirement benefit plans of approximately $51.3 million in 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650921530480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected balance sheet components consist of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and restricted cash</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,664.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses consist primarily of prepaid rent, insurance and other individually insignificant items. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,936.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,145.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,083.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,137.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other assets</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred consideration due from Biocon Biologics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCPS in Biocon Biologics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts payable</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales allowances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and professional accruals, including litigation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee benefit liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to Biocon Biologics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,192.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term obligations</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax related items, including contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Components</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920478112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Ordinary Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) per Ordinary Share</a></td>
<td class="text">Earnings&#160;per ShareBasic earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.<div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional stock awards and Restricted Stock Awards were outstanding during the three months ended March&#160;31, 2023 and 2022, but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares at March&#160;31, 2023 include certain share-based compensation awards whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 13.9 million shares and 15.5 million shares for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid a quarterly dividend of $0.12 per share on the Company&#8217;s issued and outstanding common stock on March 17, 2023. On May&#160;5, 2023, the Company&#8217;s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company&#8217;s issued and outstanding common stock, which will be payable on June&#160;16, 2023 to shareholders of record as of the close of business on May&#160;24, 2023. The declaration and payment of future dividends to holders of the Company&#8217;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#8217;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.</span></div>On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0&#160;billion of the Company&#8217;s shares of common stock. Such repurchases may be made from time-to-time at the Company&#8217;s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the three months ended March 31, 2023, the Company repurchased approximately 21.2&#160;million shares of common stock at a cost of approximately $250 million. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920590992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Intangible Assets<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,461.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,425.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,616.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $385.0&#160;million.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $117.0&#160;million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following components at March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Original Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,975.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,604.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,370.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,306.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,604.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,701.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,490.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,923.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,566.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,530.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,923.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,607.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents amortizable intangible assets. Other intangible assets consists principally of customer lists and contractual rights. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, the Company acquired product rights and licenses from Oyster Point of approximately $334.0 million and IPR&amp;D of approximately $290.0 million from Famy Life Sciences. Refer to Note 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Other Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense and intangible asset disposal &amp; impairment charges (which are included as a component of amortization expense) are classified primarily within cost of sales in the condensed consolidated statements of operations and were as follows for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset disposal &amp; impairment charges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible asset amortization expense (including disposal &amp; impairment charges)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company recognized an intangible asset charge of approximately $32.0&#160;million, which was recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statement of operations, to write down the disposal group to fair value, less cost to sell, related to our Upjohn Distributor Markets, which are classified as held for sale. As of March&#160;31, 2023 and December&#160;31, 2022, the Company has approximately $198.3&#160;million and $230.3&#160;million, respectively, of intangible assets related to the Upjohn Distributor Markets that are classified as held for sale in the condensed consolidated balance sheets. Refer to Note 5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense over the remainder of 2023 and for the years ending December&#160;31, 2024 through 2027 is estimated to be as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:88.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650923537920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments and Risk Management</a></td>
<td class="text">Financial Instruments and Risk Management <div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain financial risks relating to its ongoing business operations. The primary financial risks that are managed by using derivative instruments are foreign currency risk and interest rate risk.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage certain foreign currency risks, the Company enters into foreign exchange forward contracts to mitigate risk associated with changes in spot exchange rates of mainly non-functional currency denominated assets or liabilities. The foreign exchange forward contracts are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. Any gains or losses on the foreign exchange forward contracts are recognized in earnings in the period incurred in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also entered into forward contracts to hedge forecasted foreign currency denominated sales from certain international subsidiaries and a portion of forecasted intercompany inventory sales denominated in Euro, Japanese Yen, Chinese Renminbi and Indian Rupee for up to twenty-four months. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are deferred in AOCE and are reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries by either borrowing directly in foreign currencies and designating all or a portion of the foreign currency debt as a hedge of the applicable net investment position or entering into foreign currency swaps that are designated as hedges of net investments. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated certain Euro and Yen borrowings as a hedge of its investment in certain Euro-functional and Yen-functional currency subsidiaries in order to manage foreign currency translation risk. Borrowings designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of AOCE until the sale or substantial liquidation of the underlying net investments. In addition, the Company manages the related foreign exchange risk of the Euro and Yen borrowings not designated as net investment hedges through certain Euro and Yen denominated financial assets and forward currency swaps. </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the principal amounts of the Company&#8217;s outstanding Euro and Yen borrowings and the notional amounts of the Euro and Yen borrowings designated as net investment hedges: </span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount Designated as a Net Investment Hedge</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250% Euro Senior Notes due 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% Euro Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.125% Euro Senior Notes due 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.023% Euro Senior Notes due 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.362% Euro Senior Notes due 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.908% Euro Senior Notes due 2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yen</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the principal amount of the Company&#8217;s outstanding Yen borrowings and the notional amount of the Yen borrowings designated as net investment hedge was $301.1&#160;million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into interest rate swaps from time to time in order to manage interest rate risk associated with the Company&#8217;s fixed-rate and floating-rate debt. Interest rate swaps that meet specific accounting criteria are accounted for as fair value or cash flow hedges. All derivative instruments used to manage interest rate risk are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. For fair value hedges, the changes in the fair value of both the hedging instrument and the underlying debt obligations are included in interest expense. For cash flow hedges, the change in fair value of the hedging instrument is deferred through AOCE and is reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews the creditworthiness of its financial counterparties and does not expect to incur a significant loss from the failure of any counterparties to perform under any agreements. The Company is not subject to any obligations to post collateral under derivative instrument contracts. Certain derivative instrument contracts entered into by the Company are governed by master agreements, which contain credit-risk-related contingent features that would allow the counterparties to terminate the contracts early and request immediate payment should the Company trigger an event of default on other specified borrowings. The Company records all derivative instruments on a gross basis in the condensed consolidated balance sheets. Accordingly, there are no offsetting amounts that net assets against liabilities. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.417%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Reclassified from AOCE into Earnings </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-derivative Financial Instruments in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.7)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.1&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">At March&#160;31, 2023, the Company expects that approximately $14.0 million of pre-tax net losses on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) recognized in earnings on derivatives.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) reclassified from AOCE into earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurement</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;2: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;3: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCPS in Biocon Biologics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial assets and liabilities that utilize Level&#160;2 inputs, the Company utilizes both direct and indirect observable price quotes, including the LIBOR yield curve, foreign exchange forward prices and bank price quotes. Below is a summary of valuation techniques for the Company&#8217;s financial assets and liabilities:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at observable net asset value prices.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, exchange traded funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the active quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, marketable securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using quoted stock prices from public exchanges at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">CCPS in Biocon Biologics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; valued using a Monte Carlo simulation model using Level 3 inputs. The fair value of the CCPS is sensitive to changes in the forecasts of operating metrics and changes in volatility and discount rates. The Company elected the fair value option for the CCPS under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 825. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value is reassessed </span></div><div style="margin-bottom:6pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarterly and any change in the fair value estimate is recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the condensed consolidated statements of operations for that period.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale fixed income investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value, net of income taxes, are included in accumulated other comprehensive loss as a component of shareholders&#8217; equity.</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign exchange derivative assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using quoted forward foreign exchange prices and spot rates at the reporting date. Counterparties to these contracts are highly rated financial institutions.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, the Company had a contingent consideration liability of $224.7&#160;million and $221.2&#160;million, respectively, relating to the Biocon Biologics Transaction. This contingent consideration liability represents the amount of the closing working capital target to which the parties have agreed that may become payable to Biocon Biologics in connection with certain events in the future, depending on the valuations attributable to such events. The remaining contingent consideration liability represents a component of the total purchase consideration for Pfizer&#8217;s Respiratory Delivery Platform and certain other acquisitions. The measurement of these contingent consideration liabilities is calculated using unobservable Level 3 inputs based on the Company&#8217;s own assumptions primarily related to the probability and timing of future events and payments which are discounted using a market rate of return. At March&#160;31, 2023 and December&#160;31, 2022, discount rates ranging from 6.4% to 9.0% were utilized in the valuations. Significant changes in unobservable inputs could result in material changes to the contingent consideration liability.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the activity in the Company&#8217;s fair value of contingent consideration from December&#160;31, 2022 to March&#160;31, 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Portion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other current liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other long-term obligations in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in litigation settlements and other contingencies, net in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company has not elected the fair value option for other financial assets and liabilities other than the CCPS, any future transacted financial asset or liability will be evaluated for the fair value election.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920492560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For additional information, see Note 11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in Viatris&#8217; 2022 Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s short-term borrowings:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term borrowings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables Facility and Note Securitization Facility </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a $400&#160;million Receivables Facility, which expires in April 2025 and a $200&#160;million Note Securitization Facility which expires in August 2023. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The amount that we may borrow at a given point in time is determined based on the amount of qualifying accounts receivable that are present at such point in time. Amounts outstanding under either facility are included as a component of short-term borrowings, while the accounts receivables securing these obligations remain as a component of accounts receivable, net, in our condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Long-Term Debt</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective April 28, 2023, we executed an amendment to the Revolving Facility to convert the benchmark interest rate from LIBOR to an adjusted SOFR, with no change in the applicable interest rate margins. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A summary of long-term debt is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate as of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current portion of long-term debt:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,069.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2046 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> **</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> *</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,069.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,015.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The fair value adjustment was amortized to interest expense over the remaining term of the notes, which were repaid at maturity in the first quarter of 2023.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Mylan Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was originally issued by Mylan N.V.; now held by Utah Acquisition Sub Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Viatris Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Upjohn Finance B.V.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022, the aggregate fair value of the Company&#8217;s outstanding notes was approximately $15.04 billion and $15.36 billion, respectively. The fair values of the outstanding notes were valued at quoted market prices from broker or dealer quotations and were classified as Level 2 in the fair value hierarchy. </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at March&#160;31, 2023 were as follows for each of the periods ending December 31:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,029&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650923544016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Earnings</a></td>
<td class="text">Comprehensive Loss<div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, is comprised of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain and prior service cost related to defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain on derivatives in net investment hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,340.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,385.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,764.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,761.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.121%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,385.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,761.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,340.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,764.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.266%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,271.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,061.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//220/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920463024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Intangible asset amortization expense and impairments of goodwill and long-lived assets;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">R&amp;D and acquired IPR&amp;D expense;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Net charges or net gains for litigation settlements and other contingencies;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including costs related to our planned divestitures and the Biocon Biologics Transaction, and, as applicable, any associated transition activities. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the segments are the same as those described in Note 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in the 2022 Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment Profitability</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reportable Segments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(603.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset disposal &amp; impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Globally managed research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements &amp; other contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction related and other special items</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other unallocated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920463024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text">Restructuring<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Restructuring Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. The remaining actions under the 2020 restructuring program include the disposal or closure of certain manufacturing facilities, which are expected to be substantially completed in 2023.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $1.4&#160;billion. Such charges are expected to include up to approximately $450&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $950&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges for restructuring and ongoing cost reduction initiatives are recorded in the period the Company commits to a restructuring or cost reduction plan, or executes specific actions contemplated by the plan and all criteria for liability recognition have been met. </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2022 to March&#160;31, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the three months ended March 31, 2023, total restructuring charges in Developed Markets, Emerging Markets, Greater China, and JANZ were approximately $7.7 million, $1.3 million, $(0.6) million, and $1.3 million, respectively.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022, accrued liabilities for restructuring and other cost reduction programs were primarily included in other current liabilities and other long-term obligations in the condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//420/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920583696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legislative Updates</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#8220;Inflation Reduction Act&#8221;) into law, which includes a new corporate alternative minimum tax (&#8220;CAMT&#8221;) and an excise tax of 1% on the fair market value of net stock repurchases. Both provisions are effective for years after December 31, 2022. The Company reflected the applicable estimated excise tax in treasury stock as part of the cost basis of the stock repurchased and recorded a corresponding liability in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our condensed consolidated balance sheet as of March 31, 2023. The share repurchase and authorization amounts disclosed in this Form 10-Q exclude the excise tax.  The Company does not anticipate being subject to the 15% CAMT tax in 2023 based on enacted law and regulatory guidance; however, our CAMT status for 2023 could change in the future, depending on new regulations or regulatory guidance issued by the U.S. Department of the Treasury.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Examinations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes and tax audits in many jurisdictions. A certain degree of estimation is thus required in recording the assets and liabilities related to income taxes. Tax audits and examinations can involve complex issues, interpretations, and judgments and the resolution of matters that may span multiple years, particularly if subject to litigation or negotiation.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that adequate provisions have been made for these uncertain tax positions, the Company&#8217;s assessment of uncertain tax positions, including those arising from legal entity restructuring transactions in connection with the Combination, is based on estimates and assumptions that the Company believes are reasonable but the estimates for unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variations from such estimates could materially affect the Company&#8217;s financial condition, results of operations or cash flows in the period of resolution, settlement or when the statutes of limitations expire.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to ongoing IRS examinations. The years 2015 through 2019 are open years under examination. The years 2012, 2013 and 2014 have one matter open, and a Tax Court petition was filed regarding the matter and a trial was held in December 2018 and is discussed further below.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several international audits are currently in progress. In some cases, the tax auditors have proposed adjustments or issued assessments to our tax positions, including with respect to intercompany transactions, and we are in ongoing discussions with some of the auditors regarding the validity of their positions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In instances where assessments have been issued, we disagree with these assessments and believe they are without merit and incorrect as a matter of law.  As a result, we anticipate that certain of these matters may become the subject of litigation before tax courts where we intend to vigorously defend our position. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Australia, the tax authorities have issued notices of assessments to the Company for the years ended December 2009 to December 2020, subject to additional interest and penalties, concerning our tax position with respect to certain intercompany transactions. The tax authorities denied our objections to the assessments for the years ended December 2009 to December 2020 and we have commenced litigation in the Australian Federal Court challenging those decisions. The Company made a partial payment of $56.0&#160;million in 2021 and $5.2&#160;million in 2022 in order to stay potential interest and penalties resulting from this litigation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In France, the tax authorities have issued notices of assessments to the Company for the years ended December 2013 to December 2015 concerning our tax position with respect to whether income earned by a Company entity not domiciled in France should be subject to French tax.  We have commenced litigation before the French tax courts where the tax authorities will seek unpaid taxes, penalties, and interest.  </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In India, the tax authorities have issued notices of assessments to the Company seeking unpaid taxes and interest for the financial years covering 2013 to 2018 concerning our tax position with respect to certain corporate tax deductions and certain intercompany transactions. Some of these issues were resolved through the Company entering into an agreement with the tax authorities in March 2023 in respect of the pricing of its international transactions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recorded tax expense of approximately $21.6&#160;million during the three months ended March 31, 2023 due to the terms of this agreement. The remaining issues are in the audit phase or are being challenged in the Indian tax courts.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded a net reserve for uncertain tax positions of $299.3&#160;million and $298.1&#160;million, including interest and penalties, in connection with its international audits at March 31, 2023 and December 31, 2022, respectively. In connection with our international tax audits, it is possible that we will incur material losses above the amounts reserved.  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s major U.S. state taxing jurisdictions remain open from fiscal year 2013 through 2021, with several state audits currently in progress. The Company&#8217;s major international taxing jurisdictions remain open from 2012 through 2021.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Court Proceedings</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. federal income tax returns for 2012 through 2014 had been subject to proceedings in U.S. Tax Court involving a dispute with the IRS regarding whether certain costs related to ANDAs were eligible to be expensed and deducted immediately or required to be amortized over longer periods. A trial was held in U.S. Tax Court in December 2018 and on April 27, 2021, the Court affirmed Mylan&#8217;s position and held that patent litigation expenses related to ANDAs are immediately deductible. The IRS appealed, the case was heard before the Third Circuit Court of Appeals on January 12, 2023 and we are awaiting a decision.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Uncertainty in Income Taxes</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of an uncertain tax position that is more likely than not of being sustained upon audit by the relevant taxing authority must be recognized at the largest amount that is more likely than not to be sustained. No portion of an uncertain tax position will be recognized if the position has less than a&#160;50%&#160;likelihood of being sustained.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920590992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Litigation</a></td>
<td class="text">Litigation<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various disputes, governmental and/or regulatory inquiries, investigations and proceedings, tax proceedings and litigation matters, both in the U.S. and abroad, that arise from time to time, some of which could result in losses, including damages, fines and/or civil penalties, and/or criminal charges against the Company. These matters are often complex and have outcomes that are difficult to predict. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in connection with the Combination, the Company has generally assumed liability for, and control of, pending and threatened legal matters relating to the Upjohn Business &#8211; including certain matters initiated against Pfizer described below &#8211; and has agreed to indemnify Pfizer for liabilities arising out of such assumed legal matters. Pfizer, however, has agreed to retain various matters &#8211; including certain specified competition law matters &#8211; to the extent they arise from conduct during the pre-Distribution period and has agreed to indemnify the Company for liabilities arising out of such matters.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes that it has meritorious defenses with respect to the claims asserted against it and the assumed legal matters referenced above, and intends to vigorously defend its position, the process of resolving these matters is inherently uncertain and may develop over a long period of time, and so it is not possible to predict the ultimate resolution of any such matter. It is possible that an unfavorable resolution of any of the ongoing matters could have a material effect on the Company&#8217;s business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of these governmental inquiries, investigations, proceedings and litigation matters with which the Company is involved are described below, and unless otherwise disclosed, the Company is unable to predict the outcome of the matter or to provide an estimate of the range of reasonably possible material losses. The Company records accruals for loss contingencies to the extent we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company is also involved in other pending proceedings for which, in the opinion of the Company based upon facts and circumstances known at the time, either the likelihood of loss is remote or any reasonably possible loss associated with the resolution of such proceedings is not expected to be material to the Company&#8217;s business, financial position, results of operations, cash flows, ability to pay dividends and/or stock price. If and when any reasonably possible losses associated with the resolution of such other pending proceedings, in the opinion of the Company, become material, the Company will disclose such matters.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal costs are recorded as incurred and are classified in SG&amp;A in the Company&#8217;s condensed consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EpiPen&#174; Auto-Injector Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in a putative direct purchaser class action filed in the U.S. District Court for the District of Kansas relating to the pricing and/or marketing of the EpiPen&#174; Auto-Injector. On September 21, 2021, after Plaintiffs&#8217; then operative complaint was dismissed with an option to file a limited amended complaint, Plaintiffs filed an amended complaint asserting federal antitrust claims which are based on allegations concerning a patent settlement between Pfizer and Teva and other alleged actions regarding the launch of Teva&#8217;s generic epinephrine auto-injector. Plaintiffs&#8217; seek monetary damages, declaratory relief, attorneys&#8217; fees and costs. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in March 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in putative direct purchaser class actions filed in the U.S. District Court for the District of Minnesota relating to contracts with certain pharmacy benefit managers concerning EpiPen&#174; Auto-Injector. The plaintiffs claim that the alleged conduct resulted in the exclusion or restriction of competing products and the elimination of pricing constraints in violation of RICO and federal antitrust law. These actions have been consolidated. Plaintiffs&#8217; seek monetary damages, attorneys&#8217; fees and costs. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 24, 2017, Sanofi Aventis U.S., LLC (&#8220;Sanofi&#8221;) filed a lawsuit against the Company in the U.S. District Court for the District of New Jersey. This lawsuit was transferred into a MDL in the U.S. District Court for the District of Kansas and alleged exclusive dealing and anti-competitive marketing practices in violation of the antitrust laws in connection with the sale and marketing of the EpiPen&#174; Auto-Injector. Sanofi sought monetary damages, declaratory relief, attorneys&#8217; fees and costs. The Court granted the Company&#8217;s motion for summary judgment and dismissed Sanofi&#8217;s claims. Sanofi&#8217;s appeal was denied. Sanofi&#8217;s petition seeking review by the U.S. Supreme Court was also denied and concludes this matter.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a total accrual of approximately $5.5 million related to these matters at March&#160;31, 2023, which is included in other current liabilities in the condensed consolidated balance sheets. Although it is reasonably possible that the Company may incur additional losses from these matters, any amount cannot be reasonably estimated at this time. In addition, the Company expects to incur additional legal and other professional service expenses associated with such matters in future periods and will recognize these expenses as services are received. The Company believes that the ultimate amount paid for these services and claims could have a material effect on the Company's business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price in future periods.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drug Pricing Matters </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Justice</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2015, the Company received a subpoena from the Antitrust Division of the DOJ seeking information relating to the marketing, pricing, and sale of certain of our generic products and any communications with competitors about such products. On September 8, 2016, the Company, as well as certain employees and a member of senior management, received subpoenas from the DOJ seeking similar information. Related search warrants also were executed.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2018, the Company received a civil investigative demand from the Civil Division of the DOJ seeking information relating to the pricing and sale of its generic drug products. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have fully cooperated with these investigations, which we believe are related to a broader industry-wide investigation of the generic pharmaceutical industry.  We have not had contact from DOJ concerning the above-described subpoenas or civil investigative demand in several years.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Civil Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2016, the Company, along with other manufacturers, has been named as a defendant in lawsuits filed in the United States and Canada generally alleging anticompetitive conduct with respect to generic drugs. The lawsuits have been filed by plaintiffs, including putative classes of direct purchasers, indirect purchasers, and indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties. The lawsuits allege harm under federal laws and the United States lawsuits also allege harm under state laws, including antitrust laws, state consumer protection laws and unjust enrichment claims. Some of the United States lawsuits also name as defendants the Company&#8217;s President, including allegations against him with respect to a single drug product, and one of the Company&#8217;s sales employees, including allegations against him with respect to certain generic drugs. The vast majority of the lawsuits have been consolidated in an MDL proceeding in the Eastern District of Pennsylvania (&#8220;EDPA&#8221;). Plaintiffs generally seek monetary damages, restitution, declaratory and injunctive relief, attorneys&#8217; fees and costs. The EDPA Court has ordered certain plaintiffs&#8217; complaints regarding two single-drug product cases to proceed as bellwethers. The Company is named in those plaintiffs&#8217; complaints that regard one of the two individual drug products. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorneys General Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2015, the Company received a subpoena and interrogatories from the Connecticut Office of the Attorney General seeking information relating to the marketing, pricing and sale of certain of the Company&#8217;s generic products and communications with competitors about such products. On December 14, 2016, attorneys general of certain states filed a complaint in the United States District Court for the District of Connecticut against several generic pharmaceutical drug manufacturers, including the Company, alleging anticompetitive conduct with respect to, among other things, a single drug product. The complaint has subsequently been amended, including on June 18, 2018, to add attorneys general alleging violations of federal and state antitrust laws, as well as violations of various states&#8217; consumer protection laws. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. The operative complaint includes attorneys general of forty-six states, the District of Columbia and the Commonwealth of Puerto Rico. The Company is alleged to have engaged in anticompetitive conduct with respect to four generic drug products. The amended complaint also includes claims asserted by attorneys general of thirty-six states and the Commonwealth of Puerto Rico against certain individuals, including the Company&#8217;s President, with respect to a single drug product. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. The States&#8217; claim for disgorgement and restitution under federal law in this case has been dismissed.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2019, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against various drug manufacturers and individuals, including the Company and one of its sales employees, alleging anticompetitive conduct with respect to additional generic drugs. On November 1, 2019, the complaint was amended, adding additional states as plaintiffs. The operative complaint is brought by attorneys general of forty-seven states, certain territories and the District of Columbia. The amended complaint also includes claims asserted by attorneys general of forty-two states and certain territories against several individuals, including a Company sales employee. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2020, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against drug manufacturers, including the Company, and individual defendants (none from the Company), alleging anticompetitive conduct with respect to additional generic drugs. On September 9, 2021, the complaint was amended, adding an additional state as a plaintiff. The operative complaint is brought by attorneys general of forty-six states, certain territories and the District of Columbia. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA and has been ordered to proceed as a bellwether.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Related Litigation </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purported class action complaints were filed in October 2016 against Mylan N.V. and Mylan Inc. (collectively &#8220;Mylan&#8221;), certain of Mylan&#8217;s former directors and officers, and certain of the Company&#8217;s current directors and officers (collectively, for purposes of this paragraph, the &#8220;defendants&#8221;) in the United States District Court for the Southern District of New York (&#8220;SDNY&#8221;) on behalf of certain purchasers of securities of Mylan on the NASDAQ. The complaints alleged that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the classification of their EpiPen&#174; Auto-Injector as a non-innovator drug for purposes of the Medicaid Drug Rebate Program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2017, a consolidated amended complaint was filed alleging substantially similar claims, but adding allegations that defendants made false or misleading statements and omissions of purportedly material fact in connection with allegedly anticompetitive conduct with respect to EpiPen&#174; Auto-Injector and certain generic drugs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operative complaint is the third amended consolidated complaint, which was filed on June 17, 2019, and contains the allegations as described above against Mylan, certain of Mylan&#8217;s former directors and officers, and certain of the Company&#8217;s current directors, officers, and employees (collectively, for purposes of this paragraph, the &#8220;defendants&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A class has been certified covering all persons or entities that purchased Mylan common stock between February 21, 2012 and May 24, 2019 excluding defendants, certain of the Company&#8217;s current directors and officers, former directors and officers of Mylan, members of their immediate families and their legal representatives, heirs, successors or assigns, and any entity in which defendants have or had a controlling interest. Plaintiffs seek damages and costs and expenses, including attorneys&#8217; fees and expert costs. On March 30, 2023, the Court dismissed all of Plaintiffs&#8217; claims by granting Defendants&#8217; motion for summary judgment and denying Plaintiffs&#8217; cross-motion for partial summary judgment. Plaintiffs have filed an appeal to the U.S. Court of Appeals for the Second Circuit.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2017, a similar lawsuit was filed in the Tel Aviv District Court (Economic Division) in Israel, which has been stayed pending a decision in the SDNY class action litigation.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Abu Dhabi Investment Authority filed a complaint against Mylan in the SDNY asserting allegations pertaining to EpiPen&#174; Auto-Injector and certain generic drugs under the federal securities laws that overlap with those asserted in the third amended complaint identified above. The Abu Dhabi Investment Authority&#8217;s complaint seeks monetary damages as well as the plaintiff&#8217;s fees and costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 26, 2020, a putative class action complaint was filed by the Public Employees Retirement System of Mississippi, which was subsequently amended on November 13, 2020, against Mylan N.V., certain of Mylan N.V.&#8217;s former directors and officers, and an officer and director of the Company (collectively for the purposes of this paragraph, the &#8220;defendants&#8221;) in the U.S. District Court for the Western District of Pennsylvania on behalf of certain purchasers of securities of Mylan N.V. The amended complaint alleges that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the Morgantown manufacturing </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plant and inspections at the plant by the FDA. Plaintiff seeks certification of a class of purchasers of Mylan N.V. securities between February 16, 2016 and May 7, 2019. The complaint seeks monetary damages, as well as the plaintiff&#8217;s fees and costs.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2021, a complaint was filed by Skandia Mutual Life Ins. Co., Lansforsakringar AB, KBC Asset Management N.V., and GIC Private Limited, against the Company, certain of Mylan N.V.&#8217;s former directors and officers, a current director and officer of the Company, and current employees of the Company. The Complaint asserts claims which are based on allegations that are similar to those in the SDNY and the Western District of Pennsylvania complaints identified above.  Plaintiffs seek compensatory damages, costs and expenses and attorneys&#8217; fees.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company and certain of its then officers and directors were named as defendants in a putative class action lawsuit filed in the Court of Common Pleas of Allegheny County, Pennsylvania on behalf of former Mylan shareholders who received Company common stock in connection with the Combination.  A non-Viatris affiliated company and persons were also named as defendants.  The complaint alleges violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 for purportedly failing to disclose or misrepresenting material information in the registration statement and related prospectus issued in connection with the Combination. On January 3, 2023, an amended complaint was filed naming the same defendants and alleging the same violations as the original complaint. Plaintiffs seek monetary damages, reasonable costs and expenses, and certain other equitable and injunctive relief. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioids</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with other manufacturers, distributors, pharmacies, pharmacy benefit managers, and individual healthcare providers is a defendant in more than 1,000 cases in the United States and Canada filed by various plaintiffs, including counties, cities and other local governmental entities, asserting civil claims related to sales, marketing and/or distribution practices with respect to prescription opioid products. In addition, lawsuits have been filed as putative class actions including on behalf of children with Neonatal Abstinence Syndrome due to alleged exposure to opioids.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lawsuits generally seek equitable relief and monetary damages (including punitive and/or exemplary damages) based on a variety of legal theories, including various statutory and/or common law claims, such as negligence, public nuisance and unjust enrichment. The vast majority of these lawsuits have been consolidated in an MDL in the U.S. District Court for the Northern District Court of Ohio.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 13, 2023, the Company received a civil subpoena from the Attorney General of the State of New York seeking information relating to opioids manufactured, marketed, or sold by the Company and related subject matter. The Company is fully cooperating with this subpoena request.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Meda Sweden Commercial Dispute</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2021, Ocular AS and other related entities (&#8220;Claimants&#8221;) initiated an arbitration in Sweden against Meda OTC AB and Meda AB (collectively, &#8220;Meda&#8221; or the &#8220;Company&#8221;) alleging breach of a 2013 sale and purchase agreement between Claimants and Meda concerning commercialization of a dental hygiene product.  Claimants are seeking approximately $155&#160;million in purported damages, plus interest and costs.  The Company believes that it acted lawfully and vigorously contested all aspects of Claimants&#8217; case &#8211; including their asserted damages &#8211; at an arbitration hearing that took place in February 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Citalopram</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2013, the European Commission issued a decision finding that Lundbeck and several generic companies, including Generics [U.K.] Limited (&#8220;GUK&#8221; or the &#8220;Company&#8221;), had violated EU competition rules relating to various settlement agreements entered into in 2002 for citalopram.  After various appeals, the European Commission&#8217;s decision was upheld in March 2021.  On March 28, 2023, bodies of the national health authorities in England &amp; Wales served a claim in the U.K. Competition Appeals Tribunal against parties to the citalopram investigation, including GUK, seeking monetary damages, plus interest, purportedly arising from the settlement agreements.  The Company, beginning in approximately 2018, has received notices from other health service authorities and insurers asserting an intention to file similar claims.  Pursuant to an indemnification agreement, Merck KGaA and GUK have agreed to equally share any damages claimed against Merck KGaA and/or GUK alleged to have been caused by the conduct which is the subject of the European Commission decision.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately &#8364;11.9 million as of March 31, 2023 related to this matter. It is reasonably possible that we will incur additional losses above the amount accrued but we cannot estimate a range of such reasonably possible losses at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, the Company is involved in a number of product liability lawsuits related to alleged personal injuries arising out of certain products manufactured/or distributed by the Company, including but not limited to those discussed below. Plaintiffs in these cases generally seek damages and other relief on various grounds for alleged personal injury and economic loss.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately $65.1 million as of March&#160;31, 2023 for its product liability matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nitrosamines</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with numerous other manufacturers, retailers, and others, are parties to litigation relating to alleged trace amounts of nitrosamine impurities in certain products, including valsartan and ranitidine. The vast majority of these lawsuits naming the Company in the United States are pending in two MDLs, namely an MDL pending in the United States District Court for the District of New Jersey concerning valsartan and an MDL pending in the United States District Court for the Southern District of Florida concerning ranitidine. The lawsuits against the Company in the MDLs include putative and certified classes seeking the refund of the purchase price and other economic and punitive damages allegedly sustained by consumers and end payors as well as individuals seeking compensatory and punitive damages for personal injuries allegedly caused by ingestion of the medications. Similar lawsuits pertaining to valsartan have been filed in other countries. Third party payor, consumer and medical monitoring classes were certified in the valsartan MDL and a Rule 23(f) petition to appeal the certification decision was denied. The Company has also received claims and inquiries related to these products, as well as requests to indemnify purchasers of the Company&#8217;s API and/ or finished dose forms of these products. The original master complaints concerning ranitidine were dismissed on December 31, 2020. The end-payor plaintiff immediately appealed to the U.S. Court of Appeals for the Eleventh Circuit, which affirmed the dismissal. The personal injury and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumer putative class plaintiffs filed amended master complaints. The Company was not named as a defendant in the amended master complaints, though it was still named in certain short form complaints filed by personal injury plaintiffs. The trial court has dismissed all remaining claims against the generic defendants. Certain of the personal injury plaintiffs appealed this dismissal, which remains pending.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lipitor</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of individual and multi-plaintiff lawsuits have been filed against Pfizer in various federal and state courts alleging that the plaintiffs developed type 2 diabetes purportedly as a result of the ingestion of Lipitor. Plaintiffs seek compensatory and punitive damages. In February 2014, the federal actions were transferred for consolidated pre-trial proceedings to an MDL in the U.S. District Court for the District of South Carolina. Since 2016, certain cases in the MDL were remanded to certain state courts. In 2017, the District Court granted Pfizer&#8217;s motion for summary judgment, dismissing all of the cases pending in the MDL. In June 2018, this dismissal was affirmed by the U.S. Court of Appeals for the Fourth Circuit. The state court proceedings remain pending in Missouri and New York. Prior state court proceedings in California have now been terminated after the California Court previously granted motions (i) to exclude the opinions of plaintiffs&#8217; only general causation expert in connection with his opinions involving the three lowest doses of Lipitor (10, 20 and 40 mg); (ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for summary judgment in connection with the 10, 20, and 40 mg plaintiffs; and (iii) seeking the dismissal of the remaining cases involving the highest dose of Lipitor (80 mg).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in a number of patent litigation lawsuits involving the validity and/or infringement of patents held by branded pharmaceutical manufacturers including but not limited to the matters described below.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its business judgment to decide to market and sell certain products, in each case based on its belief that the applicable patents are invalid and/or that its products do not infringe, notwithstanding the fact that allegations of patent infringement(s) or </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other potential third party rights have not been finally resolved by the courts. The risk involved in doing so can be substantial because the remedies available to the owner of a patent for infringement may include, a reasonable royalty on sales or damages measured by the profits lost by the patent owner. If there is a finding of willful infringement, damages may be increased up to three times. Moreover, because of the discount pricing typically involved with bioequivalent products, patented branded products generally realize a substantially higher profit margin than generic and biosimilar products. The Company also faces challenges to its patents, including suits in various jurisdictions pursuant to which generic drug manufacturers, payers, governments, or other parties are seeking damages for allegedly causing delay of generic entry. An adverse decision in any of these matters could have an adverse effect that is material to our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately $108.8 million as of March&#160;31, 2023 for its intellectual property matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lyrica - United Kingdom </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2014, Pfizer was involved in patent litigation in the English courts concerning the validity of its Lyrica pain use patent. In 2015, the High Court of Justice in London ordered that the NHS England issue guidance for prescribers and pharmacists directing the prescription and dispensing of Lyrica by brand when pregabalin was prescribed for the treatment of neuropathic pain and entered a preliminary injunction against certain Sandoz group companies preventing the sale of Sandoz&#8217;s full label pregabalin product.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pfizer undertook to compensate certain generic companies and NHS entities for losses caused by these orders, which remained in effect until patent expiration in July 2017. In November 2018, the U.K. Supreme Court ruled that all the relevant claims directed to neuropathic pain were invalid. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Reddy&#8217;s Laboratories filed a claim for monetary damages, interest, and costs in May 2020, followed by the Scottish Ministers and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fourteen </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scottish Health Boards (together, NHS Scotland) in July 2020. In September 2020, Teva, Sandoz, Ranbaxy, Actavis, and the Secretary of State for Health and Social Care, together with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 32 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other NHS entities (together, NHS England, Wales, and Northern Ireland) filed their claims. All of the claims except for those filed by Dr. Reddy&#8217;s Laboratories and NHS Scotland have been resolved. A trial on the remaining claims has been set for November 2023.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yupelri</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in January 2023, certain generic companies notified us that they had filed ANDAs with the FDA seeking approval to market generic versions of Yupelri&#174; with associated Paragraph IV certifications.  The companies assert the invalidity and/or non-infringement of polymorph patents expiring in 2030 and 2031, and a method of use patent expiring in 2039.  The companies have not filed Paragraph IV certifications to our compound patents, which currently expire in December 2025, with one compound patent subject to a patent term extension to October 2028.  In February 2023, we brought patent infringement actions against the generic filers in federal district courts, including the U.S. District Court for the District of New Jersey, the U.S. District Court for the District of Delaware, and the U.S. District Court for the Middle District of North Carolina, asserting infringement of the patents by the generic companies. The actions filed in Delaware and North Carolina have been dismissed and the actions will proceed in New Jersey. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other legal proceedings including commercial, contractual, employment, or other similar matters that are considered normal to its business. The Company has approximately $8.6 million accrued related to these various other legal proceedings at March&#160;31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915974400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting Policy</a></td>
<td class="text">The accompanying unaudited condensed consolidated financial statements (&#8220;interim financial statements&#8221;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Share Policy</a></td>
<td class="text">Basic earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments Policy</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;2: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;3: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920577584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting Policy</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Intangible asset amortization expense and impairments of goodwill and long-lived assets;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">R&amp;D and acquired IPR&amp;D expense;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Net charges or net gains for litigation settlements and other contingencies;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including costs related to our planned divestitures and the Biocon Biologics Transaction, and, as applicable, any associated transition activities. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the segments are the same as those described in Note 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in the 2022 Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915984144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2023 and 2022, respectively:</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.43pt">Amounts for the three months ended March&#160;31, 2022 include $164.8 million related to the biosimilars business which was subsequently contributed to Biocon Biologics in November 2022. The Company has not recognized the results of the biosimilars business in its consolidated financial statements subsequent to November 29, 2022.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2023 and 2022: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:71.681%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.920%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Global Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipitor &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norvasc &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyrica &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viagra &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EpiPen&#174; Auto-Injectors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celebrex &#174;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creon &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effexor &#174;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zoloft &#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xalabrands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Segment Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dymista &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yupelri &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xanax &#174;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amitiza &#174;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">The Company does not disclose net sales for any products considered competitively sensitive.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration and Accounts Receivable</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2023 and 2022, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,273.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,198.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross to net adjustments:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,350.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,584.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(992.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,205.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross to net adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,553.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,020.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable, Net</a></td>
<td class="text">Such allowances were comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:<div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net was comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:76.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,021.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,243.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,497.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,814.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650921365536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. GAAP purchase price was $392.7&#160;million, net of cash acquired. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Oyster Point is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:82.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.092%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets (excluding inventories and net of cash acquired)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $34.7 of cash acquired)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Famy Life Sciences is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:82.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.092%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $0.2 of cash acquired)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental unaudited pro forma information for the acquisition, as if it had occurred on January 1, 2022. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased amortization expense based on the fair value of assets acquired, the impact of transaction costs and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable, or have been achieved, subsequent to the closing of the acquisition. Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:65.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited, in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,729.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,194.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915984144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Awards Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock awards (stock options and SARs) activity under the 2020 Incentive Plan and 2003 LTIP:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Under Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,449,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,485,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452,279&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,185,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Nonvested Restricted Stock and Restricted Stock Unit Awards Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the Company&#8217;s nonvested Restricted Stock Awards (restricted stock and restricted stock unit awards, including PSUs) from December&#160;31, 2022 to March&#160;31, 2023 is presented below:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Restricted Stock&#160;Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair&#160;Value&#160;Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,271,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,043,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,743,490)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267,038)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,304,863&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650923450624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Postretirement Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Net Periodic Benefit Cost</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (h)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650919416448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock', window );">Schedule of Cash, cash equivalents, and restricted cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and restricted cash</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,664.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,936.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,145.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,083.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,137.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Other Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other assets</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred consideration due from Biocon Biologics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCPS in Biocon Biologics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Accounts payable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts payable</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales allowances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and professional accruals, including litigation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee benefit liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to Biocon Biologics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,192.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Noncurrent Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term obligations</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax related items, including contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Components</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650923450624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Ordinary Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V.</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Viatris Inc. common shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650921345664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,461.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,425.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,616.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $385.0&#160;million.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $117.0&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Components of Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following components at March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Original Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,975.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,604.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,370.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,306.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,604.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,701.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,490.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,923.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,566.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,530.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,923.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,607.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div>(1)Represents amortizable intangible assets. Other intangible assets consists principally of customer lists and contractual rights.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Finite-lived Intangible Assets Amortization Expense</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset disposal &amp; impairment charges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible asset amortization expense (including disposal &amp; impairment charges)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company recognized an intangible asset charge of approximately $32.0&#160;million, which was recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statement of operations, to write down the disposal group to fair value, less cost to sell, related to our Upjohn Distributor Markets, which are classified as held for sale. As of March&#160;31, 2023 and December&#160;31, 2022, the Company has approximately $198.3&#160;million and $230.3&#160;million, respectively, of intangible assets related to the Upjohn Distributor Markets that are classified as held for sale in the condensed consolidated balance sheets. Refer to Note 5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Expected Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense over the remainder of 2023 and for the years ending December&#160;31, 2024 through 2027 is estimated to be as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:88.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916330976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Financial Assets and Liabilities Carried at Fair Value</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCPS in Biocon Biologics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the principal amounts of the Company&#8217;s outstanding Euro and Yen borrowings and the notional amounts of the Euro and Yen borrowings designated as net investment hedges: </span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount Designated as a Net Investment Hedge</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250% Euro Senior Notes due 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% Euro Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.125% Euro Senior Notes due 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.023% Euro Senior Notes due 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.362% Euro Senior Notes due 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.908% Euro Senior Notes due 2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yen</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.417%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Reclassified from AOCE into Earnings </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-derivative Financial Instruments in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.7)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.1&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">At March&#160;31, 2023, the Company expects that approximately $14.0 million of pre-tax net losses on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) recognized in earnings on derivatives.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) reclassified from AOCE into earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the activity in the Company&#8217;s fair value of contingent consideration from December&#160;31, 2022 to March&#160;31, 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Portion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other current liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other long-term obligations in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in litigation settlements and other contingencies, net in the condensed consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CCC<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650923605504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of Long-Term Debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A summary of long-term debt is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate as of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current portion of long-term debt:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,069.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2046 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> **</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> *</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,069.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,015.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The fair value adjustment was amortized to interest expense over the remaining term of the notes, which were repaid at maturity in the first quarter of 2023.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Mylan Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was originally issued by Mylan N.V.; now held by Utah Acquisition Sub Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Viatris Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Upjohn Finance B.V.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Minimum Repayments on Outstanding Borrowings</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at March&#160;31, 2023 were as follows for each of the periods ending December 31:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,029&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s short-term borrowings:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term borrowings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650919883936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, is comprised of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain and prior service cost related to defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain on derivatives in net investment hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,340.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,385.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,764.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,761.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Components of Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.121%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,385.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,761.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,340.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,764.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.266%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr style="height:45pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,271.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,061.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 45<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650923442528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Reconciliation of Segment Information to Total Consolidated Information</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment Profitability</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reportable Segments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(603.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset disposal &amp; impairment charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Globally managed research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements &amp; other contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction related and other special items</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other unallocated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650919921776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring - employee related</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2022 to March&#160;31, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the three months ended March 31, 2023, total restructuring charges in Developed Markets, Emerging Markets, Greater China, and JANZ were approximately $7.7 million, $1.3 million, $(0.6) million, and $1.3 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650921551872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables', window );">Proceeds from sale and collection of receivables</a></td>
<td class="nump">$ 76.3<span></span>
</td>
<td class="nump">$ 34.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the proceeds from sale and collection of receivables during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913674016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,719.1<span></span>
</td>
<td class="nump">$ 4,178.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember', window );">Biocon Biologics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(164.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_BrandsMember', window );">Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,420.3<span></span>
</td>
<td class="nump">2,554.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember', window );">Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">136.1<span></span>
</td>
<td class="nump">390.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_GenericsMember', window );">Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,162.7<span></span>
</td>
<td class="nump">1,233.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_LipitorMember', window );">Lipitor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">417.9<span></span>
</td>
<td class="nump">440.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_NorvascMember', window );">Norvasc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">202.7<span></span>
</td>
<td class="nump">207.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_LyricaMember', window );">Lyrica &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">144.3<span></span>
</td>
<td class="nump">171.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_ViagraMember', window );">Viagra &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">115.0<span></span>
</td>
<td class="nump">129.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_EpiPenAutoInjectorsMember', window );">EpiPen&#174; Auto-Injectors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">95.8<span></span>
</td>
<td class="nump">88.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_CelebrexMember', window );">Celebrex &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">88.8<span></span>
</td>
<td class="nump">85.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_EffexorMember', window );">Effexor &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">64.6<span></span>
</td>
<td class="nump">77.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_ZoloftMember', window );">Zoloft &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">56.5<span></span>
</td>
<td class="nump">73.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_CreonMember', window );">Creon &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">72.7<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_XalabrandsMember', window );">Xalabrands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">46.7<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_AmitizaMember', window );">Amitiza &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">36.6<span></span>
</td>
<td class="nump">41.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_XanaxMember', window );">Xanax &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">39.7<span></span>
</td>
<td class="nump">40.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_DymistaMember', window );">Dymista &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">53.2<span></span>
</td>
<td class="nump">44.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_YupelriMember', window );">Yupelri &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">47.0<span></span>
</td>
<td class="nump">43.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets (1) | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,232.0<span></span>
</td>
<td class="nump">1,298.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets (1) | Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">129.9<span></span>
</td>
<td class="nump">364.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets (1) | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">808.5<span></span>
</td>
<td class="nump">813.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">562.4<span></span>
</td>
<td class="nump">569.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">190.3<span></span>
</td>
<td class="nump">249.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">145.8<span></span>
</td>
<td class="nump">164.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets (2) | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">435.6<span></span>
</td>
<td class="nump">436.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets (2) | Complex GX and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets (2) | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">206.2<span></span>
</td>
<td class="nump">252.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment | Developed Markets (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,170.4<span></span>
</td>
<td class="nump">2,476.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment | Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">564.6<span></span>
</td>
<td class="nump">573.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment | JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">342.2<span></span>
</td>
<td class="nump">423.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment | Emerging Markets (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 641.9<span></span>
</td>
<td class="nump">$ 705.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_BrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_BrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_GenericsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_GenericsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_LipitorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_LipitorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_NorvascMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_NorvascMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_LyricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_LyricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ViagraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ViagraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_EpiPenAutoInjectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_EpiPenAutoInjectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_CelebrexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_CelebrexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_EffexorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_EffexorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ZoloftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ZoloftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_CreonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_CreonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_XalabrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_XalabrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_AmitizaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_AmitizaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_XanaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_XanaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_DymistaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_DymistaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_YupelriMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_YupelriMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915865728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Variable Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_RevenuefromContractwithCustomerGross', window );">Gross sales</a></td>
<td class="nump">$ 6,273.0<span></span>
</td>
<td class="nump">$ 7,198.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Chargebacks', window );">Chargebacks</a></td>
<td class="num">(1,350.7)<span></span>
</td>
<td class="num">(1,584.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_AccruedSalesAllowances', window );">Rebates, promotional programs and other sales allowances</a></td>
<td class="num">(992.2)<span></span>
</td>
<td class="num">(1,205.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_RevenuefromContractwithCustomerReturns', window );">Returns</a></td>
<td class="num">(50.4)<span></span>
</td>
<td class="num">(82.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Medicaidandothergovernmentalrebates', window );">Medicaid and other governmental rebates</a></td>
<td class="num">(160.6)<span></span>
</td>
<td class="num">(147.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_SalesRevenueGrosstonetadjustments', window );">Sales Revenue, Gross to net adjustments</a></td>
<td class="num">(2,553.9)<span></span>
</td>
<td class="num">(3,020.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,719.1<span></span>
</td>
<td class="nump">$ 4,178.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccruedSalesAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Sales Allowances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccruedSalesAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Chargebacks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Chargebacks</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Chargebacks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Medicaidandothergovernmentalrebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medicaid and other governmental rebates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Medicaidandothergovernmentalrebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_RevenuefromContractwithCustomerGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_RevenuefromContractwithCustomerGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_RevenuefromContractwithCustomerReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Returns</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_RevenuefromContractwithCustomerReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_SalesRevenueGrosstonetadjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales Revenue, Gross to net adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_SalesRevenueGrosstonetadjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650921232800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Revenue Recognition And Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">$ 3,021.9<span></span>
</td>
<td class="nump">$ 3,243.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">475.6<span></span>
</td>
<td class="nump">570.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">3,497.5<span></span>
</td>
<td class="nump">3,814.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Revenue Recognition And Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">1,739.9<span></span>
</td>
<td class="nump">1,798.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">851.5<span></span>
</td>
<td class="nump">888.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 2,591.4<span></span>
</td>
<td class="nump">$ 2,687.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913591856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">$ 2,186.9<span></span>
</td>
<td class="nump">$ 2,420.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">98.0<span></span>
</td>
<td class="nump">128.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings attributable to Viatris Inc. common shareholders</a></td>
<td class="nump">224.7<span></span>
</td>
<td class="nump">399.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,729.1<span></span>
</td>
<td class="nump">4,191.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,763.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,811.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">244.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">5,252.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,175.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (2,764.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,761.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligation', window );">Amounts due for supplier finance program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55.5<span></span>
</td>
<td class="nump">$ 33.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-5<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-6<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 80: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 81: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 82: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 83: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 84: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 85: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 86: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 87: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 88: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 89: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 90: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 91: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 92: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation for supplier finance program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477128/405-50-55-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913357680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Narrative) (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 07, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>right </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>right </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,573.2<span></span>
</td>
<td class="nump">$ 10,573.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,425.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372.5<span></span>
</td>
<td class="nump">$ 372.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">667.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,729.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,191.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings attributable to Viatris Inc. common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 224.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Other Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Acquisitions and Other Transactions<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oyster Point Acquisition</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, the Company completed the acquisition of Oyster Point for approximately $427.4&#160;million in cash, which included $11 per share paid to Oyster Point stockholders through a tender offer, payment for vested share-based awards, and the repayment of debt of Oyster Point. In addition to the upfront cash consideration, each Oyster Point stockholder received one non-tradeable contingent value right representing up to an additional $2 per share, or approximately $60&#160;million in the aggregate, contingent upon Oyster Point achieving certain metrics based upon full year 2022 performance. Oyster Point did not achieve the metrics that would have triggered a contingent payment and the contingent value rights have expired. Oyster Point is focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested share-based awards to acquire Oyster Point common stock that were outstanding immediately prior to the closing of the acquisition were cancelled in exchange for the right to receive an amount in cash based upon a formula contained within the merger agreement. The unvested share-based awards were converted into Viatris share-based awards based upon a formula contained within the merger agreement. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. During the three months ended March&#160;31, 2023, the Company incurred acquisition related costs of approximately $18.3&#160;million, which were recorded primarily in SG&amp;A in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. GAAP purchase price was $392.7&#160;million, net of cash acquired. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Oyster Point is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:82.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.092%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets (excluding inventories and net of cash acquired)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $34.7 of cash acquired)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair value estimates for the assets acquired and liabilities assumed were based upon preliminary calculations, valuations and assumptions that are subject to change as the Company obtains additional information during the measurement period (up to one year from the acquisition date). The primary areas subject to change relate to the finalization of the valuation of intangible assets and income taxes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a step-up in the fair value of inventory of approximately $29.3&#160;million. During the three months ended March&#160;31, 2023, the Company recorded amortization of the inventory step-up of approximately $7.3&#160;million, which is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The identified intangible assets of $334.0 million are comprised of product rights and licenses related to a commercial asset, Tyrvaya&#174;, for the treatment of dry eye disease, that have an estimated useful life of 10 years. Significant assumptions utilized in the valuation of identified intangible assets were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by U.S. GAAP.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill of $5.9 million arising from the acquisition consisted largely of the value of the employee workforce and the expected value of products to be developed in the future. All of the goodwill was assigned to the Developed Markets segment. None of the goodwill recognized in this transaction is currently expected to be deductible for income tax purposes. The operating results of Oyster Point have been included in the Company&#8217;s condensed consolidated statements of operations since the acquisition date. The total revenues of Oyster Point for the period from the acquisition date to March 31, 2023, were $6.3&#160;million and net loss, net of tax, was approximately $49.3&#160;million. The net loss for the period includes the effect of the purchase accounting adjustments and acquisition related costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental unaudited pro forma information for the acquisition, as if it had occurred on January 1, 2022. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased amortization expense based on the fair value of assets acquired, the impact of transaction costs and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable, or have been achieved, subsequent to the closing of the acquisition. Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:65.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited, in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,729.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,194.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Famy Life Sciences Acquisition</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2022, the Company entered into a definitive agreement to acquire the remaining equity shares of Famy Life Sciences, a privately-owned research company with a complementary portfolio of ophthalmology therapies under development, for consideration of $281&#160;million. The Company had previously entered into a Master Development Agreement with Famy Life Sciences on December 20, 2019 under which the Company obtained rights with respect to acquiring certain pharmaceutical products and had also acquired shares representing approximately 13.5% equity interest in Famy Life Sciences for $25.0&#160;million at December 31, 2020. The investment was accounted for in accordance with ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction to acquire the remaining equity shares of Famy Life Sciences closed during the first quarter of 2023. The Company recognized a gain of $18.9&#160;million during the first quarter of 2023 as a result of remeasuring its pre-existing 13.5% equity interest in Famy Life Sciences to fair value, which was recorded as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statement of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. The U.S. GAAP purchase price allocated to the transaction was $325.0&#160;million, which consisted of $281&#160;million of cash consideration paid for the remaining equity shares and $43.9&#160;million for the fair value of the pre-existing 13.5% equity interest. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Famy Life Sciences is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:82.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.092%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $0.2 of cash acquired)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair value estimates for the assets acquired and liabilities assumed were based upon preliminary calculations, valuations and assumptions that are subject to change as the Company obtains additional information during the measurement period (up to one year from the acquisition date). The primary areas subject to change relate to the finalization of the valuation of IPR&amp;D and income taxes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount allocated to IPR&amp;D represents an estimate of the fair value of purchased in-process technology for research projects that, as of the closing date of the acquisition, had not reached technological feasibility and had no alternative future use. The fair value of IPR&amp;D of $290.0 million was based on the excess earnings method, which utilizes forecasts of expected cash inflows (including estimates for ongoing costs) and other contributory charges. A discount rate of 23.9% was utilized to discount net cash inflows to present values. IPR&amp;D is accounted for as an indefinite-lived intangible asset and will be subject to impairment testing until completion or abandonment of the projects. Upon successful completion and launch of each product, the Company will make a determination of the estimated useful life of the individual asset. The acquired IPR&amp;D projects are in various stages of completion and the estimated costs to complete these projects total approximately $120&#160;million, which are expected to be incurred through 2024. There are risks and uncertainties associated with the timely and successful completion of the projects included in IPR&amp;D, and no assurances can be given that the underlying assumptions used to estimate the fair value of IPR&amp;D will not change or the timely completion of each project to commercial success will occur.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill of $89.3 million arising from the acquisition consisted largely of the value of the employee workforce and the expected value of products to be developed in the future. All of the goodwill was assigned to the Developed Markets segment. None of the goodwill recognized in this transaction is currently expected to be deductible for income tax purposes. The acquisition did not have a material impact on the Company&#8217;s results of operations since the acquisition date or on a pro forma basis for the three months ended March 31, 2023 and 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ophthalmology is one of the key therapeutic areas of focus that the Company announced in February 2022 when it announced plans for certain strategic actions. With the combination of Viatris' global commercial footprint, R&amp;D and regulatory capabilities and supply chain, along with Oyster Point's deep knowledge of the ophthalmology space from a clinical, medical, regulatory and commercial perspective&#8212;including Tyrvaya&#174;&#8212;and Famy Life Sciences' Phase III-ready pipeline, the Company believes it has the foundation to create a leading global ophthalmology franchise, accelerating efforts to address the unmet needs of patients with ophthalmic disease and the eye care professionals who treat them.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_FamyLifeSciencesMember', window );">Famy Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vtrs_ProductRightsAndLicensesMember', window );">Product Rights And Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible assets, estimated useful life, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember', window );">Oyster Point Pharma Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,729.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,194.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 337.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 427.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights', window );">Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights | right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessAcquisitionContingentConsiderationPerShare', window );">Business Acquisition, Contingent Consideration Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.0<span></span>
</td>
<td class="nump">$ 60.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization', window );">Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392.7<span></span>
</td>
<td class="nump">392.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings attributable to Viatris Inc. common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember', window );">Oyster Point Pharma Acquisition | Product Rights And Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 334.0<span></span>
</td>
<td class="nump">$ 334.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember', window );">Famy Life Sciences Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 89.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">281.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="nump">43.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">325.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember', window );">Famy Life Sciences Acquisition | In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangible assets</a></td>
<td class="nump">$ 290.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember', window );">Famy Life Sciences Acquisition | In Process Research and Development | Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=vtrs_ViatrisIncMember', window );">Viatris Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Subsidiary, Ownership Percentage, Noncontrolling Owner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessAcquisitionContingentConsiderationPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessAcquisitionContingentConsiderationPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_FamyLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_FamyLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vtrs_ProductRightsAndLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vtrs_ProductRightsAndLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=vtrs_ViatrisIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=vtrs_ViatrisIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913332608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Purchase Price Allocations) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 07, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 10,573.2<span></span>
</td>
<td class="nump">$ 10,425.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember', window );">Oyster Point Pharma Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets (excluding inventories and net of cash acquired)</a></td>
<td class="nump">26.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">37.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred income tax benefit</a></td>
<td class="nump">17.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">431.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(37.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">392.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember', window );">Oyster Point Pharma Acquisition | Product Rights And Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangible assets</a></td>
<td class="nump">$ 334.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember', window );">Famy Life Sciences Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember', window );">Famy Life Sciences Acquisition | In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vtrs_ProductRightsAndLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vtrs_ProductRightsAndLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913553360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details) - Oyster Point Pharma Acquisition - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="nump">$ 3,729.1<span></span>
</td>
<td class="nump">$ 4,194.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="nump">$ 260.5<span></span>
</td>
<td class="nump">$ 337.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 220,000<span></span>
</td>
<td class="nump">$ 280,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 220,000<span></span>
</td>
<td class="nump">$ 280,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Basic (in shares)</a></td>
<td class="nump">1,202,500<span></span>
</td>
<td class="nump">1,210,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted', window );">Diluted (in shares)</a></td>
<td class="nump">1,205,600<span></span>
</td>
<td class="nump">1,213,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageBasicSharesOutstandingProForma</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913384944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 29, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198.3<span></span>
</td>
<td class="nump">$ 230.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (33.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Write down of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.0<span></span>
</td>
<td class="nump">172.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_UpjohnDistributorMarketsMember', window );">Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory Valuation Reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear', window );">Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_UpjohnDistributorMarketsMember', window );">Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations | Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_UpjohnDistributorMarketsMember', window );">Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations | Emerging Markets (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember', window );">Biocon Biologics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember', window );">Biocon Biologics | Scenario, Forecast | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_DivestitureOfBusinessDeferredCashConsideration', window );">Divestiture of Business, Deferred Cash Consideration.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 335.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember', window );">Biocon Biologics | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="nump">$ 3,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="nump">2,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1', window );">Noncash or Part Noncash Divestiture, Amount of Consideration Received</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset', window );">Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset</a></td>
<td class="nump">12.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm', window );">Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment', window );">Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment</a></td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DivestitureOfBusinessDeferredCashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Divestiture of Business, Deferred Cash Consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DivestitureOfBusinessDeferredCashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_UpjohnDistributorMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_UpjohnDistributorMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_InventoriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_InventoriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650921258960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 16, 2020</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option award expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,485,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,449,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long-Term Incentive Plan 2003</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="nump">6,757,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation expense, net of estimated forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 213.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue', window );">Intrinsic value of stock-based awards exercised and restricted stock units converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.8<span></span>
</td>
<td class="nump">$ 63.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="nump">13,535,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long-Term Incentive Plan 2003 | Stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Average remaining contractual term for stock awards outstanding, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term for stock awards vested and expected to vest, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term for stock awards exercisable, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long-Term Incentive Plan 2003 | Stock awards | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option award vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long-Term Incentive Plan 2003 | Stock awards | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option award vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember', window );">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares reserved for issuance</a></td>
<td class="nump">72,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650919736336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Stock Awards) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 37.01<span></span>
</td>
<td class="nump">$ 38.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</a></td>
<td class="nump">283,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 7.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="num">(5,225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 5.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</a></td>
<td class="num">(242,165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 31.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</a></td>
<td class="nump">4,452,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 37.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</a></td>
<td class="nump">4,185,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 38.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">4,485,613<span></span>
</td>
<td class="nump">4,449,642<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915955312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details) - Restricted stock awards<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of restricted stock awards, nonvested beginning of period | shares</a></td>
<td class="nump">27,271,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, nonvested beginning of period | $ / shares</a></td>
<td class="nump">$ 11.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock awards, granted | shares</a></td>
<td class="nump">19,043,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, granted | $ / shares</a></td>
<td class="nump">$ 11.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of restricted stock awards, released | shares</a></td>
<td class="num">(7,743,490)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, released | $ / shares</a></td>
<td class="nump">$ 13.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of restricted stock awards, forfeited | shares</a></td>
<td class="num">(267,038)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, forfeited | $ / shares</a></td>
<td class="nump">$ 11.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of restricted stock awards, nonvested end of period | shares</a></td>
<td class="nump">38,304,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, nonvested end of period | $ / shares</a></td>
<td class="nump">$ 11.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140651005865808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Postretirement Benefit (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear', window );">Defined benefit plans, estimated benefit payments, in current fiscal year</a></td>
<td class="nump">$ 108.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Estimated employer contributions in current year</a></td>
<td class="nump">$ 51.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plans, estimated benefit payments, in current fiscal year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916390080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember', window );">Pension and other postretirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="nump">$ 9.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">18.3<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(16.4)<span></span>
</td>
<td class="num">(16.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Recognized net actuarial gains</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plan Items | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650919725968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 506.6<span></span>
</td>
<td class="nump">$ 1,259.9<span></span>
</td>
<td class="nump">$ 752.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 510.7<span></span>
</td>
<td class="nump">$ 1,262.5<span></span>
</td>
<td class="nump">$ 757.4<span></span>
</td>
<td class="nump">$ 706.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913624288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Inventories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 667.4<span></span>
</td>
<td class="nump">$ 571.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">697.4<span></span>
</td>
<td class="nump">755.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">2,299.5<span></span>
</td>
<td class="nump">2,192.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 3,664.3<span></span>
</td>
<td class="nump">$ 3,519.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Components</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915860928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 239.7<span></span>
</td>
<td class="nump">$ 194.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">92.5<span></span>
</td>
<td class="nump">134.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">45.0<span></span>
</td>
<td class="nump">42.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">1,350.4<span></span>
</td>
<td class="nump">1,404.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,763.6<span></span>
</td>
<td class="nump">1,811.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember', window );">Available-for-sale fixed income investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">$ 36.0<span></span>
</td>
<td class="nump">$ 35.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913612544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Property, Plant and Equipment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 5,145.1<span></span>
</td>
<td class="nump">$ 5,083.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">2,137.3<span></span>
</td>
<td class="nump">2,059.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">3,007.8<span></span>
</td>
<td class="nump">3,024.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">3,051.3<span></span>
</td>
<td class="nump">2,936.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,548.0<span></span>
</td>
<td class="nump">1,539.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">410.8<span></span>
</td>
<td class="nump">474.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 135.0<span></span>
</td>
<td class="nump">$ 133.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915822336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Other Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 253.8<span></span>
</td>
<td class="nump">$ 259.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Otherlongtermassets', window );">Other long-term assets</a></td>
<td class="nump">779.9<span></span>
</td>
<td class="nump">753.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">2,418.2<span></span>
</td>
<td class="nump">2,403.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember', window );">Biocon Biologics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue', window );">Disposal Group, Including Discontinued Operation, Deferred Consideration Due</a></td>
<td class="nump">305.9<span></span>
</td>
<td class="nump">299.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity Securities, FV-NI, Cost</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">997.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=vtrs_PrivateEquitySecuritiesMember', window );">Private Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity Securities, FV-NI, Cost</a></td>
<td class="nump">$ 78.6<span></span>
</td>
<td class="nump">$ 94.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Deferred Consideration Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Otherlongtermassets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other long-term assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Otherlongtermassets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BioconBiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=vtrs_PrivateEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=vtrs_PrivateEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913621536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Trade Accounts Payable) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAbstract', window );"><strong>Accounts Payable, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent', window );">Trade accounts payable</a></td>
<td class="nump">$ 1,415.4<span></span>
</td>
<td class="nump">$ 1,158.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent', window );">Other payables</a></td>
<td class="nump">542.1<span></span>
</td>
<td class="nump">608.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 1,957.5<span></span>
</td>
<td class="nump">$ 1,766.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred and payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915725792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Other Current Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 475.6<span></span>
</td>
<td class="nump">$ 570.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal and professional accruals, including litigation accruals</a></td>
<td class="nump">288.8<span></span>
</td>
<td class="nump">297.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and employee benefit liabilities</a></td>
<td class="nump">617.7<span></span>
</td>
<td class="nump">746.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">372.5<span></span>
</td>
<td class="nump">375.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring Reserve, Current</a></td>
<td class="nump">74.6<span></span>
</td>
<td class="nump">95.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">214.0<span></span>
</td>
<td class="nump">80.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Liabilities, Current</a></td>
<td class="nump">3,192.8<span></span>
</td>
<td class="nump">3,440.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">98.5<span></span>
</td>
<td class="nump">187.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">83.5<span></span>
</td>
<td class="nump">80.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">866.7<span></span>
</td>
<td class="nump">978.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="nump">32.1<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">65.4<span></span>
</td>
<td class="nump">64.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 851.5<span></span>
</td>
<td class="nump">$ 888.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofothercurrentliabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of other current liabilities [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofothercurrentliabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916368224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Other Long-term Obligations) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems', window );"><strong>Schedule of Other Noncurrent Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Employee benefit liabilities</a></td>
<td class="nump">$ 542.1<span></span>
</td>
<td class="nump">$ 544.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">372.5<span></span>
</td>
<td class="nump">375.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Tax related items, including contingencies</a></td>
<td class="nump">418.0<span></span>
</td>
<td class="nump">414.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">173.2<span></span>
</td>
<td class="nump">181.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring Reserve, Noncurrent</a></td>
<td class="nump">58.0<span></span>
</td>
<td class="nump">60.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Other</a></td>
<td class="nump">221.4<span></span>
</td>
<td class="nump">244.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term obligations</a></td>
<td class="nump">1,719.8<span></span>
</td>
<td class="nump">1,756.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems', window );"><strong>Schedule of Other Noncurrent Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 307.1<span></span>
</td>
<td class="nump">$ 310.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph 210-10-S99-1(SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Other Noncurrent Liabilities [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920510192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Assets and Liabilities Held For Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Assets held for sale</a></td>
<td class="nump">$ 198.3<span></span>
</td>
<td class="nump">$ 230.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="nump">$ 32.1<span></span>
</td>
<td class="nump">$ 22.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913330160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Ordinary Share (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 17, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,900,000<span></span>
</td>
<td class="nump">15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650924502496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net earnings attributable to Viatris Inc. common shareholders</a></td>
<td class="nump">$ 224.7<span></span>
</td>
<td class="nump">$ 399.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding</a></td>
<td class="nump">1,202.5<span></span>
</td>
<td class="nump">1,210.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share attributable to Viatris Inc. shareholders</a></td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total dilutive shares outstanding</a></td>
<td class="nump">1,205.6<span></span>
</td>
<td class="nump">1,213.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per ordinary share</a></td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916721984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 07, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">$ 331.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">372.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Business Combination Contingent Consideration Liability Payments</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset disposal &amp; impairment charges</a></td>
<td class="nump">32.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,573.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,425.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember', window );">Oyster Point Pharma Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">60.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember', window );">Famy Life Sciences Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vtrs_ProductRightsAndLicensesMember', window );">Product Rights And Licenses | Oyster Point Pharma Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangible assets</a></td>
<td class="nump">334.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development | Famy Life Sciences Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,335.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,334.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">680.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">689.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">940.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">940.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">65.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Business Combination Contingent Consideration Liability Payments</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Reconciling items:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset disposal &amp; impairment charges</a></td>
<td class="nump">$ 32.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Liability Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_OysterPointPharmaAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_FamyLifeSciencesAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vtrs_ProductRightsAndLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vtrs_ProductRightsAndLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916269200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">$ 10,425.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">95.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="nump">52.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,573.2<span></span>
</td>
<td class="nump">$ 10,425.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">7,461.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">95.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="nump">60.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,616.8<span></span>
</td>
<td class="nump">7,461.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="num">(385.0)<span></span>
</td>
<td class="num">(385.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">940.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">940.6<span></span>
</td>
<td class="nump">940.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">689.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="num">(8.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">680.4<span></span>
</td>
<td class="nump">689.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning balance</a></td>
<td class="nump">1,334.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,335.4<span></span>
</td>
<td class="nump">1,334.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="num">$ (117.0)<span></span>
</td>
<td class="num">$ (117.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 16<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916389024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Components of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_IntangibleAssetsbyMajorClassLineItems', window );"><strong>Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset disposal &amp; impairment charges</a></td>
<td class="nump">$ 32.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, original cost</a></td>
<td class="nump">37,975.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,490.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="nump">15,604.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,923.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net book value</a></td>
<td class="nump">22,370.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,566.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">331.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross, excluding goodwill</a></td>
<td class="nump">38,306.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,530.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net book value, excluding goodwill</a></td>
<td class="nump">$ 22,701.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,607.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents and technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_IntangibleAssetsbyMajorClassLineItems', window );"><strong>Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible assets, estimated useful life, in years</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_IntangibleAssetsbyMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets by Major Class</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_IntangibleAssetsbyMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915974528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Amortization Expense) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="nump">$ 603.3<span></span>
</td>
<td class="nump">$ 648.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset disposal &amp; impairment charges</a></td>
<td class="nump">32.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Total intangible asset amortization expense (including disposal &amp; impairment charges)</a></td>
<td class="nump">$ 635.3<span></span>
</td>
<td class="nump">$ 648.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915745296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 1,772<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">2,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">2,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">$ 1,912<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650914056720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Narrative) (Details)<br> &#8364; in Millions, &#165; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3"></th>
<th class="th" colspan="3"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities', window );">Proceeds from sale of terminated interest rate swaps | $</a></td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months | $</a></td>
<td class="num">$ (14.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember', window );">2020 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 301.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 305.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember', window );">YEN Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 301.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,100.0<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,100.0<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,100.0<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2024 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2028 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2.125% Euro Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2024 Euro Senior Notes, 1.023%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2032 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | YEN Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate | Contingent consideration | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.064<span></span>
</td>
<td class="nump">0.064<span></span>
</td>
<td class="nump">0.064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate | Contingent consideration | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.090<span></span>
</td>
<td class="nump">0.090<span></span>
</td>
<td class="nump">0.090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=vtrs_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=vtrs_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913068112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.219%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 92.5<span></span>
</td>
<td class="nump">$ 134.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">98.5<span></span>
</td>
<td class="nump">187.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">22.0<span></span>
</td>
<td class="nump">30.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">26.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Prepaid expenses and other current assets | Foreign exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">22.0<span></span>
</td>
<td class="nump">30.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other Current Liabilities [Member] | Foreign exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">26.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">70.5<span></span>
</td>
<td class="nump">104.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">82.1<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments | Prepaid expenses and other current assets | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">70.5<span></span>
</td>
<td class="nump">104.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments | Other Current Liabilities [Member] | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 82.1<span></span>
</td>
<td class="nump">$ 160.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650913592368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 92.5<span></span>
</td>
<td class="nump">$ 134.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">98.5<span></span>
</td>
<td class="nump">187.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">70.5<span></span>
</td>
<td class="nump">104.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">82.1<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments | Prepaid expenses and other current assets | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">70.5<span></span>
</td>
<td class="nump">104.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments | Other current liabilities | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 82.1<span></span>
</td>
<td class="nump">$ 160.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650919128992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">$ (41.7)<span></span>
</td>
<td class="nump">$ 165.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Net unrecognized gain on derivatives in cash flow hedging relationships</a></td>
<td class="nump">44.6<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Other expense | Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Net unrecognized gain on derivatives in cash flow hedging relationships</a></td>
<td class="nump">44.6<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign currency forward contracts | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">14.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest rate swaps | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Foreign currency forward contracts | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="num">$ (51.9)<span></span>
</td>
<td class="nump">$ 156.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480627/815-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916649248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="nump">$ 42.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">92.5<span></span>
</td>
<td class="nump">134.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember', window );">Available-for-sale fixed income investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">36.0<span></span>
</td>
<td class="nump">35.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">18.9<span></span>
</td>
<td class="nump">688.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">45.0<span></span>
</td>
<td class="nump">42.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at recurring fair value measurement</a></td>
<td class="nump">63.9<span></span>
</td>
<td class="nump">731.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">18.9<span></span>
</td>
<td class="nump">688.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Exchange traded funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">44.8<span></span>
</td>
<td class="nump">42.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Equity securities</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at recurring fair value measurement</a></td>
<td class="nump">128.5<span></span>
</td>
<td class="nump">170.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">98.5<span></span>
</td>
<td class="nump">187.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign exchange derivative assets</a></td>
<td class="nump">92.5<span></span>
</td>
<td class="nump">134.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign exchange derivative liabilities</a></td>
<td class="nump">98.5<span></span>
</td>
<td class="nump">187.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Available-for-sale fixed income investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">36.0<span></span>
</td>
<td class="nump">35.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate Bond Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">14.9<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Agency mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Asset-backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at recurring fair value measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">997.4<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">372.5<span></span>
</td>
<td class="nump">375.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="nump">372.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity Securities, FV-NI</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">997.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 22.0<span></span>
</td>
<td class="nump">$ 30.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ExchangeTradedFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ExchangeTradedFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=vtrs_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=vtrs_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650915944048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">$ 375.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Payments</a></td>
<td class="nump">9.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss', window );">Fair value loss</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">372.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_BioconBiologicsMember', window );">Biocon Biologics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">221.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">224.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">64.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Payments</a></td>
<td class="nump">9.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="nump">10.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss', window );">Fair value loss</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">65.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term obligations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">310.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Payments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="num">(10.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss', window );">Fair value loss</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">$ 307.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481639/420-10-35-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Reclassifications</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Liability Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Activity in Contingent Consideration [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofActivityinContingentConsiderationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_BioconBiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_BioconBiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916425104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Receivables, Securitization Facility and Commercial Paper) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">$ 204.6<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember', window );">Receivables Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">197.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=vtrs_NoteSecuritizationFacilityMember', window );">Note Securitization Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity', window );">Accounts receivable securitization facility maximum borrowing capacity</a></td>
<td class="nump">200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember', window );">Other Current Portion of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_ReceivablesFacilityMember', window );">Receivables Facility | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable facility maximum borrowing capacity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=vtrs_NoteSecuritizationFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=vtrs_NoteSecuritizationFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_ReceivablesFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_ReceivablesFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650905627920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Summary of Long-Term Debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 500.1<span></span>
</td>
<td class="nump">$ 1,250.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance expense</a></td>
<td class="num">(33.9)<span></span>
</td>
<td class="num">(35.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">18,069.4<span></span>
</td>
<td class="nump">18,015.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities', window );">Proceeds from sale of terminated interest rate swaps</a></td>
<td class="nump">45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember', window );">Other Current Portion of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember', window );">2020 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 301.1<span></span>
</td>
<td class="nump">305.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember', window );">2023 Senior Notes (3.125% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">750.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember', window );">2023 Senior Notes (4.200% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 499.8<span></span>
</td>
<td class="nump">499.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_OtherLongTermDebtMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member', window );">2024 Euro Senior Notes, 1.023%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">1.023%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember', window );">2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">1.362%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember', window );">2027 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2024 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1,083.3<span></span>
</td>
<td class="nump">1,069.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% Euro Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 541.5<span></span>
</td>
<td class="nump">534.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2026 Senior Notes (3.950% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 2,243.7<span></span>
</td>
<td class="nump">2,243.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 808.7<span></span>
</td>
<td class="nump">798.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | SeniorNotesTwoThousandTwentyEight [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 749.0<span></span>
</td>
<td class="nump">748.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2043 Senior Notes (5.400% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 497.4<span></span>
</td>
<td class="nump">497.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2046 Senior Notes (5.250% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 999.9<span></span>
</td>
<td class="nump">999.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2048 Senior Notes (5.200%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2048 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 747.8<span></span>
</td>
<td class="nump">747.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2024 Euro Senior Notes, 1.023%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 821.8<span></span>
</td>
<td class="nump">813.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 758.6<span></span>
</td>
<td class="nump">759.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">955.7<span></span>
</td>
<td class="nump">945.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2027 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 774.0<span></span>
</td>
<td class="nump">775.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2030 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,510.9<span></span>
</td>
<td class="nump">1,512.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2032 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">1.908%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,459.8<span></span>
</td>
<td class="nump">1,444.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2040 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,648.9<span></span>
</td>
<td class="nump">1,650.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2050 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 2,199.6<span></span>
</td>
<td class="nump">2,200.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=vtrs_CurrentPortionofLongTermDebtMember', window );">Current Portion of Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance expense</a></td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (0.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_OtherLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_OtherLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2030SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2030SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2040SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2040SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2050SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2050SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=vtrs_CurrentPortionofLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=vtrs_CurrentPortionofLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920518192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 500.1<span></span>
</td>
<td class="nump">$ 1,250.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650924478368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Fair Value) (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of long-term debt</a></td>
<td class="nump">$ 15,040<span></span>
</td>
<td class="nump">$ 15,360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650924047968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Minimum Repayments on Outstanding Borrowings) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">1,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">1,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">2,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">1,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">10,118<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 18,029<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650906076224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">$ 98.0<span></span>
</td>
<td class="nump">$ 128.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized loss on marketable securities, net of tax</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="num">(269.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(3,340.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,385.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(2,764.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,761.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">3,719.1<span></span>
</td>
<td class="nump">4,178.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">147.0<span></span>
</td>
<td class="nump">146.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized gain (loss) on derivatives</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx', window );">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</a></td>
<td class="nump">325.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,061.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,744.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(259.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="num">(14.3)<span></span>
</td>
<td class="nump">44.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Gains and Losses on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized loss on marketable securities, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plan Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">6.3<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,271.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,802.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">45.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="num">(12.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized gain (loss) on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Gains and Losses on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Plan Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(469.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Mylan N.V. | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized gain (loss) on derivatives</a></td>
<td class="num">(66.2)<span></span>
</td>
<td class="nump">201.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Gains and Losses on Derivatives | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Reclassification out of Accumulated Other Comprehensive Income [Member] | AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="num">(14.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Reclassification out of Accumulated Other Comprehensive Income [Member] | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="num">(14.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Gains and Losses on Derivatives | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income [Member] | AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income [Member] | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember', window );">Pension and other postretirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge, attributable to parent. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650906487184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain (loss) on marketable securities, net of tax, beginning of period</a></td>
<td class="num">$ (2.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="num">(269.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 268.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, beginning of period</a></td>
<td class="num">(3,385.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, beginning of period</a></td>
<td class="num">(2,761.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,719.1<span></span>
</td>
<td class="nump">$ 4,178.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">147.0<span></span>
</td>
<td class="nump">146.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Change in unrecognized gain and prior service cost related to defined benefit plans</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">98.0<span></span>
</td>
<td class="nump">128.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain (loss) on marketable securities, net of tax, end of period</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period</a></td>
<td class="num">(269.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, end of period</a></td>
<td class="num">(3,340.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, end of period</a></td>
<td class="num">(2,764.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized losses on derivatives in net investment hedging relationships, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Reclassification out of Accumulated Other Comprehensive Income [Member] | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="num">(14.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives | Reclassification out of Accumulated Other Comprehensive Income [Member] | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Gains and Losses on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain (loss) on marketable securities, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain (loss) on marketable securities, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Gains and Losses on Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plan Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">6.3<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plan Items | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Change in unrecognized gain and prior service cost related to defined benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,802.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">45.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,271.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(469.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,744.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(259.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,061.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Other comprehensive earnings (loss), reclassification adjustment from AOCE, pension and other postretirement benefit plans, for net gain (loss), before tax</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(12.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="num">(14.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized losses on derivatives in net investment hedging relationships, net of tax</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</a></td>
<td class="num">(18.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="num">(16.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Gains and Losses on Derivatives | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Gains and Losses on Derivatives | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx', window );">Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</a></td>
<td class="nump">325.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 377.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(14.3)<span></span>
</td>
<td class="nump">44.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Mylan N.V. | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent', window );">Net unrecognized losses on derivatives in net investment hedging relationships, net of tax</a></td>
<td class="num">(66.2)<span></span>
</td>
<td class="nump">201.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember', window );">Pension and other postretirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Recognized net actuarial gains</a></td>
<td class="num">$ (5.0)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge, attributable to parent. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650905549424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">$ 3,719.1<span></span>
</td>
<td class="nump">$ 4,178.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,729.1<span></span>
</td>
<td class="nump">4,191.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="num">(603.3)<span></span>
</td>
<td class="num">(648.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</a></td>
<td class="num">(32.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="num">(182.9)<span></span>
</td>
<td class="num">(142.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlements and other contingencies, net</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">399.8<span></span>
</td>
<td class="nump">707.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">1,776.5<span></span>
</td>
<td class="nump">2,148.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Reconciling items:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="num">(603.3)<span></span>
</td>
<td class="num">(648.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</a></td>
<td class="num">(32.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="num">(182.9)<span></span>
</td>
<td class="num">(142.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlements and other contingencies, net</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_OtherOneTimeNonoperatingExpense', window );">Other One-Time Nonoperating Expense</a></td>
<td class="num">(178.5)<span></span>
</td>
<td class="num">(185.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate / Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Corporatecosts', window );">Corporate costs</a></td>
<td class="nump">379.4<span></span>
</td>
<td class="nump">459.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets (1) | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">2,170.4<span></span>
</td>
<td class="nump">2,476.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">938.7<span></span>
</td>
<td class="nump">1,211.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">564.6<span></span>
</td>
<td class="nump">573.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">394.3<span></span>
</td>
<td class="nump">417.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">342.2<span></span>
</td>
<td class="nump">423.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">130.5<span></span>
</td>
<td class="nump">174.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets (2) | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales Revenue, Goods, Net</a></td>
<td class="nump">641.9<span></span>
</td>
<td class="nump">705.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">$ 313.0<span></span>
</td>
<td class="nump">$ 345.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Corporatecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Corporatecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_OtherOneTimeNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other One-Time Nonoperating Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_OtherOneTimeNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650905532880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Restructuring Charges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 157.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">9.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payment</a></td>
<td class="num">(27.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Utilization</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Foreign currency translation</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">136.1<span></span>
</td>
<td class="nump">$ 157.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2020 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="nump">450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2020 Restructuring Plan | Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1', window );">Restructuring and Related Cost, Expected Cost Remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">155.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payment</a></td>
<td class="num">(24.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Utilization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Foreign currency translation</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">134.2<span></span>
</td>
<td class="nump">155.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payment</a></td>
<td class="num">(3.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Utilization</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected cost remaining for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920553904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Licensing Agreements (Details) - Maximum<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Developmentandsalesmilestonepayments', window );">Development and sales milestone payments</a></td>
<td class="nump">$ 387.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Developmentandsalesmilestonepayments', window );">Development and sales milestone payments</a></td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Developmentandsalesmilestonepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development and sales milestone payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Developmentandsalesmilestonepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650921292576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Income Taxes Disclosure (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98.0<span></span>
</td>
<td class="nump">$ 128.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties', window );">Reserve for Uncertain Tax Positions, Including Interest And Penalties</a></td>
<td class="nump">$ 299.3<span></span>
</td>
<td class="nump">299.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 298.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority | Australian Taxation Office</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense', window );">Income Tax Examination, Partial Payment Of Income Tax Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority | Ministry of Finance, India</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 21.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Partial Payment Of Income Tax Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reserve for Uncertain Tax Positions, Including Interest And Penalties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_MinistryOfFinanceIndiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_MinistryOfFinanceIndiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920545152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (Pricing and Medicaid Litigation) (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 3,192.8<span></span>
</td>
<td class="nump">$ 3,440.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920590992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated litigation liability</a></td>
<td class="nump">$ 5.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650916215936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (Drug Pricing Matters) (Details)<br></strong></div></th>
<th class="th"><div>Aug. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>state</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=vtrs_OcularASMember', window );">Ocular AS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSought', window );">Loss Contingency, Damages Sought</a></td>
<td class="text">155&#160;million<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_MultiDistrictLitigationMember', window );">Multi District Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember', window );">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithGenericDrugsMember', window );">Anticompetitive Conduct with Generic Drugs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember', window );">Amended Anticompetitive Conduct with Generic Drugs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSought">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the form and magnitude of the award the plaintiff seeks in the legal matter, which may include an unspecified amount of money.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSought</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Numberofstates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of states</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Numberofstates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=vtrs_OcularASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=vtrs_OcularASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_MultiDistrictLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_MultiDistrictLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithGenericDrugsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithGenericDrugsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920551312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (U.K. Competition and Markets Authority) (Narrative) (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_CitalopramLitigationMember', window );">Citalopram Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated litigation liability</a></td>
<td class="nump">&#8364; 11.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_CitalopramLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_CitalopramLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650920577584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (Product Liability) (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_ProductLiabilityMember', window );">Product Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="nump">$ 65.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_ProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_ProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650919115376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation (Intellectual Property) (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>entity </div>
<div>healthBoard</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_NumberOfScottishHealthBoardsNHSScotland', window );">Number Of Scottish Health Boards, NHS Scotland | healthBoard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland', window );">Number Of Entities, National Health Service England, Wales, And Northern Ireland | entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Damages to be paid | $</a></td>
<td class="nump">$ 108.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Entities, National Health Service England, Wales, And Northern Ireland</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_NumberOfScottishHealthBoardsNHSScotland">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Scottish Health Boards, NHS Scotland</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_NumberOfScottishHealthBoardsNHSScotland</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140650921231440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation (Other Litigation) (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vtrs_Numberofcases', window );">Number of cases</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_OtherMember', window );">Other Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="nump">$ 8.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Numberofcases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of cases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Numberofcases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>vtrs-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:vtrs="http://www.viatris.com/20230331"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vtrs-20230331.xsd" xlink:type="simple"/>
    <context id="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia5d1e0b219ef415a908da6f31c85ce7d_I20230503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2023-05-03</instant>
        </period>
    </context>
    <context id="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8c20f38e954342feab4c7bcbfd900aa8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3e08bc84193b4903b33772dc3585c892_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8bb079be9f2d4c24819ae36c2b302e6d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i418126eb87c5476d8026496585618173_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib5a67a90d54547af9bc6e44f907032d6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8d5b3231d1f2486e8776063341b0d566_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9440af4fd7ba4f0897656b04de8153dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8081836e4984486b7ec3a50c02a9559_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic447b8cafe1b4bf6a2da44f4d2a51964_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7cc0d13e968f4d37b19959f0bd920ba7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3c5ed2af71e43d5ae5bf2d744c4be2a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if9327c5d38c14a729ad52d76d711896b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i642a69b7eb80475580b6dfe8e7de979e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i30c7059ab4614911998f86f4b745dea0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4f24a7f585704f55918c29eab904acb3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2023-03-17</startDate>
            <endDate>2023-03-17</endDate>
        </period>
    </context>
    <context id="i561d51a7e3784b178fe2847410f076e4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i06f4f79c2ca443ba927ddb45fabccf40_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i11b6d5faae2a48a18b3efb5b7931433d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7b279406fb1545e4a9b41bef21012362_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic6bcf9a93f5b44e6adf971fc8c993b9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f829281a5504ccaaf32eb2afd8061d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee68d18c353b4a1bbbe750b60203792b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12dff40a692c45c8b91c8911ee689533_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5cca97d09754ca0bea07369d3464420_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1ed98849f874127b2a3dc2dc4a7df89_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i391ee8214e954c59b805e6ec8a55bdd2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i57b79d768af5428b9e726a123ceb19b9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id99e77e7afb3472d9a21cf0bc27a911a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic7921bbbcfff48129188154f61fc9281_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8ecb1e1f965b4571b9238fdf9bb67f7b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ica08d82424e74ae4a9d160bbc2691906_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if8e5c94cf86d4321a4e0a9f4c01d3c24_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id19bcca8b59e49f9bd2243c802592021_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i704078a8122d4548985aecc73b821530_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i92922c90fca14d05bf112c8f1126b7cc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic7512eaf443a41ad8f1edd112dd540e0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3fb2e0a0aa064c1d96030296b9432c85_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib3eb96c8f3584c52bfaa3c801011fdac_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ife01b67ec63f4327b09c466ff8b6394b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icc5e3ed0cebd408f8ab74c7381532a00_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibeb5e53a9f0d46b782ce87d07e4fbac4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifa88d983842143b5bccdb89bcd185908_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibba322c953c54a6a9a2cc16a92d69055_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8e611f955781478d9ef741924e6d669b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iacdce5f01a244464a3cad307e21ef9b6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1f4ad7a4e06444cd91270a3c5d11af96_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie98262c314234c0dada44293b3622bd2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iff6f2a14b0ce43ab83b734dd64d12bf6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3fe5245728a44cb18a87377e4c3de0c8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i717ccb375e6a4e1a88e76775cf3a0015_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id962b30d667e44d79767fd8e3799bc1d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i38d981aefd18465fa3436254a0f36c4f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1d994597d6e1416a86a2c96f63285849_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4e03815fe4df401db12f5e4fed5d678b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39b03de3e86b414dbeb9fb6d61078f2e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icbf905bb0a554b358d94dd2e66066fd6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2ff2c602eaa44eccb62f90e702abbf78_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i971cc687ee2a4eb99860d0f9c63905b5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic8a81007b4bc4e578d7d99563ce6d1da_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a00915b25a548e6a59fb781b78db94f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9c3c8f8610e944e9b5a18cae61033feb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5215e33461184efabc64594166dddbc7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i44a92534985b4fa8a89210f1ef780e8f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib17e1e4ae1dc41f4910694c744638d06_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id5874f6fd7aa4dae89158ea58919c58f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a4e2f9b5b0d48b8b618be462d213bb5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i09ea4f3f734d40279fcbeea57318b608_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i44dcb2e059604510889393247056ff68_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i37f11f4d488d4d6b8d1b2a5657ed7bd8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8791ebb35b584298bcab2b2bcfa56d9d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i63daf2f5870d4537b44c66577922f2e0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5eedbf09d08e4fe2b98d92fe6d16ed90_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i035a8072fe08425aa2db4bf6f2f43f08_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if54a5abed27e41d198391fc5eb34c417_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib1d94644d7ec4cacb1adf2ab3a5a74b4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaa045f9e59554b078d808553a9e85eb4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7813ac9a34bc41109808afe80308fb10_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i34b5947dc7a24798afe8946af5790adb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2e7b222b3a924b69bb5ce8f834eadfae_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a9412e767ac487189d1ecb36b20b8da_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3ca2f2f3badd41a5a8b132f9bfeca53a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if0665158c01343f5a7c7b1f984e8ac2f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i24b785c729ea46afa207062149ec382a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie4f3a9d5832c47df837ef0c77371bc0b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i258aad0139aa41dea358da8a65ba8ee9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if4bf34b1589a4aff9e5ca7af9d52fc39_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib00afe9957bb4659a032e5d0aa0e7fde_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2cf83d236a5d43429ebd63458e92e95a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6627a856378146a885c26dac6939f5c4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id5973b7e40c443749f09dd0bc3830976_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ief173fc589434105b1a87eaf65f45ef2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i06c43c95288348ae8a9480b0bb2345f6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i64d037b97410486e8dc70388130c2a7a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib2637a3b77344ad6bf7fc87e0c624aa0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia605839e071b4886950912140c4508cd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i34306124574e4ff48c6728b14b8379a4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i23fd6ab670e74679987bf4ab0632302b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3881f88980d444c98a395628ac04a37d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id4918a7af8b94d9fa608eb50e7d397be_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibafb46da05ec4f79a412ebc6f057d351_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i55285f970c3f4df4babe369127a8eb7e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1dd48064c677421ca76bbbd5f64574f3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i89dba480a3de4cda97573dc8978499c0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie6948cc281cf4adbac2e6725c137289c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">vtrs:ProductRightsAndLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8137e6d5778e45d7ac3a688bd6c289d4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">vtrs:ProductRightsAndLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3ad3994dc65d497295612fdbd82d203a_D20230103-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-03</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OysterPointPharmaAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icce36ab95a904a348f3538311028617b_D20221107-20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:FamyLifeSciencesAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-07</startDate>
            <endDate>2022-11-07</endDate>
        </period>
    </context>
    <context id="i7828558df2f6496fabe44db31c95df87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">vtrs:ViatrisIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i978bcc6ddcd84e688fa210aa490cfa7b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:FamyLifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i39ea09d1bb094c10861e55e7f13a92d8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:FamyLifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5eb64dc34ecb4aa689649d663412eff2_I20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:FamyLifeSciencesAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="i996c937d9d5d48bda3c5200c4b48c99f_I20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:FamyLifeSciencesAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="i2de5309c551f46c095be838450a8464a_I20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:FamyLifeSciencesAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="ia674853b0e45470192385b041b369637_I20221129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-29</instant>
        </period>
    </context>
    <context id="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-29</startDate>
            <endDate>2022-11-29</endDate>
        </period>
    </context>
    <context id="ie5675703bf7c4d4d9da547d52dcba0ae_D20240101-20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="i038641544e90455d9e0b031976fcd4f7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4b2491c72c1440ca895b054425f97641_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i92b7b3d4e0c941a592801ccaf3b5a117_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idf62a3adcc2b4c4c84b6baf6c88c9459_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InventoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6c3140d7b1784dea88bd3908f0f56a43_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i29d41bac887c45c4a70ffcc400a93b6a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f1f9e0ec712462aa02e10848d2f65c0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iddf72d19b27c4e84b44267057cabd078_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:UpjohnDistributorMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib44a8bb4acc54d0893dec83f4f70479a_I20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-16</instant>
        </period>
    </context>
    <context id="iaabcbd4e36f64c80a1d3a99c36f4e4b9_D20201116-20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-16</startDate>
            <endDate>2020-11-16</endDate>
        </period>
    </context>
    <context id="i38b4ae4464494ecba320ebadb2cf078b_I20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-16</instant>
        </period>
    </context>
    <context id="if734110c24414049836d43cd6a8c0b78_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib1eb88e565a848ebb8dc702db55d4f88_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idc3bcc18e42c4bd1a5362ab466d46293_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib6be2e59be8047b5bdb3bca88fdac9b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79133970a2b34e65b4753f058974244f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c529f37c6a8452daf8c5630c4b137dc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0a6b105d683e44f1b695dbd0fdd19afa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3f1530fe010f4d8283807e9da9561509_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1af79b8021fc47028b95741c1cc39d78_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8dea885604594444a89c859250a37b79_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idfd05d1cfff54696a4f01f4ac88a2938_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i05e11cf9ad644b68af5c0ac002a0b693_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i203edc74353240bcb584d5be70ab7977_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie899de488efe457d85cdd16eebe2e01a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i622683f47bb4406a81794008b13dda9d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic5dd0738d5ad4d438464fda8015cbfc8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iccaac04969444cd0ac6e71b631cc378d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie37168f0983848249b7f1e89a1acb5bd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iefd395d7495640418781dfc639bb703c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5aaabd86415e4b8c9c1cbaa20a6ed1e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf65b15f46464ee7bcba67fd57306449_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vtrs:PrivateEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i494e53d7c58e4d6584c23bf2ff9bfdde_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vtrs:PrivateEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife9befdab44e4072aed4aebf4c9a7ee7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i93a2d261bfaa44f3a3567fe550854179_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1b9374126f5469796e980e745fabbf4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2e2ad85211354ff6a1843c453c13ec41_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icabcde1e2ac34fc091515c433c41ff7c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idc8794cd5f5a45ab8724cd054ea59719_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4564ffd038a447684a267ff28783411_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i14e5adad79794593a0ea10be84abb721_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia7752f8ef2694f2a99cedc3a924ac6ed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic37bdf396cbd4497bee0629253c5ed9c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:BioconBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibce300835f6a4dfb8c87fe6f01d94e1f_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i44a168ceffc44ea799955f726965f1d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie2da830898fd40bb9b3668c5d10555ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc04d16f571a462c997b93a923f5bc5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2d05d24b3984c6196b0e4b79ecd82ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4cd4d116cadd4b549d18354ea24d6cf5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iba15018bb1de4cb0a89b3428e670872a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifcf87e3010d4446e9ea5180d2ecfef7e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2b51c9edce9241cf9e636f46dacbbb52_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i24c5aa3032494e489c927959f359a259_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i23d68b002f394987b51c9b480def8689_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia7adead5a097460c92b6ed763747d384_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia03f8b88b0e846a5a2bdd752c26504f1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic982925cfce647cf82de79117dfbd341_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id1f049b3f11b4f54b61c23025e02cd69_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifbe3333f61454c84aa7ec708e22cf50c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie396961017544da680998993a54500ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ica7ce119b71f4c0f84b95edb750bd215_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i885ad38fc2be452e97695525e6721fa0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8c21320592b2492982ea12b7c9ddd364_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic304f109b5af446bba86e77735791f79_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8a2b9e568d104103be8e6c431eeddd69_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8a47696467454d118794e701966eb0aa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib05ddeb5d86c4f4cbb3686204e71d481_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i57bb0ac7d16846ecaeeda10a472323ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8965fb764557415db2ad30aa82c09452_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i56a888a26f4245358cf12889162baef1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19cf17be970444d4845ad42cb06b2677_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia1f1a8fa6fa4437c9bd8dd8ddc85d818_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e3d152425d4436f82b8f359ed8c09f4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib0852b77d93a45c1a8784b9f5e09c74a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3e1cb3c13a143b689debc78a157f9c9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i32bb170f1dbc494785245d5ad91eba44_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifb5d765ee12a43d8989fbf61ed0f5502_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id328c8b356cb438ba2e2f88139f233d0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4da6cef7335b4e4db5c63ae8d42c311a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i95612143e25a4851b2e592fb2c3a2107_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic9f6de36f5e14d028a657fc060b5a560_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c95a99b1fb14d86b6a9b89d594cce92_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9d16ca0470534939982b3b58e635e4cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i76576107d9424efab6ea88538bb83135_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i56d3bcc8d2474192926ed306031b5219_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4a79042b83904696b7dab397210c97de_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i41550c188ad64365a22d3f4a47fc1c72_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8cb5fda2dcee4ee48e405c5c088a9cba_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifa16117507db4c7d96b63dc143d74a16_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id6aaffa691e74bc68e8db4464b4b93b0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i033455f156d34be29697cc8ac9e0a137_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib2d01ba8a140497580deaf3d68bc57c6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8c134b8f719242bcac28ad4399b788eb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib20e6f463286430596383180d843d2b3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id19bc1f2778e4b71aa630ae6b6490e7f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iff39c4924c6045ef84e3abaad48f1286_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib09b7735438346cf9ab1c042bed96f76_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb50b90a095f42bfbdbed451dae7f23a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i727faafb4659486cb209f1a14a62e389_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i136bafc75ccd449baf4eeb49e8ed395c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i102e0cf7ff2044a6938b0f83e352bb2d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39da740d7a5e4e9cad2bd54f10ce8b8d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icb432e1314914336835cf836fe99ecf1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f3e2b23886947408f9c609cccaed1aa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i270cf7b9b34147cdaf4584be4a06eb92_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib0d5fffc549546b2a7f21ebeacd3566a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3bf9a42591eb4cefaba32caf3d775d3d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if4d0ff8e2db44ce9ae2f1ca09cfc8552_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i643ad899563b4c6287162649c1da7644_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e0450507d0a453d85394a568087e78a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i008ef5af2daf4f18a58c19dbec22403d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0df571154fb44e9dbe311072fe73af02_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idc9395cd9b914745ac220a1b31c0d019_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6cfb2649e55847359386336e4a39492b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3b47320bd11d4ba6a393be87cd0c63dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i26f62ce70fb445afa3148d671d5ebd33_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i69dfbf841e784966a9622614817e595e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id230763240ed4c6c83ac699f54873ca3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic78bfd7523094db7ac5361c6c822eb32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9607c4d62444cf687b9b06b8559c927_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ica8cc0295da54b078e56ab7384f33b40_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ea89f8fb0aa40198430e003e80835d2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8fb8b8df80f6437d9eb2ba03e638b416_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1131eca694994821b250886968225201_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b1cf6b0039a4e34bf81064509086ca1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc9b2995dd46460594e214fd8e8ee132_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iee880d6bc130465f829292543ad30b02_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic1fa0b36fa9a43ebb31730df132d5260_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if59e5e36fb7b445db0598c8c22d1736c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icf2bf973f8224e918b2deff514202349_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i805aacd5cf1a4ce1ba773d8974bb6661_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if318bfa8c5bc43749fd2a6b351b2adc5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16bd0a431ac944bbadbc94516ff5579b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i527c9f5ddc6248d0bd4ecaeb320cfeab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2b328e8ff4e4db3903e428de1caf104_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0fa49fa66d4a4ec1b6581ce013ff9335_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:NoteSecuritizationFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i537b244fd18e4182836b3cbcea192aa1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1e90d47f433640e2bf15e3caa1252192_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf8243d3d2554b6d9cea845ed1d5d62a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8d844dcfe611431e8c69a0bffa93ef38_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i13546a349b7f46fa8d08aa0489cd82e4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if92b069c1f4e4856b8df4e367b12a543_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d3557139bf74fa9bdae809541e470fc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2b39ad011d3c4a15991d1d4ee3f647c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3836b4fcf19c4f2da97d1cb2617e47f0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9dd73adf36414a74a4252d27d4ca70ec_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if13c7fadd2634767b990dc153d4bc9d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i72f0ba982f0c46649f0f6561954343f1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1054d206503b46788f1af5e9ce6beaf3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86b93357479f4e96a4acc48b266c2ec1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibb18dcdcc883404780abde6cf47443fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if358ae2472cf4162861457de119d795e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i39cd72e6c89f4d72b882807ad54849a4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib8e8bd4e2ae64bfbab3cac97c001f7ac_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i857e28cb283b4b62abcfcd309a7a0760_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id9b1ab43a7b04663ade5cdd52c52abf3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i172d496acb304a198d699f43d147eb23_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6fd1128fe8054c7ea24c3e527cc585e4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1d043725e3814483b6471de9237a3773_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i854b8e342187430ea79336139d6db506_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4c9b36997fe44efb8dfe9e0f82e471b0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a7ccd82fc9d47beaf2c85dbe5315393_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia583e565814b4727be66c81be6c677f8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9b643f05917e4cadba7092929694b6d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2c494b24b67e4b878e564a8146c3138e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3f77f20d41cc4b8bbc1a3e3b098cc442_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i41482c056aa94a55925d9dcd2e1b6b43_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4051ef5b1fdb4486882771f6cbe8ec88_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i01e123519fbc4c39860f273c6d6d3ed5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1a6ac2dc615d4e66b3bb6dfa9566e439_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0efddbd5dd4e48c7acdd24a96aa2380e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i645867315f0942119eafce9860005bd7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i80b3a71a4e4048318317277ea1c7419c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i523192e82a694962b8a599b8e7f560b7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ef5520b9a764945b96e8cea3b80abeb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i151b130c785b49219e6112e1742e9cfa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i54e64fcf3dd741b4ab858d4916d39201_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5552e043c1c444cc88e4f40941845034_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i69039fe5d46240fa8529c57fdfe22935_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibf2097e990594c218bca3f144aca2453_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8c9f8feb05d94562b542bb89be4c3aec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i45165edb089b40d0b8b4833405ea227b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1d5c20c94e5f427e8b1f4cc452481487_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie091a09167a34a0fa7933475fb2de76d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6164435f803841129e7672cc12bb4100_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b9dbb9ff801489ba2f6837aa806ff2d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0c7eb919fe344f70963ed690e633c735_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9bb674e162c40018526646782e70d3f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i88989aa1d54540a1ba2ca6eb8ea846f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie700760d8134451a9ff6e163dcbd5a13_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id5b5d8f65e7443a99c925d594d0cd6eb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3bbf2add3a0c4216b0a8608247495af6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iac9ac025fb9047918980605e59a944c5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibcee7fb1e8624576b13773ba17f2f11f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifb3b8082108848a18225ef4298c3618f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i653a14a89cb24d7c952dd0cdd3772c49_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie2d9f4048943460b9f1afbb1f59b8dda_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie9dbeed2d83b425eb1378354668ce7a1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i87f32bd065ca46ffa60c567a5d2f9e1c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i05e33061fbdd49b7968f96b8dd318a25_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8618f25668574c53b1ce780bdda393cd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i086be58c57004badb55c1e1264fe37ea_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i19242480fa2943ffb4a03206eee18d1a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic8647ea8c4a242b99d262a0ac976d962_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5c3760f0cea642d3b75f6140cdf414f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2e1a1cbd2814cdfb45518b14ca40fa2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica5b623ff3fa4a61a5c7435e3ab00ba1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8b1995c57b4f49c3801e36a80fd70ceb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2cbade31da7d415f8970e976b4686580_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ab095d0d7984d658aad5fc11e1e6f28_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i328661c86aa84ea7b204b4667f8a7ffb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9fdf7ff53f764505aa2b21fa6a270f0f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic1cc5ed71d974468b6ff290b943426c5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8ae943df1fa3437894a62abc523b173a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i34bb0ea6145343a2bc5c0602b02aeb12_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i71aa5d94a6b94d69adfd79846798fdc1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia036fdd378d343f684dfc8d7b749bf36_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iafb16f84e2694f219ad64bdc9fb4f90c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaa100fdde39948c2bacf727a7f77eb4f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i03c4e86dc90d4fc8958401ed6a97dee9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie33127a010dd40c8adcfde67ca93dc7e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ddcf29ff66b4e319b5952469cb3a1fe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3e40190a3504890bf2e78ce510c754c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0c64ee065eb44f80bd6e5ddda1a2f52d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1f6070629af342578a23395267253ebb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib982817ac2e847f5a2ae10b0747f4ea8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaf01e5ae97624ffbb92ea194c400357c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8d522e397a694dc085575dc00034f8a1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i85d12c29bdbb4f2b854964dbfa89ef0e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i269e5c8eeb184f499dfffbeebba19832_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie69330006b9941b780f7e4587eb84648_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic684496e355c490799752193e9a06c94_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic1d68edf5bdd450abcf109bdfeb786ec_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d246e7b27fa4ad99062d6f448111e0c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia5991ed3dd3c4634aa50d484766705da_I20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="i58d64b894a014afbab8da8528839e18b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2bc609110a8445fd8d58826fa2f1726c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i453ede63a1664e9caf4cd95c380890e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iebb30913444747329b7146b7a3266a55_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idab2896257be44a2b213bb8b7d4b1350_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i596abfcb4c3b421eaf653dd8ad4d37f7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaded5ca88b1f45efbecc093436d0c031_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibc862c7415b2470d87c61bb71eb23e74_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c6b422602ba4e35ad86ae076e60232b_D20230301-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib7e0a31051704ab8bc38fb1032e348fd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:MultiDistrictLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i53082e0db5474dbba7be7c89cd35e27e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0f50d795bf3f4c409462b9ddcf0db7d9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9404440f3ab340efb47100f474f62e94_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AmendedAnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icde060aa771e4f15b2dfe00c564c524c_D20210830-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:OcularASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-30</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="i96a44216070c4ea3999f969059533ad8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:CitalopramLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i67450c71eb624b6fa6b3ab40994faf5c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:ProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1b6ee837070840fcb8fedf7b1e8f59da_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3af94b01e96b43d1b3dd129d00730688_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9823c12694d24f989d655525247c08e4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="right">
        <measure>vtrs:right</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="state">
        <measure>vtrs:state</measure>
    </unit>
    <unit id="healthboard">
        <measure>vtrs:healthBoard</measure>
    </unit>
    <unit id="entity">
        <measure>vtrs:entity</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl80LTEtMS0xLTE1MjIwOQ_c0fa964f-18e7-425e-ac20-4f12ed1227c3">0001792044</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl83LTEtMS0xLTE1MjIwOQ_5069c068-7fb8-42f5-b9bf-40d1da0c2ba1">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl84LTEtMS0xLTE1MjIwOQ_3e9e1e0a-45fa-482f-80b8-57557909dbe4">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl85LTEtMS0xLTE1MjIwOQ_5e46700d-6a3f-438e-8493-1007cad52271">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183L2ZyYWc6ODAwNDdhMzdkNzQzNGY5ODg1MjMzNGQyZGNjZWJmNTAvdGFibGU6ZWUzNjBlYWQzNjUwNDAwYjk1MzBhNGRlMGQ4NzFjNmIvdGFibGVyYW5nZTplZTM2MGVhZDM2NTA0MDBiOTUzMGE0ZGUwZDg3MWM2Yl8xMC0xLTEtMS0xNTIyMDk_326b6bc0-8a19-49ba-a1ff-269901e6536b">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if734110c24414049836d43cd6a8c0b78_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTUyOQ_2c493640-95e1-4300-976d-938a30e9093d">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQx_d68dd26b-e6de-4930-874b-fa859e1987bc">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6OTAwZThkNmI5OTU1NDlhMWI4ZTkyNDAyN2MwNGRkYzIvdGFibGVyYW5nZTo5MDBlOGQ2Yjk5NTU0OWExYjhlOTI0MDI3YzA0ZGRjMl8wLTAtMS0xLTE1MjIwOQ_12c6798b-39d3-463d-bb20-09d7b636909d">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xMjM_248a01e5-f2c1-4884-9253-bfe6ede73fda">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6YTEyYjA1OTNiYzNmNDlmYmExN2FmZjhkNTljZDYyNzIvdGFibGVyYW5nZTphMTJiMDU5M2JjM2Y0OWZiYTE3YWZmOGQ1OWNkNjI3Ml8wLTAtMS0xLTE1MjIwOQ_3959ea72-3b54-4e71-9ae1-521f7c6bff39">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQ1_b3728687-22af-48d4-89be-8c2de11ee99c">001-39695</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8yNDE_bc9fe65a-d7f5-453a-98eb-73e3bab90638">VIATRIS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ODQwZGYyNGNkNDBhNGE2MzljYzNmYWM0MGRlYzU1Y2UvdGFibGVyYW5nZTo4NDBkZjI0Y2Q0MGE0YTYzOWNjM2ZhYzQwZGVjNTVjZV8wLTAtMS0xLTE1MjIwOQ_6de01168-f3ed-40e3-abda-99a40d880374">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ODQwZGYyNGNkNDBhNGE2MzljYzNmYWM0MGRlYzU1Y2UvdGFibGVyYW5nZTo4NDBkZjI0Y2Q0MGE0YTYzOWNjM2ZhYzQwZGVjNTVjZV8wLTItMS0xLTE1MjIwOQ_7582a5a6-54db-4721-ab01-92ac0a6060be">83-4364296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQ2_970e8e83-4ccb-4165-8750-64ac4fef0637">1000 Mylan Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQy_0f8f7e76-79c6-46aa-a38b-50ddd9483c8f">Canonsburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQz_56a1997c-6e55-4207-a7d1-20cda5a15d79">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQ0_e31ea97b-9273-4ea4-9255-b787086bc761">15317</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml80OTQ3ODAyMzI2OTQ5_86983f2f-696a-41cd-8563-7458c352c91f">724</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml80OTQ3ODAyMzI2OTU4_637d0583-13f0-4dda-8d1a-f456bbba2e9e">514-1800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6NTY1NjMzNjEwNDI2NDQwOTliOWM4NjhkMTE1MGVmYWQvdGFibGVyYW5nZTo1NjU2MzM2MTA0MjY0NDA5OWI5Yzg2OGQxMTUwZWZhZF8yLTAtMS0xLTE1MjIwOQ_c103a2f6-36e7-40b6-8b2d-dcfe4b116bab">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6NTY1NjMzNjEwNDI2NDQwOTliOWM4NjhkMTE1MGVmYWQvdGFibGVyYW5nZTo1NjU2MzM2MTA0MjY0NDA5OWI5Yzg2OGQxMTUwZWZhZF8yLTItMS0xLTE1MjIwOQ_8239c224-4b13-422a-92fe-767733ff05cf">VTRS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6NTY1NjMzNjEwNDI2NDQwOTliOWM4NjhkMTE1MGVmYWQvdGFibGVyYW5nZTo1NjU2MzM2MTA0MjY0NDA5OWI5Yzg2OGQxMTUwZWZhZF8yLTQtMS0xLTE1MjIwOQ_c1ae15ae-4093-400e-adb8-d4c5b650198c">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQ3_71f46a32-1556-404f-86f7-b9c6a34e7b00">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTM5_435857ac-df25-4ba2-b533-3b0a3b17498f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ZmZlNjQ5Y2M4YzRlNGNkOTkwNWEwMjNiMjRhNDFhYzEvdGFibGVyYW5nZTpmZmU2NDljYzhjNGU0Y2Q5OTA1YTAyM2IyNGE0MWFjMV8wLTAtMS0xLTE1MjIwOQ_3803af6f-c6cf-41d9-89e0-f8b9b64f97a9">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ZmZlNjQ5Y2M4YzRlNGNkOTkwNWEwMjNiMjRhNDFhYzEvdGFibGVyYW5nZTpmZmU2NDljYzhjNGU0Y2Q5OTA1YTAyM2IyNGE0MWFjMV8yLTYtMS0xLTE1MjIwOQ_cf317d1f-8f96-4ba9-ae93-56b587e74d13">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGFibGU6ZmZlNjQ5Y2M4YzRlNGNkOTkwNWEwMjNiMjRhNDFhYzEvdGFibGVyYW5nZTpmZmU2NDljYzhjNGU0Y2Q5OTA1YTAyM2IyNGE0MWFjMV80LTYtMS0xLTE1MjIwOQ_d7ba7dc3-4a07-4f3e-bf6e-491282cdae60">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTQw_5941bb73-5725-4083-942c-39bfd1ae18c2">false</dei:EntityShellCompany>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xODkw_b767692b-e314-480b-aed9-fda5e52010ea"
      unitRef="eurPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia5d1e0b219ef415a908da6f31c85ce7d_I20230503"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xL2ZyYWc6MzI2ZTcyYzM2ZDVlNGNkNTk3MjM1NDc5ZjAzNWUzNjIvdGV4dHJlZ2lvbjozMjZlNzJjMzZkNWU0Y2Q1OTcyMzU0NzlmMDM1ZTM2Ml8xOTM1_1964ba19-e92b-421f-af08-01807c6e2dca"
      unitRef="shares">1199029984</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNC01LTEtMS0xNTIyMDk_17000761-29a4-4f90-827b-ccceebe898d2"
      unitRef="usd">3719100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNC03LTEtMS0xNTIyMDk_5658ecea-bc13-4f2d-9200-972966aa9345"
      unitRef="usd">4178200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i8c20f38e954342feab4c7bcbfd900aa8_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNS01LTEtMS0xNTIyMDk_deed90fd-6332-4d3c-a81b-e25ac9c4c703"
      unitRef="usd">10000000.0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i3e08bc84193b4903b33772dc3585c892_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNS03LTEtMS0xNTIyMDk_3be51707-5f25-44f2-acc3-a66c23e24496"
      unitRef="usd">13500000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:Revenues
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNi01LTEtMS0xNTIyMDk_f1aa26f6-1875-4cf6-8976-d6a645dceb2b"
      unitRef="usd">3729100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNi03LTEtMS0xNTIyMDk_6893d9c7-3354-4914-94b8-c7a2bd6403b3"
      unitRef="usd">4191700000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNy01LTEtMS0xNTIyMDk_c8634575-828f-4f2f-ad3e-046668d85b4f"
      unitRef="usd">2186900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfNy03LTEtMS0xNTIyMDk_2f369f31-c4d0-4291-bd08-7d4d4c51aaa4"
      unitRef="usd">2420500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfOC01LTEtMS0xNTIyMDk_3a3b031a-92f2-4dcb-b5db-eef60ddf92e6"
      unitRef="usd">1542200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfOC03LTEtMS0xNTIyMDk_ee1f1e16-023a-40a7-8e28-3dca0bc7b869"
      unitRef="usd">1771200000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTAtNS0xLTEtMTUyMjA5_c3f3ca92-aa57-4acc-b7c3-8269ba7f7cf9"
      unitRef="usd">182900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTAtNy0xLTEtMTUyMjA5_f9225dc4-df20-4396-8e39-0afedf570c11"
      unitRef="usd">142300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTEtNS0xLTEtMTUyMjA5_78215b6b-da87-4d0c-b5a7-b32abd0f34e7"
      unitRef="usd">958900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTEtNy0xLTEtMTUyMjA5_1bddaeea-c60a-4531-8be1-c193a75b040f"
      unitRef="usd">915300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTItNS0xLTEtMTUyMjA5_ab6d72ec-69cc-4db0-984f-125f39afcf78"
      unitRef="usd">-600000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTItNy0xLTEtMTUyMjA5_c600d748-f47b-45c4-8003-c364fd0d955a"
      unitRef="usd">-6200000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OperatingExpenses
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTMtNS0xLTEtMTUyMjA5_d8c3ae61-8fc4-4137-a235-f83023c559dd"
      unitRef="usd">1142400000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTMtNy0xLTEtMTUyMjA5_fbe71d41-19e8-4a0f-9e60-1a20c03ed349"
      unitRef="usd">1063800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTQtNS0xLTEtMTUyMjA5_4c132279-daa6-4c15-bf65-5f795671c67c"
      unitRef="usd">399800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTQtNy0xLTEtMTUyMjA5_713315c2-c131-4e2f-9b53-b7b94bff61b1"
      unitRef="usd">707400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTUtNS0xLTEtMTUyMjA5_4a98061c-a597-446f-807f-08000d5a316c"
      unitRef="usd">147000000.0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTUtNy0xLTEtMTUyMjA5_fb5eb2b7-8949-4d27-af1c-d748313e0946"
      unitRef="usd">146200000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTYtNS0xLTEtMTUyMjA5_418dea8e-734c-4be0-b337-9fc5f527721c"
      unitRef="usd">69900000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTYtNy0xLTEtMTUyMjA5_d0226d9a-e212-4081-9f09-92ffeb7f726d"
      unitRef="usd">-33700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTctNS0xLTEtMTUyMjA5_f2870882-8bf5-45e5-a5d1-cccce90db054"
      unitRef="usd">322700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTctNy0xLTEtMTUyMjA5_bccf82d9-ade5-475a-9a1b-8535f3aa4cfd"
      unitRef="usd">527500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTgtNS0xLTEtMTUyMjA5_48a306d6-d0b6-466d-95f0-8a1a9df80be4"
      unitRef="usd">98000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTgtNy0xLTEtMTUyMjA5_7ae0e6e3-4ddb-4299-abbb-f2f58878717e"
      unitRef="usd">128300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTktNS0xLTEtMTUyMjA5_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6"
      unitRef="usd">224700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMTktNy0xLTEtMTUyMjA5_21ea8900-812e-42b1-bf29-832a88880c0e"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjEtNS0xLTEtMTUyMjA5_b57155b6-1e81-4877-a9e2-adcfc9db994c"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjEtNy0xLTEtMTUyMjA5_1e207442-ce21-48af-b38c-5170d93323b4"
      unitRef="usdPerShare">0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjItNS0xLTEtMTUyMjA5_104acf74-a55e-4f80-ac07-90fab44094c9"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjItNy0xLTEtMTUyMjA5_39a5ebcb-0a0d-4937-9096-0d039e67dc79"
      unitRef="usdPerShare">0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjQtNS0xLTEtMTUyMjA5_76debc38-3b8b-4b93-8a36-50dd70c3cf6e"
      unitRef="shares">1202500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjQtNy0xLTEtMTUyMjA5_8b2d6b6a-6b95-4e9e-9bf5-53ff40cf0d67"
      unitRef="shares">1210500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjUtNS0xLTEtMTUyMjA5_dd88b844-0992-4cd0-9a61-cd5b49709139"
      unitRef="shares">1205600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xOS9mcmFnOmU3ZmJkYWQxYmIzYzQ3MTViM2QyN2MwM2QzNWMyNGE5L3RhYmxlOmM0ZDMzNGU4MzM4OTQzYmZhYzQ1NzQzMGE5NmU2MTBmL3RhYmxlcmFuZ2U6YzRkMzM0ZTgzMzg5NDNiZmFjNDU3NDMwYTk2ZTYxMGZfMjUtNy0xLTEtMTUyMjA5_2aeae296-7ab9-4f06-abb6-c0e092257af6"
      unitRef="shares">1213100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMy01LTEtMS0xNTIyMDk_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6"
      unitRef="usd">224700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMy03LTEtMS0xNTIyMDk_21ea8900-812e-42b1-bf29-832a88880c0e"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNS01LTEtMS0xNTIyMDk_6b4adaf8-69a8-4177-b683-4f837752f139"
      unitRef="usd">45300000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNS03LTEtMS0xNTIyMDk_e66e09a7-d9e2-4f5a-a547-0707b731f3d7"
      unitRef="usd">-469200000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNi01LTEtMS0xNTIyMDk_e5432901-7173-49af-92fb-e181d8718758"
      unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNi03LTEtMS0xNTIyMDk_93d28aa4-6ad2-4709-a89f-cadaa39f4b17"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i8bb079be9f2d4c24819ae36c2b302e6d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNy01LTEtMS0xNTIyMDk_9ad950b7-e7ee-4e17-ba1c-aaa155472292"
      unitRef="usd">2800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i418126eb87c5476d8026496585618173_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfNy03LTEtMS0xNTIyMDk_5f44b323-343b-4bac-8349-914965a712fd"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="ib5a67a90d54547af9bc6e44f907032d6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfOC01LTEtMS0xNTIyMDk_eb04e2b8-a49a-4c0c-8f41-d82bfbf4ce62"
      unitRef="usd">-66200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i8d5b3231d1f2486e8776063341b0d566_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfOC03LTEtMS0xNTIyMDk_a922f9d0-5f81-483b-9cc5-ee694a19581e"
      unitRef="usd">201300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfOS01LTEtMS0xNTIyMDk_6f7f4815-3f77-4e7b-9040-66bb5748a1f6"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfOS03LTEtMS0xNTIyMDk_8f0b55eb-3981-4090-8ba3-f023445dd3fd"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTAtNS0xLTEtMTUyMjA5_f15e7980-6cc3-4a58-bf19-63f8e4a8b6c7"
      unitRef="usd">-15900000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTAtNy0xLTEtMTUyMjA5_6c7618f4-591b-4bd7-9cb9-569105d4502e"
      unitRef="usd">-272000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTEtNS0xLTEtMTUyMjA5_2e44be18-974f-4d05-b0a6-27c3905f1c5c"
      unitRef="usd">-12500000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTEtNy0xLTEtMTUyMjA5_38f2a03e-ed15-45d2-bf95-2fdfe6d96231"
      unitRef="usd">44700000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTItNS0xLTEtMTUyMjA5_0b503fc1-2141-4ad1-bc8b-9ca4bf212fc8"
      unitRef="usd">-3400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTItNy0xLTEtMTUyMjA5_ff37b494-4346-451b-84d4-ee6d09ad05b4"
      unitRef="usd">-316700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTMtNS0xLTEtMTUyMjA5_55b0e3c1-d325-47e8-acf0-365808a02ff4"
      unitRef="usd">221300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yMi9mcmFnOmZhOWUwNDZiNDg4ZTQ4OGM5OWRjNjJmODk2MzlmNTRmL3RhYmxlOjY1NmQ4NDQ2NTJjYjRhNzk4OGU2NTM5ODAyY2QyNGZlL3RhYmxlcmFuZ2U6NjU2ZDg0NDY1MmNiNGE3OTg4ZTY1Mzk4MDJjZDI0ZmVfMTMtNy0xLTEtMTUyMjA5_0ae66880-0a04-483c-af9f-8074b8bb3603"
      unitRef="usd">82500000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNC0xLTEtMS0xNTIyMDk_74f28a0b-8f02-40c1-9459-50fa1a806160"
      unitRef="usd">506600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNC0zLTEtMS0xNTIyMDk_4e8a328d-64b7-42b6-87e0-5599999a0433"
      unitRef="usd">1259900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNS0xLTEtMS0xNTIyMDk_8e743497-9f70-4491-b3e8-4f23bbb17afe"
      unitRef="usd">3497500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNS0zLTEtMS0xNTIyMDk_ab3addb2-ebe3-44bf-a6ec-d7b0a5f3aebb"
      unitRef="usd">3814500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNi0xLTEtMS0xNTIyMDk_3d96e1d8-f0a9-4c40-8955-35f110717429"
      unitRef="usd">3664300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNi0zLTEtMS0xNTIyMDk_a5a69ec4-bbf2-4c33-8bfe-3d0b243106a6"
      unitRef="usd">3519500000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNy0xLTEtMS0xNTIyMDk_7f54f218-bf3f-4b33-b846-6f2f1e015738"
      unitRef="usd">1763600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNy0zLTEtMS0xNTIyMDk_0df26cb5-b41e-400c-a0bf-7aba3364c9c7"
      unitRef="usd">1811200000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfOC0xLTEtMS0xNTIyMDk_88157663-16a2-48c0-9810-5ef79b999670"
      unitRef="usd">198300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfOC0zLTEtMS0xNTIyMDk_12f3206a-1193-4789-8679-e7d2c256f8ec"
      unitRef="usd">230300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:AssetsCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfOS0xLTEtMS0xNTIyMDk_229e6415-422f-4af9-ad88-540bbfd1bbef"
      unitRef="usd">9630300000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfOS0zLTEtMS0xNTIyMDk_966583e7-3ee4-470f-87f4-193826581897"
      unitRef="usd">10635400000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTAtMS0xLTEtMTUyMjA5_50d20b92-ddb5-4986-884b-0a67870fd2ca"
      unitRef="usd">3007800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTAtMy0xLTEtMTUyMjA5_ea87fbb3-ef71-4558-a771-e6c1e00d63b6"
      unitRef="usd">3024500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTEtMS0xLTEtMTUyMjA5_1b9176d6-9608-4da6-88fb-9c1773c0d74a"
      unitRef="usd">22701600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTEtMy0xLTEtMTUyMjA5_1d404bce-2277-4405-9b92-86064d6e9983"
      unitRef="usd">22607100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTItMS0xLTEtMTUyMjA5_70b58e1f-a670-4fd6-ade6-fd789b1eeea6"
      unitRef="usd">10573200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTItMy0xLTEtMTUyMjA5_ca93f983-6642-4986-ae11-89cc560a8709"
      unitRef="usd">10425800000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTMtMS0xLTEtMTUyMjA5_98389ee0-b4b9-4da8-a52b-e8f69512ebe7"
      unitRef="usd">959100000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTMtMy0xLTEtMTUyMjA5_4fb85a01-9eb7-4f25-871b-4c1d1f6f63a2"
      unitRef="usd">925900000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTQtMS0xLTEtMTUyMjA5_a1a0dc9a-f0c7-448c-9b93-595dde5a7e97"
      unitRef="usd">2418200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTQtMy0xLTEtMTUyMjA5_9810154f-5307-4282-b2ec-04a827cc4da7"
      unitRef="usd">2403500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTUtMS0xLTEtMTUyMjA5_84d76a61-ef16-4d73-87ce-db7af6b8e7f4"
      unitRef="usd">49290200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMTUtMy0xLTEtMTUyMjA5_a946338b-3873-404c-b056-59fd74dca459"
      unitRef="usd">50022200000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjAtMS0xLTEtMTUyMjA5_2909fd6b-1f09-4623-8d68-ce746d6efa00"
      unitRef="usd">1957500000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjAtMy0xLTEtMTUyMjA5_6a546eb3-1b9a-4017-b910-c8b5895d68ad"
      unitRef="usd">1766600000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjEtMS0xLTEtMTUyMjA5_9ec82bdd-ead5-4135-9fce-67c318295659"
      unitRef="usd">204600000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjEtMy0xLTEtMTUyMjA5_597f9227-eadf-4d4c-b6ed-c04368c429f4"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjItMS0xLTEtMTUyMjA5_05e6e7d2-a80c-4549-9272-8070e0991c69"
      unitRef="usd">244500000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjItMy0xLTEtMTUyMjA5_652c24f7-239e-46e9-9cfe-86393d731e8e"
      unitRef="usd">279600000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjMtMS0xLTEtMTUyMjA5_5c653bd5-5f20-4921-a591-2d04897225d6"
      unitRef="usd">508700000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjMtMy0xLTEtMTUyMjA5_e6d6582a-7385-40fd-b74d-7a8010b0e7a6"
      unitRef="usd">1259100000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjUtMS0xLTEtMTUyMjA5_95c77a53-7718-4f1a-9bf8-37f31ccd1ba3"
      unitRef="usd">3192800000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjUtMy0xLTEtMTUyMjA5_d13949e9-fe7b-45ef-a497-da9fabba9014"
      unitRef="usd">3440900000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjYtMS0xLTEtMTUyMjA5_64f316ff-7404-4963-a131-2f3b1d23af7f"
      unitRef="usd">6108100000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjYtMy0xLTEtMTUyMjA5_edb96c39-18cb-4019-87d3-defdf981deda"
      unitRef="usd">6746200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjctMS0xLTEtMTUyMjA5_014ee4f0-8d76-4f7d-b2d3-73bdbc237c78"
      unitRef="usd">18069400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjctMy0xLTEtMTUyMjA5_22ba4421-2fbb-4f0a-9abb-3dc5f2cc9048"
      unitRef="usd">18015200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjgtMS0xLTEtMTUyMjA5_f585c12d-79a8-43c4-be88-884f9935efc1"
      unitRef="usd">2465000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjgtMy0xLTEtMTUyMjA5_0b77a448-97ac-47ef-8acc-2657d303cd76"
      unitRef="usd">2432000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjktMS0xLTEtMTUyMjA5_04b5a2a1-0eb5-477c-b3b0-8456beba7252"
      unitRef="usd">1719800000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMjktMy0xLTEtMTUyMjA5_14d901d3-3924-4d76-ae67-1dddf8ca026a"
      unitRef="usd">1756500000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzAtMS0xLTEtMTUyMjA5_47b9d8fd-5846-4ad1-8769-c58864aa0df0"
      unitRef="usd">28362300000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzAtMy0xLTEtMTUyMjA5_4c6bab85-4971-4f7b-a7a8-2408644b5e6d"
      unitRef="usd">28949900000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246ZmY0MGFhYTIzZGQ2NDEyZmI2NGNmNzQzNDc4OGM0ZGJfMTg_b767692b-e314-480b-aed9-fda5e52010ea"
      unitRef="eurPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246ZmY0MGFhYTIzZGQ2NDEyZmI2NGNmNzQzNDc4OGM0ZGJfMzI_3463e3c2-3db5-4b1b-a84d-685831f1c8bd"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SharesIssued
      contextRef="ic8081836e4984486b7ec3a50c02a9559_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246ZmY0MGFhYTIzZGQ2NDEyZmI2NGNmNzQzNDc4OGM0ZGJfODU_f58ca5ae-7e6d-4ea0-b643-693c9d93216a"
      unitRef="shares">1220224204</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ic447b8cafe1b4bf6a2da44f4d2a51964_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246ZmY0MGFhYTIzZGQ2NDEyZmI2NGNmNzQzNDc4OGM0ZGJfOTI_a4ef9a21-7675-4144-ab61-28a3f88477cf"
      unitRef="shares">1213793231</us-gaap:SharesIssued>
    <us-gaap:CommonStockValue
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMS0xLTEtMTUyMjA5_7a394caa-2052-43b4-ae4f-274368a24d9f"
      unitRef="usd">12200000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzMtMy0xLTEtMTUyMjA5_4e9e8cf1-13f5-4023-8f92-5e29d791269b"
      unitRef="usd">12100000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzQtMS0xLTEtMTUyMjA5_4a4ab3f9-b21a-4332-9d84-b6da92681b8c"
      unitRef="usd">18679600000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzQtMy0xLTEtMTUyMjA5_2f176414-36c1-404f-9c17-f4821fdd7b71"
      unitRef="usd">18645800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzUtMS0xLTEtMTUyMjA5_7207fd75-559c-4538-899c-227dfefadab6"
      unitRef="usd">5252500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzUtMy0xLTEtMTUyMjA5_1d3a7214-bdff-4ec9-a876-5955903d66a2"
      unitRef="usd">5175600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzYtMS0xLTEtMTUyMjA5_7aada9a8-b7a4-4e4e-a047-f7908ceb5c7e"
      unitRef="usd">-2764600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzYtMy0xLTEtMTUyMjA5_3bb63c4d-4aa6-4b1c-93e2-70ba0bf1eccd"
      unitRef="usd">-2761200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <vtrs:StockholdersEquityParentBeforeTreasuryStock
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzctMS0xLTEtMTUyMjA5_46277ec1-0158-4774-a83b-5c3743c61fb7"
      unitRef="usd">21179700000</vtrs:StockholdersEquityParentBeforeTreasuryStock>
    <vtrs:StockholdersEquityParentBeforeTreasuryStock
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfMzctMy0xLTEtMTUyMjA5_a4f78067-8496-4631-ada8-2257d9eb8fcb"
      unitRef="usd">21072300000</vtrs:StockholdersEquityParentBeforeTreasuryStock>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDAtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246NTBiNDkyYmYzZmYyNDcyNWIyMjIzZmQwNDU2MGNjZmNfNTQ5NzU1ODEzOTgy_4deabfab-8301-480a-a4a3-53cf44b7e800"
      unitRef="shares">21239521</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDAtMS0xLTEtMTUyMjA5_eda466f6-266a-4181-9ea7-0bfff33ef9b7"
      unitRef="usd">251800000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDAtMy0xLTEtMTUyMjA5_50a70577-0443-4a64-b4e9-0086f2a792d4"
      unitRef="usd">0</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDEtMS0xLTEtMTUyMjA5_07ab2797-cad7-4b12-b969-f9fe93571e3b"
      unitRef="usd">20927900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDEtMy0xLTEtMTUyMjA5_c2990a83-2e17-4d58-b4bb-f895a9bab478"
      unitRef="usd">21072300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDMtMS0xLTEtMTUyMjA5_c7f4f49f-3c0d-44e5-9974-b8b5fda8ad6c"
      unitRef="usd">49290200000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18yNS9mcmFnOjdiNDk0MGY1M2ZmNDQyZThiNzY0NWM2NDViMmU0YzNmL3RhYmxlOmEzNDhkZDMyYmYzMDRjM2RiOWZiNzk4YmQ3ZTBmODhiL3RhYmxlcmFuZ2U6YTM0OGRkMzJiZjMwNGMzZGI5ZmI3OThiZDdlMGY4OGJfNDMtMy0xLTEtMTUyMjA5_eb590cea-74e4-4f8b-8fed-178e0b659ac6"
      unitRef="usd">50022200000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ic447b8cafe1b4bf6a2da44f4d2a51964_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMS0xLTEtMTUyMjA5_a4ef9a21-7675-4144-ab61-28a3f88477cf"
      unitRef="shares">1213793231</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic447b8cafe1b4bf6a2da44f4d2a51964_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMy0xLTEtMTUyMjA5_63e5b4b7-35d2-47a1-8499-5a68fcbf1c08"
      unitRef="usd">12100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7cc0d13e968f4d37b19959f0bd920ba7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktNS0xLTEtMTUyMjA5_c6bb591e-b844-4435-be00-57f7bc7afb38"
      unitRef="usd">18645800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3c5ed2af71e43d5ae5bf2d744c4be2a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktNy0xLTEtMTUyMjA5_db98d51c-6bbf-44b3-a707-071545856fd4"
      unitRef="usd">5175600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktOS0xLTEtMTUyMjA5_f7b8b8a2-b6a1-46fa-9e29-7ae5ad87e590"
      unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMTEtMS0xLTE1MjIwOQ_92156671-e3cb-4afa-96d4-d9c39f127577"
      unitRef="usd">0</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if9327c5d38c14a729ad52d76d711896b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMTMtMS0xLTE1MjIwOQ_d70a9283-0ff5-4e00-947c-0ec93336b993"
      unitRef="usd">-2761200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMTktMTctMS0xLTE1MjIwOQ_c2990a83-2e17-4d58-b4bb-f895a9bab478"
      unitRef="usd">21072300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjAtNy0xLTEtMTUyMjA5_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6"
      unitRef="usd">224700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjAtMTctMS0xLTE1MjIwOQ_553fa887-7c39-4ec6-9abb-349826e9c8cd"
      unitRef="usd">224700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i642a69b7eb80475580b6dfe8e7de979e_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjEtMTMtMS0xLTE1MjIwOQ_471366e7-1894-4321-b055-ea7e27fe835e"
      unitRef="usd">-3400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjEtMTctMS0xLTE1MjIwOQ_32226617-4a03-4955-9609-522031930e04"
      unitRef="usd">-3400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment
      contextRef="i30c7059ab4614911998f86f4b745dea0_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjItMS0xLTEtMTUyMjA5_682e8eec-bc4f-4a16-8e84-ba537076de4b"
      unitRef="shares">6350585</vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i30c7059ab4614911998f86f4b745dea0_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjItMy0xLTEtMTUyMjA5_ef693c03-3281-439e-9b01-6068838fc225"
      unitRef="usd">100000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjItNS0xLTEtMTUyMjA5_64a43314-0b51-4981-8e52-e81373da311f"
      unitRef="usd">3600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjItMTctMS0xLTE1MjIwOQ_438db115-8236-4c3d-a770-1322de20dc2f"
      unitRef="usd">3700000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjMtNS0xLTEtMTUyMjA5_5e1bb2b0-7b47-4065-b1c4-1dbf20413e9a"
      unitRef="usd">19400000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjMtMTctMS0xLTE1MjIwOQ_99e44fe4-2d9b-4790-8e6e-751363b94e5f"
      unitRef="usd">19400000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjQtNS0xLTEtMTUyMjA5_5179174e-e710-4e97-8972-26b2e982f3f7"
      unitRef="usd">42600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjQtMTctMS0xLTE1MjIwOQ_0176d2d5-9e2f-473b-8923-2d7ea42a64bf"
      unitRef="usd">42600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i4f24a7f585704f55918c29eab904acb3_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjYtOS0xLTEtMTUyMjA5_1accb056-fa21-439b-8ed3-6636b175f0a6"
      unitRef="shares">21239521</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4f24a7f585704f55918c29eab904acb3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjYtMTEtMS0xLTE1MjIwOQ_4d51e25b-5b5e-4e63-9349-7d153020b252"
      unitRef="usd">251800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjYtMTctMS0xLTE1MjIwOQ_8827abca-c52b-4ca2-80de-04629a2e3586"
      unitRef="usd">251800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i30c7059ab4614911998f86f4b745dea0_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjgtMS0xLTEtMTUyMjA5_1002c98e-4a4a-4cfe-8043-83bd425dae01"
      unitRef="shares">80388</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id5c08a52515f4488b07ef413d3161fe5_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjgtNS0xLTEtMTUyMjA5_e2903a20-29b8-4972-9c39-5fae05d4b50e"
      unitRef="usd">900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjgtMTctMS0xLTE1MjIwOQ_b2572043-3cfd-4763-963a-6f34f581a78b"
      unitRef="usd">900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjktMC0xLTEtMTUyMjA5L3RleHRyZWdpb246YTNkY2JjMTU5YWViNGNiMjljMWU5NGMwMzEwMDEwMTVfNTQ5NzU1ODEzOTQ1_11ef565d-0cdf-43aa-8520-ab4cf2058a99"
      unitRef="usdPerShare">0.12</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i561d51a7e3784b178fe2847410f076e4_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjktNy0xLTEtMTUyMjA5_1615374d-4caf-4409-958c-6a5e02a7dd6a"
      unitRef="usd">147800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMjktMTctMS0xLTE1MjIwOQ_73b525d6-3282-4d98-9b90-a0e9728e92e9"
      unitRef="usd">147800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzAtNS0xLTEtMTUyMjA5_560c5f9f-2181-4cae-91b4-e1eaf8cda670"
      unitRef="usd">6100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzAtMTctMS0xLTE1MjIwOQ_dd7a16f8-8868-4145-b63c-c247f417fdb9"
      unitRef="usd">6100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:SharesIssued
      contextRef="ic8081836e4984486b7ec3a50c02a9559_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMS0xLTEtMTUyMjA5_f58ca5ae-7e6d-4ea0-b643-693c9d93216a"
      unitRef="shares">1220224204</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8081836e4984486b7ec3a50c02a9559_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMy0xLTEtMTUyMjA5_743a2e32-73fa-41b0-83f1-a1285c585afd"
      unitRef="usd">12200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i06f4f79c2ca443ba927ddb45fabccf40_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtNS0xLTEtMTUyMjA5_61bab21f-0041-4afc-8e46-25d9aa0f2977"
      unitRef="usd">18679600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i11b6d5faae2a48a18b3efb5b7931433d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtNy0xLTEtMTUyMjA5_534aa62b-49f5-4b01-898c-d6794cb1b288"
      unitRef="usd">5252500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtOS0xLTEtMTUyMjA5_4deabfab-8301-480a-a4a3-53cf44b7e800"
      unitRef="shares">21239521</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMTEtMS0xLTE1MjIwOQ_fd5417c5-866b-49b4-a6ae-8eeac4904d7e"
      unitRef="usd">251800000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b279406fb1545e4a9b41bef21012362_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMTMtMS0xLTE1MjIwOQ_78b344ee-72ae-498a-9995-6520173d7cfb"
      unitRef="usd">-2764600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjg1MTZhZjI1ZjEwZDRhMjg4ODhmNTlhNTNiNmY0NDA1L3RhYmxlcmFuZ2U6ODUxNmFmMjVmMTBkNGEyODg4OGY1OWE1M2I2ZjQ0MDVfMzEtMTctMS0xLTE1MjIwOQ_07ab2797-cad7-4b12-b969-f9fe93571e3b"
      unitRef="usd">20927900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ic6bcf9a93f5b44e6adf971fc8c993b9b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMS0xLTEtMTUyMjA5_3c0748c5-8960-4b13-a2e0-b37bb1e15ee7"
      unitRef="shares">1209507463</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6bcf9a93f5b44e6adf971fc8c993b9b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMy0xLTEtMTUyMjA5_f475ea06-5c68-487c-b09c-10fb5123e324"
      unitRef="usd">12100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f829281a5504ccaaf32eb2afd8061d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtNS0xLTEtMTUyMjA5_a452bd0f-3335-4666-9f73-28a095e7b60b"
      unitRef="usd">18536100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee68d18c353b4a1bbbe750b60203792b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtNy0xLTEtMTUyMjA5_f166d436-3825-4055-a275-f3ac3986b1bb"
      unitRef="usd">3688800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i12dff40a692c45c8b91c8911ee689533_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtOS0xLTEtMTUyMjA5_2ade24f2-4684-4388-967b-0d1bdfbfc3ee"
      unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="i12dff40a692c45c8b91c8911ee689533_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMTEtMS0xLTE1MjIwOQ_490d0d9a-cab1-4c44-95cb-5f6bdffe8a7e"
      unitRef="usd">0</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5cca97d09754ca0bea07369d3464420_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMTMtMS0xLTE1MjIwOQ_75c45c2d-227e-4ddf-b762-0c9916972aa2"
      unitRef="usd">-1744300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12dff40a692c45c8b91c8911ee689533_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTgtMTctMS0xLTE1MjIwOQ_2d4da9ee-2029-4039-b16c-c10e8ce6cd8d"
      unitRef="usd">20492700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTktNy0xLTEtMTUyMjA5_21ea8900-812e-42b1-bf29-832a88880c0e"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMTktMTctMS0xLTE1MjIwOQ_92c8ecae-5ca2-4cad-995e-39134add15f4"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia1ed98849f874127b2a3dc2dc4a7df89_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjAtMTMtMS0xLTE1MjIwOQ_e48e18d1-36fc-4821-9ef0-070af25aa3d9"
      unitRef="usd">-316700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjAtMTctMS0xLTE1MjIwOQ_3016c6d0-b343-40b8-bd0b-f570637e73ad"
      unitRef="usd">-316700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment
      contextRef="i391ee8214e954c59b805e6ec8a55bdd2_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjEtMS0xLTEtMTUyMjA5_0b1b61d1-fdde-4aad-9937-15045310739a"
      unitRef="shares">2816020</vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i57b79d768af5428b9e726a123ceb19b9_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjEtNS0xLTEtMTUyMjA5_2bf05af9-1249-402c-8cb4-8674d6f6045c"
      unitRef="usd">0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjEtMTctMS0xLTE1MjIwOQ_9b2a9652-f4de-4df1-836d-b3c59ca0123b"
      unitRef="usd">0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i57b79d768af5428b9e726a123ceb19b9_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjItNS0xLTEtMTUyMjA5_cdbefd22-5456-4e0d-82f9-e7681928a94a"
      unitRef="usd">9300000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjItMTctMS0xLTE1MjIwOQ_b4503bab-d409-456a-a7b2-6e09c9f4b167"
      unitRef="usd">9300000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i57b79d768af5428b9e726a123ceb19b9_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjMtNS0xLTEtMTUyMjA5_7ad4cb00-88ef-40bc-aabf-4b1106ae5ba4"
      unitRef="usd">28300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjMtMTctMS0xLTE1MjIwOQ_7664e23f-06b8-40fc-b5df-cc5a0d1c086f"
      unitRef="usd">28300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjYtMC0xLTEtMTUyMjA5L3RleHRyZWdpb246NDk4ZDMxOTllOWUwNDQyOGE2YWVjNjcxNmM1MzM3YWNfNTQ5NzU1ODEzOTQ2_11ef565d-0cdf-43aa-8520-ab4cf2058a99"
      unitRef="usdPerShare">0.12</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="id99e77e7afb3472d9a21cf0bc27a911a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjYtNy0xLTEtMTUyMjA5_b52ece8f-e140-46d2-983c-8b83fc86339b"
      unitRef="usd">146500000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjYtMTctMS0xLTE1MjIwOQ_a1065641-ea2b-449a-b4ed-659a453bdf31"
      unitRef="usd">146500000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesIssued
      contextRef="ic7921bbbcfff48129188154f61fc9281_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMS0xLTEtMTUyMjA5_d0c05aea-dd16-4d3a-b252-109111824820"
      unitRef="shares">1212323483</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7921bbbcfff48129188154f61fc9281_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMy0xLTEtMTUyMjA5_e888d1f9-2e9e-4e58-b945-b1e1f093bc25"
      unitRef="usd">12100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ecb1e1f965b4571b9238fdf9bb67f7b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtNS0xLTEtMTUyMjA5_5dc85e38-6c36-46e0-ae23-090715d20863"
      unitRef="usd">18555100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ica08d82424e74ae4a9d160bbc2691906_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtNy0xLTEtMTUyMjA5_5e7eaf54-b86a-43c4-84a5-7c8a70b569e9"
      unitRef="usd">3941500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtOS0xLTEtMTUyMjA5_ae93b6f5-81f5-4d49-8dce-e00f2a189ca3"
      unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMTEtMS0xLTE1MjIwOQ_57842de1-fa8e-4e4d-a26f-a52dc383d65f"
      unitRef="usd">0</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8e5c94cf86d4321a4e0a9f4c01d3c24_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMTMtMS0xLTE1MjIwOQ_e2933ee1-d459-4810-bda0-61ad08c1ecef"
      unitRef="usd">-2061000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zMS9mcmFnOjg0Mzg1ZWUyMWFmNzRhZjVhNjE2Yjc4NzBjYmY2OGMwL3RhYmxlOjMzZDk3ZThkMmVkNjQ1NDNiOGI2ZTVkNGNiNDc1MDNiL3RhYmxlcmFuZ2U6MzNkOTdlOGQyZWQ2NDU0M2I4YjZlNWQ0Y2I0NzUwM2JfMjgtMTctMS0xLTE1MjIwOQ_24aaa10b-3da6-40b1-b58c-5809281d02d2"
      unitRef="usd">20447700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNC0xLTEtMS0xNTIyMDk_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6"
      unitRef="usd">224700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNC0zLTEtMS0xNTIyMDk_4839a2dd-fa2e-469a-b533-15c2a308962b"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNi0xLTEtMS0xNTIyMDk_d68856ac-cffc-4605-ba2c-0a15731663a4"
      unitRef="usd">730000000.0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNi0zLTEtMS0xNTIyMDk_efd469a2-2b37-4e60-aff5-933045265d1b"
      unitRef="usd">736000000.0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNy0xLTEtMS0xNTIyMDk_c5a1c216-2e6b-4d81-b79f-1d34e5c00645"
      unitRef="usd">42600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNy0zLTEtMS0xNTIyMDk_0d5aa26a-47b5-4202-9119-6a140ea50469"
      unitRef="usd">28300000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfOC0xLTEtMS0xNTIyMDk_77b4e5b1-957c-45c8-b7b4-335686b61efe"
      unitRef="usd">-26700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfOC0zLTEtMS0xNTIyMDk_668a6485-5da0-4d2f-80da-44d586fff202"
      unitRef="usd">-52800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfOS0xLTEtMS0xNTIyMDk_191c4fc3-d687-4e2e-8040-4fe4fa568156"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfOS0zLTEtMS0xNTIyMDk_f849ff6f-19a3-4fd4-b6c3-917f3834c19c"
      unitRef="usd">100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTAtMS0xLTEtMTUyMjA5_b586c11b-3a0a-4b70-9392-b40539c7a059"
      unitRef="usd">-29600000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTAtMy0xLTEtMTUyMjA5_96c132b4-dfc3-45ce-8791-f1a2f94cee11"
      unitRef="usd">-37800000</us-gaap:OtherNoncashIncomeExpense>
    <vtrs:Changeinnoncashlitigationsettlementsnet
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTEtMS0xLTEtMTUyMjA5_3298ec5f-0819-43a1-ace9-bd3b2ae9a9db"
      unitRef="usd">-2400000</vtrs:Changeinnoncashlitigationsettlementsnet>
    <vtrs:Changeinnoncashlitigationsettlementsnet
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTEtMy0xLTEtMTUyMjA5_30f5b5ad-8296-4e32-ae81-9ed3d9352acd"
      unitRef="usd">-5200000</vtrs:Changeinnoncashlitigationsettlementsnet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTMtMS0xLTEtMTUyMjA5_4afa3a17-d2db-48db-b527-d6cdf767921b"
      unitRef="usd">-215000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTMtMy0xLTEtMTUyMjA5_f6957d8c-5587-4a79-a705-471e4e3e77d2"
      unitRef="usd">115500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTQtMS0xLTEtMTUyMjA5_f7274e95-04c0-4f1f-b123-551d3addd5c2"
      unitRef="usd">151100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTQtMy0xLTEtMTUyMjA5_94fb9804-fb17-4cb1-8161-1a8cad612f25"
      unitRef="usd">69100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTUtMS0xLTEtMTUyMjA5_d862db05-4fb8-4afd-8c7f-f04be06a0197"
      unitRef="usd">183400000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTUtMy0xLTEtMTUyMjA5_a730633d-327c-4e63-ac28-623553585a38"
      unitRef="usd">-30200000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTYtMS0xLTEtMTUyMjA5_d1cd2567-a0db-46f5-a060-4d4e727b729d"
      unitRef="usd">-53900000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTYtMy0xLTEtMTUyMjA5_ac04c9a2-13d5-4e97-bdfe-9f5c2d066bed"
      unitRef="usd">67000000.0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTctMS0xLTEtMTUyMjA5_5568f731-ece1-421f-ba4f-025e5096a3bf"
      unitRef="usd">224800000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTctMy0xLTEtMTUyMjA5_244a9dbe-9429-471b-ab15-60841b70699d"
      unitRef="usd">-132700000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTgtMS0xLTEtMTUyMjA5_dedb8ea7-c5d6-483a-85a2-b214384636f1"
      unitRef="usd">971200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMTgtMy0xLTEtMTUyMjA5_76207a31-f4ae-4d88-87a4-50c132a2c69d"
      unitRef="usd">1138500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjAtMS0xLTEtMTUyMjA5_c768d388-f896-43da-b49f-d689d0f9a270"
      unitRef="usd">667700000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjAtMy0xLTEtMTUyMjA5_479208be-282b-4d91-a515-eb6101eedcf6"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjEtMS0xLTEtMTUyMjA5_a1d14085-569f-446c-8756-6de1fd3045ad"
      unitRef="usd">47800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjEtMy0xLTEtMTUyMjA5_7baa3adb-26fa-418c-bccd-889a7c96d99d"
      unitRef="usd">64500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjItMS0xLTEtMTUyMjA5_4c6225fd-68e7-4051-82b7-f29d8fd1a22a"
      unitRef="usd">9000000.0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjItMy0xLTEtMTUyMjA5_9661f37d-d332-4a5e-9481-23db1eb98486"
      unitRef="usd">8600000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjMtMS0xLTEtMTUyMjA5_0b1fd09c-b8b2-47f4-9e05-f14fd6d85209"
      unitRef="usd">9000000.0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjMtMy0xLTEtMTUyMjA5_cbf498ec-5ab5-4276-ba62-efa469fd4b37"
      unitRef="usd">8500000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjQtMS0xLTEtMTUyMjA5_5272eb6b-19c6-4c29-b338-9cc20acbbed1"
      unitRef="usd">34700000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjQtMy0xLTEtMTUyMjA5_8a50393e-b9c5-42f8-b607-7bde64a39c0a"
      unitRef="usd">7400000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjUtMS0xLTEtMTUyMjA5_af8a4b8b-6c8c-4c9d-aa29-94c5f8bf539e"
      unitRef="usd">700000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjUtMy0xLTEtMTUyMjA5_0b8bf1af-af00-48ff-aae7-b07e533966b0"
      unitRef="usd">5100000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjYtMS0xLTEtMTUyMjA5_4809efc7-b9a9-4974-a6a8-e16b43a4c04b"
      unitRef="usd">-749500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjYtMy0xLTEtMTUyMjA5_3120b76d-7604-41d0-9b89-55d79d2c5cf7"
      unitRef="usd">-66900000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjgtMS0xLTEtMTUyMjA5_ec83cc43-f26f-4f38-b74d-b485f28f7985"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjgtMy0xLTEtMTUyMjA5_c4a6c95e-3ce0-46c7-8ee3-cfeb0c4d6e94"
      unitRef="usd">100000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjktMS0xLTEtMTUyMjA5_e6509cdb-7d4f-4bb2-9208-9432781a59aa"
      unitRef="usd">750100000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMjktMy0xLTEtMTUyMjA5_2b2516a8-b80e-4569-93f7-ac3e262ef82b"
      unitRef="usd">100000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzAtMS0xLTEtMTUyMjA5_9d4579f7-2649-4e25-9a73-c0898d82b044"
      unitRef="usd">250000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzAtMy0xLTEtMTUyMjA5_2b833327-d093-4b41-955f-9ab92dcc661e"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzEtMS0xLTEtMTUyMjA5_19ddb301-b513-40dc-82f2-62ef078d3a91"
      unitRef="usd">204600000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzEtMy0xLTEtMTUyMjA5_388415b3-5346-4da5-a587-e6dccab1fbc2"
      unitRef="usd">-837900000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzItMS0xLTEtMTUyMjA5_9ea89600-34db-415e-9b22-f3ad08d3b525"
      unitRef="usd">30000000.0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzItMy0xLTEtMTUyMjA5_4425fbf4-9054-4022-b317-450199f9dab1"
      unitRef="usd">9900000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzMtMS0xLTEtMTUyMjA5_64adcf7b-276c-476c-9f92-273391648154"
      unitRef="usd">8400000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzMtMy0xLTEtMTUyMjA5_46ba8a95-b85c-4f3c-8fda-b51e743bef77"
      unitRef="usd">15500000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzQtMS0xLTEtMTUyMjA5_72779a72-8151-4219-8114-8583a2a7aa29"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzQtMy0xLTEtMTUyMjA5_71f34dbb-07a1-4f63-9f61-554dd8c52d39"
      unitRef="usd">400000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzUtMS0xLTEtMTUyMjA5_15020c68-c22e-4d74-a0d5-1fbd41e03b5d"
      unitRef="usd">143800000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzUtMy0xLTEtMTUyMjA5_0dcb34e2-e9f6-4533-84c3-aa69c16821b7"
      unitRef="usd">145100000</us-gaap:PaymentsToMinorityShareholders>
    <vtrs:PaymentsToAcquireIntangibleAssetsFinancingActivity
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzYtMS0xLTEtMTcxMzIy_14ae3681-cad1-4f3e-b360-a3c5af5be958"
      unitRef="usd">9700000</vtrs:PaymentsToAcquireIntangibleAssetsFinancingActivity>
    <vtrs:PaymentsToAcquireIntangibleAssetsFinancingActivity
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzYtMy0xLTEtMTcxMzMz_96ddaad4-c463-4c0e-8133-e3bb2da057d1"
      unitRef="usd">0</vtrs:PaymentsToAcquireIntangibleAssetsFinancingActivity>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzYtMS0xLTEtMTUyMjA5_bed69c80-f44f-4ace-b8aa-3ddfd51f8a85"
      unitRef="usd">900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzYtMy0xLTEtMTUyMjA5_191ba854-56ab-40d7-b423-b6ba579dd0c3"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzctMS0xLTEtMTUyMjA5_32e18c98-5172-4e21-a31c-996ee919d10f"
      unitRef="usd">11800000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzctMy0xLTEtMTUyMjA5_db64f04b-d6d9-49da-9be5-7ba118ed902b"
      unitRef="usd">-200000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzgtMS0xLTEtMTUyMjA5_e25cf692-6d5d-483e-b4c0-3e8a011d3ea3"
      unitRef="usd">-974700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzgtMy0xLTEtMTUyMjA5_55023a01-267f-4c85-8fd0-3b703053009f"
      unitRef="usd">-1009000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzktMS0xLTEtMTUyMjA5_1d0f60d7-240a-4828-8026-6800a7664cd3"
      unitRef="usd">1200000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfMzktMy0xLTEtMTUyMjA5_7526e87d-6ae9-492f-9b57-03cd59de415b"
      unitRef="usd">-11400000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDAtMS0xLTEtMTUyMjA5_f7b47355-0d4e-4c0f-9f2d-c1a7de11dc48"
      unitRef="usd">-751800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDAtMy0xLTEtMTUyMjA5_a6a02a25-f2e0-484c-9599-6256b2766203"
      unitRef="usd">51200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDEtMS0xLTEtMTUyMjA5_d0264ea9-21eb-45a6-aee2-24e882bf35e0"
      unitRef="usd">1262500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i12dff40a692c45c8b91c8911ee689533_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDEtMy0xLTEtMTUyMjA5_9d1096e6-09b3-4942-aa9a-290650001739"
      unitRef="usd">706200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDItMS0xLTEtMTUyMjA5_84e966c3-6510-4cae-af8e-afb8587b91f6"
      unitRef="usd">510700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18zNC9mcmFnOmIxYzlhNDI4NjdmZDQ3ODRiYWE3NmY5MzU5ZTEwMjZiL3RhYmxlOjcyNWQxZDRkYzZiOTQ2MGI4YzdjNzU4YTJkMTQyOWFjL3RhYmxlcmFuZ2U6NzI1ZDFkNGRjNmI5NDYwYjhjN2M3NThhMmQxNDI5YWNfNDItMy0xLTEtMTUyMjA5_b385c28b-57f3-4ab3-abde-74673e3ecdbb"
      unitRef="usd">757400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180MC9mcmFnOmRjNjkyZGI1NDRjMDRmYTQ5MTA1NmVhNDIwNmRmMTJmL3RleHRyZWdpb246ZGM2OTJkYjU0NGMwNGZhNDkxMDU2ZWE0MjA2ZGYxMmZfMTY2Nw_a44b1b5a-0a00-4732-8d87-3f3cfc1255f0">General&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements (&#x201c;interim financial statements&#x201d;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto in Viatris&#x2019; 2022 Form&#160;10-K. The December&#160;31, 2022 condensed consolidated balance sheet was derived from audited financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interim results of operations, comprehensive earnings and cash flows for the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full fiscal year or any other future period.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180MC9mcmFnOmRjNjkyZGI1NDRjMDRmYTQ5MTA1NmVhNDIwNmRmMTJmL3RleHRyZWdpb246ZGM2OTJkYjU0NGMwNGZhNDkxMDU2ZWE0MjA2ZGYxMmZfMTY4MA_9a3b741f-cb0e-4ebd-ad30-5e59f160de4d">The accompanying unaudited condensed consolidated financial statements (&#x201c;interim financial statements&#x201d;) of Viatris Inc. and subsidiaries were prepared in accordance with U.S. GAAP and the rules and regulations of the SEC for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted. The interim financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the interim results of operations, comprehensive earnings, financial position, equity and cash flows for the periods presented.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzQwNA_5db3f0e0-b97b-432d-b359-47a28194b8e3">Revenue Recognition and Accounts Receivable&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenues in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the condensed consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#x2019;s subsequent sales or usages occur. Such consideration is included in other revenues in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2023 and 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,719.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,298.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,554.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt"&gt;Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.43pt"&gt;Amounts for the three months ended March&#160;31, 2022 include $164.8 million related to the biosimilars business which was subsequently contributed to Biocon Biologics in November 2022. The Company has not recognized the results of the biosimilars business in its consolidated financial statements subsequent to November 29, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2023 and 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.920%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Global Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lipitor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Norvasc &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lyrica &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Viagra &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EpiPen&#xae; Auto-Injectors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celebrex &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Creon &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effexor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zoloft &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xalabrands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Segment Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dymista &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yupelri &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xanax &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amitiza &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt"&gt;The Company does not disclose net sales for any products considered competitively sensitive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration and Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2023 and 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,273.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,198.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross to net adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chargebacks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,350.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,584.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates, promotional programs and other sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(992.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,205.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Governmental rebate programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross to net adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,553.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,020.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,719.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No significant revisions were made to the methodology used in determining these provisions or the nature of the provisions during the three months ended March&#160;31, 2023. Such allowances were comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,739.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net was comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,021.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,497.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,814.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable Factoring Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $76.3 million and $34.7 million of accounts receivable as of March&#160;31, 2023 and December&#160;31, 2022, respectively, under these factoring arrangements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzQxMA_25fae66c-bb9b-4f4f-bbe7-91715d69f22a">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s net sales by product category for each of our reportable segments for the three months ended March&#160;31, 2023 and 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,719.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,298.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,554.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt"&gt;Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.43pt"&gt;Amounts for the three months ended March&#160;31, 2022 include $164.8 million related to the biosimilars business which was subsequently contributed to Biocon Biologics in November 2022. The Company has not recognized the results of the biosimilars business in its consolidated financial statements subsequent to November 29, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales on a consolidated basis for select key products for the three months ended March&#160;31, 2023 and 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.920%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Global Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lipitor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Norvasc &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lyrica &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Viagra &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EpiPen&#xae; Auto-Injectors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celebrex &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Creon &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effexor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zoloft &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xalabrands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Segment Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dymista &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yupelri &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xanax &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amitiza &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt"&gt;The Company does not disclose net sales for any products considered competitively sensitive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;Amounts for the three months ended March&#160;31, 2023 include the unfavorable impact of foreign currency translations compared to the prior year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration and Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the three months ended March&#160;31, 2023 and 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,273.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,198.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross to net adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chargebacks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,350.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,584.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates, promotional programs and other sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(992.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,205.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Governmental rebate programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross to net adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,553.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,020.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,719.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id19bcca8b59e49f9bd2243c802592021_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi0xLTEtMS0xNTIyMDk_6a0cdd34-e7ef-47f9-9677-2fd3355a979b"
      unitRef="usd">1232000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i704078a8122d4548985aecc73b821530_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi0zLTEtMS0xNTIyMDk_2f038604-1968-408e-8834-ef8a4138f841"
      unitRef="usd">562400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92922c90fca14d05bf112c8f1126b7cc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi01LTEtMS0xNTIyMDk_6ccdf90f-cea9-4af1-a8b0-a2f08e24f28b"
      unitRef="usd">190300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7512eaf443a41ad8f1edd112dd540e0_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi03LTEtMS0xNTIyMDk_edcc06f0-fadb-4706-8a7c-6c557eb1b6f2"
      unitRef="usd">435600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fb2e0a0aa064c1d96030296b9432c85_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMi05LTEtMS0xNTIyMDk_790cf52c-e184-48d3-bf40-e12c5775bb70"
      unitRef="usd">2420300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3eb96c8f3584c52bfaa3c801011fdac_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy0xLTEtMS0xNTIyMDk_846e6f30-3ab3-4b0f-b557-55d3967f31f6"
      unitRef="usd">129900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife01b67ec63f4327b09c466ff8b6394b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy0zLTEtMS0xNTIyMDk_bf939d3f-3c34-4db2-90a6-520299779bd2"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc5e3ed0cebd408f8ab74c7381532a00_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy01LTEtMS0xNTIyMDk_62c0e876-4d05-44b0-a5ca-640dd22756f7"
      unitRef="usd">6100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibeb5e53a9f0d46b782ce87d07e4fbac4_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy03LTEtMS0xNTIyMDk_6403c157-13d6-4f25-97cb-ab4997a870cd"
      unitRef="usd">100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa88d983842143b5bccdb89bcd185908_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfMy05LTEtMS0xNTIyMDk_35f4baca-703f-4dbf-a32c-66d9f07ef445"
      unitRef="usd">136100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibba322c953c54a6a9a2cc16a92d69055_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC0xLTEtMS0xNTIyMDk_6eb77838-4509-461e-9310-9b526fdee44c"
      unitRef="usd">808500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e611f955781478d9ef741924e6d669b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC0zLTEtMS0xNTIyMDk_c5ce6df0-a1d4-4df3-a48e-bd700de6cee6"
      unitRef="usd">2200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacdce5f01a244464a3cad307e21ef9b6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC01LTEtMS0xNTIyMDk_e4e1c969-e648-4e67-a3f6-be377daf546f"
      unitRef="usd">145800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f4ad7a4e06444cd91270a3c5d11af96_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC03LTEtMS0xNTIyMDk_db169c91-5fd5-4631-8841-5425c2053d6b"
      unitRef="usd">206200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie98262c314234c0dada44293b3622bd2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNC05LTEtMS0xNTIyMDk_af76a2fa-d739-4434-af58-2de9180a12b2"
      unitRef="usd">1162700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff6f2a14b0ce43ab83b734dd64d12bf6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS0xLTEtMS0xNTIyMDk_25970763-f17c-4675-a1db-4f09144c8c8a"
      unitRef="usd">2170400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fe5245728a44cb18a87377e4c3de0c8_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS0zLTEtMS0xNTIyMDk_90db45f0-27d6-4ac3-816d-6033337c0b84"
      unitRef="usd">564600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i717ccb375e6a4e1a88e76775cf3a0015_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS01LTEtMS0xNTIyMDk_bae695cd-d7a6-43fb-99d9-5bfd69a4a186"
      unitRef="usd">342200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id962b30d667e44d79767fd8e3799bc1d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS03LTEtMS0xNTIyMDk_d927bef0-a473-41e9-bea6-e0c4cfd326ec"
      unitRef="usd">641900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjgzZGQwNDliMzU5ODQ5YWU5NmRmZTU5ZDU4NzllNTA5L3RhYmxlcmFuZ2U6ODNkZDA0OWIzNTk4NDlhZTk2ZGZlNTlkNTg3OWU1MDlfNS05LTEtMS0xNTIyMDk_17000761-29a4-4f90-827b-ccceebe898d2"
      unitRef="usd">3719100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38d981aefd18465fa3436254a0f36c4f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi0xLTEtMS0xNTIyMDk_acdd0c25-51a8-43b0-a342-3f88ade7c109"
      unitRef="usd">1298700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d994597d6e1416a86a2c96f63285849_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi0zLTEtMS0xNTIyMDk_e900fad7-7ddc-4ad9-b432-927707928c3f"
      unitRef="usd">569700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e03815fe4df401db12f5e4fed5d678b_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi01LTEtMS0xNTIyMDk_70facf9d-08c6-4866-8613-aa719d334bc3"
      unitRef="usd">249000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39b03de3e86b414dbeb9fb6d61078f2e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi03LTEtMS0xNTIyMDk_3a31bd95-266b-4fc2-bf48-db02b192d944"
      unitRef="usd">436700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icbf905bb0a554b358d94dd2e66066fd6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMi05LTEtMS0xNTIyMDk_8b5e317d-bde2-4d34-8c9d-42c8ded743e5"
      unitRef="usd">2554100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ff2c602eaa44eccb62f90e702abbf78_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy0xLTEtMS0xNTIyMDk_f3fcdee2-9cb8-418f-8c06-f1cc418df2ee"
      unitRef="usd">364100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i971cc687ee2a4eb99860d0f9c63905b5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy0zLTEtMS0xNTIyMDk_c96cd096-915e-4c77-bf59-21306119382d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8a81007b4bc4e578d7d99563ce6d1da_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy01LTEtMS0xNTIyMDk_77ab56e2-7a49-4f70-a932-9477b67ab592"
      unitRef="usd">10300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a00915b25a548e6a59fb781b78db94f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy03LTEtMS0xNTIyMDk_33561e5e-1b97-4972-b657-e5fe6e7acd70"
      unitRef="usd">16400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c3c8f8610e944e9b5a18cae61033feb_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfMy05LTEtMS0xNTIyMDk_30ccc1b9-c5d8-42f1-8ab6-0414fc1adaca"
      unitRef="usd">390800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5215e33461184efabc64594166dddbc7_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC0xLTEtMS0xNTIyMDk_c1e0f988-f980-432a-8997-c016168fbcca"
      unitRef="usd">813300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44a92534985b4fa8a89210f1ef780e8f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC0zLTEtMS0xNTIyMDk_b78ee55e-3904-4be2-870a-1bfe95406f6b"
      unitRef="usd">3400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib17e1e4ae1dc41f4910694c744638d06_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC01LTEtMS0xNTIyMDk_07be5937-fce9-4d56-a1e8-b1717e473c6f"
      unitRef="usd">164500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5874f6fd7aa4dae89158ea58919c58f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC03LTEtMS0xNTIyMDk_b364e6c3-4235-4362-ad89-6ff74016acae"
      unitRef="usd">252100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a4e2f9b5b0d48b8b618be462d213bb5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNC05LTEtMS0xNTIyMDk_97249c3e-ebd3-4d8f-922b-c3570ff4b554"
      unitRef="usd">1233300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09ea4f3f734d40279fcbeea57318b608_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS0xLTEtMS0xNTIyMDk_49fdb471-2838-45eb-b491-1ef09740d941"
      unitRef="usd">2476100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44dcb2e059604510889393247056ff68_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS0zLTEtMS0xNTIyMDk_3b63d654-bca9-4f49-8950-c2ebc63300e8"
      unitRef="usd">573100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37f11f4d488d4d6b8d1b2a5657ed7bd8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS01LTEtMS0xNTIyMDk_547ac9f4-75dc-47a8-a894-872271f3bb03"
      unitRef="usd">423800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8791ebb35b584298bcab2b2bcfa56d9d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS03LTEtMS0xNTIyMDk_3ef45d50-3390-42e9-8c53-a83d6f809408"
      unitRef="usd">705200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmM5ZGIyYWZhMWEzMjRjNzliNGI3NTUxN2ExYTE2N2IxL3RhYmxlcmFuZ2U6YzlkYjJhZmExYTMyNGM3OWI0Yjc1NTE3YTFhMTY3YjFfNS05LTEtMS0xNTIyMDk_5658ecea-bc13-4f2d-9200-972966aa9345"
      unitRef="usd">4178200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63daf2f5870d4537b44c66577922f2e0_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMjE5OTAyMzI2MDQxMw_5005eabe-f6d5-49ae-a6c4-313eace8d76b"
      unitRef="usd">-164800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5eedbf09d08e4fe2b98d92fe6d16ed90_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNC0yLTEtMS0xNTIyMDk_0f43c1a2-3148-4820-94d0-474510d9ae2c"
      unitRef="usd">417900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i035a8072fe08425aa2db4bf6f2f43f08_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNC00LTEtMS0xNTIyMDk_d1df50d0-3651-4e8e-99e6-d36a0bd449ed"
      unitRef="usd">440100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if54a5abed27e41d198391fc5eb34c417_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNS0yLTEtMS0xNTIyMDk_e409b300-a821-4227-8af7-7a3fccb96872"
      unitRef="usd">202700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1d94644d7ec4cacb1adf2ab3a5a74b4_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNS00LTEtMS0xNTIyMDk_df5952e4-1a74-45b8-8dbf-cbf6d90885e7"
      unitRef="usd">207800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa045f9e59554b078d808553a9e85eb4_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNi0yLTEtMS0xNTIyMDk_d11457e0-e550-4130-9b52-4dbdd9b0f365"
      unitRef="usd">144300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7813ac9a34bc41109808afe80308fb10_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNi00LTEtMS0xNTIyMDk_720e04dd-2236-411d-875e-fe07a261f357"
      unitRef="usd">171700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34b5947dc7a24798afe8946af5790adb_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNy0yLTEtMS0xNTIyMDk_666f79cf-cbb9-4375-ad69-4ceebd980da6"
      unitRef="usd">115000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e7b222b3a924b69bb5ce8f834eadfae_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfNy00LTEtMS0xNTIyMDk_9589b239-ce2a-463d-b911-019cbc0b7632"
      unitRef="usd">129800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a9412e767ac487189d1ecb36b20b8da_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfOC0yLTEtMS0xNTIyMDk_d3838c4b-b056-4578-9e2c-9b12d864fbcc"
      unitRef="usd">95800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ca2f2f3badd41a5a8b132f9bfeca53a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfOC00LTEtMS0xNTIyMDk_d9f765c3-dfd4-4625-bf1a-58a00eed0d05"
      unitRef="usd">88800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0665158c01343f5a7c7b1f984e8ac2f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfOS0yLTEtMS0xNTIyMDk_9c4a7735-f308-4d72-b438-283768f0a9a6"
      unitRef="usd">88800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24b785c729ea46afa207062149ec382a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfOS00LTEtMS0xNTIyMDk_e2c671b4-afdb-4f3b-ba57-36a85bee1450"
      unitRef="usd">85200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4f3a9d5832c47df837ef0c77371bc0b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTAtMi0xLTEtMTcwMjI2_e0feec0e-2a21-43ec-a9bc-8f94f3908242"
      unitRef="usd">72700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i258aad0139aa41dea358da8a65ba8ee9_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTAtNC0xLTEtMTcwMjI2_93148415-590e-43e1-9699-cc1eec2706cf"
      unitRef="usd">74700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4bf34b1589a4aff9e5ca7af9d52fc39_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTAtMi0xLTEtMTUyMjA5_572261da-d522-4ef0-9aa3-0792280833fe"
      unitRef="usd">64600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib00afe9957bb4659a032e5d0aa0e7fde_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTAtNC0xLTEtMTUyMjA5_28bba5de-467e-48ae-9355-a97baf83883c"
      unitRef="usd">77500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cf83d236a5d43429ebd63458e92e95a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTItMi0xLTEtMTUyMjA5_1fa94bea-a880-443c-8d7a-5297b5926b28"
      unitRef="usd">56500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6627a856378146a885c26dac6939f5c4_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTItNC0xLTEtMTUyMjA5_6ad6747d-3c07-455e-9ce3-f707a7296985"
      unitRef="usd">73100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5973b7e40c443749f09dd0bc3830976_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTMtMi0xLTEtMTUyMjA5_036166ce-0942-4115-add4-601c1d93ce17"
      unitRef="usd">46700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief173fc589434105b1a87eaf65f45ef2_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTMtNC0xLTEtMTUyMjA5_c0349b4b-4c2a-4718-9fef-1e3cc84b7b1d"
      unitRef="usd">53000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06c43c95288348ae8a9480b0bb2345f6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTctMi0xLTEtMTUyMjA5_f1d7d4ba-8fbf-4d3e-a446-13ad90c101aa"
      unitRef="usd">53200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64d037b97410486e8dc70388130c2a7a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTctNC0xLTEtMTUyMjA5_c2b72b82-fcd2-49fa-8abd-0e20d607ee56"
      unitRef="usd">44000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2637a3b77344ad6bf7fc87e0c624aa0_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTgtMi0xLTEtMTUyMjA5_1a91d216-49b4-4150-b370-196008c65cd6"
      unitRef="usd">47000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia605839e071b4886950912140c4508cd_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTgtNC0xLTEtMTUyMjA5_e4e5d251-0dda-4219-8954-56c2788700c1"
      unitRef="usd">43700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34306124574e4ff48c6728b14b8379a4_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTktMi0xLTEtMTcwMjMz_463a9f37-37f1-47b4-98a8-a0ee323046b3"
      unitRef="usd">39700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23fd6ab670e74679987bf4ab0632302b_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTktNC0xLTEtMTcwMjMz_ffcf2266-ae7e-4b9b-95f4-b2d269a16649"
      unitRef="usd">40000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3881f88980d444c98a395628ac04a37d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTktMi0xLTEtMTUyMjA5_a81b7bbc-cfb1-4af2-98ec-193c1f6e5ec5"
      unitRef="usd">36600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4918a7af8b94d9fa608eb50e7d397be_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjBkOGZiMTkwNDgzNjRhNWM5ZTZhMGNjNWY2MDE0ZjRjL3RhYmxlcmFuZ2U6MGQ4ZmIxOTA0ODM2NGE1YzllNmEwY2M1ZjYwMTRmNGNfMTktNC0xLTEtMTUyMjA5_b4ff5308-8961-4232-866e-3ad9ab86892a"
      unitRef="usd">41800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <vtrs:RevenuefromContractwithCustomerGross
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfMy01LTEtMS0xNTIyMDk_063f27c7-041d-4386-903e-ff66f2a3d679"
      unitRef="usd">6273000000</vtrs:RevenuefromContractwithCustomerGross>
    <vtrs:RevenuefromContractwithCustomerGross
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfMy03LTEtMS0xNTIyMDk_1be58505-c896-4691-9a97-151eb6c12727"
      unitRef="usd">7198300000</vtrs:RevenuefromContractwithCustomerGross>
    <vtrs:Chargebacks
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNS01LTEtMS0xNTIyMDk_d2531b2c-565c-4437-8cf7-eee5911f6028"
      unitRef="usd">1350700000</vtrs:Chargebacks>
    <vtrs:Chargebacks
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNS03LTEtMS0xNTIyMDk_af5635e2-f39a-4ac0-9e08-d8155f9b51d1"
      unitRef="usd">1584200000</vtrs:Chargebacks>
    <vtrs:AccruedSalesAllowances
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNi01LTEtMS0xNTIyMDk_630821dc-f5ee-4ea7-929f-4fc2e13a8535"
      unitRef="usd">992200000</vtrs:AccruedSalesAllowances>
    <vtrs:AccruedSalesAllowances
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNi03LTEtMS0xNTIyMDk_a5d9d9d8-64cc-4785-b436-461d5dcf61ff"
      unitRef="usd">1205900000</vtrs:AccruedSalesAllowances>
    <vtrs:RevenuefromContractwithCustomerReturns
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNy01LTEtMS0xNTIyMDk_d5b9342a-51c8-40b4-95f5-bd8bc9db2b3b"
      unitRef="usd">50400000</vtrs:RevenuefromContractwithCustomerReturns>
    <vtrs:RevenuefromContractwithCustomerReturns
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfNy03LTEtMS0xNTIyMDk_204e0d72-df3c-4759-8b39-310aa3a0684c"
      unitRef="usd">82600000</vtrs:RevenuefromContractwithCustomerReturns>
    <vtrs:Medicaidandothergovernmentalrebates
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfOC01LTEtMS0xNTIyMDk_973accd2-32af-4f0e-b8e9-39e5716039cd"
      unitRef="usd">160600000</vtrs:Medicaidandothergovernmentalrebates>
    <vtrs:Medicaidandothergovernmentalrebates
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfOC03LTEtMS0xNTIyMDk_9722e740-2a81-455d-b8a4-ff330c93bba9"
      unitRef="usd">147400000</vtrs:Medicaidandothergovernmentalrebates>
    <vtrs:SalesRevenueGrosstonetadjustments
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfOS01LTEtMS0xNTIyMDk_cec01bbf-7202-48be-aff4-df32fcd02fbf"
      unitRef="usd">2553900000</vtrs:SalesRevenueGrosstonetadjustments>
    <vtrs:SalesRevenueGrosstonetadjustments
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfOS03LTEtMS0xNTIyMDk_f01093b2-8bd0-4bdb-b70f-431921536ff0"
      unitRef="usd">3020100000</vtrs:SalesRevenueGrosstonetadjustments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfMTAtNS0xLTEtMTUyMjA5_17000761-29a4-4f90-827b-ccceebe898d2"
      unitRef="usd">3719100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmE4YWEwYWI2NmU4NDRlZDZiOTMxZGVlOWNlMzEyYjg2L3RhYmxlcmFuZ2U6YThhYTBhYjY2ZTg0NGVkNmI5MzFkZWU5Y2UzMTJiODZfMTAtNy0xLTEtMTUyMjA5_5658ecea-bc13-4f2d-9200-972966aa9345"
      unitRef="usd">4178200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzQxNw_ba139a1d-84aa-414d-89a8-215e05ba9378">Such allowances were comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,739.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net was comprised of the following at March&#160;31, 2023 and December&#160;31, 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,021.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,497.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,814.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ibafb46da05ec4f79a412ebc6f057d351_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMS0xLTEtMS0xNTIyMDk_2b3bb4ad-3bdb-4bee-80ad-47e8334b1afc"
      unitRef="usd">1739900000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i55285f970c3f4df4babe369127a8eb7e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMS0zLTEtMS0xNTIyMDk_881d3e18-7143-4dd6-a602-18addcbe1332"
      unitRef="usd">1798700000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ibafb46da05ec4f79a412ebc6f057d351_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMi0xLTEtMS0xNTIyMDk_83d7c5fa-e9af-4ccd-a4e0-a6c8d20e4a25"
      unitRef="usd">851500000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i55285f970c3f4df4babe369127a8eb7e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMi0zLTEtMS0xNTIyMDk_46322539-fd5a-4262-b337-3491a59285c1"
      unitRef="usd">888800000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ibafb46da05ec4f79a412ebc6f057d351_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMy0xLTEtMS0xNTIyMDk_7e419c85-bba2-4f94-bdb4-585de688ca01"
      unitRef="usd">2591400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i55285f970c3f4df4babe369127a8eb7e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOjAwYmVkMjE2NjI2NjQ3MjY4ZjFmN2UxNjkwMzc2M2M1L3RhYmxlcmFuZ2U6MDBiZWQyMTY2MjY2NDcyNjhmMWY3ZTE2OTAzNzYzYzVfMy0zLTEtMS0xNTIyMDk_cad6e565-3766-4733-a308-330cd8ffb16d"
      unitRef="usd">2687500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMS0xLTEtMS0xNTIyMDk_6ed15126-d9eb-49e6-964a-070b8368c585"
      unitRef="usd">3021900000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMS0zLTEtMS0xNTIyMDk_c6716529-d879-4ca4-a9ad-5abe67b4631b"
      unitRef="usd">3243800000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMi0xLTEtMS0xNTIyMDk_680fea5e-767a-488b-976b-9a194888e323"
      unitRef="usd">475600000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMi0zLTEtMS0xNTIyMDk_bea0e2dc-ca27-4c8d-ab51-54e04550647c"
      unitRef="usd">570700000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMy0xLTEtMS0xNTIyMDk_8e743497-9f70-4491-b3e8-4f23bbb17afe"
      unitRef="usd">3497500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RhYmxlOmRiYmRjM2Q0ZmNiYzQwNDJhYWI2NjJlMTlhMjE0MjFlL3RhYmxlcmFuZ2U6ZGJiZGMzZDRmY2JjNDA0MmFhYjY2MmUxOWEyMTQyMWVfMy0zLTEtMS0xNTIyMDk_ab3addb2-ebe3-44bf-a6ec-d7b0a5f3aebb"
      unitRef="usd">3814500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ProceedsFromSaleAndCollectionOfReceivables
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzI5NA_68ccefc5-48fb-429b-afff-cb81a506e714"
      unitRef="usd">76300000</us-gaap:ProceedsFromSaleAndCollectionOfReceivables>
    <us-gaap:ProceedsFromSaleAndCollectionOfReceivables
      contextRef="i1dd48064c677421ca76bbbd5f64574f3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180My9mcmFnOjdhOTcwYWU1MGRkYzRkY2RhNzU1MDg0NjEzZjE1Zjc4L3RleHRyZWdpb246N2E5NzBhZTUwZGRjNGRjZGE3NTUwODQ2MTNmMTVmNzhfMzMwMQ_7b321d9a-a34b-4584-87c6-267b47673257"
      unitRef="usd">34700000</us-gaap:ProceedsFromSaleAndCollectionOfReceivables>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180Ni9mcmFnOjEyOWZhNTk3MzE2NzRhY2NiZTFlZmE1YjI1YWFmNzI2L3RleHRyZWdpb246MTI5ZmE1OTczMTY3NGFjY2JlMWVmYTViMjVhYWY3MjZfNzk4_5aa1cce2-12f9-4310-8ae7-23ebb9b9aa62">Recent Accounting Pronouncements&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the FASB issued Accounting Standards Update 2022-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities&#x2014;Supplier Finance Programs (Subtopic 405-50), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which requires entities to provide qualitative and quantitative disclosures about their supplier finance programs, including a rollforward of related obligations. The adoption of ASU 2022-04 did not affect the Company&#x2019;s financial condition, results of operations or cash flows as the guidance only requires additional disclosures. We adopted this ASU effective January 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain voluntary supply chain finance programs with financial intermediaries which provide participating suppliers the option to be paid by the intermediary earlier than the original invoice due date. The Company&#x2019;s responsibility is limited to making payments on the terms originally negotiated with the suppliers, regardless of whether the intermediary pays the supplier in advance of the original due date. The range of payment terms the Company negotiates with suppliers are consistent, regardless of whether a supplier participates in a supply chain finance program. The total amounts due to financial intermediaries to settle supplier invoices under supply chain finance programs as of March&#160;31, 2023 and December&#160;31, 2022 were $55.5&#160;million and $33.4&#160;million, respectively. These amounts are included within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other significant changes in new accounting standards from those disclosed in Viatris&#x2019; 2022 Form 10-K. Refer to Viatris&#x2019; 2022 Form 10-K for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:SupplierFinanceProgramObligation
      contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180Ni9mcmFnOjEyOWZhNTk3MzE2NzRhY2NiZTFlZmE1YjI1YWFmNzI2L3RleHRyZWdpb246MTI5ZmE1OTczMTY3NGFjY2JlMWVmYTViMjVhYWY3MjZfMzg0ODI5MDcwODU2Mw_cbde3511-b345-4c3d-a9c7-f1c84a4024fe"
      unitRef="usd">55500000</us-gaap:SupplierFinanceProgramObligation>
    <us-gaap:SupplierFinanceProgramObligation
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180Ni9mcmFnOjEyOWZhNTk3MzE2NzRhY2NiZTFlZmE1YjI1YWFmNzI2L3RleHRyZWdpb246MTI5ZmE1OTczMTY3NGFjY2JlMWVmYTViMjVhYWY3MjZfMzg0ODI5MDcwODU3OA_45352586-a7d3-4ea5-8470-54ceb80ef24c"
      unitRef="usd">33400000</us-gaap:SupplierFinanceProgramObligation>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTkwNQ_810e9229-8c4f-4e07-b5da-8a0a23d46fc2">Acquisitions and Other Transactions&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Oyster Point Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2023, the Company completed the acquisition of Oyster Point for approximately $427.4&#160;million in cash, which included $11 per share paid to Oyster Point stockholders through a tender offer, payment for vested share-based awards, and the repayment of debt of Oyster Point. In addition to the upfront cash consideration, each Oyster Point stockholder received one non-tradeable contingent value right representing up to an additional $2 per share, or approximately $60&#160;million in the aggregate, contingent upon Oyster Point achieving certain metrics based upon full year 2022 performance. Oyster Point did not achieve the metrics that would have triggered a contingent payment and the contingent value rights have expired. Oyster Point is focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested share-based awards to acquire Oyster Point common stock that were outstanding immediately prior to the closing of the acquisition were cancelled in exchange for the right to receive an amount in cash based upon a formula contained within the merger agreement. The unvested share-based awards were converted into Viatris share-based awards based upon a formula contained within the merger agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. During the three months ended March&#160;31, 2023, the Company incurred acquisition related costs of approximately $18.3&#160;million, which were recorded primarily in SG&amp;amp;A in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. GAAP purchase price was $392.7&#160;million, net of cash acquired. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Oyster Point is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets (excluding inventories and net of cash acquired)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identified intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired (net of $34.7 of cash acquired)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary fair value estimates for the assets acquired and liabilities assumed were based upon preliminary calculations, valuations and assumptions that are subject to change as the Company obtains additional information during the measurement period (up to one year from the acquisition date). The primary areas subject to change relate to the finalization of the valuation of intangible assets and income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a step-up in the fair value of inventory of approximately $29.3&#160;million. During the three months ended March&#160;31, 2023, the Company recorded amortization of the inventory step-up of approximately $7.3&#160;million, which is included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The identified intangible assets of $334.0 million are comprised of product rights and licenses related to a commercial asset, Tyrvaya&#xae;, for the treatment of dry eye disease, that have an estimated useful life of 10 years. Significant assumptions utilized in the valuation of identified intangible assets were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by U.S. GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill of $5.9 million arising from the acquisition consisted largely of the value of the employee workforce and the expected value of products to be developed in the future. All of the goodwill was assigned to the Developed Markets segment. None of the goodwill recognized in this transaction is currently expected to be deductible for income tax purposes. The operating results of Oyster Point have been included in the Company&#x2019;s condensed consolidated statements of operations since the acquisition date. The total revenues of Oyster Point for the period from the acquisition date to March 31, 2023, were $6.3&#160;million and net loss, net of tax, was approximately $49.3&#160;million. The net loss for the period includes the effect of the purchase accounting adjustments and acquisition related costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental unaudited pro forma information for the acquisition, as if it had occurred on January 1, 2022. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased amortization expense based on the fair value of assets acquired, the impact of transaction costs and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable, or have been achieved, subsequent to the closing of the acquisition. Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(Unaudited, in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,729.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,194.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Famy Life Sciences Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 7, 2022, the Company entered into a definitive agreement to acquire the remaining equity shares of Famy Life Sciences, a privately-owned research company with a complementary portfolio of ophthalmology therapies under development, for consideration of $281&#160;million. The Company had previously entered into a Master Development Agreement with Famy Life Sciences on December 20, 2019 under which the Company obtained rights with respect to acquiring certain pharmaceutical products and had also acquired shares representing approximately 13.5% equity interest in Famy Life Sciences for $25.0&#160;million at December 31, 2020. The investment was accounted for in accordance with ASC 321, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction to acquire the remaining equity shares of Famy Life Sciences closed during the first quarter of 2023. The Company recognized a gain of $18.9&#160;million during the first quarter of 2023 as a result of remeasuring its pre-existing 13.5% equity interest in Famy Life Sciences to fair value, which was recorded as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (income) expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. The U.S. GAAP purchase price allocated to the transaction was $325.0&#160;million, which consisted of $281&#160;million of cash consideration paid for the remaining equity shares and $43.9&#160;million for the fair value of the pre-existing 13.5% equity interest. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Famy Life Sciences is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired (net of $0.2 of cash acquired)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary fair value estimates for the assets acquired and liabilities assumed were based upon preliminary calculations, valuations and assumptions that are subject to change as the Company obtains additional information during the measurement period (up to one year from the acquisition date). The primary areas subject to change relate to the finalization of the valuation of IPR&amp;amp;D and income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount allocated to IPR&amp;amp;D represents an estimate of the fair value of purchased in-process technology for research projects that, as of the closing date of the acquisition, had not reached technological feasibility and had no alternative future use. The fair value of IPR&amp;amp;D of $290.0 million was based on the excess earnings method, which utilizes forecasts of expected cash inflows (including estimates for ongoing costs) and other contributory charges. A discount rate of 23.9% was utilized to discount net cash inflows to present values. IPR&amp;amp;D is accounted for as an indefinite-lived intangible asset and will be subject to impairment testing until completion or abandonment of the projects. Upon successful completion and launch of each product, the Company will make a determination of the estimated useful life of the individual asset. The acquired IPR&amp;amp;D projects are in various stages of completion and the estimated costs to complete these projects total approximately $120&#160;million, which are expected to be incurred through 2024. There are risks and uncertainties associated with the timely and successful completion of the projects included in IPR&amp;amp;D, and no assurances can be given that the underlying assumptions used to estimate the fair value of IPR&amp;amp;D will not change or the timely completion of each project to commercial success will occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill of $89.3 million arising from the acquisition consisted largely of the value of the employee workforce and the expected value of products to be developed in the future. All of the goodwill was assigned to the Developed Markets segment. None of the goodwill recognized in this transaction is currently expected to be deductible for income tax purposes. The acquisition did not have a material impact on the Company&#x2019;s results of operations since the acquisition date or on a pro forma basis for the three months ended March 31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ophthalmology is one of the key therapeutic areas of focus that the Company announced in February 2022 when it announced plans for certain strategic actions. With the combination of Viatris' global commercial footprint, R&amp;amp;D and regulatory capabilities and supply chain, along with Oyster Point's deep knowledge of the ophthalmology space from a clinical, medical, regulatory and commercial perspective&#x2014;including Tyrvaya&#xae;&#x2014;and Famy Life Sciences' Phase III-ready pipeline, the Company believes it has the foundation to create a leading global ophthalmology franchise, accelerating efforts to address the unmet needs of patients with ophthalmic disease and the eye care professionals who treat them.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MDc2_8d19142f-a72e-45f0-b15e-fb504b5ae64a"
      unitRef="usd">427400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MDkw_920a2255-dbb3-439a-8a75-c39eafe5acf3"
      unitRef="usdPerShare">11</us-gaap:BusinessAcquisitionSharePrice>
    <vtrs:BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNDk0NzgwMjM5NDI3MA_b015eadd-b9a9-41a8-a6d8-6d8606965132"
      unitRef="right">1</vtrs:BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights>
    <vtrs:BusinessAcquisitionContingentConsiderationPerShare
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTA4_ae624915-1a85-41be-b66a-221a627ec097"
      unitRef="usdPerShare">2</vtrs:BusinessAcquisitionContingentConsiderationPerShare>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MDk1_bf5b040b-e7cb-4922-b398-237df014f027"
      unitRef="usd">60000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNjgzNQ_f07f7cd8-df49-4387-9152-694f4187d87e"
      unitRef="usd">18300000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNDk0NzgwMjM5NDI3OA_8ba9bff2-c935-4883-8649-b138ce7fff98">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. GAAP purchase price was $392.7&#160;million, net of cash acquired. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Oyster Point is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets (excluding inventories and net of cash acquired)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identified intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired (net of $34.7 of cash acquired)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The preliminary allocation of the purchase price to the assets acquired and liabilities assumed for Famy Life Sciences is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired (net of $0.2 of cash acquired)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMwOTU1NA_193d1675-9236-40c1-b5ad-9790cabda871"
      unitRef="usd">392700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMS0xLTEtMS0xODAyOTA_4e4b0487-c6bc-46bf-8a0d-376dfb382d7c"
      unitRef="usd">26900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMi0xLTEtMS0xODAyOTA_50287abe-fb24-4708-a5fd-8428394ed79b"
      unitRef="usd">37800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMy0xLTEtMS0xODAyOTA_d545ff68-b495-4206-9a96-78a5e9b93e75"
      unitRef="usd">1400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ie6948cc281cf4adbac2e6725c137289c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfNC0xLTEtMS0xNjgxNTE_3566d447-fa07-47d0-954b-da98e8925296"
      unitRef="usd">334000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfNS0xLTEtMS0xNjgxNjY_ac8086fe-5a30-4257-900e-87409691b791"
      unitRef="usd">5900000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfNi0xLTEtMS0xODAyOTI_6909bcd2-75d7-4a2b-818a-4b89566b425b"
      unitRef="usd">17700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfNy0xLTEtMS0xODAyOTI_126420a0-318e-453d-b0e5-8305f0f4d776"
      unitRef="usd">7700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfOC0xLTEtMS0xODAyOTM_9c39aedb-0a14-4998-a4df-a2d00e7d92e1"
      unitRef="usd">431400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfOS0xLTEtMS0xODAyOTM_035695a0-46de-408c-9379-7c077f3ac700"
      unitRef="usd">37000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMTEtMS0xLTEtMTgwMjkz_29cf26e0-67ba-41ca-83f1-f2a096df3382"
      unitRef="usd">1700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjlhNmI5YWE1ZjU4NzQyMGViNDk0ZjNkNDQxMjUyZGIxL3RhYmxlcmFuZ2U6OWE2YjlhYTVmNTg3NDIwZWI0OTRmM2Q0NDEyNTJkYjFfMTItMS0xLTEtMTY4Mjc0_193d1675-9236-40c1-b5ad-9790cabda871"
      unitRef="usd">392700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNTI0Nw_2b3ad88a-3972-4144-b9a9-664dd7c14d4c"
      unitRef="usd">29300000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <vtrs:BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNTU4MA_98ea01d9-4922-4feb-9796-d3f43a02fbdb"
      unitRef="usd">7300000</vtrs:BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ie6948cc281cf4adbac2e6725c137289c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzI5NjQ4OA_3566d447-fa07-47d0-954b-da98e8925296"
      unitRef="usd">334000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8137e6d5778e45d7ac3a688bd6c289d4_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNjY4Mw_cdea5936-960f-4b45-8d8f-b3ce233f3b1a">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:Goodwill
      contextRef="i89dba480a3de4cda97573dc8978499c0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzI5NjUxMQ_ac8086fe-5a30-4257-900e-87409691b791"
      unitRef="usd">5900000</us-gaap:Goodwill>
    <us-gaap:Revenues
      contextRef="i3ad3994dc65d497295612fdbd82d203a_D20230103-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc2ODIxMw_3f8a0b62-0db7-4cde-a579-cbc1fd7e47ac"
      unitRef="usd">6300000</us-gaap:Revenues>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i3ad3994dc65d497295612fdbd82d203a_D20230103-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODg0OTQ0_c7b79402-ab19-4e31-b7f0-e50bdaf4d980"
      unitRef="usd">49300000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNDk0NzgwMjM5NDI4Mw_c649b3e8-053c-4206-a8d7-45480b646c56">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental unaudited pro forma information for the acquisition, as if it had occurred on January 1, 2022. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased amortization expense based on the fair value of assets acquired, the impact of transaction costs and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable, or have been achieved, subsequent to the closing of the acquisition. Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(Unaudited, in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,729.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,194.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfMi0xLTEtMS0xODAzMDM_3184567f-a2ce-411c-b5f4-9043b6afe99a"
      unitRef="usd">3729100000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfMi0zLTEtMS0xODAzMDQ_95b2d23e-6157-407c-841b-5726c3467d34"
      unitRef="usd">4194400000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfMy0xLTEtMS0xODAzMDM_552c11b2-f26e-48bc-8364-1016d8e82635"
      unitRef="usd">260500000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfMy0zLTEtMS0xODAzMDQ_76b1eb7f-1a3a-4cb9-afdb-0a340ea69003"
      unitRef="usd">337000000.0</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfNS0xLTEtMS0xODAzMDY_26633659-0bcf-4141-8d8c-32c174faf3ed"
      unitRef="usdPerShare">220000</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfNS0zLTEtMS0xODAzMDg_32c801a7-3df1-4bf7-b265-edc07ca922ea"
      unitRef="usdPerShare">280000</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfNi0xLTEtMS0xODAzMDY_dbee1b3e-181f-49c2-8aee-d1e33b4c7cd0"
      unitRef="usdPerShare">220000</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfNi0zLTEtMS0xODAzMDg_d556ec82-8215-40bb-a7c4-ef25f058e2c3"
      unitRef="usdPerShare">280000</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfOC0xLTEtMS0xODAzMTA_3c6538f8-b324-443a-9f48-c2d95ea295ef"
      unitRef="shares">1202500000</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfOC0zLTEtMS0xODAzMTI_6b81ffd0-53ba-482d-b2be-3a9f2703c6ce"
      unitRef="shares">1210500000</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted
      contextRef="ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfOS0xLTEtMS0xODAzMTA_38d08582-7d2f-4f9f-9a38-40305c44d03e"
      unitRef="shares">1205600000</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted
      contextRef="id6ea9a186c7840a28ee548931dbe2477_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOmMwYjIwMjdlNWU4YjRmMTM5ZDYwNWM3NDU4NzQzZTRhL3RhYmxlcmFuZ2U6YzBiMjAyN2U1ZThiNGYxMzlkNjA1Yzc0NTg3NDNlNGFfOS0zLTEtMS0xODAzMTI_b4f44d3e-a376-487a-9f0f-8e0cce088fbd"
      unitRef="shares">1213100000</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="icce36ab95a904a348f3538311028617b_D20221107-20221107"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTEy_887df470-2690-4a7f-a8bc-7e23494c1d2a"
      unitRef="usd">281000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i7828558df2f6496fabe44db31c95df87_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTI2_b49fa32d-73a9-4638-beb1-2dd8e462c070"
      unitRef="number">0.135</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i978bcc6ddcd84e688fa210aa490cfa7b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTMz_7ba7044d-711d-41ae-8569-a40ab0937dbd"
      unitRef="usd">25000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i39ea09d1bb094c10861e55e7f13a92d8_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTQ4_34a9498a-cfc9-4a24-9f5c-544df76363f3"
      unitRef="usd">18900000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i7828558df2f6496fabe44db31c95df87_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfNTQ5NzU1ODM1MTYz_835c71bd-8da5-4f10-83c8-12cb17eafbda"
      unitRef="number">0.135</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc1Nzc5NQ_396b845e-4d64-4708-896e-762c1ae7763b"
      unitRef="usd">325000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="icce36ab95a904a348f3538311028617b_D20221107-20221107"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc1ODIyMA_887df470-2690-4a7f-a8bc-7e23494c1d2a"
      unitRef="usd">281000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="icce36ab95a904a348f3538311028617b_D20221107-20221107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc1ODI3MA_822b2e26-5e5b-4a2d-a6b9-8924dd80d686"
      unitRef="usd">43900000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i7828558df2f6496fabe44db31c95df87_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMzg0ODI5MDc1ODIwOA_835c71bd-8da5-4f10-83c8-12cb17eafbda"
      unitRef="number">0.135</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i996c937d9d5d48bda3c5200c4b48c99f_I20221107"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNC0xLTEtMS0xNjgyMzI_a80d4c82-429c-400a-b0b8-6219fda0e9e5"
      unitRef="usd">290000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNS0xLTEtMS0xNjgyNDU_4381704e-1aaf-4734-a245-ce97a7d37d1e"
      unitRef="usd">89300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNS0xLTEtMS0xODA1NzE_50c42996-10bb-419d-a68a-cfab33c23a40"
      unitRef="usd">379300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNi0xLTEtMS0xODA1ODE_0603e4b5-eead-4c2f-9ede-c56cefafb4d7"
      unitRef="usd">2200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfNy0xLTEtMS0xODA1ODM_601a0d43-e0fe-4b6a-ab6e-03986f18c89c"
      unitRef="usd">52100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RhYmxlOjMxMDdkNzE3MDY5YjRhOTZhNzE5OGVhZjI1YWU0ZmRkL3RhYmxlcmFuZ2U6MzEwN2Q3MTcwNjliNGE5NmE3MTk4ZWFmMjVhZTRmZGRfOC0xLTEtMS0xNjk3MzY_396b845e-4d64-4708-896e-762c1ae7763b"
      unitRef="usd">325000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i996c937d9d5d48bda3c5200c4b48c99f_I20221107"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxMDk3Mg_a80d4c82-429c-400a-b0b8-6219fda0e9e5"
      unitRef="usd">290000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i2de5309c551f46c095be838450a8464a_I20241231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzMxNTY2NQ_01829b9c-36bb-4d98-910d-356785fa8560"
      unitRef="usd">120000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i5eb64dc34ecb4aa689649d663412eff2_I20221107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN180OS9mcmFnOmE5NzJiMzI3YWRjMTQ2MDQ5YTdiZjhiNjQwZDljOGE0L3RleHRyZWdpb246YTk3MmIzMjdhZGMxNDYwNDlhN2JmOGI2NDBkOWM4YTRfMjE5OTAyMzI5ODAxNA_4381704e-1aaf-4734-a245-ce97a7d37d1e"
      unitRef="usd">89300000</us-gaap:Goodwill>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzQ5NDc4MDIzNjQyNjg_67941785-6f36-41fa-b280-d9b16b1e6ec3">Divestitures&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Biocon Biologics Transaction&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 29, 2022, Viatris completed a transaction to contribute its biosimilars portfolio to Biocon Biologics. Under the terms of the Biocon Agreement, Viatris received $3&#160;billion in consideration in the form of a $2&#160;billion cash payment, adjusted as set forth in the Biocon Agreement, and approximately $1&#160;billion of CCPS representing a stake of approximately 12.9% (on a fully diluted basis) in Biocon Biologics. Viatris also is entitled to $335&#160;million of additional cash payments in 2024. In addition, Viatris and Biocon Biologics have agreed to a closing working capital target of $250&#160;million. An amount of cash equal to all or a portion of the closing working capital target may become payable to Biocon Biologics in connection with certain events in the future, depending on the valuations attributable to such events. Refer to Note 8 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Balance Sheet Components&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information on assets and liabilities related to Biocon Biologics. The Company&#x2019;s CCPS in Biocon Biologics are classified as equity securities, refer to Note 11 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments and Risk Management&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris and Biocon Biologics also entered an agreement pursuant to which Viatris is providing commercialization and certain other transition services on behalf of Biocon Biologics, including billings, collections, and the remittance of rebates, to ensure business continuity for patients, customers and colleagues. The term of the transition services agreement is generally up to two years. Under the transition services agreement, Viatris is entitled to be reimbursed for its costs (subject to certain caps) plus a markup. During the three months ended March 31, 2023, the Company recognized TSA income of approximately $45.7&#160;million as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Potential Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2022, the Company provided an update on the strategic priorities announced in February 2022, including identifying the following businesses no longer considered core to its future strategy that the Company intends to divest:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;OTC;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;API (while retaining some selective development API capabilities);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Women&#x2019;s health care, primarily related to our oral and injectable contraceptives. This does not include all of our women&#x2019;s health care related products; as an example, our Xulane&#xae; product in the U.S. is excluded; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;Upjohn Distributor Markets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2022, we determined that our Upjohn Distributor Markets should be classified as held for sale. Upon classification as held for sale, we recognized a total charge of $374.2&#160;million during the three months ended December 31, 2022. This was comprised of a goodwill impairment charge of $117.0&#160;million, other charges, principally inventory write-offs, of $84.3&#160;million and a charge of approximately $172.9&#160;million to write down the disposal group to fair value, less cost to sell. During the three months ended March&#160;31, 2023, the Company recorded additional inventory reserves of $9.2&#160;million and an intangible asset charge of $32.0&#160;million to write down the disposal group to fair value, less cost to sell. As of March&#160;31, 2023 and December&#160;31, 2022, assets held for sale associated with the Upjohn Distributor Markets consisted of intangible assets of $198.3&#160;million and $230.3&#160;million, respectively. If these transactions are not completed, the distribution arrangements will expire in accordance with our agreement with Pfizer and the Company will wind down operations in these markets, which may result in additional asset write-offs and other costs being incurred. These additional charges could be in excess of $250&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ia674853b0e45470192385b041b369637_I20221129"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1NjkwNQ_0adac65d-316c-461d-9517-e8700aa9a5c0"
      unitRef="usd">3000000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1NjkxNw_06d5b10d-843a-418f-a034-9675075d10d4"
      unitRef="usd">2000000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1NjkzMA_6e8f3928-34c7-4972-9dfb-c3ec685aac47"
      unitRef="usd">1000000000</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <vtrs:DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset
      contextRef="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1Njk0Mw_33230256-de5f-4f46-98b2-62e676b6bac4"
      unitRef="number">0.129</vtrs:DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset>
    <vtrs:DivestitureOfBusinessDeferredCashConsideration
      contextRef="ie5675703bf7c4d4d9da547d52dcba0ae_D20240101-20241231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1Njk1MA_eccb7eef-8cde-4fe0-a82d-9b1eecc7d4ac"
      unitRef="usd">335000000</vtrs:DivestitureOfBusinessDeferredCashConsideration>
    <vtrs:DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment
      contextRef="ia674853b0e45470192385b041b369637_I20221129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1Njk2NA_69e5db13-1954-49ed-939e-196aec8b7daa"
      unitRef="usd">250000000</vtrs:DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment>
    <vtrs:DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm
      contextRef="i89c4ccdf861942f6a7b9b0ec8914098c_D20221129-20221129"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1NzE4OQ_93bd73ed-d5df-432e-be2a-a7a8ff2c03f8">P2Y</vtrs:DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i038641544e90455d9e0b031976fcd4f7_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1Njk3OA_71e44d3b-c27c-47c9-afa9-83f3e2bca72d"
      unitRef="usd">45700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4b2491c72c1440ca895b054425f97641_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMDgwNg_baba3bb9-1eb8-480c-823d-079fc9008f50"
      unitRef="usd">374200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i92b7b3d4e0c941a592801ccaf3b5a117_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMDc3NA_1edae42d-7326-4f45-ab61-b6972ece67dd"
      unitRef="usd">117000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:AssetImpairmentCharges
      contextRef="idf62a3adcc2b4c4c84b6baf6c88c9459_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMTEwNA_37d25eea-e33a-4f9c-96c4-f9934cc89911"
      unitRef="usd">84300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i6c3140d7b1784dea88bd3908f0f56a43_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMDc5MA_e0076cb9-7179-4dff-912e-1f1cae4f55c3"
      unitRef="usd">172900000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:InventoryValuationReserves
      contextRef="i29d41bac887c45c4a70ffcc400a93b6a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzM4NDgyOTA3MzIwMTI_a76efe19-0b57-4bfb-a4a2-52219d001e68"
      unitRef="usd">9200000</us-gaap:InventoryValuationReserves>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i3f1f9e0ec712462aa02e10848d2f65c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzM4NDgyOTA3MzE5NjI_49a088d1-e711-463f-a7c2-10bb13813cbe"
      unitRef="usd">32000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="iddf72d19b27c4e84b44267057cabd078_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTg1MzE4Mg_cfafc4da-660b-40a2-af56-5cf17b7cc543"
      unitRef="usd">198300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzIxOTkwMjMyODA2NjI_12f3206a-1193-4789-8679-e7d2c256f8ec"
      unitRef="usd">230300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <vtrs:LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear
      contextRef="iddf72d19b27c4e84b44267057cabd078_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181NDk3NTU4MTUyMTUvZnJhZzo0YjI2NTkzZDQ3Y2M0NzM3YmMzNDEwMjFiMDFhODJjOS90ZXh0cmVnaW9uOjRiMjY1OTNkNDdjYzQ3MzdiYzM0MTAyMWIwMWE4MmM5XzU0OTc1NTgzMDgyMg_2dcc09c2-5c6b-4fb9-949d-06338e4b7d71"
      unitRef="usd">250000000</vtrs:LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjU1OQ_8dc14eb6-e138-47b0-b1f8-2b49389b60be">Share-Based Incentive Plan&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Distribution, Viatris adopted and Pfizer, in the capacity as Viatris&#x2019; sole stockholder at such time, approved the 2020 Incentive Plan (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Viatris Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Stock Incentive Plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) which became effective as of the Distribution. In connection with the Combination, as of November 16, 2020, the Company assumed the 2003 LTIP (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), which had previously been approved by Mylan shareholders. The 2020 Incentive Plan and 2003 LTIP include (i) 72,500,000 shares of Common Stock authorized for grant pursuant to the 2020 Incentive Plan, which may include dividend payments payable in Common Stock on unvested shares granted under awards, (ii) 6,757,640 shares of Common Stock to be issued pursuant to the exercise of outstanding stock options granted to participants under the 2003 LTIP and assumed by Viatris in connection with the Combination and (iii) 13,535,627 shares of Common Stock subject to outstanding equity-based awards, other than stock options, assumed by Viatris in connection with the Combination, or that otherwise remain available for issuance under the 2003 LTIP.&lt;/span&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2020 Incentive Plan and 2003 LTIP, shares are reserved for issuance to key employees, consultants, independent contractors and non-employee directors of the Company through a variety of incentive awards, including: stock options, SARs, restricted stock and units, PSUs, other stock-based awards and short-term cash awards. Stock option awards are granted with an exercise price equal to the fair market value of the shares underlying the stock options at the date of the grant, generally become exercisable over periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTUyOQ_2c493640-95e1-4300-976d-938a30e9093d"&gt;three&lt;/span&gt; to four years, and generally expire in ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock awards (stock options and SARs) activity under the 2020 Incentive Plan and 2003 LTIP:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares Under Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,449,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,485,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,452,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,185,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had average remaining contractual terms of 4.4 years, 4.4 years and 4.0 years, respectively. Also, at March&#160;31, 2023, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had aggregate intrinsic values of $0.6 million, $0.5 million, and $0.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the Company&#x2019;s nonvested Restricted Stock Awards (restricted stock and restricted stock unit awards, including PSUs) from December&#160;31, 2022 to March&#160;31, 2023 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Restricted Stock&#160;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair&#160;Value&#160;Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,271,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,043,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,743,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267,038)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,304,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company had $213.8 million of total unrecognized compensation expense, net of estimated forfeitures, related to all of its stock-based awards, which we expect to recognize over the remaining weighted average vesting period of 1.7 years. The total intrinsic value of Restricted Stock Awards released during the three months ended March&#160;31, 2023 and 2022 was $100.8 million and $63.1 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ib44a8bb4acc54d0893dec83f4f70479a_I20201116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfNDAx_ea791b3e-e27e-4ace-bb03-d2891b758c93"
      unitRef="shares">72500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iaabcbd4e36f64c80a1d3a99c36f4e4b9_D20201116-20201116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfNTc2_3570a63a-6501-4333-89ae-dd92002c94be"
      unitRef="shares">6757640</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i38b4ae4464494ecba320ebadb2cf078b_I20201116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfNzgx_d312b00b-0b57-4043-8c82-735c606bb577"
      unitRef="shares">13535627</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib1eb88e565a848ebb8dc702db55d4f88_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTUzNQ_ffdd3d10-1a28-445c-b320-c4a1f22b764e">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTU2Mw_f28a2903-df75-4519-bf3f-096ed8144158">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjU3NQ_fef892f1-6de3-4163-90a7-2f0260267190">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock awards (stock options and SARs) activity under the 2020 Incentive Plan and 2003 LTIP:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares Under Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,449,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,485,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,452,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,185,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMS0xLTEtMS0xNTIyMDk_7413c8e5-9dde-4bf0-9c11-b1c80471e4a7"
      unitRef="shares">4449642</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMS0zLTEtMS0xNTIyMDk_f6411bfb-221c-4570-b0e0-51f8f49ac232"
      unitRef="usdPerShare">38.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMi0xLTEtMS0xNTIyMDk_ff2e269e-6342-4b99-9b19-c1ac7e60b5db"
      unitRef="shares">283361</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMi0zLTEtMS0xNTIyMDk_98a9110e-eff4-472c-8384-45b5d67b372b"
      unitRef="usdPerShare">7.68</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMy0xLTEtMS0xNTIyMDk_23f57d68-3566-4ecb-ae38-0834dbef971a"
      unitRef="shares">5225</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfMy0zLTEtMS0xNTIyMDk_8765327d-3d66-4393-9ca0-e532c6965479"
      unitRef="usdPerShare">5.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNC0xLTEtMS0xNTIyMDk_d433d875-b21f-4242-85bf-9327023073cb"
      unitRef="shares">242165</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNC0zLTEtMS0xNTIyMDk_c3573ea5-4695-41a2-9f08-06c6d72b06e8"
      unitRef="usdPerShare">31.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNS0xLTEtMS0xNTIyMDk_9e31d140-1999-471a-8a9d-c67e2d93618a"
      unitRef="shares">4485613</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNS0zLTEtMS0xNTIyMDk_82ac31f7-b66c-4245-86bb-b1182bb76eb4"
      unitRef="usdPerShare">37.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNi0xLTEtMS0xNTIyMDk_1d25994e-092e-4040-a834-aaad0096c555"
      unitRef="shares">4452279</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNi0zLTEtMS0xNTIyMDk_027ee9a8-68ca-40c3-bc3b-fe8120fa975e"
      unitRef="usdPerShare">37.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNy0xLTEtMS0xNTIyMDk_a8a05c23-0611-41bd-838c-87c8906539e5"
      unitRef="shares">4185316</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjI1OTE0OTIyZjIxYTQ5NzI4ZWYxMjUyODcwYmQ3MzEwL3RhYmxlcmFuZ2U6MjU5MTQ5MjJmMjFhNDk3MjhlZjEyNTI4NzBiZDczMTBfNy0zLTEtMS0xNTIyMDk_3a7d16d8-aa6b-4131-b665-4e0dbe49337f"
      unitRef="usdPerShare">38.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="idc3bcc18e42c4bd1a5362ab466d46293_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTgyNg_c02d2ce0-11c7-4479-bd00-a185a806a3a2">P4Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="idc3bcc18e42c4bd1a5362ab466d46293_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTgzMA_bfeaad81-5e6b-4395-bb1a-bab79c43a5d4">P4Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="idc3bcc18e42c4bd1a5362ab466d46293_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTgzNw_d5798688-aa2a-49ac-b737-54fed72cc876">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTY0OTI2NzQ0NTEzNw_7a627f44-83ed-4146-8013-a7e79a67bd86"
      unitRef="usd">600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTY0OTI2NzQ0NTE0Mw_554b67af-821e-43be-84cf-06fca23494b0"
      unitRef="usd">500000</vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMTY0OTI2NzQ0NTE1Mw_f7f35661-9610-4627-9567-75927e10e188"
      unitRef="usd">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjU1Mw_ae1c2100-b3fd-41b8-b851-9a96b70050f8">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the Company&#x2019;s nonvested Restricted Stock Awards (restricted stock and restricted stock unit awards, including PSUs) from December&#160;31, 2022 to March&#160;31, 2023 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Restricted Stock&#160;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair&#160;Value&#160;Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,271,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,043,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,743,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267,038)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,304,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib6be2e59be8047b5bdb3bca88fdac9b2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMS0xLTEtMS0xNTIyMDk_50c77372-7ad4-4a82-96e6-19ebda1f400b"
      unitRef="shares">27271926</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib6be2e59be8047b5bdb3bca88fdac9b2_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMS0zLTEtMS0xNTIyMDk_acaa62c2-b17d-42c8-b0ce-c1f98137d241"
      unitRef="usdPerShare">11.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMi0xLTEtMS0xNTIyMDk_e8703ba8-81a3-4674-8d59-09d4f4b32a07"
      unitRef="shares">19043465</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMi0zLTEtMS0xNTIyMDk_141d1cce-f01c-47a1-a5a8-c521f5c55f3f"
      unitRef="usdPerShare">11.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMy0xLTEtMS0xNTIyMDk_d283d588-bebd-497f-a3c6-36c90696d918"
      unitRef="shares">7743490</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfMy0zLTEtMS0xNTIyMDk_c4fd2237-3801-4fd4-9740-69ef6a6defe8"
      unitRef="usdPerShare">13.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfNC0xLTEtMS0xNTIyMDk_094c3562-1d6f-4ea8-8b7e-7fee03e3f2e7"
      unitRef="shares">267038</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i79133970a2b34e65b4753f058974244f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfNC0zLTEtMS0xNTIyMDk_16dc58e8-ebc9-49ad-a022-441b0c227868"
      unitRef="usdPerShare">11.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2c529f37c6a8452daf8c5630c4b137dc_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfNS0xLTEtMS0xNTIyMDk_c44d4c0f-313e-4568-a6c6-d2b2e0f711ae"
      unitRef="shares">38304863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2c529f37c6a8452daf8c5630c4b137dc_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RhYmxlOjZkMTJhMmNiY2RiOTQxN2M5NzAxMjdmM2Y3NmE2NGRhL3RhYmxlcmFuZ2U6NmQxMmEyY2JjZGI5NDE3Yzk3MDEyN2YzZjc2YTY0ZGFfNS0zLTEtMS0xNTIyMDk_8561a94b-ac55-4b05-a2b2-039eccdfdf0b"
      unitRef="usdPerShare">11.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i0a6b105d683e44f1b695dbd0fdd19afa_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjIzMg_63779230-24eb-4500-b7fb-2a769eeddf6c"
      unitRef="usd">213800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3f1530fe010f4d8283807e9da9561509_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjQzNA_5754a916-e085-40e0-8649-ece26b3cda68">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
      contextRef="i3f1530fe010f4d8283807e9da9561509_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjUyNw_7b717f40-5e7e-4f71-9a51-ab3e2932590d"
      unitRef="usd">100800000</vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
      contextRef="i1af79b8021fc47028b95741c1cc39d78_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181Mi9mcmFnOjFjZjNjMjdlZmQ2MTQ5Y2I4NTE4ZDY2ZGMwYmNiMzQ0L3RleHRyZWdpb246MWNmM2MyN2VmZDYxNDljYjg1MThkNjZkYzBiY2IzNDRfMjUzNA_7037727e-ae9d-456a-a6f6-ffc9a98a2948"
      unitRef="usd">63100000</vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RleHRyZWdpb246M2MxYjY1ZTY4YTc4NGYzYTg0YjMyMzc4MTBmNDg0OGFfMTM0OA_15c3d1ec-0e73-4d2b-bf20-ab6df90a044c">Pensions and Other Postretirement Benefits&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors various defined benefit pension plans in several countries. Benefits provided generally depend on length of service, pay grade and remuneration levels. Employees in the U.S., Puerto Rico and certain international locations are also provided retirement benefits through defined contribution plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also sponsors other postretirement benefit plans including plans that provide for postretirement supplemental medical coverage. Benefits from these plans are provided to employees and their spouses and dependents who meet various minimum age and service requirements. In addition, the Company sponsors other plans that provide for life insurance benefits and postretirement medical coverage for certain officers and management employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Periodic Benefit Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of net periodic benefit cost for the three months ended March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension and Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is making the minimum mandatory contributions to its defined benefit pension plans in the U.S. and Puerto Rico for the 2023 plan year. The Company expects to make total benefit payments of approximately $108.5 million from pension and other postretirement benefit plans in 2023. The Company anticipates making contributions to pension and other postretirement benefit plans of approximately $51.3 million in 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RleHRyZWdpb246M2MxYjY1ZTY4YTc4NGYzYTg0YjMyMzc4MTBmNDg0OGFfMTM0Mw_d318e262-eece-4011-a72a-a21f758d7ade">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of net periodic benefit cost for the three months ended March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension and Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNC01LTEtMS0xNTIyMDk_2fbba23c-d45b-4ac7-8f6d-28880c920cc5"
      unitRef="usd">7100000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNC03LTEtMS0xNTIyMDk_155b841e-72a8-4d7c-ad31-3247bb70eec1"
      unitRef="usd">9500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNS01LTEtMS0xNTIyMDk_1d21871a-5a40-4e8e-8164-5939c3a8a4a3"
      unitRef="usd">18300000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNS03LTEtMS0xNTIyMDk_472cd6ab-e050-4118-ab73-9819fc437ee7"
      unitRef="usd">10400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNi01LTEtMS0xNTIyMDk_cb0ba90e-73e0-42dd-995a-77eb7e7bb61d"
      unitRef="usd">16400000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNi03LTEtMS0xNTIyMDk_e903afc9-4b8e-48a8-bf52-dad53c85364a"
      unitRef="usd">16600000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNy01LTEtMS0xNTIyMDk_59dc3a84-2c6e-493f-ab74-6ed74071c4b0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfNy03LTEtMS0xNTIyMDk_187cba54-e453-49ac-9332-70c82863bfb4"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfOC01LTEtMS0xNTIyMDk_25e2bf52-d8c4-4b47-9a2c-4ccfb3c9bfb7"
      unitRef="usd">5000000.0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfOC03LTEtMS0xNTIyMDk_00c9cc7d-c64b-4dee-9243-021920116b3d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfOS01LTEtMS0xNTIyMDk_95e38c16-9b39-4774-8403-c6b6e67c0cab"
      unitRef="usd">4000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8dea885604594444a89c859250a37b79_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RhYmxlOmEyMTcxYzdjMWUxZjRiOWI5ZmJhMGZhNDFkYTYyODAyL3RhYmxlcmFuZ2U6YTIxNzFjN2MxZTFmNGI5YjlmYmEwZmE0MWRhNjI4MDJfOS03LTEtMS0xNTIyMDk_a0b8ce1c-2577-4c6f-b425-ea49cc5dc246"
      unitRef="usd">3400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RleHRyZWdpb246M2MxYjY1ZTY4YTc4NGYzYTg0YjMyMzc4MTBmNDg0OGFfMTE1OA_3b6b41c4-2bee-4632-b290-776ed2a91736"
      unitRef="usd">108500000</vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN181OC9mcmFnOjNjMWI2NWU2OGE3ODRmM2E4NGIzMjM3ODEwZjQ4NDhhL3RleHRyZWdpb246M2MxYjY1ZTY4YTc4NGYzYTg0YjMyMzc4MTBmNDg0OGFfMTMzMg_9556e5fd-3045-4467-ba61-b3da97bc571d"
      unitRef="usd">51300000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAxMA_9888bcd5-fbb9-431e-bf44-200d8808c08d">Balance Sheet Components&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected balance sheet components consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,259.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, included in prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,192.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,664.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,763.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses consist primarily of prepaid rent, insurance and other individually insignificant items. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,051.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,936.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,539.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,145.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,083.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,137.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,007.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-marketable equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred consideration due from Biocon Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CCPS in Biocon Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,418.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,957.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and professional accruals, including litigation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to Biocon Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,192.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other long-term obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax related items, including contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other long-term obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMTk5Mw_43fd57c8-e221-4019-99e6-4cd18dd36080">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,259.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, included in prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMS0xLTEtMS0xNTIyMDk_74f28a0b-8f02-40c1-9459-50fa1a806160"
      unitRef="usd">506600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMS0zLTEtMS0xNTIyMDk_4e8a328d-64b7-42b6-87e0-5599999a0433"
      unitRef="usd">1259900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMS01LTEtMS0xNTIyMDk_ba8f72e0-2f6e-4f85-aa01-72d96f1637e3"
      unitRef="usd">752400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMi0xLTEtMS0xNTIyMDk_d1d7107e-7c55-4822-95e7-c4b9c7bd3a7d"
      unitRef="usd">4100000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMi0zLTEtMS0xNTIyMDk_a5e15c3f-c3ab-42af-a82e-c94d22f3f268"
      unitRef="usd">2600000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMi01LTEtMS0xNTIyMDk_5f38ea6b-1f48-4a00-8d34-afc16bcf77f7"
      unitRef="usd">5000000.0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMy0xLTEtMS0xNTIyMDk_84e966c3-6510-4cae-af8e-afb8587b91f6"
      unitRef="usd">510700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMy0zLTEtMS0xNTIyMDk_d0264ea9-21eb-45a6-aee2-24e882bf35e0"
      unitRef="usd">1262500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmZmMTVkYWY3NmQ1YTQ3NzA4OTllYmVmYzgxYjE4Yjk5L3RhYmxlcmFuZ2U6ZmYxNWRhZjc2ZDVhNDc3MDg5OWViZWZjODFiMThiOTlfMy01LTEtMS0xNTIyMDk_eac84794-b3db-4cd5-9f96-bf38338421e2"
      unitRef="usd">757400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAzNg_0439f3b4-a594-453b-80a0-c381a33dc753">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,192.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,664.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMS0xLTEtMS0xNTIyMDk_2116a6b3-d59b-47b7-a6b8-11dba4668e6c"
      unitRef="usd">667400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMS0zLTEtMS0xNTIyMDk_826dc469-4e55-446e-8cc6-8ac99ef76409"
      unitRef="usd">571500000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMi0xLTEtMS0xNTIyMDk_05297ef7-e41c-49a6-9a58-af38cffaa9d8"
      unitRef="usd">697400000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMi0zLTEtMS0xNTIyMDk_ea4c17c8-5ef8-4a70-a7cd-04f337ec966b"
      unitRef="usd">755400000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMy0xLTEtMS0xNTIyMDk_fc35aa19-58c3-4a15-9012-c83a1de7d521"
      unitRef="usd">2299500000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfMy0zLTEtMS0xNTIyMDk_0dc8e12e-e088-4bea-9f99-fa454150eb63"
      unitRef="usd">2192600000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfNC0xLTEtMS0xNTIyMDk_3d96e1d8-f0a9-4c40-8955-35f110717429"
      unitRef="usd">3664300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYyNjRlOWQyYzk4YzQ4ZDQ4NDkzNTQ1NWY4NmMwODkxL3RhYmxlcmFuZ2U6NjI2NGU5ZDJjOThjNDhkNDg0OTM1NDU1Zjg2YzA4OTFfNC0zLTEtMS0xNTIyMDk_a5a69ec4-bbf2-4c33-8bfe-3d0b243106a6"
      unitRef="usd">3519500000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjA0OA_76e8a000-6d66-4c21-8d8f-e163f4570ba8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,763.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfMS0xLTEtMS0xNTIyMDk_9cf530a4-11ff-4a8c-aa6b-fe00fdba138f"
      unitRef="usd">239700000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfMS0zLTEtMS0xNTIyMDk_706813f7-8a93-4b45-a660-dc08892f18fc"
      unitRef="usd">194600000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idfd05d1cfff54696a4f01f4ac88a2938_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfMy0xLTEtMS0xNTIyMDk_eebb0f2d-39d9-4f65-9986-359be8d2e1c0"
      unitRef="usd">36000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i05e11cf9ad644b68af5c0ac002a0b693_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfMy0zLTEtMS0xNTIyMDk_38efbfb2-cf08-444f-9b7b-00f57f39f385"
      unitRef="usd">35300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNC0xLTEtMS0xNTIyMDk_f9d9dca7-9a73-45b9-ae62-a945dcfde9e5"
      unitRef="usd">92500000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNC0zLTEtMS0xNTIyMDk_560e0178-bbe0-4bec-ba55-641c9746c4ec"
      unitRef="usd">134700000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:TradingSecurities
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNS0xLTEtMS0xNTIyMDk_1c0838e3-5448-4e88-959c-4bc926bf8eff"
      unitRef="usd">45000000.0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNS0zLTEtMS0xNTIyMDk_1350c63d-7f66-418a-926c-05577e3374cb"
      unitRef="usd">42600000</us-gaap:TradingSecurities>
    <us-gaap:OtherAssetsCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNi0xLTEtMS0xNTIyMDk_8647db03-7c46-4f31-ac9a-cbc7cd97ca3d"
      unitRef="usd">1350400000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNi0zLTEtMS0xNTIyMDk_341b0e78-8805-4fea-b7a9-9f3e45cb1765"
      unitRef="usd">1404000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNy0xLTEtMS0xNTIyMDk_7f54f218-bf3f-4b33-b846-6f2f1e015738"
      unitRef="usd">1763600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjQwZTkzMzdhMWYzYjRjMGNhMDM5NDg4MWY3ZGQ3MzAwL3RhYmxlcmFuZ2U6NDBlOTMzN2ExZjNiNGMwY2EwMzk0ODgxZjdkZDczMDBfNy0zLTEtMS0xNTIyMDk_0df26cb5-b41e-400c-a0bf-7aba3364c9c7"
      unitRef="usd">1811200000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAxNA_a94ddcfd-2487-4006-bb32-c68b4d682c65">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,051.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,936.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,539.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,145.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,083.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,137.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,007.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i203edc74353240bcb584d5be70ab7977_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMS0xLTEtMS0xNTIyMDk_6c9ddd3a-9f91-4610-a14c-2870d99ed9ee"
      unitRef="usd">3051300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie899de488efe457d85cdd16eebe2e01a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMS0zLTEtMS0xNTIyMDk_80b1ca17-9bfb-480d-839d-46adade75c0b"
      unitRef="usd">2936700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i622683f47bb4406a81794008b13dda9d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMi0xLTEtMS0xNTIyMDk_8c618b41-b167-4f98-9131-6be5e4e17ed8"
      unitRef="usd">1548000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic5dd0738d5ad4d438464fda8015cbfc8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMi0zLTEtMS0xNTIyMDk_18f35f5e-8f71-4bf0-990c-6b3274dc05cb"
      unitRef="usd">1539700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iccaac04969444cd0ac6e71b631cc378d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMy0xLTEtMS0xNTIyMDk_1d3eb005-774f-481b-b74c-938a6fb702f6"
      unitRef="usd">410800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie37168f0983848249b7f1e89a1acb5bd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfMy0zLTEtMS0xNTIyMDk_e74e7019-c194-42c6-871d-8d35c7d19335"
      unitRef="usd">474000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iefd395d7495640418781dfc639bb703c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNC0xLTEtMS0xNTIyMDk_93f11582-dbde-4b74-8bb6-b71c7459d2b9"
      unitRef="usd">135000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5aaabd86415e4b8c9c1cbaa20a6ed1e9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNC0zLTEtMS0xNTIyMDk_b4f8e7d2-13ca-4d03-8152-1358d3979130"
      unitRef="usd">133400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNS0xLTEtMS0xNTIyMDk_99dee379-f8c5-4978-8656-637f999a6129"
      unitRef="usd">5145100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNS0zLTEtMS0xNTIyMDk_10afdbc4-3c7e-460a-b6e7-bfae7f37a59a"
      unitRef="usd">5083800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNi0xLTEtMS0xNTIyMDk_ecf24c10-d180-48bd-b68a-852aa1aaea07"
      unitRef="usd">2137300000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNi0zLTEtMS0xNTIyMDk_3058d170-01d5-47ee-a0c7-208c1bd8332a"
      unitRef="usd">2059300000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNy0xLTEtMS0xNTIyMDk_50d20b92-ddb5-4986-884b-0a67870fd2ca"
      unitRef="usd">3007800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmI4OGU4OWMzY2I4NTQ4OTJiODY4ZmVhYjIxMTQ3OWJjL3RhYmxlcmFuZ2U6Yjg4ZTg5YzNjYjg1NDg5MmI4NjhmZWFiMjExNDc5YmNfNy0zLTEtMS0xNTIyMDk_ea87fbb3-ef71-4558-a771-e6c1e00d63b6"
      unitRef="usd">3024500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMTk5Nw_a6627e0a-986a-4c89-9226-05bb547a1fd2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-marketable equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred consideration due from Biocon Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CCPS in Biocon Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,418.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="iaf65b15f46464ee7bcba67fd57306449_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMi0xLTEtMS0xNTU3MTU_6aa14494-de00-4522-9258-cbbf8e2eaeb0"
      unitRef="usd">78600000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="i494e53d7c58e4d6584c23bf2ff9bfdde_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMi0zLTEtMS0xNTU3Mjc_70740fb1-d8d3-4faf-bfd2-ad821c826b94"
      unitRef="usd">94000000.0</us-gaap:EquitySecuritiesFvNiCost>
    <vtrs:DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue
      contextRef="ife9befdab44e4072aed4aebf4c9a7ee7_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMy0xLTEtMS0xNTU3MTU_eec4d82e-8fea-4445-8c06-7599648c6446"
      unitRef="usd">305900000</vtrs:DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue>
    <vtrs:DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue
      contextRef="i93a2d261bfaa44f3a3567fe550854179_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMy0zLTEtMS0xNTU3Mjc_ba539502-888a-4f64-9b8a-1f30cc1d13f8"
      unitRef="usd">299500000</vtrs:DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="ib1b9374126f5469796e980e745fabbf4_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfNC0xLTEtMS0xNTU3NDE_0b7b5339-e2f4-44f2-a38d-c844ea24d789"
      unitRef="usd">1000000000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="i2e2ad85211354ff6a1843c453c13ec41_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfNC0zLTEtMS0xNTU3NDg_04f80433-d710-4ac0-a094-160a97101e8b"
      unitRef="usd">997400000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMi0xLTEtMS0xNTIyMDk_b312b5c4-7795-46d4-bc7d-2cc824fc971f"
      unitRef="usd">253800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMi0zLTEtMS0xNTIyMDk_a2f128ee-9d84-4e05-9b02-03a9b639209b"
      unitRef="usd">259300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <vtrs:Otherlongtermassets
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMy0xLTEtMS0xNTIyMDk_d0880237-b03a-4bfd-9ff1-2aaead05034d"
      unitRef="usd">779900000</vtrs:Otherlongtermassets>
    <vtrs:Otherlongtermassets
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfMy0zLTEtMS0xNTIyMDk_a7bd17f3-3853-47d8-8730-d1d86810e8ab"
      unitRef="usd">753300000</vtrs:Otherlongtermassets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfNC0xLTEtMS0xNTIyMDk_a1a0dc9a-f0c7-448c-9b93-595dde5a7e97"
      unitRef="usd">2418200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjRlOTBhOTgxNDQxZTQ0YTI4NjQ2ZGEyNDU5MWUwN2MxL3RhYmxlcmFuZ2U6NGU5MGE5ODE0NDFlNDRhMjg2NDZkYTI0NTkxZTA3YzFfNC0zLTEtMS0xNTIyMDk_9810154f-5307-4282-b2ec-04a827cc4da7"
      unitRef="usd">2403500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAyMw_3f9255a2-6a1b-4e08-baa2-64af5e4656c1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,957.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMS0xLTEtMS0xNTIyMDk_52fa197d-52c8-4759-b4d2-ef6d01e06ff9"
      unitRef="usd">1415400000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMS0zLTEtMS0xNTIyMDk_f682140d-4de3-400c-8a55-933724ebbb26"
      unitRef="usd">1158000000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMi0xLTEtMS0xNTIyMDk_a215af09-fecb-45fb-9235-8e6d582906e6"
      unitRef="usd">542100000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMi0zLTEtMS0xNTIyMDk_32a5b430-d837-4045-a930-716a7c90f385"
      unitRef="usd">608600000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMy0xLTEtMS0xNTIyMDk_2909fd6b-1f09-4623-8d68-ce746d6efa00"
      unitRef="usd">1957500000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjYxMzM3MTY5Y2NiMjRkZDQ5MTk5ZmZhNjQ5Yzk4MWU2L3RhYmxlcmFuZ2U6NjEzMzcxNjljY2IyNGRkNDkxOTlmZmE2NDljOTgxZTZfMy0zLTEtMS0xNTIyMDk_6a546eb3-1b9a-4017-b910-c8b5895d68ad"
      unitRef="usd">1766600000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAzNA_2ab9b85a-8a5d-4b01-a2cf-12332a7a5cd8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and professional accruals, including litigation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to Biocon Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,192.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ibafb46da05ec4f79a412ebc6f057d351_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMS0xLTEtMS0xNTIyMDk_83d7c5fa-e9af-4ccd-a4e0-a6c8d20e4a25"
      unitRef="usd">851500000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i55285f970c3f4df4babe369127a8eb7e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMS0zLTEtMS0xNTIyMDk_46322539-fd5a-4262-b337-3491a59285c1"
      unitRef="usd">888800000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMi0xLTEtMS0xNTIyMDk_d92c3fd8-ca93-4064-bfec-e34abdc2c90b"
      unitRef="usd">288800000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMi0zLTEtMS0xNTIyMDk_89a71fec-8549-4efe-8e3b-a47687c85929"
      unitRef="usd">297200000</us-gaap:LitigationReserveCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMy0xLTEtMS0xNTIyMDk_f9a8f0bf-5204-4c1d-9415-c8965a9fb911"
      unitRef="usd">617700000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMy0zLTEtMS0xNTIyMDk_ec072ec8-1e5f-4612-8f59-b5375a4e616f"
      unitRef="usd">746800000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icabcde1e2ac34fc091515c433c41ff7c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNC0xLTEtMS0xNTIyMDk_0c3f0492-629c-47e3-8249-e890726918b4"
      unitRef="usd">65400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idc8794cd5f5a45ab8724cd054ea59719_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNC0zLTEtMS0xNTIyMDk_cad52d07-58df-456a-bc8b-96c879a8d598"
      unitRef="usd">64400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RestructuringReserveCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNS0xLTEtMS0xNTIyMDk_fbaaa735-c48d-45b1-87a3-8d0e32a4366e"
      unitRef="usd">74600000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNS0zLTEtMS0xNTIyMDk_f52e87ef-ce9a-4519-b657-0ab7c65b8e25"
      unitRef="usd">95300000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNi0xLTEtMS0xNTIyMDk_8b123791-3b9f-4004-bb37-2d6c45172208"
      unitRef="usd">214000000.0</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfNi0zLTEtMS0xNTIyMDk_7cd47931-746f-42fc-a3b7-697ff49ac9a0"
      unitRef="usd">80200000</us-gaap:InterestPayableCurrent>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfOS0xLTEtMS0xNTIyMDk_bf9f9903-f10e-4c7d-b7a5-2eab15041486"
      unitRef="usd">98500000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfOS0zLTEtMS0xNTIyMDk_215fabc6-8e58-432a-93e7-8f52c02c9d9b"
      unitRef="usd">187000000.0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTAtMS0xLTEtMTU1NzYz_aca02d64-f1e4-444f-b542-8a30a1765cf9"
      unitRef="usd">32100000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTAtMy0xLTEtMTU1Nzcw_63ee7c76-7fbf-4dcb-85f2-ada6e53e75a1"
      unitRef="usd">22500000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTAtMS0xLTEtMTUyMjA5_31a46bdc-fcd2-416d-8083-609db1e56dde"
      unitRef="usd">83500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTAtMy0xLTEtMTUyMjA5_b9f86921-de6a-4add-bc00-0e4997825587"
      unitRef="usd">80600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTEtMS0xLTEtMTUyMjA5_9d263e90-9d13-4ba7-9b84-58a4e1753e0b"
      unitRef="usd">866700000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTEtMy0xLTEtMTUyMjA5_abffc416-3e23-4333-b528-24e2c0b66baf"
      unitRef="usd">978100000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTItMS0xLTEtMTUyMjA5_95c77a53-7718-4f1a-9bf8-37f31ccd1ba3"
      unitRef="usd">3192800000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOmFhNzc4MTU2ZjYwNDQ5NGY5NTk4YjlhMGY2YTM0ZGQyL3RhYmxlcmFuZ2U6YWE3NzgxNTZmNjA0NDk0Zjk1OThiOWEwZjZhMzRkZDJfMTItMy0xLTEtMTUyMjA5_d13949e9-fe7b-45ef-a497-da9fabba9014"
      unitRef="usd">3440900000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMjAyMg_fc1de333-2729-41f4-865f-b22822f5ba00">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other long-term obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax related items, including contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other long-term obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfMS0xLTEtMS0xNTIyMDk_9932fa61-854d-4e86-89c5-fff17b87a36c"
      unitRef="usd">542100000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfMS0zLTEtMS0xNTIyMDk_537efbfa-337b-41af-8f70-2eba032f0a52"
      unitRef="usd">544600000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id4564ffd038a447684a267ff28783411_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfMi0xLTEtMS0xNTIyMDk_4467f419-0ef0-4f1f-8150-e79f3b2e2a46"
      unitRef="usd">307100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i14e5adad79794593a0ea10be84abb721_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfMi0zLTEtMS0xNTIyMDk_895fb99a-66f5-4136-b1a5-61cc28bb7030"
      unitRef="usd">310600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNC0xLTEtMS0xNTIyMDk_a626c1f1-50d2-4d88-b3df-1cb17b33f4e6"
      unitRef="usd">418000000.0</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNC0zLTEtMS0xNTIyMDk_8212b814-8d7f-4efb-a132-5456e4c585e3"
      unitRef="usd">414600000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNS0xLTEtMS0xNTIyMDk_b311b34e-21dd-412b-9d6d-4d932f25ce3c"
      unitRef="usd">173200000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNS0zLTEtMS0xNTIyMDk_13a62aac-15d5-42b1-bd93-70cfe13f756a"
      unitRef="usd">181400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNi0xLTEtMS0xNTIyMDk_026876b7-f0a8-4b46-bd2b-53d7c7aee730"
      unitRef="usd">58000000.0</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNi0zLTEtMS0xNTIyMDk_dde2a22a-6771-4636-844e-7ea1d2f12189"
      unitRef="usd">60400000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNy0xLTEtMS0xNTIyMDk_af761789-ae86-42e4-a706-5fe264131190"
      unitRef="usd">221400000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfNy0zLTEtMS0xNTIyMDk_0a49138e-93c9-4745-9f05-330e5d0fbadb"
      unitRef="usd">244900000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfOC0xLTEtMS0xNTIyMDk_04b5a2a1-0eb5-477c-b3b0-8456beba7252"
      unitRef="usd">1719800000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RhYmxlOjUzNmVmNDBmYWY2YzRhZGM4YTljZjAwYThhODc4ZDI1L3RhYmxlcmFuZ2U6NTM2ZWY0MGZhZjZjNGFkYzhhOWNmMDBhOGE4NzhkMjVfOC0zLTEtMS0xNTIyMDk_14d901d3-3924-4d76-ae67-1dddf8ca026a"
      unitRef="usd">1756500000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia7752f8ef2694f2a99cedc3a924ac6ed_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMzI5ODUzNDg4NzQ3Mg_3b48ca21-a723-4a2f-82b6-f1b794c94988"
      unitRef="usd">224700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic37bdf396cbd4497bee0629253c5ed9c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN182MS9mcmFnOjU1OGExM2ZhNDA4NTQ1ZjdhYzBiM2FlY2U0NTkwYWMwL3RleHRyZWdpb246NTU4YTEzZmE0MDg1NDVmN2FjMGIzYWVjZTQ1OTBhYzBfMzI5ODUzNDg4NzUwMg_23da7e70-b881-47ef-a1b5-3a6816b8a772"
      unitRef="usd">221200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfNDk0NzgwMjMzODYwNg_20815689-e33b-4f25-86cd-9988f19fb5f3">Earnings&#160;per ShareBasic earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total dilutive shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional stock awards and Restricted Stock Awards were outstanding during the three months ended March&#160;31, 2023 and 2022, but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares at March&#160;31, 2023 include certain share-based compensation awards whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 13.9 million shares and 15.5 million shares for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid a quarterly dividend of $0.12 per share on the Company&#x2019;s issued and outstanding common stock on March 17, 2023. On May&#160;5, 2023, the Company&#x2019;s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company&#x2019;s issued and outstanding common stock, which will be payable on June&#160;16, 2023 to shareholders of record as of the close of business on May&#160;24, 2023. The declaration and payment of future dividends to holders of the Company&#x2019;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#x2019;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.&lt;/span&gt;&lt;/div&gt;On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0&#160;billion of the Company&#x2019;s shares of common stock. Such repurchases may be made from time-to-time at the Company&#x2019;s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the three months ended March 31, 2023, the Company repurchased approximately 21.2&#160;million shares of common stock at a cost of approximately $250 million. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMjYxMQ_011dd5bb-e3e4-400d-b34e-d45e0bfae99e">Basic earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMjYyNg_e0052822-9ddd-484a-b51e-fabde3d72247">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total dilutive shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNC01LTEtMS0xNTIyMDk_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6"
      unitRef="usd">224700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNC03LTEtMS0xNTIyMDk_21ea8900-812e-42b1-bf29-832a88880c0e"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNi01LTEtMS0xNTIyMDk_76debc38-3b8b-4b93-8a36-50dd70c3cf6e"
      unitRef="shares">1202500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNi03LTEtMS0xNTIyMDk_8b2d6b6a-6b95-4e9e-9bf5-53ff40cf0d67"
      unitRef="shares">1210500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNy01LTEtMS0xNTIyMDk_b57155b6-1e81-4877-a9e2-adcfc9db994c"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfNy03LTEtMS0xNTIyMDk_1e207442-ce21-48af-b38c-5170d93323b4"
      unitRef="usdPerShare">0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTAtNS0xLTEtMTUyMjA5_6d5182dc-511c-49a5-b1b0-9869bcfe6ce6"
      unitRef="usd">224700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTAtNy0xLTEtMTUyMjA5_21ea8900-812e-42b1-bf29-832a88880c0e"
      unitRef="usd">399200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTItNS0xLTEtMTUyMjA5_76debc38-3b8b-4b93-8a36-50dd70c3cf6e"
      unitRef="shares">1202500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTItNy0xLTEtMTUyMjA5_8b2d6b6a-6b95-4e9e-9bf5-53ff40cf0d67"
      unitRef="shares">1210500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTMtNS0xLTEtMTUyMjA5_90935131-8aaa-460a-993a-a37578822545"
      unitRef="shares">3100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTMtNy0xLTEtMTUyMjA5_869478ff-6fdd-496c-85bf-e8dc65777800"
      unitRef="shares">2600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTQtNS0xLTEtMTUyMjA5_dd88b844-0992-4cd0-9a61-cd5b49709139"
      unitRef="shares">1205600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTQtNy0xLTEtMTUyMjA5_2aeae296-7ab9-4f06-abb6-c0e092257af6"
      unitRef="shares">1213100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTUtNS0xLTEtMTUyMjA5_104acf74-a55e-4f80-ac07-90fab44094c9"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RhYmxlOmE4ZmQ3Nzg0ZjY4NjRiNzBiNmZlZmUwYWRjOTVhNTY5L3RhYmxlcmFuZ2U6YThmZDc3ODRmNjg2NGI3MGI2ZmVmZTBhZGM5NWE1NjlfMTUtNy0xLTEtMTUyMjA5_39a5ebcb-0a0d-4937-9096-0d039e67dc79"
      unitRef="usdPerShare">0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMTAxMQ_573af268-8ffe-4cb4-82bb-79d3842e0f56"
      unitRef="shares">13900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMTAyNQ_10cbffe2-31e4-4f21-8a1a-5c4de3d18946"
      unitRef="shares">15500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMTExMg_11ef565d-0cdf-43aa-8520-ab4cf2058a99"
      unitRef="usdPerShare">0.12</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="id9dad55e2c314d8395d549deaa53e6ce_D20230317-20230317"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMjc0ODc3OTA3NjQyNQ_11ef565d-0cdf-43aa-8520-ab4cf2058a99"
      unitRef="usdPerShare">0.12</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ibce300835f6a4dfb8c87fe6f01d94e1f_I20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfMjM0Mg_ea83f89f-b825-4f53-8795-1bd847d8564a"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfNTQ5NzU1ODI2Mzcw_86c482a7-97da-4c67-aee1-f13d536a1124"
      unitRef="shares">21200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183My9mcmFnOjdlZDNkZjA4MTFiOTQxNDdiMTU4NWU2YThmMzM2NDYwL3RleHRyZWdpb246N2VkM2RmMDgxMWI5NDE0N2IxNTg1ZTZhOGYzMzY0NjBfNTQ5NzU1ODI1MDU5_9d4579f7-2649-4e25-9a73-c0898d82b044"
      unitRef="usd">250000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNDk0NzgwMjM2Mjc1OA_e975d4c3-b6f3-4db5-b7c6-87b05eb9655d">Goodwill and Intangible Assets&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,461.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,425.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,616.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $385.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $117.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following components at March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Original Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights, licenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,975.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,604.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,370.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,306.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,604.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,701.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights, licenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,490.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,923.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,566.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,923.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,607.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents amortizable intangible assets. Other intangible assets consists principally of customer lists and contractual rights. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2023, the Company acquired product rights and licenses from Oyster Point of approximately $334.0 million and IPR&amp;amp;D of approximately $290.0 million from Famy Life Sciences. Refer to Note 4 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Other Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense and intangible asset disposal &amp;amp; impairment charges (which are included as a component of amortization expense) are classified primarily within cost of sales in the condensed consolidated statements of operations and were as follows for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset disposal &amp;amp; impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible asset amortization expense (including disposal &amp;amp; impairment charges)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, the Company recognized an intangible asset charge of approximately $32.0&#160;million, which was recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the condensed consolidated statement of operations, to write down the disposal group to fair value, less cost to sell, related to our Upjohn Distributor Markets, which are classified as held for sale. As of March&#160;31, 2023 and December&#160;31, 2022, the Company has approximately $198.3&#160;million and $230.3&#160;million, respectively, of intangible assets related to the Upjohn Distributor Markets that are classified as held for sale in the condensed consolidated balance sheets. Refer to Note 5 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible asset amortization expense over the remainder of 2023 and for the years ending December&#160;31, 2024 through 2027 is estimated to be as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNTc3Ng_29c3613a-1f8c-482b-936f-77fdbfbb9bc2">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,461.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,425.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,616.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $385.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Balances as of March&#160;31, 2023 and December&#160;31, 2022 include an accumulated impairment loss of $117.0&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i44a168ceffc44ea799955f726965f1d0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC0xLTEtMS0xNTIyMDk_aba6f7c8-ba92-4390-826d-b008c60d1d81"
      unitRef="usd">7461500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie2da830898fd40bb9b3668c5d10555ed_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC0zLTEtMS0xNTIyMDk_3d28028d-90fe-4a5e-b7c0-fc5b25b4929f"
      unitRef="usd">940600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibc04d16f571a462c997b93a923f5bc5a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC01LTEtMS0xNTIyMDk_de2ee191-bed8-4092-be78-088ef668758b"
      unitRef="usd">689000000.0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia2d05d24b3984c6196b0e4b79ecd82ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC03LTEtMS0xNTIyMDk_669134ac-1ef6-43fe-b19d-f90524dd3b68"
      unitRef="usd">1334700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNC05LTEtMS0xNTIyMDk_ca93f983-6642-4986-ae11-89cc560a8709"
      unitRef="usd">10425800000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4cd4d116cadd4b549d18354ea24d6cf5_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS0xLTEtMS0xNTcyNjc_e7f528c1-8c0f-4801-a982-bbc8f2cbfc06"
      unitRef="usd">95300000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iba15018bb1de4cb0a89b3428e670872a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS0zLTEtMS0xNTcyNzg_81d771d4-a7a9-4609-b64a-62983d694c31"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ifcf87e3010d4446e9ea5180d2ecfef7e_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS01LTEtMS0xNTcyODc_658c16c7-0772-462d-ab64-43a098cabba0"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i2b51c9edce9241cf9e636f46dacbbb52_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS03LTEtMS0xNTcyOTc_cb597eca-7b0e-4ad2-9dea-c3cdeb92a8ae"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNS05LTEtMS0xNTcwOTE_61ba202b-7745-470e-b18d-9f1a25424d95"
      unitRef="usd">95300000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i4cd4d116cadd4b549d18354ea24d6cf5_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi0xLTEtMS0xNTIyMDk_adaf76b4-194e-46e3-8dcb-47247f36ecdd"
      unitRef="usd">60000000.0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="iba15018bb1de4cb0a89b3428e670872a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi0zLTEtMS0xNTIyMDk_3e7b60eb-2dbc-489a-b4be-7bf69c8c9782"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ifcf87e3010d4446e9ea5180d2ecfef7e_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi01LTEtMS0xNTIyMDk_ebac5971-df9b-499a-a0fd-eebf4ac05506"
      unitRef="usd">-8600000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i2b51c9edce9241cf9e636f46dacbbb52_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi03LTEtMS0xNTIyMDk_f83e384f-a790-4e5b-8454-69970fec81a4"
      unitRef="usd">700000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNi05LTEtMS0xNTIyMDk_c85a0e76-8b57-4420-a66b-547ab18e7cf9"
      unitRef="usd">52100000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i24c5aa3032494e489c927959f359a259_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy0xLTEtMS0xNTIyMDk_91d71066-89c7-4e99-a358-310bf2ac4b1d"
      unitRef="usd">7616800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i23d68b002f394987b51c9b480def8689_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy0zLTEtMS0xNTIyMDk_c1e7f3ae-3985-4576-8150-c8ce3c258e80"
      unitRef="usd">940600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia7adead5a097460c92b6ed763747d384_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy01LTEtMS0xNTIyMDk_5afad424-80ca-4bb8-85a6-16437fec3646"
      unitRef="usd">680400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia03f8b88b0e846a5a2bdd752c26504f1_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy03LTEtMS0xNTIyMDk_0a38d719-4d21-4fe0-9247-f048801876d5"
      unitRef="usd">1335400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmJlMTI0MDI4YjlkNDQyY2JiZGQwYWYwMTVjMmUyZTQ4L3RhYmxlcmFuZ2U6YmUxMjQwMjhiOWQ0NDJjYmJkZDBhZjAxNWMyZTJlNDhfNy05LTEtMS0xNTIyMDk_70b58e1f-a670-4fd6-ade6-fd789b1eeea6"
      unitRef="usd">10573200000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i44a168ceffc44ea799955f726965f1d0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMTY0OTI2NzQ3MTA1MQ_1013b246-d91f-4c70-911d-f294742369d0"
      unitRef="usd">385000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i24c5aa3032494e489c927959f359a259_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMTY0OTI2NzQ3MTA1MQ_b71d1cd8-5146-4247-b6a3-d3ec465c8d0d"
      unitRef="usd">385000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia2d05d24b3984c6196b0e4b79ecd82ef_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMTY0OTI2NzQ3MTE0OA_ad71c161-e151-42b2-aaf2-aef7903aa7d8"
      unitRef="usd">117000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia03f8b88b0e846a5a2bdd752c26504f1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMTY0OTI2NzQ3MTE0OA_f2899f44-748b-48a2-9b9c-d802a39df5e6"
      unitRef="usd">117000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNTgwMQ_21a27878-106c-4eb9-8cdc-26293e929b38">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following components at March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Original Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights, licenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,975.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,604.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,370.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,306.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,604.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,701.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights, licenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,490.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,923.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,566.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,923.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,607.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;(1)Represents amortizable intangible assets. Other intangible assets consists principally of customer lists and contractual rights.</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic982925cfce647cf82de79117dfbd341_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMi0xLTEtMS0xNTIyMDk_bf2b3177-3302-410f-87c4-bdf6ee236314">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMi0zLTEtMS0xNTIyMDk_c212b51c-4977-4021-9787-7c74623daef4"
      unitRef="usd">37975100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMi01LTEtMS0xNTIyMDk_7a9bb538-2f23-4526-a8f8-1027001ff424"
      unitRef="usd">15604600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMi03LTEtMS0xNTIyMDk_6df2d826-264b-40bd-8c0b-bf1b17d14873"
      unitRef="usd">22370500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMy0zLTEtMS0xNTIyMDk_2e1c091e-99bb-446c-8b30-a77b3b1a083e"
      unitRef="usd">331100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfMy03LTEtMS0xNTIyMDk_78deeb54-2b4d-465b-9736-03f76a789b66"
      unitRef="usd">331100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNC0zLTEtMS0xNTIyMDk_17ecbcbc-7e1c-4496-90b4-d99b32d341c0"
      unitRef="usd">38306200000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNC01LTEtMS0xNTIyMDk_caeff1a4-f631-4373-bb53-e517607287a9"
      unitRef="usd">15604600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNC03LTEtMS0xNTIyMDk_1b9176d6-9608-4da6-88fb-9c1773c0d74a"
      unitRef="usd">22701600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id1f049b3f11b4f54b61c23025e02cd69_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNi0xLTEtMS0xNTIyMDk_ddd622f4-a8ad-4567-854c-112ba10d4035">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNi0zLTEtMS0xNTIyMDk_cdb07c10-a74d-4e3e-bde6-51dc30657184"
      unitRef="usd">37490500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNi01LTEtMS0xNTIyMDk_37bb4cad-7c7d-4fec-be1e-b7555f3fba88"
      unitRef="usd">14923600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNi03LTEtMS0xNTIyMDk_8c90f84c-e274-4bb5-91f2-77870289df20"
      unitRef="usd">22566900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNy0zLTEtMS0xNTIyMDk_f2f663f9-5778-496b-953e-8a70b14a6c97"
      unitRef="usd">40200000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfNy03LTEtMS0xNTIyMDk_a01e7b88-9f5b-44b1-b4df-8682df78ffdb"
      unitRef="usd">40200000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfOC0zLTEtMS0xNTIyMDk_a3a05de8-c446-4a92-aaa1-c7ef9f6f7b4a"
      unitRef="usd">37530700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfOC01LTEtMS0xNTIyMDk_0201eba0-a0c6-4fd3-ae74-e807210c8876"
      unitRef="usd">14923600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmYwNTY2MTkzZWQxMzQwMTA4ODA0MWFmZDQyZDRkODQ3L3RhYmxlcmFuZ2U6ZjA1NjYxOTNlZDEzNDAxMDg4MDQxYWZkNDJkNGQ4NDdfOC03LTEtMS0xNTIyMDk_1d404bce-2277-4405-9b92-86064d6e9983"
      unitRef="usd">22607100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ie6948cc281cf4adbac2e6725c137289c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMjE5OTAyMzI4NjgxNA_3566d447-fa07-47d0-954b-da98e8925296"
      unitRef="usd">334000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i996c937d9d5d48bda3c5200c4b48c99f_I20221107"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMjE5OTAyMzI4NjkwNg_a80d4c82-429c-400a-b0b8-6219fda0e9e5"
      unitRef="usd">290000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNTgxMQ_7e4b878c-8aad-4f21-8866-839831ce3dfc">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset disposal &amp;amp; impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible asset amortization expense (including disposal &amp;amp; impairment charges)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, the Company recognized an intangible asset charge of approximately $32.0&#160;million, which was recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the condensed consolidated statement of operations, to write down the disposal group to fair value, less cost to sell, related to our Upjohn Distributor Markets, which are classified as held for sale. As of March&#160;31, 2023 and December&#160;31, 2022, the Company has approximately $198.3&#160;million and $230.3&#160;million, respectively, of intangible assets related to the Upjohn Distributor Markets that are classified as held for sale in the condensed consolidated balance sheets. Refer to Note 5 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfMy01LTEtMS0xNTIyMDk_16e9de0a-d0f6-49ac-a5f4-c90d5912cc01"
      unitRef="usd">603300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfMy03LTEtMS0xNTIyMDk_b92b0048-3953-4c34-be38-41f0ea2a2fe7"
      unitRef="usd">648100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfNC01LTEtMS0xNTIyMDk_7e707cc5-e3e7-446d-930e-5d7a8c3c5651"
      unitRef="usd">32000000.0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfNC03LTEtMS0xNTIyMDk_f112dde4-89d9-43e4-b6b4-80db716c38e0"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:AdjustmentForAmortization
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfNi01LTEtMS0xNTIyMDk_ae796878-6d04-46cf-bd69-7776e294a640"
      unitRef="usd">635300000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOjBjODNlOTdiZTAxMjRmNmNiZjA2MWU4ZjQyNjdlNjEzL3RhYmxlcmFuZ2U6MGM4M2U5N2JlMDEyNGY2Y2JmMDYxZThmNDI2N2U2MTNfNi03LTEtMS0xNTIyMDk_295dd9b0-e38f-4277-a978-229d289f7b81"
      unitRef="usd">648100000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i3f1f9e0ec712462aa02e10848d2f65c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMzg0ODI5MDcyNzgzOA_49a088d1-e711-463f-a7c2-10bb13813cbe"
      unitRef="usd">32000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMzg0ODI5MDcyNzg1NQ_88157663-16a2-48c0-9810-5ef79b999670"
      unitRef="usd">198300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfMzg0ODI5MDcyNzkzNw_12f3206a-1193-4789-8679-e7d2c256f8ec"
      unitRef="usd">230300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RleHRyZWdpb246NTVlNDIwMWIyN2Y4NDkzYmE4ZTc3NDcxNTgyZWExZjJfNTc4NQ_5e5c34cc-3f6e-4930-b74d-998c99be6ed2">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible asset amortization expense over the remainder of 2023 and for the years ending December&#160;31, 2024 through 2027 is estimated to be as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfMS0xLTEtMS0xNTIyMDk_c81f4858-204f-459d-975d-f4bd5c909458"
      unitRef="usd">1772000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfMi0xLTEtMS0xNTIyMDk_d3855657-ca23-4345-9898-f488e9c2d401"
      unitRef="usd">2274000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfMy0xLTEtMS0xNTIyMDk_5cd4022c-f46c-4770-8fe8-a8fd82f0f703"
      unitRef="usd">2179000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfNC0xLTEtMS0xNTIyMDk_b7ac0739-4e9c-4bf3-a3d2-fe949c780372"
      unitRef="usd">2124000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183Ni9mcmFnOjU1ZTQyMDFiMjdmODQ5M2JhOGU3NzQ3MTU4MmVhMWYyL3RhYmxlOmRiMGI1MDg0ODBmYjQxMjRiNmEwMTU1MTAzNjE0NjM0L3RhYmxlcmFuZ2U6ZGIwYjUwODQ4MGZiNDEyNGI2YTAxNTUxMDM2MTQ2MzRfNS0xLTEtMS0xNTIyMDk_c3d2065e-e9e8-4673-a6af-62f3bdeab47f"
      unitRef="usd">1912000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfNDk0NzgwMjMzOTg0NA_055d44f5-69df-4941-92cf-229936e156d4">Financial Instruments and Risk Management &lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain financial risks relating to its ongoing business operations. The primary financial risks that are managed by using derivative instruments are foreign currency risk and interest rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order to manage certain foreign currency risks, the Company enters into foreign exchange forward contracts to mitigate risk associated with changes in spot exchange rates of mainly non-functional currency denominated assets or liabilities. The foreign exchange forward contracts are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. Any gains or losses on the foreign exchange forward contracts are recognized in earnings in the period incurred in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has also entered into forward contracts to hedge forecasted foreign currency denominated sales from certain international subsidiaries and a portion of forecasted intercompany inventory sales denominated in Euro, Japanese Yen, Chinese Renminbi and Indian Rupee for up to twenty-four months. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are deferred in AOCE and are reclassified into earnings when the hedged item impacts earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries by either borrowing directly in foreign currencies and designating all or a portion of the foreign currency debt as a hedge of the applicable net investment position or entering into foreign currency swaps that are designated as hedges of net investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has designated certain Euro and Yen borrowings as a hedge of its investment in certain Euro-functional and Yen-functional currency subsidiaries in order to manage foreign currency translation risk. Borrowings designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of AOCE until the sale or substantial liquidation of the underlying net investments. In addition, the Company manages the related foreign exchange risk of the Euro and Yen borrowings not designated as net investment hedges through certain Euro and Yen denominated financial assets and forward currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the principal amounts of the Company&#x2019;s outstanding Euro and Yen borrowings and the notional amounts of the Euro and Yen borrowings designated as net investment hedges: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount Designated as a Net Investment Hedge&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250% Euro Senior Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125% Euro Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.125% Euro Senior Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.023% Euro Senior Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.362% Euro Senior Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.908% Euro Senior Notes due 2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;YEN Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, the principal amount of the Company&#x2019;s outstanding Yen borrowings and the notional amount of the Yen borrowings designated as net investment hedge was $301.1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into interest rate swaps from time to time in order to manage interest rate risk associated with the Company&#x2019;s fixed-rate and floating-rate debt. Interest rate swaps that meet specific accounting criteria are accounted for as fair value or cash flow hedges. All derivative instruments used to manage interest rate risk are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. For fair value hedges, the changes in the fair value of both the hedging instrument and the underlying debt obligations are included in interest expense. For cash flow hedges, the change in fair value of the hedging instrument is deferred through AOCE and is reclassified into earnings when the hedged item impacts earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company regularly reviews the creditworthiness of its financial counterparties and does not expect to incur a significant loss from the failure of any counterparties to perform under any agreements. The Company is not subject to any obligations to post collateral under derivative instrument contracts. Certain derivative instrument contracts entered into by the Company are governed by master agreements, which contain credit-risk-related contingent features that would allow the counterparties to terminate the contracts early and request immediate payment should the Company trigger an event of default on other specified borrowings. The Company records all derivative instruments on a gross basis in the condensed consolidated balance sheets. Accordingly, there are no offsetting amounts that net assets against liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Derivatives &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &amp;amp; other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &amp;amp; other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Reclassified from AOCE into Earnings &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Cash Flow Hedging Relationships &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-derivative Financial Instruments in Net Investment Hedging Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments Not Designated as Hedging Instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option and forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;At March&#160;31, 2023, the Company expects that approximately $14.0 million of pre-tax net losses on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain/(loss) recognized in earnings on derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain/(loss) reclassified from AOCE into earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;1: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;2: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;3: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recurring fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CCPS in Biocon Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale fixed income investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial assets and liabilities that utilize Level&#160;2 inputs, the Company utilizes both direct and indirect observable price quotes, including the LIBOR yield curve, foreign exchange forward prices and bank price quotes. Below is a summary of valuation techniques for the Company&#x2019;s financial assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued at observable net asset value prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity securities, exchange traded funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued at the active quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity securities, marketable securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued using quoted stock prices from public exchanges at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (income) expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;CCPS in Biocon Biologics&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; valued using a Monte Carlo simulation model using Level 3 inputs. The fair value of the CCPS is sensitive to changes in the forecasts of operating metrics and changes in volatility and discount rates. The Company elected the fair value option for the CCPS under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC 825. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value is reassessed &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;quarterly and any change in the fair value estimate is recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (income) expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in the condensed consolidated statements of operations for that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Available-for-sale fixed income investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued at the quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value, net of income taxes, are included in accumulated other comprehensive loss as a component of shareholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign exchange derivative assets and liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued using quoted forward foreign exchange prices and spot rates at the reporting date. Counterparties to these contracts are highly rated financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022, the Company had a contingent consideration liability of $224.7&#160;million and $221.2&#160;million, respectively, relating to the Biocon Biologics Transaction. This contingent consideration liability represents the amount of the closing working capital target to which the parties have agreed that may become payable to Biocon Biologics in connection with certain events in the future, depending on the valuations attributable to such events. The remaining contingent consideration liability represents a component of the total purchase consideration for Pfizer&#x2019;s Respiratory Delivery Platform and certain other acquisitions. The measurement of these contingent consideration liabilities is calculated using unobservable Level 3 inputs based on the Company&#x2019;s own assumptions primarily related to the probability and timing of future events and payments which are discounted using a market rate of return. At March&#160;31, 2023 and December&#160;31, 2022, discount rates ranging from 6.4% to 9.0% were utilized in the valuations. Significant changes in unobservable inputs could result in material changes to the contingent consideration liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the activity in the Company&#x2019;s fair value of contingent consideration from December&#160;31, 2022 to March&#160;31, 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Portion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term Portion &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other current liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other long-term obligations in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in litigation settlements and other contingencies, net in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company has not elected the fair value option for other financial assets and liabilities other than the CCPS, any future transacted financial asset or liability will be evaluated for the fair value election.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfNDk0NzgwMjMzOTg0NQ_389109d4-ed86-433f-93d8-572986beed94">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the principal amounts of the Company&#x2019;s outstanding Euro and Yen borrowings and the notional amounts of the Euro and Yen borrowings designated as net investment hedges: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount Designated as a Net Investment Hedge&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250% Euro Senior Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125% Euro Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.125% Euro Senior Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.023% Euro Senior Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.362% Euro Senior Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.908% Euro Senior Notes due 2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;YEN Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ifbe3333f61454c84aa7ec708e22cf50c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMi0yLTEtMS0xNTIyMDk_d4610f66-402f-48f5-8b47-c28b63df1e85"
      unitRef="eur">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ifbe3333f61454c84aa7ec708e22cf50c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMi00LTEtMS0xNTIyMDk_e40750c0-31d6-4314-97d0-33c9501e39ef"
      unitRef="eur">1000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie396961017544da680998993a54500ae_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMi02LTEtMS0xNTIyMDk_0fcda3ba-cac9-4021-9466-b96b5f0226c8"
      unitRef="eur">1000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ica7ce119b71f4c0f84b95edb750bd215_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMy0yLTEtMS0xNTIyMDk_bbc95f41-dc14-4a6d-8787-64a554f1f98b"
      unitRef="eur">750000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ica7ce119b71f4c0f84b95edb750bd215_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMy00LTEtMS0xNTIyMDk_2661d4d1-00c3-4681-a172-b1eaa7e31774"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i885ad38fc2be452e97695525e6721fa0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMy02LTEtMS0xNTIyMDk_8fbeff54-ed96-4f9f-a7c0-93039ab34ea9"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i8c21320592b2492982ea12b7c9ddd364_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNS0yLTEtMS0xNTIyMDk_35a44080-fd21-4898-bdb6-6583584ae5b6"
      unitRef="eur">500000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8c21320592b2492982ea12b7c9ddd364_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNS00LTEtMS0xNTIyMDk_1eacf5f0-225c-4f44-8075-21eb01195b70"
      unitRef="eur">500000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ic304f109b5af446bba86e77735791f79_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNS02LTEtMS0xNTIyMDk_fcc41624-b12e-4da2-81b3-76a0d3f048b4"
      unitRef="eur">500000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i8a2b9e568d104103be8e6c431eeddd69_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNy0yLTEtMS0xNTIyMDk_139b39fa-1511-44e8-bd8d-846a8d8257f5"
      unitRef="eur">750000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8a2b9e568d104103be8e6c431eeddd69_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNy00LTEtMS0xNTIyMDk_290d5e63-59d7-4c87-be69-c37ff6cf32bf"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8a47696467454d118794e701966eb0aa_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfNy02LTEtMS0xNTIyMDk_4ede21c7-9380-4880-988d-6208a0fa5945"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ib05ddeb5d86c4f4cbb3686204e71d481_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOC0yLTEtMS0xNTIyMDk_99ad04f9-7464-431c-bd84-7a539c2ea776"
      unitRef="eur">850000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib05ddeb5d86c4f4cbb3686204e71d481_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOC00LTEtMS0xNTIyMDk_918aa07b-6819-4b1e-8b0a-0ae1bf368086"
      unitRef="eur">850000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i57bb0ac7d16846ecaeeda10a472323ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOC02LTEtMS0xNTIyMDk_2b06e083-0ee3-4d3d-85ab-d88a741ed57d"
      unitRef="eur">850000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i8965fb764557415db2ad30aa82c09452_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOS0yLTEtMS0xNTIyMDk_e804f6ee-4a74-4d86-866c-18054195db04"
      unitRef="eur">1250000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8965fb764557415db2ad30aa82c09452_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOS00LTEtMS0xNTIyMDk_c39a2ca9-c6c6-447a-834d-2e694e2ca832"
      unitRef="eur">1250000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i56a888a26f4245358cf12889162baef1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfOS02LTEtMS0xNTIyMDk_37a22c52-65b4-45dc-bec3-ad1ff7eb7011"
      unitRef="eur">1250000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i19cf17be970444d4845ad42cb06b2677_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTEtMi0xLTEtMTUyMjA5_a8e19829-0855-4df1-813e-a2c06db2bf67"
      unitRef="eur">5100000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i19cf17be970444d4845ad42cb06b2677_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTEtNC0xLTEtMTUyMjA5_e8780746-dc50-4702-ae9a-b626e90a5473"
      unitRef="eur">5100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia1f1a8fa6fa4437c9bd8dd8ddc85d818_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTEtNi0xLTEtMTUyMjA5_2e270228-c66b-4194-88a7-8fa48c94831b"
      unitRef="eur">5100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i3e3d152425d4436f82b8f359ed8c09f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTQtMi0xLTEtMTUyMjA5_2db5a43f-5619-4364-84bc-711af11e7204"
      unitRef="jpy">40000000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3e3d152425d4436f82b8f359ed8c09f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTQtNC0xLTEtMTUyMjA5_dc42bbd2-32e8-4b1c-b34e-766d0f812b7c"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib0852b77d93a45c1a8784b9f5e09c74a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTQtNi0xLTEtMTUyMjA5_ba82cd0f-9a55-4ac7-ac37-c191e84b28b3"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i19cf17be970444d4845ad42cb06b2677_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTUtMi0xLTEtMTUyMjA5_07056291-53a6-43ea-9fc5-ca62d8600f7e"
      unitRef="jpy">40000000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i19cf17be970444d4845ad42cb06b2677_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTUtNC0xLTEtMTUyMjA5_80e4b8c0-293b-4cac-9b95-eee7128e4e0a"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia1f1a8fa6fa4437c9bd8dd8ddc85d818_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjIwMDgwOTZkOWY2MzQxNGQ5NWYwZjU5NWNkN2QyZTFiL3RhYmxlcmFuZ2U6MjAwODA5NmQ5ZjYzNDE0ZDk1ZjBmNTk1Y2Q3ZDJlMWJfMTUtNi0xLTEtMTUyMjA5_94b963a7-901c-4373-928d-7a1815883846"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ie3e1cb3c13a143b689debc78a157f9c9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfMTY0OTI2NzQ1MTAxOQ_a99b1ab6-e63a-4c89-9c51-136746bb8001"
      unitRef="usd">301100000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfOTI5Mw_2d0fdb48-2761-4cd8-8b1a-dd63b6550a1a">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments in our condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Derivatives &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &amp;amp; other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &amp;amp; other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i32bb170f1dbc494785245d5ad91eba44_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNS0yLTEtMS0xNTIyMDk_d32c0e9a-fb12-4b42-92a7-e2f57288fec7"
      unitRef="usd">22000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifb5d765ee12a43d8989fbf61ed0f5502_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNS0zLTEtMS0xNTIyMDk_cdbc373f-4552-4b97-a9e9-6ffdd6759fa2"
      unitRef="usd">30400000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id328c8b356cb438ba2e2f88139f233d0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNS02LTEtMS0xNTIyMDk_713f9ff7-9a61-4219-91d8-4808e702866b"
      unitRef="usd">16400000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4da6cef7335b4e4db5c63ae8d42c311a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNS03LTEtMS0xNTIyMDk_1ebe22f0-5397-452d-8796-19de2dc149dd"
      unitRef="usd">26400000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i95612143e25a4851b2e592fb2c3a2107_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNi0yLTEtMS0xNTIyMDk_c2555be3-6d0d-4229-a130-3b7a19734033"
      unitRef="usd">22000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic9f6de36f5e14d028a657fc060b5a560_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNi0zLTEtMS0xNTIyMDk_f3376b37-ae0e-468a-a2ae-d2d55a479f2a"
      unitRef="usd">30400000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i95612143e25a4851b2e592fb2c3a2107_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNi02LTEtMS0xNTIyMDk_a7157c00-933c-44b2-86ab-8e4d6107edeb"
      unitRef="usd">16400000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic9f6de36f5e14d028a657fc060b5a560_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfNi03LTEtMS0xNTIyMDk_0fc1fe88-0811-409f-99c1-3a164a54f44e"
      unitRef="usd">26400000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6c95a99b1fb14d86b6a9b89d594cce92_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOC0yLTEtMS0xNTIyMDk_a6def199-8472-44ba-8f0c-54f5cfc2a40d"
      unitRef="usd">70500000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9d16ca0470534939982b3b58e635e4cc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOC0zLTEtMS0xNTIyMDk_63f81d60-d3cf-42a9-9695-d63246eb57b2"
      unitRef="usd">104300000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i76576107d9424efab6ea88538bb83135_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOC02LTEtMS0xNTIyMDk_f8190094-6b98-49eb-9d4a-6fbb2b34e493"
      unitRef="usd">82100000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i56d3bcc8d2474192926ed306031b5219_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOC03LTEtMS0xNTIyMDk_07bc996e-e790-4808-916a-dd79b08b03d3"
      unitRef="usd">160600000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4a79042b83904696b7dab397210c97de_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOS0yLTEtMS0xNTIyMDk_cf31a7bd-25d0-4c85-9bff-fe38efd12251"
      unitRef="usd">70500000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i41550c188ad64365a22d3f4a47fc1c72_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOS0zLTEtMS0xNTIyMDk_7eb34acf-4ca4-41b4-9586-f36b897ddc12"
      unitRef="usd">104300000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4a79042b83904696b7dab397210c97de_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOS02LTEtMS0xNTIyMDk_ab51e16b-a9b3-4006-9311-8622d6ca1696"
      unitRef="usd">82100000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i41550c188ad64365a22d3f4a47fc1c72_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfOS03LTEtMS0xNTIyMDk_f4ed6a04-3e70-457f-ab03-185e5565bd86"
      unitRef="usd">160600000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfMTAtMi0xLTEtMTUyMjA5_f9d9dca7-9a73-45b9-ae62-a945dcfde9e5"
      unitRef="usd">92500000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfMTAtMy0xLTEtMTUyMjA5_560e0178-bbe0-4bec-ba55-641c9746c4ec"
      unitRef="usd">134700000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfMTAtNi0xLTEtMTUyMjA5_bf9f9903-f10e-4c7d-b7a5-2eab15041486"
      unitRef="usd">98500000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOmQyMzI1MzZiM2Q2ODQ5NWM4NzcxMjZmMThiYWRjMGEwL3RhYmxlcmFuZ2U6ZDIzMjUzNmIzZDY4NDk1Yzg3NzEyNmYxOGJhZGMwYTBfMTAtNy0xLTEtMTUyMjA5_215fabc6-8e58-432a-93e7-8f52c02c9d9b"
      unitRef="usd">187000000.0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfNDk0NzgwMjMzOTg0Ng_c52f72fd-122e-43a4-8dde-57f3943de28e">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Reclassified from AOCE into Earnings &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Cash Flow Hedging Relationships &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-derivative Financial Instruments in Net Investment Hedging Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments Not Designated as Hedging Instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option and forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;At March&#160;31, 2023, the Company expects that approximately $14.0 million of pre-tax net losses on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain/(loss) recognized in earnings on derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain/(loss) reclassified from AOCE into earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i8cb5fda2dcee4ee48e405c5c088a9cba_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfNy00LTEtMS0xNTIyMDk_8e448699-8973-4dcd-95f1-3752921f468d"
      unitRef="usd">11100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ifa16117507db4c7d96b63dc143d74a16_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfNy01LTEtMS0xNTIyMDk_e73e50dd-b6ce-46c5-bfe7-4f2d029dc28f"
      unitRef="usd">9700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i8cb5fda2dcee4ee48e405c5c088a9cba_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfNy02LTEtMS0xNTIyMDk_033eef94-59d4-45f1-acd3-58d021d6150e"
      unitRef="usd">8900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ifa16117507db4c7d96b63dc143d74a16_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfNy03LTEtMS0xNTIyMDk_32b7de5f-c691-4ac2-87d0-5e8b454560df"
      unitRef="usd">14200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id6aaffa691e74bc68e8db4464b4b93b0_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfOC00LTEtMS0xNTIyMDk_d03d6d78-5be7-4351-a4ed-8b173beacea9"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i033455f156d34be29697cc8ac9e0a137_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfOC01LTEtMS0xNTIyMDk_0dbe9872-758a-4752-afa2-196c29826c2c"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="id6aaffa691e74bc68e8db4464b4b93b0_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfOC02LTEtMS0xNTIyMDk_afd960e1-e783-4c18-b095-7c9dd40afc8f"
      unitRef="usd">-1200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i033455f156d34be29697cc8ac9e0a137_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfOC03LTEtMS0xNTIyMDk_df57b89e-08dc-4560-8ec3-7f017bcb0793"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib2d01ba8a140497580deaf3d68bc57c6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTAtNC0xLTEtMTUyMjA5_083a509b-b172-4741-9fe8-f3812cab6fcf"
      unitRef="usd">-51900000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8c134b8f719242bcac28ad4399b788eb_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTAtNS0xLTEtMTUyMjA5_1f0ed790-8946-4ca5-a70b-6c395104ae46"
      unitRef="usd">156300000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib20e6f463286430596383180d843d2b3_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTItMi0xLTEtMTUyMjA5_b86eaae4-cda6-4c83-a4fb-e0b8197ca972"
      unitRef="usd">44600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="id19bc1f2778e4b71aa630ae6b6490e7f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTItMy0xLTEtMTUyMjA5_19a23206-1a4b-441a-91cb-e4d31e8bd2d5"
      unitRef="usd">21700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iff39c4924c6045ef84e3abaad48f1286_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtMi0xLTEtMTUyMjA5_4ff12583-c463-4fed-bc36-27a21ed75681"
      unitRef="usd">44600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib09b7735438346cf9ab1c042bed96f76_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtMy0xLTEtMTUyMjA5_d590b5f0-6e7c-4e53-bcda-392a6965f2a9"
      unitRef="usd">21700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNC0xLTEtMTUyMjA5_cef57db0-3b3f-45e4-b7d1-988969baa518"
      unitRef="usd">-41700000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNS0xLTEtMTUyMjA5_a993b24c-6782-4baf-a468-99f885963552"
      unitRef="usd">165100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNi0xLTEtMTUyMjA5_4887caca-f07f-4b0b-b696-c5e3db7fe373"
      unitRef="usd">7700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNi0xLTEtMTUyMjA5_515ed922-f212-410d-ae2c-d7742be1c98e"
      unitRef="usd">7700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjkyZTlmMjNmMjM1MDRhNjFhMDA1OWUxZTIwYTc5MTY5L3RhYmxlcmFuZ2U6OTJlOWYyM2YyMzUwNGE2MWEwMDU5ZTFlMjBhNzkxNjlfMTMtNy0xLTEtMTUyMjA5_4b7092c6-41e0-4d00-8ff8-fc32cd4c9ab6"
      unitRef="usd">13100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfNDg5Nw_1baaeec4-c7f4-4bc0-9735-9d64de7c7534"
      unitRef="usd">-14000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfOTI3MQ_52f92e27-69ba-47bb-85ee-b95964be6ddc">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;1: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;2: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;3: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfOTMwMg_4ae91db5-e97f-4d7a-a2c9-4112aecebc7d">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recurring fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CCPS in Biocon Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale fixed income investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibb50b90a095f42bfbdbed451dae7f23a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfNS0xLTEtMS0xNTIyMDk_5772bd00-76f7-48cf-a327-0f1185d3cc00"
      unitRef="usd">18900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i727faafb4659486cb209f1a14a62e389_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfNS03LTEtMS0xNTIyMDk_3f51c74e-5b34-4dc4-bd52-6d9d2fbc3894"
      unitRef="usd">688800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i136bafc75ccd449baf4eeb49e8ed395c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfNi0xLTEtMS0xNTIyMDk_49124d03-d18b-4c86-96b1-7d3c9200bef0"
      unitRef="usd">18900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i102e0cf7ff2044a6938b0f83e352bb2d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfNi03LTEtMS0xNTIyMDk_d391b666-6fe8-4e62-ba51-8b241679b841"
      unitRef="usd">688800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:TradingSecurities
      contextRef="i39da740d7a5e4e9cad2bd54f10ce8b8d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfOC0xLTEtMS0xNTIyMDk_7505d2de-6b23-452e-89db-5237af2a7b48"
      unitRef="usd">44800000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="icb432e1314914336835cf836fe99ecf1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfOC03LTEtMS0xNTIyMDk_3f5b97d4-d297-4a97-9681-755814173c26"
      unitRef="usd">42400000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i6f3e2b23886947408f9c609cccaed1aa_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfOS0xLTEtMS0xNTIyMDk_dfa858b0-0c51-4796-aaf2-28c8b343ac92"
      unitRef="usd">200000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i270cf7b9b34147cdaf4584be4a06eb92_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfOS03LTEtMS0xNTIyMDk_e7251e6d-8251-4561-872b-1faf7bd9f954"
      unitRef="usd">200000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i136bafc75ccd449baf4eeb49e8ed395c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTAtMS0xLTEtMTUyMjA5_ecec7923-5386-4365-9e77-c2c3727fc6b1"
      unitRef="usd">45000000.0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i102e0cf7ff2044a6938b0f83e352bb2d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTAtNy0xLTEtMTUyMjA5_14603bb8-fcd7-456e-afb0-a2e485bc40aa"
      unitRef="usd">42600000</us-gaap:TradingSecurities>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ib0d5fffc549546b2a7f21ebeacd3566a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTEtNS0xLTEtMTU2NTY0_8cc79dc7-f95e-4ca4-a49a-bd0f73c1b9e4"
      unitRef="usd">1000000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i3bf9a42591eb4cefaba32caf3d775d3d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTEtMTEtMS0xLTE1NjUxOQ_a21079ee-bda4-4695-9c23-7092e542d4b3"
      unitRef="usd">997400000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if4d0ff8e2db44ce9ae2f1ca09cfc8552_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTItMy0xLTEtMTUyMjA5_a5b5e4a0-e6a5-4974-bfc0-a0ca02fb9b40"
      unitRef="usd">14900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i643ad899563b4c6287162649c1da7644_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTItOS0xLTEtMTUyMjA5_8f2d3846-1513-4e31-99ba-3417e437af08"
      unitRef="usd">13200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9e0450507d0a453d85394a568087e78a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTMtMy0xLTEtMTUyMjA5_4809cd4b-9ece-49ea-8925-05660aff42bf"
      unitRef="usd">11900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i008ef5af2daf4f18a58c19dbec22403d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTMtOS0xLTEtMTUyMjA5_12e49f6b-f70e-4b89-b528-6491972b4856"
      unitRef="usd">11700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0df571154fb44e9dbe311072fe73af02_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTQtMy0xLTEtMTUyMjA5_9752ef66-c2e2-4ccf-9c00-8fd5ca47ea6f"
      unitRef="usd">4000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idc9395cd9b914745ac220a1b31c0d019_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTQtOS0xLTEtMTUyMjA5_a790a68d-9f4d-4fb4-b934-697aab659e7e"
      unitRef="usd">4700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6cfb2649e55847359386336e4a39492b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTUtMy0xLTEtMTUyMjA5_1ea4c462-e8d2-4856-8df8-0e8050037307"
      unitRef="usd">5000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b47320bd11d4ba6a393be87cd0c63dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTUtOS0xLTEtMTUyMjA5_811b65ea-559a-4036-8b3a-5ab11cbee512"
      unitRef="usd">5100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i26f62ce70fb445afa3148d671d5ebd33_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTYtMy0xLTEtMTUyMjA5_dc4bb772-0ba8-43fc-ab6e-b85e9a6f50ff"
      unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i69dfbf841e784966a9622614817e595e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTYtOS0xLTEtMTUyMjA5_ac4c3e09-3932-4025-a8b5-36d12ac3ba9b"
      unitRef="usd">600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id230763240ed4c6c83ac699f54873ca3_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTctMy0xLTEtMTUyMjA5_9f110b27-e22b-44b3-82c4-fdc9b764a324"
      unitRef="usd">36000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic78bfd7523094db7ac5361c6c822eb32_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTctOS0xLTEtMTUyMjA5_62a5be98-66d4-4b90-ae53-4f0d0f3d1adb"
      unitRef="usd">35300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ic9607c4d62444cf687b9b06b8559c927_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTgtMy0xLTEtMTUyMjA5_53f879bd-477e-4fcc-be44-97217a279d1b"
      unitRef="usd">92500000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ica8cc0295da54b078e56ab7384f33b40_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMTgtOS0xLTEtMTUyMjA5_033a876f-1aaa-4c73-9559-6a44c0ea39bd"
      unitRef="usd">134700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i136bafc75ccd449baf4eeb49e8ed395c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtMS0xLTEtMTUyMjA5_a378f01b-e4b1-4bbe-8b5a-f9e4ea2b8f20"
      unitRef="usd">63900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6ea89f8fb0aa40198430e003e80835d2_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtMy0xLTEtMTUyMjA5_09736fa9-810d-496c-ab43-d7484dace503"
      unitRef="usd">128500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8fb8b8df80f6437d9eb2ba03e638b416_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtNS0xLTEtMTUyMjA5_80364e62-8710-48e7-af65-5d59028f00c3"
      unitRef="usd">1000000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i102e0cf7ff2044a6938b0f83e352bb2d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtNy0xLTEtMTUyMjA5_4fa36bf8-7618-4ee8-a0f0-e0621d79bfc5"
      unitRef="usd">731400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1131eca694994821b250886968225201_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtOS0xLTEtMTUyMjA5_c7f75d2d-caa5-411f-a1bf-6a107bff7fca"
      unitRef="usd">170000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7b1cf6b0039a4e34bf81064509086ca1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjAtMTEtMS0xLTE1MjIwOQ_c17e3f4d-5115-44d8-99b7-162a14906873"
      unitRef="usd">997400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ic9607c4d62444cf687b9b06b8559c927_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjMtMy0xLTEtMTUyMjA5_41e6a64b-fa00-48a6-8bf9-7fea71a4c33f"
      unitRef="usd">98500000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ica8cc0295da54b078e56ab7384f33b40_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjMtOS0xLTEtMTUyMjA5_1e30e2fc-e1c7-49db-ab97-f9dfc8cb69f5"
      unitRef="usd">187000000.0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="idc9b2995dd46460594e214fd8e8ee132_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjQtNS0xLTEtMTUyMjA5_adbb0b23-eae8-440b-a7bf-f669bc24eafb"
      unitRef="usd">372500000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjQtMTEtMS0xLTE1MjIwOQ_57e63236-417c-4fc4-91fe-2cccc60fe31a"
      unitRef="usd">375000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6ea89f8fb0aa40198430e003e80835d2_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjUtMy0xLTEtMTUyMjA5_82733278-bfd6-439a-b534-efb199483ce2"
      unitRef="usd">98500000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iee880d6bc130465f829292543ad30b02_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjUtNS0xLTEtMTUyMjA5_c60b7894-8a29-497e-a653-2d6743f309a8"
      unitRef="usd">372500000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1131eca694994821b250886968225201_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjUtOS0xLTEtMTUyMjA5_86ada482-5263-4358-bcf0-0a9b70926fa9"
      unitRef="usd">187000000.0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7b1cf6b0039a4e34bf81064509086ca1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjY3YmNkNTZjODRhZjRkMTg5ZGUwOWE3OGM4OTA1YmViL3RhYmxlcmFuZ2U6NjdiY2Q1NmM4NGFmNGQxODlkZTA5YTc4Yzg5MDViZWJfMjUtMTEtMS0xLTE1MjIwOQ_f0e02c07-a1dd-4c01-8a14-dfeddd615567"
      unitRef="usd">375000000.0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia7752f8ef2694f2a99cedc3a924ac6ed_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfMzg0ODI5MDcwOTg1Mw_3b48ca21-a723-4a2f-82b6-f1b794c94988"
      unitRef="usd">224700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic37bdf396cbd4497bee0629253c5ed9c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfMzg0ODI5MDcwOTg2MQ_23da7e70-b881-47ef-a1b5-3a6816b8a772"
      unitRef="usd">221200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ic1fa0b36fa9a43ebb31730df132d5260_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfODYwOA_3b192cb9-a186-4b4a-8a16-b2ba4716898a"
      unitRef="number">0.064</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="if59e5e36fb7b445db0598c8c22d1736c_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfMzg0ODI5MDcwOTMzMg_bc9e32c8-149c-4070-afe6-29ea78b12f99"
      unitRef="number">0.090</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RleHRyZWdpb246ZjE5ZTE0ZmIxNWRjNDJhMGE4Y2NkMTcwMzZhZmI3Y2JfOTMwNA_6247910b-85ad-4ce4-9593-f871b6197c08">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the activity in the Company&#x2019;s fair value of contingent consideration from December&#160;31, 2022 to March&#160;31, 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Portion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term Portion &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other current liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other long-term obligations in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in litigation settlements and other contingencies, net in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idc8794cd5f5a45ab8724cd054ea59719_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMS0xLTEtMS0xNTIyMDk_cad52d07-58df-456a-bc8b-96c879a8d598"
      unitRef="usd">64400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i14e5adad79794593a0ea10be84abb721_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMS0zLTEtMS0xNTIyMDk_895fb99a-66f5-4136-b1a5-61cc28bb7030"
      unitRef="usd">310600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMS01LTEtMS0xNTIyMDk_57e63236-417c-4fc4-91fe-2cccc60fe31a"
      unitRef="usd">375000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMi0xLTEtMS0xNTIyMDk_846d7bb4-b11a-4e8a-a86f-f3c9cc182525"
      unitRef="usd">-9700000</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="icf2bf973f8224e918b2deff514202349_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMi0zLTEtMS0xNTIyMDk_cb22f485-29cb-422e-86cb-2a175e604f9c"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMi01LTEtMS0xNTIyMDk_27f16de1-ff26-4c5d-9a94-2e1161a7873d"
      unitRef="usd">-9700000</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMy0xLTEtMS0xNTIyMDk_3ac4e88e-6acc-42f4-9fb9-25631f84ac24"
      unitRef="usd">10700000</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="icf2bf973f8224e918b2deff514202349_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMy0zLTEtMS0xNTIyMDk_4dd06a3b-ddbb-4b87-9eb4-951a988f0121"
      unitRef="usd">-10700000</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfMy01LTEtMS0xNTIyMDk_b855e187-cb10-4803-b034-a8067f81e940"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <us-gaap:AccretionExpense
      contextRef="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNC0xLTEtMS0xNTIyMDk_ad4db7a1-5380-4deb-8a14-28c0dcd07107"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="icf2bf973f8224e918b2deff514202349_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNC0zLTEtMS0xNTIyMDk_f5e96fda-8709-447c-9a1e-5a58824479bb"
      unitRef="usd">5700000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNC01LTEtMS0xNTIyMDk_5f37891e-3afa-445c-81f6-de8b4338b6e5"
      unitRef="usd">5700000</us-gaap:AccretionExpense>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="i97dec5e19e5d43b596348c6174b32927_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNS0xLTEtMS0xNTIyMDk_dcc9c1e1-9756-4cd7-9234-4bcbf4f3b55e"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="icf2bf973f8224e918b2deff514202349_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNS0zLTEtMS0xNTIyMDk_0ff2c3d0-5dd8-44fe-b2ba-3e8d75bf8c09"
      unitRef="usd">1500000</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNS01LTEtMS0xNTIyMDk_634d7a42-552c-4180-84b4-23a1ef612e2e"
      unitRef="usd">1500000</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icabcde1e2ac34fc091515c433c41ff7c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNi0xLTEtMS0xNTIyMDk_0c3f0492-629c-47e3-8249-e890726918b4"
      unitRef="usd">65400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id4564ffd038a447684a267ff28783411_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNi0zLTEtMS0xNTIyMDk_4467f419-0ef0-4f1f-8150-e79f3b2e2a46"
      unitRef="usd">307100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN183OS9mcmFnOmYxOWUxNGZiMTVkYzQyYTBhOGNjZDE3MDM2YWZiN2NiL3RhYmxlOjhiOTFlNTk2ZDYxZjRiZWI4NTJhZDhhZDRhYmEyM2E3L3RhYmxlcmFuZ2U6OGI5MWU1OTZkNjFmNGJlYjg1MmFkOGFkNGFiYTIzYTdfNi01LTEtMS0xNTIyMDk_5c4914de-8b0d-4e64-8b20-325431a21d2e"
      unitRef="usd">372500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfNDk0NzgwMjMzMDY2OQ_037b0e2c-2da5-4811-b3b0-33cbdc668cfe">Debt&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For additional information, see Note 11 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;in Viatris&#x2019; 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s short-term borrowings:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables Facility and Note Securitization Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a $400&#160;million Receivables Facility, which expires in April 2025 and a $200&#160;million Note Securitization Facility which expires in August 2023. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The amount that we may borrow at a given point in time is determined based on the amount of qualifying accounts receivable that are present at such point in time. Amounts outstanding under either facility are included as a component of short-term borrowings, while the accounts receivables securing these obligations remain as a component of accounts receivable, net, in our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective April 28, 2023, we executed an amendment to the Revolving Facility to convert the benchmark interest rate from LIBOR to an adjusted SOFR, with no change in the applicable interest rate margins. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;A summary of long-term debt is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,069.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,650.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2043 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2046 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; **&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2048 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; *&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;YEN Term Loan Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,069.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,015.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The fair value adjustment was amortized to interest expense over the remaining term of the notes, which were repaid at maturity in the first quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was issued by Mylan Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was originally issued by Mylan N.V.; now held by Utah Acquisition Sub Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*** &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was issued by Viatris Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**** &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was issued by Upjohn Finance B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023 and December&#160;31, 2022, the aggregate fair value of the Company&#x2019;s outstanding notes was approximately $15.04 billion and $15.36 billion, respectively. The fair values of the outstanding notes were valued at quoted market prices from broker or dealer quotations and were classified as Level 2 in the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at March&#160;31, 2023 were as follows for each of the periods ending December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjE2OA_9d686911-fba7-49aa-9971-3e230e380255">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s short-term borrowings:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="i805aacd5cf1a4ce1ba773d8974bb6661_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfMi0xLTEtMS0xNTIyMDk_1397f033-13e1-4b73-8f10-4b4fadb79c10"
      unitRef="usd">197000000.0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="if318bfa8c5bc43749fd2a6b351b2adc5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfMi0zLTEtMS0xNTIyMDk_b0f3fbb1-30f0-4b30-8e6b-4f87e4b3a130"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i16bd0a431ac944bbadbc94516ff5579b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfNC0xLTEtMS0xNTIyMDk_2823c523-fe04-49fb-ac13-b68dbbdac99f"
      unitRef="usd">7600000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i527c9f5ddc6248d0bd4ecaeb320cfeab_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfNC0zLTEtMS0xNTIyMDk_98ef253a-5ea5-40cb-869f-30e06298582b"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfNS0xLTEtMS0xNTIyMDk_9ec82bdd-ead5-4135-9fce-67c318295659"
      unitRef="usd">204600000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOjYyYzQ5MTk4ZGUxMTQxMGQ5NGU1NGVjMGNjNGI0MjgxL3RhYmxlcmFuZ2U6NjJjNDkxOThkZTExNDEwZDk0ZTU0ZWMwY2M0YjQyODFfNS0zLTEtMS0xNTIyMDk_597f9227-eadf-4d4c-b6ed-c04368c429f4"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia2b328e8ff4e4db3903e428de1caf104_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjIz_1b0208e4-718a-481e-8ea8-11bb7f9caf67"
      unitRef="usd">400000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <vtrs:AccountsReceivableFacilityMaximumBorrowingCapacity
      contextRef="i0fa49fa66d4a4ec1b6581ce013ff9335_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjc0ODc3OTA3MzI1Ng_3072bc2e-72c0-4034-9d29-16ebda421421"
      unitRef="usd">200000000</vtrs:AccountsReceivableFacilityMaximumBorrowingCapacity>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjE4Ng_9fc3c07b-623e-4546-9a94-84f0b672a65f">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;A summary of long-term debt is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,069.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032 Euro Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;****&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,650.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2043 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2046 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; **&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2048 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; *&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Senior Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;***&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;YEN Term Loan Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,069.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,015.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The fair value adjustment was amortized to interest expense over the remaining term of the notes, which were repaid at maturity in the first quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was issued by Mylan Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was originally issued by Mylan N.V.; now held by Utah Acquisition Sub Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*** &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was issued by Viatris Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;**** &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Instrument was issued by Upjohn Finance B.V.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i537b244fd18e4182836b3cbcea192aa1_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTAtMS0xLTEtMTUyMjA5_1ae70157-cf1d-4804-aa95-d9f6532abcab"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtCurrent
      contextRef="i537b244fd18e4182836b3cbcea192aa1_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTAtMy0xLTEtMTUyMjA5_6b66ab79-b910-455c-84ae-0253e96fb01f"
      unitRef="usd">0</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i1e90d47f433640e2bf15e3caa1252192_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTAtNS0xLTEtMTUyMjA5_ffb5e7ae-66e7-496f-87e7-3f5cffcb568a"
      unitRef="usd">750600000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaf8243d3d2554b6d9cea845ed1d5d62a_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtMS0xLTEtMTU1MTI3_eff2f787-79c2-47c7-a0a4-ad55ac158b97"
      unitRef="number">0.04200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtCurrent
      contextRef="iaf8243d3d2554b6d9cea845ed1d5d62a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtMy0xLTEtMTU1MTM3_68fe9e17-d4ce-454b-9af7-140c1dbf0fb8"
      unitRef="usd">499800000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i8d844dcfe611431e8c69a0bffa93ef38_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtNS0xLTEtMTU1MTg1_cb910e4f-9f27-4365-970b-986c9f4dcd21"
      unitRef="usd">499800000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i16bd0a431ac944bbadbc94516ff5579b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtMy0xLTEtMTUyMjA5_8b553224-3f5b-4015-8385-645a96e07aae"
      unitRef="usd">700000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i527c9f5ddc6248d0bd4ecaeb320cfeab_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTEtNS0xLTEtMTUyMjA5_bc4a0b99-830c-44fb-bf41-c6ec30309355"
      unitRef="usd">700000</us-gaap:DebtCurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i13546a349b7f46fa8d08aa0489cd82e4_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTItMy0xLTEtMTUyMjA5_4cb3a69e-da01-4b8b-8694-ae8a4b4b3c05"
      unitRef="usd">400000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="if92b069c1f4e4856b8df4e367b12a543_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTItNS0xLTEtMTUyMjA5_dc8dc533-a409-4987-a0d2-cd981cb4fa43"
      unitRef="usd">600000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtCurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTMtMy0xLTEtMTUyMjA5_c754334d-9583-419f-a849-7a412114d403"
      unitRef="usd">500100000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMTMtNS0xLTEtMTUyMjA5_60f1a1f1-ac02-4c33-8c3a-965bf309eb1c"
      unitRef="usd">1250500000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8d3557139bf74fa9bdae809541e470fc_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjAtMS0xLTEtMTUyMjA5_e14f79f9-b6c7-4543-81de-ade9c29cac74"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8d3557139bf74fa9bdae809541e470fc_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjAtMy0xLTEtMTUyMjA5_c3874399-c6da-4aa1-b56c-9dceb7a74047"
      unitRef="usd">1083300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2b39ad011d3c4a15991d1d4ee3f647c9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjAtNS0xLTEtMTUyMjA5_9f36fdb1-2c77-4057-a0cc-b39401ac3eb0"
      unitRef="usd">1069800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3836b4fcf19c4f2da97d1cb2617e47f0_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjEtMS0xLTEtMTUyMjA5_326d87fd-18b2-4cd0-901c-977491f1ae51"
      unitRef="number">0.01023</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9dd73adf36414a74a4252d27d4ca70ec_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjEtMy0xLTEtMTUyMjA5_42310aaa-ef23-4632-9fe3-982ab87a115e"
      unitRef="usd">821800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if13c7fadd2634767b990dc153d4bc9d1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjEtNS0xLTEtMTUyMjA5_e83bf1a2-477c-4e5b-91ed-3bb8b095a89b"
      unitRef="usd">813500000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i72f0ba982f0c46649f0f6561954343f1_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjItMS0xLTEtMTUyMjA5_8b6e6440-7632-4a4e-b252-83e35fa5769c"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i72f0ba982f0c46649f0f6561954343f1_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjItMy0xLTEtMTUyMjA5_760091a9-9492-46d2-9517-548e84677f2d"
      unitRef="usd">541500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1054d206503b46788f1af5e9ce6beaf3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjItNS0xLTEtMTUyMjA5_36426fc7-9359-4f19-877e-ea83720e95b1"
      unitRef="usd">534800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i86b93357479f4e96a4acc48b266c2ec1_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjMtMS0xLTEtMTUyMjA5_fc1155a5-08f2-4e89-b008-7d39066c12ed"
      unitRef="number">0.01650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i86b93357479f4e96a4acc48b266c2ec1_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjMtMy0xLTEtMTUyMjA5_22bef3f7-8c35-4138-8aa1-afeb1a21bb57"
      unitRef="usd">758600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibb18dcdcc883404780abde6cf47443fd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjMtNS0xLTEtMTUyMjA5_1b2cd765-480a-4dd1-9934-bc76266afd1e"
      unitRef="usd">759600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if358ae2472cf4162861457de119d795e_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjQtMS0xLTEtMTUyMjA5_75156627-bd0f-406a-a7d5-53de15d98600"
      unitRef="number">0.03950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if358ae2472cf4162861457de119d795e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjQtMy0xLTEtMTUyMjA5_79692af8-7462-41c5-9496-d983925c34cf"
      unitRef="usd">2243700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i39cd72e6c89f4d72b882807ad54849a4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjQtNS0xLTEtMTUyMjA5_32c5d2a6-4198-4acb-b380-c7434a813add"
      unitRef="usd">2243200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8e8bd4e2ae64bfbab3cac97c001f7ac_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjUtMS0xLTEtMTUyMjA5_bbe8f3ba-4ecc-4f96-85b1-15d6fdd5c121"
      unitRef="number">0.01362</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i857e28cb283b4b62abcfcd309a7a0760_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjUtMy0xLTEtMTUyMjA5_68cda89e-34cf-468f-800e-7df0831b26c4"
      unitRef="usd">955700000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id9b1ab43a7b04663ade5cdd52c52abf3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjUtNS0xLTEtMTUyMjA5_c9cf2ff6-d53e-4a67-a583-4adf2377f782"
      unitRef="usd">945900000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i172d496acb304a198d699f43d147eb23_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjYtMS0xLTEtMTUyMjA5_6176805c-7d2b-45e1-8ada-4f02875435d7"
      unitRef="number">0.02300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6fd1128fe8054c7ea24c3e527cc585e4_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjYtMy0xLTEtMTUyMjA5_4ff2ca68-7515-4b1e-8718-4442440c02ae"
      unitRef="usd">774000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1d043725e3814483b6471de9237a3773_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjYtNS0xLTEtMTUyMjA5_4eb31cae-9171-4351-8c31-166a669241a6"
      unitRef="usd">775300000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i854b8e342187430ea79336139d6db506_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjctMS0xLTEtMTUyMjA5_7704a575-5d75-4ee6-941b-5bbf6c704e56"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i854b8e342187430ea79336139d6db506_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjctMy0xLTEtMTUyMjA5_7abb196d-de93-49ee-96a0-ed554db79e9d"
      unitRef="usd">808700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4c9b36997fe44efb8dfe9e0f82e471b0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjctNS0xLTEtMTUyMjA5_e809a58c-9cfa-42a3-8b5b-c41ea59008c4"
      unitRef="usd">798500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5a7ccd82fc9d47beaf2c85dbe5315393_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjgtMS0xLTEtMTUyMjA5_1c51dc93-ed26-462a-80d1-0f4867425e74"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia583e565814b4727be66c81be6c677f8_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjgtMy0xLTEtMTUyMjA5_01f314d4-5b8a-4beb-87d1-62cc109dc116"
      unitRef="usd">749000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9b643f05917e4cadba7092929694b6d1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjgtNS0xLTEtMTUyMjA5_2607dca2-8559-444e-9caf-e35dedab3217"
      unitRef="usd">748900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c494b24b67e4b878e564a8146c3138e_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjktMS0xLTEtMTUyMjA5_2dd1b907-7892-45fc-be87-2b4604b75ea1"
      unitRef="number">0.02700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2c494b24b67e4b878e564a8146c3138e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjktMy0xLTEtMTUyMjA5_936ed716-ea05-4f54-9477-81f4d513dfe7"
      unitRef="usd">1510900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3f77f20d41cc4b8bbc1a3e3b098cc442_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMjktNS0xLTEtMTUyMjA5_39884bd6-b773-4808-9429-afc79847bf3f"
      unitRef="usd">1512800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i41482c056aa94a55925d9dcd2e1b6b43_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzAtMS0xLTEtMTUyMjA5_8fe7c12e-fdff-40d7-9fb2-371fed63d892"
      unitRef="number">0.01908</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i41482c056aa94a55925d9dcd2e1b6b43_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzAtMy0xLTEtMTUyMjA5_6d6efef0-0331-4578-acc2-2975280372fe"
      unitRef="usd">1459800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4051ef5b1fdb4486882771f6cbe8ec88_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzAtNS0xLTEtMTUyMjA5_e5f2fa0f-d4a3-4369-ac89-c5a160651f17"
      unitRef="usd">1444400000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i01e123519fbc4c39860f273c6d6d3ed5_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzEtMS0xLTEtMTUyMjA5_dcd92f86-8c49-4aef-bf5f-9d9d317b7509"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i01e123519fbc4c39860f273c6d6d3ed5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzEtMy0xLTEtMTUyMjA5_7c30e2c9-8b1a-44ab-96ba-2ffa41375b5d"
      unitRef="usd">1648900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1a6ac2dc615d4e66b3bb6dfa9566e439_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzEtNS0xLTEtMTUyMjA5_0966d43b-02c9-4e28-84b6-f58569d98210"
      unitRef="usd">1650600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0efddbd5dd4e48c7acdd24a96aa2380e_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzItMS0xLTEtMTUyMjA5_bf9ef4f8-7eff-47d4-8001-64564639e810"
      unitRef="number">0.05400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0efddbd5dd4e48c7acdd24a96aa2380e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzItMy0xLTEtMTUyMjA5_a053a602-3561-49d2-ba4d-f80c48165f52"
      unitRef="usd">497400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i645867315f0942119eafce9860005bd7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzItNS0xLTEtMTUyMjA5_7be58539-8ac0-4d4f-bdc4-d1478dca71aa"
      unitRef="usd">497400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i80b3a71a4e4048318317277ea1c7419c_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzMtMS0xLTEtMTUyMjA5_859364b4-3b7b-4ce3-a011-32b587e8968a"
      unitRef="number">0.05250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i80b3a71a4e4048318317277ea1c7419c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzMtMy0xLTEtMTUyMjA5_72a76f7e-6012-46f9-886e-4fc951cae85b"
      unitRef="usd">999900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i523192e82a694962b8a599b8e7f560b7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzMtNS0xLTEtMTUyMjA5_f43e72ab-0269-4c07-b7a8-85e430fc7d91"
      unitRef="usd">999900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ef5520b9a764945b96e8cea3b80abeb_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzQtMS0xLTEtMTUyMjA5_65b7d255-e173-4630-9347-c645b1c9ea6a"
      unitRef="number">0.05200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i151b130c785b49219e6112e1742e9cfa_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzQtMy0xLTEtMTUyMjA5_0bea8ba9-19b9-4dac-8e82-e6e2d4b2a1ed"
      unitRef="usd">747800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i54e64fcf3dd741b4ab858d4916d39201_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzQtNS0xLTEtMTUyMjA5_aad9b2a8-f582-4543-be65-1aeedab68042"
      unitRef="usd">747800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5552e043c1c444cc88e4f40941845034_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzUtMS0xLTEtMTUyMjA5_8b5d4f15-d254-4c69-8823-42f2eef97918"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5552e043c1c444cc88e4f40941845034_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzUtMy0xLTEtMTUyMjA5_dbed274c-3351-4c90-9fab-711b59b92488"
      unitRef="usd">2199600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i69039fe5d46240fa8529c57fdfe22935_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzUtNS0xLTEtMTUyMjA5_02072ae3-dca3-4e91-a57e-a14d4af22cf3"
      unitRef="usd">2200800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibf2097e990594c218bca3f144aca2453_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzYtMy0xLTEtMTUyMjA5_75005fb6-4d08-424c-adaf-c8d5bcb03397"
      unitRef="usd">301100000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8c9f8feb05d94562b542bb89be4c3aec_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzYtNS0xLTEtMTUyMjA5_12904549-6aa4-4290-a0ae-2938cb96a8bb"
      unitRef="usd">305100000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i45165edb089b40d0b8b4833405ea227b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzctMy0xLTEtMTUyMjA5_56140850-23dd-41e7-a4ad-c3505ac71efc"
      unitRef="usd">1600000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1d5c20c94e5f427e8b1f4cc452481487_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzctNS0xLTEtMTUyMjA5_287e2fe1-711a-4cb8-b5bf-e9911723e8ed"
      unitRef="usd">2000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzgtMy0xLTEtMTUyMjA5_7559e8a1-84f3-414d-a497-c1a5f7610b4f"
      unitRef="usd">33900000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzgtNS0xLTEtMTUyMjA5_1154c5b3-b40a-4ce6-881c-9e3fd6eadc4c"
      unitRef="usd">35100000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzktMy0xLTEtMTUyMjA5_014ee4f0-8d76-4f7d-b2d3-73bdbc237c78"
      unitRef="usd">18069400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmNkMWQ2YzE5NWVjZTQxMzM4ZDNiNWI4ZjE3Y2YxODdmL3RhYmxlcmFuZ2U6Y2QxZDZjMTk1ZWNlNDEzMzhkM2I1YjhmMTdjZjE4N2ZfMzktNS0xLTEtMTUyMjA5_22ba4421-2fbb-4f0a-9abb-3dc5f2cc9048"
      unitRef="usd">18015200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMTM4Ng_b2cec4fc-47f3-461f-9138-2aed017e2d82"
      unitRef="usd">45000000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie091a09167a34a0fa7933475fb2de76d_I20230331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMTgwNw_7945866f-3f4c-4cb9-b0cd-bad0d70634d3"
      unitRef="usd">15040000000.00</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6164435f803841129e7672cc12bb4100_I20221231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMTgxNA_6c219c45-729c-49af-adfb-50d54e2ab9f0"
      unitRef="usd">15360000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RleHRyZWdpb246NDVhNjgzNzFlMTFmNDRmM2I3OWYyYTYxODQ3MWZlMzFfMjE2NA_29a63a1e-936f-4247-b3ab-9f40122e73dc">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at March&#160;31, 2023 were as follows for each of the periods ending December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfMS0xLTEtMS0xNTIyMDk_c55e603c-da6a-45a0-b56f-22c3c0280f6a"
      unitRef="usd">500000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfMi0xLTEtMS0xNTIyMDk_b9427630-803a-4dc1-974a-a6c08ab5870c"
      unitRef="usd">1897000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfMy0xLTEtMS0xNTIyMDk_63838dc7-c2f4-4c43-aadc-71c133bf02aa"
      unitRef="usd">1292000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfNC0xLTEtMS0xNTIyMDk_8b2d8fcf-a37f-49ba-9808-f8df1ee43b3b"
      unitRef="usd">2551000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfNS0xLTEtMS0xNTIyMDk_a0d7e782-4d10-4b2c-868f-b6ae715b59cb"
      unitRef="usd">1671000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfNi0xLTEtMS0xNTIyMDk_3fbb2964-4c31-4b7d-b898-01587b2cc5c8"
      unitRef="usd">10118000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184Mi9mcmFnOjQ1YTY4MzcxZTExZjQ0ZjNiNzlmMmE2MTg0NzFmZTMxL3RhYmxlOmM5MDM3YjZlNDJiNTRhYmE5NGNiNjhkNThjNGMyNzdjL3RhYmxlcmFuZ2U6YzkwMzdiNmU0MmI1NGFiYTk0Y2I2OGQ1OGM0YzI3N2NfNy0xLTEtMS0xNTIyMDk_4bf79c94-0201-4b10-b3e7-aca9676fb779"
      unitRef="usd">18029000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RleHRyZWdpb246MWY5MDU2ZWJlY2M3NDkyMjk3NzgwMTM1YTdmNjkzZjlfMjQ0_28bd8eea-fc7d-4345-920a-ac84068c00b1">Comprehensive Loss&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, is comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on marketable securities, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized gain and prior service cost related to defined benefit plans, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized gain on derivatives in net investment hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,340.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,385.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,764.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,761.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:45pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,385.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,761.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial gain included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,340.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,764.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:45pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,271.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,061.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RleHRyZWdpb246MWY5MDU2ZWJlY2M3NDkyMjk3NzgwMTM1YTdmNjkzZjlfMjU0_771a0a72-46c1-40ba-ba65-42e9c97511f8">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, is comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on marketable securities, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized gain and prior service cost related to defined benefit plans, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized gain on derivatives in net investment hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,340.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,385.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,764.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,761.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfMi0xLTEtMS0xNTIyMDk_e32b5470-e969-41ae-9145-d0e2e0be2d00"
      unitRef="usd">-1600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfMi0zLTEtMS0xNTIyMDk_8abb2c62-01a6-4d21-bc18-b3e10152f632"
      unitRef="usd">-2300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfMy0xLTEtMS0xNTIyMDk_4ec99cc1-0f15-40cf-9a49-6c70e3e5e9ad"
      unitRef="usd">269300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfMy0zLTEtMS0xNTIyMDk_700389d1-5ddc-45ce-aa48-fed75c95190f"
      unitRef="usd">-268500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i7b9dbb9ff801489ba2f6837aa806ff2d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNC0xLTEtMS0xNTIyMDk_b86725f5-e84c-4479-9128-a4ff5eb161b1"
      unitRef="usd">-16800000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i0c7eb919fe344f70963ed690e633c735_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNC0zLTEtMS0xNTIyMDk_8bb13535-bc94-4f35-96c8-9b90e7386110"
      unitRef="usd">-18500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx
      contextRef="id9bb674e162c40018526646782e70d3f_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNS0xLTEtMS0xNTIyMDk_2c34bd4f-9f6f-4495-b2dc-431e32cc54aa"
      unitRef="usd">325100000</vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx>
    <vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx
      contextRef="i88989aa1d54540a1ba2ca6eb8ea846f6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNS0zLTEtMS0xNTIyMDk_c1f57cee-224b-40df-88a0-80d78faf83fb"
      unitRef="usd">377000000.0</vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNi0xLTEtMS0xNTIyMDk_056632b1-5c90-4666-aa9f-865f6beefcf5"
      unitRef="usd">-3340600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNi0zLTEtMS0xNTIyMDk_37da2eec-75eb-4a01-9047-ee9dace929e8"
      unitRef="usd">-3385900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNy0xLTEtMS0xNTIyMDk_7aada9a8-b7a4-4e4e-a047-f7908ceb5c7e"
      unitRef="usd">-2764600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE1ZWY2ZTA0Y2I5YjQxM2FhMDZlZDA5Yjc4NDE0MmNhL3RhYmxlcmFuZ2U6MTVlZjZlMDRjYjliNDEzYWEwNmVkMDliNzg0MTQyY2FfNy0zLTEtMS0xNTIyMDk_3bb63c4d-4aa6-4b1c-93e2-70ba0bf1eccd"
      unitRef="usd">-2761200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RleHRyZWdpb246MWY5MDU2ZWJlY2M3NDkyMjk3NzgwMTM1YTdmNjkzZjlfMjU2_91e50fe0-7ea1-4734-883f-00b4ffb30830">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of accumulated other comprehensive loss, before tax, consist of the following, for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:45pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,385.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,761.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial gain included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,340.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,764.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:45pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,271.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,061.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i0c7eb919fe344f70963ed690e633c735_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy01LTEtMS0xNTIyMDk_8bb13535-bc94-4f35-96c8-9b90e7386110"
      unitRef="usd">-18500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx
      contextRef="i88989aa1d54540a1ba2ca6eb8ea846f6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy03LTEtMS0xNTIyMDk_c1f57cee-224b-40df-88a0-80d78faf83fb"
      unitRef="usd">377000000.0</vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy05LTEtMS0xNTIyMDk_8abb2c62-01a6-4d21-bc18-b3e10152f632"
      unitRef="usd">-2300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy0xMS0xLTEtMTUyMjA5_700389d1-5ddc-45ce-aa48-fed75c95190f"
      unitRef="usd">-268500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy0xMy0xLTEtMTUyMjA5_37da2eec-75eb-4a01-9047-ee9dace929e8"
      unitRef="usd">-3385900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMy0xNS0xLTEtMTUyMjA5_3bb63c4d-4aa6-4b1c-93e2-70ba0bf1eccd"
      unitRef="usd">-2761200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ie700760d8134451a9ff6e163dcbd5a13_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC01LTEtMS0xNTIyMDk_5cbb7fc7-02d5-4360-abfc-8aee973c85bc"
      unitRef="usd">10500000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="id5b5d8f65e7443a99c925d594d0cd6eb_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC03LTEtMS0xNTIyMDk_71802a2f-4413-43d4-8be2-9fe12ee318e1"
      unitRef="usd">-66200000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC05LTEtMS0xNTIyMDk_6f7f4815-3f77-4e7b-9040-66bb5748a1f6"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3bbf2add3a0c4216b0a8608247495af6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC0xMS0xLTEtMTUyMjA5_96970301-30aa-475e-9bf0-4505bd9af75e"
      unitRef="usd">6300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="iac9ac025fb9047918980605e59a944c5_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC0xMy0xLTEtMTUyMjA5_83c970db-519f-40cf-bacd-9e500e32a4fb"
      unitRef="usd">45300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i642a69b7eb80475580b6dfe8e7de979e_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNC0xNS0xLTEtMTUyMjA5_eb2c5d17-cf83-4b40-a604-70900555488c"
      unitRef="usd">-3200000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcee7fb1e8624576b13773ba17f2f11f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNi0xLTEtMS0xNTIyMDk_05abfeb6-5137-44cc-9944-753d0fdb5d84"
      unitRef="usd">-8900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb3b8082108848a18225ef4298c3618f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNi01LTEtMS0xNTIyMDk_38252b75-bcb2-4530-abc1-8a6aea033f35"
      unitRef="usd">-8900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i653a14a89cb24d7c952dd0cdd3772c49_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNi0xNS0xLTEtMTUyMjA5_9ccd48b6-2b89-43eb-a8e1-38b38734862a"
      unitRef="usd">-8900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestExpense
      contextRef="ie2d9f4048943460b9f1afbb1f59b8dda_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNy0zLTEtMS0xNTIyMDk_d90675b3-5a16-4549-a969-df02ad349a4b"
      unitRef="usd">1200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie9dbeed2d83b425eb1378354668ce7a1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNy01LTEtMS0xNTIyMDk_db7e4b6a-bbc2-4699-8b51-a7f215583d6b"
      unitRef="usd">1200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i87f32bd065ca46ffa60c567a5d2f9e1c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfNy0xNS0xLTEtMTUyMjA5_d2b5b369-f88b-406c-a419-afea2192a19f"
      unitRef="usd">1200000</us-gaap:InterestExpense>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfOS0xMS0xLTEtMTUyMjA5_25e2bf52-d8c4-4b47-9a2c-4ccfb3c9bfb7"
      unitRef="usd">5000000.0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i05e33061fbdd49b7968f96b8dd318a25_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfOS0xNS0xLTEtMTUyMjA5_16eea33d-0593-47c7-bd6c-70a29da06113"
      unitRef="usd">5000000.0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="i8bb079be9f2d4c24819ae36c2b302e6d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtNS0xLTEtMTUyMjA5_591ab22b-6b02-4c6e-8e75-bd7a3a81fbe5"
      unitRef="usd">2800000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="id5b5d8f65e7443a99c925d594d0cd6eb_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtNy0xLTEtMTUyMjA5_71802a2f-4413-43d4-8be2-9fe12ee318e1"
      unitRef="usd">-66200000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtOS0xLTEtMTUyMjA5_6f7f4815-3f77-4e7b-9040-66bb5748a1f6"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtMTEtMS0xLTE1MjIwOQ_e5432901-7173-49af-92fb-e181d8718758"
      unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="iac9ac025fb9047918980605e59a944c5_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtMTMtMS0xLTE1MjIwOQ_83c970db-519f-40cf-bacd-9e500e32a4fb"
      unitRef="usd">45300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTAtMTUtMS0xLTE1MjIwOQ_f15e7980-6cc3-4a58-bf19-63f8e4a8b6c7"
      unitRef="usd">-15900000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie700760d8134451a9ff6e163dcbd5a13_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtNS0xLTEtMTUyMjA5_d78a3740-a828-4c8d-a463-d602531b9484"
      unitRef="usd">1100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8618f25668574c53b1ce780bdda393cd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtNy0xLTEtMTUyMjA5_a0e3cf9d-ed25-457f-bca7-84b68d4cb28d"
      unitRef="usd">-14300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i086be58c57004badb55c1e1264fe37ea_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtOS0xLTEtMTUyMjA5_6899bffd-6153-4619-9039-62bf4e141e35"
      unitRef="usd">200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i19242480fa2943ffb4a03206eee18d1a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtMTEtMS0xLTE1MjIwOQ_447feef2-3c42-4c35-b537-2170d1dec56d"
      unitRef="usd">500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic8647ea8c4a242b99d262a0ac976d962_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtMTMtMS0xLTE1MjIwOQ_5446cc62-b30f-4982-b99c-9a0da0a4abff"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i05e33061fbdd49b7968f96b8dd318a25_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTEtMTUtMS0xLTE1MjIwOQ_9e22d000-0f30-4570-8e24-3cadb67751d8"
      unitRef="usd">-12500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i7b9dbb9ff801489ba2f6837aa806ff2d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtNS0xLTEtMTUyMjA5_b86725f5-e84c-4479-9128-a4ff5eb161b1"
      unitRef="usd">-16800000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx
      contextRef="id9bb674e162c40018526646782e70d3f_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtNy0xLTEtMTUyMjA5_2c34bd4f-9f6f-4495-b2dc-431e32cc54aa"
      unitRef="usd">325100000</vtrs:AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtOS0xLTEtMTUyMjA5_e32b5470-e969-41ae-9145-d0e2e0be2d00"
      unitRef="usd">-1600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtMTEtMS0xLTE1MjIwOQ_4ec99cc1-0f15-40cf-9a49-6c70e3e5e9ad"
      unitRef="usd">269300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtMTMtMS0xLTE1MjIwOQ_056632b1-5c90-4666-aa9f-865f6beefcf5"
      unitRef="usd">-3340600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjVmNWI5NmQ0M2UxNDQ2NTU5NWMwODBiOTdjOTdiZWM1L3RhYmxlcmFuZ2U6NWY1Yjk2ZDQzZTE0NDY1NTk1YzA4MGI5N2M5N2JlYzVfMTMtMTUtMS0xLTE1MjIwOQ_7aada9a8-b7a4-4e4e-a047-f7908ceb5c7e"
      unitRef="usd">-2764600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i5c3760f0cea642d3b75f6140cdf414f6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy01LTEtMS0xNTIyMDk_fa99395a-96aa-47f1-a750-c3d7f5423eb0"
      unitRef="usd">9200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="ie2e1a1cbd2814cdfb45518b14ca40fa2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy03LTEtMS0xNTIyMDk_7b3bdfff-42b9-4513-92f4-9c4f775882fa"
      unitRef="usd">16700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ica5b623ff3fa4a61a5c7435e3ab00ba1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy05LTEtMS0xNTIyMDk_a204a4d0-25a3-4ac7-840c-8aea92c6203a"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i8b1995c57b4f49c3801e36a80fd70ceb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy0xMS0xLTEtMTUyMjA5_27086a3a-b096-46a0-ab31-24de5934a3b7"
      unitRef="usd">-32200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i2cbade31da7d415f8970e976b4686580_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy0xMy0xLTEtMTUyMjA5_56e34028-defe-4ccf-b80e-094174104ea0"
      unitRef="usd">-1802400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5cca97d09754ca0bea07369d3464420_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMy0xNS0xLTEtMTUyMjA5_242f2139-1190-4ba6-a380-55aa80a54bbb"
      unitRef="usd">-1744300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7ab095d0d7984d658aad5fc11e1e6f28_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC01LTEtMS0xNTIyMDk_16d3b957-097f-471c-b4d3-82e4a30a699f"
      unitRef="usd">13300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i328661c86aa84ea7b204b4667f8a7ffb_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC03LTEtMS0xNTIyMDk_c63ff969-8479-4386-b490-d212c74219c7"
      unitRef="usd">201300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i9fdf7ff53f764505aa2b21fa6a270f0f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC05LTEtMS0xNTIyMDk_4e1a8641-80bf-4184-b296-e5f26ddcf4dc"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic1cc5ed71d974468b6ff290b943426c5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC0xMS0xLTEtMTUyMjA5_93b6080c-1ab9-432c-a784-6b90512ad00d"
      unitRef="usd">-2700000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i8ae943df1fa3437894a62abc523b173a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC0xMy0xLTEtMTUyMjA5_e71fb811-3c19-491a-a267-00578de9a5f8"
      unitRef="usd">-469200000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia1ed98849f874127b2a3dc2dc4a7df89_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNC0xNS0xLTEtMTUyMjA5_149b9d13-543b-4ada-92a1-b9a44e7cad5c"
      unitRef="usd">-259000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34bb0ea6145343a2bc5c0602b02aeb12_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNi0xLTEtMS0xNTIyMDk_23fadcb6-647a-4059-899b-874a95e20fc9"
      unitRef="usd">-14200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34bb0ea6145343a2bc5c0602b02aeb12_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNi01LTEtMS0xNTIyMDk_c1f5069a-5823-42d5-a3c2-7d44cd9cbb60"
      unitRef="usd">-14200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71aa5d94a6b94d69adfd79846798fdc1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNi0xNS0xLTEtMTUyMjA5_84560870-5eac-49aa-9fb8-4d56842d7ae2"
      unitRef="usd">-14200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestExpense
      contextRef="ia036fdd378d343f684dfc8d7b749bf36_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNy0zLTEtMS0xNTIyMDk_a3122cc9-67b9-4129-ab72-9d0422eab0f3"
      unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia036fdd378d343f684dfc8d7b749bf36_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNy01LTEtMS0xNTIyMDk_1e30d734-15fe-4d52-b9d0-f2d2a5a0efda"
      unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iafb16f84e2694f219ad64bdc9fb4f90c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfNy0xNS0xLTEtMTUyMjA5_e4f05689-68c6-4628-b3ff-de509e8ade18"
      unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="iaa100fdde39948c2bacf727a7f77eb4f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfOC0xMS0xLTEtMTUyMjA5_3ebc7c56-7848-4e7b-be35-44d7151ca982"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i03c4e86dc90d4fc8958401ed6a97dee9_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfOC0xNS0xLTEtMTUyMjA5_68b7d673-4e3b-49d3-a987-03ea8c2207fa"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="ie33127a010dd40c8adcfde67ca93dc7e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtNS0xLTEtMTUyMjA5_69dc9786-d0ca-44ba-a043-fd39d14a12f8"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent
      contextRef="i3ddcf29ff66b4e319b5952469cb3a1fe_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtNy0xLTEtMTUyMjA5_920bf228-a952-4b5a-888a-324a0785065f"
      unitRef="usd">201300000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtOS0xLTEtMTUyMjA5_8f0b55eb-3981-4090-8ba3-f023445dd3fd"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="iaa100fdde39948c2bacf727a7f77eb4f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtMTEtMS0xLTE1MjIwOQ_91914d86-aea8-485a-a839-e45b907905d5"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i8ae943df1fa3437894a62abc523b173a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtMTMtMS0xLTE1MjIwOQ_e71fb811-3c19-491a-a267-00578de9a5f8"
      unitRef="usd">-469200000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTAtMTUtMS0xLTE1MjIwOQ_6c7618f4-591b-4bd7-9cb9-569105d4502e"
      unitRef="usd">-272000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7ab095d0d7984d658aad5fc11e1e6f28_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtNS0xLTEtMTUyMjA5_d7770929-3d88-45a4-8731-5d7442bb3f63"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i328661c86aa84ea7b204b4667f8a7ffb_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtNy0xLTEtMTUyMjA5_c5e655cb-73e3-4dfa-a47a-9030533ad134"
      unitRef="usd">44900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9fdf7ff53f764505aa2b21fa6a270f0f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtOS0xLTEtMTUyMjA5_110e5780-ea04-4b65-9eda-d206efaebf05"
      unitRef="usd">-400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic1cc5ed71d974468b6ff290b943426c5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtMTEtMS0xLTE1MjIwOQ_10c61671-61b6-4e45-b1d5-8fdcfae1d3b6"
      unitRef="usd">-200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic3e40190a3504890bf2e78ce510c754c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtMTMtMS0xLTE1MjIwOQ_a95eb6c8-190e-4dbc-85da-ad4166ab2f24"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia1ed98849f874127b2a3dc2dc4a7df89_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTEtMTUtMS0xLTE1MjIwOQ_4c670969-0f04-475b-8106-4c8b03040c65"
      unitRef="usd">44700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i0c64ee065eb44f80bd6e5ddda1a2f52d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtNS0xLTEtMTUyMjA5_5fcff7d1-6859-4615-bce7-6f8fd04a6068"
      unitRef="usd">9400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i1f6070629af342578a23395267253ebb_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtNy0xLTEtMTUyMjA5_3364762e-a372-4474-9c30-eb1dcd04e272"
      unitRef="usd">173100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib982817ac2e847f5a2ae10b0747f4ea8_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtOS0xLTEtMTUyMjA5_836cecca-461c-4274-a26b-00b429a0f52e"
      unitRef="usd">-1300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iaf01e5ae97624ffbb92ea194c400357c_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtMTEtMS0xLTE1MjIwOQ_3eec3da9-5544-4d68-bf5e-572cbdcb505f"
      unitRef="usd">-29400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i8d522e397a694dc085575dc00034f8a1_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtMTMtMS0xLTE1MjIwOQ_0df4e84f-a6c8-400f-987b-4acbc212dfcc"
      unitRef="usd">-2271600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if8e5c94cf86d4321a4e0a9f4c01d3c24_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN184OC9mcmFnOjFmOTA1NmViZWNjNzQ5MjI5Nzc4MDEzNWE3ZjY5M2Y5L3RhYmxlOjE0OTliY2MwYjA2YzQ0MzU4YTUwNzY0MjQ1MjVkMmQyL3RhYmxlcmFuZ2U6MTQ5OWJjYzBiMDZjNDQzNThhNTA3NjQyNDUyNWQyZDJfMTMtMTUtMS0xLTE1MjIwOQ_d77d5036-8772-4318-8ff3-8728ae27f483"
      unitRef="usd">-2061000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RleHRyZWdpb246MTZjOWUxNjljYWE4NDQzZmI4OGI1NDljOGQ1ZWQ5ZTlfMzQ3OA_52941f5d-a81a-4580-b83c-f7bc40125e72">Segment Information&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#x2019;s ARV franchise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Intangible asset amortization expense and impairments of goodwill and long-lived assets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;R&amp;amp;D and acquired IPR&amp;amp;D expense;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Net charges or net gains for litigation settlements and other contingencies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including costs related to our planned divestitures and the Biocon Biologics Transaction, and, as applicable, any associated transition activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting policies of the segments are the same as those described in Note 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in the 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment Profitability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reportable Segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,719.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciling items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(603.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(648.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset disposal &amp;amp; impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Globally managed research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlements &amp;amp; other contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction related and other special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RleHRyZWdpb246MTZjOWUxNjljYWE4NDQzZmI4OGI1NDljOGQ1ZWQ5ZTlfMzQ5Mw_2bcbe016-e56b-409f-899b-2293dc32f30d">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#x2019;s ARV franchise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Intangible asset amortization expense and impairments of goodwill and long-lived assets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;R&amp;amp;D and acquired IPR&amp;amp;D expense;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Net charges or net gains for litigation settlements and other contingencies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including costs related to our planned divestitures and the Biocon Biologics Transaction, and, as applicable, any associated transition activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting policies of the segments are the same as those described in Note 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in the 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RleHRyZWdpb246MTZjOWUxNjljYWE4NDQzZmI4OGI1NDljOGQ1ZWQ5ZTlfMzQ5MQ_c68b5350-0050-4031-85c6-0ecaa6d27095">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment Profitability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reportable Segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,719.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciling items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(603.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(648.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset disposal &amp;amp; impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Globally managed research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlements &amp;amp; other contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction related and other special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff6f2a14b0ce43ab83b734dd64d12bf6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNS0yLTEtMS0xNTIyMDk_549c5245-bbe0-4dcd-a11d-87a7be01d7da"
      unitRef="usd">2170400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09ea4f3f734d40279fcbeea57318b608_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNS00LTEtMS0xNTIyMDk_5e963337-2205-41b6-a10d-3ccafa167c6f"
      unitRef="usd">2476100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="iff6f2a14b0ce43ab83b734dd64d12bf6_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNS02LTEtMS0xNTIyMDk_cb7c1b3a-b6db-4dcd-b3fb-5e6333cf8f38"
      unitRef="usd">938700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i09ea4f3f734d40279fcbeea57318b608_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNS04LTEtMS0xNTIyMDk_6912ede1-2182-4a74-8a73-d48f69345c2c"
      unitRef="usd">1211500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fe5245728a44cb18a87377e4c3de0c8_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNi0yLTEtMS0xNTIyMDk_8be5b063-47fb-4d52-b5a8-52e998d6bc46"
      unitRef="usd">564600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44dcb2e059604510889393247056ff68_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNi00LTEtMS0xNTIyMDk_380ef47b-8f37-4fa9-84fe-5ffedb7ce606"
      unitRef="usd">573100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3fe5245728a44cb18a87377e4c3de0c8_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNi02LTEtMS0xNTIyMDk_7b4a7822-c5d3-4baf-b6fb-5f0dde9c725e"
      unitRef="usd">394300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i44dcb2e059604510889393247056ff68_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNi04LTEtMS0xNTIyMDk_77595102-02e3-4423-8054-590af39bba3e"
      unitRef="usd">417700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i717ccb375e6a4e1a88e76775cf3a0015_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNy0yLTEtMS0xNTIyMDk_3af7668d-35a3-45ad-a39d-0b1e77559786"
      unitRef="usd">342200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37f11f4d488d4d6b8d1b2a5657ed7bd8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNy00LTEtMS0xNTIyMDk_6ab4f3f0-ebe6-4be1-952e-16936535252b"
      unitRef="usd">423800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i717ccb375e6a4e1a88e76775cf3a0015_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNy02LTEtMS0xNTIyMDk_80c99b70-ca69-4cdf-8824-947059c7d10c"
      unitRef="usd">130500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i37f11f4d488d4d6b8d1b2a5657ed7bd8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfNy04LTEtMS0xNTIyMDk_0caf10c9-6507-42d0-a539-eb284519e3a5"
      unitRef="usd">174300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id962b30d667e44d79767fd8e3799bc1d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOC0yLTEtMS0xNTIyMDk_f9b84ccb-6839-4272-9bb9-5cb6a2449456"
      unitRef="usd">641900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8791ebb35b584298bcab2b2bcfa56d9d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOC00LTEtMS0xNTIyMDk_6b9d35ce-be98-4eaa-8cfa-e504be7ddcab"
      unitRef="usd">705200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="id962b30d667e44d79767fd8e3799bc1d_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOC02LTEtMS0xNTIyMDk_5ea50b4e-9eea-4a9b-a031-7f757276c4be"
      unitRef="usd">313000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8791ebb35b584298bcab2b2bcfa56d9d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOC04LTEtMS0xNTIyMDk_70e4aca2-7705-4a72-86de-ef766b35261f"
      unitRef="usd">345300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOS0yLTEtMS0xNTIyMDk_d6a3229c-0786-4951-a5a8-4ab79b02dc94"
      unitRef="usd">3719100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOS00LTEtMS0xNTIyMDk_48830341-6acf-46f1-858e-c435eee8149f"
      unitRef="usd">4178200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i85d12c29bdbb4f2b854964dbfa89ef0e_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOS02LTEtMS0xNTIyMDk_9300acd7-35a7-4abc-8648-62d0e18f5c3b"
      unitRef="usd">1776500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i269e5c8eeb184f499dfffbeebba19832_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfOS04LTEtMS0xNTIyMDk_9234c082-3765-47a6-b011-3f12b96f2a00"
      unitRef="usd">2148800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTItNi0xLTEtMTUyMjA5_f5b85f3a-3c16-4d52-8a07-529f68455191"
      unitRef="usd">603300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTItOC0xLTEtMTUyMjA5_6a9854e5-e326-4b4b-9a8f-8234b1b24b66"
      unitRef="usd">648100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTMtNi0xLTEtMTUyMjA5_51c6d5c9-403f-46e4-bbd0-ce46122c952f"
      unitRef="usd">32000000.0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTMtOC0xLTEtMTUyMjA5_9245ad03-624f-4b0f-b240-a743f6da435d"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTQtNi0xLTEtMTUyMjA5_205a7c4e-185b-4f69-848b-d7f8064dae6e"
      unitRef="usd">182900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTQtOC0xLTEtMTUyMjA5_672b9759-4193-4ddd-9628-c5bfd3a3658e"
      unitRef="usd">142300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTUtNi0xLTEtMTUyMjA5_8f6058f7-288b-4923-a10d-3ae63d7ca7eb"
      unitRef="usd">-600000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTUtOC0xLTEtMTUyMjA5_56914bf1-2e73-4753-8cbd-20df2beddced"
      unitRef="usd">-6200000</us-gaap:GainLossRelatedToLitigationSettlement>
    <vtrs:OtherOneTimeNonoperatingExpense
      contextRef="if0aa8325fdde43488d2efb1df4a62fca_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTYtNi0xLTEtMTUyMjA5_f7b544f2-4cc3-4831-884a-030b3ed3263f"
      unitRef="usd">178500000</vtrs:OtherOneTimeNonoperatingExpense>
    <vtrs:OtherOneTimeNonoperatingExpense
      contextRef="ic035c55283484d8faeb93ac5dff52653_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTYtOC0xLTEtMTUyMjA5_1f5bed6a-4723-4d6f-a9e3-8c4dc609b76e"
      unitRef="usd">185600000</vtrs:OtherOneTimeNonoperatingExpense>
    <vtrs:Corporatecosts
      contextRef="ie69330006b9941b780f7e4587eb84648_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTctNi0xLTEtMTUyMjA5_859941c6-28dd-465c-942c-8f4f2b381285"
      unitRef="usd">379400000</vtrs:Corporatecosts>
    <vtrs:Corporatecosts
      contextRef="ic684496e355c490799752193e9a06c94_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTctOC0xLTEtMTUyMjA5_5fa56225-bdfb-477e-b620-f540e49d5c61"
      unitRef="usd">459200000</vtrs:Corporatecosts>
    <us-gaap:OperatingIncomeLoss
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTgtNi0xLTEtMTUyMjA5_1703cdf1-4e68-4b84-ad89-08608744c6d4"
      unitRef="usd">399800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i58b2368b06c1410d9e4e7be1dddf37ec_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185MS9mcmFnOjE2YzllMTY5Y2FhODQ0M2ZiODhiNTQ5YzhkNWVkOWU5L3RhYmxlOjg0MDVkYTU5YjI0NzRkNWY5MjAxODZhMGZhY2JjZGFmL3RhYmxlcmFuZ2U6ODQwNWRhNTliMjQ3NGQ1ZjkyMDE4NmEwZmFjYmNkYWZfMTgtOC0xLTEtMTUyMjA5_02276968-2b0b-48a6-8731-f6c495a4d04e"
      unitRef="usd">707400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMjA1Mg_4af14db5-11b1-41f2-a4e9-c30ecf379b24">Restructuring&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Restructuring Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. The remaining actions under the 2020 restructuring program include the disposal or closure of certain manufacturing facilities, which are expected to be substantially completed in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $1.4&#160;billion. Such charges are expected to include up to approximately $450&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $950&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges for restructuring and ongoing cost reduction initiatives are recorded in the period the Company commits to a restructuring or cost reduction plan, or executes specific actions contemplated by the plan and all criteria for liability recognition have been met. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2022 to March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the three months ended March 31, 2023, total restructuring charges in Developed Markets, Emerging Markets, Greater China, and JANZ were approximately $7.7 million, $1.3 million, $(0.6) million, and $1.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023 and December&#160;31, 2022, accrued liabilities for restructuring and other cost reduction programs were primarily included in other current liabilities and other long-term obligations in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="ic1d68edf5bdd450abcf109bdfeb786ec_D20221001-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfODE1_5cc12767-4982-44df-97d6-bd4cac9ee0dc"
      unitRef="usd">1400000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i9d246e7b27fa4ad99062d6f448111e0c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfODc2_55496292-4457-448c-ac43-8fc0375aaeff"
      unitRef="usd">450000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1
      contextRef="ia5991ed3dd3c4634aa50d484766705da_I20231231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTA2Mg_47b4dced-7ee5-4dc7-9208-4ee72a74f690"
      unitRef="usd">950000000</us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMjA0OA_7a73d142-81ff-4ffc-a524-b46901f314eb">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program from December&#160;31, 2022 to March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the three months ended March 31, 2023, total restructuring charges in Developed Markets, Emerging Markets, Greater China, and JANZ were approximately $7.7 million, $1.3 million, $(0.6) million, and $1.3 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i58d64b894a014afbab8da8528839e18b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMS0xLTEtMS0xNTIyMDk_2eaddd82-8bff-49d0-8877-2785dbb5cef9"
      unitRef="usd">155600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2bc609110a8445fd8d58826fa2f1726c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMS0zLTEtMS0xNTIyMDk_d0ea64c7-12fe-4b04-a3d6-dd48bde76714"
      unitRef="usd">1900000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMS01LTEtMS0xNTIyMDk_36689257-f8b3-489e-822e-b28d3654ff1c"
      unitRef="usd">157500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMi0xLTEtMS0xNTIyMDk_76d2be33-a115-48e9-a6c8-761def25feb7"
      unitRef="usd">2800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMi0zLTEtMS0xNTIyMDk_eb4dcb47-1bf6-49ec-9b76-ed4a446aa385"
      unitRef="usd">6900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfMi01LTEtMS0xNTIyMDk_a66069f5-6fd8-40fa-b2d5-560b740c57b2"
      unitRef="usd">9700000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNC0xLTEtMS0xNTIyMDk_5684546f-f2cb-4aeb-b3a1-965f7ec5476f"
      unitRef="usd">24500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNC0zLTEtMS0xNTIyMDk_d7deb976-1d3d-43c5-80d8-1de8796ec5c7"
      unitRef="usd">3100000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNC01LTEtMS0xNTIyMDk_07f3f702-b642-4b7f-8bc7-247e3f307a3c"
      unitRef="usd">27600000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNS0xLTEtMS0xNTIyMDk_287fa67a-0a08-4421-b3dc-b585511c3ff3"
      unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNS0zLTEtMS0xNTIyMDk_221a88e6-1b77-47c4-bce1-d4c63c975a29"
      unitRef="usd">3800000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNS01LTEtMS0xNTIyMDk_ca4cd829-3beb-4345-91c7-406abd99534d"
      unitRef="usd">3800000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i939ae96259c7461ab6c41958f0cc9eab_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNi0xLTEtMS0xNTIyMDk_bf5469ee-ba07-45eb-91cb-42732561a565"
      unitRef="usd">300000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ib54f2af16f7d48ba9793b4490e5daa13_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNi0zLTEtMS0xNTIyMDk_47b4db3e-80c0-473a-a6fe-23c6c19c8fd0"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNi01LTEtMS0xNTIyMDk_2c042d18-a22d-48d0-9730-1e1155725d52"
      unitRef="usd">300000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i453ede63a1664e9caf4cd95c380890e0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNy0xLTEtMS0xNTIyMDk_b923fc8b-0160-4edd-9c85-a407e30fe432"
      unitRef="usd">134200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iebb30913444747329b7146b7a3266a55_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNy0zLTEtMS0xNTIyMDk_77fa687a-9767-45c5-acac-735f7355abc3"
      unitRef="usd">1900000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RhYmxlOjliOGNiMzk2ZGJjNDRjMjRiY2M5NDc2YjQ4ZmQzZWZkL3RhYmxlcmFuZ2U6OWI4Y2IzOTZkYmM0NGMyNGJjYzk0NzZiNDhmZDNlZmRfNy01LTEtMS0xNTIyMDk_37d539ef-04e4-42df-bb8d-9eac3e4bde49"
      unitRef="usd">136100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i4cd4d116cadd4b549d18354ea24d6cf5_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTgyOQ_088f2dc9-9299-40f1-bace-7e0893db2363"
      unitRef="usd">7700000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2b51c9edce9241cf9e636f46dacbbb52_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTgzMw_ea4ee46f-8111-4c67-be50-62e2d846f0c4"
      unitRef="usd">1300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iba15018bb1de4cb0a89b3428e670872a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTgzNw_653aac47-7709-4c4c-a351-1e2d2aa94b5e"
      unitRef="usd">-600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifcf87e3010d4446e9ea5180d2ecfef7e_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185NC9mcmFnOmE3MjliZTc5YTE4MzRlOTdiMWViNmVkYTg5N2IxM2I4L3RleHRyZWdpb246YTcyOWJlNzlhMTgzNGU5N2IxZWI2ZWRhODk3YjEzYjhfMTg0MQ_6773a186-ef22-4a22-9b76-dac52d647753"
      unitRef="usd">1300000</us-gaap:RestructuringCharges>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185Ny9mcmFnOjNlNDBjOWM3YWRhOTQ0MDZhN2Q0NjgyMjUwMTk5ZWZhL3RleHRyZWdpb246M2U0MGM5YzdhZGE5NDQwNmE3ZDQ2ODIyNTAxOTllZmFfMjIzNQ_9bab6a64-3762-4055-8c20-998176b4159e">Licensing and Other Partner Agreements&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically enter into licensing and other partner agreements with other pharmaceutical companies for the development, manufacture, marketing and/or sale of pharmaceutical products. Our significant licensing and other partner agreements are primarily focused on the development, manufacturing, supply and commercialization of multiple complex products. Under these agreements, we have future potential milestone payments and co-development expenses payable to third parties as part of our licensing, development and co-development programs. Payments under these agreements generally become due and are payable upon the satisfaction or achievement of certain developmental, regulatory or commercial milestones or as development expenses are incurred on defined projects. Milestone payment obligations are uncertain, including the prediction of timing and the occurrence of events triggering a future obligation and are not reflected as liabilities in the condensed consolidated balance sheets, except for obligations reflected as acquisition related contingent consideration. Refer to Note 11 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments and Risk Management&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion of contingent consideration. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our potential maximum development milestones not accrued for at&#160;March&#160;31, 2023&#160;totaled approximately&#160;$387 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate that the amounts that may be paid through the end of 2023 to be approximately $5 million. These agreements may also include potential sales-based milestones and call for us to pay a percentage of amounts earned from the sale of the product as a royalty or a profit share. The amounts disclosed do not include sales-based milestones or royalty or profit share obligations on future sales of product as the timing and amount of future sales levels and costs to produce products subject to these obligations is not reasonably estimable. These sales-based milestones or royalty or profit share obligations may be significant depending upon the level of commercial sales for each product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no significant changes to our licensing and other partner agreements as disclosed in our 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <vtrs:Developmentandsalesmilestonepayments
      contextRef="idab2896257be44a2b213bb8b7d4b1350_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185Ny9mcmFnOjNlNDBjOWM3YWRhOTQ0MDZhN2Q0NjgyMjUwMTk5ZWZhL3RleHRyZWdpb246M2U0MGM5YzdhZGE5NDQwNmE3ZDQ2ODIyNTAxOTllZmFfMTQyNw_e3adbbcc-c644-43a1-a895-695769d4162f"
      unitRef="usd">387000000</vtrs:Developmentandsalesmilestonepayments>
    <vtrs:Developmentandsalesmilestonepayments
      contextRef="i596abfcb4c3b421eaf653dd8ad4d37f7_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN185Ny9mcmFnOjNlNDBjOWM3YWRhOTQ0MDZhN2Q0NjgyMjUwMTk5ZWZhL3RleHRyZWdpb246M2U0MGM5YzdhZGE5NDQwNmE3ZDQ2ODIyNTAxOTllZmFfMTUxOQ_48b6609d-bd05-41d4-a4b1-0de3ee2606da"
      unitRef="usd">5000000</vtrs:Developmentandsalesmilestonepayments>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzUxMzg_5b16e76b-c0f6-4650-984d-d63299d13cec">Income Taxes&lt;div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legislative Updates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#x201c;Inflation Reduction Act&#x201d;) into law, which includes a new corporate alternative minimum tax (&#x201c;CAMT&#x201d;) and an excise tax of 1% on the fair market value of net stock repurchases. Both provisions are effective for years after December 31, 2022. The Company reflected the applicable estimated excise tax in treasury stock as part of the cost basis of the stock repurchased and recorded a corresponding liability in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our condensed consolidated balance sheet as of March 31, 2023. The share repurchase and authorization amounts disclosed in this Form 10-Q exclude the excise tax.  The Company does not anticipate being subject to the 15% CAMT tax in 2023 based on enacted law and regulatory guidance; however, our CAMT status for 2023 could change in the future, depending on new regulations or regulatory guidance issued by the U.S. Department of the Treasury.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tax Examinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to income taxes and tax audits in many jurisdictions. A certain degree of estimation is thus required in recording the assets and liabilities related to income taxes. Tax audits and examinations can involve complex issues, interpretations, and judgments and the resolution of matters that may span multiple years, particularly if subject to litigation or negotiation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company believes that adequate provisions have been made for these uncertain tax positions, the Company&#x2019;s assessment of uncertain tax positions, including those arising from legal entity restructuring transactions in connection with the Combination, is based on estimates and assumptions that the Company believes are reasonable but the estimates for unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variations from such estimates could materially affect the Company&#x2019;s financial condition, results of operations or cash flows in the period of resolution, settlement or when the statutes of limitations expire.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to ongoing IRS examinations. The years 2015 through 2019 are open years under examination. The years 2012, 2013 and 2014 have one matter open, and a Tax Court petition was filed regarding the matter and a trial was held in December 2018 and is discussed further below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Several international audits are currently in progress. In some cases, the tax auditors have proposed adjustments or issued assessments to our tax positions, including with respect to intercompany transactions, and we are in ongoing discussions with some of the auditors regarding the validity of their positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In instances where assessments have been issued, we disagree with these assessments and believe they are without merit and incorrect as a matter of law.  As a result, we anticipate that certain of these matters may become the subject of litigation before tax courts where we intend to vigorously defend our position. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In Australia, the tax authorities have issued notices of assessments to the Company for the years ended December 2009 to December 2020, subject to additional interest and penalties, concerning our tax position with respect to certain intercompany transactions. The tax authorities denied our objections to the assessments for the years ended December 2009 to December 2020 and we have commenced litigation in the Australian Federal Court challenging those decisions. The Company made a partial payment of $56.0&#160;million in 2021 and $5.2&#160;million in 2022 in order to stay potential interest and penalties resulting from this litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In France, the tax authorities have issued notices of assessments to the Company for the years ended December 2013 to December 2015 concerning our tax position with respect to whether income earned by a Company entity not domiciled in France should be subject to French tax.  We have commenced litigation before the French tax courts where the tax authorities will seek unpaid taxes, penalties, and interest.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In India, the tax authorities have issued notices of assessments to the Company seeking unpaid taxes and interest for the financial years covering 2013 to 2018 concerning our tax position with respect to certain corporate tax deductions and certain intercompany transactions. Some of these issues were resolved through the Company entering into an agreement with the tax authorities in March 2023 in respect of the pricing of its international transactions.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company recorded tax expense of approximately $21.6&#160;million during the three months ended March 31, 2023 due to the terms of this agreement. The remaining issues are in the audit phase or are being challenged in the Indian tax courts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has recorded a net reserve for uncertain tax positions of $299.3&#160;million and $298.1&#160;million, including interest and penalties, in connection with its international audits at March 31, 2023 and December 31, 2022, respectively. In connection with our international tax audits, it is possible that we will incur material losses above the amounts reserved.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s major U.S. state taxing jurisdictions remain open from fiscal year 2013 through 2021, with several state audits currently in progress. The Company&#x2019;s major international taxing jurisdictions remain open from 2012 through 2021.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tax Court Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's U.S. federal income tax returns for 2012 through 2014 had been subject to proceedings in U.S. Tax Court involving a dispute with the IRS regarding whether certain costs related to ANDAs were eligible to be expensed and deducted immediately or required to be amortized over longer periods. A trial was held in U.S. Tax Court in December 2018 and on April 27, 2021, the Court affirmed Mylan&#x2019;s position and held that patent litigation expenses related to ANDAs are immediately deductible. The IRS appealed, the case was heard before the Third Circuit Court of Appeals on January 12, 2023 and we are awaiting a decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for Uncertainty in Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of an uncertain tax position that is more likely than not of being sustained upon audit by the relevant taxing authority must be recognized at the largest amount that is more likely than not to be sustained. No portion of an uncertain tax position will be recognized if the position has less than a&#160;50%&#160;likelihood of being sustained.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense
      contextRef="iaded5ca88b1f45efbecc093436d0c031_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzI2MjI_3dd81a3b-2357-4f71-8b95-4db25558b548"
      unitRef="usd">56000000</vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense>
    <vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense
      contextRef="ibc862c7415b2470d87c61bb71eb23e74_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzI2Mzc_be40d7f5-f8ac-43e9-bf4b-6de2621815fb"
      unitRef="usd">5200000</vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2c6b422602ba4e35ad86ae076e60232b_D20230301-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzIxOTkwMjMyNjEyODE_4eceadb9-7036-44bb-aed9-4f92374aaf18"
      unitRef="usd">21600000</us-gaap:IncomeTaxExpenseBenefit>
    <vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzM2Nzg_2198e0a1-56d1-4ef8-b755-ee013dbcc3d6"
      unitRef="usd">299300000</vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties>
    <vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties
      contextRef="i9440af4fd7ba4f0897656b04de8153dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDAvZnJhZzphM2FjNDM2ZDgxMzM0MmE3YTIzODI3MzRlMjE0ODYxYS90ZXh0cmVnaW9uOmEzYWM0MzZkODEzMzQyYTdhMjM4MjczNGUyMTQ4NjFhXzM2ODU_6fa257cf-1e51-49bb-8eca-e7ca9c278394"
      unitRef="usd">298100000</vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzQ5NDc4MDI0OTA2Mjc_25f783f1-5cd0-4a5f-a49e-d35730fe6972">Litigation&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in various disputes, governmental and/or regulatory inquiries, investigations and proceedings, tax proceedings and litigation matters, both in the U.S. and abroad, that arise from time to time, some of which could result in losses, including damages, fines and/or civil penalties, and/or criminal charges against the Company. These matters are often complex and have outcomes that are difficult to predict. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, in connection with the Combination, the Company has generally assumed liability for, and control of, pending and threatened legal matters relating to the Upjohn Business &#x2013; including certain matters initiated against Pfizer described below &#x2013; and has agreed to indemnify Pfizer for liabilities arising out of such assumed legal matters. Pfizer, however, has agreed to retain various matters &#x2013; including certain specified competition law matters &#x2013; to the extent they arise from conduct during the pre-Distribution period and has agreed to indemnify the Company for liabilities arising out of such matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company believes that it has meritorious defenses with respect to the claims asserted against it and the assumed legal matters referenced above, and intends to vigorously defend its position, the process of resolving these matters is inherently uncertain and may develop over a long period of time, and so it is not possible to predict the ultimate resolution of any such matter. It is possible that an unfavorable resolution of any of the ongoing matters could have a material effect on the Company&#x2019;s business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of these governmental inquiries, investigations, proceedings and litigation matters with which the Company is involved are described below, and unless otherwise disclosed, the Company is unable to predict the outcome of the matter or to provide an estimate of the range of reasonably possible material losses. The Company records accruals for loss contingencies to the extent we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company is also involved in other pending proceedings for which, in the opinion of the Company based upon facts and circumstances known at the time, either the likelihood of loss is remote or any reasonably possible loss associated with the resolution of such proceedings is not expected to be material to the Company&#x2019;s business, financial position, results of operations, cash flows, ability to pay dividends and/or stock price. If and when any reasonably possible losses associated with the resolution of such other pending proceedings, in the opinion of the Company, become material, the Company will disclose such matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal costs are recorded as incurred and are classified in SG&amp;amp;A in the Company&#x2019;s condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EpiPen&#xae; Auto-Injector Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in a putative direct purchaser class action filed in the U.S. District Court for the District of Kansas relating to the pricing and/or marketing of the EpiPen&#xae; Auto-Injector. On September 21, 2021, after Plaintiffs&#x2019; then operative complaint was dismissed with an option to file a limited amended complaint, Plaintiffs filed an amended complaint asserting federal antitrust claims which are based on allegations concerning a patent settlement between Pfizer and Teva and other alleged actions regarding the launch of Teva&#x2019;s generic epinephrine auto-injector. Plaintiffs&#x2019; seek monetary damages, declaratory relief, attorneys&#x2019; fees and costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in March 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in putative direct purchaser class actions filed in the U.S. District Court for the District of Minnesota relating to contracts with certain pharmacy benefit managers concerning EpiPen&#xae; Auto-Injector. The plaintiffs claim that the alleged conduct resulted in the exclusion or restriction of competing products and the elimination of pricing constraints in violation of RICO and federal antitrust law. These actions have been consolidated. Plaintiffs&#x2019; seek monetary damages, attorneys&#x2019; fees and costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 24, 2017, Sanofi Aventis U.S., LLC (&#x201c;Sanofi&#x201d;) filed a lawsuit against the Company in the U.S. District Court for the District of New Jersey. This lawsuit was transferred into a MDL in the U.S. District Court for the District of Kansas and alleged exclusive dealing and anti-competitive marketing practices in violation of the antitrust laws in connection with the sale and marketing of the EpiPen&#xae; Auto-Injector. Sanofi sought monetary damages, declaratory relief, attorneys&#x2019; fees and costs. The Court granted the Company&#x2019;s motion for summary judgment and dismissed Sanofi&#x2019;s claims. Sanofi&#x2019;s appeal was denied. Sanofi&#x2019;s petition seeking review by the U.S. Supreme Court was also denied and concludes this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a total accrual of approximately $5.5 million related to these matters at March&#160;31, 2023, which is included in other current liabilities in the condensed consolidated balance sheets. Although it is reasonably possible that the Company may incur additional losses from these matters, any amount cannot be reasonably estimated at this time. In addition, the Company expects to incur additional legal and other professional service expenses associated with such matters in future periods and will recognize these expenses as services are received. The Company believes that the ultimate amount paid for these services and claims could have a material effect on the Company's business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Drug Pricing Matters &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Department of Justice&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 3, 2015, the Company received a subpoena from the Antitrust Division of the DOJ seeking information relating to the marketing, pricing, and sale of certain of our generic products and any communications with competitors about such products. On September 8, 2016, the Company, as well as certain employees and a member of senior management, received subpoenas from the DOJ seeking similar information. Related search warrants also were executed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 10, 2018, the Company received a civil investigative demand from the Civil Division of the DOJ seeking information relating to the pricing and sale of its generic drug products. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have fully cooperated with these investigations, which we believe are related to a broader industry-wide investigation of the generic pharmaceutical industry.  We have not had contact from DOJ concerning the above-described subpoenas or civil investigative demand in several years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Civil Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in 2016, the Company, along with other manufacturers, has been named as a defendant in lawsuits filed in the United States and Canada generally alleging anticompetitive conduct with respect to generic drugs. The lawsuits have been filed by plaintiffs, including putative classes of direct purchasers, indirect purchasers, and indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties. The lawsuits allege harm under federal laws and the United States lawsuits also allege harm under state laws, including antitrust laws, state consumer protection laws and unjust enrichment claims. Some of the United States lawsuits also name as defendants the Company&#x2019;s President, including allegations against him with respect to a single drug product, and one of the Company&#x2019;s sales employees, including allegations against him with respect to certain generic drugs. The vast majority of the lawsuits have been consolidated in an MDL proceeding in the Eastern District of Pennsylvania (&#x201c;EDPA&#x201d;). Plaintiffs generally seek monetary damages, restitution, declaratory and injunctive relief, attorneys&#x2019; fees and costs. The EDPA Court has ordered certain plaintiffs&#x2019; complaints regarding two single-drug product cases to proceed as bellwethers. The Company is named in those plaintiffs&#x2019; complaints that regard one of the two individual drug products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Attorneys General Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2015, the Company received a subpoena and interrogatories from the Connecticut Office of the Attorney General seeking information relating to the marketing, pricing and sale of certain of the Company&#x2019;s generic products and communications with competitors about such products. On December 14, 2016, attorneys general of certain states filed a complaint in the United States District Court for the District of Connecticut against several generic pharmaceutical drug manufacturers, including the Company, alleging anticompetitive conduct with respect to, among other things, a single drug product. The complaint has subsequently been amended, including on June 18, 2018, to add attorneys general alleging violations of federal and state antitrust laws, as well as violations of various states&#x2019; consumer protection laws. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. The operative complaint includes attorneys general of forty-six states, the District of Columbia and the Commonwealth of Puerto Rico. The Company is alleged to have engaged in anticompetitive conduct with respect to four generic drug products. The amended complaint also includes claims asserted by attorneys general of thirty-six states and the Commonwealth of Puerto Rico against certain individuals, including the Company&#x2019;s President, with respect to a single drug product. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#x2019; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. The States&#x2019; claim for disgorgement and restitution under federal law in this case has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 10, 2019, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against various drug manufacturers and individuals, including the Company and one of its sales employees, alleging anticompetitive conduct with respect to additional generic drugs. On November 1, 2019, the complaint was amended, adding additional states as plaintiffs. The operative complaint is brought by attorneys general of forty-seven states, certain territories and the District of Columbia. The amended complaint also includes claims asserted by attorneys general of forty-two states and certain territories against several individuals, including a Company sales employee. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#x2019; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2020, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against drug manufacturers, including the Company, and individual defendants (none from the Company), alleging anticompetitive conduct with respect to additional generic drugs. On September 9, 2021, the complaint was amended, adding an additional state as a plaintiff. The operative complaint is brought by attorneys general of forty-six states, certain territories and the District of Columbia. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#x2019; fees and costs, and certain states seek monetary damages, civil penalties, restitution, and other equitable monetary relief. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA and has been ordered to proceed as a bellwether.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securities Related Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purported class action complaints were filed in October 2016 against Mylan N.V. and Mylan Inc. (collectively &#x201c;Mylan&#x201d;), certain of Mylan&#x2019;s former directors and officers, and certain of the Company&#x2019;s current directors and officers (collectively, for purposes of this paragraph, the &#x201c;defendants&#x201d;) in the United States District Court for the Southern District of New York (&#x201c;SDNY&#x201d;) on behalf of certain purchasers of securities of Mylan on the NASDAQ. The complaints alleged that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the classification of their EpiPen&#xae; Auto-Injector as a non-innovator drug for purposes of the Medicaid Drug Rebate Program.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 20, 2017, a consolidated amended complaint was filed alleging substantially similar claims, but adding allegations that defendants made false or misleading statements and omissions of purportedly material fact in connection with allegedly anticompetitive conduct with respect to EpiPen&#xae; Auto-Injector and certain generic drugs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operative complaint is the third amended consolidated complaint, which was filed on June 17, 2019, and contains the allegations as described above against Mylan, certain of Mylan&#x2019;s former directors and officers, and certain of the Company&#x2019;s current directors, officers, and employees (collectively, for purposes of this paragraph, the &#x201c;defendants&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A class has been certified covering all persons or entities that purchased Mylan common stock between February 21, 2012 and May 24, 2019 excluding defendants, certain of the Company&#x2019;s current directors and officers, former directors and officers of Mylan, members of their immediate families and their legal representatives, heirs, successors or assigns, and any entity in which defendants have or had a controlling interest. Plaintiffs seek damages and costs and expenses, including attorneys&#x2019; fees and expert costs. On March 30, 2023, the Court dismissed all of Plaintiffs&#x2019; claims by granting Defendants&#x2019; motion for summary judgment and denying Plaintiffs&#x2019; cross-motion for partial summary judgment. Plaintiffs have filed an appeal to the U.S. Court of Appeals for the Second Circuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 30, 2017, a similar lawsuit was filed in the Tel Aviv District Court (Economic Division) in Israel, which has been stayed pending a decision in the SDNY class action litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2020, the Abu Dhabi Investment Authority filed a complaint against Mylan in the SDNY asserting allegations pertaining to EpiPen&#xae; Auto-Injector and certain generic drugs under the federal securities laws that overlap with those asserted in the third amended complaint identified above. The Abu Dhabi Investment Authority&#x2019;s complaint seeks monetary damages as well as the plaintiff&#x2019;s fees and costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 26, 2020, a putative class action complaint was filed by the Public Employees Retirement System of Mississippi, which was subsequently amended on November 13, 2020, against Mylan N.V., certain of Mylan N.V.&#x2019;s former directors and officers, and an officer and director of the Company (collectively for the purposes of this paragraph, the &#x201c;defendants&#x201d;) in the U.S. District Court for the Western District of Pennsylvania on behalf of certain purchasers of securities of Mylan N.V. The amended complaint alleges that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the Morgantown manufacturing &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plant and inspections at the plant by the FDA. Plaintiff seeks certification of a class of purchasers of Mylan N.V. securities between February 16, 2016 and May 7, 2019. The complaint seeks monetary damages, as well as the plaintiff&#x2019;s fees and costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 15, 2021, a complaint was filed by Skandia Mutual Life Ins. Co., Lansforsakringar AB, KBC Asset Management N.V., and GIC Private Limited, against the Company, certain of Mylan N.V.&#x2019;s former directors and officers, a current director and officer of the Company, and current employees of the Company. The Complaint asserts claims which are based on allegations that are similar to those in the SDNY and the Western District of Pennsylvania complaints identified above.  Plaintiffs seek compensatory damages, costs and expenses and attorneys&#x2019; fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2021, the Company and certain of its then officers and directors were named as defendants in a putative class action lawsuit filed in the Court of Common Pleas of Allegheny County, Pennsylvania on behalf of former Mylan shareholders who received Company common stock in connection with the Combination.  A non-Viatris affiliated company and persons were also named as defendants.  The complaint alleges violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 for purportedly failing to disclose or misrepresenting material information in the registration statement and related prospectus issued in connection with the Combination. On January 3, 2023, an amended complaint was filed naming the same defendants and alleging the same violations as the original complaint. Plaintiffs seek monetary damages, reasonable costs and expenses, and certain other equitable and injunctive relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Opioids&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company, along with other manufacturers, distributors, pharmacies, pharmacy benefit managers, and individual healthcare providers is a defendant in more than 1,000 cases in the United States and Canada filed by various plaintiffs, including counties, cities and other local governmental entities, asserting civil claims related to sales, marketing and/or distribution practices with respect to prescription opioid products. In addition, lawsuits have been filed as putative class actions including on behalf of children with Neonatal Abstinence Syndrome due to alleged exposure to opioids.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lawsuits generally seek equitable relief and monetary damages (including punitive and/or exemplary damages) based on a variety of legal theories, including various statutory and/or common law claims, such as negligence, public nuisance and unjust enrichment. The vast majority of these lawsuits have been consolidated in an MDL in the U.S. District Court for the Northern District Court of Ohio.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 13, 2023, the Company received a civil subpoena from the Attorney General of the State of New York seeking information relating to opioids manufactured, marketed, or sold by the Company and related subject matter. The Company is fully cooperating with this subpoena request.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Meda Sweden Commercial Dispute&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 30, 2021, Ocular AS and other related entities (&#x201c;Claimants&#x201d;) initiated an arbitration in Sweden against Meda OTC AB and Meda AB (collectively, &#x201c;Meda&#x201d; or the &#x201c;Company&#x201d;) alleging breach of a 2013 sale and purchase agreement between Claimants and Meda concerning commercialization of a dental hygiene product.  Claimants are seeking approximately $155&#160;million in purported damages, plus interest and costs.  The Company believes that it acted lawfully and vigorously contested all aspects of Claimants&#x2019; case &#x2013; including their asserted damages &#x2013; at an arbitration hearing that took place in February 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Citalopram&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2013, the European Commission issued a decision finding that Lundbeck and several generic companies, including Generics [U.K.] Limited (&#x201c;GUK&#x201d; or the &#x201c;Company&#x201d;), had violated EU competition rules relating to various settlement agreements entered into in 2002 for citalopram.  After various appeals, the European Commission&#x2019;s decision was upheld in March 2021.  On March 28, 2023, bodies of the national health authorities in England &amp;amp; Wales served a claim in the U.K. Competition Appeals Tribunal against parties to the citalopram investigation, including GUK, seeking monetary damages, plus interest, purportedly arising from the settlement agreements.  The Company, beginning in approximately 2018, has received notices from other health service authorities and insurers asserting an intention to file similar claims.  Pursuant to an indemnification agreement, Merck KGaA and GUK have agreed to equally share any damages claimed against Merck KGaA and/or GUK alleged to have been caused by the conduct which is the subject of the European Commission decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has accrued approximately &#x20ac;11.9 million as of March 31, 2023 related to this matter. It is reasonably possible that we will incur additional losses above the amount accrued but we cannot estimate a range of such reasonably possible losses at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Like other pharmaceutical companies, the Company is involved in a number of product liability lawsuits related to alleged personal injuries arising out of certain products manufactured/or distributed by the Company, including but not limited to those discussed below. Plaintiffs in these cases generally seek damages and other relief on various grounds for alleged personal injury and economic loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has accrued approximately $65.1 million as of March&#160;31, 2023 for its product liability matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nitrosamines&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company, along with numerous other manufacturers, retailers, and others, are parties to litigation relating to alleged trace amounts of nitrosamine impurities in certain products, including valsartan and ranitidine. The vast majority of these lawsuits naming the Company in the United States are pending in two MDLs, namely an MDL pending in the United States District Court for the District of New Jersey concerning valsartan and an MDL pending in the United States District Court for the Southern District of Florida concerning ranitidine. The lawsuits against the Company in the MDLs include putative and certified classes seeking the refund of the purchase price and other economic and punitive damages allegedly sustained by consumers and end payors as well as individuals seeking compensatory and punitive damages for personal injuries allegedly caused by ingestion of the medications. Similar lawsuits pertaining to valsartan have been filed in other countries. Third party payor, consumer and medical monitoring classes were certified in the valsartan MDL and a Rule 23(f) petition to appeal the certification decision was denied. The Company has also received claims and inquiries related to these products, as well as requests to indemnify purchasers of the Company&#x2019;s API and/ or finished dose forms of these products. The original master complaints concerning ranitidine were dismissed on December 31, 2020. The end-payor plaintiff immediately appealed to the U.S. Court of Appeals for the Eleventh Circuit, which affirmed the dismissal. The personal injury and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consumer putative class plaintiffs filed amended master complaints. The Company was not named as a defendant in the amended master complaints, though it was still named in certain short form complaints filed by personal injury plaintiffs. The trial court has dismissed all remaining claims against the generic defendants. Certain of the personal injury plaintiffs appealed this dismissal, which remains pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lipitor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A number of individual and multi-plaintiff lawsuits have been filed against Pfizer in various federal and state courts alleging that the plaintiffs developed type 2 diabetes purportedly as a result of the ingestion of Lipitor. Plaintiffs seek compensatory and punitive damages. In February 2014, the federal actions were transferred for consolidated pre-trial proceedings to an MDL in the U.S. District Court for the District of South Carolina. Since 2016, certain cases in the MDL were remanded to certain state courts. In 2017, the District Court granted Pfizer&#x2019;s motion for summary judgment, dismissing all of the cases pending in the MDL. In June 2018, this dismissal was affirmed by the U.S. Court of Appeals for the Fourth Circuit. The state court proceedings remain pending in Missouri and New York. Prior state court proceedings in California have now been terminated after the California Court previously granted motions (i) to exclude the opinions of plaintiffs&#x2019; only general causation expert in connection with his opinions involving the three lowest doses of Lipitor (10, 20 and 40 mg); (ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for summary judgment in connection with the 10, 20, and 40 mg plaintiffs; and (iii) seeking the dismissal of the remaining cases involving the highest dose of Lipitor (80 mg).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intellectual Property&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in a number of patent litigation lawsuits involving the validity and/or infringement of patents held by branded pharmaceutical manufacturers including but not limited to the matters described below.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses its business judgment to decide to market and sell certain products, in each case based on its belief that the applicable patents are invalid and/or that its products do not infringe, notwithstanding the fact that allegations of patent infringement(s) or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;other potential third party rights have not been finally resolved by the courts. The risk involved in doing so can be substantial because the remedies available to the owner of a patent for infringement may include, a reasonable royalty on sales or damages measured by the profits lost by the patent owner. If there is a finding of willful infringement, damages may be increased up to three times. Moreover, because of the discount pricing typically involved with bioequivalent products, patented branded products generally realize a substantially higher profit margin than generic and biosimilar products. The Company also faces challenges to its patents, including suits in various jurisdictions pursuant to which generic drug manufacturers, payers, governments, or other parties are seeking damages for allegedly causing delay of generic entry. An adverse decision in any of these matters could have an adverse effect that is material to our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has accrued approximately $108.8 million as of March&#160;31, 2023 for its intellectual property matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lyrica - United Kingdom &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in 2014, Pfizer was involved in patent litigation in the English courts concerning the validity of its Lyrica pain use patent. In 2015, the High Court of Justice in London ordered that the NHS England issue guidance for prescribers and pharmacists directing the prescription and dispensing of Lyrica by brand when pregabalin was prescribed for the treatment of neuropathic pain and entered a preliminary injunction against certain Sandoz group companies preventing the sale of Sandoz&#x2019;s full label pregabalin product.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pfizer undertook to compensate certain generic companies and NHS entities for losses caused by these orders, which remained in effect until patent expiration in July 2017. In November 2018, the U.K. Supreme Court ruled that all the relevant claims directed to neuropathic pain were invalid. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dr. Reddy&#x2019;s Laboratories filed a claim for monetary damages, interest, and costs in May 2020, followed by the Scottish Ministers and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;fourteen &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scottish Health Boards (together, NHS Scotland) in July 2020. In September 2020, Teva, Sandoz, Ranbaxy, Actavis, and the Secretary of State for Health and Social Care, together with&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 32 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;other NHS entities (together, NHS England, Wales, and Northern Ireland) filed their claims. All of the claims except for those filed by Dr. Reddy&#x2019;s Laboratories and NHS Scotland have been resolved. A trial on the remaining claims has been set for November 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yupelri&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in January 2023, certain generic companies notified us that they had filed ANDAs with the FDA seeking approval to market generic versions of Yupelri&#xae; with associated Paragraph IV certifications.  The companies assert the invalidity and/or non-infringement of polymorph patents expiring in 2030 and 2031, and a method of use patent expiring in 2039.  The companies have not filed Paragraph IV certifications to our compound patents, which currently expire in December 2025, with one compound patent subject to a patent term extension to October 2028.  In February 2023, we brought patent infringement actions against the generic filers in federal district courts, including the U.S. District Court for the District of New Jersey, the U.S. District Court for the District of Delaware, and the U.S. District Court for the Middle District of North Carolina, asserting infringement of the patents by the generic companies. The actions filed in Delaware and North Carolina have been dismissed and the actions will proceed in New Jersey. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in various other legal proceedings including commercial, contractual, employment, or other similar matters that are considered normal to its business. The Company has approximately $8.6 million accrued related to these various other legal proceedings at March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LitigationReserve
      contextRef="icabcde1e2ac34fc091515c433c41ff7c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzYzMzU_696a97e2-f71c-42d5-be34-f0f081c453de"
      unitRef="usd">5500000</us-gaap:LitigationReserve>
    <vtrs:Numberofstates
      contextRef="ib7e0a31051704ab8bc38fb1032e348fd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzEwMjQ2_0af9d00a-694b-4b2a-8c93-231616f52e6c"
      unitRef="number">46</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="i53082e0db5474dbba7be7c89cd35e27e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzEwNTA1_1bd4e783-8522-4359-937d-229f707365b6"
      unitRef="number">36</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="i0f50d795bf3f4c409462b9ddcf0db7d9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzExMzI4_e5e4e5fd-7cb5-4228-a0e6-472902657fea"
      unitRef="number">47</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="i9404440f3ab340efb47100f474f62e94_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzExNDY1_13c82bd3-4025-4ece-9840-a6c6a7c7bb15"
      unitRef="number">42</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="ib7e0a31051704ab8bc38fb1032e348fd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzI4ODYz_c84bb5fd-7d4b-4fe4-8ac3-d333310614ff"
      unitRef="state">46</vtrs:Numberofstates>
    <vtrs:Numberofcases
      contextRef="iff6cf2c8fb074b0f8a4d37a56092740b_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzE3OTk4_9989232b-7695-48bb-9b34-aa607f350210"
      unitRef="number">1000</vtrs:Numberofcases>
    <us-gaap:LossContingencyDamagesSought
      contextRef="icde060aa771e4f15b2dfe00c564c524c_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzU0OTc1NTg4MDQ2OQ_f8013473-4c89-4efe-880a-4975bbb9af1b">155&#160;million</us-gaap:LossContingencyDamagesSought>
    <us-gaap:LitigationReserve
      contextRef="i96a44216070c4ea3999f969059533ad8_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzU0OTc1NTk3MDg1MQ_f307b30d-3196-41db-8136-1bf25ec6edbe"
      unitRef="eur">11900000</us-gaap:LitigationReserve>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i67450c71eb624b6fa6b3ab40994faf5c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzE5Mjgz_77751176-5d78-40ee-a89e-7baa318450eb"
      unitRef="usd">65100000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i1b6ee837070840fcb8fedf7b1e8f59da_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzI1MjA0_9293ff26-f76d-4e93-ab7b-54d927980407"
      unitRef="usd">108800000</us-gaap:LossContingencyDamagesPaidValue>
    <vtrs:NumberOfScottishHealthBoardsNHSScotland
      contextRef="i3af94b01e96b43d1b3dd129d00730688_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzU0OTc1NTg5ODg4Mw_8fc29f4c-e853-486a-9ffa-2ade36c2aab5"
      unitRef="healthboard">14</vtrs:NumberOfScottishHealthBoardsNHSScotland>
    <vtrs:NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland
      contextRef="i3af94b01e96b43d1b3dd129d00730688_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzU0OTc1NTg5OTk3NQ_6160d637-b409-4c84-a502-3544827ee947"
      unitRef="entity">32</vtrs:NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i9823c12694d24f989d655525247c08e4_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYWY5MDI5OWVhZDRmNDJhYTVkN2ExZjQ2NDk1YjI3L3NlYzo0YWFmOTAyOTllYWQ0ZjQyYWE1ZDdhMWY0NjQ5NWIyN18xMDMvZnJhZzo2OTkzNmFhNTdhYjI0ODkyYjc0Y2RhNjA5NWViODJiZC90ZXh0cmVnaW9uOjY5OTM2YWE1N2FiMjQ4OTJiNzRjZGE2MDk1ZWI4MmJkXzI4Nzgy_57f1034b-595d-41a8-8751-fc4adbbf7de5"
      unitRef="usd">8600000</us-gaap:LossContingencyAccrualAtCarryingValue>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>107
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "$@*A63L+'2P4&  "W'P  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+69[V_B-AC'_Q6+FTZ;5)K8 0H]BD33=D.[]KC2=;I->V$2 ]$E,7,<*/_]
M'@=(H'-,%!UO(+^>;_SQ8\=?V_TU%]^3!6,2O45AG-PT%E(NKRTK\18LHLDE
M7[(8[LRXB*B$4S&WDJ5@U,^"HM BMMVQ(AK$C4$_NS86@SY/91C$;"Q0DD81
M%9M;%O+U30,W]A>>@_E"J@O6H+^D<S9A\H_E6,"9E:OX0<3B). Q$FQVTQCB
M:]=Q5$#VQ&O ULG!,5(H4\Z_JY.1?].P58E8R#RI)"C\K9C+PE I03G^W8DV
M\G>JP,/CO?I#!@\P4YHPEX=_!KY<W#2Z#>2S&4U#^<S7O[$=4%OI>3Q,LE^T
MWC[;:C60ER:21[M@*$$4Q-M_^K:KB,, NR2 [ +(NP#LE 0XNX"LYJQMR3*L
M.RKIH"_X&@GU-*BI@ZQNLFB@"6*5QHD4<#> .#EP^8H)-(:,H2;Z^*'K=%J?
MD(62!14LZ5L27J$>M+R=W.U6CI3(.>B1QW*1H/O89_YQO 5%R\M']N6[)4;!
M1RHND8,O$+&)HRF/>RI\@VQ'%WU4&B>O+2>3<XRU]?=PFD@!#? ?705M%5IZ
M!=4KKY,E]=A- [I=PL2*-08?/^"._4E']X/$CF!;.6S+I#ZXXUX*'5:BE\V2
MZ4C-X=AN?M4A&:-J(K5SI'8UI*\I%9*)<(.>V9(+J<,S2TF1ZBK%-4;5Q.OD
M>)UJ>&,F NZK3HC@JZ!-GEDI[W:E_<X87Y/S*N>\JM@R!84!)1L/RO-HUIK1
M,-$FTAA6$["; W:-A;J/92 WZ"$(&7I*HRD3.C"SAFWCIM/K]-HZ.&-H3;A>
M#M>K O?,YH'ZC$(:GVBD;:-FG=?1\.5Y-$&C)_=2QVB,KLF([6)<M:M0CF*/
M"VB95#72"S21T!T1%\CE:2S%!OY]+?H)];M[';$YJ"[R@97 59!?Z!L:^= ]
M@UG@9=R&-GQ"LNLT6V!)2*^CY34&U^4E!2^IPCOT?5!/+O8'Z#,\A[[$^KR:
M);%MV^AQ$](8W?(T9"LJ?"VY4:8N>6&#L-%X_(_<56?0JE_X.M92F^5<&O,X
MF:9BKF4]APG"A0O"9A_SGC7OPF/!5T'LZ=-LUAP/M:#GL$:X\$;8[&C>@XYY
M(FF(_@J6Y5\ILR)N._A*2WH.EX0+FX3-[B9KKD.8]9:#F06N2$N+=0Y3A M7
MA,U6YC/W(%_C!8]-KN&$2!NWFKAKVUJ^<W@B7)@B;'8T+X$$/\1G").?I[^@
M"?-2 9G40IJ57!Y%,"Q-)/>^7Z E%6A%PY2AG^Q+&Z,ES/&R";"V#LYAG7#A
MG;#9](#C]8-XCB:;:,I#+?H)U_3R/-%RG<,ND<(N$;.AV2<3W;]Y"QK/6:DI
M/"'T-)S<#;433W-@7<+"'9%*[LA-A5!3E^U\)4LE#"BI=JWEA.(W[0J-:XZJ
MRUFX(E+)%8UBF%]O%^G4')3NP;6<9L4RSG-X(%)X(%+) \$<+83OA0NF8,Z%
M]F-T0N@S%=#<AY['0 AD_&S>I_MVNV:ENLB%%2*5K- DHF&(;M,$;B?ZAFO6
M*9USF^/J\A4.B%1R0/<1$W/5,W\%!;D DQ M::Q/K5FP'/0<!H@4!HB8_<L^
MD0L&B33AF67*\<YAA$AAA(C9PQP/[V,8WL&N9[[=1Z_90#^&+CLI&>)O=^KM
M3%WM@ZP&RA?TK=41XSG,$"G,$*FT1'2,FB$EZ$LJP;K'RBAH^7Z0A=G5PU:M
M<U!;&/=Z-NGUNJV\SHXI"[M#*JT5N3!P"/"VH]AG;^AWIF^L9BF86>.K'K%;
M6NMN#JZ93:>P/X[9M0PC%OO9DN9#2+5).R%0VA7-<77!"M?CF#U*OE3[$"1J
M=O*-06]\@(O:<>.$6-E:M#FL+F/A>!RS/WG/N%M]+Z<TRWW%6L9SN!WG8./K
MQ!+-SK8>IM&TO7!"KMG$I.GH07^HQ[$.MD;5L)[M&"?(4\NOVUW2_&J^*SW,
M]F*MXO'MEO8C5:X@02&;0:A]>04#A-CN$F]/)%]F&ZU3+B6/LL,%HSX3Z@&X
M/^-<[D_4"_*]^L%_4$L#!!0    ( (2 J%;YV(;W+P4  *(4   8    >&PO
M=V]R:W-H965T<R]S:&5E=#(N>&ULK9AM;^(X$,>_BL6M3ENI&V('".E1I"W=
MO:MTO5;M[>YK P:L36+.-M#[]C=.0A*PXVNE]D7)P\SD-Q[;?]N3@Y _U88Q
MC5ZR-%?7O8W6VZM^7RTV+*,J$%N6PYN5D!G5<"O7?;65C"X+IRSMDS <]3/*
M\]YT4CQ[E-.)V.F4Y^Q1(K7+,BK_O6&I.%SW<._XX(FO-]H\Z$\G6[IFSTQ_
MVSY*N.O7498\8[GB(D>2K:Y[G_'5C R-0V'QG;.#:ETCD\I<B)_FYFYYW0L-
M$4O90IL0%'[V;,;2U$0"CG^JH+WZF\:Q?7V,_K5('I*94\5F(OW!EWISW1OW
MT)*MZ"[53^+P!ZL2*@ 7(E7%?W2H;,,>6NR4%EGE# 09S\M?^E(U1,L!XK@=
M2.5 SAT&'0Y1Y1 5B99D15JW5-/I1(H#DL8:HIF+HFT*;\B&YZ:,SUK"6PY^
M>CH3^1**PI8(KI1(^9)JN'G6\ /5T@H]K-##EDEJ6EVA3^C;\RWZ^.$"J0V5
M3"&>HWN>IN;E)?K0OIWT-0":S_07%<Q-"4,Z8")T+W*]4>@+0"U/_?N06)T=
M.69W0[P![ZD,4(0O$0E)Y."9O=Z=>'"BNK&C(MZ@(]Y?,"P539FS:4K7N' U
M@V\_C6*<!'C2W[>);;,!CL<!J<U.R 8UV<!+]K?0-(5AN6?YSHU7^H]/\(B-
M9YL-<(*#V(TWK/&&7KR94!J)57?C#:W/$CP>!<D9G<-L0,)@Z*8;U70C+]WO
M4BB%ME*LN';!C:ROXN& M$I6PCG,XAAW53:NX>+"+^J J\9NOD;L96M&NKIR
M,<:^#(V67*DM7;#K'HB%8G+/>M-??\&C\#?7J'JG8"?YCNM\Q]YB/$%$*A<;
M1/,ES.=[$*JMF<A<28_M%A\3J],XK*!ZD;LL28V9>#&?0;B@*)=HS7(H4%K@
MTB7,\%QI4[ ]<Q$G%DLR'%O$#BL\["+&82,5H9?Y3Z[YNM !I)C6:240AESH
M#9-H ;,W),7R!6>@!CESMGKUE39>&(S.4G 8C;J& FZ)'7[%-">L(>'$Q';=
M3>$'YZ0.NW 4!>,.6-+ $B_L%RIS@%1H)45VA.[256)/STG28JA8;;,XC%LI
MG:(VNH;]PG:7:P9#61\;U(E8AAB=C*/X'#!R#+;NPC?RAOWZ]E#TSX\\7XB,
M71PQN[NH+6.?1DF0A*V_<^5S^$11E_#A1OFP7_KJ7C!GL&AGJ$P!:?K2T6UM
MC8L(":R&MLV&).Y20MQ((?9KX5V-9P1QS\URWXDYLGI#8O56AR*2<><\UB@B
M]@I0L0QC5;,ZV6)KC47(P&Y"V\R,N:Z^V@@8'GL5NZXXC/ARE8VHUI+/=YK.
M4VA;@;YS"@\4@M8.2I.-2)=,NM/Q"N9;M?V]HITV3B.;V*^;-U3QA1G(Q3ZD
M;J$+9^)EJ.1$:/"Y6#JMHHY.1AJQ)'ZQO.7ISNRD7H=:!?L?5*=5)VJCB@1[
M.]R/8J\+K'0/&K-FQZT=[/J5!G6'SNA<,Q*OV+ZU8[U7M--&:-26^-6VZ5AE
M]NXRV?J)86_8FC:K7%QVN'.C01JA)7ZA;?<J'Z=#1DDXM%993CL<M79UIYR-
MWI+7Z.V39S_I#_#FSO-.T4[3;42:^$6Z3->W?:X"F&5M:YEX7HZAI2A0C/-.
MTV^=]F1,KHM#, 6+[UVNRZ.1^FE]T/:Y.%XZ>WZ#KV;E<5D3ICR]NZ=RS7.%
M4K:"D&$0 Y@L#\3*&RVVQ9G27&@MLN)RPR@HD#& ]RLA]/'&?* ^EIS^!U!+
M P04    " "$@*A6A7_:Z%4$  !T$   &    'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;+58[6[;-A1]%4(KA@2H]6W9SFP#C;NB 98U:-#V-RW1%A>*]$C:
M3O?TNY1D6;)D-2G</[%(W7MT[C>9Z5[()Y42HM%SQKB:6:G6FQO'47%*,JQL
ML2$<WJR$S+"&I5P[:B,)3G*EC#F^ZT9.ABFWYM-\[T'.IV*K&>7D02*US3(L
MO]\2)O8SR[,.&Y_I.M5FPYE/-WA-'HG^LGF0L'(JE(1FA"LJ.))D-;/>>3<+
M;V04<HFOE.Q5[1D94Y9"/)G%73*S7,.(,!)K X'A9T<6A#&#!#S^+4&MZIM&
ML?Y\0/^0&P_&++$B"\&^T42G,VMLH82L\);ISV+_D90&#0U>+)C*_Z)]*>M:
M*-XJ+;)2&1ADE!>_^+ET1$T!<+H5_%+!/U4(SR@$I4*0&UHPR\UZCS6>3Z78
M(VFD <T\Y+[)M<$:RDT8'[6$MQ3T]'PA> )!(0F")R483;"&Q:.&'XB65NC3
M"EYED".I"=Z.H+^$4FB OCR^1U=OKM$;1#FZIXQ!5-34T4#*0#MQ2>"V(."?
M(1"@>\%UJM"?0"1IZCM@3&61?[#HUN\%O,?21H'W%OFN'W3P6;Q<W>^A$U0.
M#G*\\ S>WU"*!$M.^5HAK+6DRZW&2T:0%N@KQ;"AT!V/;12++(/$5BD&7PN6
M$-GISN)SH_QSIDAW<]\/[='4V=6-;$L%DXGM5U(-6\+*EC!7"\[8\DFG1!J>
MM6Q@D UOT9) 1P&3\/--%^>PST6F4]VH#8[)S )@1>2.6//??_,B]X^N^%T(
MK.&!8>6!86\TH75 8^!0F5(2'G]'6F*N&"Y:4O(/%*RIFBX?%,#C6D3"H1V<
MA*TM- BCLW&+*M91+^M%BOF:F#K=<DEBL>;T/RCR-71Y=&4">(TP3]!&4@$=
M'EQ&8P)A5AH:-<O[ >0J]$: 32#4')XTVC#<7>]1RP:O96=;9N#;4;>5H\K*
MT0\KS=B'6<LZ" X,J2=2%)XB$#ZJ*>FD/VI1<^W)"?VVS,"KE6"#_KBB/^ZE
M_Y+BZN([[N R;#$NI**&PT=GTFI2,9[T,H:N);*<%[HJL^(:DDCLJ!GR75PG
M'5Q]>WC"M2T5AN>\Z[G'0>?^I'\Y)(Y8G?-O"=L@'=CA">=.*2\Z2[LVG[W^
MVFT0/DR23J)>BX+OMTNO0VQ<CT&3IW_DZ??SQ"I%'^!4B#Z29 T<.RGV8KQV
M$%P*K6GQ<;![P:^9AE[OB>'57K@06M,+QR.!USMOJZ[;.56@[\(QANZP.:MW
M)VW83EI[?)JR;2'WW$STCJ/<ZY_EAOD=!U[YR.Y-VUZ@5P?L0FA-LX]G 2_Z
M16G;>\AXM1<NA-;TPO&LX+WLL/"S:3MJG:\'453+R=+(MICOUEMRP=ZIW=\R
M(M?YM59!C+9<%Q>?:K>Z.K_++XPG^[?F2IW?"X\PQ7T<KC60W0HQL@)(UQY!
M$LKBBELLM-CDM\2ET'#GS!]3@L$-1@#>KX30AX7Y0/6/AOG_4$L#!!0    (
M (2 J%:7YS]QDP8  /P:   8    >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL
MK9E];]LV$(>_"N$5Q08XMDCJQ4H3 VV*;056-&C:[F_:HFVADNB2M)/LT^\D
M*WHQ7Y("#9!$LH_4[X[D/4?JZE[([VK'N48/95&IZ\E.Z_WE?*[6.UXR-1-[
M7L$W&R%+IN%6;N=J+SG+FD9E,2=!$,]+EE>3Y57SV:U<7HF#+O**WTJD#F7)
MY.,[7HC[ZPF>/'WP.=_N=/W!?'FU9UM^Q_77_:V$NWG72Y:7O%*YJ)#DF^O)
M6WQY0\.Z06/Q+>?W:G"-:E=60GRO;SYDUY.@5L0+OM9U%PS^'?D-+XJZ)]#Q
MH^UTTCVS;CB\?NK]S\9Y<&;%%+\1Q;]YIG?7D\4$97S##H7^+.[_YJU#4=W?
M6A2J^8ON6]M@@M8'I479-@8%95Z=_K.'-A"#!CAT-"!M _+2!K1M0!M'3\H:
MM]XSS9974MPC65M#;_5%$YNF-7B35_4PWFD)W^;03B]O1)7!H/ ,P94219XQ
M#3?O6,&J-4=W=<<*7:"O=^_1[Z_^0*]07J&/>5' &*BKN08)=4?S=?NX=Z?'
M$<?C/C(Y0Q1/$0D(M32_\3=_S]==<S)N/@?'.^])YSUI^J,N[P]2\DHCIA2X
M>6GSY]1!:.^@7F27:L_6_'H"JTAQ>>23Y>O?<!R\L7GWBSH;^4H[7ZFO]^4-
M4SO$J@RMZPO^XY ?60'.6T?QU%72=%5G@N,R"N)9?#4_#MTQK3")TEG:F8V$
MAIW0T"OT[7HM#J +LL2:@\A5P:>HXMJF\]338J" AFDRB\Z$6LP6.!R8C81&
MG=#(*_1#=83X"9ES:PPC\Z%Q',[HF3:+6813E[:XTQ9[M=U*OF=YAOC#OE[>
MJAEYH7=<0E893GJ;\MB0A).8&L-O,5M@/"-VY4FG//$/?R,+[7B1(< 44C!+
M;2(3\^GIPHBN:45H,+ :25QT$A=>B5^$9L4+XK@P'I[&\'22]C]G<LT6.(AI
M- OM@M-.</K,; #N2_TX17O(Z[J9#'4&V .0M7-QI>;,#()DMCC3;#,CSL6%
M@YY,P3/+2[-JF\/R;T/L%-IV-!IED@38F+%6PQA\P@ZQ XQBK]B_A,CN 8M6
M>=@RJE%"!RNEE6<S#$DT"/E87L\Y[$4+@'/#8;9F0.^U*#G2[ &M>,4WN3V@
MQ)RYD-CQN5Z+&:AUY'_<DPK[4?6IR5/N==4V'PUCB!=F/&UV 75.S9Y0V(^H
M4P+P"#2!$Z8D#4R%IF$40&WC2J*X9Q..7E3:%#E;Y46N 5+6^@9[&?>S!<ZO
MZFWL= \][*=>5SKLV6-=-U@=MF KC<R:P6:7Q,,B:"RRYQOV ^YN)Z2^T%R6
M:"4D-,^KK7T66> 5A&92.YG% [/ H;$''/83[D.7)K@_F":P2!B:L;28):DS
ME#W6L)]K3Y-\#Q&M-X5B@PI1;4_!S?A*#\J>_@NQ*O(MT\X=C FT*%C,DG.?
M3+.F^G6@A/3<(W[N?1I5:8/U:]V>F$2C."4&I&UV81BX<C7IP4?\X!O70L^I
M-0$78XCM.5AL=DD8N[(B&>SW_!S\9S0[K!)-IN%%$*>#$JS5:#7$D5-DCS_B
MQY\-UD^!?;1JID8&(&%\O@BM5M2EMF<A\;/PT\^M+F(2#R>PWS$FK,TNBEWL
M)CT8B7_7=IJPSTU4<U=&%C0FQO[":IB&SDTPZ5E&8B_ O^5,RUPA2,4SI'9,
M\ITH,B[5Z]\6!"=OF@+>,1^\E/SI0XM?U-LX#CTNB1^7-Z(L(;4K+=;?+]&K
M8!9@())$1U8<^!31:1 $3[^G.,%F]Z !LOE_/'OS]%&NU(%GEPA/"0G@-YP"
M2QL\P">83I.43DE]M 3&>]X<+A;VX%HVGL0H[.Q6+C;T7"9^+K_-LKQ>6C"#
MZ^W]15ZA-=OG,*.M4BW;R44\ F^KUFH8.C<>I"<T\1/Z,]<,/H+M)I.5J] A
M%N*2B!AEA,T.DH*KCJ ]<JD?N5 W'LI#T1Q]MH<DHH39O*O/JX\<LINR'Y.9
M5+T@26S6: Y#YV$)[?E+7\+?4;(X)88I;/ V0@(^)&?J(!]/2\CJAHE;@C',
MD_.:QVH8),1UH$)[,--GP,R5ND1?1E)1D^G(&\0TC(>RXIJ:%"81-FC2FKV@
M1J:#\U0_ID^1=V=A:ME]!BE)9N>'/C9#;U1[-M.7[%,'K.M.?AR20^-$U[YO
MM1C:]ZWSP:N)^KW01R:W>:50P3?0,I@EP$]Y>M5RNM%BW[RM6 FM1=E<[C@#
M[M4&\/U&"/UT4[\ Z5YX+?\'4$L#!!0    ( (2 J%9EA? #[ $   0$   8
M    >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL?5--C],P$/TKED\@576:;!>T
M2B/1KA <$-66C[.;3!NKCAWL2;/PZQD[:51@2P[QC#WOS1M[)N^M._D: -ES
MHXU?\1JQ?1#"ES4TTL]M"X9.#M8U$LEU1^%;![**H$:+-$GN12.5X44>][:N
MR&V'6AG8.N:[II'NYQJT[5=\P2\;3^I88]@01=[*(^P O[9;1YZ86"K5@/'*
M&N;@L.+O%@_K+,3'@&\*>G]ELU#)WMI3<#Y6*YX$0:"AQ, @:3G#!K0.1"3C
MQ\C)IY0!>&U?V-_'VJF6O?2PL?J[JK!>\;><57"0G<8GVW^ L9YEX"NM]O'/
M^B%V><=9V7FTS0@F!8TRPRJ?QWNX J2+&X!T!*11]Y HJGR4*(O<V9ZY$$UL
MP8BE1C2)4R8\R@X=G2K"8;&QIJ(KAHJ1Y:U6E41RUE)+4P+;!6+/7FVE X,U
MH"JE?IT+I-2!0)1CFO60)KV1YA'*.<L6,Y8F:<I\373^3Q9!PB?UZ:0^C;1W
M-V@_NTH9ZJ61<3:N3'986Z=^0?62U('S/G*&ICT767+Y<G%^04\VZ<G^J^<+
MS87O@AZTY6GV8J&#ANP?#7^G%E>/&N;CDW1'93S3<"!,,G^SY,P-/3<X:-OX
MSGN+U#71K&E,P84 .C]8BQ<GM,XT^,5O4$L#!!0    ( (2 J%9-9=TJJ0D
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MT\CEZC>3L>:N5&=E($("4CQ9)/ABBT76XYYWN*LG<(_4A7>IBNIGEU.^;[\
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MR[WLI[3BX*LPU3A_'/;##'T@2Y)UD*S> J]LEW @8F%TA$11=$1IJ@X>YLP
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MM 'K*V.JY@M=T/Z\=_DO4$L#!!0    ( (2 J%8N>^INZ00  $P+   9
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MQ%T52Q+WJY>R1E%HBEPL)=V#[@MER6&IB-%7T7O[3>;\'NI3I;'#EA3:(32
MUNP"WB37+C-K93<#!, :M:^B,WR((/!7RF9:%OK?,@8\)\R1+H^R0@*8*AA^
M!>1H:IW!'92$LM+*<;"@^B*DJB44+%8ZH\,4;.>&XM?[@I,]3"F&/.B)3L)
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MD1VZD%(AT:.N'3P"&%1U!.D#?"2>XWU] FSVX-3DHL.IKP')3I:5L?66EIT
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M1B-#0#*V @8K  Q@6!M?W/SXS11FL4GF<PV/77HS/P+=WCR7V<[D?-RO*]$
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MRM("W*?8C#_H@/9#^)?_ 5!+ P04    " "$@*A6#PVHO# (  !?$P  &0
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MCLW\N,?#)L,PH:*&OF)#ZMHTBV-,KGIKDF4THC,81D^K0]*)>8[N\'=!A-!
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MYM)M+;T$V\0;TLP&W+?BWPH77')\ /MSB[FM>V$#JROSV5]02P,$%     @
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MI>"('Q%@?ZZ0K\T+*=C]V'+S/U!+ P04    " "$@*A61TRSMP$3   ]/P
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M4$CG#&BD .$?=+$1/!,)"I>;HJ&%,H%F5P)C=[(5F<E.5V5&T1(46O,8J\Q
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MRX4^.$']C_>?R'7(CUKL#/'O6)A<^TG""#62A!E^?15&S VW/UF%"5(*99B
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M RYQ\;/"0Y4<;\!Z:6WH!VQ@>/J>_PM02P,$%     @ A("H5F'_ +=S"P
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M!/&;<M"KBQ\^#E*UK_&?,E>538:70;?%0X7#2;>UMA$I$S^#XBZUZPQ]]GA
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MMV<3%>5G0GG(H>6?YE8AY]#PGT >"(@6X/LZH&,O#W3 \%OM^7\ 4$L#!!0
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M:@5&\ < H[(FPF>=Q3W!:+5M<17.S"J=B#:M!Z3=P,2:5\.G":,@F9-C "U
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M,0)G"+'] 7^(71!8!OH@O2!@N@!V#1S'>OKK(% ;+3L<P0+< OX2@],@=S1
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M8<P4#$;^\-R5Z%<O!>DN5F:YD@UDZW]"BT86;#5E$% #7F)<"+%1+Y%R,&S
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ME@)OP#J?W58O;&!]+1[_!U!+ P04    " "$@*A6W2WW=+P'  #($0  &0
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M@(A:D"V<;,K-5*Q+K4KN>VY@+W3@R-$1O'[EX)F=\]V5LS*+JS,TN/,ZU\B
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MD!7J>$^FI4157P+H.-?H;5WIL#D45X1&!PO*>N84)3!VD%+&'++3FJ1O'44
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MIZ@]V;_?_42+UKZ9:Z'Q!;;#$C]YF#0&N+\10C].3(#A(VK^/U!+ P04
M" "$@*A67F]9C.P"  !Y!@  &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6R-5<MNVS 0_)6%&@0Q4.CE1]+$%F"[*9I#4B-)VT/1 RVM+2(4J9)TG.;K
MNZ1DU04<HP=+),6=F5TNQ^.MTD^F1+3P4@EI)D%I;7T9128OL6(F5#5*^K)2
MNF*6IGH=F5HC*WQ0):(TCD=1Q;@,LK%?6^ALK#96<(D+#69354S_GJ%0VTF0
M!+N%>[XNK5N(LG'-UOB ]FN]T#2+.I2"5R@-5Q(TKB;!-+F<#=Q^O^$;QZW9
M&X/+9*G4DYO<%),@=H)08&X= J/7,\Y1" =$,GZUF$%'Z0+WQSOT3SYWRF7)
M#,Z5^,X+6TZ"BP *7+&-L/=J^QG;?(8.+U?"^"=LF[W#-(!\8ZRJVF!24''9
MO-E+6X>]@(OXC8"T#4B][H;(J_S(+,O&6FU!N]V$Y@8^51]-XKATA_)@-7WE
M%&>S15-? TP6\,66J&&AC-5HN48JOH492EQQ:^#LD2T%FMXXLD3LPJ.\)9DU
M).D;)'VX5=*6!JYE@<6_\1$)[E2G.]6S]"C@+=,A])/WD,9I_PA>OZM"W^/U
MW\"[/Y#NC^F2ZD!=\_-0P@W>X#">NTF7IF8Y3@*Z*@;U,P;9Z;MD%%\=43OH
MU Z.H6=W=%<7J+DJ>+[3"W,ZM4-"CT(=%CI75:TD%<. 6H$DMGK'MFS9<F(#
ML@2@CJ&?1H2J.6)T1PQT0'G9G9!O+AJDL$6-P R%"K(#<PEM__U'^SUZEOU&
MVF,YNY%T.X1PK=QK.#W? V7$<VSTGL!YF-#S0SB$&VE)BFDS22["/B1Q.(#K
MEYK\@K!)PD9+(&FU8*3/&'1W(!F%@YY_C7HPK92V_)5Y?Z%2U50E,KP]3@.G
M[R[2)+V"F*CO,5=KR5\)WE65>FO#-&<"UN2>!#X,XUX7</=FW4]@$,;T[)/>
M0^T4[=E!A7KM3<]0[$;:QAFZU<Y7IXV=_-W>F#)5>.VD"5Q1:!R>#P/0C=$U
M$ZMJ;RY+9<FJ_+"D_P;4;@-]7REE=Q-'T/W;9'\ 4$L#!!0    ( (2 J%9+
M7%9_FP8  "@3   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;)5876_;
M-A3]*X17#"V@V**^U24!DK3="K1KT'3;P[ '6J)MHI+H470^_OW.I6S%:63-
M>;$HBSR\]YY[SZ5T>J?-]W8EI67W==6T9Y.5M>NWLUE;K&0MVJE>RP9/%MK4
MPN+6+&?MVDA1ND5U-0M\/YG50C63\U/WW[4Y/]4;6ZE&7AO6;NI:F(=+6>F[
MLPF?[/[XJI8K2W_,SD_78BEOI/UC?6UP-^M12E7+IE6Z848NSB87_.TE=PO<
MC#^5O&OWQHQ<F6O]G6X^EF<3GRR2E2PL00A<;N65K"I"@AW_;D$G_9ZT<'^\
M0__@G(<S<]'**UW]I4J[.IMD$U;*A=A4]JN^^TUN'8H)K]!5ZW[973<W3B:L
MV+16U]O%L*!637<5]]M ["W(_ ,+@NV"P-G=;>2L?">L.#\U^HX9F@TT&CA7
MW6H8IQIBY<8:/%589\\O126:0K(;EP)7NE[K1C:V9:^_B7DEVS>G,XMM:/*L
MV$)>=I#! <B0?=:-7;7L?5/*\NGZ&<SK;0QV-EX&HX"?A9FRD'LL\(-P!"_L
M?0X=7OA2G_^^F+?6(%'^&?*Z XV&0:EZWK9K4<BS"<JCE>963LY__HDG_B\C
M)D>]R=$8^OD-JK'<5)+I!;L2[<IC!7Z9_'>C;D5%QGM,-"7J! ZHPLK231AR
M8W2C83=HQR%X]OIC@Z2L*M17^X:!IV+EB'HG"UG/I7$WCW^#OX#U8#]ZP%ZQ
MV$^F":[<"^)\FF.4QL$T8E^?[NLQU135!MF% 8.=:Z%*)N\A5:UL';BV*VQ?
M;(P!-!-M*[%!-.4LP ;QU#\0Q4$O81?WIVEG5Q),8V=7"KM&F(U[9N-19C\V
MM]A8&R7;(;9&%P^SM8=X'$%?Q1TDQ4JC1$4L) GY!J]3#E__@JIV8=:%;%N6
MY/0TC6/\?E"-@O:4;*EUV;+ "_(<2P*/YQ3G?4M>L=!+DF@:NE',:=Y(^)(^
M?,EH^*ZWY+_?)_^+(_]J2_Z%(W\HN*/0P\&]/CK9C@J]JXAGF*]8$.9=PN41
MXGAQ*U1%<GR"-GS2(E790MV[["]T+5DKL;>R%.8P06Z',<+\02C#D-8;)QH+
MU4#S0##6(+LWM<OVG)*9AQ'V>H\BL _[4!&5240\?AGRCWMA[",'N!?Y$68>
M'QFJHS0)MY6><3X-QE(A[5,A_9]4P%G%V >/74/?K=N?O%J3KT/TC\(=HG^W
MQ[K?0^[V\%B#?G(\[Y]%L<*FYN$IC"L0/^:N5 (O!Z4IN]RHJE3-L@NKJE&-
MM[(CD7MQE($ 7%W67&G'<'?JZ0IW::AR(ZA8QJ*4V/I$,,^A0N*<AR%X_=5H
MK%F/.<QBCR-+.*Y^%@+[HB@V]:82))VE1-B0<<X,*$*8PJ$ CN6X'A%'%P4_
M!:H;!=&X8&1]EF2C6=+E\F%-&%T]G!0=Y(O+_G?=G. D_%U:*FWG/@I003-;
M6V\;8IJY*LF)LG=R(5%':$J 5J4T76A+%/C"Z)I=*HTG=*GT4A70 C]&#^TD
M^>KJ^H:2X=DDCB#[0,^=K']9.]AFR2J)LRXS=*@]T8N3#6ZV'@8Q41TX'CO7
M*]TL3] _ZMV4-*7NG6+B;DI?^H$7\0P%[T9^.$YJWI.:CY**O-,;BMA:/% P
MAX@=11@F]D?8%Y#[S8@2$?L1@ 0OXK%KK]SC,=5M%Z#MC);%D%S.$I^8?V8
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MYG5WI>R9<6E X)2@<7C0"4#7':M>6%7Y+C%1EGJ.GQ;4Y%$[ _H^5<JN%NZ
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MLL"M7F@Z@.\KA:C:;HA!_SO!U3]02P,$%     @ A("H5H%&"G&)"0  X!T
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MA4IC*2T! A6YDVQ-^9RPUS4:49%/-%M_)@)V1A9T&EB"[10Y(F'H^7")?&]
M?FQ-20MC<H;S@B%,@.EX>10:?&S^CK"6M6%LB VIJV$N]/]'RY'OQ23P!U[4
MHN(X] (0U/>&#?H=$M5EW<K@B)R&,!/L& V\$0['=C@>@9%:X"*NX")NA8LZ
M]B=6:8RZ6T>_*962H^SZ'4QH7:<9$^K%:;VX:]RD7KQ& D)EC17P$J(?T<-
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M<12R/^<X>S)I!/!]*M 0NP=C8'6:'?T#4$L#!!0    ( (2 J%9TQ]XWL@4
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M=J-ZAW8=T++OH.7P64G;&O@H&VR^]1\1LSV][(W>=782\#/3,>3I.61)EI_
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M;"]W;W)K<VAE971S+W-H965T,SDN>&ULC55MC]HX$/XKHW15@<0E(>&M%)"
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M[C1</W);;]PIRP0LF& R(V;V9U]CN()NOQ\.W#=\Y:5AV(=E'5VKVX8D',&
MSEZ%0U@RDT/)#C2(++227MAO0RL-2:N5#,-!&SY9+O@WYF?,RQ>CI)N\=@JC
M=OU/PX-&@Z1FUAIE=@"Z8-*(RB .T\;(K4^8/T\($4U[8?)$.QV$7?CWY.>Y
MOZV+8'--Z2JJID37E,\0.Y1UEZSS1>:24O= ,[NL#._1F@Z5 ?76J34[O]-+
M8"F]RYQ+UO%WX\_YAR^P1TU1E%3W1TZS$\4!KH:4SKJD';CJ4KA/4BMVN6QD
MA_.C!M$LT8]P<0C/-51T,@0=33_J#61J)VTU#YO=YC695T/T2;UZBB@ZBM*
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M4F_4SH#N"Z7L<>,>Z/X/TI]02P,$%     @ A("H5O3+%=IE"@  ;UX  !D
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MJ>M"I:9.G<'4F:7L[(2IPD"DIH8!F,9#>>&9_/2UO/-\H9W1#<W\V!T[0GH
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MH/LR?JP=&[M6_6,C=T=R$?@AP/GAZMLVK6KLV(@+3%X&&U6/ * DL.7=!*3
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MW7Y_\.NBKHOM_N6=3&YDV39HOK\MBOK[F_87'/>8/_L?4$L#!!0    ( (2
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MHIY8?\E/HKZ5HC71U!*/,^Z\KLG*[CE(\M?51MGQOUWQZ_Q/W/[-W;]4.UK
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MKXRNH\7.%NJ-T%@";+/&EQE(8X#S6R'T8\<L,+SUEC\ 4$L#!!0    ( (2
MJ%9P-^6R^@(  )<*   9    >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;+U6
M76_:,!3]*U963:W$\AV2=!"I!4VKM&X57;N':0\FN8!5)V:V@>[?STY"%DI
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MN3^\B>>U,N> AKBA(7[CD4<*2OK='( ^Q'$WN</P^/):#/IZ+^ >EU'<XO@
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M4J JDJ3 RY<R%X_))IJ)I<3O8.P+E>*"U44LUJI8O?8IRS2&^K;&X+$A!;B
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M!,T2LJR&*@(-,QC^, C76G^V,22/&)%I2[R26]1P7=S 9:=23*6FINHQP_D
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M;-6<76_;-A2&_PKA#4,+N+8EV4[<)0822^P"]"-HUA7#L M&8FRNDNB1=-P
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MDA\(NM&/<RRH$#31;]<$AX2I"^3G2TK%PX$J8/_,T?1?4$L#!!0    ( (2
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M9_8%RK??V0D9VX WB9_N?[\[^R[9:/-J"P!D;Z54=AP4B-5M&-JL@)+;GJY
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MPX5&*FH_+*B+@G$':'^I->XFSD'7E]/?4$L#!!0    ( (2 J%:A2/K&RP,
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M69^;TX(=>=]@RJ,&SF5;K$LDA0U">KT1=D%93N_EC1:Y'8#70N,X;2\3//&
M- ;X?".$/MR8#>HSU.P?4$L#!!0    ( (2 J%8C7EKJRP(  #L)   9
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M<Z5O-R ,0']?<*Y>.N9XJ^]+\3]02P,$%     @ A("H5M/HN5". @  Z@8
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M3,)AB3#?'6)[D?5QJ%YH4=H3Q9W0>#ZQTQ4>(4&: 'R^%$(_+<PAI3V4IG\
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MHZ7NHY0HJHY7]U;:NALM3S_543N.L="ZA1]Z#HC.:=W!CN;-4HR$UI7BT,G
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M/*)N:G6@>&7[PI(KW67LL-#_ 1 F0:^O.5>'P+2:]L^2_0-02P,$%     @
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M"6IDX,H.IMW/"]A#CVE@3\RXXQ9W/(K[@RY52%4=2U#+VX@T'M#E8?\%MGB
M+79/U>NTQ39]17/H",0HG]/AU..I-UA9!C/?=^VI&2IVCW+GCH+]2*A >\)V
M56M?TURI'U6M@N:Z,#(M?4;Q<H>3&@\*MK'J3@&.3[0VW%%H/,YO4:TDW;M
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M1P[$)HXQ?[LE$=N.+6B]7W@*ERNI+]B3T1HOR3.1W]:/7)W9N9<@C D5(:.
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MX^_DCO-<BH1 \C5!8)ELR@TU)5NHK'*3-&P(QH<+)?0/EDFOZV,!'+H<>H/
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MF<AIM$R*N^Q)R+I#HY(WSA)5_4N>ZGN= 1DO59'-Z\*Z!?,X7?V-GNLO8J.
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M7],0OEEP$1 %MV)IR;6@Q#-.@6]AV^Y9 6%A:S(RS^[$9,0WRF<AO1-(;H*
MB*<+ZO/=N.6TGA_<L^5*Z0?69+0F2SJCZMOZ3L"=E:!X+*"A9#Q$@B[&K7/G
M[!+WM(.Q^,[H3F:ND4YESOF#OKGQQBU;1T1]ZBH-0>!C2R^I[VLDB./O&+25
M_*9VS%X_HU^;Y"&9.9'TDOM_,4^MQJU!"WET03:^NN>[+S1.Z%3CN=R7YG^T
MBVWM%G(W4O$@=H8( A9&G^0Q)N(M#CAVP"\<G.X>AT[LT#&)1I&9M*Z((I.1
MX#LDM#6@Z0O#C?&&;%BHEW&F!'S+P$]-KEE(0I<1']V$4HD-K)"2B(0>NF?R
M 4U)"(NI'Z+CSXL%<(_X EU1P;9$\Y_S@E51*XHN>>C!.E-/7TGN,X\HN+D@
M/OP213,=JT37A GTG?@;6H&8/M;7DBU# W4NT1?J+5FXS%J?H.,KJ@CSX>IW
M]&UVA8Z/3M 18B&:,M^'HI$C2P%G.G/+C?FYB/C!>_CIH"D/U4JBSY"4E_>W
M@.N$</Q,^ 6N!)P2T48=YR/"-NZ4Q'-9[7Y%W<0=5X332=:_8_ Z>_$2AC]F
MU^3'+1BB&T4#^;.,M0BU6XZJ9\^97!.7CELP7"056]J:?/C-Z=F?RE*N"2Q'
M0#<AH%N%/IG!8/0V?E450@'-%!2>:0,P2WOFCDNFIU&6NC*V*D,H3_ K=-*"
M^S!F=9DK,H<0HUG+_H%NT(WF^D1*MF NB28B-.U"A['584@=J9<FQ/()\8U
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MUW-SX&BEYM&Y[90(: ^)?+H 5[O=!ZI%=!0:W2B^-J>)<ZX4#\SEBA*/"FT
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M90WP>2JE>9W8*V'U$T#T#U!+ P04    " "$@*A6EK!MWA8%  #[&   &0
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MBS"Z7%$";RO& +[WA="[@9D@_;UC]@]02P,$%     @ A("H5M>Q[UV_"
M $X  !D   !X;"]W;W)K<VAE971S+W-H965T-S0N>&ULS5QK;]NX$OTKA'>Q
M:('&MEY^]"8&FG"++=#L+9IM[X?%_<#(M"U$EK(D[;3 _O@E9444)8:5O6-
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MM0]P^RNE[-[Q8]2_FOD?4$L#!!0    ( (2 J%;FE&"Z3 (  /L%   9
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M>*E'%K!D:V$>Y/8K[.J)K%\IA>ZN9-OO36*/E&MM9+T38P8U;_H[>]F=PYZ
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ME*'0U.Q(A>_;*_Q+N4SE>KM,Q4@_5-=#T1(H&D.AJ5F2NMX_IJ[WH;H>BI9
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MSXJB?ORC"?!0E)_6U;[X'U!+ P04    " "$@*A6V+WBB8T/  "6KP  &0
M 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6S%75USVS86_2L<;V<G.^/8XH=(
M*NMXQA'1-C--DTG:[D-G'V@)LK212"U)QVEG?_R"DBP0!'Q)N$=,'QI))LX%
M[P$!W(,+\.HA+SZ72\XKY^MFG96OSY95M7UU>5G.EGR3EA?YEF?B+XN\V*25
M^%K<79;;@J?S7:'-^M(;C<++3;K*SJZO=K]]**ZO\OMJO<KXA\(I[S>;M/CC
M#5_G#Z_/W+/''SZN[I95_</E]=4VO>.?>/7K]D,AOET>4>:K#<_*59XY!5^\
M/KMQ7S%W%-<E=I?\MN(/9>.S4]_+;9Y_KK^\G;\^&]55XFL^JVJ,5/SSA4_Y
M>EU#B8K\]X!Z=C1:%VQ^?D3_?G?WXFYNTY)/\_6_5O-J^?HL/G/F?)'>KZN/
M^<./_'!'XQIOEJ_+W?^=A\.UHS-G=E]6^>906-1@L\KV_Z9?#YYH%! XY@+>
MH8#7+A \4< _%/#[%@@.!8*^!<:' KM;O]S?^\YQ25JEUU=%_N 4]=4"K?ZP
M\_ZNM/#7*JM;RJ>J$']=B7+5]33?B!:VK*G_PAV6%MDJNRN=%_7O><:SJG3>
M+YSWU9(7CGKM3WE9_L-YD? J7:W%IY?.KY\2Y\5W_W"^<U:9\VZU7HN64%Y=
M5J*:M;'+V:%*;_95\IZHDN^\R[-J63HLF_.Y6OY2W-[Q'KW'>WSCD8#OTN+"
M\=USQQMYOJ$^T_[%/4/QA"Z>\!E9G/4O[A+.\(^$^SL\_PF\F]GL?G._3BL^
M-]+Z-IOE&^Z\V-/[^T^BN/.VXIORWR8F][8"LZVZEWM5;M,9?WTF+)2\^,+/
MKO_^-S<<_=-$ Q(L08(Q$)A"6' D+*#0KW\6P\5])D:!]>I/P=F=Z/V=%^L=
M.Z*C%=W[9_$$WJZY4_+9?;&J5KP\=S)1*%\X5?KUW+GE=ZNL?JSK7[:\6.5S
M$Y7[6D2[6M3CRY?KE]Z%>%R^-"DBJVI+$1*,@< 4BL9'BL:]*)KE=]F.I)H>
M7CII-G>VPM]B9!865S/NS/*R$@/L_O&K\GI($UASP5$F/E7.=IUF"GTFIO:5
MB16FPHG&%5EG6Z[&6NOPPOABK)ID(),*">&1A) D0<P;Q*P@$X-F4?!L]H=3
M%<*7PM.[^<C\/V(L%3.<JO?S$.I>]OUX?#%IN9FLE:V;D6 ,!*:P$1W9B$@V
MFL-,OAMF9LHP4S\AS^JF(D/CCT+WPFO10E;/EA8D& .!*;3$1UKBSIZJ3-?<
M."V+-=?ZD3NY<%N>C;6N('"CN$U 0E;$UF<@,,5GDZ//)J3/WF85%ZB5P[^*
M^*SD)M?M$<*&3]P@:OEMHKG7#4+-;61=;-T& E/<YHYD:#$B'3==IMD=KX,!
M97#<S6">.30:HXF1[EAM,#1<)*8W8<OY] W9>A^%IKJ_$=FY'>UV-Y,7G2O5
M<@\@S:8[B=O.<W4/>W';QPE='VOO@=!4[WG2>]YII]U<M'!R)#M40&F2;KM)
M3NEJV@YD4#2&0E,IDI&L2\9=IYQV]Z'/[S<-IV_"FD!H7(M"4PF4D:U+A[:]
MI^S=9 2FV7HPTA\G: 0+16,H-)4-&<2Z=!1K/V7OIL44JD9AH-,"#5:A: R%
MIM(BPUJ7CFM_$"//OD_[:=^]B6<C$1[_DM82NWE&A PCIU"T!(K&4&@J-S+(
M=:,!Q507&69.H6@)%(VAT%3:9!#L=D?!6DA2[J=W?#_!F\LG[%DR!5T#:R[U
MT%S$Y1/EO_9D'!I_H]!4PF0$[M(A^'O#<,2/:U7[6?DM7XCIA)CES=9I6:X6
MJ]EN'E&>/_[E"365-FW-E"'*]_5("1KEH]#4Q349YGMTF-\OSJ1!;-U\0&M&
MK:.6CZ$&&0I-];&,Y3TZEO\K/5;G+(VV;4V-+A9,+H(V.5"I (6FDB.E H^6
M"CIF:,[_G(^M3LG)[W?\])P__/Z.;VYY89PTT'6S)@^J-D#1& I-95FJ#=Z0
M"^<>=.4<BI9 T1@*3:5-:@Q>O^7SMDBD]IBU2%WWF:M,?-F)#LZ2S^_J:=Y.
M-JHG$LO5MG-IEJZ,-:VZJC'2%@R@)AD*365+:A >K4$,UI4*)$U]$K/$A[28
MBWEF5A7IK#+&UO0-6#,,U3V@: R%IC8%J7MXX9#]+502@:(E4#2&0E-IDY*(
M1R_\DRO,GF'U/M8R*DQ7N8'>\4$E"12:ZC8I27BT)#%DQW=<T"Y$(:=\2+=F
MLJ 2!A0M@:(Q%)K*O50WO,F0/1U4SX"B)5 TAD)3\VBE[N%WZ1[=>2&^*3>A
MG:IDO*B5=9/0E;%.:#V%G.%+.<.GY0Q3;_=.+JE_.BZI&WT*E2N@: D4C:'0
M5):DKN%[ _9+/E2H@*(E4#2&0E-I:R3X]TN+.'7".%T-:T+]3D47:I"AT%26
MI"[AT[K$*9<T:-/6S!AR*]R+J$T.5(9 H:GD2!G"IV6(?DL:-(BUFPVY$B--
M.(?:9"@TU<TRQ/?IU(;3Y]C1%;"FR+ G0$LU3: V&0I-I4B&\SX=SO>>J9UV
ME8.NI36/T-0(*!I#H:E\2QW"CX><\T$E!"A: D5C*#25-BDA^%U[%'H-6'IR
M@K:>,*4M67L9&O&CT-2-F#+B#^B(/SFD#;\YI U_6*?9OO6;O$V#V39^*%H"
M16,H-)46J28$[H!]5@"5%Z!H"12-H=!4VJ2\$/3;83'0KEFZ-M:\ZILW/#W-
M!6J3'=":.^]\K]%_JSQ(O2"@]8)31J*!ODDBU#>5FW92: $F?1?6OCS)EO[&
MGGXZ^N\W7M,@UDW6$,?KZ010FPR%IKI9QO'!-]N8WR/XI"MG39^N#YAZ'*@^
M@$)3Z9/Z0$#K T_/MTX;;=+5LB8.FBP 16,H-)5@J2X$0^Z?"* B 10M@:(Q
M%)I*FQ0) CI9X6:3%]7JS\-CMS!TI>: "*H&!/J>"#&<M9=-H389"DWUNXSR
M SK*'VA#/5T+:YYTT<&P\QYJDZ'0U-. I$XP1NR(&.O+_J/VB3I3VI)M+P1%
M8R@TU<LR[!_3202/^9O3Q_S-7QJ[AV^.NX>-KH?&^%"T!(K&4&@J1S+&'P^9
M0C"&AO!0M 2*QE!H*FU2$AC3D@#Z+"W:G#5Q!KW C4>>%@Q!S3(4FLJ)E S&
MWRYA8*Q+ \%8/U .*0TD4#2&0E/):1P B$@8H$&L'X-Q9\8,U"!#H:D^EFK
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MN7LU:K>CTG7QLM"G5*DT+C97@B^%S _0WS^DJ7K=R1NH7E";_0]02P,$%
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MKBQV5S^M\#D#[0SP?*&4W2Q<@.Z!S'X 4$L#!!0    ( (2 J%8KETWYVP,
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M1OVK"P*Z&<XFL*H._;U4UDU+6);N/D/M >Y\I93=!WYDNALR^P-02P,$%
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MWH($ZRZ*73#2L4U4$E62BN/^^A[*BFP9,A%OW(TERGP?D:]X2!Z.-T)^4VL
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MD*8"_K\40K\4S+EC>S ]_0E02P,$%     @ A("H5DN/T)-& @   P4  !D
M  !X;"]W;W)K<VAE971S+W-H965T.3 N>&ULM53?3]LP$/Y7+",AD*;F5RD,
MTDA0F(8&$P*Q/4Q[<)-K8^'8F7UMX;_?V0FADRAO>TGN[/L^?W?V7;XQ]LG5
M ,B>&Z7=E->([6D4N;*&1KB1:4'3SL+81B"Y=AFYUH*H JA141K'DZ@14O,B
M#VMWMLC-"I74<&>96S6-L"\7H,QFRA/^NG OES7ZA:C(6[&$!\#']LZ2%PTL
ME6Q .VDTL["8\O/D]&+LXT/ #PD;MV4SG\G<F"?O7%=3'GM!H*!$SR#HMX89
M*.6)2,:?GI,/1WK@MOW*_B7D3KG,A8.943]EA?64GW!6P4*L%-Z;S5?H\SGR
M?*51+GS9IH^-.2M7#DW3@TE!(W7W%\]]';8 :;H#D/: -.CN#@HJ+P6*(K=F
MPZR/)C9OA%0#FL1)[2_E 2WM2L)A<2-1+D4HT,'CZ-N(S4S3 LJN9+IBM\(^
M 3IVOL+:6(DOA^S@N[!6^&J2?0DHI'*';'_O))N,SYC4[%8J17B71T@2_4%1
MV<NYZ.2D.^30:2.6)9]8&J<9NWJ\9P<][^&_9!'E.22;#LFF@7V\@WTF42C3
M6M&PM[S?$_DAC>^34]>*$J:<&L&!70,O]O>227SV@<AL$)D%]FS7C1CGZ!8T
M2KT$74IP[-<-Q;!KA,;]?D]N]A_DC@>YXP]K>N504G- Q=3;4U)2S"7Y+^^I
M[?B2XT#HA\:Z2)+1YSQ:;\N(MMZT'P_T,I92.Z9@0;!X='S$F>U:KG/0M.&9
MSPU2TP2SIBD%U@?0_L(8?'5\YPQSK_@+4$L#!!0    ( (2 J%;^4,*7*0(
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M'%T]':J.52M_^\[IN%.E;]*9EJ-V 32_4,H^=UR"YOV6_@902P,$%     @
MA("H5G'Y$M!* @  ^@4  !D   !X;"]W;W)K<VAE971S+W-H965T.3,N>&UL
MM511;]HP$/XK5E9-($TD!$@K%B(5T+1*;8>*NCU,>S#ADEAU[,PVT/[[G9V0
M,00\3-M+?&?????=7>[BG50ON@ PY+7D0D^\PIAJ[/LZ+:"DNB<K$/B22552
M@ZK*?5TIH&OG5'(_#(+(+RD37A*[NX5*8KDQG E8**(W94G5VQ2XW$V\OK>_
M>&)Y8>R%G\05S6$)YKE:*-3\%F7-2A":24$49!/OMC^>1M;>&7QEL-,',K&9
MK*1\L<K=>N(%EA!P2(U%H'AL80:<6R"D\;/!]-J0UO%0WJ-_<KEC+BNJ82;Y
M-[8VQ<2[\<@:,KKAYDGN/D.3S\CBI9)K]R6[VC:*/))NM)%EXXP,2B;JD[XV
M=3AP",,S#F'C$#K>=2#'<DX-36(E=T19:T2S@DO5>2,Y)FQ3ED;A*T,_D]PS
MPW+J"M3Y8@I0Y/=-EW0>J5+4U@WE.1C*N.Z2*\($>6"<HXV.?8,T+)B?-B&G
M=<CP3,@'JGIDT/] PB <D.?EG'2NNG_"^)A%FTK8IA(ZW,&Y5*369":%82('
MD3+0Y/L]VI [ Z7^<8IH#3@\#6CG8:PKFL+$PQ]>@]J"E[Q_UX^"CQ?H#EJZ
M@TOHR>.F7&&Y9492_*M.UK$&B!R G:YMT@^"(/:W)\(.V[##BV&/FWPJ[D6$
MORS+J.4W^M=='/T'NE%+-[I8SB.Z;^0V3=6&\E,\:Z3K@W;>]**C;OH'HVRW
M(@Y+SH0F'#+T"GK7F*RJ-TVM&%FYZ5Y)@[O"B04N9U#6 -\S*<U>L0NC7??)
M+U!+ P04    " "$@*A66>KAY),#  #K&   #0   'AL+W-T>6QE<RYX;6S=
M6=UNVC 4?I4H;:=6FII VD!60-J0*DW:IDKMQ>XJ0QRPY/S,,1WL<N^RNSW%
M'F5/,I\X) %\&.W%V@Q48I\OYSN?CX^=6!WD<L7I[9Q2:2UCGN1#>RYE]L9Q
M\NF<QB0_3S.:*"1*14RDZHJ9DV>"DC 'IY@[7=?UG9BPQ!X-DD5\'<O<FJ:+
M1 [M3K>R6?KR/E16_\*V--\X#>G0OC]]]661RJO?WW]:NG7T^NC(/7?=^[.K
M7?!TC9[9CI'^TDQ_O$G>X#[>8L:(_4WBFNAOCKV#%.V3A%+W#Z!&>3'2P#A0
M]Z0Q5/<$<>ZY!\WNGJG%B#MFXE\_$-X*V$_;-0^V.:]H^GL>XKR1*CQ7%P;W
MVA5U0RI\9P'M73\%N5,NV=$@2I-ZY7JV-JCH)*;6 ^%#>TPXFP@&7A&)&5]I
M<Q<,TY2GPI)JRU!R.F#)OVFXHWNPFY0\,4M24<36$?3OI+Q]"UCW0"#CO!((
M.PL81H.,2$E%<JTZQ<V%<0>RRO;=*E,*9X*L.MU+NW8H+BK()!4A%?4.9J]-
MHP&G$<@1;#:'JTPS!T ITU@U0D9F:4(*#6N/LJ%HIY3S6]AJ/T<;W,NH,:_%
MPDFJIA)4-C6-[@!_DTUS-VG[3^*U,O:0RG<+-9RDZ$.MT!M!([8L^LNH$H"Q
M=W!VDF5\]9:S61)3/?B# XX&9.UGS5/!OJEH4"I39:#"MAZHD&S:M'P5)+NC
M2[DNIV6$:^ZV4/._S?.,)E00WA2M:O\E9_G)BLM7D^?07&PKVXJ-(KW>R]=8
MOH2]=)%^&T2V8KK[;1 9M$!D[]EVS<>([+1!9+<-(KTVB&S!4[$\%+TXD4[Y
M>MXX VR< "JK!2>MH?T)SG6\#FI-%HQ+EI2].0M#FNP<!!2])!-.-_G5_2&-
MR(++NPH<VG7[(PW9(@ZJNVX@$>5==?L##*_C5\<\%8LE(5W2<%QVQ6Q2-"W5
M4%'+#SAL(]?%QXQ@/AHS(X!A<3 %F(_VPN+\3^/IH^/1&*:M;T3ZJ$\?]=%>
M)F1<?+$X9I] ?<PC#0+/\WTLH^.Q4<$8RYOOPY^9#=,&'E@<B/2X7..SC5?(
M_CK YG1?A6 CQ2L1&RF>:T#,>0./(##/-A8'/+!9P&H'XIOC0$V9?3P/9A73
MAJU@' D"#(%:-->H[R/9\>%KGA]LE7A>$)@1P,P*/ ]#8#7B"*8 -&"(YQ7/
MP:WGD;-^3CGUOS=&?P!02P,$%     @ A("H5I>*NQS     $P(   L   !?
M<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^O
MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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MWI% [SC9[";0.Z+>D4#OB'I' KTCZAT)](ZH=R30.Z+>D4!O0[V-0&]#O8U
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M4$L! A0#%     @ A("H5I4N(C_O    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ A("H5IE<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " "$@*A63L+'2P4&  "W'P  &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ A("H5OG8AO<O!0  HA0
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M965T-BYX;6Q02P$"% ,4    " "$@*A6&3@HU0<(  #X(@  &
M    @($#*P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
MA("H5B%\R'QJ!0  6@T  !@              ("!0#,  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( (2 J%:#R,J+_@,  $X)   8
M          " @> X  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    " "$@*A6@LYK-:D*  #J&P  &0              @($4/0  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( (2 J%8N>^INZ00  $P+
M   9              " @?1'  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ A("H5D/L!T%H#P  %"\  !D              ("!%$T
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "$@*A6#PVH
MO# (  !?$P  &0              @(&S7   >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( (2 J%8ZY@UT60<  (,2   9
M  " @1IE  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
MA("H5N%Y7L"O!   >@L  !D              ("!JFP  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    " "$@*A63L(J6"0&  !0#P  &0
M            @(&0<0  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( (2 J%;N 3*<@P4  #X/   9              " @>MW  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ A("H5LMP,?Z4!@
M>!$  !D              ("!I7T  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    " "$@*A61TRSMP$3   ]/P  &0              @(%P
MA   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( (2 J%;Q
MAXF(! @  #\3   9              " @:B7  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ A("H5A1UU[:5!0  PA   !D
M     ("!XY\  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M" "$@*A6J^$&8#L)  "4%0  &0              @(&OI0  >&PO=V]R:W-H
M965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( (2 J%9H7F$ @08   8/   9
M              " @2&O  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L!
M A0#%     @ A("H5F'_ +=S"P  MQT  !D              ("!V;4  'AL
M+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "$@*A6ZH53D<$C
M  !*>@  &0              @(&#P0  >&PO=V]R:W-H965T<R]S:&5E=#(U
M+GAM;%!+ 0(4 Q0    ( (2 J%;4V/GS%P8  "(/   9              "
M@7OE  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ A("H
M5MTM]W2\!P  R!$  !D              ("!R>L  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    " "$@*A65IY8^G<'  #]$@  &0
M        @(&\\P  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( (2 J%;GM_?ZN04  '$-   9              " @6K[  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ A("H5CVCF<#W P  4 D
M !D              ("!6@$! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    " "$@*A67F]9C.P"  !Y!@  &0              @(&(!0$
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( (2 J%9+7%9_
MFP8  "@3   9              " @:L( 0!X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ A("H5C+]73<0 P  0@@  !D
M ("!?0\! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " "$
M@*A6^\2-PRP&   S$   &0              @('$$@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( (2 J%:!1@IQB0D  . =   9
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M970S.2YX;6Q02P$"% ,4    " "$@*A6T84$6($"   ;!@  &0
M    @('Q-@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M (2 J%;TRQ7:90H  &]>   9              " @:DY 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ A("H5J!<L*UZ P  ]PD  !D
M             ("!140! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    " "$@*A6<#?ELOH"  "7"@  &0              @('V1P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( (2 J%95%?2+- 0
M ! /   9              " @2=+ 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ A("H5J46(MOV&   QZ0  !D              ("!
MDD\! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "$@*A6
M%>K0\;P%  !9)   &0              @(&_: $ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( (2 J%:HFVC;0 ,  *$)   9
M      " @;)N 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ A("H5F&O]P$^"   *D4  !D              ("!*7(! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " "$@*A6#\/MDB,'  !_-
M&0              @(&>>@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( (2 J%9?*_=?XP,   <3   9              " @?B! 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ A("H5B!'<82A
M P  Z L  !D              ("!$H8! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    " "$@*A6WI =UH<"  "C!0  &0
M@('JB0$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( (2
MJ%:A2/K&RP,  $\-   9              " @:B, 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ A("H5B->6NK+ @  .PD  !D
M         ("!JI ! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4
M    " "$@*A6T^BY4(X"  #J!@  &0              @(&LDP$ >&PO=V]R
M:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( (2 J%9+-FNN1 ,  * *
M   9              " @7&6 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL
M4$L! A0#%     @ A("H5H"\WORN P  >1$  !D              ("![)D!
M 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " "$@*A6G[LG
MT.,#  "F#P  &0              @('1G0$ >&PO=V]R:W-H965T<R]S:&5E
M=#4X+GAM;%!+ 0(4 Q0    ( (2 J%:NLM^\>0(  &4&   9
M  " @>NA 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
MA("H5IYH'SYI!   CA$  !D              ("!FZ0! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    " "$@*A6)L!KX78#  #]"P  &0
M            @($[J0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( (2 J%;G-R7:F0(  #$&   9              " @>BL 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ A("H5AG:V[2Q P
MX@T  !D              ("!N*\! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    " "$@*A6?-[CMW8#   )"@  &0              @(&@
MLP$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( (2 J%:V
MTU/(]@8  +,Y   9              " @4VW 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ A("H5M836*H4!0  8QT  !D
M     ("!>KX! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (2 J%:/I-1NK@4  )P>   9              "
M@<'7 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ A("H
M5O['VV:J P  #A   !D              ("!IMT! 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    " "$@*A6EK!MWA8%  #[&   &0
M        @(&'X0$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( (2 J%;7L>]=OP@   !.   9              " @=3F 0!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ A("H5@AE3)X\!   _Q(
M !D              ("!RN\! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    " "$@*A6%BOX>XH#  ! $   &0              @($]] $
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( (2 J%;PO[V_
M>0H  .A:   9              " @?[W 0!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ A("H5C)'03Y0 @  004  !D
M ("!K@(" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    " "$
M@*A6YI1@NDP"  #[!0  &0              @($U!0( >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( (2 J%8# R0;?@(  +@&   9
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M970X-"YX;6Q02P$"% ,4    " "$@*A6QUKPWXL"   L!P  &0
M    @($J-@( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    (
M (2 J%8KETWYVP,  .@2   9              " @>PX @!X;"]W;W)K<VAE
M971S+W-H965T.#8N>&UL4$L! A0#%     @ A("H5O%>,"U& @  +04  !D
M             ("!_CP" 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"
M% ,4    " "$@*A6W!W;#4\"   7!0  &0              @(%[/P( >&PO
M=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( (2 J%: TRI%W ,
M *06   9              " @0%" @!X;"]W;W)K<VAE971S+W-H965T.#DN
M>&UL4$L! A0#%     @ A("H5DN/T)-& @   P4  !D              ("!
M%$8" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4    " "$@*A6
M_E#"ERD"  #D!   &0              @(&12 ( >&PO=V]R:W-H965T<R]S
M:&5E=#DQ+GAM;%!+ 0(4 Q0    ( (2 J%:EAC.)% ,  ,L)   9
M      " @?%* @!X;"]W;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#%
M  @ A("H5G'Y$M!* @  ^@4  !D              ("!/$X" 'AL+W=O<FMS
M:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    " "$@*A66>KAY),#  #K&
M#0              @ &]4 ( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( (2
MJ%:7BKL<P    !,"   +              "  7M4 @!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( (2 J%;&7""OR@8  $0]   /              "  615 @!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "$@*A6*"B!BK$"  "^-@  &@
M            @ %;7 ( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " "$@*A6??/N/T,"   #-0  $P              @ %$7P( 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     90!E +H;  "X80(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>385</ContextCount>
  <ElementCount>394</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>142</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Statements Of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements Of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Statements Of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements Of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ConsolidatedStatementsofEquity</Role>
      <ShortName>Consolidated Statements of Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements Of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements Of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Collaboration and Licensing Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CollaborationandLicensingAgreements</Role>
      <ShortName>Collaboration and Licensing Agreements</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Revenue Recognition and Accounts Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable</Role>
      <ShortName>Revenue Recognition and Accounts Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RecentAccountingPronouncements</Role>
      <ShortName>Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Acquisitions and Other Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactions</Role>
      <ShortName>Acquisitions and Other Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Divestitures</Role>
      <ShortName>Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Share-Based Incentive Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlan</Role>
      <ShortName>Share-Based Incentive Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Pensions and Other Postretirement Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/PensionsandOtherPostretirementBenefits</Role>
      <ShortName>Pensions and Other Postretirement Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Earnings (Loss) per Ordinary Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EarningsLossperOrdinaryShare</Role>
      <ShortName>Earnings (Loss) per Ordinary Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Financial Instruments and Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagement</Role>
      <ShortName>Financial Instruments and Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Comprehensive Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarnings</Role>
      <ShortName>Comprehensive Earnings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Litigation</Role>
      <ShortName>Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - General (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GeneralPolicies</Role>
      <ShortName>General (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RecentAccountingPronouncements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Segment Information (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationPolicies</Role>
      <ShortName>Segment Information (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RecentAccountingPronouncements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables</Role>
      <ShortName>Revenue Recognition and Accounts Receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Acquisitions and Other Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables</Role>
      <ShortName>Acquisitions and Other Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/AcquisitionsandOtherTransactions</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Share-Based Incentive Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanTables</Role>
      <ShortName>Share-Based Incentive Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlan</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Pensions and Other Postretirement Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables</Role>
      <ShortName>Pensions and Other Postretirement Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/PensionsandOtherPostretirementBenefits</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponents</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Earnings (Loss) per Ordinary Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EarningsLossperOrdinaryShareTables</Role>
      <ShortName>Earnings (Loss) per Ordinary Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EarningsLossperOrdinaryShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Financial Instruments and Risk Management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</Role>
      <ShortName>Financial Instruments and Risk Management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagement</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Debt</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Comprehensive Earnings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarningsTables</Role>
      <ShortName>Comprehensive Earnings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ComprehensiveEarnings</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SegmentInformation</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Restructuring (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RestructuringTables</Role>
      <ShortName>Restructuring (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Restructuring</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Revenue Recognition and Accounts Receivable (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Variable Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details</Role>
      <ShortName>Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Acquisitions and Other Transactions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails</Role>
      <ShortName>Acquisitions and Other Transactions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Acquisitions and Other Transactions (Purchase Price Allocations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails</Role>
      <ShortName>Acquisitions and Other Transactions (Purchase Price Allocations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails</Role>
      <ShortName>Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DivestituresDetails</Role>
      <ShortName>Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Divestitures</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Share-Based Incentive Plan (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails</Role>
      <ShortName>Share-Based Incentive Plan (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Share-Based Incentive Plan (Stock Awards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails</Role>
      <ShortName>Share-Based Incentive Plan (Stock Awards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails</Role>
      <ShortName>Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Pension and Other Postretirement Benefit (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails</Role>
      <ShortName>Pension and Other Postretirement Benefit (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails</Role>
      <ShortName>Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails</Role>
      <ShortName>Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Balance Sheet Components (Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails</Role>
      <ShortName>Balance Sheet Components (Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Balance Sheet Components (Property, Plant and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails</Role>
      <ShortName>Balance Sheet Components (Property, Plant and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Balance Sheet Components (Other Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails</Role>
      <ShortName>Balance Sheet Components (Other Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Balance Sheet Components (Trade Accounts Payable) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails</Role>
      <ShortName>Balance Sheet Components (Trade Accounts Payable) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Balance Sheet Components (Other Current Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components (Other Current Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Balance Sheet Components (Other Long-term Obligations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails</Role>
      <ShortName>Balance Sheet Components (Other Long-term Obligations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Balance Sheet Components - Assets and Liabilities Held For Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails</Role>
      <ShortName>Balance Sheet Components - Assets and Liabilities Held For Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Earnings (Loss) per Ordinary Share (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails</Role>
      <ShortName>Earnings (Loss) per Ordinary Share (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EarningsLossperOrdinaryShareTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails</Role>
      <ShortName>Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EarningsLossperOrdinaryShareTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Goodwill and Intangible Assets (Components of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Components of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Goodwill and Intangible Assets (Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Financial Instruments and Risk Management (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Debt (Receivables, Securitization Facility and Commercial Paper) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails</Role>
      <ShortName>Debt (Receivables, Securitization Facility and Commercial Paper) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Debt (Summary of Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails</Role>
      <ShortName>Debt (Summary of Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails</Role>
      <ShortName>Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Debt (Fair Value) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtFairValueNarrativeDetails</Role>
      <ShortName>Debt (Fair Value) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Debt (Minimum Repayments on Outstanding Borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails</Role>
      <ShortName>Debt (Minimum Repayments on Outstanding Borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ComprehensiveEarningsTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails</Role>
      <ShortName>Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ComprehensiveEarningsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails</Role>
      <ShortName>Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SegmentInformationTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Restructuring (Restructuring Charges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RestructuringRestructuringChargesDetails</Role>
      <ShortName>Restructuring (Restructuring Charges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RestructuringTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Collaboration and Licensing Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails</Role>
      <ShortName>Collaboration and Licensing Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Income Taxes Income Taxes Disclosure (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails</Role>
      <ShortName>Income Taxes Income Taxes Disclosure (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails</Role>
      <ShortName>Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Litigation</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails</Role>
      <ShortName>Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Litigation</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Litigation (Drug Pricing Matters) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationDrugPricingMattersDetails</Role>
      <ShortName>Litigation (Drug Pricing Matters) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Litigation</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Litigation (U.K. Competition and Markets Authority) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails</Role>
      <ShortName>Litigation (U.K. Competition and Markets Authority) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Litigation</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Litigation (Product Liability) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails</Role>
      <ShortName>Litigation (Product Liability) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Litigation</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Litigation (Intellectual Property) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails</Role>
      <ShortName>Litigation (Intellectual Property) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Litigation</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="vtrs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Litigation (Other Litigation) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails</Role>
      <ShortName>Litigation (Other Litigation) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Litigation</ParentRole>
      <Position>93</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  vtrs-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="vtrs-20230331.htm">vtrs-20230331.htm</File>
    <File>ex_103xvtrsx20230331.htm</File>
    <File>ex_104xvtrsx20230331.htm</File>
    <File>ex_22xvtrsx20230331.htm</File>
    <File>ex_311xvtrsx20230331.htm</File>
    <File>ex_312xvtrsx20230331.htm</File>
    <File>ex_32xvtrsx20230331.htm</File>
    <File>vtrs-20230331.xsd</File>
    <File>vtrs-20230331_cal.xml</File>
    <File>vtrs-20230331_def.xml</File>
    <File>vtrs-20230331_lab.xml</File>
    <File>vtrs-20230331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1039">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>113
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "vtrs-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 40,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1039,
    "http://xbrl.sec.gov/dei/2023": 29
   },
   "contextCount": 385,
   "dts": {
    "calculationLink": {
     "local": [
      "vtrs-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vtrs-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "vtrs-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vtrs-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vtrs-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vtrs-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 722,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 1,
    "http://xbrl.sec.gov/dei/2023": 5,
    "total": 6
   },
   "keyCustom": 38,
   "keyStandard": 356,
   "memberCustom": 69,
   "memberStandard": 67,
   "nsprefix": "vtrs",
   "nsuri": "http://www.viatris.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.viatris.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Revenue Recognition and Accounts Receivable",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable",
     "shortName": "Revenue Recognition and Accounts Receivable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Recent Accounting Pronouncements",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.viatris.com/role/RecentAccountingPronouncements",
     "shortName": "Recent Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Acquisitions and Other Transactions",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactions",
     "shortName": "Acquisitions and Other Transactions",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Divestitures",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.viatris.com/role/Divestitures",
     "shortName": "Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Share-Based Incentive Plan",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlan",
     "shortName": "Share-Based Incentive Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Pensions and Other Postretirement Benefits",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.viatris.com/role/PensionsandOtherPostretirementBenefits",
     "shortName": "Pensions and Other Postretirement Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Balance Sheet Components",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.viatris.com/role/BalanceSheetComponents",
     "shortName": "Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Earnings (Loss) per Ordinary Share",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.viatris.com/role/EarningsLossperOrdinaryShare",
     "shortName": "Earnings (Loss) per Ordinary Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Goodwill and Intangible Assets",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Financial Instruments and Risk Management",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagement",
     "shortName": "Financial Instruments and Risk Management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Statements Of Operations",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
     "shortName": "Condensed Consolidated Statements Of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.viatris.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Comprehensive Earnings",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.viatris.com/role/ComprehensiveEarnings",
     "shortName": "Comprehensive Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Segment Information",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.viatris.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Restructuring",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.viatris.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.viatris.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Litigation",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.viatris.com/role/Litigation",
     "shortName": "Litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - General (Policies)",
     "menuCat": "Policies",
     "order": "26",
     "role": "http://www.viatris.com/role/GeneralPolicies",
     "shortName": "General (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Segment Information (Policies)",
     "menuCat": "Policies",
     "order": "27",
     "role": "http://www.viatris.com/role/SegmentInformationPolicies",
     "shortName": "Segment Information (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables",
     "shortName": "Revenue Recognition and Accounts Receivable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Acquisitions and Other Transactions (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables",
     "shortName": "Acquisitions and Other Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Statements Of Comprehensive Loss",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements Of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Share-Based Incentive Plan (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
     "shortName": "Share-Based Incentive Plan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Pensions and Other Postretirement Benefits (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables",
     "shortName": "Pensions and Other Postretirement Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Balance Sheet Components (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsTables",
     "shortName": "Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Earnings (Loss) per Ordinary Share (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.viatris.com/role/EarningsLossperOrdinaryShareTables",
     "shortName": "Earnings (Loss) per Ordinary Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Financial Instruments and Risk Management (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables",
     "shortName": "Financial Instruments and Risk Management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.viatris.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Comprehensive Earnings (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.viatris.com/role/ComprehensiveEarningsTables",
     "shortName": "Comprehensive Earnings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Segment Information (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.viatris.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Restructuring (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.viatris.com/role/RestructuringTables",
     "shortName": "Restructuring (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleAndCollectionOfReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Revenue Recognition and Accounts Receivable (Narrative) (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails",
     "shortName": "Revenue Recognition and Accounts Receivable (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleAndCollectionOfReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
     "shortName": "Revenue Recognition and Accounts Receivable Revenue Disaggregation (Table) (Details)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i63daf2f5870d4537b44c66577922f2e0_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:RevenuefromContractwithCustomerGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails",
     "shortName": "Revenue Recognition and Accounts Receivable Variable Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:RevenuefromContractwithCustomerGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
     "shortName": "Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details",
     "shortName": "Recent Accounting Pronouncements Recent Accounting Pronouncements (Impact of Adoption - ASU 2014-09) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:SupplierFinanceProgramObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Acquisitions and Other Transactions (Narrative) (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
     "shortName": "Acquisitions and Other Transactions (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i978bcc6ddcd84e688fa210aa490cfa7b_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Acquisitions and Other Transactions (Purchase Price Allocations) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
     "shortName": "Acquisitions and Other Transactions (Purchase Price Allocations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i89dba480a3de4cda97573dc8978499c0_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
     "shortName": "Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "ic6fb0663b80e45d483dbc536992edcbf_D20230101-20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Divestitures (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.viatris.com/role/DivestituresDetails",
     "shortName": "Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i3f1f9e0ec712462aa02e10848d2f65c0_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Share-Based Incentive Plan (Narrative) (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
     "shortName": "Share-Based Incentive Plan (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i9440af4fd7ba4f0897656b04de8153dc_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i9440af4fd7ba4f0897656b04de8153dc_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Share-Based Incentive Plan (Stock Awards) (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails",
     "shortName": "Share-Based Incentive Plan (Stock Awards) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "ib6be2e59be8047b5bdb3bca88fdac9b2_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails",
     "shortName": "Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "ib6be2e59be8047b5bdb3bca88fdac9b2_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Pension and Other Postretirement Benefit (Narrative) (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
     "shortName": "Pension and Other Postretirement Benefit (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails",
     "shortName": "Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "ie14d6be9df1f4e66bc79f837e945f795_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails",
     "shortName": "Balance Sheet Components (Cash, cash equivalents, and restricted cash) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i590ad4dd55c84a6fa4fec2ecccd6283f_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Balance Sheet Components (Inventories) (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails",
     "shortName": "Balance Sheet Components (Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Balance Sheet Components (Property, Plant and Equipment) (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
     "shortName": "Balance Sheet Components (Property, Plant and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Balance Sheet Components (Other Assets) (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
     "shortName": "Balance Sheet Components (Other Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Balance Sheet Components (Trade Accounts Payable) (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails",
     "shortName": "Balance Sheet Components (Trade Accounts Payable) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i12dff40a692c45c8b91c8911ee689533_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
     "shortName": "Consolidated Statements of Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i12dff40a692c45c8b91c8911ee689533_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Balance Sheet Components (Other Current Liabilities) (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
     "shortName": "Balance Sheet Components (Other Current Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LitigationReserveCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Balance Sheet Components (Other Long-term Obligations) (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
     "shortName": "Balance Sheet Components (Other Long-term Obligations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Balance Sheet Components - Assets and Liabilities Held For Sale (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
     "shortName": "Balance Sheet Components - Assets and Liabilities Held For Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareDiluted",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Earnings (Loss) per Ordinary Share (Narrative) (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails",
     "shortName": "Earnings (Loss) per Ordinary Share (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails",
     "shortName": "Earnings (Loss) per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i9440af4fd7ba4f0897656b04de8153dc_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Goodwill and Intangible Assets (Components of Intangible Assets) (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets (Components of Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Goodwill and Intangible Assets (Amortization Expense) (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangible Assets (Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Condensed Consolidated Statements Of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements Of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Financial Instruments and Risk Management (Narrative) (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
     "shortName": "Financial Instruments and Risk Management (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i95612143e25a4851b2e592fb2c3a2107_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
     "shortName": "Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
     "shortName": "Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i136bafc75ccd449baf4eeb49e8ed395c_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i9440af4fd7ba4f0897656b04de8153dc_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
     "shortName": "Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Debt (Receivables, Securitization Facility and Commercial Paper) (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
     "shortName": "Debt (Receivables, Securitization Facility and Commercial Paper) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i805aacd5cf1a4ce1ba773d8974bb6661_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Debt (Summary of Long-Term Debt) (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
     "shortName": "Debt (Summary of Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
     "shortName": "Debt (2016 and 2018 Revolving Facility and 2016 Term Facility) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "ie091a09167a34a0fa7933475fb2de76d_I20230331",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Debt (Fair Value) (Narrative) (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
     "shortName": "Debt (Fair Value) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "ie091a09167a34a0fa7933475fb2de76d_I20230331",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Collaboration and Licensing Agreements",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.viatris.com/role/CollaborationandLicensingAgreements",
     "shortName": "Collaboration and Licensing Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i9440af4fd7ba4f0897656b04de8153dc_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Debt (Minimum Repayments on Outstanding Borrowings) (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails",
     "shortName": "Debt (Minimum Repayments on Outstanding Borrowings) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i9440af4fd7ba4f0897656b04de8153dc_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i9440af4fd7ba4f0897656b04de8153dc_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
     "shortName": "Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i7b9dbb9ff801489ba2f6837aa806ff2d_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails",
     "shortName": "Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i85d12c29bdbb4f2b854964dbfa89ef0e_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i9440af4fd7ba4f0897656b04de8153dc_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Restructuring (Restructuring Charges) (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
     "shortName": "Restructuring (Restructuring Charges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "idab2896257be44a2b213bb8b7d4b1350_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Developmentandsalesmilestonepayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Collaboration and Licensing Agreements (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
     "shortName": "Collaboration and Licensing Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "idab2896257be44a2b213bb8b7d4b1350_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Developmentandsalesmilestonepayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Income Taxes Income Taxes Disclosure (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails",
     "shortName": "Income Taxes Income Taxes Disclosure (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i9440af4fd7ba4f0897656b04de8153dc_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
     "shortName": "Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "icabcde1e2ac34fc091515c433c41ff7c_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
     "shortName": "Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "icabcde1e2ac34fc091515c433c41ff7c_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "icde060aa771e4f15b2dfe00c564c524c_D20210830-20210830",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSought",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Litigation (Drug Pricing Matters) (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
     "shortName": "Litigation (Drug Pricing Matters) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "icde060aa771e4f15b2dfe00c564c524c_D20210830-20210830",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSought",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - General",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.viatris.com/role/General",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i91c473ae9a0940dea4e7a1898c093354_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i96a44216070c4ea3999f969059533ad8_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Litigation (U.K. Competition and Markets Authority) (Narrative) (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails",
     "shortName": "Litigation (U.K. Competition and Markets Authority) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i96a44216070c4ea3999f969059533ad8_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i67450c71eb624b6fa6b3ab40994faf5c_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Litigation (Product Liability) (Narrative) (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails",
     "shortName": "Litigation (Product Liability) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i67450c71eb624b6fa6b3ab40994faf5c_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i3af94b01e96b43d1b3dd129d00730688_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:NumberOfScottishHealthBoardsNHSScotland",
      "reportCount": 1,
      "unique": true,
      "unitRef": "healthboard",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Litigation (Intellectual Property) (Narrative) (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
     "shortName": "Litigation (Intellectual Property) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "i3af94b01e96b43d1b3dd129d00730688_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:NumberOfScottishHealthBoardsNHSScotland",
      "reportCount": 1,
      "unique": true,
      "unitRef": "healthboard",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Numberofcases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Litigation (Other Litigation) (Narrative) (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
     "shortName": "Litigation (Other Litigation) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20230331.htm",
      "contextRef": "iff6cf2c8fb074b0f8a4d37a56092740b_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Numberofcases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 142,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r1029"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filler Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r1031"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r301",
      "r695",
      "r696",
      "r698",
      "r699",
      "r780",
      "r953",
      "r1107",
      "r1110",
      "r1111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r301",
      "r695",
      "r696",
      "r698",
      "r699",
      "r780",
      "r953",
      "r1107",
      "r1110",
      "r1111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r301",
      "r346",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r373",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492",
      "r493",
      "r495",
      "r497",
      "r498",
      "r1108",
      "r1109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r301",
      "r346",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r373",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492",
      "r493",
      "r495",
      "r497",
      "r498",
      "r1108",
      "r1109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r299",
      "r300",
      "r504",
      "r531",
      "r779",
      "r965",
      "r967"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case Type [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r482",
      "r483",
      "r484",
      "r485",
      "r619",
      "r812",
      "r864",
      "r889",
      "r890",
      "r937",
      "r938",
      "r939",
      "r940",
      "r949",
      "r954",
      "r955",
      "r973",
      "r987",
      "r1005",
      "r1012",
      "r1112",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r482",
      "r483",
      "r484",
      "r485",
      "r619",
      "r812",
      "r864",
      "r889",
      "r890",
      "r937",
      "r938",
      "r939",
      "r940",
      "r949",
      "r954",
      "r955",
      "r973",
      "r987",
      "r1005",
      "r1012",
      "r1112",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ParentCompanyMember": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Company [Member]",
        "terseLabel": "Mylan",
        "verboseLabel": "Mylan N.V."
       }
      }
     },
     "localname": "ParentCompanyMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r375",
      "r813",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r957",
      "r988",
      "r1011",
      "r1038",
      "r1105",
      "r1106",
      "r1114",
      "r1170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r375",
      "r813",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r957",
      "r988",
      "r1011",
      "r1038",
      "r1105",
      "r1106",
      "r1114",
      "r1170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r482",
      "r483",
      "r484",
      "r485",
      "r571",
      "r619",
      "r650",
      "r651",
      "r652",
      "r788",
      "r812",
      "r864",
      "r889",
      "r890",
      "r937",
      "r938",
      "r939",
      "r940",
      "r949",
      "r954",
      "r955",
      "r973",
      "r987",
      "r1005",
      "r1012",
      "r1015",
      "r1097",
      "r1112",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r482",
      "r483",
      "r484",
      "r485",
      "r571",
      "r619",
      "r650",
      "r651",
      "r652",
      "r788",
      "r812",
      "r864",
      "r889",
      "r890",
      "r937",
      "r938",
      "r939",
      "r940",
      "r949",
      "r954",
      "r955",
      "r973",
      "r987",
      "r1005",
      "r1012",
      "r1015",
      "r1097",
      "r1112",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r299",
      "r300",
      "r504",
      "r531",
      "r779",
      "r966",
      "r967"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r620",
      "r1069"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r321",
      "r620",
      "r1032",
      "r1069"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r321",
      "r620",
      "r1032",
      "r1033",
      "r1069"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Revenue Recognition And Accounts Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current [Abstract]",
        "terseLabel": "Accounts Payable, Current [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableOtherCurrentAndNoncurrent": {
     "auth_ref": [
      "r153"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableTradeCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred and payable classified as other.",
        "label": "Accounts Payable, Other",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r46",
      "r48"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "totalLabel": "Accounts payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": {
     "auth_ref": [
      "r153"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableTradeCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Accounts Payable, Trade",
        "terseLabel": "Trade accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r379",
      "r380"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r977",
      "r1099"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion Expense",
        "terseLabel": "Accretion expense"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r171",
      "r225"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r11",
      "r30",
      "r63",
      "r1054",
      "r1055",
      "r1056"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Plan Items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r94",
      "r255",
      "r838"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "verboseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r10",
      "r63",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Gains and Losses on Derivatives"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r278",
      "r285",
      "r286",
      "r1054"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Gains and Losses on Marketable Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r1053"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax",
        "periodEndLabel": "Net unrealized gain (loss) on marketable securities, net of tax, end of period",
        "periodStartLabel": "Net unrealized gain (loss) on marketable securities, net of tax, beginning of period",
        "terseLabel": "Net unrealized loss on marketable securities, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax": {
     "auth_ref": [
      "r10",
      "r62",
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax",
        "periodEndLabel": "Net unrecognized gains (losses) on derivatives, net of tax, end of period",
        "periodStartLabel": "Net unrecognized gains (losses) on derivatives, net of tax, beginning of period",
        "verboseLabel": "Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r12",
      "r63",
      "r1118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Net unrecognized losses and prior service cost related to defined benefit plans, net of tax",
        "negatedPeriodEndLabel": "Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r270",
      "r276",
      "r277",
      "r278",
      "r742"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Foreign currency translation adjustment, end of period",
        "periodStartLabel": "Foreign currency translation adjustment, beginning of period",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [
      "r284",
      "r285",
      "r753",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r62",
      "r63",
      "r184",
      "r264",
      "r835",
      "r872",
      "r876"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "vtrs_StockholdersEquityParentBeforeTreasuryStock",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated other comprehensive loss, net of tax, end of period",
        "periodStartLabel": "Accumulated other comprehensive loss, net of tax, beginning of period",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r284",
      "r285",
      "r753",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r7",
      "r30",
      "r63",
      "r710",
      "r713",
      "r777",
      "r867",
      "r868",
      "r1054",
      "r1055",
      "r1056",
      "r1066",
      "r1067",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r9",
      "r30",
      "r63",
      "r285",
      "r286",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r1054"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r175",
      "r1010",
      "r1173"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "vtrs_StockholdersEquityParentBeforeTreasuryStock",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r658",
      "r659",
      "r660",
      "r886",
      "r1066",
      "r1067",
      "r1068",
      "r1151",
      "r1175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r19",
      "r92"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "totalLabel": "Total intangible asset amortization expense (including disposal &amp; impairment charges)"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Taxes related to the net share settlement of equity awards"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Other Additional Capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r114",
      "r115",
      "r624"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r19",
      "r88",
      "r92"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AdjustmentForAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of Intangible Assets",
        "terseLabel": "Intangible asset amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r995",
      "r1075",
      "r1077",
      "r1078"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Asset-backed Securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r19",
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset Impairment Charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r223",
      "r259",
      "r297",
      "r344",
      "r365",
      "r371",
      "r417",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r494",
      "r496",
      "r498",
      "r499",
      "r695",
      "r698",
      "r744",
      "r832",
      "r910",
      "r1010",
      "r1025",
      "r1108",
      "r1109",
      "r1157"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r251",
      "r268",
      "r297",
      "r417",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r494",
      "r496",
      "r498",
      "r499",
      "r695",
      "r698",
      "r744",
      "r1010",
      "r1108",
      "r1109",
      "r1157"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total assets at recurring fair value measurement"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AustralianTaxationOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Australia.",
        "label": "Australian Taxation Office [Member]",
        "terseLabel": "Australian Taxation Office"
       }
      }
     },
     "localname": "AustralianTaxationOfficeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r385",
      "r435",
      "r823",
      "r1072"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Available-for-sale securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]",
        "verboseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r134",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Accounting Policy"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r688",
      "r999",
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r118",
      "r119",
      "r688",
      "r999",
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r686",
      "r687"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r686",
      "r687"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Business Combination, Acquisition Related Costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r2",
      "r3",
      "r26"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r4",
      "r124",
      "r693"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r217",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions and Other Transactions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactions",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets (excluding inventories and net of cash acquired)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Acquired intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired",
        "totalLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]",
        "terseLabel": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r73",
      "r253",
      "r958"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "verboseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r73",
      "r193",
      "r295"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash \u2014 end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash \u2014 beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r5",
      "r193"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "terseLabel": "Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r232",
      "r233",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaboration and Licensing Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "auth_ref": [
      "r1146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement.",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r205",
      "r479",
      "r480",
      "r952",
      "r1101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Litigation"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/Litigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common Stock, Capital Shares Reserved for Future Issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Dividends paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r1013",
      "r1014",
      "r1015",
      "r1017",
      "r1018",
      "r1019",
      "r1022",
      "r1066",
      "r1067",
      "r1151",
      "r1172",
      "r1175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Ordinary shares, nominal value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/CoverPage"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r174",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Ordinary shares, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r174",
      "r834",
      "r1010"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "vtrs_StockholdersEquityParentBeforeTreasuryStock",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued: 1,220,224,204 and 1,213,793,231, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r64",
      "r282",
      "r283",
      "r290",
      "r826",
      "r844"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r182",
      "r289",
      "r825",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "verboseLabel": "Comprehensive Earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarnings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r529",
      "r530",
      "r532",
      "r1017",
      "r1018",
      "r1019",
      "r1022"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate Bond Securities [Member]"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r39",
      "r364",
      "r365",
      "r366",
      "r367",
      "r373",
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate / Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r188",
      "r813"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r207",
      "r296",
      "r500",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r516",
      "r523",
      "r524",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r44",
      "r170",
      "r171",
      "r224",
      "r226",
      "r301",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r507",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r764",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r1063"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r44",
      "r226",
      "r527"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r514",
      "r743",
      "r983",
      "r984"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r54",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
        "verboseLabel": "Stated percentage rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [
      "r301",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r507",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r525",
      "r764",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r1063"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r55",
      "r301",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r507",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r764",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r1063"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r55",
      "r102",
      "r103",
      "r149",
      "r150",
      "r152",
      "r155",
      "r208",
      "r209",
      "r301",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r507",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r525",
      "r764",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r1063"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r84",
      "r1015",
      "r1176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Available-for-sale fixed income investments"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r664",
      "r665"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r19",
      "r216",
      "r235",
      "r679",
      "r680",
      "r1065"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r664",
      "r665",
      "r833"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "verboseLabel": "Deferred income tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r106",
      "r107",
      "r172",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Employee benefit liabilities"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": {
     "auth_ref": [
      "r612",
      "r998"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
        "terseLabel": "Estimated employer contributions in current year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r549",
      "r586",
      "r607",
      "r997",
      "r998"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r549",
      "r553",
      "r585",
      "r606",
      "r997",
      "r998"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r583",
      "r604",
      "r997",
      "r998"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r548",
      "r590",
      "r611"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Recognized net actuarial gains",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r551",
      "r584",
      "r605",
      "r997",
      "r998"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r19",
      "r349"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r941",
      "r943",
      "r945",
      "r947",
      "r1147",
      "r1148",
      "r1149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amount of derivative"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [
      "r888",
      "r890",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r911",
      "r912",
      "r913",
      "r914",
      "r924",
      "r925",
      "r926",
      "r927",
      "r930",
      "r931",
      "r932",
      "r933",
      "r941",
      "r942",
      "r946",
      "r948",
      "r1013",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r41",
      "r137",
      "r181",
      "r269",
      "r967"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r41",
      "r137",
      "r181",
      "r269",
      "r967"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r135",
      "r138",
      "r140",
      "r141",
      "r888",
      "r890",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r911",
      "r912",
      "r913",
      "r914",
      "r924",
      "r925",
      "r926",
      "r927",
      "r930",
      "r931",
      "r932",
      "r933",
      "r941",
      "r942",
      "r946",
      "r948",
      "r967",
      "r1013",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instruments Risk [Axis]",
        "verboseLabel": "Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r32",
      "r135",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r32",
      "r135",
      "r140",
      "r141",
      "r144",
      "r145",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r32",
      "r128",
      "r129",
      "r130",
      "r133",
      "r136",
      "r140",
      "r142",
      "r143",
      "r145",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Intellectual Property"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [
      "r544",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r544",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r1114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r622",
      "r627",
      "r654",
      "r655",
      "r657",
      "r1006"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Incentive Plan"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r20",
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r14",
      "r38",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r6",
      "r159",
      "r165",
      "r203"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r158",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations, Disclosure"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/Divestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r999",
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared, $0.12 per common share"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Earnings per share attributable to Viatris Inc. shareholders"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r291",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r324",
      "r327",
      "r332",
      "r333",
      "r334",
      "r338",
      "r728",
      "r729",
      "r827",
      "r845",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in USD per share)",
        "verboseLabel": "Basic earnings per share attributable to Viatris Inc. shareholders"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r291",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r327",
      "r332",
      "r333",
      "r334",
      "r338",
      "r728",
      "r729",
      "r827",
      "r845",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in USD per share)",
        "verboseLabel": "Diluted earnings (loss) per ordinary share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r78",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per Share Policy"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r323",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r752"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "verboseLabel": "Effect on cash of changes in exchange rates"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and employee benefit liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r656"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation expense, net of estimated forfeitures"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Related Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock awards"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r31",
      "r244",
      "r284",
      "r285",
      "r286",
      "r302",
      "r303",
      "r304",
      "r309",
      "r318",
      "r320",
      "r339",
      "r421",
      "r429",
      "r534",
      "r658",
      "r659",
      "r660",
      "r672",
      "r673",
      "r708",
      "r710",
      "r711",
      "r712",
      "r713",
      "r716",
      "r727",
      "r753",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r777",
      "r867",
      "r868",
      "r869",
      "r886",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCost": {
     "auth_ref": [
      "r831"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI, Cost",
        "terseLabel": "Equity Securities, FV-NI, Cost"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": {
     "auth_ref": [
      "r260",
      "r741",
      "r830"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExchangeTradedFundsMember": {
     "auth_ref": [
      "r1116",
      "r1152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that follows an index, commodity or basket of assets that trades similar to a stock on an exchange.",
        "label": "Exchange Traded Funds [Member]",
        "terseLabel": "Exchange traded funds"
       }
      }
     },
     "localname": "ExchangeTradedFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [
      "r734",
      "r735",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r734",
      "r735",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r147",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r514",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r735",
      "r785",
      "r786",
      "r787",
      "r983",
      "r984",
      "r995",
      "r996",
      "r997"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r148",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r514",
      "r574",
      "r579",
      "r735",
      "r785",
      "r995",
      "r996",
      "r997"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r514",
      "r574",
      "r579",
      "r735",
      "r786",
      "r983",
      "r984",
      "r995",
      "r996",
      "r997"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r514",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r735",
      "r787",
      "r983",
      "r984",
      "r995",
      "r996",
      "r997"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r514",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r785",
      "r786",
      "r787",
      "r983",
      "r984",
      "r995",
      "r996",
      "r997"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r23",
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments Policy"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r134",
      "r136",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r525",
      "r533",
      "r717",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r843",
      "r974",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1079",
      "r1080",
      "r1081",
      "r1082"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments and Risk Management"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible assets, estimated useful life, in years"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r257",
      "r456"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Finite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Finite-lived Intangible Assets Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangiblesAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r454",
      "r455",
      "r456",
      "r457",
      "r814",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r198",
      "r821"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Finite-lived intangible assets, original cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r89",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r198",
      "r814"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-lived intangible assets, net book value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign exchange derivative assets"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign exchange derivative liabilities"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r967",
      "r995",
      "r1009"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [
      "r904",
      "r908",
      "r913",
      "r926",
      "r932",
      "r944",
      "r945",
      "r946",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign exchange forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "auth_ref": [
      "r824",
      "r1057",
      "r1058",
      "r1062",
      "r1169"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee",
        "terseLabel": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee"
       }
      }
     },
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r1102"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedLabel": "Litigation settlements and other contingencies, net",
        "terseLabel": "Litigation settlements and other contingencies, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r256",
      "r441",
      "r822",
      "r975",
      "r1010",
      "r1086",
      "r1093"
     ],
     "calculation": {
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodStartLabel": "Goodwill, net, beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r445",
      "r975"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r444",
      "r451",
      "r975"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedLabel": "Goodwill, Impaired, Accumulated Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r19",
      "r442",
      "r448",
      "r453",
      "r975"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r975"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r1",
      "r1085"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r187",
      "r297",
      "r344",
      "r364",
      "r370",
      "r373",
      "r417",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r494",
      "r496",
      "r498",
      "r499",
      "r744",
      "r971",
      "r1108"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r32",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r1062",
      "r1096"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Write down of intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r1062",
      "r1096"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AdjustmentForAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "negatedTerseLabel": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Intangible asset disposal &amp; impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r185",
      "r229",
      "r344",
      "r364",
      "r370",
      "r373",
      "r828",
      "r841",
      "r971"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r19",
      "r186",
      "r228",
      "r351",
      "r413",
      "r840"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Gain from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r999",
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r24",
      "r38",
      "r45",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r168",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r458",
      "r470",
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r470",
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r28",
      "r116",
      "r214",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r298",
      "r663",
      "r667",
      "r668",
      "r669",
      "r677",
      "r681",
      "r684",
      "r685",
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r231",
      "r238",
      "r319",
      "r320",
      "r352",
      "r666",
      "r678",
      "r846"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other operating assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r328",
      "r329",
      "r330",
      "r334",
      "r626"
     ],
     "calculation": {
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r200"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross, excluding goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r87",
      "r90"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net book value, excluding goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r151",
      "r230",
      "r287",
      "r348",
      "r763",
      "r921",
      "r1023",
      "r1174"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r956",
      "r1020",
      "r1021"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property held for sale in the ordinary course of business, or in process of, or to be consumed in, production for sale.",
        "label": "Inventories [Member]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoriesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r196",
      "r962"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r265",
      "r959",
      "r1010"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r196",
      "r964"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r85",
      "r1050"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory Valuation Reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r196",
      "r963"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "verboseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held.",
        "label": "Land and Land Improvements [Member]",
        "terseLabel": "Land and improvements"
       }
      }
     },
     "localname": "LandAndLandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r51",
      "r297",
      "r417",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r494",
      "r496",
      "r498",
      "r499",
      "r696",
      "r698",
      "r699",
      "r744",
      "r897",
      "r970",
      "r1025",
      "r1108",
      "r1157",
      "r1158"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r177",
      "r227",
      "r837",
      "r1010",
      "r1064",
      "r1083",
      "r1154"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r53",
      "r252",
      "r297",
      "r417",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r494",
      "r496",
      "r498",
      "r499",
      "r696",
      "r698",
      "r699",
      "r744",
      "r1010",
      "r1108",
      "r1157",
      "r1158"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r6",
      "r159",
      "r165",
      "r203",
      "r249",
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
        "label": "Liabilities, Other than Long-Term Debt, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Tax related items, including contingencies"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r123",
      "r662",
      "r1145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licensing Agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/Debt2016and2018RevolvingFacilityand2016TermFacilityNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r57",
      "r1102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated litigation liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r57",
      "r1102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Legal and professional accruals, including litigation accruals"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r44",
      "r226",
      "r513",
      "r528",
      "r983",
      "r984",
      "r1168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r261"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt and other long-term obligations"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r22",
      "r301",
      "r1113"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r22",
      "r301",
      "r518"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r22",
      "r301",
      "r518"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r22",
      "r301",
      "r518"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r22",
      "r301",
      "r518"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r22",
      "r301",
      "r518"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r263"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r55",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r486",
      "r1103",
      "r1104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r486",
      "r1103",
      "r1104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r486",
      "r1103",
      "r1104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r481",
      "r1032"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss Contingency Accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPioglitazoneNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r1102",
      "r1103",
      "r1104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Damages to be paid"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationEuropeanCommissionProceedingsNarrativeDetails",
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSought": {
     "auth_ref": [
      "r99",
      "r100",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the form and magnitude of the award the plaintiff seeks in the legal matter, which may include an unspecified amount of money.",
        "label": "Loss Contingency, Damages Sought",
        "terseLabel": "Loss Contingency, Damages Sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSought",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r486",
      "r1103",
      "r1104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails",
      "http://www.viatris.com/role/LitigationLorazepamandClorazepateNarrativeDetails",
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails",
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Reconciling items:"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r1153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinistryOfFinanceIndiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of India.",
        "label": "Ministry of Finance, India [Member]",
        "terseLabel": "Ministry of Finance, India"
       }
      }
     },
     "localname": "MinistryOfFinanceIndiaMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Subsidiary, Ownership Percentage, Noncontrolling Owner",
        "terseLabel": "Subsidiary, Ownership Percentage, Noncontrolling Owner"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r1116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r995",
      "r996",
      "r997",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by mortgage loans.",
        "label": "Collateralized Mortgage-Backed Securities [Member]",
        "terseLabel": "Agency mortgage-backed securities"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r294"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r294"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r193",
      "r194",
      "r195"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r292",
      "r313",
      "r314",
      "r315",
      "r316",
      "r324",
      "r325",
      "r331",
      "r334",
      "r344",
      "r364",
      "r370",
      "r373",
      "r971"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net earnings attributable to Viatris Inc. common shareholders",
        "totalLabel": "Net earnings",
        "verboseLabel": "Net earnings (loss)"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r236",
      "r237",
      "r239",
      "r247",
      "r306",
      "r307",
      "r310",
      "r311",
      "r321",
      "r322",
      "r422",
      "r423",
      "r674",
      "r675",
      "r676",
      "r714",
      "r725",
      "r731",
      "r732",
      "r733",
      "r749",
      "r750",
      "r751",
      "r769",
      "r770",
      "r778",
      "r818",
      "r819",
      "r820",
      "r871",
      "r872",
      "r873",
      "r874",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RecentAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r305",
      "r308",
      "r309",
      "r310",
      "r312",
      "r315",
      "r321",
      "r338",
      "r381",
      "r382",
      "r418",
      "r419",
      "r420",
      "r421",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r465",
      "r658",
      "r659",
      "r660",
      "r670",
      "r671",
      "r672",
      "r673",
      "r690",
      "r691",
      "r692",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r715",
      "r716",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r739",
      "r740",
      "r745",
      "r746",
      "r747",
      "r748",
      "r761",
      "r762",
      "r765",
      "r766",
      "r767",
      "r768",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r815",
      "r816",
      "r817",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r77",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r305",
      "r308",
      "r309",
      "r310",
      "r312",
      "r315",
      "r321",
      "r338",
      "r381",
      "r382",
      "r418",
      "r419",
      "r420",
      "r421",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r465",
      "r658",
      "r659",
      "r660",
      "r670",
      "r671",
      "r672",
      "r673",
      "r690",
      "r691",
      "r692",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r715",
      "r716",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r739",
      "r740",
      "r745",
      "r746",
      "r747",
      "r748",
      "r761",
      "r762",
      "r765",
      "r766",
      "r767",
      "r768",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r815",
      "r816",
      "r817",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": {
     "auth_ref": [
      "r74",
      "r75",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.",
        "label": "Noncash or Part Noncash Divestiture, Amount of Consideration Received",
        "terseLabel": "Noncash or Part Noncash Divestiture, Amount of Consideration Received"
       }
      }
     },
     "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r344",
      "r364",
      "r370",
      "r373",
      "r971"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Earnings from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r772"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r772"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r771"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segment"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r157",
      "r220",
      "r877",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "General"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/General"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r267",
      "r1010"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r258"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Other assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r16",
      "r184",
      "r280",
      "r591"
     ],
     "calculation": {
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortization of prior service costs",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r273",
      "r274",
      "r276"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Net unrealized gain (loss) on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r63",
      "r285",
      "r753",
      "r756",
      "r759",
      "r842",
      "r1054"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive earnings (loss) before reclassifications, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r42",
      "r63",
      "r285",
      "r753",
      "r756",
      "r759",
      "r1054"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r289",
      "r753",
      "r754",
      "r759",
      "r825",
      "r842",
      "r1054",
      "r1055"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax [Abstract]",
        "terseLabel": "Other comprehensive loss, before tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r17",
      "r29",
      "r221"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive loss, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": {
     "auth_ref": [
      "r271",
      "r276"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax",
        "terseLabel": "Net unrecognized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r271",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r271",
      "r276",
      "r700",
      "r701",
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Net unrecognized gain on derivatives in cash flow hedging relationships"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r234",
      "r276",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent": {
     "auth_ref": [
      "r272",
      "r702"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge, attributable to parent. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax, Parent",
        "netLabel": "Net unrecognized losses on derivatives in net investment hedging relationships, net of tax",
        "verboseLabel": "Net unrecognized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r8",
      "r184"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r31",
      "r42",
      "r281",
      "r283",
      "r289",
      "r753",
      "r754",
      "r759",
      "r825",
      "r842",
      "r1054",
      "r1055"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss, net of tax",
        "totalLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r12",
      "r184",
      "r997",
      "r1117"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedNetLabel": "Change in unrecognized gain and prior service cost related to defined benefit plans",
        "negatedTerseLabel": "Change in unrecognized gain (loss) and prior service cost related to defined benefit plans",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r16",
      "r184",
      "r280",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Other comprehensive earnings (loss), reclassification adjustment from AOCE, pension and other postretirement benefit plans, for net gain (loss), before tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r13",
      "r284",
      "r289",
      "r666",
      "r682",
      "r683",
      "r753",
      "r757",
      "r759",
      "r825",
      "r842"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Income tax (benefit) provision"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r1084",
      "r1116",
      "r1152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherExpenseMember": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other expense.",
        "label": "Other Expense [Member]",
        "verboseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r52",
      "r1010"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/LitigationPricingandMedicaidLitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other liabilities.",
        "label": "Other Liabilities, Fair Value Disclosure",
        "terseLabel": "Other Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term obligations"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term obligations"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r190"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income) expense, net",
        "terseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension plan, other postretirement plan, and supplemental retirement plan, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Other Pension, Postretirement and Supplemental Plans [Member]",
        "terseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r978",
      "r979",
      "r980",
      "r981"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Exit Costs"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents and technologies"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r1034",
      "r1059"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Payments for product rights and other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Payments for Repurchase of Common Stock",
        "terseLabel": "Payments for Repurchase of Common Stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r469",
      "r1061"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payment"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedTerseLabel": "Payments of financing fees"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for financing costs associated with business combinations.",
        "label": "Payments of Merger Related Costs, Financing Activities",
        "negatedTerseLabel": "Contingent consideration payments"
       }
      }
     },
     "localname": "PaymentsOfMergerRelatedCostsFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r293"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Cash paid for acquisitions, net",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r1073"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Payments to Noncontrolling Interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r546",
      "r571",
      "r573",
      "r579",
      "r596",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r614",
      "r615",
      "r616",
      "r997"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension and Other Postretirement Benefits Disclosure"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets [Abstract]",
        "terseLabel": "Prepaid Expense and Other Assets [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r1051"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r266",
      "r439",
      "r440",
      "r961"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValuesofDerivativeInstrumentsDerivativesNotDesignatedAsHedgingInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Pro Forma Weighted Average Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "ProFormaWeightedAverageSharesOutstandingDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from Issuance of Common Stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r68",
      "r881"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r1035",
      "r1060"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other items, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "terseLabel": "Change in short-term borrowings, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfReceivables": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the proceeds from sale and collection of receivables during the period.",
        "label": "Proceeds from Sale and Collection of Receivables",
        "terseLabel": "Proceeds from sale and collection of receivables"
       }
      }
     },
     "localname": "ProceedsFromSaleAndCollectionOfReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from the sale of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r191"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "terseLabel": "Proceeds from the sale of assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.",
        "label": "Proceeds from Sale of Securities, Operating Activities",
        "terseLabel": "Proceeds from sale of terminated interest rate swaps"
       }
      }
     },
     "localname": "ProceedsFromSaleOfSecuritiesOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r1115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other Revenues"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r202",
      "r254",
      "r839"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r21",
      "r829",
      "r839",
      "r1010"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r1010"
     ],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r71",
      "r882"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Payments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r156",
      "r661",
      "r1165"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "negatedLabel": "Research and development",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r73",
      "r253",
      "r295"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsCashcashequivalentsandrestrictedcashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock awards"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "terseLabel": "Issuance of restricted stock and stock options exercised, net"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r466",
      "r467",
      "r469",
      "r472",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected cost remaining for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost Remaining",
        "terseLabel": "Restructuring and Related Cost, Expected Cost Remaining"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCostRemaining1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r468",
      "r471",
      "r475",
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "negatedLabel": "Utilization"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r19",
      "r473",
      "r475",
      "r1098"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r468",
      "r469",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [
      "r468",
      "r469",
      "r470",
      "r471",
      "r475",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r469",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r1049",
      "r1099",
      "r1100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring Reserve, Current"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r1052",
      "r1099",
      "r1100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Restructuring Reserve, Noncurrent"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r469",
      "r476"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "terseLabel": "Restructuring Reserve, Settled without Cash"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r97",
      "r1099"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r176",
      "r210",
      "r836",
      "r871",
      "r876",
      "r883",
      "r899",
      "r1010"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "vtrs_StockholdersEquityParentBeforeTreasuryStock",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r244",
      "r302",
      "r303",
      "r304",
      "r309",
      "r318",
      "r320",
      "r421",
      "r429",
      "r658",
      "r659",
      "r660",
      "r672",
      "r673",
      "r708",
      "r711",
      "r712",
      "r716",
      "r727",
      "r867",
      "r869",
      "r886",
      "r1175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r547",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r597",
      "r600",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r616",
      "r617",
      "r618",
      "r621",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r547",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r597",
      "r600",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r616",
      "r617",
      "r618",
      "r621",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r345",
      "r346",
      "r363",
      "r368",
      "r369",
      "r375",
      "r377",
      "r378",
      "r543",
      "r544",
      "r813"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Sales Revenue, Goods, Net",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r240",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition and Accounts Receivable"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r1039"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition and Deferred Revenue [Abstract]",
        "terseLabel": "Revenue Recognition and Deferred Revenue [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAndDeferredRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r288",
      "r297",
      "r345",
      "r346",
      "r363",
      "r368",
      "r369",
      "r375",
      "r377",
      "r378",
      "r417",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r494",
      "r496",
      "r498",
      "r499",
      "r744",
      "r828",
      "r1108"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales [Member]"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts Receivable, Net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r63",
      "r1155",
      "r1156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r118",
      "r119",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Summary of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r25",
      "r108",
      "r109",
      "r110",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r135",
      "r140",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedBalanceSheetsFairValueofDerivativeInstrumentsDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r1070"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V."
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Financial Assets and Liabilities Carried at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r89",
      "r91",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r89",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "verboseLabel": "Components of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r975"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r975",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "verboseLabel": "Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r47",
      "r178",
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Minimum Repayments on Outstanding Borrowings"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r1150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.",
        "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r1048"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r468",
      "r469",
      "r470",
      "r471",
      "r475",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r95",
      "r96",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring - employee related"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Reconciliation of Segment Information to Total Consolidated Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r623",
      "r625",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r35",
      "r36",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Stock Awards Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Nonvested Restricted Stock and Restricted Stock Unit Awards Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Expected Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r341",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r378",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r471",
      "r477",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r975",
      "r1038",
      "r1170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r356",
      "r367",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r377",
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting Policy"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r1006"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Stock option award vesting period, in years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Number of restricted stock awards, forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average grant-date fair value per share, forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Number of restricted stock awards, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average grant-date fair value per share, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Number of restricted stock awards, nonvested end of period",
        "periodStartLabel": "Number of restricted stock awards, nonvested beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted average grant-date fair value per share, nonvested end of period",
        "periodStartLabel": "Weighted average grant-date fair value per share, nonvested beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Number of restricted stock awards, released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average grant-date fair value per share, released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [
      "r623",
      "r625",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r1008"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Ordinary shares reserved for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r1126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r1007"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Stock option award expiration period, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Average remaining contractual term for stock awards exercisable, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Average remaining contractual term for stock awards outstanding, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Average remaining contractual term for stock awards vested and expected to vest, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r169",
      "r224",
      "r1010",
      "r1167"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Abstract]",
        "terseLabel": "Short-term Debt [Abstract]"
       }
      }
     },
     "localname": "ShortTermBorrowingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r248",
      "r341",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r378",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r459",
      "r471",
      "r477",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r975",
      "r1038",
      "r1170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r31",
      "r60",
      "r244",
      "r284",
      "r285",
      "r286",
      "r302",
      "r303",
      "r304",
      "r309",
      "r318",
      "r320",
      "r339",
      "r421",
      "r429",
      "r534",
      "r658",
      "r659",
      "r660",
      "r672",
      "r673",
      "r708",
      "r710",
      "r711",
      "r712",
      "r713",
      "r716",
      "r727",
      "r753",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r777",
      "r867",
      "r868",
      "r869",
      "r886",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/PensionsandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails",
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r339",
      "r813",
      "r880",
      "r887",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r898",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r917",
      "r918",
      "r919",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r339",
      "r813",
      "r880",
      "r887",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r898",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r917",
      "r918",
      "r919",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss",
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r31",
      "r173",
      "r174",
      "r210",
      "r881",
      "r934",
      "r950"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r31",
      "r173",
      "r174",
      "r210",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r31",
      "r173",
      "r174",
      "r210",
      "r886",
      "r934",
      "r950",
      "r1024"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Share repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "verboseLabel": "Viatris Inc. shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r244",
      "r245",
      "r285",
      "r302",
      "r303",
      "r304",
      "r309",
      "r318",
      "r421",
      "r429",
      "r534",
      "r658",
      "r659",
      "r660",
      "r672",
      "r673",
      "r708",
      "r710",
      "r711",
      "r712",
      "r713",
      "r716",
      "r727",
      "r753",
      "r755",
      "r759",
      "r777",
      "r868",
      "r869",
      "r885",
      "r900",
      "r916",
      "r935",
      "r936",
      "r951",
      "r1024",
      "r1064",
      "r1083",
      "r1154",
      "r1175"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "verboseLabel": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r760",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r760",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r1047"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "verboseLabel": "Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplierFinanceProgramObligation": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r976"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation for supplier finance program.",
        "label": "Supplier Finance Program, Obligation",
        "terseLabel": "Amounts due for supplier finance program"
       }
      }
     },
     "localname": "SupplierFinanceProgramObligation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsImpactofAdoptionASU201409Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r154",
      "r260",
      "r960"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r525",
      "r533",
      "r717",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r843",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1079",
      "r1080",
      "r1081",
      "r1082"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury Stock, Common, Shares",
        "verboseLabel": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r31",
      "r174",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Treasury Stock, Shares, Acquired"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r59",
      "r104",
      "r105"
     ],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury Stock, Value",
        "terseLabel": "Less: Treasury stock \u2014 at cost"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r31",
      "r104",
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Common stock repurchase"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails",
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r468",
      "r469",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r968",
      "r995",
      "r997",
      "r1166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasuries"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTerseLabel": "Unamortized debt issuance expense"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectOfDerivativeInstrumentsontheCondensedConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageBasicSharesOutstandingProForma": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Weighted Average Basic Shares Outstanding, Pro Forma",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageBasicSharesOutstandingProForma",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r326",
      "r334"
     ],
     "calculation": {
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Total dilutive shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r324",
      "r334"
     ],
     "calculation": {
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.viatris.com/role/EarningsLossperOrdinaryShareBasicandDilutedEarningsPerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "vtrs_A2020EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Euro Senior Notes [Member]",
        "label": "2020 Euro Senior Notes [Member]",
        "terseLabel": "2020 Euro Senior Notes"
       }
      }
     },
     "localname": "A2020EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Restructuring Plan",
        "label": "2020 Restructuring Plan [Member]",
        "terseLabel": "2020 Restructuring Plan"
       }
      }
     },
     "localname": "A2020RestructuringPlanMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan",
        "label": "2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member]",
        "terseLabel": "2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2024EuroSeniorNotes1023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2024 Euro Senior Notes, 1.023%",
        "label": "2024 Euro Senior Notes, 1.023% [Member]",
        "terseLabel": "2024 Euro Senior Notes, 1.023%"
       }
      }
     },
     "localname": "A2024EuroSeniorNotes1023Member",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2024EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2024 Euro Senior Notes [Member]",
        "label": "2024 Euro Senior Notes [Member]",
        "terseLabel": "2024 Euro Senior Notes"
       }
      }
     },
     "localname": "A2024EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2025EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Euro Senior Notes [Member]",
        "label": "2025 Euro Senior Notes [Member]",
        "terseLabel": "2.125% Euro Senior Notes due 2025"
       }
      }
     },
     "localname": "A2025EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2025SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Senior Notes",
        "label": "2025 Senior Notes [Member]",
        "terseLabel": "2025 Senior Notes"
       }
      }
     },
     "localname": "A2025SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2027EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2027 Euro Senior Notes",
        "label": "2027 Euro Senior Notes [Member]",
        "terseLabel": "2027 Euro Senior Notes"
       }
      }
     },
     "localname": "A2027EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2027SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2027 Senior Notes",
        "label": "2027 Senior Notes [Member]",
        "terseLabel": "2027 Senior Notes"
       }
      }
     },
     "localname": "A2027SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2028EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Euro Senior Notes [Member]",
        "label": "2028 Euro Senior Notes [Member]",
        "terseLabel": "2028 Euro Senior Notes"
       }
      }
     },
     "localname": "A2028EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Senior Notes [Member] [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes [Member]"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2030SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2030 Senior Notes",
        "label": "2030 Senior Notes [Member]",
        "terseLabel": "2030 Senior Notes"
       }
      }
     },
     "localname": "A2030SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2032EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2032 Euro Senior Notes",
        "label": "2032 Euro Senior Notes [Member]",
        "terseLabel": "2032 Euro Senior Notes"
       }
      }
     },
     "localname": "A2032EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2040SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2040 Senior Notes",
        "label": "2040 Senior Notes [Member]",
        "terseLabel": "2040 Senior Notes"
       }
      }
     },
     "localname": "A2040SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2048SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2048 Senior Notes [Member]",
        "label": "2048 Senior Notes [Member]",
        "terseLabel": "2048 Senior Notes [Member]"
       }
      }
     },
     "localname": "A2048SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2050SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2050 Senior Notes",
        "label": "2050 Senior Notes [Member]",
        "terseLabel": "2050 Senior Notes"
       }
      }
     },
     "localname": "A2050SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable facility maximum borrowing capacity.",
        "label": "Accounts Receivable Facility Maximum Borrowing Capacity",
        "terseLabel": "Accounts receivable securitization facility maximum borrowing capacity"
       }
      }
     },
     "localname": "AccountsReceivableFacilityMaximumBorrowingCapacity",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccruedSalesAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 2.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Sales Allowances",
        "label": "Accrued Sales Allowances",
        "negatedNetLabel": "Rebates, promotional programs and other sales allowances"
       }
      }
     },
     "localname": "AccruedSalesAllowances",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx",
        "label": "Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx",
        "terseLabel": "Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx"
       }
      }
     },
     "localname": "AccumulateOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTaxx",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsOfOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Anticompetitive Conduct with Generic Drugs [Member]",
        "label": "Amended Anticompetitive Conduct with Generic Drugs [Member]",
        "terseLabel": "Amended Anticompetitive Conduct with Generic Drugs [Member]"
       }
      }
     },
     "localname": "AmendedAnticompetitiveConductwithGenericDrugsMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AmitizaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amitiza \u00ae",
        "label": "Amitiza \u00ae [Member]",
        "terseLabel": "Amitiza \u00ae"
       }
      }
     },
     "localname": "AmitizaMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]",
        "label": "Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]",
        "terseLabel": "Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]"
       }
      }
     },
     "localname": "AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AnticompetitiveConductwithGenericDrugsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticompetitive Conduct with Generic Drugs [Member]",
        "label": "Anticompetitive Conduct with Generic Drugs [Member]",
        "terseLabel": "Anticompetitive Conduct with Generic Drugs [Member]"
       }
      }
     },
     "localname": "AnticompetitiveConductwithGenericDrugsMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_BalanceSheetComponentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance Sheet Components",
        "label": "Balance Sheet Components [Abstract]",
        "terseLabel": "Balance Sheet Components [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetComponentsAbstract",
     "nsuri": "http://www.viatris.com/20230331",
     "xbrltype": "stringItemType"
    },
    "vtrs_BioconBiologicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biocon Biologics",
        "label": "Biocon Biologics [Member]",
        "terseLabel": "Biocon Biologics"
       }
      }
     },
     "localname": "BioconBiologicsMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_BrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brands",
        "label": "Brands [Member]",
        "terseLabel": "Brands"
       }
      }
     },
     "localname": "BrandsMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_BusinessAcquisitionContingentConsiderationPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Per Share",
        "label": "Business Acquisition, Contingent Consideration Per Share",
        "terseLabel": "Business Acquisition, Contingent Consideration Per Share"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationPerShare",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "vtrs_BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights",
        "label": "Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights",
        "terseLabel": "Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights"
       }
      }
     },
     "localname": "BusinessAcquisitionNonTransferableContingentValueRightNumberOfRights",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization",
        "label": "Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization",
        "terseLabel": "Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization"
       }
      }
     },
     "localname": "BusinessAcquisitionProvisionalInformationInitialAccountingIncompleteAdjustmentAmortization",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Reclassifications",
        "label": "Business Combination, Contingent Consideration Arrangements, Reclassifications",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsReclassifications",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)",
        "terseLabel": "Fair value loss"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContingentConsiderationLiabilityPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Liability Payments",
        "label": "Business Combination Contingent Consideration Liability Payments",
        "negatedTerseLabel": "Payments",
        "terseLabel": "Business Combination Contingent Consideration Liability Payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPayments",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_CelebrexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celebrex \u00ae",
        "label": "Celebrex \u00ae [Member]",
        "terseLabel": "Celebrex \u00ae"
       }
      }
     },
     "localname": "CelebrexMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Changeinnoncashlitigationsettlementsnet": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncash litigation settlements, net",
        "label": "Change in noncash litigation settlements, net",
        "negatedTerseLabel": "Litigation settlements and other contingencies, net"
       }
      }
     },
     "localname": "Changeinnoncashlitigationsettlementsnet",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_Chargebacks": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 1.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chargebacks",
        "label": "Chargebacks",
        "negatedTerseLabel": "Chargebacks"
       }
      }
     },
     "localname": "Chargebacks",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_CitalopramLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Citalopram Litigation",
        "label": "Citalopram Litigation [Member]",
        "terseLabel": "Citalopram Litigation"
       }
      }
     },
     "localname": "CitalopramLitigationMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ComplexGXAndBiosimilarsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complex GX and Biosimilars",
        "label": "Complex GX and Biosimilars [Member]",
        "terseLabel": "Complex GX and Biosimilars"
       }
      }
     },
     "localname": "ComplexGXAndBiosimilarsMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration.",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Corporatecosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate costs",
        "label": "Corporate costs",
        "terseLabel": "Corporate costs"
       }
      }
     },
     "localname": "Corporatecosts",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_CreonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Creon \u00ae",
        "label": "Creon \u00ae [Member]",
        "terseLabel": "Creon \u00ae"
       }
      }
     },
     "localname": "CreonMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_CurrentPortionofLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Current Portion of Long-Term Debt [Member]",
        "terseLabel": "Current Portion of Long-Term Debt"
       }
      }
     },
     "localname": "CurrentPortionofLongTermDebtMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plans, estimated benefit payments, in current fiscal year",
        "label": "Defined benefit plans, estimated benefit payments, in current fiscal year",
        "terseLabel": "Defined benefit plans, estimated benefit payments, in current fiscal year"
       }
      }
     },
     "localname": "Definedbenefitplansestimatedbenefitpaymentsincurrentfiscalyear",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/PensionandOtherPostretirementBenefitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DevelopedMarketsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed Markets Segment",
        "label": "Developed Markets Segment [Member]",
        "terseLabel": "Developed Markets (1)"
       }
      }
     },
     "localname": "DevelopedMarketsSegmentMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Developmentandsalesmilestonepayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development and sales milestone payments",
        "label": "Development and sales milestone payments",
        "terseLabel": "Development and sales milestone payments"
       }
      }
     },
     "localname": "Developmentandsalesmilestonepayments",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Deferred Consideration Due",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Consideration Due",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Deferred Consideration Due"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredConsiderationDue",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset",
        "label": "Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOwnershipPercentageInDisposedAsset",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term",
        "label": "Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationTransitionServicesAgreementRevisedTerm",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vtrs_DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment",
        "label": "Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment",
        "terseLabel": "Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsContingentConsiderationLiabilityWorkingCapitalAdjustment",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DivestitureOfBusinessDeferredCashConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture of Business, Deferred Cash Consideration.",
        "label": "Divestiture of Business, Deferred Cash Consideration.",
        "terseLabel": "Divestiture of Business, Deferred Cash Consideration."
       }
      }
     },
     "localname": "DivestitureOfBusinessDeferredCashConsideration",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DymistaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dymista \u00ae",
        "label": "Dymista \u00ae [Member]",
        "terseLabel": "Dymista \u00ae"
       }
      }
     },
     "localname": "DymistaMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EffexorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effexor \u00ae",
        "label": "Effexor \u00ae [Member]",
        "terseLabel": "Effexor \u00ae"
       }
      }
     },
     "localname": "EffexorMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EmergingMarketsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets Segment",
        "label": "Emerging Markets Segment [Member]",
        "terseLabel": "Emerging Markets (2)"
       }
      }
     },
     "localname": "EmergingMarketsSegmentMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EpiPenAutoInjectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EpiPen\u00ae Auto-Injectors",
        "label": "EpiPen\u00ae Auto-Injectors [Member]",
        "terseLabel": "EpiPen\u00ae Auto-Injectors"
       }
      }
     },
     "localname": "EpiPenAutoInjectorsMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_FamyLifeSciencesAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Famy Life Sciences Acquisition",
        "label": "Famy Life Sciences Acquisition [Member]",
        "terseLabel": "Famy Life Sciences Acquisition"
       }
      }
     },
     "localname": "FamyLifeSciencesAcquisitionMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_FamyLifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Famy Life Sciences",
        "label": "Famy Life Sciences [Member]",
        "terseLabel": "Famy Life Sciences"
       }
      }
     },
     "localname": "FamyLifeSciencesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_GenericsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generics",
        "label": "Generics [Member]",
        "terseLabel": "Generics"
       }
      }
     },
     "localname": "GenericsMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_GreaterChinaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Greater China Segment",
        "label": "Greater China Segment [Member]",
        "terseLabel": "Greater China"
       }
      }
     },
     "localname": "GreaterChinaSegmentMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Partial Payment Of Income Tax Expense",
        "label": "Income Tax Examination, Partial Payment Of Income Tax Expense",
        "terseLabel": "Income Tax Examination, Partial Payment Of Income Tax Expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_IntangibleAssetsbyMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets by Major Class",
        "label": "Intangible Assets by Major Class [Line Items]",
        "terseLabel": "Intangible Assets by Major Class [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsbyMajorClassLineItems",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_JapanAustraliaAndNewZealandSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Japan, Australia and New Zealand Segment",
        "label": "Japan, Australia and New Zealand Segment [Member]",
        "terseLabel": "JANZ"
       }
      }
     },
     "localname": "JapanAustraliaAndNewZealandSegmentMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringRestructuringChargesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_LipitorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lipitor \u00ae",
        "label": "Lipitor \u00ae [Member]",
        "terseLabel": "Lipitor"
       }
      }
     },
     "localname": "LipitorMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_LongTermIncentivePlan2003Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Incentive 2003 Plan.",
        "label": "Long Term Incentive Plan 2003 [Member]",
        "terseLabel": "Long-Term Incentive Plan 2003"
       }
      }
     },
     "localname": "LongTermIncentivePlan2003Member",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year",
        "label": "Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year",
        "terseLabel": "Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year"
       }
      }
     },
     "localname": "LossContingencyAssetImpairmentDisposalTransactionsNotCompletedInCurrentFiscalYear",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_LyricaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lyrica \u00ae",
        "label": "Lyrica \u00ae [Member]",
        "terseLabel": "Lyrica \u00ae"
       }
      }
     },
     "localname": "LyricaMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Medicaidandothergovernmentalrebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 4.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and other governmental rebates",
        "label": "Medicaid and other governmental rebates",
        "negatedTerseLabel": "Medicaid and other governmental rebates"
       }
      }
     },
     "localname": "Medicaidandothergovernmentalrebates",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_MultiDistrictLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multi District Litigation [Member]",
        "label": "Multi District Litigation [Member]",
        "terseLabel": "Multi District Litigation [Member]"
       }
      }
     },
     "localname": "MultiDistrictLitigationMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NorvascMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Norvasc \u00ae",
        "label": "Norvasc \u00ae [Member]",
        "terseLabel": "Norvasc"
       }
      }
     },
     "localname": "NorvascMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NoteSecuritizationFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Securitization Facility [Member]",
        "label": "Note Securitization Facility [Member]",
        "terseLabel": "Note Securitization Facility"
       }
      }
     },
     "localname": "NoteSecuritizationFacilityMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Entities, National Health Service England, Wales, And Northern Ireland",
        "label": "Number Of Entities, National Health Service England, Wales, And Northern Ireland",
        "terseLabel": "Number Of Entities, National Health Service England, Wales, And Northern Ireland"
       }
      }
     },
     "localname": "NumberOfEntitiesNationalHealthServiceEnglandWalesAndNorthernIreland",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_NumberOfScottishHealthBoardsNHSScotland": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Scottish Health Boards, NHS Scotland",
        "label": "Number Of Scottish Health Boards, NHS Scotland",
        "terseLabel": "Number Of Scottish Health Boards, NHS Scotland"
       }
      }
     },
     "localname": "NumberOfScottishHealthBoardsNHSScotland",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationIntellectualPropertyNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_Numberofcases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of cases",
        "label": "Number of cases",
        "terseLabel": "Number of cases"
       }
      }
     },
     "localname": "Numberofcases",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_Numberofstates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of states",
        "label": "Number of states",
        "terseLabel": "Number of states"
       }
      }
     },
     "localname": "Numberofstates",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails",
      "http://www.viatris.com/role/LitigationMDRPClassificationofEpiPenAutoInjectorandEpiPenJrAutoInjectorDetails",
      "http://www.viatris.com/role/LitigationModafinilAntitrustLitigationandFTCInquiryNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_OcularASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ocular AS",
        "label": "Ocular AS [Member]",
        "terseLabel": "Ocular AS"
       }
      }
     },
     "localname": "OcularASMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationDrugPricingMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherCurrentPortionofLongtermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Portion of Long-term Debt [Member]",
        "label": "Other Current Portion of Long-term Debt [Member]",
        "terseLabel": "Other Current Portion of Long-term Debt"
       }
      }
     },
     "localname": "OtherCurrentPortionofLongtermDebtMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails",
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other long term debt.",
        "label": "Other Long Term Debt [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermDebtMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Other [Member]",
        "verboseLabel": "Other Litigation"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationOtherLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherOneTimeNonoperatingExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other One-Time Nonoperating Expense",
        "label": "Other One-Time Nonoperating Expense",
        "negatedTerseLabel": "Other One-Time Nonoperating Expense"
       }
      }
     },
     "localname": "OtherOneTimeNonoperatingExpense",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationOfSegmentInformationToTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_Otherlongtermassets": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other long-term assets",
        "label": "Other long-term assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "Otherlongtermassets",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_OysterPointPharmaAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oyster Point Pharma Acquisition",
        "label": "Oyster Point Pharma Acquisition [Member]",
        "terseLabel": "Oyster Point Pharma Acquisition"
       }
      }
     },
     "localname": "OysterPointPharmaAcquisitionMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_PaymentsToAcquireIntangibleAssetsFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire Intangible Assets, Financing Activity",
        "label": "Payments To Acquire Intangible Assets, Financing Activity",
        "negatedTerseLabel": "Payments to Acquire Productive Assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssetsFinancingActivity",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_PrivateEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Equity Securities",
        "label": "Private Equity Securities [Member]",
        "terseLabel": "Private Equity Securities"
       }
      }
     },
     "localname": "PrivateEquitySecuritiesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ProductLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liability",
        "label": "Product Liability [Member]",
        "terseLabel": "Product Liability"
       }
      }
     },
     "localname": "ProductLiabilityMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/LitigationProductLiabilityNarrativeDetails",
      "http://www.viatris.com/role/LitigationUKCompetitionandMarketsAuthorityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ProductRightsAndLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Rights And Licenses",
        "label": "Product Rights And Licenses [Member]",
        "terseLabel": "Product Rights And Licenses"
       }
      }
     },
     "localname": "ProductRightsAndLicensesMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ProgramNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Program Name",
        "label": "Program Name [Axis]",
        "terseLabel": "Program Name [Axis]"
       }
      }
     },
     "localname": "ProgramNameAxis",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ProgramNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Program Name",
        "label": "Program Name [Domain]",
        "terseLabel": "Program Name [Domain]"
       }
      }
     },
     "localname": "ProgramNameDomain",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ReceivablesFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables facility.",
        "label": "Receivables Facility [Member]",
        "terseLabel": "Receivables Facility"
       }
      }
     },
     "localname": "ReceivablesFacilityMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtReceivablesSecuritizationFacilityandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve for Uncertain Tax Positions, Including Interest And Penalties",
        "label": "Reserve for Uncertain Tax Positions, Including Interest And Penalties",
        "terseLabel": "Reserve for Uncertain Tax Positions, Including Interest And Penalties"
       }
      }
     },
     "localname": "ReserveForUncertainTaxPositionsIncludingInterestAndPenalties",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesIncomeTaxesDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_RevenuefromContractwithCustomerGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Gross",
        "label": "Revenue from Contract with Customer, Gross",
        "terseLabel": "Gross sales"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerGross",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_RevenuefromContractwithCustomerReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 3.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Returns",
        "label": "Revenue from Contract with Customer, Returns",
        "negatedLabel": "Returns"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerReturns",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_SalesRevenueGrosstonetadjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Revenue, Gross to net adjustments",
        "label": "Sales Revenue, Gross to net adjustments",
        "negatedTotalLabel": "Sales Revenue, Gross to net adjustments"
       }
      }
     },
     "localname": "SalesRevenueGrosstonetadjustments",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_ScheduleOfIntangibleAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets by Major Class [Table]",
        "label": "Schedule of Intangible Assets by Major Class [Table]",
        "terseLabel": "Schedule of Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassTable",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofActivityinContingentConsiderationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Activity in Contingent Consideration [Roll Forward]",
        "label": "Schedule of Activity in Contingent Consideration [Roll Forward]",
        "terseLabel": "Schedule of Activity in Contingent Consideration [Roll Forward]"
       }
      }
     },
     "localname": "ScheduleofActivityinContingentConsiderationRollForward",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table]",
        "label": "Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block]",
        "terseLabel": "Schedule of Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Other Noncurrent Liabilities [Table]",
        "label": "Schedule of Other Noncurrent Liabilities [Line Items]",
        "terseLabel": "Schedule of Other Noncurrent Liabilities [Line Items]"
       }
      }
     },
     "localname": "ScheduleofOtherNoncurrentLiabilitiesLineItems",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofOtherNoncurrentLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Other Noncurrent Liabilities [Table]",
        "label": "Schedule of Other Noncurrent Liabilities [Table]",
        "terseLabel": "Schedule of Other Noncurrent Liabilities [Table]"
       }
      }
     },
     "localname": "ScheduleofOtherNoncurrentLiabilitiesTable",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherLongtermObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofothercurrentliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of other current liabilities [Table]",
        "label": "Schedule of other current liabilities [Line Items]",
        "terseLabel": "Schedule of other current liabilities [Line Items]"
       }
      }
     },
     "localname": "ScheduleofothercurrentliabilitiesLineItems",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofothercurrentliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of other current liabilities [Table]",
        "label": "Schedule of other current liabilities [Table]",
        "terseLabel": "Schedule of other current liabilities [Table]"
       }
      }
     },
     "localname": "ScheduleofothercurrentliabilitiesTable",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_SeniorNotesTwoThousandFortyEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SeniorNotesTwoThousandFortyEight [Member]",
        "label": "SeniorNotesTwoThousandFortyEight [Member]",
        "terseLabel": "2048 Senior Notes (5.200%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandFortyEightMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2046 Senior Note (5.250%)",
        "label": "SeniorNotesTwoThousandFortySix5.25Precent [Member]",
        "terseLabel": "2046 Senior Notes (5.250% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandFortySix5.25PrecentMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandFortyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand forty three",
        "label": "SeniorNotesTwoThousandFortyThree [Member]",
        "terseLabel": "2043 Senior Notes (5.400% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandFortyThreeMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SeniorNotesTwoThousandTwentyEight [Member]",
        "label": "SeniorNotesTwoThousandTwentyEight [Member]",
        "terseLabel": "SeniorNotesTwoThousandTwentyEight [Member]"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyEightMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2026 Senior Notes 3.950%",
        "label": "SeniorNotesTwoThousandTwentySix3.95Precent [Member]",
        "terseLabel": "2026 Senior Notes (3.950% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentySix3.95PrecentMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand twenty three - 3.125 percent",
        "label": "SeniorNotesTwoThousandTwentyThree3.125Percent [Member]",
        "terseLabel": "2023 Senior Notes (3.125% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyThree3.125PercentMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand twenty three - 4.2 percent",
        "label": "SeniorNotesTwoThousandTwentyThree4.2Percent [Member]",
        "terseLabel": "2023 Senior Notes (4.200% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyThree4.2PercentMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of stock-based awards exercised and restricted stock units converted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment",
        "label": "Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment",
        "terseLabel": "Issuance of restricted stock, net of shares withheld (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "vtrs_StockholdersEquityParentBeforeTreasuryStock": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings that are attributable to the parent company, excluding equity attributable to noncontrolling interests, and before deducting the carrying value of treasury stock.",
        "label": "Stockholders Equity Parent Before Treasury Stock",
        "totalLabel": "Total Viatris Inc. equity, before treasury stock"
       }
      }
     },
     "localname": "StockholdersEquityParentBeforeTreasuryStock",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_UpjohnDistributorMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upjohn Distributor Markets",
        "label": "Upjohn Distributor Markets [Member]",
        "terseLabel": "Upjohn Distributor Markets"
       }
      }
     },
     "localname": "UpjohnDistributorMarketsMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/DivestituresDetails",
      "http://www.viatris.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_VariableConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Consideration [Member]",
        "label": "Variable Consideration [Member]",
        "terseLabel": "Variable Consideration"
       }
      }
     },
     "localname": "VariableConsiderationMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAssetsandLiabilitiesHeldForSaleDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ViagraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Viagra \u00ae",
        "label": "Viagra \u00ae [Member]",
        "terseLabel": "Viagra \u00ae"
       }
      }
     },
     "localname": "ViagraMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ViatrisIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Viatris Inc.",
        "label": "Viatris Inc. [Member]",
        "terseLabel": "Viatris Inc."
       }
      }
     },
     "localname": "ViatrisIncMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_XalabrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Xalabrands",
        "label": "Xalabrands [Member]",
        "terseLabel": "Xalabrands"
       }
      }
     },
     "localname": "XalabrandsMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_XanaxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Xanax \u00ae",
        "label": "Xanax \u00ae [Member]",
        "terseLabel": "Xanax \u00ae"
       }
      }
     },
     "localname": "XanaxMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_YENTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "YEN Term Loan",
        "label": "YEN Term Loan [Member]",
        "terseLabel": "YEN Term Loan"
       }
      }
     },
     "localname": "YENTermLoanMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_YupelriMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yupelri \u00ae",
        "label": "Yupelri \u00ae [Member]",
        "terseLabel": "Yupelri \u00ae"
       }
      }
     },
     "localname": "YupelriMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ZoloftMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zoloft \u00ae",
        "label": "Zoloft \u00ae [Member]",
        "terseLabel": "Zoloft \u00ae"
       }
      }
     },
     "localname": "ZoloftMember",
     "nsuri": "http://www.viatris.com/20230331",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationTableDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1026": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1027": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1028": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1029": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1031": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1041": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1042": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1043": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1044": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1045": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1046": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "https://asc.fasb.org//210/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "210-10-S99-1(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1067": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1070": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1071": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1072": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1073": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1074": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1075": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1076": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1077": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1078": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1079": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1080": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1081": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1082": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1083": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1084": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1085": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1086": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1087": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1088": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1089": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1090": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1091": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1092": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1093": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1094": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1095": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1096": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1097": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1098": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1099": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(i)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-31",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205-20/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org//220/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org//350/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org//360/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org//440/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org//470/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org//805/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org//810/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org//250/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org//606/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org//808/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.B)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org//260/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org//280/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "405",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)(1)",
   "Topic": "405",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "405",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)(2)(iv)",
   "Topic": "405",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "405",
   "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "50",
   "Subparagraph": "(a)",
   "Topic": "405",
   "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org//420/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org//715/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org//320/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(4)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13A(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column E))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "47",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "50",
   "Topic": "405",
   "URI": "https://asc.fasb.org//1943274/2147477128/405-50-55-5",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147481639/420-10-35-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>114
<FILENAME>0001792044-23-000017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001792044-23-000017-xbrl.zip
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MV>QUD8:?Q(=$%_DRT.^B,?G@OQ?HKQ"S<G>#E%4'__'^8XN7[=2V<=&P+\0
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M=@9Z1%'6O!\H2:B'A,ESH1I/$R\"<R,CLPREF36!K IP= 0JGU_9%:QT:)$
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MF.-JVEL^H T=!RH2)+#^E#:Q7L#[ IU<$I*CM"S<96Q'F"O=S.\UD6]\-]:
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M\@5*[<ZQ]TD&#;MJPPL\UP$,&4U#98HDOH*%-(:XP+A_/EXHQTM\5%GR)%4
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M4P-Z98?C;,\.1\)"_B5K2?B#_-,[/RA3RIIRDT7)Q5&*,-E9*68M#@6($_)
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M$8IEFR4[TJ.'.^ZQP.W<6^XQ5"#TXL#!/3]XRXG5'$A^5CU[^=CQET3LZT+
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M\NJ2=#9!.CF^A>+23N1/Z;+[H5"LQ%\3NL_&[K-7J[A+HX\5:Z"3Y<(=C:R
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MQ;DF;Z!FQ__&-6#6"1F?%S4^9X&+NR[ZG-5K&#8>K4UYL#9RL/9CWQMQ( C
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M2:ODBQOBBTG2*M"XY_!(X(BGVZV5DR>NC_=87!_4#W>XM:FU;=2JM2C<:N:
M/V5L?"G.:QX>6)+YHD\:P6*BDEF<P"(59&*F!J#,I4N:[6ZED,ZW3-HGK1S2
M?I9JM6/*YD6B[).%A$W)PB'69Z"MIJR6V/>B<D$.6:U:K[=:IW]G!_5Z%7Y
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ME7G^@+F305^&3F$&)L=]UP%^-UG2%K9I8GNMP6?U5QY\]L;CR!:CX^<E9A3
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M.7&6U;(&7JQ9);FU]'>W\KL45]W%H2N\[>2@5;Q#ESI8)&]EKUFY_^UV>[;
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MY/WLS(H=-6_1"/A+)[V[\ '[3#;_<^$80XRP2:4)PMI?@58>J!ST^!LW2EL
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MU(HLJ%/5-*36"Z^):H19:7JFL#(NU3JU1A2 )=>-+DXL)\R/SB^5JY*5T[R
M6W:4 C)R31G'0(,A!5IF=-#!!4;P'DT?G@0= K1Q=R+BOC"@ A'30-IG3Q[0
MUGO3?5*)+?0AZDFNCPN;H!EJ1VDFQ@R',WGW(&Z4))1E"W\RDED^,#,O>!^.
M%;?"6QP0?\EU2 UH0!+)QS0:U/V$+*4<.JK!C&35P%KE>L-I=)4TD\]7X?X>
ME7F69^K)\C--+!4FT\P?4\==92>/>"IHS;(,B^>BN%.V/OJ94?[YH3R<EN15
M'II/B:)37&L&;$R<D;BT(_Q23-C3,X"G8?&-1K76W*T-ZL#Z<8B'S)7UU7 7
M<?6?ABX:?[!ZD)DZD:JU$NZ:#)4( ECL4-H.D&58CJQ-H:6Q+PLDZ ?+S725
MK3<*FH01A%ZBL&S$%:8:CJ7Z(5%AV+C0H9 5>_!P$BH)7+0$V]B''H#78?RZ
M;'@(C IX8("]2.0A(YR68?&()7#DP(4>+=7R.@\:98HQH7?=4 43.R!/91>U
MR#2NT0\=*C@/_Q%&D+,.\"X4NG#,B>0IIYF8[7]U9T"8#NAZA%ZB1!PM+0-@
MY-CDU7*C_E<VUA6G]M>#I,Q@!P:W,:DLD >(XYBHS11VD/4M7YJSJ$2F;&>=
M7)$AAY$+X<1#@UD:LKCDP/)RWW@8H;2,1$69;FN.Z\>/G!9T$CA+ ZF<<5GJ
M9)E2)P?MPSPBEF50J:5E;FI#);74LED$[;HD,U4WK-%BV 5SZ"?JTFBY'=>G
MF?T6F5/92&*YE4[6<J.L-Q:/$CL1K'2F:>3G*,?2QR-J?L9-W/\D)R,K1U))
MS.J(6LU\C/ATQ,U<+P'J8S ]?3REF=T3"E6IDC'JI1(74Z79+'M,84H<79*7
M1JQ[$^RPDE <*RDDI; S5E^0GG4JY18'XF,#F^37 RT-XH*CE'L;:6X)=8*D
MC(Z%C?71)$2,NGE3GYQ(.T5P%U>=R )N60@@\1XRR(U&"B0EN'&J@;>&4U.W
M$Q.1Y*OS+JATEI U*A! QW Y<=^BO8KR% YI>Q\/=4 3DI):DLAL$.D#"5PK
MN.>\1VN(_E(V\L/!(=Z,50A2LLDHF8K%P-D 2E5/<QW9!,AS)R24]66'LN#5
M9NCLX$>>4IP\DNW>!3NI'^W23#I/C #2"G<:<ILU8R69RDQC%6EQX8BZ ?QX
M7$43UR#5D]8<VD%KAJJ?OI0=*)M<MJ)UHI:DQ*A:&R:M:A &&,6>>6+:6B*U
M([KDB9--141IS.J$*XB"I>XFATIIQJ &;FN>0K='JG<RVVGJ,8?RF-/4U=SI
M;LT(Z8!,E0I(8F\R@R@!1)$2LE7O. RFC(S2()LSE^0IB<6'DAXX1)!R"1BI
M;79S5?U4XQ]BB7.Z@A_FY8E_;K=O)60UDK,@U%KBP27PX%H'&C$DR8\8W4A.
M+N^;:<%6Q/7F?-ZOO2[;&W=?/\=EN",/861'3]KJI> D$V3"3"]SMZ(;T#I*
M3::BB-I4_]:,L1RU?&U.Q\<KBP4YH%!_[SWQ<>SH5:TLXI@;5<@6_3J'STQ2
M+];ZHZ;X# XZT!D>4C83%#9Q1KH'5&J1@[B;N4;*O4_M'JLWF]M,4LXM2-\L
M'><;<9QG_;V%<:%'>7B@.E*'9P5&M2DAJC.-@]>.TTQI9/*7(D9%\)K@*%/W
MR6I>%](MP:[(<7*3<#.3\</R9?5K:32-GC$#35;2BJG,\SFP#I.:1F8467LX
MU0@$5#Q24988B @'Z;T*2'SDMHIGEL//\L %OG'E<UYM.%G_L7*.>S&GG^(8
MD@/%'",SRLB4(3V .DH*#0ABA+V)'.&&/GP2^6N2]@[M L^.:UZ@ CG(Y21U
M,+EGF0\B7K#T38=+N1M7U$&REO)IM2..(57<>9;:4DPN@Y$NN[4PY$39@"IW
M*LLB6JBURL 0E<:3H?;9S& +U)#9:ED'D3RWOB^MYAA/C]Z-5+D13=': @7#
MF>D%PV"/YPTR:QJPA<QBP@@EV9),FDOQV$3]S%-Q,MBO&^Y0Q5R0FL4XH/<D
M@F(HE !-(;@3?K*FRO0J&=F3[RG_M3L8:,-NM'3*_4B]RI6EEYR)6$Q&C*QP
M5%ECR;.!#2D0^R*48AXJ+S<<":)@'91 =GX=?"#]F5%'E]C/J2)"0"KXR@2T
M @&E=7[E-$@. QT&NM><'+9ZKWP?AD[PV-]+A=F%B$:OVLID5R@U,I;O;I[D
M>J=2NY/T&^>,;7JEA2R#'XU6AV/!%(AK9 \($1"E'8FYT2MS%GAZ$(/#-/1)
M9#I('T/:U)Z.EEO^Q<^ERH?,6KFRA\C<X[&QX:@'!Y.Q2'?KU 9'08T!<"UU
MQ>XHNS*199T<K,:F6:%,@&*8V1.TB;J.+GL+R]!."I>[!'?;,KMX\:+1SZ]O
M6>IE)$RNA&K2?8?7%4@KTR:#^SBI6BIC-"'RS?!,3/&]BT J1>HJ:N.K0W&/
M%H6M7* 46^H,4$,B'>Z!BA[Z:&0'WK_5*[ <^@\J:NJ)4S$KB0D@LT;$-<M$
MDKU^]K&::1B:?ZX6):[DV@(+W]UW?TY;[)0HT$E;;/_ 4Z2\BP=*!U]264VH
MGRMZPV1OOXQ>-84 2I_94CXSLDW)G9B3IK'<EJ9MN9699F'=-BY!."9U? RB
MEF$*=^OH\%2T"04V@:[7%W@[!@\F&S-/(SJ@F)$ 54GE8,A4_'B64YEE<U"@
M5(N7&WL2)LT;(JD)TA._+!:E,OM.0I?2N"_*WTFK13)R2L?DJ*%C,"0%*5)/
M;.7YS]&\Z)[$\%5J$+4%0P476R,+S#1)Z'(FYL!I%4QJR8E%B]<LBJ*; R&E
M@DFY%5/52B,%*B]]0"U@2CW7V>13ZL*,R.PHY"FAX"1"=<J KW4#O@ZCVR+3
MD9>)G*=#ZZEPZSD[G0T@CL92>N=+[_QK\LYO%J/O")(G&(0R:&5Y=-)Y$D<&
M+_(#*ZC?CO/^;H%1&-88C1SG+O=,=C.V'+SZVJVR]NTYJ[?>U^F^>N,C2]PX
MH XT#ATY/,*7R$2[L=]*HV02JZH\C^PB&?OZPK'DG[H 4,+W1YUO,+<(KXN[
M3SXO+."D2'M\,#C<(?!.+54#DY20P<BT7PG:I)HR94C+\38*[MD8OH%T 4)_
MJ,5WTI2 @6</TNN;:*$;Y9)-Y= J0V0"BU79_0RH3-0^"Y1G8B<.5$CE H^H
M'!Z6D^*6CV&KGHC]N)'[(AS'/V,J'@E6F2M[D$8-4[$V4TE5"0<R.91G.9'1
M<E,_U!B:NJ^:J8.87G6=71%?>^["*'X3Z$F]3[&99O;*/[CG80AHXC)I2&T=
MQBF,LJ"/SBV5&QJ%E1LR__% ![(NFZ$<YSM'ZYF.'_=5>ITY)U5:W:KC:2V=
M[I67_BR;U*N*@4B0F$Y) ;O<,X;*)?4H;'<LL]"B3@"(SQ*A..@I\="'@,VW
M==;E1.)Q@*YCB8%]=Q \H<\E]EA-SUB^4[%X53$@_6$"X2=LV=+>YE/!-0J-
MET&]:D]!=R&S07*[=$==&7L XW?@"8:82@&@LQXOE,R]24Q^'%)$,YT$Q1KF
MZL*'E3Q4FM(<= VG>=Y#)1MITDIU>?$XIU9IXMN<B>]>GX0VG83BV?I2-<?C
M6CODS"(C>B+%4;$OZCN;+.VF<P%B%B 9Q__/WILVMXTLZ<)_!7&V("-@A2C9
MDGT[WHF0MQZ?<1_W6.XS=SZ] 0)%$6T08&/1TK_^YE8;""Y:"=N(F#-MD2!0
MJ,K*RN7))[,;77N+EQ&4?RR%:_(Y'BEP FJ"!B(>  $#9[>2?^.A@?ERZK=2
M(<V ;""5=.3:73H+'DF6?E6K&HE!_[!CT8&'8Q7I&.6PP@HT#(_D=3L4207H
M<&8K6_^Y.3Z&G<HOB0S$+4'0#>)>'!Q.,#(&.L#[:/KD.;33H07B VUY=_E[
ML]=;  IT8JZ*)L/:YVV1T361^J<6T)<'DT% 'T1 .3':N\/()DUM%?.-P9)[
MH=Q0GTM\&CUV[BFR]B%^O"KYCY9L?3YHY0<5>M>9[(WH!Y*HX1:27&W:B2,-
MR5O6+!\7%Z6ZP)VRY)B79Z<]-B 01H:,NQP0L-N#7F$'D+'[,&^HG;@I*O).
M&3SU^^W!4R.3>J5SKY6A7%LRN"HQX2J8;$1<-*ZOGY01-^AC>#REP*B 57/O
M\EM5A-]B3[[-G(!)DU*EBRE8C'(D8QCEJ@A<>G*7_T%K3-91/ *^^4U[?,1-
MXZ'A5^GJ\.(F$_^9:>NJ\;BOB?6LV6\7@)&)Q'1L1$KG^F#(73&F'HG0!GBA
M9&854Q#H34-C$O*,GYL((U]J)[:B4:N<10B_U^SF#0[1^"#X5U&C]!I5X0T5
M T<9T5_[#(E5NR/&-EB7JS^%M,]-7+;SN:0];T>]L%WAGCDW] ;GV-J6-:FE
M=W2;Z\WOJ?49JRX)%]NP\N81R.,P/A6##0%2#TLMSR7V)6H0DB<1!?A@'M1B
MR;4+_% ;U!Z9Y+/._)OOQA*E(^W#3+>_1F5]P^@=JLIW&@5HFH$9K]RLR#+N
MK8"S7<122*GY;(CGRO'5G?.!'.A[>+[/>Y5'F?8GCW)X<'B$MN54P<J,F?T_
M@4-CB\"EC,84,B-[D=#?NP@#(Q=YLY@R%WV"1YM3DR7U&DZ"II.7'HT#P>FX
MSXS,*>>4 Z^,3/L8@O)L.0=H*^$5U4'P'O7EFEXYM"-IBXA23A?8^Q?NFF$W
M,Q4S5A3Y.Q0K3=S'U!!@N<07M0S8;6UE VW.J!\X*CP ) : Q#<(D!A:!S^R
M#UV71=8;7WDU9V&M:=;"2TY>)&#+Q75VPP1(^J^0"Z1*\H5 UY+]0 X4?>:H
M7(>CD^EU00$+83B='OJ1VEB><O$P=FOQ"#*?/H[_<A#WNXL[5Y2^N^Q5#W8"
M;XI<&BO9%A5'XG$9GW]*Q& ?__'7YZ<_O0GT.V%LH=K=;'C P/W1()'WELCK
M)74H[XU04KQ>=T57%.IRW'!A,N4OI/"Z"CZKRR*[)(_>?RO\J8D?[BB?1RLA
M]-/G';)W^&(/<G7T_'3?<H5#V$&NR#W?WPBM4,VEYQ@*%WM)CJ._C$KPXZ+E
M/!AE% @[0[L?_(A_?_CPX6 ]YMM732=KQ&-'/32;/:T28,]G7B)Q]2["]-3C
M,\(4^"-]&\&C@W-J![BM[W4/YA1DK\ND=%QN/P5)H78^ET%>[W$JWHK2:[\3
M1?4I& #&5K'X(X<Y@UK7C+X=\?P6)!+QJ)I05;< (KF3Z/U[!>\697"@$NHJ
M>!WE7U$MXA#_MRB_AKJ#H].;K"A->Q.5QW/$5%$H-\+;(SP4_^U>/M9PJ&U/
M,^?[E9I6:<T%<A*6EAM715/&:E=0T\-9GD.GL[M;GE0!\9E*1/ME=6IDB.0\
M/?5L20$X,6VZE5+FZWU:Q_,P./_'7X]?_L2@X5^*(KDQ$CS"""0& K M*]_K
M6UFC/N 95LK S<024IY,SF<JGU,7'VQ^E*?4V$>?+UD!>Q<7C&"=3U+-37?\
M/]07*-[A17M3Q4WN__XPHJ([3X_VICM'49_R9*<X#RG3[L!IKJ2 3+:F=+"0
M:@,NX$ X!S7U*K6^XLL8H1)4T4)A-1O96$C+@L!H3.1ZGP74TH[21[1;;H5,
M>PC46L>AN_W$W:?4]#"[NK/84!P0HRQ!DLZ(H*->%9&6U)AX=IHDF7=[R3]N
M$)['9FTZW<$ZVZ>LQ'V2%:UABAR\:U0>FR1EK1C,X0&<9B>GPKN'(P\,V*!?
MN!*#0!W_MA/P)C1D@^Y=<;YD^R^?.[_,P%:HZC%6=F2,6+$ZT8@Z(E20#/<*
M.2#A#I56GZ$ETZ#>M:LOKXETL4TL_9:>Z."N-LW5OK;,Y/E)Z[1]MD=7993T
M9S,<6<7)8$YUG5)[/MP:N,;.DH4K@KZRB!MKL.\:<]Z_B\GQU9':T[I1 'J=
M$LL]]46T-)=1FF&X+6QMQA?N>AWLUQW;%E3'=P*E]%EEJ9H%'Z.K/3EE?FC=
M!"LI<E,VRSJ^"=X4B6%X^BU/J7"I1@ 46Z<XXY3#?OA$])X46);^T2"TDH($
M"+)2Y26&N9!+B3F">6:(TD<W!-;(5-U$UY .P^]"/'SP#L3A6RJJ+F?(0*C)
ME>3N*>(Z+[$K!'Y3E!=1+M6_H<>@Q.)36O'I7"'+_N,$J7]ORK1*4FD=R(09
M5$]0\'^-<?#$,;C3 7YSK_C.+&JR'D$1B-WY4O"6L(L2*6P7\PMDKT[KIJ9"
M8(91H C+:\!O])5$E9(7=8J=KPGS9W# <.,IB#=CIHU)* F(,KB*D+0L%":X
MKL<\*L !#_Q!4M=**I[HO0 I;,PGZUKKHX/)T6CVR+76G85])P<G@U:\IZRQ
MC8@?]T'@K'X4. SW*X[&)(HSL&X9>XZ%.;-&FUA"YN.SJ6/A1+6^[,NMDF68
M#5^/GI!A2>%^V_@@^ .=)"Y'$VWJH'-("\^X*GP-M%X[]&Y).%*6L/NNL3OX
MBHCE2<5_M\V].Z! [;+>J";'30=$S<E2"7!>,6\"O@\^=:0A<>;<6;F\BZ')
M2^J3#(6V$%!ZD,=$CHGTEC5W)-=U>_+&O)Z(VJ?6S!6\0877D25'I6#86V!#
MI8)4$595@V^")CG':\X1P$<):UD8309*[Z Q5K:S-)<>F04?</T#KO_[Q?7?
MZA#=%\LAJ5QJSS&]0;)BJW:]+F >,QCR3"$W(-83UE([]-&VN!&8'O+#6/6
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M9#5^"19ICUC:0I__"CV13EX9AFW!(A?,.$O6&K]6)<5*?$UHHB.[WP>_.<M
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MS-1G88'%)<)58M,,2[ASR;]VFF*M$5A*&SZQ^KXOX^WCZ^]IG_3WX78"9JW
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MA'*$B\A1.W'9!RBU3W32@"K+!54K4X7EJ^T!F^%25T=:<3C%.R4H6F!W$FP
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M;X1+X2$W\1S>G_N)!M-T.5?Y#7X%ZP/;]R(R"Z%A%EUKY1Q%:4XU,_*>V'X
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M_K.(MR'Q.!Y(/'8C\5ACGO6>%/N;M<]$:?;'3,.,G#O0T;JF=ZT "Y-NCKL
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M4:V]$'Z'>92XVAU=),K34*L67 QS@5D5F!&LXF-X1@EKFD0W9@[YI!X@S;M
MFDU%U)9SGEB/N\]Y"V9$ 2T:6(R&3!$2=6[LX^^ZE=T69?"4Y,:SC=8^;J:%
MH],BVPM+5G]]V&_)$W@=56E_*C56[.\VCSEN'8+":'+-P !\0]9RH[,V(L8:
MZ:R\NMP@V4_6Z*6:?XHIO1Z3BW$.0R(HAA>G,MQ4,S ^BRO2M7[95"=@VFY?
MFR:@9W/?5U+=ICS*U;5M+[_3/](;N18*1CU7U&")+'W8\P56 ->PQ_DG\%^'
M1X%M\4M21[FZ( M^C RY93IM:A<C\ZLF'84K.1/K9GEH&)TS%U+IL+ACL52
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M5]&A$YK8AP!":N2O^8H*5[\JFEE2VF9]%0P<IG&ZC$SG-#X8JM;)<(['"%4
M\6V<!G#J&D.$%;, TH%+IZ2'0J+T;G2=+IH%MCGCN&-T(>$6)XSCO(*I(G-6
M:P4C8T815;J/I@';"(4OVL;4):B+A;^3H!8LO)<,[M4=(G?_Y>25Z<HE#PV=
MNV T'/G .CL">'=$&XG)X!EZQ41'F@!:%KEK"%AVS'976L$!K2/H2+:+UDKD
M3.<['$I%&3MM)!T$7]!4P%9-</;;=7%$L&M=[*1C0-WD[^'._50 Y_$<%@=D
M$)9ZLE>4&#4\8=O*K#9)T!FV;>-6$NXR,^&.*P1.$T7=Z@W;1G6NCL0R-HJ
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M"V*KI<@V6$.$93IEM)]IR5K'0FI_.1;2K':/EUN+VNKNZ5S-/9Q 0X_"^YU
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M@7FXI1X-!+?[[W9]$J#?B2['J[<?)E&D["1/DVD<=)6XW<J.8GB"?23@%.&
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MFB])RU+2HF!V@RS_S,BXS;[-E10AC.[D[+<*&DHRL;3P$ 1*8*KNS;9S^9^
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M)?AQ21@@F!HL,;W\=JL)_D8-*Y0&#]J()$$:X$AIG+5"4@(@3,3L/_JL/E2
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MC 8 ^]-/)$I9)'7'+G>ZH^B[?P]ZV@[T1(FCM)L,9 *Z-XS+RG:#V.I@0'^
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M:!:&&SCT@%76B$HT1\%YL$S$-1!?EW1N<&WGN0FVO2=V;H;IIV7N@;=_<7K
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M(@-4GV,^ ?%\37O5<=0KEPY@;XBT(<?PF%6K>#*'L$*I0:[CW*A04;+<&V$
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MZ0YT^0T2/ 4LB)"58%H+8H3%BKT4D,"I$DLJ9@2WFIO.)Y/-'@VR"WB\C*/
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MKY  10Q3 =J615.FL" M* #*NY9+*GC23.#3KY.(Y?+T_>1.C,S'> )YU?N
MZI\?0/6#0/43ZP"[GE1>=4<'F(.S_Y6ZOEX>O=P<A+AV"7%9B;<^+#7PQZ2>
M0!&:NA"=PJ4V@A27%&R*@T1FP>5-=O2(68R/U# &^@&*GM[34%NPE-2*'&69
M*'0N?JGQ(N]8+F>KKB8^+"KP0QW.F3)9@_L?"*>J(V! CR=4^I[0U1M:K=[.
M#A0OC=Q+$ G]H"^KFFY6F)QK#4P$V-C38H85G<1#'@"$.>A?J5]W0FTFIR?<
M9O(?__;FY#<(8LK;)#X2__6\&Z[[6.U!_J:TZ9C+";TW183[I:NK1;CLH8W:
MS6-/0X<.8<4ER#@FZ'=Z.N)"K3N/X5^LD.9NZ]PBT>0R)M*248Q6TI*,*5H,
M"P<4K#(14S34#K!_A>&ID\)/AP!/<].T8#O!I?RWHCQK.D[X=MFL?:8-/L1:
M1Q4?8:WFI/WW"PU1KAX3HG$SF77%Q(I]H83LR%/U2H"X@J'[^^+CN$B-OPF7
MI5%Z&MB %1>5!;4*+6THQQTL9T_6!<A[R+&:V:A!:A!4;08V_3CL2 "ATPYP
M\!0A5T7$UFQ X$96@L24,LWY9D-I85)Y!"]QX0.0(*5UZKO6WWF*".X+)/"A
MQ_U80@U<"2Y0AA$21'0YJI^OBXIZ7W-(C6Z:1996-\8DY@P%I=/H)EHO>$B4
MWTED/1_//.BDKJK&X'.SGTPGA3QYU;_L7+V;/_6#9YS,HPM2715EJ,&2WN2T
MMQ)HG**.H>1T)U'2X3R%)MR VRUD#KB=-%7@&XB:H.&RU@TC&*1$=Z',\&)^
MDM_AC%*0ZK^!YZ\VI>'$:@H-"*[8UD3-)?ZX$1X(_DO]6C6-D.8I"G/ 6\$7
M1(M$+M*+"QQX*L60&'^-4R/^#B')>545XN?XT+#6*+%(CM&7$L#BSYR%I%./
MGX5?G$)[LWF1V=OS]U^>7;W_?#Y7./\KA<4%:V1=38Y/S%WP'__V_/5O:NG/
M%1S6/^\,/9=\!-V "[=MR>[&^X,JP)C]+&-)A?BOIDRK.&6@-^27/>O!"MXH
M?RONE!50M8A#+H&8;^WPPOM>> L:[GVARYNBJ!(&]W+Y7D[5OAV7UX,8H<=T
M7*83G'$VJS<'6N0K<2XSY9^#DQH99-IVXTD]#<>[2.J[),F-<B33'YCM^:IP
MYSQ8V/Z9XL:KRR+;]Z+N@BI.9DW_ZRFMZ7;J[TJG_E1K29HHI*0K=#W.<F\[
M=,B8T=6?#\>2D2+59=JT(IS'!JK <@/8!!ET$/JXNX1W9G3?=(G>\-4D(ZDD
M'NAK&]'C4P(44,;-5!*\ZNN&ZT!L+K_FQ5V6Q->R3Q/S1]*E%K]N+P4/R8JU
M)-(<)(5_KF+JJT,Q=5 Q%2SS2!:6([&.HH04RG5X$E10MI":?&(#(2E?)9:T
ML R81U50#HU^X*\GNI'5W /[/_TF[M%]G<[IMSL5]2G)$M:TYMPB+Q.3Q&A:
M)YW")[IX1/A'E.:*&9[CMPYN$J=?$[<+=5UT]A'161KN9,.,D.-[]A8DJ]LG
M,G<E4]O]EEON44 #GTY5-G;57>V$E7/LXGC;N69R=KN+I99BF4I#>Z6<7.8-
M@QMMF@A;ZQ6-"3TAI"W0OZNJ@B)[5Q/<HG44+UN"$@D<0"A$2H>%IN2%X3UI
MLJ4&J,=K)K,H:=<;U+'R<K9*1I^+-F!1&)F<T/$KK5XV*<HZU#OLD@_JY+"!
M&EY3+F^BBIL!T^JK(YM7D\TXP.</\/GOA,]+,^JP#/HWZ/=O,C-7?XMM^HPM
M<BV(*FV[0/8A-R'E&P;+(_$:HG,ICRI>219ISDU-MT2IOP3P\^A=(KE7$%4
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M51%*R_C83F[H5:ARLES@L+:B_80J/1FB0>J>!B-$YV+!]350@('[6 IO)]T
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ME2RR= =LD!+S!RFB$'N4:JOWV6U]%O.'")$"9.=29(&9: P[/!$P-!C?0T9
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M@/,@';_T4!FU4 V*KR R,&G:5J.)ODY1KR)N$'$ 2NJE$IN!H2E%"WI>@_L
M$<&Y9LEE]2*2#0727?#*@-_:.*LZ#R/4WMR9QM0H.^\34>7$38O9CO0Z$C<5
M_T_J79#?'\5@\M=H7"7CB9ZH)SI'>EXF:UM"&>VK^<><>%+?,*22=2IJ10UA
M?%-!9>QB&FQ[\=,UXVF2\A85D<0<2T!EKW8QZ"YA"A7L"OROF&=06S(P#G$J
M3MC$5"_$42 0%-:5, _-)HX&M(\_[K&"*REG!29%!U)BYZO>%8I<Y[9(8\E@
M'A?- CBN4;1,S3C&FM"T%PT,$1\UOZ%0;-/A]),A()5PU=SC06*MV66QEJ)
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M(10Q-J$=[FYG'E5\::T5<%^$7YR:JO6^U132->_S7BT-=!4=;XW,2&_];)H
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M_<*YMB2#Z@-BS3&0?DF75+<3[][Q)'+N1XKAL-::Q)46VX-HA7ZL3H?5MBF
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M6L(7WWVYR2;&Y?OK#R?6#Q1N=PE>&H^0,8[5FB3FZP9#(]P@@,],DYS;,]6
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M'1?+>8Y104L:K18)-U]YTY=$Z/K,D]N"]()@$^"Y]@/BPZ0IR_6YN:\W99C
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M@&C+>^(I#&YRV";2BT#?AX$%.%_Z+ESDME]A?0L)("7BRQ0_MYFZ=%57%C[
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MA !W=BOZBIHL=:FF/R;.C$1:G:H,DG;V@1.;HT<J\M+$3^1$^?I%$V$,007
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M+NC*&!CG]I@RJY]^:6D@5\E4$G'H\T$IETXTX _M& 3> 1%H]MB"WBBZ-/$
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M RAE 3&98,<13"-@F2!4O!MWWN8F4%]30U6CE(%?)M6->;P%TL>8M_!O(B&
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M+C)D[Y'TW2'1M4VB2R)M 1Z2.6+OF5<CKC B^\ ]7NE-CMF"38U7+N)F#9F
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MVQ]KLS#_CG#[S]HYARSPFS$W&,*KL@\7DHSW4HMW/L)9:WNE!AD3;]9\YF.
M\\X4"^Y*IID7+34A[/;P_$(OPQ<:XQ7S7N&FRQ'KP=T= SC!NN_<DZ_30G''
MCU*K_2[MBX&ZM*HC?/BN+-1[KC=XLK2B03"U+K,@.=/N)I9Z5RMU*,7&X2FC
M:@Z"F#T.<-I$N6A6 : :=G\!>R G?F'F6V$R[AL_,3!Q\ &)N#YC9$19<W1B
M&3O!!=L6?\!:"P.0K^&N&%*=P(NC8.=Y!A3<AAD*<EA:(J1BM]1$@OE\8F%F
M37J%J3/P68$WE*)^\^=ZZK)DJ?&MZXMZU3H<J46/"H: !4WZQ,8"Z+TCL(B$
M,8'S^MC,MZV*X;>HD3P$;AU\>;)W;$H90DM,P;A,K,M B\&VL0)!2JQ&*BVQ
M[ZJ.^O+98QUUYSKJG@R?A2J!&YGE[=0L8$?:8#O_ .= O9YD#85"+MFN>*6[
M.8,<U)'-0=U[']G G((!*:,^V\W[C+(8!9\8O!=ZJ\;%[V&]#4@L\9D22]2+
MSJ=\5VKU5C;&YI73)0KQS"SSY%>PJ/?TP>SI1356P@2VE#&7N23IR.OT)(*P
MV3UEN8P&$F3^/&VDW[0DH/H=*-@I()Z]HCU\(70IQRZ#"*SXYI/M++4D(XNT
M0<).[_<"0L-'L"WNH W7U,#\G-E^3QA![9&PT>.Q[AOQ#.U$ HVNNQMG+(<-
MG:G-:K&<KNG3# BPZ4MW/^?Y8]\ NG8Z\SG#;''U^PI_\E /B5>N6ZS@[<((
M$G5!JI[;F_$+W^TAL>8@Y_:TK%O8)F&9# &US .A(#IV9![A"_)O[G:%/;1%
M].[>P629AJ>8%II=IU3>^'TOO)0\^7'22),T=[TW@9DM$:1.OK^  M\^(TDA
MV@/BY)FE0%':G@EW 93PC\+;D?84]+"[';.MU>8[[^RVSEQ7-;SO27#PT>$^
M@B5OGF8@.U\8:VDF56,H*48S)W1#1(P,(>'W"^4VUYSD&_:T%V89,CS=A,?V
M>_"+]R:9U[7/Q\S*%5 1?[I.%PX;-U"*@>$?Q -4W@I>]#;_SGQD@=K0L/,7
M+)92Y1>U\;$)1^%T,R_SDKK1 M9_)+I(1JLEP4VQAE@W7WP@ UR;;;NQ%8!.
M0D2(<\,[,F#6E!+,L\G(];^!PMM=+L6ADV(/4!CKADLQ"-6KS(1IBGQ?+3K'
MF[&7I3!P3L@!ZC%]U4I U#S*-:F 0D"I1#6US'%MK#2QM$;59/E57M8+\HO-
MJOB22W!BGG<%201JR59\['6@_Z!U(?H_15T^JO5N/\9JX"MT@!I-/GKE,<+8
M)<*X.3BVRSWJAR* QWMT-!^&W)2M5)NWOTC7C3F>+; R(0%XK?!D_;^=4"$:
ME9X,,SIY,7CFBP$J-&E'P")]E]C+!19%<.0HMN2;AU;L@S26X%%[0SCWGR<%
M,2#9I%=:E-,/$WLBOZ_=[_[]CYZ&+^;HU9#?\&Z8D7M30=KE]L'N?GY(,_J?
M__'ZZ =N1,W,#\]_\!VI/^>+NB^-H:]X40YC&$1F81%3,WM+O;@=_63UAA[?
M[_VI\7S%^UULZ5W9]MX>)"[PQ2,ND(9G!W_XM/." "%0INO_6U1XNTE93[_\
M@%UST[1D/]9X03P!QZ\/7ST]WNV%;;O)//WC"5WUZ>'SUT?_YP>8=OD%##0R
MC+_L>O'-3P @K;ZQ/LBE_NH.EOKQJ\/7+Q_Z4O?,W\ESRM(_+"*&@]_'?0\?
M',Y"7NN(GR&N3BMH)M@C5^!/7\\5J'6;I^FB $(WG>5EU0!I0Z#N9-VY:G%$
MA!!(= ^W=W<KO()? XK^T2PEN%8<FN\]5=%BE6RZ%.%7UQ3K?TN]N<=<XD[<
M0KP<\RN;#(#^![T#I%G76.:"NLDK7R[H]S&_D7;TUZ-G+S8Q$72:5B(L.&9R
MY@L@W^!9ZB?!H9YAC_@&^/X)#)&.?K*2.Q\H[X7(/D1<(N(I=2U T!2^3 L
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MHT%2(&6N.WBQ_B.%S.Y\(O5D*6 +%YZ"G33YW%S>[#Q,-F,@97S1Z:79!5M
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MAT)NQ$H<0>/J 7?T]OS9LT4@'FG;$N#*EWF9$;]S"4QB8RR!\JF'%)M3J$L
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M7\4ER&;=:/-<<]%T0ZR.YR3$&7OIL<+%ULDPJ<4SHT8.K5 N<R*OF+;3U*J
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MW2@@B()&24[T07_H)"_KZS'1CVT=0TQDPP)A%#S"==5ZJGEFB)=X;>, 7X'
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MU]%<%NF$.FTB%4\7-,=KG*X.P%5'.-I+I!1-"+P)33#I/+W GAF^%7=.,VV
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M2X??#7"UGO(&O_8I:MN)==/,.F,\_OE3->*/Y(.:MV_IZ*CPQ?'J;2'Y=)S
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M59*6;7VCI0++^A4Q_Z%J</AHB:.S"A>Z7:]UP(FO5^$)SHWYQZ:;,-&:A:;
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MX4G74@#]&1D,#LXL$Q3T0Y-;]K=5"BN#(!JNPYGV*[AN>74)UM6BT-@8[)@
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MLB5;JS[1YB#FNI3RNXO00Z1+#1$44%&O4T5-O.D,\HK=:MA+XMD!;(8,7.$
M98:U:TX( F*",#9RR<@_]@#:%;#HY!ESM#)ZQS;,JB<B&6Y @O#)@"K2*8:
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M?6HY=VRJ?I/D;<2"G&V )&+%1:28'&!ABXT/)R;;/:YXWS0^V[V2D+(8])H
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M%,N/[#>W3%^I%2$^)5C(/]"BO6&+!F>;+*9/M)C8I=FTF+2"<P@6Y\)P3_A
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M_/5E%YBO.RR;3=4,S.T_C%+&LT?4P%U1 YWJ]5QGR/YH$&Y;9A/'IT@80 8
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M+HML,<Z6('/N<$Y3:>?GO@/^O>_\/JZCGVH="3 IZ*.@O:E3GR#E:Y)-_!9
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M$#Q6.%_F%S.SNHV[D94F="I"MU* LBTWMOD3T*L6JV4UOFDTJ\&DPCSL17]
M]G^>?)&R-=LWKS[MT-78*8_)W:H,MGFH=C65H5*Y];MEB^)HM%+U!<F=:>$2
MRIY\ 0Q<F1G#GQ3R+.24UQXBI1D./8,Q9AEEO-&)"CY(&\)??WEC>BB$S.;K
M;I<M$F][:O;>JKAKS #0>IPX0;O3O.'AH.>*?BJU_D+U]A2TP-%L:_!#62]V
M;YP_))3!&JX[+/'FV^   ,,@\JOVA[69M,D[VSTPO<WXUHUG?3XF5L4T<+[3
MZ[2^I'@D;DV#:;!I2H6 <Z27<#7JVW)M6!J2H1>VJP8QN#6&GV+]"'YK#3@>
MYB90X'([NO!;0#M:01WV"5W=R"PKXX.SO3#79G0T+3RA]Q2D&L)=*?#.YW.(
M&*S;Q2Z'1*]P-[*EKI6EO.<LTW.D57X@::;G'4TSG:5X0G6!T//<03$%2/EL
M;_\5+K]:TQB>P2I#YDB/?/<X\EOG[9E.I8@:TZ+Q/R(&C%$C:LHD,,H*;-_G
M6$]"J5X'(<-);G!,"EX4>B0$+"S 8TS*#++8H08@F^$X,X\ZP_Y9#7K8$//@
M/=;UUWCEY373;W-0!+9OG29R6\UKH312,W^/17@-[AOA(01==:FYQU3,I,T1
ML6E4$ BJF]E3*$AT8$^QTOE9Z!.:0W\ZC3>TE5D!..7#5X0,!I/H8!)T.=>&
MYBI<,,QR-2J-DYHB%42VP'"+\G-FRQKORK8038MD-5G-)%I@=L J@[0HUB'*
MC/IJ!+T0]<BFPRO4U$L,@ZRH4A,AQPHZMW"?FS7314@#<P2"!VT\(XP<:7!%
M:F$RA#U)L7$0(1JU0WY)L5- UQVGIZ$I9_[X!EO$S>HVA^@4H^.:^C7B\$I8
M-=X;@90<G-R8G\,ZJA0Y^9W(%Y#KM^ 2F)S>F%FH0A-!FS(R1ZM9.])N!L8#
M_%A;TVO?T^@L0* ],S^W,/PBPY<'QDJRWJ59G27^M^Q/"W7D)D]"H]?ZUM)
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M.!#8ZY\?LH/>$GPJ$XC/H-T-J?B5=M6JQP#=L@D'T*R<*3D'?_F)<NSW@EL
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MBTD+<'%3P*B1)IY'$)A2<J!2Y69<-S8MRWCVP?9Q7)Q,-I7&0)9WY8;RPN3
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MV6V/!X.IN:J8<P.KJL)FA<.Y-WO*.@F+!N%LB>^! 4_AN"#U@I@+.+HM +'
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MF6L&R[C2N0*>*B&?.N]VV 2)+K%0-3F].^C:%O#&QKGTBLJ]T7;)[6P_$J3
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M%M^Q)I:8K?,E@XT9#9L:H[:I&FO/B@ LM+Z]JO)(*\%9,!7;<@L+UV"MR\!
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M8 NN],K,N=))E5)"S)6"$RHDH!RP..MUXXLQG&VWEI]7-+DJ;5*25Z$ >0,
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MD#(&U8K]))_:KH!5YL:B4F"&)?X+"-9&X!8*Y#BMA HH.L$7JVWLP.K,0E'
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MQ UGFOC3]4MS)^OSGJS+M>C5A_K]R1XV!^^+@_<!R3^4%']7$=S!_!-A'D^
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MF^(RJV;S?.[D8YPSEGI836LN4J ]O"3/SN SMILFB&(G3B^M#M*V0ET^3K4
MD[>K/$_;L2FMUJ]!SNW&#^8X/F8E]ANFRJ4;R<2[DSLW9;9<%>!RZ%*J!X#
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MT9JCZ0)<. -']V#62-KI ?T.;D*E;TLFJZX[L2RV_ZN;2]B"M"/SZWK7M L
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M-XSK92"\&N[WLZP-*:SN%LOBW$M:V95W;O09/&FEG=GDWO/T<KU5L=4UG6=
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M;8/9MNRS5WVNL%O%5,54Q53%]-#%5$-#6QH:6OGK7?'7!6XM:Q- 3D!XM)Z
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M?MUWHP^]P7%'R_'B<VUKWC>]_.N77ISL/;5V76E9='866#I[\?0J6V_4^=Q
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M],O&V3/EIW(R[+O1A][@5+-7K<UZ7?U,G7E1Y\Z%33PU%B$5'5J[5,]F3Y>
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M4BT4)4X$Z;+TR4I3MEYK<OG[H\%WP2JNK,#5P[@:Q3XZK=@[W]Y;%:-S$4@
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MQ&-S+"^$F%&&))2LA> R(TCJ*7$(A29QR-P4EF?INJB(5Q'O<2->T)+QY#*
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MFGSCFCSG+$6-%8$AV68BHCIG+HG5P1/G 9=E9S0-<6V#5DU^R)J<G3'1&F&
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M'-K1EEZ_G,<*=?DQ1&'7*G\_ R#)T2X4 M 6-)"R\T&!M,"4BC'ZH"L M0R
M%E7Y"RS1;(TA^!<E(+@CQB*K")0IIDSVH0"08>+Z=D&M0=)>709PEDL!UD@/
MV:'!;SFCF:6L#4VFV@4MU.4YAQT:<2E)M N0+P !C\:^T=21DH["2J JEWI"
MXOIF0=7D]FJR9SJQ!"ZQ&(!EL(PJ"T$#*&$BO:5H@:K)RVCRG+..:I^D%9KD
MD"R!*!5Q+!F"PD7Q@A:AJ?*GH-;>?<BZ'*71D%6.VCF(+AG+I$E.XK\VR+HJ
MMU&7Y[QU7BA(*@BT[H4DY80F<=%8HG+6@"P;+?RTML$E7UEH3]7E%NIRV2#G
MV7KI:03CC5?,^ 2*1\Z$OXNM\AK%=RU%G_/E6<W!!I%(\A&U/9I,+.>>!"$U
MS1F\E- <UA7M,J8?5J!>K?)74U??^JZJ30ZRR*6T'U"N;0X^(4_3 C%>T5L*
M::S8OB)L7U#E#VR.'C3*SPA#0"9//)K6A*5,+=*X:(&5"&W0ZD&DKJ[% 2K"
MM@EA 6+P/%%I%07)J#%66,%!4XEVE*I!XRT$T3G_M/!*1"6!^.!*"!I88JRD
M)/#D@Q*"TF36-G#5K!!:(;1"Z*H/3NO,6$:":DR$J+R)S',GE=0I:A\KA+80
M0N<V!B1H%VP&HF5)CJ.=(<Y8($9SKED6WE.QM@%<K"Q>J$)HA= *H5,(-=JR
MY+V07AK@UB"/\1S_%S+B:+2Q0FC[('0^>CIED!%IIQ"6$N )66B0 G$4R6DV
MI?@8LE T+&JAU JA%4)7'31J/!?*>*H" T:C39"T3RS&F(5.H;I*[QF^SFV#
MH45A4D@.K7PFT,KGD5A.*;&:6Z6<LP(D4M0G3)L'@; +JOS]J+C:32EB4T/I
M_:G_+EF?3^&#3]7U*N7Z9J-""O8^%>HL(']$Q>KEH^FO>J7>UN0I8>:DRN#*
MNJR:HG4_Z_."PH"E&T2L+Z@^Y=TX38O-_=.=U(>Y?3F='6!&UYO1V]S'B3T9
M%VSJ3/82_BGE7O:'3;F7]+W<RU1#9C5?1*<W* "7FJ\<#K+[/!PU];MZ^P>H
M4J4P'3X0WSWHA,/1* W"40=!<C#N-S7&QHC.>.,('SX9-L\X&/6P 4?)C3H'
MV+EA7+],.;C',FU\FZ8-B"O/&WXR;_ZQQ.*M1'299VDTC2"%]@!!*:FUY3SS
M1"^Q>(]Q0/%37<5_O(KWT_^^.GKW=SSP'!2V0W:__;;W;O?-EW<O<"7'/^]>
M/"\K^9>76W_RG=WN_L[N7_O=;WMYY^-S6=JV\VV;[VS]^77GRWM)J4S.)Y)5
ME 2L2\2I $0PD5Q()NH2%EZ"2>=]1L?EM#J-FGQ'"?\]TU'''XYQIH['G2][
MO;#7^>+&G?&A'Z?_'J*2]X^:*33J^</9UW_K#?$WY9_^\$,OC'$F=KK#SVG?
MIU$S-=<[N_B&DEK)#8XZ>_BXP7""#0C##P-4EM@T8)3&AWV<]8AO%[8'']R;
M%(0[50LRG]2"''^O!?F]N:6!WQMCI[IR,0)> 'D+\&VIFKF,GWM2>?3M<WL^
MK3J64-'Z_>&74L=F6AOR $>_&;A!0CJ%>H9R&'3<V9%&U.Q-40G1,^%2]"D=
MX3>;REU+KW(ENU81Q=/.4J55;[F4I5DW@EZEE*5FZ\I<M:#@CZX)>[5O_K#8
M(%NW3-^CQO*++U^A,N(ERB_]]%9[GRL0SBMKJ4#X:(H/7J[(Y+7FS;V8# 67
M'W?WERJX>;S((+M*/QZ&]MVYG#HW7A3=&C?N8O&]GG*2_XN<Y$5_Z)$/SHJ*
M7J9&WTHK\:UB/;GR^VX[D\-%W/E.^&TS$?[3.^A-D(PBX=3PZUEV>9N)O1_R
M3LBB+CZ<'8V4HL_41FI*X17NK8F6YY(:3Z5HITX1<>P4$753^,)-BX^_?7KY
MXEUO9_?3E^[6AV]=;&OW[QWY;O?=WLZ+[L?NWV_YSM9S?/^KC^<W+79>_ GO
M]K>_8COIRZT=WGWQG+W]UN]W]Y]_P6_A>]Y^V=G%OK[HEK,[1W,';C.(P!PG
M@H$A8#@E%B(EH$NT:;0N\;"V 4ROVQ:=W*G05*'IA^=2A'2&:@0C:H!+YWCT
MX+/*'*=[OJUS*16:EH$F>AZ:(HM94L0BH20CD$PBUB9%HE".^@A@4T1H MJJ
M\\,K.E38,EMBL49VAZ//;AS.4\B:]? &("U+<-+Y%+E.P"*S1EB6@TQ>0,#U
MN;*MMD':ZWFVE8!:+R@ESG"$-,XU,2YKHIW((7BKC.:-A^7ZY9]J!M/VZK)G
MT8("B#H%""YXYF+FS@O4< T>*CUIGR[/TY,LK>0)"$.9$9#>$(/V, G(,]'Z
M-48F7719/\0,IO>"GOSG:(1-N0X[J4E>+HEHSE&0V294"0F>:A,--5(*9Q/J
MP0S1*CMI$:+UYME)9 RD3I0D*2D!)BBQ7I:Z;#Y&ZVE&0VQM@P&T*HM+U>45
MZ[(V3+A@72F_#(Q1BZKL<C)44),]NTRP6]7E6];E.7:B.4T48B2<"X6ZS"(Q
M6B:2$]6.*Y:%1';"-%M9H=GJ/%E.(__JN0^C:[&3:F]=]@0X>&E!QX!3'[1M
MT P-,)>EMM1%7]E)VQ#M:)Z=**6RMJ$86-X2$%H2%Q5^0OCQ$1>IZ!0B&I/K
MM$7V5M7E5:>33-ISSCV:%AR\LM[+D$PV I*+V:7*3MJGRW/LQ$IC/1>6A,0=
M 24B\98Q0ID-/E"OE2@UV;BMOI,[TLCG![T_TF!*3CJ;AY,AV1Y\3&$R_$&%
MYVI]K21=K@6&(*>T"V T,S:R%+Q0GE-O9C4G*U=I#[Z]7!!5$X41)H GGDJT
MOJ0VQ"8>B/6,1Z.@5)=9V[#R^O!6'2GM5641',\\"X^]!.:D,YZ)D@H[I^"D
MJ.5C6ZC*\]L\-FLE@R Q1T"JPB7QF3DBC:,TI4@CE6L;QK1*E6\[LW7[HIN?
MI7[RH_3U^N'-U3*[;(0*54HR:0)E D263@?M6;8&DG&!Y\I<V@9W"R)4; "G
MM9 D"VH(Q%)B%X0IZ9^U,IDZ6[PLJX"[ZF1IKRIS\-K(H'G)[ZY<=IQJJC@#
MFX(PO#*7%JKR''-!@T-IYH&X'#T!Y*'$.ZF)4,Y(GQ(#25&55Y?NK?I8EN0H
MHX1J6,-3;A[/$LY^9Z,T@@?0,>-BEC(-N-"A@@1:-X#:AF<[NYN3G=ZL' 6V
M<>?C-G^?:$XIT$2X*]&S(@7BK _$9(ORM=1PX&L;>@7!L]6KTEY=YFAYNX@V
MAG4.6$Q.2!.=<4IZ9U*RE9NT4)=/*G ?Z[(MYPV!22(M*C3J,B-664M"8*CC
M'-EFR*C+T"I=KFZ5YSFGKZLX-%Y-L<MZ5<!G 9Y)8QVX7&)L@],N(YOA.0A;
MJ4L+X>X[=7ESM/-Q4[Z7FG/%HB,H-4X R2?!Y4L06C((&FJ$R&EM0\&Z:I$M
M5G5YU>=^*'4Y62NU]Z"D=53P)"-UCB:=8XU=::,N?Z<N,UWFQGLG([(6I?$O
MXQ*Q0DJT1;1W:%H:(P)2%WW]$N7M\ZO<8^KR#M^3)S>>[J8::B>&6D!EB%PH
M5!80P&WR40F0)EF>K*R1+.U#N^UYYL*RL^"3(\X82@!$("9J1R1'N).6*\]+
M[3IU?;2K3I?VZK)27#LCE="&@<*I( -7T05EA<TRU!/+;=3E.>:B7%0:="0B
M4$U 2F0N(0F2-=6N5*FP1B)S64$9RO8Y7>[%CM#_<WWG1VX0KQ9D6PVQ2\)9
ME%8+KQ/0@"N:!EO2V$7J@S""6JTJ-6D=G.W,4Q,J%%,J)$(M\'+&L9P(BD 4
M98%%*T)B>FT#5$VF\I!U.66F10[26#0R&)6>.:.3RTIFD"GS2DU:J,MSU"10
M =:#)Q#*B2#-#+$Y9<*2",& UYY%-#-$JP[WS:C)\;M.RD<TFKIJ&Z0^XZ%R
MP9\FZGZ=/I1Z+<MDZK[Z@G+?G_%XT]$_J."XK:/]WGARD]F;:O;?AYK]5P40
MP4INC"C;,\99,-13[[D F:MUUSY&&.:MN\RBCN =,=EG E$DX@ 48<)%2P-*
MS[F&$5X[?+E]CN<*30\4FA1$*K2W&BU5,"J9&#05QC!!T>[1]6!%&Z%IWECE
M7G-O.,DA<@(V(T@Y'PE-G$9%=4I2E<SDUS=6JQ_]2AKY]O @]4>]FESK-H*:
MN!+:":^U '!1^:QS,#K1H#@X5\O M _2/BS8YG>61<X4*5XX DQ2XH6FA%E%
MJ0E*AE@@3;?*_U9U>=5I?!651MA$R[E!8Y25U#+.RC:9Q%D0*SUIH2[/T9,$
M248N&:$Q.@*<66*L!")5X-H83=%Z0ET6K=H7>TR^K?_G!FXN,T6-6[J1S)^"
M*L9!:DB0,^!*IKGQ#+P1VKJ:E[Q]@/;IW,'/G6_O00EGL]!$Z,S^/WMOVA0Y
MKJT+_Q4'9[C=$8@M:["E[AM$T$557?K=F5055->!+X0F0U(YG1R*2G[]NR3;
M.5.0D$ "/OMT-Y!.6Y:6GC5HK6<AEH*%(H422&'G**P:2S3=VJ5RHXK%JKV\
M[GQBFME$Z23%+F5)*J5(=<:4QHF7 :(KXV0#]_)LX2?LY2PS&2%)@I3SU1-:
M:B1YQI FEB12Q4G")!@GN(J=/-..W&LU!HWKBIC\2<P3(>),"$]>S1@SH-2H
MY D1RF"F:&HK\V0#(6TA=J)$K%.M#3*9!O-$903,$V=0+*F)L\1Q9SB8)TE5
MW/F:][)E,A:^,EMHR:S,5(*%TQR,%4MEJJOBSDW<RPNQ$PU>(O?4=T(FOD,C
M)4@DB4/^T%EID0A)E.^'O5'\=\$\^== Z:8K2QK#OYYXQ\0<=LS9U/_-5EE.
ME82V5.^\T4;Y6_Q!X<;%7P:=;OAUIF:4)K,P<0D[H)&-\C\UVM:U!W^@6*R_
MLC39X7=XYS^[G7[#2\ ?/==4@\8/]Z=_#43#M^<73O6=O\'6[F_J]W)^GGZ=
M9B<XQCMA]HXO7/2NTX+1C"+;@6>U.X/(-OJFV>F[J.T&41_0I1]EG5[DK^D6
M^8@>"/L-ZWK.*X16UPT:?AJ:HZCOVOWP\\X*LO!B%I_@>R^^?J[%#V.>6WQ&
M_?25V:7C%;=12XTB<Z':YRYJM*-L.!CV7-2%9W9L?QO^5&B@2/4C%?5<?]@<
M1)T,5EWU.VUXY\%H>R(0H#Y!;MKP!H7<1$TU;)L+U[^K</C,ZC<A'6:3I"/,
MWEX+=-<@W_H#@(G!1<^YJ 7WNNA'#B;:1C75,Q>Y$J3Q=N0=ED)$7/C*L)VI
M'YV>UU)1 T#&!%F!&\*SVY$9]GJN;481&#KMOI\LP)0@/,K#RJ 3[M$%T>M%
M(Z=ZA1C.B8[7R=XJ:[2'X0[+_C(E7L5K,[\:BTMUU;"#B](0G/I6(8UX\A6E
M^YWF<'#S5Z9$U(!,NM[3V[/$CRFF<_,U]>^+<2%#5YT[I'M.?4<J@\'^H9I7
M:M3?^M?LWH2-6=R<BR#0\V]_XSMFV7W>4=R6-^^E-\PTF-4@:&%IP.)RO7Q;
M_5^U*4.)8/> S_ ?#:94)C&1TBG+,D:4XC95<<82)KDFZ1D#K1QV#&P5[P6
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M>L_@OO"= U)O?67U_2_-T_W3QN%Q[>?IQW^:A]_JS=KU^]')Y3F9/S ^.;Z
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M,6OT^@,?]>[YEP._R6_O[1GGT1-3-5T>\_7I2^,W]Y?/S$K0%5UPQ'Z"23H
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MJY2@1+*,Q2*U(G7@PXLEA55SAZ1Y &=6Q@'O 6X *?QV./KXWZK5_7/OEC/
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M'[G^(,1>\H%W0-7Z:H9-6M?22_%=/+H]]\-3X#=]5:%K3T!%CZ+\#?M>1^0
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M/M!F.,<V\124LSQA;904TF$>HB:"!5]!&R5T1M"V!,<)RX)[IQ.:.U%;1G5
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M+R+7C?8'L@D&^]JVCNU);^7/RTG)S?;XXD+GID(3=W_M/:8TEV3#W.RHFFE
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MY<:I1*(VEECOA NSX@_%6N]BK9/-MQ6/"A.#/#$<<>HETHH$I ,37@62TSC
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MM_@TL\ZT/EN$O_,:?,Z#V4I?>['*EBK@<^]CH9&R"2/4"<^14D8@+@-'SJN
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MO'4^1!*I]8PGCPT11'C.F.<D)>5O2Q/>#'HPC%[O;>?0-=O5I)\OQJ4^JF-
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M_F31Q+70F6\\>=A4!7JAA,I%ZY9L-+0N76_<NR"266"]S+ILY3.21YIE^4#
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M/XH+KX;?K%N-]$X[_<MG94JJHXGS$6?KO )(06G0]J.PKXLQPGIV3G+'I3H
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MM<4.6 &SSM@!/(9(B5?(,(T1USIWH0;)*BG6%B<K#%]#R?H4S@/(-I/T!W;
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M4C&='PRA9ER%P7/J7*"(T:AS@H!'N0 A4E(&G'1=X:D@5$&H-9K@+1#*82V
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M>3W#WG']^,GI],%*.*JWI(I?XU")!12Q@Q;\"L(,[NV.14F>\(5>>W77 %M
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MVWNUM_MV[_6[F\3R%;_#&DQF6$024/KE!:B]G 2U-Q>2]UT?/A@"XR_OVW8
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M7"O% [8N0EWZY'+T511"<\6$85HR)B.WS'!#7;%L5RK4W\]:MB1:[KFD*.H
MEJT6$NF0-,)18X$Q4PRKK9WEE5(L;%O0M6Q3V:9-VZ9;Y76#Z*/8!4("=U:"
M[&,N:N4#]I(%7RS;%0O!V9!D0L!^C18)82SBF($0= S^M(X0[V(4A&8A2(H0
MW#"V73FZ/K73VX/^<>R6$]KBY5J_;;I-3Q^9)/51X7Q"*VRRC' =I")!1!<8
M*W;L2D7XAUD[-GCNG%(486<UXBQY9)V,R&D1C95)X)1*KY]-9-N"KF6;RC:M
MPIEK0G))<Q*5YD9*:R2E$@0A45$8$8L=NV(A.'M"Z[EG$1O$#*-@QU*!K'8"
M,1D(M9XY:UP6@C]=>K^P[5-#UR?82<TN7D6N]%A;DLNE]'I8_PV^39 7&,E*
M,LIQ#-Q+KYGUTI@DN%;,VV)'KU:%\',BG1,AV%&%(J4.<>X8TM1SE((W3DEN
M83.W=I@LO?6>$,<72"\;7#9XDS?X%C+;*^U24 +DLN'!*>L%DR0+;TJC8POW
MLR\R^YYD]HS9+ZD5+AJ-I P<<6<PLE$PQ!,..+% ; "SGXEM5F3VD^'X]8;T
MI]:1#3 0_FQ7\9L_MNVC",C9;7ZU_>;76-D<#/Y36<V%=N^R&!ODL7QL&WP;
M=<1(K#P/DG+.?9):.>.P=%H(XPU5B[H01APX;(SBSU_"._+;ZTR,-[;9_8]M
M#>*K9L^W.KU!-Q:MY%9:R=&L)T&PI)5Q 7&E(N@BWB,7.4=&4:(L5280T$H,
MW19+.HTHC+_^C%^0O6QPV>!-WN#;B&ZKO<?4B& %=UCI**1UBFF>&',<+^I)
M**+[?D7WC$,!M"FKE4R(6&L1]XHA ^H6DA94,!PM [&>2W0O+]>[</[Z<_YZ
M0_L-'H70[)VV['DFU?ACFBAW;N:=2XI066LWTB@PI7885;9?=;,7O0NCKQ+(
MP>IK%H3525T./N; E'OS^\V%K+5;KO^YO_FO-U3?0DDC3#J;O!+>!\X-_,YC
M=-Q$'4,NT+-PB$9-E$4=^TEU[//NN.7L1%@G4SIAXE#DCB#N7$3:"8N2B3Q:
MZG2B>&M'LJ756%\;;>R&\YT"9P7.IH/6H]4FZ>2PM1P3HSG#$6,6-=9,A,5K
M:Q8X6Q:<33N&L5%,)FN0)C@@;F1.U>(,!<4U#]9'@1E8EU3_O&>XX%G!L\W&
M,T R[7)%'IPD9RJ8Z*BS@&>2:<>)'/K0?@K/4J=[8OOPKF_]Y^W!"0J=/AH]
MJH#=+<%N?Z:T!&:21TF15@0CKJ-"-DF!1! &4U#KL,]@]PP([LF%U!:X*W W
M;8UB&K%/*H%)P[F5!E .)\TB$]0YNGCKDZ*^+0O19CI^)<ND2QHI233B,6ID
M<<(H8DE)4,8E+[9V%"/;O.!9P;,GCF>$D>@!Q[@Q7%/BJ,!:2R,UI8)B4O#L
MH?%LYK#3JZ1$H$"LU@K$"4G($I>0M 0KET 6>0L:FBKZ6<&S)X]GRA&?I,.8
M&<LCXZ '$"RYP 9KZ6W!LX=WKV4L&V(::7S>.SOXZY,G*K)<HU\0 HC&@\X=
MUA4BDEK"#99:@<UIC-H<#6U)^0)K@C]J?HY LVW;OFE;U;^:UC5;/RX)O\#D
M)W:%P;J'SL"UXLRV7!OBLHPPF3+*,LJG,\H2@_3$[UQFE9Q-3VMK+2#$2M'A
M4AMZ$\R>>TY"ZXT5OO-B$?VL1=28#3C@)$HKN0,RPOD,SN;R[LD@E:)5Q'+/
M6 )[:'GQ!H6'"]26;2K;M&G;M#ZY744B+E,BSIQYD,API,FC2+Q"W 2'K#,*
M)1.2U]Y)D\36#M&J]/W:."9>.=8^M=HN&;-@W+'=SQ#9:X(-;#.GE"XHI9)T
MV::R30_02=U1 YI8X))++ R/E/ 4=-0Q$K9PRD/=NFGBZ*EH7C^K>?TU&P]L
M@W/848:BC1IQCD'S4BZA)*5QGO)H4Z[5IY97%J?P;('6LDUEFS9MFVXA 0W@
MJ$T@\I2S/&%ME!3281ZB)N(6'5=?#'HPC%[O9>?$-=NU$G^IW+^<U.TOW!-%
M(MY2(LZ)5Q(J2D:91)PHGRO%<61(BHAZ^$_B%!FQ628NH0OY$KGXZ=2;F#C)
MO<>B$\.)SHNU*'&F2UN@]8;\9=0L7L(J;4;8=>&7)\\O*ZB+4/P#2]2&WL_&
M*FBJ&*-*(Y<"*$3,6.0$XR@F1W(*$?.1+C56H<!F@<T"F]?!9HQ:XR"=)PQS
M*9*F!OY/<&8#PPX7V%P-;,ZX5<%,=$H;CK2E!G&C(K)2,$2#5)PEAHW52W*K
M%MPLN/DT<;.89X5?"K^L=9V HF<L5<^8"9S3T@8+&X0$E0S,,P&&FD\886N<
MPH;FNG;+#9PKN%EPL^#F?=<C*+BY7+?6["%?PA%3CQ6R) 3$/29@JQ&.0HHA
M!$F$D&I)AWQK@YSU$>%O_=P$%7Z&YM>=\=3V!R? &W[GG_6'PWFY[F\[%W.L
M/X=_QK,\L=VC9GL\&3G&MF8[Q';_.9,UU#XPL])1"FB5+BH7C$O3M\.54\/^
ML>U7@S[\^3U6_XI?8VNXI;1JMD\'_=XSN"-6+SLG,('S\8V]"F9[7(5F-_I^
M_4B8[?"/CH/1?LWK6IW",L;JOX-./\)CFFW?&N1]JQ_XK[T7!V^K\V9L@0@;
M=+_&9[G8Y=6,5?C@S';#\#G#D3O;_G+EN=O5B]CJG%5-N%[U!B>P&>=5)]5'
MGW4X0-6/_KC=_.\ G@ /G)Q-;32IWWLW+M+S6^S]B#A1%FK/!9^B!D3TRL@A
M3Y?*"UZ]IR'43WS>[ /3^1L'=76U"-\6>75>VMYQ%?\[:,(FPJ+U[GG$/URT
MZHIE71^HAWS2/D'F[=@?TLWHO'U(KMN%9AZ29EX#N?3/J]Y%[^IGESC2[]H
MNY9 #JTE+65(RN+TZPC40@4D\@7H:01\J=LYJ5RW\R5V*T"P$($MNO6M-<+U
M\H<PQS;,J9M3'?+7,L[V.H.N'P:&Y%=TXVFGFR.FJF#[<;MZW^["DV#\H3JR
MS?8(]3I R?DK_6[3#6KY6/4[U7 E>P#BDY$E\+H1K,<L :I.#E.&=3^-[1X
M.C!&AOWZY: :AOQIJ!,QLCBW>:(]F$(=F=++H-TY'<5P;0[W7$NZ,X6$-IZ?
MAD194\3EQVO'3SE.\&C,1[U^QW^YPD:GH&8V_04V/"!SK-.>;^W4&075+S#
MSDG\]0K/KG1+"UQL)%R\?/GO=WGO7C0[L&'Y1ZMSU/1K 0_5%62P52-[*:J7
MMMOJ5+WFR: UM!-..B&V1C?5=E#%1B;0=G4()#G!VD![M1E13[H':-CN-6OQ
M?14,\CW9J/&V=X5@X04G$2#$#U%EXAM?.WDP.7BYOA*:/0_6<[^";\71,,:6
M6&R!M06SZD\-[;2>S(6EDX<(>@_P^CH1T=;.[KN7E:9B^[Z']<-!3&TK;"6
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M#4(IP!T1B8DB<.:$D8QK+XGBCE%#U=QCSJM0U8,)PV]CS/K:[_;N ECCS2K
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MY3245MU&JG&C*TTDZ70(T? <; 1=J&]X,#+Z) 63PM:XT7WCZL=)$XD%R6)
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MX?SC!>[KK9.TVWV3!H.#82M[5M7!&=3!EV^FU%UQF;C/DI-H I2$:DVLXX%
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M5<E_8))_/U;#N>.@!&-16Q@,>AU_,BB&Q&ZW>A/F!(6WXZ"@@E;,9"#2,D_
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MUO5BBL.\X;'F+[]5@N($\;UQ7E UROKWW:-WUH6HQ%=,ER,I)]QUPQ00B;"
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M74.R&=HD8/3LREBO9,7RK1U[1XHI(U'5/=2BT7Y4Z%(I8<AU-5.23+=1;Y@
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M*@;CN>D4;E&3BM!I3\/$_ (%NS9?D96<BG/::6$N%\/]-5E#W6X8$[K JCT
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M_(S=XU:22)3:="&:/M5*'#?*%[5DCJKLC<BQ4>_2OL#$C=XZ!NX-E2K_M5@
M<Y0Y+.J;G2:(J-Y@]2UJZUAN)R\4KZWCX)8N.,S6LMO\E)::FI36C0B":7^Z
M?%QV\_LQ2C8WHX6BD4<=U.V%A#9Q:YE)UXD$P1L7F/0"NA7JUDW>3A/ZH6WP
M1V91*_?T:G"GD%%+:>4KKK\'+)[3;B8ONIX5#P%D[SB937!E-8^QRUNTR[9Y
M>1O@4-M@RTX4IYOBW82J9&1*-<%<C5K)+VSXHR(/_0$VI( 3R+^W$@\_!K45
MS6_]7.]+[6J]#I:ISF&5KEJL$1:KYU-^>@NY@QYI8>(^TL%N DE]L'>^#=)O
M?0G5'@*?ZD*H[[L?Z:?0R,-2"F3J<^W(;UZ]*' .@R4*N)ZQU/ :AW<GC>VJ
MS2%VK<05-SG@7P'4T2B8]S;<B56; ,PXGZ[A#ZAC\#C(JJYP&NE:?;&2(]2\
M4LTB;S28+WFQN>8-"'Q.Z[EJM]'.@]B$U3T;6Z;%RL!/F_-D".\%+ A2H!?O
M>26*HEY.SFF1TR:2]6+_U:Z)8W4#@1T*O206B''-?*[GU'2C+0K5/RP*-0CQ
M5L$7W(Z.8(REC ($%2V%S-8"E4V&0R^?X*+4EVQW+UF-$^GTJ+ D5YM,+F0@
MO%Y+*E3,3H(4<\"N?+LTL=46NGB$6^ER@QLJ1(])/.Z:B[5^4SCSN$5EU[!3
MB3TWL>R:CLA5>89DD'><5.C,EE%/L#BL8RSF:=##P*X!W9>9?I=9?ILXV49+
M\$NMP 92*E,,]8J&S@T+Z>ZI5ES?!,S;_*2-"L,-@MA=T!KF:Q372[1I28,K
M^DUW>EI/+;J=<C)"OQK&KW4*L,I"W2AQ%+-I 8#L#K"I%O]9J.('R?!U(E=W
M@]AN90$,QHT;\T\.0]D ^&;[361>*CIMK@@WO:%6A'U'E>E_U10-J7MLV>!F
MK6 E=:%1(KOY"V94"G:;09T!OHO]<#9+-9 ."FZ;4NG: <&;,/#2H$>Q0 1>
MG501"8?ZKA.XD4,HBUGJQQES'=\3/HDSOCGN<7#TLM=,[T@N768*6KV0!W"G
M%,,>%YAP+XHFXN'\<!&/%Q?PN??>H5G"'8?:84*839A'[3A-?-OSW= -L\ 3
M8?KD.4!PO@1V_FD]\*& /-K (29P#3EMM&,LV2Z+"T$G<YEO^&H!S*FT7@.!
M;R@K4(DQ\+G4PD1Q1L^,[G4S>R7KNM]6Y/^I+'Q8R]54M0P:FU=KMG"HPM<C
M>. [L2<<S@(2$<X8C9B(TCA)N1\(+Q(#@M\A@A^=[KKO7<:)B&+?C@//LXD?
M)';B1]SVO"2+G,@/ Q8^>0XRXQH,OPD>-Z*P'8Y@5-#+A-TFX^I&IM-E6(R:
M3'T3PX#G]5E9&;_O-6;"J&<Q:XA<8J&L56SW3)8V=H=]X.8R:Z190^U-'>VD
M+^MD*BBJ(MU]Z\G7S?+KUKEEIG3+/FN-*&QRQ88\K"MT<N(,>5A;L)4A#VO(
MP[HV#^O:O*J5/*PLBP(_]#FA$27P"W/"P$VYYR1QQ,*4/)8\K'Y4+ADU0FI=
M6S/F;P%OOA\3N.G8LF;K-I[HJ]6!KC\4?9!K_L];^^T[R3,K'E" W%%YKOT(
M!GKS\6J95&,+JRY/W06-9E1W?'17&(HUQN1DWOC=*--.%C@\ LZ7^1E)B9.0
MT&,)YVD&"G;$DT&9OCME^M/AYP/R7@2"B"#C=I2RP":>%]O4$:%-(@_D4AA$
MF:"-M2C.17&YO=AT\125ZJ+14;$WV9$/:;4EQ"&$ '.ES">.R!B)0&W)P(3+
M0D\D9$"T.T2TH_VW8+7Y:>PQ[MO$\0#11"KL)":.3<,TI%$:,>8&!M'F%^65
M1MM&3%OQ65["F=LQBGU&_)T;7W?O/'R< 0GE\'5,,?9#:A:W\9[W-(UN4/>G
M E6+3GQ$?N/I76L5;8Y:TNV]?HU:4:QI%BK?H5$M[D>SD&]Z<#?T#\;E#\CQ
M_MO/[].8,";5"8[.YTP0.Z:I;W,?_N<ZH0N&R8V<SW>E3 S\>R/_;OK"R95,
M=D _H$\[(?WO)1W\1*0+/6#6I+:V,?;'*-->+7"BK^PMT.WNT<FGD%FZ33+9
M<3HO]5B-L!%%<FB&=;3SMVH&JGX]*-(=ZR<XQ\2,*K)TJDLS8P-S74;=,'E_
M^@:R1^S=*'.U2FTQES)L7ZV0T"4A=E,OLWF)_NY&4O+.$!XZ#TUZB6= ]V<5
MG8V5R-)':$5H4WM^&]E^4BZ0*HJU2O.W9?6Q+6[?/WK;+"]':X_I).M&\3OY
M:S)YNT%. TM3%W*T>[*_^]=*J+L35<.<F8Y:,*4<[AQDF.R.-<WKB:"2!71Z
M"4E(HLO<A*1G!I4FR[8\!963T5I-NG''=W9LTM[6*M-YT[UYO7&,Z8^4=I-W
M\^J*>G7%F+"]1EX4Y3FR=*5)K5^^L ZQ!1P6YL@JD->"H0KR"D<UT>E#C866
M5/M08Z%;_YKJ96+Z--!^0MRZ&$7]3JO$1K'$'(LY:I<JMTU7#RAS?60QU'3Y
M6EK?_2+J)O33)(()LC?4A*]"O@[+ZFO)CU!T7*%[RX0[.:RH184.?G2:)NFL
M_08]FJ2:R/@?32MA%#5MTQ>3YEEW6CZJ*74]H?1MI<MHY?MMG<U=2IH?E_/L
M:B6E43SQ@DQ#Y'-1:6Z!-8BUI'70BC&A*C>5ET9>&ATEE9%[7<EH&F<U3==T
MTJ&GE!JZ-(UI$M6>1;4H;ZYG]'7*R.AJA&SP=Z2KM>I6VC7CQ2P)]8ZI Q^J
M^MA*S#!!OE#)]EA' )]A,ODBQ4[ ^#8I&^O\K-#(*PMO$7JR98ZBTP[G53W2
M*UG[0DVO[TEW%&8OBUD:-]JF:>T@126ZEK;G9KO4?L*G09/2J<J-+/(=4SX]
M;UK'M.U?$"DP,6,];UAYA]E2]9G!5^_W" X?NK;-C"B6^,T-RU=E7=N=[V/)
M)4J;U75ZL%*E3TT+.=64QO1$QPXS:Y/?&KU2H% R$^(>HU!IFD#Y'>7"* ?=
MUDN]\I93,;%VS^%\*_KV3R\ 'B#[TZ:P3NKI!W5%Q<0(GX:;@,ZP%+SM5=^,
MR3.O086\;R>UG8IO79>U/>TD=]G"VA]3EH/-AA5H$K%WFSENZSG"?;NO"YRV
MNV%72L\48]2*^Y?H1SJ-!]]SB>V@&#Q*@0F=F3I!+!9H(C]ZGZMZ2:.VX 4I
M82(5"64L70V;3NO5OL-HU8W33>2==UO:M>K(31NXW?<0N(?RJGNAP4FZ4A6V
MYI3H, #=>.O5@DT 5UXT"M=KT-*5*\LZ6=9@"JC6A2#@X/_/9GE7\^QE>QO$
M*+NQ<+_9VIK'8UW#E'^^C9J)9KKZ@^Y:IAY=[8+=]Z48EO_U#HLKNM3](ZZI
M7OI"KX1T%5T6O45[Z[XMO?MS21R6U1EL&+N1M\$9_'Q(*[PBK= =T@JW8"M#
M6N&05GAM6N&U:8*K8]E(&&<XQ(]$A&342T(6,0]PRR,BC"B]+JWP@5@2B*/"
M5(M+UY[R-\V-^E8T$Y!?[N]VS#>M &K/1.N8IEJ745*I(Q\[$K$C>]:<$6XX
MTD$7[8S0#K+5\K7-^N?HU@KHHS)G@J;M^V5*XLE'.!HH+(>+^4(6QF8"-/H:
M;6EL*8R14%#.Z$<4U6!I[OXZLO[X=<_:!>,!V[29=CA:Y4,P_7:PAXVASM'O
M\J?J"C_:U'#X:Q7$-;]1]X&U21KR O476O=C_ZFVN*K;DKZ^8?OY9AR>L<JE
MXE/*CBP=0U#'VJ_5(#O1J'4+;,V#)/WO1:TB\6V(?,V7I/3J34ZDN^Z?LCWD
MT(1FXVZ.33>-N(.(N>KH4+0.QJ[I4=]T1D3?&:+=,SW73..K4E52<*."2H3<
M19R"'2SQD6(.N'NY9:%I1%%//0;L&Y<3+N="C<NV#-R<M>?6O7Z^(>#9[M4=
M]Q7XC%M9PJ9ID[$"(%BLSY"-0=.OWSTQ$L6%>W*]G^C3G[RGBGS=P-!K)]M@
M5Y&.F_A^&SW0EDU&\XFV0)HQ.<I&:MR^>O*9,H"Z)>WZEBIQA@2J_M985+J8
M2N4YS*I2RL$%CC>J%^J&KX4L6O=@!B&7]HV'=N-<C)9; U!-!EN-;4@ZR->T
M2.\]T(&LEFYEE9^I4:!F_75G]*9&&KI%I=CHG>Y1T$K*S<:DH U.G#MIR;1=
M*3''L[S,>?T(/4^GXULT7N)F.*:,\^E.!C(?Z](9%VN)EV-9(IJB\-1CX]2D
MQ9463M.RDEU8BULFI6=9F&9>&F?,B0ASLI@2[D<T")W$BXC#-B<I.AM3%&6'
MEIOU!OX!4])]> ]YGR1QXOD>LZ,P"6P2,V8GS"<VI:$397X ,MAY\MP= 1:O
M)RJJ%CC7M>=J]%=31[2YBY;I4C7JMJY2:#PIL=5&;Q*CB8F..NYZE66H-<!.
MUSR9Y3[J3(30S5]Y;U9L,WQB-1<"Q4]:Y6J*4BDY1:?JOM?P]]+>85A,M$G?
MJ*U>+XZ.'W*<3SAHP&HW1P)X.AY[E]5P IR=:ITL"UYA*RR^D,,>V[$;,^G6
MP[^IW3[:S(P&G"O]HUJ9I824&OBQ&J[XJ=NAK5#Y+OKFQ2>T*SH//^W8"1)/
MA6J=I2+/@(2EF?IIENPV+UF8I%HYPELI;EBE;1*!]'QEJQ!GDQSG7@K@N,K;
M7RSR6C:WWMCS[/*&7O5M6GK=P$M^!(I8/YNO47J/QWFYS::TZ^D(C-;17+\?
M1K^DE>F&/KJK_9.,"CO7 U&;[,;K&BMINNO*7VX8$/Z$47A0_HWWI6O?&+X%
MV\. 8C,W>*672+^K:&[$OHR>-">K,")47Q%#OY]VF]NEVQT*D$$G%P+V)NTW
M44EO(N Y<.3+FT4_/%XWN02+,^0*.CL$3*WC=($^B]V3CH@T:-/D"ID$W#WD
M02LQLV; /'"(BN7&9L+QG I.38@087=\NF?M_JI\=O@[_+R2"F9RHN%3_19+
MLQ6SB3:-2&ZAL7\P$J(&]5'T!/KM_";C8%13VWM3 9LCM7OJ-*I-FSO./W<\
MEUSI#>/E60[4W?8;Z:Z&#B%-V9NG7!QA8RK@VOVQ%EPXH4-I%+F"9&[ /)X)
MQTF#D*2!1]+W^WAM3NP[MOEA;:)%6=?*BXW28;FOA-*)+/[YX333-\[Q:>H>
MG9Z1P_V_O.._WF<Q8 :)?)ND<6(3,#/L.':H39(H8(PE-',9Z*A!H*90Z*$5
M1EW5=_9<#14TE0*-P3R;H#- IWMUDQ>N&'Z 4]GD3&00P8H1X_<Z4^LE?M1S
MG;5%:S7Z 1U(76J4V56(XO(7()I>Z5M>M6D?1J4Q#ZJ9\5W:!;.L4E]$]WY9
M?D0M6PTU:',!02C^V+)@#Y\L0=6?;CO?/Y"=E;4.\V)1@9RG2GZIU #CO^HD
M>&5YP1L4^'-1<";2CZHOWTH/P\X(SA;E?E,?UM;_?;/SQ\[_,_& 1I#\]N:/
M&S'WD4RG5/XL^/J+-TWO1ZDE+28K"0>-(MV.?VU8?FW)T*293"C;33N>5%K3
MYBK1]2DGY9J55+9A?2GLFK!% SITW"UF8S'AO2FG+BS=5@K$1JUD)<_;@(3R
M$C:>$1PH*Q.K]%R;%\79!.] CKVV_I$%UW)H$5?AM'S:JN=_[$B&8V!E,B-/
MT4C%-QBQ+#,P5=145I TH.@W@N_=[IL_1HUP6W<;]KC@J.>9!:#6<M2O49,W
M7E2?7^(T]$Z/\+XP57TFQW*&LM;)BU*9WO(=2J'1T#33;[I0U0%-W8&DS=8K
MY F*WK3C?DT&1F,65;U )Q6:S+*7F9@6;92S.=$(%(L*Z.>/WZBJ% 0(ZL$U
M^(AT+(!ZK8Q2].;+9&/#J.7K\(H;1:J[%IJ)N-QJ0T!EP]%%W2:%-04:9J"2
MO %M&YC)EAO8@T'MVW0"^S()\.,E^GA#HL\6;&5(]!D2?:Z?XWA=XLYJ_S#A
M>L3+2)(RE[ @B.,HH"'%)D",NF&\@2,]O*[8-53DT$8<UHC"IR=V0>OQ0_+L
MTG",6*PU" HI(1Z85)&3$D'])$FR)$R<( E\G_)XF-=X3Y;O1_]P_\P]!,O7
M=R+F.]SVW22TB<N9';M^:+LL\P*1A@)T?+!\W9WD\MF-*E-!5QCI 8W]@8[M
M^&;KX.J)BA="C1*\;)*BJEZ4!8YJ)*!!12R%A2_K48IF>")HP!4MSB1CEC[R
M32\V2_?&+ +*5VHZ4E&B"KBHT(F.-6'E!1H[([7?5E65ATK':G@UZE^4G^-$
M]*9ZJ=5&06W&B,)RI,XJ-_Q)-820AVH([,>VI5_I.1A_ZCF>RT<89/HS_RC,
MS,U^7_^.B3SO>][!Q"HGYSJ^8JD@MLR(U/ P<TV7;8"F.\%+J_PJ#T<FLGQ8
MJ,XNVL["V0C=0@0S6:$;2^A%+\5J'*%K]R'A(09/M#7?)+IAELU"%A8R,2DO
M>KDERB"MA0[PKD3?NA60C?,9HW# ;(P)?E8!I7!5U+?YR,IG)DQM&U+Y8PU3
M7B][;S,E.8Q(X*21*UCH$19F-&0^9<1)$E!@LN#F4Y+[/N5=-<%Y=[Y'JPI+
M/?^FD\4@B2_+C@@./YQ]?A]%4>"Z46B#11';Q!'"IG$B;% &J>_&<%&"/7D>
M!CONC>1O?TJR) YD#^N<0T_S_7IYC-,9Q?T*YM+49\L7K4V*-KTK'Y/X?DP#
MDX[R>576F&XH+L]?VSYFV4M6*S!$@V)C8]9:)4 03II<-/D,_HP9:*TCM*UB
M[GF7&Q=;A=$0@P& UD4+-RN?SA:MQW95\O:S/B8UO!.#+QBKIQA*A0_$S1(U
M.EFAC4*Q,7E*SJ NFH9E%R6F<<!&D,/+:)-J:]9YY$LZ,N*M_HY4M.S&3_M'
M_(I7;6P0]1(P+>\';%>AV$[Q6R]$,!M <)C^N&UFE<ENU>TT]#1&X_56.<+9
M0E8>F+I3%6-6 \ [?>B,6J(BT3IYJ%%\FG8Z]:)&5%$:F!E<I'-N\9MT*8LA
M-LUR;/?5JP?8^$*9++VN,#;;:%W&*.SK[A#8J6S_)%/-=JR3?@^"U:+V]N97
MT]>:;&&9I%?I69)8@XX4N%0'';6CFV0^EGSS!(,-LGDAGE3?B$P^;R]*WVG[
M>L0X-=7Y]0($C>?_E#VUFK (4K7N)S$6*T5*O8@.L+M\=8J]U-$P[;V)/1@!
M)8,*_UGD$K9K8JQE!IW;U/DUDO^80,)RI31J4Q>5W5<'4HZA[,P _#4*-HY:
M.6IC=<LY^L-]FHSPJ1S(V"T[V4A."LYM!Y&R.V5<*2&.6AF0U99WV.9FMAU9
MD.%(>+<]%J_NX/%B@DVR@:_K'AZF3AU+$JJI4$4U>EMTHG:PP3CX85L$M1/0
M^BFC;=ZLR2K5%0AK^-#'>:0%5(,N&[<[[Q2QKRV%JACFH5BZ9PEP%]2JS##+
MIO_GN%2L?]I%RW9P[LKUKG;6G\NBCK29U=EO>U.)J>92AE@[DJ'IL=$I7]GK
M=S&Z_.T=S$;MM$%*@[+JS;61?S_RX.H_\QGR\3NTT1E-/RI'@:V/E<G_/?MV
MO;A:]TVGQ$%*K\5DGMLM-[P\LUNCXJL,7ES)E@S:![(^&5'B=]VM_FEK<0U"
M<N"=DW*&&+F<@>P#G*1,H)K5"\HC$5>BAET:).^)?GU9ZQ5#URH;,J.]DS*$
M;7:Z+6M,WKJ4+=WVNS(IHQO0F57"5G3=]M^M==C]AEG)7<U1JI/6'JW@!05%
M90;3IM68T&;H=;<@ =\A=UG)*?1*>O7Z%>L+D4=6?9IZ+U5[D4VUX,OJ@AL9
M?D5#K9'A(Z:7F[XAM;L551IV*=^O^L>H$9P]5J3ZBAO1J3U]5PO@E_A!(WX5
MA^T<N'<?BL-U=X4=9N"Q7**'27G>P3KALKIT&?C>'C 2V $6/DHB*<H+W:19
M5%,LID-JD8DZ4B=JG][3JXGS7*7/&9 K&&,F_U.9;O%)Z?NR.FX& L%T2%GK
M6586N(K.XD;M6&F'NN_:AIH_A'BSI/+P&I-A/JX$.CLN,#^0FS8UFL"LGU0C
M?0DKXEC3LZ?/8+OYTX?4'S9W>;NDTE'M?]0>H /.9_*O<!R ?]>*:G%38W9'
M0&L*[$)P#'LSP.O!+I8 >]A>D%\^-GN[PC$'0#$R)QLEV"M,"*H>94AFI<[A
MTF@+Q32.KM>GD=!]Y .K$HRA>5.>DQ<9VJ(J?ZU9".2Z4/48K%*R8B4>U!][
M=4U\11@';J>QJXJR_+ V3?=:%Y)% ,S9HD:W9=TR*2S_!A.>R^HU52^C,UA!
MC&YRS%FR?D!F43<57')I%9)J-"S0\X&.9!:0N7'TL@&N('X8Y-#9W74;=>.E
MO%Z#-2/\#7DGMGUNAI3(OLNJIT2GR42+I5V<^ZE^BF;_T$GKB@0[?TBPVX*M
M# EV0X+=]9VT;I4PMS6=L73.1RG3Q:4GN75F5_A<;6R8N3'V"YD! 3:WTD>:
M_&QE0:)\J_+Z8T]AX:5L[EAB>!66Z8X+@%^EU]ZHST*6%-!SFD\D)6D]HKPH
ME+Y#C2S)5G68*5V:2,A(.@6:!B!5N:03#$05>M ;9HWHD,(4'L-,$G,.$'@9
M"KY)63=-P?0;Y1[ 1I6J/LI,]#V88A/8&H99L\6DMZM1^R**U5.X0]P9O' Q
M4X=#JPJCP0"\P[(2I0S[&JAHNP*35&2X&@,T4MHN9ZB.398MG*4EP_(2B\)!
MF OYM%$0U!'PF$:M,X*]36J!?4T =;!'<V^<@S1;*@T92Z&N:FEA7(ZHF<";
M38U!WUO?%/5BM $T!*P*&*-^4)PI,I5ZAM)%NB%&H\0V?B0,]]0\UWZ76:=^
M0?DHNTV&5V.G,[J4_[:]$VI9?:SQ7X=/NX6/W9A3/\*D6L5/J(QLFI?"BM42
M>&?11.2[#:?Q_$TPP^C$<*,3KDLIVJ^)+!-&BU()B:K1#U93+ZI&51Q)2E1L
M#&LC=.,%Y0J3.I>NB"ZQ!SSHA6,K \4;XS8ZMP([.L 9I+=/8(Z2UOU4IR49
M"1P2D3 1R66A$+$?.9$3$R=+69P)GD7,%7$6))S*NE;?<1W7_J*,)%WE^HKF
M?,A%NFJLG'OX8==YGWB)GV5>:&=1R&TB$M^F+&)V0'CB14GL$"=Z\MQUXIWX
M:Y*1\JX?8:;]"$-"TI"0=.,XT1)8* 5E4B>)_ 'DSLOI70Z6>_# T:_=ZD85
M(]'QGPO:]UFM^ZG,!,+B;)*#=-(QH4X O^>UTFT.-5!GZ/Y _4@M:P(7@0I<
M_ _LL T*_+ZHL:@2W_<G",JR,^+0.$6._N>DJ4^5]<36V0*,!8RKR)232GNO
M=$J+:1B&&0^JRZ+9;J]%DFK"6&.826N(>O?&NP9ZBT O#A I@W.J9(WF9;P)
M8\R!Q.;&3U<(K'*D0+.I H-*LE'5P12_CBZX EW>IHE=V3:R,*ZC$_A6^5FF
M)\_:'&\9>] =!F5])56VK'JZ[7*Z /(%]5Q,NILWG22VSK7WX%2B24)Z%&1+
M HR_F?BC6!N2T5Z'##P!;C;-3! C-'?OE<?*)I%<:KC=>+TB/:U18E>QB:%#
M\6F6M]U.?E^H<N1($E(S*L%$X71)]LEBA@::IBPL8.>-LT^;;Q-QCBJY%BV*
M-I3,64-;&9'4;L<[G2#]X->]#T;B:\%YF^?T)TAY.7%6WJ$9P2)KWO%&U\O0
MVPKT=KR2+,A?ZMD563G!2%QCMIZD "!DHX>81C4WG.HA/=V7:MBJHIV5M%K5
MM'V:)80YKDA"1GSN,I]SUTNXXT2^$\:JT,YQO9M,9C[.#$S^1[[O5WQ?#=2$
M?T9./XQLWM1K)CC>/R.'%^_C+/62C*2VB /?)G%([23+J.U1+OPP]2AE 0YO
M!E8@1+&N:&\E(VZH1*&$I7#"^FE>GLG)QB/);0V"/.VP1DP0/.C./E=D> K\
M;J3%X\AZ30M&/X%^NYO.Z7FN\[3GJOEOI4@<I:E,'4#"U]O ITY*:<KO@>H-
M+%?O1_IT'C2"?GF5K)PF=Z_T^T)+O2/=6$1!ZT0UPM#JFNPCLEMPT[;O ,T<
MI.T?MI]IAY)//_I'?[T/P;SEH1_96#N%K:.(30/'L[$8//8B(1("]K+O/1(:
M5AZ[GE:T0K\:-4:JR8PBPJ:MHT:0IUH,J_Y2IBG*;B='2:DP:*#.3!Z63$PV
MF9S72'FCNAEFTLF7,ZYS>)_.]RQ-X^Z5],YVFIU0>^BH9E>UL-K6C(W--_IV
M,1.3*M_VHIV>K6MZ;*I&2)=K\-C01^;V+^K&W%S*QE *D7:/]G?K-@GIY?YN
MO_/>N?+\Z@P LSYZ6$QH74-/C^!38X[K&J6)3-8S \2L@[_[)0+=YO;:VI =
MA'0.Y6JZB)JRO9(R4DZ6T[*"Q4TJ@30K&G> K]+!X =7#T>SID"GI:P[::WW
MU6\E:SMK0E *:%<<RKC)\;O(I-K @K*+]#@-D.GRI=(KT-0"P&4&(]TVO!"K
M:S3=AC!ST_P-4_I@J3G:^*HDHYG<X'@Q'.1@I>_<")UZK)(=#3>E131YI9M2
MNS-9_H5[-EFHW.1H*O=)-WYRFYS2M@)J=*OO[0,SO9 JB]%TKOKF8<[Y9.7%
M9=5)9NTVL5Y%MC805QNC9XW<]!PZ#<&F9,?LLI4$S1L[;+F3:J_/TJ3XHKM2
M)WGB>BVTOO5HQRW+M3N6LKAM:_+(PT4K:78F[JA[KTM7>C_5MVW9;EJMCM3T
M9"K#!B,]M4<%@IMHHPF3FCA@,X0'L\9SY9HLT#2=F.BH"?IM*.'ZXJA6$GM^
MZGIA0KA'LB1.>!@$@1=X)$J=6)"AO/Y;A+3(T>>SY?L@RES')\P.DH#;Q*6Q
M'4>!:V<IH9RQ+.("C.UX)[PBH*7#1FMAGNNPF,XWA<%NTR[OYL0]=-!;2? C
MER?XX78E-5R;=>8ZX9,A+?#1IP7>1&C.,))<G-D3D<&%D15*L_$O#Y1T=W#Z
MXM#R0.&5_[MGG]5M.]_O'NW^]N+PQ=&IMM5/K/V#D[TW)R<'QT<RW1$>^//M
MR<&)=?S2>GEPM'NT=[#[I[5W?+1_<&J>>?WBY,V?I_*1XU<O7N_B!QMR(V]*
ML\F3FUUY)\DRW"ZU2<4@9#:4ZJ%D@IZTH)-EC>EQG%="1JN:-*;_O[TO;6X;
M2=+^*XA>]X;\!@3SE$1[IB-D6_9HQM=([IG=_;(!DD42;1!@XY#,_?5O'E6%
M @A2)'40I#"Q.R.38*&.K+SSR<'$I;PO&?TM26*2W1]*\ICP7ZJMVV4P<#@C
M/NV#TN2YD8J/R4)7+QQR,)7RWASK]\#'#'NI U')NH<]GTDNWGJQR+785N@<
M"NE9?BS?7OP8K!P#$EI^>"O49\ G!+567)@\*G?F AXT$/9TM,!E>J4D$$\H
MRZV/WBU7M9G386FCS]P=";JVBC#2$V:*[QV)O=QB5?7\U,ZZ]_GYGJOY(C2'
M'N9=CB:O,IK\FM&D3#FEI<GS5=5WH$BUK ]8"MYL'/^#5Y"J-&..\6$$4+^N
MT/T\OUCS/=_<*&%][9+_A][8>F,A%^9/FKJ'/$Y ?M8X_B>#>Z3*%KF^>(=V
M,FN"5 5+W7B,INAL<ZC)EM]+#E).X;9-T!$"%K5P*8<CMHXP7/TR2V6@=-<I
MT-0$,<UQ/27:IPQ[ZJ3%.W^> 3IRZE)B!6( UQTN%:7(,O;'C<ZG5<L "@+*
MQ')(BE.KUU""P\A#L\2:PU(L:M0ZEWLV2C&K5/*8S3T 3W@]&Z?J>BHJ_"<Q
M0"KEEVP*UGSK1L-C/PS)[9@1H61?1 "QR%%GA%FLA#B3)>%RPLA(@%T:]2EK
M)KSQM)L2OU4==HU6F)GO *X7H2;HYIB]+J8<P-DNGV$^YQN9"8(&4@F:!'XW
M)]W'+ZL6TZ C(F=6B)7+Z"1($USI8O^U,@05ZO,IQG!E93<;(/+X3MS#Q7&2
MV_!X-J&\]&Q(/C[F"[I"8.@1LCY> =G#<P"2E"VO^,V.@I6TB[0PV;>1IQ;/
M P%2DRN5S7G:^670KD?6V _[+J)LP!:DF#I.+=.B<!RYTS?JVH<S!!\@L !#
MX3 [5YEU<V^D-%2\PZ!'S)R*M*>V>"#Z;5D2=R8H<+ZZWY7D99CD/4.5&--Q
MPH&D?Y7=C;YZ;R"1#MRY%*F<ZAT)A=2#^R+ZH!SAKR57OQ&!2P]C/<# FY%(
MT@6+B'"#'2;D=!7;MZFK.N8?H9_B1G4H-$: ^W:;3%0OL/RNVIH&N2&T[@3!
M_P)"EO,'7C;"Y7%VGYR#W@\Q@M-A)H\U%PFP"!%,**M/^>)0[P.1[.,VR'3#
ME(0$D@/,YD],!62J@ 4ER* ,\#4I. PAF("2)A(FBYR8 #'Z834;"\%(I^(8
MHW.V]'/+0A#*3=$]])26Z?F^9-2Z_Q0,5_R(:@V*'[)N5OSTMNQ#H&>,?10_
MENV BA]G!UW\AG=L870@EH4G9<9S\7/86@&:P>(8BD,M?.'-!#*+XN?4(V-A
MH0H&O?@YG^S"#@KQ0VGYU/H(%([,5F$''!\;-T2<N1$Y N@SQWHKJWQ62#@O
MP(QLBEA)WS255\6R3Z*,/,K[Q<GJ^7M Q#7T1B,"%&0K#/M,<Q<3#&G#F9"5
M-L1)>M.9+TDO7BU\@:)=[B].#FRN9I%52Q&[P0F5ESJ/XE \";RM<2:T43XI
MG2V34:^W:[:<<X^TB^;R\>.FAZ^4340D)SL4CWG74;/#<22RE:EL0-8$J8QH
M)<]DU5H:J&(\52262*. =' M=,,1Q3G<P0390OZA.Q4<F\WA,HWF37WDNSMR
M=9K:3%+';1L*%@E%K9. Z 4! %==08D6 %>6ZV)$/]3J=H4R1H-(#Y*>%1:P
MC"+L(8\42%G)-=D\&-F 7' 1>0FSNR<H"^,LH"DSTO.A)_-4J<^KK"50JB,/
M@/'^9-^N-S7:W>TYP1267^\%6\+U?-D(>^$NH_U"J@VZ/UAQR.R,_*6&/RB*
MJ[HT2P7CS7(/2"5/K\JWC)FS,K7QSK$W1+KE9"\X$* 4V$,;9P;FPA2[%;)E
M%_"_BGE 83"F$GRC\'I!?T2I8+10^/JOR_?'S9X>LS[FASMFG>.%%6*R3)PL
M!C[@@<I5*F O16*<^IA@6C/,AV.81D!*UR\AA)9D<;3CK*:L=*J9<2WWIWW'
M29:]0&H\8)L=Y2]OQ@:PDC9("@XY>!U&F-!W:B!)OMPS$JGR=:5<P PUP4TH
MP4N>'R7^_A *VC<0M=;YL#M?U&9\#VP'3$W./)Z849]& ^60SHXJ[-/Q2(TF
M&-="[ &%6##/)!(<!J>6::, N)88>NS$6A)T, ZJ3^9= +/5P#0Z[?T.SJM\
MCLDQX0[Y+F@U$Z&B5_6)/]R)Q^D @ZK4E0M^09*,"EABG3)=/&+5V<>-D@#X
MHXJ,&R<O?HH!>@G#P#S^0IB%%24"A+9-:!\5>9;9M^B8RB(O]<$_Y%4W%!QJ
MNH8>'L0&%[&9Q9$__>RDJ'&V.\!3+[1;+T8YO8#^9)6+ <%<,RW(\ :9L:4X
MG<U\FB5/$!N !P3N+2-T!LE-!:%I9L&H(0%CUQ3SL((['H0SS*KRIMR5'/-.
M$KBLY :BD*BT2A>2DDWZR!"[C+8D\H!UAW>CU#;3EO$5%'@PTYUEJ9VDU/K(
M'Y9)Q-Z8>\C#:?4)& @/8N@FKA5STL><P?<21"KQ;MP!_]N+HW26*^#R JX8
MH*HJ,9@$L+(QO& >)V*Z;_9OE8]-1A.SDD'&@7<).-H\3R/?2UFJ]?5Y-",3
M>%:"$K$<AHP\ !$WD5[R"*-WUA?EP0XHE[GL1=@HBO992/_-Q)O52N<#7P@)
M722%>2%W?$U;8Y#&2:B:L9&:Z'&KWNS8V(Q0S\EL* IY4(E>WOFGG\.P%T.?
MJFRH3(Y9?4'*"^4=18R6:J29JL1YQ/W,0J$L"G74K":FAR4FU@S9?,URRLRC
M'0H&YR42TU#!A(F64H'\0K,AH@'X6Z:Q46>6&(V2.?<!*B#UUT?Z2/Q8Y%M5
MEI25%)L0%ME%?30/=S3YN&*6Z"H#S&QNVQK,FBU[;]I/HYCK_0MIM9K%ZWM4
MG]7CG!6U?)-UZ7TQ#Z513=E\H<^<3M72W.&756VG,/.8HUZY1O?9Q<1Q1KYL
M6<Q]?^%!F?\#')7N.7_SQNR'6=</=[IU@Y *3.71*X%KIK9IMIK,FBYDN)CH
M'J0SR!QSYC@98C4AJ\IGP,S&K&W54+*L6B]S/E+-D^H'D8V>^YWL.,%=F]P!
MT!,C#9/?A>!S/IZ??\M5 %*3)5>FD9,KW'*'?X =@ODZ8*G$BU!@#X$VL\.:
MT@\$BTJZ C6]'^8<@@HOK3P1?L&9I:IV$5K+^&'6DTR65%J7MG4)9VHUS]7I
M%TLX\]63JG)2!T"N+]XYUG^'*34Z<3E:5B@*+?L-UC52;V'U[UO1!UDD,(WU
M]O;6B<7 &8<W',K@)W$2\BF>E:HMCD%0!V,$N H0$XIZ6,QA1MA1++3BT-%/
MPD );#PCQU.I@>%RQ:Q@U;)DBJ$X6>7';G?,^L=SR":!4U7?.3?\!@?,+)[<
M+1>Q4#VJ_@$7A[-5!9>"-719>8I72->,YR;&H629$$?-\/I1Z YM0BB3]E=(
M\-=3K$"*&,$;6\;*CI5RC[5.>:53<*P/KA=193#7OEI'\)WUX?U+1^*1,<-6
M]4%Z(;)\ ;2A$#O3<H74G,N^57%2DJ_")%\$)N/)SCI C!CJTD4N2/*JL(0$
MC8(15863%THOTO62[0[U9)<-K+-C9MAI]P>AT5DA[-M8;V4Z&U)3 73=9S4G
MR#L];NF*O4AE=EJD_2]9\U(F9HL&,>N->9%\2<CW(9O$>[+3CN_>EJ 7K@F=
MT&QM#IWP)"V6%M2&9A=8F;(WO]X@<JFXW4-NK$B).AY)Q=Q(<!O(%>(ME0AI
M!DYEP[JE,B-J!(QXXQ3C$<!4;M'9)L(9%T3YPUO9[]#'2FT>'UUUP%FP]021
M*'>^\+V1L*5=Z<N,A+$("1.0#/L!=OR=HM@<",>ZG))<ENETRLG.;0D]E: R
M=CW-LJEB*49Y0LH:P7?"=AS_F;KT4V/M"!F0DCL1B[3PQU03C=V&OP:R&0A&
MK8E?\EU"WH3E"UA/A067JBVP"G+WX7$X]&-N=C]P9SQCO/6RMPBV*5)E,I0Q
MV$\]/^'RG"GV$^F[4>01"/@@0@\5KELF#U-T/4JGG"HUO.%T;EZWBNOL8]^?
M@IB-J2\*]D[6]JJ5"'>*!S8*!ZELD2F"F',)%LI@J!$R*G"XORKK0((#JO*6
M1#9"P]RS(??L1-J-<M3#-:74;8FIS4;.'XE)Z#-BOW(HQT9E*284QLBTY5..
M]6^JFU&W#^[+#[AN XZEYT#@VF<V[+2=6\R$NG$,X45 >SYPUB)JW=5_NM/9
MF_=V+J,KE[ZA$KS(0R"&9-!S'VFLH446P UAF,&[4@\QZG5Q"]0%XJ)H$$VH
M6ON^0 5/76#$N0S#9 8O3<P]S=U F@$ZW<V-1<Y#2B.)G.9)UZ*F:1J/%RY:
MY#$^KU-4RU#%&86^QYT9X L$K<G&LH'H)"(K]>/V01*C>UC>+]<BWJ5;\^#Q
MX3FZ,\KX117!S6<UJ%S?" S*<0!T#GP3% SIO\3?4XL0;%G&*)>QZ@6 &_U3
M?YJ'!.08K2CB F(_ZUPJ#NHML<ETD?K9N8;%.FC=(*H*M_G&>6/Q+U*SK,?&
M&<!WR(Z1Z?/VGG^[S/85[P]PG"$<6,2]28SD9 FR*FF972AT>M^\)(G[:32>
MV-8W$03QW <&Y2'&.NH>$]>SK7<3Q.W$%_YMCB"H?53^+H.AY^XQVZ(;.F))
M0MHV<HY8L#WZVGK/N6\,=_)#( _Y*$-+M!VV]??S+__#%'(QQ9(\.&3Y:)Y"
M>/A8C5UF5I%%F04UI#M.B=>LP\@(8\[<P)@X*OZ>\C@)OA5A*U$QEVUP"+*8
MBMJSFX;58-R.T%Z@:UN^E1%>S:10J3'@79?S(^W@%K56$+JPA0N[I5>;W6TR
MXK*,!OATJL!B)$3L^510MQ[:4VQ>(D?/;;RQCU30O# P#"=/Z+OKW;HLX?^&
MG/$?\%\\(IZ='DCOZ^) ?P=5(+"M<V3CP 9Y:DB'_P.B'?[FT8KGKT=&@Q"(
M(%;+9W L-D\,5M<RV2;=4YEYR3991A)"O4CZ=(4)B0ICGL=X<<]'N(NV=>%B
M6Y) ;J5M?<*BLMPF&Q#!^##:#+?8[MJ-2V,!YU?_LD;8G@R,#K$]<%95>H:Q
MK2#CA9^SCM^72FS+:OL]Y''(?Q2*1KX.1NLD9%F@A,<<3A6<O<E4;U_GFI,D
MX5\Y0&(Z(DO VMA>%#X)J(,$]0R3CQZCVHN93-2C/)2Z5E8.I_'!<7>RI"?D
M!S*?D%@S%3PZ#%:U% */YDO9-R!%IPIS"I0DE.KFZV70.(N$[*, ^UA@T39W
M4P7UR(V8G692/^LU:\!#3+'3;G[/R9!10?> P&+B6':>E1T+N6>NW%LODFG_
M+#7PI\S1XI!ZSTDTP-(X/1><YQY202P37UQF"Q#)85*IK>8@G;UF[KJ'P3+\
MBQ@WDA0W><VETRFZ*L]ER=S%BNA(BF.769=9MG2$*?R<D=EDTIBPL>>$%PT3
M'3,46GX"-Z&?3F6MF@S+2E^92SDX1LM@V /]*G^>A7%):4 0&_V+?D;O89H@
MMG4A"*_7*P.,#D9%J'\D#KP@_;.UD.7AD?0BHQNF#ZMBNQZ-!=?R0;R2?P&/
ME5Z+].(I 812A0%9LHIU)M),%1BFNO\TS(WF;F0CAZ32P$4H%&[*%%5%^<"V
MD&[V\&:C#[[8+MJ61/='&$D?B@Q[X+?&:2K+4EJ_Z(:,4[/+-.B$RO!6&$FX
M8\R%C3&):A=O+75C4F?&_)A<JL1OR8+6.HS-;19+,G2X!42<TS3-UAJNG@25
M<2KK+V/=J+@FU#$5+[E&<&)GE='CG&(Y[LRC:E^?S%9)'87]S7#=,/EHA5+S
M_$+=)W6HNP)3V07H=478H=+-E0FDN17HG<,P2P(M2#J*Z)+\IUT<8V>93(H<
M8W M%BQT45@HM8$UF5%*;:O6^0'Q*)UBJN"5*>%*XFAF@6<7A6,6@22 ID@+
M+JG*$M /:+<VC>Q[/P1K9E*7*=$C.&,R4]B J8V\1,XE5KH*L+6_J6;2N>(>
MC?9$B$&%W>8F&;,9HK'")$;N#4BG!06!0<@FPI]1G1>#B\JX8QK0CX@F95YQ
MG]!#T3='0(HJ5J^&)1;N):GVS,_@BX3OQ%XB->?U-M-.*B-JZ4Q<3M!>YO,E
M+9K06-5G=I&L1N:!Y<Q >JT;2,!&B@!Q; A)',CEHU;[P(IS.6Q2&#Q3LH/<
M09<1)Y.E# ,A,#@-A#<D/VBNTC0BH&Z@**OO#24YBAC]=-A/DF>Z8HF&\OS[
MC%"P MWCFM_*FI7Z7(74J/60;*".;V&U:^;#P#I1TBTHN6PJY-8B=1,%"4B(
M7*JY%K$E6!2GK02XA:Q!P>W :A(.QL.)9(J^;*&-)W4K.0V_CE^MDJ)=-0D*
M"%#1A,5%$_C#23A%*I.%F^??+CEIPH]7L1@TPY>>Y#5]H1 <);BS&@3>8=HE
M^5+! C49_$>KD<LU^(I<[LM FX#*:LD6F$MX-[BN3L$U$&GX])6TP#09T/[8
M2B)Q(_*QWQBM L,]DL<&MTT8[R6IV9)MT]'W1>Z8>"Z<KX/9(2$GFTI12ZCD
M@9NQM&7 *7G\) V:9&LTU5+((R,Q%8W1,,MDI2[IRU&60O@9-CCKB^066XM=
MH6>(G9R__XBP,7<NO0M$RE#GV.*DW$ I ;FR9K)P$MB>$B@G"4AK9-=2*RFW
M;!RCW!([24= 18'LC#>89QFW(Q]CGOH8LW3[\H(S7<6;B 5BRJ**:IPGZ)RV
MHTXH5PS2(X,04]9[UYKT2;'#2U5\T]SL;38!J>=/N1#WW$!PW$--Z'WF?!AY
M49Q8,DZ)S(([$)CA<PY.)4*U!30JMD;65Q0:D?4M])0\SO=DZ[1.G0Z[*%2S
M+I0KP!65TUFW=GC1;*(LY_P 8$,>,=W<"PBR6R8%Z&1 +6A#1-BU%<(WS093
M\L20ASSN$\([-D,<&EFKF.$Z5WT6"0"\L"SRMA2%2SH;12'&U)"_Y_B-;5'E
M][)Y*WUF2-H&INT1 R1]C87W&.?"GB,J8\49<B<7/+24E'LW,#V>+UK9QC$$
M;?X03AH+)T!'.1YC%A'F4!IO3E%#R\V>81.)[2J[1& /R]CB':5?4-<(:A=!
M6:,&7**3'VWH#2GMSX3)5>-QA@^;,:@%P:?C,<7/77.*ZL#4$9;OF^R<RGZN
M86$6^4081NR,$>\=4S^&&??2>0<:9,5(AH[,5*6"RLL)$![G:"08-06]@'D(
MMQBA4KO*ZU5?C72V4^HRTLIS!W*+<4,7[ P[%".R95&%!>H2*O>%V$8D$Y!U
MIV=,B@3A283+W6?<Z=SZY(V$=4T(NF2O,U@"DO)Q>!M0FS_8/6Q\DAD*E!Z4
MY>%@EEDNU![F^'=V.)Q>FCOP$0-X9S<:?_^B==;,7:)B-THJ2;_!9H/^PJ9\
MINBO*12M<[TY-/?%=2-9&KUY<>M!.>/I9GYBG?I"4%^X-4SY15P9WG[S"B^Q
MT#CFZ$I]5)[:4)U0CA/EF0PV9_U5'2BIIL!ZD=.4+ UW^$6KZQ38DIMD*Y8M
M;1JJ 0\R<MXNC.,,R#"1/6M*"@G.K]]9[18,L:M6;,N,%+6,V#JV+GBOLK3F
M'=61T-2DV1S!$+)[ZGTNK84YY/DH1ZFBL3'[NT,-K@C3O%(MS[!YE=6I&!6:
MRBM==VYD_#T[^YU2(MUIBE\;V5D/32C[9'I<DSY\I?O46-\8!WX/#8^O9C_X
MLS)UP@V"$.N9AJP+8B+=VQ 4=NJW#KR(X^DDH-)D$D843'6ES9#U\M%8^:J6
MVO@*1F(E^D73:5A]*7R6A.8S+H<Z('I24967,06C=Y J%Z+&8-Q>!#;N. F/
M*?*>3Z_6HZ/.&0GM81>&[X>:$6!=T.I"8QN]33J^FVMF9+8GPQXS<9FDO*)$
MWF:CWSUNHN4 ?QTWSXRJ&[/4QLXT,?0LAHFG/#B:<YCPO9A7[XM(%O'EFRVI
M XI?JO9RL+]]50@ VQUST ;.>!@7DN"H7$AF^<ZPY8QT^JHS'X94[9-HGSB9
M #SRD)XV#. [F^KEZ3-;P;"@ +6:3DLWI"XG&VK,0$[#Q<1UT(<:5JENJ0PF
M8_.H9*G\%=G)+;T30 9X\?@M2Y_2NRB+ID1N'PSM /^993U9[A1ULX4;4P?S
M=3#_M [F5V J.^]@72DE@TK5KG( H_NK9IC^S1"3" IV!UC3JO(@TS?R"8HK
M&_"8(4#EQLHW Z+**I'55871V V4[V@'Q55FW[Y\9=4Y@P 9O6&S!>=%GYJV
M]W^JQ,'(=,L5ZO$.8'288&\",ZE#UC?;(%]N@YC'RI"_3!_C$OC<K'J(LR(B
M73XL0YZARGZ\\3C=P:-ERWQ&.)>9GW)EX8!QU&4L*<OPMX;SP*6^(A1@CB?>
MB%P91F]+P[N4A.A19I-%%7)D >_O.=M9:4F9E*:+MXS,R#.NO),@Z1AB7!5H
MHXB]8[.4DSV7'L/[9*3H^::3G[6#%:9Y=>_]!ZGL<]E=(LH@DXD0<PY,VI:8
MR_L'*5[JA!QBH+V[/[-^3\IJ**AM317>Z"O=C4P#];/BQJLS+1VKTRUXQ#"U
M.@R..<@@1T12\N=FORE3SQZBAVY@@$93CREKL8&5:59D<-&W$=@5Q^%HM$"Y
M"L]CJ$(><;)\4WK%A9307Y9I;"PEQLPHW6-) $V&<V'TM<4Q NQ6;Y3'J(S7
MN!B3QKIK8VP*,6-(W"@Y-L.T:",EV46C 7.Q']LLIY7-/]DPR?J1@#S!N'!,
M"++%KF#Q:M*\D67.M#WE^]HH$@AN%89>YOE\)++MIM+0X#>K*>6HD6K#A='F
M2N<K/,3]7^:$61?JH+L>U,&.0MT?="['=3J%6<W7W+%V=1@F^7Q)2%*R(Q<B
MQ;R:91Z1A>*,#=O;+Q0>4&(7APXYE6NQ_^EZ,!<$?O0763VJS$34T["QN>_.
M8O%:_?$&K[GOSE\#+\5=H1^]R0^/UM0-5G@/7%_:C71L_'5F:#D--K:2"/Y_
MJ-XLOW;HJU?)</&[DZ[3:2W_NN$TEWZW:MB>TSUM;37JZN^Z[7JN)^N."G2&
M)/S77]J_J.<4Q8% %YL_^8JH*ZH'KY^L-[;>V/U\LM[8>F/WZ\EZ8^N-W:\G
M[]A8&8%XW;":9"TMC Y&=_'9UNPG/OUF(8!6-(_8,GIH6_;..$^#35DT/C^S
M\7F!QJ>V(I_SMNA8]C:[4;)"C%P]\?J61K+*5WQT&:@X.K8(_SD0L\3(*^?P
M=/PRMQ_EVR"=!X2@"6,P*)A:T5Y1 ?I='FK!2Z_(@6Y<J]ZX+3;N'24-K;%U
MCRKM^N[@QSB""S\\ENL>T7]6[>73<;@U(-Y)LH7<Y9DA@8I;>M=*UR:IAK4/
MF_'B\=9OKIO2Z"NU\+9]VNHYL@;AT38!O]UP,U:QL[NN7Y$EUL3\/(BY8S=[
M3>>T)N::F/>?F(\Z)RWG9,&@J"@9/[&^-1@(L6?ZUD<#OF>I MO:;,VE5[AZ
MI-RTNYV6T]J0+Y>?\:.RWL(KEYI6AWI,IZ?-^IBJ?DQ'+=#8&^L+AD<_H-K6
MONO(+MPHH"PY*N'*@'RVD@,EZ]\3RFWW>L[9=MIYA13P S^DTX:&5JD/J:J'
M=-2&4]K<.#@8&;"'^O\7!$J6<N"9Z?^M5F=CKTRM5NY .->Z?\4/Z:AYVG&Z
MM>Z_1WS_O8?EXT/-^[.D@?M([P-UWNZ1?[;A-'M[KR;7)+=?)-=NUR17D]Q3
M*AS YCJ'96>^HJJ\W_:I OT<.QJ[V+_<[(FV=B4E8L#W";0B&*J23$8GC85$
MY?,2/^N4?I6!CG_5ODI'M4[/03MXL3$C:A='"(_<$5.BRAN@K58:*P@-K$#_
M>'[^S9BOAD>'H>54$#$3X00TE+::12 2 [0^R24S49$Y]L90XU&KZF$.^DWA
MLTH8*MB/52-BO7LZ]51/X^7XWMSO H'$$..(/QQJS/*L+I4P*^C7B2Q/Y<IX
MKF+U8NZ?2:"8".%!#>WR&R%?)5M;RA\RM+\?(O:F?E N*BF4Q68$(U>37X1C
M_1M;=*4)4"-BCR(J"'>NB%9OE7G<I1./0]Y%'J% I-C-'5:,E>;P[@+D_!W[
M+AM'<8<TA*K@XG/5RP%ATV17AVR;"<75[ J*U?:Z:MZ6S<-]B2E,F^CIHY%X
M"$CQDL2P)Y<8I7Z.U B@ 8%($&1.E37'[A1Q!+"C]N9%\<PP_TCCQ!O-J\*E
M/A?0%2VW'Q*RG+SH^CH2/K+L%Z$1^E9P%0/[;8AK1K0("4) -&1GG^>Z&AJ?
M!X;W379IE]]<O+W\_O[<.G)]'P?,@$T(<U@U['F99Z+ +B2#NL1.("VG8F"<
MGS6BA+[E[S/!08VE@=#GLB=Q!CGP3K6/V"E4YW'%=K-4'C[V'%?."$ZP6EMD
ME>_1L?4[0V-^44P@H[7/DATXN]Q(J4X\#@.^ RWV^4$4GBV'*-P$P.7LE]]J
M8,.GGLH.@ T?G4R7-9LI865;PPVUFK_<N=A'U=G6+W1KE5<\EL+MO#/@=M;Z
M26M-'GNR>_2=7L_I4.OXC<%WV@WGK+D=O,QJD)B3=G>K4>\"M-ENU'JN]5P/
M::Z]M4:];[%WN[P4^L0Y*:B5U:N[?.0R^#W>F;H2GBKA?ZU+W^L*[KKT_1$W
M[E=K[>+W76_>2A[VE'Z)]>^R]4Z%%"XYVO H3JFNTUIC1B7.(#R"XY9SMFB]
M8*]$=A4<-5\6+.SJ4DCUKI<T:F6L2E/#U1)\A KNZ9[=NL6]5AQN'^]>J^SN
M/5!:.Z5/G#JGW8KGP7Q14>%U+LNRM3_8+=HZ<[B>9#W)9S')!\J^YAR]EM.J
M.G^2C7+9._U#)!N#'M6IB55:6\MNGC8.H%2QIKK]HKK.Z<FV@%D5HKJU"J7V
MN$"VV7KJK.5=+//7K53MFB$=$$,Z;6]<MED];E23W#Z17,MN==K.R=Y3W:'+
MP-[S$X$/Z7+;!YOV8R1<[$#[;N(%[C.#E>B>=#9F0C5BP5,?$N@GFUI+]2$]
MN;7TU) 2NY<4-66LA0K3=1KU[:WV&75[O5H.5OZ0=G) NV>SSRW(]/?S+__S
MW& ]MP!WKIT!3WQ(G5:[QEZM^B$=-9^ARZ8FC;68;.UPK?X9G79K'EOU0SIJ
M;N#L.!0>^]S<XA=3@56_XV697@=N;)YTFLZFX)2U1^"I _>-;@VX7/5#VB2&
M>B@NFYHRUG+H=9U-P5CKV_O4<K!W6K/8JA_2<PP^/JA7O%=Q99P[30?+JL/N
M6G/=T/0P&IJV[=-FW6JZ)N:#(.:.W3P]VS;JM2_$7'L"#\\36/.YFL]MTA,8
M+*A:9->D? "DW+9[S9-:9.^WR'[RGJ>[E]C25Z FH9Z4P+A/#S11CU&/L;=C
M/'7'20-W2PYQC,^_/B$XIQWQEZ_8)B=KV/,H<%LGA*Y_UUR6P6VUG1*@;@-N
MJWT7U-UABK]F8^-JC#J_Z*G/"&CW<,[H?JRQ>J?SY7.=>[KQIC4VCG17F*(/
M\XB:!W5&!\YU'B@;\]Y*:+-)F9P[VA0$@$4WBIN(A1Z2>ZB2=I:HI'<=JO0L
MR?XT;;B!PS#%;C=JI<_6__CP&U1M+M&V3UN;!\@??)=VG.U4WY?ZOJP=@^\U
MG=-G?E\./COP&:8'UJRT9J5/'N;?%$GYT!AI?5OJV[)V)D'K9&,O[Z'=ET-7
M/#9(-3@4O8,<4Z^H;^YO.^U9O+*-^/\:_UFSJ3!<LS<YUQ=V:;^KD_MQ\^SA
MU[B&$ZJUO1,JTY6?_F#R&]QL.)TV;I]N[^1Q8S4OMN))>!M8;FREP<B]"2-J
M[GRD_WSIU*>ZI+E494[U^T2  ) =O ;JB&<BPI9B[AB^Y%9><-H@S&"E0ZL_
MMY((YH$K#\99/9 5&KD((_A'@F/3D F.Z(5#RX6_X(_(F@LW@A=C[W':0/6
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M+->5B 75DOZG.YV]44C,!(UV44C0V!\HE2M:S'N58K(=FLI9R^DMZS[4:1F
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MB[CI)[/%,?EC@;%Z9RR2XW3&SMB?7J)V([LK.LI(,\["M=(B"&=H$TA?L!?
MD9+.')NY>^@PP# DV0TK&9)Y[&6,A Z[4#U=7]M'O[:<,(IX_S^I3'Z9SV<
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MQ  LWHR5V]SO1-X:E LG9RWG9-.N'2=% GN*1C[E=M!E('<I]A8[^I0?B8;
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ML/Q..V_4D\I<(7\\O%[\9$-O=7;?+DBFN:<DTR2:^7WV1S@)K/=>S-@YH+^
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MS: _P09+T,.=6&WGM(L;W70:#5V(J[XW:G"MG#^9$GV,IZ39!E8Q!GUMU ]
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MJ(D;6T/,]22=><@8(!%79L!K^L**X=@X7QM%6E],7'^$=14X$)&5?(#2-=,
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MC#*LU<!(F*.4>Z/0D]-"$/>!G!VZG/GR3Z?6%*9AHL7JJ(@5,$0I1Y1GV2"
M.H[<(0G%34AU?92;6M[C6/YPZG@\M&RT(+670<JR5"-),459K@W"Z4H:_"*@
M@>P;4TQR)-K^/U[N_RQY@SKZ>21MNPLLJ6]]F"5D+W2E\6?8YV74VNX_6>Y^
MQ:FE6*$%+P3,&@1&%_:4F2FERT3 I=7-U3Q](3=# VJ\C!@RTT)UN@Q5PC@S
M2^5YHX1Y@Z#+>F7 ;<G\&BM^";$6FG?+T.0<-RAEU2 @KC'WY19'@+=X0O@C
M=ZF/^5S-+X9P5++0@O)^&92$'7H##']$DB5*>$;S7H/@^<R8^T*E.>W+)2/
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M15$G\6^#:TB>4M\L(I<3&8-:;^+Q]/@*D:733J26&YHL$EES8,$!9R8&6W@
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M14>/=_%K._X@]T\?>DAOCNK6(R/N4K)YU.KQ%VT'HDF^5,E$E@:]"(Q/DM;
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M)Z^GO^,$?_P,DS/X;39=?&J5R[1W20$SNEW3L*YE]3M@TJ0BBQ?*)>IMO+T
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MWE:FW%69+X;CR=ORRW"8Q\\&^0..OO03CC\,3W.O$)=0 'D7W)&O5IQC,8C
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MD7C.K"TJ:.YD=JW/U.^ \^!/-5N)NON8+U&<\":0=ZTRK7):J.J/)!:!/)5
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MFS?M=;.$03L?Z+_L?^EG'.3QE?VSYD/W!%J;?0:&1I/M[H1C@6O:0\&8% T
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M65)2TAD-3OA:XL]KBGJPI #:,1FSM+SU0,\M<(Y395K)O\-4JE_/+_*<X'W
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MW*PHL*OS-W5VC.DDC6G=.VIB?7G")?'>U&4,&QW4Y-[-Q]75I7688Q((/.8
MJL[A\3IK2-':DAQ+V;<.H-<"V5LIQJY$S5I+N4=7_GSQZ_FWO#I<OX_,:'2<
M 1=2D*HG#]XJ#E(8P2SYI*%YEO1F-,>B!(WD/752H\C>F%#DJ@,G&3P-6,@Q
M--I(E514//1K-7@X28W/V,E]$I4=CG2WYN$,P?8SR7$TBV/2V)Y"P=1)CF@R
M%X8L+OTOUN.1",B,)"=,6&88^A1:3ZU[7DF.W;1CC.0G3W(TG%;F50:AD'QS
MXPV$'"2PG)A*66FI6@^5>4Y)CJ.X&Y7D.$;P'7S8#3U:-6H"41N&4UA69RD)
M0*4"2.9+9K5U7/-4Z&?1#G<7/6@@ZB[]D->Z6$M3&+4/7&--Z#495-;D1T5>
MP)&7S;A)%+2W+L?9 N>GX[K5<6U%9(<+X0W0KMZI(> Z.:Y;@>W'<VU&XS#U
MV(&#Z8S1=?,=;3+R9" AF5R5 E*0CP*6M\C&NI)4ZR87>U"01WS7_>C'&-%W
MT(N/>'93OQID4@(Q@>:9MN 8+: MBA;II3,J"ZU;9WO>>?ST_DA#8F9MI-K1
M#;TJ:K\")6TV!<G;BK84BL<L0HBT.)E=429D(73[%WX-D&,B?7=)]\JM_1&1
M\13Z: K#@ZI-2R/6P6:%07!,(8\I,].E.\#1$K^CC#L<9]82]U5I>HZ?ST__
MYS*OVJAXISW7#GBJS=I\=(0J,S $,EEMC;"MCR+6(_D9<&P-.!K0UR&K[R&J
MZ]9* W!U"C,V8=I/A-&"MT=580>A=]A?-N)303/.C -6&S4I0Q8P,$%>D(Z&
M!>X+3ZUWF6F5X9%H8DI=&"/K'C'$M6W\Y7\N3R^^UQ3FV7FUK*O6!EF:*$K%
M)4V]ER[D_T8/W'O2SA09RN91Q39 /_>>K7M/.S(?:IK>5=/N8;KN@#( 5*?]
M9RV@_6P^#8F;]9)Z!^.S'EP,.@A.H78TFJ(N$3QXI#= N=I\7]?TIM:9(1.J
MPB-;S]2:,$;8'33@58R77R[/:C^%]_GBVJ*^);'<#C7Z??Y_+_'LM'PG$_M#
M+<W-C.^B@@F1;"2WD423': 0M8^U$[P$J57S\4,M<$\?1C=0@=F>^>MPRK:A
M.WH.6804"\1D:]J#D>"9"N3R&>N,\=:XUO49AS60XIDX/0WH>ZA4IMLL@B&X
M7O* BE&\#1U*\!2A3SF@@M&>[I%,<*XM355]"1P+&KRR)>40-'WSK)7A:0,J
MNNC"&%E/-*!"!R>C<!X8(].LF"\0LE+ =?"HHC4IM\XK.NP!%:,X&C"@8HR
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M7$!B.8.RNAZ?E#K]S07,.1GO6P^*7H?CI^ZTH:A#5/IF-O\ZF^-%?CT[3P_
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MQHBO]3'4^]E%7I]G=-U!3P=G:S(&.I[)F:'M+=3$M"2R44K0GI:'<?O8DXZ
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M#<9QLD>FD&6S@B)6^A(L*;YQQ1CA0J'XZ!DKP5/R&CKHP!@I3[+;NX@I&!1
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M,O16I> P:DQLT/ST$4O? &5Z*]A53^[;QQ8$= B8!\K@U3=Z+VML\'8VKWW
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MMTWCU4S=W?+N7FX?8V&)!V Z15 Q4T2'H8# Y 4%?SP$G-#L#UG+-VSHDYE
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ML1C/S[8:ZZ7OE.*O6ROOC>?8$L?*9'(1&6*H,Y7KV!E7BVAC#($'G474'<_
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M%DWB4LHPZ#[KN2%ACSS[6!4SW76]:"CSUG/B;O"L*"3:(-J.2AL"JN%\R)U
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MCM8C6QG59; 11,JUA*F2RV@DH\.,G 5GO@KB7GB/[-Z*[B+227MD<Y!:1>O
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M1TS87:(<^_.P;_N[U:,>@*)\^BM=/M2?K,^RDN6CK!94A!F/*(*8)'H5(J(
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M9E_^4>ZPTHW^5T6Y(9J_Y>N[3WI)\'13G+JZ2U[$C!&>*K-4"C172+U42J,
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M"2D@B1(*>29X&-*4AG%J_6D9K,8,/S!!<RH%-MH"HV[MFQI=@+$&&G.>7>%
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M_G<[S40D%3R-$(<\P E$$140,X$AR5!&4\4#+IRR6/J$S8U MKINVD$"H^W
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MUD,><PR1B$/(I$QAS((DDRQ)$'4*HYY0][GQ\7/'Y0JTUH/:_(8A-@" '00
M>P(=!J !H6X3T<  =G$ 6R# [P8*4&-QF2\YZALVR#>=RWLSL:\[CU?F4D=Z
MBL$;QS$?5?.7=/2G&)(S"X=)5!BX$!'__E"MZZ][V^OEIKBAW_^6K^_NBJ61
M_TM1U@&CKYX'C"XXX3R)> )#Q3*(PHQ!*O3W-%64IARI+ Z"KK+PC</:9+A*
M5ORV7W7X9H+/H]9>FKK#S0[ENM"^L00K37*5L0)4<KU>-JYSH8#\CP<3\STD
MK>F2P;1<OHP\-C.)TN\"#.O29=H^L&/@*(6W/.#J:TUS@2;3KF\NA^Q@K>/A
MD0-;EQ:ES&]7;[_S._,6ZA_-].]JA*I8X80&,(CC""*"",2I8# 4# >4JTAQ
M[K)0Z1,VMY5%JRN0K;)F1AIM@?DFFH-41XKL!=J. WW!-S+)=<AU>H)6T1%2
M/FT0\=4TM$_4M*U!+8P^: !J<\^ L/6FFT2AN*8E<^Z4,9Q&"J;<;&P03"$A
MH8 H33*9*2()MJH]>OCHN;%#HYSQFFKU'$*B]Q'KG_B7X3#R-/<%@4/L]V H
M)HKPMH7$+8#[J-6]8=K[=TP7C'U4T[V0Z^-7#"">_TGOZ>KZP<0T+7-J]H?E
MM_\CS7)7?)&W9JS;3VL2$1X(I""-(@21$I%>*RH%$8J"+$Q2'F.K*&LGJ7.C
MJ_]Y_>'_.$Q0:W MZ&L,R$9FMEKE*[!1NCGHD]] JS=H%1^2$6,-K0,MC@'Q
M1(QI"[4G*G5%JI=EK1\V'0&[VK?'S<XW#]SXX[Q\,'WHS4YEO4'5IN LTC",
M:(PDQ#*F$%&]YF1QED 41R*)"5,HB]SZA9Z4Y3(5IFD4VAY+K.L=NT$9UJ>!
MM=QB\P'6R-3<ZM@%5M9:CE"$]2P4OO:\3LJ9=D?KG+D'^U5G;Q@:7?XH5P]Z
M44!0'"<ABF$6<$T%422TUT85#%(DD$A#1$P7BV)-EW9$T#W8R3';/'[$#7HC
M Y2M=J[AVRU8 64)"Z+ M#LSI;!3!G&,.,0)D9)0@57F6$EV %B3A,A?!),=
M"PXQ?F32.VOW@ #R?2.]!8.WCYTXL'O?F,,@[6=_'\9-7;7[7%9UG-G-'5WM
M)@OO-&@@:1(+21F,!)>F!X\)GU0)S&@6H#A,PLBM7HR]Z+E-V5I=M_GJ@+/=
MC!X'O9'G_([25[MQC76M@)NN5L XW3'< ?/$'PZ")V48=T"><]" )PQLVK,M
M";M]YB:#-4J3D(5<0!($ B)I(@^UZP!%0(.813SE=M5CK*3-DHO: L>[$V=P
M[G _UG;DY W!D?GH$O#<V_/8@.*K-4^OK&G;\MB8?="2Q^JF@<$!-"_K'A@[
M]/6;I"9L3'Q<?99&6KZZ?46KO/K+JF"5+.ONSN]6]P]K_6>MC[ZKWD)\];3I
M%O3:I,RU93J$2I5BJ8199-8O89!!+'E0QQH@RGF$W3+51M=X;J1F# :UQ28Z
M=:,QJ%4>F( R_K#;<>.L!G-D?KUP'-TC)Z;"UE?XQ>CZ3AO#,17\!X$@DPD>
M<*C;58HM5&&^:NW';+G5M"[^NL@2Q+C()"11HC\5*5609#&%@0JCF'.LG=O
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M< 5V*L]OK+BT<8#5&-EQQVBXC\PL1V&MN]M>_W7,>OXN,/FNS6\E^V7J[+O
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MK+4P@%\H%-=8]8A\IQ^W+%$@.&?5B4+'"?0GV4)'C9W9O&2E*HH<801$A@E
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MS/Y"3,];?"L5A+4Z-3'O@F0]ELN-:8==@H'I]5;R2+M+5MQ"8/WA&S[+Y)H
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MMMX/K/-V[#W'"_MN?MJLA5)R^]8HV)BK6_-EKIR$;Q<KMA*+U?V=V"U^5&[
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M)7O2")^TI$]^L_(GE0(^#.*Q' XT/ S(0_O))H*O!UL/@_-(S-U&LFJTX[@
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M0&PVA+I4@DJ:(:\Z+1US3>U-;[RS1M:3V*5>35\N@^P:2A$%NL&C)@)1"^P
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M 4FSW+QZB .J)0*E3*'92)EO/BQZ1A5,\66\=-P=U/3]&JYN7_((: W\_H8
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MK3/#KW^LOWY;/V[92KXU%/ST9?%G\7=8?-HHH5:[?3 %3BGA>0D0UX8#,=>
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M3M2ID9/5-*E535JZSI)&VZ12-]GK.[.&W?&Z9*]SXSL("8,9\+%P8\5I+/;
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M4/#8=X>C,=(>VQD5OSWW9;T[]]?/;AEO+WU9UI-]\Y5+XENZ1YM&YK10C"#
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M.4DIS%.!-/$*"EDN*8PQ0QPADIB"XE;$.S3,_!BW%=1A4WP./PLG0@!,1N:
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MT^F:+B^LO4 Z-GV;S0Q85[J;B;QS6L>,PK#5&.RC O9@ >P1[%_70P-:;&Y
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M&&>PT-L-B!#-(,M1#"FE4L8%S:6P"@]P&'-N'-T7&=O)?+.7T['7+,&-KFW
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M-IOC]2R),TPB*&.SB4BY@E00 O,TSCFBB$>(6'//Z3'FQD)&2-!)"5HQ';[
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MXCR7D,I8%(0EG"*G<(^S(\V.!'I!-V6$[F4-/M2BK&C=6]YN6Z3S$-OM=H(
M-S8;;##30G88@=]'J;MT$8Q 6X;SXTQJ_5]4]ZDA?_D&CV(<]4H\\/6'3=/>
MVQ]ELY D4@G-$$P1)=I H FD"J=0**D00E&2I/8E)4X,,#=6Z&5L4X<WG<)_
M-X):)LZ<!7*8!$+ ,_*W[X&,6[6) ?6O*3=QZK'3U9L84.J@X,30==XEQE;?
MY+:>V;O50>.(.)$LHB*#19;I/;=BV@#(\@CR(HD%1EC&KHV;!D:;VT?>";LK
M^P@VXGKVZ1B&VF[Y#P;@R#1P!78^I;XN8Q*NL-? 6%.7\;JL]HFB718W75M<
MP/3J[;+@E<KB.,D)5#&G$#'.(,M3!4F1\APSJ:T$J_"8@3'F1AM/4^:-H->5
M%=C!>=E=$ "DD:G! Y\K"@H<(1"@G,#NF<]43.!(J?.E!(XO]3SU/:KMIZFD
MZQ[V<56WYP/K=5VRAS:RZ<O*A#NNJK763S_T[FVEOSS9K!=QE.<R0SE$'#&(
M9))!:CSY"+&H8+D4BD8NK0W"B.5$(1-T-/ABQ@"RU<?Q!#;,-/$\IPG1AI[F
M;SU7282Z?&DE\R1A&>:,J,5]>[RCUY)Z/=?)>BKB>%/V@BY-Y=]GF2T<"VV>
M8[WG9H707Q;)(4VE_J@*%!'"XSA'>3];KRLQ[[G:"/@_<Z;LC/SIL1_;(=@J
M<0.V:H!>#["OB.G?<J@*V.@2,#0A*+:A0A+""#5M*$)0((]"$,(^W2-E_V.]
MNJOIM_?ZM=XX0P2)."XDC"DR140PA4Q% F:IE"0768*850#"Z<?/;1O3"PB,
MA(X.CS/X#9/?]:B,[]D,#(A#6O]5P$R4W+_!!*A5#?;1"I3J?Q:#P83_X[NF
M2_L_*_%!\O_YJ]Q/9WXKJ_+;P[<^=CR1*([C%,%()K'>;1'2A4RQ1,H<%4SO
MNJR\+T=/GAM9]<+9'[X<XG3YU,5;^Y%)J9<K<$GOD]I><;IR^+S)CE5.JK%_
MGG+Z C\'B?Z*]0YF_?A1S\_ZMA+&:KDWK&L:_N42YX5 !*82ZP\1\0QB@7/(
M\YAQQ:((*>IRCC(TV-R^S8VL-^#>2-N>#,J-O#>@&FC:YP$TXCE3L8)QA@J]
M%<8"8L1R&!5)CJ,LS6A.7?Q+P8">H@_FE$#;[61#P3>^:=<C]W&+W.L=<D'[
M2MI $FA;.3C4I)M%&Z6?;@&M[O'CZB>%(]X_&/[_H-H8F?T"$[>L6=>4KQ<B
MS2(J9*1YA"N(6"P@PPF'@J(<B1PCJH1;HK*K""Y?RS1YS-O:,;2O'=.TLH/5
M3OC_Y48XSM-B1T)C0CTR,1W5Y^F$-XD[G?B'Y7Q>E<L'<_7O&U4"GK+[HAB(
MRYR'GY3??,%YRGG>S_'CP4^2R_*[\: UFE1?/M2FG\U"\!0CE6"8Y*;2#<TP
MQ$6$82[3(DTBRA!QZBM[<I2Y6:E?:LWOH-Z)ZF$PG8;3CJ2N!FED)OJTC\Q[
M4\FVES$<PPQ"$(A&3H\Q*5<,JOF4$(8OOK83]>E$O];WWJ?RW?)U^;U</[;-
M<W>QZH0AS#)M $F&M#U$HP*R'">0BT@*KO>ZF#$W>^AZH>9G(76U3-K,2--N
MJ!/:MUNT]UQ9GCE.BO_(9'6Q&%>GR,UV4B;J#GTMM,';07L+]$S]GZ\%\'S#
MYZN??'5!L5?ZZ4)68INM\9(V7S_24BSR(L\CG!60$)E!I%1F(CTDS)@0/)&B
MH(5OC;&S@\[-/ML*"NZU=."GL@)BM5S2NFE3LMJ]Y\_>5;3.8V_'GJ$1'9D?
M]VMMF5UC+_'-+F%+FW>F6*&1>Y0:7!=1"E^6Z_R0SU6IZR(( \6[+M\;NIU*
M\^+Q-_I?J_KEDC9-FZRD[3PJLTAJ Y!2B$0:F^-%#EF44,IHD6'DM%%T&'MN
M]#38]:,Q55I:^4&K@%.JF,_$V)'62'"/S%U!D0[8:>4L9J,W7#D>>29]5\Y"
M8M]^Y?PC_.CMP_JKK(V%5\NOVLC3(W89,2:Y6V^P/Z@O],="YD2R7!,9SK6I
MA9A$D!:\@#'6OU6Q$)%R"E*W&71NAXFMS(#O"PV6JZ9SBQG_\YK^<",P*^@%
MBU'.)8.Y,!$KU$P"2Q0D+!5YG.4D2KG+DA(<^@G6DF>"WF[1" WHR*M%A^6!
MO*#/3>P*.FP+H7T9 -5YF7!!*=#Z8#7DI N#"PA/5P2G>SVWWMI@?K-<_?$7
M*>[DK[2LS+._K%[(3Y*;U:94I11_+]=?R^K+'W+Y7?ZVJM9?FP6-TU0P@F":
MX 2B)*604"I@E%.]4:>10JE3+(^G''-CK8^UA)J86HXR;&5.@BO0EKQ76COP
MU:C7F!A_UIZS;%4#YLT!MQ]>OC9="5= ;JJ'Z"U^9?QQZU9K\*U5VW&+[SG'
MEKO^\6=N;$> F1ZC FAU $:)3:6;;J;V50%_M+J . &_#4^&NVO@.BA#>0L\
MI9C6@7 =5$<^A2L?YT>^K\KF?M70Y:_UZN'^93].EXO>[F!)'C&1IUC/46PJ
MB),,8N-I(*R(D(I8D?#<A60OC#<W,MV("UIYP:' 7NZ#2X#;,5Y &$=FMJL0
M=*8O2UP"T=2ET2:E(TO5G]*.[6V^V>I]@8L/:L-OS2Z8+V912E4*"\*%YA;!
M(<GU?VB.*4ME6F1VA61M!IL;L>P*LN@MSW;U;VPBQMR!MCQY#@3?V&?*_LAY
M)*E>AB18ZNG 4!,GE%Y6^CA-U.(>7PNE/V#9.W0Q8RQ8$B-)(\T<6:[_PX3>
M_Q4*Z_\@SK",")'4H7_SI?&L/H%GZ.=LO@"Q/905QEBLI;@!_T_TB]X?W'<>
M+'/*V+@7R3R+O:V5<@644YDGVS/7P\-8(V=(NV08B6 &R9EA)K9$AI4]-D$N
M7.]''-VYQ<[:8%&!8UG V+BUD4SU3D;2 A8)S10K2)%1[A8J=SC _,+>;C]_
M?OWEL]L7_P0TN^_<'XB1O^[^+'(,T^"TSH&^XR</G_3K/:W8TV_VS%4>]1U>
M/#1E)1OS\;.R:C<>+U?5NJSNM#FA_]5H;JC;7[\K*2N7Y?KQ#2WKO]'EP]9-
MLF %2O.,2YBI@FN#@)L:/+G^UN-"8RN++(FLFA<%DVAN^PTC(/AN)&R=P@[E
M$H+,SS"// OJ(U//1AVPIX^Q,38:@0.5;L!6J1O0SE6KU[X?>.HI<RB*,?74
M351'8[HI=*N_$1+NP9(=00::KLI'2%P."H,$?;"?,?OK:B7^*)?+V^HH,N=5
MV7#-Z0^UW)IMA'$1%WI#G%%)S'(H(,E,G4>,3$9(7I!4NGC6G$:?V]*W$;[-
M)C\.5-LIX.U\<YL<.YMZ-,A'7O>"HNULE7NA%LAH=QM[4IO>"Y:G)K_?0[R+
MN' I1?-&J_*V:1Y,H<@/ZMVJNOLBZV^O)%LO6$H3)!("F2 Y1**((":1A(((
MHF)3#8 [)6-<'G)NQ+:1N O<*'N9C5M\J:6&6H1O0&BYG:N-7(+>CL'" CHR
M;1UB^78/2R,P-!*#5T-8^M0?L80G7!622P-.78O$$H 3%4EL[_2CGXT95\IF
M:\CM.&Y!L,@3E#/(T]14(:$99)&VL40<(942SB.W*E+#P\V-=MYH$[CB)>V6
M^/>K2FU_L:?(P1YHIXP;%UV8!SL>"H?NR!QT!7K.[&,'2B#FN3#8I*QCI_A3
MQK&\Z]HZ *]D77[7&TD39:OMJ-;)T;RM]DY7MQ_?QU53FAWG5IQ=HGF<X%3E
M.#-%[O3NCY$,$LHHQ#Q*5%(@S5&I4UQ%6/GFQF<;]<QBOU,0[&EH(F /P@YV
M%+A1<_^#]:TL$&;V[4CQ&>=T9!8-/IT3U20(.@_!"Q2$D>Z9JA4$A?9\Z8*P
MPWANG+LJ&\TGN6PC4%9?Z \3-&Q*N)?5W9M5?;K PH+F64QPAB!"A$*$&8.D
M8 4T?:495S3G:>(13>,KSTRC;;3TLJ]\4'<:F?!\DVK11M> 1J[7RRVO=(UC
M &T+SSCNPGWGT7)O/N:T3+1C[U2X,0EC8$_V&W"AZDS +?R5*(;:V/N*,>UV
M_TJPCIP US[O:M? UJ//1,03E.<P3S)M< OC#XBC'&+,(BF(3%F2N(46G1AE
M?O%%>T)Z;^L=3T6NQ&6Z#?PHIQL#VH??J3_/2<6 B@-[\G"G#J:M[VTE^KZ^
M;?9KWYN L@A+1!04%$N(TA1!G)ER*PIC3HL<T\SI3'5HL+EMD;OL[4_RNZP>
M7#_V05"M3Q*"0#7^&<+3EMLWH(,N7%L(%TS"'1R<'VKJ(X.+2I\X++A\CT?<
M8OL8<]!FSMEH>PRZ("G.8Z4- ;TW22 R*9.LX!3F),&D2#-%6&P=AGAB@'GR
MPNZTL9/2(5+M%(C#G! "FI%Y8!14',+QKD1GHN@Z1Y3<0N0&(!B,>#MUWW0!
M; -2'\2C#5WG9_G\]?.76M+FH7[\+/E#W1I5_1(M4RH49CEDLBW"E!)(!(X@
M(30I&$>$1-C%[CD_U-S8[:^_?/X%],(Z[W$&$+4S>L+@-#+5_?7S!J!'L!-S
M!'/G,AJ!C)V!@28U=2XK_-30L;C#K_VF,9\^F7X(C3:BWFD+JFJV[W*B/W_)
M90ISEB.(*$*09(6 C&(D*8IS@:WJ0UB,-3=ZV)C[G;A RPLV KMUHQS"U\(8
M"H?:1/NC$X!=9@QGY-R:>@9"<"+;R>?5<^[Q:0')I8:?0X^8M/NGA2Y/6X':
MW.)G;)D&$J9(<+TR>:_BQ>-?&U-OLS\<K.[Z N>:OA=)*@J:1Q1256CCB^($
M8EIP6)""9"02 J7"I0*F_=!.;#M!'4Q3'; M8O9@CG7*"JB-S(!NA78ST1SF
MP<YD&P?=D5G9 -O5&._%-J5[?_IKA_+/8"L\N+T,L[-9YXY8(#//8>!)S3YW
M0)Z:@1Y/\"S,(96L:_-L4Q#R"_W1Y0*TW3\3$F6QWC,6U$2@10F"#&4I3".<
MR#S".<VQVX'8^<'F=RZVD55_/VV!4U.-D<E*JM(Q%'\ 83M""H/:R 2TA:NO
M!VO.\SLY W?\O(Q&J#(<YP>:MA#'186/2G%<OL.WP]VZK-OP"]-&](M^2%OM
M3G)>)$HP&*DTARA!'+*L*&!$XH@*A0BG3DD\IX>9V\YQ)V7;YQ88.;V*"9Y!
MU8X<KL=J9&+P@<FCV=T0"L&ZW9T<9.)V=T.*'O>[&[S:PY'T\JL)P"JK2HNK
M[1-S<'_7;I-W,7--I5>V5 F!L;88"F%:M"N10891"G.98YH6,::9< A$=!G;
MZMV?/NCPW5;<O?C"ICUF7O4EZOMD=%XZ]<MTFA<+3U1(F">JN]Q*W%:X[F0&
MRY-@CP6J@Y-J!' G\E:% =G-?^6(UJ CR_99TWFT'+4[<&VYWNO?3Z]<MP^[
MK<3+?8+:Y4WMDE:$C'&6T!3&,4\@,AW>B1 1+#+)1"SS+&*1VX;138#Y;2)W
MI._>3,\!>#M3<3PPQ^;WG>#M>GD@^D$QBE&R>_QP"]ARSV'PR9OON0-SJ@V?
MQU.NRZQYLZKW\\_;6(RWU7?9K ]=QJ)@,1,X@U3$!41IAB&)LQ1&7"0QCK)$
MI2YVK*<8,S5I-UH M:K!?7^:57>G65N[UJ/SN^LDV='?&)A/FB33X?S309&+
MG_O0U*T"HSCX/:$+G!EC._JS),0X0G,N#\;U,;Y._^]RN;HW+,&_5JOEZNZQ
M.R3M3]VQ*E@6R1R:[B FC1!#2DVI78Q(BK)(Q-0J M9RO+EY]MY6:[E<2KY^
M,,G$M1:\=NTT?PEA6\]_,-Q&=__WDH*=J)O AO!Q9):X!#L(&!YMXM, *]6/
MCP3L;O,^%Z!E)<7KOMG8)G@G4W&&N((Q0=IXRC"!-$,8%C&2,2.8,"3=]H.G
M!YK?OF\C)]@(ZGPB< I/%N<B$AF%E)LVT4G[+XUL(1%A.65)09W:>5Z/YD3G
M+(=8.H:970#5^ICE2JC&/V9Q1<GGE&4 A'"G+*<&F?J494#1$Z<L0U=[G+)\
MEE6YJM^OUK+Y\L?JR]?50Z/W4U_^T!;BXQ>-LT2_)!^E?G.J=?\6<VV58944
MD*N<:(N-(D@PII#EB4@%5A+9=?KU&WYNE&%>*M!I 5HUP$]:Y"CZ?P%?/=RO
M*I<RW.YS87'&,BK"(S.-@^P^ <'N>#L<OXR*^T0',?U[7;7O]?J/%5CW:IC6
MKEH/_;-6!$"@=3&=@WB0:AG7P3=X,N/^U.G.:+PU/CBM\7^*9WF+O2*:+Q_J
M6C]W42C$4YDD$*E<[^D)DY!$/(6<%3%EI.!".AF/)\:8VS+0BP7N5W5[2GE4
M4W?O]'WWAQ5;;L[2' MBG$#=SKJ\$LN1"?^P=NX-V,#Z&UWW"4H!BV.<1R)4
M<8P3(TQ;'..\BD?%,08NO;[P327:)EVFU([^&%^W9:X6-$]4@6@$.6*Q-B15
M#'$J4IA@HJU(F8L\3EUR%2X-Z,09$V0H?#%C@.5>#1C#$5T-,/_Z.">AMN2&
M@ ".311/4'L]C-I5E7.&H!BAC,[)X9ZMILZ0\D,%=@;O\^S/]V"*]NCOI?I"
M?[2KY@>E2BY[V]RX^H2B.2R$H1/$(T@SKG]$0DHI\E043GGGP\/-S0#920LV
MXH).7L=^?L,@VQ%)..A&II'SJ(W@T[)#)51'P.'!INT0:*7X4<= N[O\N*0]
M[>QS%;02O0F-\Q0+DY)>$%I 5+0=@@F#1!8)216-1*3<3A%.CC._0X3N9-^E
M[LPPD&F4%2)G%,J"91#%J=X!)@+#*#55SY*T0"IV,>VNAG$*>RXTB'9<>S4T
M(U-LA\HV/VLK8CA>'40@$)V>'F-2%AU4\REY#E_LQIE-O5Y\^*/21LS7\O[5
MZALMJT4J4Y[',8%1(A1$J<I,'E8"DP11EM.DP$K9&%LGGCTWRVHK'OB]$]#2
MQ7P*MN%/^DHPQOZ0[7&P_H0'-![Z</5M>Q^M_FGWP9YZXB2?Z8 JFX]SZ!+/
M+1'GJX=JW7RDCZ;EP)>:"ME[;_0.;&\M$5F2Y$I(F&<)A@AGVK))>09%SE.J
M9,04BYPV1Y8#S^UC;@4%M)<>W'?B.VZ1;$&WW"R- .78VZ8-?KW,-Z"5.N!6
MR1&34)LFVV&GW3XY@G&TD7*]WW-+==_VM*WNWDG:R#;DZX/Z:]-U?%Q$!2TR
M4>0014I 1 F'C&<(QDE6Q$RHE"'FN+4:&F^&6ZR-N&!IY.V"U^%*P0?]@]>F
M81!OR\U#* S'MCVVX+6"WG3QG@8]+6RWN0BXG[ !)=2^8G"L:?<7-FH?[3.L
M;O(CE$V0TT>Y[<Q0\D42DYCC5, $,4TD(DH@03R!-&>(YJH03%D5$!P<96YF
M2RL4^*FLP%\_OS*1%EW[&,O@HF% I2ABB2(&H[B@IB*CA'H+E\)<19C)F&$:
M(3=FOAK2:1BY U5N@ABWJ *Z7M<E>UBW7;S6*_"WDNI?-*;>S"_=)?VQ1@CX
M[8CZ:DA')NAM**@6L.NG<P-:&</1\B $@>CX]!B3TO"@FD_I=_ABWXP=MM[U
M(VM;V2T4P4@F+(<D0P2B/*<0QSF".<%,X2Q1FI+=LG2.QI@;Y>ZW!7RWC=@Q
M@A^T!NQZ_3G&AY^"V(X'K@1N9!8XPNR+%V8>23IG40F6F',\PL3).&=5/$[
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M8Y$VS&46FV 1!%G&,HERI3BR\O8]??#<]M.M:.!?_R4NT+\[?/[[4%EPI2<
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M33F"$M$T,IFI*'>J_FD[\-RH<RLW5*L:MIM)W^VC-?:6?L$1$!V98XU@>WO
M&W"(KM$BH+?.$9]0+CC;8:?UJSF"<>0L<[W?PVY[_V ([H/ZS%?K==E\_8ND
MR_77%RM3E?']7SZ;7^NW22Q8G*7::HM@83)W$$,,LB)1D$5,I7$F!"XB:R/.
M<M"YT5(G-OB@P$9PT$D..M%O@!8>;*1W,%YL)\'"[!L!VI'YZ=E1=; /1T!W
M(F,Q$,IN1J0C7(,6I>VSIC,O';4[L#5=[_7M$[:JUZ8'R(M57:_^**N[9I$G
M.8E9AF""BD03>1%#S$D!!46%2E2>4&E%Y -CS(VW6Q%AVQV+;85T[7AUC*2=
MQ7@E/B.3;P>-$0\8FR)DQZ6S:@=K?70\PL0]B,ZJ>-P,Z/RE5X;E=NUC;RNQ
M5]_]-TE-,33QH?IDC$13.DE?\'Y5U9L?7]"F;-Z5E7R[EM_TQA,ISC+&H)!*
M6W<H32&E2$*4T23."B58E'B%[X:0;FYTL@M)O>E[+K>G;WL:@HV*H$WXZ[5J
MK]I7$[1Z@M^-IJ!5U3$)(NQ+8,=GSS:U(S/AL\RJ?Q1R2/1#1RL'D>UYHII#
MPGHV^CGH(->FN;V7Z[>5:09J-B%_D>+.U!BV#--I\TMVY7V$HIBD"$&1F#H?
M191 PF,,DTR;G$IB5$C/ D_AA)S;8K*?M67"YW9J@D[/KN.T0[R>;QY=P!?!
MTC)^YND=V[0./K,3%7X*/QO!\_L"BOA,.8#A03Z?)SC"6+[116T#GU(_\J-^
M)62M%[PV$J$_J2TBO>'(\QABI=K(R@(2&:40DR2.8YDJC)'+ G)AO+FM!7OB
M@JV\7>",:VC1,,YV_!P0O9&I=@"X$4HQ6.(2+-9H>+2)XXVL5#^..;*[S:<)
M7<]R*]6RV*ZSW9YMO=OB2I1FL4I22#-%3;&&!+*4"4A5D15$1:H0TKX;G,O0
M<^.:?>ND,SQV\A]L>MV]$Q[S8G&P-1K:$YJ!SP^T2Q.NL0"?Z,1K'T^@5C6P
MGXE0=3'\<1QN"N7TQ F[,_EH>M@FR>L)OIV9Z_*[?@>-M;M)0?]4-O^X_5$V
M"Q11(1$B,%5Y#A&F.<0%,JG!,E%%%"O$K!8*F\'FMC3L9#VH7&'$!;\;@1V]
MU(- %QB16.("2LXX1'H)AOHW"11%IF14(,X2XI94$ KJ:;(*3H(]$M9V9G\H
M_$9>5T\#=P$SCV;5E\$(UIIZ8*B)&U%?5OJX[;3%/;Y$S=:[A[ZD=?UHO./?
M5@_5>L'3/*9)'D,A*8:(,4W4L31,4HB4\0REC"S6IEF>+7N<'\R)J+=#CO<)
MM#T 7?EA $M;?@B#T,C\\&Y5W>T"&V[ K_6J"9@ :8-",&(8&&IB8KBL]#$Q
M6-SC1PQ#?LN7M/GZ9KGZHW5W_DK+ROSR5FG[Z9/D2]HTI2IYNP-Y(?7F0+:E
M8(HX2BB)H%(1@JC(,HA%3J$F&"(9EX@53D7, LLW-SO1'&H\F//)U5UETL?
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M6OV_=F:J+%N5IN0;F>VV<)^ZG:N=E6[[.SO!5:^;U>Z=7\PT1"DT&0)I*CG
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M;N24JR& /4[7&J25'N7.ZJ,)G^;ZKORF;2N+M6##)G6#II05F%NB=B4#D*"
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MN_P RR_3",^^3E>3P+W,$3=+Y[@EDD=/K!9H,YU/BCH9LG^J1<4-0O %.^C
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M9Z3FM(/9P#;TWL1NNV5QNXB?8S!<LKW@3/1!*9("H'@A).)M$"0DEH%K8<0
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MN0&8/%+=OF5&"9%X1EE$#^5.-%/$:25)E$S)$"EX4QLR3Q(T;DQ>'S[UI-\
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M1<&^\]]*(F'"N3;)I$ABC+1<>D:NN7:$9N=LC F<O]<U[:G>+]7H&G=\Z#D
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MS54JZZ<!9_]#_ 3I:@8W8?2JU(2MWBQ\U]7K9HS<C@VX;:]E$^-E)"8DF<N
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M\#G <N*=$& H<F-+XROA?>E<A'***KKD;="F_CS;[Y+5&J2.T?^#X:]UE=$
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M0J]K3OUP\I" \3(DI^OT(4!.%/#8&\OS)>Z+UTD= R&9E-"/5H&7GKI /&=
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MG#R[;4&Z>OX-O[E<K/SLU^7BZG*%CYA=I3)6##_3]5>_@K2]*+.8;XK>-:X
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MH?;%NT/H.]6X_@Y_/*:;M\L7G_S\ E[/=S\Q19?Z\MJ3]E%;T%Z1*,I$709
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M:;SXGXSS,\VD3TEZ,$83]\)3@*,#!3C,(2:6E']8OOE$>7ISTEY[<?)AP.X
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MT=.#E;^L%.>- >L3$9^9 <]+!G)MSN4D.+.MWX/N$3!R#?4X('A^M_<.&ND
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MK".DN(*09*&\V6>NG14%NYF_L2-O)]KO_)K,] "P=;'IYEB2>?D4$Q*+D+%
MG<L.BC$%OD0&FD>%/F!)S1]@NV'^1)NV7Z\AMX7K*[?T^TL8SM I3Z:&X(VE
M;,.%!.AM@<CJTJ_ BU*G<X5TG[<3;0E_379Z -@.;7L]*3-\^01SQ21KM 67
M(IU@6#CI%Q&**I+^QG'D1Q_@<"SF3[0E_?4:<ENXOG*'N^E'OG,,*BU+02E
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MREO/(7^<DI'G<APQ/CA8#UVB:6.07)4D79U1:3A911)D%;K.SG*Q>!)25D?
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MI#.6>//RH=4\40SPR \?-VIJCXDF0NP@HG]4,F=>,6[J5!<>8YT=6F_P0B%
MDS\OM36<R4$:RAX2,FZ@,^!)<K#4FP4WAPS3K,O2OI ^UFO/[H0#-4U(:5(5
MA1=WE@;_<D6_^3Y;X 6EOY??%_0C+B[KBT3]-[,IG:V7.6V.V=ETLV.8!4Q"
M10M2)!*+00_>,ZPS5XQ6))2D8F,P'HFU<6]PAX-WC\CHX*S=#.7 B_>K)Y,J
MFE5] @9G$LD4I-64U!A56YQ)\MJ4(!D%#MJTGM;X!"GC1FY=PN;A]+(&.NP
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MFUVLQ:0>#E=Z\5'\A4_VN[]]%\T^\1;>4MP=^,TG*YDT^7>#+E':8BAMD<H
M,C3 8A&AI,Q0=54Y.+3;:ZKW;8L'=U%"IV"ZG@1%'IC'NG\(=:VJS75\ ?/
M$M>4"EO'FJ\$/;GBP9VTO7WQX"ZB[P!$3QO:IGC-R(A%U@8 +@(HP7@UL@*<
M91U=$LFEYI<1+]#4'Z#VT?UC"6(K1?131?@T6[<I#,DF6<IAP$=5G[,$Q0DH
M:_D_9TDGX]+#_>L'Q$P?QMTA>P0_-[ &.CBT?LV%2$^_Y"G]8ODI3Q=UYR.9
MY1WF[DP?2$&6@L&#U-Q1MFH"8+0:#'<&B_4ZN];W7;M1V'G(M2=.?KK,'TQI
M'4!RG^H0IR@-BH4B$!')7<@0P:$Q8+Q3$9DMV+RD8JC*GO'.R3;@'%I]'2#T
MAO!WL_E?%,#,EQ2R_(G_^C1;3-:39&^-CS'A- D35IL^E%'D@*PKP++15J2Z
M0K?UJ^<.Y'51^#@T(H=25P=(?.*Q[0Y#W,=HH^/ G6:@F(P0<D)BC3E?/"8>
MCO0"NB/JAJYP'!IU;573 =8>*Z.[RXUT##-*$)&2-84Z4GQ=.[^0,>^SD\JW
M+AUZGJ(N"AN'1EE#I70 L;NO:%5P?WZEF';SOO)K#LL[G&FOA-=)0S*&C*>X
MNDE3,@@4SN82BTVN]?[2[:GKH@SR6&ZUL;(Z@.'#RKP[G.24M?=UEU"]0%!1
M6*@M78!2\9+0N9 'Z0'>/]D=ND9R<#_:1AD-]W$?X_5\O;05IW<K7/Y/OD@4
MPG[! >8,;_F]X=[2]V&XU5R[^3E.)_^^3E47LXM)6EO1-'VZP^6=!68W<[MO
MGVBE*8PB-T-G7)2$\2"@UGU#R8)[;3EB:?U0U(3P_I>%K.]OM18EY-76;$\^
M)"L-/H0(Z+!HSZ/DN;7#[VE']' C_8Z._K%V2>^"H!&CD,5\>78CC"\Q3W$^
MF:W>687T]#]:@-8RU=KL4-N /66-/.NL&4]BJ]99^L(=^-/O;J'_Y,=?^Z*/
M/2 R:ZFOL0&WH?NOZ>)[CI,RR6GS$IM%=**@ 5NW-JAB.* R"6((IK@:P:NM
MSMV70/<4 >, KY%29ZTEW E,*"K+$1?+Z\6]B2$E=9DB;T_1N!$1 J.XG$64
M3O%@T6]5<[4E1NY_?42 M%'I(R Y0+XC(^1M'9"9YR2\Y55=J+>RF6R8]R0/
ML*5N.J_;&0/+"-K$5+2(48JM1HF\@(_'OOW:M_P<YK<.UM;(:/N<OU_.XU=<
MY#?G\[R2\4.6-A:9>*ZT2Y"H-2@6$]3+)[!,<(TI,QU;N+&M"1KOU#I<Y[.A
M%3!VT=7C6SQ+\4)ELJH<:XX3<GVOKCNMN,_.( DI/.BXZ7]1ZH Z?'DMZBX"
M[>!:^*#IS\&0D))*$&(A%QXC ^], 9=D\HIS96/K5=&#3W,_^<6E^[C-HZ.A
M ^0_.K]:1.8S%@LA8.U),0)\U!RB=TP$PZ)+K1']RB;"[X2";2;"[Z*2L7WL
M<U/,N<YV-9"GZ.1!^:3 ^\0@LL(=UTYB,%MYVM.:"+^3^K:="+^++#LX:IYL
M,E$N\R"]!6;KXJM89S9Q1AFVM"AS""RIU@LH#NKK:EZ_=$K.L8D6.T7C]16/
M4D9J#&!<+E!_#2@Y Q%X\2:0S;G6[N_D&L-VTO;VC6&[B+X#$#T_TMR0G3D3
M$J2Z>$]Q0YEW=@ZL%M;H.CDL^\8X.LVI\CMI?:>I\KNHH ,\'7-UN//:%^<8
ML(*1++@4\(HID#DF-,9JS5I7-1R1O7%*1$_)D?>*M0[,<(<I+^\)5=/S"2EC
M7>9TQA5:J;@%PQFIA%L#SJ8 C"%%^D&@3*TG$1] [FM_^]\3@@^[\HZ$APZ@
MO_^T(^T<^6H&UM)_E!,<?-U15GSPS#JF&&\]G&/0H54G_'#8!O1'04*G<Z]^
MP_F4^%M\F"T6Q-?'.7&+\ZLO7TG#?^!\OIJL>4"E[DX_OT5E[OX,-:K$O2;@
M4YZO/GI37LA%M$5D3S%+G?Y>4!!$5?U/(N JC%JU[F)[BI:#-V0\^+F_3BXN
MESF=,2=89G3P*T:QF4*M(%A9(%7C5$A<ZM;UK4^0,JZ[;X*!G]9?-!!Z!W[W
M#1VCJ9).=O@EQ\OYZN#][5_UI,WI'<FR%M1?7A?L_B3*;_6MXLRZDK*Q"HJS
MFO(!+'6Q5@%A3$Z.L<"Q]1"')H2/ZY$'P>7Q%=H!BHFE;[/IE^4L_N/7R8])
M(L]QP]%;7'S]A)-T)KBR@J&$PNH ()<1G @*LB'_&'Q*/+;.D+:A:]QW\4$P
MV%P='4!LQ<UM7<NG^>Q\CM_>7"Z_SN:3?^>T-AQ^%C%IIV0 KNMVK:(9!)<<
MA)19"N0:@F^]XVQ+TL9]8QH$:$,HI0.L_3G/2 G8U8J]E;06;^+_7DZ(DC,9
MDV*45@$&)T!Y+\%A1(@JJ<AXSBA;+SM[AIQQKSL'P50KX9]@BOD++B81IVD3
MR]X1[[U_-E "NN/7ATY/#Q'&T,FK\.BC=6ZS$4C3KT). :(1E&PP:81J'<H,
ME;S^D9?KFZFJ@S<_2):K$I;9G1CBZ^R"SI'%2B%G15MMN$20D=4DBY,0K$?(
MP6FAO7<IM'X^VI'$3I/=73#S\$P<4DD=^-O_SI/SKV3C;W[D.9[G/R[K&^['
MLC[\/UXN%TLZ!TBH:^82<6&2#N"RLC7#SX \U)5*V@K.733-]R+O1&"G2>TA
M^!M.00V'.+0[Y]=L,&F%7F7>=9RLRHH!1F> 0EBE@S?>YJ$/^>WQ=/P$]1 \
M'2[P+G!#9_)\]9B#%YN3>!VN+BG*"9?+]1E]S6!.G_"J_N,W\SE.S]?=]F?)
M^F"XR, 5UBZ=' &K*)7-!4LR.NKV>QX/I;K33/801!Y9E?TZW4VX_=/1?A8Y
MH_3-1Y#68*W\,Q!*K6Q6F'RVW#O=>AK<CB1VF@P/X'B;*&E_#,[(2@9QO->/
M.$X%B8Q3Z&IJV;S-"H+1'KQF:)TH3(B>7LZ:SWT[JO/=1^C=SM[ZVVR6_CFY
MN"![>%B2T^(!?Y<?W^*"9&]V&MV 7'__S<_?OZU3N4$E&E7G:%C@K!:'*T<(
MHO^"*-DEA3E$UWJ4WDX$'OP&L1F1MQJ<-%GF#R3]GSZ[V4U@C,RH)<12RS0#
M_<?)(LA*M?,\28RAM;?<GKIQ;TB&P]1/SQ/#Z&OT>1QW1GJMZKU6G1E%L>*8
MI\1)UXGKMKI^;CVDFCAQ;9R16XTE?W$BQV-?'Q=10^EYUE3HW<%FTX5ALC3:
M60/&L%RO:XB'*!E$$8SWO 3&MEH[NC-PQA^;<;A.GX7('@+N(#'\'>EG3?#B
M<XZS:9S0/SM?<;-IK?':2UU* .%270T6)?A$6:_PWIJ4I>"Z]0/[\Q3U!*!]
M-#X;3/P=@.G)1D)GG4$I(SER7^>#Y +!!0Z4H":>A(I86C?)'=3\.]B%_<#.
MJZDB.@74QNJ8"B07S*!CW?3A-((S@DR/%14$"JN:O\J>7/_N3MK>OG]W%]%W
M *(7FD>9\"8Z#Q9K%. - Z\E @^*#FYNI6^^$NTT^W=WTOIN_;L[J&#L@77U
M!6#=&R]3CD8G8 $3>?T4P%&."I;DY(SFQLL6@?3-!\=]&#Q"TK6?:'O P_64
MS^B-*D(0;CG!6'(#=1DI,.6"+LQ&;6TK1(P=#.^IK(?JWD-R(RO\=X+_M\MO
M&\+IT&,B) $E,6*^^$18MPQR\:$DX27FK1YT7U#YO8^.K/1]5#9K(;^Q%8__
MND,X"J6=*9I@S@*HY#AXEQ6XHK5*R!6++6S]WD?'R5R:*7YO^7400MXV\FZV
M8W[)Y^L%"JL[I,C0VX1@;"&1%"'!\:Q!<\<I\!;!A*W L%,7PC,$C5NQ<:04
MMYU*>L#7FO;KY>G::1Z1@ZE#;10+'D*,'&*R,1?%(]E8:SS=)6#D^_UVBGT(
MF;VE//:PQ=^^Y?GY9'K^.\[_0=:S8>1Z#"^F'*1@4*2I3M3:.J6+/*GW3ON4
M?4P/[FB?F+;XW%=&QL3^FIL-(<:Q\?#_X7><OKFLKZ87$WPS37_D?_[?7'/W
M]( IYW0,E% G7B0H'21X(Q""S]P$E:T(>BML;/O%D:]7V^!D$/&.C9F_S7-]
M;'C[=3+%^UQH&955BJ(OP>IZBKAB0 'WFJ--)J>'9:E/@.3)3XQ\>=$&%6T$
MV$&T\?NJYV[E8]]/OU\N;P8:*R.Y]T$ T>SH"(QUXZ/EM9'3:BN]U*+UG?I3
MM(Q;WGFD&+:)(CH%U,;:B.!<@@C G3)U-J.$4/VKUBZ1P^6!E=9C?Y^F9MP@
MIHVVMX#0'J+O$$2KN5.7T^5G.G0WYVSP@I-_M2!DJ \%VM83ET'.P41A2];-
M$^V7J>H/5/OH_P58':B,#N#US$'^R]7O^/?9_.T%+M9))J68R10*YH04D4*$
MY, '1X+TC*D89*8_;HRS'<@;MTK]2*YQ*'7UC<1;QNYL[0F88LDJ0Y2Q/KR6
M5-=D"TC%(BJAN$RMF[!W)''<(W PJ&P/R8/U-G9R^-?WO\^^3NF47W? S>:;
M*Y+-6<^2H$RW% C*%Q*;$4#,>3#>%E=X%L5L=\7T_'>ZQ='A^IT-(^RQ<?-I
M/DN7<?FY-J[5U3D?)C%/%S>5'9X9X^H>3692 "6R =36 <H<M<Z9 @6Q%6Z>
M_\ZXETY'PTU#87?@!M]/B9^8%XO/I"ZBY"MQ]&O^D2]FW^]<K42NL5[ 0G2:
MA%4G"P0E.!CA6,C62B-:YX];$3;NC=8Q(#><GCH W_7;TFK8U&)R4S')E$.N
MZ;#EJDXEH$0) J>DO"BMI#&HTG957;M4E3Y.RE8 LR<>Y;=00Z=H6D\QNS;
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MU%X%(^)I,;^Z>!_H5"QM;YU\HA0= N64I;\(!F1Q$V2AD2673>8[[2REG_H
M,_1/]WAY],&Q8^'CW9?#Y=>#TE=859%Q"LP->.DE*)\]1*8"9!<39XX5DYJI
M?<S;Y0AE/57W 9(;6>&_3Z:3+]=?5H0'Y,X*NNDL15\4UGD-,90 18F@M?0B
M.]% Y8\^.K+2#U'9K(7\QE9\^.L!X86'[*W-@%+7YYU"0;@5=:AE)O<0?;1E
MIZKE'RG^X4?'N?Z;*?Y@^77@)][?<6_N!YV3X6.I..!TIX%2Z( L88"HDZ3
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M\@'!>:;J5/^:3(@*BO;6NHS.RM88_Q?K)M@+)[MU$^RCM"ZAM\JL.NEMB<(
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MZA1OMX]:*'E0I4!.=?1[S(;.+XM03 J:X@A/[MX)$-?#6W$;;>^^P6@?T7<
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M]6]U/^:W</FHZ?1^Y.F%#EEIQ@VX94=[C<^\+JJ6*Q:IA#+>M*[MVYFX3E*
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MO1"^%'*\$+Q0Q&T4":)'01=85$7&A/+II(A-+NGA1(P339\:DR=5U?[ ]#?
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M>6)A-_(6* :I$4).Q)%2(8-7U4-@/-F45+&[O0#MXR[M05]'H=MQV!M<.1T
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M7;Z9DSYO0WZ.W*0L 6T=R!4I=O.>:1 Z9^F1J\1W3Z!L_LYNR#BSC&TCL?:
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M%S2I-[+<3#*J/EHK<-8[X"D)D2(9=KKU1?SR0\M#L')HU?T .73@J?V \]J
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MQJ/P<Q2K3Q\YW/ZB_A%(9?[7?_P_4$L! A0#%     @ A("H5L_\F17-(@
MY](  !@              ( !     &5X7S$P,WAV=')S>#(P,C,P,S,Q+FAT
M;5!+ 0(4 Q0    ( (2 J%:<Z<XZ.Y@" +U>%0 8              "  0,C
M  !E>%\Q,#1X=G1R<W@R,#(S,#,S,2YH=&U02P$"% ,4    " "$@*A6NN_Q
M$AD#   !"P  %P              @ %TNP( 97A?,C)X=G1R<W@R,#(S,#,S
M,2YH=&U02P$"% ,4    " "$@*A6!P'O[.<'  !P(0  &
M@ '"O@( 97A?,S$Q>'9T<G-X,C R,S S,S$N:'1M4$L! A0#%     @ A("H
M5J^##O[I!P  IR$  !@              ( !W\8" &5X7S,Q,GAV=')S>#(P
M,C,P,S,Q+FAT;5!+ 0(4 Q0    ( (2 J%86-9]^L 4  *P8   7
M      "  ?[. @!E>%\S,GAV=')S>#(P,C,P,S,Q+FAT;5!+ 0(4 Q0    (
M (2 J%8F/V$+S/$" **W(@ 1              "  >/4 @!V=')S+3(P,C,P
M,S,Q+FAT;5!+ 0(4 Q0    ( (2 J%8&_GOXM!H  +@O 0 1
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M" !V=')S+3(P,C,P,S,Q7W!R92YX;6Q02P4&      P #  L P  DCT)

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
